,title,publish_time,journal,url,abstract,doi,cord_uid,words
2785,"36th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 15-18 March 2016",2016-04-20,Crit Care,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493079/,"P001 - Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP efflux R. M. Bateman, M. D. Sharpe, J. E. Jagger, C. G. Ellis P002 - Lower serum immunoglobulin G2 level does not predispose to severe flu. J. Solé-Violán, M. López-Rodríguez, E. Herrera-Ramos, J. Ruíz-Hernández, L. Borderías, J. Horcajada, N. González-Quevedo, O. Rajas, M. Briones, F. Rodríguez de Castro, C. Rodríguez Gallego P003 - Brain protective effects of intravenous immunoglobulin through inhibition of complement activation and apoptosis in a rat model of sepsis F. Esen, G. Orhun, P. Ergin Ozcan, E. Senturk, C. Ugur Yilmaz, N. Orhan, N. Arican, M. Kaya, M. Kucukerden, M. Giris, U. Akcan, S. Bilgic Gazioglu, E. Tuzun P004 - Adenosine a1 receptor dysfunction is associated with leukopenia: A possible mechanism for sepsis-induced leukopenia R. Riff, O. Naamani, A. Douvdevani P005 - Analysis of neutrophil by hyper spectral imaging - A preliminary report R. Takegawa, H. Yoshida, T. Hirose, N. Yamamoto, H. Hagiya, M. Ojima, Y. Akeda, O. Tasaki, K. Tomono, T. Shimazu P006 - Chemiluminescent intensity assessed by eaa predicts the incidence of postoperative infectious complications following gastrointestinal surgery S. Ono, T. Kubo, S. Suda, T. Ueno, T. Ikeda P007 - Serial change of c1 inhibitor in patients with sepsis – A prospective observational study T. Hirose, H. Ogura, H. Takahashi, M. Ojima, J. Kang, Y. Nakamura, T. Kojima, T. Shimazu P008 - Comparison of bacteremia and sepsis on sepsis related biomarkers T. Ikeda, S. Suda, Y. Izutani, T. Ueno, S. Ono P009 - The changes of procalcitonin levels in critical patients with abdominal septic shock during blood purification T. Taniguchi, M. O P010 - Validation of a new sensitive point of care device for rapid measurement of procalcitonin C. Dinter, J. Lotz, B. Eilers, C. Wissmann, R. Lott P011 - Infection biomarkers in primary care patients with acute respiratory tract infections – Comparison of procalcitonin and C-reactive protein M. M. Meili, P. S. Schuetz P012 - Do we need a lower procalcitonin cut off? H. Hawa, M. Sharshir, M. Aburageila, N. Salahuddin P013 - The predictive role of C-reactive protein and procalcitonin biomarkers in central nervous system infections with extensively drug resistant bacteria V. Chantziara, S. Georgiou, A. Tsimogianni, P. Alexandropoulos, A. Vassi, F. Lagiou, M. Valta, G. Micha, E. Chinou, G. Michaloudis P014 - Changes in endotoxin activity assay and procalcitonin levels after direct hemoperfusion with polymyxin-b immobilized fiber A. Kodaira, T. Ikeda, S. Ono, T. Ueno, S. Suda, Y. Izutani, H. Imaizumi P015 - Diagnostic usefullness of combination biomarkers on ICU admission M. V. De la Torre-Prados, A. Garcia-De la Torre, A. Enguix-Armada, A. Puerto-Morlan, V. Perez-Valero, A. Garcia-Alcantara P016 - Platelet function analysis utilising the PFA-100 does not predict infection, bacteraemia, sepsis or outcome in critically ill patients N. Bolton, J. Dudziak, S. Bonney, A. Tridente, P. Nee P017 - Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients G. Nicolaes, M. Wiewel, M. Schultz, K. Wildhagen, J. Horn, R. Schrijver, T. Van der Poll, C. Reutelingsperger P018 - Il-8: is this a more reliable biomarker for sepsis severity than CRP, Procalcitonin, E-selectin, IL-6 and TNF-[alpha] S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P019 - Relation between adrenomedullin and short-term outcome in ICU patients: Results from the frog ICU study E. G. Gayat, J. Struck, A. Cariou, N. Deye, B. Guidet, S. Jabert, J. Launay, M. Legrand, M. Léone, M. Resche-Rigon, E. Vicaut, A. Vieillard-Baron, A. Mebazaa P020 - Impact of disease severity assessment on performance of heparin-binding protein for the prediction of septic shock R. Arnold, M. Capan, A. Linder, P. Akesson P021 - Kinetics and prognostic value of presepsin (sCD14) in septic patients. A pilot study M. Popescu, D. Tomescu P022 - Comparison of CD64 levels performed by the facs and accellix systems C. L. Sprung, R. Calderon Morales, G. Munteanu, E. Orenbuch-Harroch, P. Levin, H. Kasdan, A. Reiter, T. Volker, Y. Himmel, Y. Cohen, J. Meissonnier P023 - Diagnosing sepsis in 5 minutes: Nanofluidic technology study with pancreatic-stone protein (PSP/ reg) L. Girard, F. Rebeaud P024 - How nanotechnology-based approaches could contribute to sepsis prevention, diagnosis and treatment I. Herrmann P025 - Il7r transcriptional expression analysis during septic shock B. Delwarde, E. Peronnet, E. Cerrato, F. Venet, A. Lepape, T. Rimmelé, G. Monneret, J. Textoris P026 - Disbalance of microbial metabolites of aromatic acids affects the severity in critically ill patients N. Beloborodova, V. Moroz, A. Osipov, A. Bedova, Y. Sarshor, A. Pautova, A. Sergeev, E. Chernevskaya P027 - Copeptin predicts 10-year all-cause mortality in community patients J. Odermatt, R. Bolliger, L. Hersberger, M. Ottiger, M. Christ-Crain, B. Mueller, P. Schuetz P028 - Identification of differential proteomic response in septic patients secondary to community and hospital acquired pneumonia N. K. Sharma, A. K. Tashima, M. K. Brunialti, F. R. Machado, M. Assuncao, O. Rigato, R. Salomao P029 - Monocyte HLA-DR expression in community-acquired bacteremic sepsis - dynamics associated to aetiology and prediction of secondary sepsis S. C. Cajander, G. Rasmussen, E. Tina, B. Söderquist, J. Källman, K. Strålin P030 - Soluble B- and T-lymphocyte attenuator: A possible prognostic marker in sepsis A. L. Lange, J. S. Sundén-Cullberg, A. M. Magnuson, O. H. Hultgren P031 - Fractal dimension: A new biomarker for quantifying clot microstructure in patients across the sepsis spectrum G. Davies, S. Pillai, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P032 - Comparison between the new biomarker for coagulation, clot microstructure (Df) with rotational thromboelastometry (ROTEM) in patients across the sepsis spectrum S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P033 - Changes in fibrinolysis across the sepsis spectrum: The use of rotational thromboelastometry (ROTEM) lysis index (LI60) and D-Dimer concentration S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P034 - The intensive care infection score – a promising marker for the prediction of infection and its severity. P. Van der Geest, M. Mohseni, J. Linssen, R. De Jonge, S. Duran, J. Groeneveld P035 - Challenges in the clinical diagnosis of sepsis R. Miller III, B. K. Lopansri, L. C. McHugh, A. Seldon, J. P. Burke P036 - Does zero heat flux thermometry more accurately identify sepsis on intensive care? J. Johnston, R. Reece-Anthony, A. Bond, A. Molokhia P037 - Advancing quality (AQ) sepsis programme: Improving early identification & treatment of sepsis in North West England. C. Mcgrath, E. Nsutebu P038 - Prehospital transport of acute septic patients P. Bank Pedersen, D. Pilsgaard Henriksen, S. Mikkelsen, A. Touborg Lassen P039 - Vasodilatory plant extracts gel as an alternative treatment for fever in critically ill patients R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P040 - Host response and outcome of hypothermic sepsis M. A. Wiewel, M. B. Harmon, L. A. Van Vught, B. P. Scicluna, A. J. Hoogendijk, J. Horn, A. H. Zwinderman, O. L. Cremer, M. J. Bonten, M. J. Schultz, T. Van der Poll, N. P. Juffermans, W. J. Wiersinga P041 - Septic shock alert over SIRS criteria has an impact on outcome but needs to be revised G. Eren, Y Tekdos, M. Dogan, O. Acicbe, E. Kaya, O. Hergunsel P042 - Association between previous prescription of βblockers and mortality rate among septic patients: A retrospective observational study S. Alsolamy, G. Ghamdi, L. Alswaidan, S. Alharbi, F. Alenezi, Y. Arabi P043 - Recognition and treatment of sepsis on labour ward– teaching & information resources can improve knowledge J. Heaton, A. Boyce, L. Nolan, J. Johnston, A. Dukoff-Gordon, A. Dean, A. Molokhia P044 - Culture negative sepsis in the ICU – what is unique to this patient population? T. Mann Ben Yehudah P045 - Organ dysfunction in severe sepsis patients identified in administrative data in Germany, 2007-2013 C. Fleischmann, D. Thomas-Rueddel, C. Haas, U. Dennler, K. Reinhart P046 - A comparison of residents’ knowledge regarding; the Surviving Sepsis Campaign 2012 guideline O. Suntornlohanakul, B. Khwannimit P047 - Effectiveness of a septic shock bundle to improve outcomes in the ICU F. Breckenridge, A. Puxty P048 - Dose of norepinephrine in the first 24 hours as a parameter evaluating the effectiveness of treatment in patients with severe sepsis and septic shock P. Szturz, P. Folwarzcny, J. Svancara, R. Kula, P. Sevcik P049 - Norepinephrine or vasopressin + norepinephrine in septic shock. A retrospective series of 39 patients L. Caneva, A. Casazza, E. Bellazzi, S. Marra, L. Pagani, M. Vetere, R. Vanzino, D. Ciprandi, R. Preda, R. Boschi, L. Carnevale P050 - Methylene blue effectiveness as contributory treatment in patients with septic shock V. Lopez, M. Aguilar Arzapalo, L. Barradas, A. Escalante, J. Gongora, M. Cetina P051 - Coagulation disorders in patients with severe sepsis and DIC evaluated with thromboelastometry. B Adamik, D Jakubczyk, A Kübler P052 - Frequency and outcome of early sepsis-associated coagulopathy A. Radford, T. Lee, J. Singer, J. Boyd, D. Fineberg, M. Williams, J. Russell P053 - Assessment of coagulopathy in cancer patients with severe sepsis or septic shock. A case-control pilot study E. Scarlatescu, D. Tomescu, G. Droc, S. Arama P054 - Thromboelastometry in critically ill patients with disseminated intravascular coagulation M. Müller, M. Straat, S. S. Zeerleder, N. P. Juffermans P055 - Cessation of a preexisting chronic antiplatelet therapy is associated with increased mortality rates in severe sepsis and septic shock C. F. Fuchs, C. S. Scheer, S. W. Wauschkuhn, M. V. Vollmer, K. M. Meissner, S. K. Kuhn, K. H. Hahnenkamp, S. R. Rehberg, M. G. Gründling P056 - Neutrophil Extracellular Traps (NETs) production under hypoxic condition N. Yamamoto, M. Ojima, S. Hamaguchi, T. Hirose, Y. Akeda, R. Takegawa, O. Tasaki, T. Shimazu, K. Tomono P057 - Impact of ultraviolet air sterilizer in intensive care unit room, and clinical outcomes of patients E. Gómez-Sánchez, M. Heredia-Rodríguez, E. Álvarez-Fuente, M. Lorenzo-López, E. Gómez-Pesquera, M. Aragón-Camino, P. Liu-Zhu, A. Sánchez-López, A. Hernández-Lozano, M. T. Peláez-Jareño, E. Tamayo P058 - Focus of infection in severe sepsis - comparison of administrative data and prospective cohorts from Germany D. O. Thomas-Rüddel, C. Fleischmann, C. Haas, U. Dennler, K. Reinhart P059 - “Zero CLABSI” – can we get there? Obstacles on the 4 year journey and our strategies to overcome them – experience from an Indian ICU V. Adora, A. Kar, A. Chakraborty, S. Roy, A. Bandyopadhyay, M. Das P060 - Novel molecular techniques to identify central venous catheter (CVC) associated blood stream infections (BSIs) T. Mann Ben Yehudah, G. Ben Yehudah, M. Salim, N. Kumar, L. Arabi, T. Burger, P. Lephart, E. Toth-martin P061 - Zero clabsi” – can we get there? Obstacles on the 4 year journey and our strategies to overcome them – experience from an Indian ICU R. Rao, A. Kar, A. Chakraborty P062 - Prevention of central line-associated bloodstream infections in intensive care units: An international online survey C. Valencia, N. Hammami, S. Blot, J. L. Vincent, M. L. Lambert P063 - 30 days antimicrobial efficacy of non-leaching central venous catheters J. Brunke, T. Riemann, I. Roschke P064 - Efficacy of noble metal alloy-coated catheter in prevention of bacteriuria R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P065 - Predicting bacteremic urinary tract infection in community setting: A prospective observational study S. Nimitvilai, K. Jintanapramote, S. Jarupongprapa P066 - Eight-year analysis of acinetobacter spp. monobacteremia in surgical and medical intensive care units at university hospital in Lithuania D. Adukauskiene, D. Valanciene P067 - Group A and group B streptococcal infections in intensive care unit – our experience in a tertiary centre G. Bose, V. Lostarakos, B. Carr P068 - Improved detection of spontaneous bacterial peritonitis by uritop + tm strip test and inoculation of blood culture bottles with ascitic fluid S. Khedher, A. Maaoui, A. Ezzamouri, M. Salem P069 - Increased risk of cellulitis in patients with congestive heart failure: a population based cohort study J. Chen P070 - Outcomes of severe cellulitis and necrotizing fasciitis in the critically ill D. R. Cranendonk, L. A. Van Vught, M. A. Wiewel, O. L. Cremer, J. Horn, M. J. Bonten, M. J. Schultz, T. Van der Poll, W. J. Wiersinga P071 - Botulism outbreak associated with people who inject drugs (PWIDs) in Scotland. M. Day, G. Penrice, K. Roy, P. Robertson, G. Godbole, B. Jones, M. Booth, L. Donaldson P072 - Surveillance of ESBL-producing enterobacteriaceae fecal carriers in the ICU Y. Kawano, H. Ishikura P073 - Prevalence of ESBL and carbapenemase producing uropathogens in a newly opened hospital in south India S. Sreevidya, N. Brahmananda Reddy, P. Muraray Govind, R. Pratheema, J. Devachandran Apollo Speciality Hospital - OMR, Chennai, India P074 - Prevalence, risk factors and outcomes of methicillin-resistant staphylococcus aureus nasal colonization in critically ill patients H. Al-Dorzi, M. Almutairi, B. Alhamadi, A. Crizaldo Toledo, R. Khan, B. Al Raiy, Y. Arabi P075 - Multidrug-resistant Acinetobacter baumannii infection in intensive care unit patients in a hospital with building construction: Is there an association? H. Talaie P076 - Multidrug-resistant organisms in a Dutch ICU J. A. Van Oers, A. Harts, E. Nieuwkoop, P. Vos P077 - Epidemiology and risk factors of ICU acquired infections caused by multidrug-resistant gram negative bacilli Y. Boussarsar, F. Boutouta, S. Kamoun, I. Mezghani, S. Koubaji, A. Ben Souissi, A. Riahi, M. S. Mebazaa P078 - Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins E. Giamarellos-Bourboulis, N. Tziolos, C. Routsi, C. Katsenos, I. Tsangaris, I. Pneumatikos, G. Vlachogiannis, V. Theodorou, A. Prekates, E. Antypa, V. Koulouras, N. Kapravelos, C. Gogos, E. Antoniadou, K. Mandragos, A. Armaganidis P079 - Must change the medical practice in ICU? A. R. Robles Caballero, B. Civantos, J. C. Figueira, J. López P080 - Mediterranean spotted fever in an infectious diseases intensive care unit A. Silva-Pinto, F. Ceia, A. Sarmento, L. Santos P081 - Clinical features and outcomes of patients with Middle East respiratory syndrome requiring admission to a saudi intensive care unit: A retrospective analysis of 31 cases G. Almekhlafi, Y. Sakr P082 - The ICU response to a hospital outbreak of Middle East respiratory syndrome coronavirus infection H. Al-Dorzi, R. Khan, S. Baharoon, A. Aldawood, A. Matroud, J. Alchin, S. Al Johani, H. Balkhy, Y. Arabi P083 - Middle East respiratory syndrome: Surveillance data analysis S. Alsolamy, S. Y. Yousif, B. O. Alotabi, A. S. Alsaawi P085 - Use of Taqman array card molecular diagnostics in severe pneumonia: A case series J. Ang, MD Curran, D. Enoch, V. Navapurkar, A. Conway Morris P086 - ‘BUNS’: An investigation protocol improves the ICU management of pneumonia R. Sharvill, J. Astin P087 - Pneumonia in patients following secondary peritonitis: epidemiological features and impact on mortality M. Heredia-Rodríguez, E. Gómez-Sánchez, M. T. Peláez-Jareño, E. Gómez-Pesquera, M. Lorenzo-López, P. Liu-Zhu, M. Aragón-Camino, A. Hernández-Lozano, A. Sánchez-López, E. Álvarez-Fuente, E. Tamayo P088 - The use of the “CURB-65 score” by emergency room clinicians in a large teaching hospital J. Patel, C. Kruger P089 - Incidence of community acquired pneumonia with viral infection in mechanically ventilated patients in the medical intensive care unit J. O’Neal, H. Rhodes, J. Jancik P090 - The SAATELLITE Study: Prevention of S aureus Nosocomial Pneumonia (NP) with MEDI4893, a Human Monoclonal Antibody (mAb) Against S aureus B. François, P. F. Laterre, P. Eggimann, A. Torres, M. Sánchez, P. F. Dequin, G. L. Bassi, J. Chastre, H. S. Jafri P091 - Risk factors and microbiological profile for nosocomial infections in trauma patients M. Ben Romdhane, Z. Douira, S. Kamoun, M. Bousselmi, A. Ben Souissi, Y. Boussarsar, A. Riahi, M.S. Mebazaa P092 - Correlation between percentages of ventilated patients developed vap and use of antimicrobial agents in ICU patients. A. Vakalos, V. Avramidis P093 - A comparison of two ventilator associated pneumonia surveillance techniques T. H. Craven, G. Wojcik, K. Kefala, J. McCoubrey, J. Reilly, R. Paterson, D. Inverarity, I. Laurenson, T. S. Walsh P094 - Lung ultrasound before and after fiberbronchoscopy - modifications may improve ventilator-associated pneumonia diagnosis S. Mongodi, B. Bouhemad, A. Orlando, A. Stella, G. Via, G. Iotti, A. Braschi, F. Mojoli P095 - Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia M. Haliloglu, B. Bilgili, U. Kasapoglu, I. Sayan, M. Süzer Aslan, A. Yalcın, I. Cinel P096 - Impact of pRBCs transfusion on percentage of ventilated patients developed VAP in ICU patients A. Vakalos, V. Avramidis P097 - The impact of a series of interventions on the rate of ventilator associated pneumonia in a large teaching hospital H. E. Ellis, K. Bauchmuller, D. Miller, A Temple P098 - The EVADE study: Prevention of Nosocomial Pneumonia (NP) caused by P aeruginosa with MEDI3902, a Novel Bispecific Monoclonal Antibody, against P aeruginosa virulence factors J. Chastre, B. François, A. Torres, C. E. Luyt, M. Sánchez, M. Singer, H. S. Jafri P099 - Short-term inhaled colistin adjunctive therapy for ventilator-associated pneumonia Y. Nassar, M. S. Ayad P100 - Effect of aerosolised colistin on weaning from mechanical ventilation A. Trifi, S. Abdellatif, F. Daly, R. Nasri, S. Ben Lakhal P101 - Septic shock is an independent risk factor for colistin-induced severe acute kidney injury: a retrospective cohort study B. Bilgili, M. Haliloglu, F. Gul, I. Cinel P102 - Nosocomial pneumonia - emphasis on inhaled tobramycin A. Kuzovlev, A. Shabanov, S. Polovnikov, V. Moroz P103 - In vitro evaluation of amikacin inhale and commercial nebulizers in a mechanical ventilator N. Kadrichu, T. Dang, K. Corkery, P. Challoner P104 - The effects of nebulized amikacin/fosfomycin and systemic meropenem on severe amikacin-resistant meropenem-susceptible P.aeruginosa pneumonia G. Li Bassi, E. Aguilera, C. Chiurazzi, C. Travierso, A. Motos, L. Fernandez, R. Amaro, T. Senussi, F. Idone, J. Bobi, M. Rigol, A. Torres P105 - Optimization of gentamicin peak concentrations in critically ill patients C. J. Hodiamont, N. P. Juffermans, J. M. Janssen, C. S. Bouman, R. A. Mathôt, M. D. De Jong, R. M. Van Hest P106 - Systematic review of cefepime induced neurotoxicity L. Payne, G. L. Fraser P107 - Unasyn® causes QT prolongation during treatment of intensive care patients B. Tudor, M. Lahner, G. Roth, C. Krenn P108 - Comparative study between teicoplanin and vancomycin in methicillin-resistant staphylococcus aureus (mrsa) infectious of toxicological intensive care unit (ticu) patients – Tehran, Iran H. Talaie P109 - Phage therapy against antimicrobial resistance, design of the first clinical study phagoburn P. Jault, J. Gabard, T. Leclerc, S. Jennes, Y. Que, A. Rousseau, F. Ravat P110 - Antibiotic dosing errors in critically ill patients with severe sepsis or septic shock H. Al-Dorzi, A. Eissa, S. Al-Harbi, T. Aldabbagh, R. Khan, Y. Arabi P111 - Does empiric antifungal therapy improve survival in septic critically ill patients? (immunocompromised excluded) A. Trifi, S. Abdellatif, F. Daly, R. Nasri, S. Ben Lakhal P112 - Neurocysticercosis-Qatar experience F. Paramba, N. Purayil, V. Naushad, O. Mohammad, V. Negi, P. Chandra P113 - Early indicators in acute haemorrhagic shock A. Kleinsasser P114 - Filtering of red blood cells reduces the inflammatory response of pulmonary cells in an in vitro model of mechanical ventilation M. R. Witrz, J. F. Buchner-Doeven, A. M. Tuip-de Boer, J. C. Goslings, N. P. Juffermans P115 - Microparticles from red blood cell transfusion induce a pro-coagulant and pro-inflammatory endothelial cell response M. Van Hezel, M. Straat, A Boing, R Van Bruggen, N Juffermans P116 - The contribution of cytokines on thrombosis development during hospitalization in ICU D. Markopoulou, K. Venetsanou, V. Kaldis, D. Koutete, D. Chroni, I. Alamanos P117 - Prophylactic enoxaparin dosing and adjustment through anti-xa monitoring in an inpatient burn unit L. Koch, J. Jancik, H. Rhodes, E. Walter P118 - Determination of optimal cut-off values of haemoglobin, platelet count and fibrinogen at 24 hours after injury associated with mortality in trauma patients K. Maekawa, M. Hayakawa, S. Kushimoto, A. Shiraishi, H. Kato, J. Sasaki, H. Ogura, T. Matauoka, T. Uejima, N. Morimura, H. Ishikura, A. Hagiwara, M. Takeda P119 - Trauma-induced coagulopathy - prothrombin complex concentrate vs fresh frozen plasma O. Tarabrin, S. Shcherbakow, D. Gavrychenko, G. Mazurenko, V. Ivanova, O. Chystikov P120 - First study to prove the superiority of prothrombin complex concentrates on mortality rate over fresh frozen plasma in patients with acute bleeding C. Plourde, J. Lessard, J. Chauny, R. Daoust P121 - Prothrombin complex concentrate vs fresh frozen plasma in obstetric massive bleeding S. Shcherbakow, O. Tarabrin, D. Gavrychenko, G. Mazurenko, O. Chystikov P122 - Impact of FFP transfusion on VAP in ICU patients A. Vakalos, V. Avramidis P123 - Preoperative platelet function test and the thrombin generation assay are predictive for blood loss after cardiac surgery L. Kropman, L. In het Panhuis, J. Konings, D. Huskens, E. Schurgers, M. Roest, B. De Laat, M. Lance P124 - Rotational thromboelastometry versus standard coagulation tests before surgical interventions M. Durila, P. Lukas, M. Astraverkhava, J. Jonas P125 - Correction of impaired clot quality and stability by fibrinogen and activated prothrombin complex concentrate in a model of severe thrombocytopenia I. Budnik, B. Shenkman P126 - Assessment of point-of-care prothrombin time analyzer as a monitor after cardiopulmonary bypass H. Hayami, Y. Koide, T. Goto P127 - Disseminated intravascular coagulation (dic) is underdiagnosed in critically ill patients: do we need d-dimer measurements? R. Iqbal, Y. Alhamdi, N. Venugopal, S. Abrams, C. Downey, C. H. Toh, I. D. Welters P128 - Validity of the age-adjusted d-dimer cutoff in patients with COPD B. Bombay, J. M. Chauny, R. D. Daoust, J. L. Lessard, M. M. Marquis, J. P. Paquet P129 - A scoping review of strategies for prevention and management of bleeding following paediatric cardiopulmonary bypass surgery K. Siemens, D. Sangaran, B. J. Hunt, A. Durward, A. Nyman, I. A. Murdoch, S. M. Tibby P130 - Nadir hemoglobulin during cardiopulmonary bypass: impact on postoperative morbidity and mortality F. Ampatzidou, D. Moisidou, E. Dalampini, M. Nastou, E. Vasilarou, V. Kalaizi, H. Chatzikostenoglou, G. Drossos P131 - Red blood cell transfusion do not influence the prognostic value of RDW in critically ill patients S. Spadaro, A. Fogagnolo, T. Fiore, A. Schiavi, V. Fontana, F. Taccone, C. Volta P132 - Reasons for admission in the paediatric intensive care unit and the need for blood and blood products transfusions E. Chochliourou, E. Volakli, A. Violaki, E. Samkinidou, G. Evlavis, V. Panagiotidou, M. Sdougka P133 - The implementation of a massive haemorrhage protocol (mhp) for the management of major trauma: a ten year, single-centre study R. Mothukuri, C. Battle, K. Guy, G. Mills, P. Evans P134 - An integrated major haemorrhage protocol for pre-hospital and retrieval medical teams J. Wijesuriya, S. Keogh P135 - The impact of transfusion thresholds on mortality and cardiovascular events in patients with cardiovascular disease (non-cardiac surgery): a systematic review and meta-analysis A. Docherty, R. O’Donnell, S. Brunskill, M. Trivella, C. Doree, L. Holst, M. Parker, M. Gregersen, J. Almeida, T. Walsh, S. Stanworth P136 - The relationship between poor pre-operative immune status and outcome from cardiac surgery is specific to the peri-operative antigenic threat S. Moravcova, J. Mansell, A. Rogers, R. A. Smith, C. Hamilton-Davies P137 - Impact of simple clinical practice guidelines for reducing post-operative atrial fibrillation after cardiac surgery. A. Omar, M. Allam, O. Bilala, A. Kindawi, H. Ewila P138 - Dexamethasone administration during cardiopulmonary bypass has no beneficial effects on elective postoperative cardiac surgery patients F. Ampatzidou, D. Moisidou, M. Nastou, E. Dalampini, A. Malamas, E. Vasilarou, G. Drossos P139 - Intra-aortic balloon counterpulsation in patients undergoing cardiac surgery (IABCS): preliminary results G. Ferreira, J. Caldas, J. Fukushima, E. A. Osawa, E. Arita, L. Camara, S. Zeferino, J. Jardim, F. Gaioto, L. Dallan, F. B. Jatene, R. Kalil Filho, .F Galas, L. A. Hajjar P140 - Effects of low-dose atrial natriuretic peptide infusion on cardiac surgery-associated acute kidney injury C. Mitaka, T. Ohnuma, T. Murayama, F. Kunimoto, M. Nagashima, T. Takei, M. Tomita P141 - Acute kidney injury influence on high sensitive troponin measurements after cardiac surgery A. Omar, K. Mahmoud, S. Hanoura, S. Sudarsanan, P. Sivadasan, H. Othamn, Y. Shouman, R. Singh, A. Al Khulaifi P142 - Complex evaluation of endothelial dysfunction markers for prognosis of outcomes in patients undergoing cardiac surgery I. Mandel, S. Mikheev, I. Suhodolo, V. Kiselev, Y. Svirko, Y. Podoksenov P143 - New-onset atrial fibrillation in intensive care: incidence, management and outcome S. A. Jenkins, R. Griffin P144 - One single spot measurement of the sublingual microcirculation during acute pulmonary hypertension in a pig model of shock M. S. Tovar Doncel, A. Lima, C. Aldecoa, C. Ince P145 - Assessment of levosimendan as a therapeutic option to recruit the microcirculation in cardiogenic shock – initial experience in cardiac ICU A. Taha, A. Shafie, M. Mostafa, N. Syed, H. Hon P146 - Terlipressin vs. norepinephrine in the Potential Multiorgan Donor(PMD) F. Righetti, E. Colombaroli, G. Castellano P147 - Echocardiography in the potential heart donor exposed to substitution hormonotherapy F. Righetti, E. Colombaroli P148 - Machine learning can reduce rate of monitor alarms M. Hravnak, L. C. Chen, A. D. Dubrawski, G. C. Clermont, M. R. Pinsky P149 - Peripherally inserted central catheters placed in the ICU S. Gonzalez, D. Macias, J. Acosta, P. Jimenez, A. Loza, A. Lesmes, F. Lucena, C. Leon P150 - Recordings of abnormal central venous pressure waveform morphology during an episode of pulmonary hypertension in a porcine shock model M. S. Tovar Doncel, C. Ince, C. Aldecoa, A. Lima P151 - Ultrasound guided central venous access technique among French intensivists M. Bastide, J. Richecoeur, E. Frenoy, C. Lemaire, B. Sauneuf, F. Tamion, S. Nseir, D. Du Cheyron, H. Dupont, J. Maizel P152 - Predictive ability of the Pv-aCO2 gap in patients with shock M. Shaban, R. Kolko, N. Salahuddin, M. Sharshir, M. AbuRageila, A. AlHussain P153 - Comparison of echocardiography and pulmonary artery catheter measurements of hemodynamic parameters in critical ill patients P. Mercado, J. Maizel, L. Kontar, D. Titeca, F. Brazier, A. Riviere, M. Joris, T. Soupison, B. De Cagny, M. Slama P154 - The volume clamp method for noninvasive cardiac output measurement in postoperative cardiothoracic surgery patients: a comparison with intermittent pulmonary artery thermodilution J. Wagner, A. Körner, M. Kubik, S. Kluge, D. Reuter, B. Saugel P155 - Hemodynamic monitoring in patients with septic shock (SS) – CPCCO (continuous pulse contour cardiac output) vs. TEE (transesophageal echocardiography) E. Colombaroli, F. Righetti, G. Castellano P156 - Cardiac output measurement with transthoracic echocardiography in critically ill patients: a pragmatic clinical study T. Tran, D. De Bels, A. Cudia, M. Strachinaru, P. Ghottignies, J. Devriendt, C. Pierrakos P157 - Left ventricular outflow tract velocity time integral correlates with stroke volume index in mechanically ventilated patients Ó. Martínez González, R. Blancas, J. Luján, D. Ballesteros, C. Martínez Díaz, A. Núñez, C. Martín Parra, B. López Matamala, M. Alonso Fernández, M. Chana P158 - Transpulmonary thermodilution (TPTD) derived from femoral vs. jugular central venous catheter: validation of a previously published correction formula and a proprietary correction formula for global end-diastolic volume index (GEDVI) W. Huber, M. Eckmann, F. Elkmann, A. Gruber, I. Klein, R. M. Schmid, T. Lahmer P160 - Dynamic arterial elastance calculated with lidcoplus monitor does not predict changes in arterial pressure after a fluid challenge in postsurgical patients D. Bastoni, H. Aya, L. Toscani, L. Pigozzi, A. Rhodes, M. Cecconi P159 - Venous return driving pressure and resistance in acute blood volume changes P. W. Moller, S. Sondergaard, S. M. Jakob, J. Takala, D. Berger P160 - Dynamic arterial elastance calculated with lidcoplus monitor does not predict changes in arterial pressure after a fluid challenge in postsurgical patients D. Bastoni, H. Aya, L. Toscani, L. Pigozzi, A. Rhodes, M. Cecconi P161 - Analysis of duration of post-operative goal-directed therapy protocol C. Ostrowska, H. Aya, A. Abbas, J. Mellinghoff, C. Ryan, D. Dawson, A. Rhodes, M. Cecconi P162 - Hemodynamic optimization – back to square one? M. Cronhjort, O. Wall, E. Nyberg, R. Zeng, C. Svensen, J. Mårtensson, E. Joelsson-Alm P163 - Effectiveness of fluid thoracic content measurement by bioimpedance guiding intravascular volume optimization in patients with septic shock M. Aguilar Arzapalo, L. Barradas, V. Lopez, M. Cetina P164 - A systematic review on the role of internal jugular vein ultrasound measurements in assessment of volume status in critical shock patients N. Parenti, C. Palazzi, L. A. Amidei, F. B. Borrelli, S. C. Campanale, F. T. Tagliazucchi, G. S. Sedoni, D. L. Lucchesi, E. C. Carella, A. L Luciani P165 - Importance of recognizing dehydration in medical Intensive Care Unit M. Mackovic, N. Maric, M. Bakula P166 - Effect of volume for a fluid challenge in septic patients H. Aya, A. Rhodes, R. M. Grounds, N. Fletcher, M. Cecconi P167 - Fluid bolus practices in a large Australian intensive care unit B. Avard, P. Zhang P168 - Liberal late fluid management is associated with longer ventilation duration and worst outcome in severe trauma patients: a retrospective cohort of 294 patients M. Mezidi, J. Charbit, M. Ould-Chikh, P. Deras, C. Maury, O. Martinez, X. Capdevila P169 - Association of fluids and outcomes in emergency department patients hospitalized with community-acquired pneumonia P. Hou, W. Z. Linde-Zwirble, I. D. Douglas, N. S. Shapiro P170 - Association of positive fluid balance with poor outcome in medicosurgical ICU patients A. Ben Souissi, I. Mezghani, Y. Ben Aicha, S. Kamoun, B. Laribi, B. Jeribi, A. Riahi, M. S. Mebazaa P171 - Impact of fluid balance to organ dysfunction in critically ill patients C. Pereira, R. Marinho, R. Antunes, A. Marinho P172 - Volume bolus in ICU patients: do we need to balance our crystalloids? M. Crivits, M. Raes, J. Decruyenaere, E. Hoste P173 - The use of 6 % HES solution do not reduce total fluid requirement in the therapy of patients with burn shock V. Bagin, V. Rudnov, A. Savitsky, M. Astafyeva, I. Korobko, V. Vein P174 - Electron microscopic assessment of acute kidney injury in septic sheep resuscitated with crystalloids or different colloids T. Kampmeier , P. Arnemann, M. Hessler, A. Wald, K. Bockbreder, A. Morelli, H. Van Aken, S. Rehberg, C. Ertmer P175 - Alterations of conjunctival microcirculation in a sheep model of haemorrhagic shock and resuscitation with 0.9 % saline or balanced tetrastarch P. Arnemann, M. Hessler, T. Kampmeier, S. Rehberg, H. Van Aken, C. Ince, C. Ertmer P176 - A single centre nested pilot study investigating the effect of using 0.9 % saline or Plasma-Lyte 148 ® as crystalloid fluid therapy on gastrointestinal feeding intolerance in mechanically ventilated patients receiving nasogastric enteral nutrition S. Reddy, M. Bailey, R. Beasley, R. Bellomo, D. Mackle, A. Psirides, P. Young P177 - A single centre nested pilot study investigating the effect on post-operative bleeding of using 0.9 % saline or Plasma-Lyte® 148 as crystalloid fluid therapy in adults in ICU after heart surgery S. Reddy, M. Bailey, R. Beasley, R. Bellomo, D. Mackle, P. Young P178 - Extreme hypernatremia and sepsis in a patient with Huntington’s dementia: a conundrum in fluid management H. Venkatesh, S. Ramachandran, A. Basu, H. Nair P179 - Diagnosis and management of severe hypernatraemia in the critical care setting S. Egan, J. Bates P180 - Correlation between arterial blood gas and electrolyte disturbances during hospitalization and outcome in critically ill patients S. Oliveira, N. R. Rangel Neto, F. Q. Reis P181 - Missing the “I” in MUDPILES – a rare cause of high anion gap metabolic acidosis (HAGMA) C. P. Lee, X. L. Lin, C. Choong , K. M. Eu, W. Y. Sim , K. S. Tee, J. Pau , J. Abisheganaden P182 - Plasma NGAL and urinary output: potential parameters for early initiation of renal replacement therapy K. Maas, H. De Geus P183 - Renal replacement therapy for critically ill patients: an intermittent continuity E. Lafuente, R. Marinho, J. Moura, R. Antunes, A. Marinho P184 - A survey of practices related to renal replacement therapy in critically ill patients in the north of England. T. E. Doris, D. Monkhouse, T. Shipley, S. Kardasz, I Gonzalez P185 - High initiation creatinine associated with lower 28-day mortality in critically ill patients necessitating continuous renal replacement therapy S. Stads, A. J. Groeneveld P186 - The impact of Karnofsky performance scale on outcomes in acute kidney injury patients receiving renal replacement therapy on the intensive care unit I. Elsayed, N. Ward, A. Tridente, A. Raithatha P187 - Severe hypophosphatemia during citrate-anticoagulated CRRT A. Steuber, C. Pelletier, S. Schroeder, E. Michael, T. Slowinski, D. Kindgen-Milles P188 - Citrate regional anticoagulation for post dilution continuous renal replacement therapy S. Ghabina P189 - Citrate 18 mmol/l improves anticoagulation during RRT with adsorbing filters F. Turani, A. Belli, S. Busatti, G. Barettin, F. Candidi, F. Gargano, R. Barchetta, M. Falco P190 - Calcium gluconate instead of calcium chloride in citrate-anticoagulated CVVHD O. Demirkiran, M. Kosuk, S. Bozbay P191 - Enhanced clearance of interleukin-6 with continuous veno-venous haemodialysis (CVVHD) using Ultraflux EMiC2 vs. Ultraflux AV1000S V. Weber, J. Hartmann, S. Harm, I. Linsberger, T. Eichhorn, G. Valicek, G. Miestinger, C. Hoermann P192 - Removal of bilirubin with a new adsorbent system: in vitro kinetics S. Faenza, D. Ricci, E. Mancini, C. Gemelli, A. Cuoghi, S. Magnani, M. Atti P193 - Case series of patients with severe sepsis and septic shock treated with a new extracorporeal sorbent T. Laddomada, A. Doronzio, B. Balicco P194 - In vitro adsorption of a broad spectrum of inflammatory mediators with CytoSorb® hemoadsorbent polymer beads M. C. Gruda, P. O’Sullivan, V. P. Dan, T. Guliashvili, A. Scheirer, T. D. Golobish, V. J. Capponi, P. P. Chan P195 - Observations in early vs. late use of cytosorb therapy in critically ill patients K. Kogelmann, M. Drüner, D. Jarczak P196 - Oxiris membrane decreases endotoxin during rrt in septic patients with basal EAA > 0,6 F. Turani, A. B. Belli, S. M. Martni, V. C. Cotticelli, F. Mounajergi, R. Barchetta P197 - An observational prospective study on the onset of augmented renal clearance: the first report S. Morimoto, H. Ishikura P198 - An ultrasound- guided algorithm for the management of oliguria in severe sepsis I. Hussain, N. Salahuddin, A. Nadeem, K. Ghorab, K. Maghrabi P199 - Ultrasound in acute kidney injury (aki). First findings of farius, an education-programme in structural ultrasonography S. K. Kloesel, C. Goldfuss, A. Stieglitz, A. S. Stieglitz, L. Krstevska, G. Albuszies P200 - Effectiveness of renal angina index score predicting acute kidney injury on critically ill patients M. Aguilar Arzapalo, L. Barradas, V. Lopez, A. Escalante, G. Jimmy, M. Cetina P201 - Time length below blood pressure thresholds and progression of acute kidney injury in critically ill patients with or without sepsis: a retrospective, exploratory cohort study J. Izawa, T. Iwami, S. Uchino, M. Takinami, T. Kitamura, T. Kawamura P202 - Anaemia does not affect renal recovery in acute kidney injury J. G. Powell-Tuck, S. Crichton, M. Raimundo, L. Camporota, D. Wyncoll, M. Ostermann P203 - Estimated glomerular filtration rate based on serum creatinine: actual practice in Dutch ICU’s A. Hana, H. R. De Geus P204 - Comparison of estimated glomerular filtration rate calculated by mdrd, ckd-epi-serum-creatinine and ckd-epi-cystatin-c in adult critically ill patients H. R. De Geus, A. Hana P205 - Early diagnosis of septic acute kidney injury in medical critical care patients with a urine cell cycle arrest marker: insulin like growth factor binding protein-7 (IGFBP-7) M. Aydogdu, N. Boyaci, S. Yuksel, G. Gursel, A. B. Cayci Sivri P206 - Urinary neutrophil gelatinase-associated lipocalin as early biomarker of severe acute kidney injury in intensive care J. Meza-Márquez, J. Nava-López, R. Carrillo-Esper P207 - Shrunken pore syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting A. Dardashti, A. Grubb P208 - The biomarker nephrocheck™ can discriminate the septic shock patients with an akin 1 or 2 acute renal failure who will not progress toward the akin 3 level J. Maizel, M. Wetzstein, D. Titeca, L. Kontar, F. Brazier, B. De Cagny, A. Riviere, T. Soupison, M. Joris, M. Slama P209 - A worldwide multicentre evaluation of acute kidney injury in septic and non-septic critically ill patients: the intensive care over nations (icon) audit E. Peters, H. Njimi, P. Pickkers, J. L. Vincent P210 - Does enhanced recovery after surgery reduce the incidence of acute kidney injury in those undergoing major gynae-oncological surgery? M. Waraich , J. Doyle, T. Samuels, L. Forni P211 - Identification of risk factors for the development of acute kidney injury after lower limb arthroplasty N. Desai, R. Baumber, P. Gunning, A. Sell P212 - Incidences and associations of acute kidney injury after major trauma S. Lin, H. Torrence, M. O’Dwyer, C. Kirwan, J. Prowle P213 - Acute kidney injury of major trauma patients T Kim P214 - Trajectory of serum creatinine after major surgery and the diagnosis of acute kidney injury M. E. O’Connor, R. W. Hewson, C. J. Kirwan, R. M. Pearse, J. Prowle P215 - Epidemiology of acute kidney injury after cardiac surgery. A single center retrospective study S. Hanoura , A. Omar, H. Othamn, S. Sudarsanan , M. Allam, M. Maksoud, R. Singh, A. Al Khulaifi P216 - Post-operative acute kidney injury after major non-cardiac surgery and its association with death in the following year M. E. O’Connor, R. W. Hewson, C. J. Kirwan, R. M. Pearse, J. Prowle P217 - Factors affecting acute renal failure in intensive care unit and effect of these factors on mortality O. Uzundere, D. Memis , M. Ýnal, A. , N. Turan P218 - Results of the live kidney transplantations according to national data of turkish organ and tissue information system M. A. Aydin, H. Basar, I. Sencan, A. Kapuagasi, M. Ozturk, Z. Uzundurukan, D. Gokmen, A. Ozcan, C. Kaymak P219 - Anaesthesia procedure and intensive therapy in patients with neck phlegmon V. A. Artemenko, A. Budnyuk P220 - Nasal high flow oygen for acute respiratory failure: a systematic review R. Pugh , S. Bhandari P221 - Setting optimal flow rate during high flow nasal cannula support: preliminary results T. Mauri, C. Turrini, T. Langer, P. Taccone, C. A. Volta, C. Marenghi, L. Gattinoni, A. Pesenti P222 - Dose to dose consistency across two different gas flow rates using cystic fibrosis and normal adult breathing profiles during nasal high flow oxygen therapy L. Sweeney, A . O’ Sullivan, P. Kelly, E. Mukeria, R. MacLoughlin P223 - Final results of an evaluation of airway medix closed suction system compared to a standard closed suction system M. Pfeffer, J. T. Thomas, G. B. Bregman, G. K. Karp, E. K. Kishinevsky, D. S. Stavi, N. A. Adi P224 - Different cuff materials and different leak tests - one size does not fit all T. Poropat, R. Knafelj P225 - Observational study on the value of the cuff-leak test and the onset of upper airway obstruction after extubation E. Llopart, M. Batlle, C. De Haro, J. Mesquida, A. Artigas P226 - A device for emergency transtracheal lung ventilation D. Pavlovic, L. Lewerentz, A. Spassov, R. Schneider P227 - Long-term outcome and health-related quality of life in patients discharged from the intensive care unit with a tracheostomy and with or without prolonged mechanical ventilation S. De Smet, S. De Raedt, E. Derom, P Depuydt, S. Oeyen, D. Benoit, J. Decruyenaere P228 - Ultrasound-guided percutaneous dilational tracheostomy versus bronchoscopy-guided percutaneous dilational tracheostomy in critically ill patients (trachus): a randomized clinical trial A. Gobatto, B. Bese, P. Tierno, L. Melro, P. Mendes, F. Cadamuro, M. Park, L. M. Malbouisson P229 - Is it safe to discharge patients with tracheostomy from the ICU to the ward? B. C. Civanto, J. L. Lopez, A. Robles, J. Figueira, S. Yus, A. Garcia P230 - The application of tracheostomy in children in ICU A. Oglinda, G. Ciobanu, C. Oglinda, L. Schirca, T. Sertinean, V. Lupu P231 - The impact of passive humidifiers on aerosol drug delivery during mechanical ventilation P. Kelly, A. O’Sullivan, L. Sweeney, R. MacLoughlin P232 - Evaluation of vibrating mesh and jet nebuliser performance at two different attachment setups in line with a humidifier nebuliser system A. O’Sullivan, P. Kelly, L. Sweeney, E. Mukeria, M. Wolny , R. MacLoughlin P233 - Psv-niv versus cpap in the treatment of acute cardiogenic pulmonary edema A. Pagano, F. Numis, G. Vison, L. Saldamarco, T. Russo, G. Porta, F. Paladino P234 - Noninvasive ventilation in patients with haematologic malignancy: a retrospective review C. Bell, J. Liu, J. Debacker, C. Lee, E. Tamberg, V. Campbell, S. Mehta P235 - Use of non-invasive ventilation in infectious diseases besides classical indications A. Silva-Pinto, A. Sarmento, L. Santos P236 - The impact of fragility on noninvasive mechanical ventilation application and results in the ICU Ý. Kara, F. Yýldýrým, A. Zerman, Z. Güllü, N. Boyacý, B. Basarýk Aydogan, Ü. Gaygýsýz, K. Gönderen, G. Arýk, M. Turkoglu, M. Aydogdu, G. Aygencel, Z. Ülger, G. Gursel P237 - Effects of metabolic alkalosis on noninvasive ventilation success and ICU outcome in patients with hypercapnic respiratory failure N. Boyacý, Z. Isýkdogan, Ö. Özdedeoglu, Z. Güllü, M. Badoglu, U. Gaygýsýz, M. Aydogdu, G. Gursel P238 - Asynchrony index and breathing patterns of acute exacerbation copd patients assisted with noninvasive pressure support ventilation and neurally adjusted ventilatory assist N. Kongpolprom, C. Sittipunt P239 - High frequency jet ventilation for severe acute hypoxemia A. Eden, Y. Kokhanovsky, S. Bursztein – De Myttenaere, R. Pizov P240 - HFOV revisited: a 7 year retrospective analysis of patients receiving HFOV who met oscillate trial entry criteria L. Neilans, N. MacIntyre P241 - Implementation of a goal-directed mechanical ventilation order set driven by respiratory therapists can improve compliance with best practices for mechanical ventilation M. Radosevich, B. Wanta, V. Weber, T. Meyer, N. Smischney, D. Brown, D. Diedrich P242 - A reduction in tidal volumes for ventilated patients on ICU calculated from IBW. can it minimise mortality in comparison to traditional strategies? A . Fuller, P. McLindon, K. Sim P243 - Predictive value of lung aeration scoring using lung ultrasound in weaning failure M. Shoaeir, K. Noeam, A. Mahrous, R. Matsa, A. Ali P244 - Conventional versus automated weaning from mechanical ventilation using SmartCare™ C. Dridi, S. Koubaji, S. Kamoun, F. Haddad, A. Ben Souissi, B. Laribi, A. Riahi, M. S. Mebazaa P245 - Ultrasonographic evaluation protocol for weaning from mechanichal ventilation A. Pérez-Calatayud, R. Carrillo-Esper, A. Zepeda-Mendoza, M. Diaz-Carrillo, E. Arch-Tirado P246 - Diaphragm ultrasonography: a method for weaning patients from mechanical ventilation S. Carbognin, L. Pelacani, F. Zannoni, A. Agnoli, G. Gagliardi P247 - Dorsal diaphragmatic excursion tracks transpulmonary pressure in ventilated ARDS patients: a potential non-invasive indicator of lung recruitment? R. Cho, A. Adams , S. Lunos, S. Ambur, R. Shapiro, M. Prekker P248 - Pulse oximetry in the icu patient: is the perfusion index of any value? M. Thijssen, L. Janssen, N. Foudraine P249 - Ventilation is a better assessment of respiratory status than EtCO2 C. J. Voscopoulos, J. Freeman P250 - Evaluation of the relationship between non-invasive minute ventilation and end-tidal CO2 in patients undergoing general vs spinal anesthesia C. J. Voscopoulos, J. Freeman, E. George P251 - Respiratory volume monitoring provides early warning of respiratory depression and can be used to reduce false alarms in non-intubated patients C. J. Voscopoulos, D. Eversole, J. Freeman, E. George P252 - P/i index: a predictive edi-derived weaning index during nava S. Muttini, R. Bigi, G. Villani, N. Patroniti P253 - Adequacy of ventilation in patients receiving opioids in the post anesthesia care unit: minute ventilation versus respiratory rate G. Williams, C. J. Voscopoulos, J. Freeman, E. George P254 - Comparison of regional and global expiratory time constants measured by electrical impedance tomography (EIT) A. Waldmann, S. Böhm, W. Windisch, S. Strassmann, C. Karagiannidis P255 - Electrical impedance tomography: robustness of a new pixel wise regional expiratory time constant calculation A. Waldmann, S. Böhm, W. Windisch, S. Strassmann, C. Karagiannidis P256 - Validation of regional and global expiratory time constant measurement by electrical impedance tomography in ards and obstructive pulmonary diseases C. K. Karagiannidis, A. W. Waldmann, S. B. Böhm, S. Strassmann, W. W. Windisch P257 - Transpulmonary pressure in a model with elastic recoiling lung and expanding chest wall P. Persson, S. Lundin, O. Stenqvist P258 - Lactate in pleural and abdominal effusion G. Porta, F. Numis, C. S. Serra, A. P. Pagano, M. M. Masarone, L. R. Rinaldi, A. A. Amelia, M. F. Fascione, L. A. Adinolfi, E. R. Ruggiero P259 - Outcome of patients admitted to the intensive care with pulmonary fibrosis F. Asota, K. O’Rourke, S. Ranjan, P. Morgan P260 - Sedation and analgesia practice in extra-corporeal membrane oxygenation (ECMO)-treated patients with acute respiratory distress syndrome (ARDS): a retrospective study J. W. DeBacker, E. Tamberg, L. O’Neill, L. Munshi, L. Burry, E. Fan, S. Mehta P261 - Characteristics and outcomes of patients deemed not eligible when referred for veno-venous extracorporeal membrane oxygenation (vv-ECMO) S. Poo, K. Mahendran, J. Fowles, C. Gerrard, A. Vuylsteke P262 - The SAVE SMR for veno-arterial ECMO R. Loveridge, C. Chaddock, S. Patel, V. Kakar, C. Willars, T. Hurst, C. Park, T. Best, A. Vercueil, G. Auzinger P263 - A simplified score to predict early (48 h) mortality in patients being considered for VA-ECMO A. Borgman, A. G. Proudfoot, E. Grins, K. E. Emiley, J. Schuitema, S. J. Fitch, G. Marco, J. Sturgill, M. G. Dickinson, M. Strueber, A. Khaghani, P. Wilton, S. M. Jovinge P264 - Lung function six months post extra corporeal membrane oxygenation (ECMO) for severe acute respiratory failure in adult survivors C. Sampson, S. Harris-Fox P265 - Bicarbonate dialysis removes carbon dioxide in hypoventilated rodents. M. E. Cove, L. H. Vu, A. Sen, W. J. Federspiel, J. A. Kellum P266 - Procalcitonin as predictor of primary graft dysfunction and mortality in post-lung transplantation C. Mazo Torre, J. Riera, S. Ramirez, B. Borgatta, L. Lagunes, J. Rello P267 - New molecular biomarkers of acute respiratory distress syndrome in abdominal sepsis A. K. Kuzovlev, V. Moroz, A. Goloubev, S. Polovnikov, S. Nenchuk P268 - Tight junction’s proteins claudin -5 and regulation by tnf in experimental murine lung injury model of ali/ards V. Karavana, C. Glynos, A. Asimakos, K. Pappas, C. Vrettou, M. Magkou, E. Ischaki, G. Stathopoulos, S. Zakynthinos P269 - Cell counts in endobronchial aspirate to assess airway inflammation in ARDS patients: a pilot study S. Spadaro, I. Kozhevnikova, F. Dalla Corte, S. Grasso, P. Casolari, G. Caramori, C. Volta P270 - Epidemiological and clinical profile of patients with acute respiratory distress syndrome in the surgical intensive care unit surgical, hospital JRA, Antananarivo T. Andrianjafiarinoa, T. Randriamandrato, T. Rajaonera P271 - Effect of high PEEP after recruitment maneuver on right ventricular function in ARDS. Is it good for the lung and for the heart? S. El-Dash, ELV Costa, MR Tucci, F Leleu, L Kontar, B. De Cagny, F. Brazier, D. Titeca, G. Bacari-Risal, J. Maizel, M. Amato, M. Slama P272 - Effect of recruitment maneuver on left ventricular systolic strain P. Mercado, J. Maizel, L. Kontar, D. Titeca, F. Brazier, A. Riviere, M. Joris, T. Soupison, B. De Cagny, S. El Dash, M. Slama P273 - Inhaled nitric oxide – is switching supplier cost effective? Remmington, A. Fischer, S. Squire, M. Boichat P274 - Epidemiological study of severe acute pancreatitis in Japan, comparison of the etiology and the patient outcomes on 1159 patients. H. Honzawa, H. Yasuda, T. Adati, S. Suzaki, M. Horibe, M. Sasaki, M. Sanui P275 - Extracorporeal liver support therapy. Experience in an intensive care unit R. Marinho, J. Daniel, H. Miranda, A. Marinho P276 - Accuracy of mortality prediction models in acute versus acute-on-chronic liver failure in the intensive care setting K. Milinis, M. Cooper, G. R. Williams, E. McCarron, S. Simants, I. Patanwala, I. Welters P277 - Risk of coronary artery disease in patients with chronic liver disease: a population based cohort study Y. Su P278 - 20 years of liver transplantation in Santiago de Compostela (Spain). Experience review J. Fernández Villanueva, R. Fernández Garda, A. López Lago, E. Rodríguez Ruíz, R. Hernández Vaquero, S. Tomé Martínez de Rituerto, E. Varo Pérez P279 - Diarrhea is a risk factor for liver injury and may lead to intestinal failure associated liver disease in critical illness N. Lefel, F. Schaap, D. Bergmans, S. Olde Damink, M. Van de Poll P280 - Bowel care on the intensive care unit: constipation guideline compliance and complications K. Tizard, C. Lister, L. Poole P281 - Malnutrition assessed by phase angle determines outcomes in low risk cardiac surgery patients D. Ringaitiene, D. Gineityte, V. Vicka, I. Norkiene, J. Sipylaite P282 - Preoperative fasting times in an irish hospital A. O’Loughlin, V. Maraj, J. Dowling P283 - Costs and final outcome of early x delayed feeding in a private Brazil ICU M. B. Velasco, D. M. Dalcomune, E. B. Dias, S. L. Fernandes P284 - Can ventilator derived energy expenditure measurements replace indirect calorimetry? T. Oshima, S. Graf, C. Heidegger, L. Genton, V. Karsegard, Y. Dupertuis, C. Pichard P285 - Revisiting the refeeding syndrome: results of a systematic review N. Friedli, Z. Stanga, B. Mueller, P. Schuetz P286 - Compliance with the new protocol for parenteral nutrition in our ICU L. Vandersteen, B. Stessel, S. Evers, A. Van Assche, L. Jamaer, J. Dubois P287 - Nutrition may be another treatment in the intensive care unit where less is more? R. Marinho, H. Castro, J. Moura, J. Valente, P. Martins, P. Casteloes, C. Magalhaes, S. Cabral, M. Santos, B. Oliveira, A. Salgueiro, A. Marinho P288 - Should we provide more protein to critically ill patients? R. Marinho, M. Santos, E. Lafuente, H. Castro, S. Cabral, J. Moura, P. Martins, B. Oliveira, A. Salgueiro, S. Duarte, S. Castro, M. Melo, P. Casteloes, A. Marinho P289 Protein provision in an adult intensive care unit S. Gray P290 - Prevalence and clinical outcomes of vitamin d deficiency in the medical critically ill patients in Songklanagarind hospital K. Maipang, R. Bhurayanontachai P291 - Vitamin d deficiency strongly predicts adverse medical outcome across different medical inpatient populations: results from a prospective study L. G. Grädel, P. Schütz P292 - Omega-3 fatty acids in patients undergoing cardiac surgery: a systematic review and meta-analysis P. Langlois, W. Manzanares P293 - Can 5-hydroxytriptophan prevent post-traumatic stress disorder in critically ill patients? R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P294 - Parenteral selenium in the critically ill: an updated systematic review and meta-analysis W. Manzanares, P. Langlois, M. Lemieux, G. Elke, F. Bloos, K. Reinhart, D. Heyland P295 - Probiotics in the critically ill: an updated systematic review and meta-analysis P. Langlois, M. Lemieux, I. Aramendi, D. Heyland, W. Manzanares P296 - Diabetes with hyperglycemic crisis episodes may be associated with higher risk of pancreatic cancer: a population-based cohort study Y. Su P297 - Incidence of hypoglycemia in an intensive care unit depending on insulin protocol R. Marinho, N. Babo, A. Marinho P298 - Severity of the diseases is two-dimensionally correlated to blood glucose, including blood glucose variability, especially in moderately to severely ill patients with glucose intolerance. M. Hoshino, Y. Haraguchi, S. Kajiwara, T. Mitsuhashi, T. Tsubata, M. Aida P299 - A study of glycemic control by subcutaneous glargine injection transition from continuous regular insulin infusion in critically ill patients T. Rattanapraphat, R. Bhurayanontachai, C. Kongkamol, B. Khwannimit P300 - Glycemic control in Portuguese intensive care unit R. Marinho, M. Santos, H. Castro, E. Lafuente, A. Salgueiro, S. Cabral, P. Martins, J. Moura, B. Oliveira, M. Melo, B. Xavier, J. Valente, C. Magalhaes, P. Casteloes, A. Marinho P301 - Impact of hyperglycemia duration on the day of operation on short-term outcome of cardiac surgery patients D. Moisidou, F. Ampatzidou, C. Koutsogiannidis, M. Moschopoulou, G. Drossos P302 - Lactate levels in diabetic ketoacidosis patients at ICU admissions G. Taskin, M. Çakir, AK Güler, A. Taskin, N. Öcal, S. Özer, L. Yamanel P303 - Intensive care implications of merging heart attack centre units in London J. M. Wong, C. Fitton, S. Anwar, S. Stacey P304 - Special characteristics of in-hospital cardiac arrests M. Aggou, B. Fyntanidou, S. Patsatzakis, E. Oloktsidou, K. Lolakos, E. Papapostolou, V. Grosomanidis P305 - Clinical evaluation of ICU-admitted patients who were resuscitated in the general medicine ward S. Suda , T. Ikeda, S. Ono, T. Ueno, Y. Izutani P306 - Serious game evaluation of a one-hour training basic life support session for secondary school students: new tools for future bystanders S. Gaudry, V. Desailly, P. Pasquier, PB Brun, AT Tesnieres, JD Ricard, D. Dreyfuss, A. Mignon P307 - Public and clinical staff perceptions and knowledge of CPR compared to local and national data J. C White, A. Molokhia, A. Dean, A. Stilwell, G. Friedlaender P308 Dispatcher-assisted telephone cardiopulmonary resuscitation using a French-language compression-ventilation pediatric protocol M. Peters, S. Stipulante, A. Delfosse, AF Donneau, A. Ghuysen P309 Dantrolene versus amiodarone for resuscitation – an experimental study C. Feldmann, D. Freitag, W. Dersch, M. Irqsusi, D. Eschbach, T. Steinfeldt, H. Wulf, T. Wiesmann P310 Long term survival and functional neurological outcome in comatose survivors undergoing therapeutic hypothermia N. Kongpolprom, J. Cholkraisuwat P311 Impact of kidney disease on mortality and neurological outcome in out-of-hospital cardiac arrest: a prospective observational study S. Beitland , E. Nakstad, H. Stær-Jensen , T. Drægni , G. Andersen , D. Jacobsen , C. Brunborg, B. Waldum-Grevbo , K. Sunde P312 ICU dependency of patients admitted after primary percutaneous coronary intervention (PPCI) following out of the hospital cardiac arrest K. Hoyland, D. Pandit P313 Prognostic indicators and outcome prediction model for patients with return of spontaneous circulation from cardiopulmonary arrest: comprehensive registry of in-hospital intensive care on OHCA survival (critical) study in Osaka, Japan K. Hayakawa P314 Cerebral oxygen saturation during resuscitation in a porcine model of cardiac arrest E. Oloktsidou, K. Kotzampassi, B. Fyntanidou, S. Patsatzakis, L. Loukipoudi, E. Doumaki, V. Grosomanidis P315 Presumption of cardiopulmonary resuscitation for sustaining cerebral oxidation using regional cerebral saturation of oxygen: observational cohort study (press study) H. Yasuda P316 EEG reactivity in patients after cardiac arrest: a close look at stimuli MM Admiraal, M. Van Assen, MJ Van Putten, M. Tjepkema-Cloostermans, AF Van Rootselaar, J. Horn P317 Prognostic value of neuron-specific enolase after cardiac arrest F. Ragusa, A. Marudi , S. Baroni, A. Gaspari, E. Bertellini P318 Correlation between electroencephalographic findings and serum neuron specific enolase with outcome of post cardiac arrest patients A. Taha, T. Abdullah, S. Abdel Monem P319 Introduction of a targeted temperature management strategy following cardiac arrest in a district general hospital intensive care unit. S. Alcorn, S. McNeill, S. Russell P320 The evolution of cerebral oxygen saturation in post-cardiac arrest patients treated with therapeutic hypothermia W. Eertmans, C. Genbrugge, I. Meex, J. Dens, F. Jans, C. De Deyne P321 Prognostic factors and neurological outcomes of therapeutic hypothermia in comatose survivors from cardiac arrest: 8-year single center experience J. Cholkraisuwat, N. Kongpolprom P322 Adherence to targeted temperature management after out of hospital cardiac arrest B. Avard, R. Burns P323 Implementation of a therapeutic hypothermia protocol for comatose survivors of out-of-hospital cardiac arrest. A. Patarchi, T. Spina P324 Factors associated with ventilator weaning after targeted temperature management for cardiac arrest patients in japan H. Tanaka, N. Otani, S. Ode, S. Ishimatsu P325 Differential activation of c-fos in paraventricular nuclei of the hypothalamus and thalamus of the rat following myocardial infarction J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin, M. H. Won P326 Monitoring of cTroponin I in patients with acute ischemic stroke - predictor of inhospital mortality S. Dakova, Z. Ramsheva, K. Ramshev P327 Hyperthermic preconditioning severely accelerates neuronal damage in the gerbil ischemic hippocampal dentate gyrus via decreasing sods expressions J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin P328 Failure in neuroprotection of remote limb ischemic post conditioning in the hippocampus of a gerbil model of transient cerebral ischemia J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin P329 Brain death and admission diagnosis in neurologic intensive care unit, a correlation? A Marudi, S Baroni, A Gaspari, E Bertellini P330 Brain magnetic resonance imaging findings in patients with septic shock G. Orhun, E. Senturk, P. E. Ozcan, S. Sencer, C. Ulusoy, E. Tuzun, F . Esen P331 Benefits of L-carnitine in valproic acid induced encephalopathy R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P332Automatic analysis of EEG reactivity in comatose patients M. Van Assen, M. M. Admiraal, M. J. Van Putten, M. Tjepkema-Cloostermans, A. F. Van Rootselaar, J. Horn P333 Usefulness of common ICU severity scoring systems in predicting outcome after spontaneous intracerebral hemorrhage M. Fallenius, M. B. Skrifvars, M. Reinikainen, S. Bendel, R. Raj P334 Evalution of patients with suspected subarachnoid haemorrhage and negative ct imaging M. Abu-Habsa, C. Hymers, A. Borowska, H. Sivadhas, S. Sahiba, S. Perkins P335 Timing of endovascular and surgical treatment for aneurysmal subarachnoid haemorrhage: early but not so fast. J. Rubio, J. A. Rubio, R. Sierra P336 Red blood cell transfusion in aneurysmal subarachnoid hemorrhage – the Sahara cohort study S. English, M. Chasse, A. Turgeon, F. Lauzier, D. Griesdale, A. Garland, D. Fergusson, R. Zarychanski, A. Tinmouth, C. Van Walraven, K. Montroy, J. Ziegler, R. Dupont Chouinard, R. Carignan, A. Dhaliwal, C. Lum, J. Sinclair, G. Pagliarello, L. McIntyre P337 - Aneurysmal subarachnoid hemorrhage and anemia: a canadian multi-centre retrospective cohort study S. English, M. Chasse, A. Turgeon, F. Lauzier, D. Griesdale, A. Garland, D. Fergusson, R. Zarychanski, A. Tinmouth, C. Van Walraven, K. Montroy, J. Ziegler, R. Dupont Chouinard, R. Carignan, A. Dhaliwal, C. Lum, J. Sinclair, G. Pagliarello, L. McIntyre P338 - Does the neutrophil-to-lymphocyte (NLR) ratio predict symptomatic vasospasm or delayed cerebral ischemia (DCI) after aneurysmal subarachnoid haemorrhage (SAH)? T. Groza, N. Moreau, D. Castanares-Zapatero, P. Hantson P339 - ICU-acquired infections in aneurysmal subarachnoid hemorrhage patients: impact on ICU and hospital length of stay M. Carbonara , F. Ortolano, T. Zoerle, S. Magnoni, S. Pifferi, V. Conte, N. Stocchetti P340 - Cerebral metabolic effects of normobaric hyperoxia during the acute phase of aneurysmal subarachnoid hemorrhage L. Carteron, T. Suys, C. Patet, H. Quintard, M. Oddo P341 - Postoperative care for elective craniotomy: where is best done? J. A. Rubio, J. Rubio, R. Sierra P342 - 5-year follow-up of patients after transplantation of organs from donors from neurocritical care V. Spatenkova, E. Pokorna, P. Suchomel P343 - Evaluation of levetiracetam pharmacokinetics after severe traumatic brain injury in neurocritical care patients at a level one trauma center N. Ebert, J. Jancik, H. Rhodes P344 - Model based time series cluster analysis to determine unique patient states in traumatic brain injury T. Bylinski, C. Hawthorne, M. Shaw, I. Piper, J. Kinsella P345 - Brain compartment monitoring capabilities from ICP to BI (bioimpedance) during HS (hypertonic saline) administration. State of art simulation outcome depending on brain swelling type A. K. Kink , I. R. Rätsep P346 - Transfusion of red blood cells in patients with traumatic brain injury admitted to Canadian trauma health centers: a multicenter cohort study A. Boutin, L. Moore, M. Chasse, R. Zarychanski, F. Lauzier, S. English, L. McIntyre, J. Lacroix, D. Griesdale, P. Lessard-Bonaventure, A. F. Turgeon P347 - Hemoglobin thresholds and red blood cell transfusions in adult patients with moderate or severe traumatic brain injury: a retrospective cohort study A. Boutin, L. Moore, R. Green, P. Lessard-Bonaventure, M. Erdogan, M. Butler, F. Lauzier, M. Chasse, S. English, L. McIntyre, R. Zarychanski, J. Lacroix, D. Griesdale, P. Desjardins, D. A. Fergusson, A. F. Turgeon P348 - Characteristics of patients with gunshot wounds to the head - an observational Brazilian study B. Goncalves, B. Vidal, C. Valdez, A. C. Rodrigues, L. Miguez, G. Moralez P349 - Base excess as predictor for ICU admission and the injury severity in blunt trauma patients T. Hong P350 - Enhancement of usual emergency department care with proadrenomedullin to improve outcome prediction - Results from the multi-national, prospective, observational TRIAGE study A. Kutz, P. Hausfater, D. Amin, T. Struja, S. Haubitz, A. Huber, B. Mueller, P. Schuetz P351 - Developing an innovative emergency medicine point-of-care simulation programme T. Brown, J. Collinson, C. Pritchett, T. Slade P352 - The InSim program: an in situ simulation program for junior trainees in intensive care M. Le Guen, S. Hellings, R. Ramsaran P353 - Impact of excessive and inappropriate troponin testing in the emergency setting how good are we A. Alsheikhly P354 - The development of time tracking monitor at emergency department T. Abe P355 - Role of focussed echocardiography in emergency assessment of syncope L. Kanapeckaite, M. Abu-Habsa, R. Bahl P356 - Insertion of an open-ended 14-gauge catheter through the chest wall causes a significant pneumothorax in a self-ventilating swine model M. Q Russell, K. J. Real, M. Abu-Habsa , R. M. Lyon, N. P. Oveland P357 - Ez-io® intraosseous access teaching in the workplace using a mobile ‘tea trolley’ training method J. Penketh, M. Mcdonald, F. Kelly P358 - Black widow envenomation in Saudi Arabia: a prospective observational case series M. Alfafi, S. Alsolamy, W. Almutairi, B. Alotaibi P359 - Mechanical ventilation in patients with overdose not yet intubated on icu admission A. E. Van den Berg, Y. Schriel, L. Dawson, I. A. Meynaar P360 - Central nervous system depressants poisoning and ventilator associated pneumonia: an underrated risk factor in toxicological intensive care unit H. Talaie P361 - Acute barium intoxication treated with hemodiafiltration D. Silva, S. Fernandes, J. Gouveia, J. Santos Silva P362 - Major trauma presenting to the emergency department. the spectrum of cycling injuries in Ireland J. Foley, A. Kaskovagheorgescu, D. Evoy, J. Cronin, J. Ryan P363 - Burns from French military operations: a 14-year retrospective observational analysis. M. Huck, C. Hoffmann, J. Renner, P. Laitselart, N. Donat, A. Cirodde, J. V. Schaal, Y. Masson, A. Nau, T. Leclerc P364 - A comparison of mortality scores in burns patients on the intensive care unit. O. Howarth, K. Davenport, P. Jeanrenaud, S. Raftery P365 - Clasification of pain and its treatment and an intensive care rehabiliation clinic P. MacTavish, H. Devine, J. McPeake, M. Daniel, J. Kinsella, T. Quasim P366 - Pain management adequacy in critical care areas ,the process and the barriers perceived by critical care nurses S. Alrabiee, A. Alrashid , S. Alsolamy P367 - Pain assessment in critically ill adult patients: validation of the Turkish version of the critical-care pain observation tool O. Gundogan, C. Bor, E. Akýn Korhan, K. Demirag , M. Uyar P368 - An audit of pain and sedation assessments in the intensive care unit: recommendations for clinical practice F. Frame, C. Ashton, L. Bergstrom Niska P369 - Impact of pharmaceutical care on treatment of pain and agitation in medical intensive care unit P. Dilokpattanamongkol, T. Suansanae, C. Suthisisang, S. Morakul, C. Karnjanarachata, V. Tangsujaritvijit P370 - Agitation in trauma ICU, prevention and outcome S. Mahmood, H. Al Thani, A. Almenyar P371 Correlation between percentages of ventilated patients developed vap and use of sedative agents in icu patients. A. Vakalos , V. Avramidis P372 - Improving recording of sedation events in the Emergency Department: The implementation of the SIVA International Taskforce adverse event reporting tool for procedural sedation R. Sharvill, J. Penketh P373 - Impact of sedative drug use on the length of mechanical ventilation S. E. Morton, Y. S. Chiew, C. Pretty, J. G. Chase, G. M. Shaw P374 - Co-administration of nitric oxide and sevoflurane using anaconda R. Knafelj, P. Kordis P375 - A retrospective study of the use of Dexmedetomidine in an oncological critical care setting S. Patel, V. Grover P376 - Dexmedetomidine and posttraumatic stress disorder incidence in alcohol withdrawal icu patients I. Kuchyn, K. Bielka P377 - Hemodynamic effects of dexmedetomidine in a porcine model of septic shock Z. Aidoni, V. Grosomanidis, K. Kotzampassi, G. Stavrou, B. Fyntanidou, S. Patsatzakis, C. Skourtis P378 - Ketamine for analgosedation in severe hypoxic respiratory failure S. D. Lee, K. Williams, I. D. Weltes P379 - Madness from the moon? lunar cycle and the incidence of delirium on the intensive care unit S. Berhane, C. Arrowsmith, C. Peters, S. Robert P380 - Impaired dynamic cerebral autoregulation after coronary artery bypass grafting and association with postoperative delirium J. Caldas, R. B. Panerai, T. G. Robinson, L. Camara, G. Ferreira, E. Borg-Seng-Shu, M. De Lima Oliveira, N. C. Mian, L. Santos, R. Nogueira, S. P. Zeferino, M. Jacobsen Teixeira, F. Galas, L. A. Hajjar P381 - Risk factors predicting prolonged intensive care unit length of stay after major elective surgery. P. Killeen, M. McPhail, W. Bernal, J. Maggs, J. Wendon, T. Hughes P382 - Systemic inflammatory response syndrome criteria and hospital mortality prediction in a brazilian cohort of critically ill patients L. U. Taniguchi, E. M. Siqueira, J. M. Vieira Jr, L. C. Azevedo P383 - Evaluating the efficacy of a risk predictor panel in identifying patients at elevated risk of morbidity following emergency admission A. N. Ahmad, M. Abu-Habsa, R. Bahl, E. Helme, S. Hadfield, R. Loveridge P384 - A retrospective comparison of outcomes for elective surgical patients admitted post-operatively to the critical care unit or general ward J. Shak, C. Senver, R. Howard-Griffin P385 - Effect of obesity on mortality in surgical critically ill patients. P. Wacharasint, P. Fuengfoo, N. Sukcharoen, R. Rangsin P386 - The national early warning score (news) reliably improves adverse clinical outcome prediction in community-acquired pneumonia - results from a 6 year follow-up D. Sbiti-Rohr, P. Schuetz P387 - Clinical usefulness of the charlson¡¯s weighted index of comorbidities _as prognostic factor in patients with prolonged acute mechanical ventilation H. Na, S. Song, S. Lee, E. Jeong, K. Lee P388 - Comparison of mortality prediction scoring systems in patients with cirrhosis admitted to general intensive care unit M. Cooper, K. Milinis, G. Williams, E. McCarron, S. Simants, I. Patanwala, I. D. Welters P389 - Impact of admission source and time of admission on outcome of pediatric intensive care patients: retrospective 15 years study E. Zoumpelouli, EA Volakli, V. Chrysohoidou, S. Georgiou, K. Charisopoulou, E. Kotzapanagiotou, V. Panagiotidou, K. Manavidou, Z. Stathi, M. Sdougka P390 - Heart rate variability and outcomes prediction in critical illness N. Salahuddin, B. AlGhamdi, Q. Marashly, K. Zaza, M. Sharshir, M. Khurshid, Z. Ali, M. Malgapo, M. Jamil, A. Shafquat, M. Shoukri, M. Hijazi P391 - The incidence and outcome of hyperlactatemia in the post anaesthesia care unit T. Abe, S. Uchino, M. Takinami P392 - Correlation between arterial blood gas disturbances and arterial lactate levels during hospitalization and outcome in critically septic patients N. R. Rangel Neto, S. Oliveira, F. Q. Reis, F. A. Rocha P393 - External validation of saps 3 and mpm iii scores in 48,816 patients from 72 brazilian icus G. Moralez, K. Ebecken, L. S. Rabello, M. F. Lima, R. Hatum, F. V. De Marco, A. Alves, J. E. Pinto, M. Godoy, P. E. Brasil, F. A. Bozza, J. I. Salluh, M. Soares P394 - The frailty penalty: pre-admission functional status confounds mortality prediction models in critically ill patients J. Krinsley, G. Kang P395 - ‘sooner rather than later”: how delayed discharge from critical care leads to increased out of hours discharges and subsequent increase in in-hospital mortality. J. Perry, H. Hines P396 - Identifying poor outcome patient groups in a resource-constrained critical care unit K. M. Wilkinson, C. Tordoff, B. Sloan, M. C. Bellamy P397 - Effects of icu weekend admission and discharge on mortality. E. Moreira, F. Verga, M. Barbato, G. Burghi P398 - Organizational factors, outcomes and resource use in 9,946 cancer patients admitted to 70 ICUs M Soares, U. V. Silva, L. C. Azevedo, A. P. Torelly, J. M. Kahn, D. C. Angus, M. F. Knibel, P. E. Brasil, F. A. Bozza, J. I. Salluh P399 - Evaluation of oncological critically ill patients, severity score and outcome compared to not oncological in a particular hospital cti. M. B. Velasco, D. M. Dalcomune P400 - Outcomes of patients admitted to a large uk critical care department with palliative oncological diagnoses R. Marshall, T. Gilpin, A. Tridente, A. Raithatha P401 - Predictors of mortality in febrile neutropenic patients with haematological malignancies admitted to an intensive care unit of a cancer center D. Mota, B. Loureiro, J. Dias, O. Afonso, F. Coelho, A. Martins, F. Faria P402 - Patients with hematologic malignancies requiring invasive mechanical ventilation: characteristics and predictors of mortality H. Al-Dorzi, H. Al Orainni , F. AlEid, H. Tlaygeh, A. Itani, A. Hejazi, Y. Arabi P403 - Patient-important outcomes in randomized controlled trials in critically ill patients: a systematic review S. Gaudry, J. Messika, J. D. Ricard, S. Guillo, B. Pasquet, E. Dubief, D. Dreyfuss, F. Tubach P404 - Alopecia in survivors of critical illness: a qualitative study C . Battle, K. James, P. Temblett P405 - The impact of mental health on icu admission L. Davies, C. Battle, C. Lynch P406 - Cognitive impairment 5 years after ICU discharge S. Pereira, S. Cavaco, J. Fernandes, I. Moreira, E. Almeida, F. Seabra Pereira, M. Malheiro, F. Cardoso, I. Aragão, T. Cardoso P407 - Apache ii versus apache iv for octagenerians in medical icu M. Fister, R. Knafelj P408 - Outcomes of octagenarians in an indian icu P. Muraray Govind, N. Brahmananda Reddy, R. Pratheema, E. D. Arul, J. Devachandran P409 - Mortality and outcomes in elderly patients 80 years of age or older admitted to the icu M. B. Velasco , D. M. Dalcomune P410 - Octagenerians in medical icu - adding days to life or life to days? R. Knafelj, M. Fister P411 - The very elderly admitted to intensive care unit: outcomes and economic evaluation N. Chin-Yee, G. D’Egidio, K. Thavorn, D. Heyland, K. Kyeremanteng P412 - The very elderly in intensive care: relationship between acuity of illness and long-term mortality A. G. Murchison, K. Swalwell, J. Mandeville, D. Stott P413 - Acquired weakness in an oncological intensive care unit I. Guerreiro P414 - Musculoskeletal problems in intensive care unit (ICU) patients post-discharge H. Devine, P. MacTavish, J. McPeake, T. Quasim, J. Kinsella, M. Daniel P415 - Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness C. Goossens M. B. Marques, S. Derde, S. Vander Perre, T. Dufour, S. E. Thiessen, F. Güiza, T. Janssens, G. Hermans, I. Vanhorebeek, K. De Bock, G. Van den Berghe, L. Langouche P416 - Physical outcome measures for critical care patients following intensive care unit (icu) discharge H. Devine, P. MacTavish, T. Quasim, J. Kinsella, M. Daniel, J. McPeake P417 - Improving active mobilisation in a general intensive care unit B. Miles , S. Madden, H. Devine P418 - Mobilization in patients on vasoactive drugs use – a pilot study. M. Weiler, P. Marques, C. Rodrigues, M. Boeira, K. Brenner, C. Leães, A. Machado, R. Townsend, J. Andrade P419 - Pharmacy intervention at an intensive care rehabilitation clinic P. MacTavish, J. McPeake, H. Devine, J. Kinsella, M. Daniel, R. Kishore, C. Fenlon, T. Quasim P420 - Interactive gaming is feasible and potentially increases icu patients’ motivation to be engaged in rehabilitation programs T. Fiks, A. Ruijter, M. Te Raa, P. Spronk P421 - Simulation-based design of a robust stopping rule to ensure patient safety Y. S. Chiew, P. Docherty, J. Dickson, E. Moltchanova, C. Scarrot, C. Pretty, G. M. Shaw, J. G. Chase P422 - Are daily blood tests on the intensive care unit necessary? T. Hall, W. C. Ngu, J. M. Jack, P. Morgan P423 - Measuring urine output in ward patients: is it helpful? B. Avard, A. Pavli, X. Gee P424 - The incidence of pressure ulcers in an adult mixed intensive care unit in turkey C . Bor, E. Akin Korhan, K. Demirag, M. Uyar P425 - Intensivist/patient ratios in closed ICUs in Alexandria, Egypt; an overview M. Shirazy, A. Fayed P426 - Eicu (electronic intensive care unit): impact on ALOS (average length of stay) in a developing country like India S. Gupta, A. Kaushal, S. Dewan, A. Varma P427 - Predicting deterioration in general ward using early deterioration indicator E. Ghosh, L. Yang, L. Eshelman, B. Lord, E. Carlson P428 - High impact enhanced critical care outreach - the imobile service: making a difference E. Helme, R. Broderick, S. Hadfield, R. Loveridge P429 - Impact of bed availability and cognitive load on intensive care unit (ICU) bed allocation: a vignette-based trial J. Ramos, D. Forte P430 - Characteristics of critically ill patients admitted through the emergency department F. Yang, P. Hou P431 - Admission to critical care: the quantification of functional reserve J. Dudziak, J. Feeney, K. Wilkinson, K. Bauchmuller, K. Shuker, M. Faulds, A. Raithatha, D. Bryden, L. England, N. Bolton, A. Tridente P432 - Admission to critical care: the importance of frailty K. Bauchmuller, K Shuker, A Tridente, M Faulds, A Matheson, J. Gaynor, D Bryden, S South Yorkshire Hospitals Research Collaboration P433 - Development of an instrument to aid triage decisions for intensive care unit admission J. Ramos, B. Peroni, R. Daglius-Dias, L. Miranda, C. Cohen, C. Carvalho, I . Velasco, D. Forte P434 - Using selective serotonin re-uptake inhibitors and serotonin-norepinephrine re-uptake inhibitors in critical care: a systematic review of the evidence for benefit or harm J. M. Kelly, A. Neill, G. Rubenfeld, N. Masson, A. Min P435 - Measuring adaptive coping of hospitalized patients with a severe medical condition:the sickness insight in coping questionnaire (sicq) E. Boezeman, J. Hofhuis , A. Hovingh, R. De Vries, P. Spronk P436 - Results of a national survey regarding intensive care medicine training G. Cabral-Campello, I. Aragão, T. Cardoso P437 - Work engagement among healthcare professionals in the intensive care unit M. Van Mol, M. Nijkamp, E . Kompanje P438 - Empowering the intensive care practitioners. is it a burnout ameliorating intervention? P. Ostrowski, A. Omar P439 - Icu patients suffer from circadian rhythm desynchronisation K. Kiss , B. Köves, V. Csernus, Z. Molnár P440 - Noise reduction in the ICU: feasible ? Y. Hoydonckx, S. Vanwing, B. Stessel, A. Van Assche, L. Jamaer, J. Dubois P441 - Accidental removal of invasive devices in the critical patient into the bed-washing. does the presence of professional nurse modify his incidence? V. Medo, R. Galvez, J. P. Miranda P442 - Deprivation of liberty safeguards (dols): audit of compliance in a of a 16-bed specialist cancer critical care unit. C. Stone, T. Wigmore P443 - Use of a modified cristal score to predict futility of critical care in the elderly Y. Arunan, A. Wheeler, K. Bauchmuller, D. Bryden P444 - Improvement of Referral Rate to Palliative Care for Patients with Poor Prognosis in Neurosurgical Intensive Care Unit Y. Wong, C. Poi, C. Gu P445 - Factors associated with limitation of life supporting care (lsc) in a medico-surgical intermediate care unit, and outcome of patients with lsc limitation: a monocentric, six-month study. P. Molmy, N. Van Grunderbeeck, O. Nigeon, M. Lemyze, D. Thevenin, J. Mallat P446 - Palliative care consultation and intensive care unit admission request: a cohort study J. Ramos, M. Correa, R. T. Carvalho, D. Forte P447 - Nursing and medicine together in postsurgical intensive care unit: situations of prognostic conflict at the end of life. our critical care nurses suffer with our medical activism? A. Fernandez, C. McBride P448 - End of life who may decide E. Koonthalloor, C. Walsh P449 - Correctly diagnosing death A. Webber, M. Ashe, K. Smith, P. Jeanrenaud P450 - Skin procurement performed by intensive care physicians: yes, we can. A. Marudi , S. Baroni, F. Ragusa, E. Bertellini P451 - Death analysis in pediatric intensive care patients E. A. Volakli , E. Chochliourou, M. Dimitriadou, A. Violaki, P. Mantzafleri, E. Samkinidou, O. Vrani, A. Arbouti, T. Varsami, M. Sdougka P452 - The potential impact of euthanasia on organ donation: analysis of data from belgium J. A. Bollen, T. C. Van Smaalen, W. C. De Jongh, M. M. Ten Hoopen, D. Ysebaert, L. W. Van Heurn, W. N. Van Mook P453 - Communication within an intensive care setting K. Sim, A. Fuller P454 - Development and implementation of a longitudinal communication curriculum for critical care medicine fellows A. Roze des Ordons, P. Couillard, C. Doig P455 - Staff-family conflict in a multi-ethnic intensive care unit R. V. Van Keer, R. D. Deschepper, A. F. Francke, L. H. Huyghens, J. B. Bilsen P456 - Does the source of admission to critical care affect family satisfaction? B. Nyamaizi, C. Dalrymple, A. Molokhia, A. Dobru P457 - A simple alternative to the family satisfaction survey (fs-icu) E. Marrinan, A. Ankuli, A. Molokhia P458 - A study to explore the experiences of patient and family volunteers in a critical care environment: a phenomenological analysis J. McPeake, R. Struthers, R. Crawford , H. Devine , P. Mactavish , T. Quasim P459 - Prevalence and risk factors of anxiety and depression in relatives of burn patients. P. Morelli, M. Degiovanangelo, F. Lemos, V. MArtinez, F. Verga, J. Cabrera, G. Burghi P460 - Guidance of visiting children at an adult intensive care unit (icu) A. Rutten , S. Van Ieperen, S. De Geer, M. Van Vugt, E. Der Kinderen P461 - Visiting policies in Italian pediatric ICUs: an update A. Giannini, G Miccinesi, T Marchesi, E Prandi",10.1186/s13054-016-1208-6,1vimqhdp,"['P001', 'Sepsis', 'impairs', 'the', 'capillary', 'response', 'within', 'hypoxic', 'capillaries', 'and', 'decreases', 'erythrocyte', 'oxygen', 'dependent', 'ATP', 'efflux', 'R', 'M', 'Bateman', 'M', 'D', 'Sharpe', 'J', 'E', 'Jagger', 'C', 'G', 'Ellis', 'P002', 'Lower', 'serum', 'immunoglobulin', 'G2', 'level', 'does', 'not', 'predispose', 'to', 'severe', 'flu', 'J', 'Solé', 'Violán', 'M', 'López', 'Rodríguez', 'E', 'Herrera', 'Ramos', 'J', 'Ruíz', 'Hernández', 'L', 'Borderías', 'J', 'Horcajada', 'N', 'González', 'Quevedo', 'O', 'Rajas', 'M', 'Briones', 'F', 'Rodríguez', 'de', 'Castro', 'C', 'Rodríguez', 'Gallego', 'P003', 'Brain', 'protective', 'effects', 'of', 'intravenous', 'immunoglobulin', 'through', 'inhibition', 'of', 'complement', 'activation', 'and', 'apoptosis', 'in', 'a', 'rat', 'model', 'of', 'sepsis', 'F', 'Esen', 'G', 'Orhun', 'P', 'Ergin', 'Ozcan', 'E', 'Senturk', 'C', 'Ugur', 'Yilmaz', 'N', 'Orhan', 'N', 'Arican', 'M', 'Kaya', 'M', 'Kucukerden', 'M', 'Giris', 'U', 'Akcan', 'S', 'Bilgic', 'Gazioglu', 'E', 'Tuzun', 'P004', 'Adenosine', 'a1', 'receptor', 'dysfunction', 'is', 'associated', 'with', 'leukopenia', 'A', 'possible', 'mechanism', 'for', 'sepsis', 'induced', 'leukopenia', 'R', 'Riff', 'O', 'Naamani', 'A', 'Douvdevani', 'P005', 'Analysis', 'of', 'neutrophil', 'by', 'hyper', 'spectral', 'imaging', 'A', 'preliminary', 'report', 'R', 'Takegawa', 'H', 'Yoshida', 'T', 'Hirose', 'N', 'Yamamoto', 'H', 'Hagiya', 'M', 'Ojima', 'Y', 'Akeda', 'O', 'Tasaki', 'K', 'Tomono', 'T', 'Shimazu', 'P006', 'Chemiluminescent', 'intensity', 'assessed', 'by', 'eaa', 'predicts', 'the', 'incidence', 'of', 'postoperative', 'infectious', 'complications', 'following', 'gastrointestinal', 'surgery', 'S', 'Ono', 'T', 'Kubo', 'S', 'Suda', 'T', 'Ueno', 'T', 'Ikeda', 'P007', 'Serial', 'change', 'of', 'c1', 'inhibitor', 'in', 'patients', 'with', 'sepsis', 'A', 'prospective', 'observational', 'study', 'T', 'Hirose', 'H', 'Ogura', 'H', 'Takahashi', 'M', 'Ojima', 'J', 'Kang', 'Y', 'Nakamura', 'T', 'Kojima', 'T', 'Shimazu', 'P008', 'Comparison', 'of', 'bacteremia', 'and', 'sepsis', 'on', 'sepsis', 'related', 'biomarkers', 'T', 'Ikeda', 'S', 'Suda', 'Y', 'Izutani', 'T', 'Ueno', 'S', 'Ono', 'P009', 'The', 'changes', 'of', 'procalcitonin', 'levels', 'in', 'critical', 'patients', 'with', 'abdominal', 'septic', 'shock', 'during', 'blood', 'purification', 'T', 'Taniguchi', 'M', 'O', 'P010', 'Validation', 'of', 'a', 'new', 'sensitive', 'point', 'of', 'care', 'device', 'for', 'rapid', 'measurement', 'of', 'procalcitonin', 'C', 'Dinter', 'J', 'Lotz', 'B', 'Eilers', 'C', 'Wissmann', 'R', 'Lott', 'P011', 'Infection', 'biomarkers', 'in', 'primary', 'care', 'patients', 'with', 'acute', 'respiratory', 'tract', 'infections', 'Comparison', 'of', 'procalcitonin', 'and', 'C', 'reactive', 'protein', 'M', 'M', 'Meili', 'P', 'S', 'Schuetz', 'P012', 'Do', 'we', 'need', 'a', 'lower', 'procalcitonin', 'cut', 'off', 'H', 'Hawa', 'M', 'Sharshir', 'M', 'Aburageila', 'N', 'Salahuddin', 'P013', 'The', 'predictive', 'role', 'of', 'C', 'reactive', 'protein', 'and', 'procalcitonin', 'biomarkers', 'in', 'central', 'nervous', 'system', 'infections', 'with', 'extensively', 'drug', 'resistant', 'bacteria', 'V', 'Chantziara', 'S', 'Georgiou', 'A', 'Tsimogianni', 'P', 'Alexandropoulos', 'A', 'Vassi', 'F', 'Lagiou', 'M', 'Valta', 'G', 'Micha', 'E', 'Chinou', 'G', 'Michaloudis', 'P014', 'Changes', 'in', 'endotoxin', 'activity', 'assay', 'and', 'procalcitonin', 'levels', 'after', 'direct', 'hemoperfusion', 'with', 'polymyxin', 'b', 'immobilized', 'fiber', 'A', 'Kodaira', 'T', 'Ikeda', 'S', 'Ono', 'T', 'Ueno', 'S', 'Suda', 'Y', 'Izutani', 'H', 'Imaizumi', 'P015', 'Diagnostic', 'usefullness', 'of', 'combination', 'biomarkers', 'on', 'ICU', 'admission', 'M', 'V', 'De', 'la', 'Torre', 'Prados', 'A', 'Garcia', 'De', 'la', 'Torre', 'A', 'Enguix', 'Armada', 'A', 'Puerto', 'Morlan', 'V', 'Perez', 'Valero', 'A', 'Garcia', 'Alcantara', 'P016', 'Platelet', 'function', 'analysis', 'utilising', 'the', 'PFA', '100', 'does', 'not', 'predict', 'infection', 'bacteraemia', 'sepsis', 'or', 'outcome', 'in', 'critically', 'ill', 'patients', 'N', 'Bolton', 'J', 'Dudziak', 'S', 'Bonney', 'A', 'Tridente', 'P', 'Nee', 'P017', 'Extracellular', 'histone', 'H3', 'levels', 'are', 'inversely', 'correlated', 'with', 'antithrombin', 'levels', 'and', 'platelet', 'counts', 'and', 'are', 'associated', 'with', 'mortality', 'in', 'sepsis', 'patients', 'G', 'Nicolaes', 'M', 'Wiewel', 'M', 'Schultz', 'K', 'Wildhagen', 'J', 'Horn', 'R', 'Schrijver', 'T', 'Van', 'der', 'Poll', 'C', 'Reutelingsperger', 'P018', 'Il', '8', 'is', 'this', 'a', 'more', 'reliable', 'biomarker', 'for', 'sepsis', 'severity', 'than', 'CRP', 'Procalcitonin', 'E', 'selectin', 'IL', '6', 'and', 'TNF', 'alpha', 'S', 'Pillai', 'G', 'Davies', 'G', 'Mills', 'R', 'Aubrey', 'K', 'Morris', 'P', 'Williams', 'P', 'Evans', 'P019', 'Relation', 'between', 'adrenomedullin', 'and', 'short', 'term', 'outcome', 'in', 'ICU', 'patients', 'Results', 'from', 'the', 'frog', 'ICU', 'study', 'E', 'G', 'Gayat', 'J', 'Struck', 'A', 'Cariou', 'N', 'Deye', 'B', 'Guidet', 'S', 'Jabert', 'J', 'Launay', 'M', 'Legrand', 'M', 'Léone', 'M', 'Resche', 'Rigon', 'E', 'Vicaut', 'A', 'Vieillard', 'Baron', 'A', 'Mebazaa', 'P020', 'Impact', 'of', 'disease', 'severity', 'assessment', 'on', 'performance', 'of', 'heparin', 'binding', 'protein', 'for', 'the', 'prediction', 'of', 'septic', 'shock', 'R', 'Arnold', 'M', 'Capan', 'A', 'Linder', 'P', 'Akesson', 'P021', 'Kinetics', 'and', 'prognostic', 'value', 'of', 'presepsin', 'sCD14', 'in', 'septic', 'patients', 'A', 'pilot', 'study', 'M', 'Popescu', 'D', 'Tomescu', 'P022', 'Comparison', 'of', 'CD64', 'levels', 'performed', 'by', 'the', 'facs', 'and', 'accellix', 'systems', 'C', 'L', 'Sprung', 'R', 'Calderon', 'Morales', 'G', 'Munteanu', 'E', 'Orenbuch', 'Harroch', 'P', 'Levin', 'H', 'Kasdan', 'A', 'Reiter', 'T', 'Volker', 'Y', 'Himmel', 'Y', 'Cohen', 'J', 'Meissonnier', 'P023', 'Diagnosing', 'sepsis', 'in', '5', 'minutes', 'Nanofluidic', 'technology', 'study', 'with', 'pancreatic', 'stone', 'protein', 'PSP', 'reg', 'L', 'Girard', 'F', 'Rebeaud', 'P024', 'How', 'nanotechnology', 'based', 'approaches', 'could', 'contribute', 'to', 'sepsis', 'prevention', 'diagnosis', 'and', 'treatment', 'I', 'Herrmann', 'P025', 'Il7r', 'transcriptional', 'expression', 'analysis', 'during', 'septic', 'shock', 'B', 'Delwarde', 'E', 'Peronnet', 'E', 'Cerrato', 'F', 'Venet', 'A', 'Lepape', 'T', 'Rimmelé', 'G', 'Monneret', 'J', 'Textoris', 'P026', 'Disbalance', 'of', 'microbial', 'metabolites', 'of', 'aromatic', 'acids', 'affects', 'the', 'severity', 'in', 'critically', 'ill', 'patients', 'N', 'Beloborodova', 'V', 'Moroz', 'A', 'Osipov', 'A', 'Bedova', 'Y', 'Sarshor', 'A', 'Pautova', 'A', 'Sergeev', 'E', 'Chernevskaya', 'P027', 'Copeptin', 'predicts', '10', 'year', 'all', 'cause', 'mortality', 'in', 'community', 'patients', 'J', 'Odermatt', 'R', 'Bolliger', 'L', 'Hersberger', 'M', 'Ottiger', 'M', 'Christ', 'Crain', 'B', 'Mueller', 'P', 'Schuetz', 'P028', 'Identification', 'of', 'differential', 'proteomic', 'response', 'in', 'septic', 'patients', 'secondary', 'to', 'community', 'and', 'hospital', 'acquired', 'pneumonia', 'N', 'K', 'Sharma', 'A', 'K', 'Tashima', 'M', 'K', 'Brunialti', 'F', 'R', 'Machado', 'M', 'Assuncao', 'O', 'Rigato', 'R', 'Salomao', 'P029', 'Monocyte', 'HLA', 'DR', 'expression', 'in', 'community', 'acquired', 'bacteremic', 'sepsis', 'dynamics', 'associated', 'to', 'aetiology', 'and', 'prediction', 'of', 'secondary', 'sepsis', 'S', 'C', 'Cajander', 'G', 'Rasmussen', 'E', 'Tina', 'B', 'Söderquist', 'J', 'Källman', 'K', 'Strålin', 'P030', 'Soluble', 'B', 'and', 'T', 'lymphocyte', 'attenuator', 'A', 'possible', 'prognostic', 'marker', 'in', 'sepsis', 'A', 'L', 'Lange', 'J', 'S', 'Sundén', 'Cullberg', 'A', 'M', 'Magnuson', 'O', 'H', 'Hultgren', 'P031', 'Fractal', 'dimension', 'A', 'new', 'biomarker', 'for', 'quantifying', 'clot', 'microstructure', 'in', 'patients', 'across', 'the', 'sepsis', 'spectrum', 'G', 'Davies', 'S', 'Pillai', 'G', 'Mills', 'R', 'Aubrey', 'K', 'Morris', 'P', 'Williams', 'P', 'Evans', 'P032', 'Comparison', 'between', 'the', 'new', 'biomarker', 'for', 'coagulation', 'clot', 'microstructure', 'Df', 'with', 'rotational', 'thromboelastometry', 'ROTEM', 'in', 'patients', 'across', 'the', 'sepsis', 'spectrum', 'S', 'Pillai', 'G', 'Davies', 'G', 'Mills', 'R', 'Aubrey', 'K', 'Morris', 'P', 'Williams', 'P', 'Evans', 'P033', 'Changes', 'in', 'fibrinolysis', 'across', 'the', 'sepsis', 'spectrum', 'The', 'use', 'of', 'rotational', 'thromboelastometry', 'ROTEM', 'lysis', 'index', 'LI60', 'and', 'D', 'Dimer', 'concentration', 'S', 'Pillai', 'G', 'Davies', 'G', 'Mills', 'R', 'Aubrey', 'K', 'Morris', 'P', 'Williams', 'P', 'Evans', 'P034', 'The', 'intensive', 'care', 'infection', 'score', 'a', 'promising', 'marker', 'for', 'the', 'prediction', 'of', 'infection', 'and', 'its', 'severity', 'P', 'Van', 'der', 'Geest', 'M', 'Mohseni', 'J', 'Linssen', 'R', 'De', 'Jonge', 'S', 'Duran', 'J', 'Groeneveld', 'P035', 'Challenges', 'in', 'the', 'clinical', 'diagnosis', 'of', 'sepsis', 'R', 'Miller', 'III', 'B', 'K', 'Lopansri', 'L', 'C', 'McHugh', 'A', 'Seldon', 'J', 'P', 'Burke', 'P036', 'Does', 'zero', 'heat', 'flux', 'thermometry', 'more', 'accurately', 'identify', 'sepsis', 'on', 'intensive', 'care', 'J', 'Johnston', 'R', 'Reece', 'Anthony', 'A', 'Bond', 'A', 'Molokhia', 'P037', 'Advancing', 'quality', 'AQ', 'sepsis', 'programme', 'Improving', 'early', 'identification', 'treatment', 'of', 'sepsis', 'in', 'North', 'West', 'England', 'C', 'Mcgrath', 'E', 'Nsutebu', 'P038', 'Prehospital', 'transport', 'of', 'acute', 'septic', 'patients', 'P', 'Bank', 'Pedersen', 'D', 'Pilsgaard', 'Henriksen', 'S', 'Mikkelsen', 'A', 'Touborg', 'Lassen', 'P039', 'Vasodilatory', 'plant', 'extracts', 'gel', 'as', 'an', 'alternative', 'treatment', 'for', 'fever', 'in', 'critically', 'ill', 'patients', 'R', 'Tincu', 'C', 'Cobilinschi', 'D', 'Tomescu', 'Z', 'Ghiorghiu', 'R', 'Macovei', 'P040', 'Host', 'response', 'and', 'outcome', 'of', 'hypothermic', 'sepsis', 'M', 'A', 'Wiewel', 'M', 'B', 'Harmon', 'L', 'A', 'Van', 'Vught', 'B', 'P', 'Scicluna', 'A', 'J', 'Hoogendijk', 'J', 'Horn', 'A', 'H', 'Zwinderman', 'O', 'L', 'Cremer', 'M', 'J', 'Bonten', 'M', 'J', 'Schultz', 'T', 'Van', 'der', 'Poll', 'N', 'P', 'Juffermans', 'W', 'J', 'Wiersinga', 'P041', 'Septic', 'shock', 'alert', 'over', 'SIRS', 'criteria', 'has', 'an', 'impact', 'on', 'outcome', 'but', 'needs', 'to', 'be', 'revised', 'G', 'Eren', 'Y', 'Tekdos', 'M', 'Dogan', 'O', 'Acicbe', 'E', 'Kaya', 'O', 'Hergunsel', 'P042', 'Association', 'between', 'previous', 'prescription', 'of', 'βblockers', 'and', 'mortality', 'rate', 'among', 'septic', 'patients', 'A', 'retrospective', 'observational', 'study', 'S', 'Alsolamy', 'G', 'Ghamdi', 'L', 'Alswaidan', 'S', 'Alharbi', 'F', 'Alenezi', 'Y', 'Arabi', 'P043', 'Recognition', 'and', 'treatment', 'of', 'sepsis', 'on', 'labour', 'ward', 'teaching', 'information', 'resources', 'can', 'improve', 'knowledge', 'J', 'Heaton', 'A', 'Boyce', 'L', 'Nolan', 'J', 'Johnston', 'A', 'Dukoff', 'Gordon', 'A', 'Dean', 'A', 'Molokhia', 'P044', 'Culture', 'negative', 'sepsis', 'in', 'the', 'ICU', 'what', 'is', 'unique', 'to', 'this', 'patient', 'population', 'T', 'Mann', 'Ben', 'Yehudah', 'P045', 'Organ', 'dysfunction', 'in', 'severe', 'sepsis', 'patients', 'identified', 'in', 'administrative', 'data', 'in', 'Germany', '2007', '2013', 'C', 'Fleischmann', 'D', 'Thomas', 'Rueddel', 'C', 'Haas', 'U', 'Dennler', 'K', 'Reinhart', 'P046', 'A', 'comparison', 'of', 'residents', 'knowledge', 'regarding', 'the', 'Surviving', 'Sepsis', 'Campaign', '2012', 'guideline', 'O', 'Suntornlohanakul', 'B', 'Khwannimit', 'P047', 'Effectiveness', 'of', 'a', 'septic', 'shock', 'bundle', 'to', 'improve', 'outcomes', 'in', 'the', 'ICU', 'F', 'Breckenridge', 'A', 'Puxty', 'P048', 'Dose', 'of', 'norepinephrine', 'in', 'the', 'first', '24', 'hours', 'as', 'a', 'parameter', 'evaluating', 'the', 'effectiveness', 'of', 'treatment', 'in', 'patients', 'with', 'severe', 'sepsis', 'and', 'septic', 'shock', 'P', 'Szturz', 'P', 'Folwarzcny', 'J', 'Svancara', 'R', 'Kula', 'P', 'Sevcik', 'P049', 'Norepinephrine', 'or', 'vasopressin', 'norepinephrine', 'in', 'septic', 'shock', 'A', 'retrospective', 'series', 'of', '39', 'patients', 'L', 'Caneva', 'A', 'Casazza', 'E', 'Bellazzi', 'S', 'Marra', 'L', 'Pagani', 'M', 'Vetere', 'R', 'Vanzino', 'D', 'Ciprandi', 'R', 'Preda', 'R', 'Boschi', 'L', 'Carnevale', 'P050', 'Methylene', 'blue', 'effectiveness', 'as', 'contributory', 'treatment', 'in', 'patients', 'with', 'septic', 'shock', 'V', 'Lopez', 'M', 'Aguilar', 'Arzapalo', 'L', 'Barradas', 'A', 'Escalante', 'J', 'Gongora', 'M', 'Cetina', 'P051', 'Coagulation', 'disorders', 'in', 'patients', 'with', 'severe', 'sepsis', 'and', 'DIC', 'evaluated', 'with', 'thromboelastometry', 'B', 'Adamik', 'D', 'Jakubczyk', 'A', 'Kübler', 'P052', 'Frequency', 'and', 'outcome', 'of', 'early', 'sepsis', 'associated', 'coagulopathy', 'A', 'Radford', 'T', 'Lee', 'J', 'Singer', 'J', 'Boyd', 'D', 'Fineberg', 'M', 'Williams', 'J', 'Russell', 'P053', 'Assessment', 'of', 'coagulopathy', 'in', 'cancer', 'patients', 'with', 'severe', 'sepsis', 'or', 'septic', 'shock', 'A', 'case', 'control', 'pilot', 'study', 'E', 'Scarlatescu', 'D', 'Tomescu', 'G', 'Droc', 'S', 'Arama', 'P054', 'Thromboelastometry', 'in', 'critically', 'ill', 'patients', 'with', 'disseminated', 'intravascular', 'coagulation', 'M', 'Müller', 'M', 'Straat', 'S', 'S', 'Zeerleder', 'N', 'P', 'Juffermans', 'P055', 'Cessation', 'of', 'a', 'preexisting', 'chronic', 'antiplatelet', 'therapy', 'is', 'associated', 'with', 'increased', 'mortality', 'rates', 'in', 'severe', 'sepsis', 'and', 'septic', 'shock', 'C', 'F', 'Fuchs', 'C', 'S', 'Scheer', 'S', 'W', 'Wauschkuhn', 'M', 'V', 'Vollmer', 'K', 'M', 'Meissner', 'S', 'K', 'Kuhn', 'K', 'H', 'Hahnenkamp', 'S', 'R', 'Rehberg', 'M', 'G', 'Gründling', 'P056', 'Neutrophil', 'Extracellular', 'Traps', 'NETs', 'production', 'under', 'hypoxic', 'condition', 'N', 'Yamamoto', 'M', 'Ojima', 'S', 'Hamaguchi', 'T', 'Hirose', 'Y', 'Akeda', 'R', 'Takegawa', 'O', 'Tasaki', 'T', 'Shimazu', 'K', 'Tomono', 'P057', 'Impact', 'of', 'ultraviolet', 'air', 'sterilizer', 'in', 'intensive', 'care', 'unit', 'room', 'and', 'clinical', 'outcomes', 'of', 'patients', 'E', 'Gómez', 'Sánchez', 'M', 'Heredia', 'Rodríguez', 'E', 'Álvarez', 'Fuente', 'M', 'Lorenzo', 'López', 'E', 'Gómez', 'Pesquera', 'M', 'Aragón', 'Camino', 'P', 'Liu', 'Zhu', 'A', 'Sánchez', 'López', 'A', 'Hernández', 'Lozano', 'M', 'T', 'Peláez', 'Jareño', 'E', 'Tamayo', 'P058', 'Focus', 'of', 'infection', 'in', 'severe', 'sepsis', 'comparison', 'of', 'administrative', 'data', 'and', 'prospective', 'cohorts', 'from', 'Germany', 'D', 'O', 'Thomas', 'Rüddel', 'C', 'Fleischmann', 'C', 'Haas', 'U', 'Dennler', 'K', 'Reinhart', 'P059', 'Zero', 'CLABSI', 'can', 'we', 'get', 'there', 'Obstacles', 'on', 'the', '4', 'year', 'journey', 'and', 'our', 'strategies', 'to', 'overcome', 'them', 'experience', 'from', 'an', 'Indian', 'ICU', 'V', 'Adora', 'A', 'Kar', 'A', 'Chakraborty', 'S', 'Roy', 'A', 'Bandyopadhyay', 'M', 'Das', 'P060', 'Novel', 'molecular', 'techniques', 'to', 'identify', 'central', 'venous', 'catheter', 'CVC', 'associated', 'blood', 'stream', 'infections', 'BSIs', 'T', 'Mann', 'Ben', 'Yehudah', 'G', 'Ben', 'Yehudah', 'M', 'Salim', 'N', 'Kumar', 'L', 'Arabi', 'T', 'Burger', 'P', 'Lephart', 'E', 'Toth', 'martin', 'P061', 'Zero', 'clabsi', 'can', 'we', 'get', 'there', 'Obstacles', 'on', 'the', '4', 'year', 'journey', 'and', 'our', 'strategies', 'to', 'overcome', 'them', 'experience', 'from', 'an', 'Indian', 'ICU', 'R', 'Rao', 'A', 'Kar', 'A', 'Chakraborty', 'P062', 'Prevention', 'of', 'central', 'line', 'associated', 'bloodstream', 'infections', 'in', 'intensive', 'care', 'units', 'An', 'international', 'online', 'survey', 'C', 'Valencia', 'N', 'Hammami', 'S', 'Blot', 'J', 'L', 'Vincent', 'M', 'L', 'Lambert', 'P063', '30', 'days', 'antimicrobial', 'efficacy', 'of', 'non', 'leaching', 'central', 'venous', 'catheters', 'J', 'Brunke', 'T', 'Riemann', 'I', 'Roschke', 'P064', 'Efficacy', 'of', 'noble', 'metal', 'alloy', 'coated', 'catheter', 'in', 'prevention', 'of', 'bacteriuria', 'R', 'Tincu', 'C', 'Cobilinschi', 'D', 'Tomescu', 'Z', 'Ghiorghiu', 'R', 'Macovei', 'P065', 'Predicting', 'bacteremic', 'urinary', 'tract', 'infection', 'in', 'community', 'setting', 'A', 'prospective', 'observational', 'study', 'S', 'Nimitvilai', 'K', 'Jintanapramote', 'S', 'Jarupongprapa', 'P066', 'Eight', 'year', 'analysis', 'of', 'acinetobacter', 'spp', 'monobacteremia', 'in', 'surgical', 'and', 'medical', 'intensive', 'care', 'units', 'at', 'university', 'hospital', 'in', 'Lithuania', 'D', 'Adukauskiene', 'D', 'Valanciene', 'P067', 'Group', 'A', 'and', 'group', 'B', 'streptococcal', 'infections', 'in', 'intensive', 'care', 'unit', 'our', 'experience', 'in', 'a', 'tertiary', 'centre', 'G', 'Bose', 'V', 'Lostarakos', 'B', 'Carr', 'P068', 'Improved', 'detection', 'of', 'spontaneous', 'bacterial', 'peritonitis', 'by', 'uritop', 'tm', 'strip', 'test', 'and', 'inoculation', 'of', 'blood', 'culture', 'bottles', 'with', 'ascitic', 'fluid', 'S', 'Khedher', 'A', 'Maaoui', 'A', 'Ezzamouri', 'M', 'Salem', 'P069', 'Increased', 'risk', 'of', 'cellulitis', 'in', 'patients', 'with', 'congestive', 'heart', 'failure', 'a', 'population', 'based', 'cohort', 'study', 'J', 'Chen', 'P070', 'Outcomes', 'of', 'severe', 'cellulitis', 'and', 'necrotizing', 'fasciitis', 'in', 'the', 'critically', 'ill', 'D', 'R', 'Cranendonk', 'L', 'A', 'Van', 'Vught', 'M', 'A', 'Wiewel', 'O', 'L', 'Cremer', 'J', 'Horn', 'M', 'J', 'Bonten', 'M', 'J', 'Schultz', 'T', 'Van', 'der', 'Poll', 'W', 'J', 'Wiersinga', 'P071', 'Botulism', 'outbreak', 'associated', 'with', 'people', 'who', 'inject', 'drugs', 'PWIDs', 'in', 'Scotland', 'M', 'Day', 'G', 'Penrice', 'K', 'Roy', 'P', 'Robertson', 'G', 'Godbole', 'B', 'Jones', 'M', 'Booth', 'L', 'Donaldson', 'P072', 'Surveillance', 'of', 'ESBL', 'producing', 'enterobacteriaceae', 'fecal', 'carriers', 'in', 'the', 'ICU', 'Y', 'Kawano', 'H', 'Ishikura', 'P073', 'Prevalence', 'of', 'ESBL', 'and', 'carbapenemase', 'producing', 'uropathogens', 'in', 'a', 'newly', 'opened', 'hospital', 'in', 'south', 'India', 'S', 'Sreevidya', 'N', 'Brahmananda', 'Reddy', 'P', 'Muraray', 'Govind', 'R', 'Pratheema', 'J', 'Devachandran', 'Apollo', 'Speciality', 'Hospital', 'OMR', 'Chennai', 'India', 'P074', 'Prevalence', 'risk', 'factors', 'and', 'outcomes', 'of', 'methicillin', 'resistant', 'staphylococcus', 'aureus', 'nasal', 'colonization', 'in', 'critically', 'ill', 'patients', 'H', 'Al', 'Dorzi', 'M', 'Almutairi', 'B', 'Alhamadi', 'A', 'Crizaldo', 'Toledo', 'R', 'Khan', 'B', 'Al', 'Raiy', 'Y', 'Arabi', 'P075', 'Multidrug', 'resistant', 'Acinetobacter', 'baumannii', 'infection', 'in', 'intensive', 'care', 'unit', 'patients', 'in', 'a', 'hospital', 'with', 'building', 'construction', 'Is', 'there', 'an', 'association', 'H', 'Talaie', 'P076', 'Multidrug', 'resistant', 'organisms', 'in', 'a', 'Dutch', 'ICU', 'J', 'A', 'Van', 'Oers', 'A', 'Harts', 'E', 'Nieuwkoop', 'P', 'Vos', 'P077', 'Epidemiology', 'and', 'risk', 'factors', 'of', 'ICU', 'acquired', 'infections', 'caused', 'by', 'multidrug', 'resistant', 'gram', 'negative', 'bacilli', 'Y', 'Boussarsar', 'F', 'Boutouta', 'S', 'Kamoun', 'I', 'Mezghani', 'S', 'Koubaji', 'A', 'Ben', 'Souissi', 'A', 'Riahi', 'M', 'S', 'Mebazaa', 'P078', 'Improving', 'outcomes', 'of', 'severe', 'infections', 'by', 'multidrug', 'resistant', 'pathogens', 'with', 'polyclonal', 'IgM', 'enriched', 'immunoglobulins', 'E', 'Giamarellos', 'Bourboulis', 'N', 'Tziolos', 'C', 'Routsi', 'C', 'Katsenos', 'I', 'Tsangaris', 'I', 'Pneumatikos', 'G', 'Vlachogiannis', 'V', 'Theodorou', 'A', 'Prekates', 'E', 'Antypa', 'V', 'Koulouras', 'N', 'Kapravelos', 'C', 'Gogos', 'E', 'Antoniadou', 'K', 'Mandragos', 'A', 'Armaganidis', 'P079', 'Must', 'change', 'the', 'medical', 'practice', 'in', 'ICU', 'A', 'R', 'Robles', 'Caballero', 'B', 'Civantos', 'J', 'C', 'Figueira', 'J', 'López', 'P080', 'Mediterranean', 'spotted', 'fever', 'in', 'an', 'infectious', 'diseases', 'intensive', 'care', 'unit', 'A', 'Silva', 'Pinto', 'F', 'Ceia', 'A', 'Sarmento', 'L', 'Santos', 'P081', 'Clinical', 'features', 'and', 'outcomes', 'of', 'patients', 'with', 'Middle', 'East', 'respiratory', 'syndrome', 'requiring', 'admission', 'to', 'a', 'saudi', 'intensive', 'care', 'unit', 'A', 'retrospective', 'analysis', 'of', '31', 'cases', 'G', 'Almekhlafi', 'Y', 'Sakr', 'P082', 'The', 'ICU', 'response', 'to', 'a', 'hospital', 'outbreak', 'of', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'infection', 'H', 'Al', 'Dorzi', 'R', 'Khan', 'S', 'Baharoon', 'A', 'Aldawood', 'A', 'Matroud', 'J', 'Alchin', 'S', 'Al', 'Johani', 'H', 'Balkhy', 'Y', 'Arabi', 'P083', 'Middle', 'East', 'respiratory', 'syndrome', 'Surveillance', 'data', 'analysis', 'S', 'Alsolamy', 'S', 'Y', 'Yousif', 'B', 'O', 'Alotabi', 'A', 'S', 'Alsaawi', 'P085', 'Use', 'of', 'Taqman', 'array', 'card', 'molecular', 'diagnostics', 'in', 'severe', 'pneumonia', 'A', 'case', 'series', 'J', 'Ang', 'MD', 'Curran', 'D', 'Enoch', 'V', 'Navapurkar', 'A', 'Conway', 'Morris', 'P086', 'BUNS', 'An', 'investigation', 'protocol', 'improves', 'the', 'ICU', 'management', 'of', 'pneumonia', 'R', 'Sharvill', 'J', 'Astin', 'P087', 'Pneumonia', 'in', 'patients', 'following', 'secondary', 'peritonitis', 'epidemiological', 'features', 'and', 'impact', 'on', 'mortality', 'M', 'Heredia', 'Rodríguez', 'E', 'Gómez', 'Sánchez', 'M', 'T', 'Peláez', 'Jareño', 'E', 'Gómez', 'Pesquera', 'M', 'Lorenzo', 'López', 'P', 'Liu', 'Zhu', 'M', 'Aragón', 'Camino', 'A', 'Hernández', 'Lozano', 'A', 'Sánchez', 'López', 'E', 'Álvarez', 'Fuente', 'E', 'Tamayo', 'P088', 'The', 'use', 'of', 'the', 'CURB', '65', 'score', 'by', 'emergency', 'room', 'clinicians', 'in', 'a', 'large', 'teaching', 'hospital', 'J', 'Patel', 'C', 'Kruger', 'P089', 'Incidence', 'of', 'community', 'acquired', 'pneumonia', 'with', 'viral', 'infection', 'in', 'mechanically', 'ventilated', 'patients', 'in', 'the', 'medical', 'intensive', 'care', 'unit', 'J', 'O', 'Neal', 'H', 'Rhodes', 'J', 'Jancik', 'P090', 'The', 'SAATELLITE', 'Study', 'Prevention', 'of', 'S', 'aureus', 'Nosocomial', 'Pneumonia', 'NP', 'with', 'MEDI4893', 'a', 'Human', 'Monoclonal', 'Antibody', 'mAb', 'Against', 'S', 'aureus', 'B', 'François', 'P', 'F', 'Laterre', 'P', 'Eggimann', 'A', 'Torres', 'M', 'Sánchez', 'P', 'F', 'Dequin', 'G', 'L', 'Bassi', 'J', 'Chastre', 'H', 'S', 'Jafri', 'P091', 'Risk', 'factors', 'and', 'microbiological', 'profile', 'for', 'nosocomial', 'infections', 'in', 'trauma', 'patients', 'M', 'Ben', 'Romdhane', 'Z', 'Douira', 'S', 'Kamoun', 'M', 'Bousselmi', 'A', 'Ben', 'Souissi', 'Y', 'Boussarsar', 'A', 'Riahi', 'M', 'S', 'Mebazaa', 'P092', 'Correlation', 'between', 'percentages', 'of', 'ventilated', 'patients', 'developed', 'vap', 'and', 'use', 'of', 'antimicrobial', 'agents', 'in', 'ICU', 'patients', 'A', 'Vakalos', 'V', 'Avramidis', 'P093', 'A', 'comparison', 'of', 'two', 'ventilator', 'associated', 'pneumonia', 'surveillance', 'techniques', 'T', 'H', 'Craven', 'G', 'Wojcik', 'K', 'Kefala', 'J', 'McCoubrey', 'J', 'Reilly', 'R', 'Paterson', 'D', 'Inverarity', 'I', 'Laurenson', 'T', 'S', 'Walsh', 'P094', 'Lung', 'ultrasound', 'before', 'and', 'after', 'fiberbronchoscopy', 'modifications', 'may', 'improve', 'ventilator', 'associated', 'pneumonia', 'diagnosis', 'S', 'Mongodi', 'B', 'Bouhemad', 'A', 'Orlando', 'A', 'Stella', 'G', 'Via', 'G', 'Iotti', 'A', 'Braschi', 'F', 'Mojoli', 'P095', 'Comparing', 'the', 'accuracy', 'of', 'predictors', 'of', 'mortality', 'in', 'ventilator', 'associated', 'pneumonia', 'M', 'Haliloglu', 'B', 'Bilgili', 'U', 'Kasapoglu', 'I', 'Sayan', 'M', 'Süzer', 'Aslan', 'A', 'Yalcın', 'I', 'Cinel', 'P096', 'Impact', 'of', 'pRBCs', 'transfusion', 'on', 'percentage', 'of', 'ventilated', 'patients', 'developed', 'VAP', 'in', 'ICU', 'patients', 'A', 'Vakalos', 'V', 'Avramidis', 'P097', 'The', 'impact', 'of', 'a', 'series', 'of', 'interventions', 'on', 'the', 'rate', 'of', 'ventilator', 'associated', 'pneumonia', 'in', 'a', 'large', 'teaching', 'hospital', 'H', 'E', 'Ellis', 'K', 'Bauchmuller', 'D', 'Miller', 'A', 'Temple', 'P098', 'The', 'EVADE', 'study', 'Prevention', 'of', 'Nosocomial', 'Pneumonia', 'NP', 'caused', 'by', 'P', 'aeruginosa', 'with', 'MEDI3902', 'a', 'Novel', 'Bispecific', 'Monoclonal', 'Antibody', 'against', 'P', 'aeruginosa', 'virulence', 'factors', 'J', 'Chastre', 'B', 'François', 'A', 'Torres', 'C', 'E', 'Luyt', 'M', 'Sánchez', 'M', 'Singer', 'H', 'S', 'Jafri', 'P099', 'Short', 'term', 'inhaled', 'colistin', 'adjunctive', 'therapy', 'for', 'ventilator', 'associated', 'pneumonia', 'Y', 'Nassar', 'M', 'S', 'Ayad', 'P100', 'Effect', 'of', 'aerosolised', 'colistin', 'on', 'weaning', 'from', 'mechanical', 'ventilation', 'A', 'Trifi', 'S', 'Abdellatif', 'F', 'Daly', 'R', 'Nasri', 'S', 'Ben', 'Lakhal', 'P101', 'Septic', 'shock', 'is', 'an', 'independent', 'risk', 'factor', 'for', 'colistin', 'induced', 'severe', 'acute', 'kidney', 'injury', 'a', 'retrospective', 'cohort', 'study', 'B', 'Bilgili', 'M', 'Haliloglu', 'F', 'Gul', 'I', 'Cinel', 'P102', 'Nosocomial', 'pneumonia', 'emphasis', 'on', 'inhaled', 'tobramycin', 'A', 'Kuzovlev', 'A', 'Shabanov', 'S', 'Polovnikov', 'V', 'Moroz', 'P103', 'In', 'vitro', 'evaluation', 'of', 'amikacin', 'inhale', 'and', 'commercial', 'nebulizers', 'in', 'a', 'mechanical', 'ventilator', 'N', 'Kadrichu', 'T', 'Dang', 'K', 'Corkery', 'P', 'Challoner', 'P104', 'The', 'effects', 'of', 'nebulized', 'amikacin', 'fosfomycin', 'and', 'systemic', 'meropenem', 'on', 'severe', 'amikacin', 'resistant', 'meropenem', 'susceptible', 'P', 'aeruginosa', 'pneumonia', 'G', 'Li', 'Bassi', 'E', 'Aguilera', 'C', 'Chiurazzi', 'C', 'Travierso', 'A', 'Motos', 'L', 'Fernandez', 'R', 'Amaro', 'T', 'Senussi', 'F', 'Idone', 'J', 'Bobi', 'M', 'Rigol', 'A', 'Torres', 'P105', 'Optimization', 'of', 'gentamicin', 'peak', 'concentrations', 'in', 'critically', 'ill', 'patients', 'C', 'J', 'Hodiamont', 'N', 'P', 'Juffermans', 'J', 'M', 'Janssen', 'C', 'S', 'Bouman', 'R', 'A', 'Mathôt', 'M', 'D', 'De', 'Jong', 'R', 'M', 'Van', 'Hest', 'P106', 'Systematic', 'review', 'of', 'cefepime', 'induced', 'neurotoxicity', 'L', 'Payne', 'G', 'L', 'Fraser', 'P107', 'Unasyn', 'causes', 'QT', 'prolongation', 'during', 'treatment', 'of', 'intensive', 'care', 'patients', 'B', 'Tudor', 'M', 'Lahner', 'G', 'Roth', 'C', 'Krenn', 'P108', 'Comparative', 'study', 'between', 'teicoplanin', 'and', 'vancomycin', 'in', 'methicillin', 'resistant', 'staphylococcus', 'aureus', 'mrsa', 'infectious', 'of', 'toxicological', 'intensive', 'care', 'unit', 'ticu', 'patients', 'Tehran', 'Iran', 'H', 'Talaie', 'P109', 'Phage', 'therapy', 'against', 'antimicrobial', 'resistance', 'design', 'of', 'the', 'first', 'clinical', 'study', 'phagoburn', 'P', 'Jault', 'J', 'Gabard', 'T', 'Leclerc', 'S', 'Jennes', 'Y', 'Que', 'A', 'Rousseau', 'F', 'Ravat', 'P110', 'Antibiotic', 'dosing', 'errors', 'in', 'critically', 'ill', 'patients', 'with', 'severe', 'sepsis', 'or', 'septic', 'shock', 'H', 'Al', 'Dorzi', 'A', 'Eissa', 'S', 'Al', 'Harbi', 'T', 'Aldabbagh', 'R', 'Khan', 'Y', 'Arabi', 'P111', 'Does', 'empiric', 'antifungal', 'therapy', 'improve', 'survival', 'in', 'septic', 'critically', 'ill', 'patients', 'immunocompromised', 'excluded', 'A', 'Trifi', 'S', 'Abdellatif', 'F', 'Daly', 'R', 'Nasri', 'S', 'Ben', 'Lakhal', 'P112', 'Neurocysticercosis', 'Qatar', 'experience', 'F', 'Paramba', 'N', 'Purayil', 'V', 'Naushad', 'O', 'Mohammad', 'V', 'Negi', 'P', 'Chandra', 'P113', 'Early', 'indicators', 'in', 'acute', 'haemorrhagic', 'shock', 'A', 'Kleinsasser', 'P114', 'Filtering', 'of', 'red', 'blood', 'cells', 'reduces', 'the', 'inflammatory', 'response', 'of', 'pulmonary', 'cells', 'in', 'an', 'in', 'vitro', 'model', 'of', 'mechanical', 'ventilation', 'M', 'R', 'Witrz', 'J', 'F', 'Buchner', 'Doeven', 'A', 'M', 'Tuip', 'de', 'Boer', 'J', 'C', 'Goslings', 'N', 'P', 'Juffermans', 'P115', 'Microparticles', 'from', 'red', 'blood', 'cell', 'transfusion', 'induce', 'a', 'pro', 'coagulant', 'and', 'pro', 'inflammatory', 'endothelial', 'cell', 'response', 'M', 'Van', 'Hezel', 'M', 'Straat', 'A', 'Boing', 'R', 'Van', 'Bruggen', 'N', 'Juffermans', 'P116', 'The', 'contribution', 'of', 'cytokines', 'on', 'thrombosis', 'development', 'during', 'hospitalization', 'in', 'ICU', 'D', 'Markopoulou', 'K', 'Venetsanou', 'V', 'Kaldis', 'D', 'Koutete', 'D', 'Chroni', 'I', 'Alamanos', 'P117', 'Prophylactic', 'enoxaparin', 'dosing', 'and', 'adjustment', 'through', 'anti', 'xa', 'monitoring', 'in', 'an', 'inpatient', 'burn', 'unit', 'L', 'Koch', 'J', 'Jancik', 'H', 'Rhodes', 'E', 'Walter', 'P118', 'Determination', 'of', 'optimal', 'cut', 'off', 'values', 'of', 'haemoglobin', 'platelet', 'count', 'and', 'fibrinogen', 'at', '24', 'hours', 'after', 'injury', 'associated', 'with', 'mortality', 'in', 'trauma', 'patients', 'K', 'Maekawa', 'M', 'Hayakawa', 'S', 'Kushimoto', 'A', 'Shiraishi', 'H', 'Kato', 'J', 'Sasaki', 'H', 'Ogura', 'T', 'Matauoka', 'T', 'Uejima', 'N', 'Morimura', 'H', 'Ishikura', 'A', 'Hagiwara', 'M', 'Takeda', 'P119', 'Trauma', 'induced', 'coagulopathy', 'prothrombin', 'complex', 'concentrate', 'vs', 'fresh', 'frozen', 'plasma', 'O', 'Tarabrin', 'S', 'Shcherbakow', 'D', 'Gavrychenko', 'G', 'Mazurenko', 'V', 'Ivanova', 'O', 'Chystikov', 'P120', 'First', 'study', 'to', 'prove', 'the', 'superiority', 'of', 'prothrombin', 'complex', 'concentrates', 'on', 'mortality', 'rate', 'over', 'fresh', 'frozen', 'plasma', 'in', 'patients', 'with', 'acute', 'bleeding', 'C', 'Plourde', 'J', 'Lessard', 'J', 'Chauny', 'R', 'Daoust', 'P121', 'Prothrombin', 'complex', 'concentrate', 'vs', 'fresh', 'frozen', 'plasma', 'in', 'obstetric', 'massive', 'bleeding', 'S', 'Shcherbakow', 'O', 'Tarabrin', 'D', 'Gavrychenko', 'G', 'Mazurenko', 'O', 'Chystikov', 'P122', 'Impact', 'of', 'FFP', 'transfusion', 'on', 'VAP', 'in', 'ICU', 'patients', 'A', 'Vakalos', 'V', 'Avramidis', 'P123', 'Preoperative', 'platelet', 'function', 'test', 'and', 'the', 'thrombin', 'generation', 'assay', 'are', 'predictive', 'for', 'blood', 'loss', 'after', 'cardiac', 'surgery', 'L', 'Kropman', 'L', 'In', 'het', 'Panhuis', 'J', 'Konings', 'D', 'Huskens', 'E', 'Schurgers', 'M', 'Roest', 'B', 'De', 'Laat', 'M', 'Lance', 'P124', 'Rotational', 'thromboelastometry', 'versus', 'standard', 'coagulation', 'tests', 'before', 'surgical', 'interventions', 'M', 'Durila', 'P', 'Lukas', 'M', 'Astraverkhava', 'J', 'Jonas', 'P125', 'Correction', 'of', 'impaired', 'clot', 'quality', 'and', 'stability', 'by', 'fibrinogen', 'and', 'activated', 'prothrombin', 'complex', 'concentrate', 'in', 'a', 'model', 'of', 'severe', 'thrombocytopenia', 'I', 'Budnik', 'B', 'Shenkman', 'P126', 'Assessment', 'of', 'point', 'of', 'care', 'prothrombin', 'time', 'analyzer', 'as', 'a', 'monitor', 'after', 'cardiopulmonary', 'bypass', 'H', 'Hayami', 'Y', 'Koide', 'T', 'Goto', 'P127', 'Disseminated', 'intravascular', 'coagulation', 'dic', 'is', 'underdiagnosed', 'in', 'critically', 'ill', 'patients', 'do', 'we', 'need', 'd', 'dimer', 'measurements', 'R', 'Iqbal', 'Y', 'Alhamdi', 'N', 'Venugopal', 'S', 'Abrams', 'C', 'Downey', 'C', 'H', 'Toh', 'I', 'D', 'Welters', 'P128', 'Validity', 'of', 'the', 'age', 'adjusted', 'd', 'dimer', 'cutoff', 'in', 'patients', 'with', 'COPD', 'B', 'Bombay', 'J', 'M', 'Chauny', 'R', 'D', 'Daoust', 'J', 'L', 'Lessard', 'M', 'M', 'Marquis', 'J', 'P', 'Paquet', 'P129', 'A', 'scoping', 'review', 'of', 'strategies', 'for', 'prevention', 'and', 'management', 'of', 'bleeding', 'following', 'paediatric', 'cardiopulmonary', 'bypass', 'surgery', 'K', 'Siemens', 'D', 'Sangaran', 'B', 'J', 'Hunt', 'A', 'Durward', 'A', 'Nyman', 'I', 'A', 'Murdoch', 'S', 'M', 'Tibby', 'P130', 'Nadir', 'hemoglobulin', 'during', 'cardiopulmonary', 'bypass', 'impact', 'on', 'postoperative', 'morbidity', 'and', 'mortality', 'F', 'Ampatzidou', 'D', 'Moisidou', 'E', 'Dalampini', 'M', 'Nastou', 'E', 'Vasilarou', 'V', 'Kalaizi', 'H', 'Chatzikostenoglou', 'G', 'Drossos', 'P131', 'Red', 'blood', 'cell', 'transfusion', 'do', 'not', 'influence', 'the', 'prognostic', 'value', 'of', 'RDW', 'in', 'critically', 'ill', 'patients', 'S', 'Spadaro', 'A', 'Fogagnolo', 'T', 'Fiore', 'A', 'Schiavi', 'V', 'Fontana', 'F', 'Taccone', 'C', 'Volta', 'P132', 'Reasons', 'for', 'admission', 'in', 'the', 'paediatric', 'intensive', 'care', 'unit', 'and', 'the', 'need', 'for', 'blood', 'and', 'blood', 'products', 'transfusions', 'E', 'Chochliourou', 'E', 'Volakli', 'A', 'Violaki', 'E', 'Samkinidou', 'G', 'Evlavis', 'V', 'Panagiotidou', 'M', 'Sdougka', 'P133', 'The', 'implementation', 'of', 'a', 'massive', 'haemorrhage', 'protocol', 'mhp', 'for', 'the', 'management', 'of', 'major', 'trauma', 'a', 'ten', 'year', 'single', 'centre', 'study', 'R', 'Mothukuri', 'C', 'Battle', 'K', 'Guy', 'G', 'Mills', 'P', 'Evans', 'P134', 'An', 'integrated', 'major', 'haemorrhage', 'protocol', 'for', 'pre', 'hospital', 'and', 'retrieval', 'medical', 'teams', 'J', 'Wijesuriya', 'S', 'Keogh', 'P135', 'The', 'impact', 'of', 'transfusion', 'thresholds', 'on', 'mortality', 'and', 'cardiovascular', 'events', 'in', 'patients', 'with', 'cardiovascular', 'disease', 'non', 'cardiac', 'surgery', 'a', 'systematic', 'review', 'and', 'meta', 'analysis', 'A', 'Docherty', 'R', 'O', 'Donnell', 'S', 'Brunskill', 'M', 'Trivella', 'C', 'Doree', 'L', 'Holst', 'M', 'Parker', 'M', 'Gregersen', 'J', 'Almeida', 'T', 'Walsh', 'S', 'Stanworth', 'P136', 'The', 'relationship', 'between', 'poor', 'pre', 'operative', 'immune', 'status', 'and', 'outcome', 'from', 'cardiac', 'surgery', 'is', 'specific', 'to', 'the', 'peri', 'operative', 'antigenic', 'threat', 'S', 'Moravcova', 'J', 'Mansell', 'A', 'Rogers', 'R', 'A', 'Smith', 'C', 'Hamilton', 'Davies', 'P137', 'Impact', 'of', 'simple', 'clinical', 'practice', 'guidelines', 'for', 'reducing', 'post', 'operative', 'atrial', 'fibrillation', 'after', 'cardiac', 'surgery', 'A', 'Omar', 'M', 'Allam', 'O', 'Bilala', 'A', 'Kindawi', 'H', 'Ewila', 'P138', 'Dexamethasone', 'administration', 'during', 'cardiopulmonary', 'bypass', 'has', 'no', 'beneficial', 'effects', 'on', 'elective', 'postoperative', 'cardiac', 'surgery', 'patients', 'F', 'Ampatzidou', 'D', 'Moisidou', 'M', 'Nastou', 'E', 'Dalampini', 'A', 'Malamas', 'E', 'Vasilarou', 'G', 'Drossos', 'P139', 'Intra', 'aortic', 'balloon', 'counterpulsation', 'in', 'patients', 'undergoing', 'cardiac', 'surgery', 'IABCS', 'preliminary', 'results', 'G', 'Ferreira', 'J', 'Caldas', 'J', 'Fukushima', 'E', 'A', 'Osawa', 'E', 'Arita', 'L', 'Camara', 'S', 'Zeferino', 'J', 'Jardim', 'F', 'Gaioto', 'L', 'Dallan', 'F', 'B', 'Jatene', 'R', 'Kalil', 'Filho', 'F', 'Galas', 'L', 'A', 'Hajjar', 'P140', 'Effects', 'of', 'low', 'dose', 'atrial', 'natriuretic', 'peptide', 'infusion', 'on', 'cardiac', 'surgery', 'associated', 'acute', 'kidney', 'injury', 'C', 'Mitaka', 'T', 'Ohnuma', 'T', 'Murayama', 'F', 'Kunimoto', 'M', 'Nagashima', 'T', 'Takei', 'M', 'Tomita', 'P141', 'Acute', 'kidney', 'injury', 'influence', 'on', 'high', 'sensitive', 'troponin', 'measurements', 'after', 'cardiac', 'surgery', 'A', 'Omar', 'K', 'Mahmoud', 'S', 'Hanoura', 'S', 'Sudarsanan', 'P', 'Sivadasan', 'H', 'Othamn', 'Y', 'Shouman', 'R', 'Singh', 'A', 'Al', 'Khulaifi', 'P142', 'Complex', 'evaluation', 'of', 'endothelial', 'dysfunction', 'markers', 'for', 'prognosis', 'of', 'outcomes', 'in', 'patients', 'undergoing', 'cardiac', 'surgery', 'I', 'Mandel', 'S', 'Mikheev', 'I', 'Suhodolo', 'V', 'Kiselev', 'Y', 'Svirko', 'Y', 'Podoksenov', 'P143', 'New', 'onset', 'atrial', 'fibrillation', 'in', 'intensive', 'care', 'incidence', 'management', 'and', 'outcome', 'S', 'A', 'Jenkins', 'R', 'Griffin', 'P144', 'One', 'single', 'spot', 'measurement', 'of', 'the', 'sublingual', 'microcirculation', 'during', 'acute', 'pulmonary', 'hypertension', 'in', 'a', 'pig', 'model', 'of', 'shock', 'M', 'S', 'Tovar', 'Doncel', 'A', 'Lima', 'C', 'Aldecoa', 'C', 'Ince', 'P145', 'Assessment', 'of', 'levosimendan', 'as', 'a', 'therapeutic', 'option', 'to', 'recruit', 'the', 'microcirculation', 'in', 'cardiogenic', 'shock', 'initial', 'experience', 'in', 'cardiac', 'ICU', 'A', 'Taha', 'A', 'Shafie', 'M', 'Mostafa', 'N', 'Syed', 'H', 'Hon', 'P146', 'Terlipressin', 'vs', 'norepinephrine', 'in', 'the', 'Potential', 'Multiorgan', 'Donor', 'PMD', 'F', 'Righetti', 'E', 'Colombaroli', 'G', 'Castellano', 'P147', 'Echocardiography', 'in', 'the', 'potential', 'heart', 'donor', 'exposed', 'to', 'substitution', 'hormonotherapy', 'F', 'Righetti', 'E', 'Colombaroli', 'P148', 'Machine', 'learning', 'can', 'reduce', 'rate', 'of', 'monitor', 'alarms', 'M', 'Hravnak', 'L', 'C', 'Chen', 'A', 'D', 'Dubrawski', 'G', 'C', 'Clermont', 'M', 'R', 'Pinsky', 'P149', 'Peripherally', 'inserted', 'central', 'catheters', 'placed', 'in', 'the', 'ICU', 'S', 'Gonzalez', 'D', 'Macias', 'J', 'Acosta', 'P', 'Jimenez', 'A', 'Loza', 'A', 'Lesmes', 'F', 'Lucena', 'C', 'Leon', 'P150', 'Recordings', 'of', 'abnormal', 'central', 'venous', 'pressure', 'waveform', 'morphology', 'during', 'an', 'episode', 'of', 'pulmonary', 'hypertension', 'in', 'a', 'porcine', 'shock', 'model', 'M', 'S', 'Tovar', 'Doncel', 'C', 'Ince', 'C', 'Aldecoa', 'A', 'Lima', 'P151', 'Ultrasound', 'guided', 'central', 'venous', 'access', 'technique', 'among', 'French', 'intensivists', 'M', 'Bastide', 'J', 'Richecoeur', 'E', 'Frenoy', 'C', 'Lemaire', 'B', 'Sauneuf', 'F', 'Tamion', 'S', 'Nseir', 'D', 'Du', 'Cheyron', 'H', 'Dupont', 'J', 'Maizel', 'P152', 'Predictive', 'ability', 'of', 'the', 'Pv', 'aCO2', 'gap', 'in', 'patients', 'with', 'shock', 'M', 'Shaban', 'R', 'Kolko', 'N', 'Salahuddin', 'M', 'Sharshir', 'M', 'AbuRageila', 'A', 'AlHussain', 'P153', 'Comparison', 'of', 'echocardiography', 'and', 'pulmonary', 'artery', 'catheter', 'measurements', 'of', 'hemodynamic', 'parameters', 'in', 'critical', 'ill', 'patients', 'P', 'Mercado', 'J', 'Maizel', 'L', 'Kontar', 'D', 'Titeca', 'F', 'Brazier', 'A', 'Riviere', 'M', 'Joris', 'T', 'Soupison', 'B', 'De', 'Cagny', 'M', 'Slama', 'P154', 'The', 'volume', 'clamp', 'method', 'for', 'noninvasive', 'cardiac', 'output', 'measurement', 'in', 'postoperative', 'cardiothoracic', 'surgery', 'patients', 'a', 'comparison', 'with', 'intermittent', 'pulmonary', 'artery', 'thermodilution', 'J', 'Wagner', 'A', 'Körner', 'M', 'Kubik', 'S', 'Kluge', 'D', 'Reuter', 'B', 'Saugel', 'P155', 'Hemodynamic', 'monitoring', 'in', 'patients', 'with', 'septic', 'shock', 'SS', 'CPCCO', 'continuous', 'pulse', 'contour', 'cardiac', 'output', 'vs', 'TEE', 'transesophageal', 'echocardiography', 'E', 'Colombaroli', 'F', 'Righetti', 'G', 'Castellano', 'P156', 'Cardiac', 'output', 'measurement', 'with', 'transthoracic', 'echocardiography', 'in', 'critically', 'ill', 'patients', 'a', 'pragmatic', 'clinical', 'study', 'T', 'Tran', 'D', 'De', 'Bels', 'A', 'Cudia', 'M', 'Strachinaru', 'P', 'Ghottignies', 'J', 'Devriendt', 'C', 'Pierrakos', 'P157', 'Left', 'ventricular', 'outflow', 'tract', 'velocity', 'time', 'integral', 'correlates', 'with', 'stroke', 'volume', 'index', 'in', 'mechanically', 'ventilated', 'patients', 'Ó', 'Martínez', 'González', 'R', 'Blancas', 'J', 'Luján', 'D', 'Ballesteros', 'C', 'Martínez', 'Díaz', 'A', 'Núñez', 'C', 'Martín', 'Parra', 'B', 'López', 'Matamala', 'M', 'Alonso', 'Fernández', 'M', 'Chana', 'P158', 'Transpulmonary', 'thermodilution', 'TPTD', 'derived', 'from', 'femoral', 'vs', 'jugular', 'central', 'venous', 'catheter', 'validation', 'of', 'a', 'previously', 'published', 'correction', 'formula', 'and', 'a', 'proprietary', 'correction', 'formula', 'for', 'global', 'end', 'diastolic', 'volume', 'index', 'GEDVI', 'W', 'Huber', 'M', 'Eckmann', 'F', 'Elkmann', 'A', 'Gruber', 'I', 'Klein', 'R', 'M', 'Schmid', 'T', 'Lahmer', 'P160', 'Dynamic', 'arterial', 'elastance', 'calculated', 'with', 'lidcoplus', 'monitor', 'does', 'not', 'predict', 'changes', 'in', 'arterial', 'pressure', 'after', 'a', 'fluid', 'challenge', 'in', 'postsurgical', 'patients', 'D', 'Bastoni', 'H', 'Aya', 'L', 'Toscani', 'L', 'Pigozzi', 'A', 'Rhodes', 'M', 'Cecconi', 'P159', 'Venous', 'return', 'driving', 'pressure', 'and', 'resistance', 'in', 'acute', 'blood', 'volume', 'changes', 'P', 'W', 'Moller', 'S', 'Sondergaard', 'S', 'M', 'Jakob', 'J', 'Takala', 'D', 'Berger', 'P160', 'Dynamic', 'arterial', 'elastance', 'calculated', 'with', 'lidcoplus', 'monitor', 'does', 'not', 'predict', 'changes', 'in', 'arterial', 'pressure', 'after', 'a', 'fluid', 'challenge', 'in', 'postsurgical', 'patients', 'D', 'Bastoni', 'H', 'Aya', 'L', 'Toscani', 'L', 'Pigozzi', 'A', 'Rhodes', 'M', 'Cecconi', 'P161', 'Analysis', 'of', 'duration', 'of', 'post', 'operative', 'goal', 'directed', 'therapy', 'protocol', 'C', 'Ostrowska', 'H', 'Aya', 'A', 'Abbas', 'J', 'Mellinghoff', 'C', 'Ryan', 'D', 'Dawson', 'A', 'Rhodes', 'M', 'Cecconi', 'P162', 'Hemodynamic', 'optimization', 'back', 'to', 'square', 'one', 'M', 'Cronhjort', 'O', 'Wall', 'E', 'Nyberg', 'R', 'Zeng', 'C', 'Svensen', 'J', 'Mårtensson', 'E', 'Joelsson', 'Alm', 'P163', 'Effectiveness', 'of', 'fluid', 'thoracic', 'content', 'measurement', 'by', 'bioimpedance', 'guiding', 'intravascular', 'volume', 'optimization', 'in', 'patients', 'with', 'septic', 'shock', 'M', 'Aguilar', 'Arzapalo', 'L', 'Barradas', 'V', 'Lopez', 'M', 'Cetina', 'P164', 'A', 'systematic', 'review', 'on', 'the', 'role', 'of', 'internal', 'jugular', 'vein', 'ultrasound', 'measurements', 'in', 'assessment', 'of', 'volume', 'status', 'in', 'critical', 'shock', 'patients', 'N', 'Parenti', 'C', 'Palazzi', 'L', 'A', 'Amidei', 'F', 'B', 'Borrelli', 'S', 'C', 'Campanale', 'F', 'T', 'Tagliazucchi', 'G', 'S', 'Sedoni', 'D', 'L', 'Lucchesi', 'E', 'C', 'Carella', 'A', 'L', 'Luciani', 'P165', 'Importance', 'of', 'recognizing', 'dehydration', 'in', 'medical', 'Intensive', 'Care', 'Unit', 'M', 'Mackovic', 'N', 'Maric', 'M', 'Bakula', 'P166', 'Effect', 'of', 'volume', 'for', 'a', 'fluid', 'challenge', 'in', 'septic', 'patients', 'H', 'Aya', 'A', 'Rhodes', 'R', 'M', 'Grounds', 'N', 'Fletcher', 'M', 'Cecconi', 'P167', 'Fluid', 'bolus', 'practices', 'in', 'a', 'large', 'Australian', 'intensive', 'care', 'unit', 'B', 'Avard', 'P', 'Zhang', 'P168', 'Liberal', 'late', 'fluid', 'management', 'is', 'associated', 'with', 'longer', 'ventilation', 'duration', 'and', 'worst', 'outcome', 'in', 'severe', 'trauma', 'patients', 'a', 'retrospective', 'cohort', 'of', '294', 'patients', 'M', 'Mezidi', 'J', 'Charbit', 'M', 'Ould', 'Chikh', 'P', 'Deras', 'C', 'Maury', 'O', 'Martinez', 'X', 'Capdevila', 'P169', 'Association', 'of', 'fluids', 'and', 'outcomes', 'in', 'emergency', 'department', 'patients', 'hospitalized', 'with', 'community', 'acquired', 'pneumonia', 'P', 'Hou', 'W', 'Z', 'Linde', 'Zwirble', 'I', 'D', 'Douglas', 'N', 'S', 'Shapiro', 'P170', 'Association', 'of', 'positive', 'fluid', 'balance', 'with', 'poor', 'outcome', 'in', 'medicosurgical', 'ICU', 'patients', 'A', 'Ben', 'Souissi', 'I', 'Mezghani', 'Y', 'Ben', 'Aicha', 'S', 'Kamoun', 'B', 'Laribi', 'B', 'Jeribi', 'A', 'Riahi', 'M', 'S', 'Mebazaa', 'P171', 'Impact', 'of', 'fluid', 'balance', 'to', 'organ', 'dysfunction', 'in', 'critically', 'ill', 'patients', 'C', 'Pereira', 'R', 'Marinho', 'R', 'Antunes', 'A', 'Marinho', 'P172', 'Volume', 'bolus', 'in', 'ICU', 'patients', 'do', 'we', 'need', 'to', 'balance', 'our', 'crystalloids', 'M', 'Crivits', 'M', 'Raes', 'J', 'Decruyenaere', 'E', 'Hoste', 'P173', 'The', 'use', 'of', '6', 'HES', 'solution', 'do', 'not', 'reduce', 'total', 'fluid', 'requirement', 'in', 'the', 'therapy', 'of', 'patients', 'with', 'burn', 'shock', 'V', 'Bagin', 'V', 'Rudnov', 'A', 'Savitsky', 'M', 'Astafyeva', 'I', 'Korobko', 'V', 'Vein', 'P174', 'Electron', 'microscopic', 'assessment', 'of', 'acute', 'kidney', 'injury', 'in', 'septic', 'sheep', 'resuscitated', 'with', 'crystalloids', 'or', 'different', 'colloids', 'T', 'Kampmeier', 'P', 'Arnemann', 'M', 'Hessler', 'A', 'Wald', 'K', 'Bockbreder', 'A', 'Morelli', 'H', 'Van', 'Aken', 'S', 'Rehberg', 'C', 'Ertmer', 'P175', 'Alterations', 'of', 'conjunctival', 'microcirculation', 'in', 'a', 'sheep', 'model', 'of', 'haemorrhagic', 'shock', 'and', 'resuscitation', 'with', '0', '9', 'saline', 'or', 'balanced', 'tetrastarch', 'P', 'Arnemann', 'M', 'Hessler', 'T', 'Kampmeier', 'S', 'Rehberg', 'H', 'Van', 'Aken', 'C', 'Ince', 'C', 'Ertmer', 'P176', 'A', 'single', 'centre', 'nested', 'pilot', 'study', 'investigating', 'the', 'effect', 'of', 'using', '0', '9', 'saline', 'or', 'Plasma', 'Lyte', '148', 'as', 'crystalloid', 'fluid', 'therapy', 'on', 'gastrointestinal', 'feeding', 'intolerance', 'in', 'mechanically', 'ventilated', 'patients', 'receiving', 'nasogastric', 'enteral', 'nutrition', 'S', 'Reddy', 'M', 'Bailey', 'R', 'Beasley', 'R', 'Bellomo', 'D', 'Mackle', 'A', 'Psirides', 'P', 'Young', 'P177', 'A', 'single', 'centre', 'nested', 'pilot', 'study', 'investigating', 'the', 'effect', 'on', 'post', 'operative', 'bleeding', 'of', 'using', '0', '9', 'saline', 'or', 'Plasma', 'Lyte', '148', 'as', 'crystalloid', 'fluid', 'therapy', 'in', 'adults', 'in', 'ICU', 'after', 'heart', 'surgery', 'S', 'Reddy', 'M', 'Bailey', 'R', 'Beasley', 'R', 'Bellomo', 'D', 'Mackle', 'P', 'Young', 'P178', 'Extreme', 'hypernatremia', 'and', 'sepsis', 'in', 'a', 'patient', 'with', 'Huntington', 's', 'dementia', 'a', 'conundrum', 'in', 'fluid', 'management', 'H', 'Venkatesh', 'S', 'Ramachandran', 'A', 'Basu', 'H', 'Nair', 'P179', 'Diagnosis', 'and', 'management', 'of', 'severe', 'hypernatraemia', 'in', 'the', 'critical', 'care', 'setting', 'S', 'Egan', 'J', 'Bates', 'P180', 'Correlation', 'between', 'arterial', 'blood', 'gas', 'and', 'electrolyte', 'disturbances', 'during', 'hospitalization', 'and', 'outcome', 'in', 'critically', 'ill', 'patients', 'S', 'Oliveira', 'N', 'R', 'Rangel', 'Neto', 'F', 'Q', 'Reis', 'P181', 'Missing', 'the', 'I', 'in', 'MUDPILES', 'a', 'rare', 'cause', 'of', 'high', 'anion', 'gap', 'metabolic', 'acidosis', 'HAGMA', 'C', 'P', 'Lee', 'X', 'L', 'Lin', 'C', 'Choong', 'K', 'M', 'Eu', 'W', 'Y', 'Sim', 'K', 'S', 'Tee', 'J', 'Pau', 'J', 'Abisheganaden', 'P182', 'Plasma', 'NGAL', 'and', 'urinary', 'output', 'potential', 'parameters', 'for', 'early', 'initiation', 'of', 'renal', 'replacement', 'therapy', 'K', 'Maas', 'H', 'De', 'Geus', 'P183', 'Renal', 'replacement', 'therapy', 'for', 'critically', 'ill', 'patients', 'an', 'intermittent', 'continuity', 'E', 'Lafuente', 'R', 'Marinho', 'J', 'Moura', 'R', 'Antunes', 'A', 'Marinho', 'P184', 'A', 'survey', 'of', 'practices', 'related', 'to', 'renal', 'replacement', 'therapy', 'in', 'critically', 'ill', 'patients', 'in', 'the', 'north', 'of', 'England', 'T', 'E', 'Doris', 'D', 'Monkhouse', 'T', 'Shipley', 'S', 'Kardasz', 'I', 'Gonzalez', 'P185', 'High', 'initiation', 'creatinine', 'associated', 'with', 'lower', '28', 'day', 'mortality', 'in', 'critically', 'ill', 'patients', 'necessitating', 'continuous', 'renal', 'replacement', 'therapy', 'S', 'Stads', 'A', 'J', 'Groeneveld', 'P186', 'The', 'impact', 'of', 'Karnofsky', 'performance', 'scale', 'on', 'outcomes', 'in', 'acute', 'kidney', 'injury', 'patients', 'receiving', 'renal', 'replacement', 'therapy', 'on', 'the', 'intensive', 'care', 'unit', 'I', 'Elsayed', 'N', 'Ward', 'A', 'Tridente', 'A', 'Raithatha', 'P187', 'Severe', 'hypophosphatemia', 'during', 'citrate', 'anticoagulated', 'CRRT', 'A', 'Steuber', 'C', 'Pelletier', 'S', 'Schroeder', 'E', 'Michael', 'T', 'Slowinski', 'D', 'Kindgen', 'Milles', 'P188', 'Citrate', 'regional', 'anticoagulation', 'for', 'post', 'dilution', 'continuous', 'renal', 'replacement', 'therapy', 'S', 'Ghabina', 'P189', 'Citrate', '18', 'mmol', 'l', 'improves', 'anticoagulation', 'during', 'RRT', 'with', 'adsorbing', 'filters', 'F', 'Turani', 'A', 'Belli', 'S', 'Busatti', 'G', 'Barettin', 'F', 'Candidi', 'F', 'Gargano', 'R', 'Barchetta', 'M', 'Falco', 'P190', 'Calcium', 'gluconate', 'instead', 'of', 'calcium', 'chloride', 'in', 'citrate', 'anticoagulated', 'CVVHD', 'O', 'Demirkiran', 'M', 'Kosuk', 'S', 'Bozbay', 'P191', 'Enhanced', 'clearance', 'of', 'interleukin', '6', 'with', 'continuous', 'veno', 'venous', 'haemodialysis', 'CVVHD', 'using', 'Ultraflux', 'EMiC2', 'vs', 'Ultraflux', 'AV1000S', 'V', 'Weber', 'J', 'Hartmann', 'S', 'Harm', 'I', 'Linsberger', 'T', 'Eichhorn', 'G', 'Valicek', 'G', 'Miestinger', 'C', 'Hoermann', 'P192', 'Removal', 'of', 'bilirubin', 'with', 'a', 'new', 'adsorbent', 'system', 'in', 'vitro', 'kinetics', 'S', 'Faenza', 'D', 'Ricci', 'E', 'Mancini', 'C', 'Gemelli', 'A', 'Cuoghi', 'S', 'Magnani', 'M', 'Atti', 'P193', 'Case', 'series', 'of', 'patients', 'with', 'severe', 'sepsis', 'and', 'septic', 'shock', 'treated', 'with', 'a', 'new', 'extracorporeal', 'sorbent', 'T', 'Laddomada', 'A', 'Doronzio', 'B', 'Balicco', 'P194', 'In', 'vitro', 'adsorption', 'of', 'a', 'broad', 'spectrum', 'of', 'inflammatory', 'mediators', 'with', 'CytoSorb', 'hemoadsorbent', 'polymer', 'beads', 'M', 'C', 'Gruda', 'P', 'O', 'Sullivan', 'V', 'P', 'Dan', 'T', 'Guliashvili', 'A', 'Scheirer', 'T', 'D', 'Golobish', 'V', 'J', 'Capponi', 'P', 'P', 'Chan', 'P195', 'Observations', 'in', 'early', 'vs', 'late', 'use', 'of', 'cytosorb', 'therapy', 'in', 'critically', 'ill', 'patients', 'K', 'Kogelmann', 'M', 'Drüner', 'D', 'Jarczak', 'P196', 'Oxiris', 'membrane', 'decreases', 'endotoxin', 'during', 'rrt', 'in', 'septic', 'patients', 'with', 'basal', 'EAA', '0', '6', 'F', 'Turani', 'A', 'B', 'Belli', 'S', 'M', 'Martni', 'V', 'C', 'Cotticelli', 'F', 'Mounajergi', 'R', 'Barchetta', 'P197', 'An', 'observational', 'prospective', 'study', 'on', 'the', 'onset', 'of', 'augmented', 'renal', 'clearance', 'the', 'first', 'report', 'S', 'Morimoto', 'H', 'Ishikura', 'P198', 'An', 'ultrasound', 'guided', 'algorithm', 'for', 'the', 'management', 'of', 'oliguria', 'in', 'severe', 'sepsis', 'I', 'Hussain', 'N', 'Salahuddin', 'A', 'Nadeem', 'K', 'Ghorab', 'K', 'Maghrabi', 'P199', 'Ultrasound', 'in', 'acute', 'kidney', 'injury', 'aki', 'First', 'findings', 'of', 'farius', 'an', 'education', 'programme', 'in', 'structural', 'ultrasonography', 'S', 'K', 'Kloesel', 'C', 'Goldfuss', 'A', 'Stieglitz', 'A', 'S', 'Stieglitz', 'L', 'Krstevska', 'G', 'Albuszies', 'P200', 'Effectiveness', 'of', 'renal', 'angina', 'index', 'score', 'predicting', 'acute', 'kidney', 'injury', 'on', 'critically', 'ill', 'patients', 'M', 'Aguilar', 'Arzapalo', 'L', 'Barradas', 'V', 'Lopez', 'A', 'Escalante', 'G', 'Jimmy', 'M', 'Cetina', 'P201', 'Time', 'length', 'below', 'blood', 'pressure', 'thresholds', 'and', 'progression', 'of', 'acute', 'kidney', 'injury', 'in', 'critically', 'ill', 'patients', 'with', 'or', 'without', 'sepsis', 'a', 'retrospective', 'exploratory', 'cohort', 'study', 'J', 'Izawa', 'T', 'Iwami', 'S', 'Uchino', 'M', 'Takinami', 'T', 'Kitamura', 'T', 'Kawamura', 'P202', 'Anaemia', 'does', 'not', 'affect', 'renal', 'recovery', 'in', 'acute', 'kidney', 'injury', 'J', 'G', 'Powell', 'Tuck', 'S', 'Crichton', 'M', 'Raimundo', 'L', 'Camporota', 'D', 'Wyncoll', 'M', 'Ostermann', 'P203', 'Estimated', 'glomerular', 'filtration', 'rate', 'based', 'on', 'serum', 'creatinine', 'actual', 'practice', 'in', 'Dutch', 'ICU', 's', 'A', 'Hana', 'H', 'R', 'De', 'Geus', 'P204', 'Comparison', 'of', 'estimated', 'glomerular', 'filtration', 'rate', 'calculated', 'by', 'mdrd', 'ckd', 'epi', 'serum', 'creatinine', 'and', 'ckd', 'epi', 'cystatin', 'c', 'in', 'adult', 'critically', 'ill', 'patients', 'H', 'R', 'De', 'Geus', 'A', 'Hana', 'P205', 'Early', 'diagnosis', 'of', 'septic', 'acute', 'kidney', 'injury', 'in', 'medical', 'critical', 'care', 'patients', 'with', 'a', 'urine', 'cell', 'cycle', 'arrest', 'marker', 'insulin', 'like', 'growth', 'factor', 'binding', 'protein', '7', 'IGFBP', '7', 'M', 'Aydogdu', 'N', 'Boyaci', 'S', 'Yuksel', 'G', 'Gursel', 'A', 'B', 'Cayci', 'Sivri', 'P206', 'Urinary', 'neutrophil', 'gelatinase', 'associated', 'lipocalin', 'as', 'early', 'biomarker', 'of', 'severe', 'acute', 'kidney', 'injury', 'in', 'intensive', 'care', 'J', 'Meza', 'Márquez', 'J', 'Nava', 'López', 'R', 'Carrillo', 'Esper', 'P207', 'Shrunken', 'pore', 'syndrome', 'is', 'associated', 'with', 'a', 'sharp', 'rise', 'in', 'mortality', 'in', 'patients', 'undergoing', 'elective', 'coronary', 'artery', 'bypass', 'grafting', 'A', 'Dardashti', 'A', 'Grubb', 'P208', 'The', 'biomarker', 'nephrocheck', 'can', 'discriminate', 'the', 'septic', 'shock', 'patients', 'with', 'an', 'akin', '1', 'or', '2', 'acute', 'renal', 'failure', 'who', 'will', 'not', 'progress', 'toward', 'the', 'akin', '3', 'level', 'J', 'Maizel', 'M', 'Wetzstein', 'D', 'Titeca', 'L', 'Kontar', 'F', 'Brazier', 'B', 'De', 'Cagny', 'A', 'Riviere', 'T', 'Soupison', 'M', 'Joris', 'M', 'Slama', 'P209', 'A', 'worldwide', 'multicentre', 'evaluation', 'of', 'acute', 'kidney', 'injury', 'in', 'septic', 'and', 'non', 'septic', 'critically', 'ill', 'patients', 'the', 'intensive', 'care', 'over', 'nations', 'icon', 'audit', 'E', 'Peters', 'H', 'Njimi', 'P', 'Pickkers', 'J', 'L', 'Vincent', 'P210', 'Does', 'enhanced', 'recovery', 'after', 'surgery', 'reduce', 'the', 'incidence', 'of', 'acute', 'kidney', 'injury', 'in', 'those', 'undergoing', 'major', 'gynae', 'oncological', 'surgery', 'M', 'Waraich', 'J', 'Doyle', 'T', 'Samuels', 'L', 'Forni', 'P211', 'Identification', 'of', 'risk', 'factors', 'for', 'the', 'development', 'of', 'acute', 'kidney', 'injury', 'after', 'lower', 'limb', 'arthroplasty', 'N', 'Desai', 'R', 'Baumber', 'P', 'Gunning', 'A', 'Sell', 'P212', 'Incidences', 'and', 'associations', 'of', 'acute', 'kidney', 'injury', 'after', 'major', 'trauma', 'S', 'Lin', 'H', 'Torrence', 'M', 'O', 'Dwyer', 'C', 'Kirwan', 'J', 'Prowle', 'P213', 'Acute', 'kidney', 'injury', 'of', 'major', 'trauma', 'patients', 'T', 'Kim', 'P214', 'Trajectory', 'of', 'serum', 'creatinine', 'after', 'major', 'surgery', 'and', 'the', 'diagnosis', 'of', 'acute', 'kidney', 'injury', 'M', 'E', 'O', 'Connor', 'R', 'W', 'Hewson', 'C', 'J', 'Kirwan', 'R', 'M', 'Pearse', 'J', 'Prowle', 'P215', 'Epidemiology', 'of', 'acute', 'kidney', 'injury', 'after', 'cardiac', 'surgery', 'A', 'single', 'center', 'retrospective', 'study', 'S', 'Hanoura', 'A', 'Omar', 'H', 'Othamn', 'S', 'Sudarsanan', 'M', 'Allam', 'M', 'Maksoud', 'R', 'Singh', 'A', 'Al', 'Khulaifi', 'P216', 'Post', 'operative', 'acute', 'kidney', 'injury', 'after', 'major', 'non', 'cardiac', 'surgery', 'and', 'its', 'association', 'with', 'death', 'in', 'the', 'following', 'year', 'M', 'E', 'O', 'Connor', 'R', 'W', 'Hewson', 'C', 'J', 'Kirwan', 'R', 'M', 'Pearse', 'J', 'Prowle', 'P217', 'Factors', 'affecting', 'acute', 'renal', 'failure', 'in', 'intensive', 'care', 'unit', 'and', 'effect', 'of', 'these', 'factors', 'on', 'mortality', 'O', 'Uzundere', 'D', 'Memis', 'M', 'Ýnal', 'A', 'N', 'Turan', 'P218', 'Results', 'of', 'the', 'live', 'kidney', 'transplantations', 'according', 'to', 'national', 'data', 'of', 'turkish', 'organ', 'and', 'tissue', 'information', 'system', 'M', 'A', 'Aydin', 'H', 'Basar', 'I', 'Sencan', 'A', 'Kapuagasi', 'M', 'Ozturk', 'Z', 'Uzundurukan', 'D', 'Gokmen', 'A', 'Ozcan', 'C', 'Kaymak', 'P219', 'Anaesthesia', 'procedure', 'and', 'intensive', 'therapy', 'in', 'patients', 'with', 'neck', 'phlegmon', 'V', 'A', 'Artemenko', 'A', 'Budnyuk', 'P220', 'Nasal', 'high', 'flow', 'oygen', 'for', 'acute', 'respiratory', 'failure', 'a', 'systematic', 'review', 'R', 'Pugh', 'S', 'Bhandari', 'P221', 'Setting', 'optimal', 'flow', 'rate', 'during', 'high', 'flow', 'nasal', 'cannula', 'support', 'preliminary', 'results', 'T', 'Mauri', 'C', 'Turrini', 'T', 'Langer', 'P', 'Taccone', 'C', 'A', 'Volta', 'C', 'Marenghi', 'L', 'Gattinoni', 'A', 'Pesenti', 'P222', 'Dose', 'to', 'dose', 'consistency', 'across', 'two', 'different', 'gas', 'flow', 'rates', 'using', 'cystic', 'fibrosis', 'and', 'normal', 'adult', 'breathing', 'profiles', 'during', 'nasal', 'high', 'flow', 'oxygen', 'therapy', 'L', 'Sweeney', 'A', 'O', 'Sullivan', 'P', 'Kelly', 'E', 'Mukeria', 'R', 'MacLoughlin', 'P223', 'Final', 'results', 'of', 'an', 'evaluation', 'of', 'airway', 'medix', 'closed', 'suction', 'system', 'compared', 'to', 'a', 'standard', 'closed', 'suction', 'system', 'M', 'Pfeffer', 'J', 'T', 'Thomas', 'G', 'B', 'Bregman', 'G', 'K', 'Karp', 'E', 'K', 'Kishinevsky', 'D', 'S', 'Stavi', 'N', 'A', 'Adi', 'P224', 'Different', 'cuff', 'materials', 'and', 'different', 'leak', 'tests', 'one', 'size', 'does', 'not', 'fit', 'all', 'T', 'Poropat', 'R', 'Knafelj', 'P225', 'Observational', 'study', 'on', 'the', 'value', 'of', 'the', 'cuff', 'leak', 'test', 'and', 'the', 'onset', 'of', 'upper', 'airway', 'obstruction', 'after', 'extubation', 'E', 'Llopart', 'M', 'Batlle', 'C', 'De', 'Haro', 'J', 'Mesquida', 'A', 'Artigas', 'P226', 'A', 'device', 'for', 'emergency', 'transtracheal', 'lung', 'ventilation', 'D', 'Pavlovic', 'L', 'Lewerentz', 'A', 'Spassov', 'R', 'Schneider', 'P227', 'Long', 'term', 'outcome', 'and', 'health', 'related', 'quality', 'of', 'life', 'in', 'patients', 'discharged', 'from', 'the', 'intensive', 'care', 'unit', 'with', 'a', 'tracheostomy', 'and', 'with', 'or', 'without', 'prolonged', 'mechanical', 'ventilation', 'S', 'De', 'Smet', 'S', 'De', 'Raedt', 'E', 'Derom', 'P', 'Depuydt', 'S', 'Oeyen', 'D', 'Benoit', 'J', 'Decruyenaere', 'P228', 'Ultrasound', 'guided', 'percutaneous', 'dilational', 'tracheostomy', 'versus', 'bronchoscopy', 'guided', 'percutaneous', 'dilational', 'tracheostomy', 'in', 'critically', 'ill', 'patients', 'trachus', 'a', 'randomized', 'clinical', 'trial', 'A', 'Gobatto', 'B', 'Bese', 'P', 'Tierno', 'L', 'Melro', 'P', 'Mendes', 'F', 'Cadamuro', 'M', 'Park', 'L', 'M', 'Malbouisson', 'P229', 'Is', 'it', 'safe', 'to', 'discharge', 'patients', 'with', 'tracheostomy', 'from', 'the', 'ICU', 'to', 'the', 'ward', 'B', 'C', 'Civanto', 'J', 'L', 'Lopez', 'A', 'Robles', 'J', 'Figueira', 'S', 'Yus', 'A', 'Garcia', 'P230', 'The', 'application', 'of', 'tracheostomy', 'in', 'children', 'in', 'ICU', 'A', 'Oglinda', 'G', 'Ciobanu', 'C', 'Oglinda', 'L', 'Schirca', 'T', 'Sertinean', 'V', 'Lupu', 'P231', 'The', 'impact', 'of', 'passive', 'humidifiers', 'on', 'aerosol', 'drug', 'delivery', 'during', 'mechanical', 'ventilation', 'P', 'Kelly', 'A', 'O', 'Sullivan', 'L', 'Sweeney', 'R', 'MacLoughlin', 'P232', 'Evaluation', 'of', 'vibrating', 'mesh', 'and', 'jet', 'nebuliser', 'performance', 'at', 'two', 'different', 'attachment', 'setups', 'in', 'line', 'with', 'a', 'humidifier', 'nebuliser', 'system', 'A', 'O', 'Sullivan', 'P', 'Kelly', 'L', 'Sweeney', 'E', 'Mukeria', 'M', 'Wolny', 'R', 'MacLoughlin', 'P233', 'Psv', 'niv', 'versus', 'cpap', 'in', 'the', 'treatment', 'of', 'acute', 'cardiogenic', 'pulmonary', 'edema', 'A', 'Pagano', 'F', 'Numis', 'G', 'Vison', 'L', 'Saldamarco', 'T', 'Russo', 'G', 'Porta', 'F', 'Paladino', 'P234', 'Noninvasive', 'ventilation', 'in', 'patients', 'with', 'haematologic', 'malignancy', 'a', 'retrospective', 'review', 'C', 'Bell', 'J', 'Liu', 'J', 'Debacker', 'C', 'Lee', 'E', 'Tamberg', 'V', 'Campbell', 'S', 'Mehta', 'P235', 'Use', 'of', 'non', 'invasive', 'ventilation', 'in', 'infectious', 'diseases', 'besides', 'classical', 'indications', 'A', 'Silva', 'Pinto', 'A', 'Sarmento', 'L', 'Santos', 'P236', 'The', 'impact', 'of', 'fragility', 'on', 'noninvasive', 'mechanical', 'ventilation', 'application', 'and', 'results', 'in', 'the', 'ICU', 'Ý', 'Kara', 'F', 'Yýldýrým', 'A', 'Zerman', 'Z', 'Güllü', 'N', 'Boyacý', 'B', 'Basarýk', 'Aydogan', 'Ü', 'Gaygýsýz', 'K', 'Gönderen', 'G', 'Arýk', 'M', 'Turkoglu', 'M', 'Aydogdu', 'G', 'Aygencel', 'Z', 'Ülger', 'G', 'Gursel', 'P237', 'Effects', 'of', 'metabolic', 'alkalosis', 'on', 'noninvasive', 'ventilation', 'success', 'and', 'ICU', 'outcome', 'in', 'patients', 'with', 'hypercapnic', 'respiratory', 'failure', 'N', 'Boyacý', 'Z', 'Isýkdogan', 'Ö', 'Özdedeoglu', 'Z', 'Güllü', 'M', 'Badoglu', 'U', 'Gaygýsýz', 'M', 'Aydogdu', 'G', 'Gursel', 'P238', 'Asynchrony', 'index', 'and', 'breathing', 'patterns', 'of', 'acute', 'exacerbation', 'copd', 'patients', 'assisted', 'with', 'noninvasive', 'pressure', 'support', 'ventilation', 'and', 'neurally', 'adjusted', 'ventilatory', 'assist', 'N', 'Kongpolprom', 'C', 'Sittipunt', 'P239', 'High', 'frequency', 'jet', 'ventilation', 'for', 'severe', 'acute', 'hypoxemia', 'A', 'Eden', 'Y', 'Kokhanovsky', 'S', 'Bursztein', 'De', 'Myttenaere', 'R', 'Pizov', 'P240', 'HFOV', 'revisited', 'a', '7', 'year', 'retrospective', 'analysis', 'of', 'patients', 'receiving', 'HFOV', 'who', 'met', 'oscillate', 'trial', 'entry', 'criteria', 'L', 'Neilans', 'N', 'MacIntyre', 'P241', 'Implementation', 'of', 'a', 'goal', 'directed', 'mechanical', 'ventilation', 'order', 'set', 'driven', 'by', 'respiratory', 'therapists', 'can', 'improve', 'compliance', 'with', 'best', 'practices', 'for', 'mechanical', 'ventilation', 'M', 'Radosevich', 'B', 'Wanta', 'V', 'Weber', 'T', 'Meyer', 'N', 'Smischney', 'D', 'Brown', 'D', 'Diedrich', 'P242', 'A', 'reduction', 'in', 'tidal', 'volumes', 'for', 'ventilated', 'patients', 'on', 'ICU', 'calculated', 'from', 'IBW', 'can', 'it', 'minimise', 'mortality', 'in', 'comparison', 'to', 'traditional', 'strategies', 'A', 'Fuller', 'P', 'McLindon', 'K', 'Sim', 'P243', 'Predictive', 'value', 'of', 'lung', 'aeration', 'scoring', 'using', 'lung', 'ultrasound', 'in', 'weaning', 'failure', 'M', 'Shoaeir', 'K', 'Noeam', 'A', 'Mahrous', 'R', 'Matsa', 'A', 'Ali', 'P244', 'Conventional', 'versus', 'automated', 'weaning', 'from', 'mechanical', 'ventilation', 'using', 'SmartCare', 'C', 'Dridi', 'S', 'Koubaji', 'S', 'Kamoun', 'F', 'Haddad', 'A', 'Ben', 'Souissi', 'B', 'Laribi', 'A', 'Riahi', 'M', 'S', 'Mebazaa', 'P245', 'Ultrasonographic', 'evaluation', 'protocol', 'for', 'weaning', 'from', 'mechanichal', 'ventilation', 'A', 'Pérez', 'Calatayud', 'R', 'Carrillo', 'Esper', 'A', 'Zepeda', 'Mendoza', 'M', 'Diaz', 'Carrillo', 'E', 'Arch', 'Tirado', 'P246', 'Diaphragm', 'ultrasonography', 'a', 'method', 'for', 'weaning', 'patients', 'from', 'mechanical', 'ventilation', 'S', 'Carbognin', 'L', 'Pelacani', 'F', 'Zannoni', 'A', 'Agnoli', 'G', 'Gagliardi', 'P247', 'Dorsal', 'diaphragmatic', 'excursion', 'tracks', 'transpulmonary', 'pressure', 'in', 'ventilated', 'ARDS', 'patients', 'a', 'potential', 'non', 'invasive', 'indicator', 'of', 'lung', 'recruitment', 'R', 'Cho', 'A', 'Adams', 'S', 'Lunos', 'S', 'Ambur', 'R', 'Shapiro', 'M', 'Prekker', 'P248', 'Pulse', 'oximetry', 'in', 'the', 'icu', 'patient', 'is', 'the', 'perfusion', 'index', 'of', 'any', 'value', 'M', 'Thijssen', 'L', 'Janssen', 'N', 'Foudraine', 'P249', 'Ventilation', 'is', 'a', 'better', 'assessment', 'of', 'respiratory', 'status', 'than', 'EtCO2', 'C', 'J', 'Voscopoulos', 'J', 'Freeman', 'P250', 'Evaluation', 'of', 'the', 'relationship', 'between', 'non', 'invasive', 'minute', 'ventilation', 'and', 'end', 'tidal', 'CO2', 'in', 'patients', 'undergoing', 'general', 'vs', 'spinal', 'anesthesia', 'C', 'J', 'Voscopoulos', 'J', 'Freeman', 'E', 'George', 'P251', 'Respiratory', 'volume', 'monitoring', 'provides', 'early', 'warning', 'of', 'respiratory', 'depression', 'and', 'can', 'be', 'used', 'to', 'reduce', 'false', 'alarms', 'in', 'non', 'intubated', 'patients', 'C', 'J', 'Voscopoulos', 'D', 'Eversole', 'J', 'Freeman', 'E', 'George', 'P252', 'P', 'i', 'index', 'a', 'predictive', 'edi', 'derived', 'weaning', 'index', 'during', 'nava', 'S', 'Muttini', 'R', 'Bigi', 'G', 'Villani', 'N', 'Patroniti', 'P253', 'Adequacy', 'of', 'ventilation', 'in', 'patients', 'receiving', 'opioids', 'in', 'the', 'post', 'anesthesia', 'care', 'unit', 'minute', 'ventilation', 'versus', 'respiratory', 'rate', 'G', 'Williams', 'C', 'J', 'Voscopoulos', 'J', 'Freeman', 'E', 'George', 'P254', 'Comparison', 'of', 'regional', 'and', 'global', 'expiratory', 'time', 'constants', 'measured', 'by', 'electrical', 'impedance', 'tomography', 'EIT', 'A', 'Waldmann', 'S', 'Böhm', 'W', 'Windisch', 'S', 'Strassmann', 'C', 'Karagiannidis', 'P255', 'Electrical', 'impedance', 'tomography', 'robustness', 'of', 'a', 'new', 'pixel', 'wise', 'regional', 'expiratory', 'time', 'constant', 'calculation', 'A', 'Waldmann', 'S', 'Böhm', 'W', 'Windisch', 'S', 'Strassmann', 'C', 'Karagiannidis', 'P256', 'Validation', 'of', 'regional', 'and', 'global', 'expiratory', 'time', 'constant', 'measurement', 'by', 'electrical', 'impedance', 'tomography', 'in', 'ards', 'and', 'obstructive', 'pulmonary', 'diseases', 'C', 'K', 'Karagiannidis', 'A', 'W', 'Waldmann', 'S', 'B', 'Böhm', 'S', 'Strassmann', 'W', 'W', 'Windisch', 'P257', 'Transpulmonary', 'pressure', 'in', 'a', 'model', 'with', 'elastic', 'recoiling', 'lung', 'and', 'expanding', 'chest', 'wall', 'P', 'Persson', 'S', 'Lundin', 'O', 'Stenqvist', 'P258', 'Lactate', 'in', 'pleural', 'and', 'abdominal', 'effusion', 'G', 'Porta', 'F', 'Numis', 'C', 'S', 'Serra', 'A', 'P', 'Pagano', 'M', 'M', 'Masarone', 'L', 'R', 'Rinaldi', 'A', 'A', 'Amelia', 'M', 'F', 'Fascione', 'L', 'A', 'Adinolfi', 'E', 'R', 'Ruggiero', 'P259', 'Outcome', 'of', 'patients', 'admitted', 'to', 'the', 'intensive', 'care', 'with', 'pulmonary', 'fibrosis', 'F', 'Asota', 'K', 'O', 'Rourke', 'S', 'Ranjan', 'P', 'Morgan', 'P260', 'Sedation', 'and', 'analgesia', 'practice', 'in', 'extra', 'corporeal', 'membrane', 'oxygenation', 'ECMO', 'treated', 'patients', 'with', 'acute', 'respiratory', 'distress', 'syndrome', 'ARDS', 'a', 'retrospective', 'study', 'J', 'W', 'DeBacker', 'E', 'Tamberg', 'L', 'O', 'Neill', 'L', 'Munshi', 'L', 'Burry', 'E', 'Fan', 'S', 'Mehta', 'P261', 'Characteristics', 'and', 'outcomes', 'of', 'patients', 'deemed', 'not', 'eligible', 'when', 'referred', 'for', 'veno', 'venous', 'extracorporeal', 'membrane', 'oxygenation', 'vv', 'ECMO', 'S', 'Poo', 'K', 'Mahendran', 'J', 'Fowles', 'C', 'Gerrard', 'A', 'Vuylsteke', 'P262', 'The', 'SAVE', 'SMR', 'for', 'veno', 'arterial', 'ECMO', 'R', 'Loveridge', 'C', 'Chaddock', 'S', 'Patel', 'V', 'Kakar', 'C', 'Willars', 'T', 'Hurst', 'C', 'Park', 'T', 'Best', 'A', 'Vercueil', 'G', 'Auzinger', 'P263', 'A', 'simplified', 'score', 'to', 'predict', 'early', '48', 'h', 'mortality', 'in', 'patients', 'being', 'considered', 'for', 'VA', 'ECMO', 'A', 'Borgman', 'A', 'G', 'Proudfoot', 'E', 'Grins', 'K', 'E', 'Emiley', 'J', 'Schuitema', 'S', 'J', 'Fitch', 'G', 'Marco', 'J', 'Sturgill', 'M', 'G', 'Dickinson', 'M', 'Strueber', 'A', 'Khaghani', 'P', 'Wilton', 'S', 'M', 'Jovinge', 'P264', 'Lung', 'function', 'six', 'months', 'post', 'extra', 'corporeal', 'membrane', 'oxygenation', 'ECMO', 'for', 'severe', 'acute', 'respiratory', 'failure', 'in', 'adult', 'survivors', 'C', 'Sampson', 'S', 'Harris', 'Fox', 'P265', 'Bicarbonate', 'dialysis', 'removes', 'carbon', 'dioxide', 'in', 'hypoventilated', 'rodents', 'M', 'E', 'Cove', 'L', 'H', 'Vu', 'A', 'Sen', 'W', 'J', 'Federspiel', 'J', 'A', 'Kellum', 'P266', 'Procalcitonin', 'as', 'predictor', 'of', 'primary', 'graft', 'dysfunction', 'and', 'mortality', 'in', 'post', 'lung', 'transplantation', 'C', 'Mazo', 'Torre', 'J', 'Riera', 'S', 'Ramirez', 'B', 'Borgatta', 'L', 'Lagunes', 'J', 'Rello', 'P267', 'New', 'molecular', 'biomarkers', 'of', 'acute', 'respiratory', 'distress', 'syndrome', 'in', 'abdominal', 'sepsis', 'A', 'K', 'Kuzovlev', 'V', 'Moroz', 'A', 'Goloubev', 'S', 'Polovnikov', 'S', 'Nenchuk', 'P268', 'Tight', 'junction', 's', 'proteins', 'claudin', '5', 'and', 'regulation', 'by', 'tnf', 'in', 'experimental', 'murine', 'lung', 'injury', 'model', 'of', 'ali', 'ards', 'V', 'Karavana', 'C', 'Glynos', 'A', 'Asimakos', 'K', 'Pappas', 'C', 'Vrettou', 'M', 'Magkou', 'E', 'Ischaki', 'G', 'Stathopoulos', 'S', 'Zakynthinos', 'P269', 'Cell', 'counts', 'in', 'endobronchial', 'aspirate', 'to', 'assess', 'airway', 'inflammation', 'in', 'ARDS', 'patients', 'a', 'pilot', 'study', 'S', 'Spadaro', 'I', 'Kozhevnikova', 'F', 'Dalla', 'Corte', 'S', 'Grasso', 'P', 'Casolari', 'G', 'Caramori', 'C', 'Volta', 'P270', 'Epidemiological', 'and', 'clinical', 'profile', 'of', 'patients', 'with', 'acute', 'respiratory', 'distress', 'syndrome', 'in', 'the', 'surgical', 'intensive', 'care', 'unit', 'surgical', 'hospital', 'JRA', 'Antananarivo', 'T', 'Andrianjafiarinoa', 'T', 'Randriamandrato', 'T', 'Rajaonera', 'P271', 'Effect', 'of', 'high', 'PEEP', 'after', 'recruitment', 'maneuver', 'on', 'right', 'ventricular', 'function', 'in', 'ARDS', 'Is', 'it', 'good', 'for', 'the', 'lung', 'and', 'for', 'the', 'heart', 'S', 'El', 'Dash', 'ELV', 'Costa', 'MR', 'Tucci', 'F', 'Leleu', 'L', 'Kontar', 'B', 'De', 'Cagny', 'F', 'Brazier', 'D', 'Titeca', 'G', 'Bacari', 'Risal', 'J', 'Maizel', 'M', 'Amato', 'M', 'Slama', 'P272', 'Effect', 'of', 'recruitment', 'maneuver', 'on', 'left', 'ventricular', 'systolic', 'strain', 'P', 'Mercado', 'J', 'Maizel', 'L', 'Kontar', 'D', 'Titeca', 'F', 'Brazier', 'A', 'Riviere', 'M', 'Joris', 'T', 'Soupison', 'B', 'De', 'Cagny', 'S', 'El', 'Dash', 'M', 'Slama', 'P273', 'Inhaled', 'nitric', 'oxide', 'is', 'switching', 'supplier', 'cost', 'effective', 'Remmington', 'A', 'Fischer', 'S', 'Squire', 'M', 'Boichat', 'P274', 'Epidemiological', 'study', 'of', 'severe', 'acute', 'pancreatitis', 'in', 'Japan', 'comparison', 'of', 'the', 'etiology', 'and', 'the', 'patient', 'outcomes', 'on', '1159', 'patients', 'H', 'Honzawa', 'H', 'Yasuda', 'T', 'Adati', 'S', 'Suzaki', 'M', 'Horibe', 'M', 'Sasaki', 'M', 'Sanui', 'P275', 'Extracorporeal', 'liver', 'support', 'therapy', 'Experience', 'in', 'an', 'intensive', 'care', 'unit', 'R', 'Marinho', 'J', 'Daniel', 'H', 'Miranda', 'A', 'Marinho', 'P276', 'Accuracy', 'of', 'mortality', 'prediction', 'models', 'in', 'acute', 'versus', 'acute', 'on', 'chronic', 'liver', 'failure', 'in', 'the', 'intensive', 'care', 'setting', 'K', 'Milinis', 'M', 'Cooper', 'G', 'R', 'Williams', 'E', 'McCarron', 'S', 'Simants', 'I', 'Patanwala', 'I', 'Welters', 'P277', 'Risk', 'of', 'coronary', 'artery', 'disease', 'in', 'patients', 'with', 'chronic', 'liver', 'disease', 'a', 'population', 'based', 'cohort', 'study', 'Y', 'Su', 'P278', '20', 'years', 'of', 'liver', 'transplantation', 'in', 'Santiago', 'de', 'Compostela', 'Spain', 'Experience', 'review', 'J', 'Fernández', 'Villanueva', 'R', 'Fernández', 'Garda', 'A', 'López', 'Lago', 'E', 'Rodríguez', 'Ruíz', 'R', 'Hernández', 'Vaquero', 'S', 'Tomé', 'Martínez', 'de', 'Rituerto', 'E', 'Varo', 'Pérez', 'P279', 'Diarrhea', 'is', 'a', 'risk', 'factor', 'for', 'liver', 'injury', 'and', 'may', 'lead', 'to', 'intestinal', 'failure', 'associated', 'liver', 'disease', 'in', 'critical', 'illness', 'N', 'Lefel', 'F', 'Schaap', 'D', 'Bergmans', 'S', 'Olde', 'Damink', 'M', 'Van', 'de', 'Poll', 'P280', 'Bowel', 'care', 'on', 'the', 'intensive', 'care', 'unit', 'constipation', 'guideline', 'compliance', 'and', 'complications', 'K', 'Tizard', 'C', 'Lister', 'L', 'Poole', 'P281', 'Malnutrition', 'assessed', 'by', 'phase', 'angle', 'determines', 'outcomes', 'in', 'low', 'risk', 'cardiac', 'surgery', 'patients', 'D', 'Ringaitiene', 'D', 'Gineityte', 'V', 'Vicka', 'I', 'Norkiene', 'J', 'Sipylaite', 'P282', 'Preoperative', 'fasting', 'times', 'in', 'an', 'irish', 'hospital', 'A', 'O', 'Loughlin', 'V', 'Maraj', 'J', 'Dowling', 'P283', 'Costs', 'and', 'final', 'outcome', 'of', 'early', 'x', 'delayed', 'feeding', 'in', 'a', 'private', 'Brazil', 'ICU', 'M', 'B', 'Velasco', 'D', 'M', 'Dalcomune', 'E', 'B', 'Dias', 'S', 'L', 'Fernandes', 'P284', 'Can', 'ventilator', 'derived', 'energy', 'expenditure', 'measurements', 'replace', 'indirect', 'calorimetry', 'T', 'Oshima', 'S', 'Graf', 'C', 'Heidegger', 'L', 'Genton', 'V', 'Karsegard', 'Y', 'Dupertuis', 'C', 'Pichard', 'P285', 'Revisiting', 'the', 'refeeding', 'syndrome', 'results', 'of', 'a', 'systematic', 'review', 'N', 'Friedli', 'Z', 'Stanga', 'B', 'Mueller', 'P', 'Schuetz', 'P286', 'Compliance', 'with', 'the', 'new', 'protocol', 'for', 'parenteral', 'nutrition', 'in', 'our', 'ICU', 'L', 'Vandersteen', 'B', 'Stessel', 'S', 'Evers', 'A', 'Van', 'Assche', 'L', 'Jamaer', 'J', 'Dubois', 'P287', 'Nutrition', 'may', 'be', 'another', 'treatment', 'in', 'the', 'intensive', 'care', 'unit', 'where', 'less', 'is', 'more', 'R', 'Marinho', 'H', 'Castro', 'J', 'Moura', 'J', 'Valente', 'P', 'Martins', 'P', 'Casteloes', 'C', 'Magalhaes', 'S', 'Cabral', 'M', 'Santos', 'B', 'Oliveira', 'A', 'Salgueiro', 'A', 'Marinho', 'P288', 'Should', 'we', 'provide', 'more', 'protein', 'to', 'critically', 'ill', 'patients', 'R', 'Marinho', 'M', 'Santos', 'E', 'Lafuente', 'H', 'Castro', 'S', 'Cabral', 'J', 'Moura', 'P', 'Martins', 'B', 'Oliveira', 'A', 'Salgueiro', 'S', 'Duarte', 'S', 'Castro', 'M', 'Melo', 'P', 'Casteloes', 'A', 'Marinho', 'P289', 'Protein', 'provision', 'in', 'an', 'adult', 'intensive', 'care', 'unit', 'S', 'Gray', 'P290', 'Prevalence', 'and', 'clinical', 'outcomes', 'of', 'vitamin', 'd', 'deficiency', 'in', 'the', 'medical', 'critically', 'ill', 'patients', 'in', 'Songklanagarind', 'hospital', 'K', 'Maipang', 'R', 'Bhurayanontachai', 'P291', 'Vitamin', 'd', 'deficiency', 'strongly', 'predicts', 'adverse', 'medical', 'outcome', 'across', 'different', 'medical', 'inpatient', 'populations', 'results', 'from', 'a', 'prospective', 'study', 'L', 'G', 'Grädel', 'P', 'Schütz', 'P292', 'Omega', '3', 'fatty', 'acids', 'in', 'patients', 'undergoing', 'cardiac', 'surgery', 'a', 'systematic', 'review', 'and', 'meta', 'analysis', 'P', 'Langlois', 'W', 'Manzanares', 'P293', 'Can', '5', 'hydroxytriptophan', 'prevent', 'post', 'traumatic', 'stress', 'disorder', 'in', 'critically', 'ill', 'patients', 'R', 'Tincu', 'C', 'Cobilinschi', 'D', 'Tomescu', 'Z', 'Ghiorghiu', 'R', 'Macovei', 'P294', 'Parenteral', 'selenium', 'in', 'the', 'critically', 'ill', 'an', 'updated', 'systematic', 'review', 'and', 'meta', 'analysis', 'W', 'Manzanares', 'P', 'Langlois', 'M', 'Lemieux', 'G', 'Elke', 'F', 'Bloos', 'K', 'Reinhart', 'D', 'Heyland', 'P295', 'Probiotics', 'in', 'the', 'critically', 'ill', 'an', 'updated', 'systematic', 'review', 'and', 'meta', 'analysis', 'P', 'Langlois', 'M', 'Lemieux', 'I', 'Aramendi', 'D', 'Heyland', 'W', 'Manzanares', 'P296', 'Diabetes', 'with', 'hyperglycemic', 'crisis', 'episodes', 'may', 'be', 'associated', 'with', 'higher', 'risk', 'of', 'pancreatic', 'cancer', 'a', 'population', 'based', 'cohort', 'study', 'Y', 'Su', 'P297', 'Incidence', 'of', 'hypoglycemia', 'in', 'an', 'intensive', 'care', 'unit', 'depending', 'on', 'insulin', 'protocol', 'R', 'Marinho', 'N', 'Babo', 'A', 'Marinho', 'P298', 'Severity', 'of', 'the', 'diseases', 'is', 'two', 'dimensionally', 'correlated', 'to', 'blood', 'glucose', 'including', 'blood', 'glucose', 'variability', 'especially', 'in', 'moderately', 'to', 'severely', 'ill', 'patients', 'with', 'glucose', 'intolerance', 'M', 'Hoshino', 'Y', 'Haraguchi', 'S', 'Kajiwara', 'T', 'Mitsuhashi', 'T', 'Tsubata', 'M', 'Aida', 'P299', 'A', 'study', 'of', 'glycemic', 'control', 'by', 'subcutaneous', 'glargine', 'injection', 'transition', 'from', 'continuous', 'regular', 'insulin', 'infusion', 'in', 'critically', 'ill', 'patients', 'T', 'Rattanapraphat', 'R', 'Bhurayanontachai', 'C', 'Kongkamol', 'B', 'Khwannimit', 'P300', 'Glycemic', 'control', 'in', 'Portuguese', 'intensive', 'care', 'unit', 'R', 'Marinho', 'M', 'Santos', 'H', 'Castro', 'E', 'Lafuente', 'A', 'Salgueiro', 'S', 'Cabral', 'P', 'Martins', 'J', 'Moura', 'B', 'Oliveira', 'M', 'Melo', 'B', 'Xavier', 'J', 'Valente', 'C', 'Magalhaes', 'P', 'Casteloes', 'A', 'Marinho', 'P301', 'Impact', 'of', 'hyperglycemia', 'duration', 'on', 'the', 'day', 'of', 'operation', 'on', 'short', 'term', 'outcome', 'of', 'cardiac', 'surgery', 'patients', 'D', 'Moisidou', 'F', 'Ampatzidou', 'C', 'Koutsogiannidis', 'M', 'Moschopoulou', 'G', 'Drossos', 'P302', 'Lactate', 'levels', 'in', 'diabetic', 'ketoacidosis', 'patients', 'at', 'ICU', 'admissions', 'G', 'Taskin', 'M', 'Çakir', 'AK', 'Güler', 'A', 'Taskin', 'N', 'Öcal', 'S', 'Özer', 'L', 'Yamanel', 'P303', 'Intensive', 'care', 'implications', 'of', 'merging', 'heart', 'attack', 'centre', 'units', 'in', 'London', 'J', 'M', 'Wong', 'C', 'Fitton', 'S', 'Anwar', 'S', 'Stacey', 'P304', 'Special', 'characteristics', 'of', 'in', 'hospital', 'cardiac', 'arrests', 'M', 'Aggou', 'B', 'Fyntanidou', 'S', 'Patsatzakis', 'E', 'Oloktsidou', 'K', 'Lolakos', 'E', 'Papapostolou', 'V', 'Grosomanidis', 'P305', 'Clinical', 'evaluation', 'of', 'ICU', 'admitted', 'patients', 'who', 'were', 'resuscitated', 'in', 'the', 'general', 'medicine', 'ward', 'S', 'Suda', 'T', 'Ikeda', 'S', 'Ono', 'T', 'Ueno', 'Y', 'Izutani', 'P306', 'Serious', 'game', 'evaluation', 'of', 'a', 'one', 'hour', 'training', 'basic', 'life', 'support', 'session', 'for', 'secondary', 'school', 'students', 'new', 'tools', 'for', 'future', 'bystanders', 'S', 'Gaudry', 'V', 'Desailly', 'P', 'Pasquier', 'PB', 'Brun', 'AT', 'Tesnieres', 'JD', 'Ricard', 'D', 'Dreyfuss', 'A', 'Mignon', 'P307', 'Public', 'and', 'clinical', 'staff', 'perceptions', 'and', 'knowledge', 'of', 'CPR', 'compared', 'to', 'local', 'and', 'national', 'data', 'J', 'C', 'White', 'A', 'Molokhia', 'A', 'Dean', 'A', 'Stilwell', 'G', 'Friedlaender', 'P308', 'Dispatcher', 'assisted', 'telephone', 'cardiopulmonary', 'resuscitation', 'using', 'a', 'French', 'language', 'compression', 'ventilation', 'pediatric', 'protocol', 'M', 'Peters', 'S', 'Stipulante', 'A', 'Delfosse', 'AF', 'Donneau', 'A', 'Ghuysen', 'P309', 'Dantrolene', 'versus', 'amiodarone', 'for', 'resuscitation', 'an', 'experimental', 'study', 'C', 'Feldmann', 'D', 'Freitag', 'W', 'Dersch', 'M', 'Irqsusi', 'D', 'Eschbach', 'T', 'Steinfeldt', 'H', 'Wulf', 'T', 'Wiesmann', 'P310', 'Long', 'term', 'survival', 'and', 'functional', 'neurological', 'outcome', 'in', 'comatose', 'survivors', 'undergoing', 'therapeutic', 'hypothermia', 'N', 'Kongpolprom', 'J', 'Cholkraisuwat', 'P311', 'Impact', 'of', 'kidney', 'disease', 'on', 'mortality', 'and', 'neurological', 'outcome', 'in', 'out', 'of', 'hospital', 'cardiac', 'arrest', 'a', 'prospective', 'observational', 'study', 'S', 'Beitland', 'E', 'Nakstad', 'H', 'Stær', 'Jensen', 'T', 'Drægni', 'G', 'Andersen', 'D', 'Jacobsen', 'C', 'Brunborg', 'B', 'Waldum', 'Grevbo', 'K', 'Sunde', 'P312', 'ICU', 'dependency', 'of', 'patients', 'admitted', 'after', 'primary', 'percutaneous', 'coronary', 'intervention', 'PPCI', 'following', 'out', 'of', 'the', 'hospital', 'cardiac', 'arrest', 'K', 'Hoyland', 'D', 'Pandit', 'P313', 'Prognostic', 'indicators', 'and', 'outcome', 'prediction', 'model', 'for', 'patients', 'with', 'return', 'of', 'spontaneous', 'circulation', 'from', 'cardiopulmonary', 'arrest', 'comprehensive', 'registry', 'of', 'in', 'hospital', 'intensive', 'care', 'on', 'OHCA', 'survival', 'critical', 'study', 'in', 'Osaka', 'Japan', 'K', 'Hayakawa', 'P314', 'Cerebral', 'oxygen', 'saturation', 'during', 'resuscitation', 'in', 'a', 'porcine', 'model', 'of', 'cardiac', 'arrest', 'E', 'Oloktsidou', 'K', 'Kotzampassi', 'B', 'Fyntanidou', 'S', 'Patsatzakis', 'L', 'Loukipoudi', 'E', 'Doumaki', 'V', 'Grosomanidis', 'P315', 'Presumption', 'of', 'cardiopulmonary', 'resuscitation', 'for', 'sustaining', 'cerebral', 'oxidation', 'using', 'regional', 'cerebral', 'saturation', 'of', 'oxygen', 'observational', 'cohort', 'study', 'press', 'study', 'H', 'Yasuda', 'P316', 'EEG', 'reactivity', 'in', 'patients', 'after', 'cardiac', 'arrest', 'a', 'close', 'look', 'at', 'stimuli', 'MM', 'Admiraal', 'M', 'Van', 'Assen', 'MJ', 'Van', 'Putten', 'M', 'Tjepkema', 'Cloostermans', 'AF', 'Van', 'Rootselaar', 'J', 'Horn', 'P317', 'Prognostic', 'value', 'of', 'neuron', 'specific', 'enolase', 'after', 'cardiac', 'arrest', 'F', 'Ragusa', 'A', 'Marudi', 'S', 'Baroni', 'A', 'Gaspari', 'E', 'Bertellini', 'P318', 'Correlation', 'between', 'electroencephalographic', 'findings', 'and', 'serum', 'neuron', 'specific', 'enolase', 'with', 'outcome', 'of', 'post', 'cardiac', 'arrest', 'patients', 'A', 'Taha', 'T', 'Abdullah', 'S', 'Abdel', 'Monem', 'P319', 'Introduction', 'of', 'a', 'targeted', 'temperature', 'management', 'strategy', 'following', 'cardiac', 'arrest', 'in', 'a', 'district', 'general', 'hospital', 'intensive', 'care', 'unit', 'S', 'Alcorn', 'S', 'McNeill', 'S', 'Russell', 'P320', 'The', 'evolution', 'of', 'cerebral', 'oxygen', 'saturation', 'in', 'post', 'cardiac', 'arrest', 'patients', 'treated', 'with', 'therapeutic', 'hypothermia', 'W', 'Eertmans', 'C', 'Genbrugge', 'I', 'Meex', 'J', 'Dens', 'F', 'Jans', 'C', 'De', 'Deyne', 'P321', 'Prognostic', 'factors', 'and', 'neurological', 'outcomes', 'of', 'therapeutic', 'hypothermia', 'in', 'comatose', 'survivors', 'from', 'cardiac', 'arrest', '8', 'year', 'single', 'center', 'experience', 'J', 'Cholkraisuwat', 'N', 'Kongpolprom', 'P322', 'Adherence', 'to', 'targeted', 'temperature', 'management', 'after', 'out', 'of', 'hospital', 'cardiac', 'arrest', 'B', 'Avard', 'R', 'Burns', 'P323', 'Implementation', 'of', 'a', 'therapeutic', 'hypothermia', 'protocol', 'for', 'comatose', 'survivors', 'of', 'out', 'of', 'hospital', 'cardiac', 'arrest', 'A', 'Patarchi', 'T', 'Spina', 'P324', 'Factors', 'associated', 'with', 'ventilator', 'weaning', 'after', 'targeted', 'temperature', 'management', 'for', 'cardiac', 'arrest', 'patients', 'in', 'japan', 'H', 'Tanaka', 'N', 'Otani', 'S', 'Ode', 'S', 'Ishimatsu', 'P325', 'Differential', 'activation', 'of', 'c', 'fos', 'in', 'paraventricular', 'nuclei', 'of', 'the', 'hypothalamus', 'and', 'thalamus', 'of', 'the', 'rat', 'following', 'myocardial', 'infarction', 'J', 'Cho', 'J', 'B', 'Moon', 'C', 'W', 'Park', 'T', 'G', 'Ohk', 'M', 'C', 'Shin', 'M', 'H', 'Won', 'P326', 'Monitoring', 'of', 'cTroponin', 'I', 'in', 'patients', 'with', 'acute', 'ischemic', 'stroke', 'predictor', 'of', 'inhospital', 'mortality', 'S', 'Dakova', 'Z', 'Ramsheva', 'K', 'Ramshev', 'P327', 'Hyperthermic', 'preconditioning', 'severely', 'accelerates', 'neuronal', 'damage', 'in', 'the', 'gerbil', 'ischemic', 'hippocampal', 'dentate', 'gyrus', 'via', 'decreasing', 'sods', 'expressions', 'J', 'Cho', 'J', 'B', 'Moon', 'C', 'W', 'Park', 'T', 'G', 'Ohk', 'M', 'C', 'Shin', 'P328', 'Failure', 'in', 'neuroprotection', 'of', 'remote', 'limb', 'ischemic', 'post', 'conditioning', 'in', 'the', 'hippocampus', 'of', 'a', 'gerbil', 'model', 'of', 'transient', 'cerebral', 'ischemia', 'J', 'Cho', 'J', 'B', 'Moon', 'C', 'W', 'Park', 'T', 'G', 'Ohk', 'M', 'C', 'Shin', 'P329', 'Brain', 'death', 'and', 'admission', 'diagnosis', 'in', 'neurologic', 'intensive', 'care', 'unit', 'a', 'correlation', 'A', 'Marudi', 'S', 'Baroni', 'A', 'Gaspari', 'E', 'Bertellini', 'P330', 'Brain', 'magnetic', 'resonance', 'imaging', 'findings', 'in', 'patients', 'with', 'septic', 'shock', 'G', 'Orhun', 'E', 'Senturk', 'P', 'E', 'Ozcan', 'S', 'Sencer', 'C', 'Ulusoy', 'E', 'Tuzun', 'F', 'Esen', 'P331', 'Benefits', 'of', 'L', 'carnitine', 'in', 'valproic', 'acid', 'induced', 'encephalopathy', 'R', 'Tincu', 'C', 'Cobilinschi', 'D', 'Tomescu', 'Z', 'Ghiorghiu', 'R', 'Macovei', 'P332Automatic', 'analysis', 'of', 'EEG', 'reactivity', 'in', 'comatose', 'patients', 'M', 'Van', 'Assen', 'M', 'M', 'Admiraal', 'M', 'J', 'Van', 'Putten', 'M', 'Tjepkema', 'Cloostermans', 'A', 'F', 'Van', 'Rootselaar', 'J', 'Horn', 'P333', 'Usefulness', 'of', 'common', 'ICU', 'severity', 'scoring', 'systems', 'in', 'predicting', 'outcome', 'after', 'spontaneous', 'intracerebral', 'hemorrhage', 'M', 'Fallenius', 'M', 'B', 'Skrifvars', 'M', 'Reinikainen', 'S', 'Bendel', 'R', 'Raj', 'P334', 'Evalution', 'of', 'patients', 'with', 'suspected', 'subarachnoid', 'haemorrhage', 'and', 'negative', 'ct', 'imaging', 'M', 'Abu', 'Habsa', 'C', 'Hymers', 'A', 'Borowska', 'H', 'Sivadhas', 'S', 'Sahiba', 'S', 'Perkins', 'P335', 'Timing', 'of', 'endovascular', 'and', 'surgical', 'treatment', 'for', 'aneurysmal', 'subarachnoid', 'haemorrhage', 'early', 'but', 'not', 'so', 'fast', 'J', 'Rubio', 'J', 'A', 'Rubio', 'R', 'Sierra', 'P336', 'Red', 'blood', 'cell', 'transfusion', 'in', 'aneurysmal', 'subarachnoid', 'hemorrhage', 'the', 'Sahara', 'cohort', 'study', 'S', 'English', 'M', 'Chasse', 'A', 'Turgeon', 'F', 'Lauzier', 'D', 'Griesdale', 'A', 'Garland', 'D', 'Fergusson', 'R', 'Zarychanski', 'A', 'Tinmouth', 'C', 'Van', 'Walraven', 'K', 'Montroy', 'J', 'Ziegler', 'R', 'Dupont', 'Chouinard', 'R', 'Carignan', 'A', 'Dhaliwal', 'C', 'Lum', 'J', 'Sinclair', 'G', 'Pagliarello', 'L', 'McIntyre', 'P337', 'Aneurysmal', 'subarachnoid', 'hemorrhage', 'and', 'anemia', 'a', 'canadian', 'multi', 'centre', 'retrospective', 'cohort', 'study', 'S', 'English', 'M', 'Chasse', 'A', 'Turgeon', 'F', 'Lauzier', 'D', 'Griesdale', 'A', 'Garland', 'D', 'Fergusson', 'R', 'Zarychanski', 'A', 'Tinmouth', 'C', 'Van', 'Walraven', 'K', 'Montroy', 'J', 'Ziegler', 'R', 'Dupont', 'Chouinard', 'R', 'Carignan', 'A', 'Dhaliwal', 'C', 'Lum', 'J', 'Sinclair', 'G', 'Pagliarello', 'L', 'McIntyre', 'P338', 'Does', 'the', 'neutrophil', 'to', 'lymphocyte', 'NLR', 'ratio', 'predict', 'symptomatic', 'vasospasm', 'or', 'delayed', 'cerebral', 'ischemia', 'DCI', 'after', 'aneurysmal', 'subarachnoid', 'haemorrhage', 'SAH', 'T', 'Groza', 'N', 'Moreau', 'D', 'Castanares', 'Zapatero', 'P', 'Hantson', 'P339', 'ICU', 'acquired', 'infections', 'in', 'aneurysmal', 'subarachnoid', 'hemorrhage', 'patients', 'impact', 'on', 'ICU', 'and', 'hospital', 'length', 'of', 'stay', 'M', 'Carbonara', 'F', 'Ortolano', 'T', 'Zoerle', 'S', 'Magnoni', 'S', 'Pifferi', 'V', 'Conte', 'N', 'Stocchetti', 'P340', 'Cerebral', 'metabolic', 'effects', 'of', 'normobaric', 'hyperoxia', 'during', 'the', 'acute', 'phase', 'of', 'aneurysmal', 'subarachnoid', 'hemorrhage', 'L', 'Carteron', 'T', 'Suys', 'C', 'Patet', 'H', 'Quintard', 'M', 'Oddo', 'P341', 'Postoperative', 'care', 'for', 'elective', 'craniotomy', 'where', 'is', 'best', 'done', 'J', 'A', 'Rubio', 'J', 'Rubio', 'R', 'Sierra', 'P342', '5', 'year', 'follow', 'up', 'of', 'patients', 'after', 'transplantation', 'of', 'organs', 'from', 'donors', 'from', 'neurocritical', 'care', 'V', 'Spatenkova', 'E', 'Pokorna', 'P', 'Suchomel', 'P343', 'Evaluation', 'of', 'levetiracetam', 'pharmacokinetics', 'after', 'severe', 'traumatic', 'brain', 'injury', 'in', 'neurocritical', 'care', 'patients', 'at', 'a', 'level', 'one', 'trauma', 'center', 'N', 'Ebert', 'J', 'Jancik', 'H', 'Rhodes', 'P344', 'Model', 'based', 'time', 'series', 'cluster', 'analysis', 'to', 'determine', 'unique', 'patient', 'states', 'in', 'traumatic', 'brain', 'injury', 'T', 'Bylinski', 'C', 'Hawthorne', 'M', 'Shaw', 'I', 'Piper', 'J', 'Kinsella', 'P345', 'Brain', 'compartment', 'monitoring', 'capabilities', 'from', 'ICP', 'to', 'BI', 'bioimpedance', 'during', 'HS', 'hypertonic', 'saline', 'administration', 'State', 'of', 'art', 'simulation', 'outcome', 'depending', 'on', 'brain', 'swelling', 'type', 'A', 'K', 'Kink', 'I', 'R', 'Rätsep', 'P346', 'Transfusion', 'of', 'red', 'blood', 'cells', 'in', 'patients', 'with', 'traumatic', 'brain', 'injury', 'admitted', 'to', 'Canadian', 'trauma', 'health', 'centers', 'a', 'multicenter', 'cohort', 'study', 'A', 'Boutin', 'L', 'Moore', 'M', 'Chasse', 'R', 'Zarychanski', 'F', 'Lauzier', 'S', 'English', 'L', 'McIntyre', 'J', 'Lacroix', 'D', 'Griesdale', 'P', 'Lessard', 'Bonaventure', 'A', 'F', 'Turgeon', 'P347', 'Hemoglobin', 'thresholds', 'and', 'red', 'blood', 'cell', 'transfusions', 'in', 'adult', 'patients', 'with', 'moderate', 'or', 'severe', 'traumatic', 'brain', 'injury', 'a', 'retrospective', 'cohort', 'study', 'A', 'Boutin', 'L', 'Moore', 'R', 'Green', 'P', 'Lessard', 'Bonaventure', 'M', 'Erdogan', 'M', 'Butler', 'F', 'Lauzier', 'M', 'Chasse', 'S', 'English', 'L', 'McIntyre', 'R', 'Zarychanski', 'J', 'Lacroix', 'D', 'Griesdale', 'P', 'Desjardins', 'D', 'A', 'Fergusson', 'A', 'F', 'Turgeon', 'P348', 'Characteristics', 'of', 'patients', 'with', 'gunshot', 'wounds', 'to', 'the', 'head', 'an', 'observational', 'Brazilian', 'study', 'B', 'Goncalves', 'B', 'Vidal', 'C', 'Valdez', 'A', 'C', 'Rodrigues', 'L', 'Miguez', 'G', 'Moralez', 'P349', 'Base', 'excess', 'as', 'predictor', 'for', 'ICU', 'admission', 'and', 'the', 'injury', 'severity', 'in', 'blunt', 'trauma', 'patients', 'T', 'Hong', 'P350', 'Enhancement', 'of', 'usual', 'emergency', 'department', 'care', 'with', 'proadrenomedullin', 'to', 'improve', 'outcome', 'prediction', 'Results', 'from', 'the', 'multi', 'national', 'prospective', 'observational', 'TRIAGE', 'study', 'A', 'Kutz', 'P', 'Hausfater', 'D', 'Amin', 'T', 'Struja', 'S', 'Haubitz', 'A', 'Huber', 'B', 'Mueller', 'P', 'Schuetz', 'P351', 'Developing', 'an', 'innovative', 'emergency', 'medicine', 'point', 'of', 'care', 'simulation', 'programme', 'T', 'Brown', 'J', 'Collinson', 'C', 'Pritchett', 'T', 'Slade', 'P352', 'The', 'InSim', 'program', 'an', 'in', 'situ', 'simulation', 'program', 'for', 'junior', 'trainees', 'in', 'intensive', 'care', 'M', 'Le', 'Guen', 'S', 'Hellings', 'R', 'Ramsaran', 'P353', 'Impact', 'of', 'excessive', 'and', 'inappropriate', 'troponin', 'testing', 'in', 'the', 'emergency', 'setting', 'how', 'good', 'are', 'we', 'A', 'Alsheikhly', 'P354', 'The', 'development', 'of', 'time', 'tracking', 'monitor', 'at', 'emergency', 'department', 'T', 'Abe', 'P355', 'Role', 'of', 'focussed', 'echocardiography', 'in', 'emergency', 'assessment', 'of', 'syncope', 'L', 'Kanapeckaite', 'M', 'Abu', 'Habsa', 'R', 'Bahl', 'P356', 'Insertion', 'of', 'an', 'open', 'ended', '14', 'gauge', 'catheter', 'through', 'the', 'chest', 'wall', 'causes', 'a', 'significant', 'pneumothorax', 'in', 'a', 'self', 'ventilating', 'swine', 'model', 'M', 'Q', 'Russell', 'K', 'J', 'Real', 'M', 'Abu', 'Habsa', 'R', 'M', 'Lyon', 'N', 'P', 'Oveland', 'P357', 'Ez', 'io', 'intraosseous', 'access', 'teaching', 'in', 'the', 'workplace', 'using', 'a', 'mobile', 'tea', 'trolley', 'training', 'method', 'J', 'Penketh', 'M', 'Mcdonald', 'F', 'Kelly', 'P358', 'Black', 'widow', 'envenomation', 'in', 'Saudi', 'Arabia', 'a', 'prospective', 'observational', 'case', 'series', 'M', 'Alfafi', 'S', 'Alsolamy', 'W', 'Almutairi', 'B', 'Alotaibi', 'P359', 'Mechanical', 'ventilation', 'in', 'patients', 'with', 'overdose', 'not', 'yet', 'intubated', 'on', 'icu', 'admission', 'A', 'E', 'Van', 'den', 'Berg', 'Y', 'Schriel', 'L', 'Dawson', 'I', 'A', 'Meynaar', 'P360', 'Central', 'nervous', 'system', 'depressants', 'poisoning', 'and', 'ventilator', 'associated', 'pneumonia', 'an', 'underrated', 'risk', 'factor', 'in', 'toxicological', 'intensive', 'care', 'unit', 'H', 'Talaie', 'P361', 'Acute', 'barium', 'intoxication', 'treated', 'with', 'hemodiafiltration', 'D', 'Silva', 'S', 'Fernandes', 'J', 'Gouveia', 'J', 'Santos', 'Silva', 'P362', 'Major', 'trauma', 'presenting', 'to', 'the', 'emergency', 'department', 'the', 'spectrum', 'of', 'cycling', 'injuries', 'in', 'Ireland', 'J', 'Foley', 'A', 'Kaskovagheorgescu', 'D', 'Evoy', 'J', 'Cronin', 'J', 'Ryan', 'P363', 'Burns', 'from', 'French', 'military', 'operations', 'a', '14', 'year', 'retrospective', 'observational', 'analysis', 'M', 'Huck', 'C', 'Hoffmann', 'J', 'Renner', 'P', 'Laitselart', 'N', 'Donat', 'A', 'Cirodde', 'J', 'V', 'Schaal', 'Y', 'Masson', 'A', 'Nau', 'T', 'Leclerc', 'P364', 'A', 'comparison', 'of', 'mortality', 'scores', 'in', 'burns', 'patients', 'on', 'the', 'intensive', 'care', 'unit', 'O', 'Howarth', 'K', 'Davenport', 'P', 'Jeanrenaud', 'S', 'Raftery', 'P365', 'Clasification', 'of', 'pain', 'and', 'its', 'treatment', 'and', 'an', 'intensive', 'care', 'rehabiliation', 'clinic', 'P', 'MacTavish', 'H', 'Devine', 'J', 'McPeake', 'M', 'Daniel', 'J', 'Kinsella', 'T', 'Quasim', 'P366', 'Pain', 'management', 'adequacy', 'in', 'critical', 'care', 'areas', 'the', 'process', 'and', 'the', 'barriers', 'perceived', 'by', 'critical', 'care', 'nurses', 'S', 'Alrabiee', 'A', 'Alrashid', 'S', 'Alsolamy', 'P367', 'Pain', 'assessment', 'in', 'critically', 'ill', 'adult', 'patients', 'validation', 'of', 'the', 'Turkish', 'version', 'of', 'the', 'critical', 'care', 'pain', 'observation', 'tool', 'O', 'Gundogan', 'C', 'Bor', 'E', 'Akýn', 'Korhan', 'K', 'Demirag', 'M', 'Uyar', 'P368', 'An', 'audit', 'of', 'pain', 'and', 'sedation', 'assessments', 'in', 'the', 'intensive', 'care', 'unit', 'recommendations', 'for', 'clinical', 'practice', 'F', 'Frame', 'C', 'Ashton', 'L', 'Bergstrom', 'Niska', 'P369', 'Impact', 'of', 'pharmaceutical', 'care', 'on', 'treatment', 'of', 'pain', 'and', 'agitation', 'in', 'medical', 'intensive', 'care', 'unit', 'P', 'Dilokpattanamongkol', 'T', 'Suansanae', 'C', 'Suthisisang', 'S', 'Morakul', 'C', 'Karnjanarachata', 'V', 'Tangsujaritvijit', 'P370', 'Agitation', 'in', 'trauma', 'ICU', 'prevention', 'and', 'outcome', 'S', 'Mahmood', 'H', 'Al', 'Thani', 'A', 'Almenyar', 'P371', 'Correlation', 'between', 'percentages', 'of', 'ventilated', 'patients', 'developed', 'vap', 'and', 'use', 'of', 'sedative', 'agents', 'in', 'icu', 'patients', 'A', 'Vakalos', 'V', 'Avramidis', 'P372', 'Improving', 'recording', 'of', 'sedation', 'events', 'in', 'the', 'Emergency', 'Department', 'The', 'implementation', 'of', 'the', 'SIVA', 'International', 'Taskforce', 'adverse', 'event', 'reporting', 'tool', 'for', 'procedural', 'sedation', 'R', 'Sharvill', 'J', 'Penketh', 'P373', 'Impact', 'of', 'sedative', 'drug', 'use', 'on', 'the', 'length', 'of', 'mechanical', 'ventilation', 'S', 'E', 'Morton', 'Y', 'S', 'Chiew', 'C', 'Pretty', 'J', 'G', 'Chase', 'G', 'M', 'Shaw', 'P374', 'Co', 'administration', 'of', 'nitric', 'oxide', 'and', 'sevoflurane', 'using', 'anaconda', 'R', 'Knafelj', 'P', 'Kordis', 'P375', 'A', 'retrospective', 'study', 'of', 'the', 'use', 'of', 'Dexmedetomidine', 'in', 'an', 'oncological', 'critical', 'care', 'setting', 'S', 'Patel', 'V', 'Grover', 'P376', 'Dexmedetomidine', 'and', 'posttraumatic', 'stress', 'disorder', 'incidence', 'in', 'alcohol', 'withdrawal', 'icu', 'patients', 'I', 'Kuchyn', 'K', 'Bielka', 'P377', 'Hemodynamic', 'effects', 'of', 'dexmedetomidine', 'in', 'a', 'porcine', 'model', 'of', 'septic', 'shock', 'Z', 'Aidoni', 'V', 'Grosomanidis', 'K', 'Kotzampassi', 'G', 'Stavrou', 'B', 'Fyntanidou', 'S', 'Patsatzakis', 'C', 'Skourtis', 'P378', 'Ketamine', 'for', 'analgosedation', 'in', 'severe', 'hypoxic', 'respiratory', 'failure', 'S', 'D', 'Lee', 'K', 'Williams', 'I', 'D', 'Weltes', 'P379', 'Madness', 'from', 'the', 'moon', 'lunar', 'cycle', 'and', 'the', 'incidence', 'of', 'delirium', 'on', 'the', 'intensive', 'care', 'unit', 'S', 'Berhane', 'C', 'Arrowsmith', 'C', 'Peters', 'S', 'Robert', 'P380', 'Impaired', 'dynamic', 'cerebral', 'autoregulation', 'after', 'coronary', 'artery', 'bypass', 'grafting', 'and', 'association', 'with', 'postoperative', 'delirium', 'J', 'Caldas', 'R', 'B', 'Panerai', 'T', 'G', 'Robinson', 'L', 'Camara', 'G', 'Ferreira', 'E', 'Borg', 'Seng', 'Shu', 'M', 'De', 'Lima', 'Oliveira', 'N', 'C', 'Mian', 'L', 'Santos', 'R', 'Nogueira', 'S', 'P', 'Zeferino', 'M', 'Jacobsen', 'Teixeira', 'F', 'Galas', 'L', 'A', 'Hajjar', 'P381', 'Risk', 'factors', 'predicting', 'prolonged', 'intensive', 'care', 'unit', 'length', 'of', 'stay', 'after', 'major', 'elective', 'surgery', 'P', 'Killeen', 'M', 'McPhail', 'W', 'Bernal', 'J', 'Maggs', 'J', 'Wendon', 'T', 'Hughes', 'P382', 'Systemic', 'inflammatory', 'response', 'syndrome', 'criteria', 'and', 'hospital', 'mortality', 'prediction', 'in', 'a', 'brazilian', 'cohort', 'of', 'critically', 'ill', 'patients', 'L', 'U', 'Taniguchi', 'E', 'M', 'Siqueira', 'J', 'M', 'Vieira', 'Jr', 'L', 'C', 'Azevedo', 'P383', 'Evaluating', 'the', 'efficacy', 'of', 'a', 'risk', 'predictor', 'panel', 'in', 'identifying', 'patients', 'at', 'elevated', 'risk', 'of', 'morbidity', 'following', 'emergency', 'admission', 'A', 'N', 'Ahmad', 'M', 'Abu', 'Habsa', 'R', 'Bahl', 'E', 'Helme', 'S', 'Hadfield', 'R', 'Loveridge', 'P384', 'A', 'retrospective', 'comparison', 'of', 'outcomes', 'for', 'elective', 'surgical', 'patients', 'admitted', 'post', 'operatively', 'to', 'the', 'critical', 'care', 'unit', 'or', 'general', 'ward', 'J', 'Shak', 'C', 'Senver', 'R', 'Howard', 'Griffin', 'P385', 'Effect', 'of', 'obesity', 'on', 'mortality', 'in', 'surgical', 'critically', 'ill', 'patients', 'P', 'Wacharasint', 'P', 'Fuengfoo', 'N', 'Sukcharoen', 'R', 'Rangsin', 'P386', 'The', 'national', 'early', 'warning', 'score', 'news', 'reliably', 'improves', 'adverse', 'clinical', 'outcome', 'prediction', 'in', 'community', 'acquired', 'pneumonia', 'results', 'from', 'a', '6', 'year', 'follow', 'up', 'D', 'Sbiti', 'Rohr', 'P', 'Schuetz', 'P387', 'Clinical', 'usefulness', 'of', 'the', 'charlson', 's', 'weighted', 'index', 'of', 'comorbidities', 'as', 'prognostic', 'factor', 'in', 'patients', 'with', 'prolonged', 'acute', 'mechanical', 'ventilation', 'H', 'Na', 'S', 'Song', 'S', 'Lee', 'E', 'Jeong', 'K', 'Lee', 'P388', 'Comparison', 'of', 'mortality', 'prediction', 'scoring', 'systems', 'in', 'patients', 'with', 'cirrhosis', 'admitted', 'to', 'general', 'intensive', 'care', 'unit', 'M', 'Cooper', 'K', 'Milinis', 'G', 'Williams', 'E', 'McCarron', 'S', 'Simants', 'I', 'Patanwala', 'I', 'D', 'Welters', 'P389', 'Impact', 'of', 'admission', 'source', 'and', 'time', 'of', 'admission', 'on', 'outcome', 'of', 'pediatric', 'intensive', 'care', 'patients', 'retrospective', '15', 'years', 'study', 'E', 'Zoumpelouli', 'EA', 'Volakli', 'V', 'Chrysohoidou', 'S', 'Georgiou', 'K', 'Charisopoulou', 'E', 'Kotzapanagiotou', 'V', 'Panagiotidou', 'K', 'Manavidou', 'Z', 'Stathi', 'M', 'Sdougka', 'P390', 'Heart', 'rate', 'variability', 'and', 'outcomes', 'prediction', 'in', 'critical', 'illness', 'N', 'Salahuddin', 'B', 'AlGhamdi', 'Q', 'Marashly', 'K', 'Zaza', 'M', 'Sharshir', 'M', 'Khurshid', 'Z', 'Ali', 'M', 'Malgapo', 'M', 'Jamil', 'A', 'Shafquat', 'M', 'Shoukri', 'M', 'Hijazi', 'P391', 'The', 'incidence', 'and', 'outcome', 'of', 'hyperlactatemia', 'in', 'the', 'post', 'anaesthesia', 'care', 'unit', 'T', 'Abe', 'S', 'Uchino', 'M', 'Takinami', 'P392', 'Correlation', 'between', 'arterial', 'blood', 'gas', 'disturbances', 'and', 'arterial', 'lactate', 'levels', 'during', 'hospitalization', 'and', 'outcome', 'in', 'critically', 'septic', 'patients', 'N', 'R', 'Rangel', 'Neto', 'S', 'Oliveira', 'F', 'Q', 'Reis', 'F', 'A', 'Rocha', 'P393', 'External', 'validation', 'of', 'saps', '3', 'and', 'mpm', 'iii', 'scores', 'in', '48', '816', 'patients', 'from', '72', 'brazilian', 'icus', 'G', 'Moralez', 'K', 'Ebecken', 'L', 'S', 'Rabello', 'M', 'F', 'Lima', 'R', 'Hatum', 'F', 'V', 'De', 'Marco', 'A', 'Alves', 'J', 'E', 'Pinto', 'M', 'Godoy', 'P', 'E', 'Brasil', 'F', 'A', 'Bozza', 'J', 'I', 'Salluh', 'M', 'Soares', 'P394', 'The', 'frailty', 'penalty', 'pre', 'admission', 'functional', 'status', 'confounds', 'mortality', 'prediction', 'models', 'in', 'critically', 'ill', 'patients', 'J', 'Krinsley', 'G', 'Kang', 'P395', 'sooner', 'rather', 'than', 'later', 'how', 'delayed', 'discharge', 'from', 'critical', 'care', 'leads', 'to', 'increased', 'out', 'of', 'hours', 'discharges', 'and', 'subsequent', 'increase', 'in', 'in', 'hospital', 'mortality', 'J', 'Perry', 'H', 'Hines', 'P396', 'Identifying', 'poor', 'outcome', 'patient', 'groups', 'in', 'a', 'resource', 'constrained', 'critical', 'care', 'unit', 'K', 'M', 'Wilkinson', 'C', 'Tordoff', 'B', 'Sloan', 'M', 'C', 'Bellamy', 'P397', 'Effects', 'of', 'icu', 'weekend', 'admission', 'and', 'discharge', 'on', 'mortality', 'E', 'Moreira', 'F', 'Verga', 'M', 'Barbato', 'G', 'Burghi', 'P398', 'Organizational', 'factors', 'outcomes', 'and', 'resource', 'use', 'in', '9', '946', 'cancer', 'patients', 'admitted', 'to', '70', 'ICUs', 'M', 'Soares', 'U', 'V', 'Silva', 'L', 'C', 'Azevedo', 'A', 'P', 'Torelly', 'J', 'M', 'Kahn', 'D', 'C', 'Angus', 'M', 'F', 'Knibel', 'P', 'E', 'Brasil', 'F', 'A', 'Bozza', 'J', 'I', 'Salluh', 'P399', 'Evaluation', 'of', 'oncological', 'critically', 'ill', 'patients', 'severity', 'score', 'and', 'outcome', 'compared', 'to', 'not', 'oncological', 'in', 'a', 'particular', 'hospital', 'cti', 'M', 'B', 'Velasco', 'D', 'M', 'Dalcomune', 'P400', 'Outcomes', 'of', 'patients', 'admitted', 'to', 'a', 'large', 'uk', 'critical', 'care', 'department', 'with', 'palliative', 'oncological', 'diagnoses', 'R', 'Marshall', 'T', 'Gilpin', 'A', 'Tridente', 'A', 'Raithatha', 'P401', 'Predictors', 'of', 'mortality', 'in', 'febrile', 'neutropenic', 'patients', 'with', 'haematological', 'malignancies', 'admitted', 'to', 'an', 'intensive', 'care', 'unit', 'of', 'a', 'cancer', 'center', 'D', 'Mota', 'B', 'Loureiro', 'J', 'Dias', 'O', 'Afonso', 'F', 'Coelho', 'A', 'Martins', 'F', 'Faria', 'P402', 'Patients', 'with', 'hematologic', 'malignancies', 'requiring', 'invasive', 'mechanical', 'ventilation', 'characteristics', 'and', 'predictors', 'of', 'mortality', 'H', 'Al', 'Dorzi', 'H', 'Al', 'Orainni', 'F', 'AlEid', 'H', 'Tlaygeh', 'A', 'Itani', 'A', 'Hejazi', 'Y', 'Arabi', 'P403', 'Patient', 'important', 'outcomes', 'in', 'randomized', 'controlled', 'trials', 'in', 'critically', 'ill', 'patients', 'a', 'systematic', 'review', 'S', 'Gaudry', 'J', 'Messika', 'J', 'D', 'Ricard', 'S', 'Guillo', 'B', 'Pasquet', 'E', 'Dubief', 'D', 'Dreyfuss', 'F', 'Tubach', 'P404', 'Alopecia', 'in', 'survivors', 'of', 'critical', 'illness', 'a', 'qualitative', 'study', 'C', 'Battle', 'K', 'James', 'P', 'Temblett', 'P405', 'The', 'impact', 'of', 'mental', 'health', 'on', 'icu', 'admission', 'L', 'Davies', 'C', 'Battle', 'C', 'Lynch', 'P406', 'Cognitive', 'impairment', '5', 'years', 'after', 'ICU', 'discharge', 'S', 'Pereira', 'S', 'Cavaco', 'J', 'Fernandes', 'I', 'Moreira', 'E', 'Almeida', 'F', 'Seabra', 'Pereira', 'M', 'Malheiro', 'F', 'Cardoso', 'I', 'Aragão', 'T', 'Cardoso', 'P407', 'Apache', 'ii', 'versus', 'apache', 'iv', 'for', 'octagenerians', 'in', 'medical', 'icu', 'M', 'Fister', 'R', 'Knafelj', 'P408', 'Outcomes', 'of', 'octagenarians', 'in', 'an', 'indian', 'icu', 'P', 'Muraray', 'Govind', 'N', 'Brahmananda', 'Reddy', 'R', 'Pratheema', 'E', 'D', 'Arul', 'J', 'Devachandran', 'P409', 'Mortality', 'and', 'outcomes', 'in', 'elderly', 'patients', '80', 'years', 'of', 'age', 'or', 'older', 'admitted', 'to', 'the', 'icu', 'M', 'B', 'Velasco', 'D', 'M', 'Dalcomune', 'P410', 'Octagenerians', 'in', 'medical', 'icu', 'adding', 'days', 'to', 'life', 'or', 'life', 'to', 'days', 'R', 'Knafelj', 'M', 'Fister', 'P411', 'The', 'very', 'elderly', 'admitted', 'to', 'intensive', 'care', 'unit', 'outcomes', 'and', 'economic', 'evaluation', 'N', 'Chin', 'Yee', 'G', 'D', 'Egidio', 'K', 'Thavorn', 'D', 'Heyland', 'K', 'Kyeremanteng', 'P412', 'The', 'very', 'elderly', 'in', 'intensive', 'care', 'relationship', 'between', 'acuity', 'of', 'illness', 'and', 'long', 'term', 'mortality', 'A', 'G', 'Murchison', 'K', 'Swalwell', 'J', 'Mandeville', 'D', 'Stott', 'P413', 'Acquired', 'weakness', 'in', 'an', 'oncological', 'intensive', 'care', 'unit', 'I', 'Guerreiro', 'P414', 'Musculoskeletal', 'problems', 'in', 'intensive', 'care', 'unit', 'ICU', 'patients', 'post', 'discharge', 'H', 'Devine', 'P', 'MacTavish', 'J', 'McPeake', 'T', 'Quasim', 'J', 'Kinsella', 'M', 'Daniel', 'P415', 'Premorbid', 'obesity', 'but', 'not', 'nutrition', 'prevents', 'critical', 'illness', 'induced', 'muscle', 'wasting', 'and', 'weakness', 'C', 'Goossens', 'M', 'B', 'Marques', 'S', 'Derde', 'S', 'Vander', 'Perre', 'T', 'Dufour', 'S', 'E', 'Thiessen', 'F', 'Güiza', 'T', 'Janssens', 'G', 'Hermans', 'I', 'Vanhorebeek', 'K', 'De', 'Bock', 'G', 'Van', 'den', 'Berghe', 'L', 'Langouche', 'P416', 'Physical', 'outcome', 'measures', 'for', 'critical', 'care', 'patients', 'following', 'intensive', 'care', 'unit', 'icu', 'discharge', 'H', 'Devine', 'P', 'MacTavish', 'T', 'Quasim', 'J', 'Kinsella', 'M', 'Daniel', 'J', 'McPeake', 'P417', 'Improving', 'active', 'mobilisation', 'in', 'a', 'general', 'intensive', 'care', 'unit', 'B', 'Miles', 'S', 'Madden', 'H', 'Devine', 'P418', 'Mobilization', 'in', 'patients', 'on', 'vasoactive', 'drugs', 'use', 'a', 'pilot', 'study', 'M', 'Weiler', 'P', 'Marques', 'C', 'Rodrigues', 'M', 'Boeira', 'K', 'Brenner', 'C', 'Leães', 'A', 'Machado', 'R', 'Townsend', 'J', 'Andrade', 'P419', 'Pharmacy', 'intervention', 'at', 'an', 'intensive', 'care', 'rehabilitation', 'clinic', 'P', 'MacTavish', 'J', 'McPeake', 'H', 'Devine', 'J', 'Kinsella', 'M', 'Daniel', 'R', 'Kishore', 'C', 'Fenlon', 'T', 'Quasim', 'P420', 'Interactive', 'gaming', 'is', 'feasible', 'and', 'potentially', 'increases', 'icu', 'patients', 'motivation', 'to', 'be', 'engaged', 'in', 'rehabilitation', 'programs', 'T', 'Fiks', 'A', 'Ruijter', 'M', 'Te', 'Raa', 'P', 'Spronk', 'P421', 'Simulation', 'based', 'design', 'of', 'a', 'robust', 'stopping', 'rule', 'to', 'ensure', 'patient', 'safety', 'Y', 'S', 'Chiew', 'P', 'Docherty', 'J', 'Dickson', 'E', 'Moltchanova', 'C', 'Scarrot', 'C', 'Pretty', 'G', 'M', 'Shaw', 'J', 'G', 'Chase', 'P422', 'Are', 'daily', 'blood', 'tests', 'on', 'the', 'intensive', 'care', 'unit', 'necessary', 'T', 'Hall', 'W', 'C', 'Ngu', 'J', 'M', 'Jack', 'P', 'Morgan', 'P423', 'Measuring', 'urine', 'output', 'in', 'ward', 'patients', 'is', 'it', 'helpful', 'B', 'Avard', 'A', 'Pavli', 'X', 'Gee', 'P424', 'The', 'incidence', 'of', 'pressure', 'ulcers', 'in', 'an', 'adult', 'mixed', 'intensive', 'care', 'unit', 'in', 'turkey', 'C', 'Bor', 'E', 'Akin', 'Korhan', 'K', 'Demirag', 'M', 'Uyar', 'P425', 'Intensivist', 'patient', 'ratios', 'in', 'closed', 'ICUs', 'in', 'Alexandria', 'Egypt', 'an', 'overview', 'M', 'Shirazy', 'A', 'Fayed', 'P426', 'Eicu', 'electronic', 'intensive', 'care', 'unit', 'impact', 'on', 'ALOS', 'average', 'length', 'of', 'stay', 'in', 'a', 'developing', 'country', 'like', 'India', 'S', 'Gupta', 'A', 'Kaushal', 'S', 'Dewan', 'A', 'Varma', 'P427', 'Predicting', 'deterioration', 'in', 'general', 'ward', 'using', 'early', 'deterioration', 'indicator', 'E', 'Ghosh', 'L', 'Yang', 'L', 'Eshelman', 'B', 'Lord', 'E', 'Carlson', 'P428', 'High', 'impact', 'enhanced', 'critical', 'care', 'outreach', 'the', 'imobile', 'service', 'making', 'a', 'difference', 'E', 'Helme', 'R', 'Broderick', 'S', 'Hadfield', 'R', 'Loveridge', 'P429', 'Impact', 'of', 'bed', 'availability', 'and', 'cognitive', 'load', 'on', 'intensive', 'care', 'unit', 'ICU', 'bed', 'allocation', 'a', 'vignette', 'based', 'trial', 'J', 'Ramos', 'D', 'Forte', 'P430', 'Characteristics', 'of', 'critically', 'ill', 'patients', 'admitted', 'through', 'the', 'emergency', 'department', 'F', 'Yang', 'P', 'Hou', 'P431', 'Admission', 'to', 'critical', 'care', 'the', 'quantification', 'of', 'functional', 'reserve', 'J', 'Dudziak', 'J', 'Feeney', 'K', 'Wilkinson', 'K', 'Bauchmuller', 'K', 'Shuker', 'M', 'Faulds', 'A', 'Raithatha', 'D', 'Bryden', 'L', 'England', 'N', 'Bolton', 'A', 'Tridente', 'P432', 'Admission', 'to', 'critical', 'care', 'the', 'importance', 'of', 'frailty', 'K', 'Bauchmuller', 'K', 'Shuker', 'A', 'Tridente', 'M', 'Faulds', 'A', 'Matheson', 'J', 'Gaynor', 'D', 'Bryden', 'S', 'South', 'Yorkshire', 'Hospitals', 'Research', 'Collaboration', 'P433', 'Development', 'of', 'an', 'instrument', 'to', 'aid', 'triage', 'decisions', 'for', 'intensive', 'care', 'unit', 'admission', 'J', 'Ramos', 'B', 'Peroni', 'R', 'Daglius', 'Dias', 'L', 'Miranda', 'C', 'Cohen', 'C', 'Carvalho', 'I', 'Velasco', 'D', 'Forte', 'P434', 'Using', 'selective', 'serotonin', 're', 'uptake', 'inhibitors', 'and', 'serotonin', 'norepinephrine', 're', 'uptake', 'inhibitors', 'in', 'critical', 'care', 'a', 'systematic', 'review', 'of', 'the', 'evidence', 'for', 'benefit', 'or', 'harm', 'J', 'M', 'Kelly', 'A', 'Neill', 'G', 'Rubenfeld', 'N', 'Masson', 'A', 'Min', 'P435', 'Measuring', 'adaptive', 'coping', 'of', 'hospitalized', 'patients', 'with', 'a', 'severe', 'medical', 'condition', 'the', 'sickness', 'insight', 'in', 'coping', 'questionnaire', 'sicq', 'E', 'Boezeman', 'J', 'Hofhuis', 'A', 'Hovingh', 'R', 'De', 'Vries', 'P', 'Spronk', 'P436', 'Results', 'of', 'a', 'national', 'survey', 'regarding', 'intensive', 'care', 'medicine', 'training', 'G', 'Cabral', 'Campello', 'I', 'Aragão', 'T', 'Cardoso', 'P437', 'Work', 'engagement', 'among', 'healthcare', 'professionals', 'in', 'the', 'intensive', 'care', 'unit', 'M', 'Van', 'Mol', 'M', 'Nijkamp', 'E', 'Kompanje', 'P438', 'Empowering', 'the', 'intensive', 'care', 'practitioners', 'is', 'it', 'a', 'burnout', 'ameliorating', 'intervention', 'P', 'Ostrowski', 'A', 'Omar', 'P439', 'Icu', 'patients', 'suffer', 'from', 'circadian', 'rhythm', 'desynchronisation', 'K', 'Kiss', 'B', 'Köves', 'V', 'Csernus', 'Z', 'Molnár', 'P440', 'Noise', 'reduction', 'in', 'the', 'ICU', 'feasible', 'Y', 'Hoydonckx', 'S', 'Vanwing', 'B', 'Stessel', 'A', 'Van', 'Assche', 'L', 'Jamaer', 'J', 'Dubois', 'P441', 'Accidental', 'removal', 'of', 'invasive', 'devices', 'in', 'the', 'critical', 'patient', 'into', 'the', 'bed', 'washing', 'does', 'the', 'presence', 'of', 'professional', 'nurse', 'modify', 'his', 'incidence', 'V', 'Medo', 'R', 'Galvez', 'J', 'P', 'Miranda', 'P442', 'Deprivation', 'of', 'liberty', 'safeguards', 'dols', 'audit', 'of', 'compliance', 'in', 'a', 'of', 'a', '16', 'bed', 'specialist', 'cancer', 'critical', 'care', 'unit', 'C', 'Stone', 'T', 'Wigmore', 'P443', 'Use', 'of', 'a', 'modified', 'cristal', 'score', 'to', 'predict', 'futility', 'of', 'critical', 'care', 'in', 'the', 'elderly', 'Y', 'Arunan', 'A', 'Wheeler', 'K', 'Bauchmuller', 'D', 'Bryden', 'P444', 'Improvement', 'of', 'Referral', 'Rate', 'to', 'Palliative', 'Care', 'for', 'Patients', 'with', 'Poor', 'Prognosis', 'in', 'Neurosurgical', 'Intensive', 'Care', 'Unit', 'Y', 'Wong', 'C', 'Poi', 'C', 'Gu', 'P445', 'Factors', 'associated', 'with', 'limitation', 'of', 'life', 'supporting', 'care', 'lsc', 'in', 'a', 'medico', 'surgical', 'intermediate', 'care', 'unit', 'and', 'outcome', 'of', 'patients', 'with', 'lsc', 'limitation', 'a', 'monocentric', 'six', 'month', 'study', 'P', 'Molmy', 'N', 'Van', 'Grunderbeeck', 'O', 'Nigeon', 'M', 'Lemyze', 'D', 'Thevenin', 'J', 'Mallat', 'P446', 'Palliative', 'care', 'consultation', 'and', 'intensive', 'care', 'unit', 'admission', 'request', 'a', 'cohort', 'study', 'J', 'Ramos', 'M', 'Correa', 'R', 'T', 'Carvalho', 'D', 'Forte', 'P447', 'Nursing', 'and', 'medicine', 'together', 'in', 'postsurgical', 'intensive', 'care', 'unit', 'situations', 'of', 'prognostic', 'conflict', 'at', 'the', 'end', 'of', 'life', 'our', 'critical', 'care', 'nurses', 'suffer', 'with', 'our', 'medical', 'activism', 'A', 'Fernandez', 'C', 'McBride', 'P448', 'End', 'of', 'life', 'who', 'may', 'decide', 'E', 'Koonthalloor', 'C', 'Walsh', 'P449', 'Correctly', 'diagnosing', 'death', 'A', 'Webber', 'M', 'Ashe', 'K', 'Smith', 'P', 'Jeanrenaud', 'P450', 'Skin', 'procurement', 'performed', 'by', 'intensive', 'care', 'physicians', 'yes', 'we', 'can', 'A', 'Marudi', 'S', 'Baroni', 'F', 'Ragusa', 'E', 'Bertellini', 'P451', 'Death', 'analysis', 'in', 'pediatric', 'intensive', 'care', 'patients', 'E', 'A', 'Volakli', 'E', 'Chochliourou', 'M', 'Dimitriadou', 'A', 'Violaki', 'P', 'Mantzafleri', 'E', 'Samkinidou', 'O', 'Vrani', 'A', 'Arbouti', 'T', 'Varsami', 'M', 'Sdougka', 'P452', 'The', 'potential', 'impact', 'of', 'euthanasia', 'on', 'organ', 'donation', 'analysis', 'of', 'data', 'from', 'belgium', 'J', 'A', 'Bollen', 'T', 'C', 'Van', 'Smaalen', 'W', 'C', 'De', 'Jongh', 'M', 'M', 'Ten', 'Hoopen', 'D', 'Ysebaert', 'L', 'W', 'Van', 'Heurn', 'W', 'N', 'Van', 'Mook', 'P453', 'Communication', 'within', 'an', 'intensive', 'care', 'setting', 'K', 'Sim', 'A', 'Fuller', 'P454', 'Development', 'and', 'implementation', 'of', 'a', 'longitudinal', 'communication', 'curriculum', 'for', 'critical', 'care', 'medicine', 'fellows', 'A', 'Roze', 'des', 'Ordons', 'P', 'Couillard', 'C', 'Doig', 'P455', 'Staff', 'family', 'conflict', 'in', 'a', 'multi', 'ethnic', 'intensive', 'care', 'unit', 'R', 'V', 'Van', 'Keer', 'R', 'D', 'Deschepper', 'A', 'F', 'Francke', 'L', 'H', 'Huyghens', 'J', 'B', 'Bilsen', 'P456', 'Does', 'the', 'source', 'of', 'admission', 'to', 'critical', 'care', 'affect', 'family', 'satisfaction', 'B', 'Nyamaizi', 'C', 'Dalrymple', 'A', 'Molokhia', 'A', 'Dobru', 'P457', 'A', 'simple', 'alternative', 'to', 'the', 'family', 'satisfaction', 'survey', 'fs', 'icu', 'E', 'Marrinan', 'A', 'Ankuli', 'A', 'Molokhia', 'P458', 'A', 'study', 'to', 'explore', 'the', 'experiences', 'of', 'patient', 'and', 'family', 'volunteers', 'in', 'a', 'critical', 'care', 'environment', 'a', 'phenomenological', 'analysis', 'J', 'McPeake', 'R', 'Struthers', 'R', 'Crawford', 'H', 'Devine', 'P', 'Mactavish', 'T', 'Quasim', 'P459', 'Prevalence', 'and', 'risk', 'factors', 'of', 'anxiety', 'and', 'depression', 'in', 'relatives', 'of', 'burn', 'patients', 'P', 'Morelli', 'M', 'Degiovanangelo', 'F', 'Lemos', 'V', 'MArtinez', 'F', 'Verga', 'J', 'Cabrera', 'G', 'Burghi', 'P460', 'Guidance', 'of', 'visiting', 'children', 'at', 'an', 'adult', 'intensive', 'care', 'unit', 'icu', 'A', 'Rutten', 'S', 'Van', 'Ieperen', 'S', 'De', 'Geer', 'M', 'Van', 'Vugt', 'E', 'Der', 'Kinderen', 'P461', 'Visiting', 'policies', 'in', 'Italian', 'pediatric', 'ICUs', 'an', 'update', 'A', 'Giannini', 'G', 'Miccinesi', 'T', 'Marchesi', 'E', 'Prandi']"
12643,452. Spectrum of Respiratory Pathogens Detected by Multiplex PCR in a Study of Respiratory Tract Infections Among Travelers,2018-11-26,Open Forum Infect Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254379/,"BACKGROUND: Respiratory tract infections (RTI) are a significant cause of health problems, accounting for about 10% of consultations in returning travelers. Nevertheless, the precise microbial etiology is not identified in many cases. METHODS: Prospectively collected 63 respiratory specimens (sputum or throat swab) from patients presented with respiratory symptoms (cough, sputum, chest pain, dyspnea, tachypnea, or abnormal findings of chest auscultation) after travel were tested using multiplex real-time PCR. The FTD Respiratory pathogens 33 (Fast-track diagnostics, Ltd.) can simultaneously detect 33 different respiratory pathogens directly from respiratory specimens. This test ran in the PCR-Only mode on BD MAX™ (Nippon Becton Dickinson Company, Ltd.) and LightCycler480 System (Roche). RESULTS: Fifty-nine consecutive cases were included in the study. Thirty-nine cases were diagnosed as non-specific upper respiratory tract infections, five cases were influenza, bronchitis, pneumonia, threecases was acute sinusitis, and one case was acute pharyngitis, dengue fever. Twenty-four cases had returned from travel in Southeast Asia, nine from Africa, and 8 from Latin America, seven from South Asia, six from middle east, threefrom North America, threefrom East Asia, 2 from Oceania, and one from Europe. Of the 59 specimens analyzed, 48 (81.4%) tested positive for pathogens whereas 11 tested negative. Commonly detected pathogens were Haemophilus influenzae (14 cases; 23.7%), influenza A (10 cases; 17.0%), rhinovirus (9 cases; 15.2%), Staphylococcus aureus (8 cases; 13.6%), Moraxella catarrhalis (8 cases; 13.6%), Streptococcus pneumonia, coronaviruses OC43, and Mycoplasma pneumoniae (4 cases; 6.8%, respectively). Multiple pathogens were detected in 30.5% of the specimens. In 14 cases (23.7%), both virus and bacteria were detected from one specimen. CONCLUSION: Not only viruses, bacterial pathogens were detected frequently than expected in the patients of RTI. Comprehensive molecular testing such as multiplex real-time PCR would change our understandings of epidemiology of RTI among travelers. [Image: see text] DISCLOSURES: All authors: No reported disclosures.",10.1093/ofid/ofy210.461,ijjpaxlo,"['BACKGROUND', 'Respiratory', 'tract', 'infections', 'RTI', 'are', 'a', 'significant', 'cause', 'of', 'health', 'problems', 'accounting', 'for', 'about', '10', 'of', 'consultations', 'in', 'returning', 'travelers', 'Nevertheless', 'the', 'precise', 'microbial', 'etiology', 'is', 'not', 'identified', 'in', 'many', 'cases', 'METHODS', 'Prospectively', 'collected', '63', 'respiratory', 'specimens', 'sputum', 'or', 'throat', 'swab', 'from', 'patients', 'presented', 'with', 'respiratory', 'symptoms', 'cough', 'sputum', 'chest', 'pain', 'dyspnea', 'tachypnea', 'or', 'abnormal', 'findings', 'of', 'chest', 'auscultation', 'after', 'travel', 'were', 'tested', 'using', 'multiplex', 'real', 'time', 'PCR', 'The', 'FTD', 'Respiratory', 'pathogens', '33', 'Fast', 'track', 'diagnostics', 'Ltd', 'can', 'simultaneously', 'detect', '33', 'different', 'respiratory', 'pathogens', 'directly', 'from', 'respiratory', 'specimens', 'This', 'test', 'ran', 'in', 'the', 'PCR', 'Only', 'mode', 'on', 'BD', 'MAX', 'Nippon', 'Becton', 'Dickinson', 'Company', 'Ltd', 'and', 'LightCycler480', 'System', 'Roche', 'RESULTS', 'Fifty', 'nine', 'consecutive', 'cases', 'were', 'included', 'in', 'the', 'study', 'Thirty', 'nine', 'cases', 'were', 'diagnosed', 'as', 'non', 'specific', 'upper', 'respiratory', 'tract', 'infections', 'five', 'cases', 'were', 'influenza', 'bronchitis', 'pneumonia', 'threecases', 'was', 'acute', 'sinusitis', 'and', 'one', 'case', 'was', 'acute', 'pharyngitis', 'dengue', 'fever', 'Twenty', 'four', 'cases', 'had', 'returned', 'from', 'travel', 'in', 'Southeast', 'Asia', 'nine', 'from', 'Africa', 'and', '8', 'from', 'Latin', 'America', 'seven', 'from', 'South', 'Asia', 'six', 'from', 'middle', 'east', 'threefrom', 'North', 'America', 'threefrom', 'East', 'Asia', '2', 'from', 'Oceania', 'and', 'one', 'from', 'Europe', 'Of', 'the', '59', 'specimens', 'analyzed', '48', '81', '4', 'tested', 'positive', 'for', 'pathogens', 'whereas', '11', 'tested', 'negative', 'Commonly', 'detected', 'pathogens', 'were', 'Haemophilus', 'influenzae', '14', 'cases', '23', '7', 'influenza', 'A', '10', 'cases', '17', '0', 'rhinovirus', '9', 'cases', '15', '2', 'Staphylococcus', 'aureus', '8', 'cases', '13', '6', 'Moraxella', 'catarrhalis', '8', 'cases', '13', '6', 'Streptococcus', 'pneumonia', 'coronaviruses', 'OC43', 'and', 'Mycoplasma', 'pneumoniae', '4', 'cases', '6', '8', 'respectively', 'Multiple', 'pathogens', 'were', 'detected', 'in', '30', '5', 'of', 'the', 'specimens', 'In', '14', 'cases', '23', '7', 'both', 'virus', 'and', 'bacteria', 'were', 'detected', 'from', 'one', 'specimen', 'CONCLUSION', 'Not', 'only', 'viruses', 'bacterial', 'pathogens', 'were', 'detected', 'frequently', 'than', 'expected', 'in', 'the', 'patients', 'of', 'RTI', 'Comprehensive', 'molecular', 'testing', 'such', 'as', 'multiplex', 'real', 'time', 'PCR', 'would', 'change', 'our', 'understandings', 'of', 'epidemiology', 'of', 'RTI', 'among', 'travelers', 'Image', 'see', 'text', 'DISCLOSURES', 'All', 'authors', 'No', 'reported', 'disclosures', '']"
12646,739. Middle East Respiratory Syndrome Coronavirus Infection Profile in Qatar: A 7-Year Retrospective Study,2018-11-26,Open Forum Infect Dis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255065/,"BACKGROUND: A deadly zoonotic Middle East respiratory syndrome coronavirus (MERS-CoV) had emerged over the last 7 years in the Arabian Peninsula. As of February 28, 2018, 2,182 cases of MERS-CoV infection (with 779 deaths) in 27 countries were reported to WHO worldwide. The objectives of this study were to identify the clinical and epidemiological characteristics of MERS-CoV infection as well as determine its clinical outcome. METHODS: This was a retrospective-observational study of all laboratory confirmed cases of MERS-CoV infection conducted at the main seven hospitals in the State of Qatar from January, 2012 to April 2018. We used the Fast Track diagnostics real-time reverse-transcription polymerase chain reaction (rRT-PCR), targeting the upE and ORF1a genes respectively. Demographics, clinical information, potential contacts and probable risk factors were collected and analyzed by standard statistical methods. RESULTS: The mean annual incidence was 1.7 per 100,0000 person-years. Among the 24 confirmed cases of of MERS-CoV, males constituted the vast majority of cases (23 males) with a median age of 52 years (range 22–74). Fifty percent of the cases were Qatari and 42% reside in the same region. 67% of the cases had contact with camels, and 21% had contact with MERS-CoV-infected patient. Thirty-eight had travel history within 2 weeks of symptoms onset to the Kingdom of Saudi Arabia. Fifty percent were smokers and 42% had comorbidities. The median symptoms duration was 4.5 days. Most of the patient presented with flu-like symptoms, were fever was the most common presentation, followed by cough, SOB, diarrhea, abdominal pain and headache, 96%, 83%, 33%, 8%, 8% and 4%, respectively. All patients were admitted to a tertiary hospital with a median hospital stay 41 days (8–97). Forty-five percent patients developed severe sepsis with multi-organ failure and needed ICU admission. Fifty percent patients developed acute kidney injury, 29% patients were on hemodialysis and 16% needed extra-corporeal membrane oxygenation. Thirty-three percent patients died. The rest of patients had recovered from the infection and discharged home. Among those who died all had one or more comorbidities. CONCLUSION: MERS-CoV infection is a rare infection in the State of Qatar, seen in both Qataris and expatriates with and without travel history. The infection in patients with comorbidities carries high mortality. DISCLOSURES: All authors: No reported disclosures.",10.1093/ofid/ofy210.746,2g0zq9dh,"['BACKGROUND', 'A', 'deadly', 'zoonotic', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'had', 'emerged', 'over', 'the', 'last', '7', 'years', 'in', 'the', 'Arabian', 'Peninsula', 'As', 'of', 'February', '28', '2018', '2', '182', 'cases', 'of', 'MERS', 'CoV', 'infection', 'with', '779', 'deaths', 'in', '27', 'countries', 'were', 'reported', 'to', 'WHO', 'worldwide', 'The', 'objectives', 'of', 'this', 'study', 'were', 'to', 'identify', 'the', 'clinical', 'and', 'epidemiological', 'characteristics', 'of', 'MERS', 'CoV', 'infection', 'as', 'well', 'as', 'determine', 'its', 'clinical', 'outcome', 'METHODS', 'This', 'was', 'a', 'retrospective', 'observational', 'study', 'of', 'all', 'laboratory', 'confirmed', 'cases', 'of', 'MERS', 'CoV', 'infection', 'conducted', 'at', 'the', 'main', 'seven', 'hospitals', 'in', 'the', 'State', 'of', 'Qatar', 'from', 'January', '2012', 'to', 'April', '2018', 'We', 'used', 'the', 'Fast', 'Track', 'diagnostics', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'rRT', 'PCR', 'targeting', 'the', 'upE', 'and', 'ORF1a', 'genes', 'respectively', 'Demographics', 'clinical', 'information', 'potential', 'contacts', 'and', 'probable', 'risk', 'factors', 'were', 'collected', 'and', 'analyzed', 'by', 'standard', 'statistical', 'methods', 'RESULTS', 'The', 'mean', 'annual', 'incidence', 'was', '1', '7', 'per', '100', '0000', 'person', 'years', 'Among', 'the', '24', 'confirmed', 'cases', 'of', 'of', 'MERS', 'CoV', 'males', 'constituted', 'the', 'vast', 'majority', 'of', 'cases', '23', 'males', 'with', 'a', 'median', 'age', 'of', '52', 'years', 'range', '22', '74', 'Fifty', 'percent', 'of', 'the', 'cases', 'were', 'Qatari', 'and', '42', 'reside', 'in', 'the', 'same', 'region', '67', 'of', 'the', 'cases', 'had', 'contact', 'with', 'camels', 'and', '21', 'had', 'contact', 'with', 'MERS', 'CoV', 'infected', 'patient', 'Thirty', 'eight', 'had', 'travel', 'history', 'within', '2', 'weeks', 'of', 'symptoms', 'onset', 'to', 'the', 'Kingdom', 'of', 'Saudi', 'Arabia', 'Fifty', 'percent', 'were', 'smokers', 'and', '42', 'had', 'comorbidities', 'The', 'median', 'symptoms', 'duration', 'was', '4', '5', 'days', 'Most', 'of', 'the', 'patient', 'presented', 'with', 'flu', 'like', 'symptoms', 'were', 'fever', 'was', 'the', 'most', 'common', 'presentation', 'followed', 'by', 'cough', 'SOB', 'diarrhea', 'abdominal', 'pain', 'and', 'headache', '96', '83', '33', '8', '8', 'and', '4', 'respectively', 'All', 'patients', 'were', 'admitted', 'to', 'a', 'tertiary', 'hospital', 'with', 'a', 'median', 'hospital', 'stay', '41', 'days', '8', '97', 'Forty', 'five', 'percent', 'patients', 'developed', 'severe', 'sepsis', 'with', 'multi', 'organ', 'failure', 'and', 'needed', 'ICU', 'admission', 'Fifty', 'percent', 'patients', 'developed', 'acute', 'kidney', 'injury', '29', 'patients', 'were', 'on', 'hemodialysis', 'and', '16', 'needed', 'extra', 'corporeal', 'membrane', 'oxygenation', 'Thirty', 'three', 'percent', 'patients', 'died', 'The', 'rest', 'of', 'patients', 'had', 'recovered', 'from', 'the', 'infection', 'and', 'discharged', 'home', 'Among', 'those', 'who', 'died', 'all', 'had', 'one', 'or', 'more', 'comorbidities', 'CONCLUSION', 'MERS', 'CoV', 'infection', 'is', 'a', 'rare', 'infection', 'in', 'the', 'State', 'of', 'Qatar', 'seen', 'in', 'both', 'Qataris', 'and', 'expatriates', 'with', 'and', 'without', 'travel', 'history', 'The', 'infection', 'in', 'patients', 'with', 'comorbidities', 'carries', 'high', 'mortality', 'DISCLOSURES', 'All', 'authors', 'No', 'reported', 'disclosures', '']"
14383,"The Domestic Cat, Felis catus, as a Model of Hereditary and Infectious Disease",2008,Sourcebook of Models for Biomedical Research,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120622/,"The domestic cat, currently the most frequent of companion animals, has enjoyed a medical surveillance, as a nonprimate species, second only to the dog. With over 200 hereditary disease pathologies reported in the cat, the clinical and physiological study of these feline hereditary diseases provides a strong comparative medicine opportunity for prevention, diagnostics, and treatment studies in a laboratory setting. Causal mutations have been characterized in 19 felid genes, with the largest representation from lysosomal storage enzyme disorders. Corrective therapeutic strategies for several disorders have been proposed and examined in the cat, including enzyme replacement, heterologous bone marrow transplantation, and substrate reduction therapy. Genomics tools developed in the cat, including the recent completion of the 2-fold whole genome sequence of the cat and genome browser, radiation hybrid map of 1793 integrated coding and microsatellite loci, a 5-cM genetic linkage map, arrayed BAC libraries, and flow sorted chromosomes, are providing resources that are being utilized in mapping and characterization of genes of interest. A recent report of the mapping and characterization of a novel causative gene for feline spinal muscular atrophy marked the first identification of a disease gene purely from positional reasoning. With the development of genomic resources in the cat and the application of complementary comparative tools developed in other species, the domestic cat is emerging as a promising resource of phenotypically defined genetic variation of biomedical significance. Additionally, the cat has provided several useful models for infectious disease. These include feline leukemia and feline sarcoma virus, feline coronavirus, and Type C retroviruses that interact with cellular oncogenes to induce leukemia, lymphoma, and sarcoma.",10.1007/978-1-59745-285-4_25,80l5mua2,"['The', 'domestic', 'cat', 'currently', 'the', 'most', 'frequent', 'of', 'companion', 'animals', 'has', 'enjoyed', 'a', 'medical', 'surveillance', 'as', 'a', 'nonprimate', 'species', 'second', 'only', 'to', 'the', 'dog', 'With', 'over', '200', 'hereditary', 'disease', 'pathologies', 'reported', 'in', 'the', 'cat', 'the', 'clinical', 'and', 'physiological', 'study', 'of', 'these', 'feline', 'hereditary', 'diseases', 'provides', 'a', 'strong', 'comparative', 'medicine', 'opportunity', 'for', 'prevention', 'diagnostics', 'and', 'treatment', 'studies', 'in', 'a', 'laboratory', 'setting', 'Causal', 'mutations', 'have', 'been', 'characterized', 'in', '19', 'felid', 'genes', 'with', 'the', 'largest', 'representation', 'from', 'lysosomal', 'storage', 'enzyme', 'disorders', 'Corrective', 'therapeutic', 'strategies', 'for', 'several', 'disorders', 'have', 'been', 'proposed', 'and', 'examined', 'in', 'the', 'cat', 'including', 'enzyme', 'replacement', 'heterologous', 'bone', 'marrow', 'transplantation', 'and', 'substrate', 'reduction', 'therapy', 'Genomics', 'tools', 'developed', 'in', 'the', 'cat', 'including', 'the', 'recent', 'completion', 'of', 'the', '2', 'fold', 'whole', 'genome', 'sequence', 'of', 'the', 'cat', 'and', 'genome', 'browser', 'radiation', 'hybrid', 'map', 'of', '1793', 'integrated', 'coding', 'and', 'microsatellite', 'loci', 'a', '5', 'cM', 'genetic', 'linkage', 'map', 'arrayed', 'BAC', 'libraries', 'and', 'flow', 'sorted', 'chromosomes', 'are', 'providing', 'resources', 'that', 'are', 'being', 'utilized', 'in', 'mapping', 'and', 'characterization', 'of', 'genes', 'of', 'interest', 'A', 'recent', 'report', 'of', 'the', 'mapping', 'and', 'characterization', 'of', 'a', 'novel', 'causative', 'gene', 'for', 'feline', 'spinal', 'muscular', 'atrophy', 'marked', 'the', 'first', 'identification', 'of', 'a', 'disease', 'gene', 'purely', 'from', 'positional', 'reasoning', 'With', 'the', 'development', 'of', 'genomic', 'resources', 'in', 'the', 'cat', 'and', 'the', 'application', 'of', 'complementary', 'comparative', 'tools', 'developed', 'in', 'other', 'species', 'the', 'domestic', 'cat', 'is', 'emerging', 'as', 'a', 'promising', 'resource', 'of', 'phenotypically', 'defined', 'genetic', 'variation', 'of', 'biomedical', 'significance', 'Additionally', 'the', 'cat', 'has', 'provided', 'several', 'useful', 'models', 'for', 'infectious', 'disease', 'These', 'include', 'feline', 'leukemia', 'and', 'feline', 'sarcoma', 'virus', 'feline', 'coronavirus', 'and', 'Type', 'C', 'retroviruses', 'that', 'interact', 'with', 'cellular', 'oncogenes', 'to', 'induce', 'leukemia', 'lymphoma', 'and', 'sarcoma', '']"
15570,The Human Coronaviruses,2018-11-10,Advanced Techniques in Diagnostic Microbiology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122141/,"The human coronaviruses have been shown to be a major player in clinical microbiology and frequently occur as pathogens responsible for mild to severe respiratory infections. Moreover, two of the most dangerous viral respiratory infections are caused by novel coronaviruses, namely, the SARS and the MERS coronavirus. This chapter briefly summarizes the most important facts and knowledge required for the appropriate laboratory diagnostics of infections caused by the human coronaviruses.",10.1007/978-3-319-95111-9_11,3qzlo90e,"['The', 'human', 'coronaviruses', 'have', 'been', 'shown', 'to', 'be', 'a', 'major', 'player', 'in', 'clinical', 'microbiology', 'and', 'frequently', 'occur', 'as', 'pathogens', 'responsible', 'for', 'mild', 'to', 'severe', 'respiratory', 'infections', 'Moreover', 'two', 'of', 'the', 'most', 'dangerous', 'viral', 'respiratory', 'infections', 'are', 'caused', 'by', 'novel', 'coronaviruses', 'namely', 'the', 'SARS', 'and', 'the', 'MERS', 'coronavirus', 'This', 'chapter', 'briefly', 'summarizes', 'the', 'most', 'important', 'facts', 'and', 'knowledge', 'required', 'for', 'the', 'appropriate', 'laboratory', 'diagnostics', 'of', 'infections', 'caused', 'by', 'the', 'human', 'coronaviruses', '']"
25404,"Diagnostik und Therapie schlafbezogener Atmungsstörungen im Zusammenhang mit der Corona‑Pandemie: Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP), Deutsche Gesellschaft für Schlafforschung und Schlafmedizin (DGSM)",2020-06-22,Somnologie (Berl),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306656/,"When providing sleep medical services special aspects must be taken into account in the context of the coronavirus pandemic. Despite all prevention, due to the high number of unrecognized cases, SARS-CoV2 contacts in the sleep laboratory must be expected and appropriate precautions are necessary. Nevertheless, the continuation or resumption of sleep medical services under the appropriate hygiene measures is strongly recommended to avoid medical and psychosocial complications. There is no evidence for a deterioration of COVID-19 through CPAP therapy. In principle, the application of positive pressure therapy via various mask systems can be accompanied by the formation of infectious aerosols. In the case of confirmed infection with SARS-CoV2, a pre-existing PAP therapy should be continued in an outpatient setting in accordance with the local guidelines for home isolation, since discontinuation of PAP therapy is associated with additional cardiopulmonary complications due to the untreated sleep-related breathing disorder. According to the current state of knowledge inhalation therapy, nasal high-flow (NHF), and PAP therapy can be carried out without increased risk of infection for health care workers (HCW) as long as appropriate personal protective equipment (eye protection, FFP2 or FFP-3 mask, gown) is being used. This position paper of the German Society for Pneumology and Respiratory Medicine (DGP) and the German Society for Sleep Medicine (DGSM) offers detailed recommendations for the implementation of sleep medicine diagnostics and therapy in the context of the coronavirus pandemic.",10.1007/s11818-020-00253-w,urvkvo9m,"['When', 'providing', 'sleep', 'medical', 'services', 'special', 'aspects', 'must', 'be', 'taken', 'into', 'account', 'in', 'the', 'context', 'of', 'the', 'coronavirus', 'pandemic', 'Despite', 'all', 'prevention', 'due', 'to', 'the', 'high', 'number', 'of', 'unrecognized', 'cases', 'SARS', 'CoV2', 'contacts', 'in', 'the', 'sleep', 'laboratory', 'must', 'be', 'expected', 'and', 'appropriate', 'precautions', 'are', 'necessary', 'Nevertheless', 'the', 'continuation', 'or', 'resumption', 'of', 'sleep', 'medical', 'services', 'under', 'the', 'appropriate', 'hygiene', 'measures', 'is', 'strongly', 'recommended', 'to', 'avoid', 'medical', 'and', 'psychosocial', 'complications', 'There', 'is', 'no', 'evidence', 'for', 'a', 'deterioration', 'of', 'COVID', '19', 'through', 'CPAP', 'therapy', 'In', 'principle', 'the', 'application', 'of', 'positive', 'pressure', 'therapy', 'via', 'various', 'mask', 'systems', 'can', 'be', 'accompanied', 'by', 'the', 'formation', 'of', 'infectious', 'aerosols', 'In', 'the', 'case', 'of', 'confirmed', 'infection', 'with', 'SARS', 'CoV2', 'a', 'pre', 'existing', 'PAP', 'therapy', 'should', 'be', 'continued', 'in', 'an', 'outpatient', 'setting', 'in', 'accordance', 'with', 'the', 'local', 'guidelines', 'for', 'home', 'isolation', 'since', 'discontinuation', 'of', 'PAP', 'therapy', 'is', 'associated', 'with', 'additional', 'cardiopulmonary', 'complications', 'due', 'to', 'the', 'untreated', 'sleep', 'related', 'breathing', 'disorder', 'According', 'to', 'the', 'current', 'state', 'of', 'knowledge', 'inhalation', 'therapy', 'nasal', 'high', 'flow', 'NHF', 'and', 'PAP', 'therapy', 'can', 'be', 'carried', 'out', 'without', 'increased', 'risk', 'of', 'infection', 'for', 'health', 'care', 'workers', 'HCW', 'as', 'long', 'as', 'appropriate', 'personal', 'protective', 'equipment', 'eye', 'protection', 'FFP2', 'or', 'FFP', '3', 'mask', 'gown', 'is', 'being', 'used', 'This', 'position', 'paper', 'of', 'the', 'German', 'Society', 'for', 'Pneumology', 'and', 'Respiratory', 'Medicine', 'DGP', 'and', 'the', 'German', 'Society', 'for', 'Sleep', 'Medicine', 'DGSM', 'offers', 'detailed', 'recommendations', 'for', 'the', 'implementation', 'of', 'sleep', 'medicine', 'diagnostics', 'and', 'therapy', 'in', 'the', 'context', 'of', 'the', 'coronavirus', 'pandemic', '']"
28404,How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation.,2016,Blood,https://doi.org/10.1182/blood-2016-01-634873; https://www.ncbi.nlm.nih.gov/pubmed/26968533/,"The widespread use of multiplex molecular diagnostics has led to a significant increase in the detection of respiratory viruses in patients undergoing cytotoxic chemotherapy and hematopoietic cell transplantation (HCT). Respiratory viruses initially infect the upper respiratory tract and then progress to lower respiratory tract disease in a subset of patients. Lower respiratory tract disease can manifest itself as airflow obstruction or viral pneumonia, which can be fatal. Infection in HCT candidates may require delay of transplantation. The risk of progression differs between viruses and immunosuppressive regimens. Risk factors for progression and severity scores have been described, which may allow targeting treatment to high-risk patients. Ribavirin is the only antiviral treatment option for noninfluenza respiratory viruses; however, high-quality data demonstrating its efficacy and relative advantages of the aerosolized versus oral form are lacking. There are significant unmet needs, including data defining the virologic characteristics and clinical significance of human rhinoviruses, human coronaviruses, human metapneumovirus, and human bocavirus, as well as the need for new treatment and preventative options.",10.1182/blood-2016-01-634873,0fj0onoh,"['The', 'widespread', 'use', 'of', 'multiplex', 'molecular', 'diagnostics', 'has', 'led', 'to', 'a', 'significant', 'increase', 'in', 'the', 'detection', 'of', 'respiratory', 'viruses', 'in', 'patients', 'undergoing', 'cytotoxic', 'chemotherapy', 'and', 'hematopoietic', 'cell', 'transplantation', 'HCT', 'Respiratory', 'viruses', 'initially', 'infect', 'the', 'upper', 'respiratory', 'tract', 'and', 'then', 'progress', 'to', 'lower', 'respiratory', 'tract', 'disease', 'in', 'a', 'subset', 'of', 'patients', 'Lower', 'respiratory', 'tract', 'disease', 'can', 'manifest', 'itself', 'as', 'airflow', 'obstruction', 'or', 'viral', 'pneumonia', 'which', 'can', 'be', 'fatal', 'Infection', 'in', 'HCT', 'candidates', 'may', 'require', 'delay', 'of', 'transplantation', 'The', 'risk', 'of', 'progression', 'differs', 'between', 'viruses', 'and', 'immunosuppressive', 'regimens', 'Risk', 'factors', 'for', 'progression', 'and', 'severity', 'scores', 'have', 'been', 'described', 'which', 'may', 'allow', 'targeting', 'treatment', 'to', 'high', 'risk', 'patients', 'Ribavirin', 'is', 'the', 'only', 'antiviral', 'treatment', 'option', 'for', 'noninfluenza', 'respiratory', 'viruses', 'however', 'high', 'quality', 'data', 'demonstrating', 'its', 'efficacy', 'and', 'relative', 'advantages', 'of', 'the', 'aerosolized', 'versus', 'oral', 'form', 'are', 'lacking', 'There', 'are', 'significant', 'unmet', 'needs', 'including', 'data', 'defining', 'the', 'virologic', 'characteristics', 'and', 'clinical', 'significance', 'of', 'human', 'rhinoviruses', 'human', 'coronaviruses', 'human', 'metapneumovirus', 'and', 'human', 'bocavirus', 'as', 'well', 'as', 'the', 'need', 'for', 'new', 'treatment', 'and', 'preventative', 'options', '']"
28766,"Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: ménage à trois.",2020-07-09,Current opinion in rheumatology,https://doi.org/10.1097/bor.0000000000000728; https://www.ncbi.nlm.nih.gov/pubmed/32657802/,"BACKGROUND Shortly after its emergence in December 2019, the coronavirus disease 2019 (COVID-19) was declared as a pandemic by the World Health Organization. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the seventh member of the Coronaviridae family of viruses that causes disease in humans. THE PROBLEM Despite the established role of molecular diagnostics, COVID-19 serodiagnosis remains a poorly discovered and enigmatic area. Although there are numerous commercial serological products available globally, there is a severe paucity of high-quality peer-reviewed literature on their true performance characteristics. That being said, publications including in-house developed serological tests started to shed light on the kinetics of the humoral response. SUMMARY In spite of intense focus of assessing the performance characteristics of the commercially-available kits, the main issue remains rather invisible, that is, lack of solid science behind COVID-19 serology its clinical usefulness thereof. This short review summarizes the key points as to why COVID-19 is not jest ready to fly. PURPOSE OF REVIEW Despite having been mentioned as a testing option, COVID-19 serology has significant shortcomings that needs discussing. This short review is meant to shed light on one of those aspects.",10.1097/bor.0000000000000728,ugx8unte,"['BACKGROUND', 'Shortly', 'after', 'its', 'emergence', 'in', 'December', '2019', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'declared', 'as', 'a', 'pandemic', 'by', 'the', 'World', 'Health', 'Organization', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'the', 'seventh', 'member', 'of', 'the', 'Coronaviridae', 'family', 'of', 'viruses', 'that', 'causes', 'disease', 'in', 'humans', 'THE', 'PROBLEM', 'Despite', 'the', 'established', 'role', 'of', 'molecular', 'diagnostics', 'COVID', '19', 'serodiagnosis', 'remains', 'a', 'poorly', 'discovered', 'and', 'enigmatic', 'area', 'Although', 'there', 'are', 'numerous', 'commercial', 'serological', 'products', 'available', 'globally', 'there', 'is', 'a', 'severe', 'paucity', 'of', 'high', 'quality', 'peer', 'reviewed', 'literature', 'on', 'their', 'true', 'performance', 'characteristics', 'That', 'being', 'said', 'publications', 'including', 'in', 'house', 'developed', 'serological', 'tests', 'started', 'to', 'shed', 'light', 'on', 'the', 'kinetics', 'of', 'the', 'humoral', 'response', 'SUMMARY', 'In', 'spite', 'of', 'intense', 'focus', 'of', 'assessing', 'the', 'performance', 'characteristics', 'of', 'the', 'commercially', 'available', 'kits', 'the', 'main', 'issue', 'remains', 'rather', 'invisible', 'that', 'is', 'lack', 'of', 'solid', 'science', 'behind', 'COVID', '19', 'serology', 'its', 'clinical', 'usefulness', 'thereof', 'This', 'short', 'review', 'summarizes', 'the', 'key', 'points', 'as', 'to', 'why', 'COVID', '19', 'is', 'not', 'jest', 'ready', 'to', 'fly', 'PURPOSE', 'OF', 'REVIEW', 'Despite', 'having', 'been', 'mentioned', 'as', 'a', 'testing', 'option', 'COVID', '19', 'serology', 'has', 'significant', 'shortcomings', 'that', 'needs', 'discussing', 'This', 'short', 'review', 'is', 'meant', 'to', 'shed', 'light', 'on', 'one', 'of', 'those', 'aspects', '']"
30780,Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens.,2020-04-27,Journal of clinical microbiology,https://doi.org/10.1128/jcm.00743-20; https://www.ncbi.nlm.nih.gov/pubmed/32341143/,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel human coronavirus that causes coronavirus disease 2019 (COVID-19), was first discovered in December 2019 as the cause of an outbreak of pneumonia in the city of Wuhan, Hubei province, China. The clinical presentation of COVID-19 is fairly non-specific, and symptoms overlap with other seasonal respiratory infections concurrently circulating in the population. Furthermore, it is estimated that up to 80% of infected individuals experience mild symptoms or are asymptomatic, confounding efforts to reliably diagnose COVID-19 empirically. To support infection control measures, there is an urgent need for rapid and accurate molecular diagnostics to identify COVID-19 positive patients. In the present study, we have evaluated the analytical sensitivity and clinical performance of four SARS-CoV-2 molecular diagnostic assays granted Emergency Use Authorization by the FDA using nasopharyngeal swabs from symptomatic patients: the New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Panel (Modified CDC), the Simplexa COVID-19 Direct (Diasorin Molecular), GenMark ePlex SARS-CoV-2 assay (GenMark) and the Hologic Panther Fusion® SARS-CoV-2 assay (Hologic). This information is crucial for both laboratories and clinical teams, as decisions on which testing platform to implement are made.",10.1128/jcm.00743-20,b0qtzzac,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'the', 'novel', 'human', 'coronavirus', 'that', 'causes', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'first', 'discovered', 'in', 'December', '2019', 'as', 'the', 'cause', 'of', 'an', 'outbreak', 'of', 'pneumonia', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'province', 'China', 'The', 'clinical', 'presentation', 'of', 'COVID', '19', 'is', 'fairly', 'non', 'specific', 'and', 'symptoms', 'overlap', 'with', 'other', 'seasonal', 'respiratory', 'infections', 'concurrently', 'circulating', 'in', 'the', 'population', 'Furthermore', 'it', 'is', 'estimated', 'that', 'up', 'to', '80', 'of', 'infected', 'individuals', 'experience', 'mild', 'symptoms', 'or', 'are', 'asymptomatic', 'confounding', 'efforts', 'to', 'reliably', 'diagnose', 'COVID', '19', 'empirically', 'To', 'support', 'infection', 'control', 'measures', 'there', 'is', 'an', 'urgent', 'need', 'for', 'rapid', 'and', 'accurate', 'molecular', 'diagnostics', 'to', 'identify', 'COVID', '19', 'positive', 'patients', 'In', 'the', 'present', 'study', 'we', 'have', 'evaluated', 'the', 'analytical', 'sensitivity', 'and', 'clinical', 'performance', 'of', 'four', 'SARS', 'CoV', '2', 'molecular', 'diagnostic', 'assays', 'granted', 'Emergency', 'Use', 'Authorization', 'by', 'the', 'FDA', 'using', 'nasopharyngeal', 'swabs', 'from', 'symptomatic', 'patients', 'the', 'New', 'York', 'SARS', 'CoV', '2', 'Real', 'time', 'Reverse', 'Transcriptase', 'RT', 'PCR', 'Diagnostic', 'Panel', 'Modified', 'CDC', 'the', 'Simplexa', 'COVID', '19', 'Direct', 'Diasorin', 'Molecular', 'GenMark', 'ePlex', 'SARS', 'CoV', '2', 'assay', 'GenMark', 'and', 'the', 'Hologic', 'Panther', 'Fusion', 'SARS', 'CoV', '2', 'assay', 'Hologic', 'This', 'information', 'is', 'crucial', 'for', 'both', 'laboratories', 'and', 'clinical', 'teams', 'as', 'decisions', 'on', 'which', 'testing', 'platform', 'to', 'implement', 'are', 'made', '']"
30993,Potential impact of seasonal forcing on a SARS-CoV-2 pandemic.,2020-03-09,Swiss medical weekly,https://doi.org/10.4414/smw.2020.20224; https://www.ncbi.nlm.nih.gov/pubmed/32176808/,"A novel coronavirus (SARS-CoV-2) first detected in Wuhan, China, has spread rapidly since December 2019, causing more than 100,000 confirmed infections and 4000 fatalities (as of 10 March 2020). The outbreak has been declared a pandemic by the WHO on Mar 11, 2020. Here, we explore how seasonal variation in transmissibility could modulate a SARS-CoV-2 pandemic. Data from routine diagnostics show a strong and consistent seasonal variation of the four endemic coronaviruses (229E, HKU1, NL63, OC43) and we parameterise our model for SARS-CoV-2 using these data. The model allows for many subpopulations of different size with variable parameters. Simulations of different scenarios show that plausible parameters result in a small peak in early 2020 in temperate regions of the Northern Hemisphere and a larger peak in winter 2020/2021. Variation in transmission and migration rates can result in substantial variation in prevalence between regions. While the uncertainty in parameters is large, the scenarios we explore show that transient reductions in the incidence rate might be due to a combination of seasonal variation and infection control efforts but do not necessarily mean the epidemic is contained. Seasonal forcing on SARS-CoV-2 should thus be taken into account in the further monitoring of the global transmission. The likely aggregated effect of seasonal variation, infection control measures, and transmission rate variation is a prolonged pandemic wave with lower prevalence at any given time, thereby providing a window of opportunity for better preparation of health care systems.",10.4414/smw.2020.20224,28sgnyh1,"['A', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'first', 'detected', 'in', 'Wuhan', 'China', 'has', 'spread', 'rapidly', 'since', 'December', '2019', 'causing', 'more', 'than', '100', '000', 'confirmed', 'infections', 'and', '4000', 'fatalities', 'as', 'of', '10', 'March', '2020', 'The', 'outbreak', 'has', 'been', 'declared', 'a', 'pandemic', 'by', 'the', 'WHO', 'on', 'Mar', '11', '2020', 'Here', 'we', 'explore', 'how', 'seasonal', 'variation', 'in', 'transmissibility', 'could', 'modulate', 'a', 'SARS', 'CoV', '2', 'pandemic', 'Data', 'from', 'routine', 'diagnostics', 'show', 'a', 'strong', 'and', 'consistent', 'seasonal', 'variation', 'of', 'the', 'four', 'endemic', 'coronaviruses', '229E', 'HKU1', 'NL63', 'OC43', 'and', 'we', 'parameterise', 'our', 'model', 'for', 'SARS', 'CoV', '2', 'using', 'these', 'data', 'The', 'model', 'allows', 'for', 'many', 'subpopulations', 'of', 'different', 'size', 'with', 'variable', 'parameters', 'Simulations', 'of', 'different', 'scenarios', 'show', 'that', 'plausible', 'parameters', 'result', 'in', 'a', 'small', 'peak', 'in', 'early', '2020', 'in', 'temperate', 'regions', 'of', 'the', 'Northern', 'Hemisphere', 'and', 'a', 'larger', 'peak', 'in', 'winter', '2020', '2021', 'Variation', 'in', 'transmission', 'and', 'migration', 'rates', 'can', 'result', 'in', 'substantial', 'variation', 'in', 'prevalence', 'between', 'regions', 'While', 'the', 'uncertainty', 'in', 'parameters', 'is', 'large', 'the', 'scenarios', 'we', 'explore', 'show', 'that', 'transient', 'reductions', 'in', 'the', 'incidence', 'rate', 'might', 'be', 'due', 'to', 'a', 'combination', 'of', 'seasonal', 'variation', 'and', 'infection', 'control', 'efforts', 'but', 'do', 'not', 'necessarily', 'mean', 'the', 'epidemic', 'is', 'contained', 'Seasonal', 'forcing', 'on', 'SARS', 'CoV', '2', 'should', 'thus', 'be', 'taken', 'into', 'account', 'in', 'the', 'further', 'monitoring', 'of', 'the', 'global', 'transmission', 'The', 'likely', 'aggregated', 'effect', 'of', 'seasonal', 'variation', 'infection', 'control', 'measures', 'and', 'transmission', 'rate', 'variation', 'is', 'a', 'prolonged', 'pandemic', 'wave', 'with', 'lower', 'prevalence', 'at', 'any', 'given', 'time', 'thereby', 'providing', 'a', 'window', 'of', 'opportunity', 'for', 'better', 'preparation', 'of', 'health', 'care', 'systems', '']"
32553,Emerging prophylaxis strategies against COVID-19.,2020-03-30,Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace,https://doi.org/10.4081/monaldi.2020.1289; https://www.ncbi.nlm.nih.gov/pubmed/32231348/,"The Novel corona virus 2019 which started as an outbreak in China in December 2019 has rapidly spread all over the world, such that on 11th March 2020 WHO declared this disease as pandemic. The emergency that the world faces today demands that we develop urgent and effective measures to protect people at high risk of transmission. WHO has accelerated research in diagnostics, vaccines and therapeutics for this novel coronavirus.",10.4081/monaldi.2020.1289,q21fwlcu,"['The', 'Novel', 'corona', 'virus', '2019', 'which', 'started', 'as', 'an', 'outbreak', 'in', 'China', 'in', 'December', '2019', 'has', 'rapidly', 'spread', 'all', 'over', 'the', 'world', 'such', 'that', 'on', '11th', 'March', '2020', 'WHO', 'declared', 'this', 'disease', 'as', 'pandemic', 'The', 'emergency', 'that', 'the', 'world', 'faces', 'today', 'demands', 'that', 'we', 'develop', 'urgent', 'and', 'effective', 'measures', 'to', 'protect', 'people', 'at', 'high', 'risk', 'of', 'transmission', 'WHO', 'has', 'accelerated', 'research', 'in', 'diagnostics', 'vaccines', 'and', 'therapeutics', 'for', 'this', 'novel', 'coronavirus', '']"
33239,"2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness.",2020-01-31,Journal of infection in developing countries,https://doi.org/10.3855/jidc.12425; https://www.ncbi.nlm.nih.gov/pubmed/32088679/,"On 31 December 2019 the Wuhan Health Commission reported a cluster of atypical pneumonia cases that was linked to a wet market in the city of Wuhan, China. The first patients began experiencing symptoms of illness in mid-December 2019. Clinical isolates were found to contain a novel coronavirus with similarity to bat coronaviruses. As of 28 January 2020, there are in excess of 4,500 laboratory-confirmed cases, with > 100 known deaths. As with the SARS-CoV, infections in children appear to be rare. Travel-related cases have been confirmed in multiple countries and regions outside mainland China including Germany, France, Thailand, Japan, South Korea, Vietnam, Canada, and the United States, as well as Hong Kong and Taiwan. Domestically in China, the virus has also been noted in several cities and provinces with cases in all but one provinence. While zoonotic transmission appears to be the original source of infections, the most alarming development is that human-to-human transmission is now prevelant. Of particular concern is that many healthcare workers have been infected in the current epidemic. There are several critical clinical questions that need to be resolved, including how efficient is human-to-human transmission? What is the animal reservoir? Is there an intermediate animal reservoir? Do the vaccines generated to the SARS-CoV or MERS-CoV or their proteins offer protection against 2019-nCoV? We offer a research perspective on the next steps for the generation of vaccines. We also present data on the use of in silico docking in gaining insight into 2019-nCoV Spike-receptor binding to aid in therapeutic development. Diagnostic PCR protocols can be found at https://www.who.int/health-topics/coronavirus/laboratory-diagnostics-for-novel-coronavirus.",10.3855/jidc.12425,rxrlbw60,"['On', '31', 'December', '2019', 'the', 'Wuhan', 'Health', 'Commission', 'reported', 'a', 'cluster', 'of', 'atypical', 'pneumonia', 'cases', 'that', 'was', 'linked', 'to', 'a', 'wet', 'market', 'in', 'the', 'city', 'of', 'Wuhan', 'China', 'The', 'first', 'patients', 'began', 'experiencing', 'symptoms', 'of', 'illness', 'in', 'mid', 'December', '2019', 'Clinical', 'isolates', 'were', 'found', 'to', 'contain', 'a', 'novel', 'coronavirus', 'with', 'similarity', 'to', 'bat', 'coronaviruses', 'As', 'of', '28', 'January', '2020', 'there', 'are', 'in', 'excess', 'of', '4', '500', 'laboratory', 'confirmed', 'cases', 'with', '100', 'known', 'deaths', 'As', 'with', 'the', 'SARS', 'CoV', 'infections', 'in', 'children', 'appear', 'to', 'be', 'rare', 'Travel', 'related', 'cases', 'have', 'been', 'confirmed', 'in', 'multiple', 'countries', 'and', 'regions', 'outside', 'mainland', 'China', 'including', 'Germany', 'France', 'Thailand', 'Japan', 'South', 'Korea', 'Vietnam', 'Canada', 'and', 'the', 'United', 'States', 'as', 'well', 'as', 'Hong', 'Kong', 'and', 'Taiwan', 'Domestically', 'in', 'China', 'the', 'virus', 'has', 'also', 'been', 'noted', 'in', 'several', 'cities', 'and', 'provinces', 'with', 'cases', 'in', 'all', 'but', 'one', 'provinence', 'While', 'zoonotic', 'transmission', 'appears', 'to', 'be', 'the', 'original', 'source', 'of', 'infections', 'the', 'most', 'alarming', 'development', 'is', 'that', 'human', 'to', 'human', 'transmission', 'is', 'now', 'prevelant', 'Of', 'particular', 'concern', 'is', 'that', 'many', 'healthcare', 'workers', 'have', 'been', 'infected', 'in', 'the', 'current', 'epidemic', 'There', 'are', 'several', 'critical', 'clinical', 'questions', 'that', 'need', 'to', 'be', 'resolved', 'including', 'how', 'efficient', 'is', 'human', 'to', 'human', 'transmission', 'What', 'is', 'the', 'animal', 'reservoir', 'Is', 'there', 'an', 'intermediate', 'animal', 'reservoir', 'Do', 'the', 'vaccines', 'generated', 'to', 'the', 'SARS', 'CoV', 'or', 'MERS', 'CoV', 'or', 'their', 'proteins', 'offer', 'protection', 'against', '2019', 'nCoV', 'We', 'offer', 'a', 'research', 'perspective', 'on', 'the', 'next', 'steps', 'for', 'the', 'generation', 'of', 'vaccines', 'We', 'also', 'present', 'data', 'on', 'the', 'use', 'of', 'in', 'silico', 'docking', 'in', 'gaining', 'insight', 'into', '2019', 'nCoV', 'Spike', 'receptor', 'binding', 'to', 'aid', 'in', 'therapeutic', 'development', 'Diagnostic', 'PCR', 'protocols', 'can', 'be', 'found', 'at', 'https', 'www', 'who', 'int', 'health', 'topics', 'coronavirus', 'laboratory', 'diagnostics', 'for', 'novel', 'coronavirus', '']"
33401,Current laboratory diagnostics of coronavirus disease 2019 (COVID-19).,2020-05-11,Acta bio-medica : Atenei Parmensis,https://doi.org/10.23750/abm.v91i2.9548; https://www.ncbi.nlm.nih.gov/pubmed/32420937/,"Laboratory medicine provides an almost irreplaceable contribution to the diagnostic reasoning and managed care of most human pathologies. The novel coronavirus disease 2019 (COVID-19) is not an exception to this paradigm. Although the relatively recent emergence does not allow to draw definitive conclusions on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics, some standpoints can be conveyed. First and foremost, it seems now clear that we will be living together with this virus for quite a long time, so that our vigilance and responsiveness against the emergence of new local outbreaks shall be maintained at the highest possible levels. The etiological diagnosis of COVID-19 is, and will remain for the foreseeable future, deeply based on direct identification of viral RNA by means of molecular biology techniques in biological materials, especially upper and lower respiratory tract specimens. Whether other materials, such as blood, urine, stools, saliva and throat washing, will become valid alternatives has not been unequivocally defined so far. As concerns serological testing, promising information can be garnered from preliminary investigations, showing that the vast majority of COVID-19 patients seem to develop a sustained immune response against the virus, characterized especially by emergence of anti-SARS-CoV-2 IgG and IgA, 1 to 2 weeks after the onset of fever and/or respiratory symptoms. Whether these antibodies will have persistent neutralizing activity against the virus is still to be elucidated on individual and general basis. The availability of rapid tests for detecting either viral antigens or anti-SARS-CoV-2 antibodies are a potentially viable opportunity for purposes of epidemiologic surveillance, though more information is needed on accuracy and reliability of these portable immunoassays.",10.23750/abm.v91i2.9548,r2rnnsfh,"['Laboratory', 'medicine', 'provides', 'an', 'almost', 'irreplaceable', 'contribution', 'to', 'the', 'diagnostic', 'reasoning', 'and', 'managed', 'care', 'of', 'most', 'human', 'pathologies', 'The', 'novel', 'coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'not', 'an', 'exception', 'to', 'this', 'paradigm', 'Although', 'the', 'relatively', 'recent', 'emergence', 'does', 'not', 'allow', 'to', 'draw', 'definitive', 'conclusions', 'on', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'diagnostics', 'some', 'standpoints', 'can', 'be', 'conveyed', 'First', 'and', 'foremost', 'it', 'seems', 'now', 'clear', 'that', 'we', 'will', 'be', 'living', 'together', 'with', 'this', 'virus', 'for', 'quite', 'a', 'long', 'time', 'so', 'that', 'our', 'vigilance', 'and', 'responsiveness', 'against', 'the', 'emergence', 'of', 'new', 'local', 'outbreaks', 'shall', 'be', 'maintained', 'at', 'the', 'highest', 'possible', 'levels', 'The', 'etiological', 'diagnosis', 'of', 'COVID', '19', 'is', 'and', 'will', 'remain', 'for', 'the', 'foreseeable', 'future', 'deeply', 'based', 'on', 'direct', 'identification', 'of', 'viral', 'RNA', 'by', 'means', 'of', 'molecular', 'biology', 'techniques', 'in', 'biological', 'materials', 'especially', 'upper', 'and', 'lower', 'respiratory', 'tract', 'specimens', 'Whether', 'other', 'materials', 'such', 'as', 'blood', 'urine', 'stools', 'saliva', 'and', 'throat', 'washing', 'will', 'become', 'valid', 'alternatives', 'has', 'not', 'been', 'unequivocally', 'defined', 'so', 'far', 'As', 'concerns', 'serological', 'testing', 'promising', 'information', 'can', 'be', 'garnered', 'from', 'preliminary', 'investigations', 'showing', 'that', 'the', 'vast', 'majority', 'of', 'COVID', '19', 'patients', 'seem', 'to', 'develop', 'a', 'sustained', 'immune', 'response', 'against', 'the', 'virus', 'characterized', 'especially', 'by', 'emergence', 'of', 'anti', 'SARS', 'CoV', '2', 'IgG', 'and', 'IgA', '1', 'to', '2', 'weeks', 'after', 'the', 'onset', 'of', 'fever', 'and', 'or', 'respiratory', 'symptoms', 'Whether', 'these', 'antibodies', 'will', 'have', 'persistent', 'neutralizing', 'activity', 'against', 'the', 'virus', 'is', 'still', 'to', 'be', 'elucidated', 'on', 'individual', 'and', 'general', 'basis', 'The', 'availability', 'of', 'rapid', 'tests', 'for', 'detecting', 'either', 'viral', 'antigens', 'or', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'are', 'a', 'potentially', 'viable', 'opportunity', 'for', 'purposes', 'of', 'epidemiologic', 'surveillance', 'though', 'more', 'information', 'is', 'needed', 'on', 'accuracy', 'and', 'reliability', 'of', 'these', 'portable', 'immunoassays', '']"
33778,Replication of SARS-CoV-2 in human respiratory epithelium.,2020-05-20,Journal of virology,https://doi.org/10.1128/jvi.00957-20; https://www.ncbi.nlm.nih.gov/pubmed/32434888/,"Currently, there are four seasonal coronaviruses associated with relatively mild respiratory tract disease in humans. However, there are also a plethora of animal coronaviruses, which have the potential to cross the species border. This regularly results in the emergence of new viruses in humans. In 2002 SARS-CoV emerged, to rapidly disappear in May 2003. In 2012 MERS-CoV was identified as a possible threat to humans, but its pandemic potential so far is minimal, as the human-to-human transmission is ineffective. The end of 2019 brought us information about the SARS-CoV-2 emergence, and the virus rapidly spread in 2020 causing an unprecedented pandemic.At present, the studies on the virus are carried out using a surrogate system based on the immortalized simian Vero E6 cell line. This model is convenient for diagnostics, but it has serious limitations and does not allow for the understanding of virus biology and evolution.Here we show that fully differentiated human airway epithelium cultures constitute an excellent model to study the infection with the novel human coronavirus SARS-CoV-2. We observed an efficient replication of the virus in the tissue, with the maximal replication at 2 days post-infection. The virus replicated in ciliated cells and was released apically.IMPORTANCE SARS-CoV-2 emerged by the end of 2019 to rapidly spread in 2020. At present, it is of utmost importance to understand the virus biology and to rapidly assess the potential of existing drugs and develop new active compounds. While some animal models for such studies are under development, most of the research is carried out in the Vero E6 cells. Here, we propose fully differentiated human airway epithelium cultures as a model for studies on the SARS-CoV-2.",10.1128/jvi.00957-20,4v42ezk8,"['Currently', 'there', 'are', 'four', 'seasonal', 'coronaviruses', 'associated', 'with', 'relatively', 'mild', 'respiratory', 'tract', 'disease', 'in', 'humans', 'However', 'there', 'are', 'also', 'a', 'plethora', 'of', 'animal', 'coronaviruses', 'which', 'have', 'the', 'potential', 'to', 'cross', 'the', 'species', 'border', 'This', 'regularly', 'results', 'in', 'the', 'emergence', 'of', 'new', 'viruses', 'in', 'humans', 'In', '2002', 'SARS', 'CoV', 'emerged', 'to', 'rapidly', 'disappear', 'in', 'May', '2003', 'In', '2012', 'MERS', 'CoV', 'was', 'identified', 'as', 'a', 'possible', 'threat', 'to', 'humans', 'but', 'its', 'pandemic', 'potential', 'so', 'far', 'is', 'minimal', 'as', 'the', 'human', 'to', 'human', 'transmission', 'is', 'ineffective', 'The', 'end', 'of', '2019', 'brought', 'us', 'information', 'about', 'the', 'SARS', 'CoV', '2', 'emergence', 'and', 'the', 'virus', 'rapidly', 'spread', 'in', '2020', 'causing', 'an', 'unprecedented', 'pandemic', 'At', 'present', 'the', 'studies', 'on', 'the', 'virus', 'are', 'carried', 'out', 'using', 'a', 'surrogate', 'system', 'based', 'on', 'the', 'immortalized', 'simian', 'Vero', 'E6', 'cell', 'line', 'This', 'model', 'is', 'convenient', 'for', 'diagnostics', 'but', 'it', 'has', 'serious', 'limitations', 'and', 'does', 'not', 'allow', 'for', 'the', 'understanding', 'of', 'virus', 'biology', 'and', 'evolution', 'Here', 'we', 'show', 'that', 'fully', 'differentiated', 'human', 'airway', 'epithelium', 'cultures', 'constitute', 'an', 'excellent', 'model', 'to', 'study', 'the', 'infection', 'with', 'the', 'novel', 'human', 'coronavirus', 'SARS', 'CoV', '2', 'We', 'observed', 'an', 'efficient', 'replication', 'of', 'the', 'virus', 'in', 'the', 'tissue', 'with', 'the', 'maximal', 'replication', 'at', '2', 'days', 'post', 'infection', 'The', 'virus', 'replicated', 'in', 'ciliated', 'cells', 'and', 'was', 'released', 'apically', 'IMPORTANCE', 'SARS', 'CoV', '2', 'emerged', 'by', 'the', 'end', 'of', '2019', 'to', 'rapidly', 'spread', 'in', '2020', 'At', 'present', 'it', 'is', 'of', 'utmost', 'importance', 'to', 'understand', 'the', 'virus', 'biology', 'and', 'to', 'rapidly', 'assess', 'the', 'potential', 'of', 'existing', 'drugs', 'and', 'develop', 'new', 'active', 'compounds', 'While', 'some', 'animal', 'models', 'for', 'such', 'studies', 'are', 'under', 'development', 'most', 'of', 'the', 'research', 'is', 'carried', 'out', 'in', 'the', 'Vero', 'E6', 'cells', 'Here', 'we', 'propose', 'fully', 'differentiated', 'human', 'airway', 'epithelium', 'cultures', 'as', 'a', 'model', 'for', 'studies', 'on', 'the', 'SARS', 'CoV', '2', '']"
34879,The many faces of interstitial pneumonia: a case of presumed SARS-CoV-2 infection.,2020-06-28,Swiss medical weekly,https://doi.org/10.4414/smw.2020.20312; https://www.ncbi.nlm.nih.gov/pubmed/32662060/,"We present the case of an oncology patient admitted to our hospital during the current COVID-19 pandemic with clinical and radiological features strongly suggestive of interstitial pneumonia. Multiple laboratory tests were negative for SARS-CoV-2 (polymerase chain reaction testing of nasopharyngeal swabs, and of induced sputum and stool samples, investigation of serum immunoglobulins G and M). In the setting of an immunocompromised status due to recent chemotherapy cycles for lung adenocarcinoma and prolonged corticosteroid therapy (due to frequent exacerbations of chronic obstructive pulmonary disease in recent months), we actively searched for the pathological agent and found it to be Pneumocystis jirovecii. The patient started specific antibiotic treatment but finally had a negative outcome due to the progression of the lung adenocarcinoma. The importance of differential diagnostics in clinical practice should be a given, especially during times of pandemic. The novel coronavirus infection introduced new guidelines for and approaches to the investigation of immunocompromised patients, so it is especially important not to forget the basis of differential diagnosis, to and adopt a thorough approach when assessing these complex patients. We want to stress the importance of thorough investigation to avoid misdiagnosis of atypical pathogens in the current setting of SARS-CoV-2 pandemic.",10.4414/smw.2020.20312,kczyj503,"['We', 'present', 'the', 'case', 'of', 'an', 'oncology', 'patient', 'admitted', 'to', 'our', 'hospital', 'during', 'the', 'current', 'COVID', '19', 'pandemic', 'with', 'clinical', 'and', 'radiological', 'features', 'strongly', 'suggestive', 'of', 'interstitial', 'pneumonia', 'Multiple', 'laboratory', 'tests', 'were', 'negative', 'for', 'SARS', 'CoV', '2', 'polymerase', 'chain', 'reaction', 'testing', 'of', 'nasopharyngeal', 'swabs', 'and', 'of', 'induced', 'sputum', 'and', 'stool', 'samples', 'investigation', 'of', 'serum', 'immunoglobulins', 'G', 'and', 'M', 'In', 'the', 'setting', 'of', 'an', 'immunocompromised', 'status', 'due', 'to', 'recent', 'chemotherapy', 'cycles', 'for', 'lung', 'adenocarcinoma', 'and', 'prolonged', 'corticosteroid', 'therapy', 'due', 'to', 'frequent', 'exacerbations', 'of', 'chronic', 'obstructive', 'pulmonary', 'disease', 'in', 'recent', 'months', 'we', 'actively', 'searched', 'for', 'the', 'pathological', 'agent', 'and', 'found', 'it', 'to', 'be', 'Pneumocystis', 'jirovecii', 'The', 'patient', 'started', 'specific', 'antibiotic', 'treatment', 'but', 'finally', 'had', 'a', 'negative', 'outcome', 'due', 'to', 'the', 'progression', 'of', 'the', 'lung', 'adenocarcinoma', 'The', 'importance', 'of', 'differential', 'diagnostics', 'in', 'clinical', 'practice', 'should', 'be', 'a', 'given', 'especially', 'during', 'times', 'of', 'pandemic', 'The', 'novel', 'coronavirus', 'infection', 'introduced', 'new', 'guidelines', 'for', 'and', 'approaches', 'to', 'the', 'investigation', 'of', 'immunocompromised', 'patients', 'so', 'it', 'is', 'especially', 'important', 'not', 'to', 'forget', 'the', 'basis', 'of', 'differential', 'diagnosis', 'to', 'and', 'adopt', 'a', 'thorough', 'approach', 'when', 'assessing', 'these', 'complex', 'patients', 'We', 'want', 'to', 'stress', 'the', 'importance', 'of', 'thorough', 'investigation', 'to', 'avoid', 'misdiagnosis', 'of', 'atypical', 'pathogens', 'in', 'the', 'current', 'setting', 'of', 'SARS', 'CoV', '2', 'pandemic', '']"
35921,Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.,2020-05-26,Viruses,https://doi.org/10.3390/v12060582; https://www.ncbi.nlm.nih.gov/pubmed/32466458/,"The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19.",10.3390/v12060582,h2mloxuh,"['The', 'recent', 'outbreak', 'of', 'the', 'Coronavirus', 'disease', '2019', 'COVID', '19', 'has', 'quickly', 'spread', 'worldwide', 'since', 'its', 'discovery', 'in', 'Wuhan', 'city', 'China', 'in', 'December', '2019', 'A', 'comprehensive', 'strategy', 'including', 'surveillance', 'diagnostics', 'research', 'clinical', 'treatment', 'and', 'development', 'of', 'vaccines', 'is', 'urgently', 'needed', 'to', 'win', 'the', 'battle', 'against', 'COVID', '19', 'The', 'past', 'three', 'unprecedented', 'outbreaks', 'of', 'emerging', 'human', 'coronavirus', 'infections', 'at', 'the', 'beginning', 'of', 'the', '21st', 'century', 'have', 'highlighted', 'the', 'importance', 'of', 'readily', 'available', 'accurate', 'and', 'rapid', 'diagnostic', 'technologies', 'to', 'contain', 'emerging', 'and', 're', 'emerging', 'pandemics', 'Real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'rRT', 'PCR', 'based', 'assays', 'performed', 'on', 'respiratory', 'specimens', 'remain', 'the', 'gold', 'standard', 'for', 'COVID', '19', 'diagnostics', 'However', 'point', 'of', 'care', 'technologies', 'and', 'serologic', 'immunoassays', 'are', 'rapidly', 'emerging', 'with', 'high', 'sensitivity', 'and', 'specificity', 'as', 'well', 'Even', 'though', 'excellent', 'techniques', 'are', 'available', 'for', 'the', 'diagnosis', 'of', 'symptomatic', 'patients', 'with', 'COVID', '19', 'in', 'well', 'equipped', 'laboratories', 'critical', 'gaps', 'still', 'remain', 'in', 'screening', 'asymptomatic', 'people', 'who', 'are', 'in', 'the', 'incubation', 'phase', 'of', 'the', 'virus', 'as', 'well', 'as', 'in', 'the', 'accurate', 'determination', 'of', 'live', 'viral', 'shedding', 'during', 'convalescence', 'to', 'inform', 'decisions', 'for', 'ending', 'isolation', 'This', 'review', 'article', 'aims', 'to', 'discuss', 'the', 'currently', 'available', 'laboratory', 'methods', 'and', 'surveillance', 'technologies', 'available', 'for', 'the', 'detection', 'of', 'COVID', '19', 'their', 'performance', 'characteristics', 'and', 'highlight', 'the', 'gaps', 'in', 'current', 'diagnostic', 'capacity', 'and', 'finally', 'propose', 'potential', 'solutions', 'We', 'also', 'summarize', 'the', 'specifications', 'of', 'the', 'majority', 'of', 'the', 'available', 'commercial', 'kits', 'PCR', 'EIA', 'and', 'POC', 'for', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
36241,Lab-on-a-Chip Devices for Point-of-Care Medical Diagnostics.,2020-05-21,Advances in biochemical engineering/biotechnology,https://doi.org/10.1007/10_2020_127; https://www.ncbi.nlm.nih.gov/pubmed/32435872/,"The recent coronavirus (COVID-19) pandemic has underscored the need to move from traditional lab-centralized diagnostics to point-of-care (PoC) settings. Lab-on-a-chip (LoC) platforms facilitate the translation to PoC settings via the miniaturization, portability, integration, and automation of multiple assay functions onto a single chip. For this purpose, paper-based assays and microfluidic platforms are currently being extensively studied, and much focus is being directed towards simplifying their design while simultaneously improving multiplexing and automation capabilities. Signal amplification strategies are being applied to improve the performance of assays with respect to both sensitivity and selectivity, while smartphones are being integrated to expand the analytical power of the technology and promote its accessibility. In this chapter, we review the main technologies in the field of LoC platforms for PoC medical diagnostics and survey recent approaches for improving these assays.",10.1007/10_2020_127,ken6ml2i,"['The', 'recent', 'coronavirus', 'COVID', '19', 'pandemic', 'has', 'underscored', 'the', 'need', 'to', 'move', 'from', 'traditional', 'lab', 'centralized', 'diagnostics', 'to', 'point', 'of', 'care', 'PoC', 'settings', 'Lab', 'on', 'a', 'chip', 'LoC', 'platforms', 'facilitate', 'the', 'translation', 'to', 'PoC', 'settings', 'via', 'the', 'miniaturization', 'portability', 'integration', 'and', 'automation', 'of', 'multiple', 'assay', 'functions', 'onto', 'a', 'single', 'chip', 'For', 'this', 'purpose', 'paper', 'based', 'assays', 'and', 'microfluidic', 'platforms', 'are', 'currently', 'being', 'extensively', 'studied', 'and', 'much', 'focus', 'is', 'being', 'directed', 'towards', 'simplifying', 'their', 'design', 'while', 'simultaneously', 'improving', 'multiplexing', 'and', 'automation', 'capabilities', 'Signal', 'amplification', 'strategies', 'are', 'being', 'applied', 'to', 'improve', 'the', 'performance', 'of', 'assays', 'with', 'respect', 'to', 'both', 'sensitivity', 'and', 'selectivity', 'while', 'smartphones', 'are', 'being', 'integrated', 'to', 'expand', 'the', 'analytical', 'power', 'of', 'the', 'technology', 'and', 'promote', 'its', 'accessibility', 'In', 'this', 'chapter', 'we', 'review', 'the', 'main', 'technologies', 'in', 'the', 'field', 'of', 'LoC', 'platforms', 'for', 'PoC', 'medical', 'diagnostics', 'and', 'survey', 'recent', 'approaches', 'for', 'improving', 'these', 'assays', '']"
36832,Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests.,2020-07-06,Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,https://doi.org/10.1016/j.jcv.2020.104544; https://www.ncbi.nlm.nih.gov/pubmed/32663788/,"The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) has been followed by the rapid development of antibody tests. To assess the utility of the tests for clinical use and seroepidemiologic studies, we examined the sensitivity of commercial antibody tests from Roche, Abbott, Novatec, Virotech Siemens, Euroimmun, and Mediagnost in a prospective diagnostic study. The tests were evaluated with 73 sera from SARS CoV-2 RNA positive individuals with mild to moderate disease or asymptomatic infection. Sera were obtained at 2-3 weeks (N = 25) or > 4 weeks (N = 48) after symptom onset and viral RNA test. The overall sensitivity of the tests ranged from 64.4-93.2%. The most sensitive assays recognized 95.8-100 % of the sera obtained after 4 weeks or later. Sera drawn at 2-3 weeks were recognized with lower sensitivity indicating that the optimal time point for serologic testing is later than 3 weeks after onset of the disease. Nucleoprotein- and glycoproteinbased assays had similar sensitivity indicating that tests with both antigens are suitable for serological diagnostics. Breakdown of the test results showed that nucleoprotein- and glycoprotein-based tests of comparable sensitivity reacted with different sets of sera. The observation indicates that a combination of nucleoprotein- and glycoprotein-based tests would increase the percentage of positive results.",10.1016/j.jcv.2020.104544,555g14yx,"['The', 'emergence', 'of', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'been', 'followed', 'by', 'the', 'rapid', 'development', 'of', 'antibody', 'tests', 'To', 'assess', 'the', 'utility', 'of', 'the', 'tests', 'for', 'clinical', 'use', 'and', 'seroepidemiologic', 'studies', 'we', 'examined', 'the', 'sensitivity', 'of', 'commercial', 'antibody', 'tests', 'from', 'Roche', 'Abbott', 'Novatec', 'Virotech', 'Siemens', 'Euroimmun', 'and', 'Mediagnost', 'in', 'a', 'prospective', 'diagnostic', 'study', 'The', 'tests', 'were', 'evaluated', 'with', '73', 'sera', 'from', 'SARS', 'CoV', '2', 'RNA', 'positive', 'individuals', 'with', 'mild', 'to', 'moderate', 'disease', 'or', 'asymptomatic', 'infection', 'Sera', 'were', 'obtained', 'at', '2', '3', 'weeks', 'N', '25', 'or', '4', 'weeks', 'N', '48', 'after', 'symptom', 'onset', 'and', 'viral', 'RNA', 'test', 'The', 'overall', 'sensitivity', 'of', 'the', 'tests', 'ranged', 'from', '64', '4', '93', '2', 'The', 'most', 'sensitive', 'assays', 'recognized', '95', '8', '100', 'of', 'the', 'sera', 'obtained', 'after', '4', 'weeks', 'or', 'later', 'Sera', 'drawn', 'at', '2', '3', 'weeks', 'were', 'recognized', 'with', 'lower', 'sensitivity', 'indicating', 'that', 'the', 'optimal', 'time', 'point', 'for', 'serologic', 'testing', 'is', 'later', 'than', '3', 'weeks', 'after', 'onset', 'of', 'the', 'disease', 'Nucleoprotein', 'and', 'glycoproteinbased', 'assays', 'had', 'similar', 'sensitivity', 'indicating', 'that', 'tests', 'with', 'both', 'antigens', 'are', 'suitable', 'for', 'serological', 'diagnostics', 'Breakdown', 'of', 'the', 'test', 'results', 'showed', 'that', 'nucleoprotein', 'and', 'glycoprotein', 'based', 'tests', 'of', 'comparable', 'sensitivity', 'reacted', 'with', 'different', 'sets', 'of', 'sera', 'The', 'observation', 'indicates', 'that', 'a', 'combination', 'of', 'nucleoprotein', 'and', 'glycoprotein', 'based', 'tests', 'would', 'increase', 'the', 'percentage', 'of', 'positive', 'results', '']"
36894,Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.,2020-07-20,The Lancet. Oncology,https://doi.org/10.1016/s1470-2045(20)30392-2; https://www.ncbi.nlm.nih.gov/pubmed/32702311/,"BACKGROUND During the COVID-19 lockdown, referrals via the 2-week-wait urgent pathway for suspected cancer in England, UK, are reported to have decreased by up to 84%. We aimed to examine the impact of different scenarios of lockdown-accumulated backlog in cancer referrals on cancer survival, and the impact on survival per referred patient due to delayed referral versus risk of death from nosocomial infection with severe acute respiratory syndrome coronavirus 2. METHODS In this modelling study, we used age-stratified and stage-stratified 10-year cancer survival estimates for patients in England, UK, for 20 common tumour types diagnosed in 2008-17 at age 30 years and older from Public Health England. We also used data for cancer diagnoses made via the 2-week-wait referral pathway in 2013-16 from the Cancer Waiting Times system from NHS Digital. We applied per-day hazard ratios (HRs) for cancer progression that we generated from observational studies of delay to treatment. We quantified the annual numbers of cancers at stage I-III diagnosed via the 2-week-wait pathway using 2-week-wait age-specific and stage-specific breakdowns. From these numbers, we estimated the aggregate number of lives and life-years lost in England for per-patient delays of 1-6 months in presentation, diagnosis, or cancer treatment, or a combination of these. We assessed three scenarios of a 3-month period of lockdown during which 25%, 50%, and 75% of the normal monthly volumes of symptomatic patients delayed their presentation until after lockdown. Using referral-to-diagnosis conversion rates and COVID-19 case-fatality rates, we also estimated the survival increment per patient referred. FINDINGS Across England in 2013-16, an average of 6281 patients with stage I-III cancer were diagnosed via the 2-week-wait pathway per month, of whom 1691 (27%) would be predicted to die within 10 years from their disease. Delays in presentation via the 2-week-wait pathway over a 3-month lockdown period (with an average presentational delay of 2 months per patient) would result in 181 additional lives and 3316 life-years lost as a result of a backlog of referrals of 25%, 361 additional lives and 6632 life-years lost for a 50% backlog of referrals, and 542 additional lives and 9948 life-years lost for a 75% backlog in referrals. Compared with all diagnostics for the backlog being done in month 1 after lockdown, additional capacity across months 1-3 would result in 90 additional lives and 1662 live-years lost due to diagnostic delays for the 25% backlog scenario, 183 additional lives and 3362 life-years lost under the 50% backlog scenario, and 276 additional lives and 5075 life-years lost under the 75% backlog scenario. However, a delay in additional diagnostic capacity with provision spread across months 3-8 after lockdown would result in 401 additional lives and 7332 life-years lost due to diagnostic delays under the 25% backlog scenario, 811 additional lives and 14 873 life-years lost under the 50% backlog scenario, and 1231 additional lives and 22 635 life-years lost under the 75% backlog scenario. A 2-month delay in 2-week-wait investigatory referrals results in an estimated loss of between 0·0 and 0·7 life-years per referred patient, depending on age and tumour type. INTERPRETATION Prompt provision of additional capacity to address the backlog of diagnostics will minimise deaths as a result of diagnostic delays that could add to those predicted due to expected presentational delays. Prioritisation of patient groups for whom delay would result in most life-years lost warrants consideration as an option for mitigating the aggregate burden of mortality in patients with cancer. FUNDING None.",10.1016/s1470-2045(20)30392-2,rlm5m07t,"['BACKGROUND', 'During', 'the', 'COVID', '19', 'lockdown', 'referrals', 'via', 'the', '2', 'week', 'wait', 'urgent', 'pathway', 'for', 'suspected', 'cancer', 'in', 'England', 'UK', 'are', 'reported', 'to', 'have', 'decreased', 'by', 'up', 'to', '84', 'We', 'aimed', 'to', 'examine', 'the', 'impact', 'of', 'different', 'scenarios', 'of', 'lockdown', 'accumulated', 'backlog', 'in', 'cancer', 'referrals', 'on', 'cancer', 'survival', 'and', 'the', 'impact', 'on', 'survival', 'per', 'referred', 'patient', 'due', 'to', 'delayed', 'referral', 'versus', 'risk', 'of', 'death', 'from', 'nosocomial', 'infection', 'with', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'METHODS', 'In', 'this', 'modelling', 'study', 'we', 'used', 'age', 'stratified', 'and', 'stage', 'stratified', '10', 'year', 'cancer', 'survival', 'estimates', 'for', 'patients', 'in', 'England', 'UK', 'for', '20', 'common', 'tumour', 'types', 'diagnosed', 'in', '2008', '17', 'at', 'age', '30', 'years', 'and', 'older', 'from', 'Public', 'Health', 'England', 'We', 'also', 'used', 'data', 'for', 'cancer', 'diagnoses', 'made', 'via', 'the', '2', 'week', 'wait', 'referral', 'pathway', 'in', '2013', '16', 'from', 'the', 'Cancer', 'Waiting', 'Times', 'system', 'from', 'NHS', 'Digital', 'We', 'applied', 'per', 'day', 'hazard', 'ratios', 'HRs', 'for', 'cancer', 'progression', 'that', 'we', 'generated', 'from', 'observational', 'studies', 'of', 'delay', 'to', 'treatment', 'We', 'quantified', 'the', 'annual', 'numbers', 'of', 'cancers', 'at', 'stage', 'I', 'III', 'diagnosed', 'via', 'the', '2', 'week', 'wait', 'pathway', 'using', '2', 'week', 'wait', 'age', 'specific', 'and', 'stage', 'specific', 'breakdowns', 'From', 'these', 'numbers', 'we', 'estimated', 'the', 'aggregate', 'number', 'of', 'lives', 'and', 'life', 'years', 'lost', 'in', 'England', 'for', 'per', 'patient', 'delays', 'of', '1', '6', 'months', 'in', 'presentation', 'diagnosis', 'or', 'cancer', 'treatment', 'or', 'a', 'combination', 'of', 'these', 'We', 'assessed', 'three', 'scenarios', 'of', 'a', '3', 'month', 'period', 'of', 'lockdown', 'during', 'which', '25', '50', 'and', '75', 'of', 'the', 'normal', 'monthly', 'volumes', 'of', 'symptomatic', 'patients', 'delayed', 'their', 'presentation', 'until', 'after', 'lockdown', 'Using', 'referral', 'to', 'diagnosis', 'conversion', 'rates', 'and', 'COVID', '19', 'case', 'fatality', 'rates', 'we', 'also', 'estimated', 'the', 'survival', 'increment', 'per', 'patient', 'referred', 'FINDINGS', 'Across', 'England', 'in', '2013', '16', 'an', 'average', 'of', '6281', 'patients', 'with', 'stage', 'I', 'III', 'cancer', 'were', 'diagnosed', 'via', 'the', '2', 'week', 'wait', 'pathway', 'per', 'month', 'of', 'whom', '1691', '27', 'would', 'be', 'predicted', 'to', 'die', 'within', '10', 'years', 'from', 'their', 'disease', 'Delays', 'in', 'presentation', 'via', 'the', '2', 'week', 'wait', 'pathway', 'over', 'a', '3', 'month', 'lockdown', 'period', 'with', 'an', 'average', 'presentational', 'delay', 'of', '2', 'months', 'per', 'patient', 'would', 'result', 'in', '181', 'additional', 'lives', 'and', '3316', 'life', 'years', 'lost', 'as', 'a', 'result', 'of', 'a', 'backlog', 'of', 'referrals', 'of', '25', '361', 'additional', 'lives', 'and', '6632', 'life', 'years', 'lost', 'for', 'a', '50', 'backlog', 'of', 'referrals', 'and', '542', 'additional', 'lives', 'and', '9948', 'life', 'years', 'lost', 'for', 'a', '75', 'backlog', 'in', 'referrals', 'Compared', 'with', 'all', 'diagnostics', 'for', 'the', 'backlog', 'being', 'done', 'in', 'month', '1', 'after', 'lockdown', 'additional', 'capacity', 'across', 'months', '1', '3', 'would', 'result', 'in', '90', 'additional', 'lives', 'and', '1662', 'live', 'years', 'lost', 'due', 'to', 'diagnostic', 'delays', 'for', 'the', '25', 'backlog', 'scenario', '183', 'additional', 'lives', 'and', '3362', 'life', 'years', 'lost', 'under', 'the', '50', 'backlog', 'scenario', 'and', '276', 'additional', 'lives', 'and', '5075', 'life', 'years', 'lost', 'under', 'the', '75', 'backlog', 'scenario', 'However', 'a', 'delay', 'in', 'additional', 'diagnostic', 'capacity', 'with', 'provision', 'spread', 'across', 'months', '3', '8', 'after', 'lockdown', 'would', 'result', 'in', '401', 'additional', 'lives', 'and', '7332', 'life', 'years', 'lost', 'due', 'to', 'diagnostic', 'delays', 'under', 'the', '25', 'backlog', 'scenario', '811', 'additional', 'lives', 'and', '14', '873', 'life', 'years', 'lost', 'under', 'the', '50', 'backlog', 'scenario', 'and', '1231', 'additional', 'lives', 'and', '22', '635', 'life', 'years', 'lost', 'under', 'the', '75', 'backlog', 'scenario', 'A', '2', 'month', 'delay', 'in', '2', 'week', 'wait', 'investigatory', 'referrals', 'results', 'in', 'an', 'estimated', 'loss', 'of', 'between', '0', '0', 'and', '0', '7', 'life', 'years', 'per', 'referred', 'patient', 'depending', 'on', 'age', 'and', 'tumour', 'type', 'INTERPRETATION', 'Prompt', 'provision', 'of', 'additional', 'capacity', 'to', 'address', 'the', 'backlog', 'of', 'diagnostics', 'will', 'minimise', 'deaths', 'as', 'a', 'result', 'of', 'diagnostic', 'delays', 'that', 'could', 'add', 'to', 'those', 'predicted', 'due', 'to', 'expected', 'presentational', 'delays', 'Prioritisation', 'of', 'patient', 'groups', 'for', 'whom', 'delay', 'would', 'result', 'in', 'most', 'life', 'years', 'lost', 'warrants', 'consideration', 'as', 'an', 'option', 'for', 'mitigating', 'the', 'aggregate', 'burden', 'of', 'mortality', 'in', 'patients', 'with', 'cancer', 'FUNDING', 'None', '']"
39123,Clinical Molecular Genetics Evaluation in Women with Reproductive Failures.,2020-07-25,American journal of reproductive immunology,https://doi.org/10.1111/aji.13313; https://www.ncbi.nlm.nih.gov/pubmed/32710571/,"Molecular diagnostics is a rapidly growing branch of the clinical laboratory and has accelerated the advance of personalized medicine in the fields of pharmacogenomics, pharmacogenetics, and nutrigenomics. The versatility of molecular biology allows it to be effective in several medical fields that include reproduction, immunogenetics and virology. Implementation of molecular and sequencing technology in reproductive medicine can add another layer of understanding to better define the causes behind infertility and recurrent reproductive loss. In the following we examine current molecular methods for probing factors behind reproductive pregnancy loss including reverse transcription PCR (RT-PCR), and Next Generation Sequencing (NGS). We review several current and potential genetic (DNA) and transcriptional (RNA) based parameters in women with infertility that can be significant in diagnosis and treatment. These molecular factors can be inferred either from genomic DNA, or RNA locally within the endometrium. Furthermore, we consider infection-based abnormalities such as Human Herpes Virus-6 (HHV-6), and Severe acute respiratory syndrome coronavirus-2 (SARS CoV-2). Finally, we present future directions as well as data demonstrating the potential role of Human Endogenous Retroviruses (HERV) in pregnancy loss. We hope these discussions will assist the clinician in delineating some of the intricate molecular factors that can contribute to infertility and recurrent reproductive failures.",10.1111/aji.13313,zhklwsit,"['Molecular', 'diagnostics', 'is', 'a', 'rapidly', 'growing', 'branch', 'of', 'the', 'clinical', 'laboratory', 'and', 'has', 'accelerated', 'the', 'advance', 'of', 'personalized', 'medicine', 'in', 'the', 'fields', 'of', 'pharmacogenomics', 'pharmacogenetics', 'and', 'nutrigenomics', 'The', 'versatility', 'of', 'molecular', 'biology', 'allows', 'it', 'to', 'be', 'effective', 'in', 'several', 'medical', 'fields', 'that', 'include', 'reproduction', 'immunogenetics', 'and', 'virology', 'Implementation', 'of', 'molecular', 'and', 'sequencing', 'technology', 'in', 'reproductive', 'medicine', 'can', 'add', 'another', 'layer', 'of', 'understanding', 'to', 'better', 'define', 'the', 'causes', 'behind', 'infertility', 'and', 'recurrent', 'reproductive', 'loss', 'In', 'the', 'following', 'we', 'examine', 'current', 'molecular', 'methods', 'for', 'probing', 'factors', 'behind', 'reproductive', 'pregnancy', 'loss', 'including', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'and', 'Next', 'Generation', 'Sequencing', 'NGS', 'We', 'review', 'several', 'current', 'and', 'potential', 'genetic', 'DNA', 'and', 'transcriptional', 'RNA', 'based', 'parameters', 'in', 'women', 'with', 'infertility', 'that', 'can', 'be', 'significant', 'in', 'diagnosis', 'and', 'treatment', 'These', 'molecular', 'factors', 'can', 'be', 'inferred', 'either', 'from', 'genomic', 'DNA', 'or', 'RNA', 'locally', 'within', 'the', 'endometrium', 'Furthermore', 'we', 'consider', 'infection', 'based', 'abnormalities', 'such', 'as', 'Human', 'Herpes', 'Virus', '6', 'HHV', '6', 'and', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'Finally', 'we', 'present', 'future', 'directions', 'as', 'well', 'as', 'data', 'demonstrating', 'the', 'potential', 'role', 'of', 'Human', 'Endogenous', 'Retroviruses', 'HERV', 'in', 'pregnancy', 'loss', 'We', 'hope', 'these', 'discussions', 'will', 'assist', 'the', 'clinician', 'in', 'delineating', 'some', 'of', 'the', 'intricate', 'molecular', 'factors', 'that', 'can', 'contribute', 'to', 'infertility', 'and', 'recurrent', 'reproductive', 'failures', '']"
39839,Clinical characteristics of children with viral single- and co-infections and a petechial rash.,2013,The Pediatric infectious disease journal,https://doi.org/10.1097/inf.0b013e318280618d; https://www.ncbi.nlm.nih.gov/pubmed/23249918/,"BACKGROUND Children with petechial rash are more likely to undergo invasive diagnostics, to be treated with antibiotics for potential bacterial infection and to be hospitalized. However, viruses have also been associated with petechial rash. Nonetheless, a systematic analysis of viral infections with modern available techniques as quantitative real-time polymerase chain reaction in the context of petechial rash is lacking. The purpose of this pediatric study was to prospectively uncover viral pathogens that may promote the emergence of petechiae and to analyze the correlation with the clinical characteristics and course. METHODS We conducted a prospective study in children (0 to 18 years) presenting with petechiae and signs or symptoms of infection at the emergency department between November 2009 and March 2012. In nasopharyngeal aspirates the following viruses were analyzed by quantitative real-time polymerase chain reaction: cytomegalovirus, Epstein-Barr virus, parvovirus B19, influenza A and B, parainfluenza viruses, human respiratory syncytial virus A and B, human metapneumovirus, rhinovirus, enterovirus, adenovirus, human coronavirus OC43, 229E, NL63 and human bocavirus. RESULTS A viral pathogen was identified in 67% of the analyzed 58 cases with petechial rash. Virus positive patients showed a significantly higher incidence of lower respiratory tract infections. Forty-one percent were viral coinfections, which were significantly younger than virus negative patients, had a higher leukocyte count and were hospitalized for a longer time. CONCLUSIONS A petechial rash is frequently associated viral single- and coinfections and can rapidly be identified via quantitative real-time polymerase chain reaction.",10.1097/inf.0b013e318280618d,yceesg9n,"['BACKGROUND', 'Children', 'with', 'petechial', 'rash', 'are', 'more', 'likely', 'to', 'undergo', 'invasive', 'diagnostics', 'to', 'be', 'treated', 'with', 'antibiotics', 'for', 'potential', 'bacterial', 'infection', 'and', 'to', 'be', 'hospitalized', 'However', 'viruses', 'have', 'also', 'been', 'associated', 'with', 'petechial', 'rash', 'Nonetheless', 'a', 'systematic', 'analysis', 'of', 'viral', 'infections', 'with', 'modern', 'available', 'techniques', 'as', 'quantitative', 'real', 'time', 'polymerase', 'chain', 'reaction', 'in', 'the', 'context', 'of', 'petechial', 'rash', 'is', 'lacking', 'The', 'purpose', 'of', 'this', 'pediatric', 'study', 'was', 'to', 'prospectively', 'uncover', 'viral', 'pathogens', 'that', 'may', 'promote', 'the', 'emergence', 'of', 'petechiae', 'and', 'to', 'analyze', 'the', 'correlation', 'with', 'the', 'clinical', 'characteristics', 'and', 'course', 'METHODS', 'We', 'conducted', 'a', 'prospective', 'study', 'in', 'children', '0', 'to', '18', 'years', 'presenting', 'with', 'petechiae', 'and', 'signs', 'or', 'symptoms', 'of', 'infection', 'at', 'the', 'emergency', 'department', 'between', 'November', '2009', 'and', 'March', '2012', 'In', 'nasopharyngeal', 'aspirates', 'the', 'following', 'viruses', 'were', 'analyzed', 'by', 'quantitative', 'real', 'time', 'polymerase', 'chain', 'reaction', 'cytomegalovirus', 'Epstein', 'Barr', 'virus', 'parvovirus', 'B19', 'influenza', 'A', 'and', 'B', 'parainfluenza', 'viruses', 'human', 'respiratory', 'syncytial', 'virus', 'A', 'and', 'B', 'human', 'metapneumovirus', 'rhinovirus', 'enterovirus', 'adenovirus', 'human', 'coronavirus', 'OC43', '229E', 'NL63', 'and', 'human', 'bocavirus', 'RESULTS', 'A', 'viral', 'pathogen', 'was', 'identified', 'in', '67', 'of', 'the', 'analyzed', '58', 'cases', 'with', 'petechial', 'rash', 'Virus', 'positive', 'patients', 'showed', 'a', 'significantly', 'higher', 'incidence', 'of', 'lower', 'respiratory', 'tract', 'infections', 'Forty', 'one', 'percent', 'were', 'viral', 'coinfections', 'which', 'were', 'significantly', 'younger', 'than', 'virus', 'negative', 'patients', 'had', 'a', 'higher', 'leukocyte', 'count', 'and', 'were', 'hospitalized', 'for', 'a', 'longer', 'time', 'CONCLUSIONS', 'A', 'petechial', 'rash', 'is', 'frequently', 'associated', 'viral', 'single', 'and', 'coinfections', 'and', 'can', 'rapidly', 'be', 'identified', 'via', 'quantitative', 'real', 'time', 'polymerase', 'chain', 'reaction', '']"
40248,Nucleic acid amplification-based diagnosis of respiratory virus infections.,2010,Expert review of anti-infective therapy,https://doi.org/10.1586/eri.10.121; https://www.ncbi.nlm.nih.gov/pubmed/21073292/,"The appearance of eight new respiratory viruses in the human population in the past 9 years, including two new pandemics (SARS coronavirus in 2003 and swine-origin influenza A/H1N1 in 2009), has tested the ability of virology laboratories to develop diagnostic tests to identify these viruses. Nucleic acid amplification tests (NATs) that first appeared two decades ago have been developed for both conventional and emerging viruses and now form the backbone of the clinical laboratory. NATs provide fast, accurate and sensitive detection of respiratory viruses and have significantly increased our understanding of the epidemiology of these viruses. Multiplex PCR assays have been introduced recently and several commercial tests are now available. The final chapter in the evolution of respiratory virus diagnostics will be the addition of allelic discrimination and detection of single nucleotide polymorphisms associated with antiviral resistance to multiplex assays. These resistance assays together with new viral load tests will enable clinical laboratories to provide physicians with important information for optimal treatment of patients.",10.1586/eri.10.121,558e6nnl,"['The', 'appearance', 'of', 'eight', 'new', 'respiratory', 'viruses', 'in', 'the', 'human', 'population', 'in', 'the', 'past', '9', 'years', 'including', 'two', 'new', 'pandemics', 'SARS', 'coronavirus', 'in', '2003', 'and', 'swine', 'origin', 'influenza', 'A', 'H1N1', 'in', '2009', 'has', 'tested', 'the', 'ability', 'of', 'virology', 'laboratories', 'to', 'develop', 'diagnostic', 'tests', 'to', 'identify', 'these', 'viruses', 'Nucleic', 'acid', 'amplification', 'tests', 'NATs', 'that', 'first', 'appeared', 'two', 'decades', 'ago', 'have', 'been', 'developed', 'for', 'both', 'conventional', 'and', 'emerging', 'viruses', 'and', 'now', 'form', 'the', 'backbone', 'of', 'the', 'clinical', 'laboratory', 'NATs', 'provide', 'fast', 'accurate', 'and', 'sensitive', 'detection', 'of', 'respiratory', 'viruses', 'and', 'have', 'significantly', 'increased', 'our', 'understanding', 'of', 'the', 'epidemiology', 'of', 'these', 'viruses', 'Multiplex', 'PCR', 'assays', 'have', 'been', 'introduced', 'recently', 'and', 'several', 'commercial', 'tests', 'are', 'now', 'available', 'The', 'final', 'chapter', 'in', 'the', 'evolution', 'of', 'respiratory', 'virus', 'diagnostics', 'will', 'be', 'the', 'addition', 'of', 'allelic', 'discrimination', 'and', 'detection', 'of', 'single', 'nucleotide', 'polymorphisms', 'associated', 'with', 'antiviral', 'resistance', 'to', 'multiplex', 'assays', 'These', 'resistance', 'assays', 'together', 'with', 'new', 'viral', 'load', 'tests', 'will', 'enable', 'clinical', 'laboratories', 'to', 'provide', 'physicians', 'with', 'important', 'information', 'for', 'optimal', 'treatment', 'of', 'patients', '']"
41290,Community-acquired pneumonia.,2015,Current opinion in pulmonary medicine,https://doi.org/10.1097/mcp.0000000000000150; https://www.ncbi.nlm.nih.gov/pubmed/25775050/,"PURPOSE OF REVIEW Community-acquired pneumonia (CAP) is the most common infectious disease cause of death. We summarize recent findings regarding the epidemiology of CAP in adults, efficacy of vaccines against Streptococcus pneumoniae, diagnostics, and discuss the current controversy between CAP and healthcare-associated pneumonia (HCAP). RECENT FINDINGS The emergence of the Middle East respiratory syndrome coronavirus and the avian influenza A strain H7N9 are of concern but still these are infrequent causes of CAP. Recent data indicate that vaccinating children also protects adults against CAP by generating significant herd immunity, and that the conjugated pneumococcal vaccine in adults may offer some efficacy in preventing CAP caused by vaccine serotypes. The immunochromotagraphic urinary antigen test has improved the diagnostic yield for the aetiology of CAP, and initial data demonstrate that a novel multiplex urinary antigen test will further increase the sensitivity for detection of S. pneumoniae. There has been significant concern that a relatively recently described pneumonia category, HCAP, requires empirical treatment for potentially multidrug-resistant organisms (MDRO). However, new evidence shows that (at least in Europe) pneumonia caused by MDRO remains uncommon even in HCAP category patients. SUMMARY CAP remains a major cause of morbidity and mortality. Advances in vaccination and diagnosis should help reduce the amount of disease due to S. pneumoniae, the commonest cause of CAP. Outside of the United States, MDRO are relatively uncommon causes of CAP, and the increased mortality of HCAP category patients seems to be related to their comorbidities and age rather than microbial aetiology.",10.1097/mcp.0000000000000150,53y7ilzb,"['PURPOSE', 'OF', 'REVIEW', 'Community', 'acquired', 'pneumonia', 'CAP', 'is', 'the', 'most', 'common', 'infectious', 'disease', 'cause', 'of', 'death', 'We', 'summarize', 'recent', 'findings', 'regarding', 'the', 'epidemiology', 'of', 'CAP', 'in', 'adults', 'efficacy', 'of', 'vaccines', 'against', 'Streptococcus', 'pneumoniae', 'diagnostics', 'and', 'discuss', 'the', 'current', 'controversy', 'between', 'CAP', 'and', 'healthcare', 'associated', 'pneumonia', 'HCAP', 'RECENT', 'FINDINGS', 'The', 'emergence', 'of', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'and', 'the', 'avian', 'influenza', 'A', 'strain', 'H7N9', 'are', 'of', 'concern', 'but', 'still', 'these', 'are', 'infrequent', 'causes', 'of', 'CAP', 'Recent', 'data', 'indicate', 'that', 'vaccinating', 'children', 'also', 'protects', 'adults', 'against', 'CAP', 'by', 'generating', 'significant', 'herd', 'immunity', 'and', 'that', 'the', 'conjugated', 'pneumococcal', 'vaccine', 'in', 'adults', 'may', 'offer', 'some', 'efficacy', 'in', 'preventing', 'CAP', 'caused', 'by', 'vaccine', 'serotypes', 'The', 'immunochromotagraphic', 'urinary', 'antigen', 'test', 'has', 'improved', 'the', 'diagnostic', 'yield', 'for', 'the', 'aetiology', 'of', 'CAP', 'and', 'initial', 'data', 'demonstrate', 'that', 'a', 'novel', 'multiplex', 'urinary', 'antigen', 'test', 'will', 'further', 'increase', 'the', 'sensitivity', 'for', 'detection', 'of', 'S', 'pneumoniae', 'There', 'has', 'been', 'significant', 'concern', 'that', 'a', 'relatively', 'recently', 'described', 'pneumonia', 'category', 'HCAP', 'requires', 'empirical', 'treatment', 'for', 'potentially', 'multidrug', 'resistant', 'organisms', 'MDRO', 'However', 'new', 'evidence', 'shows', 'that', 'at', 'least', 'in', 'Europe', 'pneumonia', 'caused', 'by', 'MDRO', 'remains', 'uncommon', 'even', 'in', 'HCAP', 'category', 'patients', 'SUMMARY', 'CAP', 'remains', 'a', 'major', 'cause', 'of', 'morbidity', 'and', 'mortality', 'Advances', 'in', 'vaccination', 'and', 'diagnosis', 'should', 'help', 'reduce', 'the', 'amount', 'of', 'disease', 'due', 'to', 'S', 'pneumoniae', 'the', 'commonest', 'cause', 'of', 'CAP', 'Outside', 'of', 'the', 'United', 'States', 'MDRO', 'are', 'relatively', 'uncommon', 'causes', 'of', 'CAP', 'and', 'the', 'increased', 'mortality', 'of', 'HCAP', 'category', 'patients', 'seems', 'to', 'be', 'related', 'to', 'their', 'comorbidities', 'and', 'age', 'rather', 'than', 'microbial', 'aetiology', '']"
42334,HEALTH-SCREENING PROTOCOLS FOR VINACEOUS AMAZONS (AMAZONA VINACEA) IN A REINTRODUCTION PROJECT.,2015,Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians,https://doi.org/10.1638/2013-0152.1; https://www.ncbi.nlm.nih.gov/pubmed/26667526/,"Reintroduction is a growing field in the conservation of endangered species. The vinaceous Amazon parrot (Amazona vinacea) is extinct in several areas, and a project to release confiscated individuals to their former range is currently underway. The objective of this study was to evaluate and improve the selection and treatment of individual release candidates by detecting possible pathogen carriers using samples taken before and during release. As part of prerelease health protocols, samples were obtained from 29 parrots on three different occasions while in captivity and once after their release. Samples were screened for paramyxovirus type 1, avian influenza, poxvirus, coronavirus, psittacine herpesvirus 1, Chlamydia psittaci , enteropathogenic Escherichia coli (EPEC), Salmonella spp., and endoparasites. The majority of samples returned negative results, with the exception of two individuals that tested positive for C. psittaci in the first sampling and for Ascaridia spp. in the second pooled sampling. Treatments for C. psittaci and endoparasites were administered prior to release, and negative results were obtained in subsequent exams. The number of positive results for E. coli (non-EPEC) decreased during the rehabilitation period. Adequate quarantine procedures and health examinations greatly minimize disease risks. The protocols employed in this study resulted in acceptable health status in accordance with current environmental legislation in Brazil. Additionally, protocols allowed informed decisions to release candidates, minimized risks, and favored the selection of healthy individuals, thereby contributing to the recovery of this species. It is important to determine appropriate minimum health-screening protocols when advanced diagnostics may not be available or high costs make the tests prohibitive in countries where confiscations occur. We hypothesize that a minimum panel of tests of pooled samples can serve as an alternative approach that minimizes costs and overall workload and supports projects intended to restore and promote flagship species and hamper their illegal trade.",10.1638/2013-0152.1,z9p5s3ud,"['Reintroduction', 'is', 'a', 'growing', 'field', 'in', 'the', 'conservation', 'of', 'endangered', 'species', 'The', 'vinaceous', 'Amazon', 'parrot', 'Amazona', 'vinacea', 'is', 'extinct', 'in', 'several', 'areas', 'and', 'a', 'project', 'to', 'release', 'confiscated', 'individuals', 'to', 'their', 'former', 'range', 'is', 'currently', 'underway', 'The', 'objective', 'of', 'this', 'study', 'was', 'to', 'evaluate', 'and', 'improve', 'the', 'selection', 'and', 'treatment', 'of', 'individual', 'release', 'candidates', 'by', 'detecting', 'possible', 'pathogen', 'carriers', 'using', 'samples', 'taken', 'before', 'and', 'during', 'release', 'As', 'part', 'of', 'prerelease', 'health', 'protocols', 'samples', 'were', 'obtained', 'from', '29', 'parrots', 'on', 'three', 'different', 'occasions', 'while', 'in', 'captivity', 'and', 'once', 'after', 'their', 'release', 'Samples', 'were', 'screened', 'for', 'paramyxovirus', 'type', '1', 'avian', 'influenza', 'poxvirus', 'coronavirus', 'psittacine', 'herpesvirus', '1', 'Chlamydia', 'psittaci', 'enteropathogenic', 'Escherichia', 'coli', 'EPEC', 'Salmonella', 'spp', 'and', 'endoparasites', 'The', 'majority', 'of', 'samples', 'returned', 'negative', 'results', 'with', 'the', 'exception', 'of', 'two', 'individuals', 'that', 'tested', 'positive', 'for', 'C', 'psittaci', 'in', 'the', 'first', 'sampling', 'and', 'for', 'Ascaridia', 'spp', 'in', 'the', 'second', 'pooled', 'sampling', 'Treatments', 'for', 'C', 'psittaci', 'and', 'endoparasites', 'were', 'administered', 'prior', 'to', 'release', 'and', 'negative', 'results', 'were', 'obtained', 'in', 'subsequent', 'exams', 'The', 'number', 'of', 'positive', 'results', 'for', 'E', 'coli', 'non', 'EPEC', 'decreased', 'during', 'the', 'rehabilitation', 'period', 'Adequate', 'quarantine', 'procedures', 'and', 'health', 'examinations', 'greatly', 'minimize', 'disease', 'risks', 'The', 'protocols', 'employed', 'in', 'this', 'study', 'resulted', 'in', 'acceptable', 'health', 'status', 'in', 'accordance', 'with', 'current', 'environmental', 'legislation', 'in', 'Brazil', 'Additionally', 'protocols', 'allowed', 'informed', 'decisions', 'to', 'release', 'candidates', 'minimized', 'risks', 'and', 'favored', 'the', 'selection', 'of', 'healthy', 'individuals', 'thereby', 'contributing', 'to', 'the', 'recovery', 'of', 'this', 'species', 'It', 'is', 'important', 'to', 'determine', 'appropriate', 'minimum', 'health', 'screening', 'protocols', 'when', 'advanced', 'diagnostics', 'may', 'not', 'be', 'available', 'or', 'high', 'costs', 'make', 'the', 'tests', 'prohibitive', 'in', 'countries', 'where', 'confiscations', 'occur', 'We', 'hypothesize', 'that', 'a', 'minimum', 'panel', 'of', 'tests', 'of', 'pooled', 'samples', 'can', 'serve', 'as', 'an', 'alternative', 'approach', 'that', 'minimizes', 'costs', 'and', 'overall', 'workload', 'and', 'supports', 'projects', 'intended', 'to', 'restore', 'and', 'promote', 'flagship', 'species', 'and', 'hamper', 'their', 'illegal', 'trade', '']"
42914,Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination.,2020-05-20,Emerging infectious diseases,https://doi.org/10.3201/eid2608.201843; https://www.ncbi.nlm.nih.gov/pubmed/32433015/,"The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) created an exceptional situation in which numerous laboratories in Europe simultaneously implemented SARS-CoV-2 diagnostics. These laboratories reported in February 2020 that commercial primer and probe batches for SARS-CoV-2 detection were contaminated with synthetic control material, causing delays of regional testing roll-out in various countries.",10.3201/eid2608.201843,z1jr2urk,"['The', 'emergence', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'created', 'an', 'exceptional', 'situation', 'in', 'which', 'numerous', 'laboratories', 'in', 'Europe', 'simultaneously', 'implemented', 'SARS', 'CoV', '2', 'diagnostics', 'These', 'laboratories', 'reported', 'in', 'February', '2020', 'that', 'commercial', 'primer', 'and', 'probe', 'batches', 'for', 'SARS', 'CoV', '2', 'detection', 'were', 'contaminated', 'with', 'synthetic', 'control', 'material', 'causing', 'delays', 'of', 'regional', 'testing', 'roll', 'out', 'in', 'various', 'countries', '']"
45694,Attenuation of Influenza A Virus Disease Severity by Viral Coinfection in a Mouse Model.,2018,Journal of virology,https://doi.org/10.1128/jvi.00881-18; https://www.ncbi.nlm.nih.gov/pubmed/30232180/,"Influenza viruses and rhinoviruses are responsible for a large number of acute respiratory viral infections in human populations and are detected as copathogens within hosts. Clinical and epidemiological studies suggest that coinfection by rhinovirus and influenza virus may reduce disease severity and that they may also interfere with each other's spread within a host population. To determine how coinfection by these two unrelated respiratory viruses affects pathogenesis, we established a mouse model using a minor serogroup rhinovirus (rhinovirus strain 1B [RV1B]) and mouse-adapted influenza A virus (A/Puerto Rico/8/1934 [PR8]). Infection of mice with RV1B 2 days before PR8 reduced the severity of infection by a low or medium, but not high, dose of PR8. Disease attenuation was associated with an early inflammatory response in the lungs and enhanced clearance of PR8. However, coinfection by RV1B did not reduce PR8 viral loads early in infection or inhibit replication of PR8 within respiratory epithelia or in vitro Inflammation in coinfected mice remained focal compared to diffuse inflammation and damage in the lungs of mice infected by PR8. The timing of RV1B coinfection was a critical determinant of protection, suggesting that sufficient time is needed to induce this response. Finally, disease attenuation was not unique to RV1B: dose-dependent coinfection by a murine coronavirus (mouse hepatitis virus strain 1 [MHV-1]) also reduced the severity of PR8 infection. Unlike RV1B, coinfection with MHV-1 reduced early PR8 replication, which was associated with upregulation of beta interferon (IFN-β) expression. This model is critical for understanding the mechanisms responsible for influenza disease attenuation during coinfection by unrelated respiratory viruses.IMPORTANCE Viral infections in the respiratory tract can cause severe disease and are responsible for a majority of pediatric hospitalizations. Molecular diagnostics have revealed that approximately 20% of these patients are infected by more than one unrelated viral pathogen. To understand how viral coinfection affects disease severity, we inoculated mice with a mild viral pathogen (rhinovirus or murine coronavirus), followed 2 days later by a virulent viral pathogen (influenza A virus). This model demonstrated that rhinovirus can reduce the severity of influenza A virus, which corresponded with an early but controlled inflammatory response in the lungs and early clearance of influenza A virus. We further determined the dose and timing parameters that were important for effective disease attenuation and showed that influenza disease is also reduced by coinfection with a murine coronavirus. These findings demonstrate that coinfecting viruses can alter immune responses and pathogenesis in the respiratory tract.",10.1128/jvi.00881-18,adiqqmxh,"['Influenza', 'viruses', 'and', 'rhinoviruses', 'are', 'responsible', 'for', 'a', 'large', 'number', 'of', 'acute', 'respiratory', 'viral', 'infections', 'in', 'human', 'populations', 'and', 'are', 'detected', 'as', 'copathogens', 'within', 'hosts', 'Clinical', 'and', 'epidemiological', 'studies', 'suggest', 'that', 'coinfection', 'by', 'rhinovirus', 'and', 'influenza', 'virus', 'may', 'reduce', 'disease', 'severity', 'and', 'that', 'they', 'may', 'also', 'interfere', 'with', 'each', 'other', 's', 'spread', 'within', 'a', 'host', 'population', 'To', 'determine', 'how', 'coinfection', 'by', 'these', 'two', 'unrelated', 'respiratory', 'viruses', 'affects', 'pathogenesis', 'we', 'established', 'a', 'mouse', 'model', 'using', 'a', 'minor', 'serogroup', 'rhinovirus', 'rhinovirus', 'strain', '1B', 'RV1B', 'and', 'mouse', 'adapted', 'influenza', 'A', 'virus', 'A', 'Puerto', 'Rico', '8', '1934', 'PR8', 'Infection', 'of', 'mice', 'with', 'RV1B', '2', 'days', 'before', 'PR8', 'reduced', 'the', 'severity', 'of', 'infection', 'by', 'a', 'low', 'or', 'medium', 'but', 'not', 'high', 'dose', 'of', 'PR8', 'Disease', 'attenuation', 'was', 'associated', 'with', 'an', 'early', 'inflammatory', 'response', 'in', 'the', 'lungs', 'and', 'enhanced', 'clearance', 'of', 'PR8', 'However', 'coinfection', 'by', 'RV1B', 'did', 'not', 'reduce', 'PR8', 'viral', 'loads', 'early', 'in', 'infection', 'or', 'inhibit', 'replication', 'of', 'PR8', 'within', 'respiratory', 'epithelia', 'or', 'in', 'vitro', 'Inflammation', 'in', 'coinfected', 'mice', 'remained', 'focal', 'compared', 'to', 'diffuse', 'inflammation', 'and', 'damage', 'in', 'the', 'lungs', 'of', 'mice', 'infected', 'by', 'PR8', 'The', 'timing', 'of', 'RV1B', 'coinfection', 'was', 'a', 'critical', 'determinant', 'of', 'protection', 'suggesting', 'that', 'sufficient', 'time', 'is', 'needed', 'to', 'induce', 'this', 'response', 'Finally', 'disease', 'attenuation', 'was', 'not', 'unique', 'to', 'RV1B', 'dose', 'dependent', 'coinfection', 'by', 'a', 'murine', 'coronavirus', 'mouse', 'hepatitis', 'virus', 'strain', '1', 'MHV', '1', 'also', 'reduced', 'the', 'severity', 'of', 'PR8', 'infection', 'Unlike', 'RV1B', 'coinfection', 'with', 'MHV', '1', 'reduced', 'early', 'PR8', 'replication', 'which', 'was', 'associated', 'with', 'upregulation', 'of', 'beta', 'interferon', 'IFN', 'β', 'expression', 'This', 'model', 'is', 'critical', 'for', 'understanding', 'the', 'mechanisms', 'responsible', 'for', 'influenza', 'disease', 'attenuation', 'during', 'coinfection', 'by', 'unrelated', 'respiratory', 'viruses', 'IMPORTANCE', 'Viral', 'infections', 'in', 'the', 'respiratory', 'tract', 'can', 'cause', 'severe', 'disease', 'and', 'are', 'responsible', 'for', 'a', 'majority', 'of', 'pediatric', 'hospitalizations', 'Molecular', 'diagnostics', 'have', 'revealed', 'that', 'approximately', '20', 'of', 'these', 'patients', 'are', 'infected', 'by', 'more', 'than', 'one', 'unrelated', 'viral', 'pathogen', 'To', 'understand', 'how', 'viral', 'coinfection', 'affects', 'disease', 'severity', 'we', 'inoculated', 'mice', 'with', 'a', 'mild', 'viral', 'pathogen', 'rhinovirus', 'or', 'murine', 'coronavirus', 'followed', '2', 'days', 'later', 'by', 'a', 'virulent', 'viral', 'pathogen', 'influenza', 'A', 'virus', 'This', 'model', 'demonstrated', 'that', 'rhinovirus', 'can', 'reduce', 'the', 'severity', 'of', 'influenza', 'A', 'virus', 'which', 'corresponded', 'with', 'an', 'early', 'but', 'controlled', 'inflammatory', 'response', 'in', 'the', 'lungs', 'and', 'early', 'clearance', 'of', 'influenza', 'A', 'virus', 'We', 'further', 'determined', 'the', 'dose', 'and', 'timing', 'parameters', 'that', 'were', 'important', 'for', 'effective', 'disease', 'attenuation', 'and', 'showed', 'that', 'influenza', 'disease', 'is', 'also', 'reduced', 'by', 'coinfection', 'with', 'a', 'murine', 'coronavirus', 'These', 'findings', 'demonstrate', 'that', 'coinfecting', 'viruses', 'can', 'alter', 'immune', 'responses', 'and', 'pathogenesis', 'in', 'the', 'respiratory', 'tract', '']"
45781,Assessing the Detection of Middle East Respiratory Syndrome Coronavirus IgG in Suspected and Proven Cases of Middle East Respiratory Syndrome Coronavirus Infection.,2017,Viral immunology,https://doi.org/10.1089/vim.2017.0091; https://www.ncbi.nlm.nih.gov/pubmed/28873020/,"Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory disease with significant mortality. Two testing methods are currently used for MERS-CoV diagnostics: nucleic acid detection (the gold standard) and serological analysis. In this study, we evaluated the detection of MERS-CoV-IgG in suspected and proven cases of MERS-CoV infection. We enrolled 174 patients: 113 had respiratory symptoms/suspected MERS-CoV infection, 31 had confirmed influenza A or B infection, 23 had a recent confirmed MERS-CoV infection, and 7 had confirmed MERS-CoV infection 1 year before. All underwent MERS-CoV RNA and MERS-CoV-IgG testing. Thirty patients were found to be MERS-CoV RNA positive; however, during serological analysis, only 6 (3.4%) patients were positive for MERS-CoV-IgG, 1 (0.6%) patient was equivocal, and 167 (96%) patients were negative. Among the serological positives, four were recently MERS-CoV RNA positive and two were MERS-CoV RNA negative. No cross-reactivity to influenza A or B was detected. Based on the lack of correlation between nucleic acid and serological analysis, we conclude that MERS-CoV-IgG testing may not be suitable for diagnosing acute infection or estimating its prevalence during an outbreak. In addition, our findings show that MERS-CoV-IgG may not have significant value in determining disease severity or prognosis.",10.1089/vim.2017.0091,rziotno9,"['Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'causes', 'severe', 'respiratory', 'disease', 'with', 'significant', 'mortality', 'Two', 'testing', 'methods', 'are', 'currently', 'used', 'for', 'MERS', 'CoV', 'diagnostics', 'nucleic', 'acid', 'detection', 'the', 'gold', 'standard', 'and', 'serological', 'analysis', 'In', 'this', 'study', 'we', 'evaluated', 'the', 'detection', 'of', 'MERS', 'CoV', 'IgG', 'in', 'suspected', 'and', 'proven', 'cases', 'of', 'MERS', 'CoV', 'infection', 'We', 'enrolled', '174', 'patients', '113', 'had', 'respiratory', 'symptoms', 'suspected', 'MERS', 'CoV', 'infection', '31', 'had', 'confirmed', 'influenza', 'A', 'or', 'B', 'infection', '23', 'had', 'a', 'recent', 'confirmed', 'MERS', 'CoV', 'infection', 'and', '7', 'had', 'confirmed', 'MERS', 'CoV', 'infection', '1', 'year', 'before', 'All', 'underwent', 'MERS', 'CoV', 'RNA', 'and', 'MERS', 'CoV', 'IgG', 'testing', 'Thirty', 'patients', 'were', 'found', 'to', 'be', 'MERS', 'CoV', 'RNA', 'positive', 'however', 'during', 'serological', 'analysis', 'only', '6', '3', '4', 'patients', 'were', 'positive', 'for', 'MERS', 'CoV', 'IgG', '1', '0', '6', 'patient', 'was', 'equivocal', 'and', '167', '96', 'patients', 'were', 'negative', 'Among', 'the', 'serological', 'positives', 'four', 'were', 'recently', 'MERS', 'CoV', 'RNA', 'positive', 'and', 'two', 'were', 'MERS', 'CoV', 'RNA', 'negative', 'No', 'cross', 'reactivity', 'to', 'influenza', 'A', 'or', 'B', 'was', 'detected', 'Based', 'on', 'the', 'lack', 'of', 'correlation', 'between', 'nucleic', 'acid', 'and', 'serological', 'analysis', 'we', 'conclude', 'that', 'MERS', 'CoV', 'IgG', 'testing', 'may', 'not', 'be', 'suitable', 'for', 'diagnosing', 'acute', 'infection', 'or', 'estimating', 'its', 'prevalence', 'during', 'an', 'outbreak', 'In', 'addition', 'our', 'findings', 'show', 'that', 'MERS', 'CoV', 'IgG', 'may', 'not', 'have', 'significant', 'value', 'in', 'determining', 'disease', 'severity', 'or', 'prognosis', '']"
46309,COVID-19 diagnostics in context.,2020-06-03,Science translational medicine,https://doi.org/10.1126/scitranslmed.abc1931; https://www.ncbi.nlm.nih.gov/pubmed/32493791/,"The coronavirus disease 2019 (COVID-19) pandemic has highlighted the need for different types of diagnostics, comparative validation of new tests, faster approval by federal agencies, and rapid production of test kits to meet global demands. In this Perspective, we discuss the utility and challenges of current diagnostics for COVID-19.",10.1126/scitranslmed.abc1931,n9ju3flv,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'has', 'highlighted', 'the', 'need', 'for', 'different', 'types', 'of', 'diagnostics', 'comparative', 'validation', 'of', 'new', 'tests', 'faster', 'approval', 'by', 'federal', 'agencies', 'and', 'rapid', 'production', 'of', 'test', 'kits', 'to', 'meet', 'global', 'demands', 'In', 'this', 'Perspective', 'we', 'discuss', 'the', 'utility', 'and', 'challenges', 'of', 'current', 'diagnostics', 'for', 'COVID', '19', '']"
47018,Community-acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria.,2013,Thorax,https://doi.org/10.1136/thoraxjnl-2013-203551; https://www.ncbi.nlm.nih.gov/pubmed/23783373/,"BACKGROUND Adult community-acquired pneumonia (CAP) is a relevant worldwide cause of morbidity and mortality, however the aetiology often remains uncertain and the therapy is empirical. We applied conventional and molecular diagnostics to identify viruses and atypical bacteria associated with CAP in Chile. METHODS We used sputum and blood cultures, IgG/IgM serology and molecular diagnostic techniques (PCR, reverse transcriptase PCR) for detection of classical and atypical bacteria (Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumoniae) and respiratory viruses (adenovirus, respiratory syncytial virus (RSV), human metapneumovirus, influenza virus, parainfluenzavirus, rhinovirus, coronavirus) in adults >18 years old presenting with CAP in Santiago from February 2005 to September 2007. Severity was qualified at admission by Fine's pneumonia severity index. RESULTS Overall detection in 356 enrolled adults were 92 (26%) cases of a single bacterial pathogen, 80 (22%) cases of a single viral pathogen, 60 (17%) cases with mixed bacterial and viral infection and 124 (35%) cases with no identified pathogen. Streptococcus pneumoniae and RSV were the most common bacterial and viral pathogens identified. Infectious agent detection by PCR provided greater sensitivity than conventional techniques. To our surprise, no relationship was observed between clinical severity and sole or coinfections. CONCLUSIONS The use of molecular diagnostics expanded the detection of viruses and atypical bacteria in adults with CAP, as unique or coinfections. Clinical severity and outcome were independent of the aetiological agents detected.",10.1136/thoraxjnl-2013-203551,vpf8bzs3,"['BACKGROUND', 'Adult', 'community', 'acquired', 'pneumonia', 'CAP', 'is', 'a', 'relevant', 'worldwide', 'cause', 'of', 'morbidity', 'and', 'mortality', 'however', 'the', 'aetiology', 'often', 'remains', 'uncertain', 'and', 'the', 'therapy', 'is', 'empirical', 'We', 'applied', 'conventional', 'and', 'molecular', 'diagnostics', 'to', 'identify', 'viruses', 'and', 'atypical', 'bacteria', 'associated', 'with', 'CAP', 'in', 'Chile', 'METHODS', 'We', 'used', 'sputum', 'and', 'blood', 'cultures', 'IgG', 'IgM', 'serology', 'and', 'molecular', 'diagnostic', 'techniques', 'PCR', 'reverse', 'transcriptase', 'PCR', 'for', 'detection', 'of', 'classical', 'and', 'atypical', 'bacteria', 'Mycoplasma', 'pneumoniae', 'Chlamydia', 'pneumoniae', 'Legionella', 'pneumoniae', 'and', 'respiratory', 'viruses', 'adenovirus', 'respiratory', 'syncytial', 'virus', 'RSV', 'human', 'metapneumovirus', 'influenza', 'virus', 'parainfluenzavirus', 'rhinovirus', 'coronavirus', 'in', 'adults', '18', 'years', 'old', 'presenting', 'with', 'CAP', 'in', 'Santiago', 'from', 'February', '2005', 'to', 'September', '2007', 'Severity', 'was', 'qualified', 'at', 'admission', 'by', 'Fine', 's', 'pneumonia', 'severity', 'index', 'RESULTS', 'Overall', 'detection', 'in', '356', 'enrolled', 'adults', 'were', '92', '26', 'cases', 'of', 'a', 'single', 'bacterial', 'pathogen', '80', '22', 'cases', 'of', 'a', 'single', 'viral', 'pathogen', '60', '17', 'cases', 'with', 'mixed', 'bacterial', 'and', 'viral', 'infection', 'and', '124', '35', 'cases', 'with', 'no', 'identified', 'pathogen', 'Streptococcus', 'pneumoniae', 'and', 'RSV', 'were', 'the', 'most', 'common', 'bacterial', 'and', 'viral', 'pathogens', 'identified', 'Infectious', 'agent', 'detection', 'by', 'PCR', 'provided', 'greater', 'sensitivity', 'than', 'conventional', 'techniques', 'To', 'our', 'surprise', 'no', 'relationship', 'was', 'observed', 'between', 'clinical', 'severity', 'and', 'sole', 'or', 'coinfections', 'CONCLUSIONS', 'The', 'use', 'of', 'molecular', 'diagnostics', 'expanded', 'the', 'detection', 'of', 'viruses', 'and', 'atypical', 'bacteria', 'in', 'adults', 'with', 'CAP', 'as', 'unique', 'or', 'coinfections', 'Clinical', 'severity', 'and', 'outcome', 'were', 'independent', 'of', 'the', 'aetiological', 'agents', 'detected', '']"
48177,"A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilized in a commercial dual-target diagnostic assay.",2020-07-20,Journal of clinical microbiology,https://doi.org/10.1128/jcm.01598-20; https://www.ncbi.nlm.nih.gov/pubmed/32690547/,"Control of the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic requires accurate laboratory testing to identify infected individuals, while also clearing essential staff to continue work. At the current time a number of qRT-PCR assays have been developed to identify SARS-CoV-2, targeting multiple positions in the viral genome. While the mutation rate of SARS-CoV-2 is moderate, given the large number of transmission chains it is prudent to monitor circulating viruses for variants that might compromise these assays. Here we report the identification of a C-to-U transition at position 26,340 of the SARS-CoV-2 genome which is associated with failure of the cobas® SARS-CoV-2 E-gene qRT-PCR in eight patients. As the cobas® SARS-CoV-2 assay targets two positions in the genome, the individuals carrying this variant were still called as SARS-CoV-2 positive. Whole genome sequencing of SARS-CoV-2 showed all to carry closely related viruses. Examination of viral genomes deposited on GISAID showed this mutation has arisen independently at least four times. This work highlights the necessity of monitoring SARS-CoV-2 for the emergence of SNPs which might adversely affect RT-PCRs used in diagnostics. Additionally, it argues that two regions in SARS-CoV-2 should be targeted to avoid false negatives.",10.1128/jcm.01598-20,lpoelp91,"['Control', 'of', 'the', 'ongoing', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'pandemic', 'requires', 'accurate', 'laboratory', 'testing', 'to', 'identify', 'infected', 'individuals', 'while', 'also', 'clearing', 'essential', 'staff', 'to', 'continue', 'work', 'At', 'the', 'current', 'time', 'a', 'number', 'of', 'qRT', 'PCR', 'assays', 'have', 'been', 'developed', 'to', 'identify', 'SARS', 'CoV', '2', 'targeting', 'multiple', 'positions', 'in', 'the', 'viral', 'genome', 'While', 'the', 'mutation', 'rate', 'of', 'SARS', 'CoV', '2', 'is', 'moderate', 'given', 'the', 'large', 'number', 'of', 'transmission', 'chains', 'it', 'is', 'prudent', 'to', 'monitor', 'circulating', 'viruses', 'for', 'variants', 'that', 'might', 'compromise', 'these', 'assays', 'Here', 'we', 'report', 'the', 'identification', 'of', 'a', 'C', 'to', 'U', 'transition', 'at', 'position', '26', '340', 'of', 'the', 'SARS', 'CoV', '2', 'genome', 'which', 'is', 'associated', 'with', 'failure', 'of', 'the', 'cobas', 'SARS', 'CoV', '2', 'E', 'gene', 'qRT', 'PCR', 'in', 'eight', 'patients', 'As', 'the', 'cobas', 'SARS', 'CoV', '2', 'assay', 'targets', 'two', 'positions', 'in', 'the', 'genome', 'the', 'individuals', 'carrying', 'this', 'variant', 'were', 'still', 'called', 'as', 'SARS', 'CoV', '2', 'positive', 'Whole', 'genome', 'sequencing', 'of', 'SARS', 'CoV', '2', 'showed', 'all', 'to', 'carry', 'closely', 'related', 'viruses', 'Examination', 'of', 'viral', 'genomes', 'deposited', 'on', 'GISAID', 'showed', 'this', 'mutation', 'has', 'arisen', 'independently', 'at', 'least', 'four', 'times', 'This', 'work', 'highlights', 'the', 'necessity', 'of', 'monitoring', 'SARS', 'CoV', '2', 'for', 'the', 'emergence', 'of', 'SNPs', 'which', 'might', 'adversely', 'affect', 'RT', 'PCRs', 'used', 'in', 'diagnostics', 'Additionally', 'it', 'argues', 'that', 'two', 'regions', 'in', 'SARS', 'CoV', '2', 'should', 'be', 'targeted', 'to', 'avoid', 'false', 'negatives', '']"
48602,Nanoplasmonic On-Chip PCR for Rapid Precision Molecular Diagnostics.,2020-02-26,ACS applied materials & interfaces,https://doi.org/10.1021/acsami.9b23591; https://www.ncbi.nlm.nih.gov/pubmed/32101396/,"Emerging molecular diagnosis requires ultrafast polymerase chain reaction (PCR) on chip for rapid precise detection of infectious diseases in the point-of-care test. Here we report nanoplasmonic on-chip PCR for rapid precision molecular diagnostics. The nanoplasmonic pillar arrays (NPA) comprise gold nanoislands on the top and sidewall of large-scale glass nanopillar arrays. The nanoplasmonic pillars enhance light absorption of a white light-emitting diode (LED) over the whole visible range due to strong electromagnetic hotspots between the nanoislands. As a result, they effectively induce photothermal heating for ultrafast PCR thermal cycling. The temperature profile of NPA exhibit 30 cycles between 98 ℃ and 60 ℃ for total 3 min 30 sec during the cyclic excitation of white LED light. The experimental results also demonstrate the rapid DNA amplification of both 0.1 ng μl-1 of λ-DNA in 20 thermal cycles and 0.1 ng μl-1 of complementary DNA of Middle East respiratory syndrome coronavirus in 30 thermal cycles using a conventional PCR volume of 15 μl. This nanoplasmonic PCR technique provides a new opportunity for rapid precision molecular diagnostics.",10.1021/acsami.9b23591,jp0idc7d,"['Emerging', 'molecular', 'diagnosis', 'requires', 'ultrafast', 'polymerase', 'chain', 'reaction', 'PCR', 'on', 'chip', 'for', 'rapid', 'precise', 'detection', 'of', 'infectious', 'diseases', 'in', 'the', 'point', 'of', 'care', 'test', 'Here', 'we', 'report', 'nanoplasmonic', 'on', 'chip', 'PCR', 'for', 'rapid', 'precision', 'molecular', 'diagnostics', 'The', 'nanoplasmonic', 'pillar', 'arrays', 'NPA', 'comprise', 'gold', 'nanoislands', 'on', 'the', 'top', 'and', 'sidewall', 'of', 'large', 'scale', 'glass', 'nanopillar', 'arrays', 'The', 'nanoplasmonic', 'pillars', 'enhance', 'light', 'absorption', 'of', 'a', 'white', 'light', 'emitting', 'diode', 'LED', 'over', 'the', 'whole', 'visible', 'range', 'due', 'to', 'strong', 'electromagnetic', 'hotspots', 'between', 'the', 'nanoislands', 'As', 'a', 'result', 'they', 'effectively', 'induce', 'photothermal', 'heating', 'for', 'ultrafast', 'PCR', 'thermal', 'cycling', 'The', 'temperature', 'profile', 'of', 'NPA', 'exhibit', '30', 'cycles', 'between', '98', 'and', '60', 'for', 'total', '3', 'min', '30', 'sec', 'during', 'the', 'cyclic', 'excitation', 'of', 'white', 'LED', 'light', 'The', 'experimental', 'results', 'also', 'demonstrate', 'the', 'rapid', 'DNA', 'amplification', 'of', 'both', '0', '1', 'ng', 'μl', '1', 'of', 'λ', 'DNA', 'in', '20', 'thermal', 'cycles', 'and', '0', '1', 'ng', 'μl', '1', 'of', 'complementary', 'DNA', 'of', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'in', '30', 'thermal', 'cycles', 'using', 'a', 'conventional', 'PCR', 'volume', 'of', '15', 'μl', 'This', 'nanoplasmonic', 'PCR', 'technique', 'provides', 'a', 'new', 'opportunity', 'for', 'rapid', 'precision', 'molecular', 'diagnostics', '']"
48643,The Effects of the COVID-19/SARS-CoV-2 Pandemic Outbreak on Otolaryngology Activity in Italy.,2020-04-29,"Ear, nose, & throat journal",https://doi.org/10.1177/0145561320923893; https://www.ncbi.nlm.nih.gov/pubmed/32347112/,"The coronavirus disease 2019 (COVID-19) pandemic during the first months of 2020 is causing profound changes in worldwide health care systems, resulting in a major reduction of surgical interventions and routine non-urgent outpatient diagnostic procedures. The lockdown due to the COVID-19 pandemic in Italy, one of the most affected countries in Europe, is having severe effects on the otolaryngology medical and surgical activities. The main changes are represented by the postponement of outpatient visits and scheduled surgery, while the only guaranteed service is reserved to diagnostics and surgery for oncology and urgent patients. In these cases, given the sites of action typical of the otolaryngology practice, physicians and nurses are exposed to a high risk of contagion through virus aerosol transmission. Furthermore, as the current measures of lockdown continue, it will be difficult to perform scheduled and new diagnostic assessments, medical treatments and surgical procedures in a timely manner favoring the risk of diagnostic and therapeutic delays with severe impact on patients' health.",10.1177/0145561320923893,s7vnra3o,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'during', 'the', 'first', 'months', 'of', '2020', 'is', 'causing', 'profound', 'changes', 'in', 'worldwide', 'health', 'care', 'systems', 'resulting', 'in', 'a', 'major', 'reduction', 'of', 'surgical', 'interventions', 'and', 'routine', 'non', 'urgent', 'outpatient', 'diagnostic', 'procedures', 'The', 'lockdown', 'due', 'to', 'the', 'COVID', '19', 'pandemic', 'in', 'Italy', 'one', 'of', 'the', 'most', 'affected', 'countries', 'in', 'Europe', 'is', 'having', 'severe', 'effects', 'on', 'the', 'otolaryngology', 'medical', 'and', 'surgical', 'activities', 'The', 'main', 'changes', 'are', 'represented', 'by', 'the', 'postponement', 'of', 'outpatient', 'visits', 'and', 'scheduled', 'surgery', 'while', 'the', 'only', 'guaranteed', 'service', 'is', 'reserved', 'to', 'diagnostics', 'and', 'surgery', 'for', 'oncology', 'and', 'urgent', 'patients', 'In', 'these', 'cases', 'given', 'the', 'sites', 'of', 'action', 'typical', 'of', 'the', 'otolaryngology', 'practice', 'physicians', 'and', 'nurses', 'are', 'exposed', 'to', 'a', 'high', 'risk', 'of', 'contagion', 'through', 'virus', 'aerosol', 'transmission', 'Furthermore', 'as', 'the', 'current', 'measures', 'of', 'lockdown', 'continue', 'it', 'will', 'be', 'difficult', 'to', 'perform', 'scheduled', 'and', 'new', 'diagnostic', 'assessments', 'medical', 'treatments', 'and', 'surgical', 'procedures', 'in', 'a', 'timely', 'manner', 'favoring', 'the', 'risk', 'of', 'diagnostic', 'and', 'therapeutic', 'delays', 'with', 'severe', 'impact', 'on', 'patients', 'health', '']"
49504,Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management.,2020-04-29,IEEE reviews in biomedical engineering,https://doi.org/10.1109/rbme.2020.2991444; https://www.ncbi.nlm.nih.gov/pubmed/32356761/,"Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To counter COVID-19 spreading, an infrastructure to provide rapid and thorough molecular diagnostics and serology testing is the cornerstone of outbreak and pandemic management. We hereby review the clinical insights with regard to using molecular tests and immunoassays in the context of COVID-19 management life cycle: the preventive phase, the preparedness phase, the response phase and the recovery phase. The spatial and temporal distribution of viral RNA, antigens and antibodies during human infection is summarized to provide a biological foundation for accurate detection of the disease. We shared the lessons learned and the obstacles encountered during real world high-volume screening programs. Clinical needs are discussed to identify existing technology gaps in these tests. Leverage technologies, such as engineered polymerases, isothermal amplification, and direct amplification from complex matrices may improve the productivity of current infrastructure, while emerging technologies like CRISPR diagnostics, visual end point detection, and PCR free methods for nucleic acid sensing may lead to at-home tests. The lessons learned, and innovations spurred from the COVID-19 pandemic could upgrade our global public health infrastructure to better combat potential outbreaks in the future.",10.1109/rbme.2020.2991444,6wlbl0wg,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'an', 'infectious', 'disease', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'To', 'counter', 'COVID', '19', 'spreading', 'an', 'infrastructure', 'to', 'provide', 'rapid', 'and', 'thorough', 'molecular', 'diagnostics', 'and', 'serology', 'testing', 'is', 'the', 'cornerstone', 'of', 'outbreak', 'and', 'pandemic', 'management', 'We', 'hereby', 'review', 'the', 'clinical', 'insights', 'with', 'regard', 'to', 'using', 'molecular', 'tests', 'and', 'immunoassays', 'in', 'the', 'context', 'of', 'COVID', '19', 'management', 'life', 'cycle', 'the', 'preventive', 'phase', 'the', 'preparedness', 'phase', 'the', 'response', 'phase', 'and', 'the', 'recovery', 'phase', 'The', 'spatial', 'and', 'temporal', 'distribution', 'of', 'viral', 'RNA', 'antigens', 'and', 'antibodies', 'during', 'human', 'infection', 'is', 'summarized', 'to', 'provide', 'a', 'biological', 'foundation', 'for', 'accurate', 'detection', 'of', 'the', 'disease', 'We', 'shared', 'the', 'lessons', 'learned', 'and', 'the', 'obstacles', 'encountered', 'during', 'real', 'world', 'high', 'volume', 'screening', 'programs', 'Clinical', 'needs', 'are', 'discussed', 'to', 'identify', 'existing', 'technology', 'gaps', 'in', 'these', 'tests', 'Leverage', 'technologies', 'such', 'as', 'engineered', 'polymerases', 'isothermal', 'amplification', 'and', 'direct', 'amplification', 'from', 'complex', 'matrices', 'may', 'improve', 'the', 'productivity', 'of', 'current', 'infrastructure', 'while', 'emerging', 'technologies', 'like', 'CRISPR', 'diagnostics', 'visual', 'end', 'point', 'detection', 'and', 'PCR', 'free', 'methods', 'for', 'nucleic', 'acid', 'sensing', 'may', 'lead', 'to', 'at', 'home', 'tests', 'The', 'lessons', 'learned', 'and', 'innovations', 'spurred', 'from', 'the', 'COVID', '19', 'pandemic', 'could', 'upgrade', 'our', 'global', 'public', 'health', 'infrastructure', 'to', 'better', 'combat', 'potential', 'outbreaks', 'in', 'the', 'future', '']"
50274,Molecular diagnosis of respiratory virus infections.,2011,Critical reviews in clinical laboratory sciences,https://doi.org/10.3109/10408363.2011.640976; https://www.ncbi.nlm.nih.gov/pubmed/22185616/,"The appearance of eight new respiratory viruses, including the SARS coronavirus in 2003 and swine-origin influenza A/H1N1 in 2009, in the human population in the past nine years has tested the ability of virology laboratories to develop diagnostic tests to identify these viruses. Nucleic acid based amplification tests (NATs) for respiratory viruses were first introduced two decades ago and today are utilized for the detection of both conventional and emerging viruses. These tests are more sensitive than other diagnostic approaches, including virus isolation in cell culture, shell vial culture (SVC), antigen detection by direct fluorescent antibody (DFA) staining, and rapid enzyme immunoassay (EIA), and now form the backbone of clinical virology laboratory testing around the world. NATs not only provide fast, accurate and sensitive detection of respiratory viruses in clinical specimens but also have increased our understanding of the epidemiology of both new emerging viruses such as the pandemic H1N1 influenza virus of 2009, and conventional viruses such as the common cold viruses, including rhinovirus and coronavirus. Multiplex polymerase chain reaction (PCR) assays introduced in the last five years detect up to 19 different viruses in a single test. Several multiplex PCR tests are now commercially available and tests are working their way into clinical laboratories. The final chapter in the evolution of respiratory virus diagnostics has been the addition of allelic discrimination and detection of single nucleotide polymorphisms associated with antiviral resistance. These assays are now being multiplexed with primary detection and subtyping assays, especially in the case of influenza virus. These resistance assays, together with viral load assays, will enable clinical laboratories to provide physicians with new and important information for optimal treatment of respiratory virus infections.",10.3109/10408363.2011.640976,lulg7gw7,"['The', 'appearance', 'of', 'eight', 'new', 'respiratory', 'viruses', 'including', 'the', 'SARS', 'coronavirus', 'in', '2003', 'and', 'swine', 'origin', 'influenza', 'A', 'H1N1', 'in', '2009', 'in', 'the', 'human', 'population', 'in', 'the', 'past', 'nine', 'years', 'has', 'tested', 'the', 'ability', 'of', 'virology', 'laboratories', 'to', 'develop', 'diagnostic', 'tests', 'to', 'identify', 'these', 'viruses', 'Nucleic', 'acid', 'based', 'amplification', 'tests', 'NATs', 'for', 'respiratory', 'viruses', 'were', 'first', 'introduced', 'two', 'decades', 'ago', 'and', 'today', 'are', 'utilized', 'for', 'the', 'detection', 'of', 'both', 'conventional', 'and', 'emerging', 'viruses', 'These', 'tests', 'are', 'more', 'sensitive', 'than', 'other', 'diagnostic', 'approaches', 'including', 'virus', 'isolation', 'in', 'cell', 'culture', 'shell', 'vial', 'culture', 'SVC', 'antigen', 'detection', 'by', 'direct', 'fluorescent', 'antibody', 'DFA', 'staining', 'and', 'rapid', 'enzyme', 'immunoassay', 'EIA', 'and', 'now', 'form', 'the', 'backbone', 'of', 'clinical', 'virology', 'laboratory', 'testing', 'around', 'the', 'world', 'NATs', 'not', 'only', 'provide', 'fast', 'accurate', 'and', 'sensitive', 'detection', 'of', 'respiratory', 'viruses', 'in', 'clinical', 'specimens', 'but', 'also', 'have', 'increased', 'our', 'understanding', 'of', 'the', 'epidemiology', 'of', 'both', 'new', 'emerging', 'viruses', 'such', 'as', 'the', 'pandemic', 'H1N1', 'influenza', 'virus', 'of', '2009', 'and', 'conventional', 'viruses', 'such', 'as', 'the', 'common', 'cold', 'viruses', 'including', 'rhinovirus', 'and', 'coronavirus', 'Multiplex', 'polymerase', 'chain', 'reaction', 'PCR', 'assays', 'introduced', 'in', 'the', 'last', 'five', 'years', 'detect', 'up', 'to', '19', 'different', 'viruses', 'in', 'a', 'single', 'test', 'Several', 'multiplex', 'PCR', 'tests', 'are', 'now', 'commercially', 'available', 'and', 'tests', 'are', 'working', 'their', 'way', 'into', 'clinical', 'laboratories', 'The', 'final', 'chapter', 'in', 'the', 'evolution', 'of', 'respiratory', 'virus', 'diagnostics', 'has', 'been', 'the', 'addition', 'of', 'allelic', 'discrimination', 'and', 'detection', 'of', 'single', 'nucleotide', 'polymorphisms', 'associated', 'with', 'antiviral', 'resistance', 'These', 'assays', 'are', 'now', 'being', 'multiplexed', 'with', 'primary', 'detection', 'and', 'subtyping', 'assays', 'especially', 'in', 'the', 'case', 'of', 'influenza', 'virus', 'These', 'resistance', 'assays', 'together', 'with', 'viral', 'load', 'assays', 'will', 'enable', 'clinical', 'laboratories', 'to', 'provide', 'physicians', 'with', 'new', 'and', 'important', 'information', 'for', 'optimal', 'treatment', 'of', 'respiratory', 'virus', 'infections', '']"
53877,Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA's Diagnostics Committee.,2020-05-05,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,https://doi.org/10.1093/cid/ciaa508; https://www.ncbi.nlm.nih.gov/pubmed/32369578/,"The clinical signs and symptoms of acute respiratory tract infections (RTIs) are not pathogen specific. Highly sensitive and specific nucleic acid amplification tests have become the diagnostic reference standard for viruses and translation of bacterial assays from basic research to routine clinical practice represents an exciting advance in respiratory medicine. Most recently, molecular diagnostics have played an essential role in the global health response to the novel coronavirus pandemic. How best to use newer molecular tests for RTI in combination with clinical judgment and traditional methods can be bewildering given the plethora of available assays and rapidly evolving technologies. Here, we summarize the current state of the art with respect to the diagnosis of viral and bacterial RTIs, provide a practical framework for diagnostic decision-making using selected patient-centered vignettes, and make recommendations for future studies to advance the field.",10.1093/cid/ciaa508,gti6tm0q,"['The', 'clinical', 'signs', 'and', 'symptoms', 'of', 'acute', 'respiratory', 'tract', 'infections', 'RTIs', 'are', 'not', 'pathogen', 'specific', 'Highly', 'sensitive', 'and', 'specific', 'nucleic', 'acid', 'amplification', 'tests', 'have', 'become', 'the', 'diagnostic', 'reference', 'standard', 'for', 'viruses', 'and', 'translation', 'of', 'bacterial', 'assays', 'from', 'basic', 'research', 'to', 'routine', 'clinical', 'practice', 'represents', 'an', 'exciting', 'advance', 'in', 'respiratory', 'medicine', 'Most', 'recently', 'molecular', 'diagnostics', 'have', 'played', 'an', 'essential', 'role', 'in', 'the', 'global', 'health', 'response', 'to', 'the', 'novel', 'coronavirus', 'pandemic', 'How', 'best', 'to', 'use', 'newer', 'molecular', 'tests', 'for', 'RTI', 'in', 'combination', 'with', 'clinical', 'judgment', 'and', 'traditional', 'methods', 'can', 'be', 'bewildering', 'given', 'the', 'plethora', 'of', 'available', 'assays', 'and', 'rapidly', 'evolving', 'technologies', 'Here', 'we', 'summarize', 'the', 'current', 'state', 'of', 'the', 'art', 'with', 'respect', 'to', 'the', 'diagnosis', 'of', 'viral', 'and', 'bacterial', 'RTIs', 'provide', 'a', 'practical', 'framework', 'for', 'diagnostic', 'decision', 'making', 'using', 'selected', 'patient', 'centered', 'vignettes', 'and', 'make', 'recommendations', 'for', 'future', 'studies', 'to', 'advance', 'the', 'field', '']"
54905,New respiratory viral infections.,2012,Current opinion in pulmonary medicine,https://doi.org/10.1097/mcp.0b013e328351f8d4; https://www.ncbi.nlm.nih.gov/pubmed/22366993/,"PURPOSE OF REVIEW The first era in the discoveries of respiratory viruses occured between 1933 and 1965 when influenza virus, enteroviruses, adenovirus, respiratory syncytial virus, rhinovirus, parainfluenza virus and coronavirus (CoV) were found by virus culture. In the 1990s, the development of high throughput viral detection and diagnostics instruments increased diagnostic sensitivity and enabled the search for new viruses. This article briefly reviews the clinical significance of newly discovered respiratory viruses. RECENT FINDINGS In 2001, the second era in the discoveries of respiratory viruses began, and several new respiratory viruses and their subgroups have been found: human metapneumovirus, CoVs NL63 and HKU1, human bocavirus and human rhinovirus C and D groups. SUMMARY Currently, a viral cause of pediatric respiratory illness is identifiable in up to 95% of cases, but the detection rates decrease steadily by age, to 30-40% in the elderly. The new viruses cause respiratory illnesses such as common cold, bronchitis, bronchiolitis, exacerbations of asthma and chronic obstructive pulmonary disease and pneumonia. Rarely, acute respiratory failure may occur. The clinical role of other new viruses, KI and WU polyomaviruses and the torque teno virus, as respiratory pathogens is not clear.",10.1097/mcp.0b013e328351f8d4,trhok8y8,"['PURPOSE', 'OF', 'REVIEW', 'The', 'first', 'era', 'in', 'the', 'discoveries', 'of', 'respiratory', 'viruses', 'occured', 'between', '1933', 'and', '1965', 'when', 'influenza', 'virus', 'enteroviruses', 'adenovirus', 'respiratory', 'syncytial', 'virus', 'rhinovirus', 'parainfluenza', 'virus', 'and', 'coronavirus', 'CoV', 'were', 'found', 'by', 'virus', 'culture', 'In', 'the', '1990s', 'the', 'development', 'of', 'high', 'throughput', 'viral', 'detection', 'and', 'diagnostics', 'instruments', 'increased', 'diagnostic', 'sensitivity', 'and', 'enabled', 'the', 'search', 'for', 'new', 'viruses', 'This', 'article', 'briefly', 'reviews', 'the', 'clinical', 'significance', 'of', 'newly', 'discovered', 'respiratory', 'viruses', 'RECENT', 'FINDINGS', 'In', '2001', 'the', 'second', 'era', 'in', 'the', 'discoveries', 'of', 'respiratory', 'viruses', 'began', 'and', 'several', 'new', 'respiratory', 'viruses', 'and', 'their', 'subgroups', 'have', 'been', 'found', 'human', 'metapneumovirus', 'CoVs', 'NL63', 'and', 'HKU1', 'human', 'bocavirus', 'and', 'human', 'rhinovirus', 'C', 'and', 'D', 'groups', 'SUMMARY', 'Currently', 'a', 'viral', 'cause', 'of', 'pediatric', 'respiratory', 'illness', 'is', 'identifiable', 'in', 'up', 'to', '95', 'of', 'cases', 'but', 'the', 'detection', 'rates', 'decrease', 'steadily', 'by', 'age', 'to', '30', '40', 'in', 'the', 'elderly', 'The', 'new', 'viruses', 'cause', 'respiratory', 'illnesses', 'such', 'as', 'common', 'cold', 'bronchitis', 'bronchiolitis', 'exacerbations', 'of', 'asthma', 'and', 'chronic', 'obstructive', 'pulmonary', 'disease', 'and', 'pneumonia', 'Rarely', 'acute', 'respiratory', 'failure', 'may', 'occur', 'The', 'clinical', 'role', 'of', 'other', 'new', 'viruses', 'KI', 'and', 'WU', 'polyomaviruses', 'and', 'the', 'torque', 'teno', 'virus', 'as', 'respiratory', 'pathogens', 'is', 'not', 'clear', '']"
57892,Broad-spectrum inhibition of common respiratory RNA viruses by a pyrimidine synthesis inhibitor with involvement of the host antiviral response.,2017,The Journal of general virology,https://doi.org/10.1099/jgv.0.000758; https://www.ncbi.nlm.nih.gov/pubmed/28555543/,"Our previous screening of 50 240 structurally diverse compounds led to the identification of 39 influenza A virus infection inhibitors (Kao R.Y., Yang D., Lau L.S., Tsui W.H., Hu L. et al. Nat Biotechnol 2010;28:600-605). Further screening of these compounds against common respiratory viruses led to the discovery of compound FA-613. This inhibitor exhibited low micromolar antiviral activity against various influenza A and B virus strains, including the highly pathogenic influenza A strains H5N1 and H7N9, enterovirus A71, respiratory syncytial virus, human rhinovirus A, SARS- and MERS-coronavirus. No significant cellular toxicity was observed at the effective concentrations. Animal studies showed an improved survival rate in BALB/c mice that received intranasal FA-613 treatments against a lethal dose infection of A/HK/415742Md/2009 (H1N1). Further cell-based assays indicated that FA-613 interfer with the de novo pyrimidine biosynthesis pathway by targeting the dihydroorotate dehydrogenase. Surprisingly, FA-613 lost its antiviral potency in the interferon-deficient Vero cell line, while maintaining its inhibitory activity in an interferon-competent cell line which showed elevated expression of host antiviral genes when infected in the presence of FA-613. Further investigation of the specific connection between pyrimidine synthesis inhibition and the induction of host innate immunity might aid clinical development of this type of drug in antiviral therapies. Therefore, in acute cases of respiratory tract infections, when rapid diagnostics of the causative agent are not readily available, an antiviral drug with properties like FA-613 could prove to be very valuable.",10.1099/jgv.0.000758,g4oku7wp,"['Our', 'previous', 'screening', 'of', '50', '240', 'structurally', 'diverse', 'compounds', 'led', 'to', 'the', 'identification', 'of', '39', 'influenza', 'A', 'virus', 'infection', 'inhibitors', 'Kao', 'R', 'Y', 'Yang', 'D', 'Lau', 'L', 'S', 'Tsui', 'W', 'H', 'Hu', 'L', 'et', 'al', 'Nat', 'Biotechnol', '2010', '28', '600', '605', 'Further', 'screening', 'of', 'these', 'compounds', 'against', 'common', 'respiratory', 'viruses', 'led', 'to', 'the', 'discovery', 'of', 'compound', 'FA', '613', 'This', 'inhibitor', 'exhibited', 'low', 'micromolar', 'antiviral', 'activity', 'against', 'various', 'influenza', 'A', 'and', 'B', 'virus', 'strains', 'including', 'the', 'highly', 'pathogenic', 'influenza', 'A', 'strains', 'H5N1', 'and', 'H7N9', 'enterovirus', 'A71', 'respiratory', 'syncytial', 'virus', 'human', 'rhinovirus', 'A', 'SARS', 'and', 'MERS', 'coronavirus', 'No', 'significant', 'cellular', 'toxicity', 'was', 'observed', 'at', 'the', 'effective', 'concentrations', 'Animal', 'studies', 'showed', 'an', 'improved', 'survival', 'rate', 'in', 'BALB', 'c', 'mice', 'that', 'received', 'intranasal', 'FA', '613', 'treatments', 'against', 'a', 'lethal', 'dose', 'infection', 'of', 'A', 'HK', '415742Md', '2009', 'H1N1', 'Further', 'cell', 'based', 'assays', 'indicated', 'that', 'FA', '613', 'interfer', 'with', 'the', 'de', 'novo', 'pyrimidine', 'biosynthesis', 'pathway', 'by', 'targeting', 'the', 'dihydroorotate', 'dehydrogenase', 'Surprisingly', 'FA', '613', 'lost', 'its', 'antiviral', 'potency', 'in', 'the', 'interferon', 'deficient', 'Vero', 'cell', 'line', 'while', 'maintaining', 'its', 'inhibitory', 'activity', 'in', 'an', 'interferon', 'competent', 'cell', 'line', 'which', 'showed', 'elevated', 'expression', 'of', 'host', 'antiviral', 'genes', 'when', 'infected', 'in', 'the', 'presence', 'of', 'FA', '613', 'Further', 'investigation', 'of', 'the', 'specific', 'connection', 'between', 'pyrimidine', 'synthesis', 'inhibition', 'and', 'the', 'induction', 'of', 'host', 'innate', 'immunity', 'might', 'aid', 'clinical', 'development', 'of', 'this', 'type', 'of', 'drug', 'in', 'antiviral', 'therapies', 'Therefore', 'in', 'acute', 'cases', 'of', 'respiratory', 'tract', 'infections', 'when', 'rapid', 'diagnostics', 'of', 'the', 'causative', 'agent', 'are', 'not', 'readily', 'available', 'an', 'antiviral', 'drug', 'with', 'properties', 'like', 'FA', '613', 'could', 'prove', 'to', 'be', 'very', 'valuable', '']"
58670,An update on the status of COVID-19: a comprehensive review.,2020-04-01,European review for medical and pharmacological sciences,https://doi.org/10.26355/eurrev_202004_21046; https://www.ncbi.nlm.nih.gov/pubmed/32374000/,"The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19).",10.26355/eurrev_202004_21046,irqcpi6g,"['The', 'last', 'two', 'decades', 'have', 'witnessed', 'two', 'large', 'scale', 'pandemics', 'caused', 'by', 'coronaviruses', 'including', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'and', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'At', 'the', 'end', 'of', '2019', 'another', 'novel', 'coronavirus', 'designated', 'as', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'hit', 'Wuhan', 'a', 'city', 'in', 'the', 'center', 'of', 'China', 'and', 'subsequently', 'spread', 'rapidly', 'to', 'the', 'whole', 'world', 'Latest', 'reports', 'revealed', 'that', 'more', 'than', '800', 'thousand', 'people', 'in', 'over', '200', 'countries', 'are', 'involved', 'in', 'the', 'epidemic', 'disease', 'by', 'SARS', 'CoV', '2', 'Due', 'to', 'the', 'high', 'mortality', 'rate', 'and', 'the', 'lack', 'of', 'optimum', 'therapeutics', 'it', 'is', 'crucial', 'to', 'understand', 'the', 'biological', 'characteristics', 'of', 'the', 'virus', 'and', 'its', 'possible', 'pathogenesis', 'to', 'respond', 'to', 'the', 'SARS', 'CoV', '2', 'Rapid', 'diagnostics', 'and', 'effective', 'therapeutics', 'are', 'also', 'important', 'interventions', 'for', 'the', 'management', 'of', 'infection', 'control', 'However', 'the', 'rapid', 'evolution', 'of', 'SARS', 'CoV', '2', 'exerted', 'tremendous', 'challenges', 'on', 'its', 'diagnostics', 'and', 'therapeutics', 'Therefore', 'there', 'is', 'an', 'urgent', 'need', 'to', 'summarize', 'the', 'existing', 'research', 'results', 'to', 'guide', 'decision', 'making', 'on', 'the', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'In', 'this', 'review', 'we', 'focus', 'on', 'our', 'current', 'understanding', 'of', 'epidemiology', 'pathogenesis', 'diagnostics', 'and', 'therapeutics', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', '']"
60925,Recent advances in vaccines and diagnostics against Middle East respiratory syndrome coronavirus.,2020,Acta virologica,https://doi.org/10.4149/av_2020_208; https://www.ncbi.nlm.nih.gov/pubmed/32551793/,"Middle East respiratory syndrome coronavirus (MERS-CoV) is an RNA virus that causes severe respiratory disease. Since it was identified in 2012, approximately 2500 MERS cases with high mortality have been confirmed in 27 countries. Although most cases have occurred in the Middle East, an outbreak in South Korea in 2015 showed that MERS could be a global threat via human-to-human transmission. There is no licensed vaccine against MERS. Thus, early detection is the best way to limit the spread of this fatal disease. In this review, we focus on transmission, the infection process, and scientific efforts in vaccine development and diagnostics for MERS-CoV. Keywords: Middle East respiratory syndrome coronavirus; epidemiology; virology; vaccine; diagnostics.",10.4149/av_2020_208,5z6w3zfk,"['Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'is', 'an', 'RNA', 'virus', 'that', 'causes', 'severe', 'respiratory', 'disease', 'Since', 'it', 'was', 'identified', 'in', '2012', 'approximately', '2500', 'MERS', 'cases', 'with', 'high', 'mortality', 'have', 'been', 'confirmed', 'in', '27', 'countries', 'Although', 'most', 'cases', 'have', 'occurred', 'in', 'the', 'Middle', 'East', 'an', 'outbreak', 'in', 'South', 'Korea', 'in', '2015', 'showed', 'that', 'MERS', 'could', 'be', 'a', 'global', 'threat', 'via', 'human', 'to', 'human', 'transmission', 'There', 'is', 'no', 'licensed', 'vaccine', 'against', 'MERS', 'Thus', 'early', 'detection', 'is', 'the', 'best', 'way', 'to', 'limit', 'the', 'spread', 'of', 'this', 'fatal', 'disease', 'In', 'this', 'review', 'we', 'focus', 'on', 'transmission', 'the', 'infection', 'process', 'and', 'scientific', 'efforts', 'in', 'vaccine', 'development', 'and', 'diagnostics', 'for', 'MERS', 'CoV', 'Keywords', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'epidemiology', 'virology', 'vaccine', 'diagnostics', '']"
61011,RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look.,2020-05-12,RNA,https://doi.org/10.1261/rna.076141.120; https://www.ncbi.nlm.nih.gov/pubmed/32398273/,"As the COVID-19 outbreak spreads, there is a growing need for a compilation of conserved RNA genome regions in the SARS-CoV-2 virus along with their structural propensities to guide development of antivirals and diagnostics. Here we present a first look at RNA sequence conservation and structural propensities in the SARS-CoV-2 genome. Using sequence alignments spanning a range of betacoronaviruses, we rank genomic regions by RNA sequence conservation, identifying 79 regions of length at least 15 nucleotides as exactly conserved over SARS-related complete genome sequences available near the beginning of the COVID-19 outbreak. We then confirm the conservation of the majority of these genome regions across 739 SARS-CoV-2 sequences subsequently reported from the COVID-19 outbreak, and we present a curated list of 30 'SARS-related-conserved' regions. We find that known RNA structured elements curated as Rfam families and in prior literature are enriched in these conserved genome regions, and we predict additional conserved, stable secondary structures across the viral genome. We provide 106 'SARS-CoV-2-conserved-structured' regions as potential targets for antivirals that bind to structured RNA. We further provide detailed secondary structure models for the extended 5' UTR, frame-shifting element, and 3' UTR. Last, we predict regions of the SARS-CoV-2 viral genome that have low propensity for RNA secondary structure and are conserved within SARS-CoV-2 strains. These 59 'SARS-CoV-2-conserved-unstructured' genomic regions may be most easily targeted in primer-based diagnostic and oligonucleotide-based therapeutic strategies.",10.1261/rna.076141.120,16swzibp,"['As', 'the', 'COVID', '19', 'outbreak', 'spreads', 'there', 'is', 'a', 'growing', 'need', 'for', 'a', 'compilation', 'of', 'conserved', 'RNA', 'genome', 'regions', 'in', 'the', 'SARS', 'CoV', '2', 'virus', 'along', 'with', 'their', 'structural', 'propensities', 'to', 'guide', 'development', 'of', 'antivirals', 'and', 'diagnostics', 'Here', 'we', 'present', 'a', 'first', 'look', 'at', 'RNA', 'sequence', 'conservation', 'and', 'structural', 'propensities', 'in', 'the', 'SARS', 'CoV', '2', 'genome', 'Using', 'sequence', 'alignments', 'spanning', 'a', 'range', 'of', 'betacoronaviruses', 'we', 'rank', 'genomic', 'regions', 'by', 'RNA', 'sequence', 'conservation', 'identifying', '79', 'regions', 'of', 'length', 'at', 'least', '15', 'nucleotides', 'as', 'exactly', 'conserved', 'over', 'SARS', 'related', 'complete', 'genome', 'sequences', 'available', 'near', 'the', 'beginning', 'of', 'the', 'COVID', '19', 'outbreak', 'We', 'then', 'confirm', 'the', 'conservation', 'of', 'the', 'majority', 'of', 'these', 'genome', 'regions', 'across', '739', 'SARS', 'CoV', '2', 'sequences', 'subsequently', 'reported', 'from', 'the', 'COVID', '19', 'outbreak', 'and', 'we', 'present', 'a', 'curated', 'list', 'of', '30', 'SARS', 'related', 'conserved', 'regions', 'We', 'find', 'that', 'known', 'RNA', 'structured', 'elements', 'curated', 'as', 'Rfam', 'families', 'and', 'in', 'prior', 'literature', 'are', 'enriched', 'in', 'these', 'conserved', 'genome', 'regions', 'and', 'we', 'predict', 'additional', 'conserved', 'stable', 'secondary', 'structures', 'across', 'the', 'viral', 'genome', 'We', 'provide', '106', 'SARS', 'CoV', '2', 'conserved', 'structured', 'regions', 'as', 'potential', 'targets', 'for', 'antivirals', 'that', 'bind', 'to', 'structured', 'RNA', 'We', 'further', 'provide', 'detailed', 'secondary', 'structure', 'models', 'for', 'the', 'extended', '5', 'UTR', 'frame', 'shifting', 'element', 'and', '3', 'UTR', 'Last', 'we', 'predict', 'regions', 'of', 'the', 'SARS', 'CoV', '2', 'viral', 'genome', 'that', 'have', 'low', 'propensity', 'for', 'RNA', 'secondary', 'structure', 'and', 'are', 'conserved', 'within', 'SARS', 'CoV', '2', 'strains', 'These', '59', 'SARS', 'CoV', '2', 'conserved', 'unstructured', 'genomic', 'regions', 'may', 'be', 'most', 'easily', 'targeted', 'in', 'primer', 'based', 'diagnostic', 'and', 'oligonucleotide', 'based', 'therapeutic', 'strategies', '']"
61130,What we know so far: COVID-19 current clinical knowledge and research.,2020-03-05,Clinical medicine,https://doi.org/10.7861/clinmed.2019-coron; https://www.ncbi.nlm.nih.gov/pubmed/32139372/,"In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features.",10.7861/clinmed.2019-coron,sn72mkzq,"['In', 'December', '2019', 'health', 'authorities', 'in', 'Wuhan', 'China', 'identified', 'a', 'cluster', 'of', 'pneumonia', 'cases', 'of', 'unknown', 'aetiology', 'linked', 'to', 'the', 'city', 's', 'South', 'China', 'Seafood', 'Market', 'Subsequent', 'investigations', 'revealed', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'as', 'the', 'causative', 'agent', 'now', 'at', 'the', 'heart', 'of', 'a', 'major', 'outbreak', 'The', 'rising', 'case', 'numbers', 'have', 'been', 'accompanied', 'by', 'unprecedented', 'public', 'health', 'action', 'including', 'the', 'wholesale', 'isolation', 'of', 'Wuhan', 'Alongside', 'this', 'has', 'been', 'a', 'robust', 'scientific', 'response', 'including', 'early', 'publication', 'of', 'the', 'pathogen', 'genome', 'and', 'rapid', 'development', 'of', 'highly', 'specific', 'diagnostics', 'This', 'article', 'will', 'review', 'the', 'new', 'knowledge', 'of', 'SARS', 'CoV', '2', 'COVID', '19', 'acute', 'respiratory', 'disease', 'and', 'summarise', 'its', 'clinical', 'features', '']"
61215,[Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic].,2020-05-04,Kardiologiia,https://doi.org/10.18087/cardio.2020.5.n1130; https://www.ncbi.nlm.nih.gov/pubmed/32515698/,"The beginning of 2020 was characterized by the development of a new coronavirus pandemic (COVID-19). Information about the epidemiology, etiology, pathogenesis, clinical and laboratory diagnostics, as well as prevention and therapy for this disease is constantly being expanded and reviewed. The COVID-19 pandemic creates the need for the emergence of new conditions of specialized care for patients with heart rhythm and conduction disorders [1]. These recommendations are intended for general practitioners, internists, cardiologists, electrophysiologists/arrhythmologists, cardiovascular surgeons, functional diagnostics doctors, anesthesiologists-resuscitators, laboratory diagnostics specialists, health care organizers in the system of organizations and healthcare institutions that provide specialized care to patients with heart rhythm and conduction disorders.",10.18087/cardio.2020.5.n1130,oaxn8my7,"['The', 'beginning', 'of', '2020', 'was', 'characterized', 'by', 'the', 'development', 'of', 'a', 'new', 'coronavirus', 'pandemic', 'COVID', '19', 'Information', 'about', 'the', 'epidemiology', 'etiology', 'pathogenesis', 'clinical', 'and', 'laboratory', 'diagnostics', 'as', 'well', 'as', 'prevention', 'and', 'therapy', 'for', 'this', 'disease', 'is', 'constantly', 'being', 'expanded', 'and', 'reviewed', 'The', 'COVID', '19', 'pandemic', 'creates', 'the', 'need', 'for', 'the', 'emergence', 'of', 'new', 'conditions', 'of', 'specialized', 'care', 'for', 'patients', 'with', 'heart', 'rhythm', 'and', 'conduction', 'disorders', '1', 'These', 'recommendations', 'are', 'intended', 'for', 'general', 'practitioners', 'internists', 'cardiologists', 'electrophysiologists', 'arrhythmologists', 'cardiovascular', 'surgeons', 'functional', 'diagnostics', 'doctors', 'anesthesiologists', 'resuscitators', 'laboratory', 'diagnostics', 'specialists', 'health', 'care', 'organizers', 'in', 'the', 'system', 'of', 'organizations', 'and', 'healthcare', 'institutions', 'that', 'provide', 'specialized', 'care', 'to', 'patients', 'with', 'heart', 'rhythm', 'and', 'conduction', 'disorders', '']"
61811,COVID-19 - what should anaethesiologists and intensivists know about it?,2020-03-20,Anaesthesiology intensive therapy,https://doi.org/10.5114/ait.2020.93756; https://www.ncbi.nlm.nih.gov/pubmed/32191830/,"Over the past three months, the world has faced an unprecedented health hazard. The World Health Organization has announced a pandemic infection with an unknown species of coronavirus called SARS-CoV-2. Spreading mainly through the droplet route, the virus causes mild symptoms in the majority of cases, the most common being: fever (80%), dry cough (56%), fatigue (22%) and muscle pain (7%); less common symptoms include a sore throat, a runny nose, diarrhea, hemoptysis and chills. A life-threatening complication of SARS-CoV-2 infection is an acute respiratory distress syndrome (ARDS), which occurs more often in older adults, those with immune disorders and co-morbidities. Severe forms of the infection, being an indication for treatment in the intensive care unit, comprise acute lung inflammation, ARDS, sepsis and septic shock. The article presents basic information about etiology, pathogenesis and diagnostics (with particular emphasis on the importance of tomocomputer imaging), clinical picture, treatment and prevention of the infection. It goes on to emphasize the specific risks of providing anesthesiology and intensive care services. Due to the fact that effective causal treatment is not yet available and the number of infections and deaths increases day by day, infection prevention and strict adherence to recommendations of infection control organizations remain the basis for fighting the virus.",10.5114/ait.2020.93756,n8n1hf5o,"['Over', 'the', 'past', 'three', 'months', 'the', 'world', 'has', 'faced', 'an', 'unprecedented', 'health', 'hazard', 'The', 'World', 'Health', 'Organization', 'has', 'announced', 'a', 'pandemic', 'infection', 'with', 'an', 'unknown', 'species', 'of', 'coronavirus', 'called', 'SARS', 'CoV', '2', 'Spreading', 'mainly', 'through', 'the', 'droplet', 'route', 'the', 'virus', 'causes', 'mild', 'symptoms', 'in', 'the', 'majority', 'of', 'cases', 'the', 'most', 'common', 'being', 'fever', '80', 'dry', 'cough', '56', 'fatigue', '22', 'and', 'muscle', 'pain', '7', 'less', 'common', 'symptoms', 'include', 'a', 'sore', 'throat', 'a', 'runny', 'nose', 'diarrhea', 'hemoptysis', 'and', 'chills', 'A', 'life', 'threatening', 'complication', 'of', 'SARS', 'CoV', '2', 'infection', 'is', 'an', 'acute', 'respiratory', 'distress', 'syndrome', 'ARDS', 'which', 'occurs', 'more', 'often', 'in', 'older', 'adults', 'those', 'with', 'immune', 'disorders', 'and', 'co', 'morbidities', 'Severe', 'forms', 'of', 'the', 'infection', 'being', 'an', 'indication', 'for', 'treatment', 'in', 'the', 'intensive', 'care', 'unit', 'comprise', 'acute', 'lung', 'inflammation', 'ARDS', 'sepsis', 'and', 'septic', 'shock', 'The', 'article', 'presents', 'basic', 'information', 'about', 'etiology', 'pathogenesis', 'and', 'diagnostics', 'with', 'particular', 'emphasis', 'on', 'the', 'importance', 'of', 'tomocomputer', 'imaging', 'clinical', 'picture', 'treatment', 'and', 'prevention', 'of', 'the', 'infection', 'It', 'goes', 'on', 'to', 'emphasize', 'the', 'specific', 'risks', 'of', 'providing', 'anesthesiology', 'and', 'intensive', 'care', 'services', 'Due', 'to', 'the', 'fact', 'that', 'effective', 'causal', 'treatment', 'is', 'not', 'yet', 'available', 'and', 'the', 'number', 'of', 'infections', 'and', 'deaths', 'increases', 'day', 'by', 'day', 'infection', 'prevention', 'and', 'strict', 'adherence', 'to', 'recommendations', 'of', 'infection', 'control', 'organizations', 'remain', 'the', 'basis', 'for', 'fighting', 'the', 'virus', '']"
62158,The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.,2020-03-19,Clinical chemistry and laboratory medicine,https://doi.org/10.1515/cclm-2020-0240; https://www.ncbi.nlm.nih.gov/pubmed/32191623/,"Coronavirus disease 2019, abbreviated to COVID-19 and sustained by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the latest biological hazard to assume the relevance of insidious worldwide threat. One obvious question that is now engaging the minds of many scientists and healthcare professionals is whether and eventually how laboratory medicine could efficiently contribute to counteract this and other (future) viral outbreaks. Despite there being evidence that laboratory tests are vital throughout many clinical pathways, there are at least three major areas where in vitro diagnostics can also provide essential contributions to diagnostic reasoning and managed care of patients with suspected or confirmed SARS-CoV-2 infection. These include etiological diagnosis, patient monitoring, as well as epidemiologic surveillance. Nonetheless, some structural and practical aspects may generate substantial hurdles in providing timely and efficient response to this infectious emergency, which basically include inadequate (insufficient) environment and shortage of technical and human resources for facing enhanced volume of tests on many infected patients, some of whom are with severe disease. Some proactive and reactive strategies may hence be identified to confront this serious healthcare challenge, which entail major investments on conventional laboratory resources, reinforcement of regional networks of clinical laboratories, installation of mobile laboratories, as well as being proactive in establishing laboratory emergency plans.",10.1515/cclm-2020-0240,lazqwdn0,"['Coronavirus', 'disease', '2019', 'abbreviated', 'to', 'COVID', '19', 'and', 'sustained', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'the', 'latest', 'biological', 'hazard', 'to', 'assume', 'the', 'relevance', 'of', 'insidious', 'worldwide', 'threat', 'One', 'obvious', 'question', 'that', 'is', 'now', 'engaging', 'the', 'minds', 'of', 'many', 'scientists', 'and', 'healthcare', 'professionals', 'is', 'whether', 'and', 'eventually', 'how', 'laboratory', 'medicine', 'could', 'efficiently', 'contribute', 'to', 'counteract', 'this', 'and', 'other', 'future', 'viral', 'outbreaks', 'Despite', 'there', 'being', 'evidence', 'that', 'laboratory', 'tests', 'are', 'vital', 'throughout', 'many', 'clinical', 'pathways', 'there', 'are', 'at', 'least', 'three', 'major', 'areas', 'where', 'in', 'vitro', 'diagnostics', 'can', 'also', 'provide', 'essential', 'contributions', 'to', 'diagnostic', 'reasoning', 'and', 'managed', 'care', 'of', 'patients', 'with', 'suspected', 'or', 'confirmed', 'SARS', 'CoV', '2', 'infection', 'These', 'include', 'etiological', 'diagnosis', 'patient', 'monitoring', 'as', 'well', 'as', 'epidemiologic', 'surveillance', 'Nonetheless', 'some', 'structural', 'and', 'practical', 'aspects', 'may', 'generate', 'substantial', 'hurdles', 'in', 'providing', 'timely', 'and', 'efficient', 'response', 'to', 'this', 'infectious', 'emergency', 'which', 'basically', 'include', 'inadequate', 'insufficient', 'environment', 'and', 'shortage', 'of', 'technical', 'and', 'human', 'resources', 'for', 'facing', 'enhanced', 'volume', 'of', 'tests', 'on', 'many', 'infected', 'patients', 'some', 'of', 'whom', 'are', 'with', 'severe', 'disease', 'Some', 'proactive', 'and', 'reactive', 'strategies', 'may', 'hence', 'be', 'identified', 'to', 'confront', 'this', 'serious', 'healthcare', 'challenge', 'which', 'entail', 'major', 'investments', 'on', 'conventional', 'laboratory', 'resources', 'reinforcement', 'of', 'regional', 'networks', 'of', 'clinical', 'laboratories', 'installation', 'of', 'mobile', 'laboratories', 'as', 'well', 'as', 'being', 'proactive', 'in', 'establishing', 'laboratory', 'emergency', 'plans', '']"
65902,A meta-analysis to evaluate the effectiveness of real-time PCR for diagnosing novel coronavirus infections.,2015,Genetics and molecular research : GMR,https://doi.org/10.4238/2015.december.1.15; https://www.ncbi.nlm.nih.gov/pubmed/26634531/,"Novel coronavirus (nCoV) belongs to the Coronaviridae family, which includes the virus that causes SARS, or severe acute respiratory syndrome. However, infection source, transmission route, and host of nCoV have not yet been thoroughly characterized. In some cases, nCoV presented a limited person-to-person transmission. Therefore, early diagnosis of nCoV may be of importance for reducing the spread of disease in public. Methods for nCoV diagnosis involve smear dyeing inspection, culture identification, and real-time PCR detection, all of which are proved highly effective. Here, we performed a meta-analysis to evaluate the effectiveness of real-time PCR for diagnosing nCoV infection. Fifteen articles conformed to the inclusion and exclusion criteria for further meta-analysis on the basis of a wide range of publications searched from databases involving PubMed, EMBASE, Web of Science, Medline, ISI. We analyzed the stability and publication bias as well as examined the heterogeneity inspection of real-time PCR detection in contrast to smear staining and culture identification. The fixed-effect model was adopted in our meta-analysis. Our result demonstrated that the combination of real-time PCR and smear diagnostics yielded an odds ratio (OR) = 1.91, 95% confidence interval (CI) = 1.51-2.41, Z = 5.43, P < 0.05, while the combination of real-time PCR and culture identification yielded OR = 2.44, 95%CI = 1.77-3.37, Z = 5.41, P < 0.05. Therefore, we propose real-time PCR as an efficient method that offers an auxiliary support for future nCoV diagnosis.",10.4238/2015.december.1.15,kgtojyhl,"['Novel', 'coronavirus', 'nCoV', 'belongs', 'to', 'the', 'Coronaviridae', 'family', 'which', 'includes', 'the', 'virus', 'that', 'causes', 'SARS', 'or', 'severe', 'acute', 'respiratory', 'syndrome', 'However', 'infection', 'source', 'transmission', 'route', 'and', 'host', 'of', 'nCoV', 'have', 'not', 'yet', 'been', 'thoroughly', 'characterized', 'In', 'some', 'cases', 'nCoV', 'presented', 'a', 'limited', 'person', 'to', 'person', 'transmission', 'Therefore', 'early', 'diagnosis', 'of', 'nCoV', 'may', 'be', 'of', 'importance', 'for', 'reducing', 'the', 'spread', 'of', 'disease', 'in', 'public', 'Methods', 'for', 'nCoV', 'diagnosis', 'involve', 'smear', 'dyeing', 'inspection', 'culture', 'identification', 'and', 'real', 'time', 'PCR', 'detection', 'all', 'of', 'which', 'are', 'proved', 'highly', 'effective', 'Here', 'we', 'performed', 'a', 'meta', 'analysis', 'to', 'evaluate', 'the', 'effectiveness', 'of', 'real', 'time', 'PCR', 'for', 'diagnosing', 'nCoV', 'infection', 'Fifteen', 'articles', 'conformed', 'to', 'the', 'inclusion', 'and', 'exclusion', 'criteria', 'for', 'further', 'meta', 'analysis', 'on', 'the', 'basis', 'of', 'a', 'wide', 'range', 'of', 'publications', 'searched', 'from', 'databases', 'involving', 'PubMed', 'EMBASE', 'Web', 'of', 'Science', 'Medline', 'ISI', 'We', 'analyzed', 'the', 'stability', 'and', 'publication', 'bias', 'as', 'well', 'as', 'examined', 'the', 'heterogeneity', 'inspection', 'of', 'real', 'time', 'PCR', 'detection', 'in', 'contrast', 'to', 'smear', 'staining', 'and', 'culture', 'identification', 'The', 'fixed', 'effect', 'model', 'was', 'adopted', 'in', 'our', 'meta', 'analysis', 'Our', 'result', 'demonstrated', 'that', 'the', 'combination', 'of', 'real', 'time', 'PCR', 'and', 'smear', 'diagnostics', 'yielded', 'an', 'odds', 'ratio', 'OR', '1', '91', '95', 'confidence', 'interval', 'CI', '1', '51', '2', '41', 'Z', '5', '43', 'P', '0', '05', 'while', 'the', 'combination', 'of', 'real', 'time', 'PCR', 'and', 'culture', 'identification', 'yielded', 'OR', '2', '44', '95', 'CI', '1', '77', '3', '37', 'Z', '5', '41', 'P', '0', '05', 'Therefore', 'we', 'propose', 'real', 'time', 'PCR', 'as', 'an', 'efficient', 'method', 'that', 'offers', 'an', 'auxiliary', 'support', 'for', 'future', 'nCoV', 'diagnosis', '']"
68762,Evaluation and clinical validation of an alcohol-based transport medium for preservation and inactivation of respiratory viruses.,2011,Journal of clinical microbiology,https://doi.org/10.1128/jcm.00327-11; https://www.ncbi.nlm.nih.gov/pubmed/21508158/,"The clinical and public health importance of influenza and other respiratory viruses has accelerated the development of highly sensitive molecular diagnostics, but data are limited regarding preanalytical stages of diagnostic testing. We evaluated CyMol, an alcohol-based transport medium, for its ability to maintain specimen integrity for up to 21 days of storage at various temperatures; for its ability to inactivate virus; and for its compatibility with antigen- or nucleic acid-based diagnostics for respiratory viruses in clinical samples. In mock-infected samples, both universal transport medium (UTM-RT) and CyMol maintained equivalent viral quantities for at least 14 days at room temperature or colder, whereas a dry swab collection maintained viral quantities only if refrigerated or frozen. CyMol inactivated influenza virus within 5 min of sample immersion. UTM-RT- and CyMol-collected nasal swab specimens from 73 symptomatic students attending a campus health clinic were positive for a respiratory virus in 56.2% of subjects by multiplex PCR testing, including influenza A and B viruses, rhinovirus/enteroviruses, coronaviruses, respiratory syncytial virus, parainfluenza viruses, metapneumovirus, and adenovirus. Detection by PCR was equivalent in UTM-RT- and CyMol-collected specimens and in self- and staff-collected swabs. Direct fluorescent antibody (DFA) testing was substantially less sensitive (23.3%) than multiplex PCR, and DFA testing from UTM-RT-collected swabs was more sensitive than that from CyMol-collected swabs. These data indicate that an alcohol-based transport medium such as CyMol preserves respiratory virus integrity, rapidly inactivates viruses, and is compatible with PCR-based respiratory diagnostics.",10.1128/jcm.00327-11,4cgs2kp5,"['The', 'clinical', 'and', 'public', 'health', 'importance', 'of', 'influenza', 'and', 'other', 'respiratory', 'viruses', 'has', 'accelerated', 'the', 'development', 'of', 'highly', 'sensitive', 'molecular', 'diagnostics', 'but', 'data', 'are', 'limited', 'regarding', 'preanalytical', 'stages', 'of', 'diagnostic', 'testing', 'We', 'evaluated', 'CyMol', 'an', 'alcohol', 'based', 'transport', 'medium', 'for', 'its', 'ability', 'to', 'maintain', 'specimen', 'integrity', 'for', 'up', 'to', '21', 'days', 'of', 'storage', 'at', 'various', 'temperatures', 'for', 'its', 'ability', 'to', 'inactivate', 'virus', 'and', 'for', 'its', 'compatibility', 'with', 'antigen', 'or', 'nucleic', 'acid', 'based', 'diagnostics', 'for', 'respiratory', 'viruses', 'in', 'clinical', 'samples', 'In', 'mock', 'infected', 'samples', 'both', 'universal', 'transport', 'medium', 'UTM', 'RT', 'and', 'CyMol', 'maintained', 'equivalent', 'viral', 'quantities', 'for', 'at', 'least', '14', 'days', 'at', 'room', 'temperature', 'or', 'colder', 'whereas', 'a', 'dry', 'swab', 'collection', 'maintained', 'viral', 'quantities', 'only', 'if', 'refrigerated', 'or', 'frozen', 'CyMol', 'inactivated', 'influenza', 'virus', 'within', '5', 'min', 'of', 'sample', 'immersion', 'UTM', 'RT', 'and', 'CyMol', 'collected', 'nasal', 'swab', 'specimens', 'from', '73', 'symptomatic', 'students', 'attending', 'a', 'campus', 'health', 'clinic', 'were', 'positive', 'for', 'a', 'respiratory', 'virus', 'in', '56', '2', 'of', 'subjects', 'by', 'multiplex', 'PCR', 'testing', 'including', 'influenza', 'A', 'and', 'B', 'viruses', 'rhinovirus', 'enteroviruses', 'coronaviruses', 'respiratory', 'syncytial', 'virus', 'parainfluenza', 'viruses', 'metapneumovirus', 'and', 'adenovirus', 'Detection', 'by', 'PCR', 'was', 'equivalent', 'in', 'UTM', 'RT', 'and', 'CyMol', 'collected', 'specimens', 'and', 'in', 'self', 'and', 'staff', 'collected', 'swabs', 'Direct', 'fluorescent', 'antibody', 'DFA', 'testing', 'was', 'substantially', 'less', 'sensitive', '23', '3', 'than', 'multiplex', 'PCR', 'and', 'DFA', 'testing', 'from', 'UTM', 'RT', 'collected', 'swabs', 'was', 'more', 'sensitive', 'than', 'that', 'from', 'CyMol', 'collected', 'swabs', 'These', 'data', 'indicate', 'that', 'an', 'alcohol', 'based', 'transport', 'medium', 'such', 'as', 'CyMol', 'preserves', 'respiratory', 'virus', 'integrity', 'rapidly', 'inactivates', 'viruses', 'and', 'is', 'compatible', 'with', 'PCR', 'based', 'respiratory', 'diagnostics', '']"
69017,Detection of respiratory viruses with a multiplex polymerase chain reaction assay (MultiCode-PLx Respiratory Virus Panel) in patients with hematologic malignancies.,2009,Leukemia & lymphoma,https://doi.org/10.1080/10428190902777665; https://www.ncbi.nlm.nih.gov/pubmed/19373660/,"Respiratory viral pathogens are a common cause of morbidity in patients with hematologic malignancies. Sensitive molecular assays have increased the detection of common respiratory viruses and expanded the panel of detectable viruses. Both a rapid viral culture with direct fluorescence antibody (DFA) staining and a PCR-based assay (MultiCode-PLx Respiratory Virus Panel) were performed on patients with hematologic malignancies, who underwent collection of a nasopharyngeal swab or bronchoalveolar lavage from October 2006 to April 2007. Eighty-two samples from 70 patients were obtained; all patients had upper respiratory tract symptoms. Respiratory viruses were detected in 10 samples (12%) by conventional virological methods and in 31 samples (38%) by the MultiCode-PLx assay. This increased diagnostic yield resulted from better sensitivity for those viruses detectable by both methods and detection of viruses not covered by the antigen detection/rapid culture method (human metapneumovirus, coronaviruses and rhinoviruses). The MultiCode-PLx assay frequently identified respiratory viral infections which are not detected by rapid viral culture/DFA; 40% of these patients had pneumonia in addition to the upper respiratory tract symptoms. Improved diagnostics for respiratory viruses may lead to more effective management and better outcomes in this patient population.",10.1080/10428190902777665,p1cf5yxc,"['Respiratory', 'viral', 'pathogens', 'are', 'a', 'common', 'cause', 'of', 'morbidity', 'in', 'patients', 'with', 'hematologic', 'malignancies', 'Sensitive', 'molecular', 'assays', 'have', 'increased', 'the', 'detection', 'of', 'common', 'respiratory', 'viruses', 'and', 'expanded', 'the', 'panel', 'of', 'detectable', 'viruses', 'Both', 'a', 'rapid', 'viral', 'culture', 'with', 'direct', 'fluorescence', 'antibody', 'DFA', 'staining', 'and', 'a', 'PCR', 'based', 'assay', 'MultiCode', 'PLx', 'Respiratory', 'Virus', 'Panel', 'were', 'performed', 'on', 'patients', 'with', 'hematologic', 'malignancies', 'who', 'underwent', 'collection', 'of', 'a', 'nasopharyngeal', 'swab', 'or', 'bronchoalveolar', 'lavage', 'from', 'October', '2006', 'to', 'April', '2007', 'Eighty', 'two', 'samples', 'from', '70', 'patients', 'were', 'obtained', 'all', 'patients', 'had', 'upper', 'respiratory', 'tract', 'symptoms', 'Respiratory', 'viruses', 'were', 'detected', 'in', '10', 'samples', '12', 'by', 'conventional', 'virological', 'methods', 'and', 'in', '31', 'samples', '38', 'by', 'the', 'MultiCode', 'PLx', 'assay', 'This', 'increased', 'diagnostic', 'yield', 'resulted', 'from', 'better', 'sensitivity', 'for', 'those', 'viruses', 'detectable', 'by', 'both', 'methods', 'and', 'detection', 'of', 'viruses', 'not', 'covered', 'by', 'the', 'antigen', 'detection', 'rapid', 'culture', 'method', 'human', 'metapneumovirus', 'coronaviruses', 'and', 'rhinoviruses', 'The', 'MultiCode', 'PLx', 'assay', 'frequently', 'identified', 'respiratory', 'viral', 'infections', 'which', 'are', 'not', 'detected', 'by', 'rapid', 'viral', 'culture', 'DFA', '40', 'of', 'these', 'patients', 'had', 'pneumonia', 'in', 'addition', 'to', 'the', 'upper', 'respiratory', 'tract', 'symptoms', 'Improved', 'diagnostics', 'for', 'respiratory', 'viruses', 'may', 'lead', 'to', 'more', 'effective', 'management', 'and', 'better', 'outcomes', 'in', 'this', 'patient', 'population', '']"
70300,Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe.,2005,Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,https://doi.org/10.2807/esm.10.06.00545-en; https://www.ncbi.nlm.nih.gov/pubmed/29183474/,"The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of ""Imported"" Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. A public website is available at http://www.enivd.de.",10.2807/esm.10.06.00545-en,v9qrsy9n,"['The', 'threat', 'posed', 'by', 'emerging', 'and', 're', 'emerging', 'communicable', 'diseases', 'and', 'more', 'recently', 'by', 'the', 'intentional', 'release', 'of', 'infectious', 'agents', 'in', 'a', 'susceptible', 'population', 'has', 'been', 'receiving', 'considerable', 'attention', 'at', 'the', 'national', 'and', 'international', 'levels', 'Public', 'health', 'efforts', 'to', 'strengthen', 'disease', 'detection', 'surveillance', 'and', 'control', 'have', 'been', 'intensified', 'However', 'clinicians', 'and', 'clinical', 'microbiology', 'laboratories', 'play', 'an', 'important', 'role', 'in', 'the', 'early', 'detection', 'of', 'disease', 'the', 'identification', 'of', 'the', 'putative', 'agent', 'and', 'notification', 'of', 'the', 'appropriate', 'authorities', 'To', 'be', 'effective', 'in', 'this', 'role', 'laboratories', 'must', 'be', 'specially', 'prepared', 'to', 'handle', 'viral', 'agents', 'safely', 'and', 'need', 'among', 'other', 'things', 'the', 'appropriate', 'rapid', 'and', 'sensitive', 'diagnostic', 'tests', 'In', '1998', 'the', 'European', 'Network', 'for', 'Diagnostics', 'of', 'Imported', 'Viral', 'Diseases', 'ENIVD', 'was', 'established', 'ENIVD', 'presently', 'comprises', 'as', 'permanent', 'members', '44', 'expert', 'laboratories', 'in', '21', 'European', 'Union', 'EU', 'member', 'states', 'and', '4', 'non', 'EU', 'countries', 'and', 'is', 'one', 'of', 'the', 'networks', 'on', 'infectious', 'diseases', 'funded', 'by', 'the', 'European', 'Commission', 'ENIVD', 'fulfils', 'many', 'of', 'the', 'important', 'tasks', 'required', 'for', 'the', 'surveillance', 'and', 'control', 'of', 'imported', 'rare', 'and', 'emerging', 'viral', 'infections', 'such', 'as', 'the', 'exchange', 'of', 'expertise', 'and', 'the', 'organisation', 'of', 'external', 'quality', 'assurance', 'EQA', 'programmes', 'both', 'of', 'which', 'are', 'needed', 'to', 'improve', 'diagnostics', 'Here', 'we', 'summarise', 'the', 'data', 'generated', 'by', 'recent', 'EQA', 'activities', 'focussed', 'on', 'the', 'diagnostics', 'of', 'infections', 'with', 'hantavirus', 'dengue', 'virus', 'filovirus', 'Lassa', 'virus', 'orthopox', 'virus', 'and', 'the', 'SARS', 'coronavirus', 'SARS', 'CoV', 'These', 'were', 'carried', 'out', 'between', '1999', 'and', '2004', 'and', 'involved', '93', 'laboratories', 'from', '41', 'countries', 'including', 'laboratories', 'from', 'additional', 'countries', 'outside', 'of', 'Europe', 'Particularly', 'the', 'EU', 'candidate', 'countries', 'and', 'Eastern', 'neighbouring', 'countries', 'will', 'be', 'invited', 'to', 'join', 'the', 'network', 'in', 'the', 'near', 'future', 'A', 'public', 'website', 'is', 'available', 'at', 'http', 'www', 'enivd', 'de', '']"
71368,Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan,2020-07-11,,http://medrxiv.org/cgi/content/short/2020.07.10.20150904v1?rss=1,"Serological tests for SARS-CoV-2 coronavirus in pre-COVID-19 samples in Japan showed 1.5%-1.75% positives, and previous surveys might overestimate COVID-19 seroprevalence in several population of Japan. These false negatives could be excluded by combination of different diagnostics to 0.25%.",10.1101/2020.07.10.20150904,hkvh2lc9,"['Serological', 'tests', 'for', 'SARS', 'CoV', '2', 'coronavirus', 'in', 'pre', 'COVID', '19', 'samples', 'in', 'Japan', 'showed', '1', '5', '1', '75', 'positives', 'and', 'previous', 'surveys', 'might', 'overestimate', 'COVID', '19', 'seroprevalence', 'in', 'several', 'population', 'of', 'Japan', 'These', 'false', 'negatives', 'could', 'be', 'excluded', 'by', 'combination', 'of', 'different', 'diagnostics', 'to', '0', '25', '']"
71564,SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies,2020-03-28,bioRxiv,https://doi.org/10.1101/2020.03.27.009480,"In December 2019, an outbreak of atypical pneumonia (Coronavirus disease 2019 - COVID-19) associated with a novel coronavirus (SARS-CoV-2) was reported in Wuhan city, Hubei province, China. The outbreak was traced to a seafood wholesale market and human to human transmission was confirmed. The rapid spread and the death toll of the new epidemic warrants immediate intervention. The intra-host genomic variability of SARS-CoV-2 plays a pivotal role in the development of effective antiviral agents and vaccines, but also in the design of accurate diagnostics. We analyzed NGS data derived from clinical samples of three Chinese patients infected with SARS-CoV-2, in order to identify small- and large-scale intra-host variations in the viral genome. We identified tens of low- or higher-frequency single nucleotide variations (SNVs) with variable density across the viral genome, affecting 7 out of 10 protein-coding viral genes. The majority of these SNVs corresponded to missense changes. The annotation of the identified SNVs but also of all currently circulating strain variations revealed colocalization of intra-host but also strain specific SNVs with primers and probes currently used in molecular diagnostics assays. Moreover, we de-novo assembled the viral genome, in order to isolate and validate intra-host structural variations and recombination breakpoints. The bioinformatics analysis disclosed genomic rearrangements over poly-A / poly-U regions located in ORF1ab and spike (S) gene, including a potential recombination hot-spot within S gene. Our results highlight the intra-host genomic diversity and plasticity of SARS-CoV-2, pointing out genomic regions that are prone to alterations. The isolated SNVs and genomic rearrangements, reflect the intra-patient capacity of the polymorphic quasispecies, which may arise rapidly during the outbreak, allowing immunological escape of the virus, offering resistance to anti-viral drugs and affecting the sensitivity of the molecular diagnostics assays.",10.1101/2020.03.27.009480,jxm69ndw,"['In', 'December', '2019', 'an', 'outbreak', 'of', 'atypical', 'pneumonia', 'Coronavirus', 'disease', '2019', 'COVID', '19', 'associated', 'with', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'was', 'reported', 'in', 'Wuhan', 'city', 'Hubei', 'province', 'China', 'The', 'outbreak', 'was', 'traced', 'to', 'a', 'seafood', 'wholesale', 'market', 'and', 'human', 'to', 'human', 'transmission', 'was', 'confirmed', 'The', 'rapid', 'spread', 'and', 'the', 'death', 'toll', 'of', 'the', 'new', 'epidemic', 'warrants', 'immediate', 'intervention', 'The', 'intra', 'host', 'genomic', 'variability', 'of', 'SARS', 'CoV', '2', 'plays', 'a', 'pivotal', 'role', 'in', 'the', 'development', 'of', 'effective', 'antiviral', 'agents', 'and', 'vaccines', 'but', 'also', 'in', 'the', 'design', 'of', 'accurate', 'diagnostics', 'We', 'analyzed', 'NGS', 'data', 'derived', 'from', 'clinical', 'samples', 'of', 'three', 'Chinese', 'patients', 'infected', 'with', 'SARS', 'CoV', '2', 'in', 'order', 'to', 'identify', 'small', 'and', 'large', 'scale', 'intra', 'host', 'variations', 'in', 'the', 'viral', 'genome', 'We', 'identified', 'tens', 'of', 'low', 'or', 'higher', 'frequency', 'single', 'nucleotide', 'variations', 'SNVs', 'with', 'variable', 'density', 'across', 'the', 'viral', 'genome', 'affecting', '7', 'out', 'of', '10', 'protein', 'coding', 'viral', 'genes', 'The', 'majority', 'of', 'these', 'SNVs', 'corresponded', 'to', 'missense', 'changes', 'The', 'annotation', 'of', 'the', 'identified', 'SNVs', 'but', 'also', 'of', 'all', 'currently', 'circulating', 'strain', 'variations', 'revealed', 'colocalization', 'of', 'intra', 'host', 'but', 'also', 'strain', 'specific', 'SNVs', 'with', 'primers', 'and', 'probes', 'currently', 'used', 'in', 'molecular', 'diagnostics', 'assays', 'Moreover', 'we', 'de', 'novo', 'assembled', 'the', 'viral', 'genome', 'in', 'order', 'to', 'isolate', 'and', 'validate', 'intra', 'host', 'structural', 'variations', 'and', 'recombination', 'breakpoints', 'The', 'bioinformatics', 'analysis', 'disclosed', 'genomic', 'rearrangements', 'over', 'poly', 'A', 'poly', 'U', 'regions', 'located', 'in', 'ORF1ab', 'and', 'spike', 'S', 'gene', 'including', 'a', 'potential', 'recombination', 'hot', 'spot', 'within', 'S', 'gene', 'Our', 'results', 'highlight', 'the', 'intra', 'host', 'genomic', 'diversity', 'and', 'plasticity', 'of', 'SARS', 'CoV', '2', 'pointing', 'out', 'genomic', 'regions', 'that', 'are', 'prone', 'to', 'alterations', 'The', 'isolated', 'SNVs', 'and', 'genomic', 'rearrangements', 'reflect', 'the', 'intra', 'patient', 'capacity', 'of', 'the', 'polymorphic', 'quasispecies', 'which', 'may', 'arise', 'rapidly', 'during', 'the', 'outbreak', 'allowing', 'immunological', 'escape', 'of', 'the', 'virus', 'offering', 'resistance', 'to', 'anti', 'viral', 'drugs', 'and', 'affecting', 'the', 'sensitivity', 'of', 'the', 'molecular', 'diagnostics', 'assays', '']"
71965,Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in Colombia,2020-06-04,,http://medrxiv.org/cgi/content/short/2020.06.02.20120782v1?rss=1,"Introduction: SARS-CoV-2 is a new member of the genus Betacoronavirus, responsible for the COVID-19 pandemics. The virus crossed the species barrier and established in the human population due to its ability to exploit the ACE receptor for virus entry, which is present and abundant in several tissues, including the lung and respiratory tract, gastrointestinal tract and hearth. Virus interaction with the cellular receptor is mediated by the surface protein, known as Spike. Another structural protein of major importance in the Nucleocapsid, directly interacting with the viral RNA to form the ribonucleocapsid, considered a multifunctional protein, and being the target of the most molecular diagnostics assays. Objective: To describe the frequency of substitutions in spike and nucleocapsid proteins of SARS-CoV-2 circulating in Colombia and evaluate the frequency of these substitutions in SARS-CoV-2 sequences from other countries of South America. Materials and methods: Samples of 43 patients were included for viral RNA detection by real-time RT-PCR using the Charite-Berlin protocol for the amplification of the SARS-CoV-2 E and RdRp genes. Genome sequences were obtained through the Oxford Nanopore and Illumina MiSeq technologies, following the artic.network ""nCoV-2019 sequencing protocol"". Available genomes were consulted from GISAID, GenBank, and Genome sequence archive (GSA) and a total of 371 genomes sequences from South America were included. The genome sequences were aligned with the Muscle tool using the MEGA X software. Substitution matrices of the Colombian sequences respect to the reference genome (NC_045512) at the nucleotide and amino acid levels were generated for the spike and nucleocapsid gene. Results: substitution D614G in the amino acid sequence of spike protein was found in 86.7% of the Colombian sequences; substitutions G181V and D936Y in 2.3%, respectively. Five substitutions were found in the nucleocapsid protein, with substitution R203K and G204R being the most frequent (13.95 %) in Colombia. The substitutions D614G in Spike and R203K-G204R in nucleocapsid have a frequency of 83% and 28% respectively in sequences from South America. Conclusion: Non-synonymous substitutions were found in the spike and nucleocapsid proteins in Colombian genomes, the most frequent being D614G in Spike and R203K-G204R in nucleocapsid. These substitutions are frequent in the genomes reported for other South American countries. It is necessary to continue with genomic surveillance of the changes in Spike and Nucleocapsid proteins during the SARS-CoV-2 pandemic in Colombia and South America, even more considering that these proteins are the most commonly used antigen in serological tests.",10.1101/2020.06.02.20120782,zb034sbv,"['Introduction', 'SARS', 'CoV', '2', 'is', 'a', 'new', 'member', 'of', 'the', 'genus', 'Betacoronavirus', 'responsible', 'for', 'the', 'COVID', '19', 'pandemics', 'The', 'virus', 'crossed', 'the', 'species', 'barrier', 'and', 'established', 'in', 'the', 'human', 'population', 'due', 'to', 'its', 'ability', 'to', 'exploit', 'the', 'ACE', 'receptor', 'for', 'virus', 'entry', 'which', 'is', 'present', 'and', 'abundant', 'in', 'several', 'tissues', 'including', 'the', 'lung', 'and', 'respiratory', 'tract', 'gastrointestinal', 'tract', 'and', 'hearth', 'Virus', 'interaction', 'with', 'the', 'cellular', 'receptor', 'is', 'mediated', 'by', 'the', 'surface', 'protein', 'known', 'as', 'Spike', 'Another', 'structural', 'protein', 'of', 'major', 'importance', 'in', 'the', 'Nucleocapsid', 'directly', 'interacting', 'with', 'the', 'viral', 'RNA', 'to', 'form', 'the', 'ribonucleocapsid', 'considered', 'a', 'multifunctional', 'protein', 'and', 'being', 'the', 'target', 'of', 'the', 'most', 'molecular', 'diagnostics', 'assays', 'Objective', 'To', 'describe', 'the', 'frequency', 'of', 'substitutions', 'in', 'spike', 'and', 'nucleocapsid', 'proteins', 'of', 'SARS', 'CoV', '2', 'circulating', 'in', 'Colombia', 'and', 'evaluate', 'the', 'frequency', 'of', 'these', 'substitutions', 'in', 'SARS', 'CoV', '2', 'sequences', 'from', 'other', 'countries', 'of', 'South', 'America', 'Materials', 'and', 'methods', 'Samples', 'of', '43', 'patients', 'were', 'included', 'for', 'viral', 'RNA', 'detection', 'by', 'real', 'time', 'RT', 'PCR', 'using', 'the', 'Charite', 'Berlin', 'protocol', 'for', 'the', 'amplification', 'of', 'the', 'SARS', 'CoV', '2', 'E', 'and', 'RdRp', 'genes', 'Genome', 'sequences', 'were', 'obtained', 'through', 'the', 'Oxford', 'Nanopore', 'and', 'Illumina', 'MiSeq', 'technologies', 'following', 'the', 'artic', 'network', 'nCoV', '2019', 'sequencing', 'protocol', 'Available', 'genomes', 'were', 'consulted', 'from', 'GISAID', 'GenBank', 'and', 'Genome', 'sequence', 'archive', 'GSA', 'and', 'a', 'total', 'of', '371', 'genomes', 'sequences', 'from', 'South', 'America', 'were', 'included', 'The', 'genome', 'sequences', 'were', 'aligned', 'with', 'the', 'Muscle', 'tool', 'using', 'the', 'MEGA', 'X', 'software', 'Substitution', 'matrices', 'of', 'the', 'Colombian', 'sequences', 'respect', 'to', 'the', 'reference', 'genome', 'NC', '045512', 'at', 'the', 'nucleotide', 'and', 'amino', 'acid', 'levels', 'were', 'generated', 'for', 'the', 'spike', 'and', 'nucleocapsid', 'gene', 'Results', 'substitution', 'D614G', 'in', 'the', 'amino', 'acid', 'sequence', 'of', 'spike', 'protein', 'was', 'found', 'in', '86', '7', 'of', 'the', 'Colombian', 'sequences', 'substitutions', 'G181V', 'and', 'D936Y', 'in', '2', '3', 'respectively', 'Five', 'substitutions', 'were', 'found', 'in', 'the', 'nucleocapsid', 'protein', 'with', 'substitution', 'R203K', 'and', 'G204R', 'being', 'the', 'most', 'frequent', '13', '95', 'in', 'Colombia', 'The', 'substitutions', 'D614G', 'in', 'Spike', 'and', 'R203K', 'G204R', 'in', 'nucleocapsid', 'have', 'a', 'frequency', 'of', '83', 'and', '28', 'respectively', 'in', 'sequences', 'from', 'South', 'America', 'Conclusion', 'Non', 'synonymous', 'substitutions', 'were', 'found', 'in', 'the', 'spike', 'and', 'nucleocapsid', 'proteins', 'in', 'Colombian', 'genomes', 'the', 'most', 'frequent', 'being', 'D614G', 'in', 'Spike', 'and', 'R203K', 'G204R', 'in', 'nucleocapsid', 'These', 'substitutions', 'are', 'frequent', 'in', 'the', 'genomes', 'reported', 'for', 'other', 'South', 'American', 'countries', 'It', 'is', 'necessary', 'to', 'continue', 'with', 'genomic', 'surveillance', 'of', 'the', 'changes', 'in', 'Spike', 'and', 'Nucleocapsid', 'proteins', 'during', 'the', 'SARS', 'CoV', '2', 'pandemic', 'in', 'Colombia', 'and', 'South', 'America', 'even', 'more', 'considering', 'that', 'these', 'proteins', 'are', 'the', 'most', 'commonly', 'used', 'antigen', 'in', 'serological', 'tests', '']"
72341,"Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration",2020-05-05,,http://medrxiv.org/cgi/content/short/2020.04.29.20082099v1?rss=1,"In January, Mologic, embarked on a product development pathway for COVID-19 diagnostics focusing on ELISA and rapid diagnostic tests (RDTs), with anticipated funding from Wellcome Trust and DFID. 755 clinical samples from known COVID-19 patients and hospital negative controls were tested on Mologics IgG ELISA. The reported sensitivity on 191 SGUL prospectively enrolled patients was 95% on day 7 or more post diagnosis, and 97% 10 days or more post-diagnosis. A specificity panel comprising 564 samples pre-December 2019 were tested to include most common respiratory pathogens, other types of coronavirus, and flaviviruses. Specificity in this panel was 97%. This is the first in a series of Mologic products for COVID-19, which will be deployed for COVID-19 diagnosis, contact tracing and sero-epidemiological studies to estimate disease burden and transmission with a focus on ensuring access, affordability, and availability to lowest resource settings.",10.1101/2020.04.29.20082099,nol2n8fo,"['In', 'January', 'Mologic', 'embarked', 'on', 'a', 'product', 'development', 'pathway', 'for', 'COVID', '19', 'diagnostics', 'focusing', 'on', 'ELISA', 'and', 'rapid', 'diagnostic', 'tests', 'RDTs', 'with', 'anticipated', 'funding', 'from', 'Wellcome', 'Trust', 'and', 'DFID', '755', 'clinical', 'samples', 'from', 'known', 'COVID', '19', 'patients', 'and', 'hospital', 'negative', 'controls', 'were', 'tested', 'on', 'Mologics', 'IgG', 'ELISA', 'The', 'reported', 'sensitivity', 'on', '191', 'SGUL', 'prospectively', 'enrolled', 'patients', 'was', '95', 'on', 'day', '7', 'or', 'more', 'post', 'diagnosis', 'and', '97', '10', 'days', 'or', 'more', 'post', 'diagnosis', 'A', 'specificity', 'panel', 'comprising', '564', 'samples', 'pre', 'December', '2019', 'were', 'tested', 'to', 'include', 'most', 'common', 'respiratory', 'pathogens', 'other', 'types', 'of', 'coronavirus', 'and', 'flaviviruses', 'Specificity', 'in', 'this', 'panel', 'was', '97', 'This', 'is', 'the', 'first', 'in', 'a', 'series', 'of', 'Mologic', 'products', 'for', 'COVID', '19', 'which', 'will', 'be', 'deployed', 'for', 'COVID', '19', 'diagnosis', 'contact', 'tracing', 'and', 'sero', 'epidemiological', 'studies', 'to', 'estimate', 'disease', 'burden', 'and', 'transmission', 'with', 'a', 'focus', 'on', 'ensuring', 'access', 'affordability', 'and', 'availability', 'to', 'lowest', 'resource', 'settings', '']"
72823,Rapid implementation of SARS-CoV-2 emergency use authorization RT-PCR testing and experience at an academic medical institution,2020-06-08,,http://medrxiv.org/cgi/content/short/2020.06.05.20109637v1?rss=1,"An epidemic caused by an outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China in December 2019 has since rapidly spread internationally, requiring urgent response from the clinical diagnostics community. We present a detailed overview of the clinical validation and implementation of the first laboratory-developed real-time reverse-transcription-PCR (rRT-PCR) test offered in the NewYork-Presbyterian Hospital system following the emergency use authority (EUA) guidance issued by the US Food and Drug Administration. Validation was performed on nasopharyngeal and sputum specimens (n=124) using newly designed dual-target rRT-PCR (altona RealStar SARS-CoV-2 Reagent) for detecting of SARS-CoV-2 in upper respiratory and lower respiratory tract specimens, including bronchoalveolar lavage and tracheal aspirates. Accuracy testing demonstrated excellent assay agreement between expected and observed values. The limit of detection (LOD) was 2.7 and 23.0 gene copies/reaction for nasopharyngeal and sputum specimens, respectively. Retrospective analysis of 1,694 tests from 1,571 patients revealed increased positivity in older patients and males compared to females, and an increasing positivity rate from approximately 20% at the start of testing to 50% at the end of testing three weeks later. Our findings demonstrate that the assay accurately and sensitively identifies SARS-CoV-2 in multiple specimen types in the clinical setting and summarizes clinical data from early in the epidemic in New York City.",10.1101/2020.06.05.20109637,mb784dam,"['An', 'epidemic', 'caused', 'by', 'an', 'outbreak', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'in', 'China', 'in', 'December', '2019', 'has', 'since', 'rapidly', 'spread', 'internationally', 'requiring', 'urgent', 'response', 'from', 'the', 'clinical', 'diagnostics', 'community', 'We', 'present', 'a', 'detailed', 'overview', 'of', 'the', 'clinical', 'validation', 'and', 'implementation', 'of', 'the', 'first', 'laboratory', 'developed', 'real', 'time', 'reverse', 'transcription', 'PCR', 'rRT', 'PCR', 'test', 'offered', 'in', 'the', 'NewYork', 'Presbyterian', 'Hospital', 'system', 'following', 'the', 'emergency', 'use', 'authority', 'EUA', 'guidance', 'issued', 'by', 'the', 'US', 'Food', 'and', 'Drug', 'Administration', 'Validation', 'was', 'performed', 'on', 'nasopharyngeal', 'and', 'sputum', 'specimens', 'n', '124', 'using', 'newly', 'designed', 'dual', 'target', 'rRT', 'PCR', 'altona', 'RealStar', 'SARS', 'CoV', '2', 'Reagent', 'for', 'detecting', 'of', 'SARS', 'CoV', '2', 'in', 'upper', 'respiratory', 'and', 'lower', 'respiratory', 'tract', 'specimens', 'including', 'bronchoalveolar', 'lavage', 'and', 'tracheal', 'aspirates', 'Accuracy', 'testing', 'demonstrated', 'excellent', 'assay', 'agreement', 'between', 'expected', 'and', 'observed', 'values', 'The', 'limit', 'of', 'detection', 'LOD', 'was', '2', '7', 'and', '23', '0', 'gene', 'copies', 'reaction', 'for', 'nasopharyngeal', 'and', 'sputum', 'specimens', 'respectively', 'Retrospective', 'analysis', 'of', '1', '694', 'tests', 'from', '1', '571', 'patients', 'revealed', 'increased', 'positivity', 'in', 'older', 'patients', 'and', 'males', 'compared', 'to', 'females', 'and', 'an', 'increasing', 'positivity', 'rate', 'from', 'approximately', '20', 'at', 'the', 'start', 'of', 'testing', 'to', '50', 'at', 'the', 'end', 'of', 'testing', 'three', 'weeks', 'later', 'Our', 'findings', 'demonstrate', 'that', 'the', 'assay', 'accurately', 'and', 'sensitively', 'identifies', 'SARS', 'CoV', '2', 'in', 'multiple', 'specimen', 'types', 'in', 'the', 'clinical', 'setting', 'and', 'summarizes', 'clinical', 'data', 'from', 'early', 'in', 'the', 'epidemic', 'in', 'New', 'York', 'City', '']"
72984,A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19,2020,Cureus,https://doi.org/10.7759/cureus.7708,"Saliva is an exocrine secretion produced from the salivary glands and has numerous functions, such as cleansing and protection of the oral cavity, antimicrobial effects and aids in digestion Due to the speedy development in the field of salivaomics, saliva is now well accepted as a pool of biological markers that vary from changes in biochemicals, nucleic acids and proteins to the microflora Saliva has an immense potential as a diagnostic fluid and offers an edge over other biological fluids as its collection method does not require invasive procedure, economical and is useful for monitoring systemic health Development of sensitive and precise salivary diagnostic tools and the formulation of defined guidelines following meticulous testing will allow salivary diagnostics to be utilised as chair side tests for various oral and systemic diseases in the near future The coronavirus disease (Covid-19) pandemic is the biggest challenge and global health crisis for the world since World War Two Rapid and accurate diagnosis of Covid-19 is crucial in controlling the outbreak in the community and in hospitals Nasopharyngeal and oropharyngeal swabs are the recommended specimen types for Covid-19 diagnostic testing The collection of these specimen types requires close contact between healthcare workers and patients and poses a risk of transmission of the virus, causes discomfort and may cause bleeding, especially in patients with condition such as thrombocytopenia Hence, nasopharyngeal or oropharyngeal swabs are not desirable for sequential monitoring of viral load Saliva specimens can be obtained easily as the patient is asked to spit into a sterile bottle The collection of saliva is non-invasive and greatly minimizes the exposure of healthcare workers to Covid-19 Saliva has a high consistency rate of greater than 90% with nasopharyngeal specimens in the detection of respiratory viruses, including coronaviruses Saliva has also been used in screening respiratory viruses among hospitalized patients without pyrexia or respiratory symptoms SARS-CoV can be detected in saliva at high titers Salivary diagnostics is a dynamic field that is being incorporated as part of disease diagnosis, clinical monitoring of systemic health and to make significant clinical decisions for patient care More research is required to analyze the potential diagnostic of Covid-19 in saliva to develop rapid chair side tests for the detection of Covid-19 and it is also pivotal to improve and develop successful strategies for prevention, especially for dentists and healthcare professionals who are involved in performing aerosol-generating procedures",10.7759/cureus.7708,awy3aans,"['Saliva', 'is', 'an', 'exocrine', 'secretion', 'produced', 'from', 'the', 'salivary', 'glands', 'and', 'has', 'numerous', 'functions', 'such', 'as', 'cleansing', 'and', 'protection', 'of', 'the', 'oral', 'cavity', 'antimicrobial', 'effects', 'and', 'aids', 'in', 'digestion', 'Due', 'to', 'the', 'speedy', 'development', 'in', 'the', 'field', 'of', 'salivaomics', 'saliva', 'is', 'now', 'well', 'accepted', 'as', 'a', 'pool', 'of', 'biological', 'markers', 'that', 'vary', 'from', 'changes', 'in', 'biochemicals', 'nucleic', 'acids', 'and', 'proteins', 'to', 'the', 'microflora', 'Saliva', 'has', 'an', 'immense', 'potential', 'as', 'a', 'diagnostic', 'fluid', 'and', 'offers', 'an', 'edge', 'over', 'other', 'biological', 'fluids', 'as', 'its', 'collection', 'method', 'does', 'not', 'require', 'invasive', 'procedure', 'economical', 'and', 'is', 'useful', 'for', 'monitoring', 'systemic', 'health', 'Development', 'of', 'sensitive', 'and', 'precise', 'salivary', 'diagnostic', 'tools', 'and', 'the', 'formulation', 'of', 'defined', 'guidelines', 'following', 'meticulous', 'testing', 'will', 'allow', 'salivary', 'diagnostics', 'to', 'be', 'utilised', 'as', 'chair', 'side', 'tests', 'for', 'various', 'oral', 'and', 'systemic', 'diseases', 'in', 'the', 'near', 'future', 'The', 'coronavirus', 'disease', 'Covid', '19', 'pandemic', 'is', 'the', 'biggest', 'challenge', 'and', 'global', 'health', 'crisis', 'for', 'the', 'world', 'since', 'World', 'War', 'Two', 'Rapid', 'and', 'accurate', 'diagnosis', 'of', 'Covid', '19', 'is', 'crucial', 'in', 'controlling', 'the', 'outbreak', 'in', 'the', 'community', 'and', 'in', 'hospitals', 'Nasopharyngeal', 'and', 'oropharyngeal', 'swabs', 'are', 'the', 'recommended', 'specimen', 'types', 'for', 'Covid', '19', 'diagnostic', 'testing', 'The', 'collection', 'of', 'these', 'specimen', 'types', 'requires', 'close', 'contact', 'between', 'healthcare', 'workers', 'and', 'patients', 'and', 'poses', 'a', 'risk', 'of', 'transmission', 'of', 'the', 'virus', 'causes', 'discomfort', 'and', 'may', 'cause', 'bleeding', 'especially', 'in', 'patients', 'with', 'condition', 'such', 'as', 'thrombocytopenia', 'Hence', 'nasopharyngeal', 'or', 'oropharyngeal', 'swabs', 'are', 'not', 'desirable', 'for', 'sequential', 'monitoring', 'of', 'viral', 'load', 'Saliva', 'specimens', 'can', 'be', 'obtained', 'easily', 'as', 'the', 'patient', 'is', 'asked', 'to', 'spit', 'into', 'a', 'sterile', 'bottle', 'The', 'collection', 'of', 'saliva', 'is', 'non', 'invasive', 'and', 'greatly', 'minimizes', 'the', 'exposure', 'of', 'healthcare', 'workers', 'to', 'Covid', '19', 'Saliva', 'has', 'a', 'high', 'consistency', 'rate', 'of', 'greater', 'than', '90', 'with', 'nasopharyngeal', 'specimens', 'in', 'the', 'detection', 'of', 'respiratory', 'viruses', 'including', 'coronaviruses', 'Saliva', 'has', 'also', 'been', 'used', 'in', 'screening', 'respiratory', 'viruses', 'among', 'hospitalized', 'patients', 'without', 'pyrexia', 'or', 'respiratory', 'symptoms', 'SARS', 'CoV', 'can', 'be', 'detected', 'in', 'saliva', 'at', 'high', 'titers', 'Salivary', 'diagnostics', 'is', 'a', 'dynamic', 'field', 'that', 'is', 'being', 'incorporated', 'as', 'part', 'of', 'disease', 'diagnosis', 'clinical', 'monitoring', 'of', 'systemic', 'health', 'and', 'to', 'make', 'significant', 'clinical', 'decisions', 'for', 'patient', 'care', 'More', 'research', 'is', 'required', 'to', 'analyze', 'the', 'potential', 'diagnostic', 'of', 'Covid', '19', 'in', 'saliva', 'to', 'develop', 'rapid', 'chair', 'side', 'tests', 'for', 'the', 'detection', 'of', 'Covid', '19', 'and', 'it', 'is', 'also', 'pivotal', 'to', 'improve', 'and', 'develop', 'successful', 'strategies', 'for', 'prevention', 'especially', 'for', 'dentists', 'and', 'healthcare', 'professionals', 'who', 'are', 'involved', 'in', 'performing', 'aerosol', 'generating', 'procedures']"
73021,The UCSC SARS-CoV-2 Genome Browser,2020-05-04,bioRxiv,https://doi.org/10.1101/2020.05.04.075945,"Background Researchers are generating molecular data pertaining to the SARS-CoV-2 RNA genome and its proteins at an unprecedented rate during the COVID-19 pandemic. As a result, there is a critical need for rapid and continuously updated access to the latest molecular data in a format in which all data can be quickly cross-referenced and compared. We adapted our genome browser visualization tool to the viral genome for this purpose. Molecular data, curated from published studies or from database submissions, are mapped to the viral genome and grouped together into “annotation tracks” where they can be visualized along the linear map of the viral genome sequence and programmatically downloaded in standard format for analysis. Results The UCSC Genome Browser for SARS-CoV-2 (https://genome.ucsc.edu/covid19.html) provides continuously updated access to the mutations in the many thousands of SARS-CoV-2 genomes deposited in GISAID and the international nucleotide sequencing databases, displayed alongside phylogenetic trees. These data are augmented with alignments of bat, pangolin, and other animal and human coronavirus genomes, including per-base evolutionary rate analysis. All available annotations are cross-referenced on the virus genome, including those from major databases (PDB, RFAM, IEDB, UniProt) as well as up-to-date individual results from preprints. Annotated data include predicted and validated immune epitopes, promising antibodies, RT-PCR and sequencing primers, CRISPR guides (from research, diagnostics, vaccines, and therapies), and points of interaction between human and viral genes. As a community resource, any user can add manual annotations which are quality checked and shared publicly on the browser the next day. Conclusions We invite all investigators to contribute additional data and annotations to this resource to accelerate research and development activities globally. Contact us at genome-www@soe.ucsc.edu with data suggestions or requests for support for adding data. Rapid sharing of data will accelerate SARS-CoV-2 research, especially when researchers take time to integrate their data with those from other labs on a widely-used community browser platform with standardized machine-readable data formats, such as the SARS-CoV-2 Genome Browser.",10.1101/2020.05.04.075945,gmk4qo4i,"['Background', 'Researchers', 'are', 'generating', 'molecular', 'data', 'pertaining', 'to', 'the', 'SARS', 'CoV', '2', 'RNA', 'genome', 'and', 'its', 'proteins', 'at', 'an', 'unprecedented', 'rate', 'during', 'the', 'COVID', '19', 'pandemic', 'As', 'a', 'result', 'there', 'is', 'a', 'critical', 'need', 'for', 'rapid', 'and', 'continuously', 'updated', 'access', 'to', 'the', 'latest', 'molecular', 'data', 'in', 'a', 'format', 'in', 'which', 'all', 'data', 'can', 'be', 'quickly', 'cross', 'referenced', 'and', 'compared', 'We', 'adapted', 'our', 'genome', 'browser', 'visualization', 'tool', 'to', 'the', 'viral', 'genome', 'for', 'this', 'purpose', 'Molecular', 'data', 'curated', 'from', 'published', 'studies', 'or', 'from', 'database', 'submissions', 'are', 'mapped', 'to', 'the', 'viral', 'genome', 'and', 'grouped', 'together', 'into', 'annotation', 'tracks', 'where', 'they', 'can', 'be', 'visualized', 'along', 'the', 'linear', 'map', 'of', 'the', 'viral', 'genome', 'sequence', 'and', 'programmatically', 'downloaded', 'in', 'standard', 'format', 'for', 'analysis', 'Results', 'The', 'UCSC', 'Genome', 'Browser', 'for', 'SARS', 'CoV', '2', 'https', 'genome', 'ucsc', 'edu', 'covid19', 'html', 'provides', 'continuously', 'updated', 'access', 'to', 'the', 'mutations', 'in', 'the', 'many', 'thousands', 'of', 'SARS', 'CoV', '2', 'genomes', 'deposited', 'in', 'GISAID', 'and', 'the', 'international', 'nucleotide', 'sequencing', 'databases', 'displayed', 'alongside', 'phylogenetic', 'trees', 'These', 'data', 'are', 'augmented', 'with', 'alignments', 'of', 'bat', 'pangolin', 'and', 'other', 'animal', 'and', 'human', 'coronavirus', 'genomes', 'including', 'per', 'base', 'evolutionary', 'rate', 'analysis', 'All', 'available', 'annotations', 'are', 'cross', 'referenced', 'on', 'the', 'virus', 'genome', 'including', 'those', 'from', 'major', 'databases', 'PDB', 'RFAM', 'IEDB', 'UniProt', 'as', 'well', 'as', 'up', 'to', 'date', 'individual', 'results', 'from', 'preprints', 'Annotated', 'data', 'include', 'predicted', 'and', 'validated', 'immune', 'epitopes', 'promising', 'antibodies', 'RT', 'PCR', 'and', 'sequencing', 'primers', 'CRISPR', 'guides', 'from', 'research', 'diagnostics', 'vaccines', 'and', 'therapies', 'and', 'points', 'of', 'interaction', 'between', 'human', 'and', 'viral', 'genes', 'As', 'a', 'community', 'resource', 'any', 'user', 'can', 'add', 'manual', 'annotations', 'which', 'are', 'quality', 'checked', 'and', 'shared', 'publicly', 'on', 'the', 'browser', 'the', 'next', 'day', 'Conclusions', 'We', 'invite', 'all', 'investigators', 'to', 'contribute', 'additional', 'data', 'and', 'annotations', 'to', 'this', 'resource', 'to', 'accelerate', 'research', 'and', 'development', 'activities', 'globally', 'Contact', 'us', 'at', 'genome', 'www', 'soe', 'ucsc', 'edu', 'with', 'data', 'suggestions', 'or', 'requests', 'for', 'support', 'for', 'adding', 'data', 'Rapid', 'sharing', 'of', 'data', 'will', 'accelerate', 'SARS', 'CoV', '2', 'research', 'especially', 'when', 'researchers', 'take', 'time', 'to', 'integrate', 'their', 'data', 'with', 'those', 'from', 'other', 'labs', 'on', 'a', 'widely', 'used', 'community', 'browser', 'platform', 'with', 'standardized', 'machine', 'readable', 'data', 'formats', 'such', 'as', 'the', 'SARS', 'CoV', '2', 'Genome', 'Browser', '']"
73070,Diagnostic accuracy of six commercial SARS-CoV-2 IgG/total antibody assays and identification of SARS-CoV-2 neutralizing antibodies in convalescent sera,2020-06-17,,http://medrxiv.org/cgi/content/short/2020.06.15.20131672v1?rss=1,"The reliable detection of immunoglobulin G (IgG) or total antibodies directed against the novel severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is important for clinical diagnostics and epidemiological studies. Here, we compare the diagnostic accuracy of six commercially available SARS-CoV-2 IgG (Abbott SARS-CoV-2 IgG; Diasorin Liaison SARS-CoV-2 S1/2 IgG; Epitope EDI Novel Coronavirus COVID-19 IgG ELISA Kit; Euroimmun Anti-SARS-CoV-2 ELISA (IgG); Mikrogen recomWell SARS-CoV-2 IgG) or total SARS-CoV-2 antibody assays (Roche Elecsys Anti-SARS-CoV-2). The test sensitivities were analyzed with a set of 34 sera obtained from 26 patients after PCR-confirmed SARS-CoV-2 infection and varied from 76.9% (Euroimmun) to 96.2% (Abbott). The majority of assay results were confirmed in a laboratory-developed plaque reduction neutralization test and by a SARS-CoV-2 IgG-specific line assay including measurement of generally low IgG avidities (Mikrogen recomLine Coronavirus IgG [Aviditaet], prototype). Moreover, 100 stored sera collected during summer 2018 (N = 50) and winter season 2018/2019 (N = 50) were included to demonstrate test specificities. These varied from 96.0% (DiaSorin) to 100% (Epitope EDI). A subset of sera were retested with a lateral flow test (STANDARD Q COVID-19 IgM/IgG Duo) and a considerably lower sensitivity was noted. Overall, the diagnostic accuracy of the six SARS-CoV-2 IgG/total antibody assays was good and varied from 92.9% (Euroimmun) to 98.4% (Abbott). Due to the different specificities, results of commercially available SARS-CoV-2 antibody tests should be interpreted with caution. A high proportion of antibody-positive patient sera demonstrated neutralizing capacity against SARS-CoV-2.",10.1101/2020.06.15.20131672,tbr2ynx0,"['The', 'reliable', 'detection', 'of', 'immunoglobulin', 'G', 'IgG', 'or', 'total', 'antibodies', 'directed', 'against', 'the', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'type', '2', 'SARS', 'CoV', '2', 'is', 'important', 'for', 'clinical', 'diagnostics', 'and', 'epidemiological', 'studies', 'Here', 'we', 'compare', 'the', 'diagnostic', 'accuracy', 'of', 'six', 'commercially', 'available', 'SARS', 'CoV', '2', 'IgG', 'Abbott', 'SARS', 'CoV', '2', 'IgG', 'Diasorin', 'Liaison', 'SARS', 'CoV', '2', 'S1', '2', 'IgG', 'Epitope', 'EDI', 'Novel', 'Coronavirus', 'COVID', '19', 'IgG', 'ELISA', 'Kit', 'Euroimmun', 'Anti', 'SARS', 'CoV', '2', 'ELISA', 'IgG', 'Mikrogen', 'recomWell', 'SARS', 'CoV', '2', 'IgG', 'or', 'total', 'SARS', 'CoV', '2', 'antibody', 'assays', 'Roche', 'Elecsys', 'Anti', 'SARS', 'CoV', '2', 'The', 'test', 'sensitivities', 'were', 'analyzed', 'with', 'a', 'set', 'of', '34', 'sera', 'obtained', 'from', '26', 'patients', 'after', 'PCR', 'confirmed', 'SARS', 'CoV', '2', 'infection', 'and', 'varied', 'from', '76', '9', 'Euroimmun', 'to', '96', '2', 'Abbott', 'The', 'majority', 'of', 'assay', 'results', 'were', 'confirmed', 'in', 'a', 'laboratory', 'developed', 'plaque', 'reduction', 'neutralization', 'test', 'and', 'by', 'a', 'SARS', 'CoV', '2', 'IgG', 'specific', 'line', 'assay', 'including', 'measurement', 'of', 'generally', 'low', 'IgG', 'avidities', 'Mikrogen', 'recomLine', 'Coronavirus', 'IgG', 'Aviditaet', 'prototype', 'Moreover', '100', 'stored', 'sera', 'collected', 'during', 'summer', '2018', 'N', '50', 'and', 'winter', 'season', '2018', '2019', 'N', '50', 'were', 'included', 'to', 'demonstrate', 'test', 'specificities', 'These', 'varied', 'from', '96', '0', 'DiaSorin', 'to', '100', 'Epitope', 'EDI', 'A', 'subset', 'of', 'sera', 'were', 'retested', 'with', 'a', 'lateral', 'flow', 'test', 'STANDARD', 'Q', 'COVID', '19', 'IgM', 'IgG', 'Duo', 'and', 'a', 'considerably', 'lower', 'sensitivity', 'was', 'noted', 'Overall', 'the', 'diagnostic', 'accuracy', 'of', 'the', 'six', 'SARS', 'CoV', '2', 'IgG', 'total', 'antibody', 'assays', 'was', 'good', 'and', 'varied', 'from', '92', '9', 'Euroimmun', 'to', '98', '4', 'Abbott', 'Due', 'to', 'the', 'different', 'specificities', 'results', 'of', 'commercially', 'available', 'SARS', 'CoV', '2', 'antibody', 'tests', 'should', 'be', 'interpreted', 'with', 'caution', 'A', 'high', 'proportion', 'of', 'antibody', 'positive', 'patient', 'sera', 'demonstrated', 'neutralizing', 'capacity', 'against', 'SARS', 'CoV', '2', '']"
73566,Guillain Barr e syndrome in COVID-19:A scoping review,2020-06-16,,http://medrxiv.org/cgi/content/short/2020.06.13.20130062v1?rss=1,"Introduction The novel coronavirus (COVID19) can result in several neurological complications. Guillain-Barre Syndrome (GBS) is one of them and has been reported from different parts of the world in this pandemic. It is an acute post-infectious polyneuropathy. The review aims to summarize the demographic features, clinical presentation, diagnostics workup, and management strategies of COVID-19 associated GBS reported in the literature. Material and method We searched Medline, PubMed Central, SCOPUS, and Google Scholar using pre-defined keywords, with no time limits and in the English language only. We aimed to include all kinds of manuscripts. The last search was done on 18th May 2020. Demographics, clinical features, diagnostic workup, management, and outcomes were documented in the datasheet. Results We identified 24 cases of COVID-19 associated GBS. Most of the cases were reported from Italy followed by the USA. The majority were males (18 /24) The age ranged from 23 -84 years. The clinical presentation was typical sensory-motor GBS in most. Nine patients had facial palsy of which five had bilateral involvement. Two patients had bilateral abducent nerve palsy while two presented as paraparetic GBS variant with autonomic dysfunction. Electrodiagnostics was performed in 17 patients only and 12 had typical features of acute inflammatory demyelinating polyneuropathy. Intravenous immunoglobulins were the preferred mode of treatment in most of the patient. There was one death, and most were discharged to rehabilitation or home. Conclusion GBS is a frequent neurological complication associated with COVID-19. There is no clear causative relationship between GBS, and COVID-19 at present, and more data are needed to establish the casualty. However, most cases have a post-infectious onset with male preponderance. Most of the cases have a typical presentation but some may present in an atypical way. Prognosis is generally good.",10.1101/2020.06.13.20130062,oc2pb00b,"['Introduction', 'The', 'novel', 'coronavirus', 'COVID19', 'can', 'result', 'in', 'several', 'neurological', 'complications', 'Guillain', 'Barre', 'Syndrome', 'GBS', 'is', 'one', 'of', 'them', 'and', 'has', 'been', 'reported', 'from', 'different', 'parts', 'of', 'the', 'world', 'in', 'this', 'pandemic', 'It', 'is', 'an', 'acute', 'post', 'infectious', 'polyneuropathy', 'The', 'review', 'aims', 'to', 'summarize', 'the', 'demographic', 'features', 'clinical', 'presentation', 'diagnostics', 'workup', 'and', 'management', 'strategies', 'of', 'COVID', '19', 'associated', 'GBS', 'reported', 'in', 'the', 'literature', 'Material', 'and', 'method', 'We', 'searched', 'Medline', 'PubMed', 'Central', 'SCOPUS', 'and', 'Google', 'Scholar', 'using', 'pre', 'defined', 'keywords', 'with', 'no', 'time', 'limits', 'and', 'in', 'the', 'English', 'language', 'only', 'We', 'aimed', 'to', 'include', 'all', 'kinds', 'of', 'manuscripts', 'The', 'last', 'search', 'was', 'done', 'on', '18th', 'May', '2020', 'Demographics', 'clinical', 'features', 'diagnostic', 'workup', 'management', 'and', 'outcomes', 'were', 'documented', 'in', 'the', 'datasheet', 'Results', 'We', 'identified', '24', 'cases', 'of', 'COVID', '19', 'associated', 'GBS', 'Most', 'of', 'the', 'cases', 'were', 'reported', 'from', 'Italy', 'followed', 'by', 'the', 'USA', 'The', 'majority', 'were', 'males', '18', '24', 'The', 'age', 'ranged', 'from', '23', '84', 'years', 'The', 'clinical', 'presentation', 'was', 'typical', 'sensory', 'motor', 'GBS', 'in', 'most', 'Nine', 'patients', 'had', 'facial', 'palsy', 'of', 'which', 'five', 'had', 'bilateral', 'involvement', 'Two', 'patients', 'had', 'bilateral', 'abducent', 'nerve', 'palsy', 'while', 'two', 'presented', 'as', 'paraparetic', 'GBS', 'variant', 'with', 'autonomic', 'dysfunction', 'Electrodiagnostics', 'was', 'performed', 'in', '17', 'patients', 'only', 'and', '12', 'had', 'typical', 'features', 'of', 'acute', 'inflammatory', 'demyelinating', 'polyneuropathy', 'Intravenous', 'immunoglobulins', 'were', 'the', 'preferred', 'mode', 'of', 'treatment', 'in', 'most', 'of', 'the', 'patient', 'There', 'was', 'one', 'death', 'and', 'most', 'were', 'discharged', 'to', 'rehabilitation', 'or', 'home', 'Conclusion', 'GBS', 'is', 'a', 'frequent', 'neurological', 'complication', 'associated', 'with', 'COVID', '19', 'There', 'is', 'no', 'clear', 'causative', 'relationship', 'between', 'GBS', 'and', 'COVID', '19', 'at', 'present', 'and', 'more', 'data', 'are', 'needed', 'to', 'establish', 'the', 'casualty', 'However', 'most', 'cases', 'have', 'a', 'post', 'infectious', 'onset', 'with', 'male', 'preponderance', 'Most', 'of', 'the', 'cases', 'have', 'a', 'typical', 'presentation', 'but', 'some', 'may', 'present', 'in', 'an', 'atypical', 'way', 'Prognosis', 'is', 'generally', 'good', '']"
74114,Failure of the cobas(R) SARS-CoV-2 (Roche) E-gene assay is associated with a C-to-T transition at position 26340 of the SARS-CoV-2 genome,2020-05-03,,http://medrxiv.org/cgi/content/short/2020.04.28.20083337v1?rss=1,"Control of the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic requires accurate laboratory testing to identify infected individuals, while also clearing essential staff to continue work. At the current time a number of RT-PCR tests have been developed to identify SARS-CoV-2, targeting multiple regions in the viral genome. In comparison to other RNA viruses the mutation rate of SARS-CoV-2 is moderate, however given the large number of transmission chains it is prudent to monitor circulating viruses for mutations that might compromise these tests. Here we report the identification of a C-to-T transition at position 26340 of the SARS-CoV-2 genome which is associated with failure of the cobas(R) SARS-CoV-2 E-gene assay. This variant was detected in four health care workers from the same team. Whole genome sequencing of SARS-CoV-2 showed all four to carry genetically identical viruses. Examination of viral genomes deposited on GISAID showed this mutation has arisen independently on three occasions. This work highlights the necessity of monitoring SARS-CoV-2 for the emergence of SNPs which might adversely affect the RT-PCRs used in diagnostics. Additionally, it argues that two regions in the SARS-CoV-2 should be targeted in RT-PCRs to avoid false negatives.",10.1101/2020.04.28.20083337,vd62r8qu,"['Control', 'of', 'the', 'ongoing', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'pandemic', 'requires', 'accurate', 'laboratory', 'testing', 'to', 'identify', 'infected', 'individuals', 'while', 'also', 'clearing', 'essential', 'staff', 'to', 'continue', 'work', 'At', 'the', 'current', 'time', 'a', 'number', 'of', 'RT', 'PCR', 'tests', 'have', 'been', 'developed', 'to', 'identify', 'SARS', 'CoV', '2', 'targeting', 'multiple', 'regions', 'in', 'the', 'viral', 'genome', 'In', 'comparison', 'to', 'other', 'RNA', 'viruses', 'the', 'mutation', 'rate', 'of', 'SARS', 'CoV', '2', 'is', 'moderate', 'however', 'given', 'the', 'large', 'number', 'of', 'transmission', 'chains', 'it', 'is', 'prudent', 'to', 'monitor', 'circulating', 'viruses', 'for', 'mutations', 'that', 'might', 'compromise', 'these', 'tests', 'Here', 'we', 'report', 'the', 'identification', 'of', 'a', 'C', 'to', 'T', 'transition', 'at', 'position', '26340', 'of', 'the', 'SARS', 'CoV', '2', 'genome', 'which', 'is', 'associated', 'with', 'failure', 'of', 'the', 'cobas', 'R', 'SARS', 'CoV', '2', 'E', 'gene', 'assay', 'This', 'variant', 'was', 'detected', 'in', 'four', 'health', 'care', 'workers', 'from', 'the', 'same', 'team', 'Whole', 'genome', 'sequencing', 'of', 'SARS', 'CoV', '2', 'showed', 'all', 'four', 'to', 'carry', 'genetically', 'identical', 'viruses', 'Examination', 'of', 'viral', 'genomes', 'deposited', 'on', 'GISAID', 'showed', 'this', 'mutation', 'has', 'arisen', 'independently', 'on', 'three', 'occasions', 'This', 'work', 'highlights', 'the', 'necessity', 'of', 'monitoring', 'SARS', 'CoV', '2', 'for', 'the', 'emergence', 'of', 'SNPs', 'which', 'might', 'adversely', 'affect', 'the', 'RT', 'PCRs', 'used', 'in', 'diagnostics', 'Additionally', 'it', 'argues', 'that', 'two', 'regions', 'in', 'the', 'SARS', 'CoV', '2', 'should', 'be', 'targeted', 'in', 'RT', 'PCRs', 'to', 'avoid', 'false', 'negatives', '']"
74274,Optimized qRT-PCR approach for the detection of intra- and extra-cellular SARS-CoV-2 RNAs,2020-04-25,bioRxiv,https://doi.org/10.1101/2020.04.20.052258,"The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19 which has become a global concern due to its rapid spread. Meanwhile, increased demand in testing has led to shortage of reagents, supplies, and compromised the performance of diagnostic laboratories in many countries. Both the world health organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate interpretation of the test results especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in the diagnostics as well as in research labs using a low cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infection and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.",10.1101/2020.04.20.052258,t9jaspf2,"['The', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'is', 'the', 'causative', 'agent', 'of', 'the', 'acute', 'respiratory', 'disease', 'COVID', '19', 'which', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'its', 'rapid', 'spread', 'Meanwhile', 'increased', 'demand', 'in', 'testing', 'has', 'led', 'to', 'shortage', 'of', 'reagents', 'supplies', 'and', 'compromised', 'the', 'performance', 'of', 'diagnostic', 'laboratories', 'in', 'many', 'countries', 'Both', 'the', 'world', 'health', 'organization', 'WHO', 'and', 'the', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommend', 'multi', 'step', 'RT', 'PCR', 'assays', 'using', 'multiple', 'primer', 'and', 'probe', 'pairs', 'which', 'might', 'complicate', 'interpretation', 'of', 'the', 'test', 'results', 'especially', 'for', 'borderline', 'cases', 'In', 'this', 'study', 'we', 'describe', 'an', 'alternative', 'RT', 'PCR', 'approach', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'that', 'can', 'be', 'used', 'for', 'the', 'probe', 'based', 'detection', 'of', 'clinical', 'isolates', 'in', 'the', 'diagnostics', 'as', 'well', 'as', 'in', 'research', 'labs', 'using', 'a', 'low', 'cost', 'SYBR', 'green', 'method', 'For', 'the', 'evaluation', 'we', 'used', 'samples', 'from', 'patients', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infection', 'and', 'performed', 'RT', 'PCR', 'assays', 'along', 'with', 'successive', 'dilutions', 'of', 'RNA', 'standards', 'to', 'determine', 'the', 'limit', 'of', 'detection', 'We', 'identified', 'an', 'M', 'gene', 'binding', 'primer', 'and', 'probe', 'pair', 'highly', 'suitable', 'for', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'for', 'diagnostic', 'and', 'research', 'purposes', '']"
74556,A Highly Scalable and Rapidly Deployable RNA Extraction-Free COVID-19 Assay by Quantitative Sanger Sequencing,2020-04-10,bioRxiv,https://doi.org/10.1101/2020.04.07.029199,"There is currently an urgent unmet need to increase coronavirus disease 2019 (COVID-19) testing capability to effectively respond to the COVID-19 pandemic. However, the current shortage in RNA extraction reagents as well as limitations in qPCR protocols have resulted in bottlenecks in testing capacity. Herein, we describe a novel molecular diagnostic for COVID-19 based on Sanger sequencing. This assay uses the addition of a frame-shifted spike-in, a modified PCR master mix, and custom Sanger sequencing data analysis to detect and quantify SARS-CoV-2 RNA at a limit of detection comparable to existing qPCR-based assays, at 10-20 genome copy equivalents. Crucially, our assay was able to detect SARS-CoV-2 RNA from viral particles suspended in transport media that was directly added to the PCR master mix, suggesting that RNA extraction can be skipped entirely without any degradation of test performance. Since Sanger sequencing instruments are widespread in clinical laboratories and commonly have built-in liquid handling automation to support up to 3840 samples per instrument per day, the widespread adoption of qSanger COVID-19 diagnostics can unlock more than 1,000,000 tests per day in the US.",10.1101/2020.04.07.029199,eui41zyg,"['There', 'is', 'currently', 'an', 'urgent', 'unmet', 'need', 'to', 'increase', 'coronavirus', 'disease', '2019', 'COVID', '19', 'testing', 'capability', 'to', 'effectively', 'respond', 'to', 'the', 'COVID', '19', 'pandemic', 'However', 'the', 'current', 'shortage', 'in', 'RNA', 'extraction', 'reagents', 'as', 'well', 'as', 'limitations', 'in', 'qPCR', 'protocols', 'have', 'resulted', 'in', 'bottlenecks', 'in', 'testing', 'capacity', 'Herein', 'we', 'describe', 'a', 'novel', 'molecular', 'diagnostic', 'for', 'COVID', '19', 'based', 'on', 'Sanger', 'sequencing', 'This', 'assay', 'uses', 'the', 'addition', 'of', 'a', 'frame', 'shifted', 'spike', 'in', 'a', 'modified', 'PCR', 'master', 'mix', 'and', 'custom', 'Sanger', 'sequencing', 'data', 'analysis', 'to', 'detect', 'and', 'quantify', 'SARS', 'CoV', '2', 'RNA', 'at', 'a', 'limit', 'of', 'detection', 'comparable', 'to', 'existing', 'qPCR', 'based', 'assays', 'at', '10', '20', 'genome', 'copy', 'equivalents', 'Crucially', 'our', 'assay', 'was', 'able', 'to', 'detect', 'SARS', 'CoV', '2', 'RNA', 'from', 'viral', 'particles', 'suspended', 'in', 'transport', 'media', 'that', 'was', 'directly', 'added', 'to', 'the', 'PCR', 'master', 'mix', 'suggesting', 'that', 'RNA', 'extraction', 'can', 'be', 'skipped', 'entirely', 'without', 'any', 'degradation', 'of', 'test', 'performance', 'Since', 'Sanger', 'sequencing', 'instruments', 'are', 'widespread', 'in', 'clinical', 'laboratories', 'and', 'commonly', 'have', 'built', 'in', 'liquid', 'handling', 'automation', 'to', 'support', 'up', 'to', '3840', 'samples', 'per', 'instrument', 'per', 'day', 'the', 'widespread', 'adoption', 'of', 'qSanger', 'COVID', '19', 'diagnostics', 'can', 'unlock', 'more', 'than', '1', '000', '000', 'tests', 'per', 'day', 'in', 'the', 'US', '']"
74792,Development and Evaluation of A CRISPR-based Diagnostic For 2019-novel Coronavirus,2020-02-23,,https://doi.org/10.1101/2020.02.22.20025460,"Background: The recent outbreak of infections by the 2019 novel coronavirus (2019-nCoV), the third zoonotic CoV has raised great public health concern. The demand for rapid and accurate diagnosis of this novel pathogen brought significant clinical and technological challenges. Currently, metagenomic next-generation sequencing (mNGS) and reverse-transcription PCR (RT-PCR) are the most widely used molecular diagnostics. Methods: 2019-nCoV infections were confirmed in 52 specimens by mNGS. Genomic information was analyzed and used for the design and development of an isothermal, CRISPR-based diagnostic for this novel virus. The diagnostic performance of CRISPR-nCoV was assessed and compared across three technology platforms (mNGS, RT-PCR and CRISPR). Results: 2019-nCoVs sequenced in our study were conserved with the Wuhan strain, and shared certain genetic similarity with SARS-CoV. A high degree of variation in the level of viral RNA was observed in clinical specimens. CRISPR-nCoV demonstrated a near single-copy sensitivity and great clinical sensitivity with a shorter turn-around time than RT-PCR. Conclusion: CRISPR-nCoV presents as a promising diagnostic option for the emerging pathogen.",10.1101/2020.02.22.20025460,hth8f5sn,"['Background', 'The', 'recent', 'outbreak', 'of', 'infections', 'by', 'the', '2019', 'novel', 'coronavirus', '2019', 'nCoV', 'the', 'third', 'zoonotic', 'CoV', 'has', 'raised', 'great', 'public', 'health', 'concern', 'The', 'demand', 'for', 'rapid', 'and', 'accurate', 'diagnosis', 'of', 'this', 'novel', 'pathogen', 'brought', 'significant', 'clinical', 'and', 'technological', 'challenges', 'Currently', 'metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'and', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'are', 'the', 'most', 'widely', 'used', 'molecular', 'diagnostics', 'Methods', '2019', 'nCoV', 'infections', 'were', 'confirmed', 'in', '52', 'specimens', 'by', 'mNGS', 'Genomic', 'information', 'was', 'analyzed', 'and', 'used', 'for', 'the', 'design', 'and', 'development', 'of', 'an', 'isothermal', 'CRISPR', 'based', 'diagnostic', 'for', 'this', 'novel', 'virus', 'The', 'diagnostic', 'performance', 'of', 'CRISPR', 'nCoV', 'was', 'assessed', 'and', 'compared', 'across', 'three', 'technology', 'platforms', 'mNGS', 'RT', 'PCR', 'and', 'CRISPR', 'Results', '2019', 'nCoVs', 'sequenced', 'in', 'our', 'study', 'were', 'conserved', 'with', 'the', 'Wuhan', 'strain', 'and', 'shared', 'certain', 'genetic', 'similarity', 'with', 'SARS', 'CoV', 'A', 'high', 'degree', 'of', 'variation', 'in', 'the', 'level', 'of', 'viral', 'RNA', 'was', 'observed', 'in', 'clinical', 'specimens', 'CRISPR', 'nCoV', 'demonstrated', 'a', 'near', 'single', 'copy', 'sensitivity', 'and', 'great', 'clinical', 'sensitivity', 'with', 'a', 'shorter', 'turn', 'around', 'time', 'than', 'RT', 'PCR', 'Conclusion', 'CRISPR', 'nCoV', 'presents', 'as', 'a', 'promising', 'diagnostic', 'option', 'for', 'the', 'emerging', 'pathogen', '']"
75514,"Distinct systems serology features in children, elderly and COVID patients",2020-05-18,,http://medrxiv.org/cgi/content/short/2020.05.11.20098459v1?rss=1,"SARS-CoV-2, the pandemic coronavirus that causes COVID-19, has infected millions worldwide, causing unparalleled social and economic disruptions. COVID-19 results in higher pathogenicity and mortality in the elderly compared to children. Examining baseline SARS-CoV-2 cross-reactive coronavirus immunological responses, induced by circulating human coronaviruses, is critical to understand such divergent clinical outcomes. The cross-reactivity of coronavirus antibody responses of healthy children (n=89), adults (n=98), elderly (n=57), and COVID-19 patients (n=19) were analysed by systems serology. While moderate levels of cross-reactive SARS-CoV-2 IgG, IgM, and IgA were detected in healthy individuals, we identified serological signatures associated with SARS-CoV-2 antigen-specific Fc{gamma} receptor binding, which accurately distinguished COVID-19 patients from healthy individuals and suggested that SARS-CoV-2 induces qualitative changes to antibody Fc upon infection, enhancing Fc{gamma} receptor engagement. Vastly different serological signatures were observed between healthy children and elderly, with markedly higher cross-reactive SARS-CoV-2 IgA and IgG observed in elderly, whereas children displayed elevated SARS-CoV-2 IgM, including receptor binding domain-specific IgM with higher avidity. These results suggest that less-experienced humoral immunity associated with higher IgM, as observed in children, may have the potential to induce more potent antibodies upon SARS-CoV-2 infection. These key insights will inform COVID-19 vaccination strategies, improved serological diagnostics and therapeutics.",10.1101/2020.05.11.20098459,8nbmrjrw,"['SARS', 'CoV', '2', 'the', 'pandemic', 'coronavirus', 'that', 'causes', 'COVID', '19', 'has', 'infected', 'millions', 'worldwide', 'causing', 'unparalleled', 'social', 'and', 'economic', 'disruptions', 'COVID', '19', 'results', 'in', 'higher', 'pathogenicity', 'and', 'mortality', 'in', 'the', 'elderly', 'compared', 'to', 'children', 'Examining', 'baseline', 'SARS', 'CoV', '2', 'cross', 'reactive', 'coronavirus', 'immunological', 'responses', 'induced', 'by', 'circulating', 'human', 'coronaviruses', 'is', 'critical', 'to', 'understand', 'such', 'divergent', 'clinical', 'outcomes', 'The', 'cross', 'reactivity', 'of', 'coronavirus', 'antibody', 'responses', 'of', 'healthy', 'children', 'n', '89', 'adults', 'n', '98', 'elderly', 'n', '57', 'and', 'COVID', '19', 'patients', 'n', '19', 'were', 'analysed', 'by', 'systems', 'serology', 'While', 'moderate', 'levels', 'of', 'cross', 'reactive', 'SARS', 'CoV', '2', 'IgG', 'IgM', 'and', 'IgA', 'were', 'detected', 'in', 'healthy', 'individuals', 'we', 'identified', 'serological', 'signatures', 'associated', 'with', 'SARS', 'CoV', '2', 'antigen', 'specific', 'Fc', 'gamma', 'receptor', 'binding', 'which', 'accurately', 'distinguished', 'COVID', '19', 'patients', 'from', 'healthy', 'individuals', 'and', 'suggested', 'that', 'SARS', 'CoV', '2', 'induces', 'qualitative', 'changes', 'to', 'antibody', 'Fc', 'upon', 'infection', 'enhancing', 'Fc', 'gamma', 'receptor', 'engagement', 'Vastly', 'different', 'serological', 'signatures', 'were', 'observed', 'between', 'healthy', 'children', 'and', 'elderly', 'with', 'markedly', 'higher', 'cross', 'reactive', 'SARS', 'CoV', '2', 'IgA', 'and', 'IgG', 'observed', 'in', 'elderly', 'whereas', 'children', 'displayed', 'elevated', 'SARS', 'CoV', '2', 'IgM', 'including', 'receptor', 'binding', 'domain', 'specific', 'IgM', 'with', 'higher', 'avidity', 'These', 'results', 'suggest', 'that', 'less', 'experienced', 'humoral', 'immunity', 'associated', 'with', 'higher', 'IgM', 'as', 'observed', 'in', 'children', 'may', 'have', 'the', 'potential', 'to', 'induce', 'more', 'potent', 'antibodies', 'upon', 'SARS', 'CoV', '2', 'infection', 'These', 'key', 'insights', 'will', 'inform', 'COVID', '19', 'vaccination', 'strategies', 'improved', 'serological', 'diagnostics', 'and', 'therapeutics', '']"
75563,A CRISPR-based SARS-CoV-2 diagnostic assay that is robust against viral evolution and RNA editing,2020-07-03,bioRxiv,https://doi.org/10.1101/2020.07.03.185850,"Extensive testing is essential to break the transmission of the new coronavirus SARS-CoV-2, which causes the ongoing COVID-19 pandemic. Recently, CRISPR-based diagnostics have emerged as attractive alternatives to quantitative real-time PCR due to their faster turnaround time and their potential to be used in point-of-care testing scenarios. However, existing CRISPR-based assays for COVID-19 have not considered viral genome mutations and RNA editing in human cells. Here, we present the VaNGuard (Variant Nucleotide Guard) test that is not only specific and sensitive for SARS-CoV-2, but can also detect the virus when its genome or transcriptome has evolved or has been edited by deaminases in infected human cells. We show that an engineered AsCas12a enzyme is more tolerant of mismatches than wildtype LbCas12a and that multiplexed Cas12a targeting can overcome the presence of single nucleotide variations. Our assay can be completed in 30 minutes with a dipstick for a rapid point-of-care test.",10.1101/2020.07.03.185850,648r94o8,"['Extensive', 'testing', 'is', 'essential', 'to', 'break', 'the', 'transmission', 'of', 'the', 'new', 'coronavirus', 'SARS', 'CoV', '2', 'which', 'causes', 'the', 'ongoing', 'COVID', '19', 'pandemic', 'Recently', 'CRISPR', 'based', 'diagnostics', 'have', 'emerged', 'as', 'attractive', 'alternatives', 'to', 'quantitative', 'real', 'time', 'PCR', 'due', 'to', 'their', 'faster', 'turnaround', 'time', 'and', 'their', 'potential', 'to', 'be', 'used', 'in', 'point', 'of', 'care', 'testing', 'scenarios', 'However', 'existing', 'CRISPR', 'based', 'assays', 'for', 'COVID', '19', 'have', 'not', 'considered', 'viral', 'genome', 'mutations', 'and', 'RNA', 'editing', 'in', 'human', 'cells', 'Here', 'we', 'present', 'the', 'VaNGuard', 'Variant', 'Nucleotide', 'Guard', 'test', 'that', 'is', 'not', 'only', 'specific', 'and', 'sensitive', 'for', 'SARS', 'CoV', '2', 'but', 'can', 'also', 'detect', 'the', 'virus', 'when', 'its', 'genome', 'or', 'transcriptome', 'has', 'evolved', 'or', 'has', 'been', 'edited', 'by', 'deaminases', 'in', 'infected', 'human', 'cells', 'We', 'show', 'that', 'an', 'engineered', 'AsCas12a', 'enzyme', 'is', 'more', 'tolerant', 'of', 'mismatches', 'than', 'wildtype', 'LbCas12a', 'and', 'that', 'multiplexed', 'Cas12a', 'targeting', 'can', 'overcome', 'the', 'presence', 'of', 'single', 'nucleotide', 'variations', 'Our', 'assay', 'can', 'be', 'completed', 'in', '30', 'minutes', 'with', 'a', 'dipstick', 'for', 'a', 'rapid', 'point', 'of', 'care', 'test', '']"
75708,SARS-CoV-2 assays to detect functional antibody responses that block ACE2 recognition in vaccinated animals and infected patients,2020-06-18,bioRxiv,https://doi.org/10.1101/2020.06.17.158527,"SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) has caused a global pandemic of COVID-19 resulting in cases of mild to severe respiratory distress and significant mortality. The global outbreak of this novel coronavirus has now infected >8 million people worldwide with >2 million cases in the US (June 17th, 2020). There is an urgent need for vaccines and therapeutics to combat the spread of this coronavirus. Similarly, the development of diagnostic and research tools to determine infection and vaccine efficacy are critically needed. Molecular assays have been developed to determine viral genetic material present in patients. Serological assays have been developed to determine humoral responses to the spike protein or receptor binding domain (RBD). Detection of functional antibodies can be accomplished through neutralization of live SARS-CoV2 virus, but requires significant expertise, an infectible stable cell line, a specialized BioSafety Level 3 (BSL-3) facility. As large numbers of people return from quarantine, it is critical to have rapid diagnostics that can be widely adopted and employed to assess functional antibody levels in the returning workforce. This type of surrogate neutralization diagnostic can also be used to assess humoral immune responses induced in patients from the large number of vaccine and immunotherapy trials currently on-going. Here we describe a rapid serological diagnostic assay for determining antibody receptor blocking and demonstrate the broad utility of the assay by measuring the antibody functionality of sera from small animals and non-human primates immunized with an experimental SARS-CoV-2 vaccine and using sera from infected patients.",10.1101/2020.06.17.158527,qpbgq5d8,"['SARS', 'CoV', '2', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'Coronavirus', '2', 'has', 'caused', 'a', 'global', 'pandemic', 'of', 'COVID', '19', 'resulting', 'in', 'cases', 'of', 'mild', 'to', 'severe', 'respiratory', 'distress', 'and', 'significant', 'mortality', 'The', 'global', 'outbreak', 'of', 'this', 'novel', 'coronavirus', 'has', 'now', 'infected', '8', 'million', 'people', 'worldwide', 'with', '2', 'million', 'cases', 'in', 'the', 'US', 'June', '17th', '2020', 'There', 'is', 'an', 'urgent', 'need', 'for', 'vaccines', 'and', 'therapeutics', 'to', 'combat', 'the', 'spread', 'of', 'this', 'coronavirus', 'Similarly', 'the', 'development', 'of', 'diagnostic', 'and', 'research', 'tools', 'to', 'determine', 'infection', 'and', 'vaccine', 'efficacy', 'are', 'critically', 'needed', 'Molecular', 'assays', 'have', 'been', 'developed', 'to', 'determine', 'viral', 'genetic', 'material', 'present', 'in', 'patients', 'Serological', 'assays', 'have', 'been', 'developed', 'to', 'determine', 'humoral', 'responses', 'to', 'the', 'spike', 'protein', 'or', 'receptor', 'binding', 'domain', 'RBD', 'Detection', 'of', 'functional', 'antibodies', 'can', 'be', 'accomplished', 'through', 'neutralization', 'of', 'live', 'SARS', 'CoV2', 'virus', 'but', 'requires', 'significant', 'expertise', 'an', 'infectible', 'stable', 'cell', 'line', 'a', 'specialized', 'BioSafety', 'Level', '3', 'BSL', '3', 'facility', 'As', 'large', 'numbers', 'of', 'people', 'return', 'from', 'quarantine', 'it', 'is', 'critical', 'to', 'have', 'rapid', 'diagnostics', 'that', 'can', 'be', 'widely', 'adopted', 'and', 'employed', 'to', 'assess', 'functional', 'antibody', 'levels', 'in', 'the', 'returning', 'workforce', 'This', 'type', 'of', 'surrogate', 'neutralization', 'diagnostic', 'can', 'also', 'be', 'used', 'to', 'assess', 'humoral', 'immune', 'responses', 'induced', 'in', 'patients', 'from', 'the', 'large', 'number', 'of', 'vaccine', 'and', 'immunotherapy', 'trials', 'currently', 'on', 'going', 'Here', 'we', 'describe', 'a', 'rapid', 'serological', 'diagnostic', 'assay', 'for', 'determining', 'antibody', 'receptor', 'blocking', 'and', 'demonstrate', 'the', 'broad', 'utility', 'of', 'the', 'assay', 'by', 'measuring', 'the', 'antibody', 'functionality', 'of', 'sera', 'from', 'small', 'animals', 'and', 'non', 'human', 'primates', 'immunized', 'with', 'an', 'experimental', 'SARS', 'CoV', '2', 'vaccine', 'and', 'using', 'sera', 'from', 'infected', 'patients', '']"
75721,"Features, Evaluation and Treatment Coronavirus (COVID-19) Discussing the ABCs of Health Security-Antibiotic Resistance, Biothreats, and Coronavirus",2020,StatPearls,https://doi.org/10.1001/jama.2019.21022,"According to the World Health Organization (WHO), viral diseases continue to emerge and represent a serious issue to public health In the last twenty years, several viral epidemics such as the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 to 2003, and H1N1 influenza in 2009, have been recorded Most recently, the Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia in 2012 In a timeline that reaches the present day, an epidemic of cases with unexplained low respiratory infections detected in Wuhan, the largest metropolitan area in China's Hubei province, was first reported to the WHO Country Office in China, on December 31, 2019 Published literature can trace the beginning of symptomatic individuals back to the beginning of December 2019 As they were unable to identify the causative agent, these first cases were classified as ""pneumonia of unknown etiology "" The Chinese Center for Disease Control and Prevention (CDC) and local CDCs organized an intensive outbreak investigation program The etiology of this illness is now attributed to a novel virus belonging to the coronavirus (CoV) family, COVID-19 On February 11, 2020, the WHO Director-General, Dr Tedros Adhanom Ghebreyesus, announced that the disease caused by this new CoV was a ""COVID-19,"" which is the acronym of ""coronavirus disease 2019"" In the past twenty years, two additional coronavirus epidemics have occurred SARS-CoV provoked a large-scale epidemic beginning in China and involving two dozen countries with approximately 8000 cases and 800 deaths, and the MERS-CoV that began in Saudi Arabia and has approximately 2,500 cases and 800 deaths and still causes as sporadic cases This new virus seems to be very contagious and has quickly spread globally In a meeting on January 30, 2020, per the International Health Regulations (IHR, 2005), the outbreak was declared by the WHO a Public Health Emergency of International Concern (PHEIC) as it had spread to 18 countries with four countries reporting human-to-human transmission An additional landmark occurred on February 26, 2020, as the first case of the disease, not imported from China, was recorded in the United States Initially, the new virus was called 2019-nCoV Subsequently, the task of experts of the International Committee on Taxonomy of Viruses (ICTV) termed it the SARS-CoV-2 virus as it is very similar to the one that caused the SARS outbreak (SARS-CoVs) The CoVs have become the major pathogens of emerging respiratory disease outbreaks They are a large family of single-stranded RNA viruses (+ssRNA) that can be isolated in different animal species For reasons yet to be explained, these viruses can cross species barriers and can cause, in humans, illness ranging from the common cold to more severe diseases such as MERS and SARS Interestingly, these latter viruses have probably originated from bats and then moving into other mammalian hosts — the Himalayan palm civet for SARS-CoV, and the dromedary camel for MERS-CoV — before jumping to humans The dynamics of SARS-Cov-2 are currently unknown, but there is speculation that it also has an animal origin The potential for these viruses to grow to become a pandemic worldwide seems to be a serious public health risk Concerning COVID-19, the WHO raised the threat to the CoV epidemic to the ""very high"" level, on February 28, 2020 Probably, the effects of the epidemic caused by the new CoV has yet to emerge as the situation is quickly evolving World governments are at work to establish countermeasures to stem possible devastating effects Health organizations coordinate information flows and issues directives and guidelines to best mitigate the impact of the threat At the same time, scientists around the world work tirelessly, and information about the transmission mechanisms, the clinical spectrum of disease, new diagnostics, and prevention and therapeutic strategies are rapidly developing Many uncertainties remain with regard to both the virus-host interaction and the evolution of the epidemic, with specific reference to the times when the epidemic will reach its peak At the moment, the therapeutic strategies to deal with the infection are only supportive, and prevention aimed at reducing transmission in the community is our best weapon Aggressive isolation measures in China have led to a progressive reduction of cases in the last few days In Italy, in geographic regions of the north of the peninsula, political and health authorities are making incredible efforts to contain a shock wave that is severely testing the health system In the midst of the crisis, the authors have chosen to use the ""Statpearls"" platform because, within the PubMed scenario, it represents a unique tool that may allow them to make updates in real-time The aim, therefore, is to collect information and scientific evidence and to provide an overview of the topic that will be continuously updated",10.1001/jama.2019.21022,zzpw375i,"['According', 'to', 'the', 'World', 'Health', 'Organization', 'WHO', 'viral', 'diseases', 'continue', 'to', 'emerge', 'and', 'represent', 'a', 'serious', 'issue', 'to', 'public', 'health', 'In', 'the', 'last', 'twenty', 'years', 'several', 'viral', 'epidemics', 'such', 'as', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'SARS', 'CoV', 'in', '2002', 'to', '2003', 'and', 'H1N1', 'influenza', 'in', '2009', 'have', 'been', 'recorded', 'Most', 'recently', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'was', 'first', 'identified', 'in', 'Saudi', 'Arabia', 'in', '2012', 'In', 'a', 'timeline', 'that', 'reaches', 'the', 'present', 'day', 'an', 'epidemic', 'of', 'cases', 'with', 'unexplained', 'low', 'respiratory', 'infections', 'detected', 'in', 'Wuhan', 'the', 'largest', 'metropolitan', 'area', 'in', 'China', 's', 'Hubei', 'province', 'was', 'first', 'reported', 'to', 'the', 'WHO', 'Country', 'Office', 'in', 'China', 'on', 'December', '31', '2019', 'Published', 'literature', 'can', 'trace', 'the', 'beginning', 'of', 'symptomatic', 'individuals', 'back', 'to', 'the', 'beginning', 'of', 'December', '2019', 'As', 'they', 'were', 'unable', 'to', 'identify', 'the', 'causative', 'agent', 'these', 'first', 'cases', 'were', 'classified', 'as', 'pneumonia', 'of', 'unknown', 'etiology', 'The', 'Chinese', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'and', 'local', 'CDCs', 'organized', 'an', 'intensive', 'outbreak', 'investigation', 'program', 'The', 'etiology', 'of', 'this', 'illness', 'is', 'now', 'attributed', 'to', 'a', 'novel', 'virus', 'belonging', 'to', 'the', 'coronavirus', 'CoV', 'family', 'COVID', '19', 'On', 'February', '11', '2020', 'the', 'WHO', 'Director', 'General', 'Dr', 'Tedros', 'Adhanom', 'Ghebreyesus', 'announced', 'that', 'the', 'disease', 'caused', 'by', 'this', 'new', 'CoV', 'was', 'a', 'COVID', '19', 'which', 'is', 'the', 'acronym', 'of', 'coronavirus', 'disease', '2019', 'In', 'the', 'past', 'twenty', 'years', 'two', 'additional', 'coronavirus', 'epidemics', 'have', 'occurred', 'SARS', 'CoV', 'provoked', 'a', 'large', 'scale', 'epidemic', 'beginning', 'in', 'China', 'and', 'involving', 'two', 'dozen', 'countries', 'with', 'approximately', '8000', 'cases', 'and', '800', 'deaths', 'and', 'the', 'MERS', 'CoV', 'that', 'began', 'in', 'Saudi', 'Arabia', 'and', 'has', 'approximately', '2', '500', 'cases', 'and', '800', 'deaths', 'and', 'still', 'causes', 'as', 'sporadic', 'cases', 'This', 'new', 'virus', 'seems', 'to', 'be', 'very', 'contagious', 'and', 'has', 'quickly', 'spread', 'globally', 'In', 'a', 'meeting', 'on', 'January', '30', '2020', 'per', 'the', 'International', 'Health', 'Regulations', 'IHR', '2005', 'the', 'outbreak', 'was', 'declared', 'by', 'the', 'WHO', 'a', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'PHEIC', 'as', 'it', 'had', 'spread', 'to', '18', 'countries', 'with', 'four', 'countries', 'reporting', 'human', 'to', 'human', 'transmission', 'An', 'additional', 'landmark', 'occurred', 'on', 'February', '26', '2020', 'as', 'the', 'first', 'case', 'of', 'the', 'disease', 'not', 'imported', 'from', 'China', 'was', 'recorded', 'in', 'the', 'United', 'States', 'Initially', 'the', 'new', 'virus', 'was', 'called', '2019', 'nCoV', 'Subsequently', 'the', 'task', 'of', 'experts', 'of', 'the', 'International', 'Committee', 'on', 'Taxonomy', 'of', 'Viruses', 'ICTV', 'termed', 'it', 'the', 'SARS', 'CoV', '2', 'virus', 'as', 'it', 'is', 'very', 'similar', 'to', 'the', 'one', 'that', 'caused', 'the', 'SARS', 'outbreak', 'SARS', 'CoVs', 'The', 'CoVs', 'have', 'become', 'the', 'major', 'pathogens', 'of', 'emerging', 'respiratory', 'disease', 'outbreaks', 'They', 'are', 'a', 'large', 'family', 'of', 'single', 'stranded', 'RNA', 'viruses', 'ssRNA', 'that', 'can', 'be', 'isolated', 'in', 'different', 'animal', 'species', 'For', 'reasons', 'yet', 'to', 'be', 'explained', 'these', 'viruses', 'can', 'cross', 'species', 'barriers', 'and', 'can', 'cause', 'in', 'humans', 'illness', 'ranging', 'from', 'the', 'common', 'cold', 'to', 'more', 'severe', 'diseases', 'such', 'as', 'MERS', 'and', 'SARS', 'Interestingly', 'these', 'latter', 'viruses', 'have', 'probably', 'originated', 'from', 'bats', 'and', 'then', 'moving', 'into', 'other', 'mammalian', 'hosts', 'the', 'Himalayan', 'palm', 'civet', 'for', 'SARS', 'CoV', 'and', 'the', 'dromedary', 'camel', 'for', 'MERS', 'CoV', 'before', 'jumping', 'to', 'humans', 'The', 'dynamics', 'of', 'SARS', 'Cov', '2', 'are', 'currently', 'unknown', 'but', 'there', 'is', 'speculation', 'that', 'it', 'also', 'has', 'an', 'animal', 'origin', 'The', 'potential', 'for', 'these', 'viruses', 'to', 'grow', 'to', 'become', 'a', 'pandemic', 'worldwide', 'seems', 'to', 'be', 'a', 'serious', 'public', 'health', 'risk', 'Concerning', 'COVID', '19', 'the', 'WHO', 'raised', 'the', 'threat', 'to', 'the', 'CoV', 'epidemic', 'to', 'the', 'very', 'high', 'level', 'on', 'February', '28', '2020', 'Probably', 'the', 'effects', 'of', 'the', 'epidemic', 'caused', 'by', 'the', 'new', 'CoV', 'has', 'yet', 'to', 'emerge', 'as', 'the', 'situation', 'is', 'quickly', 'evolving', 'World', 'governments', 'are', 'at', 'work', 'to', 'establish', 'countermeasures', 'to', 'stem', 'possible', 'devastating', 'effects', 'Health', 'organizations', 'coordinate', 'information', 'flows', 'and', 'issues', 'directives', 'and', 'guidelines', 'to', 'best', 'mitigate', 'the', 'impact', 'of', 'the', 'threat', 'At', 'the', 'same', 'time', 'scientists', 'around', 'the', 'world', 'work', 'tirelessly', 'and', 'information', 'about', 'the', 'transmission', 'mechanisms', 'the', 'clinical', 'spectrum', 'of', 'disease', 'new', 'diagnostics', 'and', 'prevention', 'and', 'therapeutic', 'strategies', 'are', 'rapidly', 'developing', 'Many', 'uncertainties', 'remain', 'with', 'regard', 'to', 'both', 'the', 'virus', 'host', 'interaction', 'and', 'the', 'evolution', 'of', 'the', 'epidemic', 'with', 'specific', 'reference', 'to', 'the', 'times', 'when', 'the', 'epidemic', 'will', 'reach', 'its', 'peak', 'At', 'the', 'moment', 'the', 'therapeutic', 'strategies', 'to', 'deal', 'with', 'the', 'infection', 'are', 'only', 'supportive', 'and', 'prevention', 'aimed', 'at', 'reducing', 'transmission', 'in', 'the', 'community', 'is', 'our', 'best', 'weapon', 'Aggressive', 'isolation', 'measures', 'in', 'China', 'have', 'led', 'to', 'a', 'progressive', 'reduction', 'of', 'cases', 'in', 'the', 'last', 'few', 'days', 'In', 'Italy', 'in', 'geographic', 'regions', 'of', 'the', 'north', 'of', 'the', 'peninsula', 'political', 'and', 'health', 'authorities', 'are', 'making', 'incredible', 'efforts', 'to', 'contain', 'a', 'shock', 'wave', 'that', 'is', 'severely', 'testing', 'the', 'health', 'system', 'In', 'the', 'midst', 'of', 'the', 'crisis', 'the', 'authors', 'have', 'chosen', 'to', 'use', 'the', 'Statpearls', 'platform', 'because', 'within', 'the', 'PubMed', 'scenario', 'it', 'represents', 'a', 'unique', 'tool', 'that', 'may', 'allow', 'them', 'to', 'make', 'updates', 'in', 'real', 'time', 'The', 'aim', 'therefore', 'is', 'to', 'collect', 'information', 'and', 'scientific', 'evidence', 'and', 'to', 'provide', 'an', 'overview', 'of', 'the', 'topic', 'that', 'will', 'be', 'continuously', 'updated']"
75776,Understanding the B and T cells epitopes of spike protein of severe respiratory syndrome coronavirus-2: A computational way to predict the immunogens,2020-04-10,bioRxiv,https://doi.org/10.1101/2020.04.08.013516,The 2019 novel severe respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak has caused a large number of deaths with thousands of confirmed cases worldwide. The present study followed computational approaches to identify B- and T-cell epitopes for spike glycoprotein of SARS-CoV-2 by its interactions with the human leukocyte antigen alleles. We identified twenty-four peptide stretches on the SARS-CoV-2 spike protein that are well conserved among the reported strains. The S protein structure further validated the presence of predicted peptides on the surface. Out of which twenty are surface exposed and predicted to have reasonable epitope binding efficiency. The work could be useful for understanding the immunodominant regions in the surface protein of SARS-CoV-2 and could potentially help in designing some peptide-based diagnostics.,10.1101/2020.04.08.013516,ch004jxy,"['The', '2019', 'novel', 'severe', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'outbreak', 'has', 'caused', 'a', 'large', 'number', 'of', 'deaths', 'with', 'thousands', 'of', 'confirmed', 'cases', 'worldwide', 'The', 'present', 'study', 'followed', 'computational', 'approaches', 'to', 'identify', 'B', 'and', 'T', 'cell', 'epitopes', 'for', 'spike', 'glycoprotein', 'of', 'SARS', 'CoV', '2', 'by', 'its', 'interactions', 'with', 'the', 'human', 'leukocyte', 'antigen', 'alleles', 'We', 'identified', 'twenty', 'four', 'peptide', 'stretches', 'on', 'the', 'SARS', 'CoV', '2', 'spike', 'protein', 'that', 'are', 'well', 'conserved', 'among', 'the', 'reported', 'strains', 'The', 'S', 'protein', 'structure', 'further', 'validated', 'the', 'presence', 'of', 'predicted', 'peptides', 'on', 'the', 'surface', 'Out', 'of', 'which', 'twenty', 'are', 'surface', 'exposed', 'and', 'predicted', 'to', 'have', 'reasonable', 'epitope', 'binding', 'efficiency', 'The', 'work', 'could', 'be', 'useful', 'for', 'understanding', 'the', 'immunodominant', 'regions', 'in', 'the', 'surface', 'protein', 'of', 'SARS', 'CoV', '2', 'and', 'could', 'potentially', 'help', 'in', 'designing', 'some', 'peptide', 'based', 'diagnostics', '']"
76158,Multi-site Validation of a SARS-CoV-2 IgG/IgM Rapid Antibody Detection Kit,2020-05-26,,http://medrxiv.org/cgi/content/short/2020.05.25.20112227v1?rss=1,"Deaths from coronavirus disease (COVID-19) have exceeded 300,000 persons globally, calling for rapid development of mobile diagnostics that can assay widespread prevalence and infection rates. Data provided in this study supports the utility of a newly-designed lateral flow immunoassay (LFA) for detecting SARS-CoV-2 IgM and IgG antibodies. We employed a clinical cohort of 1,892 SARS-CoV-2 patients and controls, including individuals diagnosed by RT-qPCR at Yale New Haven Hospital, The First Affiliated Hospital of Anhui Medical University, the Chinese Center for Disease Control and Prevention of Hefei City (Hefei CDC), Anhui Province (Anhui Province CDC), and Fuyang City (Fuyang CDC). The LFA studied here detects SARS-CoV-2 IgM and IgG antibodies with a specificity of 97.9-100% for IgM, 99.7-100% for IgG, and sensitivities ranging from 94.1-100% for patients >14-days post symptom onset. Sensitivity decreases in patients <14-days post symptom onset, which is likely due to lower IgG/IgM antibody levels in this population. Finally, we developed a visual intensity reporting system that we believe will be suitable for laboratory and point-of-care settings, and will provide granular information about antibody levels. Overall our results support the widespread utility of this and other LFAs in assessing population-level epidemiological statistics.",10.1101/2020.05.25.20112227,lqed8b0b,"['Deaths', 'from', 'coronavirus', 'disease', 'COVID', '19', 'have', 'exceeded', '300', '000', 'persons', 'globally', 'calling', 'for', 'rapid', 'development', 'of', 'mobile', 'diagnostics', 'that', 'can', 'assay', 'widespread', 'prevalence', 'and', 'infection', 'rates', 'Data', 'provided', 'in', 'this', 'study', 'supports', 'the', 'utility', 'of', 'a', 'newly', 'designed', 'lateral', 'flow', 'immunoassay', 'LFA', 'for', 'detecting', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'antibodies', 'We', 'employed', 'a', 'clinical', 'cohort', 'of', '1', '892', 'SARS', 'CoV', '2', 'patients', 'and', 'controls', 'including', 'individuals', 'diagnosed', 'by', 'RT', 'qPCR', 'at', 'Yale', 'New', 'Haven', 'Hospital', 'The', 'First', 'Affiliated', 'Hospital', 'of', 'Anhui', 'Medical', 'University', 'the', 'Chinese', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'of', 'Hefei', 'City', 'Hefei', 'CDC', 'Anhui', 'Province', 'Anhui', 'Province', 'CDC', 'and', 'Fuyang', 'City', 'Fuyang', 'CDC', 'The', 'LFA', 'studied', 'here', 'detects', 'SARS', 'CoV', '2', 'IgM', 'and', 'IgG', 'antibodies', 'with', 'a', 'specificity', 'of', '97', '9', '100', 'for', 'IgM', '99', '7', '100', 'for', 'IgG', 'and', 'sensitivities', 'ranging', 'from', '94', '1', '100', 'for', 'patients', '14', 'days', 'post', 'symptom', 'onset', 'Sensitivity', 'decreases', 'in', 'patients', '14', 'days', 'post', 'symptom', 'onset', 'which', 'is', 'likely', 'due', 'to', 'lower', 'IgG', 'IgM', 'antibody', 'levels', 'in', 'this', 'population', 'Finally', 'we', 'developed', 'a', 'visual', 'intensity', 'reporting', 'system', 'that', 'we', 'believe', 'will', 'be', 'suitable', 'for', 'laboratory', 'and', 'point', 'of', 'care', 'settings', 'and', 'will', 'provide', 'granular', 'information', 'about', 'antibody', 'levels', 'Overall', 'our', 'results', 'support', 'the', 'widespread', 'utility', 'of', 'this', 'and', 'other', 'LFAs', 'in', 'assessing', 'population', 'level', 'epidemiological', 'statistics', '']"
76548,Antibody Profiling and Prevalence in the US population during the SARS-CoV2 Pandemic,2020-05-05,,http://medrxiv.org/cgi/content/short/2020.04.29.20085068v1?rss=1,"ABSTRACT Background: Antibody diagnostics play an important role in disease detection and can potentially aid in monitoring of the immune responses to see if an individual has developed immunity. Developing high throughput diagnostics which does not involve handling of infectious material becomes imperative in the case of pandemics such as the recent outbreak of SARS-CoV2. Methods: A protein microarray technology was used to detect the plurality of antibody response to four novel antigens namely S1 glycoprotein, Receptor binding domain (RBD), S2 glycoprotein and Nucleoprotein of the novel coronavirus named SARS-CoV2 using serum samples. A DBS card was additionally used to compare its performance with a venipuncture-based serum separator tube (SST) draw. Results: The three main subclasses of antibodies IgM, IgA and IgG were analyzed to see the variations in immune responses in the affected population and compared to their microbial RT-PCR based NP swab results. The clinical sensitivity and specificity were determined to be 98.1% and 98.6%. In the matrix comparison study, which would enable patients to test without risk of transmitting the virus, DBS matched with higher than 98% accuracy to a venipuncture-based SST collection. Conclusion: Multiplex testing enables higher sensitivity and specificity which is essential while establishing exposure on a population scale. This flexible platform along with a discrete collection methodology would be crucial and broadly useful to scale up testing in current and future pandemics. Minimum sample volume that can be collected using DBS cards can be processed in this multiplex pillar plate format enabling the capacity to provide the reliability of high throughput analyzers while having the ease of collection similar to rapid tests. Keywords: COVID19, SARS-CoV2, Antibody, Multiplex, serology, biomarker, immune modulation, prevalence, high sensitivity, high specificity, Dried blood spot, pandemic, venipuncture",10.1101/2020.04.29.20085068,8uu10t4p,"['ABSTRACT', 'Background', 'Antibody', 'diagnostics', 'play', 'an', 'important', 'role', 'in', 'disease', 'detection', 'and', 'can', 'potentially', 'aid', 'in', 'monitoring', 'of', 'the', 'immune', 'responses', 'to', 'see', 'if', 'an', 'individual', 'has', 'developed', 'immunity', 'Developing', 'high', 'throughput', 'diagnostics', 'which', 'does', 'not', 'involve', 'handling', 'of', 'infectious', 'material', 'becomes', 'imperative', 'in', 'the', 'case', 'of', 'pandemics', 'such', 'as', 'the', 'recent', 'outbreak', 'of', 'SARS', 'CoV2', 'Methods', 'A', 'protein', 'microarray', 'technology', 'was', 'used', 'to', 'detect', 'the', 'plurality', 'of', 'antibody', 'response', 'to', 'four', 'novel', 'antigens', 'namely', 'S1', 'glycoprotein', 'Receptor', 'binding', 'domain', 'RBD', 'S2', 'glycoprotein', 'and', 'Nucleoprotein', 'of', 'the', 'novel', 'coronavirus', 'named', 'SARS', 'CoV2', 'using', 'serum', 'samples', 'A', 'DBS', 'card', 'was', 'additionally', 'used', 'to', 'compare', 'its', 'performance', 'with', 'a', 'venipuncture', 'based', 'serum', 'separator', 'tube', 'SST', 'draw', 'Results', 'The', 'three', 'main', 'subclasses', 'of', 'antibodies', 'IgM', 'IgA', 'and', 'IgG', 'were', 'analyzed', 'to', 'see', 'the', 'variations', 'in', 'immune', 'responses', 'in', 'the', 'affected', 'population', 'and', 'compared', 'to', 'their', 'microbial', 'RT', 'PCR', 'based', 'NP', 'swab', 'results', 'The', 'clinical', 'sensitivity', 'and', 'specificity', 'were', 'determined', 'to', 'be', '98', '1', 'and', '98', '6', 'In', 'the', 'matrix', 'comparison', 'study', 'which', 'would', 'enable', 'patients', 'to', 'test', 'without', 'risk', 'of', 'transmitting', 'the', 'virus', 'DBS', 'matched', 'with', 'higher', 'than', '98', 'accuracy', 'to', 'a', 'venipuncture', 'based', 'SST', 'collection', 'Conclusion', 'Multiplex', 'testing', 'enables', 'higher', 'sensitivity', 'and', 'specificity', 'which', 'is', 'essential', 'while', 'establishing', 'exposure', 'on', 'a', 'population', 'scale', 'This', 'flexible', 'platform', 'along', 'with', 'a', 'discrete', 'collection', 'methodology', 'would', 'be', 'crucial', 'and', 'broadly', 'useful', 'to', 'scale', 'up', 'testing', 'in', 'current', 'and', 'future', 'pandemics', 'Minimum', 'sample', 'volume', 'that', 'can', 'be', 'collected', 'using', 'DBS', 'cards', 'can', 'be', 'processed', 'in', 'this', 'multiplex', 'pillar', 'plate', 'format', 'enabling', 'the', 'capacity', 'to', 'provide', 'the', 'reliability', 'of', 'high', 'throughput', 'analyzers', 'while', 'having', 'the', 'ease', 'of', 'collection', 'similar', 'to', 'rapid', 'tests', 'Keywords', 'COVID19', 'SARS', 'CoV2', 'Antibody', 'Multiplex', 'serology', 'biomarker', 'immune', 'modulation', 'prevalence', 'high', 'sensitivity', 'high', 'specificity', 'Dried', 'blood', 'spot', 'pandemic', 'venipuncture']"
76565,Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs,2020-04-22,,http://medrxiv.org/cgi/content/short/2020.04.16.20067835v1?rss=1,"Rapid and accurate SARS-CoV-2 diagnostic testing is essential for controlling the ongoing COVID-19 pandemic. The current gold standard for COVID-19 diagnosis is real-time RT-PCR detection of SARS-CoV-2 from nasopharyngeal swabs. Low sensitivity, exposure risks to healthcare workers, and global shortages of swabs and personal protective equipment, however, necessitate the validation of new diagnostic approaches. Saliva is a promising candidate for SARS-CoV-2 diagnostics because (1) collection is minimally invasive and can reliably be self-administered and (2) saliva has exhibited comparable sensitivity to nasopharyngeal swabs in detection of other respiratory pathogens, including endemic human coronaviruses, in previous studies. To validate the use of saliva for SARS-CoV-2 detection, we tested nasopharyngeal and saliva samples from confirmed COVID-19 patients and self-collected samples from healthcare workers on COVID-19 wards. When we compared SARS-CoV-2 detection from patient-matched nasopharyngeal and saliva samples, we found that saliva yielded greater detection sensitivity and consistency throughout the course of infection. Furthermore, we report less variability in self-sample collection of saliva. Taken together, our findings demonstrate that saliva is a viable and more sensitive alternative to nasopharyngeal swabs and could enable at-home self-administered sample collection for accurate large-scale SARS-CoV-2 testing.",10.1101/2020.04.16.20067835,lt7qsxxh,"['Rapid', 'and', 'accurate', 'SARS', 'CoV', '2', 'diagnostic', 'testing', 'is', 'essential', 'for', 'controlling', 'the', 'ongoing', 'COVID', '19', 'pandemic', 'The', 'current', 'gold', 'standard', 'for', 'COVID', '19', 'diagnosis', 'is', 'real', 'time', 'RT', 'PCR', 'detection', 'of', 'SARS', 'CoV', '2', 'from', 'nasopharyngeal', 'swabs', 'Low', 'sensitivity', 'exposure', 'risks', 'to', 'healthcare', 'workers', 'and', 'global', 'shortages', 'of', 'swabs', 'and', 'personal', 'protective', 'equipment', 'however', 'necessitate', 'the', 'validation', 'of', 'new', 'diagnostic', 'approaches', 'Saliva', 'is', 'a', 'promising', 'candidate', 'for', 'SARS', 'CoV', '2', 'diagnostics', 'because', '1', 'collection', 'is', 'minimally', 'invasive', 'and', 'can', 'reliably', 'be', 'self', 'administered', 'and', '2', 'saliva', 'has', 'exhibited', 'comparable', 'sensitivity', 'to', 'nasopharyngeal', 'swabs', 'in', 'detection', 'of', 'other', 'respiratory', 'pathogens', 'including', 'endemic', 'human', 'coronaviruses', 'in', 'previous', 'studies', 'To', 'validate', 'the', 'use', 'of', 'saliva', 'for', 'SARS', 'CoV', '2', 'detection', 'we', 'tested', 'nasopharyngeal', 'and', 'saliva', 'samples', 'from', 'confirmed', 'COVID', '19', 'patients', 'and', 'self', 'collected', 'samples', 'from', 'healthcare', 'workers', 'on', 'COVID', '19', 'wards', 'When', 'we', 'compared', 'SARS', 'CoV', '2', 'detection', 'from', 'patient', 'matched', 'nasopharyngeal', 'and', 'saliva', 'samples', 'we', 'found', 'that', 'saliva', 'yielded', 'greater', 'detection', 'sensitivity', 'and', 'consistency', 'throughout', 'the', 'course', 'of', 'infection', 'Furthermore', 'we', 'report', 'less', 'variability', 'in', 'self', 'sample', 'collection', 'of', 'saliva', 'Taken', 'together', 'our', 'findings', 'demonstrate', 'that', 'saliva', 'is', 'a', 'viable', 'and', 'more', 'sensitive', 'alternative', 'to', 'nasopharyngeal', 'swabs', 'and', 'could', 'enable', 'at', 'home', 'self', 'administered', 'sample', 'collection', 'for', 'accurate', 'large', 'scale', 'SARS', 'CoV', '2', 'testing', '']"
77228,A novel in-cell ELISA assay allows rapid and automated quantification of SARS-CoV-2 to analyse neutralizing antibodies and antiviral compounds,2020-06-05,bioRxiv,https://doi.org/10.1101/2020.06.05.135806,"The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the most pressing medical and socioeconomic challenge. Constituting important correlates of protection, determination of virus-neutralizing antibodies (NAbs) is indispensable for convalescent plasma selection, vaccine candidate evaluation, and immunity certificates. In contrast to standard serology ELISAs, plaque reduction neutralization tests (PRNTs) are laborious, time-consuming, expensive, and restricted to specialized laboratories. To replace microscopic counting-based SARS-CoV-2 PRNTs by a novel assay exempt from genetically modified viruses, which are inapplicable in most diagnostics departments, we established a simple, rapid, and automated SARS-CoV-2 neutralization assay employing an in-cell ELISA (icELISA) approach. After optimization of various parameters such as virus-specific antibodies, cell lines, virus doses, and duration of infection, SARS-CoV-2-infected cells became amenable as direct antigen source for quantitative icELISA. Using commercially available nucleocapsid protein-specific antibodies, viral infection could easily be quantified in human and highly permissive Vero E6 cells by icELISA. Antiviral agents such as human sera containing NAbs or antiviral interferons dose-dependently reduced the SARS-CoV-2-specific signal. Applying increased infectious doses, the icNT was superior to PRNT in discriminating convalescent sera with high from those with intermediate neutralizing capacities. The SARS-CoV-2 icELISA test allows rapid (<48h in total, read-out in seconds) and automated quantification of virus infection in cell culture to evaluate the efficacy of NAbs as well as antiviral drugs, using reagents and equipment present in most routine diagnostics departments. We propose the icELISA and the icNT for COVID-19 research and diagnostics.",10.1101/2020.06.05.135806,grs1zpag,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'currently', 'the', 'most', 'pressing', 'medical', 'and', 'socioeconomic', 'challenge', 'Constituting', 'important', 'correlates', 'of', 'protection', 'determination', 'of', 'virus', 'neutralizing', 'antibodies', 'NAbs', 'is', 'indispensable', 'for', 'convalescent', 'plasma', 'selection', 'vaccine', 'candidate', 'evaluation', 'and', 'immunity', 'certificates', 'In', 'contrast', 'to', 'standard', 'serology', 'ELISAs', 'plaque', 'reduction', 'neutralization', 'tests', 'PRNTs', 'are', 'laborious', 'time', 'consuming', 'expensive', 'and', 'restricted', 'to', 'specialized', 'laboratories', 'To', 'replace', 'microscopic', 'counting', 'based', 'SARS', 'CoV', '2', 'PRNTs', 'by', 'a', 'novel', 'assay', 'exempt', 'from', 'genetically', 'modified', 'viruses', 'which', 'are', 'inapplicable', 'in', 'most', 'diagnostics', 'departments', 'we', 'established', 'a', 'simple', 'rapid', 'and', 'automated', 'SARS', 'CoV', '2', 'neutralization', 'assay', 'employing', 'an', 'in', 'cell', 'ELISA', 'icELISA', 'approach', 'After', 'optimization', 'of', 'various', 'parameters', 'such', 'as', 'virus', 'specific', 'antibodies', 'cell', 'lines', 'virus', 'doses', 'and', 'duration', 'of', 'infection', 'SARS', 'CoV', '2', 'infected', 'cells', 'became', 'amenable', 'as', 'direct', 'antigen', 'source', 'for', 'quantitative', 'icELISA', 'Using', 'commercially', 'available', 'nucleocapsid', 'protein', 'specific', 'antibodies', 'viral', 'infection', 'could', 'easily', 'be', 'quantified', 'in', 'human', 'and', 'highly', 'permissive', 'Vero', 'E6', 'cells', 'by', 'icELISA', 'Antiviral', 'agents', 'such', 'as', 'human', 'sera', 'containing', 'NAbs', 'or', 'antiviral', 'interferons', 'dose', 'dependently', 'reduced', 'the', 'SARS', 'CoV', '2', 'specific', 'signal', 'Applying', 'increased', 'infectious', 'doses', 'the', 'icNT', 'was', 'superior', 'to', 'PRNT', 'in', 'discriminating', 'convalescent', 'sera', 'with', 'high', 'from', 'those', 'with', 'intermediate', 'neutralizing', 'capacities', 'The', 'SARS', 'CoV', '2', 'icELISA', 'test', 'allows', 'rapid', '48h', 'in', 'total', 'read', 'out', 'in', 'seconds', 'and', 'automated', 'quantification', 'of', 'virus', 'infection', 'in', 'cell', 'culture', 'to', 'evaluate', 'the', 'efficacy', 'of', 'NAbs', 'as', 'well', 'as', 'antiviral', 'drugs', 'using', 'reagents', 'and', 'equipment', 'present', 'in', 'most', 'routine', 'diagnostics', 'departments', 'We', 'propose', 'the', 'icELISA', 'and', 'the', 'icNT', 'for', 'COVID', '19', 'research', 'and', 'diagnostics', '']"
77421,A rapid and sensitive method to detect SARS-CoV-2 virus using targeted-mass spectrometry,2020-07-29,,http://medrxiv.org/cgi/content/short/2020.07.27.20161836v1?rss=1,"In the last few months, there has been a global catastrophic outbreak of severe acute respiratory syndrome disease caused by the novel corona virus SARS-CoV-2 affecting millions of people worldwide. Early diagnosis and isolation is key to contain the rapid spread of the virus. Towards this goal, we report a simple, sensitive and rapid method to detect the virus using a targeted mass spectrometric approach, which can directly detect the presence of virus from naso-oropharyngeal swabs. Using a multiple reaction monitoring we can detect the presence of two peptides specific to SARS-CoV-2 in a 2.3 minute gradient run with 100% specificity and 90.4 % sensitivity when compared to RT-PCR. Importantly, we further show that these peptides could be detected even in the patients who have recovered from the symptoms and have tested negative for the virus by RT-PCR highlighting the sensitivity of the technique. This method has the translational potential of in terms of the rapid diagnostics of symptomatic and asymptomatic COVID-19 and can augment current methods available for diagnosis of SARS-CoV-2.",10.1101/2020.07.27.20161836,h1ovifuq,"['In', 'the', 'last', 'few', 'months', 'there', 'has', 'been', 'a', 'global', 'catastrophic', 'outbreak', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'disease', 'caused', 'by', 'the', 'novel', 'corona', 'virus', 'SARS', 'CoV', '2', 'affecting', 'millions', 'of', 'people', 'worldwide', 'Early', 'diagnosis', 'and', 'isolation', 'is', 'key', 'to', 'contain', 'the', 'rapid', 'spread', 'of', 'the', 'virus', 'Towards', 'this', 'goal', 'we', 'report', 'a', 'simple', 'sensitive', 'and', 'rapid', 'method', 'to', 'detect', 'the', 'virus', 'using', 'a', 'targeted', 'mass', 'spectrometric', 'approach', 'which', 'can', 'directly', 'detect', 'the', 'presence', 'of', 'virus', 'from', 'naso', 'oropharyngeal', 'swabs', 'Using', 'a', 'multiple', 'reaction', 'monitoring', 'we', 'can', 'detect', 'the', 'presence', 'of', 'two', 'peptides', 'specific', 'to', 'SARS', 'CoV', '2', 'in', 'a', '2', '3', 'minute', 'gradient', 'run', 'with', '100', 'specificity', 'and', '90', '4', 'sensitivity', 'when', 'compared', 'to', 'RT', 'PCR', 'Importantly', 'we', 'further', 'show', 'that', 'these', 'peptides', 'could', 'be', 'detected', 'even', 'in', 'the', 'patients', 'who', 'have', 'recovered', 'from', 'the', 'symptoms', 'and', 'have', 'tested', 'negative', 'for', 'the', 'virus', 'by', 'RT', 'PCR', 'highlighting', 'the', 'sensitivity', 'of', 'the', 'technique', 'This', 'method', 'has', 'the', 'translational', 'potential', 'of', 'in', 'terms', 'of', 'the', 'rapid', 'diagnostics', 'of', 'symptomatic', 'and', 'asymptomatic', 'COVID', '19', 'and', 'can', 'augment', 'current', 'methods', 'available', 'for', 'diagnosis', 'of', 'SARS', 'CoV', '2', '']"
77844,Rapid and accurate detection of novel coronavirus SARS-CoV-2 using CRISPR-Cas3,2020-06-02,,http://medrxiv.org/cgi/content/short/2020.06.02.20119875v1?rss=1,"Novel coronavirus SARS-CoV-2 outbreaks have rapidly spread to multiple countries, highlighting the urgent necessity for fast, sensitive, and specific diagnostic tools for virus surveillance. Here, the previously unknown collateral single-stranded DNA cleavage we observed with type I CRISPR-Cas3 highlights its potential for development as a Cas3-mediated rapid (within 40 min), low-cost, instrument-free detection method for SARS-CoV-2. This Cas3-based assay is comparable with Cas12- and real-time reverse-transcriptase PCR-based assays in its speed and sensitivity, but offers greater specificity for single-base-pair discrimination while negating the need for highly trained operators. These findings support the use of CRISPR diagnostics for point-of-care testing in patients with suspected SARS-CoV-2 infections.",10.1101/2020.06.02.20119875,mqvp28h1,"['Novel', 'coronavirus', 'SARS', 'CoV', '2', 'outbreaks', 'have', 'rapidly', 'spread', 'to', 'multiple', 'countries', 'highlighting', 'the', 'urgent', 'necessity', 'for', 'fast', 'sensitive', 'and', 'specific', 'diagnostic', 'tools', 'for', 'virus', 'surveillance', 'Here', 'the', 'previously', 'unknown', 'collateral', 'single', 'stranded', 'DNA', 'cleavage', 'we', 'observed', 'with', 'type', 'I', 'CRISPR', 'Cas3', 'highlights', 'its', 'potential', 'for', 'development', 'as', 'a', 'Cas3', 'mediated', 'rapid', 'within', '40', 'min', 'low', 'cost', 'instrument', 'free', 'detection', 'method', 'for', 'SARS', 'CoV', '2', 'This', 'Cas3', 'based', 'assay', 'is', 'comparable', 'with', 'Cas12', 'and', 'real', 'time', 'reverse', 'transcriptase', 'PCR', 'based', 'assays', 'in', 'its', 'speed', 'and', 'sensitivity', 'but', 'offers', 'greater', 'specificity', 'for', 'single', 'base', 'pair', 'discrimination', 'while', 'negating', 'the', 'need', 'for', 'highly', 'trained', 'operators', 'These', 'findings', 'support', 'the', 'use', 'of', 'CRISPR', 'diagnostics', 'for', 'point', 'of', 'care', 'testing', 'in', 'patients', 'with', 'suspected', 'SARS', 'CoV', '2', 'infections', '']"
77924,Potential impact of seasonal forcing on a SARS-CoV-2 pandemic,2020-02-17,,https://doi.org/10.1101/2020.02.13.20022806,"A novel coronavirus (SARS-CoV-2) first detected in Wuhan, China, has spread rapidly since December 2019, causing more than 80,000 confirmed infections and 2,700 fatalities (as of Feb 27, 2020). Imported cases and transmission clusters of various sizes have been reported globally suggesting a pandemic is likely. Here, we explore how seasonal variation in transmissibility could modulate a SARS-CoV-2 pandemic. Data from routine diagnostics show a strong and consistent seasonal variation of the four endemic coronaviruses (229E, HKU1, NL63, OC43) and we parameterize our model for SARS-CoV-2 using these data. The model allows for many subpopulations of different size with variable parameters. Simulations of different scenarios show that plausible parameters result in a small peak in early 2020 in temperate regions of the Northern Hemisphere and a larger peak in winter 2020/2021. Variation in transmission and migration rates can result in substantial variation in prevalence between regions. While the uncertainty in parameters is large, the scenarios we explore show that transient reductions in the incidence rate might be due to a combination of seasonal variation and infection control efforts but do not necessarily mean the epidemic is contained. Seasonal forcing on SARS-CoV-2 should thus be taken into account in the further monitoring of the global transmission. The likely aggregated effect of seasonal variation, infection control measures and transmission rate variation is a prolonged pandemic wave with lower prevalence at any given time, thereby providing a window of opportunity for better preparation of health care systems.",10.1101/2020.02.13.20022806,3p2dl8yf,"['A', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'first', 'detected', 'in', 'Wuhan', 'China', 'has', 'spread', 'rapidly', 'since', 'December', '2019', 'causing', 'more', 'than', '80', '000', 'confirmed', 'infections', 'and', '2', '700', 'fatalities', 'as', 'of', 'Feb', '27', '2020', 'Imported', 'cases', 'and', 'transmission', 'clusters', 'of', 'various', 'sizes', 'have', 'been', 'reported', 'globally', 'suggesting', 'a', 'pandemic', 'is', 'likely', 'Here', 'we', 'explore', 'how', 'seasonal', 'variation', 'in', 'transmissibility', 'could', 'modulate', 'a', 'SARS', 'CoV', '2', 'pandemic', 'Data', 'from', 'routine', 'diagnostics', 'show', 'a', 'strong', 'and', 'consistent', 'seasonal', 'variation', 'of', 'the', 'four', 'endemic', 'coronaviruses', '229E', 'HKU1', 'NL63', 'OC43', 'and', 'we', 'parameterize', 'our', 'model', 'for', 'SARS', 'CoV', '2', 'using', 'these', 'data', 'The', 'model', 'allows', 'for', 'many', 'subpopulations', 'of', 'different', 'size', 'with', 'variable', 'parameters', 'Simulations', 'of', 'different', 'scenarios', 'show', 'that', 'plausible', 'parameters', 'result', 'in', 'a', 'small', 'peak', 'in', 'early', '2020', 'in', 'temperate', 'regions', 'of', 'the', 'Northern', 'Hemisphere', 'and', 'a', 'larger', 'peak', 'in', 'winter', '2020', '2021', 'Variation', 'in', 'transmission', 'and', 'migration', 'rates', 'can', 'result', 'in', 'substantial', 'variation', 'in', 'prevalence', 'between', 'regions', 'While', 'the', 'uncertainty', 'in', 'parameters', 'is', 'large', 'the', 'scenarios', 'we', 'explore', 'show', 'that', 'transient', 'reductions', 'in', 'the', 'incidence', 'rate', 'might', 'be', 'due', 'to', 'a', 'combination', 'of', 'seasonal', 'variation', 'and', 'infection', 'control', 'efforts', 'but', 'do', 'not', 'necessarily', 'mean', 'the', 'epidemic', 'is', 'contained', 'Seasonal', 'forcing', 'on', 'SARS', 'CoV', '2', 'should', 'thus', 'be', 'taken', 'into', 'account', 'in', 'the', 'further', 'monitoring', 'of', 'the', 'global', 'transmission', 'The', 'likely', 'aggregated', 'effect', 'of', 'seasonal', 'variation', 'infection', 'control', 'measures', 'and', 'transmission', 'rate', 'variation', 'is', 'a', 'prolonged', 'pandemic', 'wave', 'with', 'lower', 'prevalence', 'at', 'any', 'given', 'time', 'thereby', 'providing', 'a', 'window', 'of', 'opportunity', 'for', 'better', 'preparation', 'of', 'health', 'care', 'systems', '']"
78208,"Controlling the SARS-CoV-2 outbreak, insights from large scale whole genome sequences generated across the world",2020-05-26,bioRxiv,https://doi.org/10.1101/2020.04.28.066977,"Background SARS-CoV-2 most likely evolved from a bat beta-coronavirus and started infecting humans in December 2019. Since then it has rapidly infected people around the world, with more than 4.5 million confirmed cases by the middle of May 2020. Early genome sequencing of the virus has enabled the development of molecular diagnostics and the commencement of therapy and vaccine development. The analysis of the early sequences showed relatively few evolutionary selection pressures. However, with the rapid worldwide expansion into diverse human populations, significant genetic variations are becoming increasingly likely. The current limitations on social movement between countries also offers the opportunity for these viral variants to become distinct strains with potential implications for diagnostics, therapies and vaccines. Methods We used the current sequencing archives (NCBI and GISAID) to investigate 15,487 whole genomes, looking for evidence of strain diversification and selective pressure. Results We used 6,294 SNPs to build a phylogenetic tree of SARS-CoV-2 diversity and noted strong evidence for the existence of two major clades and six sub-clades, unevenly distributed across the world. We also noted that convergent evolution has potentially occurred across several locations in the genome, showing selection pressures, including on the spike glycoprotein where we noted a potentially critical mutation that could affect its binding to the ACE2 receptor. We also report on mutations that could prevent current molecular diagnostics from detecting some of the sub-clades. Conclusion The worldwide whole genome sequencing effort is revealing the challenge of developing SARS-CoV-2 containment tools suitable for everyone and the need for data to be continually evaluated to ensure accuracy in outbreak estimations.",10.1101/2020.04.28.066977,tutit2bc,"['Background', 'SARS', 'CoV', '2', 'most', 'likely', 'evolved', 'from', 'a', 'bat', 'beta', 'coronavirus', 'and', 'started', 'infecting', 'humans', 'in', 'December', '2019', 'Since', 'then', 'it', 'has', 'rapidly', 'infected', 'people', 'around', 'the', 'world', 'with', 'more', 'than', '4', '5', 'million', 'confirmed', 'cases', 'by', 'the', 'middle', 'of', 'May', '2020', 'Early', 'genome', 'sequencing', 'of', 'the', 'virus', 'has', 'enabled', 'the', 'development', 'of', 'molecular', 'diagnostics', 'and', 'the', 'commencement', 'of', 'therapy', 'and', 'vaccine', 'development', 'The', 'analysis', 'of', 'the', 'early', 'sequences', 'showed', 'relatively', 'few', 'evolutionary', 'selection', 'pressures', 'However', 'with', 'the', 'rapid', 'worldwide', 'expansion', 'into', 'diverse', 'human', 'populations', 'significant', 'genetic', 'variations', 'are', 'becoming', 'increasingly', 'likely', 'The', 'current', 'limitations', 'on', 'social', 'movement', 'between', 'countries', 'also', 'offers', 'the', 'opportunity', 'for', 'these', 'viral', 'variants', 'to', 'become', 'distinct', 'strains', 'with', 'potential', 'implications', 'for', 'diagnostics', 'therapies', 'and', 'vaccines', 'Methods', 'We', 'used', 'the', 'current', 'sequencing', 'archives', 'NCBI', 'and', 'GISAID', 'to', 'investigate', '15', '487', 'whole', 'genomes', 'looking', 'for', 'evidence', 'of', 'strain', 'diversification', 'and', 'selective', 'pressure', 'Results', 'We', 'used', '6', '294', 'SNPs', 'to', 'build', 'a', 'phylogenetic', 'tree', 'of', 'SARS', 'CoV', '2', 'diversity', 'and', 'noted', 'strong', 'evidence', 'for', 'the', 'existence', 'of', 'two', 'major', 'clades', 'and', 'six', 'sub', 'clades', 'unevenly', 'distributed', 'across', 'the', 'world', 'We', 'also', 'noted', 'that', 'convergent', 'evolution', 'has', 'potentially', 'occurred', 'across', 'several', 'locations', 'in', 'the', 'genome', 'showing', 'selection', 'pressures', 'including', 'on', 'the', 'spike', 'glycoprotein', 'where', 'we', 'noted', 'a', 'potentially', 'critical', 'mutation', 'that', 'could', 'affect', 'its', 'binding', 'to', 'the', 'ACE2', 'receptor', 'We', 'also', 'report', 'on', 'mutations', 'that', 'could', 'prevent', 'current', 'molecular', 'diagnostics', 'from', 'detecting', 'some', 'of', 'the', 'sub', 'clades', 'Conclusion', 'The', 'worldwide', 'whole', 'genome', 'sequencing', 'effort', 'is', 'revealing', 'the', 'challenge', 'of', 'developing', 'SARS', 'CoV', '2', 'containment', 'tools', 'suitable', 'for', 'everyone', 'and', 'the', 'need', 'for', 'data', 'to', 'be', 'continually', 'evaluated', 'to', 'ensure', 'accuracy', 'in', 'outbreak', 'estimations', '']"
78281,An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection,2020-06-15,bioRxiv,https://doi.org/10.1101/2020.06.14.150862,"SARS-CoV-2 is a novel pandemic coronavirus that caused a global health and economic crisis. The development of efficient drugs and vaccines against COVID-19 requires detailed knowledge about SARS-CoV-2 biology. Several techniques to detect SARS-CoV-2 infection have been established, mainly based on counting infected cells by staining plaques or foci, or by quantifying the viral genome by PCR. These methods are laborious, time-consuming and expensive and therefore not suitable for a high sample throughput or rapid diagnostics. We here report a novel enzyme-based immunodetection assay that directly quantifies the amount of de novo synthesized viral spike protein within fixed and permeabilized cells. This in-cell ELISA enables a rapid and quantitative detection of SARS-CoV-2 infection in microtiter format, regardless of the virus isolate or target cell culture. It follows the established method of performing ELISA assays and does not require expensive instrumentation. Utilization of the in-cell ELISA allows to e.g. determine TCID50 of virus stocks, antiviral efficiencies (IC50 values) of drugs or neutralizing activity of sera. Thus, the in-cell spike ELISA represents a promising alternative to study SARS-CoV-2 infection and inhibition and may facilitate future research. Highlights Determination of SARS-CoV-2 infection by enzymatically quantifying the expression of viral spike protein in bulk cell cultures Targeting a highly conserved region in the S2 subunit of the S protein allows broad detection of several SARS-CoV-2 isolates in different cell lines Screening of antivirals in microtiter format and determining the antiviral activity as inhibitory concentrations 50 (IC50)",10.1101/2020.06.14.150862,ew78trl9,"['SARS', 'CoV', '2', 'is', 'a', 'novel', 'pandemic', 'coronavirus', 'that', 'caused', 'a', 'global', 'health', 'and', 'economic', 'crisis', 'The', 'development', 'of', 'efficient', 'drugs', 'and', 'vaccines', 'against', 'COVID', '19', 'requires', 'detailed', 'knowledge', 'about', 'SARS', 'CoV', '2', 'biology', 'Several', 'techniques', 'to', 'detect', 'SARS', 'CoV', '2', 'infection', 'have', 'been', 'established', 'mainly', 'based', 'on', 'counting', 'infected', 'cells', 'by', 'staining', 'plaques', 'or', 'foci', 'or', 'by', 'quantifying', 'the', 'viral', 'genome', 'by', 'PCR', 'These', 'methods', 'are', 'laborious', 'time', 'consuming', 'and', 'expensive', 'and', 'therefore', 'not', 'suitable', 'for', 'a', 'high', 'sample', 'throughput', 'or', 'rapid', 'diagnostics', 'We', 'here', 'report', 'a', 'novel', 'enzyme', 'based', 'immunodetection', 'assay', 'that', 'directly', 'quantifies', 'the', 'amount', 'of', 'de', 'novo', 'synthesized', 'viral', 'spike', 'protein', 'within', 'fixed', 'and', 'permeabilized', 'cells', 'This', 'in', 'cell', 'ELISA', 'enables', 'a', 'rapid', 'and', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'infection', 'in', 'microtiter', 'format', 'regardless', 'of', 'the', 'virus', 'isolate', 'or', 'target', 'cell', 'culture', 'It', 'follows', 'the', 'established', 'method', 'of', 'performing', 'ELISA', 'assays', 'and', 'does', 'not', 'require', 'expensive', 'instrumentation', 'Utilization', 'of', 'the', 'in', 'cell', 'ELISA', 'allows', 'to', 'e', 'g', 'determine', 'TCID50', 'of', 'virus', 'stocks', 'antiviral', 'efficiencies', 'IC50', 'values', 'of', 'drugs', 'or', 'neutralizing', 'activity', 'of', 'sera', 'Thus', 'the', 'in', 'cell', 'spike', 'ELISA', 'represents', 'a', 'promising', 'alternative', 'to', 'study', 'SARS', 'CoV', '2', 'infection', 'and', 'inhibition', 'and', 'may', 'facilitate', 'future', 'research', 'Highlights', 'Determination', 'of', 'SARS', 'CoV', '2', 'infection', 'by', 'enzymatically', 'quantifying', 'the', 'expression', 'of', 'viral', 'spike', 'protein', 'in', 'bulk', 'cell', 'cultures', 'Targeting', 'a', 'highly', 'conserved', 'region', 'in', 'the', 'S2', 'subunit', 'of', 'the', 'S', 'protein', 'allows', 'broad', 'detection', 'of', 'several', 'SARS', 'CoV', '2', 'isolates', 'in', 'different', 'cell', 'lines', 'Screening', 'of', 'antivirals', 'in', 'microtiter', 'format', 'and', 'determining', 'the', 'antiviral', 'activity', 'as', 'inhibitory', 'concentrations', '50', 'IC50', '']"
78547,Global Status of COVID-19 Diagnosis: An Overview,2020,Journal of Pure and Applied Microbiology,https://doi.org/10.22207/jpam.14.spl1.25,"Since the beginning of the New Year 2020, countries around the world are stumbling due to the coronavirus disease (COVID-19) pandemic Better approaches of diagnostics and medical facilities have helped some countries recover early Previous exposures to epidemics have imparted lessons to handle such a pandemic with a high level of preparedness The World Health Organization (WHO) and national health authorities are taking great efforts via efficient and impactful interventions to contain the virus Diagnostic tests such as reverse transcription-polymerase chain reaction are increasingly being used to confirm the diagnosis because testing biological samples for the presence of the virus is the definitive method to identify the disease, analyze the risk for transmission, and determine whether someone has been cured or not It is also important to screen asymptomatic individuals to get the exact overview of the virus spread Antibody detection plays a pivotal role in diagnosis;however, using it at the wrong time yields negative results and conveys dissenting opinion about the tests Although the scaling up of testing has been significant, overall testing has been limited by the availability of diagnostics Rapid diagnoses and discontinuation of transmission are keys to ending this pandemic Diagnostics manufacturers are developing test kits and distributing them to different countries Therefore, more than 500 commercial test kits for molecular- and immunoassays, most with Emergency Use Authorization, are now becoming available in the market In this review, we discuss the importance of diagnostics, approaches of different countries toward the epidemic, global testing situation, and lessons to countries at the start of the epidemic for better preparedness",10.22207/jpam.14.spl1.25,tn1jzpbx,"['Since', 'the', 'beginning', 'of', 'the', 'New', 'Year', '2020', 'countries', 'around', 'the', 'world', 'are', 'stumbling', 'due', 'to', 'the', 'coronavirus', 'disease', 'COVID', '19', 'pandemic', 'Better', 'approaches', 'of', 'diagnostics', 'and', 'medical', 'facilities', 'have', 'helped', 'some', 'countries', 'recover', 'early', 'Previous', 'exposures', 'to', 'epidemics', 'have', 'imparted', 'lessons', 'to', 'handle', 'such', 'a', 'pandemic', 'with', 'a', 'high', 'level', 'of', 'preparedness', 'The', 'World', 'Health', 'Organization', 'WHO', 'and', 'national', 'health', 'authorities', 'are', 'taking', 'great', 'efforts', 'via', 'efficient', 'and', 'impactful', 'interventions', 'to', 'contain', 'the', 'virus', 'Diagnostic', 'tests', 'such', 'as', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'are', 'increasingly', 'being', 'used', 'to', 'confirm', 'the', 'diagnosis', 'because', 'testing', 'biological', 'samples', 'for', 'the', 'presence', 'of', 'the', 'virus', 'is', 'the', 'definitive', 'method', 'to', 'identify', 'the', 'disease', 'analyze', 'the', 'risk', 'for', 'transmission', 'and', 'determine', 'whether', 'someone', 'has', 'been', 'cured', 'or', 'not', 'It', 'is', 'also', 'important', 'to', 'screen', 'asymptomatic', 'individuals', 'to', 'get', 'the', 'exact', 'overview', 'of', 'the', 'virus', 'spread', 'Antibody', 'detection', 'plays', 'a', 'pivotal', 'role', 'in', 'diagnosis', 'however', 'using', 'it', 'at', 'the', 'wrong', 'time', 'yields', 'negative', 'results', 'and', 'conveys', 'dissenting', 'opinion', 'about', 'the', 'tests', 'Although', 'the', 'scaling', 'up', 'of', 'testing', 'has', 'been', 'significant', 'overall', 'testing', 'has', 'been', 'limited', 'by', 'the', 'availability', 'of', 'diagnostics', 'Rapid', 'diagnoses', 'and', 'discontinuation', 'of', 'transmission', 'are', 'keys', 'to', 'ending', 'this', 'pandemic', 'Diagnostics', 'manufacturers', 'are', 'developing', 'test', 'kits', 'and', 'distributing', 'them', 'to', 'different', 'countries', 'Therefore', 'more', 'than', '500', 'commercial', 'test', 'kits', 'for', 'molecular', 'and', 'immunoassays', 'most', 'with', 'Emergency', 'Use', 'Authorization', 'are', 'now', 'becoming', 'available', 'in', 'the', 'market', 'In', 'this', 'review', 'we', 'discuss', 'the', 'importance', 'of', 'diagnostics', 'approaches', 'of', 'different', 'countries', 'toward', 'the', 'epidemic', 'global', 'testing', 'situation', 'and', 'lessons', 'to', 'countries', 'at', 'the', 'start', 'of', 'the', 'epidemic', 'for', 'better', 'preparedness']"
78806,Evaluation of commercial qPCR kits for detection of SARS-CoV-2 in pooled samples,2020-05-28,bioRxiv,https://doi.org/10.1101/2020.05.28.120667,"Due to the current pandemic, global shortage of reagents has drawn interest in developing alternatives to increase the number coronavirus tests. One such alternative is sample pooling. Here we compared commercial kits that are used in COVID-19 diagnostics, in terms of sensitivity and feasibility for use in pooling. We showed that pooling of up to 60 samples did not affect the efficiency of the kits. Also, the RNA dependent RNA polymerase (RdRp) is a more suitable target in pooled samples than the Envelope (E) protein. This approach could provide an easy method of screening large number of samples and help adjust different government regulations.",10.1101/2020.05.28.120667,72gmj59l,"['Due', 'to', 'the', 'current', 'pandemic', 'global', 'shortage', 'of', 'reagents', 'has', 'drawn', 'interest', 'in', 'developing', 'alternatives', 'to', 'increase', 'the', 'number', 'coronavirus', 'tests', 'One', 'such', 'alternative', 'is', 'sample', 'pooling', 'Here', 'we', 'compared', 'commercial', 'kits', 'that', 'are', 'used', 'in', 'COVID', '19', 'diagnostics', 'in', 'terms', 'of', 'sensitivity', 'and', 'feasibility', 'for', 'use', 'in', 'pooling', 'We', 'showed', 'that', 'pooling', 'of', 'up', 'to', '60', 'samples', 'did', 'not', 'affect', 'the', 'efficiency', 'of', 'the', 'kits', 'Also', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'is', 'a', 'more', 'suitable', 'target', 'in', 'pooled', 'samples', 'than', 'the', 'Envelope', 'E', 'protein', 'This', 'approach', 'could', 'provide', 'an', 'easy', 'method', 'of', 'screening', 'large', 'number', 'of', 'samples', 'and', 'help', 'adjust', 'different', 'government', 'regulations', '']"
78961,Fighting COVID-19: Integrated Micro- and Nanosystems for Viral Infection Diagnostics,2020,Matter,https://doi.org/10.1016/j.matt.2020.06.015,"SummaryThe pandemic of coronavirus disease 2019 (COVID-19) highlights the importance of rapid and sensitive diagnostics of viral infection that enables the efficient tracing of cases and the implementation of public health measures for disease containment The immediate actions from both academia and industry have led to the development of many COVID-19 diagnostic systems that have secured fast-track regulatory approvals and have been serving our healthcare frontlines since the early stage of the pandemic On diagnostic technologies, many of these clinically validated systems have significantly benefited from the recent advances in micro- and nanotechnologies in terms of platform design, analytical method, and system integration and miniaturization The continued development of new diagnostic platforms integrating micro- and nanocomponents will address some of the shortcomings we have witnessed in the existing COVID-19 diagnostic systems This Perspective reviews the previous and ongoing research efforts on developing integrated micro- and nanosystems for nucleic acid-based virus detection, and highlights promising technologies that could provide better solutions for the diagnosis of COVID-19 and other viral infectious diseases With the summary and outlook of this rapidly evolving research field, we hope to inspire more research and development activities to better prepare our society for future public health crises",10.1016/j.matt.2020.06.015,7v6rj65a,"['SummaryThe', 'pandemic', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'highlights', 'the', 'importance', 'of', 'rapid', 'and', 'sensitive', 'diagnostics', 'of', 'viral', 'infection', 'that', 'enables', 'the', 'efficient', 'tracing', 'of', 'cases', 'and', 'the', 'implementation', 'of', 'public', 'health', 'measures', 'for', 'disease', 'containment', 'The', 'immediate', 'actions', 'from', 'both', 'academia', 'and', 'industry', 'have', 'led', 'to', 'the', 'development', 'of', 'many', 'COVID', '19', 'diagnostic', 'systems', 'that', 'have', 'secured', 'fast', 'track', 'regulatory', 'approvals', 'and', 'have', 'been', 'serving', 'our', 'healthcare', 'frontlines', 'since', 'the', 'early', 'stage', 'of', 'the', 'pandemic', 'On', 'diagnostic', 'technologies', 'many', 'of', 'these', 'clinically', 'validated', 'systems', 'have', 'significantly', 'benefited', 'from', 'the', 'recent', 'advances', 'in', 'micro', 'and', 'nanotechnologies', 'in', 'terms', 'of', 'platform', 'design', 'analytical', 'method', 'and', 'system', 'integration', 'and', 'miniaturization', 'The', 'continued', 'development', 'of', 'new', 'diagnostic', 'platforms', 'integrating', 'micro', 'and', 'nanocomponents', 'will', 'address', 'some', 'of', 'the', 'shortcomings', 'we', 'have', 'witnessed', 'in', 'the', 'existing', 'COVID', '19', 'diagnostic', 'systems', 'This', 'Perspective', 'reviews', 'the', 'previous', 'and', 'ongoing', 'research', 'efforts', 'on', 'developing', 'integrated', 'micro', 'and', 'nanosystems', 'for', 'nucleic', 'acid', 'based', 'virus', 'detection', 'and', 'highlights', 'promising', 'technologies', 'that', 'could', 'provide', 'better', 'solutions', 'for', 'the', 'diagnosis', 'of', 'COVID', '19', 'and', 'other', 'viral', 'infectious', 'diseases', 'With', 'the', 'summary', 'and', 'outlook', 'of', 'this', 'rapidly', 'evolving', 'research', 'field', 'we', 'hope', 'to', 'inspire', 'more', 'research', 'and', 'development', 'activities', 'to', 'better', 'prepare', 'our', 'society', 'for', 'future', 'public', 'health', 'crises']"
79007,Nano-enabled biosensing systems for intelligent healthcare: towards COVID-19 management,2020,Mater. Today Chem.,https://doi.org/10.1016/j.mtchem.2020.100306,"Biosensors are emerging as efficient (sensitive and selective) and affordable analytical diagnostic tools for early-stage disease detection, as required for personalized health wellness management. Low-level detection of a targeted disease biomarker (pM level) has emerged extremely useful to evaluate the progression of disease under therapy. Such collected bioinformatics and its multi-aspects-oriented analytics is in demand to explore the effectiveness of a prescribed treatment, optimize therapy, and correlate biomarker level with disease pathogenesis. Owing to nanotechnology-enabled advancements in sensing unit fabrication, device integration, interfacing, packaging, and sensing performance at point-of-care (POC) has rendered diagnostics according to the requirements of disease management and patient disease profile i.e. in a personalized manner. Efforts are continuously being made to promote the state of art biosensing technology as a next-generation non-invasive disease diagnostics methodology. Keeping this in view, this progressive opinion article describes personalized health care management related analytical tools which can provide access to better health for everyone, with overreaching aim to manage healthy tomorrow timely. Considering accomplishments and predictions, such affordable intelligent diagnostics tools are urgently required to manage COVID-19 pandemic, a life-threatening respiratory infectious disease, where a rapid, selective and sensitive detection of human beta severe acute respiratory system coronavirus (SARS-COoV-2) protein is the key factor.",10.1016/j.mtchem.2020.100306,4vjf6sgs,"['Biosensors', 'are', 'emerging', 'as', 'efficient', 'sensitive', 'and', 'selective', 'and', 'affordable', 'analytical', 'diagnostic', 'tools', 'for', 'early', 'stage', 'disease', 'detection', 'as', 'required', 'for', 'personalized', 'health', 'wellness', 'management', 'Low', 'level', 'detection', 'of', 'a', 'targeted', 'disease', 'biomarker', 'pM', 'level', 'has', 'emerged', 'extremely', 'useful', 'to', 'evaluate', 'the', 'progression', 'of', 'disease', 'under', 'therapy', 'Such', 'collected', 'bioinformatics', 'and', 'its', 'multi', 'aspects', 'oriented', 'analytics', 'is', 'in', 'demand', 'to', 'explore', 'the', 'effectiveness', 'of', 'a', 'prescribed', 'treatment', 'optimize', 'therapy', 'and', 'correlate', 'biomarker', 'level', 'with', 'disease', 'pathogenesis', 'Owing', 'to', 'nanotechnology', 'enabled', 'advancements', 'in', 'sensing', 'unit', 'fabrication', 'device', 'integration', 'interfacing', 'packaging', 'and', 'sensing', 'performance', 'at', 'point', 'of', 'care', 'POC', 'has', 'rendered', 'diagnostics', 'according', 'to', 'the', 'requirements', 'of', 'disease', 'management', 'and', 'patient', 'disease', 'profile', 'i', 'e', 'in', 'a', 'personalized', 'manner', 'Efforts', 'are', 'continuously', 'being', 'made', 'to', 'promote', 'the', 'state', 'of', 'art', 'biosensing', 'technology', 'as', 'a', 'next', 'generation', 'non', 'invasive', 'disease', 'diagnostics', 'methodology', 'Keeping', 'this', 'in', 'view', 'this', 'progressive', 'opinion', 'article', 'describes', 'personalized', 'health', 'care', 'management', 'related', 'analytical', 'tools', 'which', 'can', 'provide', 'access', 'to', 'better', 'health', 'for', 'everyone', 'with', 'overreaching', 'aim', 'to', 'manage', 'healthy', 'tomorrow', 'timely', 'Considering', 'accomplishments', 'and', 'predictions', 'such', 'affordable', 'intelligent', 'diagnostics', 'tools', 'are', 'urgently', 'required', 'to', 'manage', 'COVID', '19', 'pandemic', 'a', 'life', 'threatening', 'respiratory', 'infectious', 'disease', 'where', 'a', 'rapid', 'selective', 'and', 'sensitive', 'detection', 'of', 'human', 'beta', 'severe', 'acute', 'respiratory', 'system', 'coronavirus', 'SARS', 'COoV', '2', 'protein', 'is', 'the', 'key', 'factor', '']"
79060,Sensitive one-step isothermal detection of pathogen-derived RNAs,2020-03-09,,https://doi.org/10.1101/2020.03.05.20031971,"The recent outbreaks of Ebola, Zika, MERS, and SARS-CoV-2 (2019-nCoV) require fast, simple, and sensitive onsite nucleic acid diagnostics that can be developed rapidly to prevent the spread of diseases. We have developed a SENsitive Splint-based one-step isothermal RNA detection (SENSR) method for rapid and straightforward onsite detection of pathogen RNAs with high sensitivity and specificity. SENSR consists of two simple enzymatic reactions: a ligation reaction by SplintR ligase and subsequent transcription by T7 RNA polymerase. The resulting transcript forms an RNA aptamer that induces fluorescence. Here, we demonstrate that SENSR is an effective and highly sensitive method for the detection of the current epidemic pathogen, severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2). We also show that the platform can be extended to the detection of five other pathogens. Overall, SENSR is a molecular diagnostic method that can be developed rapidly for onsite uses requiring high sensitivity, specificity, and short assaying times.",10.1101/2020.03.05.20031971,1uqjmeic,"['The', 'recent', 'outbreaks', 'of', 'Ebola', 'Zika', 'MERS', 'and', 'SARS', 'CoV', '2', '2019', 'nCoV', 'require', 'fast', 'simple', 'and', 'sensitive', 'onsite', 'nucleic', 'acid', 'diagnostics', 'that', 'can', 'be', 'developed', 'rapidly', 'to', 'prevent', 'the', 'spread', 'of', 'diseases', 'We', 'have', 'developed', 'a', 'SENsitive', 'Splint', 'based', 'one', 'step', 'isothermal', 'RNA', 'detection', 'SENSR', 'method', 'for', 'rapid', 'and', 'straightforward', 'onsite', 'detection', 'of', 'pathogen', 'RNAs', 'with', 'high', 'sensitivity', 'and', 'specificity', 'SENSR', 'consists', 'of', 'two', 'simple', 'enzymatic', 'reactions', 'a', 'ligation', 'reaction', 'by', 'SplintR', 'ligase', 'and', 'subsequent', 'transcription', 'by', 'T7', 'RNA', 'polymerase', 'The', 'resulting', 'transcript', 'forms', 'an', 'RNA', 'aptamer', 'that', 'induces', 'fluorescence', 'Here', 'we', 'demonstrate', 'that', 'SENSR', 'is', 'an', 'effective', 'and', 'highly', 'sensitive', 'method', 'for', 'the', 'detection', 'of', 'the', 'current', 'epidemic', 'pathogen', 'severe', 'acute', 'respiratory', 'syndrome', 'related', 'coronavirus', '2', 'SARS', 'CoV', '2', 'We', 'also', 'show', 'that', 'the', 'platform', 'can', 'be', 'extended', 'to', 'the', 'detection', 'of', 'five', 'other', 'pathogens', 'Overall', 'SENSR', 'is', 'a', 'molecular', 'diagnostic', 'method', 'that', 'can', 'be', 'developed', 'rapidly', 'for', 'onsite', 'uses', 'requiring', 'high', 'sensitivity', 'specificity', 'and', 'short', 'assaying', 'times', '']"
79266,Labs scramble to spot hidden coronavirus infections,2020,Science,https://doi.org/10.1126/science.abb2651,"The seeming precision of the global tallies of cases and deaths caused by the novel coronavirus now spreading from Wuhan, China belies an alarming fact (A study group of the International Committee on Taxonomy of Viruses christened the novel virus severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, the same day) But many news stories have reported shortages of diagnostics in Hubei",10.1126/science.abb2651,hp8bzwcq,"['The', 'seeming', 'precision', 'of', 'the', 'global', 'tallies', 'of', 'cases', 'and', 'deaths', 'caused', 'by', 'the', 'novel', 'coronavirus', 'now', 'spreading', 'from', 'Wuhan', 'China', 'belies', 'an', 'alarming', 'fact', 'A', 'study', 'group', 'of', 'the', 'International', 'Committee', 'on', 'Taxonomy', 'of', 'Viruses', 'christened', 'the', 'novel', 'virus', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'or', 'SARS', 'CoV', '2', 'the', 'same', 'day', 'But', 'many', 'news', 'stories', 'have', 'reported', 'shortages', 'of', 'diagnostics', 'in', 'Hubei']"
79288,COVID-MATCH65 - A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2,2020-07-02,,http://medrxiv.org/cgi/content/short/2020.06.30.20143818v1?rss=1,"Due to the ongoing COVID-19 pandemic and increased pressure on testing resources, understanding the clinical and epidemiological features closely associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is vital at point of care to enable risk stratification. We demonstrate that an internally derived and validated clinical decision rule, COVID-MATCH65, has a high sensitivity (92.6%) and NPV (99.5%) for SARS-CoV-2 and could be used to aid COVID-19 risk-assessment and resource allocation for SARS-CoV-2 diagnostics.",10.1101/2020.06.30.20143818,8bfafpe0,"['Due', 'to', 'the', 'ongoing', 'COVID', '19', 'pandemic', 'and', 'increased', 'pressure', 'on', 'testing', 'resources', 'understanding', 'the', 'clinical', 'and', 'epidemiological', 'features', 'closely', 'associated', 'with', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'vital', 'at', 'point', 'of', 'care', 'to', 'enable', 'risk', 'stratification', 'We', 'demonstrate', 'that', 'an', 'internally', 'derived', 'and', 'validated', 'clinical', 'decision', 'rule', 'COVID', 'MATCH65', 'has', 'a', 'high', 'sensitivity', '92', '6', 'and', 'NPV', '99', '5', 'for', 'SARS', 'CoV', '2', 'and', 'could', 'be', 'used', 'to', 'aid', 'COVID', '19', 'risk', 'assessment', 'and', 'resource', 'allocation', 'for', 'SARS', 'CoV', '2', 'diagnostics', '']"
79738,Scalable Transcriptional Analysis Routine—Multiplexed Quantitative Real-Time Polymerase Chain Reaction Platform for Gene Expression Analysis and Molecular Diagnostics,2005-10-31,The Journal of Molecular Diagnostics,https://api.elsevier.com/content/article/pii/S1525157810605752; https://www.sciencedirect.com/science/article/pii/S1525157810605752,"We report the development of a new technology for simultaneous quantitative detection of multiple targets in a single sample. Scalable transcriptional analysis routine (STAR) represents a novel integration of reverse transcriptase-polymerase chain reaction and capillary electrophoresis that allows detection of dozens of gene transcripts in a multiplexed format using amplicon size as an identifier for each target. STAR demonstrated similar or better sensitivity and precision compared to two commonly used methods, SYBR Green-based and TaqMan probe-based real-time reverse transcriptase-polymerase chain reaction. STAR can be used as a flexible platform for building a variety of applications to monitor gene expression, from single gene assays to assays analyzing the expression level of multiple genes. Using severe acute respiratory syndrome (SARS) corona virus as a model system, STAR technology detected single copies of the viral genome in a two-gene multiplex. Blinded studies using RNA extracted from various tissues of a SARS-infected individual showed that STAR correctly identified all samples containing SARS virus and yielded negative results for non-SARS control samples. Using alternate priming strategies, STAR technology can be adapted to transcriptional profiling studies without requiring a priori sequence information. Thus, STAR technology offers a flexible platform for development of highly multiplexed assays in gene expression analysis and molecular diagnostics.",10.1016/s1525-1578(10)60575-2,qhftb6d7,"['We', 'report', 'the', 'development', 'of', 'a', 'new', 'technology', 'for', 'simultaneous', 'quantitative', 'detection', 'of', 'multiple', 'targets', 'in', 'a', 'single', 'sample', 'Scalable', 'transcriptional', 'analysis', 'routine', 'STAR', 'represents', 'a', 'novel', 'integration', 'of', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'and', 'capillary', 'electrophoresis', 'that', 'allows', 'detection', 'of', 'dozens', 'of', 'gene', 'transcripts', 'in', 'a', 'multiplexed', 'format', 'using', 'amplicon', 'size', 'as', 'an', 'identifier', 'for', 'each', 'target', 'STAR', 'demonstrated', 'similar', 'or', 'better', 'sensitivity', 'and', 'precision', 'compared', 'to', 'two', 'commonly', 'used', 'methods', 'SYBR', 'Green', 'based', 'and', 'TaqMan', 'probe', 'based', 'real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'STAR', 'can', 'be', 'used', 'as', 'a', 'flexible', 'platform', 'for', 'building', 'a', 'variety', 'of', 'applications', 'to', 'monitor', 'gene', 'expression', 'from', 'single', 'gene', 'assays', 'to', 'assays', 'analyzing', 'the', 'expression', 'level', 'of', 'multiple', 'genes', 'Using', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'corona', 'virus', 'as', 'a', 'model', 'system', 'STAR', 'technology', 'detected', 'single', 'copies', 'of', 'the', 'viral', 'genome', 'in', 'a', 'two', 'gene', 'multiplex', 'Blinded', 'studies', 'using', 'RNA', 'extracted', 'from', 'various', 'tissues', 'of', 'a', 'SARS', 'infected', 'individual', 'showed', 'that', 'STAR', 'correctly', 'identified', 'all', 'samples', 'containing', 'SARS', 'virus', 'and', 'yielded', 'negative', 'results', 'for', 'non', 'SARS', 'control', 'samples', 'Using', 'alternate', 'priming', 'strategies', 'STAR', 'technology', 'can', 'be', 'adapted', 'to', 'transcriptional', 'profiling', 'studies', 'without', 'requiring', 'a', 'priori', 'sequence', 'information', 'Thus', 'STAR', 'technology', 'offers', 'a', 'flexible', 'platform', 'for', 'development', 'of', 'highly', 'multiplexed', 'assays', 'in', 'gene', 'expression', 'analysis', 'and', 'molecular', 'diagnostics', '']"
79740,Understand Research Hotspots Surrounding COVID-19 and Other Coronavirus Infections Using Topic Modeling,2020-03-30,,https://doi.org/10.1101/2020.03.26.20044164,"Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that causes severe respiratory illness in humans, which eventually results in the current outbreak of novel coronavirus disease (COVID-19) around the world. The research community is interested to know what are the hotspots in coronavirus (CoV) research and how much is known about COVID-19. This study aimed to evaluate the characteristics of publications involving coronaviruses as well as COVID-19 by using a topic modeling analysis. Methods: We extracted all abstracts and retained the most informative words from the COVID-19 Open Research Dataset, which contains all the 35,092 pieces of coronavirus related literature published up to March 20, 2020. Using Latent Dirichlet Allocation modeling, we trained an eight-topic model from the corpus. We then analyzed the semantic relationships between topics and compared the topic distribution between COVID-19 and other CoV infections. Results: Eight topics emerged overall: clinical characterization, pathogenesis research, therapeutics research, epidemiological study, virus transmission, vaccines research, virus diagnostics, and viral genomics. It was observed that COVID-19 research puts more emphasis on clinical characterization, epidemiological study, and virus transmission at present. In contrast, topics about diagnostics, therapeutics, vaccines, genomics and pathogenesis only accounted for less than 10% or even 4% of all the COVID-19 publications, much lower than those of other CoV infections. Conclusions: These results identified knowledge gaps in the area of COVID-19 and offered directions for future research. Keywords: COVID-19, coronavirus, topic modeling, hotspots, text mining",10.1101/2020.03.26.20044164,3wuh6k6g,"['Background', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'a', 'virus', 'that', 'causes', 'severe', 'respiratory', 'illness', 'in', 'humans', 'which', 'eventually', 'results', 'in', 'the', 'current', 'outbreak', 'of', 'novel', 'coronavirus', 'disease', 'COVID', '19', 'around', 'the', 'world', 'The', 'research', 'community', 'is', 'interested', 'to', 'know', 'what', 'are', 'the', 'hotspots', 'in', 'coronavirus', 'CoV', 'research', 'and', 'how', 'much', 'is', 'known', 'about', 'COVID', '19', 'This', 'study', 'aimed', 'to', 'evaluate', 'the', 'characteristics', 'of', 'publications', 'involving', 'coronaviruses', 'as', 'well', 'as', 'COVID', '19', 'by', 'using', 'a', 'topic', 'modeling', 'analysis', 'Methods', 'We', 'extracted', 'all', 'abstracts', 'and', 'retained', 'the', 'most', 'informative', 'words', 'from', 'the', 'COVID', '19', 'Open', 'Research', 'Dataset', 'which', 'contains', 'all', 'the', '35', '092', 'pieces', 'of', 'coronavirus', 'related', 'literature', 'published', 'up', 'to', 'March', '20', '2020', 'Using', 'Latent', 'Dirichlet', 'Allocation', 'modeling', 'we', 'trained', 'an', 'eight', 'topic', 'model', 'from', 'the', 'corpus', 'We', 'then', 'analyzed', 'the', 'semantic', 'relationships', 'between', 'topics', 'and', 'compared', 'the', 'topic', 'distribution', 'between', 'COVID', '19', 'and', 'other', 'CoV', 'infections', 'Results', 'Eight', 'topics', 'emerged', 'overall', 'clinical', 'characterization', 'pathogenesis', 'research', 'therapeutics', 'research', 'epidemiological', 'study', 'virus', 'transmission', 'vaccines', 'research', 'virus', 'diagnostics', 'and', 'viral', 'genomics', 'It', 'was', 'observed', 'that', 'COVID', '19', 'research', 'puts', 'more', 'emphasis', 'on', 'clinical', 'characterization', 'epidemiological', 'study', 'and', 'virus', 'transmission', 'at', 'present', 'In', 'contrast', 'topics', 'about', 'diagnostics', 'therapeutics', 'vaccines', 'genomics', 'and', 'pathogenesis', 'only', 'accounted', 'for', 'less', 'than', '10', 'or', 'even', '4', 'of', 'all', 'the', 'COVID', '19', 'publications', 'much', 'lower', 'than', 'those', 'of', 'other', 'CoV', 'infections', 'Conclusions', 'These', 'results', 'identified', 'knowledge', 'gaps', 'in', 'the', 'area', 'of', 'COVID', '19', 'and', 'offered', 'directions', 'for', 'future', 'research', 'Keywords', 'COVID', '19', 'coronavirus', 'topic', 'modeling', 'hotspots', 'text', 'mining']"
79819,Comparison of commercial RT-PCR diagnostic kits for COVID-19,2020-04-24,bioRxiv,https://doi.org/10.1101/2020.04.22.056747,"The final months of 2019 witnessed the emergence of a novel coronavirus in the human population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread across the globe and is posing a major burden on society. Measures taken to reduce its spread critically depend on timely and accurate identification of virus-infected individuals by the most sensitive and specific method available, i.e. real-time reverse transcriptase PCR (RT-PCR). Many commercial kits have recently become available, but their performance has not yet been independently assessed. The aim of this study was to compare basic analytical and clinical performance of selected RT-PCR kits from seven different manufacturers (Altona Diagnostics, BGI, CerTest Biotec, KH Medical, PrimerDesign, R-Biopharm AG, and Seegene). We used serial dilutions of viral RNA to establish PCR efficiency and estimate the 95% limit of detection (LOD95%). Furthermore, we ran a panel of SARS-CoV-2-positive clinical samples (n=16) for a preliminary evaluation of clinical sensitivity. Finally, we used clinical samples positive for non-coronavirus respiratory viral infections (n=6) and a panel of RNA from related human coronaviruses to evaluate assay specificity. PCR efficiency was ≥96% for all assays and the estimated LOD95% varied within a 6-fold range. Using clinical samples, we observed some variations in detection rate between kits. Importantly, none of the assays showed cross-reactivity with other respiratory (corona)viruses, except as expected for the SARS-CoV-1 E-gene. We conclude that all RT-PCR kits assessed in this study may be used for routine diagnostics of COVID-19 in patients by experienced molecular diagnostic laboratories.",10.1101/2020.04.22.056747,dpk3fqqj,"['The', 'final', 'months', 'of', '2019', 'witnessed', 'the', 'emergence', 'of', 'a', 'novel', 'coronavirus', 'in', 'the', 'human', 'population', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'since', 'spread', 'across', 'the', 'globe', 'and', 'is', 'posing', 'a', 'major', 'burden', 'on', 'society', 'Measures', 'taken', 'to', 'reduce', 'its', 'spread', 'critically', 'depend', 'on', 'timely', 'and', 'accurate', 'identification', 'of', 'virus', 'infected', 'individuals', 'by', 'the', 'most', 'sensitive', 'and', 'specific', 'method', 'available', 'i', 'e', 'real', 'time', 'reverse', 'transcriptase', 'PCR', 'RT', 'PCR', 'Many', 'commercial', 'kits', 'have', 'recently', 'become', 'available', 'but', 'their', 'performance', 'has', 'not', 'yet', 'been', 'independently', 'assessed', 'The', 'aim', 'of', 'this', 'study', 'was', 'to', 'compare', 'basic', 'analytical', 'and', 'clinical', 'performance', 'of', 'selected', 'RT', 'PCR', 'kits', 'from', 'seven', 'different', 'manufacturers', 'Altona', 'Diagnostics', 'BGI', 'CerTest', 'Biotec', 'KH', 'Medical', 'PrimerDesign', 'R', 'Biopharm', 'AG', 'and', 'Seegene', 'We', 'used', 'serial', 'dilutions', 'of', 'viral', 'RNA', 'to', 'establish', 'PCR', 'efficiency', 'and', 'estimate', 'the', '95', 'limit', 'of', 'detection', 'LOD95', 'Furthermore', 'we', 'ran', 'a', 'panel', 'of', 'SARS', 'CoV', '2', 'positive', 'clinical', 'samples', 'n', '16', 'for', 'a', 'preliminary', 'evaluation', 'of', 'clinical', 'sensitivity', 'Finally', 'we', 'used', 'clinical', 'samples', 'positive', 'for', 'non', 'coronavirus', 'respiratory', 'viral', 'infections', 'n', '6', 'and', 'a', 'panel', 'of', 'RNA', 'from', 'related', 'human', 'coronaviruses', 'to', 'evaluate', 'assay', 'specificity', 'PCR', 'efficiency', 'was', '96', 'for', 'all', 'assays', 'and', 'the', 'estimated', 'LOD95', 'varied', 'within', 'a', '6', 'fold', 'range', 'Using', 'clinical', 'samples', 'we', 'observed', 'some', 'variations', 'in', 'detection', 'rate', 'between', 'kits', 'Importantly', 'none', 'of', 'the', 'assays', 'showed', 'cross', 'reactivity', 'with', 'other', 'respiratory', 'corona', 'viruses', 'except', 'as', 'expected', 'for', 'the', 'SARS', 'CoV', '1', 'E', 'gene', 'We', 'conclude', 'that', 'all', 'RT', 'PCR', 'kits', 'assessed', 'in', 'this', 'study', 'may', 'be', 'used', 'for', 'routine', 'diagnostics', 'of', 'COVID', '19', 'in', 'patients', 'by', 'experienced', 'molecular', 'diagnostic', 'laboratories', '']"
80056,An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets,2020-05-12,bioRxiv,https://doi.org/10.1101/2020.05.11.089409,"Background The COVID-19 pandemic is causing a major global health and socio-economic burden, instigating the mobilisation of resources into the development of control tools, such as diagnostics and vaccines. The poor performance of some diagnostic serological tools has emphasised the need for up to date immune-informatic analyses to inform the selection of viable targets for further study. This requires the integration and analysis of genetic and immunological data for SARS-CoV-2 and its homology with other human coronavirus species to understand cross-reactivity. Methods We have developed an online tool for SARS-CoV-2 research, which combines an extensive epitope mapping and prediction meta-analysis, with an updated variant database (55,944 non-synonymous mutations) based on 16,087 whole genome sequences, and an analysis of human coronavirus homology. To demonstrate its utility, we present an integrated analysis of the SARS-CoV-2 spike and nucleocapsid proteins, which are candidate vaccine and serological diagnostic targets. Results Our analysis reveals that the nucleocapsid protein in its native form appears to be a sub-optimal target for use in serological diagnostic platforms. Whilst, a further analysis suggests that orf3a proteins may be a suitable alternative target for diagnostic assays. Conclusions The tool can be accessed online (http://genomics.lshtm.ac.uk/immuno) and will serve as a useful tool for biological discovery in the fight against SARS-CoV-2. Further, it may be adapted to inform on biological targets in future outbreaks, including new human coronaviruses that spill over from animal hosts.",10.1101/2020.05.11.089409,0kxo3a4q,"['Background', 'The', 'COVID', '19', 'pandemic', 'is', 'causing', 'a', 'major', 'global', 'health', 'and', 'socio', 'economic', 'burden', 'instigating', 'the', 'mobilisation', 'of', 'resources', 'into', 'the', 'development', 'of', 'control', 'tools', 'such', 'as', 'diagnostics', 'and', 'vaccines', 'The', 'poor', 'performance', 'of', 'some', 'diagnostic', 'serological', 'tools', 'has', 'emphasised', 'the', 'need', 'for', 'up', 'to', 'date', 'immune', 'informatic', 'analyses', 'to', 'inform', 'the', 'selection', 'of', 'viable', 'targets', 'for', 'further', 'study', 'This', 'requires', 'the', 'integration', 'and', 'analysis', 'of', 'genetic', 'and', 'immunological', 'data', 'for', 'SARS', 'CoV', '2', 'and', 'its', 'homology', 'with', 'other', 'human', 'coronavirus', 'species', 'to', 'understand', 'cross', 'reactivity', 'Methods', 'We', 'have', 'developed', 'an', 'online', 'tool', 'for', 'SARS', 'CoV', '2', 'research', 'which', 'combines', 'an', 'extensive', 'epitope', 'mapping', 'and', 'prediction', 'meta', 'analysis', 'with', 'an', 'updated', 'variant', 'database', '55', '944', 'non', 'synonymous', 'mutations', 'based', 'on', '16', '087', 'whole', 'genome', 'sequences', 'and', 'an', 'analysis', 'of', 'human', 'coronavirus', 'homology', 'To', 'demonstrate', 'its', 'utility', 'we', 'present', 'an', 'integrated', 'analysis', 'of', 'the', 'SARS', 'CoV', '2', 'spike', 'and', 'nucleocapsid', 'proteins', 'which', 'are', 'candidate', 'vaccine', 'and', 'serological', 'diagnostic', 'targets', 'Results', 'Our', 'analysis', 'reveals', 'that', 'the', 'nucleocapsid', 'protein', 'in', 'its', 'native', 'form', 'appears', 'to', 'be', 'a', 'sub', 'optimal', 'target', 'for', 'use', 'in', 'serological', 'diagnostic', 'platforms', 'Whilst', 'a', 'further', 'analysis', 'suggests', 'that', 'orf3a', 'proteins', 'may', 'be', 'a', 'suitable', 'alternative', 'target', 'for', 'diagnostic', 'assays', 'Conclusions', 'The', 'tool', 'can', 'be', 'accessed', 'online', 'http', 'genomics', 'lshtm', 'ac', 'uk', 'immuno', 'and', 'will', 'serve', 'as', 'a', 'useful', 'tool', 'for', 'biological', 'discovery', 'in', 'the', 'fight', 'against', 'SARS', 'CoV', '2', 'Further', 'it', 'may', 'be', 'adapted', 'to', 'inform', 'on', 'biological', 'targets', 'in', 'future', 'outbreaks', 'including', 'new', 'human', 'coronaviruses', 'that', 'spill', 'over', 'from', 'animal', 'hosts', '']"
80192,Recombinant SARS-CoV-2 spike proteins for sero-surveillance and epitope mapping,2020-05-22,bioRxiv,https://doi.org/10.1101/2020.05.21.109298,"The newly emergent SARS-CoV-2 coronavirus is closely related to SARS-CoV which emerged in 2002. Studies on coronaviruses in general, and SARS in particular, have identified the virus spike protein (S) as being central to virus tropism, to the generation of a protective antibody response and to the unambiguous detection of past infections. As a result of this centrality SARS-CoV-2 S protein has a role in many aspects of research from vaccines to diagnostic tests. We describe a number of recombinant forms of SARS-CoV-2 S expressed in commonly available expression systems and their preliminary use in diagnostics and epitope mapping. These sources may find use in the current and future analysis of the virus and the Covid-19 disease it causes.",10.1101/2020.05.21.109298,e20gtx0z,"['The', 'newly', 'emergent', 'SARS', 'CoV', '2', 'coronavirus', 'is', 'closely', 'related', 'to', 'SARS', 'CoV', 'which', 'emerged', 'in', '2002', 'Studies', 'on', 'coronaviruses', 'in', 'general', 'and', 'SARS', 'in', 'particular', 'have', 'identified', 'the', 'virus', 'spike', 'protein', 'S', 'as', 'being', 'central', 'to', 'virus', 'tropism', 'to', 'the', 'generation', 'of', 'a', 'protective', 'antibody', 'response', 'and', 'to', 'the', 'unambiguous', 'detection', 'of', 'past', 'infections', 'As', 'a', 'result', 'of', 'this', 'centrality', 'SARS', 'CoV', '2', 'S', 'protein', 'has', 'a', 'role', 'in', 'many', 'aspects', 'of', 'research', 'from', 'vaccines', 'to', 'diagnostic', 'tests', 'We', 'describe', 'a', 'number', 'of', 'recombinant', 'forms', 'of', 'SARS', 'CoV', '2', 'S', 'expressed', 'in', 'commonly', 'available', 'expression', 'systems', 'and', 'their', 'preliminary', 'use', 'in', 'diagnostics', 'and', 'epitope', 'mapping', 'These', 'sources', 'may', 'find', 'use', 'in', 'the', 'current', 'and', 'future', 'analysis', 'of', 'the', 'virus', 'and', 'the', 'Covid', '19', 'disease', 'it', 'causes', '']"
80253,Pharma mobilizes to combat the coronavirus,2020,C&amp;EN Global Enterprise,https://doi.org/10.1021/cen-09805-buscon4,"The World Health Organization has declared the fast-moving coronavirus outbreak in China a “public health emergency of international concern,” a measure that can spur coordinated global efforts to combat it With infections steadily rising, major drug companies are mobilizing to develop diagnostics, vaccines, and possible treatments for the virus, 2019-nCoV According to WHO, as of Jan 30 more than 7,800 people worldwide are confirmed to have been infected by the virus, and another 12,000-plus cases are suspected Almost all of the cases are in China, where 170 people have died Although smaller biotech firms were among the first to publicly respond to the outbreak, big pharma firms say they have been quietly working on tests and treatments for several weeks Roche has sent the first commercial diagnostic to China, and Johnson & Johnson says it is using the same technologies deployed for the rapid development of an Ebola vaccine to( )",10.1021/cen-09805-buscon4,0tetqt33,"['The', 'World', 'Health', 'Organization', 'has', 'declared', 'the', 'fast', 'moving', 'coronavirus', 'outbreak', 'in', 'China', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'a', 'measure', 'that', 'can', 'spur', 'coordinated', 'global', 'efforts', 'to', 'combat', 'it', 'With', 'infections', 'steadily', 'rising', 'major', 'drug', 'companies', 'are', 'mobilizing', 'to', 'develop', 'diagnostics', 'vaccines', 'and', 'possible', 'treatments', 'for', 'the', 'virus', '2019', 'nCoV', 'According', 'to', 'WHO', 'as', 'of', 'Jan', '30', 'more', 'than', '7', '800', 'people', 'worldwide', 'are', 'confirmed', 'to', 'have', 'been', 'infected', 'by', 'the', 'virus', 'and', 'another', '12', '000', 'plus', 'cases', 'are', 'suspected', 'Almost', 'all', 'of', 'the', 'cases', 'are', 'in', 'China', 'where', '170', 'people', 'have', 'died', 'Although', 'smaller', 'biotech', 'firms', 'were', 'among', 'the', 'first', 'to', 'publicly', 'respond', 'to', 'the', 'outbreak', 'big', 'pharma', 'firms', 'say', 'they', 'have', 'been', 'quietly', 'working', 'on', 'tests', 'and', 'treatments', 'for', 'several', 'weeks', 'Roche', 'has', 'sent', 'the', 'first', 'commercial', 'diagnostic', 'to', 'China', 'and', 'Johnson', 'Johnson', 'says', 'it', 'is', 'using', 'the', 'same', 'technologies', 'deployed', 'for', 'the', 'rapid', 'development', 'of', 'an', 'Ebola', 'vaccine', 'to', '']"
80526,Real-time RT-PCR diagnostics of virus causing COVID-19,2020,Farmakoekonomika,https://doi.org/10.17749/2070-4909.2020.13.1.52-63,"Aim: the study was aimed to develop a reagent kit for the real-time RT-PCR diagnostics of virus causing COVID-19 Materials and Methods Three target sites were chosen in the genome SARS-CoV-2 The testing included 220 samples, 48 artificially created positive samples (made from patients' biomaterial) and 172 clinical samples (scrapes from nasal and pharyngeal cavities, bronchoalveolar lavage, expectoration, endotracheal/nasopharyngeal aspirate, feces, post-mortem material), obtained from two medical centers Preliminary, the obtained biomaterial was analyzed with a reagent kit of comparison The evaluation was performed with a confidential interval CI 95% The calculation of CI for the sensitivity and specificity was made based on the distribution of χ2 Results The authors developed a technology of novel coronavirus infection (COVID-19) real-time RT-PCR diagnostics for the application in practical healthcare and proposed the variants of testing at all the stages (preanalytical, analytical, and post-analytical, including automated results processing) The proposed reagent kit meets the requirements of the World Health Organization and the Ministry of Healthcare of the Russian Federation The study results demonstrated high sensitivity and specificity The sensitivity was 100% (95% CI) 95 6-100%;the specificity was 100% (95% CI) 96 7-100% Conclusion The proposed reagent kit was registered in the RF as a medical product;the registration certificate No RZN 2020/9948 dated 01 04 2020 The application of the reagent kit in network laboratories will provide patients with access to testing for the virus causing COVID-19 and contribute to quick differential diagnostics, improvement of pandemic control, and accurate statistics on the spread of the virus",10.17749/2070-4909.2020.13.1.52-63,5wqirhd1,"['Aim', 'the', 'study', 'was', 'aimed', 'to', 'develop', 'a', 'reagent', 'kit', 'for', 'the', 'real', 'time', 'RT', 'PCR', 'diagnostics', 'of', 'virus', 'causing', 'COVID', '19', 'Materials', 'and', 'Methods', 'Three', 'target', 'sites', 'were', 'chosen', 'in', 'the', 'genome', 'SARS', 'CoV', '2', 'The', 'testing', 'included', '220', 'samples', '48', 'artificially', 'created', 'positive', 'samples', 'made', 'from', 'patients', 'biomaterial', 'and', '172', 'clinical', 'samples', 'scrapes', 'from', 'nasal', 'and', 'pharyngeal', 'cavities', 'bronchoalveolar', 'lavage', 'expectoration', 'endotracheal', 'nasopharyngeal', 'aspirate', 'feces', 'post', 'mortem', 'material', 'obtained', 'from', 'two', 'medical', 'centers', 'Preliminary', 'the', 'obtained', 'biomaterial', 'was', 'analyzed', 'with', 'a', 'reagent', 'kit', 'of', 'comparison', 'The', 'evaluation', 'was', 'performed', 'with', 'a', 'confidential', 'interval', 'CI', '95', 'The', 'calculation', 'of', 'CI', 'for', 'the', 'sensitivity', 'and', 'specificity', 'was', 'made', 'based', 'on', 'the', 'distribution', 'of', 'χ2', 'Results', 'The', 'authors', 'developed', 'a', 'technology', 'of', 'novel', 'coronavirus', 'infection', 'COVID', '19', 'real', 'time', 'RT', 'PCR', 'diagnostics', 'for', 'the', 'application', 'in', 'practical', 'healthcare', 'and', 'proposed', 'the', 'variants', 'of', 'testing', 'at', 'all', 'the', 'stages', 'preanalytical', 'analytical', 'and', 'post', 'analytical', 'including', 'automated', 'results', 'processing', 'The', 'proposed', 'reagent', 'kit', 'meets', 'the', 'requirements', 'of', 'the', 'World', 'Health', 'Organization', 'and', 'the', 'Ministry', 'of', 'Healthcare', 'of', 'the', 'Russian', 'Federation', 'The', 'study', 'results', 'demonstrated', 'high', 'sensitivity', 'and', 'specificity', 'The', 'sensitivity', 'was', '100', '95', 'CI', '95', '6', '100', 'the', 'specificity', 'was', '100', '95', 'CI', '96', '7', '100', 'Conclusion', 'The', 'proposed', 'reagent', 'kit', 'was', 'registered', 'in', 'the', 'RF', 'as', 'a', 'medical', 'product', 'the', 'registration', 'certificate', 'No', 'RZN', '2020', '9948', 'dated', '01', '04', '2020', 'The', 'application', 'of', 'the', 'reagent', 'kit', 'in', 'network', 'laboratories', 'will', 'provide', 'patients', 'with', 'access', 'to', 'testing', 'for', 'the', 'virus', 'causing', 'COVID', '19', 'and', 'contribute', 'to', 'quick', 'differential', 'diagnostics', 'improvement', 'of', 'pandemic', 'control', 'and', 'accurate', 'statistics', 'on', 'the', 'spread', 'of', 'the', 'virus']"
81011,Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens,2020-04-22,,http://medrxiv.org/cgi/content/short/2020.04.17.20069864v1?rss=1,"The novel human coronavirus SARS-CoV-2 was first discovered in the city of Wuhan, Hubei province, China, causing an outbreak of pneumonia in January 2020. As of April 10, 2020, the virus has rapidly disseminated to over 200 countries and territories, causing more than 1.6 million confirmed cases of COVID-19 and 97,000 deaths worldwide. The clinical presentation of COVID-19 is fairly non-specific, and symptoms overlap with other seasonal respiratory infections concurrently circulating in the population. Further, it is estimated that up to 80% of infected individuals experience mild symptoms or are asymptomatic, confounding efforts to reliably diagnose COVID-19 empirically. To support infection control measures, there is an urgent need for rapid and accurate molecular diagnostics to identify COVID-19 positive patients. In the present study, we have evaluated the analytical sensitivity and clinical performance of four SARS-CoV-2 molecular diagnostic assays granted Emergency Use Authorization by the FDA using nasopharyngeal swabs from symptomatic patients. This information is crucial for both laboratories and clinical teams, as decisions on which testing platform to implement are made.",10.1101/2020.04.17.20069864,2bf3xzni,"['The', 'novel', 'human', 'coronavirus', 'SARS', 'CoV', '2', 'was', 'first', 'discovered', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'province', 'China', 'causing', 'an', 'outbreak', 'of', 'pneumonia', 'in', 'January', '2020', 'As', 'of', 'April', '10', '2020', 'the', 'virus', 'has', 'rapidly', 'disseminated', 'to', 'over', '200', 'countries', 'and', 'territories', 'causing', 'more', 'than', '1', '6', 'million', 'confirmed', 'cases', 'of', 'COVID', '19', 'and', '97', '000', 'deaths', 'worldwide', 'The', 'clinical', 'presentation', 'of', 'COVID', '19', 'is', 'fairly', 'non', 'specific', 'and', 'symptoms', 'overlap', 'with', 'other', 'seasonal', 'respiratory', 'infections', 'concurrently', 'circulating', 'in', 'the', 'population', 'Further', 'it', 'is', 'estimated', 'that', 'up', 'to', '80', 'of', 'infected', 'individuals', 'experience', 'mild', 'symptoms', 'or', 'are', 'asymptomatic', 'confounding', 'efforts', 'to', 'reliably', 'diagnose', 'COVID', '19', 'empirically', 'To', 'support', 'infection', 'control', 'measures', 'there', 'is', 'an', 'urgent', 'need', 'for', 'rapid', 'and', 'accurate', 'molecular', 'diagnostics', 'to', 'identify', 'COVID', '19', 'positive', 'patients', 'In', 'the', 'present', 'study', 'we', 'have', 'evaluated', 'the', 'analytical', 'sensitivity', 'and', 'clinical', 'performance', 'of', 'four', 'SARS', 'CoV', '2', 'molecular', 'diagnostic', 'assays', 'granted', 'Emergency', 'Use', 'Authorization', 'by', 'the', 'FDA', 'using', 'nasopharyngeal', 'swabs', 'from', 'symptomatic', 'patients', 'This', 'information', 'is', 'crucial', 'for', 'both', 'laboratories', 'and', 'clinical', 'teams', 'as', 'decisions', 'on', 'which', 'testing', 'platform', 'to', 'implement', 'are', 'made', '']"
81053,Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-qPCR,2020-04-17,,https://doi.org/10.1101/2020.04.17.20067348,"Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The most widely used method of COVID-19 diagnostics is a reverse transcription quantitative polymerase chain reaction (RT-qPCR) assay, detecting the presence of SARS-CoV-2 RNA in patient samples, typically from nasopharyngeal swabs. The RNA extraction is a major bottleneck in current COVID-19 testing, in terms of turn-around, logistics, component availability and cost, which delays or completely precludes COVID-19 diagnostics in many settings. Efforts to simplify the current methods are important, as increased diagnostic availability and efficiency is expected to benefit patient care and infection control. Here, we describe methods to circumvent RNA extraction in COVID-19 testing by performing RT-qPCR directly on heat-inactivated subject samples as well as samples lysed with readily available detergents. Our data, including cross-comparisons with clinically diagnosed patient samples, suggest that direct RT-qPCR is a viable option to extraction-based COVID-19 diagnostics. We argue that significant savings in terms of time and cost can be achieved by embracing RNA-extraction-free protocols, that feeds directly into the established PCR-based testing pipeline. This could aid the expansion of COVID-19 testing.",10.1101/2020.04.17.20067348,jeufhpkq,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'The', 'most', 'widely', 'used', 'method', 'of', 'COVID', '19', 'diagnostics', 'is', 'a', 'reverse', 'transcription', 'quantitative', 'polymerase', 'chain', 'reaction', 'RT', 'qPCR', 'assay', 'detecting', 'the', 'presence', 'of', 'SARS', 'CoV', '2', 'RNA', 'in', 'patient', 'samples', 'typically', 'from', 'nasopharyngeal', 'swabs', 'The', 'RNA', 'extraction', 'is', 'a', 'major', 'bottleneck', 'in', 'current', 'COVID', '19', 'testing', 'in', 'terms', 'of', 'turn', 'around', 'logistics', 'component', 'availability', 'and', 'cost', 'which', 'delays', 'or', 'completely', 'precludes', 'COVID', '19', 'diagnostics', 'in', 'many', 'settings', 'Efforts', 'to', 'simplify', 'the', 'current', 'methods', 'are', 'important', 'as', 'increased', 'diagnostic', 'availability', 'and', 'efficiency', 'is', 'expected', 'to', 'benefit', 'patient', 'care', 'and', 'infection', 'control', 'Here', 'we', 'describe', 'methods', 'to', 'circumvent', 'RNA', 'extraction', 'in', 'COVID', '19', 'testing', 'by', 'performing', 'RT', 'qPCR', 'directly', 'on', 'heat', 'inactivated', 'subject', 'samples', 'as', 'well', 'as', 'samples', 'lysed', 'with', 'readily', 'available', 'detergents', 'Our', 'data', 'including', 'cross', 'comparisons', 'with', 'clinically', 'diagnosed', 'patient', 'samples', 'suggest', 'that', 'direct', 'RT', 'qPCR', 'is', 'a', 'viable', 'option', 'to', 'extraction', 'based', 'COVID', '19', 'diagnostics', 'We', 'argue', 'that', 'significant', 'savings', 'in', 'terms', 'of', 'time', 'and', 'cost', 'can', 'be', 'achieved', 'by', 'embracing', 'RNA', 'extraction', 'free', 'protocols', 'that', 'feeds', 'directly', 'into', 'the', 'established', 'PCR', 'based', 'testing', 'pipeline', 'This', 'could', 'aid', 'the', 'expansion', 'of', 'COVID', '19', 'testing', '']"
81237,Serological signatures of SARS-CoV-2 infection: Implications for antibody-based diagnostics,2020-05-11,,http://medrxiv.org/cgi/content/short/2020.05.07.20093963v1?rss=1,"Background The antibody response generated following infection with SARS-CoV-2 is expected to decline over time. This may cause individuals with confirmed SARS-CoV-2 infection to test negative according to serological diagnostic tests in the months and years following symptom onset. Methods A multiplex serological assay was developed to measure IgG and IgM antibody responses to four SARS-CoV-2 Spike (S) antigens: spike trimeric ectodomain (Stri), its receptor-binding domain (RBD), spike subunit 1 (S1), and spike subunit 2 (S2). Antibody responses were measured in serum samples from patients in French hospitals with RT-qPCR confirmed infection (n = 259), and negative control serum samples collected before the start of the SARS-CoV-2 epidemic in 2019 (n = 335). The multiplex antibody data was used to train a random forests algorithm for classifying individuals with previous SARS-CoV-2 infection. A mathematical model of antibody kinetics informed by prior information from other coronaviruses was used to estimate time-varying antibody responses and assess the potential sensitivity and classification performance of serological diagnostics during the first year following symptom onset. Results IgG antibody responses to one S antigen identified individuals with previous RT-qPCR confirmed SARS-CoV-2 infection with 90.3% sensitivity (95% confidence interval (CI); 86.1%, 93.4%) and 99.1% specificity (95% CI; 97.4%, 99.7%). Using a serological signature of IgG to four antigens, it was possible to identify infected individuals with 96.1% sensitivity (95% CI; 93.0%, 97.9%) and 99.1% specificity (95% CI; 97.4%, 99.7%). Antibody responses to SARS-CoV-2 increase rapidly 1-2 weeks after symptom onset, with antibody responses predicted to peak within 2-4 weeks. Informed by prior data from other coronaviruses, one year following symptom onset antibody responses are predicted to decay by approximately 60% from the peak response. Depending on the selection of sero-positivity cutoff, we estimate that the sensitivity of serological diagnostics may reduce to 56%-97% after six months, and to 49%-93% after one year. Conclusion Serological signatures based on antibody responses to multiple antigens can provide more accurate and robust serological classification of individuals with previous SARS-CoV-2 infection. Changes in antibody levels over time may cause reductions in the sensitivity of serological diagnostics leading to an underestimation of sero-prevalence. It is essential that data continue to be collected to evaluate this potential risk.",10.1101/2020.05.07.20093963,gqjyusjw,"['Background', 'The', 'antibody', 'response', 'generated', 'following', 'infection', 'with', 'SARS', 'CoV', '2', 'is', 'expected', 'to', 'decline', 'over', 'time', 'This', 'may', 'cause', 'individuals', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infection', 'to', 'test', 'negative', 'according', 'to', 'serological', 'diagnostic', 'tests', 'in', 'the', 'months', 'and', 'years', 'following', 'symptom', 'onset', 'Methods', 'A', 'multiplex', 'serological', 'assay', 'was', 'developed', 'to', 'measure', 'IgG', 'and', 'IgM', 'antibody', 'responses', 'to', 'four', 'SARS', 'CoV', '2', 'Spike', 'S', 'antigens', 'spike', 'trimeric', 'ectodomain', 'Stri', 'its', 'receptor', 'binding', 'domain', 'RBD', 'spike', 'subunit', '1', 'S1', 'and', 'spike', 'subunit', '2', 'S2', 'Antibody', 'responses', 'were', 'measured', 'in', 'serum', 'samples', 'from', 'patients', 'in', 'French', 'hospitals', 'with', 'RT', 'qPCR', 'confirmed', 'infection', 'n', '259', 'and', 'negative', 'control', 'serum', 'samples', 'collected', 'before', 'the', 'start', 'of', 'the', 'SARS', 'CoV', '2', 'epidemic', 'in', '2019', 'n', '335', 'The', 'multiplex', 'antibody', 'data', 'was', 'used', 'to', 'train', 'a', 'random', 'forests', 'algorithm', 'for', 'classifying', 'individuals', 'with', 'previous', 'SARS', 'CoV', '2', 'infection', 'A', 'mathematical', 'model', 'of', 'antibody', 'kinetics', 'informed', 'by', 'prior', 'information', 'from', 'other', 'coronaviruses', 'was', 'used', 'to', 'estimate', 'time', 'varying', 'antibody', 'responses', 'and', 'assess', 'the', 'potential', 'sensitivity', 'and', 'classification', 'performance', 'of', 'serological', 'diagnostics', 'during', 'the', 'first', 'year', 'following', 'symptom', 'onset', 'Results', 'IgG', 'antibody', 'responses', 'to', 'one', 'S', 'antigen', 'identified', 'individuals', 'with', 'previous', 'RT', 'qPCR', 'confirmed', 'SARS', 'CoV', '2', 'infection', 'with', '90', '3', 'sensitivity', '95', 'confidence', 'interval', 'CI', '86', '1', '93', '4', 'and', '99', '1', 'specificity', '95', 'CI', '97', '4', '99', '7', 'Using', 'a', 'serological', 'signature', 'of', 'IgG', 'to', 'four', 'antigens', 'it', 'was', 'possible', 'to', 'identify', 'infected', 'individuals', 'with', '96', '1', 'sensitivity', '95', 'CI', '93', '0', '97', '9', 'and', '99', '1', 'specificity', '95', 'CI', '97', '4', '99', '7', 'Antibody', 'responses', 'to', 'SARS', 'CoV', '2', 'increase', 'rapidly', '1', '2', 'weeks', 'after', 'symptom', 'onset', 'with', 'antibody', 'responses', 'predicted', 'to', 'peak', 'within', '2', '4', 'weeks', 'Informed', 'by', 'prior', 'data', 'from', 'other', 'coronaviruses', 'one', 'year', 'following', 'symptom', 'onset', 'antibody', 'responses', 'are', 'predicted', 'to', 'decay', 'by', 'approximately', '60', 'from', 'the', 'peak', 'response', 'Depending', 'on', 'the', 'selection', 'of', 'sero', 'positivity', 'cutoff', 'we', 'estimate', 'that', 'the', 'sensitivity', 'of', 'serological', 'diagnostics', 'may', 'reduce', 'to', '56', '97', 'after', 'six', 'months', 'and', 'to', '49', '93', 'after', 'one', 'year', 'Conclusion', 'Serological', 'signatures', 'based', 'on', 'antibody', 'responses', 'to', 'multiple', 'antigens', 'can', 'provide', 'more', 'accurate', 'and', 'robust', 'serological', 'classification', 'of', 'individuals', 'with', 'previous', 'SARS', 'CoV', '2', 'infection', 'Changes', 'in', 'antibody', 'levels', 'over', 'time', 'may', 'cause', 'reductions', 'in', 'the', 'sensitivity', 'of', 'serological', 'diagnostics', 'leading', 'to', 'an', 'underestimation', 'of', 'sero', 'prevalence', 'It', 'is', 'essential', 'that', 'data', 'continue', 'to', 'be', 'collected', 'to', 'evaluate', 'this', 'potential', 'risk', '']"
82843,Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).,2008,"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",https://www.ncbi.nlm.nih.gov/pubmed/19203466/,"PURPOSE The large number of deaths in a short period of time due to the spread of severe acute respiratory syndrome (SARS) infection led to the unparalleled collaborative efforts world wide to determine and characterize the new coronavirus (SARS-CoV). The full genome sequence was determined within weeks of the first outbreak by the Canadian group with international collaboration. As per the World Health Organization (WHO), the continual lack of a rapid laboratory test to aid the early diagnosis of suspected cases of SARS makes this area a priority for future research. To prevent deaths in the future, early diagnosis and therapy of this infectious disease is of paramount importance. METHODS This review describes the specific molecular targets for diagnostics and therapeutics of viral infection. RESULTS The three major diagnostic methods available for SARS includes viral RNA detection by reverse transcription polymerase chain reaction (RT-PCR), virus induced antibodies by immunofluorescence assay (IFA) or by enzyme linked immunosorbant assay (ELISA) of nucleocapsid protein (NP). The spike glycoprotein of SARS-CoV is the major inducer of neutralizing antibodies. The receptor binding domain (RBD) in the S1 region of the spike glycoprotein contains multiple conformational epitopes that induces highly potent neutralizing antibodies. The genetically engineered attenuated form of the virus or viral vector vaccine encoding for the SARS-CoV spike glycoprotein has been shown to elicit protective immunity in vaccinated animals. CONCLUSION NP is the preferred target for routine detection of SARS-CoV infection by ELISA which is an economical method compared to other methods. The RBD of the spike glycoprotein is both a functional domain for cell receptor binding and also a major neutralizing determinant of SARS-CoV. The progress in evaluating a therapeutic or vaccine would depend on the avail ability of clinically relevant animal model.",,qxiyo47f,"['PURPOSE', 'The', 'large', 'number', 'of', 'deaths', 'in', 'a', 'short', 'period', 'of', 'time', 'due', 'to', 'the', 'spread', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'infection', 'led', 'to', 'the', 'unparalleled', 'collaborative', 'efforts', 'world', 'wide', 'to', 'determine', 'and', 'characterize', 'the', 'new', 'coronavirus', 'SARS', 'CoV', 'The', 'full', 'genome', 'sequence', 'was', 'determined', 'within', 'weeks', 'of', 'the', 'first', 'outbreak', 'by', 'the', 'Canadian', 'group', 'with', 'international', 'collaboration', 'As', 'per', 'the', 'World', 'Health', 'Organization', 'WHO', 'the', 'continual', 'lack', 'of', 'a', 'rapid', 'laboratory', 'test', 'to', 'aid', 'the', 'early', 'diagnosis', 'of', 'suspected', 'cases', 'of', 'SARS', 'makes', 'this', 'area', 'a', 'priority', 'for', 'future', 'research', 'To', 'prevent', 'deaths', 'in', 'the', 'future', 'early', 'diagnosis', 'and', 'therapy', 'of', 'this', 'infectious', 'disease', 'is', 'of', 'paramount', 'importance', 'METHODS', 'This', 'review', 'describes', 'the', 'specific', 'molecular', 'targets', 'for', 'diagnostics', 'and', 'therapeutics', 'of', 'viral', 'infection', 'RESULTS', 'The', 'three', 'major', 'diagnostic', 'methods', 'available', 'for', 'SARS', 'includes', 'viral', 'RNA', 'detection', 'by', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'virus', 'induced', 'antibodies', 'by', 'immunofluorescence', 'assay', 'IFA', 'or', 'by', 'enzyme', 'linked', 'immunosorbant', 'assay', 'ELISA', 'of', 'nucleocapsid', 'protein', 'NP', 'The', 'spike', 'glycoprotein', 'of', 'SARS', 'CoV', 'is', 'the', 'major', 'inducer', 'of', 'neutralizing', 'antibodies', 'The', 'receptor', 'binding', 'domain', 'RBD', 'in', 'the', 'S1', 'region', 'of', 'the', 'spike', 'glycoprotein', 'contains', 'multiple', 'conformational', 'epitopes', 'that', 'induces', 'highly', 'potent', 'neutralizing', 'antibodies', 'The', 'genetically', 'engineered', 'attenuated', 'form', 'of', 'the', 'virus', 'or', 'viral', 'vector', 'vaccine', 'encoding', 'for', 'the', 'SARS', 'CoV', 'spike', 'glycoprotein', 'has', 'been', 'shown', 'to', 'elicit', 'protective', 'immunity', 'in', 'vaccinated', 'animals', 'CONCLUSION', 'NP', 'is', 'the', 'preferred', 'target', 'for', 'routine', 'detection', 'of', 'SARS', 'CoV', 'infection', 'by', 'ELISA', 'which', 'is', 'an', 'economical', 'method', 'compared', 'to', 'other', 'methods', 'The', 'RBD', 'of', 'the', 'spike', 'glycoprotein', 'is', 'both', 'a', 'functional', 'domain', 'for', 'cell', 'receptor', 'binding', 'and', 'also', 'a', 'major', 'neutralizing', 'determinant', 'of', 'SARS', 'CoV', 'The', 'progress', 'in', 'evaluating', 'a', 'therapeutic', 'or', 'vaccine', 'would', 'depend', 'on', 'the', 'avail', 'ability', 'of', 'clinically', 'relevant', 'animal', 'model', '']"
83081,Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins.,2007,Clinical and vaccine immunology : CVI,https://www.ncbi.nlm.nih.gov/pubmed/17229882/,Recombinant severe acute respiratory syndrome (SARS) nucleocapsid and spike protein-based immunoglobulin G immunoassays were developed and evaluated. Our assays demonstrated high sensitivity and specificity to the SARS coronavirus in sera collected from patients as late as 2 years postonset of symptoms. These assays will be useful not only for routine SARS coronavirus diagnostics but also for epidemiological and antibody kinetic studies.,,qfsxuyow,"['Recombinant', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'nucleocapsid', 'and', 'spike', 'protein', 'based', 'immunoglobulin', 'G', 'immunoassays', 'were', 'developed', 'and', 'evaluated', 'Our', 'assays', 'demonstrated', 'high', 'sensitivity', 'and', 'specificity', 'to', 'the', 'SARS', 'coronavirus', 'in', 'sera', 'collected', 'from', 'patients', 'as', 'late', 'as', '2', 'years', 'postonset', 'of', 'symptoms', 'These', 'assays', 'will', 'be', 'useful', 'not', 'only', 'for', 'routine', 'SARS', 'coronavirus', 'diagnostics', 'but', 'also', 'for', 'epidemiological', 'and', 'antibody', 'kinetic', 'studies', '']"
83431,Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe.,2005,Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,https://www.ncbi.nlm.nih.gov/pubmed/16077216/,"The threat posed by emerging and re-emerging communicable diseases and, more recently, by the intentional release of infectious agents in a susceptible population, has been receiving considerable attention at the national and international levels. Public health efforts to strengthen disease detection, surveillance and control have been intensified. However, clinicians and clinical microbiology laboratories play an important role in the early detection of disease, the identification of the putative agent, and notification of the appropriate authorities. To be effective in this role, laboratories must be specially prepared to handle viral agents safely, and need, among other things, the appropriate rapid and sensitive diagnostic tests. In 1998 the European Network for Diagnostics of 'Imported' Viral Diseases (ENIVD) was established. ENIVD presently comprises, as permanent members, 44 expert laboratories in 21 European Union (EU) member states and 4 non-EU countries and is one of the networks on infectious diseases funded by the European Commission. ENIVD fulfils many of the important tasks required for the surveillance and control of imported, rare and emerging viral infections such as the exchange of expertise and the organisation of external quality assurance (EQA) programmes, both of which are needed to improve diagnostics. Here, we summarise the data generated by recent EQA activities focussed on the diagnostics of infections with hantavirus, dengue virus, filovirus, Lassa virus, orthopox virus and the SARS-coronavirus (SARS-CoV). These were carried out between 1999 and 2004 and involved 93 laboratories from 41 countries, including laboratories from additional countries outside of Europe. Particularly the EU-candidate countries and Eastern neighbouring countries will be invited to join the network in the near future. A public website is available at http://www.enivd.de.",,9x79p8m8,"['The', 'threat', 'posed', 'by', 'emerging', 'and', 're', 'emerging', 'communicable', 'diseases', 'and', 'more', 'recently', 'by', 'the', 'intentional', 'release', 'of', 'infectious', 'agents', 'in', 'a', 'susceptible', 'population', 'has', 'been', 'receiving', 'considerable', 'attention', 'at', 'the', 'national', 'and', 'international', 'levels', 'Public', 'health', 'efforts', 'to', 'strengthen', 'disease', 'detection', 'surveillance', 'and', 'control', 'have', 'been', 'intensified', 'However', 'clinicians', 'and', 'clinical', 'microbiology', 'laboratories', 'play', 'an', 'important', 'role', 'in', 'the', 'early', 'detection', 'of', 'disease', 'the', 'identification', 'of', 'the', 'putative', 'agent', 'and', 'notification', 'of', 'the', 'appropriate', 'authorities', 'To', 'be', 'effective', 'in', 'this', 'role', 'laboratories', 'must', 'be', 'specially', 'prepared', 'to', 'handle', 'viral', 'agents', 'safely', 'and', 'need', 'among', 'other', 'things', 'the', 'appropriate', 'rapid', 'and', 'sensitive', 'diagnostic', 'tests', 'In', '1998', 'the', 'European', 'Network', 'for', 'Diagnostics', 'of', 'Imported', 'Viral', 'Diseases', 'ENIVD', 'was', 'established', 'ENIVD', 'presently', 'comprises', 'as', 'permanent', 'members', '44', 'expert', 'laboratories', 'in', '21', 'European', 'Union', 'EU', 'member', 'states', 'and', '4', 'non', 'EU', 'countries', 'and', 'is', 'one', 'of', 'the', 'networks', 'on', 'infectious', 'diseases', 'funded', 'by', 'the', 'European', 'Commission', 'ENIVD', 'fulfils', 'many', 'of', 'the', 'important', 'tasks', 'required', 'for', 'the', 'surveillance', 'and', 'control', 'of', 'imported', 'rare', 'and', 'emerging', 'viral', 'infections', 'such', 'as', 'the', 'exchange', 'of', 'expertise', 'and', 'the', 'organisation', 'of', 'external', 'quality', 'assurance', 'EQA', 'programmes', 'both', 'of', 'which', 'are', 'needed', 'to', 'improve', 'diagnostics', 'Here', 'we', 'summarise', 'the', 'data', 'generated', 'by', 'recent', 'EQA', 'activities', 'focussed', 'on', 'the', 'diagnostics', 'of', 'infections', 'with', 'hantavirus', 'dengue', 'virus', 'filovirus', 'Lassa', 'virus', 'orthopox', 'virus', 'and', 'the', 'SARS', 'coronavirus', 'SARS', 'CoV', 'These', 'were', 'carried', 'out', 'between', '1999', 'and', '2004', 'and', 'involved', '93', 'laboratories', 'from', '41', 'countries', 'including', 'laboratories', 'from', 'additional', 'countries', 'outside', 'of', 'Europe', 'Particularly', 'the', 'EU', 'candidate', 'countries', 'and', 'Eastern', 'neighbouring', 'countries', 'will', 'be', 'invited', 'to', 'join', 'the', 'network', 'in', 'the', 'near', 'future', 'A', 'public', 'website', 'is', 'available', 'at', 'http', 'www', 'enivd', 'de', '']"
84050,Clinical role of respiratory virus infection in acute otitis media.,1990,Pediatrics,https://www.ncbi.nlm.nih.gov/pubmed/2174535/,"The clinical characteristics of acute otitis media in relation to coexisting respiratory virus infection were studied in a 1-year prospective study of 363 children with acute otitis media. Respiratory viruses were detected using virus isolation and virus antigen detection in nasopharyngeal specimens of 42% of the patients at the time of diagnosis. Rhinovirus (24%) and respiratory syncytial virus (13%) were the two most common viruses detected. Adenovirus, parainfluenza viruses, and coronavirus OC43 were found less frequently. The mean duration of preceding symptoms was 5.9 days before the diagnosis of acute otitis media. Ninety-four percent of the children had symptoms of upper respiratory tract infection. Fever was reported in 55% and earache in 47% of cases. Patients with respiratory syncytial virus infection had fever, cough, and vomiting significantly more often than patients with rhinovirus infection or virus-negative patients. No significant differences were found in the appearance of the tympanic membrane and outcome of illness between virus-negative and virus-positive patients with acute otitis. Most patients respond well to antimicrobial therapy despite the coexisting viral infection. If the symptoms of infection persist, they can be due to the underlying viral infection, and viral diagnostics preferably with rapid methods may be clinically useful in these patients.",,fp6d76yv,"['The', 'clinical', 'characteristics', 'of', 'acute', 'otitis', 'media', 'in', 'relation', 'to', 'coexisting', 'respiratory', 'virus', 'infection', 'were', 'studied', 'in', 'a', '1', 'year', 'prospective', 'study', 'of', '363', 'children', 'with', 'acute', 'otitis', 'media', 'Respiratory', 'viruses', 'were', 'detected', 'using', 'virus', 'isolation', 'and', 'virus', 'antigen', 'detection', 'in', 'nasopharyngeal', 'specimens', 'of', '42', 'of', 'the', 'patients', 'at', 'the', 'time', 'of', 'diagnosis', 'Rhinovirus', '24', 'and', 'respiratory', 'syncytial', 'virus', '13', 'were', 'the', 'two', 'most', 'common', 'viruses', 'detected', 'Adenovirus', 'parainfluenza', 'viruses', 'and', 'coronavirus', 'OC43', 'were', 'found', 'less', 'frequently', 'The', 'mean', 'duration', 'of', 'preceding', 'symptoms', 'was', '5', '9', 'days', 'before', 'the', 'diagnosis', 'of', 'acute', 'otitis', 'media', 'Ninety', 'four', 'percent', 'of', 'the', 'children', 'had', 'symptoms', 'of', 'upper', 'respiratory', 'tract', 'infection', 'Fever', 'was', 'reported', 'in', '55', 'and', 'earache', 'in', '47', 'of', 'cases', 'Patients', 'with', 'respiratory', 'syncytial', 'virus', 'infection', 'had', 'fever', 'cough', 'and', 'vomiting', 'significantly', 'more', 'often', 'than', 'patients', 'with', 'rhinovirus', 'infection', 'or', 'virus', 'negative', 'patients', 'No', 'significant', 'differences', 'were', 'found', 'in', 'the', 'appearance', 'of', 'the', 'tympanic', 'membrane', 'and', 'outcome', 'of', 'illness', 'between', 'virus', 'negative', 'and', 'virus', 'positive', 'patients', 'with', 'acute', 'otitis', 'Most', 'patients', 'respond', 'well', 'to', 'antimicrobial', 'therapy', 'despite', 'the', 'coexisting', 'viral', 'infection', 'If', 'the', 'symptoms', 'of', 'infection', 'persist', 'they', 'can', 'be', 'due', 'to', 'the', 'underlying', 'viral', 'infection', 'and', 'viral', 'diagnostics', 'preferably', 'with', 'rapid', 'methods', 'may', 'be', 'clinically', 'useful', 'in', 'these', 'patients', '']"
86313,Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR.,2004,Journal of clinical microbiology,https://www.ncbi.nlm.nih.gov/pubmed/15243082/,"The severe acute respiratory syndrome coronavirus (SARS-CoV) is the causative agent of the recent outbreak of severe acute respiratory syndrome. VeroE6 cells, fetal rhesus monkey kidney cells, and human peripheral blood mononuclear cells were the only cells known to be susceptible to SARS-CoV. We developed a multiplex reverse transcription-PCR assay to analyze the susceptibility of cells derived from a variety of tissues and species to SARS-CoV. Additionally, productive infection was determined by titration of cellular supernatants. Cells derived from three species of monkey were susceptible to SARS-CoV. However, the levels of SARS-CoV produced differed by 4 log(10). Mink lung epithelial cells (Mv1Lu) and R-Mix, a mixed monolayer of human lung-derived cells (A549) and mink lung-derived cells (Mv1Lu), are used by diagnostic laboratories to detect respiratory viruses (e.g., influenza virus); they were also infected with SARS-CoV, indicating that the practices of diagnostic laboratories should be examined to ensure appropriate biosafety precautions. Mv1Lu cells produce little SARS-CoV compared to that produced by VeroE6 cells, which indicates that they are a safer alternative for SARS-CoV diagnostics. Evaluation of cells permissive to other coronaviruses indicated that these cell types are not infected by SARS-CoV, providing additional evidence that SARS-CoV binds an alternative receptor. Analysis of human cells derived from lung, kidney, liver, and intestine led to the discovery that human cell lines were productively infected by SARS-CoV. This study identifies new cell lines that may be used for SARS-CoV diagnostics and/or basic research. Our data and other in vivo studies indicate that SARS-CoV has a wide host range, suggesting that the cellular receptor(s) utilized by SARS-CoV is highly conserved and is expressed by a variety of tissues.",,j5ogel6y,"['The', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'SARS', 'CoV', 'is', 'the', 'causative', 'agent', 'of', 'the', 'recent', 'outbreak', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'VeroE6', 'cells', 'fetal', 'rhesus', 'monkey', 'kidney', 'cells', 'and', 'human', 'peripheral', 'blood', 'mononuclear', 'cells', 'were', 'the', 'only', 'cells', 'known', 'to', 'be', 'susceptible', 'to', 'SARS', 'CoV', 'We', 'developed', 'a', 'multiplex', 'reverse', 'transcription', 'PCR', 'assay', 'to', 'analyze', 'the', 'susceptibility', 'of', 'cells', 'derived', 'from', 'a', 'variety', 'of', 'tissues', 'and', 'species', 'to', 'SARS', 'CoV', 'Additionally', 'productive', 'infection', 'was', 'determined', 'by', 'titration', 'of', 'cellular', 'supernatants', 'Cells', 'derived', 'from', 'three', 'species', 'of', 'monkey', 'were', 'susceptible', 'to', 'SARS', 'CoV', 'However', 'the', 'levels', 'of', 'SARS', 'CoV', 'produced', 'differed', 'by', '4', 'log', '10', 'Mink', 'lung', 'epithelial', 'cells', 'Mv1Lu', 'and', 'R', 'Mix', 'a', 'mixed', 'monolayer', 'of', 'human', 'lung', 'derived', 'cells', 'A549', 'and', 'mink', 'lung', 'derived', 'cells', 'Mv1Lu', 'are', 'used', 'by', 'diagnostic', 'laboratories', 'to', 'detect', 'respiratory', 'viruses', 'e', 'g', 'influenza', 'virus', 'they', 'were', 'also', 'infected', 'with', 'SARS', 'CoV', 'indicating', 'that', 'the', 'practices', 'of', 'diagnostic', 'laboratories', 'should', 'be', 'examined', 'to', 'ensure', 'appropriate', 'biosafety', 'precautions', 'Mv1Lu', 'cells', 'produce', 'little', 'SARS', 'CoV', 'compared', 'to', 'that', 'produced', 'by', 'VeroE6', 'cells', 'which', 'indicates', 'that', 'they', 'are', 'a', 'safer', 'alternative', 'for', 'SARS', 'CoV', 'diagnostics', 'Evaluation', 'of', 'cells', 'permissive', 'to', 'other', 'coronaviruses', 'indicated', 'that', 'these', 'cell', 'types', 'are', 'not', 'infected', 'by', 'SARS', 'CoV', 'providing', 'additional', 'evidence', 'that', 'SARS', 'CoV', 'binds', 'an', 'alternative', 'receptor', 'Analysis', 'of', 'human', 'cells', 'derived', 'from', 'lung', 'kidney', 'liver', 'and', 'intestine', 'led', 'to', 'the', 'discovery', 'that', 'human', 'cell', 'lines', 'were', 'productively', 'infected', 'by', 'SARS', 'CoV', 'This', 'study', 'identifies', 'new', 'cell', 'lines', 'that', 'may', 'be', 'used', 'for', 'SARS', 'CoV', 'diagnostics', 'and', 'or', 'basic', 'research', 'Our', 'data', 'and', 'other', 'in', 'vivo', 'studies', 'indicate', 'that', 'SARS', 'CoV', 'has', 'a', 'wide', 'host', 'range', 'suggesting', 'that', 'the', 'cellular', 'receptor', 's', 'utilized', 'by', 'SARS', 'CoV', 'is', 'highly', 'conserved', 'and', 'is', 'expressed', 'by', 'a', 'variety', 'of', 'tissues', '']"
86712,The laboratory diagnosis of severe acute respiratory syndrome: emerging laboratory tests for an emerging pathogen.,2004,The Clinical biochemist. Reviews,https://www.ncbi.nlm.nih.gov/pubmed/18458711/,"The 2003 pandemic of Severe Acute Respiratory Syndrome (SARS) profiled the ability of modern diagnostic microbiology and molecular biology to identify, isolate and characterize, within weeks, a previously unknown viral infectious pathogen. The culprit, SARS coronavirus (SARS-CoV), was detected in patient specimens by traditional cell culture using an unusual cell line for respiratory viruses, Vero E6, and by reverse transcriptase polymerase chain reaction (RT-PCR) targeting the polymerase 1 B region of the genome. In addition, serologic assays were rapidly developed, and the genome of this large virus was sequenced within one month of its spread to North America. At the present time, diagnostics have progressed to the point that RT-PCR has a sensitivity approaching 80% within the first few days of onset of illness, while serology has a sensitivity close to 100% on convalescent sera taken >21 days after illness onset. Viral culture remains a method confined to biosafety level III laboratories. The specificity of RT-PCR and serology remains to be conclusively defined, but in most studies to date seems to be >90%. Serologic cross-reactivity with human coronaviruses causing the common cold may be a problem with some serologic assays. The early development of SARS-CoV diagnostics is now being replaced by refinement and optimization of these assays. Although at the present time we do not have a test that will definitively rule in or rule out SARS at the time of initial presentation of a patient with a respiratory infection, modifications of existing assays will hopefully result in our ability to make this diagnosis with a high degree of accuracy in the future.",,ycch15k8,"['The', '2003', 'pandemic', 'of', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'SARS', 'profiled', 'the', 'ability', 'of', 'modern', 'diagnostic', 'microbiology', 'and', 'molecular', 'biology', 'to', 'identify', 'isolate', 'and', 'characterize', 'within', 'weeks', 'a', 'previously', 'unknown', 'viral', 'infectious', 'pathogen', 'The', 'culprit', 'SARS', 'coronavirus', 'SARS', 'CoV', 'was', 'detected', 'in', 'patient', 'specimens', 'by', 'traditional', 'cell', 'culture', 'using', 'an', 'unusual', 'cell', 'line', 'for', 'respiratory', 'viruses', 'Vero', 'E6', 'and', 'by', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'targeting', 'the', 'polymerase', '1', 'B', 'region', 'of', 'the', 'genome', 'In', 'addition', 'serologic', 'assays', 'were', 'rapidly', 'developed', 'and', 'the', 'genome', 'of', 'this', 'large', 'virus', 'was', 'sequenced', 'within', 'one', 'month', 'of', 'its', 'spread', 'to', 'North', 'America', 'At', 'the', 'present', 'time', 'diagnostics', 'have', 'progressed', 'to', 'the', 'point', 'that', 'RT', 'PCR', 'has', 'a', 'sensitivity', 'approaching', '80', 'within', 'the', 'first', 'few', 'days', 'of', 'onset', 'of', 'illness', 'while', 'serology', 'has', 'a', 'sensitivity', 'close', 'to', '100', 'on', 'convalescent', 'sera', 'taken', '21', 'days', 'after', 'illness', 'onset', 'Viral', 'culture', 'remains', 'a', 'method', 'confined', 'to', 'biosafety', 'level', 'III', 'laboratories', 'The', 'specificity', 'of', 'RT', 'PCR', 'and', 'serology', 'remains', 'to', 'be', 'conclusively', 'defined', 'but', 'in', 'most', 'studies', 'to', 'date', 'seems', 'to', 'be', '90', 'Serologic', 'cross', 'reactivity', 'with', 'human', 'coronaviruses', 'causing', 'the', 'common', 'cold', 'may', 'be', 'a', 'problem', 'with', 'some', 'serologic', 'assays', 'The', 'early', 'development', 'of', 'SARS', 'CoV', 'diagnostics', 'is', 'now', 'being', 'replaced', 'by', 'refinement', 'and', 'optimization', 'of', 'these', 'assays', 'Although', 'at', 'the', 'present', 'time', 'we', 'do', 'not', 'have', 'a', 'test', 'that', 'will', 'definitively', 'rule', 'in', 'or', 'rule', 'out', 'SARS', 'at', 'the', 'time', 'of', 'initial', 'presentation', 'of', 'a', 'patient', 'with', 'a', 'respiratory', 'infection', 'modifications', 'of', 'existing', 'assays', 'will', 'hopefully', 'result', 'in', 'our', 'ability', 'to', 'make', 'this', 'diagnosis', 'with', 'a', 'high', 'degree', 'of', 'accuracy', 'in', 'the', 'future', '']"
87480,Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.,2004,Journal of immunology,https://www.ncbi.nlm.nih.gov/pubmed/15356154/,"The spike (S) protein of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) is not only responsible for receptor binding and virus fusion, but also a major Ag among the SARS-CoV proteins that induces protective Ab responses. In this study, we showed that the S protein of SARS-CoV is highly immunogenic during infection and immunizations, and contains five linear immunodominant sites (sites I to V) as determined by Pepscan analysis with a set of synthetic peptides overlapping the entire S protein sequence against the convalescent sera from SARS patients and antisera from small animals immunized with inactivated SARS-CoV. Site IV located in the middle region of the S protein (residues 528-635) is a major immunodominant epitope. The synthetic peptide S(603-634), which overlaps the site IV sequence reacted with all the convalescent sera from 42 SARS patient, but none of the 30 serum samples from healthy blood donors, suggesting its potential application as an Ag for developing SARS diagnostics. This study also provides information useful for designing SARS vaccines and understanding the SARS pathogenesis.",,mbu7m4u9,"['The', 'spike', 'S', 'protein', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'coronavirus', 'SARS', 'CoV', 'is', 'not', 'only', 'responsible', 'for', 'receptor', 'binding', 'and', 'virus', 'fusion', 'but', 'also', 'a', 'major', 'Ag', 'among', 'the', 'SARS', 'CoV', 'proteins', 'that', 'induces', 'protective', 'Ab', 'responses', 'In', 'this', 'study', 'we', 'showed', 'that', 'the', 'S', 'protein', 'of', 'SARS', 'CoV', 'is', 'highly', 'immunogenic', 'during', 'infection', 'and', 'immunizations', 'and', 'contains', 'five', 'linear', 'immunodominant', 'sites', 'sites', 'I', 'to', 'V', 'as', 'determined', 'by', 'Pepscan', 'analysis', 'with', 'a', 'set', 'of', 'synthetic', 'peptides', 'overlapping', 'the', 'entire', 'S', 'protein', 'sequence', 'against', 'the', 'convalescent', 'sera', 'from', 'SARS', 'patients', 'and', 'antisera', 'from', 'small', 'animals', 'immunized', 'with', 'inactivated', 'SARS', 'CoV', 'Site', 'IV', 'located', 'in', 'the', 'middle', 'region', 'of', 'the', 'S', 'protein', 'residues', '528', '635', 'is', 'a', 'major', 'immunodominant', 'epitope', 'The', 'synthetic', 'peptide', 'S', '603', '634', 'which', 'overlaps', 'the', 'site', 'IV', 'sequence', 'reacted', 'with', 'all', 'the', 'convalescent', 'sera', 'from', '42', 'SARS', 'patient', 'but', 'none', 'of', 'the', '30', 'serum', 'samples', 'from', 'healthy', 'blood', 'donors', 'suggesting', 'its', 'potential', 'application', 'as', 'an', 'Ag', 'for', 'developing', 'SARS', 'diagnostics', 'This', 'study', 'also', 'provides', 'information', 'useful', 'for', 'designing', 'SARS', 'vaccines', 'and', 'understanding', 'the', 'SARS', 'pathogenesis', '']"
87973,Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus.,2005,Journal of clinical microbiology,https://www.ncbi.nlm.nih.gov/pubmed/16081901/,"Similar to other coronaviruses, the membrane (M) protein of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) is a major transmembrane glycoprotein with multiple biological functions. To date, limited information is available about its antigenic properties. In this study, we identified two major immunodominant epitopes on the M protein located in the extreme N-terminal region (residues 1 to 31) and the interior C-terminal region (residues 132 to 161), respectively, by Pepscan analyses against convalescent-phase sera from SARS patients and antisera from virus-immunized mice and rabbits. Synthetic peptides M1-31 derived from the N-terminal epitope and M132-161 derived from the C-terminal epitope were highly reactive with all of the convalescent-phase sera from 40 SARS patients but not with 30 control serum samples from healthy blood donors, suggesting their potential application for serologic diagnosis of SARS. We showed that both peptides (M1-31 and M132-161) were able to induce high titers of antibody responses in the immunized rabbits, highlighting their antigenicity and immunogenicity. These findings provide important information for developing SARS diagnostics and vaccines.",,40m4hx06,"['Similar', 'to', 'other', 'coronaviruses', 'the', 'membrane', 'M', 'protein', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'associated', 'coronavirus', 'SARS', 'CoV', 'is', 'a', 'major', 'transmembrane', 'glycoprotein', 'with', 'multiple', 'biological', 'functions', 'To', 'date', 'limited', 'information', 'is', 'available', 'about', 'its', 'antigenic', 'properties', 'In', 'this', 'study', 'we', 'identified', 'two', 'major', 'immunodominant', 'epitopes', 'on', 'the', 'M', 'protein', 'located', 'in', 'the', 'extreme', 'N', 'terminal', 'region', 'residues', '1', 'to', '31', 'and', 'the', 'interior', 'C', 'terminal', 'region', 'residues', '132', 'to', '161', 'respectively', 'by', 'Pepscan', 'analyses', 'against', 'convalescent', 'phase', 'sera', 'from', 'SARS', 'patients', 'and', 'antisera', 'from', 'virus', 'immunized', 'mice', 'and', 'rabbits', 'Synthetic', 'peptides', 'M1', '31', 'derived', 'from', 'the', 'N', 'terminal', 'epitope', 'and', 'M132', '161', 'derived', 'from', 'the', 'C', 'terminal', 'epitope', 'were', 'highly', 'reactive', 'with', 'all', 'of', 'the', 'convalescent', 'phase', 'sera', 'from', '40', 'SARS', 'patients', 'but', 'not', 'with', '30', 'control', 'serum', 'samples', 'from', 'healthy', 'blood', 'donors', 'suggesting', 'their', 'potential', 'application', 'for', 'serologic', 'diagnosis', 'of', 'SARS', 'We', 'showed', 'that', 'both', 'peptides', 'M1', '31', 'and', 'M132', '161', 'were', 'able', 'to', 'induce', 'high', 'titers', 'of', 'antibody', 'responses', 'in', 'the', 'immunized', 'rabbits', 'highlighting', 'their', 'antigenicity', 'and', 'immunogenicity', 'These', 'findings', 'provide', 'important', 'information', 'for', 'developing', 'SARS', 'diagnostics', 'and', 'vaccines', '']"
88005,[Rapid point-of-care serology testing for sars-cov-2].,2020-05-27,Lakartidningen,https://www.ncbi.nlm.nih.gov/pubmed/32463475/,"Increasing evidence indicates immunity against severe acute respiratory syndrome coronavirus 2 (sars-cov-2) after covid-19, but it remains unclear for how long the protection remains. Serology testing seems to have a higher sensitivity than molecular diagnostics from 8 days after onset of symtoms, and should be part of risk assessment and epidemiological studies of COVID-19. The performance of commercial serological point-of-care (POC) lateral flow tests are highly manufacturer-dependant. Low sensitivity increases the risk of false negative results and could result in unnecessary quarantine of test persons with developed antibodies. Low specificity increases the risk of false positive results and could lead to false assumptions of immunity. Carefully selected serological POC tests for sars-cov-2 can be used in large scale testing but should only be used by licensed medical staff able to understand their limitations and interpret the results.",,91872v0l,"['Increasing', 'evidence', 'indicates', 'immunity', 'against', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'after', 'covid', '19', 'but', 'it', 'remains', 'unclear', 'for', 'how', 'long', 'the', 'protection', 'remains', 'Serology', 'testing', 'seems', 'to', 'have', 'a', 'higher', 'sensitivity', 'than', 'molecular', 'diagnostics', 'from', '8', 'days', 'after', 'onset', 'of', 'symtoms', 'and', 'should', 'be', 'part', 'of', 'risk', 'assessment', 'and', 'epidemiological', 'studies', 'of', 'COVID', '19', 'The', 'performance', 'of', 'commercial', 'serological', 'point', 'of', 'care', 'POC', 'lateral', 'flow', 'tests', 'are', 'highly', 'manufacturer', 'dependant', 'Low', 'sensitivity', 'increases', 'the', 'risk', 'of', 'false', 'negative', 'results', 'and', 'could', 'result', 'in', 'unnecessary', 'quarantine', 'of', 'test', 'persons', 'with', 'developed', 'antibodies', 'Low', 'specificity', 'increases', 'the', 'risk', 'of', 'false', 'positive', 'results', 'and', 'could', 'lead', 'to', 'false', 'assumptions', 'of', 'immunity', 'Carefully', 'selected', 'serological', 'POC', 'tests', 'for', 'sars', 'cov', '2', 'can', 'be', 'used', 'in', 'large', 'scale', 'testing', 'but', 'should', 'only', 'be', 'used', 'by', 'licensed', 'medical', 'staff', 'able', 'to', 'understand', 'their', 'limitations', 'and', 'interpret', 'the', 'results', '']"
88243,[Electron microscopic demonstration of viruses in feces of dogs with diarrhea].,1995,Tierarztliche Praxis,https://www.ncbi.nlm.nih.gov/pubmed/7792778/,"4044 stool samples of dogs with diarrhoea were examined by electron microscopy. The samples were sent for routine diagnostics in the years 1988-1993. Over the examination period virus was detected in 32% of the samples. Parvovirus was diagnosed in 17.2% and coronavirus in 12.4% of the cases. The number of parvovirus-positive samples was lower than in former years, whereas the number of coronavirus-positive samples was higher. Other virus particles (paramyxo-, picorna-, calici- and astrovirus or morphologically similar particles as well as rota- and adenovirus) were altogether detected in 2.5% of the samples. This detection rate corresponded to the results of former years. The majority of parvovirus-positive samples (80.7%) was found in animals aged between six weeks and six months. Of the coronavirus-positive samples 56.5% were detected in dogs older than six months of age and 42.5% in animals between six weeks and six months. In puppies up to six weeks viruses were only detected infrequently (parvovirus 4.7%, coronavirus 0.9%).",,js2ffnpt,"['4044', 'stool', 'samples', 'of', 'dogs', 'with', 'diarrhoea', 'were', 'examined', 'by', 'electron', 'microscopy', 'The', 'samples', 'were', 'sent', 'for', 'routine', 'diagnostics', 'in', 'the', 'years', '1988', '1993', 'Over', 'the', 'examination', 'period', 'virus', 'was', 'detected', 'in', '32', 'of', 'the', 'samples', 'Parvovirus', 'was', 'diagnosed', 'in', '17', '2', 'and', 'coronavirus', 'in', '12', '4', 'of', 'the', 'cases', 'The', 'number', 'of', 'parvovirus', 'positive', 'samples', 'was', 'lower', 'than', 'in', 'former', 'years', 'whereas', 'the', 'number', 'of', 'coronavirus', 'positive', 'samples', 'was', 'higher', 'Other', 'virus', 'particles', 'paramyxo', 'picorna', 'calici', 'and', 'astrovirus', 'or', 'morphologically', 'similar', 'particles', 'as', 'well', 'as', 'rota', 'and', 'adenovirus', 'were', 'altogether', 'detected', 'in', '2', '5', 'of', 'the', 'samples', 'This', 'detection', 'rate', 'corresponded', 'to', 'the', 'results', 'of', 'former', 'years', 'The', 'majority', 'of', 'parvovirus', 'positive', 'samples', '80', '7', 'was', 'found', 'in', 'animals', 'aged', 'between', 'six', 'weeks', 'and', 'six', 'months', 'Of', 'the', 'coronavirus', 'positive', 'samples', '56', '5', 'were', 'detected', 'in', 'dogs', 'older', 'than', 'six', 'months', 'of', 'age', 'and', '42', '5', 'in', 'animals', 'between', 'six', 'weeks', 'and', 'six', 'months', 'In', 'puppies', 'up', 'to', 'six', 'weeks', 'viruses', 'were', 'only', 'detected', 'infrequently', 'parvovirus', '4', '7', 'coronavirus', '0', '9', '']"
90073,Mass spectrometric characterization of proteins from the SARS virus: a preliminary report.,2003,Molecular & cellular proteomics : MCP,https://www.ncbi.nlm.nih.gov/pubmed/12775768/,"A new coronavirus has been implicated as the causative agent of severe acute respiratory syndrome (SARS). We have used convalescent sera from several SARS patients to detect proteins in the culture supernatants from cells exposed to lavage another SARS patient. The most prominent protein in the supernatant was identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) as a approximately 46-kDa species. This was found to be a novel nucleocapsid protein that matched almost exactly one predicted by an open reading frame in the recently published nucleotide sequence of the same virus isolate (>96% coverage). A second viral protein corresponding to the predicted approximately 139-kDa spike glycoprotein has also been examined by MALDI-TOF MS (42% coverage). After peptide N-glycosidase F digestion, 12 glycosylation sites in this protein were confirmed. The sugars attached to four of the sites were also identified. These results suggest that the nucleocapsid protein is a major immunogen that may be useful for early diagnostics, and that the spike glycoprotein may present a particularly attractive target for prophylactic intervention in combating SARS.",,n9z83zcf,"['A', 'new', 'coronavirus', 'has', 'been', 'implicated', 'as', 'the', 'causative', 'agent', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'We', 'have', 'used', 'convalescent', 'sera', 'from', 'several', 'SARS', 'patients', 'to', 'detect', 'proteins', 'in', 'the', 'culture', 'supernatants', 'from', 'cells', 'exposed', 'to', 'lavage', 'another', 'SARS', 'patient', 'The', 'most', 'prominent', 'protein', 'in', 'the', 'supernatant', 'was', 'identified', 'by', 'matrix', 'assisted', 'laser', 'desorption', 'ionization', 'time', 'of', 'flight', 'mass', 'spectrometry', 'MALDI', 'TOF', 'MS', 'as', 'a', 'approximately', '46', 'kDa', 'species', 'This', 'was', 'found', 'to', 'be', 'a', 'novel', 'nucleocapsid', 'protein', 'that', 'matched', 'almost', 'exactly', 'one', 'predicted', 'by', 'an', 'open', 'reading', 'frame', 'in', 'the', 'recently', 'published', 'nucleotide', 'sequence', 'of', 'the', 'same', 'virus', 'isolate', '96', 'coverage', 'A', 'second', 'viral', 'protein', 'corresponding', 'to', 'the', 'predicted', 'approximately', '139', 'kDa', 'spike', 'glycoprotein', 'has', 'also', 'been', 'examined', 'by', 'MALDI', 'TOF', 'MS', '42', 'coverage', 'After', 'peptide', 'N', 'glycosidase', 'F', 'digestion', '12', 'glycosylation', 'sites', 'in', 'this', 'protein', 'were', 'confirmed', 'The', 'sugars', 'attached', 'to', 'four', 'of', 'the', 'sites', 'were', 'also', 'identified', 'These', 'results', 'suggest', 'that', 'the', 'nucleocapsid', 'protein', 'is', 'a', 'major', 'immunogen', 'that', 'may', 'be', 'useful', 'for', 'early', 'diagnostics', 'and', 'that', 'the', 'spike', 'glycoprotein', 'may', 'present', 'a', 'particularly', 'attractive', 'target', 'for', 'prophylactic', 'intervention', 'in', 'combating', 'SARS', '']"
90555,"New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus.",2005,Antiviral chemistry & chemotherapy,https://www.ncbi.nlm.nih.gov/pubmed/15739618/,"Severe acute respiratory syndrome (SARS) is caused by one of two recently discovered coronaviruses. The virus is emergent from South East (SE) Asian mammals: either the civet cat, a related species or a rat species. The virus has a long incubation period and low reproduction number (R0 value) and hence the first outbreak in 2004 was controlled by hygiene and quarantine. However, the healthcare system was compromised and the economic cost was extremely high. Fortunately, the virus is easily cultivated in Vero E6 cells and therefore the search for new antivirals and vaccines was initiated within weeks of the discovery of the virus using classic techniques of cell culture and electron microscopy. Molecular diagnostics facilitated rapid and accurate diagnosis, a key factor in containing the outbreak. The broad-spectrum molecule ribavirin was used in SE Asia in infected patients alongside corticosteroids. In retrospect, many patients survived due to careful nursing. The only currently accepted intervention is interferon. Coronavirus replicon systems should facilitate rapid screening of new inhibitors and the complex mechanism of viral replication will ensure that drugs are developed against at least five molecular targets, in particular the viral protease.",,e40xhnng,"['Severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'is', 'caused', 'by', 'one', 'of', 'two', 'recently', 'discovered', 'coronaviruses', 'The', 'virus', 'is', 'emergent', 'from', 'South', 'East', 'SE', 'Asian', 'mammals', 'either', 'the', 'civet', 'cat', 'a', 'related', 'species', 'or', 'a', 'rat', 'species', 'The', 'virus', 'has', 'a', 'long', 'incubation', 'period', 'and', 'low', 'reproduction', 'number', 'R0', 'value', 'and', 'hence', 'the', 'first', 'outbreak', 'in', '2004', 'was', 'controlled', 'by', 'hygiene', 'and', 'quarantine', 'However', 'the', 'healthcare', 'system', 'was', 'compromised', 'and', 'the', 'economic', 'cost', 'was', 'extremely', 'high', 'Fortunately', 'the', 'virus', 'is', 'easily', 'cultivated', 'in', 'Vero', 'E6', 'cells', 'and', 'therefore', 'the', 'search', 'for', 'new', 'antivirals', 'and', 'vaccines', 'was', 'initiated', 'within', 'weeks', 'of', 'the', 'discovery', 'of', 'the', 'virus', 'using', 'classic', 'techniques', 'of', 'cell', 'culture', 'and', 'electron', 'microscopy', 'Molecular', 'diagnostics', 'facilitated', 'rapid', 'and', 'accurate', 'diagnosis', 'a', 'key', 'factor', 'in', 'containing', 'the', 'outbreak', 'The', 'broad', 'spectrum', 'molecule', 'ribavirin', 'was', 'used', 'in', 'SE', 'Asia', 'in', 'infected', 'patients', 'alongside', 'corticosteroids', 'In', 'retrospect', 'many', 'patients', 'survived', 'due', 'to', 'careful', 'nursing', 'The', 'only', 'currently', 'accepted', 'intervention', 'is', 'interferon', 'Coronavirus', 'replicon', 'systems', 'should', 'facilitate', 'rapid', 'screening', 'of', 'new', 'inhibitors', 'and', 'the', 'complex', 'mechanism', 'of', 'viral', 'replication', 'will', 'ensure', 'that', 'drugs', 'are', 'developed', 'against', 'at', 'least', 'five', 'molecular', 'targets', 'in', 'particular', 'the', 'viral', 'protease', '']"
90566,SARS: an emerging global microbial threat.,2004,Transactions of the American Clinical and Climatological Association,https://www.ncbi.nlm.nih.gov/pubmed/17060979/,"In March 2003, the Institute of Medicine published an update to its 1992 landmark report on emerging infections. The new report, Microbial Threats to Health: Emergence, Detection, and Response, describes the current spectrum of global microbial threats, factors affecting their emergence or resurgence, and measures that should be undertaken to effectively address them. Coincident with this publication came increasing reports of severe atypical pneumonia of unknown etiology among persons in southeast Asia. This new disease, designated severe acute respiratory syndrome (SARS), spread globally in a matter of weeks, infecting primarily close contacts of index patients (e.g., household members and healthcare workers caring for index patients) but also resulting in community transmission in some areas. An unprecedented worldwide collaborative effort was undertaken to determine the cause of the illness and implement prevention measures. A previously unrecognized coronavirus was identified as the causative agent, and health officials throughout the world struggled to implement measures to contain its spread, including isolation of suspect SARS cases and quarantine of exposed persons. The emergence of SARS is a timely reminder of the need to expect the unexpected and to ensure strong national and global public health partnerships when preparing for and responding to infectious diseases. Effectively addressing the threat of SARS will require enhanced global infectious disease surveillance, the development of rapid diagnostics, new therapies, and vaccines, implementation of aggressive evidence-based infection control strategies, and effective communication.",,pdpg55aq,"['In', 'March', '2003', 'the', 'Institute', 'of', 'Medicine', 'published', 'an', 'update', 'to', 'its', '1992', 'landmark', 'report', 'on', 'emerging', 'infections', 'The', 'new', 'report', 'Microbial', 'Threats', 'to', 'Health', 'Emergence', 'Detection', 'and', 'Response', 'describes', 'the', 'current', 'spectrum', 'of', 'global', 'microbial', 'threats', 'factors', 'affecting', 'their', 'emergence', 'or', 'resurgence', 'and', 'measures', 'that', 'should', 'be', 'undertaken', 'to', 'effectively', 'address', 'them', 'Coincident', 'with', 'this', 'publication', 'came', 'increasing', 'reports', 'of', 'severe', 'atypical', 'pneumonia', 'of', 'unknown', 'etiology', 'among', 'persons', 'in', 'southeast', 'Asia', 'This', 'new', 'disease', 'designated', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'spread', 'globally', 'in', 'a', 'matter', 'of', 'weeks', 'infecting', 'primarily', 'close', 'contacts', 'of', 'index', 'patients', 'e', 'g', 'household', 'members', 'and', 'healthcare', 'workers', 'caring', 'for', 'index', 'patients', 'but', 'also', 'resulting', 'in', 'community', 'transmission', 'in', 'some', 'areas', 'An', 'unprecedented', 'worldwide', 'collaborative', 'effort', 'was', 'undertaken', 'to', 'determine', 'the', 'cause', 'of', 'the', 'illness', 'and', 'implement', 'prevention', 'measures', 'A', 'previously', 'unrecognized', 'coronavirus', 'was', 'identified', 'as', 'the', 'causative', 'agent', 'and', 'health', 'officials', 'throughout', 'the', 'world', 'struggled', 'to', 'implement', 'measures', 'to', 'contain', 'its', 'spread', 'including', 'isolation', 'of', 'suspect', 'SARS', 'cases', 'and', 'quarantine', 'of', 'exposed', 'persons', 'The', 'emergence', 'of', 'SARS', 'is', 'a', 'timely', 'reminder', 'of', 'the', 'need', 'to', 'expect', 'the', 'unexpected', 'and', 'to', 'ensure', 'strong', 'national', 'and', 'global', 'public', 'health', 'partnerships', 'when', 'preparing', 'for', 'and', 'responding', 'to', 'infectious', 'diseases', 'Effectively', 'addressing', 'the', 'threat', 'of', 'SARS', 'will', 'require', 'enhanced', 'global', 'infectious', 'disease', 'surveillance', 'the', 'development', 'of', 'rapid', 'diagnostics', 'new', 'therapies', 'and', 'vaccines', 'implementation', 'of', 'aggressive', 'evidence', 'based', 'infection', 'control', 'strategies', 'and', 'effective', 'communication', '']"
90632,[Laboratory diagnostics in evaluation of acute respiratory viral infection morbidity in 2010 - 2011 epidemic season].,2013,"Zhurnal mikrobiologii, epidemiologii, i immunobiologii",https://www.ncbi.nlm.nih.gov/pubmed/23805649/,"AIM Study of etiological structure of ARVI and evaluation of acute respiratory virus infection morbidity in 2010 - 2011 epidemic season taking into account the data of laboratory diagnostics by method of polymerase chain reaction with hybridization-fluorescent detection. MATERIALS AND METHODS By using reagent kits produced by Central Research Institute of Epidemiology for the detection of primary causative agents of influenza and ARVI 129 children and 94 adult patients monitored in an outpatient setting as well as 103 children hospitalized due to ARI were examined. RESULTS Etiological structure of ARVI was studied; proportion of influenza and other actual causative agents of ARVI in monthly dynamics were established. During epidemic rise of influenza (January-March 2011) the proportion of influenza A viruses was 24% (peak in January--31%), the proportion of influenza B viruses--5%, rhinoviruses--9%, metapneumovirus was detected in 6% of cases, parainfluenza viruses (1 - 4 type) and adenovirses--4% each, coronaviruses--in 3%, respiratory syncytial virus--in 2%, bocavirus--in 1% of the studied samples. In influenza structure A/H1N1pdm2009 virus, its proportion was 70%, influenza virus B (26.9%), influenza virus A/H3N2 (2.6%) predominated. Indexes for monthly morbidity caused by each of the ARVI causative agents were calculated. CONCLUSION The proposed approach allowed to evaluate ARVI morbidity taking into account laboratory-confirmed etiological factors. A 5 time increase in ARI morbidity in adults in February 2011 was shown to be mostly due to an increase in influenza A morbidity as well as involvement of influenza B virus, metapneumoviruses, coronaviruses, parainfluenza viruses and rhinoviruses into the epidemic process. Increase of morbidity of children by 1.4 times was also seen during activization of influenza viruses and metapneumovirus. The analysis of monitoring results allowed to prognose increase of respiratory-syncytial viral infection epidemic activity from September 2011 to February 2012.",,gtewf8tp,"['AIM', 'Study', 'of', 'etiological', 'structure', 'of', 'ARVI', 'and', 'evaluation', 'of', 'acute', 'respiratory', 'virus', 'infection', 'morbidity', 'in', '2010', '2011', 'epidemic', 'season', 'taking', 'into', 'account', 'the', 'data', 'of', 'laboratory', 'diagnostics', 'by', 'method', 'of', 'polymerase', 'chain', 'reaction', 'with', 'hybridization', 'fluorescent', 'detection', 'MATERIALS', 'AND', 'METHODS', 'By', 'using', 'reagent', 'kits', 'produced', 'by', 'Central', 'Research', 'Institute', 'of', 'Epidemiology', 'for', 'the', 'detection', 'of', 'primary', 'causative', 'agents', 'of', 'influenza', 'and', 'ARVI', '129', 'children', 'and', '94', 'adult', 'patients', 'monitored', 'in', 'an', 'outpatient', 'setting', 'as', 'well', 'as', '103', 'children', 'hospitalized', 'due', 'to', 'ARI', 'were', 'examined', 'RESULTS', 'Etiological', 'structure', 'of', 'ARVI', 'was', 'studied', 'proportion', 'of', 'influenza', 'and', 'other', 'actual', 'causative', 'agents', 'of', 'ARVI', 'in', 'monthly', 'dynamics', 'were', 'established', 'During', 'epidemic', 'rise', 'of', 'influenza', 'January', 'March', '2011', 'the', 'proportion', 'of', 'influenza', 'A', 'viruses', 'was', '24', 'peak', 'in', 'January', '31', 'the', 'proportion', 'of', 'influenza', 'B', 'viruses', '5', 'rhinoviruses', '9', 'metapneumovirus', 'was', 'detected', 'in', '6', 'of', 'cases', 'parainfluenza', 'viruses', '1', '4', 'type', 'and', 'adenovirses', '4', 'each', 'coronaviruses', 'in', '3', 'respiratory', 'syncytial', 'virus', 'in', '2', 'bocavirus', 'in', '1', 'of', 'the', 'studied', 'samples', 'In', 'influenza', 'structure', 'A', 'H1N1pdm2009', 'virus', 'its', 'proportion', 'was', '70', 'influenza', 'virus', 'B', '26', '9', 'influenza', 'virus', 'A', 'H3N2', '2', '6', 'predominated', 'Indexes', 'for', 'monthly', 'morbidity', 'caused', 'by', 'each', 'of', 'the', 'ARVI', 'causative', 'agents', 'were', 'calculated', 'CONCLUSION', 'The', 'proposed', 'approach', 'allowed', 'to', 'evaluate', 'ARVI', 'morbidity', 'taking', 'into', 'account', 'laboratory', 'confirmed', 'etiological', 'factors', 'A', '5', 'time', 'increase', 'in', 'ARI', 'morbidity', 'in', 'adults', 'in', 'February', '2011', 'was', 'shown', 'to', 'be', 'mostly', 'due', 'to', 'an', 'increase', 'in', 'influenza', 'A', 'morbidity', 'as', 'well', 'as', 'involvement', 'of', 'influenza', 'B', 'virus', 'metapneumoviruses', 'coronaviruses', 'parainfluenza', 'viruses', 'and', 'rhinoviruses', 'into', 'the', 'epidemic', 'process', 'Increase', 'of', 'morbidity', 'of', 'children', 'by', '1', '4', 'times', 'was', 'also', 'seen', 'during', 'activization', 'of', 'influenza', 'viruses', 'and', 'metapneumovirus', 'The', 'analysis', 'of', 'monitoring', 'results', 'allowed', 'to', 'prognose', 'increase', 'of', 'respiratory', 'syncytial', 'viral', 'infection', 'epidemic', 'activity', 'from', 'September', '2011', 'to', 'February', '2012', '']"
90813,COVID 19 diagnostic multiplicity and its role in community surveillance and control.,2020-06-01,Le infezioni in medicina,https://www.ncbi.nlm.nih.gov/pubmed/32532934/,"Diagnosis of persons exposed to/infected with severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) is central to controlling the global pandemic of COVID-19. Currently, several diagnostic modalities are available for COVID-19, each with its own pros and cons. Although there is a global consensus to increase the testing capacity, it is also essential to prudently utilize these tests to control the pandemic. In this paper, we have reviewed the current array of diagnostics for SARS-CoV-2, highlighted the gaps in current diagnostic modalities, and their role in community surveillance and control of the pandemic. The different modalities of COVID-19 diagnosis discussed are: clinical and radiological, molecular based (laboratory based and point-of-care), Immunoassay based (ELISA, rapid antigen and antibody detection tests) and digital diagnostics (artificial intelligence based algorithms). The role of rapid antigen/antibody detection tests in community surveillance has also been described here. These tests can be used to identify asymptomatic persons exposed to the virus and in community based seroprevalence surveys to assess the epidemiology of spread of the virus. However, there are few concerns about the accuracy of these tests which needs to evaluated beforehand.",,846t2t8g,"['Diagnosis', 'of', 'persons', 'exposed', 'to', 'infected', 'with', 'severe', 'acute', 'respiratory', 'syndrome', 'related', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'central', 'to', 'controlling', 'the', 'global', 'pandemic', 'of', 'COVID', '19', 'Currently', 'several', 'diagnostic', 'modalities', 'are', 'available', 'for', 'COVID', '19', 'each', 'with', 'its', 'own', 'pros', 'and', 'cons', 'Although', 'there', 'is', 'a', 'global', 'consensus', 'to', 'increase', 'the', 'testing', 'capacity', 'it', 'is', 'also', 'essential', 'to', 'prudently', 'utilize', 'these', 'tests', 'to', 'control', 'the', 'pandemic', 'In', 'this', 'paper', 'we', 'have', 'reviewed', 'the', 'current', 'array', 'of', 'diagnostics', 'for', 'SARS', 'CoV', '2', 'highlighted', 'the', 'gaps', 'in', 'current', 'diagnostic', 'modalities', 'and', 'their', 'role', 'in', 'community', 'surveillance', 'and', 'control', 'of', 'the', 'pandemic', 'The', 'different', 'modalities', 'of', 'COVID', '19', 'diagnosis', 'discussed', 'are', 'clinical', 'and', 'radiological', 'molecular', 'based', 'laboratory', 'based', 'and', 'point', 'of', 'care', 'Immunoassay', 'based', 'ELISA', 'rapid', 'antigen', 'and', 'antibody', 'detection', 'tests', 'and', 'digital', 'diagnostics', 'artificial', 'intelligence', 'based', 'algorithms', 'The', 'role', 'of', 'rapid', 'antigen', 'antibody', 'detection', 'tests', 'in', 'community', 'surveillance', 'has', 'also', 'been', 'described', 'here', 'These', 'tests', 'can', 'be', 'used', 'to', 'identify', 'asymptomatic', 'persons', 'exposed', 'to', 'the', 'virus', 'and', 'in', 'community', 'based', 'seroprevalence', 'surveys', 'to', 'assess', 'the', 'epidemiology', 'of', 'spread', 'of', 'the', 'virus', 'However', 'there', 'are', 'few', 'concerns', 'about', 'the', 'accuracy', 'of', 'these', 'tests', 'which', 'needs', 'to', 'evaluated', 'beforehand', '']"
92286,Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis.,2005,Clinical science,https://www.ncbi.nlm.nih.gov/pubmed/16171460/,"qRT-PCR (real-time reverse transcription-PCR) has become the benchmark for the detection and quantification of RNA targets and is being utilized increasingly in novel clinical diagnostic assays. Quantitative results obtained by this technology are not only more informative than qualitative data, but simplify assay standardization and quality management. qRT-PCR assays are most established for the detection of viral load and therapy monitoring, and the development of SARS (severe acute respiratory syndrome)-associated coronavirus qRT-PCR assays provide a textbook example of the value of this technology for clinical diagnostics. The widespread use of qRT-PCR assays for diagnosis and the detection of disease-specific prognostic markers in leukaemia patients provide further examples of their usefulness. Their value for the detection of disease-associated mRNA expressed by circulating tumour cells in patients with solid malignancies is far less apparent, and the clinical significance of results obtained from such tests remains unclear. This is because of conceptual reservations as well as technical limitations that can interfere with the diagnostic specificity of qRT-PCR assays. Therefore, although it is evident that qRT-PCR assay has become a useful and important technology in the clinical diagnostic laboratory, it must be used appropriately and it is essential to be aware of its limitations if it is to fulfil its potential.",,z1d8i5em,"['qRT', 'PCR', 'real', 'time', 'reverse', 'transcription', 'PCR', 'has', 'become', 'the', 'benchmark', 'for', 'the', 'detection', 'and', 'quantification', 'of', 'RNA', 'targets', 'and', 'is', 'being', 'utilized', 'increasingly', 'in', 'novel', 'clinical', 'diagnostic', 'assays', 'Quantitative', 'results', 'obtained', 'by', 'this', 'technology', 'are', 'not', 'only', 'more', 'informative', 'than', 'qualitative', 'data', 'but', 'simplify', 'assay', 'standardization', 'and', 'quality', 'management', 'qRT', 'PCR', 'assays', 'are', 'most', 'established', 'for', 'the', 'detection', 'of', 'viral', 'load', 'and', 'therapy', 'monitoring', 'and', 'the', 'development', 'of', 'SARS', 'severe', 'acute', 'respiratory', 'syndrome', 'associated', 'coronavirus', 'qRT', 'PCR', 'assays', 'provide', 'a', 'textbook', 'example', 'of', 'the', 'value', 'of', 'this', 'technology', 'for', 'clinical', 'diagnostics', 'The', 'widespread', 'use', 'of', 'qRT', 'PCR', 'assays', 'for', 'diagnosis', 'and', 'the', 'detection', 'of', 'disease', 'specific', 'prognostic', 'markers', 'in', 'leukaemia', 'patients', 'provide', 'further', 'examples', 'of', 'their', 'usefulness', 'Their', 'value', 'for', 'the', 'detection', 'of', 'disease', 'associated', 'mRNA', 'expressed', 'by', 'circulating', 'tumour', 'cells', 'in', 'patients', 'with', 'solid', 'malignancies', 'is', 'far', 'less', 'apparent', 'and', 'the', 'clinical', 'significance', 'of', 'results', 'obtained', 'from', 'such', 'tests', 'remains', 'unclear', 'This', 'is', 'because', 'of', 'conceptual', 'reservations', 'as', 'well', 'as', 'technical', 'limitations', 'that', 'can', 'interfere', 'with', 'the', 'diagnostic', 'specificity', 'of', 'qRT', 'PCR', 'assays', 'Therefore', 'although', 'it', 'is', 'evident', 'that', 'qRT', 'PCR', 'assay', 'has', 'become', 'a', 'useful', 'and', 'important', 'technology', 'in', 'the', 'clinical', 'diagnostic', 'laboratory', 'it', 'must', 'be', 'used', 'appropriately', 'and', 'it', 'is', 'essential', 'to', 'be', 'aware', 'of', 'its', 'limitations', 'if', 'it', 'is', 'to', 'fulfil', 'its', 'potential', '']"
93097,"Features, Evaluation and Treatment Coronavirus (COVID-19)",2020,StatPearls,,"According to the World Health Organization (WHO), viral diseases continue to emerge and represent a serious issue to public health In the last twenty years, several viral epidemics such as the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 to 2003, and H1N1 influenza in 2009, have been recorded Most recently, the Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia in 2012 In a timeline that reaches the present day, an epidemic of cases with unexplained low respiratory infections detected in Wuhan, the largest metropolitan area in China's Hubei province, was first reported to the WHO Country Office in China, on December 31, 2019 Published literature can trace the beginning of symptomatic individuals back to the beginning of December 2019 As they were unable to identify the causative agent, these first cases were classified as ""pneumonia of unknown etiology "" The Chinese Center for Disease Control and Prevention (CDC) and local CDCs organized an intensive outbreak investigation program The etiology of this illness is now attributed to a novel virus belonging to the coronavirus (CoV) family, COVID-19 On February 11, 2020, the WHO Director-General, Dr Tedros Adhanom Ghebreyesus, announced that the disease caused by this new CoV was a ""COVID-19,"" which is the acronym of ""coronavirus disease 2019"" In the past twenty years, two additional coronavirus epidemics have occurred SARS-CoV provoked a large-scale epidemic beginning in China and involving two dozen countries with approximately 8000 cases and 800 deaths, and the MERS-CoV that began in Saudi Arabia and has approximately 2,500 cases and 800 deaths and still causes as sporadic cases This new virus seems to be very contagious and has quickly spread globally In a meeting on January 30, 2020, per the International Health Regulations (IHR, 2005), the outbreak was declared by the WHO a Public Health Emergency of International Concern (PHEIC) as it had spread to 18 countries with four countries reporting human-to-human transmission An additional landmark occurred on February 26, 2020, as the first case of the disease, not imported from China, was recorded in the United States Initially, the new virus was called 2019-nCoV Subsequently, the task of experts of the International Committee on Taxonomy of Viruses (ICTV) termed it the SARS-CoV-2 virus as it is very similar to the one that caused the SARS outbreak (SARS-CoVs) The CoVs have become the major pathogens of emerging respiratory disease outbreaks They are a large family of single-stranded RNA viruses (+ssRNA) that can be isolated in different animal species For reasons yet to be explained, these viruses can cross species barriers and can cause, in humans, illness ranging from the common cold to more severe diseases such as MERS and SARS Interestingly, these latter viruses have probably originated from bats and then moving into other mammalian hosts — the Himalayan palm civet for SARS-CoV, and the dromedary camel for MERS-CoV — before jumping to humans The dynamics of SARS-Cov-2 are currently unknown, but there is speculation that it also has an animal origin The potential for these viruses to grow to become a pandemic worldwide seems to be a serious public health risk Concerning COVID-19, the WHO raised the threat to the CoV epidemic to the ""very high"" level, on February 28, 2020 Probably, the effects of the epidemic caused by the new CoV has yet to emerge as the situation is quickly evolving World governments are at work to establish countermeasures to stem possible devastating effects Health organizations coordinate information flows and issues directives and guidelines to best mitigate the impact of the threat At the same time, scientists around the world work tirelessly, and information about the transmission mechanisms, the clinical spectrum of disease, new diagnostics, and prevention and therapeutic strategies are rapidly developing Many uncertainties remain with regard to both the virus-host interac ion and the evolution of the epidemic, with specific reference to the times when the epidemic will reach its peak At the moment, the therapeutic strategies to deal with the infection are only supportive, and prevention aimed at reducing transmission in the community is our best weapon Aggressive isolation measures in China have led to a progressive reduction of cases in the last few days In Italy, in geographic regions of the north of the peninsula, political and health authorities are making incredible efforts to contain a shock wave that is severely testing the health system In the midst of the crisis, the authors have chosen to use the ""Statpearls"" platform because, within the PubMed scenario, it represents a unique tool that may allow them to make updates in real-time The aim, therefore, is to collect information and scientific evidence and to provide an overview of the topic that will be continuously updated",,n4v4n8d1,"['According', 'to', 'the', 'World', 'Health', 'Organization', 'WHO', 'viral', 'diseases', 'continue', 'to', 'emerge', 'and', 'represent', 'a', 'serious', 'issue', 'to', 'public', 'health', 'In', 'the', 'last', 'twenty', 'years', 'several', 'viral', 'epidemics', 'such', 'as', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'SARS', 'CoV', 'in', '2002', 'to', '2003', 'and', 'H1N1', 'influenza', 'in', '2009', 'have', 'been', 'recorded', 'Most', 'recently', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'was', 'first', 'identified', 'in', 'Saudi', 'Arabia', 'in', '2012', 'In', 'a', 'timeline', 'that', 'reaches', 'the', 'present', 'day', 'an', 'epidemic', 'of', 'cases', 'with', 'unexplained', 'low', 'respiratory', 'infections', 'detected', 'in', 'Wuhan', 'the', 'largest', 'metropolitan', 'area', 'in', 'China', 's', 'Hubei', 'province', 'was', 'first', 'reported', 'to', 'the', 'WHO', 'Country', 'Office', 'in', 'China', 'on', 'December', '31', '2019', 'Published', 'literature', 'can', 'trace', 'the', 'beginning', 'of', 'symptomatic', 'individuals', 'back', 'to', 'the', 'beginning', 'of', 'December', '2019', 'As', 'they', 'were', 'unable', 'to', 'identify', 'the', 'causative', 'agent', 'these', 'first', 'cases', 'were', 'classified', 'as', 'pneumonia', 'of', 'unknown', 'etiology', 'The', 'Chinese', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'and', 'local', 'CDCs', 'organized', 'an', 'intensive', 'outbreak', 'investigation', 'program', 'The', 'etiology', 'of', 'this', 'illness', 'is', 'now', 'attributed', 'to', 'a', 'novel', 'virus', 'belonging', 'to', 'the', 'coronavirus', 'CoV', 'family', 'COVID', '19', 'On', 'February', '11', '2020', 'the', 'WHO', 'Director', 'General', 'Dr', 'Tedros', 'Adhanom', 'Ghebreyesus', 'announced', 'that', 'the', 'disease', 'caused', 'by', 'this', 'new', 'CoV', 'was', 'a', 'COVID', '19', 'which', 'is', 'the', 'acronym', 'of', 'coronavirus', 'disease', '2019', 'In', 'the', 'past', 'twenty', 'years', 'two', 'additional', 'coronavirus', 'epidemics', 'have', 'occurred', 'SARS', 'CoV', 'provoked', 'a', 'large', 'scale', 'epidemic', 'beginning', 'in', 'China', 'and', 'involving', 'two', 'dozen', 'countries', 'with', 'approximately', '8000', 'cases', 'and', '800', 'deaths', 'and', 'the', 'MERS', 'CoV', 'that', 'began', 'in', 'Saudi', 'Arabia', 'and', 'has', 'approximately', '2', '500', 'cases', 'and', '800', 'deaths', 'and', 'still', 'causes', 'as', 'sporadic', 'cases', 'This', 'new', 'virus', 'seems', 'to', 'be', 'very', 'contagious', 'and', 'has', 'quickly', 'spread', 'globally', 'In', 'a', 'meeting', 'on', 'January', '30', '2020', 'per', 'the', 'International', 'Health', 'Regulations', 'IHR', '2005', 'the', 'outbreak', 'was', 'declared', 'by', 'the', 'WHO', 'a', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'PHEIC', 'as', 'it', 'had', 'spread', 'to', '18', 'countries', 'with', 'four', 'countries', 'reporting', 'human', 'to', 'human', 'transmission', 'An', 'additional', 'landmark', 'occurred', 'on', 'February', '26', '2020', 'as', 'the', 'first', 'case', 'of', 'the', 'disease', 'not', 'imported', 'from', 'China', 'was', 'recorded', 'in', 'the', 'United', 'States', 'Initially', 'the', 'new', 'virus', 'was', 'called', '2019', 'nCoV', 'Subsequently', 'the', 'task', 'of', 'experts', 'of', 'the', 'International', 'Committee', 'on', 'Taxonomy', 'of', 'Viruses', 'ICTV', 'termed', 'it', 'the', 'SARS', 'CoV', '2', 'virus', 'as', 'it', 'is', 'very', 'similar', 'to', 'the', 'one', 'that', 'caused', 'the', 'SARS', 'outbreak', 'SARS', 'CoVs', 'The', 'CoVs', 'have', 'become', 'the', 'major', 'pathogens', 'of', 'emerging', 'respiratory', 'disease', 'outbreaks', 'They', 'are', 'a', 'large', 'family', 'of', 'single', 'stranded', 'RNA', 'viruses', 'ssRNA', 'that', 'can', 'be', 'isolated', 'in', 'different', 'animal', 'species', 'For', 'reasons', 'yet', 'to', 'be', 'explained', 'these', 'viruses', 'can', 'cross', 'species', 'barriers', 'and', 'can', 'cause', 'in', 'humans', 'illness', 'ranging', 'from', 'the', 'common', 'cold', 'to', 'more', 'severe', 'diseases', 'such', 'as', 'MERS', 'and', 'SARS', 'Interestingly', 'these', 'latter', 'viruses', 'have', 'probably', 'originated', 'from', 'bats', 'and', 'then', 'moving', 'into', 'other', 'mammalian', 'hosts', 'the', 'Himalayan', 'palm', 'civet', 'for', 'SARS', 'CoV', 'and', 'the', 'dromedary', 'camel', 'for', 'MERS', 'CoV', 'before', 'jumping', 'to', 'humans', 'The', 'dynamics', 'of', 'SARS', 'Cov', '2', 'are', 'currently', 'unknown', 'but', 'there', 'is', 'speculation', 'that', 'it', 'also', 'has', 'an', 'animal', 'origin', 'The', 'potential', 'for', 'these', 'viruses', 'to', 'grow', 'to', 'become', 'a', 'pandemic', 'worldwide', 'seems', 'to', 'be', 'a', 'serious', 'public', 'health', 'risk', 'Concerning', 'COVID', '19', 'the', 'WHO', 'raised', 'the', 'threat', 'to', 'the', 'CoV', 'epidemic', 'to', 'the', 'very', 'high', 'level', 'on', 'February', '28', '2020', 'Probably', 'the', 'effects', 'of', 'the', 'epidemic', 'caused', 'by', 'the', 'new', 'CoV', 'has', 'yet', 'to', 'emerge', 'as', 'the', 'situation', 'is', 'quickly', 'evolving', 'World', 'governments', 'are', 'at', 'work', 'to', 'establish', 'countermeasures', 'to', 'stem', 'possible', 'devastating', 'effects', 'Health', 'organizations', 'coordinate', 'information', 'flows', 'and', 'issues', 'directives', 'and', 'guidelines', 'to', 'best', 'mitigate', 'the', 'impact', 'of', 'the', 'threat', 'At', 'the', 'same', 'time', 'scientists', 'around', 'the', 'world', 'work', 'tirelessly', 'and', 'information', 'about', 'the', 'transmission', 'mechanisms', 'the', 'clinical', 'spectrum', 'of', 'disease', 'new', 'diagnostics', 'and', 'prevention', 'and', 'therapeutic', 'strategies', 'are', 'rapidly', 'developing', 'Many', 'uncertainties', 'remain', 'with', 'regard', 'to', 'both', 'the', 'virus', 'host', 'interac', 'ion', 'and', 'the', 'evolution', 'of', 'the', 'epidemic', 'with', 'specific', 'reference', 'to', 'the', 'times', 'when', 'the', 'epidemic', 'will', 'reach', 'its', 'peak', 'At', 'the', 'moment', 'the', 'therapeutic', 'strategies', 'to', 'deal', 'with', 'the', 'infection', 'are', 'only', 'supportive', 'and', 'prevention', 'aimed', 'at', 'reducing', 'transmission', 'in', 'the', 'community', 'is', 'our', 'best', 'weapon', 'Aggressive', 'isolation', 'measures', 'in', 'China', 'have', 'led', 'to', 'a', 'progressive', 'reduction', 'of', 'cases', 'in', 'the', 'last', 'few', 'days', 'In', 'Italy', 'in', 'geographic', 'regions', 'of', 'the', 'north', 'of', 'the', 'peninsula', 'political', 'and', 'health', 'authorities', 'are', 'making', 'incredible', 'efforts', 'to', 'contain', 'a', 'shock', 'wave', 'that', 'is', 'severely', 'testing', 'the', 'health', 'system', 'In', 'the', 'midst', 'of', 'the', 'crisis', 'the', 'authors', 'have', 'chosen', 'to', 'use', 'the', 'Statpearls', 'platform', 'because', 'within', 'the', 'PubMed', 'scenario', 'it', 'represents', 'a', 'unique', 'tool', 'that', 'may', 'allow', 'them', 'to', 'make', 'updates', 'in', 'real', 'time', 'The', 'aim', 'therefore', 'is', 'to', 'collect', 'information', 'and', 'scientific', 'evidence', 'and', 'to', 'provide', 'an', 'overview', 'of', 'the', 'topic', 'that', 'will', 'be', 'continuously', 'updated']"
93124,Comparison of seven commercial RT-PCR diagnostic kits for COVID-19,2020,J Clin Virol,,"The final months of 2019 witnessed the emergence of a novel coronavirus in the human population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread across the globe and is posing a major burden on society. Measures taken to reduce its spread critically depend on timely and accurate identification of virus-infected individuals by the most sensitive and specific method available, i.e. real-time reverse transcriptase PCR (RT-PCR). Many commercial kits have recently become available, but their performance has not yet been independently assessed. The aim of this study was to compare basic analytical and clinical performance of selected RT-PCR kits from seven different manufacturers (Altona Diagnostics, BGI, CerTest Biotec, KH Medical, PrimerDesign, R-Biopharm AG, and Seegene). We used serial dilutions of viral RNA to establish PCR efficiency and estimate the 95 % limit of detection (LOD95). Furthermore, we ran a panel of SARS-CoV-2-positive clinical samples (n = 13) for a preliminary evaluation of clinical sensitivity. Finally, we used clinical samples positive for non-coronavirus respiratory viral infections (n = 6) and a panel of RNA from related human coronaviruses to evaluate assay specificity. PCR efficiency was &#8805;96 % for all assays and the estimated LOD95 varied within a 6-fold range. Using clinical samples, we observed some variations in detection rate between kits. Importantly, none of the assays showed cross-reactivity with other respiratory (corona)viruses, except as expected for the SARS-CoV-1 E-gene. We conclude that all RT-PCR kits assessed in this study may be used for routine diagnostics of COVID-19 in patients by experienced molecular diagnostic laboratories.",,u5gjsvq8,"['The', 'final', 'months', 'of', '2019', 'witnessed', 'the', 'emergence', 'of', 'a', 'novel', 'coronavirus', 'in', 'the', 'human', 'population', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'since', 'spread', 'across', 'the', 'globe', 'and', 'is', 'posing', 'a', 'major', 'burden', 'on', 'society', 'Measures', 'taken', 'to', 'reduce', 'its', 'spread', 'critically', 'depend', 'on', 'timely', 'and', 'accurate', 'identification', 'of', 'virus', 'infected', 'individuals', 'by', 'the', 'most', 'sensitive', 'and', 'specific', 'method', 'available', 'i', 'e', 'real', 'time', 'reverse', 'transcriptase', 'PCR', 'RT', 'PCR', 'Many', 'commercial', 'kits', 'have', 'recently', 'become', 'available', 'but', 'their', 'performance', 'has', 'not', 'yet', 'been', 'independently', 'assessed', 'The', 'aim', 'of', 'this', 'study', 'was', 'to', 'compare', 'basic', 'analytical', 'and', 'clinical', 'performance', 'of', 'selected', 'RT', 'PCR', 'kits', 'from', 'seven', 'different', 'manufacturers', 'Altona', 'Diagnostics', 'BGI', 'CerTest', 'Biotec', 'KH', 'Medical', 'PrimerDesign', 'R', 'Biopharm', 'AG', 'and', 'Seegene', 'We', 'used', 'serial', 'dilutions', 'of', 'viral', 'RNA', 'to', 'establish', 'PCR', 'efficiency', 'and', 'estimate', 'the', '95', 'limit', 'of', 'detection', 'LOD95', 'Furthermore', 'we', 'ran', 'a', 'panel', 'of', 'SARS', 'CoV', '2', 'positive', 'clinical', 'samples', 'n', '13', 'for', 'a', 'preliminary', 'evaluation', 'of', 'clinical', 'sensitivity', 'Finally', 'we', 'used', 'clinical', 'samples', 'positive', 'for', 'non', 'coronavirus', 'respiratory', 'viral', 'infections', 'n', '6', 'and', 'a', 'panel', 'of', 'RNA', 'from', 'related', 'human', 'coronaviruses', 'to', 'evaluate', 'assay', 'specificity', 'PCR', 'efficiency', 'was', '8805', '96', 'for', 'all', 'assays', 'and', 'the', 'estimated', 'LOD95', 'varied', 'within', 'a', '6', 'fold', 'range', 'Using', 'clinical', 'samples', 'we', 'observed', 'some', 'variations', 'in', 'detection', 'rate', 'between', 'kits', 'Importantly', 'none', 'of', 'the', 'assays', 'showed', 'cross', 'reactivity', 'with', 'other', 'respiratory', 'corona', 'viruses', 'except', 'as', 'expected', 'for', 'the', 'SARS', 'CoV', '1', 'E', 'gene', 'We', 'conclude', 'that', 'all', 'RT', 'PCR', 'kits', 'assessed', 'in', 'this', 'study', 'may', 'be', 'used', 'for', 'routine', 'diagnostics', 'of', 'COVID', '19', 'in', 'patients', 'by', 'experienced', 'molecular', 'diagnostic', 'laboratories', '']"
93125,Comparison of seven commercial RT-PCR diagnostic kits for COVID-19,2020,J Clin Virol,,"The final months of 2019 witnessed the emergence of a novel coronavirus in the human population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread across the globe and is posing a major burden on society. Measures taken to reduce its spread critically depend on timely and accurate identification of virus-infected individuals by the most sensitive and specific method available, i.e. real-time reverse transcriptase PCR (RT-PCR). Many commercial kits have recently become available, but their performance has not yet been independently assessed. The aim of this study was to compare basic analytical and clinical performance of selected RT-PCR kits from seven different manufacturers (Altona Diagnostics, BGI, CerTest Biotec, KH Medical, PrimerDesign, R-Biopharm AG, and Seegene). We used serial dilutions of viral RNA to establish PCR efficiency and estimate the 95 % limit of detection (LOD95). Furthermore, we ran a panel of SARS-CoV-2-positive clinical samples (n = 13) for a preliminary evaluation of clinical sensitivity. Finally, we used clinical samples positive for non-coronavirus respiratory viral infections (n = 6) and a panel of RNA from related human coronaviruses to evaluate assay specificity. PCR efficiency was &#8805;96 % for all assays and the estimated LOD95 varied within a 6-fold range. Using clinical samples, we observed some variations in detection rate between kits. Importantly, none of the assays showed cross-reactivity with other respiratory (corona)viruses, except as expected for the SARS-CoV-1 E-gene. We conclude that all RT-PCR kits assessed in this study may be used for routine diagnostics of COVID-19 in patients by experienced molecular diagnostic laboratories.",,ce4ukaua,"['The', 'final', 'months', 'of', '2019', 'witnessed', 'the', 'emergence', 'of', 'a', 'novel', 'coronavirus', 'in', 'the', 'human', 'population', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'since', 'spread', 'across', 'the', 'globe', 'and', 'is', 'posing', 'a', 'major', 'burden', 'on', 'society', 'Measures', 'taken', 'to', 'reduce', 'its', 'spread', 'critically', 'depend', 'on', 'timely', 'and', 'accurate', 'identification', 'of', 'virus', 'infected', 'individuals', 'by', 'the', 'most', 'sensitive', 'and', 'specific', 'method', 'available', 'i', 'e', 'real', 'time', 'reverse', 'transcriptase', 'PCR', 'RT', 'PCR', 'Many', 'commercial', 'kits', 'have', 'recently', 'become', 'available', 'but', 'their', 'performance', 'has', 'not', 'yet', 'been', 'independently', 'assessed', 'The', 'aim', 'of', 'this', 'study', 'was', 'to', 'compare', 'basic', 'analytical', 'and', 'clinical', 'performance', 'of', 'selected', 'RT', 'PCR', 'kits', 'from', 'seven', 'different', 'manufacturers', 'Altona', 'Diagnostics', 'BGI', 'CerTest', 'Biotec', 'KH', 'Medical', 'PrimerDesign', 'R', 'Biopharm', 'AG', 'and', 'Seegene', 'We', 'used', 'serial', 'dilutions', 'of', 'viral', 'RNA', 'to', 'establish', 'PCR', 'efficiency', 'and', 'estimate', 'the', '95', 'limit', 'of', 'detection', 'LOD95', 'Furthermore', 'we', 'ran', 'a', 'panel', 'of', 'SARS', 'CoV', '2', 'positive', 'clinical', 'samples', 'n', '13', 'for', 'a', 'preliminary', 'evaluation', 'of', 'clinical', 'sensitivity', 'Finally', 'we', 'used', 'clinical', 'samples', 'positive', 'for', 'non', 'coronavirus', 'respiratory', 'viral', 'infections', 'n', '6', 'and', 'a', 'panel', 'of', 'RNA', 'from', 'related', 'human', 'coronaviruses', 'to', 'evaluate', 'assay', 'specificity', 'PCR', 'efficiency', 'was', '8805', '96', 'for', 'all', 'assays', 'and', 'the', 'estimated', 'LOD95', 'varied', 'within', 'a', '6', 'fold', 'range', 'Using', 'clinical', 'samples', 'we', 'observed', 'some', 'variations', 'in', 'detection', 'rate', 'between', 'kits', 'Importantly', 'none', 'of', 'the', 'assays', 'showed', 'cross', 'reactivity', 'with', 'other', 'respiratory', 'corona', 'viruses', 'except', 'as', 'expected', 'for', 'the', 'SARS', 'CoV', '1', 'E', 'gene', 'We', 'conclude', 'that', 'all', 'RT', 'PCR', 'kits', 'assessed', 'in', 'this', 'study', 'may', 'be', 'used', 'for', 'routine', 'diagnostics', 'of', 'COVID', '19', 'in', 'patients', 'by', 'experienced', 'molecular', 'diagnostic', 'laboratories', '']"
93260,Improvements in Patient Monitoring in the Intensive Care Unit: Survey Study,2020,J Med Internet Res,,"BACKGROUND: Due to demographic change and, more recently, coronavirus disease (COVID-19), the importance of modern intensive care units (ICU) is becoming apparent. One of the key components of an ICU is the continuous monitoring of patients' vital parameters. However, existing advances in informatics, signal processing, or engineering that could alleviate the burden on ICUs have not yet been applied. This could be due to the lack of user involvement in research and development. OBJECTIVE: This study focused on the satisfaction of ICU staff with current patient monitoring and their suggestions for future improvements. We aimed to identify aspects of monitoring that interrupt patient care, display devices for remote monitoring, use cases for artificial intelligence (AI), and whether ICU staff members are willing to improve their digital literacy or contribute to the improvement of patient monitoring. We further aimed to identify differences in the responses of different professional groups. METHODS: This survey study was performed with ICU staff from 4 ICUs of a German university hospital between November 2019 and January 2020. We developed a web-based 36-item survey questionnaire, by analyzing a preceding qualitative interview study with ICU staff, about the clinical requirements of future patient monitoring. Statistical analyses of questionnaire results included median values with their bootstrapped 95% confidence intervals, and chi-square tests to compare the distributions of item responses of the professional groups. RESULTS: In total, 86 of the 270 ICU physicians and nurses completed the survey questionnaire. The majority stated they felt confident using the patient monitoring equipment, but that high rates of false-positive alarms and the many sensor cables interrupted patient care. Regarding future improvements, respondents asked for wireless sensors, a reduction in the number of false-positive alarms, and hospital standard operating procedures for alarm management. Responses to the display devices proposed for remote patient monitoring were divided. Most respondents indicated it would be useful for earlier alerting or when they were responsible for multiple wards. AI for ICUs would be useful for early detection of complications and an increased risk of mortality; in addition, the AI could propose guidelines for therapy and diagnostics. Transparency, interoperability, usability, and staff training were essential to promote the use of AI. The majority wanted to learn more about new technologies for the ICU and required more time for learning. Physicians had fewer reservations than nurses about AI-based intelligent alarm management and using mobile phones for remote monitoring. CONCLUSIONS: This survey study of ICU staff revealed key improvements for patient monitoring in intensive care medicine. Hospital providers and medical device manufacturers should focus on reducing false alarms, implementing hospital alarm standard operating procedures, introducing wireless sensors, preparing for the use of AI, and enhancing the digital literacy of ICU staff. Our results may contribute to the user-centered transfer of digital technologies into practice to alleviate challenges in intensive care medicine. TRIAL REGISTRATION: ClinicalTrials.gov NCT03514173; https://clinicaltrials.gov/ct2/show/NCT03514173.",,vn5boexq,"['BACKGROUND', 'Due', 'to', 'demographic', 'change', 'and', 'more', 'recently', 'coronavirus', 'disease', 'COVID', '19', 'the', 'importance', 'of', 'modern', 'intensive', 'care', 'units', 'ICU', 'is', 'becoming', 'apparent', 'One', 'of', 'the', 'key', 'components', 'of', 'an', 'ICU', 'is', 'the', 'continuous', 'monitoring', 'of', 'patients', 'vital', 'parameters', 'However', 'existing', 'advances', 'in', 'informatics', 'signal', 'processing', 'or', 'engineering', 'that', 'could', 'alleviate', 'the', 'burden', 'on', 'ICUs', 'have', 'not', 'yet', 'been', 'applied', 'This', 'could', 'be', 'due', 'to', 'the', 'lack', 'of', 'user', 'involvement', 'in', 'research', 'and', 'development', 'OBJECTIVE', 'This', 'study', 'focused', 'on', 'the', 'satisfaction', 'of', 'ICU', 'staff', 'with', 'current', 'patient', 'monitoring', 'and', 'their', 'suggestions', 'for', 'future', 'improvements', 'We', 'aimed', 'to', 'identify', 'aspects', 'of', 'monitoring', 'that', 'interrupt', 'patient', 'care', 'display', 'devices', 'for', 'remote', 'monitoring', 'use', 'cases', 'for', 'artificial', 'intelligence', 'AI', 'and', 'whether', 'ICU', 'staff', 'members', 'are', 'willing', 'to', 'improve', 'their', 'digital', 'literacy', 'or', 'contribute', 'to', 'the', 'improvement', 'of', 'patient', 'monitoring', 'We', 'further', 'aimed', 'to', 'identify', 'differences', 'in', 'the', 'responses', 'of', 'different', 'professional', 'groups', 'METHODS', 'This', 'survey', 'study', 'was', 'performed', 'with', 'ICU', 'staff', 'from', '4', 'ICUs', 'of', 'a', 'German', 'university', 'hospital', 'between', 'November', '2019', 'and', 'January', '2020', 'We', 'developed', 'a', 'web', 'based', '36', 'item', 'survey', 'questionnaire', 'by', 'analyzing', 'a', 'preceding', 'qualitative', 'interview', 'study', 'with', 'ICU', 'staff', 'about', 'the', 'clinical', 'requirements', 'of', 'future', 'patient', 'monitoring', 'Statistical', 'analyses', 'of', 'questionnaire', 'results', 'included', 'median', 'values', 'with', 'their', 'bootstrapped', '95', 'confidence', 'intervals', 'and', 'chi', 'square', 'tests', 'to', 'compare', 'the', 'distributions', 'of', 'item', 'responses', 'of', 'the', 'professional', 'groups', 'RESULTS', 'In', 'total', '86', 'of', 'the', '270', 'ICU', 'physicians', 'and', 'nurses', 'completed', 'the', 'survey', 'questionnaire', 'The', 'majority', 'stated', 'they', 'felt', 'confident', 'using', 'the', 'patient', 'monitoring', 'equipment', 'but', 'that', 'high', 'rates', 'of', 'false', 'positive', 'alarms', 'and', 'the', 'many', 'sensor', 'cables', 'interrupted', 'patient', 'care', 'Regarding', 'future', 'improvements', 'respondents', 'asked', 'for', 'wireless', 'sensors', 'a', 'reduction', 'in', 'the', 'number', 'of', 'false', 'positive', 'alarms', 'and', 'hospital', 'standard', 'operating', 'procedures', 'for', 'alarm', 'management', 'Responses', 'to', 'the', 'display', 'devices', 'proposed', 'for', 'remote', 'patient', 'monitoring', 'were', 'divided', 'Most', 'respondents', 'indicated', 'it', 'would', 'be', 'useful', 'for', 'earlier', 'alerting', 'or', 'when', 'they', 'were', 'responsible', 'for', 'multiple', 'wards', 'AI', 'for', 'ICUs', 'would', 'be', 'useful', 'for', 'early', 'detection', 'of', 'complications', 'and', 'an', 'increased', 'risk', 'of', 'mortality', 'in', 'addition', 'the', 'AI', 'could', 'propose', 'guidelines', 'for', 'therapy', 'and', 'diagnostics', 'Transparency', 'interoperability', 'usability', 'and', 'staff', 'training', 'were', 'essential', 'to', 'promote', 'the', 'use', 'of', 'AI', 'The', 'majority', 'wanted', 'to', 'learn', 'more', 'about', 'new', 'technologies', 'for', 'the', 'ICU', 'and', 'required', 'more', 'time', 'for', 'learning', 'Physicians', 'had', 'fewer', 'reservations', 'than', 'nurses', 'about', 'AI', 'based', 'intelligent', 'alarm', 'management', 'and', 'using', 'mobile', 'phones', 'for', 'remote', 'monitoring', 'CONCLUSIONS', 'This', 'survey', 'study', 'of', 'ICU', 'staff', 'revealed', 'key', 'improvements', 'for', 'patient', 'monitoring', 'in', 'intensive', 'care', 'medicine', 'Hospital', 'providers', 'and', 'medical', 'device', 'manufacturers', 'should', 'focus', 'on', 'reducing', 'false', 'alarms', 'implementing', 'hospital', 'alarm', 'standard', 'operating', 'procedures', 'introducing', 'wireless', 'sensors', 'preparing', 'for', 'the', 'use', 'of', 'AI', 'and', 'enhancing', 'the', 'digital', 'literacy', 'of', 'ICU', 'staff', 'Our', 'results', 'may', 'contribute', 'to', 'the', 'user', 'centered', 'transfer', 'of', 'digital', 'technologies', 'into', 'practice', 'to', 'alleviate', 'challenges', 'in', 'intensive', 'care', 'medicine', 'TRIAL', 'REGISTRATION', 'ClinicalTrials', 'gov', 'NCT03514173', 'https', 'clinicaltrials', 'gov', 'ct2', 'show', 'NCT03514173', '']"
93261,Improvements in Patient Monitoring in the Intensive Care Unit: Survey Study,2020,J Med Internet Res,,"BACKGROUND: Due to demographic change and, more recently, coronavirus disease (COVID-19), the importance of modern intensive care units (ICU) is becoming apparent. One of the key components of an ICU is the continuous monitoring of patients' vital parameters. However, existing advances in informatics, signal processing, or engineering that could alleviate the burden on ICUs have not yet been applied. This could be due to the lack of user involvement in research and development. OBJECTIVE: This study focused on the satisfaction of ICU staff with current patient monitoring and their suggestions for future improvements. We aimed to identify aspects of monitoring that interrupt patient care, display devices for remote monitoring, use cases for artificial intelligence (AI), and whether ICU staff members are willing to improve their digital literacy or contribute to the improvement of patient monitoring. We further aimed to identify differences in the responses of different professional groups. METHODS: This survey study was performed with ICU staff from 4 ICUs of a German university hospital between November 2019 and January 2020. We developed a web-based 36-item survey questionnaire, by analyzing a preceding qualitative interview study with ICU staff, about the clinical requirements of future patient monitoring. Statistical analyses of questionnaire results included median values with their bootstrapped 95% confidence intervals, and chi-square tests to compare the distributions of item responses of the professional groups. RESULTS: In total, 86 of the 270 ICU physicians and nurses completed the survey questionnaire. The majority stated they felt confident using the patient monitoring equipment, but that high rates of false-positive alarms and the many sensor cables interrupted patient care. Regarding future improvements, respondents asked for wireless sensors, a reduction in the number of false-positive alarms, and hospital standard operating procedures for alarm management. Responses to the display devices proposed for remote patient monitoring were divided. Most respondents indicated it would be useful for earlier alerting or when they were responsible for multiple wards. AI for ICUs would be useful for early detection of complications and an increased risk of mortality; in addition, the AI could propose guidelines for therapy and diagnostics. Transparency, interoperability, usability, and staff training were essential to promote the use of AI. The majority wanted to learn more about new technologies for the ICU and required more time for learning. Physicians had fewer reservations than nurses about AI-based intelligent alarm management and using mobile phones for remote monitoring. CONCLUSIONS: This survey study of ICU staff revealed key improvements for patient monitoring in intensive care medicine. Hospital providers and medical device manufacturers should focus on reducing false alarms, implementing hospital alarm standard operating procedures, introducing wireless sensors, preparing for the use of AI, and enhancing the digital literacy of ICU staff. Our results may contribute to the user-centered transfer of digital technologies into practice to alleviate challenges in intensive care medicine. TRIAL REGISTRATION: ClinicalTrials.gov NCT03514173; https://clinicaltrials.gov/ct2/show/NCT03514173.",,x065xgd3,"['BACKGROUND', 'Due', 'to', 'demographic', 'change', 'and', 'more', 'recently', 'coronavirus', 'disease', 'COVID', '19', 'the', 'importance', 'of', 'modern', 'intensive', 'care', 'units', 'ICU', 'is', 'becoming', 'apparent', 'One', 'of', 'the', 'key', 'components', 'of', 'an', 'ICU', 'is', 'the', 'continuous', 'monitoring', 'of', 'patients', 'vital', 'parameters', 'However', 'existing', 'advances', 'in', 'informatics', 'signal', 'processing', 'or', 'engineering', 'that', 'could', 'alleviate', 'the', 'burden', 'on', 'ICUs', 'have', 'not', 'yet', 'been', 'applied', 'This', 'could', 'be', 'due', 'to', 'the', 'lack', 'of', 'user', 'involvement', 'in', 'research', 'and', 'development', 'OBJECTIVE', 'This', 'study', 'focused', 'on', 'the', 'satisfaction', 'of', 'ICU', 'staff', 'with', 'current', 'patient', 'monitoring', 'and', 'their', 'suggestions', 'for', 'future', 'improvements', 'We', 'aimed', 'to', 'identify', 'aspects', 'of', 'monitoring', 'that', 'interrupt', 'patient', 'care', 'display', 'devices', 'for', 'remote', 'monitoring', 'use', 'cases', 'for', 'artificial', 'intelligence', 'AI', 'and', 'whether', 'ICU', 'staff', 'members', 'are', 'willing', 'to', 'improve', 'their', 'digital', 'literacy', 'or', 'contribute', 'to', 'the', 'improvement', 'of', 'patient', 'monitoring', 'We', 'further', 'aimed', 'to', 'identify', 'differences', 'in', 'the', 'responses', 'of', 'different', 'professional', 'groups', 'METHODS', 'This', 'survey', 'study', 'was', 'performed', 'with', 'ICU', 'staff', 'from', '4', 'ICUs', 'of', 'a', 'German', 'university', 'hospital', 'between', 'November', '2019', 'and', 'January', '2020', 'We', 'developed', 'a', 'web', 'based', '36', 'item', 'survey', 'questionnaire', 'by', 'analyzing', 'a', 'preceding', 'qualitative', 'interview', 'study', 'with', 'ICU', 'staff', 'about', 'the', 'clinical', 'requirements', 'of', 'future', 'patient', 'monitoring', 'Statistical', 'analyses', 'of', 'questionnaire', 'results', 'included', 'median', 'values', 'with', 'their', 'bootstrapped', '95', 'confidence', 'intervals', 'and', 'chi', 'square', 'tests', 'to', 'compare', 'the', 'distributions', 'of', 'item', 'responses', 'of', 'the', 'professional', 'groups', 'RESULTS', 'In', 'total', '86', 'of', 'the', '270', 'ICU', 'physicians', 'and', 'nurses', 'completed', 'the', 'survey', 'questionnaire', 'The', 'majority', 'stated', 'they', 'felt', 'confident', 'using', 'the', 'patient', 'monitoring', 'equipment', 'but', 'that', 'high', 'rates', 'of', 'false', 'positive', 'alarms', 'and', 'the', 'many', 'sensor', 'cables', 'interrupted', 'patient', 'care', 'Regarding', 'future', 'improvements', 'respondents', 'asked', 'for', 'wireless', 'sensors', 'a', 'reduction', 'in', 'the', 'number', 'of', 'false', 'positive', 'alarms', 'and', 'hospital', 'standard', 'operating', 'procedures', 'for', 'alarm', 'management', 'Responses', 'to', 'the', 'display', 'devices', 'proposed', 'for', 'remote', 'patient', 'monitoring', 'were', 'divided', 'Most', 'respondents', 'indicated', 'it', 'would', 'be', 'useful', 'for', 'earlier', 'alerting', 'or', 'when', 'they', 'were', 'responsible', 'for', 'multiple', 'wards', 'AI', 'for', 'ICUs', 'would', 'be', 'useful', 'for', 'early', 'detection', 'of', 'complications', 'and', 'an', 'increased', 'risk', 'of', 'mortality', 'in', 'addition', 'the', 'AI', 'could', 'propose', 'guidelines', 'for', 'therapy', 'and', 'diagnostics', 'Transparency', 'interoperability', 'usability', 'and', 'staff', 'training', 'were', 'essential', 'to', 'promote', 'the', 'use', 'of', 'AI', 'The', 'majority', 'wanted', 'to', 'learn', 'more', 'about', 'new', 'technologies', 'for', 'the', 'ICU', 'and', 'required', 'more', 'time', 'for', 'learning', 'Physicians', 'had', 'fewer', 'reservations', 'than', 'nurses', 'about', 'AI', 'based', 'intelligent', 'alarm', 'management', 'and', 'using', 'mobile', 'phones', 'for', 'remote', 'monitoring', 'CONCLUSIONS', 'This', 'survey', 'study', 'of', 'ICU', 'staff', 'revealed', 'key', 'improvements', 'for', 'patient', 'monitoring', 'in', 'intensive', 'care', 'medicine', 'Hospital', 'providers', 'and', 'medical', 'device', 'manufacturers', 'should', 'focus', 'on', 'reducing', 'false', 'alarms', 'implementing', 'hospital', 'alarm', 'standard', 'operating', 'procedures', 'introducing', 'wireless', 'sensors', 'preparing', 'for', 'the', 'use', 'of', 'AI', 'and', 'enhancing', 'the', 'digital', 'literacy', 'of', 'ICU', 'staff', 'Our', 'results', 'may', 'contribute', 'to', 'the', 'user', 'centered', 'transfer', 'of', 'digital', 'technologies', 'into', 'practice', 'to', 'alleviate', 'challenges', 'in', 'intensive', 'care', 'medicine', 'TRIAL', 'REGISTRATION', 'ClinicalTrials', 'gov', 'NCT03514173', 'https', 'clinicaltrials', 'gov', 'ct2', 'show', 'NCT03514173', '']"
93262,Improvements in Patient Monitoring in the Intensive Care Unit: Survey Study,2020,J Med Internet Res,,"BACKGROUND: Due to demographic change and, more recently, coronavirus disease (COVID-19), the importance of modern intensive care units (ICU) is becoming apparent. One of the key components of an ICU is the continuous monitoring of patients' vital parameters. However, existing advances in informatics, signal processing, or engineering that could alleviate the burden on ICUs have not yet been applied. This could be due to the lack of user involvement in research and development. OBJECTIVE: This study focused on the satisfaction of ICU staff with current patient monitoring and their suggestions for future improvements. We aimed to identify aspects of monitoring that interrupt patient care, display devices for remote monitoring, use cases for artificial intelligence (AI), and whether ICU staff members are willing to improve their digital literacy or contribute to the improvement of patient monitoring. We further aimed to identify differences in the responses of different professional groups. METHODS: This survey study was performed with ICU staff from 4 ICUs of a German university hospital between November 2019 and January 2020. We developed a web-based 36-item survey questionnaire, by analyzing a preceding qualitative interview study with ICU staff, about the clinical requirements of future patient monitoring. Statistical analyses of questionnaire results included median values with their bootstrapped 95% confidence intervals, and chi-square tests to compare the distributions of item responses of the professional groups. RESULTS: In total, 86 of the 270 ICU physicians and nurses completed the survey questionnaire. The majority stated they felt confident using the patient monitoring equipment, but that high rates of false-positive alarms and the many sensor cables interrupted patient care. Regarding future improvements, respondents asked for wireless sensors, a reduction in the number of false-positive alarms, and hospital standard operating procedures for alarm management. Responses to the display devices proposed for remote patient monitoring were divided. Most respondents indicated it would be useful for earlier alerting or when they were responsible for multiple wards. AI for ICUs would be useful for early detection of complications and an increased risk of mortality; in addition, the AI could propose guidelines for therapy and diagnostics. Transparency, interoperability, usability, and staff training were essential to promote the use of AI. The majority wanted to learn more about new technologies for the ICU and required more time for learning. Physicians had fewer reservations than nurses about AI-based intelligent alarm management and using mobile phones for remote monitoring. CONCLUSIONS: This survey study of ICU staff revealed key improvements for patient monitoring in intensive care medicine. Hospital providers and medical device manufacturers should focus on reducing false alarms, implementing hospital alarm standard operating procedures, introducing wireless sensors, preparing for the use of AI, and enhancing the digital literacy of ICU staff. Our results may contribute to the user-centered transfer of digital technologies into practice to alleviate challenges in intensive care medicine. TRIAL REGISTRATION: ClinicalTrials.gov NCT03514173; https://clinicaltrials.gov/ct2/show/NCT03514173.",,zxr52une,"['BACKGROUND', 'Due', 'to', 'demographic', 'change', 'and', 'more', 'recently', 'coronavirus', 'disease', 'COVID', '19', 'the', 'importance', 'of', 'modern', 'intensive', 'care', 'units', 'ICU', 'is', 'becoming', 'apparent', 'One', 'of', 'the', 'key', 'components', 'of', 'an', 'ICU', 'is', 'the', 'continuous', 'monitoring', 'of', 'patients', 'vital', 'parameters', 'However', 'existing', 'advances', 'in', 'informatics', 'signal', 'processing', 'or', 'engineering', 'that', 'could', 'alleviate', 'the', 'burden', 'on', 'ICUs', 'have', 'not', 'yet', 'been', 'applied', 'This', 'could', 'be', 'due', 'to', 'the', 'lack', 'of', 'user', 'involvement', 'in', 'research', 'and', 'development', 'OBJECTIVE', 'This', 'study', 'focused', 'on', 'the', 'satisfaction', 'of', 'ICU', 'staff', 'with', 'current', 'patient', 'monitoring', 'and', 'their', 'suggestions', 'for', 'future', 'improvements', 'We', 'aimed', 'to', 'identify', 'aspects', 'of', 'monitoring', 'that', 'interrupt', 'patient', 'care', 'display', 'devices', 'for', 'remote', 'monitoring', 'use', 'cases', 'for', 'artificial', 'intelligence', 'AI', 'and', 'whether', 'ICU', 'staff', 'members', 'are', 'willing', 'to', 'improve', 'their', 'digital', 'literacy', 'or', 'contribute', 'to', 'the', 'improvement', 'of', 'patient', 'monitoring', 'We', 'further', 'aimed', 'to', 'identify', 'differences', 'in', 'the', 'responses', 'of', 'different', 'professional', 'groups', 'METHODS', 'This', 'survey', 'study', 'was', 'performed', 'with', 'ICU', 'staff', 'from', '4', 'ICUs', 'of', 'a', 'German', 'university', 'hospital', 'between', 'November', '2019', 'and', 'January', '2020', 'We', 'developed', 'a', 'web', 'based', '36', 'item', 'survey', 'questionnaire', 'by', 'analyzing', 'a', 'preceding', 'qualitative', 'interview', 'study', 'with', 'ICU', 'staff', 'about', 'the', 'clinical', 'requirements', 'of', 'future', 'patient', 'monitoring', 'Statistical', 'analyses', 'of', 'questionnaire', 'results', 'included', 'median', 'values', 'with', 'their', 'bootstrapped', '95', 'confidence', 'intervals', 'and', 'chi', 'square', 'tests', 'to', 'compare', 'the', 'distributions', 'of', 'item', 'responses', 'of', 'the', 'professional', 'groups', 'RESULTS', 'In', 'total', '86', 'of', 'the', '270', 'ICU', 'physicians', 'and', 'nurses', 'completed', 'the', 'survey', 'questionnaire', 'The', 'majority', 'stated', 'they', 'felt', 'confident', 'using', 'the', 'patient', 'monitoring', 'equipment', 'but', 'that', 'high', 'rates', 'of', 'false', 'positive', 'alarms', 'and', 'the', 'many', 'sensor', 'cables', 'interrupted', 'patient', 'care', 'Regarding', 'future', 'improvements', 'respondents', 'asked', 'for', 'wireless', 'sensors', 'a', 'reduction', 'in', 'the', 'number', 'of', 'false', 'positive', 'alarms', 'and', 'hospital', 'standard', 'operating', 'procedures', 'for', 'alarm', 'management', 'Responses', 'to', 'the', 'display', 'devices', 'proposed', 'for', 'remote', 'patient', 'monitoring', 'were', 'divided', 'Most', 'respondents', 'indicated', 'it', 'would', 'be', 'useful', 'for', 'earlier', 'alerting', 'or', 'when', 'they', 'were', 'responsible', 'for', 'multiple', 'wards', 'AI', 'for', 'ICUs', 'would', 'be', 'useful', 'for', 'early', 'detection', 'of', 'complications', 'and', 'an', 'increased', 'risk', 'of', 'mortality', 'in', 'addition', 'the', 'AI', 'could', 'propose', 'guidelines', 'for', 'therapy', 'and', 'diagnostics', 'Transparency', 'interoperability', 'usability', 'and', 'staff', 'training', 'were', 'essential', 'to', 'promote', 'the', 'use', 'of', 'AI', 'The', 'majority', 'wanted', 'to', 'learn', 'more', 'about', 'new', 'technologies', 'for', 'the', 'ICU', 'and', 'required', 'more', 'time', 'for', 'learning', 'Physicians', 'had', 'fewer', 'reservations', 'than', 'nurses', 'about', 'AI', 'based', 'intelligent', 'alarm', 'management', 'and', 'using', 'mobile', 'phones', 'for', 'remote', 'monitoring', 'CONCLUSIONS', 'This', 'survey', 'study', 'of', 'ICU', 'staff', 'revealed', 'key', 'improvements', 'for', 'patient', 'monitoring', 'in', 'intensive', 'care', 'medicine', 'Hospital', 'providers', 'and', 'medical', 'device', 'manufacturers', 'should', 'focus', 'on', 'reducing', 'false', 'alarms', 'implementing', 'hospital', 'alarm', 'standard', 'operating', 'procedures', 'introducing', 'wireless', 'sensors', 'preparing', 'for', 'the', 'use', 'of', 'AI', 'and', 'enhancing', 'the', 'digital', 'literacy', 'of', 'ICU', 'staff', 'Our', 'results', 'may', 'contribute', 'to', 'the', 'user', 'centered', 'transfer', 'of', 'digital', 'technologies', 'into', 'practice', 'to', 'alleviate', 'challenges', 'in', 'intensive', 'care', 'medicine', 'TRIAL', 'REGISTRATION', 'ClinicalTrials', 'gov', 'NCT03514173', 'https', 'clinicaltrials', 'gov', 'ct2', 'show', 'NCT03514173', '']"
93520,"Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: ménage à trois",2020,Curr. opin. rheumatol,,"BACKGROUND: Shortly after its emergence in December 2019, the coronavirus disease 2019 (COVID-19) was declared as a pandemic by the World Health Organization. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the seventh member of the Coronaviridae family of viruses that causes disease in humans. THE PROBLEM: Despite the established role of molecular diagnostics, COVID-19 serodiagnosis remains a poorly discovered and enigmatic area. Although there are numerous commercial serological products available globally, there is a severe paucity of high-quality peer-reviewed literature on their true performance characteristics. That being said, publications including in-house developed serological tests started to shed light on the kinetics of the humoral response. SUMMARY: In spite of intense focus of assessing the performance characteristics of the commercially-available kits, the main issue remains rather invisible, that is, lack of solid science behind COVID-19 serology its clinical usefulness thereof. This short review summarizes the key points as to why COVID-19 is not jest ready to fly. PURPOSE OF REVIEW: Despite having been mentioned as a testing option, COVID-19 serology has significant shortcomings that needs discussing. This short review is meant to shed light on one of those aspects.",,m7y37ue6,"['BACKGROUND', 'Shortly', 'after', 'its', 'emergence', 'in', 'December', '2019', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'declared', 'as', 'a', 'pandemic', 'by', 'the', 'World', 'Health', 'Organization', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'the', 'seventh', 'member', 'of', 'the', 'Coronaviridae', 'family', 'of', 'viruses', 'that', 'causes', 'disease', 'in', 'humans', 'THE', 'PROBLEM', 'Despite', 'the', 'established', 'role', 'of', 'molecular', 'diagnostics', 'COVID', '19', 'serodiagnosis', 'remains', 'a', 'poorly', 'discovered', 'and', 'enigmatic', 'area', 'Although', 'there', 'are', 'numerous', 'commercial', 'serological', 'products', 'available', 'globally', 'there', 'is', 'a', 'severe', 'paucity', 'of', 'high', 'quality', 'peer', 'reviewed', 'literature', 'on', 'their', 'true', 'performance', 'characteristics', 'That', 'being', 'said', 'publications', 'including', 'in', 'house', 'developed', 'serological', 'tests', 'started', 'to', 'shed', 'light', 'on', 'the', 'kinetics', 'of', 'the', 'humoral', 'response', 'SUMMARY', 'In', 'spite', 'of', 'intense', 'focus', 'of', 'assessing', 'the', 'performance', 'characteristics', 'of', 'the', 'commercially', 'available', 'kits', 'the', 'main', 'issue', 'remains', 'rather', 'invisible', 'that', 'is', 'lack', 'of', 'solid', 'science', 'behind', 'COVID', '19', 'serology', 'its', 'clinical', 'usefulness', 'thereof', 'This', 'short', 'review', 'summarizes', 'the', 'key', 'points', 'as', 'to', 'why', 'COVID', '19', 'is', 'not', 'jest', 'ready', 'to', 'fly', 'PURPOSE', 'OF', 'REVIEW', 'Despite', 'having', 'been', 'mentioned', 'as', 'a', 'testing', 'option', 'COVID', '19', 'serology', 'has', 'significant', 'shortcomings', 'that', 'needs', 'discussing', 'This', 'short', 'review', 'is', 'meant', 'to', 'shed', 'light', 'on', 'one', 'of', 'those', 'aspects', '']"
93521,"Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: ménage à trois",2020,Curr. opin. rheumatol,,"BACKGROUND: Shortly after its emergence in December 2019, the coronavirus disease 2019 (COVID-19) was declared as a pandemic by the World Health Organization. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the seventh member of the Coronaviridae family of viruses that causes disease in humans. THE PROBLEM: Despite the established role of molecular diagnostics, COVID-19 serodiagnosis remains a poorly discovered and enigmatic area. Although there are numerous commercial serological products available globally, there is a severe paucity of high-quality peer-reviewed literature on their true performance characteristics. That being said, publications including in-house developed serological tests started to shed light on the kinetics of the humoral response. SUMMARY: In spite of intense focus of assessing the performance characteristics of the commercially-available kits, the main issue remains rather invisible, that is, lack of solid science behind COVID-19 serology its clinical usefulness thereof. This short review summarizes the key points as to why COVID-19 is not jest ready to fly. PURPOSE OF REVIEW: Despite having been mentioned as a testing option, COVID-19 serology has significant shortcomings that needs discussing. This short review is meant to shed light on one of those aspects.",,llf0iqop,"['BACKGROUND', 'Shortly', 'after', 'its', 'emergence', 'in', 'December', '2019', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'declared', 'as', 'a', 'pandemic', 'by', 'the', 'World', 'Health', 'Organization', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'the', 'seventh', 'member', 'of', 'the', 'Coronaviridae', 'family', 'of', 'viruses', 'that', 'causes', 'disease', 'in', 'humans', 'THE', 'PROBLEM', 'Despite', 'the', 'established', 'role', 'of', 'molecular', 'diagnostics', 'COVID', '19', 'serodiagnosis', 'remains', 'a', 'poorly', 'discovered', 'and', 'enigmatic', 'area', 'Although', 'there', 'are', 'numerous', 'commercial', 'serological', 'products', 'available', 'globally', 'there', 'is', 'a', 'severe', 'paucity', 'of', 'high', 'quality', 'peer', 'reviewed', 'literature', 'on', 'their', 'true', 'performance', 'characteristics', 'That', 'being', 'said', 'publications', 'including', 'in', 'house', 'developed', 'serological', 'tests', 'started', 'to', 'shed', 'light', 'on', 'the', 'kinetics', 'of', 'the', 'humoral', 'response', 'SUMMARY', 'In', 'spite', 'of', 'intense', 'focus', 'of', 'assessing', 'the', 'performance', 'characteristics', 'of', 'the', 'commercially', 'available', 'kits', 'the', 'main', 'issue', 'remains', 'rather', 'invisible', 'that', 'is', 'lack', 'of', 'solid', 'science', 'behind', 'COVID', '19', 'serology', 'its', 'clinical', 'usefulness', 'thereof', 'This', 'short', 'review', 'summarizes', 'the', 'key', 'points', 'as', 'to', 'why', 'COVID', '19', 'is', 'not', 'jest', 'ready', 'to', 'fly', 'PURPOSE', 'OF', 'REVIEW', 'Despite', 'having', 'been', 'mentioned', 'as', 'a', 'testing', 'option', 'COVID', '19', 'serology', 'has', 'significant', 'shortcomings', 'that', 'needs', 'discussing', 'This', 'short', 'review', 'is', 'meant', 'to', 'shed', 'light', 'on', 'one', 'of', 'those', 'aspects', '']"
94617,Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation,2020,Clin. res. cardiol,,"Coronavirus diseases 2019 (COVID-19) has become a worldwide pandemic affecting people at high risk and particularly at advanced age, cardiovascular and pulmonary disease. As cardiovascular patients are at high risk but also have dyspnea and fatigue as leading symptoms, prevention, diagnostics and treatment in these patients are important to provide adequate care for those with or without COVID-19 but most importantly when comorbid cardiovascular conditions are present. Severe COVID-19 with acute respiratory distress (ARDS) is challenging as patients with elevated myocardial markers such as troponin are at enhanced high risk for fatal outcomes. As angiotensin-converting enzyme 2 (ACE2) is regarded as the viral receptor for cell entry and as the Coronavirus is downregulating this enzyme, which provides cardiovascular and pulmonary protection, there is ongoing discussions on whether treatment with cardiovascular drugs, which upregulate the viral receptor ACE2 should be modified. As most of the COVID-19 patients have cardiovascular comorbidities like hypertension, diabetes, coronary artery disease and heart failure, which imposes a high risk on these patients, cardiovascular therapy should not be modified or even withdrawn. As cardiac injury is a common feature of COVID-19 associated ARDS and is linked with poor outcomes, swift diagnostic management and specialist care of cardiovascular patients in the area of COVID-19 is of particular importance and deserves special attention.",,0zkwn7hi,"['Coronavirus', 'diseases', '2019', 'COVID', '19', 'has', 'become', 'a', 'worldwide', 'pandemic', 'affecting', 'people', 'at', 'high', 'risk', 'and', 'particularly', 'at', 'advanced', 'age', 'cardiovascular', 'and', 'pulmonary', 'disease', 'As', 'cardiovascular', 'patients', 'are', 'at', 'high', 'risk', 'but', 'also', 'have', 'dyspnea', 'and', 'fatigue', 'as', 'leading', 'symptoms', 'prevention', 'diagnostics', 'and', 'treatment', 'in', 'these', 'patients', 'are', 'important', 'to', 'provide', 'adequate', 'care', 'for', 'those', 'with', 'or', 'without', 'COVID', '19', 'but', 'most', 'importantly', 'when', 'comorbid', 'cardiovascular', 'conditions', 'are', 'present', 'Severe', 'COVID', '19', 'with', 'acute', 'respiratory', 'distress', 'ARDS', 'is', 'challenging', 'as', 'patients', 'with', 'elevated', 'myocardial', 'markers', 'such', 'as', 'troponin', 'are', 'at', 'enhanced', 'high', 'risk', 'for', 'fatal', 'outcomes', 'As', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'is', 'regarded', 'as', 'the', 'viral', 'receptor', 'for', 'cell', 'entry', 'and', 'as', 'the', 'Coronavirus', 'is', 'downregulating', 'this', 'enzyme', 'which', 'provides', 'cardiovascular', 'and', 'pulmonary', 'protection', 'there', 'is', 'ongoing', 'discussions', 'on', 'whether', 'treatment', 'with', 'cardiovascular', 'drugs', 'which', 'upregulate', 'the', 'viral', 'receptor', 'ACE2', 'should', 'be', 'modified', 'As', 'most', 'of', 'the', 'COVID', '19', 'patients', 'have', 'cardiovascular', 'comorbidities', 'like', 'hypertension', 'diabetes', 'coronary', 'artery', 'disease', 'and', 'heart', 'failure', 'which', 'imposes', 'a', 'high', 'risk', 'on', 'these', 'patients', 'cardiovascular', 'therapy', 'should', 'not', 'be', 'modified', 'or', 'even', 'withdrawn', 'As', 'cardiac', 'injury', 'is', 'a', 'common', 'feature', 'of', 'COVID', '19', 'associated', 'ARDS', 'and', 'is', 'linked', 'with', 'poor', 'outcomes', 'swift', 'diagnostic', 'management', 'and', 'specialist', 'care', 'of', 'cardiovascular', 'patients', 'in', 'the', 'area', 'of', 'COVID', '19', 'is', 'of', 'particular', 'importance', 'and', 'deserves', 'special', 'attention', '']"
95608,Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience,2020,J. med. virol,,"A pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading throughout the world. Though molecular diagnostic tests are the gold standard for COVID-19, serological testing is emerging as a potential surveillance tool, in addition to its complementary role in COVID-19 diagnostics. Indubitably quantitative serological testing provides greater advantages than qualitative tests but today there is still little known about serological diagnostics and what the most appropriate role quantitative tests might play. Sixty-one COVID-19 patients and 64 patients from a control group were tested by iFlash1800 CLIA analyzer for anti-SARS CoV-2 antibodies IgM and IgG. All COVID-19 patients were hospitalized in San Giovanni di Dio Hospital (Florence, Italy) and had a positive oro/nasopharyngeal swab reverse-transcription polymerase chain reaction result. The highest sensitivity with a very good specificity performance was reached at a cutoff value of 10.0 AU/mL for IgM and of 7.1 for IgG antibodies, hence near to the manufacturer's cutoff values of 10 AU/mL for both isotypes. The receiver operating characteristic curves showed area under the curve values of 0.918 and 0.980 for anti-SARS CoV-2 antibodies IgM and IgG, respectively. iFlash1800 CLIA analyzer has shown highly accurate results for the anti-SARS-CoV-2 antibodies profile and can be considered an excellent tool for COVID-19 diagnostics.",,1dbeh8q7,"['A', 'pandemic', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'been', 'spreading', 'throughout', 'the', 'world', 'Though', 'molecular', 'diagnostic', 'tests', 'are', 'the', 'gold', 'standard', 'for', 'COVID', '19', 'serological', 'testing', 'is', 'emerging', 'as', 'a', 'potential', 'surveillance', 'tool', 'in', 'addition', 'to', 'its', 'complementary', 'role', 'in', 'COVID', '19', 'diagnostics', 'Indubitably', 'quantitative', 'serological', 'testing', 'provides', 'greater', 'advantages', 'than', 'qualitative', 'tests', 'but', 'today', 'there', 'is', 'still', 'little', 'known', 'about', 'serological', 'diagnostics', 'and', 'what', 'the', 'most', 'appropriate', 'role', 'quantitative', 'tests', 'might', 'play', 'Sixty', 'one', 'COVID', '19', 'patients', 'and', '64', 'patients', 'from', 'a', 'control', 'group', 'were', 'tested', 'by', 'iFlash1800', 'CLIA', 'analyzer', 'for', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'IgM', 'and', 'IgG', 'All', 'COVID', '19', 'patients', 'were', 'hospitalized', 'in', 'San', 'Giovanni', 'di', 'Dio', 'Hospital', 'Florence', 'Italy', 'and', 'had', 'a', 'positive', 'oro', 'nasopharyngeal', 'swab', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'result', 'The', 'highest', 'sensitivity', 'with', 'a', 'very', 'good', 'specificity', 'performance', 'was', 'reached', 'at', 'a', 'cutoff', 'value', 'of', '10', '0', 'AU', 'mL', 'for', 'IgM', 'and', 'of', '7', '1', 'for', 'IgG', 'antibodies', 'hence', 'near', 'to', 'the', 'manufacturer', 's', 'cutoff', 'values', 'of', '10', 'AU', 'mL', 'for', 'both', 'isotypes', 'The', 'receiver', 'operating', 'characteristic', 'curves', 'showed', 'area', 'under', 'the', 'curve', 'values', 'of', '0', '918', 'and', '0', '980', 'for', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'IgM', 'and', 'IgG', 'respectively', 'iFlash1800', 'CLIA', 'analyzer', 'has', 'shown', 'highly', 'accurate', 'results', 'for', 'the', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'profile', 'and', 'can', 'be', 'considered', 'an', 'excellent', 'tool', 'for', 'COVID', '19', 'diagnostics', '']"
95898,Potential impact of seasonal forcing on a SARS-CoV-2 pandemic,2020,Swiss Med Wkly,,"A novel coronavirus (SARS-CoV-2) first detected in Wuhan, China, has spread rapidly since December 2019, causing more than 100,000 confirmed infections and 4000 fatalities (as of 10 March 2020). The outbreak has been declared a pandemic by the WHO on Mar 11, 2020. Here, we explore how seasonal variation in transmissibility could modulate a SARS-CoV-2 pandemic. Data from routine diagnostics show a strong and consistent seasonal variation of the four endemic coronaviruses (229E, HKU1, NL63, OC43) and we parameterise our model for SARS-CoV-2 using these data. The model allows for many subpopulations of different size with variable parameters. Simulations of different scenarios show that plausible parameters result in a small peak in early 2020 in temperate regions of the Northern Hemisphere and a larger peak in winter 2020/2021. Variation in transmission and migration rates can result in substantial variation in prevalence between regions. While the uncertainty in parameters is large, the scenarios we explore show that transient reductions in the incidence rate might be due to a combination of seasonal variation and infection control efforts but do not necessarily mean the epidemic is contained. Seasonal forcing on SARS-CoV-2 should thus be taken into account in the further monitoring of the global transmission. The likely aggregated effect of seasonal variation, infection control measures, and transmission rate variation is a prolonged pandemic wave with lower prevalence at any given time, thereby providing a window of opportunity for better preparation of health care systems.",,ac0whd9v,"['A', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'first', 'detected', 'in', 'Wuhan', 'China', 'has', 'spread', 'rapidly', 'since', 'December', '2019', 'causing', 'more', 'than', '100', '000', 'confirmed', 'infections', 'and', '4000', 'fatalities', 'as', 'of', '10', 'March', '2020', 'The', 'outbreak', 'has', 'been', 'declared', 'a', 'pandemic', 'by', 'the', 'WHO', 'on', 'Mar', '11', '2020', 'Here', 'we', 'explore', 'how', 'seasonal', 'variation', 'in', 'transmissibility', 'could', 'modulate', 'a', 'SARS', 'CoV', '2', 'pandemic', 'Data', 'from', 'routine', 'diagnostics', 'show', 'a', 'strong', 'and', 'consistent', 'seasonal', 'variation', 'of', 'the', 'four', 'endemic', 'coronaviruses', '229E', 'HKU1', 'NL63', 'OC43', 'and', 'we', 'parameterise', 'our', 'model', 'for', 'SARS', 'CoV', '2', 'using', 'these', 'data', 'The', 'model', 'allows', 'for', 'many', 'subpopulations', 'of', 'different', 'size', 'with', 'variable', 'parameters', 'Simulations', 'of', 'different', 'scenarios', 'show', 'that', 'plausible', 'parameters', 'result', 'in', 'a', 'small', 'peak', 'in', 'early', '2020', 'in', 'temperate', 'regions', 'of', 'the', 'Northern', 'Hemisphere', 'and', 'a', 'larger', 'peak', 'in', 'winter', '2020', '2021', 'Variation', 'in', 'transmission', 'and', 'migration', 'rates', 'can', 'result', 'in', 'substantial', 'variation', 'in', 'prevalence', 'between', 'regions', 'While', 'the', 'uncertainty', 'in', 'parameters', 'is', 'large', 'the', 'scenarios', 'we', 'explore', 'show', 'that', 'transient', 'reductions', 'in', 'the', 'incidence', 'rate', 'might', 'be', 'due', 'to', 'a', 'combination', 'of', 'seasonal', 'variation', 'and', 'infection', 'control', 'efforts', 'but', 'do', 'not', 'necessarily', 'mean', 'the', 'epidemic', 'is', 'contained', 'Seasonal', 'forcing', 'on', 'SARS', 'CoV', '2', 'should', 'thus', 'be', 'taken', 'into', 'account', 'in', 'the', 'further', 'monitoring', 'of', 'the', 'global', 'transmission', 'The', 'likely', 'aggregated', 'effect', 'of', 'seasonal', 'variation', 'infection', 'control', 'measures', 'and', 'transmission', 'rate', 'variation', 'is', 'a', 'prolonged', 'pandemic', 'wave', 'with', 'lower', 'prevalence', 'at', 'any', 'given', 'time', 'thereby', 'providing', 'a', 'window', 'of', 'opportunity', 'for', 'better', 'preparation', 'of', 'health', 'care', 'systems', '']"
96521,The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review,2020,Int. j. infect. dis,,"BACKGROUND: the recent outbreak of the coronavirus disease 2019 (COVID-19) has quickly spread globally since its discovery in Wuhan, China, in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, and clinical treatment is urgently needed to win the battle against COVID-19. Recently, numerous studies reported the incidence of SARS-CoV-2 in asymptomatic patients. Yet, the incidence and viral transmission from the asymptomatic cases are not apparent yet. AIM: this study aims to systematically review the published literature on SARS-CoV-2 in the asymptomatic patients to estimate the incidence of COVID-19 among asymptomatic cases, as well as describe its epidemiological and clinical significance. METHOD: the literature was searched through four scientific databases: PubMed, Web of Science, Scopus, and Science Direct. RESULTS: a total of 63 studies satisfied the inclusion criteria where the majority of the reported studies were from China. However, there was a lack of SARS-CoV-2 epidemiological studies from several countries worldwide, tracing the actual incidence of COVID-19, especially in asymptomatic patients. Studies with a large sample size (n>1000) estimated that percentage of people contracting SARS-CoV-2 and are likely to be asymptomatic ranges from 1.2-12.9%. However, the other studies with a smaller sample size reported a much higher incidence and indicated that up to 87.9% of COVID-19 infected individuals could be asymptomatic. Most of these studies indicated that asymptopatics are a potential source of infection to the community. CONCLUSION: this review highlighted the need for more robust and well-designed studies to better estimate COVID-19 incidence among asymptomatic patients worldwide. The early identification of the asymptomatic cases, as well as monitoring and tracing close contact, could help in mitigating the spread of COVID-19.",,6sf5xepa,"['BACKGROUND', 'the', 'recent', 'outbreak', 'of', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'has', 'quickly', 'spread', 'globally', 'since', 'its', 'discovery', 'in', 'Wuhan', 'China', 'in', 'December', '2019', 'A', 'comprehensive', 'strategy', 'including', 'surveillance', 'diagnostics', 'research', 'and', 'clinical', 'treatment', 'is', 'urgently', 'needed', 'to', 'win', 'the', 'battle', 'against', 'COVID', '19', 'Recently', 'numerous', 'studies', 'reported', 'the', 'incidence', 'of', 'SARS', 'CoV', '2', 'in', 'asymptomatic', 'patients', 'Yet', 'the', 'incidence', 'and', 'viral', 'transmission', 'from', 'the', 'asymptomatic', 'cases', 'are', 'not', 'apparent', 'yet', 'AIM', 'this', 'study', 'aims', 'to', 'systematically', 'review', 'the', 'published', 'literature', 'on', 'SARS', 'CoV', '2', 'in', 'the', 'asymptomatic', 'patients', 'to', 'estimate', 'the', 'incidence', 'of', 'COVID', '19', 'among', 'asymptomatic', 'cases', 'as', 'well', 'as', 'describe', 'its', 'epidemiological', 'and', 'clinical', 'significance', 'METHOD', 'the', 'literature', 'was', 'searched', 'through', 'four', 'scientific', 'databases', 'PubMed', 'Web', 'of', 'Science', 'Scopus', 'and', 'Science', 'Direct', 'RESULTS', 'a', 'total', 'of', '63', 'studies', 'satisfied', 'the', 'inclusion', 'criteria', 'where', 'the', 'majority', 'of', 'the', 'reported', 'studies', 'were', 'from', 'China', 'However', 'there', 'was', 'a', 'lack', 'of', 'SARS', 'CoV', '2', 'epidemiological', 'studies', 'from', 'several', 'countries', 'worldwide', 'tracing', 'the', 'actual', 'incidence', 'of', 'COVID', '19', 'especially', 'in', 'asymptomatic', 'patients', 'Studies', 'with', 'a', 'large', 'sample', 'size', 'n', '1000', 'estimated', 'that', 'percentage', 'of', 'people', 'contracting', 'SARS', 'CoV', '2', 'and', 'are', 'likely', 'to', 'be', 'asymptomatic', 'ranges', 'from', '1', '2', '12', '9', 'However', 'the', 'other', 'studies', 'with', 'a', 'smaller', 'sample', 'size', 'reported', 'a', 'much', 'higher', 'incidence', 'and', 'indicated', 'that', 'up', 'to', '87', '9', 'of', 'COVID', '19', 'infected', 'individuals', 'could', 'be', 'asymptomatic', 'Most', 'of', 'these', 'studies', 'indicated', 'that', 'asymptopatics', 'are', 'a', 'potential', 'source', 'of', 'infection', 'to', 'the', 'community', 'CONCLUSION', 'this', 'review', 'highlighted', 'the', 'need', 'for', 'more', 'robust', 'and', 'well', 'designed', 'studies', 'to', 'better', 'estimate', 'COVID', '19', 'incidence', 'among', 'asymptomatic', 'patients', 'worldwide', 'The', 'early', 'identification', 'of', 'the', 'asymptomatic', 'cases', 'as', 'well', 'as', 'monitoring', 'and', 'tracing', 'close', 'contact', 'could', 'help', 'in', 'mitigating', 'the', 'spread', 'of', 'COVID', '19', '']"
97239,Lung ultrasound in the diagnosis of COVID-19 infection - A case series and review of the literature,2020,Adv Med Sci,,"COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and spreading worldwide has become a serious challenge for the entire health care system as regards infection prevention, rapid diagnosis, and treatment. Lung ultrasound (LUS) is a dynamically developing diagnostic method used in intensive care, cardiology and nephrology, it can also be helpful in diagnosing and monitoring pneumonia. Interstitial pneumonia appears to be the most common clinical manifestation of coronavirus infection. We present 4 case reports of COVID-19 involving the lungs, in which transthoracic lung ultrasound was successfully utilized as a constituent of bedside diagnostics and a review of the literature concerning potential use of LUS in COVID-19 diagnostics. The possibility to perform this examination repeatedly, its non-invasiveness and high sensitivity make it an important element of care provided for patients with viral pneumonia.",,lq4sgnga,"['COVID', '19', 'pandemic', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'and', 'spreading', 'worldwide', 'has', 'become', 'a', 'serious', 'challenge', 'for', 'the', 'entire', 'health', 'care', 'system', 'as', 'regards', 'infection', 'prevention', 'rapid', 'diagnosis', 'and', 'treatment', 'Lung', 'ultrasound', 'LUS', 'is', 'a', 'dynamically', 'developing', 'diagnostic', 'method', 'used', 'in', 'intensive', 'care', 'cardiology', 'and', 'nephrology', 'it', 'can', 'also', 'be', 'helpful', 'in', 'diagnosing', 'and', 'monitoring', 'pneumonia', 'Interstitial', 'pneumonia', 'appears', 'to', 'be', 'the', 'most', 'common', 'clinical', 'manifestation', 'of', 'coronavirus', 'infection', 'We', 'present', '4', 'case', 'reports', 'of', 'COVID', '19', 'involving', 'the', 'lungs', 'in', 'which', 'transthoracic', 'lung', 'ultrasound', 'was', 'successfully', 'utilized', 'as', 'a', 'constituent', 'of', 'bedside', 'diagnostics', 'and', 'a', 'review', 'of', 'the', 'literature', 'concerning', 'potential', 'use', 'of', 'LUS', 'in', 'COVID', '19', 'diagnostics', 'The', 'possibility', 'to', 'perform', 'this', 'examination', 'repeatedly', 'its', 'non', 'invasiveness', 'and', 'high', 'sensitivity', 'make', 'it', 'an', 'important', 'element', 'of', 'care', 'provided', 'for', 'patients', 'with', 'viral', 'pneumonia', '']"
97496,Full-genome sequences of the first two SARS-CoV-2 viruses from India,2020,Indian J Med Res,,"Background & objectives: Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has globally affected 195 countries. In India, suspected cases were screened for SARS-CoV-2 as per the advisory of the Ministry of Health and Family Welfare. The objective of this study was to characterize SARS-CoV-2 sequences from three identified positive cases as on February 29, 2020. Methods: Throat swab/nasal swab specimens for a total of 881 suspected cases were screened by E gene and confirmed by RdRp (1), RdRp (2) and N gene real-time reverse transcription-polymerase chain reactions and next-generation sequencing. Phylogenetic analysis, molecular characterization and prediction of B- and T-cell epitopes for Indian SARS-CoV-2 sequences were undertaken. Results: Three cases with a travel history from Wuhan, China, were confirmed positive for SARS-CoV-2. Almost complete (29,851 nucleotides) genomes of case 1, case 3 and a fragmented genome for case 2 were obtained. The sequences of Indian SARS-CoV-2 though not identical showed high (~99.98%) identity with Wuhan seafood market pneumonia virus (accession number: NC 045512). Phylogenetic analysis showed that the Indian sequences belonged to different clusters. Predicted linear B-cell epitopes were found to be concentrated in the S1 domain of spike protein, and a conformational epitope was identified in the receptor-binding domain. The predicted T-cell epitopes showed broad human leucocyte antigen allele coverage of A and B supertypes predominant in the Indian population. Interpretation & conclusions: The two SARS-CoV-2 sequences obtained from India represent two different introductions into the country. The genetic heterogeneity is as noted globally. The identified B- and T-cell epitopes may be considered suitable for future experiments towards the design of vaccines and diagnostics. Continuous monitoring and analysis of the sequences of new cases from India and the other affected countries would be vital to understand the genetic evolution and rates of substitution of the SARS-CoV-2.",,35wfw3zn,"['Background', 'objectives', 'Since', 'December', '2019', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'globally', 'affected', '195', 'countries', 'In', 'India', 'suspected', 'cases', 'were', 'screened', 'for', 'SARS', 'CoV', '2', 'as', 'per', 'the', 'advisory', 'of', 'the', 'Ministry', 'of', 'Health', 'and', 'Family', 'Welfare', 'The', 'objective', 'of', 'this', 'study', 'was', 'to', 'characterize', 'SARS', 'CoV', '2', 'sequences', 'from', 'three', 'identified', 'positive', 'cases', 'as', 'on', 'February', '29', '2020', 'Methods', 'Throat', 'swab', 'nasal', 'swab', 'specimens', 'for', 'a', 'total', 'of', '881', 'suspected', 'cases', 'were', 'screened', 'by', 'E', 'gene', 'and', 'confirmed', 'by', 'RdRp', '1', 'RdRp', '2', 'and', 'N', 'gene', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reactions', 'and', 'next', 'generation', 'sequencing', 'Phylogenetic', 'analysis', 'molecular', 'characterization', 'and', 'prediction', 'of', 'B', 'and', 'T', 'cell', 'epitopes', 'for', 'Indian', 'SARS', 'CoV', '2', 'sequences', 'were', 'undertaken', 'Results', 'Three', 'cases', 'with', 'a', 'travel', 'history', 'from', 'Wuhan', 'China', 'were', 'confirmed', 'positive', 'for', 'SARS', 'CoV', '2', 'Almost', 'complete', '29', '851', 'nucleotides', 'genomes', 'of', 'case', '1', 'case', '3', 'and', 'a', 'fragmented', 'genome', 'for', 'case', '2', 'were', 'obtained', 'The', 'sequences', 'of', 'Indian', 'SARS', 'CoV', '2', 'though', 'not', 'identical', 'showed', 'high', '99', '98', 'identity', 'with', 'Wuhan', 'seafood', 'market', 'pneumonia', 'virus', 'accession', 'number', 'NC', '045512', 'Phylogenetic', 'analysis', 'showed', 'that', 'the', 'Indian', 'sequences', 'belonged', 'to', 'different', 'clusters', 'Predicted', 'linear', 'B', 'cell', 'epitopes', 'were', 'found', 'to', 'be', 'concentrated', 'in', 'the', 'S1', 'domain', 'of', 'spike', 'protein', 'and', 'a', 'conformational', 'epitope', 'was', 'identified', 'in', 'the', 'receptor', 'binding', 'domain', 'The', 'predicted', 'T', 'cell', 'epitopes', 'showed', 'broad', 'human', 'leucocyte', 'antigen', 'allele', 'coverage', 'of', 'A', 'and', 'B', 'supertypes', 'predominant', 'in', 'the', 'Indian', 'population', 'Interpretation', 'conclusions', 'The', 'two', 'SARS', 'CoV', '2', 'sequences', 'obtained', 'from', 'India', 'represent', 'two', 'different', 'introductions', 'into', 'the', 'country', 'The', 'genetic', 'heterogeneity', 'is', 'as', 'noted', 'globally', 'The', 'identified', 'B', 'and', 'T', 'cell', 'epitopes', 'may', 'be', 'considered', 'suitable', 'for', 'future', 'experiments', 'towards', 'the', 'design', 'of', 'vaccines', 'and', 'diagnostics', 'Continuous', 'monitoring', 'and', 'analysis', 'of', 'the', 'sequences', 'of', 'new', 'cases', 'from', 'India', 'and', 'the', 'other', 'affected', 'countries', 'would', 'be', 'vital', 'to', 'understand', 'the', 'genetic', 'evolution', 'and', 'rates', 'of', 'substitution', 'of', 'the', 'SARS', 'CoV', '2', '']"
97497,Full-genome sequences of the first two SARS-CoV-2 viruses from India,2020,Indian J Med Res,,"Background & objectives: Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has globally affected 195 countries. In India, suspected cases were screened for SARS-CoV-2 as per the advisory of the Ministry of Health and Family Welfare. The objective of this study was to characterize SARS-CoV-2 sequences from three identified positive cases as on February 29, 2020. Methods: Throat swab/nasal swab specimens for a total of 881 suspected cases were screened by E gene and confirmed by RdRp (1), RdRp (2) and N gene real-time reverse transcription-polymerase chain reactions and next-generation sequencing. Phylogenetic analysis, molecular characterization and prediction of B- and T-cell epitopes for Indian SARS-CoV-2 sequences were undertaken. Results: Three cases with a travel history from Wuhan, China, were confirmed positive for SARS-CoV-2. Almost complete (29,851 nucleotides) genomes of case 1, case 3 and a fragmented genome for case 2 were obtained. The sequences of Indian SARS-CoV-2 though not identical showed high (~99.98%) identity with Wuhan seafood market pneumonia virus (accession number: NC 045512). Phylogenetic analysis showed that the Indian sequences belonged to different clusters. Predicted linear B-cell epitopes were found to be concentrated in the S1 domain of spike protein, and a conformational epitope was identified in the receptor-binding domain. The predicted T-cell epitopes showed broad human leucocyte antigen allele coverage of A and B supertypes predominant in the Indian population. Interpretation & conclusions: The two SARS-CoV-2 sequences obtained from India represent two different introductions into the country. The genetic heterogeneity is as noted globally. The identified B- and T-cell epitopes may be considered suitable for future experiments towards the design of vaccines and diagnostics. Continuous monitoring and analysis of the sequences of new cases from India and the other affected countries would be vital to understand the genetic evolution and rates of substitution of the SARS-CoV-2.",,h6s3kx92,"['Background', 'objectives', 'Since', 'December', '2019', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'globally', 'affected', '195', 'countries', 'In', 'India', 'suspected', 'cases', 'were', 'screened', 'for', 'SARS', 'CoV', '2', 'as', 'per', 'the', 'advisory', 'of', 'the', 'Ministry', 'of', 'Health', 'and', 'Family', 'Welfare', 'The', 'objective', 'of', 'this', 'study', 'was', 'to', 'characterize', 'SARS', 'CoV', '2', 'sequences', 'from', 'three', 'identified', 'positive', 'cases', 'as', 'on', 'February', '29', '2020', 'Methods', 'Throat', 'swab', 'nasal', 'swab', 'specimens', 'for', 'a', 'total', 'of', '881', 'suspected', 'cases', 'were', 'screened', 'by', 'E', 'gene', 'and', 'confirmed', 'by', 'RdRp', '1', 'RdRp', '2', 'and', 'N', 'gene', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reactions', 'and', 'next', 'generation', 'sequencing', 'Phylogenetic', 'analysis', 'molecular', 'characterization', 'and', 'prediction', 'of', 'B', 'and', 'T', 'cell', 'epitopes', 'for', 'Indian', 'SARS', 'CoV', '2', 'sequences', 'were', 'undertaken', 'Results', 'Three', 'cases', 'with', 'a', 'travel', 'history', 'from', 'Wuhan', 'China', 'were', 'confirmed', 'positive', 'for', 'SARS', 'CoV', '2', 'Almost', 'complete', '29', '851', 'nucleotides', 'genomes', 'of', 'case', '1', 'case', '3', 'and', 'a', 'fragmented', 'genome', 'for', 'case', '2', 'were', 'obtained', 'The', 'sequences', 'of', 'Indian', 'SARS', 'CoV', '2', 'though', 'not', 'identical', 'showed', 'high', '99', '98', 'identity', 'with', 'Wuhan', 'seafood', 'market', 'pneumonia', 'virus', 'accession', 'number', 'NC', '045512', 'Phylogenetic', 'analysis', 'showed', 'that', 'the', 'Indian', 'sequences', 'belonged', 'to', 'different', 'clusters', 'Predicted', 'linear', 'B', 'cell', 'epitopes', 'were', 'found', 'to', 'be', 'concentrated', 'in', 'the', 'S1', 'domain', 'of', 'spike', 'protein', 'and', 'a', 'conformational', 'epitope', 'was', 'identified', 'in', 'the', 'receptor', 'binding', 'domain', 'The', 'predicted', 'T', 'cell', 'epitopes', 'showed', 'broad', 'human', 'leucocyte', 'antigen', 'allele', 'coverage', 'of', 'A', 'and', 'B', 'supertypes', 'predominant', 'in', 'the', 'Indian', 'population', 'Interpretation', 'conclusions', 'The', 'two', 'SARS', 'CoV', '2', 'sequences', 'obtained', 'from', 'India', 'represent', 'two', 'different', 'introductions', 'into', 'the', 'country', 'The', 'genetic', 'heterogeneity', 'is', 'as', 'noted', 'globally', 'The', 'identified', 'B', 'and', 'T', 'cell', 'epitopes', 'may', 'be', 'considered', 'suitable', 'for', 'future', 'experiments', 'towards', 'the', 'design', 'of', 'vaccines', 'and', 'diagnostics', 'Continuous', 'monitoring', 'and', 'analysis', 'of', 'the', 'sequences', 'of', 'new', 'cases', 'from', 'India', 'and', 'the', 'other', 'affected', 'countries', 'would', 'be', 'vital', 'to', 'understand', 'the', 'genetic', 'evolution', 'and', 'rates', 'of', 'substitution', 'of', 'the', 'SARS', 'CoV', '2', '']"
97600,Emerging prophylaxis strategies against COVID-19,2020,Monaldi arch. chest dis,,"The Novel corona virus 2019 which started as an outbreak in China in December 2019 has rapidly spread all over the world, such that on 11th March 2020 WHO declared this disease as pandemic. The emergency that the world faces today demands that we develop urgent and effective measures to protect people at high risk of transmission. WHO has accelerated research in diagnostics, vaccines and therapeutics for this novel coronavirus.",,ar3b23zq,"['The', 'Novel', 'corona', 'virus', '2019', 'which', 'started', 'as', 'an', 'outbreak', 'in', 'China', 'in', 'December', '2019', 'has', 'rapidly', 'spread', 'all', 'over', 'the', 'world', 'such', 'that', 'on', '11th', 'March', '2020', 'WHO', 'declared', 'this', 'disease', 'as', 'pandemic', 'The', 'emergency', 'that', 'the', 'world', 'faces', 'today', 'demands', 'that', 'we', 'develop', 'urgent', 'and', 'effective', 'measures', 'to', 'protect', 'people', 'at', 'high', 'risk', 'of', 'transmission', 'WHO', 'has', 'accelerated', 'research', 'in', 'diagnostics', 'vaccines', 'and', 'therapeutics', 'for', 'this', 'novel', 'coronavirus', '']"
97601,Emerging prophylaxis strategies against COVID-19,2020,Monaldi arch. chest dis,,"The Novel corona virus 2019 which started as an outbreak in China in December 2019 has rapidly spread all over the world, such that on 11th March 2020 WHO declared this disease as pandemic. The emergency that the world faces today demands that we develop urgent and effective measures to protect people at high risk of transmission. WHO has accelerated research in diagnostics, vaccines and therapeutics for this novel coronavirus.",,xkcsgiz2,"['The', 'Novel', 'corona', 'virus', '2019', 'which', 'started', 'as', 'an', 'outbreak', 'in', 'China', 'in', 'December', '2019', 'has', 'rapidly', 'spread', 'all', 'over', 'the', 'world', 'such', 'that', 'on', '11th', 'March', '2020', 'WHO', 'declared', 'this', 'disease', 'as', 'pandemic', 'The', 'emergency', 'that', 'the', 'world', 'faces', 'today', 'demands', 'that', 'we', 'develop', 'urgent', 'and', 'effective', 'measures', 'to', 'protect', 'people', 'at', 'high', 'risk', 'of', 'transmission', 'WHO', 'has', 'accelerated', 'research', 'in', 'diagnostics', 'vaccines', 'and', 'therapeutics', 'for', 'this', 'novel', 'coronavirus', '']"
98381,"2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness",2020,J Infect Dev Ctries,,"On 31 December 2019 the Wuhan Health Commission reported a cluster of atypical pneumonia cases that was linked to a wet market in the city of Wuhan, China. The first patients began experiencing symptoms of illness in mid-December 2019. Clinical isolates were found to contain a novel coronavirus with similarity to bat coronaviruses. As of 28 January 2020, there are in excess of 4,500 laboratory-confirmed cases, with > 100 known deaths. As with the SARS-CoV, infections in children appear to be rare. Travel-related cases have been confirmed in multiple countries and regions outside mainland China including Germany, France, Thailand, Japan, South Korea, Vietnam, Canada, and the United States, as well as Hong Kong and Taiwan. Domestically in China, the virus has also been noted in several cities and provinces with cases in all but one provinence. While zoonotic transmission appears to be the original source of infections, the most alarming development is that human-to-human transmission is now prevelant. Of particular concern is that many healthcare workers have been infected in the current epidemic. There are several critical clinical questions that need to be resolved, including how efficient is human-to-human transmission? What is the animal reservoir? Is there an intermediate animal reservoir? Do the vaccines generated to the SARS-CoV or MERS-CoV or their proteins offer protection against 2019-nCoV? We offer a research perspective on the next steps for the generation of vaccines. We also present data on the use of in silico docking in gaining insight into 2019-nCoV Spike-receptor binding to aid in therapeutic development. Diagnostic PCR protocols can be found at https://www.who.int/health-topics/coronavirus/laboratory-diagnostics-for-novel-coronavirus.",,bu1ib2ul,"['On', '31', 'December', '2019', 'the', 'Wuhan', 'Health', 'Commission', 'reported', 'a', 'cluster', 'of', 'atypical', 'pneumonia', 'cases', 'that', 'was', 'linked', 'to', 'a', 'wet', 'market', 'in', 'the', 'city', 'of', 'Wuhan', 'China', 'The', 'first', 'patients', 'began', 'experiencing', 'symptoms', 'of', 'illness', 'in', 'mid', 'December', '2019', 'Clinical', 'isolates', 'were', 'found', 'to', 'contain', 'a', 'novel', 'coronavirus', 'with', 'similarity', 'to', 'bat', 'coronaviruses', 'As', 'of', '28', 'January', '2020', 'there', 'are', 'in', 'excess', 'of', '4', '500', 'laboratory', 'confirmed', 'cases', 'with', '100', 'known', 'deaths', 'As', 'with', 'the', 'SARS', 'CoV', 'infections', 'in', 'children', 'appear', 'to', 'be', 'rare', 'Travel', 'related', 'cases', 'have', 'been', 'confirmed', 'in', 'multiple', 'countries', 'and', 'regions', 'outside', 'mainland', 'China', 'including', 'Germany', 'France', 'Thailand', 'Japan', 'South', 'Korea', 'Vietnam', 'Canada', 'and', 'the', 'United', 'States', 'as', 'well', 'as', 'Hong', 'Kong', 'and', 'Taiwan', 'Domestically', 'in', 'China', 'the', 'virus', 'has', 'also', 'been', 'noted', 'in', 'several', 'cities', 'and', 'provinces', 'with', 'cases', 'in', 'all', 'but', 'one', 'provinence', 'While', 'zoonotic', 'transmission', 'appears', 'to', 'be', 'the', 'original', 'source', 'of', 'infections', 'the', 'most', 'alarming', 'development', 'is', 'that', 'human', 'to', 'human', 'transmission', 'is', 'now', 'prevelant', 'Of', 'particular', 'concern', 'is', 'that', 'many', 'healthcare', 'workers', 'have', 'been', 'infected', 'in', 'the', 'current', 'epidemic', 'There', 'are', 'several', 'critical', 'clinical', 'questions', 'that', 'need', 'to', 'be', 'resolved', 'including', 'how', 'efficient', 'is', 'human', 'to', 'human', 'transmission', 'What', 'is', 'the', 'animal', 'reservoir', 'Is', 'there', 'an', 'intermediate', 'animal', 'reservoir', 'Do', 'the', 'vaccines', 'generated', 'to', 'the', 'SARS', 'CoV', 'or', 'MERS', 'CoV', 'or', 'their', 'proteins', 'offer', 'protection', 'against', '2019', 'nCoV', 'We', 'offer', 'a', 'research', 'perspective', 'on', 'the', 'next', 'steps', 'for', 'the', 'generation', 'of', 'vaccines', 'We', 'also', 'present', 'data', 'on', 'the', 'use', 'of', 'in', 'silico', 'docking', 'in', 'gaining', 'insight', 'into', '2019', 'nCoV', 'Spike', 'receptor', 'binding', 'to', 'aid', 'in', 'therapeutic', 'development', 'Diagnostic', 'PCR', 'protocols', 'can', 'be', 'found', 'at', 'https', 'www', 'who', 'int', 'health', 'topics', 'coronavirus', 'laboratory', 'diagnostics', 'for', 'novel', 'coronavirus', '']"
98529,Current laboratory diagnostics of coronavirus disease 2019 (COVID-19),2020,Acta Biomed,,"Laboratory medicine provides an almost irreplaceable contribution to the diagnostic reasoning and managed care of most human pathologies. The novel coronavirus disease 2019 (COVID-19) is not an exception to this paradigm. Although the relatively recent emergence does not allow to draw definitive conclusions on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics, some standpoints can be conveyed. First and foremost, it seems now clear that we will be living together with this virus for quite a long time, so that our vigilance and responsiveness against the emergence of new local outbreaks shall be maintained at the highest possible levels. The etiological diagnosis of COVID-19 is, and will remain for the foreseeable future, deeply based on direct identification of viral RNA by means of molecular biology techniques in biological materials, especially upper and lower respiratory tract specimens. Whether other materials, such as blood, urine, stools, saliva and throat washing, will become valid alternatives has not been unequivocally defined so far. As concerns serological testing, promising information can be garnered from preliminary investigations, showing that the vast majority of COVID-19 patients seem to develop a sustained immune response against the virus, characterized especially by emergence of anti-SARS-CoV-2 IgG and IgA, 1 to 2 weeks after the onset of fever and/or respiratory symptoms. Whether these antibodies will have persistent neutralizing activity against the virus is still to be elucidated on individual and general basis. The availability of rapid tests for detecting either viral antigens or anti-SARS-CoV-2 antibodies are a potentially viable opportunity for purposes of epidemiologic surveillance, though more information is needed on accuracy and reliability of these portable immunoassays.",,3y47oszt,"['Laboratory', 'medicine', 'provides', 'an', 'almost', 'irreplaceable', 'contribution', 'to', 'the', 'diagnostic', 'reasoning', 'and', 'managed', 'care', 'of', 'most', 'human', 'pathologies', 'The', 'novel', 'coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'not', 'an', 'exception', 'to', 'this', 'paradigm', 'Although', 'the', 'relatively', 'recent', 'emergence', 'does', 'not', 'allow', 'to', 'draw', 'definitive', 'conclusions', 'on', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'diagnostics', 'some', 'standpoints', 'can', 'be', 'conveyed', 'First', 'and', 'foremost', 'it', 'seems', 'now', 'clear', 'that', 'we', 'will', 'be', 'living', 'together', 'with', 'this', 'virus', 'for', 'quite', 'a', 'long', 'time', 'so', 'that', 'our', 'vigilance', 'and', 'responsiveness', 'against', 'the', 'emergence', 'of', 'new', 'local', 'outbreaks', 'shall', 'be', 'maintained', 'at', 'the', 'highest', 'possible', 'levels', 'The', 'etiological', 'diagnosis', 'of', 'COVID', '19', 'is', 'and', 'will', 'remain', 'for', 'the', 'foreseeable', 'future', 'deeply', 'based', 'on', 'direct', 'identification', 'of', 'viral', 'RNA', 'by', 'means', 'of', 'molecular', 'biology', 'techniques', 'in', 'biological', 'materials', 'especially', 'upper', 'and', 'lower', 'respiratory', 'tract', 'specimens', 'Whether', 'other', 'materials', 'such', 'as', 'blood', 'urine', 'stools', 'saliva', 'and', 'throat', 'washing', 'will', 'become', 'valid', 'alternatives', 'has', 'not', 'been', 'unequivocally', 'defined', 'so', 'far', 'As', 'concerns', 'serological', 'testing', 'promising', 'information', 'can', 'be', 'garnered', 'from', 'preliminary', 'investigations', 'showing', 'that', 'the', 'vast', 'majority', 'of', 'COVID', '19', 'patients', 'seem', 'to', 'develop', 'a', 'sustained', 'immune', 'response', 'against', 'the', 'virus', 'characterized', 'especially', 'by', 'emergence', 'of', 'anti', 'SARS', 'CoV', '2', 'IgG', 'and', 'IgA', '1', 'to', '2', 'weeks', 'after', 'the', 'onset', 'of', 'fever', 'and', 'or', 'respiratory', 'symptoms', 'Whether', 'these', 'antibodies', 'will', 'have', 'persistent', 'neutralizing', 'activity', 'against', 'the', 'virus', 'is', 'still', 'to', 'be', 'elucidated', 'on', 'individual', 'and', 'general', 'basis', 'The', 'availability', 'of', 'rapid', 'tests', 'for', 'detecting', 'either', 'viral', 'antigens', 'or', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'are', 'a', 'potentially', 'viable', 'opportunity', 'for', 'purposes', 'of', 'epidemiologic', 'surveillance', 'though', 'more', 'information', 'is', 'needed', 'on', 'accuracy', 'and', 'reliability', 'of', 'these', 'portable', 'immunoassays', '']"
98530,Current laboratory diagnostics of coronavirus disease 2019 (COVID-19),2020,Acta Biomed,,"Laboratory medicine provides an almost irreplaceable contribution to the diagnostic reasoning and managed care of most human pathologies. The novel coronavirus disease 2019 (COVID-19) is not an exception to this paradigm. Although the relatively recent emergence does not allow to draw definitive conclusions on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics, some standpoints can be conveyed. First and foremost, it seems now clear that we will be living together with this virus for quite a long time, so that our vigilance and responsiveness against the emergence of new local outbreaks shall be maintained at the highest possible levels. The etiological diagnosis of COVID-19 is, and will remain for the foreseeable future, deeply based on direct identification of viral RNA by means of molecular biology techniques in biological materials, especially upper and lower respiratory tract specimens. Whether other materials, such as blood, urine, stools, saliva and throat washing, will become valid alternatives has not been unequivocally defined so far. As concerns serological testing, promising information can be garnered from preliminary investigations, showing that the vast majority of COVID-19 patients seem to develop a sustained immune response against the virus, characterized especially by emergence of anti-SARS-CoV-2 IgG and IgA, 1 to 2 weeks after the onset of fever and/or respiratory symptoms. Whether these antibodies will have persistent neutralizing activity against the virus is still to be elucidated on individual and general basis. The availability of rapid tests for detecting either viral antigens or anti-SARS-CoV-2 antibodies are a potentially viable opportunity for purposes of epidemiologic surveillance, though more information is needed on accuracy and reliability of these portable immunoassays.",,40tgyur8,"['Laboratory', 'medicine', 'provides', 'an', 'almost', 'irreplaceable', 'contribution', 'to', 'the', 'diagnostic', 'reasoning', 'and', 'managed', 'care', 'of', 'most', 'human', 'pathologies', 'The', 'novel', 'coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'not', 'an', 'exception', 'to', 'this', 'paradigm', 'Although', 'the', 'relatively', 'recent', 'emergence', 'does', 'not', 'allow', 'to', 'draw', 'definitive', 'conclusions', 'on', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'diagnostics', 'some', 'standpoints', 'can', 'be', 'conveyed', 'First', 'and', 'foremost', 'it', 'seems', 'now', 'clear', 'that', 'we', 'will', 'be', 'living', 'together', 'with', 'this', 'virus', 'for', 'quite', 'a', 'long', 'time', 'so', 'that', 'our', 'vigilance', 'and', 'responsiveness', 'against', 'the', 'emergence', 'of', 'new', 'local', 'outbreaks', 'shall', 'be', 'maintained', 'at', 'the', 'highest', 'possible', 'levels', 'The', 'etiological', 'diagnosis', 'of', 'COVID', '19', 'is', 'and', 'will', 'remain', 'for', 'the', 'foreseeable', 'future', 'deeply', 'based', 'on', 'direct', 'identification', 'of', 'viral', 'RNA', 'by', 'means', 'of', 'molecular', 'biology', 'techniques', 'in', 'biological', 'materials', 'especially', 'upper', 'and', 'lower', 'respiratory', 'tract', 'specimens', 'Whether', 'other', 'materials', 'such', 'as', 'blood', 'urine', 'stools', 'saliva', 'and', 'throat', 'washing', 'will', 'become', 'valid', 'alternatives', 'has', 'not', 'been', 'unequivocally', 'defined', 'so', 'far', 'As', 'concerns', 'serological', 'testing', 'promising', 'information', 'can', 'be', 'garnered', 'from', 'preliminary', 'investigations', 'showing', 'that', 'the', 'vast', 'majority', 'of', 'COVID', '19', 'patients', 'seem', 'to', 'develop', 'a', 'sustained', 'immune', 'response', 'against', 'the', 'virus', 'characterized', 'especially', 'by', 'emergence', 'of', 'anti', 'SARS', 'CoV', '2', 'IgG', 'and', 'IgA', '1', 'to', '2', 'weeks', 'after', 'the', 'onset', 'of', 'fever', 'and', 'or', 'respiratory', 'symptoms', 'Whether', 'these', 'antibodies', 'will', 'have', 'persistent', 'neutralizing', 'activity', 'against', 'the', 'virus', 'is', 'still', 'to', 'be', 'elucidated', 'on', 'individual', 'and', 'general', 'basis', 'The', 'availability', 'of', 'rapid', 'tests', 'for', 'detecting', 'either', 'viral', 'antigens', 'or', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'are', 'a', 'potentially', 'viable', 'opportunity', 'for', 'purposes', 'of', 'epidemiologic', 'surveillance', 'though', 'more', 'information', 'is', 'needed', 'on', 'accuracy', 'and', 'reliability', 'of', 'these', 'portable', 'immunoassays', '']"
98660,Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019-2020,2020,Virusdisease,,"Wuhan, the city in Hubei province in China is in the focus of global community due to the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), formerly known as 2019-nCoV. The virus emerged in humans from Wuhan seafood market probably via zoonotic transmission. Within a few days the virus spread its tentacles rapidly to neighboring cities in China and to different geographical regions through travelers and to some extent by human to human transmission leading to significant disease burden globally. More than 2,00,000 people (including more than 8000 deaths) have been infected with this respiratory illness across 167 countries and territories worldwide leading to a pandemic. The present review provides an outline about emergence and spread of SARS-CoV-2 from Wuhan, China in 2019-2020. We have also provided information about the classification, genome, proteins, clinical presentation of COVID-19, type of clinical specimens to be collected and diagnostic methods adopted to identify the respiratory illness. In addition we have also provided information about transmission dynamics, prevention measures and treatment options that are available at the present. Subsequently, we have given a comprehensive overview of the spread of this infection from China to the other parts of the globe. Management of the ongoing outbreak of SARS-CoV-2 encompassing surveillance, clinical, immunological, genetic and evolutionary investigations are likely to provide the desired results. Joint efforts of global scientific community are needed at this hour in terms of enhancement of research on development of accurate diagnostics, antiviral therapeutics and finally into formation of an effective vaccine against the emerging novel coronavirus.",,9yenf9w3,"['Wuhan', 'the', 'city', 'in', 'Hubei', 'province', 'in', 'China', 'is', 'in', 'the', 'focus', 'of', 'global', 'community', 'due', 'to', 'the', 'outbreak', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'formerly', 'known', 'as', '2019', 'nCoV', 'The', 'virus', 'emerged', 'in', 'humans', 'from', 'Wuhan', 'seafood', 'market', 'probably', 'via', 'zoonotic', 'transmission', 'Within', 'a', 'few', 'days', 'the', 'virus', 'spread', 'its', 'tentacles', 'rapidly', 'to', 'neighboring', 'cities', 'in', 'China', 'and', 'to', 'different', 'geographical', 'regions', 'through', 'travelers', 'and', 'to', 'some', 'extent', 'by', 'human', 'to', 'human', 'transmission', 'leading', 'to', 'significant', 'disease', 'burden', 'globally', 'More', 'than', '2', '00', '000', 'people', 'including', 'more', 'than', '8000', 'deaths', 'have', 'been', 'infected', 'with', 'this', 'respiratory', 'illness', 'across', '167', 'countries', 'and', 'territories', 'worldwide', 'leading', 'to', 'a', 'pandemic', 'The', 'present', 'review', 'provides', 'an', 'outline', 'about', 'emergence', 'and', 'spread', 'of', 'SARS', 'CoV', '2', 'from', 'Wuhan', 'China', 'in', '2019', '2020', 'We', 'have', 'also', 'provided', 'information', 'about', 'the', 'classification', 'genome', 'proteins', 'clinical', 'presentation', 'of', 'COVID', '19', 'type', 'of', 'clinical', 'specimens', 'to', 'be', 'collected', 'and', 'diagnostic', 'methods', 'adopted', 'to', 'identify', 'the', 'respiratory', 'illness', 'In', 'addition', 'we', 'have', 'also', 'provided', 'information', 'about', 'transmission', 'dynamics', 'prevention', 'measures', 'and', 'treatment', 'options', 'that', 'are', 'available', 'at', 'the', 'present', 'Subsequently', 'we', 'have', 'given', 'a', 'comprehensive', 'overview', 'of', 'the', 'spread', 'of', 'this', 'infection', 'from', 'China', 'to', 'the', 'other', 'parts', 'of', 'the', 'globe', 'Management', 'of', 'the', 'ongoing', 'outbreak', 'of', 'SARS', 'CoV', '2', 'encompassing', 'surveillance', 'clinical', 'immunological', 'genetic', 'and', 'evolutionary', 'investigations', 'are', 'likely', 'to', 'provide', 'the', 'desired', 'results', 'Joint', 'efforts', 'of', 'global', 'scientific', 'community', 'are', 'needed', 'at', 'this', 'hour', 'in', 'terms', 'of', 'enhancement', 'of', 'research', 'on', 'development', 'of', 'accurate', 'diagnostics', 'antiviral', 'therapeutics', 'and', 'finally', 'into', 'formation', 'of', 'an', 'effective', 'vaccine', 'against', 'the', 'emerging', 'novel', 'coronavirus', '']"
98724,Femtomolar-level detection of SARS-CoV-2 spike proteins using toroidal plasmonic metasensors,2020-06-15,,https://arxiv.org/pdf/2006.08536v1.pdf,"Effective and efficient management of human betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 infection i.e., COVID-19 pandemic, required sensitive sensors with short sample-to-result durations for performing diagnostics. In this direction, one of appropriate alternative approach to detect SARS-CoV-2 at low level (fmol) is exploring plasmonic metasensor technology for COVID-19 diagnostics, which offers exquisite opportunities in advanced healthcare programs, and modern clinical diagnostics. The intrinsic merits of plasmonic metasensors stem from their capability to squeeze electromagnetic fields, simultaneously in frequency, time, and space. However, the detection of low-molecular weight biomolecules at low densities is a typical drawback of conventional metasensors that has recently been addressed using toroidal metasurface technology. This research reports fabrication of a miniaturized plasmonic immunosensor based on toroidal electrodynamics concept that can sustain robustly confined plasmonic modes with ultranarrow lineshapes in the terahertz (THz) frequencies. By exciting toroidal dipole mode using our quasi-infinite metasurface and a judiciously optimized protocol based on functionalized gold nanoparticles (NPs) conjugated with the specific monoclonal antibody of SARS-CoV-2 onto the metasurface, the resonance shifts for diverse concentrations of the spike protein is monitored. Possessing molecular weight around ~76 kDa allowed us to detect the presence of spike protein with significantly low LoD ~4.2 fmol.",,5eumxu3k,"['Effective', 'and', 'efficient', 'management', 'of', 'human', 'betacoronavirus', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', '2', 'infection', 'i', 'e', 'COVID', '19', 'pandemic', 'required', 'sensitive', 'sensors', 'with', 'short', 'sample', 'to', 'result', 'durations', 'for', 'performing', 'diagnostics', 'In', 'this', 'direction', 'one', 'of', 'appropriate', 'alternative', 'approach', 'to', 'detect', 'SARS', 'CoV', '2', 'at', 'low', 'level', 'fmol', 'is', 'exploring', 'plasmonic', 'metasensor', 'technology', 'for', 'COVID', '19', 'diagnostics', 'which', 'offers', 'exquisite', 'opportunities', 'in', 'advanced', 'healthcare', 'programs', 'and', 'modern', 'clinical', 'diagnostics', 'The', 'intrinsic', 'merits', 'of', 'plasmonic', 'metasensors', 'stem', 'from', 'their', 'capability', 'to', 'squeeze', 'electromagnetic', 'fields', 'simultaneously', 'in', 'frequency', 'time', 'and', 'space', 'However', 'the', 'detection', 'of', 'low', 'molecular', 'weight', 'biomolecules', 'at', 'low', 'densities', 'is', 'a', 'typical', 'drawback', 'of', 'conventional', 'metasensors', 'that', 'has', 'recently', 'been', 'addressed', 'using', 'toroidal', 'metasurface', 'technology', 'This', 'research', 'reports', 'fabrication', 'of', 'a', 'miniaturized', 'plasmonic', 'immunosensor', 'based', 'on', 'toroidal', 'electrodynamics', 'concept', 'that', 'can', 'sustain', 'robustly', 'confined', 'plasmonic', 'modes', 'with', 'ultranarrow', 'lineshapes', 'in', 'the', 'terahertz', 'THz', 'frequencies', 'By', 'exciting', 'toroidal', 'dipole', 'mode', 'using', 'our', 'quasi', 'infinite', 'metasurface', 'and', 'a', 'judiciously', 'optimized', 'protocol', 'based', 'on', 'functionalized', 'gold', 'nanoparticles', 'NPs', 'conjugated', 'with', 'the', 'specific', 'monoclonal', 'antibody', 'of', 'SARS', 'CoV', '2', 'onto', 'the', 'metasurface', 'the', 'resonance', 'shifts', 'for', 'diverse', 'concentrations', 'of', 'the', 'spike', 'protein', 'is', 'monitored', 'Possessing', 'molecular', 'weight', 'around', '76', 'kDa', 'allowed', 'us', 'to', 'detect', 'the', 'presence', 'of', 'spike', 'protein', 'with', 'significantly', 'low', 'LoD', '4', '2', 'fmol', '']"
99675,SARS-CoV-2 testing in infertile patients: different recommendations in Europe and America,2020,J. assist. reprod. genet,,"The incorporation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing into patient care algorithms has been proposed to mitigate risk. However, the two main professional societies for human reproduction (ESHRE and ASRM) appear divergent on their clinical utility and whether they should be adopted. In this opinion paper, we review the currently available tests and discuss the strengths and weaknesses of the proposed clinical care pathways. Nucleic acid amplification tests are the cornerstone of SARS-CoV-2 testing but test results are largely influenced by viral load, sample site, specimen collection method, and specimen shipment technique, such that a negative result in a symptomatic patient cannot be relied upon. Serological assays for SARS-CoV-2 antibodies exhibit a temporal increase in sensitivity and specificity after symptom onset irrespective of the assay used, with sensitivity estimates ranging from 0 to 50% with the first 3 days of symptoms, to 83 to 88% at 10 days, increasing to almost 100% at &#8805; 14 days. These inherent constraints in diagnostics would suggest that at present there is inadequate evidence to utilize SARS-CoV-2 testing to stratify fertility patients and reliably inform clinical decision-making. The failure to appreciate the characteristics and limitations of the diagnostic tests may lead to disastrous consequences for the patient and the multidisciplinary team looking after them.",,z1ad5uc2,"['The', 'incorporation', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'testing', 'into', 'patient', 'care', 'algorithms', 'has', 'been', 'proposed', 'to', 'mitigate', 'risk', 'However', 'the', 'two', 'main', 'professional', 'societies', 'for', 'human', 'reproduction', 'ESHRE', 'and', 'ASRM', 'appear', 'divergent', 'on', 'their', 'clinical', 'utility', 'and', 'whether', 'they', 'should', 'be', 'adopted', 'In', 'this', 'opinion', 'paper', 'we', 'review', 'the', 'currently', 'available', 'tests', 'and', 'discuss', 'the', 'strengths', 'and', 'weaknesses', 'of', 'the', 'proposed', 'clinical', 'care', 'pathways', 'Nucleic', 'acid', 'amplification', 'tests', 'are', 'the', 'cornerstone', 'of', 'SARS', 'CoV', '2', 'testing', 'but', 'test', 'results', 'are', 'largely', 'influenced', 'by', 'viral', 'load', 'sample', 'site', 'specimen', 'collection', 'method', 'and', 'specimen', 'shipment', 'technique', 'such', 'that', 'a', 'negative', 'result', 'in', 'a', 'symptomatic', 'patient', 'cannot', 'be', 'relied', 'upon', 'Serological', 'assays', 'for', 'SARS', 'CoV', '2', 'antibodies', 'exhibit', 'a', 'temporal', 'increase', 'in', 'sensitivity', 'and', 'specificity', 'after', 'symptom', 'onset', 'irrespective', 'of', 'the', 'assay', 'used', 'with', 'sensitivity', 'estimates', 'ranging', 'from', '0', 'to', '50', 'with', 'the', 'first', '3', 'days', 'of', 'symptoms', 'to', '83', 'to', '88', 'at', '10', 'days', 'increasing', 'to', 'almost', '100', 'at', '8805', '14', 'days', 'These', 'inherent', 'constraints', 'in', 'diagnostics', 'would', 'suggest', 'that', 'at', 'present', 'there', 'is', 'inadequate', 'evidence', 'to', 'utilize', 'SARS', 'CoV', '2', 'testing', 'to', 'stratify', 'fertility', 'patients', 'and', 'reliably', 'inform', 'clinical', 'decision', 'making', 'The', 'failure', 'to', 'appreciate', 'the', 'characteristics', 'and', 'limitations', 'of', 'the', 'diagnostic', 'tests', 'may', 'lead', 'to', 'disastrous', 'consequences', 'for', 'the', 'patient', 'and', 'the', 'multidisciplinary', 'team', 'looking', 'after', 'them', '']"
100123,The many faces of interstitial pneumonia: a case of presumed SARS-CoV-2 infection,2020,Swiss Med Wkly,,"We present the case of an oncology patient admitted to our hospital during the current COVID-19 pandemic with clinical and radiological features strongly suggestive of interstitial pneumonia. Multiple laboratory tests were negative for SARS-CoV-2 (polymerase chain reaction testing of nasopharyngeal swabs, and of induced sputum and stool samples, investigation of serum immunoglobulins G and M). In the setting of an immunocompromised status due to recent chemotherapy cycles for lung adenocarcinoma and prolonged corticosteroid therapy (due to frequent exacerbations of chronic obstructive pulmonary disease in recent months), we actively searched for the pathological agent and found it to be Pneumocystis jirovecii. The patient started specific antibiotic treatment but finally had a negative outcome due to the progression of the lung adenocarcinoma. The importance of differential diagnostics in clinical practice should be a given, especially during times of pandemic. The novel coronavirus infection introduced new guidelines for and approaches to the investigation of immunocompromised patients, so it is especially important not to forget the basis of differential diagnosis, to and adopt a thorough approach when assessing these complex patients. We want to stress the importance of thorough investigation to avoid misdiagnosis of atypical pathogens in the current setting of SARS-CoV-2 pandemic.",,lp79phjd,"['We', 'present', 'the', 'case', 'of', 'an', 'oncology', 'patient', 'admitted', 'to', 'our', 'hospital', 'during', 'the', 'current', 'COVID', '19', 'pandemic', 'with', 'clinical', 'and', 'radiological', 'features', 'strongly', 'suggestive', 'of', 'interstitial', 'pneumonia', 'Multiple', 'laboratory', 'tests', 'were', 'negative', 'for', 'SARS', 'CoV', '2', 'polymerase', 'chain', 'reaction', 'testing', 'of', 'nasopharyngeal', 'swabs', 'and', 'of', 'induced', 'sputum', 'and', 'stool', 'samples', 'investigation', 'of', 'serum', 'immunoglobulins', 'G', 'and', 'M', 'In', 'the', 'setting', 'of', 'an', 'immunocompromised', 'status', 'due', 'to', 'recent', 'chemotherapy', 'cycles', 'for', 'lung', 'adenocarcinoma', 'and', 'prolonged', 'corticosteroid', 'therapy', 'due', 'to', 'frequent', 'exacerbations', 'of', 'chronic', 'obstructive', 'pulmonary', 'disease', 'in', 'recent', 'months', 'we', 'actively', 'searched', 'for', 'the', 'pathological', 'agent', 'and', 'found', 'it', 'to', 'be', 'Pneumocystis', 'jirovecii', 'The', 'patient', 'started', 'specific', 'antibiotic', 'treatment', 'but', 'finally', 'had', 'a', 'negative', 'outcome', 'due', 'to', 'the', 'progression', 'of', 'the', 'lung', 'adenocarcinoma', 'The', 'importance', 'of', 'differential', 'diagnostics', 'in', 'clinical', 'practice', 'should', 'be', 'a', 'given', 'especially', 'during', 'times', 'of', 'pandemic', 'The', 'novel', 'coronavirus', 'infection', 'introduced', 'new', 'guidelines', 'for', 'and', 'approaches', 'to', 'the', 'investigation', 'of', 'immunocompromised', 'patients', 'so', 'it', 'is', 'especially', 'important', 'not', 'to', 'forget', 'the', 'basis', 'of', 'differential', 'diagnosis', 'to', 'and', 'adopt', 'a', 'thorough', 'approach', 'when', 'assessing', 'these', 'complex', 'patients', 'We', 'want', 'to', 'stress', 'the', 'importance', 'of', 'thorough', 'investigation', 'to', 'avoid', 'misdiagnosis', 'of', 'atypical', 'pathogens', 'in', 'the', 'current', 'setting', 'of', 'SARS', 'CoV', '2', 'pandemic', '']"
101264,Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2,2020,Viruses,,"The recent outbreak of the Coronavirus disease 2019 (COVID-19) has quickly spread worldwide since its discovery in Wuhan city, China in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, clinical treatment, and development of vaccines, is urgently needed to win the battle against COVID-19. The past three unprecedented outbreaks of emerging human coronavirus infections at the beginning of the 21st century have highlighted the importance of readily available, accurate, and rapid diagnostic technologies to contain emerging and re-emerging pandemics. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays performed on respiratory specimens remain the gold standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging with high sensitivity and specificity as well. Even though excellent techniques are available for the diagnosis of symptomatic patients with COVID-19 in well-equipped laboratories; critical gaps still remain in screening asymptomatic people who are in the incubation phase of the virus, as well as in the accurate determination of live viral shedding during convalescence to inform decisions for ending isolation. This review article aims to discuss the currently available laboratory methods and surveillance technologies available for the detection of COVID-19, their performance characteristics and highlight the gaps in current diagnostic capacity, and finally, propose potential solutions. We also summarize the specifications of the majority of the available commercial kits (PCR, EIA, and POC) for laboratory diagnosis of COVID-19.",,nm8a3jxt,"['The', 'recent', 'outbreak', 'of', 'the', 'Coronavirus', 'disease', '2019', 'COVID', '19', 'has', 'quickly', 'spread', 'worldwide', 'since', 'its', 'discovery', 'in', 'Wuhan', 'city', 'China', 'in', 'December', '2019', 'A', 'comprehensive', 'strategy', 'including', 'surveillance', 'diagnostics', 'research', 'clinical', 'treatment', 'and', 'development', 'of', 'vaccines', 'is', 'urgently', 'needed', 'to', 'win', 'the', 'battle', 'against', 'COVID', '19', 'The', 'past', 'three', 'unprecedented', 'outbreaks', 'of', 'emerging', 'human', 'coronavirus', 'infections', 'at', 'the', 'beginning', 'of', 'the', '21st', 'century', 'have', 'highlighted', 'the', 'importance', 'of', 'readily', 'available', 'accurate', 'and', 'rapid', 'diagnostic', 'technologies', 'to', 'contain', 'emerging', 'and', 're', 'emerging', 'pandemics', 'Real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'rRT', 'PCR', 'based', 'assays', 'performed', 'on', 'respiratory', 'specimens', 'remain', 'the', 'gold', 'standard', 'for', 'COVID', '19', 'diagnostics', 'However', 'point', 'of', 'care', 'technologies', 'and', 'serologic', 'immunoassays', 'are', 'rapidly', 'emerging', 'with', 'high', 'sensitivity', 'and', 'specificity', 'as', 'well', 'Even', 'though', 'excellent', 'techniques', 'are', 'available', 'for', 'the', 'diagnosis', 'of', 'symptomatic', 'patients', 'with', 'COVID', '19', 'in', 'well', 'equipped', 'laboratories', 'critical', 'gaps', 'still', 'remain', 'in', 'screening', 'asymptomatic', 'people', 'who', 'are', 'in', 'the', 'incubation', 'phase', 'of', 'the', 'virus', 'as', 'well', 'as', 'in', 'the', 'accurate', 'determination', 'of', 'live', 'viral', 'shedding', 'during', 'convalescence', 'to', 'inform', 'decisions', 'for', 'ending', 'isolation', 'This', 'review', 'article', 'aims', 'to', 'discuss', 'the', 'currently', 'available', 'laboratory', 'methods', 'and', 'surveillance', 'technologies', 'available', 'for', 'the', 'detection', 'of', 'COVID', '19', 'their', 'performance', 'characteristics', 'and', 'highlight', 'the', 'gaps', 'in', 'current', 'diagnostic', 'capacity', 'and', 'finally', 'propose', 'potential', 'solutions', 'We', 'also', 'summarize', 'the', 'specifications', 'of', 'the', 'majority', 'of', 'the', 'available', 'commercial', 'kits', 'PCR', 'EIA', 'and', 'POC', 'for', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
101647,Lab-on-a-Chip Devices for Point-of-Care Medical Diagnostics,2020,Adv. biochem. eng. biotechnol,,"The recent coronavirus (COVID-19) pandemic has underscored the need to move from traditional lab-centralized diagnostics to point-of-care (PoC) settings. Lab-on-a-chip (LoC) platforms facilitate the translation to PoC settings via the miniaturization, portability, integration, and automation of multiple assay functions onto a single chip. For this purpose, paper-based assays and microfluidic platforms are currently being extensively studied, and much focus is being directed towards simplifying their design while simultaneously improving multiplexing and automation capabilities. Signal amplification strategies are being applied to improve the performance of assays with respect to both sensitivity and selectivity, while smartphones are being integrated to expand the analytical power of the technology and promote its accessibility. In this chapter, we review the main technologies in the field of LoC platforms for PoC medical diagnostics and survey recent approaches for improving these assays.",,mwzmicqp,"['The', 'recent', 'coronavirus', 'COVID', '19', 'pandemic', 'has', 'underscored', 'the', 'need', 'to', 'move', 'from', 'traditional', 'lab', 'centralized', 'diagnostics', 'to', 'point', 'of', 'care', 'PoC', 'settings', 'Lab', 'on', 'a', 'chip', 'LoC', 'platforms', 'facilitate', 'the', 'translation', 'to', 'PoC', 'settings', 'via', 'the', 'miniaturization', 'portability', 'integration', 'and', 'automation', 'of', 'multiple', 'assay', 'functions', 'onto', 'a', 'single', 'chip', 'For', 'this', 'purpose', 'paper', 'based', 'assays', 'and', 'microfluidic', 'platforms', 'are', 'currently', 'being', 'extensively', 'studied', 'and', 'much', 'focus', 'is', 'being', 'directed', 'towards', 'simplifying', 'their', 'design', 'while', 'simultaneously', 'improving', 'multiplexing', 'and', 'automation', 'capabilities', 'Signal', 'amplification', 'strategies', 'are', 'being', 'applied', 'to', 'improve', 'the', 'performance', 'of', 'assays', 'with', 'respect', 'to', 'both', 'sensitivity', 'and', 'selectivity', 'while', 'smartphones', 'are', 'being', 'integrated', 'to', 'expand', 'the', 'analytical', 'power', 'of', 'the', 'technology', 'and', 'promote', 'its', 'accessibility', 'In', 'this', 'chapter', 'we', 'review', 'the', 'main', 'technologies', 'in', 'the', 'field', 'of', 'LoC', 'platforms', 'for', 'PoC', 'medical', 'diagnostics', 'and', 'survey', 'recent', 'approaches', 'for', 'improving', 'these', 'assays', '']"
101670,"Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned",2020,Emerg Microbes Infect,,"Unexplained pneumonia (UP) caused by a novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) emerged in China in late December 2019 and has infected more than 9000 cases by 31 January 2020. Shanghai reported the first imported case of COVID-19 (Coronavirus Disease 2019) in 20 January 2020. A combinative approach of real-time RT-PCR, CRISPR-based assay and metagenomic next-generation sequencing (mNGS) were used to diagnose this unexplained pneumonia patient. Real-time RT-PCR and CRISPR-based assay both reported positive. This sample belonged to Betacoronavirus and shared a more than 99% nucleotide (nt) identity with the Wuhan SARS-CoV-2 isolates. We further compared pros and cons of common molecular diagnostics in UP. In this study, we illustrated the importance of combining molecular diagnostics to rule out common pathogens and performed mNGS to obtain unbiased potential pathogen result for the diagnosis of UP.",,em12jvad,"['Unexplained', 'pneumonia', 'UP', 'caused', 'by', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'emerged', 'in', 'China', 'in', 'late', 'December', '2019', 'and', 'has', 'infected', 'more', 'than', '9000', 'cases', 'by', '31', 'January', '2020', 'Shanghai', 'reported', 'the', 'first', 'imported', 'case', 'of', 'COVID', '19', 'Coronavirus', 'Disease', '2019', 'in', '20', 'January', '2020', 'A', 'combinative', 'approach', 'of', 'real', 'time', 'RT', 'PCR', 'CRISPR', 'based', 'assay', 'and', 'metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'were', 'used', 'to', 'diagnose', 'this', 'unexplained', 'pneumonia', 'patient', 'Real', 'time', 'RT', 'PCR', 'and', 'CRISPR', 'based', 'assay', 'both', 'reported', 'positive', 'This', 'sample', 'belonged', 'to', 'Betacoronavirus', 'and', 'shared', 'a', 'more', 'than', '99', 'nucleotide', 'nt', 'identity', 'with', 'the', 'Wuhan', 'SARS', 'CoV', '2', 'isolates', 'We', 'further', 'compared', 'pros', 'and', 'cons', 'of', 'common', 'molecular', 'diagnostics', 'in', 'UP', 'In', 'this', 'study', 'we', 'illustrated', 'the', 'importance', 'of', 'combining', 'molecular', 'diagnostics', 'to', 'rule', 'out', 'common', 'pathogens', 'and', 'performed', 'mNGS', 'to', 'obtain', 'unbiased', 'potential', 'pathogen', 'result', 'for', 'the', 'diagnosis', 'of', 'UP', '']"
102294,Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests,2020,J Clin Virol,,"The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) has been followed by the rapid development of antibody tests. To assess the utility of the tests for clinical use and seroepidemiologic studies, we examined the sensitivity of commercial antibody tests from Roche, Abbott, Novatec, Virotech Siemens, Euroimmun, and Mediagnost in a prospective diagnostic study. The tests were evaluated with 73 sera from SARS CoV-2 RNA positive individuals with mild to moderate disease or asymptomatic infection. Sera were obtained at 2-3 weeks (Nâ¯=â¯25) or > 4 weeks (Nâ¯=â¯48) after symptom onset and viral RNA test. The overall sensitivity of the tests ranged from 64.4-93.2%. The most sensitive assays recognized 95.8-100 % of the sera obtained after 4 weeks or later. Sera drawn at 2-3 weeks were recognized with lower sensitivity indicating that the optimal time point for serologic testing is later than 3 weeks after onset of the disease. Nucleoprotein- and glycoproteinbased assays had similar sensitivity indicating that tests with both antigens are suitable for serological diagnostics. Breakdown of the test results showed that nucleoprotein- and glycoprotein-based tests of comparable sensitivity reacted with different sets of sera. The observation indicates that a combination of nucleoprotein- and glycoprotein-based tests would increase the percentage of positive results.",,57fkrkiz,"['The', 'emergence', 'of', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'been', 'followed', 'by', 'the', 'rapid', 'development', 'of', 'antibody', 'tests', 'To', 'assess', 'the', 'utility', 'of', 'the', 'tests', 'for', 'clinical', 'use', 'and', 'seroepidemiologic', 'studies', 'we', 'examined', 'the', 'sensitivity', 'of', 'commercial', 'antibody', 'tests', 'from', 'Roche', 'Abbott', 'Novatec', 'Virotech', 'Siemens', 'Euroimmun', 'and', 'Mediagnost', 'in', 'a', 'prospective', 'diagnostic', 'study', 'The', 'tests', 'were', 'evaluated', 'with', '73', 'sera', 'from', 'SARS', 'CoV', '2', 'RNA', 'positive', 'individuals', 'with', 'mild', 'to', 'moderate', 'disease', 'or', 'asymptomatic', 'infection', 'Sera', 'were', 'obtained', 'at', '2', '3', 'weeks', 'Nâ', 'â', '25', 'or', '4', 'weeks', 'Nâ', 'â', '48', 'after', 'symptom', 'onset', 'and', 'viral', 'RNA', 'test', 'The', 'overall', 'sensitivity', 'of', 'the', 'tests', 'ranged', 'from', '64', '4', '93', '2', 'The', 'most', 'sensitive', 'assays', 'recognized', '95', '8', '100', 'of', 'the', 'sera', 'obtained', 'after', '4', 'weeks', 'or', 'later', 'Sera', 'drawn', 'at', '2', '3', 'weeks', 'were', 'recognized', 'with', 'lower', 'sensitivity', 'indicating', 'that', 'the', 'optimal', 'time', 'point', 'for', 'serologic', 'testing', 'is', 'later', 'than', '3', 'weeks', 'after', 'onset', 'of', 'the', 'disease', 'Nucleoprotein', 'and', 'glycoproteinbased', 'assays', 'had', 'similar', 'sensitivity', 'indicating', 'that', 'tests', 'with', 'both', 'antigens', 'are', 'suitable', 'for', 'serological', 'diagnostics', 'Breakdown', 'of', 'the', 'test', 'results', 'showed', 'that', 'nucleoprotein', 'and', 'glycoprotein', 'based', 'tests', 'of', 'comparable', 'sensitivity', 'reacted', 'with', 'different', 'sets', 'of', 'sera', 'The', 'observation', 'indicates', 'that', 'a', 'combination', 'of', 'nucleoprotein', 'and', 'glycoprotein', 'based', 'tests', 'would', 'increase', 'the', 'percentage', 'of', 'positive', 'results', '']"
102366,Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study,2020,Lancet oncol,,"BACKGROUND: During the COVID-19 lockdown, referrals via the 2-week-wait urgent pathway for suspected cancer in England, UK, are reported to have decreased by up to 84%. We aimed to examine the impact of different scenarios of lockdown-accumulated backlog in cancer referrals on cancer survival, and the impact on survival per referred patient due to delayed referral versus risk of death from nosocomial infection with severe acute respiratory syndrome coronavirus 2. METHODS: In this modelling study, we used age-stratified and stage-stratified 10-year cancer survival estimates for patients in England, UK, for 20 common tumour types diagnosed in 2008-17 at age 30 years and older from Public Health England. We also used data for cancer diagnoses made via the 2-week-wait referral pathway in 2013-16 from the Cancer Waiting Times system from NHS Digital. We applied per-day hazard ratios (HRs) for cancer progression that we generated from observational studies of delay to treatment. We quantified the annual numbers of cancers at stage I-III diagnosed via the 2-week-wait pathway using 2-week-wait age-specific and stage-specific breakdowns. From these numbers, we estimated the aggregate number of lives and life-years lost in England for per-patient delays of 1-6 months in presentation, diagnosis, or cancer treatment, or a combination of these. We assessed three scenarios of a 3-month period of lockdown during which 25%, 50%, and 75% of the normal monthly volumes of symptomatic patients delayed their presentation until after lockdown. Using referral-to-diagnosis conversion rates and COVID-19 case-fatality rates, we also estimated the survival increment per patient referred. FINDINGS: Across England in 2013-16, an average of 6281 patients with stage I-III cancer were diagnosed via the 2-week-wait pathway per month, of whom 1691 (27%) would be predicted to die within 10 years from their disease. Delays in presentation via the 2-week-wait pathway over a 3-month lockdown period (with an average presentational delay of 2 months per patient) would result in 181 additional lives and 3316 life-years lost as a result of a backlog of referrals of 25%, 361 additional lives and 6632 life-years lost for a 50% backlog of referrals, and 542 additional lives and 9948 life-years lost for a 75% backlog in referrals. Compared with all diagnostics for the backlog being done in month 1 after lockdown, additional capacity across months 1-3 would result in 90 additional lives and 1662 live-years lost due to diagnostic delays for the 25% backlog scenario, 183 additional lives and 3362 life-years lost under the 50% backlog scenario, and 276 additional lives and 5075 life-years lost under the 75% backlog scenario. However, a delay in additional diagnostic capacity with provision spread across months 3-8 after lockdown would result in 401 additional lives and 7332 life-years lost due to diagnostic delays under the 25% backlog scenario, 811 additional lives and 14â873 life-years lost under the 50% backlog scenario, and 1231 additional lives and 22â635 life-years lost under the 75% backlog scenario. A 2-month delay in 2-week-wait investigatory referrals results in an estimated loss of between 0·0 and 0·7 life-years per referred patient, depending on age and tumour type. INTERPRETATION: Prompt provision of additional capacity to address the backlog of diagnostics will minimise deaths as a result of diagnostic delays that could add to those predicted due to expected presentational delays. Prioritisation of patient groups for whom delay would result in most life-years lost warrants consideration as an option for mitigating the aggregate burden of mortality in patients with cancer. FUNDING: None.",,akaqcb4k,"['BACKGROUND', 'During', 'the', 'COVID', '19', 'lockdown', 'referrals', 'via', 'the', '2', 'week', 'wait', 'urgent', 'pathway', 'for', 'suspected', 'cancer', 'in', 'England', 'UK', 'are', 'reported', 'to', 'have', 'decreased', 'by', 'up', 'to', '84', 'We', 'aimed', 'to', 'examine', 'the', 'impact', 'of', 'different', 'scenarios', 'of', 'lockdown', 'accumulated', 'backlog', 'in', 'cancer', 'referrals', 'on', 'cancer', 'survival', 'and', 'the', 'impact', 'on', 'survival', 'per', 'referred', 'patient', 'due', 'to', 'delayed', 'referral', 'versus', 'risk', 'of', 'death', 'from', 'nosocomial', 'infection', 'with', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'METHODS', 'In', 'this', 'modelling', 'study', 'we', 'used', 'age', 'stratified', 'and', 'stage', 'stratified', '10', 'year', 'cancer', 'survival', 'estimates', 'for', 'patients', 'in', 'England', 'UK', 'for', '20', 'common', 'tumour', 'types', 'diagnosed', 'in', '2008', '17', 'at', 'age', '30', 'years', 'and', 'older', 'from', 'Public', 'Health', 'England', 'We', 'also', 'used', 'data', 'for', 'cancer', 'diagnoses', 'made', 'via', 'the', '2', 'week', 'wait', 'referral', 'pathway', 'in', '2013', '16', 'from', 'the', 'Cancer', 'Waiting', 'Times', 'system', 'from', 'NHS', 'Digital', 'We', 'applied', 'per', 'day', 'hazard', 'ratios', 'HRs', 'for', 'cancer', 'progression', 'that', 'we', 'generated', 'from', 'observational', 'studies', 'of', 'delay', 'to', 'treatment', 'We', 'quantified', 'the', 'annual', 'numbers', 'of', 'cancers', 'at', 'stage', 'I', 'III', 'diagnosed', 'via', 'the', '2', 'week', 'wait', 'pathway', 'using', '2', 'week', 'wait', 'age', 'specific', 'and', 'stage', 'specific', 'breakdowns', 'From', 'these', 'numbers', 'we', 'estimated', 'the', 'aggregate', 'number', 'of', 'lives', 'and', 'life', 'years', 'lost', 'in', 'England', 'for', 'per', 'patient', 'delays', 'of', '1', '6', 'months', 'in', 'presentation', 'diagnosis', 'or', 'cancer', 'treatment', 'or', 'a', 'combination', 'of', 'these', 'We', 'assessed', 'three', 'scenarios', 'of', 'a', '3', 'month', 'period', 'of', 'lockdown', 'during', 'which', '25', '50', 'and', '75', 'of', 'the', 'normal', 'monthly', 'volumes', 'of', 'symptomatic', 'patients', 'delayed', 'their', 'presentation', 'until', 'after', 'lockdown', 'Using', 'referral', 'to', 'diagnosis', 'conversion', 'rates', 'and', 'COVID', '19', 'case', 'fatality', 'rates', 'we', 'also', 'estimated', 'the', 'survival', 'increment', 'per', 'patient', 'referred', 'FINDINGS', 'Across', 'England', 'in', '2013', '16', 'an', 'average', 'of', '6281', 'patients', 'with', 'stage', 'I', 'III', 'cancer', 'were', 'diagnosed', 'via', 'the', '2', 'week', 'wait', 'pathway', 'per', 'month', 'of', 'whom', '1691', '27', 'would', 'be', 'predicted', 'to', 'die', 'within', '10', 'years', 'from', 'their', 'disease', 'Delays', 'in', 'presentation', 'via', 'the', '2', 'week', 'wait', 'pathway', 'over', 'a', '3', 'month', 'lockdown', 'period', 'with', 'an', 'average', 'presentational', 'delay', 'of', '2', 'months', 'per', 'patient', 'would', 'result', 'in', '181', 'additional', 'lives', 'and', '3316', 'life', 'years', 'lost', 'as', 'a', 'result', 'of', 'a', 'backlog', 'of', 'referrals', 'of', '25', '361', 'additional', 'lives', 'and', '6632', 'life', 'years', 'lost', 'for', 'a', '50', 'backlog', 'of', 'referrals', 'and', '542', 'additional', 'lives', 'and', '9948', 'life', 'years', 'lost', 'for', 'a', '75', 'backlog', 'in', 'referrals', 'Compared', 'with', 'all', 'diagnostics', 'for', 'the', 'backlog', 'being', 'done', 'in', 'month', '1', 'after', 'lockdown', 'additional', 'capacity', 'across', 'months', '1', '3', 'would', 'result', 'in', '90', 'additional', 'lives', 'and', '1662', 'live', 'years', 'lost', 'due', 'to', 'diagnostic', 'delays', 'for', 'the', '25', 'backlog', 'scenario', '183', 'additional', 'lives', 'and', '3362', 'life', 'years', 'lost', 'under', 'the', '50', 'backlog', 'scenario', 'and', '276', 'additional', 'lives', 'and', '5075', 'life', 'years', 'lost', 'under', 'the', '75', 'backlog', 'scenario', 'However', 'a', 'delay', 'in', 'additional', 'diagnostic', 'capacity', 'with', 'provision', 'spread', 'across', 'months', '3', '8', 'after', 'lockdown', 'would', 'result', 'in', '401', 'additional', 'lives', 'and', '7332', 'life', 'years', 'lost', 'due', 'to', 'diagnostic', 'delays', 'under', 'the', '25', 'backlog', 'scenario', '811', 'additional', 'lives', 'and', '14â', '873', 'life', 'years', 'lost', 'under', 'the', '50', 'backlog', 'scenario', 'and', '1231', 'additional', 'lives', 'and', '22â', '635', 'life', 'years', 'lost', 'under', 'the', '75', 'backlog', 'scenario', 'A', '2', 'month', 'delay', 'in', '2', 'week', 'wait', 'investigatory', 'referrals', 'results', 'in', 'an', 'estimated', 'loss', 'of', 'between', '0', '0', 'and', '0', '7', 'life', 'years', 'per', 'referred', 'patient', 'depending', 'on', 'age', 'and', 'tumour', 'type', 'INTERPRETATION', 'Prompt', 'provision', 'of', 'additional', 'capacity', 'to', 'address', 'the', 'backlog', 'of', 'diagnostics', 'will', 'minimise', 'deaths', 'as', 'a', 'result', 'of', 'diagnostic', 'delays', 'that', 'could', 'add', 'to', 'those', 'predicted', 'due', 'to', 'expected', 'presentational', 'delays', 'Prioritisation', 'of', 'patient', 'groups', 'for', 'whom', 'delay', 'would', 'result', 'in', 'most', 'life', 'years', 'lost', 'warrants', 'consideration', 'as', 'an', 'option', 'for', 'mitigating', 'the', 'aggregate', 'burden', 'of', 'mortality', 'in', 'patients', 'with', 'cancer', 'FUNDING', 'None', '']"
102425,Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes,2020,Bioinformatics,,"SUMMARY: Genome detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next-generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present the Genome Detective Coronavirus Typing Tool that can accurately identify the novel severe acute respiratory syndrome (SARS)-related coronavirus (SARS-CoV-2) sequences isolated in China and around the world. The tool can accept up to 2000 sequences per submission and the analysis of a new whole-genome sequence will take approximately 1 min. The tool has been tested and validated with hundreds of whole genomes from 10 coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for SARS-CoV-2. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease. AVAILABILITY AND IMPLEMENTATION: https://www.genomedetective.com/app/typingtool/cov. CONTACT: koen@emweb.be or deoliveira@ukzn.ac.za. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.",,88hswyln,"['SUMMARY', 'Genome', 'detective', 'is', 'a', 'web', 'based', 'user', 'friendly', 'software', 'application', 'to', 'quickly', 'and', 'accurately', 'assemble', 'all', 'known', 'virus', 'genomes', 'from', 'next', 'generation', 'sequencing', 'datasets', 'This', 'application', 'allows', 'the', 'identification', 'of', 'phylogenetic', 'clusters', 'and', 'genotypes', 'from', 'assembled', 'genomes', 'in', 'FASTA', 'format', 'Since', 'its', 'release', 'in', '2019', 'we', 'have', 'produced', 'a', 'number', 'of', 'typing', 'tools', 'for', 'emergent', 'viruses', 'that', 'have', 'caused', 'large', 'outbreaks', 'such', 'as', 'Zika', 'and', 'Yellow', 'Fever', 'Virus', 'in', 'Brazil', 'Here', 'we', 'present', 'the', 'Genome', 'Detective', 'Coronavirus', 'Typing', 'Tool', 'that', 'can', 'accurately', 'identify', 'the', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'related', 'coronavirus', 'SARS', 'CoV', '2', 'sequences', 'isolated', 'in', 'China', 'and', 'around', 'the', 'world', 'The', 'tool', 'can', 'accept', 'up', 'to', '2000', 'sequences', 'per', 'submission', 'and', 'the', 'analysis', 'of', 'a', 'new', 'whole', 'genome', 'sequence', 'will', 'take', 'approximately', '1', 'min', 'The', 'tool', 'has', 'been', 'tested', 'and', 'validated', 'with', 'hundreds', 'of', 'whole', 'genomes', 'from', '10', 'coronavirus', 'species', 'and', 'correctly', 'classified', 'all', 'of', 'the', 'SARS', 'related', 'coronavirus', 'SARSr', 'CoV', 'and', 'all', 'of', 'the', 'available', 'public', 'data', 'for', 'SARS', 'CoV', '2', 'The', 'tool', 'also', 'allows', 'tracking', 'of', 'new', 'viral', 'mutations', 'as', 'the', 'outbreak', 'expands', 'globally', 'which', 'may', 'help', 'to', 'accelerate', 'the', 'development', 'of', 'novel', 'diagnostics', 'drugs', 'and', 'vaccines', 'to', 'stop', 'the', 'COVID', '19', 'disease', 'AVAILABILITY', 'AND', 'IMPLEMENTATION', 'https', 'www', 'genomedetective', 'com', 'app', 'typingtool', 'cov', 'CONTACT', 'koen', 'emweb', 'be', 'or', 'deoliveira', 'ukzn', 'ac', 'za', 'SUPPLEMENTARY', 'INFORMATION', 'Supplementary', 'data', 'are', 'available', 'at', 'Bioinformatics', 'online', '']"
102426,Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes,2020,Bioinformatics,,"SUMMARY: Genome detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next-generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present the Genome Detective Coronavirus Typing Tool that can accurately identify the novel severe acute respiratory syndrome (SARS)-related coronavirus (SARS-CoV-2) sequences isolated in China and around the world. The tool can accept up to 2000 sequences per submission and the analysis of a new whole-genome sequence will take approximately 1 min. The tool has been tested and validated with hundreds of whole genomes from 10 coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for SARS-CoV-2. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease. AVAILABILITY AND IMPLEMENTATION: https://www.genomedetective.com/app/typingtool/cov. CONTACT: koen@emweb.be or deoliveira@ukzn.ac.za. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.",,xgpxa84g,"['SUMMARY', 'Genome', 'detective', 'is', 'a', 'web', 'based', 'user', 'friendly', 'software', 'application', 'to', 'quickly', 'and', 'accurately', 'assemble', 'all', 'known', 'virus', 'genomes', 'from', 'next', 'generation', 'sequencing', 'datasets', 'This', 'application', 'allows', 'the', 'identification', 'of', 'phylogenetic', 'clusters', 'and', 'genotypes', 'from', 'assembled', 'genomes', 'in', 'FASTA', 'format', 'Since', 'its', 'release', 'in', '2019', 'we', 'have', 'produced', 'a', 'number', 'of', 'typing', 'tools', 'for', 'emergent', 'viruses', 'that', 'have', 'caused', 'large', 'outbreaks', 'such', 'as', 'Zika', 'and', 'Yellow', 'Fever', 'Virus', 'in', 'Brazil', 'Here', 'we', 'present', 'the', 'Genome', 'Detective', 'Coronavirus', 'Typing', 'Tool', 'that', 'can', 'accurately', 'identify', 'the', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'related', 'coronavirus', 'SARS', 'CoV', '2', 'sequences', 'isolated', 'in', 'China', 'and', 'around', 'the', 'world', 'The', 'tool', 'can', 'accept', 'up', 'to', '2000', 'sequences', 'per', 'submission', 'and', 'the', 'analysis', 'of', 'a', 'new', 'whole', 'genome', 'sequence', 'will', 'take', 'approximately', '1', 'min', 'The', 'tool', 'has', 'been', 'tested', 'and', 'validated', 'with', 'hundreds', 'of', 'whole', 'genomes', 'from', '10', 'coronavirus', 'species', 'and', 'correctly', 'classified', 'all', 'of', 'the', 'SARS', 'related', 'coronavirus', 'SARSr', 'CoV', 'and', 'all', 'of', 'the', 'available', 'public', 'data', 'for', 'SARS', 'CoV', '2', 'The', 'tool', 'also', 'allows', 'tracking', 'of', 'new', 'viral', 'mutations', 'as', 'the', 'outbreak', 'expands', 'globally', 'which', 'may', 'help', 'to', 'accelerate', 'the', 'development', 'of', 'novel', 'diagnostics', 'drugs', 'and', 'vaccines', 'to', 'stop', 'the', 'COVID', '19', 'disease', 'AVAILABILITY', 'AND', 'IMPLEMENTATION', 'https', 'www', 'genomedetective', 'com', 'app', 'typingtool', 'cov', 'CONTACT', 'koen', 'emweb', 'be', 'or', 'deoliveira', 'ukzn', 'ac', 'za', 'SUPPLEMENTARY', 'INFORMATION', 'Supplementary', 'data', 'are', 'available', 'at', 'Bioinformatics', 'online', '']"
102610,Retrospective estimation of respiratory virus covariances using Bayesian multivariate autoregressive models,2016-11-28,,https://arxiv.org/pdf/1611.09063v3.pdf,"Respiratory infections in humans are caused by a diverse community of co-circulating viral species including viruses that cause influenza and the common cold. Public health interventions such as vaccination programs typically focus on individual viral species. However, observational data suggest that the spread of one species may impact the dynamics of another. This finding would have important implications for the predicted impact of seasonal vaccines but currently lacks statistical support. The aim of this paper is to develop a statistical framework to identify non-independent viral dynamics. As Bayesian multivariate disease mapping models naturally encompass a between-disease covariance matrix, we extended this framework to model multivariate time series data accounting for within- and between-year dependencies. By inferring non-zero off-diagonal entries of the between-disease covariance matrix, we present a novel technique that successfully identifies significant viral interactions. We illustrate this framework using incidence data from five co-circulating respiratory viruses (adenovirus [AdV], coronavirus [Cov], human metapneumovirus [MPV], influenza B virus [IBV] and respiratory syncytial virus [RSV]) detected by routine diagnostics at the West of Scotland Specialist Virology Center (WoSSVC) between 2005 and 2013. We found a significant positive covariance between RSV \&MPV and a negative covariance between IBV \&AdV paving the way for future examination of biological or behavioural factors that may generate interactions between certain virus pairs.",,yy48avnp,"['Respiratory', 'infections', 'in', 'humans', 'are', 'caused', 'by', 'a', 'diverse', 'community', 'of', 'co', 'circulating', 'viral', 'species', 'including', 'viruses', 'that', 'cause', 'influenza', 'and', 'the', 'common', 'cold', 'Public', 'health', 'interventions', 'such', 'as', 'vaccination', 'programs', 'typically', 'focus', 'on', 'individual', 'viral', 'species', 'However', 'observational', 'data', 'suggest', 'that', 'the', 'spread', 'of', 'one', 'species', 'may', 'impact', 'the', 'dynamics', 'of', 'another', 'This', 'finding', 'would', 'have', 'important', 'implications', 'for', 'the', 'predicted', 'impact', 'of', 'seasonal', 'vaccines', 'but', 'currently', 'lacks', 'statistical', 'support', 'The', 'aim', 'of', 'this', 'paper', 'is', 'to', 'develop', 'a', 'statistical', 'framework', 'to', 'identify', 'non', 'independent', 'viral', 'dynamics', 'As', 'Bayesian', 'multivariate', 'disease', 'mapping', 'models', 'naturally', 'encompass', 'a', 'between', 'disease', 'covariance', 'matrix', 'we', 'extended', 'this', 'framework', 'to', 'model', 'multivariate', 'time', 'series', 'data', 'accounting', 'for', 'within', 'and', 'between', 'year', 'dependencies', 'By', 'inferring', 'non', 'zero', 'off', 'diagonal', 'entries', 'of', 'the', 'between', 'disease', 'covariance', 'matrix', 'we', 'present', 'a', 'novel', 'technique', 'that', 'successfully', 'identifies', 'significant', 'viral', 'interactions', 'We', 'illustrate', 'this', 'framework', 'using', 'incidence', 'data', 'from', 'five', 'co', 'circulating', 'respiratory', 'viruses', 'adenovirus', 'AdV', 'coronavirus', 'Cov', 'human', 'metapneumovirus', 'MPV', 'influenza', 'B', 'virus', 'IBV', 'and', 'respiratory', 'syncytial', 'virus', 'RSV', 'detected', 'by', 'routine', 'diagnostics', 'at', 'the', 'West', 'of', 'Scotland', 'Specialist', 'Virology', 'Center', 'WoSSVC', 'between', '2005', 'and', '2013', 'We', 'found', 'a', 'significant', 'positive', 'covariance', 'between', 'RSV', 'MPV', 'and', 'a', 'negative', 'covariance', 'between', 'IBV', 'AdV', 'paving', 'the', 'way', 'for', 'future', 'examination', 'of', 'biological', 'or', 'behavioural', 'factors', 'that', 'may', 'generate', 'interactions', 'between', 'certain', 'virus', 'pairs', '']"
103050,Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens,2020,Infect Genet Evol,,"The 2019 novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak has caused a large number of deaths, with thousands of confirmed cases worldwide. The present study followed computational approaches to identify B- and T-cell epitopes for the spike (S) glycoprotein of SARS-CoV-2 by its interactions with the human leukocyte antigen alleles. We identified 24 peptide stretches on the SARS-CoV-2 S protein that are well conserved among the reported strains. The S protein structure further validated the presence of predicted peptides on the surface, of which 20 are surface exposed and predicted to have reasonable epitope binding efficiency. The work could be useful for understanding the immunodominant regions in the surface protein of SARS-CoV-2 and could potentially help in designing some peptide-based diagnostics. Also, identified T-cell epitopes might be considered for incorporation in vaccine designs.",,f2pj1w4m,"['The', '2019', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'outbreak', 'has', 'caused', 'a', 'large', 'number', 'of', 'deaths', 'with', 'thousands', 'of', 'confirmed', 'cases', 'worldwide', 'The', 'present', 'study', 'followed', 'computational', 'approaches', 'to', 'identify', 'B', 'and', 'T', 'cell', 'epitopes', 'for', 'the', 'spike', 'S', 'glycoprotein', 'of', 'SARS', 'CoV', '2', 'by', 'its', 'interactions', 'with', 'the', 'human', 'leukocyte', 'antigen', 'alleles', 'We', 'identified', '24', 'peptide', 'stretches', 'on', 'the', 'SARS', 'CoV', '2', 'S', 'protein', 'that', 'are', 'well', 'conserved', 'among', 'the', 'reported', 'strains', 'The', 'S', 'protein', 'structure', 'further', 'validated', 'the', 'presence', 'of', 'predicted', 'peptides', 'on', 'the', 'surface', 'of', 'which', '20', 'are', 'surface', 'exposed', 'and', 'predicted', 'to', 'have', 'reasonable', 'epitope', 'binding', 'efficiency', 'The', 'work', 'could', 'be', 'useful', 'for', 'understanding', 'the', 'immunodominant', 'regions', 'in', 'the', 'surface', 'protein', 'of', 'SARS', 'CoV', '2', 'and', 'could', 'potentially', 'help', 'in', 'designing', 'some', 'peptide', 'based', 'diagnostics', 'Also', 'identified', 'T', 'cell', 'epitopes', 'might', 'be', 'considered', 'for', 'incorporation', 'in', 'vaccine', 'designs', '']"
104372,Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks,2020,Tissue Eng Part A,,"In light of the current novel coronavirus (COVID-19) pandemic, as well as other viral outbreaks in the 21st century, there is a dire need for new diagnostic and therapeutic strategies to combat infectious diseases worldwide. As a convergence science, tissue engineering has traditionally focused on the application of engineering principles to biological systems, collaboration across disciplines, and rapid translation of technologies from the benchtop to the bedside. Given these strengths, tissue engineers are particularly well suited to apply their skill set to the current crisis and viral outbreaks in general. This work introduces the basics of virology and epidemiology for tissue engineers, and highlights important developments in the field of tissue engineering relevant to the current pandemic, including in vitro model systems, vaccine technology, and small-molecule drug delivery. COVID-19 serves as a call to arms for scientists across all disciplines, and tissue engineers are well trained to be leaders and contributors in this time of need. Impact statement Given the steep mortality caused by the recent novel coronavirus (COVID-19) pandemic, there is clear need for advances in diagnostics and therapeutics for viral outbreaks. Tissue engineering has the potential for critical impact on clinical outcomes in viral outbreaks. Tissue engineers, if mobilized, could play key roles as leaders in the outbreak, given their ability to apply engineering principles to biological processes, experience in collaborative environments, and penchant for technological translation from benchtop to bedside. In this work, three areas pioneered by tissue engineers that could be applied to the current COVID-19 crisis and future viral outbreaks are highlighted.",,pt2pokvt,"['In', 'light', 'of', 'the', 'current', 'novel', 'coronavirus', 'COVID', '19', 'pandemic', 'as', 'well', 'as', 'other', 'viral', 'outbreaks', 'in', 'the', '21st', 'century', 'there', 'is', 'a', 'dire', 'need', 'for', 'new', 'diagnostic', 'and', 'therapeutic', 'strategies', 'to', 'combat', 'infectious', 'diseases', 'worldwide', 'As', 'a', 'convergence', 'science', 'tissue', 'engineering', 'has', 'traditionally', 'focused', 'on', 'the', 'application', 'of', 'engineering', 'principles', 'to', 'biological', 'systems', 'collaboration', 'across', 'disciplines', 'and', 'rapid', 'translation', 'of', 'technologies', 'from', 'the', 'benchtop', 'to', 'the', 'bedside', 'Given', 'these', 'strengths', 'tissue', 'engineers', 'are', 'particularly', 'well', 'suited', 'to', 'apply', 'their', 'skill', 'set', 'to', 'the', 'current', 'crisis', 'and', 'viral', 'outbreaks', 'in', 'general', 'This', 'work', 'introduces', 'the', 'basics', 'of', 'virology', 'and', 'epidemiology', 'for', 'tissue', 'engineers', 'and', 'highlights', 'important', 'developments', 'in', 'the', 'field', 'of', 'tissue', 'engineering', 'relevant', 'to', 'the', 'current', 'pandemic', 'including', 'in', 'vitro', 'model', 'systems', 'vaccine', 'technology', 'and', 'small', 'molecule', 'drug', 'delivery', 'COVID', '19', 'serves', 'as', 'a', 'call', 'to', 'arms', 'for', 'scientists', 'across', 'all', 'disciplines', 'and', 'tissue', 'engineers', 'are', 'well', 'trained', 'to', 'be', 'leaders', 'and', 'contributors', 'in', 'this', 'time', 'of', 'need', 'Impact', 'statement', 'Given', 'the', 'steep', 'mortality', 'caused', 'by', 'the', 'recent', 'novel', 'coronavirus', 'COVID', '19', 'pandemic', 'there', 'is', 'clear', 'need', 'for', 'advances', 'in', 'diagnostics', 'and', 'therapeutics', 'for', 'viral', 'outbreaks', 'Tissue', 'engineering', 'has', 'the', 'potential', 'for', 'critical', 'impact', 'on', 'clinical', 'outcomes', 'in', 'viral', 'outbreaks', 'Tissue', 'engineers', 'if', 'mobilized', 'could', 'play', 'key', 'roles', 'as', 'leaders', 'in', 'the', 'outbreak', 'given', 'their', 'ability', 'to', 'apply', 'engineering', 'principles', 'to', 'biological', 'processes', 'experience', 'in', 'collaborative', 'environments', 'and', 'penchant', 'for', 'technological', 'translation', 'from', 'benchtop', 'to', 'bedside', 'In', 'this', 'work', 'three', 'areas', 'pioneered', 'by', 'tissue', 'engineers', 'that', 'could', 'be', 'applied', 'to', 'the', 'current', 'COVID', '19', 'crisis', 'and', 'future', 'viral', 'outbreaks', 'are', 'highlighted', '']"
104373,Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks,2020,Tissue Eng Part A,,"In light of the current novel coronavirus (COVID-19) pandemic, as well as other viral outbreaks in the 21st century, there is a dire need for new diagnostic and therapeutic strategies to combat infectious diseases worldwide. As a convergence science, tissue engineering has traditionally focused on the application of engineering principles to biological systems, collaboration across disciplines, and rapid translation of technologies from the benchtop to the bedside. Given these strengths, tissue engineers are particularly well suited to apply their skill set to the current crisis and viral outbreaks in general. This work introduces the basics of virology and epidemiology for tissue engineers, and highlights important developments in the field of tissue engineering relevant to the current pandemic, including in vitro model systems, vaccine technology, and small-molecule drug delivery. COVID-19 serves as a call to arms for scientists across all disciplines, and tissue engineers are well trained to be leaders and contributors in this time of need. Impact statement Given the steep mortality caused by the recent novel coronavirus (COVID-19) pandemic, there is clear need for advances in diagnostics and therapeutics for viral outbreaks. Tissue engineering has the potential for critical impact on clinical outcomes in viral outbreaks. Tissue engineers, if mobilized, could play key roles as leaders in the outbreak, given their ability to apply engineering principles to biological processes, experience in collaborative environments, and penchant for technological translation from benchtop to bedside. In this work, three areas pioneered by tissue engineers that could be applied to the current COVID-19 crisis and future viral outbreaks are highlighted.",,anyvz7bo,"['In', 'light', 'of', 'the', 'current', 'novel', 'coronavirus', 'COVID', '19', 'pandemic', 'as', 'well', 'as', 'other', 'viral', 'outbreaks', 'in', 'the', '21st', 'century', 'there', 'is', 'a', 'dire', 'need', 'for', 'new', 'diagnostic', 'and', 'therapeutic', 'strategies', 'to', 'combat', 'infectious', 'diseases', 'worldwide', 'As', 'a', 'convergence', 'science', 'tissue', 'engineering', 'has', 'traditionally', 'focused', 'on', 'the', 'application', 'of', 'engineering', 'principles', 'to', 'biological', 'systems', 'collaboration', 'across', 'disciplines', 'and', 'rapid', 'translation', 'of', 'technologies', 'from', 'the', 'benchtop', 'to', 'the', 'bedside', 'Given', 'these', 'strengths', 'tissue', 'engineers', 'are', 'particularly', 'well', 'suited', 'to', 'apply', 'their', 'skill', 'set', 'to', 'the', 'current', 'crisis', 'and', 'viral', 'outbreaks', 'in', 'general', 'This', 'work', 'introduces', 'the', 'basics', 'of', 'virology', 'and', 'epidemiology', 'for', 'tissue', 'engineers', 'and', 'highlights', 'important', 'developments', 'in', 'the', 'field', 'of', 'tissue', 'engineering', 'relevant', 'to', 'the', 'current', 'pandemic', 'including', 'in', 'vitro', 'model', 'systems', 'vaccine', 'technology', 'and', 'small', 'molecule', 'drug', 'delivery', 'COVID', '19', 'serves', 'as', 'a', 'call', 'to', 'arms', 'for', 'scientists', 'across', 'all', 'disciplines', 'and', 'tissue', 'engineers', 'are', 'well', 'trained', 'to', 'be', 'leaders', 'and', 'contributors', 'in', 'this', 'time', 'of', 'need', 'Impact', 'statement', 'Given', 'the', 'steep', 'mortality', 'caused', 'by', 'the', 'recent', 'novel', 'coronavirus', 'COVID', '19', 'pandemic', 'there', 'is', 'clear', 'need', 'for', 'advances', 'in', 'diagnostics', 'and', 'therapeutics', 'for', 'viral', 'outbreaks', 'Tissue', 'engineering', 'has', 'the', 'potential', 'for', 'critical', 'impact', 'on', 'clinical', 'outcomes', 'in', 'viral', 'outbreaks', 'Tissue', 'engineers', 'if', 'mobilized', 'could', 'play', 'key', 'roles', 'as', 'leaders', 'in', 'the', 'outbreak', 'given', 'their', 'ability', 'to', 'apply', 'engineering', 'principles', 'to', 'biological', 'processes', 'experience', 'in', 'collaborative', 'environments', 'and', 'penchant', 'for', 'technological', 'translation', 'from', 'benchtop', 'to', 'bedside', 'In', 'this', 'work', 'three', 'areas', 'pioneered', 'by', 'tissue', 'engineers', 'that', 'could', 'be', 'applied', 'to', 'the', 'current', 'COVID', '19', 'crisis', 'and', 'future', 'viral', 'outbreaks', 'are', 'highlighted', '']"
104699,"Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines",2020,Biomed. j. (Mumbai.Online),,"The coronavirus disease 2019 (COVID-19) pandemic caused by a novel coronavirus, SARS-CoV-2, has infected more than 4.9 million individuals and resulted in over 300,000 deaths globally. The rapid spread of the virus and the precipitously increasing numbers of cases necessitate the urgent development of accurate diagnostic methods, effective treatments, and vaccines. Here, we review the progress of developing diagnostic methods, therapies, and vaccines for SARS-CoV-2 with a focus on current clinical trials and their challenges. For diagnosis, nucleic acid amplification tests remain the mainstay diagnostics for laboratory confirmation of SARS-CoV-2 infection, while serological antibody tests are used to aid contact tracing, epidemiological, and vaccine evaluation studies. Viral isolation is not recommended for routine diagnostic procedures due to safety concerns. Currently, no single effective drug or specific vaccine is available against SARS-CoV-2. Some candidate drugs targeting different levels and stages of human responses against COVID-19 such as cell membrane fusion, RNA-dependent RNA polymerase, viral protease inhibitor, interleukin 6 blocker, and convalescent plasma may improve the clinical outcomes of critical COVID-19 patients. Other supportive care measures for critical patients are still necessary. Advances in genetic sequencing and other technological developments have sped up the establishment of a variety of vaccine platforms. Accordingly, numerous vaccines are under development. Vaccine candidates against SARS-CoV-2 are mainly based upon the viral spike protein due to its vital role in viral infectivity, and most of these candidates have recently moved into clinical trials. Before the efficacy of such vaccines in humans is demonstrated, strong international coordination and collaboration among studies, pharmaceutical companies, regulators, and governments are needed to limit further damage due the emerging SARS-CoV-2 virus.",,2vevp0fg,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'caused', 'by', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'has', 'infected', 'more', 'than', '4', '9', 'million', 'individuals', 'and', 'resulted', 'in', 'over', '300', '000', 'deaths', 'globally', 'The', 'rapid', 'spread', 'of', 'the', 'virus', 'and', 'the', 'precipitously', 'increasing', 'numbers', 'of', 'cases', 'necessitate', 'the', 'urgent', 'development', 'of', 'accurate', 'diagnostic', 'methods', 'effective', 'treatments', 'and', 'vaccines', 'Here', 'we', 'review', 'the', 'progress', 'of', 'developing', 'diagnostic', 'methods', 'therapies', 'and', 'vaccines', 'for', 'SARS', 'CoV', '2', 'with', 'a', 'focus', 'on', 'current', 'clinical', 'trials', 'and', 'their', 'challenges', 'For', 'diagnosis', 'nucleic', 'acid', 'amplification', 'tests', 'remain', 'the', 'mainstay', 'diagnostics', 'for', 'laboratory', 'confirmation', 'of', 'SARS', 'CoV', '2', 'infection', 'while', 'serological', 'antibody', 'tests', 'are', 'used', 'to', 'aid', 'contact', 'tracing', 'epidemiological', 'and', 'vaccine', 'evaluation', 'studies', 'Viral', 'isolation', 'is', 'not', 'recommended', 'for', 'routine', 'diagnostic', 'procedures', 'due', 'to', 'safety', 'concerns', 'Currently', 'no', 'single', 'effective', 'drug', 'or', 'specific', 'vaccine', 'is', 'available', 'against', 'SARS', 'CoV', '2', 'Some', 'candidate', 'drugs', 'targeting', 'different', 'levels', 'and', 'stages', 'of', 'human', 'responses', 'against', 'COVID', '19', 'such', 'as', 'cell', 'membrane', 'fusion', 'RNA', 'dependent', 'RNA', 'polymerase', 'viral', 'protease', 'inhibitor', 'interleukin', '6', 'blocker', 'and', 'convalescent', 'plasma', 'may', 'improve', 'the', 'clinical', 'outcomes', 'of', 'critical', 'COVID', '19', 'patients', 'Other', 'supportive', 'care', 'measures', 'for', 'critical', 'patients', 'are', 'still', 'necessary', 'Advances', 'in', 'genetic', 'sequencing', 'and', 'other', 'technological', 'developments', 'have', 'sped', 'up', 'the', 'establishment', 'of', 'a', 'variety', 'of', 'vaccine', 'platforms', 'Accordingly', 'numerous', 'vaccines', 'are', 'under', 'development', 'Vaccine', 'candidates', 'against', 'SARS', 'CoV', '2', 'are', 'mainly', 'based', 'upon', 'the', 'viral', 'spike', 'protein', 'due', 'to', 'its', 'vital', 'role', 'in', 'viral', 'infectivity', 'and', 'most', 'of', 'these', 'candidates', 'have', 'recently', 'moved', 'into', 'clinical', 'trials', 'Before', 'the', 'efficacy', 'of', 'such', 'vaccines', 'in', 'humans', 'is', 'demonstrated', 'strong', 'international', 'coordination', 'and', 'collaboration', 'among', 'studies', 'pharmaceutical', 'companies', 'regulators', 'and', 'governments', 'are', 'needed', 'to', 'limit', 'further', 'damage', 'due', 'the', 'emerging', 'SARS', 'CoV', '2', 'virus', '']"
105141,Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?,2020,Nanomedicine (Lond),,"Prior research on nanotechnologies in diagnostics, prevention and treatment of coronavirus infections is reviewed. Gold nanoparticles and semiconductor quantum dots in colorimetric and immunochromatographic assays, silica nanoparticles in the polymerase chain reaction and spike protein nanospheres as antigen carriers and adjuvants in vaccine formulations present notable examples in diagnostics and prevention, while uses of nanoparticles in coronavirus infection treatments have been merely sporadic. The current absence of antiviral therapeutics that specifically target human coronaviruses, including SARS-CoV-2, might be largely due to the underuse of nanotechnologies. Elucidating the interface between nanoparticles and coronaviruses is timely, but presents the only route to the rational design of precisely targeted therapeutics for coronavirus infections. Such a fundamental approach is also a viable prophylaxis against future pandemics of this type.",,8yvdjgfa,"['Prior', 'research', 'on', 'nanotechnologies', 'in', 'diagnostics', 'prevention', 'and', 'treatment', 'of', 'coronavirus', 'infections', 'is', 'reviewed', 'Gold', 'nanoparticles', 'and', 'semiconductor', 'quantum', 'dots', 'in', 'colorimetric', 'and', 'immunochromatographic', 'assays', 'silica', 'nanoparticles', 'in', 'the', 'polymerase', 'chain', 'reaction', 'and', 'spike', 'protein', 'nanospheres', 'as', 'antigen', 'carriers', 'and', 'adjuvants', 'in', 'vaccine', 'formulations', 'present', 'notable', 'examples', 'in', 'diagnostics', 'and', 'prevention', 'while', 'uses', 'of', 'nanoparticles', 'in', 'coronavirus', 'infection', 'treatments', 'have', 'been', 'merely', 'sporadic', 'The', 'current', 'absence', 'of', 'antiviral', 'therapeutics', 'that', 'specifically', 'target', 'human', 'coronaviruses', 'including', 'SARS', 'CoV', '2', 'might', 'be', 'largely', 'due', 'to', 'the', 'underuse', 'of', 'nanotechnologies', 'Elucidating', 'the', 'interface', 'between', 'nanoparticles', 'and', 'coronaviruses', 'is', 'timely', 'but', 'presents', 'the', 'only', 'route', 'to', 'the', 'rational', 'design', 'of', 'precisely', 'targeted', 'therapeutics', 'for', 'coronavirus', 'infections', 'Such', 'a', 'fundamental', 'approach', 'is', 'also', 'a', 'viable', 'prophylaxis', 'against', 'future', 'pandemics', 'of', 'this', 'type', '']"
105460,Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19),2020,Clin. infect. dis,,"Coronavirus-disease-2019 (COVID-19) caused by the severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2) shows a rapid spread over-the-world. Given scarce resources, non-laboratory diagnostics is crucial. In this cross-sectional study, two-thirds of European patients with polymerase chain reaction confirmed COVID-19 reported olfactory and gustatory dysfunction, indicating the significance of this history in the early diagnostics.",,ct67dmgg,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'shows', 'a', 'rapid', 'spread', 'over', 'the', 'world', 'Given', 'scarce', 'resources', 'non', 'laboratory', 'diagnostics', 'is', 'crucial', 'In', 'this', 'cross', 'sectional', 'study', 'two', 'thirds', 'of', 'European', 'patients', 'with', 'polymerase', 'chain', 'reaction', 'confirmed', 'COVID', '19', 'reported', 'olfactory', 'and', 'gustatory', 'dysfunction', 'indicating', 'the', 'significance', 'of', 'this', 'history', 'in', 'the', 'early', 'diagnostics', '']"
106232,SARS-CoV-2 antibody testing-questions to be asked,2020,J Allergy Clin Immunol,,"Severe acute respiratory syndrome coronavirus 2 infection and development of coronavirus disease 2019 presents a major health care challenge of global dimensions. Laboratory diagnostics of infected patients, and the assessment of immunity against severe acute respiratory syndrome coronavirus 2, presents a major cornerstone in handling the pandemic. Currently, there is an increase in demand for antibody testing and a large number of tests are already marketed or are in the late stage of development. However, the interpretation of test results depends on many variables and factors, including sensitivity, specificity, potential cross-reactivity and cross-protectivity, the diagnostic value of antibodies of different isotypes, and the use of antibody testing in identification of acutely ill patients or in epidemiological settings. In this article, the recently established COVID-19 Task Force of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) addresses these issues on the basis of currently available data sets in this rapidly moving field.",,laobflfb,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'infection', 'and', 'development', 'of', 'coronavirus', 'disease', '2019', 'presents', 'a', 'major', 'health', 'care', 'challenge', 'of', 'global', 'dimensions', 'Laboratory', 'diagnostics', 'of', 'infected', 'patients', 'and', 'the', 'assessment', 'of', 'immunity', 'against', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'presents', 'a', 'major', 'cornerstone', 'in', 'handling', 'the', 'pandemic', 'Currently', 'there', 'is', 'an', 'increase', 'in', 'demand', 'for', 'antibody', 'testing', 'and', 'a', 'large', 'number', 'of', 'tests', 'are', 'already', 'marketed', 'or', 'are', 'in', 'the', 'late', 'stage', 'of', 'development', 'However', 'the', 'interpretation', 'of', 'test', 'results', 'depends', 'on', 'many', 'variables', 'and', 'factors', 'including', 'sensitivity', 'specificity', 'potential', 'cross', 'reactivity', 'and', 'cross', 'protectivity', 'the', 'diagnostic', 'value', 'of', 'antibodies', 'of', 'different', 'isotypes', 'and', 'the', 'use', 'of', 'antibody', 'testing', 'in', 'identification', 'of', 'acutely', 'ill', 'patients', 'or', 'in', 'epidemiological', 'settings', 'In', 'this', 'article', 'the', 'recently', 'established', 'COVID', '19', 'Task', 'Force', 'of', 'the', 'German', 'Society', 'for', 'Clinical', 'Chemistry', 'and', 'Laboratory', 'Medicine', 'DGKL', 'addresses', 'these', 'issues', 'on', 'the', 'basis', 'of', 'currently', 'available', 'data', 'sets', 'in', 'this', 'rapidly', 'moving', 'field', '']"
106520,Biochemical characterization of SARS-CoV-2 nucleocapsid protein,2020,Biochem Biophys Res Commun,,"The nucleocapsid (N) protein is an important antigen for coronavirus, which participate in RNA package and virus particle release. In this study, we expressed the N protein of SARS-CoV-2 and characterized its biochemical properties. Static light scattering, size exclusive chromatography, and small-angle X-ray scattering (SAXS) showed that the purified N protein is largely a dimer in solution. CD spectra showed that it has a high percentage of disordered region at room temperature while it was best structured at 55 °C, suggesting its structural dynamics. Fluorescence polarization assay showed it has non-specific nucleic acid binding capability, which raised a concern in using it as a diagnostic marker. Immunoblot assays confirmed the presence of IgA, IgM and IgG antibodies against N antigen in COVID-19 infection patients' sera, proving the importance of this antigen in host immunity and diagnostics.",,5v06k96c,"['The', 'nucleocapsid', 'N', 'protein', 'is', 'an', 'important', 'antigen', 'for', 'coronavirus', 'which', 'participate', 'in', 'RNA', 'package', 'and', 'virus', 'particle', 'release', 'In', 'this', 'study', 'we', 'expressed', 'the', 'N', 'protein', 'of', 'SARS', 'CoV', '2', 'and', 'characterized', 'its', 'biochemical', 'properties', 'Static', 'light', 'scattering', 'size', 'exclusive', 'chromatography', 'and', 'small', 'angle', 'X', 'ray', 'scattering', 'SAXS', 'showed', 'that', 'the', 'purified', 'N', 'protein', 'is', 'largely', 'a', 'dimer', 'in', 'solution', 'CD', 'spectra', 'showed', 'that', 'it', 'has', 'a', 'high', 'percentage', 'of', 'disordered', 'region', 'at', 'room', 'temperature', 'while', 'it', 'was', 'best', 'structured', 'at', '55', 'C', 'suggesting', 'its', 'structural', 'dynamics', 'Fluorescence', 'polarization', 'assay', 'showed', 'it', 'has', 'non', 'specific', 'nucleic', 'acid', 'binding', 'capability', 'which', 'raised', 'a', 'concern', 'in', 'using', 'it', 'as', 'a', 'diagnostic', 'marker', 'Immunoblot', 'assays', 'confirmed', 'the', 'presence', 'of', 'IgA', 'IgM', 'and', 'IgG', 'antibodies', 'against', 'N', 'antigen', 'in', 'COVID', '19', 'infection', 'patients', 'sera', 'proving', 'the', 'importance', 'of', 'this', 'antigen', 'in', 'host', 'immunity', 'and', 'diagnostics', '']"
107264,Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs,2020,,,"The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Meanwhile, increased demand for testing has led to a shortage of reagents and supplies and compromised the performance of diagnostic laboratories in many countries. Both the World Health Organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate the interpretation of the test results, especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in diagnostics as well as in research labs using a low-cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infections and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for the quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.",,d08pnq1u,"['The', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'is', 'the', 'causative', 'agent', 'of', 'the', 'acute', 'respiratory', 'disease', 'COVID', '19', 'which', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'its', 'rapid', 'spread', 'Meanwhile', 'increased', 'demand', 'for', 'testing', 'has', 'led', 'to', 'a', 'shortage', 'of', 'reagents', 'and', 'supplies', 'and', 'compromised', 'the', 'performance', 'of', 'diagnostic', 'laboratories', 'in', 'many', 'countries', 'Both', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'the', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommend', 'multi', 'step', 'RT', 'PCR', 'assays', 'using', 'multiple', 'primer', 'and', 'probe', 'pairs', 'which', 'might', 'complicate', 'the', 'interpretation', 'of', 'the', 'test', 'results', 'especially', 'for', 'borderline', 'cases', 'In', 'this', 'study', 'we', 'describe', 'an', 'alternative', 'RT', 'PCR', 'approach', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'that', 'can', 'be', 'used', 'for', 'the', 'probe', 'based', 'detection', 'of', 'clinical', 'isolates', 'in', 'diagnostics', 'as', 'well', 'as', 'in', 'research', 'labs', 'using', 'a', 'low', 'cost', 'SYBR', 'green', 'method', 'For', 'the', 'evaluation', 'we', 'used', 'samples', 'from', 'patients', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infections', 'and', 'performed', 'RT', 'PCR', 'assays', 'along', 'with', 'successive', 'dilutions', 'of', 'RNA', 'standards', 'to', 'determine', 'the', 'limit', 'of', 'detection', 'We', 'identified', 'an', 'M', 'gene', 'binding', 'primer', 'and', 'probe', 'pair', 'highly', 'suitable', 'for', 'the', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'for', 'diagnostic', 'and', 'research', 'purposes', '']"
107265,Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs,2020,,,"The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Meanwhile, increased demand for testing has led to a shortage of reagents and supplies and compromised the performance of diagnostic laboratories in many countries. Both the World Health Organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate the interpretation of the test results, especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in diagnostics as well as in research labs using a low-cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infections and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for the quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.",,2svdhayy,"['The', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'is', 'the', 'causative', 'agent', 'of', 'the', 'acute', 'respiratory', 'disease', 'COVID', '19', 'which', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'its', 'rapid', 'spread', 'Meanwhile', 'increased', 'demand', 'for', 'testing', 'has', 'led', 'to', 'a', 'shortage', 'of', 'reagents', 'and', 'supplies', 'and', 'compromised', 'the', 'performance', 'of', 'diagnostic', 'laboratories', 'in', 'many', 'countries', 'Both', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'the', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommend', 'multi', 'step', 'RT', 'PCR', 'assays', 'using', 'multiple', 'primer', 'and', 'probe', 'pairs', 'which', 'might', 'complicate', 'the', 'interpretation', 'of', 'the', 'test', 'results', 'especially', 'for', 'borderline', 'cases', 'In', 'this', 'study', 'we', 'describe', 'an', 'alternative', 'RT', 'PCR', 'approach', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'that', 'can', 'be', 'used', 'for', 'the', 'probe', 'based', 'detection', 'of', 'clinical', 'isolates', 'in', 'diagnostics', 'as', 'well', 'as', 'in', 'research', 'labs', 'using', 'a', 'low', 'cost', 'SYBR', 'green', 'method', 'For', 'the', 'evaluation', 'we', 'used', 'samples', 'from', 'patients', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infections', 'and', 'performed', 'RT', 'PCR', 'assays', 'along', 'with', 'successive', 'dilutions', 'of', 'RNA', 'standards', 'to', 'determine', 'the', 'limit', 'of', 'detection', 'We', 'identified', 'an', 'M', 'gene', 'binding', 'primer', 'and', 'probe', 'pair', 'highly', 'suitable', 'for', 'the', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'for', 'diagnostic', 'and', 'research', 'purposes', '']"
107580,Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients,2020,Nat Commun,,"Given the ongoing SARS-CoV-2 pandemic, identification of immunogenic targets against the coronavirus spike glycoprotein will provide crucial advances towards the development of sensitive diagnostic tools and potential vaccine candidate targets. In this study, using pools of overlapping linear B-cell peptides, we report two IgG immunodominant regions on SARS-CoV-2 spike glycoprotein that are recognised by sera from COVID-19 convalescent patients. Notably, one is specific to SARS-CoV-2, which is located in close proximity to the receptor binding domain. The other region, which is localised at the fusion peptide, could potentially function as a pan-SARS target. Functionally, antibody depletion assays demonstrate that antibodies targeting these immunodominant regions significantly alter virus neutralisation capacities. Taken together, identification and validation of these neutralising B-cell epitopes will provide insights towards the design of diagnostics and vaccine candidates against this high priority coronavirus.",,budjcbej,"['Given', 'the', 'ongoing', 'SARS', 'CoV', '2', 'pandemic', 'identification', 'of', 'immunogenic', 'targets', 'against', 'the', 'coronavirus', 'spike', 'glycoprotein', 'will', 'provide', 'crucial', 'advances', 'towards', 'the', 'development', 'of', 'sensitive', 'diagnostic', 'tools', 'and', 'potential', 'vaccine', 'candidate', 'targets', 'In', 'this', 'study', 'using', 'pools', 'of', 'overlapping', 'linear', 'B', 'cell', 'peptides', 'we', 'report', 'two', 'IgG', 'immunodominant', 'regions', 'on', 'SARS', 'CoV', '2', 'spike', 'glycoprotein', 'that', 'are', 'recognised', 'by', 'sera', 'from', 'COVID', '19', 'convalescent', 'patients', 'Notably', 'one', 'is', 'specific', 'to', 'SARS', 'CoV', '2', 'which', 'is', 'located', 'in', 'close', 'proximity', 'to', 'the', 'receptor', 'binding', 'domain', 'The', 'other', 'region', 'which', 'is', 'localised', 'at', 'the', 'fusion', 'peptide', 'could', 'potentially', 'function', 'as', 'a', 'pan', 'SARS', 'target', 'Functionally', 'antibody', 'depletion', 'assays', 'demonstrate', 'that', 'antibodies', 'targeting', 'these', 'immunodominant', 'regions', 'significantly', 'alter', 'virus', 'neutralisation', 'capacities', 'Taken', 'together', 'identification', 'and', 'validation', 'of', 'these', 'neutralising', 'B', 'cell', 'epitopes', 'will', 'provide', 'insights', 'towards', 'the', 'design', 'of', 'diagnostics', 'and', 'vaccine', 'candidates', 'against', 'this', 'high', 'priority', 'coronavirus', '']"
109228,Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination,2020,Emerg Infect Dis,,"The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) created an exceptional situation in which numerous laboratories in Europe simultaneously implemented SARS-CoV-2 diagnostics. These laboratories reported in February 2020 that commercial primer and probe batches for SARS-CoV-2 detection were contaminated with synthetic control material, causing delays of regional testing roll-out in various countries.",,xa5iy0ra,"['The', 'emergence', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'created', 'an', 'exceptional', 'situation', 'in', 'which', 'numerous', 'laboratories', 'in', 'Europe', 'simultaneously', 'implemented', 'SARS', 'CoV', '2', 'diagnostics', 'These', 'laboratories', 'reported', 'in', 'February', '2020', 'that', 'commercial', 'primer', 'and', 'probe', 'batches', 'for', 'SARS', 'CoV', '2', 'detection', 'were', 'contaminated', 'with', 'synthetic', 'control', 'material', 'causing', 'delays', 'of', 'regional', 'testing', 'roll', 'out', 'in', 'various', 'countries', '']"
109461,"SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities",2020,Shock (Augusta Ga.),,"Approximately 3 billion people around the world have gone into some form of social separation to mitigate the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. The uncontrolled influx of patients in need of emergency care has rapidly brought several national health systems to near-collapse with deadly consequences to those afflicted by Coronavirus Disease 2019 (COVID-19) and other critical diseases associated with COVID-19. Solid scientific evidence regarding SARS-CoV-2/COVID-19 remains scarce; there is an urgent need to expand our understanding of the SARS-CoV-2 pathophysiology to facilitate precise and targeted treatments. The capacity for rapid information dissemination has emerged as a double-edged sword; the existing gap of high-quality data is frequently filled by anecdotal reports, contradictory statements, and misinformation. This review addresses several important aspects unique to the SARS-CoV-2/COVID-19 pandemic highlighting the most relevant knowledge gaps and existing windows-of-opportunity. Specifically, focus is given on SARS-CoV-2 immunopathogenesis in the context of experimental therapies and preclinical evidence and their applicability in supporting efficacious clinical trial planning. The review discusses the existing challenges of SARS-CoV-2 diagnostics and the potential application of translational technology for epidemiological predictions, patient monitoring, and treatment decision-making in COVID-19. Furthermore, solutions for enhancing international strategies in translational research, cooperative networks, and regulatory partnerships are contemplated.",,cujy4r31,"['Approximately', '3', 'billion', 'people', 'around', 'the', 'world', 'have', 'gone', 'into', 'some', 'form', 'of', 'social', 'separation', 'to', 'mitigate', 'the', 'current', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'pandemic', 'The', 'uncontrolled', 'influx', 'of', 'patients', 'in', 'need', 'of', 'emergency', 'care', 'has', 'rapidly', 'brought', 'several', 'national', 'health', 'systems', 'to', 'near', 'collapse', 'with', 'deadly', 'consequences', 'to', 'those', 'afflicted', 'by', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'and', 'other', 'critical', 'diseases', 'associated', 'with', 'COVID', '19', 'Solid', 'scientific', 'evidence', 'regarding', 'SARS', 'CoV', '2', 'COVID', '19', 'remains', 'scarce', 'there', 'is', 'an', 'urgent', 'need', 'to', 'expand', 'our', 'understanding', 'of', 'the', 'SARS', 'CoV', '2', 'pathophysiology', 'to', 'facilitate', 'precise', 'and', 'targeted', 'treatments', 'The', 'capacity', 'for', 'rapid', 'information', 'dissemination', 'has', 'emerged', 'as', 'a', 'double', 'edged', 'sword', 'the', 'existing', 'gap', 'of', 'high', 'quality', 'data', 'is', 'frequently', 'filled', 'by', 'anecdotal', 'reports', 'contradictory', 'statements', 'and', 'misinformation', 'This', 'review', 'addresses', 'several', 'important', 'aspects', 'unique', 'to', 'the', 'SARS', 'CoV', '2', 'COVID', '19', 'pandemic', 'highlighting', 'the', 'most', 'relevant', 'knowledge', 'gaps', 'and', 'existing', 'windows', 'of', 'opportunity', 'Specifically', 'focus', 'is', 'given', 'on', 'SARS', 'CoV', '2', 'immunopathogenesis', 'in', 'the', 'context', 'of', 'experimental', 'therapies', 'and', 'preclinical', 'evidence', 'and', 'their', 'applicability', 'in', 'supporting', 'efficacious', 'clinical', 'trial', 'planning', 'The', 'review', 'discusses', 'the', 'existing', 'challenges', 'of', 'SARS', 'CoV', '2', 'diagnostics', 'and', 'the', 'potential', 'application', 'of', 'translational', 'technology', 'for', 'epidemiological', 'predictions', 'patient', 'monitoring', 'and', 'treatment', 'decision', 'making', 'in', 'COVID', '19', 'Furthermore', 'solutions', 'for', 'enhancing', 'international', 'strategies', 'in', 'translational', 'research', 'cooperative', 'networks', 'and', 'regulatory', 'partnerships', 'are', 'contemplated', '']"
109462,"SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities",2020,Shock (Augusta Ga.),,"Approximately 3 billion people around the world have gone into some form of social separation to mitigate the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. The uncontrolled influx of patients in need of emergency care has rapidly brought several national health systems to near-collapse with deadly consequences to those afflicted by Coronavirus Disease 2019 (COVID-19) and other critical diseases associated with COVID-19. Solid scientific evidence regarding SARS-CoV-2/COVID-19 remains scarce; there is an urgent need to expand our understanding of the SARS-CoV-2 pathophysiology to facilitate precise and targeted treatments. The capacity for rapid information dissemination has emerged as a double-edged sword; the existing gap of high-quality data is frequently filled by anecdotal reports, contradictory statements, and misinformation. This review addresses several important aspects unique to the SARS-CoV-2/COVID-19 pandemic highlighting the most relevant knowledge gaps and existing windows-of-opportunity. Specifically, focus is given on SARS-CoV-2 immunopathogenesis in the context of experimental therapies and preclinical evidence and their applicability in supporting efficacious clinical trial planning. The review discusses the existing challenges of SARS-CoV-2 diagnostics and the potential application of translational technology for epidemiological predictions, patient monitoring, and treatment decision-making in COVID-19. Furthermore, solutions for enhancing international strategies in translational research, cooperative networks, and regulatory partnerships are contemplated.",,65t1uaoo,"['Approximately', '3', 'billion', 'people', 'around', 'the', 'world', 'have', 'gone', 'into', 'some', 'form', 'of', 'social', 'separation', 'to', 'mitigate', 'the', 'current', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'pandemic', 'The', 'uncontrolled', 'influx', 'of', 'patients', 'in', 'need', 'of', 'emergency', 'care', 'has', 'rapidly', 'brought', 'several', 'national', 'health', 'systems', 'to', 'near', 'collapse', 'with', 'deadly', 'consequences', 'to', 'those', 'afflicted', 'by', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'and', 'other', 'critical', 'diseases', 'associated', 'with', 'COVID', '19', 'Solid', 'scientific', 'evidence', 'regarding', 'SARS', 'CoV', '2', 'COVID', '19', 'remains', 'scarce', 'there', 'is', 'an', 'urgent', 'need', 'to', 'expand', 'our', 'understanding', 'of', 'the', 'SARS', 'CoV', '2', 'pathophysiology', 'to', 'facilitate', 'precise', 'and', 'targeted', 'treatments', 'The', 'capacity', 'for', 'rapid', 'information', 'dissemination', 'has', 'emerged', 'as', 'a', 'double', 'edged', 'sword', 'the', 'existing', 'gap', 'of', 'high', 'quality', 'data', 'is', 'frequently', 'filled', 'by', 'anecdotal', 'reports', 'contradictory', 'statements', 'and', 'misinformation', 'This', 'review', 'addresses', 'several', 'important', 'aspects', 'unique', 'to', 'the', 'SARS', 'CoV', '2', 'COVID', '19', 'pandemic', 'highlighting', 'the', 'most', 'relevant', 'knowledge', 'gaps', 'and', 'existing', 'windows', 'of', 'opportunity', 'Specifically', 'focus', 'is', 'given', 'on', 'SARS', 'CoV', '2', 'immunopathogenesis', 'in', 'the', 'context', 'of', 'experimental', 'therapies', 'and', 'preclinical', 'evidence', 'and', 'their', 'applicability', 'in', 'supporting', 'efficacious', 'clinical', 'trial', 'planning', 'The', 'review', 'discusses', 'the', 'existing', 'challenges', 'of', 'SARS', 'CoV', '2', 'diagnostics', 'and', 'the', 'potential', 'application', 'of', 'translational', 'technology', 'for', 'epidemiological', 'predictions', 'patient', 'monitoring', 'and', 'treatment', 'decision', 'making', 'in', 'COVID', '19', 'Furthermore', 'solutions', 'for', 'enhancing', 'international', 'strategies', 'in', 'translational', 'research', 'cooperative', 'networks', 'and', 'regulatory', 'partnerships', 'are', 'contemplated', '']"
109581,Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?,2020,Cell Immunol,,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a severe acute respiratory syndrome that is called COVID-19. Clinical manifestations of COVID-19 include diarrhea, pneumonia, lymphopenia, exhausted lymphocytes, and pro-inflammatory cytokine production. Immunology is part of the process of clinical evolution, but there are some questions around immunity-based protection: (1) why some infected people have only mild symptoms of the disease or are asymptomatic; (2) why delayed and weak antibody responses are associated with severe outcomes; and (3) why positivity in molecular tests does not represent protective antibody IgG. Perhaps T cell responses may be the key to solving those questions. SARS-CoV-2-specific memory T cells persist in peripheral blood and may be capable of providing effective information about protective immunity. The T cells studies can be helpful in elucidating the pathways for development of vaccines, therapies, and diagnostics for COVID-19 and for filling these immunology knowledge gaps.",,rs79r7kc,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'induces', 'a', 'severe', 'acute', 'respiratory', 'syndrome', 'that', 'is', 'called', 'COVID', '19', 'Clinical', 'manifestations', 'of', 'COVID', '19', 'include', 'diarrhea', 'pneumonia', 'lymphopenia', 'exhausted', 'lymphocytes', 'and', 'pro', 'inflammatory', 'cytokine', 'production', 'Immunology', 'is', 'part', 'of', 'the', 'process', 'of', 'clinical', 'evolution', 'but', 'there', 'are', 'some', 'questions', 'around', 'immunity', 'based', 'protection', '1', 'why', 'some', 'infected', 'people', 'have', 'only', 'mild', 'symptoms', 'of', 'the', 'disease', 'or', 'are', 'asymptomatic', '2', 'why', 'delayed', 'and', 'weak', 'antibody', 'responses', 'are', 'associated', 'with', 'severe', 'outcomes', 'and', '3', 'why', 'positivity', 'in', 'molecular', 'tests', 'does', 'not', 'represent', 'protective', 'antibody', 'IgG', 'Perhaps', 'T', 'cell', 'responses', 'may', 'be', 'the', 'key', 'to', 'solving', 'those', 'questions', 'SARS', 'CoV', '2', 'specific', 'memory', 'T', 'cells', 'persist', 'in', 'peripheral', 'blood', 'and', 'may', 'be', 'capable', 'of', 'providing', 'effective', 'information', 'about', 'protective', 'immunity', 'The', 'T', 'cells', 'studies', 'can', 'be', 'helpful', 'in', 'elucidating', 'the', 'pathways', 'for', 'development', 'of', 'vaccines', 'therapies', 'and', 'diagnostics', 'for', 'COVID', '19', 'and', 'for', 'filling', 'these', 'immunology', 'knowledge', 'gaps', '']"
110168,Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG,2020,J Clin Virol,,"BACKGROUND: Facing the ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is an urgent need for serological assays identifying individuals with past coronavirus disease 2019 (COVID-19). STUDY DESIGN: Our study is the first to compare four new commercially available assays using 75 sera from patients tested positive or negative by SARS-CoV-2 PCR: the anti SARS-CoV-2 ELISA (IgG) (Euroimmun, Germany), the EDI New Coronavirus COVID-19 IgG ELISA, (Epitope diagnostics (EDI), USA), the recomWell SARS-CoV-2 IgG ELISA (Mikrogen, Germany), and the SARS-CoV-2 Virachip IgG (Viramed, Germany). RESULTS: We found a sensitivity of 86.4 %, 100 %, 86.4 %, and 77.3 % and a specificity of 96,2 %, 88,7 %, 100 %, and 100 % for the Euroimmun assay, the EDI assay, the Mikrogen assay, and the Viramed assay, respectively. CONCLUSIONS: Commercially available SARS-CoV-2 IgG assays have a sufficient specificity and sensitivity for identifying individuals with past SARS-CoV-2 infection.",,7e79o2gy,"['BACKGROUND', 'Facing', 'the', 'ongoing', 'pandemic', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'there', 'is', 'an', 'urgent', 'need', 'for', 'serological', 'assays', 'identifying', 'individuals', 'with', 'past', 'coronavirus', 'disease', '2019', 'COVID', '19', 'STUDY', 'DESIGN', 'Our', 'study', 'is', 'the', 'first', 'to', 'compare', 'four', 'new', 'commercially', 'available', 'assays', 'using', '75', 'sera', 'from', 'patients', 'tested', 'positive', 'or', 'negative', 'by', 'SARS', 'CoV', '2', 'PCR', 'the', 'anti', 'SARS', 'CoV', '2', 'ELISA', 'IgG', 'Euroimmun', 'Germany', 'the', 'EDI', 'New', 'Coronavirus', 'COVID', '19', 'IgG', 'ELISA', 'Epitope', 'diagnostics', 'EDI', 'USA', 'the', 'recomWell', 'SARS', 'CoV', '2', 'IgG', 'ELISA', 'Mikrogen', 'Germany', 'and', 'the', 'SARS', 'CoV', '2', 'Virachip', 'IgG', 'Viramed', 'Germany', 'RESULTS', 'We', 'found', 'a', 'sensitivity', 'of', '86', '4', '100', '86', '4', 'and', '77', '3', 'and', 'a', 'specificity', 'of', '96', '2', '88', '7', '100', 'and', '100', 'for', 'the', 'Euroimmun', 'assay', 'the', 'EDI', 'assay', 'the', 'Mikrogen', 'assay', 'and', 'the', 'Viramed', 'assay', 'respectively', 'CONCLUSIONS', 'Commercially', 'available', 'SARS', 'CoV', '2', 'IgG', 'assays', 'have', 'a', 'sufficient', 'specificity', 'and', 'sensitivity', 'for', 'identifying', 'individuals', 'with', 'past', 'SARS', 'CoV', '2', 'infection', '']"
110169,Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG,2020,J Clin Virol,,"BACKGROUND: Facing the ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is an urgent need for serological assays identifying individuals with past coronavirus disease 2019 (COVID-19). STUDY DESIGN: Our study is the first to compare four new commercially available assays using 75 sera from patients tested positive or negative by SARS-CoV-2 PCR: the anti SARS-CoV-2 ELISA (IgG) (Euroimmun, Germany), the EDI New Coronavirus COVID-19 IgG ELISA, (Epitope diagnostics (EDI), USA), the recomWell SARS-CoV-2 IgG ELISA (Mikrogen, Germany), and the SARS-CoV-2 Virachip IgG (Viramed, Germany). RESULTS: We found a sensitivity of 86.4 %, 100 %, 86.4 %, and 77.3 % and a specificity of 96,2 %, 88,7 %, 100 %, and 100 % for the Euroimmun assay, the EDI assay, the Mikrogen assay, and the Viramed assay, respectively. CONCLUSIONS: Commercially available SARS-CoV-2 IgG assays have a sufficient specificity and sensitivity for identifying individuals with past SARS-CoV-2 infection.",,856mfbkb,"['BACKGROUND', 'Facing', 'the', 'ongoing', 'pandemic', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'there', 'is', 'an', 'urgent', 'need', 'for', 'serological', 'assays', 'identifying', 'individuals', 'with', 'past', 'coronavirus', 'disease', '2019', 'COVID', '19', 'STUDY', 'DESIGN', 'Our', 'study', 'is', 'the', 'first', 'to', 'compare', 'four', 'new', 'commercially', 'available', 'assays', 'using', '75', 'sera', 'from', 'patients', 'tested', 'positive', 'or', 'negative', 'by', 'SARS', 'CoV', '2', 'PCR', 'the', 'anti', 'SARS', 'CoV', '2', 'ELISA', 'IgG', 'Euroimmun', 'Germany', 'the', 'EDI', 'New', 'Coronavirus', 'COVID', '19', 'IgG', 'ELISA', 'Epitope', 'diagnostics', 'EDI', 'USA', 'the', 'recomWell', 'SARS', 'CoV', '2', 'IgG', 'ELISA', 'Mikrogen', 'Germany', 'and', 'the', 'SARS', 'CoV', '2', 'Virachip', 'IgG', 'Viramed', 'Germany', 'RESULTS', 'We', 'found', 'a', 'sensitivity', 'of', '86', '4', '100', '86', '4', 'and', '77', '3', 'and', 'a', 'specificity', 'of', '96', '2', '88', '7', '100', 'and', '100', 'for', 'the', 'Euroimmun', 'assay', 'the', 'EDI', 'assay', 'the', 'Mikrogen', 'assay', 'and', 'the', 'Viramed', 'assay', 'respectively', 'CONCLUSIONS', 'Commercially', 'available', 'SARS', 'CoV', '2', 'IgG', 'assays', 'have', 'a', 'sufficient', 'specificity', 'and', 'sensitivity', 'for', 'identifying', 'individuals', 'with', 'past', 'SARS', 'CoV', '2', 'infection', '']"
111023,Technologies to Optimize the Care of Severe COVID-19 Patients for Health Care Providers Challenged by Limited Resources,2020,Anesth Analg,,"Health care systems are belligerently responding to the new coronavirus disease 2019 (COVID-19). The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a specific condition, whose distinctive features are severe hypoxemia associated with (>50% of cases) normal respiratory system compliance. When a patient requires intubation and invasive ventilation, the outcome is poor, and the length of stay in the intensive care unit (ICU) is usually 2 or 3 weeks. In this article, the authors review several technological devices, which could support health care providers at the bedside to optimize the care for COVID-19 patients who are sedated, paralyzed, and ventilated. Particular attention is provided to the use of videolaryngoscopes (VL) because these can assist anesthetists to perform a successful intubation outside the ICU while protecting health care providers from this viral infection. Authors will also review processed electroencephalographic (EEG) monitors which are used to better titrate sedation and the train-of-four monitors which are utilized to better administer neuromuscular blocking agents in the view of sparing limited pharmacological resources. COVID-19 can rapidly exhaust human and technological resources too within the ICU. This review features a series of technological advancements that can significantly improve the care of patients requiring isolation. The working conditions in isolation could cause gaps or barriers in communication, fatigue, and poor documentation of provided care. The available technology has several advantages including (a) facilitating appropriate paperless documentation and communication between all health care givers working in isolation rooms or large isolation areas; (b) testing patients and staff at the bedside using smart point-of-care diagnostics (SPOCD) to confirm COVID-19 infection; (c) allowing diagnostics and treatment at the bedside through point-of-care ultrasound (POCUS) and thromboelastography (TEG); (d) adapting the use of anesthetic machines and the use of volatile anesthetics. Implementing technologies for safeguarding health care providers as well as monitoring the limited pharmacological resources are paramount. Only by leveraging new technologies, it will be possible to sustain and support health care systems during the expected long course of this pandemic.",,9lromyuz,"['Health', 'care', 'systems', 'are', 'belligerently', 'responding', 'to', 'the', 'new', 'coronavirus', 'disease', '2019', 'COVID', '19', 'The', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'a', 'specific', 'condition', 'whose', 'distinctive', 'features', 'are', 'severe', 'hypoxemia', 'associated', 'with', '50', 'of', 'cases', 'normal', 'respiratory', 'system', 'compliance', 'When', 'a', 'patient', 'requires', 'intubation', 'and', 'invasive', 'ventilation', 'the', 'outcome', 'is', 'poor', 'and', 'the', 'length', 'of', 'stay', 'in', 'the', 'intensive', 'care', 'unit', 'ICU', 'is', 'usually', '2', 'or', '3', 'weeks', 'In', 'this', 'article', 'the', 'authors', 'review', 'several', 'technological', 'devices', 'which', 'could', 'support', 'health', 'care', 'providers', 'at', 'the', 'bedside', 'to', 'optimize', 'the', 'care', 'for', 'COVID', '19', 'patients', 'who', 'are', 'sedated', 'paralyzed', 'and', 'ventilated', 'Particular', 'attention', 'is', 'provided', 'to', 'the', 'use', 'of', 'videolaryngoscopes', 'VL', 'because', 'these', 'can', 'assist', 'anesthetists', 'to', 'perform', 'a', 'successful', 'intubation', 'outside', 'the', 'ICU', 'while', 'protecting', 'health', 'care', 'providers', 'from', 'this', 'viral', 'infection', 'Authors', 'will', 'also', 'review', 'processed', 'electroencephalographic', 'EEG', 'monitors', 'which', 'are', 'used', 'to', 'better', 'titrate', 'sedation', 'and', 'the', 'train', 'of', 'four', 'monitors', 'which', 'are', 'utilized', 'to', 'better', 'administer', 'neuromuscular', 'blocking', 'agents', 'in', 'the', 'view', 'of', 'sparing', 'limited', 'pharmacological', 'resources', 'COVID', '19', 'can', 'rapidly', 'exhaust', 'human', 'and', 'technological', 'resources', 'too', 'within', 'the', 'ICU', 'This', 'review', 'features', 'a', 'series', 'of', 'technological', 'advancements', 'that', 'can', 'significantly', 'improve', 'the', 'care', 'of', 'patients', 'requiring', 'isolation', 'The', 'working', 'conditions', 'in', 'isolation', 'could', 'cause', 'gaps', 'or', 'barriers', 'in', 'communication', 'fatigue', 'and', 'poor', 'documentation', 'of', 'provided', 'care', 'The', 'available', 'technology', 'has', 'several', 'advantages', 'including', 'a', 'facilitating', 'appropriate', 'paperless', 'documentation', 'and', 'communication', 'between', 'all', 'health', 'care', 'givers', 'working', 'in', 'isolation', 'rooms', 'or', 'large', 'isolation', 'areas', 'b', 'testing', 'patients', 'and', 'staff', 'at', 'the', 'bedside', 'using', 'smart', 'point', 'of', 'care', 'diagnostics', 'SPOCD', 'to', 'confirm', 'COVID', '19', 'infection', 'c', 'allowing', 'diagnostics', 'and', 'treatment', 'at', 'the', 'bedside', 'through', 'point', 'of', 'care', 'ultrasound', 'POCUS', 'and', 'thromboelastography', 'TEG', 'd', 'adapting', 'the', 'use', 'of', 'anesthetic', 'machines', 'and', 'the', 'use', 'of', 'volatile', 'anesthetics', 'Implementing', 'technologies', 'for', 'safeguarding', 'health', 'care', 'providers', 'as', 'well', 'as', 'monitoring', 'the', 'limited', 'pharmacological', 'resources', 'are', 'paramount', 'Only', 'by', 'leveraging', 'new', 'technologies', 'it', 'will', 'be', 'possible', 'to', 'sustain', 'and', 'support', 'health', 'care', 'systems', 'during', 'the', 'expected', 'long', 'course', 'of', 'this', 'pandemic', '']"
112514,Supporting pandemic response using genomics and bioinformatics: A case study on the emergent SARS-CoV-2 outbreak,2020,Transbound Emerg Dis,,"Pre-clinical responses to fast-moving infectious disease outbreaks heavily depend on choosing the best isolates for animal models that inform diagnostics, vaccines and treatments. Current approaches are driven by practical considerations (e.g. first available virus isolate) rather than a detailed analysis of the characteristics of the virus strain chosen, which can lead to animal models that are not representative of the circulating or emerging clusters. Here, we suggest a combination of epidemiological, experimental and bioinformatic considerations when choosing virus strains for animal model generation. We discuss the currently chosen SARS-CoV-2 strains for international coronavirus disease (COVID-19) models in the context of their phylogeny as well as in a novel alignment-free bioinformatic approach. Unlike phylogenetic trees, which focus on individual shared mutations, this new approach assesses genome-wide co-developing functionalities and hence offers a more fluid view of the 'cloud of variances' that RNA viruses are prone to accumulate. This joint approach concludes that while the current animal models cover the existing viral strains adequately, there is substantial evolutionary activity that is likely not considered by the current models. Based on insights from the non-discrete alignment-free approach and experimental observations, we suggest isolates for future animal models.",,md8en2qy,"['Pre', 'clinical', 'responses', 'to', 'fast', 'moving', 'infectious', 'disease', 'outbreaks', 'heavily', 'depend', 'on', 'choosing', 'the', 'best', 'isolates', 'for', 'animal', 'models', 'that', 'inform', 'diagnostics', 'vaccines', 'and', 'treatments', 'Current', 'approaches', 'are', 'driven', 'by', 'practical', 'considerations', 'e', 'g', 'first', 'available', 'virus', 'isolate', 'rather', 'than', 'a', 'detailed', 'analysis', 'of', 'the', 'characteristics', 'of', 'the', 'virus', 'strain', 'chosen', 'which', 'can', 'lead', 'to', 'animal', 'models', 'that', 'are', 'not', 'representative', 'of', 'the', 'circulating', 'or', 'emerging', 'clusters', 'Here', 'we', 'suggest', 'a', 'combination', 'of', 'epidemiological', 'experimental', 'and', 'bioinformatic', 'considerations', 'when', 'choosing', 'virus', 'strains', 'for', 'animal', 'model', 'generation', 'We', 'discuss', 'the', 'currently', 'chosen', 'SARS', 'CoV', '2', 'strains', 'for', 'international', 'coronavirus', 'disease', 'COVID', '19', 'models', 'in', 'the', 'context', 'of', 'their', 'phylogeny', 'as', 'well', 'as', 'in', 'a', 'novel', 'alignment', 'free', 'bioinformatic', 'approach', 'Unlike', 'phylogenetic', 'trees', 'which', 'focus', 'on', 'individual', 'shared', 'mutations', 'this', 'new', 'approach', 'assesses', 'genome', 'wide', 'co', 'developing', 'functionalities', 'and', 'hence', 'offers', 'a', 'more', 'fluid', 'view', 'of', 'the', 'cloud', 'of', 'variances', 'that', 'RNA', 'viruses', 'are', 'prone', 'to', 'accumulate', 'This', 'joint', 'approach', 'concludes', 'that', 'while', 'the', 'current', 'animal', 'models', 'cover', 'the', 'existing', 'viral', 'strains', 'adequately', 'there', 'is', 'substantial', 'evolutionary', 'activity', 'that', 'is', 'likely', 'not', 'considered', 'by', 'the', 'current', 'models', 'Based', 'on', 'insights', 'from', 'the', 'non', 'discrete', 'alignment', 'free', 'approach', 'and', 'experimental', 'observations', 'we', 'suggest', 'isolates', 'for', 'future', 'animal', 'models', '']"
112936,Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2,2020,Emerg Microbes Infect,,"The previous outbreaks of SARS-CoV and MERS-CoV have led researchers to study the role of diagnostics in impediment of further spread and transmission. With the recent emergence of the novel SARS-CoV-2, the availability of rapid, sensitive, and reliable diagnostic methods is essential for disease control. Hence, we have developed a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for the specific detection of SARS-CoV-2. The primer sets for RT-LAMP assay were designed to target the nucleocapsid gene of the viral RNA, and displayed a detection limit of 102 RNA copies close to that of qRT-PCR. Notably, the assay has exhibited a rapid detection span of 30â min combined with the colorimetric visualization. This test can detect specifically viral RNAs of the SARS-CoV-2 with no cross-reactivity to related coronaviruses, such as HCoV-229E, HCoV-NL63, HCoV-OC43, and MERS-CoV as well as human infectious influenza viruses (type B, H1N1pdm, H3N2, H5N1, H5N6, H5N8, and H7N9), and other respiratory disease-causing viruses (RSVA, RSVB, ADV, PIV, MPV, and HRV). Furthermore, the developed RT-LAMP assay has been evaluated using specimens collected from COVID-19 patients that exhibited high agreement to the qRT-PCR. Our RT-LAMP assay is simple to perform, less expensive, time-efficient, and can be used in clinical laboratories for preliminary detection of SARS-CoV-2 in suspected patients. In addition to the high sensitivity and specificity, this isothermal amplification conjugated with a single-tube colorimetric detection method may contribute to the public health responses and disease control, especially in the areas with limited laboratory capacities.",,77jpm4o0,"['The', 'previous', 'outbreaks', 'of', 'SARS', 'CoV', 'and', 'MERS', 'CoV', 'have', 'led', 'researchers', 'to', 'study', 'the', 'role', 'of', 'diagnostics', 'in', 'impediment', 'of', 'further', 'spread', 'and', 'transmission', 'With', 'the', 'recent', 'emergence', 'of', 'the', 'novel', 'SARS', 'CoV', '2', 'the', 'availability', 'of', 'rapid', 'sensitive', 'and', 'reliable', 'diagnostic', 'methods', 'is', 'essential', 'for', 'disease', 'control', 'Hence', 'we', 'have', 'developed', 'a', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'assay', 'for', 'the', 'specific', 'detection', 'of', 'SARS', 'CoV', '2', 'The', 'primer', 'sets', 'for', 'RT', 'LAMP', 'assay', 'were', 'designed', 'to', 'target', 'the', 'nucleocapsid', 'gene', 'of', 'the', 'viral', 'RNA', 'and', 'displayed', 'a', 'detection', 'limit', 'of', '102', 'RNA', 'copies', 'close', 'to', 'that', 'of', 'qRT', 'PCR', 'Notably', 'the', 'assay', 'has', 'exhibited', 'a', 'rapid', 'detection', 'span', 'of', '30â', 'min', 'combined', 'with', 'the', 'colorimetric', 'visualization', 'This', 'test', 'can', 'detect', 'specifically', 'viral', 'RNAs', 'of', 'the', 'SARS', 'CoV', '2', 'with', 'no', 'cross', 'reactivity', 'to', 'related', 'coronaviruses', 'such', 'as', 'HCoV', '229E', 'HCoV', 'NL63', 'HCoV', 'OC43', 'and', 'MERS', 'CoV', 'as', 'well', 'as', 'human', 'infectious', 'influenza', 'viruses', 'type', 'B', 'H1N1pdm', 'H3N2', 'H5N1', 'H5N6', 'H5N8', 'and', 'H7N9', 'and', 'other', 'respiratory', 'disease', 'causing', 'viruses', 'RSVA', 'RSVB', 'ADV', 'PIV', 'MPV', 'and', 'HRV', 'Furthermore', 'the', 'developed', 'RT', 'LAMP', 'assay', 'has', 'been', 'evaluated', 'using', 'specimens', 'collected', 'from', 'COVID', '19', 'patients', 'that', 'exhibited', 'high', 'agreement', 'to', 'the', 'qRT', 'PCR', 'Our', 'RT', 'LAMP', 'assay', 'is', 'simple', 'to', 'perform', 'less', 'expensive', 'time', 'efficient', 'and', 'can', 'be', 'used', 'in', 'clinical', 'laboratories', 'for', 'preliminary', 'detection', 'of', 'SARS', 'CoV', '2', 'in', 'suspected', 'patients', 'In', 'addition', 'to', 'the', 'high', 'sensitivity', 'and', 'specificity', 'this', 'isothermal', 'amplification', 'conjugated', 'with', 'a', 'single', 'tube', 'colorimetric', 'detection', 'method', 'may', 'contribute', 'to', 'the', 'public', 'health', 'responses', 'and', 'disease', 'control', 'especially', 'in', 'the', 'areas', 'with', 'limited', 'laboratory', 'capacities', '']"
113122,COVID-19 diagnostics in context,2020,Sci. transl. med,,"The coronavirus disease 2019 (COVID-19) pandemic has highlighted the need for different types of diagnostics, comparative validation of new tests, faster approval by federal agencies, and rapid production of test kits to meet global demands. In this Perspective, we discuss the utility and challenges of current diagnostics for COVID-19.",,rk8pract,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'has', 'highlighted', 'the', 'need', 'for', 'different', 'types', 'of', 'diagnostics', 'comparative', 'validation', 'of', 'new', 'tests', 'faster', 'approval', 'by', 'federal', 'agencies', 'and', 'rapid', 'production', 'of', 'test', 'kits', 'to', 'meet', 'global', 'demands', 'In', 'this', 'Perspective', 'we', 'discuss', 'the', 'utility', 'and', 'challenges', 'of', 'current', 'diagnostics', 'for', 'COVID', '19', '']"
113123,COVID-19 diagnostics in context,2020,Sci. transl. med,,"The coronavirus disease 2019 (COVID-19) pandemic has highlighted the need for different types of diagnostics, comparative validation of new tests, faster approval by federal agencies, and rapid production of test kits to meet global demands. In this Perspective, we discuss the utility and challenges of current diagnostics for COVID-19.",,qgeiani2,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'has', 'highlighted', 'the', 'need', 'for', 'different', 'types', 'of', 'diagnostics', 'comparative', 'validation', 'of', 'new', 'tests', 'faster', 'approval', 'by', 'federal', 'agencies', 'and', 'rapid', 'production', 'of', 'test', 'kits', 'to', 'meet', 'global', 'demands', 'In', 'this', 'Perspective', 'we', 'discuss', 'the', 'utility', 'and', 'challenges', 'of', 'current', 'diagnostics', 'for', 'COVID', '19', '']"
113701,Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation,2020,Science,,"The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo-electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.",,2b5hue2r,"['The', 'outbreak', 'of', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'represents', 'a', 'pandemic', 'threat', 'that', 'has', 'been', 'declared', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'The', 'CoV', 'spike', 'S', 'glycoprotein', 'is', 'a', 'key', 'target', 'for', 'vaccines', 'therapeutic', 'antibodies', 'and', 'diagnostics', 'To', 'facilitate', 'medical', 'countermeasure', 'development', 'we', 'determined', 'a', '3', '5', 'angstrom', 'resolution', 'cryo', 'electron', 'microscopy', 'structure', 'of', 'the', '2019', 'nCoV', 'S', 'trimer', 'in', 'the', 'prefusion', 'conformation', 'The', 'predominant', 'state', 'of', 'the', 'trimer', 'has', 'one', 'of', 'the', 'three', 'receptor', 'binding', 'domains', 'RBDs', 'rotated', 'up', 'in', 'a', 'receptor', 'accessible', 'conformation', 'We', 'also', 'provide', 'biophysical', 'and', 'structural', 'evidence', 'that', 'the', '2019', 'nCoV', 'S', 'protein', 'binds', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'with', 'higher', 'affinity', 'than', 'does', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'S', 'Additionally', 'we', 'tested', 'several', 'published', 'SARS', 'CoV', 'RBD', 'specific', 'monoclonal', 'antibodies', 'and', 'found', 'that', 'they', 'do', 'not', 'have', 'appreciable', 'binding', 'to', '2019', 'nCoV', 'S', 'suggesting', 'that', 'antibody', 'cross', 'reactivity', 'may', 'be', 'limited', 'between', 'the', 'two', 'RBDs', 'The', 'structure', 'of', '2019', 'nCoV', 'S', 'should', 'enable', 'the', 'rapid', 'development', 'and', 'evaluation', 'of', 'medical', 'countermeasures', 'to', 'address', 'the', 'ongoing', 'public', 'health', 'crisis', '']"
113702,Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation,2020,Science,,"The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo-electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.",,sb297tzj,"['The', 'outbreak', 'of', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'represents', 'a', 'pandemic', 'threat', 'that', 'has', 'been', 'declared', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'The', 'CoV', 'spike', 'S', 'glycoprotein', 'is', 'a', 'key', 'target', 'for', 'vaccines', 'therapeutic', 'antibodies', 'and', 'diagnostics', 'To', 'facilitate', 'medical', 'countermeasure', 'development', 'we', 'determined', 'a', '3', '5', 'angstrom', 'resolution', 'cryo', 'electron', 'microscopy', 'structure', 'of', 'the', '2019', 'nCoV', 'S', 'trimer', 'in', 'the', 'prefusion', 'conformation', 'The', 'predominant', 'state', 'of', 'the', 'trimer', 'has', 'one', 'of', 'the', 'three', 'receptor', 'binding', 'domains', 'RBDs', 'rotated', 'up', 'in', 'a', 'receptor', 'accessible', 'conformation', 'We', 'also', 'provide', 'biophysical', 'and', 'structural', 'evidence', 'that', 'the', '2019', 'nCoV', 'S', 'protein', 'binds', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'with', 'higher', 'affinity', 'than', 'does', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'S', 'Additionally', 'we', 'tested', 'several', 'published', 'SARS', 'CoV', 'RBD', 'specific', 'monoclonal', 'antibodies', 'and', 'found', 'that', 'they', 'do', 'not', 'have', 'appreciable', 'binding', 'to', '2019', 'nCoV', 'S', 'suggesting', 'that', 'antibody', 'cross', 'reactivity', 'may', 'be', 'limited', 'between', 'the', 'two', 'RBDs', 'The', 'structure', 'of', '2019', 'nCoV', 'S', 'should', 'enable', 'the', 'rapid', 'development', 'and', 'evaluation', 'of', 'medical', 'countermeasures', 'to', 'address', 'the', 'ongoing', 'public', 'health', 'crisis', '']"
113877,Cytology in the time of coronavirus disease (covid-19): an Italian perspective,2020,J. clin. pathol,,"INTRODUCTION: The coronavirus disease 2019 (covid-19) is changing the way we practice pathology, including fine needle aspiration (FNA) diagnostics. Although recommendations have been issued to prioritise patients at high oncological risk, postponing those with unsuspicious presentations, real world data have not been reported yet. METHODS: The percentages of the cytological sample types processed at the University of Naples Federico II, during the first 3 weeks of Italian national lockdown were compared with those of the same period in 2019. RESULTS: During the emergency, the percentage of cytology samples reported as malignant increased (p<0.001), reflecting higher percentages of breast (p=0.002) and lymph nodes FNAs (p=0.008), effusions (p<0.001) and urine (p=0.005). Conversely, thyroid FNAs (p<0.001) and Pap smears (p=0.003) were reduced. CONCLUSIONS: Even in times of covid-19 outbreak, cytological examination may be safely carried out in patients at high oncological risk, without the need to be postponed.",,g78fh7vk,"['INTRODUCTION', 'The', 'coronavirus', 'disease', '2019', 'covid', '19', 'is', 'changing', 'the', 'way', 'we', 'practice', 'pathology', 'including', 'fine', 'needle', 'aspiration', 'FNA', 'diagnostics', 'Although', 'recommendations', 'have', 'been', 'issued', 'to', 'prioritise', 'patients', 'at', 'high', 'oncological', 'risk', 'postponing', 'those', 'with', 'unsuspicious', 'presentations', 'real', 'world', 'data', 'have', 'not', 'been', 'reported', 'yet', 'METHODS', 'The', 'percentages', 'of', 'the', 'cytological', 'sample', 'types', 'processed', 'at', 'the', 'University', 'of', 'Naples', 'Federico', 'II', 'during', 'the', 'first', '3', 'weeks', 'of', 'Italian', 'national', 'lockdown', 'were', 'compared', 'with', 'those', 'of', 'the', 'same', 'period', 'in', '2019', 'RESULTS', 'During', 'the', 'emergency', 'the', 'percentage', 'of', 'cytology', 'samples', 'reported', 'as', 'malignant', 'increased', 'p', '0', '001', 'reflecting', 'higher', 'percentages', 'of', 'breast', 'p', '0', '002', 'and', 'lymph', 'nodes', 'FNAs', 'p', '0', '008', 'effusions', 'p', '0', '001', 'and', 'urine', 'p', '0', '005', 'Conversely', 'thyroid', 'FNAs', 'p', '0', '001', 'and', 'Pap', 'smears', 'p', '0', '003', 'were', 'reduced', 'CONCLUSIONS', 'Even', 'in', 'times', 'of', 'covid', '19', 'outbreak', 'cytological', 'examination', 'may', 'be', 'safely', 'carried', 'out', 'in', 'patients', 'at', 'high', 'oncological', 'risk', 'without', 'the', 'need', 'to', 'be', 'postponed', '']"
114783,Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic,2020,Ann. oncol,,"BACKGROUND: Cancer diagnostics and surgery have been disrupted by the response of health care services to the coronavirus disease 2019 (COVID-19) pandemic. Progression of cancers during delay will impact on patients' long-term survival. PATIENTS AND METHODS: We generated per-day hazard ratios of cancer progression from observational studies and applied these to age-specific, stage-specific cancer survival for England 2013-2017. We modelled per-patient delay of 3 and 6 months and periods of disruption of 1 and 2 years. Using health care resource costing, we contextualise attributable lives saved and life-years gained (LYGs) from cancer surgery to equivalent volumes of COVID-19 hospitalisations. RESULTS: Per year, 94 912 resections for major cancers result in 80 406 long-term survivors and 1 717 051 LYGs. Per-patient delay of 3/6 months would cause attributable death of 4755/10 760 of these individuals with loss of 92 214/208 275 life-years, respectively. For cancer surgery, average LYGs per patient are 18.1 under standard conditions and 17.1/15.9 with a delay of 3/6 months (an average loss of 0.97/2.19 LYGs per patient), respectively. Taking into account health care resource units (HCRUs), surgery results on average per patient in 2.25 resource-adjusted life-years gained (RALYGs) under standard conditions and 2.12/1.97 RALYGs following delay of 3/6 months. For 94 912 hospital COVID-19 admissions, there are 482 022 LYGs requiring 1 052 949 HCRUs. Hospitalisation of community-acquired COVID-19 patients yields on average per patient 5.08 LYG and 0.46 RALYGs. CONCLUSIONS: Modest delays in surgery for cancer incur significant impact on survival. Delay of 3/6 months in surgery for incident cancers would mitigate 19%/43% of LYGs, respectively, by hospitalisation of an equivalent volume of admissions for community-acquired COVID-19. This rises to 26%/59%, respectively, when considering RALYGs. To avoid a downstream public health crisis of avoidable cancer deaths, cancer diagnostic and surgical pathways must be maintained at normal throughput, with rapid attention to any backlog already accrued.",,x2tjm7y8,"['BACKGROUND', 'Cancer', 'diagnostics', 'and', 'surgery', 'have', 'been', 'disrupted', 'by', 'the', 'response', 'of', 'health', 'care', 'services', 'to', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'Progression', 'of', 'cancers', 'during', 'delay', 'will', 'impact', 'on', 'patients', 'long', 'term', 'survival', 'PATIENTS', 'AND', 'METHODS', 'We', 'generated', 'per', 'day', 'hazard', 'ratios', 'of', 'cancer', 'progression', 'from', 'observational', 'studies', 'and', 'applied', 'these', 'to', 'age', 'specific', 'stage', 'specific', 'cancer', 'survival', 'for', 'England', '2013', '2017', 'We', 'modelled', 'per', 'patient', 'delay', 'of', '3', 'and', '6', 'months', 'and', 'periods', 'of', 'disruption', 'of', '1', 'and', '2', 'years', 'Using', 'health', 'care', 'resource', 'costing', 'we', 'contextualise', 'attributable', 'lives', 'saved', 'and', 'life', 'years', 'gained', 'LYGs', 'from', 'cancer', 'surgery', 'to', 'equivalent', 'volumes', 'of', 'COVID', '19', 'hospitalisations', 'RESULTS', 'Per', 'year', '94', '912', 'resections', 'for', 'major', 'cancers', 'result', 'in', '80', '406', 'long', 'term', 'survivors', 'and', '1', '717', '051', 'LYGs', 'Per', 'patient', 'delay', 'of', '3', '6', 'months', 'would', 'cause', 'attributable', 'death', 'of', '4755', '10', '760', 'of', 'these', 'individuals', 'with', 'loss', 'of', '92', '214', '208', '275', 'life', 'years', 'respectively', 'For', 'cancer', 'surgery', 'average', 'LYGs', 'per', 'patient', 'are', '18', '1', 'under', 'standard', 'conditions', 'and', '17', '1', '15', '9', 'with', 'a', 'delay', 'of', '3', '6', 'months', 'an', 'average', 'loss', 'of', '0', '97', '2', '19', 'LYGs', 'per', 'patient', 'respectively', 'Taking', 'into', 'account', 'health', 'care', 'resource', 'units', 'HCRUs', 'surgery', 'results', 'on', 'average', 'per', 'patient', 'in', '2', '25', 'resource', 'adjusted', 'life', 'years', 'gained', 'RALYGs', 'under', 'standard', 'conditions', 'and', '2', '12', '1', '97', 'RALYGs', 'following', 'delay', 'of', '3', '6', 'months', 'For', '94', '912', 'hospital', 'COVID', '19', 'admissions', 'there', 'are', '482', '022', 'LYGs', 'requiring', '1', '052', '949', 'HCRUs', 'Hospitalisation', 'of', 'community', 'acquired', 'COVID', '19', 'patients', 'yields', 'on', 'average', 'per', 'patient', '5', '08', 'LYG', 'and', '0', '46', 'RALYGs', 'CONCLUSIONS', 'Modest', 'delays', 'in', 'surgery', 'for', 'cancer', 'incur', 'significant', 'impact', 'on', 'survival', 'Delay', 'of', '3', '6', 'months', 'in', 'surgery', 'for', 'incident', 'cancers', 'would', 'mitigate', '19', '43', 'of', 'LYGs', 'respectively', 'by', 'hospitalisation', 'of', 'an', 'equivalent', 'volume', 'of', 'admissions', 'for', 'community', 'acquired', 'COVID', '19', 'This', 'rises', 'to', '26', '59', 'respectively', 'when', 'considering', 'RALYGs', 'To', 'avoid', 'a', 'downstream', 'public', 'health', 'crisis', 'of', 'avoidable', 'cancer', 'deaths', 'cancer', 'diagnostic', 'and', 'surgical', 'pathways', 'must', 'be', 'maintained', 'at', 'normal', 'throughput', 'with', 'rapid', 'attention', 'to', 'any', 'backlog', 'already', 'accrued', '']"
115157,Assessment of the Angolan (CHERRT) Mobile Laboratory Curriculum for Disaster and Pandemic Response,2020,West J Emerg Med,,"INTRODUCTION: As of April 5, 2020, the World Health Organization reported over one million confirmed cases and more than 62,000 confirmed coronavirus (COVID-19) deaths affecting 204 countries/regions. The lack of COVID-19 testing capacity threatens the ability of both the United States (US) and low middle income countries (LMIC) to respond to this growing threat, The purpose of this study was to assess the effectiveness through participant self-assessment of a rapid response team (RRT) mobile laboratory curriculum METHODS: We conducted a pre and post survey for the purpose of a process improvement assessment in Angola, involving 32 individuals. The survey was performed before and after a 14-day training workshop held in Luanda, Angola, in December 2019. A paired t-test was used to identify any significant change on six 7-point Likert scale questions with &#945;< 0.05 (95% confidence interval). RESULTS: All six of the questions - 1) ""I feel confident managing a real laboratory sample test for Ebola or other highly contagious sample;"" 2) ""I feel safe working in the lab environment during a real scenario;"" 3) ""I feel as if I can appropriately manage a potentially highly contagious laboratory sample;"" 4)""I feel that I can interpret a positive or negative sample during a suspected contagious outbreak;"" 5) ""I understand basic Biobubble/mobile laboratory concepts and procedures;"" and 6) ""I understand polymerase chain reaction (PCR) principles"" - showed statistical significant change pre and post training. Additionally, the final two questions - ""I can more effectively perform my role/position because of the training I received during this course;"" and ""This training was valuable"" - received high scores on the Likert scale. CONCLUSION: This Angolan RRT mobile laboratory training curriculum provides the nation of Angola with the confidence to rapidly respond and test at the national level a highly infectious contagion in the region and perform on-scene diagnostics. This mobile RRT laboratory provides a mobile and rapid diagnostic resource when epidemic/pandemic resource allocation may need to be prioritized based on confirmed disease prevalence.",,63cznc3h,"['INTRODUCTION', 'As', 'of', 'April', '5', '2020', 'the', 'World', 'Health', 'Organization', 'reported', 'over', 'one', 'million', 'confirmed', 'cases', 'and', 'more', 'than', '62', '000', 'confirmed', 'coronavirus', 'COVID', '19', 'deaths', 'affecting', '204', 'countries', 'regions', 'The', 'lack', 'of', 'COVID', '19', 'testing', 'capacity', 'threatens', 'the', 'ability', 'of', 'both', 'the', 'United', 'States', 'US', 'and', 'low', 'middle', 'income', 'countries', 'LMIC', 'to', 'respond', 'to', 'this', 'growing', 'threat', 'The', 'purpose', 'of', 'this', 'study', 'was', 'to', 'assess', 'the', 'effectiveness', 'through', 'participant', 'self', 'assessment', 'of', 'a', 'rapid', 'response', 'team', 'RRT', 'mobile', 'laboratory', 'curriculum', 'METHODS', 'We', 'conducted', 'a', 'pre', 'and', 'post', 'survey', 'for', 'the', 'purpose', 'of', 'a', 'process', 'improvement', 'assessment', 'in', 'Angola', 'involving', '32', 'individuals', 'The', 'survey', 'was', 'performed', 'before', 'and', 'after', 'a', '14', 'day', 'training', 'workshop', 'held', 'in', 'Luanda', 'Angola', 'in', 'December', '2019', 'A', 'paired', 't', 'test', 'was', 'used', 'to', 'identify', 'any', 'significant', 'change', 'on', 'six', '7', 'point', 'Likert', 'scale', 'questions', 'with', '945', '0', '05', '95', 'confidence', 'interval', 'RESULTS', 'All', 'six', 'of', 'the', 'questions', '1', 'I', 'feel', 'confident', 'managing', 'a', 'real', 'laboratory', 'sample', 'test', 'for', 'Ebola', 'or', 'other', 'highly', 'contagious', 'sample', '2', 'I', 'feel', 'safe', 'working', 'in', 'the', 'lab', 'environment', 'during', 'a', 'real', 'scenario', '3', 'I', 'feel', 'as', 'if', 'I', 'can', 'appropriately', 'manage', 'a', 'potentially', 'highly', 'contagious', 'laboratory', 'sample', '4', 'I', 'feel', 'that', 'I', 'can', 'interpret', 'a', 'positive', 'or', 'negative', 'sample', 'during', 'a', 'suspected', 'contagious', 'outbreak', '5', 'I', 'understand', 'basic', 'Biobubble', 'mobile', 'laboratory', 'concepts', 'and', 'procedures', 'and', '6', 'I', 'understand', 'polymerase', 'chain', 'reaction', 'PCR', 'principles', 'showed', 'statistical', 'significant', 'change', 'pre', 'and', 'post', 'training', 'Additionally', 'the', 'final', 'two', 'questions', 'I', 'can', 'more', 'effectively', 'perform', 'my', 'role', 'position', 'because', 'of', 'the', 'training', 'I', 'received', 'during', 'this', 'course', 'and', 'This', 'training', 'was', 'valuable', 'received', 'high', 'scores', 'on', 'the', 'Likert', 'scale', 'CONCLUSION', 'This', 'Angolan', 'RRT', 'mobile', 'laboratory', 'training', 'curriculum', 'provides', 'the', 'nation', 'of', 'Angola', 'with', 'the', 'confidence', 'to', 'rapidly', 'respond', 'and', 'test', 'at', 'the', 'national', 'level', 'a', 'highly', 'infectious', 'contagion', 'in', 'the', 'region', 'and', 'perform', 'on', 'scene', 'diagnostics', 'This', 'mobile', 'RRT', 'laboratory', 'provides', 'a', 'mobile', 'and', 'rapid', 'diagnostic', 'resource', 'when', 'epidemic', 'pandemic', 'resource', 'allocation', 'may', 'need', 'to', 'be', 'prioritized', 'based', 'on', 'confirmed', 'disease', 'prevalence', '']"
115158,Assessment of the Angolan (CHERRT) Mobile Laboratory Curriculum for Disaster and Pandemic Response,2020,West J Emerg Med,,"INTRODUCTION: As of April 5, 2020, the World Health Organization reported over one million confirmed cases and more than 62,000 confirmed coronavirus (COVID-19) deaths affecting 204 countries/regions. The lack of COVID-19 testing capacity threatens the ability of both the United States (US) and low middle income countries (LMIC) to respond to this growing threat, The purpose of this study was to assess the effectiveness through participant self-assessment of a rapid response team (RRT) mobile laboratory curriculum METHODS: We conducted a pre and post survey for the purpose of a process improvement assessment in Angola, involving 32 individuals. The survey was performed before and after a 14-day training workshop held in Luanda, Angola, in December 2019. A paired t-test was used to identify any significant change on six 7-point Likert scale questions with &#945;< 0.05 (95% confidence interval). RESULTS: All six of the questions - 1) ""I feel confident managing a real laboratory sample test for Ebola or other highly contagious sample;"" 2) ""I feel safe working in the lab environment during a real scenario;"" 3) ""I feel as if I can appropriately manage a potentially highly contagious laboratory sample;"" 4)""I feel that I can interpret a positive or negative sample during a suspected contagious outbreak;"" 5) ""I understand basic Biobubble/mobile laboratory concepts and procedures;"" and 6) ""I understand polymerase chain reaction (PCR) principles"" - showed statistical significant change pre and post training. Additionally, the final two questions - ""I can more effectively perform my role/position because of the training I received during this course;"" and ""This training was valuable"" - received high scores on the Likert scale. CONCLUSION: This Angolan RRT mobile laboratory training curriculum provides the nation of Angola with the confidence to rapidly respond and test at the national level a highly infectious contagion in the region and perform on-scene diagnostics. This mobile RRT laboratory provides a mobile and rapid diagnostic resource when epidemic/pandemic resource allocation may need to be prioritized based on confirmed disease prevalence.",,c8gvrfd7,"['INTRODUCTION', 'As', 'of', 'April', '5', '2020', 'the', 'World', 'Health', 'Organization', 'reported', 'over', 'one', 'million', 'confirmed', 'cases', 'and', 'more', 'than', '62', '000', 'confirmed', 'coronavirus', 'COVID', '19', 'deaths', 'affecting', '204', 'countries', 'regions', 'The', 'lack', 'of', 'COVID', '19', 'testing', 'capacity', 'threatens', 'the', 'ability', 'of', 'both', 'the', 'United', 'States', 'US', 'and', 'low', 'middle', 'income', 'countries', 'LMIC', 'to', 'respond', 'to', 'this', 'growing', 'threat', 'The', 'purpose', 'of', 'this', 'study', 'was', 'to', 'assess', 'the', 'effectiveness', 'through', 'participant', 'self', 'assessment', 'of', 'a', 'rapid', 'response', 'team', 'RRT', 'mobile', 'laboratory', 'curriculum', 'METHODS', 'We', 'conducted', 'a', 'pre', 'and', 'post', 'survey', 'for', 'the', 'purpose', 'of', 'a', 'process', 'improvement', 'assessment', 'in', 'Angola', 'involving', '32', 'individuals', 'The', 'survey', 'was', 'performed', 'before', 'and', 'after', 'a', '14', 'day', 'training', 'workshop', 'held', 'in', 'Luanda', 'Angola', 'in', 'December', '2019', 'A', 'paired', 't', 'test', 'was', 'used', 'to', 'identify', 'any', 'significant', 'change', 'on', 'six', '7', 'point', 'Likert', 'scale', 'questions', 'with', '945', '0', '05', '95', 'confidence', 'interval', 'RESULTS', 'All', 'six', 'of', 'the', 'questions', '1', 'I', 'feel', 'confident', 'managing', 'a', 'real', 'laboratory', 'sample', 'test', 'for', 'Ebola', 'or', 'other', 'highly', 'contagious', 'sample', '2', 'I', 'feel', 'safe', 'working', 'in', 'the', 'lab', 'environment', 'during', 'a', 'real', 'scenario', '3', 'I', 'feel', 'as', 'if', 'I', 'can', 'appropriately', 'manage', 'a', 'potentially', 'highly', 'contagious', 'laboratory', 'sample', '4', 'I', 'feel', 'that', 'I', 'can', 'interpret', 'a', 'positive', 'or', 'negative', 'sample', 'during', 'a', 'suspected', 'contagious', 'outbreak', '5', 'I', 'understand', 'basic', 'Biobubble', 'mobile', 'laboratory', 'concepts', 'and', 'procedures', 'and', '6', 'I', 'understand', 'polymerase', 'chain', 'reaction', 'PCR', 'principles', 'showed', 'statistical', 'significant', 'change', 'pre', 'and', 'post', 'training', 'Additionally', 'the', 'final', 'two', 'questions', 'I', 'can', 'more', 'effectively', 'perform', 'my', 'role', 'position', 'because', 'of', 'the', 'training', 'I', 'received', 'during', 'this', 'course', 'and', 'This', 'training', 'was', 'valuable', 'received', 'high', 'scores', 'on', 'the', 'Likert', 'scale', 'CONCLUSION', 'This', 'Angolan', 'RRT', 'mobile', 'laboratory', 'training', 'curriculum', 'provides', 'the', 'nation', 'of', 'Angola', 'with', 'the', 'confidence', 'to', 'rapidly', 'respond', 'and', 'test', 'at', 'the', 'national', 'level', 'a', 'highly', 'infectious', 'contagion', 'in', 'the', 'region', 'and', 'perform', 'on', 'scene', 'diagnostics', 'This', 'mobile', 'RRT', 'laboratory', 'provides', 'a', 'mobile', 'and', 'rapid', 'diagnostic', 'resource', 'when', 'epidemic', 'pandemic', 'resource', 'allocation', 'may', 'need', 'to', 'be', 'prioritized', 'based', 'on', 'confirmed', 'disease', 'prevalence', '']"
115219,"A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilized in a commercial dual-target diagnostic assay",2020,J. clin. microbiol,,"Control of the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic requires accurate laboratory testing to identify infected individuals, while also clearing essential staff to continue work. At the current time a number of qRT-PCR assays have been developed to identify SARS-CoV-2, targeting multiple positions in the viral genome. While the mutation rate of SARS-CoV-2 is moderate, given the large number of transmission chains it is prudent to monitor circulating viruses for variants that might compromise these assays. Here we report the identification of a C-to-U transition at position 26,340 of the SARS-CoV-2 genome which is associated with failure of the cobas® SARS-CoV-2 E-gene qRT-PCR in eight patients. As the cobas® SARS-CoV-2 assay targets two positions in the genome, the individuals carrying this variant were still called as SARS-CoV-2 positive. Whole genome sequencing of SARS-CoV-2 showed all to carry closely related viruses. Examination of viral genomes deposited on GISAID showed this mutation has arisen independently at least four times. This work highlights the necessity of monitoring SARS-CoV-2 for the emergence of SNPs which might adversely affect RT-PCRs used in diagnostics. Additionally, it argues that two regions in SARS-CoV-2 should be targeted to avoid false negatives.",,uwrps3x3,"['Control', 'of', 'the', 'ongoing', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'pandemic', 'requires', 'accurate', 'laboratory', 'testing', 'to', 'identify', 'infected', 'individuals', 'while', 'also', 'clearing', 'essential', 'staff', 'to', 'continue', 'work', 'At', 'the', 'current', 'time', 'a', 'number', 'of', 'qRT', 'PCR', 'assays', 'have', 'been', 'developed', 'to', 'identify', 'SARS', 'CoV', '2', 'targeting', 'multiple', 'positions', 'in', 'the', 'viral', 'genome', 'While', 'the', 'mutation', 'rate', 'of', 'SARS', 'CoV', '2', 'is', 'moderate', 'given', 'the', 'large', 'number', 'of', 'transmission', 'chains', 'it', 'is', 'prudent', 'to', 'monitor', 'circulating', 'viruses', 'for', 'variants', 'that', 'might', 'compromise', 'these', 'assays', 'Here', 'we', 'report', 'the', 'identification', 'of', 'a', 'C', 'to', 'U', 'transition', 'at', 'position', '26', '340', 'of', 'the', 'SARS', 'CoV', '2', 'genome', 'which', 'is', 'associated', 'with', 'failure', 'of', 'the', 'cobas', 'SARS', 'CoV', '2', 'E', 'gene', 'qRT', 'PCR', 'in', 'eight', 'patients', 'As', 'the', 'cobas', 'SARS', 'CoV', '2', 'assay', 'targets', 'two', 'positions', 'in', 'the', 'genome', 'the', 'individuals', 'carrying', 'this', 'variant', 'were', 'still', 'called', 'as', 'SARS', 'CoV', '2', 'positive', 'Whole', 'genome', 'sequencing', 'of', 'SARS', 'CoV', '2', 'showed', 'all', 'to', 'carry', 'closely', 'related', 'viruses', 'Examination', 'of', 'viral', 'genomes', 'deposited', 'on', 'GISAID', 'showed', 'this', 'mutation', 'has', 'arisen', 'independently', 'at', 'least', 'four', 'times', 'This', 'work', 'highlights', 'the', 'necessity', 'of', 'monitoring', 'SARS', 'CoV', '2', 'for', 'the', 'emergence', 'of', 'SNPs', 'which', 'might', 'adversely', 'affect', 'RT', 'PCRs', 'used', 'in', 'diagnostics', 'Additionally', 'it', 'argues', 'that', 'two', 'regions', 'in', 'SARS', 'CoV', '2', 'should', 'be', 'targeted', 'to', 'avoid', 'false', 'negatives', '']"
115750,The Effects of the COVID-19/SARS-CoV-2 Pandemic Outbreak on Otolaryngology Activity in Italy,2020,Ear Nose Throat J,,"The coronavirus disease 2019 (COVID-19) pandemic during the first months of 2020 is causing profound changes in worldwide health care systems, resulting in a major reduction of surgical interventions and routine non-urgent outpatient diagnostic procedures. The lockdown due to the COVID-19 pandemic in Italy, one of the most affected countries in Europe, is having severe effects on the otolaryngology medical and surgical activities. The main changes are represented by the postponement of outpatient visits and scheduled surgery, while the only guaranteed service is reserved to diagnostics and surgery for oncology and urgent patients. In these cases, given the sites of action typical of the otolaryngology practice, physicians and nurses are exposed to a high risk of contagion through virus aerosol transmission. Furthermore, as the current measures of lockdown continue, it will be difficult to perform scheduled and new diagnostic assessments, medical treatments and surgical procedures in a timely manner favoring the risk of diagnostic and therapeutic delays with severe impact on patients' health.",,1jnxxkxk,"['The', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'during', 'the', 'first', 'months', 'of', '2020', 'is', 'causing', 'profound', 'changes', 'in', 'worldwide', 'health', 'care', 'systems', 'resulting', 'in', 'a', 'major', 'reduction', 'of', 'surgical', 'interventions', 'and', 'routine', 'non', 'urgent', 'outpatient', 'diagnostic', 'procedures', 'The', 'lockdown', 'due', 'to', 'the', 'COVID', '19', 'pandemic', 'in', 'Italy', 'one', 'of', 'the', 'most', 'affected', 'countries', 'in', 'Europe', 'is', 'having', 'severe', 'effects', 'on', 'the', 'otolaryngology', 'medical', 'and', 'surgical', 'activities', 'The', 'main', 'changes', 'are', 'represented', 'by', 'the', 'postponement', 'of', 'outpatient', 'visits', 'and', 'scheduled', 'surgery', 'while', 'the', 'only', 'guaranteed', 'service', 'is', 'reserved', 'to', 'diagnostics', 'and', 'surgery', 'for', 'oncology', 'and', 'urgent', 'patients', 'In', 'these', 'cases', 'given', 'the', 'sites', 'of', 'action', 'typical', 'of', 'the', 'otolaryngology', 'practice', 'physicians', 'and', 'nurses', 'are', 'exposed', 'to', 'a', 'high', 'risk', 'of', 'contagion', 'through', 'virus', 'aerosol', 'transmission', 'Furthermore', 'as', 'the', 'current', 'measures', 'of', 'lockdown', 'continue', 'it', 'will', 'be', 'difficult', 'to', 'perform', 'scheduled', 'and', 'new', 'diagnostic', 'assessments', 'medical', 'treatments', 'and', 'surgical', 'procedures', 'in', 'a', 'timely', 'manner', 'favoring', 'the', 'risk', 'of', 'diagnostic', 'and', 'therapeutic', 'delays', 'with', 'severe', 'impact', 'on', 'patients', 'health', '']"
116783,Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management,2020,IEEE reviews in biomedical engineering (Online),,"Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To counter COVID-19 spreading, an infrastructure to provide rapid and thorough molecular diagnostics and serology testing is the cornerstone of outbreak and pandemic management. We hereby review the clinical insights with regard to using molecular tests and immunoassays in the context of COVID-19 management life cycle: the preventive phase, the preparedness phase, the response phase and the recovery phase. The spatial and temporal distribution of viral RNA, antigens and antibodies during human infection is summarized to provide a biological foundation for accurate detection of the disease. We shared the lessons learned and the obstacles encountered during real world high-volume screening programs. Clinical needs are discussed to identify existing technology gaps in these tests. Leverage technologies, such as engineered polymerases, isothermal amplification, and direct amplification from complex matrices may improve the productivity of current infrastructure, while emerging technologies like CRISPR diagnostics, visual end point detection, and PCR free methods for nucleic acid sensing may lead to at-home tests. The lessons learned, and innovations spurred from the COVID-19 pandemic could upgrade our global public health infrastructure to better combat potential outbreaks in the future.",,kawhus2f,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'an', 'infectious', 'disease', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'To', 'counter', 'COVID', '19', 'spreading', 'an', 'infrastructure', 'to', 'provide', 'rapid', 'and', 'thorough', 'molecular', 'diagnostics', 'and', 'serology', 'testing', 'is', 'the', 'cornerstone', 'of', 'outbreak', 'and', 'pandemic', 'management', 'We', 'hereby', 'review', 'the', 'clinical', 'insights', 'with', 'regard', 'to', 'using', 'molecular', 'tests', 'and', 'immunoassays', 'in', 'the', 'context', 'of', 'COVID', '19', 'management', 'life', 'cycle', 'the', 'preventive', 'phase', 'the', 'preparedness', 'phase', 'the', 'response', 'phase', 'and', 'the', 'recovery', 'phase', 'The', 'spatial', 'and', 'temporal', 'distribution', 'of', 'viral', 'RNA', 'antigens', 'and', 'antibodies', 'during', 'human', 'infection', 'is', 'summarized', 'to', 'provide', 'a', 'biological', 'foundation', 'for', 'accurate', 'detection', 'of', 'the', 'disease', 'We', 'shared', 'the', 'lessons', 'learned', 'and', 'the', 'obstacles', 'encountered', 'during', 'real', 'world', 'high', 'volume', 'screening', 'programs', 'Clinical', 'needs', 'are', 'discussed', 'to', 'identify', 'existing', 'technology', 'gaps', 'in', 'these', 'tests', 'Leverage', 'technologies', 'such', 'as', 'engineered', 'polymerases', 'isothermal', 'amplification', 'and', 'direct', 'amplification', 'from', 'complex', 'matrices', 'may', 'improve', 'the', 'productivity', 'of', 'current', 'infrastructure', 'while', 'emerging', 'technologies', 'like', 'CRISPR', 'diagnostics', 'visual', 'end', 'point', 'detection', 'and', 'PCR', 'free', 'methods', 'for', 'nucleic', 'acid', 'sensing', 'may', 'lead', 'to', 'at', 'home', 'tests', 'The', 'lessons', 'learned', 'and', 'innovations', 'spurred', 'from', 'the', 'COVID', '19', 'pandemic', 'could', 'upgrade', 'our', 'global', 'public', 'health', 'infrastructure', 'to', 'better', 'combat', 'potential', 'outbreaks', 'in', 'the', 'future', '']"
116784,Navigating the Pandemic Response Life Cycle: Molecular Diagnostics and Immunoassays in the Context of COVID-19 Management,2020,,,"Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To counter COVID-19 spreading, an infrastructure to provide rapid and thorough molecular diagnostics and serology testing is the cornerstone of outbreak and pandemic management. We hereby review the clinical insights with regard to using molecular tests and immunoassays in the context of COVID-19 management life cycle: the preventive phase, the preparedness phase, the response phase and the recovery phase. The spatial and temporal distribution of viral RNA, antigens and antibodies during human infection is summarized to provide a biological foundation for accurate detection of the disease. We shared the lessons learned and the obstacles encountered during real world high-volume screening programs. Clinical needs are discussed to identify existing technology gaps in these tests. Leverage technologies, such as engineered polymerases, isothermal amplification, and direct amplification from complex matrices may improve the productivity of current infrastructure, while emerging technologies like CRISPR diagnostics, visual end point detection, and PCR free methods for nucleic acid sensing may lead to at-home tests. The lessons learned, and innovations spurred from the COVID-19 pandemic could upgrade our global public health infrastructure to better combat potential outbreaks in the future.",,ye44fr72,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'an', 'infectious', 'disease', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'To', 'counter', 'COVID', '19', 'spreading', 'an', 'infrastructure', 'to', 'provide', 'rapid', 'and', 'thorough', 'molecular', 'diagnostics', 'and', 'serology', 'testing', 'is', 'the', 'cornerstone', 'of', 'outbreak', 'and', 'pandemic', 'management', 'We', 'hereby', 'review', 'the', 'clinical', 'insights', 'with', 'regard', 'to', 'using', 'molecular', 'tests', 'and', 'immunoassays', 'in', 'the', 'context', 'of', 'COVID', '19', 'management', 'life', 'cycle', 'the', 'preventive', 'phase', 'the', 'preparedness', 'phase', 'the', 'response', 'phase', 'and', 'the', 'recovery', 'phase', 'The', 'spatial', 'and', 'temporal', 'distribution', 'of', 'viral', 'RNA', 'antigens', 'and', 'antibodies', 'during', 'human', 'infection', 'is', 'summarized', 'to', 'provide', 'a', 'biological', 'foundation', 'for', 'accurate', 'detection', 'of', 'the', 'disease', 'We', 'shared', 'the', 'lessons', 'learned', 'and', 'the', 'obstacles', 'encountered', 'during', 'real', 'world', 'high', 'volume', 'screening', 'programs', 'Clinical', 'needs', 'are', 'discussed', 'to', 'identify', 'existing', 'technology', 'gaps', 'in', 'these', 'tests', 'Leverage', 'technologies', 'such', 'as', 'engineered', 'polymerases', 'isothermal', 'amplification', 'and', 'direct', 'amplification', 'from', 'complex', 'matrices', 'may', 'improve', 'the', 'productivity', 'of', 'current', 'infrastructure', 'while', 'emerging', 'technologies', 'like', 'CRISPR', 'diagnostics', 'visual', 'end', 'point', 'detection', 'and', 'PCR', 'free', 'methods', 'for', 'nucleic', 'acid', 'sensing', 'may', 'lead', 'to', 'at', 'home', 'tests', 'The', 'lessons', 'learned', 'and', 'innovations', 'spurred', 'from', 'the', 'COVID', '19', 'pandemic', 'could', 'upgrade', 'our', 'global', 'public', 'health', 'infrastructure', 'to', 'better', 'combat', 'potential', 'outbreaks', 'in', 'the', 'future', '']"
117369,"COVID-19: Progress in diagnostics, therapy and vaccination",2020,Theranostics,,"Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently become a pandemic. As the sudden emergence and rapid spread of SARS-CoV-2 is endangering global health and the economy, the development of strategies to contain the virus's spread are urgently needed. At present, various diagnostic kits to test for SARS-CoV-2 are available for use to initiate appropriate treatment faster and to limit further spread of the virus. Several drugs have demonstrated in vitro activity against SARS-CoV-2 or potential clinical benefits. In addition, institutions and companies worldwide are working tirelessly to develop treatments and vaccines against COVID-19. However, no drug or vaccine has yet been specifically approved for COVID-19. Given the urgency of the outbreak, we focus here on recent advances in the diagnostics, treatment, and vaccine development for SARS-CoV-2 infection, helping to guide strategies to address the current COVID-19 pandemic.",,l5uf8y58,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'recently', 'become', 'a', 'pandemic', 'As', 'the', 'sudden', 'emergence', 'and', 'rapid', 'spread', 'of', 'SARS', 'CoV', '2', 'is', 'endangering', 'global', 'health', 'and', 'the', 'economy', 'the', 'development', 'of', 'strategies', 'to', 'contain', 'the', 'virus', 's', 'spread', 'are', 'urgently', 'needed', 'At', 'present', 'various', 'diagnostic', 'kits', 'to', 'test', 'for', 'SARS', 'CoV', '2', 'are', 'available', 'for', 'use', 'to', 'initiate', 'appropriate', 'treatment', 'faster', 'and', 'to', 'limit', 'further', 'spread', 'of', 'the', 'virus', 'Several', 'drugs', 'have', 'demonstrated', 'in', 'vitro', 'activity', 'against', 'SARS', 'CoV', '2', 'or', 'potential', 'clinical', 'benefits', 'In', 'addition', 'institutions', 'and', 'companies', 'worldwide', 'are', 'working', 'tirelessly', 'to', 'develop', 'treatments', 'and', 'vaccines', 'against', 'COVID', '19', 'However', 'no', 'drug', 'or', 'vaccine', 'has', 'yet', 'been', 'specifically', 'approved', 'for', 'COVID', '19', 'Given', 'the', 'urgency', 'of', 'the', 'outbreak', 'we', 'focus', 'here', 'on', 'recent', 'advances', 'in', 'the', 'diagnostics', 'treatment', 'and', 'vaccine', 'development', 'for', 'SARS', 'CoV', '2', 'infection', 'helping', 'to', 'guide', 'strategies', 'to', 'address', 'the', 'current', 'COVID', '19', 'pandemic', '']"
117936,Momentum Contrastive Learning for Few-Shot COVID-19 Diagnosis from Chest CT Images,2020-06-16,,https://arxiv.org/pdf/2006.13276v1.pdf,"The current pandemic, caused by the outbreak of a novel coronavirus (COVID-19) in December 2019, has led to a global emergency that has significantly impacted economies, healthcare systems and personal wellbeing all around the world. Controlling the rapidly evolving disease requires highly sensitive and specific diagnostics. While real-time RT-PCR is the most commonly used, these can take up to 8 hours, and require significant effort from healthcare professionals. As such, there is a critical need for a quick and automatic diagnostic system. Diagnosis from chest CT images is a promising direction. However, current studies are limited by the lack of sufficient training samples, as acquiring annotated CT images is time-consuming. To this end, we propose a new deep learning algorithm for the automated diagnosis of COVID-19, which only requires a few samples for training. Specifically, we use contrastive learning to train an encoder which can capture expressive feature representations on large and publicly available lung datasets and adopt the prototypical network for classification. We validate the efficacy of the proposed model in comparison with other competing methods on two publicly available and annotated COVID-19 CT datasets. Our results demonstrate the superior performance of our model for the accurate diagnosis of COVID-19 based on chest CT images.",,724br56j,"['The', 'current', 'pandemic', 'caused', 'by', 'the', 'outbreak', 'of', 'a', 'novel', 'coronavirus', 'COVID', '19', 'in', 'December', '2019', 'has', 'led', 'to', 'a', 'global', 'emergency', 'that', 'has', 'significantly', 'impacted', 'economies', 'healthcare', 'systems', 'and', 'personal', 'wellbeing', 'all', 'around', 'the', 'world', 'Controlling', 'the', 'rapidly', 'evolving', 'disease', 'requires', 'highly', 'sensitive', 'and', 'specific', 'diagnostics', 'While', 'real', 'time', 'RT', 'PCR', 'is', 'the', 'most', 'commonly', 'used', 'these', 'can', 'take', 'up', 'to', '8', 'hours', 'and', 'require', 'significant', 'effort', 'from', 'healthcare', 'professionals', 'As', 'such', 'there', 'is', 'a', 'critical', 'need', 'for', 'a', 'quick', 'and', 'automatic', 'diagnostic', 'system', 'Diagnosis', 'from', 'chest', 'CT', 'images', 'is', 'a', 'promising', 'direction', 'However', 'current', 'studies', 'are', 'limited', 'by', 'the', 'lack', 'of', 'sufficient', 'training', 'samples', 'as', 'acquiring', 'annotated', 'CT', 'images', 'is', 'time', 'consuming', 'To', 'this', 'end', 'we', 'propose', 'a', 'new', 'deep', 'learning', 'algorithm', 'for', 'the', 'automated', 'diagnosis', 'of', 'COVID', '19', 'which', 'only', 'requires', 'a', 'few', 'samples', 'for', 'training', 'Specifically', 'we', 'use', 'contrastive', 'learning', 'to', 'train', 'an', 'encoder', 'which', 'can', 'capture', 'expressive', 'feature', 'representations', 'on', 'large', 'and', 'publicly', 'available', 'lung', 'datasets', 'and', 'adopt', 'the', 'prototypical', 'network', 'for', 'classification', 'We', 'validate', 'the', 'efficacy', 'of', 'the', 'proposed', 'model', 'in', 'comparison', 'with', 'other', 'competing', 'methods', 'on', 'two', 'publicly', 'available', 'and', 'annotated', 'COVID', '19', 'CT', 'datasets', 'Our', 'results', 'demonstrate', 'the', 'superior', 'performance', 'of', 'our', 'model', 'for', 'the', 'accurate', 'diagnosis', 'of', 'COVID', '19', 'based', 'on', 'chest', 'CT', 'images', '']"
119302,Rapid point-of-care serology testing for sars-cov-2/ Snabbtest for covid-19-antikroppar bor utforas av utbildad personal,2020,Lakartidningen,,"Increasing evidence indicates immunity against severe acute respiratory syndrome coronavirus 2 (sars-cov-2) after covid-19, but it remains unclear for how long the protection remains Serology testing seems to have a higher sensitivity than molecular diagnostics from 8 days after onset of symtoms, and should be part of risk assessment and epidemiological studies of COVID-19 The performance of commercial serological point-of-care (POC) lateral flow tests are highly manufacturer-dependant Low sensitivity increases the risk of false negative results and could result in unnecessary quarantine of test persons with developed antibodies Low specificity increases the risk of false positive results and could lead to false assumptions of immunity Carefully selected serological POC tests for sars-cov-2 can be used in large scale testing but should only be used by licensed medical staff able to understand their limitations and interpret the results",,m60w5dnl,"['Increasing', 'evidence', 'indicates', 'immunity', 'against', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'sars', 'cov', '2', 'after', 'covid', '19', 'but', 'it', 'remains', 'unclear', 'for', 'how', 'long', 'the', 'protection', 'remains', 'Serology', 'testing', 'seems', 'to', 'have', 'a', 'higher', 'sensitivity', 'than', 'molecular', 'diagnostics', 'from', '8', 'days', 'after', 'onset', 'of', 'symtoms', 'and', 'should', 'be', 'part', 'of', 'risk', 'assessment', 'and', 'epidemiological', 'studies', 'of', 'COVID', '19', 'The', 'performance', 'of', 'commercial', 'serological', 'point', 'of', 'care', 'POC', 'lateral', 'flow', 'tests', 'are', 'highly', 'manufacturer', 'dependant', 'Low', 'sensitivity', 'increases', 'the', 'risk', 'of', 'false', 'negative', 'results', 'and', 'could', 'result', 'in', 'unnecessary', 'quarantine', 'of', 'test', 'persons', 'with', 'developed', 'antibodies', 'Low', 'specificity', 'increases', 'the', 'risk', 'of', 'false', 'positive', 'results', 'and', 'could', 'lead', 'to', 'false', 'assumptions', 'of', 'immunity', 'Carefully', 'selected', 'serological', 'POC', 'tests', 'for', 'sars', 'cov', '2', 'can', 'be', 'used', 'in', 'large', 'scale', 'testing', 'but', 'should', 'only', 'be', 'used', 'by', 'licensed', 'medical', 'staff', 'able', 'to', 'understand', 'their', 'limitations', 'and', 'interpret', 'the', 'results']"
120272,COVID-19 Outbreak: An Overview,2020,Chemotherapy,,"BACKGROUND: In late December 2019, Chinese health authorities reported an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province. SUMMARY: A few days later, the genome of a novel coronavirus was released (http://viro-logical.org/t/novel-2019-coronavirus-genome/319; Wuhan-Hu-1, GenBank accession No. MN908947) and made publicly available to the scientific community. This novel coronavirus was provisionally named 2019-nCoV, now SARS-CoV-2 according to the Coronavirus Study Group of the International Committee on Taxonomy of Viruses. SARS-CoV-2 belongs to the Coronaviridae family, Betacoronavirus genus, subgenus Sarbecovirus. Since its discovery, the virus has spread globally, causing thousands of deaths and having an enormous impact on our health systems and economies. In this review, we summarize the current knowledge about the epidemiology, phylogenesis, homology modeling, and molecular diagnostics of SARS-CoV-2. Key Messages: Phylogenetic analysis is essential to understand viral evolution, whereas homology modeling is important for vaccine strategies and therapies. Highly sensitive and specific diagnostic assays are key to case identification, contact tracing, identification of the animal source, and implementation of control measures.",,ectly1v4,"['BACKGROUND', 'In', 'late', 'December', '2019', 'Chinese', 'health', 'authorities', 'reported', 'an', 'outbreak', 'of', 'pneumonia', 'of', 'unknown', 'origin', 'in', 'Wuhan', 'Hubei', 'Province', 'SUMMARY', 'A', 'few', 'days', 'later', 'the', 'genome', 'of', 'a', 'novel', 'coronavirus', 'was', 'released', 'http', 'viro', 'logical', 'org', 't', 'novel', '2019', 'coronavirus', 'genome', '319', 'Wuhan', 'Hu', '1', 'GenBank', 'accession', 'No', 'MN908947', 'and', 'made', 'publicly', 'available', 'to', 'the', 'scientific', 'community', 'This', 'novel', 'coronavirus', 'was', 'provisionally', 'named', '2019', 'nCoV', 'now', 'SARS', 'CoV', '2', 'according', 'to', 'the', 'Coronavirus', 'Study', 'Group', 'of', 'the', 'International', 'Committee', 'on', 'Taxonomy', 'of', 'Viruses', 'SARS', 'CoV', '2', 'belongs', 'to', 'the', 'Coronaviridae', 'family', 'Betacoronavirus', 'genus', 'subgenus', 'Sarbecovirus', 'Since', 'its', 'discovery', 'the', 'virus', 'has', 'spread', 'globally', 'causing', 'thousands', 'of', 'deaths', 'and', 'having', 'an', 'enormous', 'impact', 'on', 'our', 'health', 'systems', 'and', 'economies', 'In', 'this', 'review', 'we', 'summarize', 'the', 'current', 'knowledge', 'about', 'the', 'epidemiology', 'phylogenesis', 'homology', 'modeling', 'and', 'molecular', 'diagnostics', 'of', 'SARS', 'CoV', '2', 'Key', 'Messages', 'Phylogenetic', 'analysis', 'is', 'essential', 'to', 'understand', 'viral', 'evolution', 'whereas', 'homology', 'modeling', 'is', 'important', 'for', 'vaccine', 'strategies', 'and', 'therapies', 'Highly', 'sensitive', 'and', 'specific', 'diagnostic', 'assays', 'are', 'key', 'to', 'case', 'identification', 'contact', 'tracing', 'identification', 'of', 'the', 'animal', 'source', 'and', 'implementation', 'of', 'control', 'measures', '']"
120409,"Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens",2020,J. clin. microbiol,,"On 31 December 2019, the World Health Organization was informed of a cluster of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified a novel coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from the affected patients. Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic. In this study, we developed and compared the performance of three novel real-time reverse transcription-PCR (RT-PCR) assays targeting the RNA-dependent RNA polymerase (RdRp)/helicase (Hel), spike (S), and nucleocapsid (N) genes of SARS-CoV-2 with that of the reported RdRp-P2 assay, which is used in >30 European laboratories. Among the three novel assays, the COVID-19-RdRp/Hel assay had the lowest limit of detection in vitro (1.8 50% tissue culture infective doses [TCID50]/ml with genomic RNA and 11.2 RNA copies/reaction with in vitro RNA transcripts). Among 273 specimens from 15 patients with laboratory-confirmed COVID-19 in Hong Kong, 77 (28.2%) were positive by both the COVID-19-RdRp/Hel and RdRp-P2 assays. The COVID-19-RdRp/Hel assay was positive for an additional 42 RdRp-P2-negative specimens (119/273 [43.6%] versus 77/273 [28.2%]; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens. The mean viral load of these specimens was 3.21 × 104 RNA copies/ml (range, 2.21 × 102 to 4.71 × 105 RNA copies/ml). The COVID-19-RdRp/Hel assay did not cross-react with other human-pathogenic coronaviruses and respiratory pathogens in cell culture and clinical specimens, whereas the RdRp-P2 assay cross-reacted with SARS-CoV in cell culture. The highly sensitive and specific COVID-19-RdRp/Hel assay may help to improve the laboratory diagnosis of COVID-19.",,wzd51alu,"['On', '31', 'December', '2019', 'the', 'World', 'Health', 'Organization', 'was', 'informed', 'of', 'a', 'cluster', 'of', 'cases', 'of', 'pneumonia', 'of', 'unknown', 'etiology', 'in', 'Wuhan', 'China', 'Subsequent', 'investigations', 'identified', 'a', 'novel', 'coronavirus', 'now', 'named', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'from', 'the', 'affected', 'patients', 'Highly', 'sensitive', 'and', 'specific', 'laboratory', 'diagnostics', 'are', 'important', 'for', 'controlling', 'the', 'rapidly', 'evolving', 'SARS', 'CoV', '2', 'associated', 'coronavirus', 'disease', '2019', 'COVID', '19', 'epidemic', 'In', 'this', 'study', 'we', 'developed', 'and', 'compared', 'the', 'performance', 'of', 'three', 'novel', 'real', 'time', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'assays', 'targeting', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'helicase', 'Hel', 'spike', 'S', 'and', 'nucleocapsid', 'N', 'genes', 'of', 'SARS', 'CoV', '2', 'with', 'that', 'of', 'the', 'reported', 'RdRp', 'P2', 'assay', 'which', 'is', 'used', 'in', '30', 'European', 'laboratories', 'Among', 'the', 'three', 'novel', 'assays', 'the', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'had', 'the', 'lowest', 'limit', 'of', 'detection', 'in', 'vitro', '1', '8', '50', 'tissue', 'culture', 'infective', 'doses', 'TCID50', 'ml', 'with', 'genomic', 'RNA', 'and', '11', '2', 'RNA', 'copies', 'reaction', 'with', 'in', 'vitro', 'RNA', 'transcripts', 'Among', '273', 'specimens', 'from', '15', 'patients', 'with', 'laboratory', 'confirmed', 'COVID', '19', 'in', 'Hong', 'Kong', '77', '28', '2', 'were', 'positive', 'by', 'both', 'the', 'COVID', '19', 'RdRp', 'Hel', 'and', 'RdRp', 'P2', 'assays', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'was', 'positive', 'for', 'an', 'additional', '42', 'RdRp', 'P2', 'negative', 'specimens', '119', '273', '43', '6', 'versus', '77', '273', '28', '2', 'P', '0', '001', 'including', '29', '120', '24', '2', 'respiratory', 'tract', 'specimens', 'and', '13', '153', '8', '5', 'non', 'respiratory', 'tract', 'specimens', 'The', 'mean', 'viral', 'load', 'of', 'these', 'specimens', 'was', '3', '21', '104', 'RNA', 'copies', 'ml', 'range', '2', '21', '102', 'to', '4', '71', '105', 'RNA', 'copies', 'ml', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'did', 'not', 'cross', 'react', 'with', 'other', 'human', 'pathogenic', 'coronaviruses', 'and', 'respiratory', 'pathogens', 'in', 'cell', 'culture', 'and', 'clinical', 'specimens', 'whereas', 'the', 'RdRp', 'P2', 'assay', 'cross', 'reacted', 'with', 'SARS', 'CoV', 'in', 'cell', 'culture', 'The', 'highly', 'sensitive', 'and', 'specific', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'may', 'help', 'to', 'improve', 'the', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
120410,"Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens",2020,J. clin. microbiol,,"On 31 December 2019, the World Health Organization was informed of a cluster of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified a novel coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from the affected patients. Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic. In this study, we developed and compared the performance of three novel real-time reverse transcription-PCR (RT-PCR) assays targeting the RNA-dependent RNA polymerase (RdRp)/helicase (Hel), spike (S), and nucleocapsid (N) genes of SARS-CoV-2 with that of the reported RdRp-P2 assay, which is used in >30 European laboratories. Among the three novel assays, the COVID-19-RdRp/Hel assay had the lowest limit of detection in vitro (1.8 50% tissue culture infective doses [TCID50]/ml with genomic RNA and 11.2 RNA copies/reaction with in vitro RNA transcripts). Among 273 specimens from 15 patients with laboratory-confirmed COVID-19 in Hong Kong, 77 (28.2%) were positive by both the COVID-19-RdRp/Hel and RdRp-P2 assays. The COVID-19-RdRp/Hel assay was positive for an additional 42 RdRp-P2-negative specimens (119/273 [43.6%] versus 77/273 [28.2%]; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens. The mean viral load of these specimens was 3.21 × 104 RNA copies/ml (range, 2.21 × 102 to 4.71 × 105 RNA copies/ml). The COVID-19-RdRp/Hel assay did not cross-react with other human-pathogenic coronaviruses and respiratory pathogens in cell culture and clinical specimens, whereas the RdRp-P2 assay cross-reacted with SARS-CoV in cell culture. The highly sensitive and specific COVID-19-RdRp/Hel assay may help to improve the laboratory diagnosis of COVID-19.",,jkiqhwap,"['On', '31', 'December', '2019', 'the', 'World', 'Health', 'Organization', 'was', 'informed', 'of', 'a', 'cluster', 'of', 'cases', 'of', 'pneumonia', 'of', 'unknown', 'etiology', 'in', 'Wuhan', 'China', 'Subsequent', 'investigations', 'identified', 'a', 'novel', 'coronavirus', 'now', 'named', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'from', 'the', 'affected', 'patients', 'Highly', 'sensitive', 'and', 'specific', 'laboratory', 'diagnostics', 'are', 'important', 'for', 'controlling', 'the', 'rapidly', 'evolving', 'SARS', 'CoV', '2', 'associated', 'coronavirus', 'disease', '2019', 'COVID', '19', 'epidemic', 'In', 'this', 'study', 'we', 'developed', 'and', 'compared', 'the', 'performance', 'of', 'three', 'novel', 'real', 'time', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'assays', 'targeting', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'helicase', 'Hel', 'spike', 'S', 'and', 'nucleocapsid', 'N', 'genes', 'of', 'SARS', 'CoV', '2', 'with', 'that', 'of', 'the', 'reported', 'RdRp', 'P2', 'assay', 'which', 'is', 'used', 'in', '30', 'European', 'laboratories', 'Among', 'the', 'three', 'novel', 'assays', 'the', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'had', 'the', 'lowest', 'limit', 'of', 'detection', 'in', 'vitro', '1', '8', '50', 'tissue', 'culture', 'infective', 'doses', 'TCID50', 'ml', 'with', 'genomic', 'RNA', 'and', '11', '2', 'RNA', 'copies', 'reaction', 'with', 'in', 'vitro', 'RNA', 'transcripts', 'Among', '273', 'specimens', 'from', '15', 'patients', 'with', 'laboratory', 'confirmed', 'COVID', '19', 'in', 'Hong', 'Kong', '77', '28', '2', 'were', 'positive', 'by', 'both', 'the', 'COVID', '19', 'RdRp', 'Hel', 'and', 'RdRp', 'P2', 'assays', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'was', 'positive', 'for', 'an', 'additional', '42', 'RdRp', 'P2', 'negative', 'specimens', '119', '273', '43', '6', 'versus', '77', '273', '28', '2', 'P', '0', '001', 'including', '29', '120', '24', '2', 'respiratory', 'tract', 'specimens', 'and', '13', '153', '8', '5', 'non', 'respiratory', 'tract', 'specimens', 'The', 'mean', 'viral', 'load', 'of', 'these', 'specimens', 'was', '3', '21', '104', 'RNA', 'copies', 'ml', 'range', '2', '21', '102', 'to', '4', '71', '105', 'RNA', 'copies', 'ml', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'did', 'not', 'cross', 'react', 'with', 'other', 'human', 'pathogenic', 'coronaviruses', 'and', 'respiratory', 'pathogens', 'in', 'cell', 'culture', 'and', 'clinical', 'specimens', 'whereas', 'the', 'RdRp', 'P2', 'assay', 'cross', 'reacted', 'with', 'SARS', 'CoV', 'in', 'cell', 'culture', 'The', 'highly', 'sensitive', 'and', 'specific', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'may', 'help', 'to', 'improve', 'the', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
120411,"Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens",2020,J. clin. microbiol,,"On 31 December 2019, the World Health Organization was informed of a cluster of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified a novel coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from the affected patients. Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic. In this study, we developed and compared the performance of three novel real-time reverse transcription-PCR (RT-PCR) assays targeting the RNA-dependent RNA polymerase (RdRp)/helicase (Hel), spike (S), and nucleocapsid (N) genes of SARS-CoV-2 with that of the reported RdRp-P2 assay, which is used in >30 European laboratories. Among the three novel assays, the COVID-19-RdRp/Hel assay had the lowest limit of detection in vitro (1.8 50% tissue culture infective doses [TCID50]/ml with genomic RNA and 11.2 RNA copies/reaction with in vitro RNA transcripts). Among 273 specimens from 15 patients with laboratory-confirmed COVID-19 in Hong Kong, 77 (28.2%) were positive by both the COVID-19-RdRp/Hel and RdRp-P2 assays. The COVID-19-RdRp/Hel assay was positive for an additional 42 RdRp-P2-negative specimens (119/273 [43.6%] versus 77/273 [28.2%]; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens. The mean viral load of these specimens was 3.21 × 104 RNA copies/ml (range, 2.21 × 102 to 4.71 × 105 RNA copies/ml). The COVID-19-RdRp/Hel assay did not cross-react with other human-pathogenic coronaviruses and respiratory pathogens in cell culture and clinical specimens, whereas the RdRp-P2 assay cross-reacted with SARS-CoV in cell culture. The highly sensitive and specific COVID-19-RdRp/Hel assay may help to improve the laboratory diagnosis of COVID-19.",,dxqb10r5,"['On', '31', 'December', '2019', 'the', 'World', 'Health', 'Organization', 'was', 'informed', 'of', 'a', 'cluster', 'of', 'cases', 'of', 'pneumonia', 'of', 'unknown', 'etiology', 'in', 'Wuhan', 'China', 'Subsequent', 'investigations', 'identified', 'a', 'novel', 'coronavirus', 'now', 'named', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'from', 'the', 'affected', 'patients', 'Highly', 'sensitive', 'and', 'specific', 'laboratory', 'diagnostics', 'are', 'important', 'for', 'controlling', 'the', 'rapidly', 'evolving', 'SARS', 'CoV', '2', 'associated', 'coronavirus', 'disease', '2019', 'COVID', '19', 'epidemic', 'In', 'this', 'study', 'we', 'developed', 'and', 'compared', 'the', 'performance', 'of', 'three', 'novel', 'real', 'time', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'assays', 'targeting', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'helicase', 'Hel', 'spike', 'S', 'and', 'nucleocapsid', 'N', 'genes', 'of', 'SARS', 'CoV', '2', 'with', 'that', 'of', 'the', 'reported', 'RdRp', 'P2', 'assay', 'which', 'is', 'used', 'in', '30', 'European', 'laboratories', 'Among', 'the', 'three', 'novel', 'assays', 'the', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'had', 'the', 'lowest', 'limit', 'of', 'detection', 'in', 'vitro', '1', '8', '50', 'tissue', 'culture', 'infective', 'doses', 'TCID50', 'ml', 'with', 'genomic', 'RNA', 'and', '11', '2', 'RNA', 'copies', 'reaction', 'with', 'in', 'vitro', 'RNA', 'transcripts', 'Among', '273', 'specimens', 'from', '15', 'patients', 'with', 'laboratory', 'confirmed', 'COVID', '19', 'in', 'Hong', 'Kong', '77', '28', '2', 'were', 'positive', 'by', 'both', 'the', 'COVID', '19', 'RdRp', 'Hel', 'and', 'RdRp', 'P2', 'assays', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'was', 'positive', 'for', 'an', 'additional', '42', 'RdRp', 'P2', 'negative', 'specimens', '119', '273', '43', '6', 'versus', '77', '273', '28', '2', 'P', '0', '001', 'including', '29', '120', '24', '2', 'respiratory', 'tract', 'specimens', 'and', '13', '153', '8', '5', 'non', 'respiratory', 'tract', 'specimens', 'The', 'mean', 'viral', 'load', 'of', 'these', 'specimens', 'was', '3', '21', '104', 'RNA', 'copies', 'ml', 'range', '2', '21', '102', 'to', '4', '71', '105', 'RNA', 'copies', 'ml', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'did', 'not', 'cross', 'react', 'with', 'other', 'human', 'pathogenic', 'coronaviruses', 'and', 'respiratory', 'pathogens', 'in', 'cell', 'culture', 'and', 'clinical', 'specimens', 'whereas', 'the', 'RdRp', 'P2', 'assay', 'cross', 'reacted', 'with', 'SARS', 'CoV', 'in', 'cell', 'culture', 'The', 'highly', 'sensitive', 'and', 'specific', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'may', 'help', 'to', 'improve', 'the', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
120412,"Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens",2020,J. clin. microbiol,,"On 31 December 2019, the World Health Organization was informed of a cluster of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified a novel coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from the affected patients. Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic. In this study, we developed and compared the performance of three novel real-time reverse transcription-PCR (RT-PCR) assays targeting the RNA-dependent RNA polymerase (RdRp)/helicase (Hel), spike (S), and nucleocapsid (N) genes of SARS-CoV-2 with that of the reported RdRp-P2 assay, which is used in >30 European laboratories. Among the three novel assays, the COVID-19-RdRp/Hel assay had the lowest limit of detection in vitro (1.8 50% tissue culture infective doses [TCID50]/ml with genomic RNA and 11.2 RNA copies/reaction with in vitro RNA transcripts). Among 273 specimens from 15 patients with laboratory-confirmed COVID-19 in Hong Kong, 77 (28.2%) were positive by both the COVID-19-RdRp/Hel and RdRp-P2 assays. The COVID-19-RdRp/Hel assay was positive for an additional 42 RdRp-P2-negative specimens (119/273 [43.6%] versus 77/273 [28.2%]; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens. The mean viral load of these specimens was 3.21 × 104 RNA copies/ml (range, 2.21 × 102 to 4.71 × 105 RNA copies/ml). The COVID-19-RdRp/Hel assay did not cross-react with other human-pathogenic coronaviruses and respiratory pathogens in cell culture and clinical specimens, whereas the RdRp-P2 assay cross-reacted with SARS-CoV in cell culture. The highly sensitive and specific COVID-19-RdRp/Hel assay may help to improve the laboratory diagnosis of COVID-19.",,wmd4ehfx,"['On', '31', 'December', '2019', 'the', 'World', 'Health', 'Organization', 'was', 'informed', 'of', 'a', 'cluster', 'of', 'cases', 'of', 'pneumonia', 'of', 'unknown', 'etiology', 'in', 'Wuhan', 'China', 'Subsequent', 'investigations', 'identified', 'a', 'novel', 'coronavirus', 'now', 'named', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'from', 'the', 'affected', 'patients', 'Highly', 'sensitive', 'and', 'specific', 'laboratory', 'diagnostics', 'are', 'important', 'for', 'controlling', 'the', 'rapidly', 'evolving', 'SARS', 'CoV', '2', 'associated', 'coronavirus', 'disease', '2019', 'COVID', '19', 'epidemic', 'In', 'this', 'study', 'we', 'developed', 'and', 'compared', 'the', 'performance', 'of', 'three', 'novel', 'real', 'time', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'assays', 'targeting', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'helicase', 'Hel', 'spike', 'S', 'and', 'nucleocapsid', 'N', 'genes', 'of', 'SARS', 'CoV', '2', 'with', 'that', 'of', 'the', 'reported', 'RdRp', 'P2', 'assay', 'which', 'is', 'used', 'in', '30', 'European', 'laboratories', 'Among', 'the', 'three', 'novel', 'assays', 'the', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'had', 'the', 'lowest', 'limit', 'of', 'detection', 'in', 'vitro', '1', '8', '50', 'tissue', 'culture', 'infective', 'doses', 'TCID50', 'ml', 'with', 'genomic', 'RNA', 'and', '11', '2', 'RNA', 'copies', 'reaction', 'with', 'in', 'vitro', 'RNA', 'transcripts', 'Among', '273', 'specimens', 'from', '15', 'patients', 'with', 'laboratory', 'confirmed', 'COVID', '19', 'in', 'Hong', 'Kong', '77', '28', '2', 'were', 'positive', 'by', 'both', 'the', 'COVID', '19', 'RdRp', 'Hel', 'and', 'RdRp', 'P2', 'assays', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'was', 'positive', 'for', 'an', 'additional', '42', 'RdRp', 'P2', 'negative', 'specimens', '119', '273', '43', '6', 'versus', '77', '273', '28', '2', 'P', '0', '001', 'including', '29', '120', '24', '2', 'respiratory', 'tract', 'specimens', 'and', '13', '153', '8', '5', 'non', 'respiratory', 'tract', 'specimens', 'The', 'mean', 'viral', 'load', 'of', 'these', 'specimens', 'was', '3', '21', '104', 'RNA', 'copies', 'ml', 'range', '2', '21', '102', 'to', '4', '71', '105', 'RNA', 'copies', 'ml', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'did', 'not', 'cross', 'react', 'with', 'other', 'human', 'pathogenic', 'coronaviruses', 'and', 'respiratory', 'pathogens', 'in', 'cell', 'culture', 'and', 'clinical', 'specimens', 'whereas', 'the', 'RdRp', 'P2', 'assay', 'cross', 'reacted', 'with', 'SARS', 'CoV', 'in', 'cell', 'culture', 'The', 'highly', 'sensitive', 'and', 'specific', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'may', 'help', 'to', 'improve', 'the', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
121289,Implementation of Clinical Diagnostic Criteria and Universal Symptom Survey Contributed to Lower Magnitude and Faster Resolution of the COVID-19 Epidemic in Wuhan,2020,,,"The majority of cases infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China centered in the city of Wuhan. Despite a rapid increase in the number of cases and deaths due to the coronavirus disease 2019 (COVID-19), the epidemic was stemmed via a combination of epidemic mitigation and control measures. This study evaluates how the implementation of clinical diagnostics and universal symptom surveys contributed to epidemic control in Wuhan. We extended the susceptibles-exposed-infectious-removed (SEIR) transmission dynamics model by considering three quarantined compartments (SEIR+Q). The SEIR+Q dynamics model was fitted using the daily reported number of confirmed infections and unconfirmed cases by clinical diagnostic criteria up to February 14, 2020 in Wuhan. Applying the model to carry forward the pre-February 14 trend in Wuhan, the number of daily new diagnosed cases would be expected to drop below 100 by March 25, below 10 by April 29, and reach 0 by May 31, 2020. The observed case counts after February 14 demonstrated that the daily new cases fell below 100 by March 6, below 10 by March 11, and reached 0 by March 18, or, respectively, 19, 49, and 74 d earlier than model predictions. By March 30, the observed number of cumulative confirmed cases was 50 006, which was 19 951 cases fewer than the predicted count. Effective reproductive number R(t) analysis using observed frequencies showed a remarkable decline after the implementation of clinical diagnostic criteria and universal symptom surveys, which was significantly below the R(t) curve estimated by the model assuming that the pre-February 14 trend was carried forward. In conclusion, the proposed SEIR+Q dynamics model was a good fit for the epidemic data in Wuhan and explained the large increase in the number of infections during February 12-14, 2020. The implementation of clinical diagnostic criteria and universal symptom surveys contributed to a contraction in both the magnitude and the duration of the epidemic in Wuhan.",,ilfqof0y,"['The', 'majority', 'of', 'cases', 'infected', 'with', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'in', 'China', 'centered', 'in', 'the', 'city', 'of', 'Wuhan', 'Despite', 'a', 'rapid', 'increase', 'in', 'the', 'number', 'of', 'cases', 'and', 'deaths', 'due', 'to', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'the', 'epidemic', 'was', 'stemmed', 'via', 'a', 'combination', 'of', 'epidemic', 'mitigation', 'and', 'control', 'measures', 'This', 'study', 'evaluates', 'how', 'the', 'implementation', 'of', 'clinical', 'diagnostics', 'and', 'universal', 'symptom', 'surveys', 'contributed', 'to', 'epidemic', 'control', 'in', 'Wuhan', 'We', 'extended', 'the', 'susceptibles', 'exposed', 'infectious', 'removed', 'SEIR', 'transmission', 'dynamics', 'model', 'by', 'considering', 'three', 'quarantined', 'compartments', 'SEIR', 'Q', 'The', 'SEIR', 'Q', 'dynamics', 'model', 'was', 'fitted', 'using', 'the', 'daily', 'reported', 'number', 'of', 'confirmed', 'infections', 'and', 'unconfirmed', 'cases', 'by', 'clinical', 'diagnostic', 'criteria', 'up', 'to', 'February', '14', '2020', 'in', 'Wuhan', 'Applying', 'the', 'model', 'to', 'carry', 'forward', 'the', 'pre', 'February', '14', 'trend', 'in', 'Wuhan', 'the', 'number', 'of', 'daily', 'new', 'diagnosed', 'cases', 'would', 'be', 'expected', 'to', 'drop', 'below', '100', 'by', 'March', '25', 'below', '10', 'by', 'April', '29', 'and', 'reach', '0', 'by', 'May', '31', '2020', 'The', 'observed', 'case', 'counts', 'after', 'February', '14', 'demonstrated', 'that', 'the', 'daily', 'new', 'cases', 'fell', 'below', '100', 'by', 'March', '6', 'below', '10', 'by', 'March', '11', 'and', 'reached', '0', 'by', 'March', '18', 'or', 'respectively', '19', '49', 'and', '74', 'd', 'earlier', 'than', 'model', 'predictions', 'By', 'March', '30', 'the', 'observed', 'number', 'of', 'cumulative', 'confirmed', 'cases', 'was', '50', '006', 'which', 'was', '19', '951', 'cases', 'fewer', 'than', 'the', 'predicted', 'count', 'Effective', 'reproductive', 'number', 'R', 't', 'analysis', 'using', 'observed', 'frequencies', 'showed', 'a', 'remarkable', 'decline', 'after', 'the', 'implementation', 'of', 'clinical', 'diagnostic', 'criteria', 'and', 'universal', 'symptom', 'surveys', 'which', 'was', 'significantly', 'below', 'the', 'R', 't', 'curve', 'estimated', 'by', 'the', 'model', 'assuming', 'that', 'the', 'pre', 'February', '14', 'trend', 'was', 'carried', 'forward', 'In', 'conclusion', 'the', 'proposed', 'SEIR', 'Q', 'dynamics', 'model', 'was', 'a', 'good', 'fit', 'for', 'the', 'epidemic', 'data', 'in', 'Wuhan', 'and', 'explained', 'the', 'large', 'increase', 'in', 'the', 'number', 'of', 'infections', 'during', 'February', '12', '14', '2020', 'The', 'implementation', 'of', 'clinical', 'diagnostic', 'criteria', 'and', 'universal', 'symptom', 'surveys', 'contributed', 'to', 'a', 'contraction', 'in', 'both', 'the', 'magnitude', 'and', 'the', 'duration', 'of', 'the', 'epidemic', 'in', 'Wuhan', '']"
121945,Magnetic Immunoassays: A Review of Virus and Pathogen Detection Before and Amidst the Coronavirus Disease-19 (COVID-19),2020-07-09,,https://arxiv.org/pdf/2007.04809v1.pdf,"The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is a threat to the global healthcare system and economic security. As of July 2020, no specific drugs or vaccines are yet available for COVID-19, fast and accurate diagnosis for SARS-CoV-2 is essential in slowing down the spread of COVID-19 and for efficient implementation of control and containment strategies. Magnetic immunoassay is a novel and emerging topic representing the frontiers of current biosensing and magnetics areas. The past decade has seen rapid growth in applying magnetic tools for biological and biomedical applications. Recent advances in magnetic materials and nanotechnologies have transformed current diagnostic methods to nanoscale and pushed the detection limit to early stage disease diagnosis. Herein, this review covers the literatures of magnetic immunoassay platforms for virus and pathogen detections, before COVID-19. We reviewed the popular magnetic immunoassay platforms including magnetoresistance (MR) sensors, magnetic particle spectroscopy (MPS), and nuclear magnetic resonance (NMR). Magnetic Point-of-Care (POC) diagnostic kits are also reviewed aiming at developing plug-and-play diagnostics to manage the SARS-CoV-2 outbreak as well as preventing future epidemics. In addition, other platforms that use magnetic materials as auxiliary tools for enhanced pathogen and virus detections are also covered. The goal of this review is to inform the researchers of diagnostic and surveillance platforms for SARS-CoV-2 and their performances.",,asd39zbj,"['The', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'which', 'causes', 'coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'a', 'threat', 'to', 'the', 'global', 'healthcare', 'system', 'and', 'economic', 'security', 'As', 'of', 'July', '2020', 'no', 'specific', 'drugs', 'or', 'vaccines', 'are', 'yet', 'available', 'for', 'COVID', '19', 'fast', 'and', 'accurate', 'diagnosis', 'for', 'SARS', 'CoV', '2', 'is', 'essential', 'in', 'slowing', 'down', 'the', 'spread', 'of', 'COVID', '19', 'and', 'for', 'efficient', 'implementation', 'of', 'control', 'and', 'containment', 'strategies', 'Magnetic', 'immunoassay', 'is', 'a', 'novel', 'and', 'emerging', 'topic', 'representing', 'the', 'frontiers', 'of', 'current', 'biosensing', 'and', 'magnetics', 'areas', 'The', 'past', 'decade', 'has', 'seen', 'rapid', 'growth', 'in', 'applying', 'magnetic', 'tools', 'for', 'biological', 'and', 'biomedical', 'applications', 'Recent', 'advances', 'in', 'magnetic', 'materials', 'and', 'nanotechnologies', 'have', 'transformed', 'current', 'diagnostic', 'methods', 'to', 'nanoscale', 'and', 'pushed', 'the', 'detection', 'limit', 'to', 'early', 'stage', 'disease', 'diagnosis', 'Herein', 'this', 'review', 'covers', 'the', 'literatures', 'of', 'magnetic', 'immunoassay', 'platforms', 'for', 'virus', 'and', 'pathogen', 'detections', 'before', 'COVID', '19', 'We', 'reviewed', 'the', 'popular', 'magnetic', 'immunoassay', 'platforms', 'including', 'magnetoresistance', 'MR', 'sensors', 'magnetic', 'particle', 'spectroscopy', 'MPS', 'and', 'nuclear', 'magnetic', 'resonance', 'NMR', 'Magnetic', 'Point', 'of', 'Care', 'POC', 'diagnostic', 'kits', 'are', 'also', 'reviewed', 'aiming', 'at', 'developing', 'plug', 'and', 'play', 'diagnostics', 'to', 'manage', 'the', 'SARS', 'CoV', '2', 'outbreak', 'as', 'well', 'as', 'preventing', 'future', 'epidemics', 'In', 'addition', 'other', 'platforms', 'that', 'use', 'magnetic', 'materials', 'as', 'auxiliary', 'tools', 'for', 'enhanced', 'pathogen', 'and', 'virus', 'detections', 'are', 'also', 'covered', 'The', 'goal', 'of', 'this', 'review', 'is', 'to', 'inform', 'the', 'researchers', 'of', 'diagnostic', 'and', 'surveillance', 'platforms', 'for', 'SARS', 'CoV', '2', 'and', 'their', 'performances', '']"
123445,CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia,2020,J Drug Target,,"Emerging infectious diseases, the persistent potential for destabilising pandemics, remain a global threat leading to excessive morbidity and mortality. The current outbreak of pneumonia caused by 2019 novel coronavirus (COVID-19) illustrated difficulties in lack of effective drugs for treatment. Accurate and rapid diagnostic tools are essential for early recognition and treatment of infectious diseases, allowing timely implementation of infection control, improved clinical care and other public health measures to stop the spread of the disease. CRISPR-Cas technology speed up the development of infectious disease diagnostics with high rapid and accurate. In this review, we summarise current advance regarding diverse CRISPR-Cas systems, including CRISPR-Cas9, CRISPR-Cas12 and CRISPR-Cas13, in the development of fast, accurate and portable diagnostic tests and highlight the potential of CRISPR-Cas13 in COVID-19 Pneumonia and other emerging infectious diseases diagnosis.",,5uv9kaxf,"['Emerging', 'infectious', 'diseases', 'the', 'persistent', 'potential', 'for', 'destabilising', 'pandemics', 'remain', 'a', 'global', 'threat', 'leading', 'to', 'excessive', 'morbidity', 'and', 'mortality', 'The', 'current', 'outbreak', 'of', 'pneumonia', 'caused', 'by', '2019', 'novel', 'coronavirus', 'COVID', '19', 'illustrated', 'difficulties', 'in', 'lack', 'of', 'effective', 'drugs', 'for', 'treatment', 'Accurate', 'and', 'rapid', 'diagnostic', 'tools', 'are', 'essential', 'for', 'early', 'recognition', 'and', 'treatment', 'of', 'infectious', 'diseases', 'allowing', 'timely', 'implementation', 'of', 'infection', 'control', 'improved', 'clinical', 'care', 'and', 'other', 'public', 'health', 'measures', 'to', 'stop', 'the', 'spread', 'of', 'the', 'disease', 'CRISPR', 'Cas', 'technology', 'speed', 'up', 'the', 'development', 'of', 'infectious', 'disease', 'diagnostics', 'with', 'high', 'rapid', 'and', 'accurate', 'In', 'this', 'review', 'we', 'summarise', 'current', 'advance', 'regarding', 'diverse', 'CRISPR', 'Cas', 'systems', 'including', 'CRISPR', 'Cas9', 'CRISPR', 'Cas12', 'and', 'CRISPR', 'Cas13', 'in', 'the', 'development', 'of', 'fast', 'accurate', 'and', 'portable', 'diagnostic', 'tests', 'and', 'highlight', 'the', 'potential', 'of', 'CRISPR', 'Cas13', 'in', 'COVID', '19', 'Pneumonia', 'and', 'other', 'emerging', 'infectious', 'diseases', 'diagnosis', '']"
123548,"Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020",2020,MMWR Morb Mortal Wkly Rep,,"An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in Wuhan, Hubei Province, China in December 2019, and has spread throughout China and to 31 other countries and territories, including the United States (1). As of February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases in locations outside mainland China (1). There have been 2,462 associated deaths worldwide; no deaths have been reported in the United States. Fourteen cases have been diagnosed in the United States, and an additional 39 cases have occurred among repatriated persons from high-risk settings, for a current total of 53 cases within the United States. This report summarizes the aggressive measures (2,3) that CDC, state and local health departments, multiple other federal agencies, and other partners are implementing to slow and try to contain transmission of COVID-19 in the United States. These measures require the identification of cases and contacts of persons with COVID-19 in the United States and the recommended assessment, monitoring, and care of travelers arriving from areas with substantial COVID-19 transmission. Although these measures might not prevent widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare state and local health departments, health care systems, businesses, educational organizations, and the general public in the event that widespread transmission occurs; and 3) better characterize COVID-19 to guide public health recommendations and the development and deployment of medical countermeasures, including diagnostics, therapeutics, and vaccines. U.S. public health authorities are monitoring the situation closely, and CDC is coordinating efforts with the World Health Organization (WHO) and other global partners. Interim guidance is available at https://www.cdc.gov/coronavirus/index.html. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC, state and local health departments, health care providers, and communities.",,rlqxmf1l,"['An', 'outbreak', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'the', '2019', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'began', 'in', 'Wuhan', 'Hubei', 'Province', 'China', 'in', 'December', '2019', 'and', 'has', 'spread', 'throughout', 'China', 'and', 'to', '31', 'other', 'countries', 'and', 'territories', 'including', 'the', 'United', 'States', '1', 'As', 'of', 'February', '23', '2020', 'there', 'were', '76', '936', 'reported', 'cases', 'in', 'mainland', 'China', 'and', '1', '875', 'cases', 'in', 'locations', 'outside', 'mainland', 'China', '1', 'There', 'have', 'been', '2', '462', 'associated', 'deaths', 'worldwide', 'no', 'deaths', 'have', 'been', 'reported', 'in', 'the', 'United', 'States', 'Fourteen', 'cases', 'have', 'been', 'diagnosed', 'in', 'the', 'United', 'States', 'and', 'an', 'additional', '39', 'cases', 'have', 'occurred', 'among', 'repatriated', 'persons', 'from', 'high', 'risk', 'settings', 'for', 'a', 'current', 'total', 'of', '53', 'cases', 'within', 'the', 'United', 'States', 'This', 'report', 'summarizes', 'the', 'aggressive', 'measures', '2', '3', 'that', 'CDC', 'state', 'and', 'local', 'health', 'departments', 'multiple', 'other', 'federal', 'agencies', 'and', 'other', 'partners', 'are', 'implementing', 'to', 'slow', 'and', 'try', 'to', 'contain', 'transmission', 'of', 'COVID', '19', 'in', 'the', 'United', 'States', 'These', 'measures', 'require', 'the', 'identification', 'of', 'cases', 'and', 'contacts', 'of', 'persons', 'with', 'COVID', '19', 'in', 'the', 'United', 'States', 'and', 'the', 'recommended', 'assessment', 'monitoring', 'and', 'care', 'of', 'travelers', 'arriving', 'from', 'areas', 'with', 'substantial', 'COVID', '19', 'transmission', 'Although', 'these', 'measures', 'might', 'not', 'prevent', 'widespread', 'transmission', 'of', 'the', 'virus', 'in', 'the', 'United', 'States', 'they', 'are', 'being', 'implemented', 'to', '1', 'slow', 'the', 'spread', 'of', 'illness', '2', 'provide', 'time', 'to', 'better', 'prepare', 'state', 'and', 'local', 'health', 'departments', 'health', 'care', 'systems', 'businesses', 'educational', 'organizations', 'and', 'the', 'general', 'public', 'in', 'the', 'event', 'that', 'widespread', 'transmission', 'occurs', 'and', '3', 'better', 'characterize', 'COVID', '19', 'to', 'guide', 'public', 'health', 'recommendations', 'and', 'the', 'development', 'and', 'deployment', 'of', 'medical', 'countermeasures', 'including', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'U', 'S', 'public', 'health', 'authorities', 'are', 'monitoring', 'the', 'situation', 'closely', 'and', 'CDC', 'is', 'coordinating', 'efforts', 'with', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'other', 'global', 'partners', 'Interim', 'guidance', 'is', 'available', 'at', 'https', 'www', 'cdc', 'gov', 'coronavirus', 'index', 'html', 'As', 'more', 'is', 'learned', 'about', 'this', 'novel', 'virus', 'and', 'this', 'outbreak', 'CDC', 'will', 'rapidly', 'incorporate', 'new', 'knowledge', 'into', 'guidance', 'for', 'action', 'by', 'CDC', 'state', 'and', 'local', 'health', 'departments', 'health', 'care', 'providers', 'and', 'communities', '']"
123549,"Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020",2020,MMWR Morb Mortal Wkly Rep,,"An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in Wuhan, Hubei Province, China in December 2019, and has spread throughout China and to 31 other countries and territories, including the United States (1). As of February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases in locations outside mainland China (1). There have been 2,462 associated deaths worldwide; no deaths have been reported in the United States. Fourteen cases have been diagnosed in the United States, and an additional 39 cases have occurred among repatriated persons from high-risk settings, for a current total of 53 cases within the United States. This report summarizes the aggressive measures (2,3) that CDC, state and local health departments, multiple other federal agencies, and other partners are implementing to slow and try to contain transmission of COVID-19 in the United States. These measures require the identification of cases and contacts of persons with COVID-19 in the United States and the recommended assessment, monitoring, and care of travelers arriving from areas with substantial COVID-19 transmission. Although these measures might not prevent widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare state and local health departments, health care systems, businesses, educational organizations, and the general public in the event that widespread transmission occurs; and 3) better characterize COVID-19 to guide public health recommendations and the development and deployment of medical countermeasures, including diagnostics, therapeutics, and vaccines. U.S. public health authorities are monitoring the situation closely, and CDC is coordinating efforts with the World Health Organization (WHO) and other global partners. Interim guidance is available at https://www.cdc.gov/coronavirus/index.html. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC, state and local health departments, health care providers, and communities.",,2ff6qg5g,"['An', 'outbreak', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'the', '2019', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'began', 'in', 'Wuhan', 'Hubei', 'Province', 'China', 'in', 'December', '2019', 'and', 'has', 'spread', 'throughout', 'China', 'and', 'to', '31', 'other', 'countries', 'and', 'territories', 'including', 'the', 'United', 'States', '1', 'As', 'of', 'February', '23', '2020', 'there', 'were', '76', '936', 'reported', 'cases', 'in', 'mainland', 'China', 'and', '1', '875', 'cases', 'in', 'locations', 'outside', 'mainland', 'China', '1', 'There', 'have', 'been', '2', '462', 'associated', 'deaths', 'worldwide', 'no', 'deaths', 'have', 'been', 'reported', 'in', 'the', 'United', 'States', 'Fourteen', 'cases', 'have', 'been', 'diagnosed', 'in', 'the', 'United', 'States', 'and', 'an', 'additional', '39', 'cases', 'have', 'occurred', 'among', 'repatriated', 'persons', 'from', 'high', 'risk', 'settings', 'for', 'a', 'current', 'total', 'of', '53', 'cases', 'within', 'the', 'United', 'States', 'This', 'report', 'summarizes', 'the', 'aggressive', 'measures', '2', '3', 'that', 'CDC', 'state', 'and', 'local', 'health', 'departments', 'multiple', 'other', 'federal', 'agencies', 'and', 'other', 'partners', 'are', 'implementing', 'to', 'slow', 'and', 'try', 'to', 'contain', 'transmission', 'of', 'COVID', '19', 'in', 'the', 'United', 'States', 'These', 'measures', 'require', 'the', 'identification', 'of', 'cases', 'and', 'contacts', 'of', 'persons', 'with', 'COVID', '19', 'in', 'the', 'United', 'States', 'and', 'the', 'recommended', 'assessment', 'monitoring', 'and', 'care', 'of', 'travelers', 'arriving', 'from', 'areas', 'with', 'substantial', 'COVID', '19', 'transmission', 'Although', 'these', 'measures', 'might', 'not', 'prevent', 'widespread', 'transmission', 'of', 'the', 'virus', 'in', 'the', 'United', 'States', 'they', 'are', 'being', 'implemented', 'to', '1', 'slow', 'the', 'spread', 'of', 'illness', '2', 'provide', 'time', 'to', 'better', 'prepare', 'state', 'and', 'local', 'health', 'departments', 'health', 'care', 'systems', 'businesses', 'educational', 'organizations', 'and', 'the', 'general', 'public', 'in', 'the', 'event', 'that', 'widespread', 'transmission', 'occurs', 'and', '3', 'better', 'characterize', 'COVID', '19', 'to', 'guide', 'public', 'health', 'recommendations', 'and', 'the', 'development', 'and', 'deployment', 'of', 'medical', 'countermeasures', 'including', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'U', 'S', 'public', 'health', 'authorities', 'are', 'monitoring', 'the', 'situation', 'closely', 'and', 'CDC', 'is', 'coordinating', 'efforts', 'with', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'other', 'global', 'partners', 'Interim', 'guidance', 'is', 'available', 'at', 'https', 'www', 'cdc', 'gov', 'coronavirus', 'index', 'html', 'As', 'more', 'is', 'learned', 'about', 'this', 'novel', 'virus', 'and', 'this', 'outbreak', 'CDC', 'will', 'rapidly', 'incorporate', 'new', 'knowledge', 'into', 'guidance', 'for', 'action', 'by', 'CDC', 'state', 'and', 'local', 'health', 'departments', 'health', 'care', 'providers', 'and', 'communities', '']"
123930,Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses,2020,Proc Natl Acad Sci U S A,,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses an immediate, major threat to public health across the globe. Here we report an in-depth molecular analysis to reconstruct the evolutionary origins of the enhanced pathogenicity of SARS-CoV-2 and other coronaviruses that are severe human pathogens. Using integrated comparative genomics and machine learning techniques, we identify key genomic features that differentiate SARS-CoV-2 and the viruses behind the two previous deadly coronavirus outbreaks, SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), from less pathogenic coronaviruses. These features include enhancement of the nuclear localization signals in the nucleocapsid protein and distinct inserts in the spike glycoprotein that appear to be associated with high case fatality rate of these coronaviruses as well as the host switch from animals to humans. The identified features could be crucial contributors to coronavirus pathogenicity and possible targets for diagnostics, prognostication, and interventions.",,f8g14heh,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'poses', 'an', 'immediate', 'major', 'threat', 'to', 'public', 'health', 'across', 'the', 'globe', 'Here', 'we', 'report', 'an', 'in', 'depth', 'molecular', 'analysis', 'to', 'reconstruct', 'the', 'evolutionary', 'origins', 'of', 'the', 'enhanced', 'pathogenicity', 'of', 'SARS', 'CoV', '2', 'and', 'other', 'coronaviruses', 'that', 'are', 'severe', 'human', 'pathogens', 'Using', 'integrated', 'comparative', 'genomics', 'and', 'machine', 'learning', 'techniques', 'we', 'identify', 'key', 'genomic', 'features', 'that', 'differentiate', 'SARS', 'CoV', '2', 'and', 'the', 'viruses', 'behind', 'the', 'two', 'previous', 'deadly', 'coronavirus', 'outbreaks', 'SARS', 'CoV', 'and', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'from', 'less', 'pathogenic', 'coronaviruses', 'These', 'features', 'include', 'enhancement', 'of', 'the', 'nuclear', 'localization', 'signals', 'in', 'the', 'nucleocapsid', 'protein', 'and', 'distinct', 'inserts', 'in', 'the', 'spike', 'glycoprotein', 'that', 'appear', 'to', 'be', 'associated', 'with', 'high', 'case', 'fatality', 'rate', 'of', 'these', 'coronaviruses', 'as', 'well', 'as', 'the', 'host', 'switch', 'from', 'animals', 'to', 'humans', 'The', 'identified', 'features', 'could', 'be', 'crucial', 'contributors', 'to', 'coronavirus', 'pathogenicity', 'and', 'possible', 'targets', 'for', 'diagnostics', 'prognostication', 'and', 'interventions', '']"
123931,Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses,2020,Proc. Natl. Acad. Sci. U. S. A,,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses an immediate, major threat to public health across the globe. Here we report an in-depth molecular analysis to reconstruct the evolutionary origins of the enhanced pathogenicity of SARS-CoV-2 and other coronaviruses that are severe human pathogens. Using integrated comparative genomics and machine learning techniques, we identify key genomic features that differentiate SARS-CoV-2 and the viruses behind the two previous deadly coronavirus outbreaks, SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), from less pathogenic coronaviruses. These features include enhancement of the nuclear localization signals in the nucleocapsid protein and distinct inserts in the spike glycoprotein that appear to be associated with high case fatality rate of these coronaviruses as well as the host switch from animals to humans. The identified features could be crucial contributors to coronavirus pathogenicity and possible targets for diagnostics, prognostication, and interventions.",,u3qplplg,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'poses', 'an', 'immediate', 'major', 'threat', 'to', 'public', 'health', 'across', 'the', 'globe', 'Here', 'we', 'report', 'an', 'in', 'depth', 'molecular', 'analysis', 'to', 'reconstruct', 'the', 'evolutionary', 'origins', 'of', 'the', 'enhanced', 'pathogenicity', 'of', 'SARS', 'CoV', '2', 'and', 'other', 'coronaviruses', 'that', 'are', 'severe', 'human', 'pathogens', 'Using', 'integrated', 'comparative', 'genomics', 'and', 'machine', 'learning', 'techniques', 'we', 'identify', 'key', 'genomic', 'features', 'that', 'differentiate', 'SARS', 'CoV', '2', 'and', 'the', 'viruses', 'behind', 'the', 'two', 'previous', 'deadly', 'coronavirus', 'outbreaks', 'SARS', 'CoV', 'and', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'from', 'less', 'pathogenic', 'coronaviruses', 'These', 'features', 'include', 'enhancement', 'of', 'the', 'nuclear', 'localization', 'signals', 'in', 'the', 'nucleocapsid', 'protein', 'and', 'distinct', 'inserts', 'in', 'the', 'spike', 'glycoprotein', 'that', 'appear', 'to', 'be', 'associated', 'with', 'high', 'case', 'fatality', 'rate', 'of', 'these', 'coronaviruses', 'as', 'well', 'as', 'the', 'host', 'switch', 'from', 'animals', 'to', 'humans', 'The', 'identified', 'features', 'could', 'be', 'crucial', 'contributors', 'to', 'coronavirus', 'pathogenicity', 'and', 'possible', 'targets', 'for', 'diagnostics', 'prognostication', 'and', 'interventions', '']"
123939,"Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020",2020,MMWR Morb Mortal Wkly Rep,,"On December 31, 2019, Chinese health officials reported a cluster of cases of acute respiratory illness in persons associated with the Hunan seafood and animal market in the city of Wuhan, Hubei Province, in central China. On January 7, 2020, Chinese health officials confirmed that a novel coronavirus (2019-nCoV) was associated with this initial cluster (1). As of February 4, 2020, a total of 20,471 confirmed cases, including 2,788 (13.6%) with severe illness,* and 425 deaths (2.1%) had been reported by the National Health Commission of China (2). Cases have also been reported in 26 locations outside of mainland China, including documentation of some person-to-person transmission and one death (2). As of February 4, 11 cases had been reported in the United States. On January 30, the World Health Organization (WHO) Director-General declared that the 2019-nCoV outbreak constitutes a Public Health Emergency of International Concern. On January 31, the U.S. Department of Health and Human Services (HHS) Secretary declared a U.S. public health emergency to respond to 2019-nCoV.§ Also on January 31, the president of the United States signed a ""Proclamation on Suspension of Entry as Immigrants and Nonimmigrants of Persons who Pose a Risk of Transmitting 2019 Novel Coronavirus,"" which limits entry into the United States of persons who traveled to mainland China to U.S. citizens and lawful permanent residents and their families (3). CDC, multiple other federal agencies, state and local health departments, and other partners are implementing aggressive measures to slow transmission of 2019-nCoV in the United States (4,5). These measures require the identification of cases and their contacts in the United States and the appropriate assessment and care of travelers arriving from mainland China to the United States. These measures are being implemented in anticipation of additional 2019-nCoV cases in the United States. Although these measures might not prevent the eventual establishment of ongoing, widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare health care systems and the general public to be ready if widespread transmission with substantial associated illness occurs; and 3) better characterize 2019-nCoV infection to guide public health recommendations and the development of medical countermeasures including diagnostics, therapeutics, and vaccines. Public health authorities are monitoring the situation closely. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC and state and local health departments.",,emcn4wcj,"['On', 'December', '31', '2019', 'Chinese', 'health', 'officials', 'reported', 'a', 'cluster', 'of', 'cases', 'of', 'acute', 'respiratory', 'illness', 'in', 'persons', 'associated', 'with', 'the', 'Hunan', 'seafood', 'and', 'animal', 'market', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'Province', 'in', 'central', 'China', 'On', 'January', '7', '2020', 'Chinese', 'health', 'officials', 'confirmed', 'that', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'was', 'associated', 'with', 'this', 'initial', 'cluster', '1', 'As', 'of', 'February', '4', '2020', 'a', 'total', 'of', '20', '471', 'confirmed', 'cases', 'including', '2', '788', '13', '6', 'with', 'severe', 'illness', 'and', '425', 'deaths', '2', '1', 'had', 'been', 'reported', 'by', 'the', 'National', 'Health', 'Commission', 'of', 'China', '2', 'Cases', 'have', 'also', 'been', 'reported', 'in', '26', 'locations', 'outside', 'of', 'mainland', 'China', 'including', 'documentation', 'of', 'some', 'person', 'to', 'person', 'transmission', 'and', 'one', 'death', '2', 'As', 'of', 'February', '4', '11', 'cases', 'had', 'been', 'reported', 'in', 'the', 'United', 'States', 'On', 'January', '30', 'the', 'World', 'Health', 'Organization', 'WHO', 'Director', 'General', 'declared', 'that', 'the', '2019', 'nCoV', 'outbreak', 'constitutes', 'a', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'On', 'January', '31', 'the', 'U', 'S', 'Department', 'of', 'Health', 'and', 'Human', 'Services', 'HHS', 'Secretary', 'declared', 'a', 'U', 'S', 'public', 'health', 'emergency', 'to', 'respond', 'to', '2019', 'nCoV', 'Also', 'on', 'January', '31', 'the', 'president', 'of', 'the', 'United', 'States', 'signed', 'a', 'Proclamation', 'on', 'Suspension', 'of', 'Entry', 'as', 'Immigrants', 'and', 'Nonimmigrants', 'of', 'Persons', 'who', 'Pose', 'a', 'Risk', 'of', 'Transmitting', '2019', 'Novel', 'Coronavirus', 'which', 'limits', 'entry', 'into', 'the', 'United', 'States', 'of', 'persons', 'who', 'traveled', 'to', 'mainland', 'China', 'to', 'U', 'S', 'citizens', 'and', 'lawful', 'permanent', 'residents', 'and', 'their', 'families', '3', 'CDC', 'multiple', 'other', 'federal', 'agencies', 'state', 'and', 'local', 'health', 'departments', 'and', 'other', 'partners', 'are', 'implementing', 'aggressive', 'measures', 'to', 'slow', 'transmission', 'of', '2019', 'nCoV', 'in', 'the', 'United', 'States', '4', '5', 'These', 'measures', 'require', 'the', 'identification', 'of', 'cases', 'and', 'their', 'contacts', 'in', 'the', 'United', 'States', 'and', 'the', 'appropriate', 'assessment', 'and', 'care', 'of', 'travelers', 'arriving', 'from', 'mainland', 'China', 'to', 'the', 'United', 'States', 'These', 'measures', 'are', 'being', 'implemented', 'in', 'anticipation', 'of', 'additional', '2019', 'nCoV', 'cases', 'in', 'the', 'United', 'States', 'Although', 'these', 'measures', 'might', 'not', 'prevent', 'the', 'eventual', 'establishment', 'of', 'ongoing', 'widespread', 'transmission', 'of', 'the', 'virus', 'in', 'the', 'United', 'States', 'they', 'are', 'being', 'implemented', 'to', '1', 'slow', 'the', 'spread', 'of', 'illness', '2', 'provide', 'time', 'to', 'better', 'prepare', 'health', 'care', 'systems', 'and', 'the', 'general', 'public', 'to', 'be', 'ready', 'if', 'widespread', 'transmission', 'with', 'substantial', 'associated', 'illness', 'occurs', 'and', '3', 'better', 'characterize', '2019', 'nCoV', 'infection', 'to', 'guide', 'public', 'health', 'recommendations', 'and', 'the', 'development', 'of', 'medical', 'countermeasures', 'including', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'Public', 'health', 'authorities', 'are', 'monitoring', 'the', 'situation', 'closely', 'As', 'more', 'is', 'learned', 'about', 'this', 'novel', 'virus', 'and', 'this', 'outbreak', 'CDC', 'will', 'rapidly', 'incorporate', 'new', 'knowledge', 'into', 'guidance', 'for', 'action', 'by', 'CDC', 'and', 'state', 'and', 'local', 'health', 'departments', '']"
123940,"Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020",2020,MMWR Morb Mortal Wkly Rep,,"On December 31, 2019, Chinese health officials reported a cluster of cases of acute respiratory illness in persons associated with the Hunan seafood and animal market in the city of Wuhan, Hubei Province, in central China. On January 7, 2020, Chinese health officials confirmed that a novel coronavirus (2019-nCoV) was associated with this initial cluster (1). As of February 4, 2020, a total of 20,471 confirmed cases, including 2,788 (13.6%) with severe illness,* and 425 deaths (2.1%) had been reported by the National Health Commission of China (2). Cases have also been reported in 26 locations outside of mainland China, including documentation of some person-to-person transmission and one death (2). As of February 4, 11 cases had been reported in the United States. On January 30, the World Health Organization (WHO) Director-General declared that the 2019-nCoV outbreak constitutes a Public Health Emergency of International Concern. On January 31, the U.S. Department of Health and Human Services (HHS) Secretary declared a U.S. public health emergency to respond to 2019-nCoV.§ Also on January 31, the president of the United States signed a ""Proclamation on Suspension of Entry as Immigrants and Nonimmigrants of Persons who Pose a Risk of Transmitting 2019 Novel Coronavirus,"" which limits entry into the United States of persons who traveled to mainland China to U.S. citizens and lawful permanent residents and their families (3). CDC, multiple other federal agencies, state and local health departments, and other partners are implementing aggressive measures to slow transmission of 2019-nCoV in the United States (4,5). These measures require the identification of cases and their contacts in the United States and the appropriate assessment and care of travelers arriving from mainland China to the United States. These measures are being implemented in anticipation of additional 2019-nCoV cases in the United States. Although these measures might not prevent the eventual establishment of ongoing, widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare health care systems and the general public to be ready if widespread transmission with substantial associated illness occurs; and 3) better characterize 2019-nCoV infection to guide public health recommendations and the development of medical countermeasures including diagnostics, therapeutics, and vaccines. Public health authorities are monitoring the situation closely. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC and state and local health departments.",,2qrxoqmh,"['On', 'December', '31', '2019', 'Chinese', 'health', 'officials', 'reported', 'a', 'cluster', 'of', 'cases', 'of', 'acute', 'respiratory', 'illness', 'in', 'persons', 'associated', 'with', 'the', 'Hunan', 'seafood', 'and', 'animal', 'market', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'Province', 'in', 'central', 'China', 'On', 'January', '7', '2020', 'Chinese', 'health', 'officials', 'confirmed', 'that', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'was', 'associated', 'with', 'this', 'initial', 'cluster', '1', 'As', 'of', 'February', '4', '2020', 'a', 'total', 'of', '20', '471', 'confirmed', 'cases', 'including', '2', '788', '13', '6', 'with', 'severe', 'illness', 'and', '425', 'deaths', '2', '1', 'had', 'been', 'reported', 'by', 'the', 'National', 'Health', 'Commission', 'of', 'China', '2', 'Cases', 'have', 'also', 'been', 'reported', 'in', '26', 'locations', 'outside', 'of', 'mainland', 'China', 'including', 'documentation', 'of', 'some', 'person', 'to', 'person', 'transmission', 'and', 'one', 'death', '2', 'As', 'of', 'February', '4', '11', 'cases', 'had', 'been', 'reported', 'in', 'the', 'United', 'States', 'On', 'January', '30', 'the', 'World', 'Health', 'Organization', 'WHO', 'Director', 'General', 'declared', 'that', 'the', '2019', 'nCoV', 'outbreak', 'constitutes', 'a', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'On', 'January', '31', 'the', 'U', 'S', 'Department', 'of', 'Health', 'and', 'Human', 'Services', 'HHS', 'Secretary', 'declared', 'a', 'U', 'S', 'public', 'health', 'emergency', 'to', 'respond', 'to', '2019', 'nCoV', 'Also', 'on', 'January', '31', 'the', 'president', 'of', 'the', 'United', 'States', 'signed', 'a', 'Proclamation', 'on', 'Suspension', 'of', 'Entry', 'as', 'Immigrants', 'and', 'Nonimmigrants', 'of', 'Persons', 'who', 'Pose', 'a', 'Risk', 'of', 'Transmitting', '2019', 'Novel', 'Coronavirus', 'which', 'limits', 'entry', 'into', 'the', 'United', 'States', 'of', 'persons', 'who', 'traveled', 'to', 'mainland', 'China', 'to', 'U', 'S', 'citizens', 'and', 'lawful', 'permanent', 'residents', 'and', 'their', 'families', '3', 'CDC', 'multiple', 'other', 'federal', 'agencies', 'state', 'and', 'local', 'health', 'departments', 'and', 'other', 'partners', 'are', 'implementing', 'aggressive', 'measures', 'to', 'slow', 'transmission', 'of', '2019', 'nCoV', 'in', 'the', 'United', 'States', '4', '5', 'These', 'measures', 'require', 'the', 'identification', 'of', 'cases', 'and', 'their', 'contacts', 'in', 'the', 'United', 'States', 'and', 'the', 'appropriate', 'assessment', 'and', 'care', 'of', 'travelers', 'arriving', 'from', 'mainland', 'China', 'to', 'the', 'United', 'States', 'These', 'measures', 'are', 'being', 'implemented', 'in', 'anticipation', 'of', 'additional', '2019', 'nCoV', 'cases', 'in', 'the', 'United', 'States', 'Although', 'these', 'measures', 'might', 'not', 'prevent', 'the', 'eventual', 'establishment', 'of', 'ongoing', 'widespread', 'transmission', 'of', 'the', 'virus', 'in', 'the', 'United', 'States', 'they', 'are', 'being', 'implemented', 'to', '1', 'slow', 'the', 'spread', 'of', 'illness', '2', 'provide', 'time', 'to', 'better', 'prepare', 'health', 'care', 'systems', 'and', 'the', 'general', 'public', 'to', 'be', 'ready', 'if', 'widespread', 'transmission', 'with', 'substantial', 'associated', 'illness', 'occurs', 'and', '3', 'better', 'characterize', '2019', 'nCoV', 'infection', 'to', 'guide', 'public', 'health', 'recommendations', 'and', 'the', 'development', 'of', 'medical', 'countermeasures', 'including', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'Public', 'health', 'authorities', 'are', 'monitoring', 'the', 'situation', 'closely', 'As', 'more', 'is', 'learned', 'about', 'this', 'novel', 'virus', 'and', 'this', 'outbreak', 'CDC', 'will', 'rapidly', 'incorporate', 'new', 'knowledge', 'into', 'guidance', 'for', 'action', 'by', 'CDC', 'and', 'state', 'and', 'local', 'health', 'departments', '']"
125221,Novel coronavirus: From discovery to clinical diagnostics,2020,Infect Genet Evol,,"A novel coronavirus designated as 2019-nCoV first appeared in Wuhan, China in late December 2019. Dozens of people died in China, and thousands of people infected as 2019-nCoV continues to spread around the world. We have described the discovery, emergence, genomic characteristics, and clinical diagnostics of 2019-nCoV.",,s9tw6p56,"['A', 'novel', 'coronavirus', 'designated', 'as', '2019', 'nCoV', 'first', 'appeared', 'in', 'Wuhan', 'China', 'in', 'late', 'December', '2019', 'Dozens', 'of', 'people', 'died', 'in', 'China', 'and', 'thousands', 'of', 'people', 'infected', 'as', '2019', 'nCoV', 'continues', 'to', 'spread', 'around', 'the', 'world', 'We', 'have', 'described', 'the', 'discovery', 'emergence', 'genomic', 'characteristics', 'and', 'clinical', 'diagnostics', 'of', '2019', 'nCoV', '']"
125741,Automated detection of COVID-19 cases using deep neural networks with X-ray images,2020,Comput Biol Med,,"The novel coronavirus 2019 (COVID-2019), which first appeared in Wuhan city of China in December 2019, spread rapidly around the world and became a pandemic. It has caused a devastating effect on both daily lives, public health, and the global economy. It is critical to detect the positive cases as early as possible so as to prevent the further spread of this epidemic and to quickly treat affected patients. The need for auxiliary diagnostic tools has increased as there are no accurate automated toolkits available. Recent findings obtained using radiology imaging techniques suggest that such images contain salient information about the COVID-19 virus. Application of advanced artificial intelligence (AI) techniques coupled with radiological imaging can be helpful for the accurate detection of this disease, and can also be assistive to overcome the problem of a lack of specialized physicians in remote villages. In this study, a new model for automatic COVID-19 detection using raw chest X-ray images is presented. The proposed model is developed to provide accurate diagnostics for binary classification (COVID vs. No-Findings) and multi-class classification (COVID vs. No-Findings vs. Pneumonia). Our model produced a classification accuracy of 98.08% for binary classes and 87.02% for multi-class cases. The DarkNet model was used in our study as a classifier for the you only look once (YOLO) real time object detection system. We implemented 17 convolutional layers and introduced different filtering on each layer. Our model (available at (https://github.com/muhammedtalo/COVID-19)) can be employed to assist radiologists in validating their initial screening, and can also be employed via cloud to immediately screen patients.",,6aj8zsto,"['The', 'novel', 'coronavirus', '2019', 'COVID', '2019', 'which', 'first', 'appeared', 'in', 'Wuhan', 'city', 'of', 'China', 'in', 'December', '2019', 'spread', 'rapidly', 'around', 'the', 'world', 'and', 'became', 'a', 'pandemic', 'It', 'has', 'caused', 'a', 'devastating', 'effect', 'on', 'both', 'daily', 'lives', 'public', 'health', 'and', 'the', 'global', 'economy', 'It', 'is', 'critical', 'to', 'detect', 'the', 'positive', 'cases', 'as', 'early', 'as', 'possible', 'so', 'as', 'to', 'prevent', 'the', 'further', 'spread', 'of', 'this', 'epidemic', 'and', 'to', 'quickly', 'treat', 'affected', 'patients', 'The', 'need', 'for', 'auxiliary', 'diagnostic', 'tools', 'has', 'increased', 'as', 'there', 'are', 'no', 'accurate', 'automated', 'toolkits', 'available', 'Recent', 'findings', 'obtained', 'using', 'radiology', 'imaging', 'techniques', 'suggest', 'that', 'such', 'images', 'contain', 'salient', 'information', 'about', 'the', 'COVID', '19', 'virus', 'Application', 'of', 'advanced', 'artificial', 'intelligence', 'AI', 'techniques', 'coupled', 'with', 'radiological', 'imaging', 'can', 'be', 'helpful', 'for', 'the', 'accurate', 'detection', 'of', 'this', 'disease', 'and', 'can', 'also', 'be', 'assistive', 'to', 'overcome', 'the', 'problem', 'of', 'a', 'lack', 'of', 'specialized', 'physicians', 'in', 'remote', 'villages', 'In', 'this', 'study', 'a', 'new', 'model', 'for', 'automatic', 'COVID', '19', 'detection', 'using', 'raw', 'chest', 'X', 'ray', 'images', 'is', 'presented', 'The', 'proposed', 'model', 'is', 'developed', 'to', 'provide', 'accurate', 'diagnostics', 'for', 'binary', 'classification', 'COVID', 'vs', 'No', 'Findings', 'and', 'multi', 'class', 'classification', 'COVID', 'vs', 'No', 'Findings', 'vs', 'Pneumonia', 'Our', 'model', 'produced', 'a', 'classification', 'accuracy', 'of', '98', '08', 'for', 'binary', 'classes', 'and', '87', '02', 'for', 'multi', 'class', 'cases', 'The', 'DarkNet', 'model', 'was', 'used', 'in', 'our', 'study', 'as', 'a', 'classifier', 'for', 'the', 'you', 'only', 'look', 'once', 'YOLO', 'real', 'time', 'object', 'detection', 'system', 'We', 'implemented', '17', 'convolutional', 'layers', 'and', 'introduced', 'different', 'filtering', 'on', 'each', 'layer', 'Our', 'model', 'available', 'at', 'https', 'github', 'com', 'muhammedtalo', 'COVID', '19', 'can', 'be', 'employed', 'to', 'assist', 'radiologists', 'in', 'validating', 'their', 'initial', 'screening', 'and', 'can', 'also', 'be', 'employed', 'via', 'cloud', 'to', 'immediately', 'screen', 'patients', '']"
126361,Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium,2020,J. virol,,"Currently, there are four seasonal coronaviruses associated with relatively mild respiratory tract disease in humans. However, there is also a plethora of animal coronaviruses which have the potential to cross the species border. This regularly results in the emergence of new viruses in humans. In 2002, severe acute respiratory syndrome coronavirus (SARS-CoV) emerged and rapidly disappeared in May 2003. In 2012, Middle East respiratory syndrome coronavirus (MERS-CoV) was identified as a possible threat to humans, but its pandemic potential so far is minimal, as human-to-human transmission is ineffective. The end of 2019 brought us information about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emergence, and the virus rapidly spread in 2020, causing an unprecedented pandemic. At present, studies on the virus are carried out using a surrogate system based on the immortalized simian Vero E6 cell line. This model is convenient for diagnostics, but it has serious limitations and does not allow for understanding of the biology and evolution of the virus. Here, we show that fully differentiated human airway epithelium cultures constitute an excellent model to study infection with the novel human coronavirus SARS-CoV-2. We observed efficient replication of the virus in the tissue, with maximal replication at 2 days postinfection. The virus replicated in ciliated cells and was released apically.IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged by the end of 2019 and rapidly spread in 2020. At present, it is of utmost importance to understand the biology of the virus, rapidly assess the treatment potential of existing drugs, and develop new active compounds. While some animal models for such studies are under development, most of the research is carried out in Vero E6 cells. Here, we propose fully differentiated human airway epithelium cultures as a model for studies on SARS-CoV-2.",,598n91gb,"['Currently', 'there', 'are', 'four', 'seasonal', 'coronaviruses', 'associated', 'with', 'relatively', 'mild', 'respiratory', 'tract', 'disease', 'in', 'humans', 'However', 'there', 'is', 'also', 'a', 'plethora', 'of', 'animal', 'coronaviruses', 'which', 'have', 'the', 'potential', 'to', 'cross', 'the', 'species', 'border', 'This', 'regularly', 'results', 'in', 'the', 'emergence', 'of', 'new', 'viruses', 'in', 'humans', 'In', '2002', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'SARS', 'CoV', 'emerged', 'and', 'rapidly', 'disappeared', 'in', 'May', '2003', 'In', '2012', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'was', 'identified', 'as', 'a', 'possible', 'threat', 'to', 'humans', 'but', 'its', 'pandemic', 'potential', 'so', 'far', 'is', 'minimal', 'as', 'human', 'to', 'human', 'transmission', 'is', 'ineffective', 'The', 'end', 'of', '2019', 'brought', 'us', 'information', 'about', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'emergence', 'and', 'the', 'virus', 'rapidly', 'spread', 'in', '2020', 'causing', 'an', 'unprecedented', 'pandemic', 'At', 'present', 'studies', 'on', 'the', 'virus', 'are', 'carried', 'out', 'using', 'a', 'surrogate', 'system', 'based', 'on', 'the', 'immortalized', 'simian', 'Vero', 'E6', 'cell', 'line', 'This', 'model', 'is', 'convenient', 'for', 'diagnostics', 'but', 'it', 'has', 'serious', 'limitations', 'and', 'does', 'not', 'allow', 'for', 'understanding', 'of', 'the', 'biology', 'and', 'evolution', 'of', 'the', 'virus', 'Here', 'we', 'show', 'that', 'fully', 'differentiated', 'human', 'airway', 'epithelium', 'cultures', 'constitute', 'an', 'excellent', 'model', 'to', 'study', 'infection', 'with', 'the', 'novel', 'human', 'coronavirus', 'SARS', 'CoV', '2', 'We', 'observed', 'efficient', 'replication', 'of', 'the', 'virus', 'in', 'the', 'tissue', 'with', 'maximal', 'replication', 'at', '2', 'days', 'postinfection', 'The', 'virus', 'replicated', 'in', 'ciliated', 'cells', 'and', 'was', 'released', 'apically', 'IMPORTANCE', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'emerged', 'by', 'the', 'end', 'of', '2019', 'and', 'rapidly', 'spread', 'in', '2020', 'At', 'present', 'it', 'is', 'of', 'utmost', 'importance', 'to', 'understand', 'the', 'biology', 'of', 'the', 'virus', 'rapidly', 'assess', 'the', 'treatment', 'potential', 'of', 'existing', 'drugs', 'and', 'develop', 'new', 'active', 'compounds', 'While', 'some', 'animal', 'models', 'for', 'such', 'studies', 'are', 'under', 'development', 'most', 'of', 'the', 'research', 'is', 'carried', 'out', 'in', 'Vero', 'E6', 'cells', 'Here', 'we', 'propose', 'fully', 'differentiated', 'human', 'airway', 'epithelium', 'cultures', 'as', 'a', 'model', 'for', 'studies', 'on', 'SARS', 'CoV', '2', '']"
127362,An update on the status of COVID-19: a comprehensive review,2020,Eur Rev Med Pharmacol Sci,,"The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19).",,limug35b,"['The', 'last', 'two', 'decades', 'have', 'witnessed', 'two', 'large', 'scale', 'pandemics', 'caused', 'by', 'coronaviruses', 'including', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'and', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'At', 'the', 'end', 'of', '2019', 'another', 'novel', 'coronavirus', 'designated', 'as', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'hit', 'Wuhan', 'a', 'city', 'in', 'the', 'center', 'of', 'China', 'and', 'subsequently', 'spread', 'rapidly', 'to', 'the', 'whole', 'world', 'Latest', 'reports', 'revealed', 'that', 'more', 'than', '800', 'thousand', 'people', 'in', 'over', '200', 'countries', 'are', 'involved', 'in', 'the', 'epidemic', 'disease', 'by', 'SARS', 'CoV', '2', 'Due', 'to', 'the', 'high', 'mortality', 'rate', 'and', 'the', 'lack', 'of', 'optimum', 'therapeutics', 'it', 'is', 'crucial', 'to', 'understand', 'the', 'biological', 'characteristics', 'of', 'the', 'virus', 'and', 'its', 'possible', 'pathogenesis', 'to', 'respond', 'to', 'the', 'SARS', 'CoV', '2', 'Rapid', 'diagnostics', 'and', 'effective', 'therapeutics', 'are', 'also', 'important', 'interventions', 'for', 'the', 'management', 'of', 'infection', 'control', 'However', 'the', 'rapid', 'evolution', 'of', 'SARS', 'CoV', '2', 'exerted', 'tremendous', 'challenges', 'on', 'its', 'diagnostics', 'and', 'therapeutics', 'Therefore', 'there', 'is', 'an', 'urgent', 'need', 'to', 'summarize', 'the', 'existing', 'research', 'results', 'to', 'guide', 'decision', 'making', 'on', 'the', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'In', 'this', 'review', 'we', 'focus', 'on', 'our', 'current', 'understanding', 'of', 'epidemiology', 'pathogenesis', 'diagnostics', 'and', 'therapeutics', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', '']"
127363,An update on the status of COVID-19: a comprehensive review,2020,Eur Rev Med Pharmacol Sci,,"The last two decades have witnessed two large-scale pandemics caused by coronaviruses, including severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS). At the end of 2019, another novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), hit Wuhan, a city in the center of China, and subsequently spread rapidly to the whole world. Latest reports revealed that more than 800 thousand people in over 200 countries are involved in the epidemic disease by SARS-CoV-2. Due to the high mortality rate and the lack of optimum therapeutics, it is crucial to understand the biological characteristics of the virus and its possible pathogenesis to respond to the SARS-CoV-2. Rapid diagnostics and effective therapeutics are also important interventions for the management of infection control. However, the rapid evolution of SARS-CoV-2 exerted tremendous challenges on its diagnostics and therapeutics. Therefore, there is an urgent need to summarize the existing research results to guide decision-making on the prioritization of resources for research and development. In this review, we focus on our current understanding of epidemiology, pathogenesis, diagnostics and therapeutics of coronavirus disease 2019 (COVID-19).",,gj8ng7xg,"['The', 'last', 'two', 'decades', 'have', 'witnessed', 'two', 'large', 'scale', 'pandemics', 'caused', 'by', 'coronaviruses', 'including', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'and', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'At', 'the', 'end', 'of', '2019', 'another', 'novel', 'coronavirus', 'designated', 'as', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'hit', 'Wuhan', 'a', 'city', 'in', 'the', 'center', 'of', 'China', 'and', 'subsequently', 'spread', 'rapidly', 'to', 'the', 'whole', 'world', 'Latest', 'reports', 'revealed', 'that', 'more', 'than', '800', 'thousand', 'people', 'in', 'over', '200', 'countries', 'are', 'involved', 'in', 'the', 'epidemic', 'disease', 'by', 'SARS', 'CoV', '2', 'Due', 'to', 'the', 'high', 'mortality', 'rate', 'and', 'the', 'lack', 'of', 'optimum', 'therapeutics', 'it', 'is', 'crucial', 'to', 'understand', 'the', 'biological', 'characteristics', 'of', 'the', 'virus', 'and', 'its', 'possible', 'pathogenesis', 'to', 'respond', 'to', 'the', 'SARS', 'CoV', '2', 'Rapid', 'diagnostics', 'and', 'effective', 'therapeutics', 'are', 'also', 'important', 'interventions', 'for', 'the', 'management', 'of', 'infection', 'control', 'However', 'the', 'rapid', 'evolution', 'of', 'SARS', 'CoV', '2', 'exerted', 'tremendous', 'challenges', 'on', 'its', 'diagnostics', 'and', 'therapeutics', 'Therefore', 'there', 'is', 'an', 'urgent', 'need', 'to', 'summarize', 'the', 'existing', 'research', 'results', 'to', 'guide', 'decision', 'making', 'on', 'the', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'In', 'this', 'review', 'we', 'focus', 'on', 'our', 'current', 'understanding', 'of', 'epidemiology', 'pathogenesis', 'diagnostics', 'and', 'therapeutics', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', '']"
129977,RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look,2020,RNA,,"As the COVID-19 outbreak spreads, there is a growing need for a compilation of conserved RNA genome regions in the SARS-CoV-2 virus along with their structural propensities to guide development of antivirals and diagnostics. Here we present a first look at RNA sequence conservation and structural propensities in the SARS-CoV-2 genome. Using sequence alignments spanning a range of betacoronaviruses, we rank genomic regions by RNA sequence conservation, identifying 79 regions of length at least 15 nt as exactly conserved over SARS-related complete genome sequences available near the beginning of the COVID-19 outbreak. We then confirm the conservation of the majority of these genome regions across 739 SARS-CoV-2 sequences subsequently reported from the COVID-19 outbreak, and we present a curated list of 30 ""SARS-related-conserved"" regions. We find that known RNA structured elements curated as Rfam families and in prior literature are enriched in these conserved genome regions, and we predict additional conserved, stable secondary structures across the viral genome. We provide 106 ""SARS-CoV-2-conserved-structured"" regions as potential targets for antivirals that bind to structured RNA. We further provide detailed secondary structure models for the extended 5' UTR, frameshifting stimulation element, and 3' UTR. Lastly, we predict regions of the SARS-CoV-2 viral genome that have low propensity for RNA secondary structure and are conserved within SARS-CoV-2 strains. These 59 ""SARS-CoV-2-conserved-unstructured"" genomic regions may be most easily accessible by hybridization in primer-based diagnostic strategies.",,6kv372ue,"['As', 'the', 'COVID', '19', 'outbreak', 'spreads', 'there', 'is', 'a', 'growing', 'need', 'for', 'a', 'compilation', 'of', 'conserved', 'RNA', 'genome', 'regions', 'in', 'the', 'SARS', 'CoV', '2', 'virus', 'along', 'with', 'their', 'structural', 'propensities', 'to', 'guide', 'development', 'of', 'antivirals', 'and', 'diagnostics', 'Here', 'we', 'present', 'a', 'first', 'look', 'at', 'RNA', 'sequence', 'conservation', 'and', 'structural', 'propensities', 'in', 'the', 'SARS', 'CoV', '2', 'genome', 'Using', 'sequence', 'alignments', 'spanning', 'a', 'range', 'of', 'betacoronaviruses', 'we', 'rank', 'genomic', 'regions', 'by', 'RNA', 'sequence', 'conservation', 'identifying', '79', 'regions', 'of', 'length', 'at', 'least', '15', 'nt', 'as', 'exactly', 'conserved', 'over', 'SARS', 'related', 'complete', 'genome', 'sequences', 'available', 'near', 'the', 'beginning', 'of', 'the', 'COVID', '19', 'outbreak', 'We', 'then', 'confirm', 'the', 'conservation', 'of', 'the', 'majority', 'of', 'these', 'genome', 'regions', 'across', '739', 'SARS', 'CoV', '2', 'sequences', 'subsequently', 'reported', 'from', 'the', 'COVID', '19', 'outbreak', 'and', 'we', 'present', 'a', 'curated', 'list', 'of', '30', 'SARS', 'related', 'conserved', 'regions', 'We', 'find', 'that', 'known', 'RNA', 'structured', 'elements', 'curated', 'as', 'Rfam', 'families', 'and', 'in', 'prior', 'literature', 'are', 'enriched', 'in', 'these', 'conserved', 'genome', 'regions', 'and', 'we', 'predict', 'additional', 'conserved', 'stable', 'secondary', 'structures', 'across', 'the', 'viral', 'genome', 'We', 'provide', '106', 'SARS', 'CoV', '2', 'conserved', 'structured', 'regions', 'as', 'potential', 'targets', 'for', 'antivirals', 'that', 'bind', 'to', 'structured', 'RNA', 'We', 'further', 'provide', 'detailed', 'secondary', 'structure', 'models', 'for', 'the', 'extended', '5', 'UTR', 'frameshifting', 'stimulation', 'element', 'and', '3', 'UTR', 'Lastly', 'we', 'predict', 'regions', 'of', 'the', 'SARS', 'CoV', '2', 'viral', 'genome', 'that', 'have', 'low', 'propensity', 'for', 'RNA', 'secondary', 'structure', 'and', 'are', 'conserved', 'within', 'SARS', 'CoV', '2', 'strains', 'These', '59', 'SARS', 'CoV', '2', 'conserved', 'unstructured', 'genomic', 'regions', 'may', 'be', 'most', 'easily', 'accessible', 'by', 'hybridization', 'in', 'primer', 'based', 'diagnostic', 'strategies', '']"
130054,"Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments",2020,Vet Q,,"Coronaviruses are the well-known cause of severe respiratory, enteric and systemic infections in a wide range of hosts including man, mammals, fish, and avian. The scientific interest on coronaviruses increased after the emergence of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) outbreaks in 2002-2003 followed by Middle East Respiratory Syndrome CoV (MERS-CoV). This decade's first CoV, named 2019-nCoV, emerged from Wuhan, China, and declared as 'Public Health Emergency of International Concern' on January 30th, 2020 by the World Health Organization (WHO). As on February 4, 2020, 425 deaths reported in China only and one death outside China (Philippines). In a short span of time, the virus spread has been noted in 24 countries. The zoonotic transmission (animal-to-human) is suspected as the route of disease origin. The genetic analyses predict bats as the most probable source of 2019-nCoV though further investigations needed to confirm the origin of the novel virus. The ongoing nCoV outbreak highlights the hidden wild animal reservoir of the deadly viruses and possible threat of spillover zoonoses as well. The successful virus isolation attempts have made doors open for developing better diagnostics and effective vaccines helping in combating the spread of the virus to newer areas.",,22fc1qly,"['Coronaviruses', 'are', 'the', 'well', 'known', 'cause', 'of', 'severe', 'respiratory', 'enteric', 'and', 'systemic', 'infections', 'in', 'a', 'wide', 'range', 'of', 'hosts', 'including', 'man', 'mammals', 'fish', 'and', 'avian', 'The', 'scientific', 'interest', 'on', 'coronaviruses', 'increased', 'after', 'the', 'emergence', 'of', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'coronavirus', 'SARS', 'CoV', 'outbreaks', 'in', '2002', '2003', 'followed', 'by', 'Middle', 'East', 'Respiratory', 'Syndrome', 'CoV', 'MERS', 'CoV', 'This', 'decade', 's', 'first', 'CoV', 'named', '2019', 'nCoV', 'emerged', 'from', 'Wuhan', 'China', 'and', 'declared', 'as', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'on', 'January', '30th', '2020', 'by', 'the', 'World', 'Health', 'Organization', 'WHO', 'As', 'on', 'February', '4', '2020', '425', 'deaths', 'reported', 'in', 'China', 'only', 'and', 'one', 'death', 'outside', 'China', 'Philippines', 'In', 'a', 'short', 'span', 'of', 'time', 'the', 'virus', 'spread', 'has', 'been', 'noted', 'in', '24', 'countries', 'The', 'zoonotic', 'transmission', 'animal', 'to', 'human', 'is', 'suspected', 'as', 'the', 'route', 'of', 'disease', 'origin', 'The', 'genetic', 'analyses', 'predict', 'bats', 'as', 'the', 'most', 'probable', 'source', 'of', '2019', 'nCoV', 'though', 'further', 'investigations', 'needed', 'to', 'confirm', 'the', 'origin', 'of', 'the', 'novel', 'virus', 'The', 'ongoing', 'nCoV', 'outbreak', 'highlights', 'the', 'hidden', 'wild', 'animal', 'reservoir', 'of', 'the', 'deadly', 'viruses', 'and', 'possible', 'threat', 'of', 'spillover', 'zoonoses', 'as', 'well', 'The', 'successful', 'virus', 'isolation', 'attempts', 'have', 'made', 'doors', 'open', 'for', 'developing', 'better', 'diagnostics', 'and', 'effective', 'vaccines', 'helping', 'in', 'combating', 'the', 'spread', 'of', 'the', 'virus', 'to', 'newer', 'areas', '']"
130086,What we know so far: COVID-19 current clinical knowledge and research,2020,Clin Med (Lond),,"In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features.",,3mnmib3o,"['In', 'December', '2019', 'health', 'authorities', 'in', 'Wuhan', 'China', 'identified', 'a', 'cluster', 'of', 'pneumonia', 'cases', 'of', 'unknown', 'aetiology', 'linked', 'to', 'the', 'city', 's', 'South', 'China', 'Seafood', 'Market', 'Subsequent', 'investigations', 'revealed', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'as', 'the', 'causative', 'agent', 'now', 'at', 'the', 'heart', 'of', 'a', 'major', 'outbreak', 'The', 'rising', 'case', 'numbers', 'have', 'been', 'accompanied', 'by', 'unprecedented', 'public', 'health', 'action', 'including', 'the', 'wholesale', 'isolation', 'of', 'Wuhan', 'Alongside', 'this', 'has', 'been', 'a', 'robust', 'scientific', 'response', 'including', 'early', 'publication', 'of', 'the', 'pathogen', 'genome', 'and', 'rapid', 'development', 'of', 'highly', 'specific', 'diagnostics', 'This', 'article', 'will', 'review', 'the', 'new', 'knowledge', 'of', 'SARS', 'CoV', '2', 'COVID', '19', 'acute', 'respiratory', 'disease', 'and', 'summarise', 'its', 'clinical', 'features', '']"
130087,What we know so far: COVID-19 current clinical knowledge and research,2020,Clin Med (Lond),,"In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features.",,os8nw36g,"['In', 'December', '2019', 'health', 'authorities', 'in', 'Wuhan', 'China', 'identified', 'a', 'cluster', 'of', 'pneumonia', 'cases', 'of', 'unknown', 'aetiology', 'linked', 'to', 'the', 'city', 's', 'South', 'China', 'Seafood', 'Market', 'Subsequent', 'investigations', 'revealed', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'as', 'the', 'causative', 'agent', 'now', 'at', 'the', 'heart', 'of', 'a', 'major', 'outbreak', 'The', 'rising', 'case', 'numbers', 'have', 'been', 'accompanied', 'by', 'unprecedented', 'public', 'health', 'action', 'including', 'the', 'wholesale', 'isolation', 'of', 'Wuhan', 'Alongside', 'this', 'has', 'been', 'a', 'robust', 'scientific', 'response', 'including', 'early', 'publication', 'of', 'the', 'pathogen', 'genome', 'and', 'rapid', 'development', 'of', 'highly', 'specific', 'diagnostics', 'This', 'article', 'will', 'review', 'the', 'new', 'knowledge', 'of', 'SARS', 'CoV', '2', 'COVID', '19', 'acute', 'respiratory', 'disease', 'and', 'summarise', 'its', 'clinical', 'features', '']"
130088,What we know so far: COVID-19 current clinical knowledge and research,2020,Clinical Medicine,,"In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features , Copyright Notice (C) 2020 Royal College of Physicians",,9griuata,"['In', 'December', '2019', 'health', 'authorities', 'in', 'Wuhan', 'China', 'identified', 'a', 'cluster', 'of', 'pneumonia', 'cases', 'of', 'unknown', 'aetiology', 'linked', 'to', 'the', 'city', 's', 'South', 'China', 'Seafood', 'Market', 'Subsequent', 'investigations', 'revealed', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'as', 'the', 'causative', 'agent', 'now', 'at', 'the', 'heart', 'of', 'a', 'major', 'outbreak', 'The', 'rising', 'case', 'numbers', 'have', 'been', 'accompanied', 'by', 'unprecedented', 'public', 'health', 'action', 'including', 'the', 'wholesale', 'isolation', 'of', 'Wuhan', 'Alongside', 'this', 'has', 'been', 'a', 'robust', 'scientific', 'response', 'including', 'early', 'publication', 'of', 'the', 'pathogen', 'genome', 'and', 'rapid', 'development', 'of', 'highly', 'specific', 'diagnostics', 'This', 'article', 'will', 'review', 'the', 'new', 'knowledge', 'of', 'SARS', 'CoV', '2', 'COVID', '19', 'acute', 'respiratory', 'disease', 'and', 'summarise', 'its', 'clinical', 'features', 'Copyright', 'Notice', 'C', '2020', 'Royal', 'College', 'of', 'Physicians']"
130183,[Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic],2020,Kardiologiia,,"The beginning of 2020 was characterized by the development of a new coronavirus pandemic (COVID-19). Information about the epidemiology, etiology, pathogenesis, clinical and laboratory diagnostics, as well as prevention and therapy for this disease is constantly being expanded and reviewed. The COVID-19 pandemic creates the need for the emergence of new conditions of specialized care for patients with heart rhythm and conduction disorders [1]. These recommendations are intended for general practitioners, internists, cardiologists, electrophysiologists/arrhythmologists, cardiovascular surgeons, functional diagnostics doctors, anesthesiologists-resuscitators, laboratory diagnostics specialists, health care organizers in the system of organizations and healthcare institutions that provide specialized care to patients with heart rhythm and conduction disorders.",,3n3jjiyl,"['The', 'beginning', 'of', '2020', 'was', 'characterized', 'by', 'the', 'development', 'of', 'a', 'new', 'coronavirus', 'pandemic', 'COVID', '19', 'Information', 'about', 'the', 'epidemiology', 'etiology', 'pathogenesis', 'clinical', 'and', 'laboratory', 'diagnostics', 'as', 'well', 'as', 'prevention', 'and', 'therapy', 'for', 'this', 'disease', 'is', 'constantly', 'being', 'expanded', 'and', 'reviewed', 'The', 'COVID', '19', 'pandemic', 'creates', 'the', 'need', 'for', 'the', 'emergence', 'of', 'new', 'conditions', 'of', 'specialized', 'care', 'for', 'patients', 'with', 'heart', 'rhythm', 'and', 'conduction', 'disorders', '1', 'These', 'recommendations', 'are', 'intended', 'for', 'general', 'practitioners', 'internists', 'cardiologists', 'electrophysiologists', 'arrhythmologists', 'cardiovascular', 'surgeons', 'functional', 'diagnostics', 'doctors', 'anesthesiologists', 'resuscitators', 'laboratory', 'diagnostics', 'specialists', 'health', 'care', 'organizers', 'in', 'the', 'system', 'of', 'organizations', 'and', 'healthcare', 'institutions', 'that', 'provide', 'specialized', 'care', 'to', 'patients', 'with', 'heart', 'rhythm', 'and', 'conduction', 'disorders', '']"
130184,[Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic],2020,Kardiologiia,,"The beginning of 2020 was characterized by the development of a new coronavirus pandemic (COVID-19). Information about the epidemiology, etiology, pathogenesis, clinical and laboratory diagnostics, as well as prevention and therapy for this disease is constantly being expanded and reviewed. The COVID-19 pandemic creates the need for the emergence of new conditions of specialized care for patients with heart rhythm and conduction disorders [1]. These recommendations are intended for general practitioners, internists, cardiologists, electrophysiologists/arrhythmologists, cardiovascular surgeons, functional diagnostics doctors, anesthesiologists-resuscitators, laboratory diagnostics specialists, health care organizers in the system of organizations and healthcare institutions that provide specialized care to patients with heart rhythm and conduction disorders.",,xlyi0qap,"['The', 'beginning', 'of', '2020', 'was', 'characterized', 'by', 'the', 'development', 'of', 'a', 'new', 'coronavirus', 'pandemic', 'COVID', '19', 'Information', 'about', 'the', 'epidemiology', 'etiology', 'pathogenesis', 'clinical', 'and', 'laboratory', 'diagnostics', 'as', 'well', 'as', 'prevention', 'and', 'therapy', 'for', 'this', 'disease', 'is', 'constantly', 'being', 'expanded', 'and', 'reviewed', 'The', 'COVID', '19', 'pandemic', 'creates', 'the', 'need', 'for', 'the', 'emergence', 'of', 'new', 'conditions', 'of', 'specialized', 'care', 'for', 'patients', 'with', 'heart', 'rhythm', 'and', 'conduction', 'disorders', '1', 'These', 'recommendations', 'are', 'intended', 'for', 'general', 'practitioners', 'internists', 'cardiologists', 'electrophysiologists', 'arrhythmologists', 'cardiovascular', 'surgeons', 'functional', 'diagnostics', 'doctors', 'anesthesiologists', 'resuscitators', 'laboratory', 'diagnostics', 'specialists', 'health', 'care', 'organizers', 'in', 'the', 'system', 'of', 'organizations', 'and', 'healthcare', 'institutions', 'that', 'provide', 'specialized', 'care', 'to', 'patients', 'with', 'heart', 'rhythm', 'and', 'conduction', 'disorders', '']"
130840,COVID-19 - what should anaethesiologists and intensivists know about it?,2020,Anaesthesiol Intensive Ther,,"Over the past three months, the world has faced an unprecedented health hazard. The World Health Organization has announced a pandemic infection with an unknown species of coronavirus called SARS-CoV-2. Spreading mainly through the droplet route, the virus causes mild symptoms in the majority of cases, the most common being: fever (80%), dry cough (56%), fatigue (22%) and muscle pain (7%); less common symptoms include a sore throat, a runny nose, diarrhea, hemoptysis and chills. A life-threatening complication of SARS-CoV-2 infection is an acute respiratory distress syndrome (ARDS), which occurs more often in older adults, those with immune disorders and co-morbidities. Severe forms of the infection, being an indication for treatment in the intensive care unit, comprise acute lung inflammation, ARDS, sepsis and septic shock. The article presents basic information about etiology, pathogenesis and diagnostics (with particular emphasis on the importance of tomocomputer imaging), clinical picture, treatment and prevention of the infection. It goes on to emphasize the specific risks of providing anesthesiology and intensive care services. Due to the fact that effective causal treatment is not yet available and the number of infections and deaths increases day by day, infection prevention and strict adherence to recommendations of infection control organizations remain the basis for fighting the virus.",,jl6v2ajd,"['Over', 'the', 'past', 'three', 'months', 'the', 'world', 'has', 'faced', 'an', 'unprecedented', 'health', 'hazard', 'The', 'World', 'Health', 'Organization', 'has', 'announced', 'a', 'pandemic', 'infection', 'with', 'an', 'unknown', 'species', 'of', 'coronavirus', 'called', 'SARS', 'CoV', '2', 'Spreading', 'mainly', 'through', 'the', 'droplet', 'route', 'the', 'virus', 'causes', 'mild', 'symptoms', 'in', 'the', 'majority', 'of', 'cases', 'the', 'most', 'common', 'being', 'fever', '80', 'dry', 'cough', '56', 'fatigue', '22', 'and', 'muscle', 'pain', '7', 'less', 'common', 'symptoms', 'include', 'a', 'sore', 'throat', 'a', 'runny', 'nose', 'diarrhea', 'hemoptysis', 'and', 'chills', 'A', 'life', 'threatening', 'complication', 'of', 'SARS', 'CoV', '2', 'infection', 'is', 'an', 'acute', 'respiratory', 'distress', 'syndrome', 'ARDS', 'which', 'occurs', 'more', 'often', 'in', 'older', 'adults', 'those', 'with', 'immune', 'disorders', 'and', 'co', 'morbidities', 'Severe', 'forms', 'of', 'the', 'infection', 'being', 'an', 'indication', 'for', 'treatment', 'in', 'the', 'intensive', 'care', 'unit', 'comprise', 'acute', 'lung', 'inflammation', 'ARDS', 'sepsis', 'and', 'septic', 'shock', 'The', 'article', 'presents', 'basic', 'information', 'about', 'etiology', 'pathogenesis', 'and', 'diagnostics', 'with', 'particular', 'emphasis', 'on', 'the', 'importance', 'of', 'tomocomputer', 'imaging', 'clinical', 'picture', 'treatment', 'and', 'prevention', 'of', 'the', 'infection', 'It', 'goes', 'on', 'to', 'emphasize', 'the', 'specific', 'risks', 'of', 'providing', 'anesthesiology', 'and', 'intensive', 'care', 'services', 'Due', 'to', 'the', 'fact', 'that', 'effective', 'causal', 'treatment', 'is', 'not', 'yet', 'available', 'and', 'the', 'number', 'of', 'infections', 'and', 'deaths', 'increases', 'day', 'by', 'day', 'infection', 'prevention', 'and', 'strict', 'adherence', 'to', 'recommendations', 'of', 'infection', 'control', 'organizations', 'remain', 'the', 'basis', 'for', 'fighting', 'the', 'virus', '']"
131260,The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks,2020,Clin Chem Lab Med,,"Coronavirus disease 2019, abbreviated to COVID-19 and sustained by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the latest biological hazard to assume the relevance of insidious worldwide threat. One obvious question that is now engaging the minds of many scientists and healthcare professionals is whether and eventually how laboratory medicine could efficiently contribute to counteract this and other (future) viral outbreaks. Despite there being evidence that laboratory tests are vital throughout many clinical pathways, there are at least three major areas where in vitro diagnostics can also provide essential contributions to diagnostic reasoning and managed care of patients with suspected or confirmed SARS-CoV-2 infection. These include etiological diagnosis, patient monitoring, as well as epidemiologic surveillance. Nonetheless, some structural and practical aspects may generate substantial hurdles in providing timely and efficient response to this infectious emergency, which basically include inadequate (insufficient) environment and shortage of technical and human resources for facing enhanced volume of tests on many infected patients, some of whom are with severe disease. Some proactive and reactive strategies may hence be identified to confront this serious healthcare challenge, which entail major investments on conventional laboratory resources, reinforcement of regional networks of clinical laboratories, installation of mobile laboratories, as well as being proactive in establishing laboratory emergency plans.",,2uaicw30,"['Coronavirus', 'disease', '2019', 'abbreviated', 'to', 'COVID', '19', 'and', 'sustained', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'the', 'latest', 'biological', 'hazard', 'to', 'assume', 'the', 'relevance', 'of', 'insidious', 'worldwide', 'threat', 'One', 'obvious', 'question', 'that', 'is', 'now', 'engaging', 'the', 'minds', 'of', 'many', 'scientists', 'and', 'healthcare', 'professionals', 'is', 'whether', 'and', 'eventually', 'how', 'laboratory', 'medicine', 'could', 'efficiently', 'contribute', 'to', 'counteract', 'this', 'and', 'other', 'future', 'viral', 'outbreaks', 'Despite', 'there', 'being', 'evidence', 'that', 'laboratory', 'tests', 'are', 'vital', 'throughout', 'many', 'clinical', 'pathways', 'there', 'are', 'at', 'least', 'three', 'major', 'areas', 'where', 'in', 'vitro', 'diagnostics', 'can', 'also', 'provide', 'essential', 'contributions', 'to', 'diagnostic', 'reasoning', 'and', 'managed', 'care', 'of', 'patients', 'with', 'suspected', 'or', 'confirmed', 'SARS', 'CoV', '2', 'infection', 'These', 'include', 'etiological', 'diagnosis', 'patient', 'monitoring', 'as', 'well', 'as', 'epidemiologic', 'surveillance', 'Nonetheless', 'some', 'structural', 'and', 'practical', 'aspects', 'may', 'generate', 'substantial', 'hurdles', 'in', 'providing', 'timely', 'and', 'efficient', 'response', 'to', 'this', 'infectious', 'emergency', 'which', 'basically', 'include', 'inadequate', 'insufficient', 'environment', 'and', 'shortage', 'of', 'technical', 'and', 'human', 'resources', 'for', 'facing', 'enhanced', 'volume', 'of', 'tests', 'on', 'many', 'infected', 'patients', 'some', 'of', 'whom', 'are', 'with', 'severe', 'disease', 'Some', 'proactive', 'and', 'reactive', 'strategies', 'may', 'hence', 'be', 'identified', 'to', 'confront', 'this', 'serious', 'healthcare', 'challenge', 'which', 'entail', 'major', 'investments', 'on', 'conventional', 'laboratory', 'resources', 'reinforcement', 'of', 'regional', 'networks', 'of', 'clinical', 'laboratories', 'installation', 'of', 'mobile', 'laboratories', 'as', 'well', 'as', 'being', 'proactive', 'in', 'establishing', 'laboratory', 'emergency', 'plans', '']"
131334,Road toward rapid-molecular point of care test to detect novel SARS-coronavirus 2019 (COVID-19): Review from updated literature,2020,Allergol. immunopatol,,"Coronavirus disease 2019 (COVID-19) named by the WHO as a result of the global public health emergency. COVID-19 is caused by a new coronavirus named as novel coronavirus (2019-nCOV). From the first case reported in December 2019 it is now a pandemic situation and a major public health emergency. The COVID-19 transmission rate is very high, infecting two to three persons on average with contact to an already infected person. There is a need for the health system, specially in developing countries such as in Pakistan, to combat such a novel disease by rapid, accurate, and high quality diagnostic testing in order to screen suspected cases and also surveillance of the disease. A rapid, accurate and low-cost diagnostic point-of-care device is needed for timely diagnosis of COVID-19 and is essential to combat such outbreaks for compelling preventive measures against the disease spread. This review is to highlight the importance of point-of-care diagnostics device for robust and accurate diagnosis of COVID-19 in physician offices and other urgent healthcare-type settings and encourage academics and stake holders towards advancement in order to control outbreaks and develop the public health surveillance system.",,yvsv8ns2,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'named', 'by', 'the', 'WHO', 'as', 'a', 'result', 'of', 'the', 'global', 'public', 'health', 'emergency', 'COVID', '19', 'is', 'caused', 'by', 'a', 'new', 'coronavirus', 'named', 'as', 'novel', 'coronavirus', '2019', 'nCOV', 'From', 'the', 'first', 'case', 'reported', 'in', 'December', '2019', 'it', 'is', 'now', 'a', 'pandemic', 'situation', 'and', 'a', 'major', 'public', 'health', 'emergency', 'The', 'COVID', '19', 'transmission', 'rate', 'is', 'very', 'high', 'infecting', 'two', 'to', 'three', 'persons', 'on', 'average', 'with', 'contact', 'to', 'an', 'already', 'infected', 'person', 'There', 'is', 'a', 'need', 'for', 'the', 'health', 'system', 'specially', 'in', 'developing', 'countries', 'such', 'as', 'in', 'Pakistan', 'to', 'combat', 'such', 'a', 'novel', 'disease', 'by', 'rapid', 'accurate', 'and', 'high', 'quality', 'diagnostic', 'testing', 'in', 'order', 'to', 'screen', 'suspected', 'cases', 'and', 'also', 'surveillance', 'of', 'the', 'disease', 'A', 'rapid', 'accurate', 'and', 'low', 'cost', 'diagnostic', 'point', 'of', 'care', 'device', 'is', 'needed', 'for', 'timely', 'diagnosis', 'of', 'COVID', '19', 'and', 'is', 'essential', 'to', 'combat', 'such', 'outbreaks', 'for', 'compelling', 'preventive', 'measures', 'against', 'the', 'disease', 'spread', 'This', 'review', 'is', 'to', 'highlight', 'the', 'importance', 'of', 'point', 'of', 'care', 'diagnostics', 'device', 'for', 'robust', 'and', 'accurate', 'diagnosis', 'of', 'COVID', '19', 'in', 'physician', 'offices', 'and', 'other', 'urgent', 'healthcare', 'type', 'settings', 'and', 'encourage', 'academics', 'and', 'stake', 'holders', 'towards', 'advancement', 'in', 'order', 'to', 'control', 'outbreaks', 'and', 'develop', 'the', 'public', 'health', 'surveillance', 'system', '']"
132059,"An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies",2020,Travel Med Infect Dis,,"Coronavirus Disease 2019 (COVID-19), emerged in early December 2019 in China and became a pandemic situation worldwide by its rapid spread to more than 200 countries or territories. Bats are considered as the reservoir host, and the search of a probable intermediate host is still going on. The severe form of the infection is associated with death is mainly reported in older and immune-compromised patients with pre-existing disease history. Death in severe cases is attributed to respiratory failure associated with hyperinflammation. Cytokine storm syndrome associated with inflammation in response to SARS-CoV-2 infection is considered as the leading cause of mortality in COVID-19 patients. COVID-19 patients have thus higher levels of many proinflammatory cytokines and chemokines. The blood laboratory profile of the COVID-19 patients exhibits lymphopenia, leukopenia, thrombocytopenia, and RNAaemia, along with increased levels of aspartate aminotransferase. SARS-CoV-2 infection in pregnant women does not lead to fetus mortality, unlike other zoonotic coronaviruses such as SARS-CoV and MERS-CoV, and there is, to date, no evidence of intrauterine transmission to neonates. Rapid diagnostics have been developed, and significant efforts are being made to develop effective vaccines and therapeutics. In the absence of any virus-specific therapy, internationally, health care authorities are recommending the adoption of effective community mitigation measures to counter and contain this pandemic virus. This paper is an overview of this virus and the disease with a particular focus on SARS-CoV-2/COVID-19 clinical pathology, pathogenesis, and immunopathology, along with recent research developments.",,uojjp4dd,"['Coronavirus', 'Disease', '2019', 'COVID', '19', 'emerged', 'in', 'early', 'December', '2019', 'in', 'China', 'and', 'became', 'a', 'pandemic', 'situation', 'worldwide', 'by', 'its', 'rapid', 'spread', 'to', 'more', 'than', '200', 'countries', 'or', 'territories', 'Bats', 'are', 'considered', 'as', 'the', 'reservoir', 'host', 'and', 'the', 'search', 'of', 'a', 'probable', 'intermediate', 'host', 'is', 'still', 'going', 'on', 'The', 'severe', 'form', 'of', 'the', 'infection', 'is', 'associated', 'with', 'death', 'is', 'mainly', 'reported', 'in', 'older', 'and', 'immune', 'compromised', 'patients', 'with', 'pre', 'existing', 'disease', 'history', 'Death', 'in', 'severe', 'cases', 'is', 'attributed', 'to', 'respiratory', 'failure', 'associated', 'with', 'hyperinflammation', 'Cytokine', 'storm', 'syndrome', 'associated', 'with', 'inflammation', 'in', 'response', 'to', 'SARS', 'CoV', '2', 'infection', 'is', 'considered', 'as', 'the', 'leading', 'cause', 'of', 'mortality', 'in', 'COVID', '19', 'patients', 'COVID', '19', 'patients', 'have', 'thus', 'higher', 'levels', 'of', 'many', 'proinflammatory', 'cytokines', 'and', 'chemokines', 'The', 'blood', 'laboratory', 'profile', 'of', 'the', 'COVID', '19', 'patients', 'exhibits', 'lymphopenia', 'leukopenia', 'thrombocytopenia', 'and', 'RNAaemia', 'along', 'with', 'increased', 'levels', 'of', 'aspartate', 'aminotransferase', 'SARS', 'CoV', '2', 'infection', 'in', 'pregnant', 'women', 'does', 'not', 'lead', 'to', 'fetus', 'mortality', 'unlike', 'other', 'zoonotic', 'coronaviruses', 'such', 'as', 'SARS', 'CoV', 'and', 'MERS', 'CoV', 'and', 'there', 'is', 'to', 'date', 'no', 'evidence', 'of', 'intrauterine', 'transmission', 'to', 'neonates', 'Rapid', 'diagnostics', 'have', 'been', 'developed', 'and', 'significant', 'efforts', 'are', 'being', 'made', 'to', 'develop', 'effective', 'vaccines', 'and', 'therapeutics', 'In', 'the', 'absence', 'of', 'any', 'virus', 'specific', 'therapy', 'internationally', 'health', 'care', 'authorities', 'are', 'recommending', 'the', 'adoption', 'of', 'effective', 'community', 'mitigation', 'measures', 'to', 'counter', 'and', 'contain', 'this', 'pandemic', 'virus', 'This', 'paper', 'is', 'an', 'overview', 'of', 'this', 'virus', 'and', 'the', 'disease', 'with', 'a', 'particular', 'focus', 'on', 'SARS', 'CoV', '2', 'COVID', '19', 'clinical', 'pathology', 'pathogenesis', 'and', 'immunopathology', 'along', 'with', 'recent', 'research', 'developments', '']"
132062,COVID 19 diagnostic multiplicity and its role in community surveillance and control,2020,Le infezioni in medicina,,"Diagnosis of persons exposed to/infected with severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) is central to controlling the global pandemic of COVID-19 Currently, several diagnostic modalities are available for COVID-19, each with its own pros and cons Although there is a global consensus to increase the testing capacity, it is also essential to prudently utilize these tests to control the pandemic In this paper, we have reviewed the current array of diagnostics for SARS-CoV-2, highlighted the gaps in current diagnostic modalities, and their role in community surveillance and control of the pandemic The different modalities of COVID-19 diagnosis discussed are: clinical and radiological, molecular based (laboratory based and point-of-care), Immunoassay based (ELISA, rapid antigen and antibody detection tests) and digital diagnostics (artificial intelligence based algorithms) The role of rapid antigen/antibody detection tests in community surveillance has also been described here These tests can be used to identify asymptomatic persons exposed to the virus and in community based seroprevalence surveys to assess the epidemiology of spread of the virus However, there are few concerns about the accuracy of these tests which needs to evaluated beforehand",,kuk0scmr,"['Diagnosis', 'of', 'persons', 'exposed', 'to', 'infected', 'with', 'severe', 'acute', 'respiratory', 'syndrome', 'related', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'central', 'to', 'controlling', 'the', 'global', 'pandemic', 'of', 'COVID', '19', 'Currently', 'several', 'diagnostic', 'modalities', 'are', 'available', 'for', 'COVID', '19', 'each', 'with', 'its', 'own', 'pros', 'and', 'cons', 'Although', 'there', 'is', 'a', 'global', 'consensus', 'to', 'increase', 'the', 'testing', 'capacity', 'it', 'is', 'also', 'essential', 'to', 'prudently', 'utilize', 'these', 'tests', 'to', 'control', 'the', 'pandemic', 'In', 'this', 'paper', 'we', 'have', 'reviewed', 'the', 'current', 'array', 'of', 'diagnostics', 'for', 'SARS', 'CoV', '2', 'highlighted', 'the', 'gaps', 'in', 'current', 'diagnostic', 'modalities', 'and', 'their', 'role', 'in', 'community', 'surveillance', 'and', 'control', 'of', 'the', 'pandemic', 'The', 'different', 'modalities', 'of', 'COVID', '19', 'diagnosis', 'discussed', 'are', 'clinical', 'and', 'radiological', 'molecular', 'based', 'laboratory', 'based', 'and', 'point', 'of', 'care', 'Immunoassay', 'based', 'ELISA', 'rapid', 'antigen', 'and', 'antibody', 'detection', 'tests', 'and', 'digital', 'diagnostics', 'artificial', 'intelligence', 'based', 'algorithms', 'The', 'role', 'of', 'rapid', 'antigen', 'antibody', 'detection', 'tests', 'in', 'community', 'surveillance', 'has', 'also', 'been', 'described', 'here', 'These', 'tests', 'can', 'be', 'used', 'to', 'identify', 'asymptomatic', 'persons', 'exposed', 'to', 'the', 'virus', 'and', 'in', 'community', 'based', 'seroprevalence', 'surveys', 'to', 'assess', 'the', 'epidemiology', 'of', 'spread', 'of', 'the', 'virus', 'However', 'there', 'are', 'few', 'concerns', 'about', 'the', 'accuracy', 'of', 'these', 'tests', 'which', 'needs', 'to', 'evaluated', 'beforehand']"
132393,Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19,2020,Clin. infect. dis,,"BACKGROUND: Accurate molecular diagnostic tests are necessary for confirming a diagnosis of coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acids in respiratory tract specimens informs patient, healthcare institution and public health level decision-making. The numbers of available SARS-CoV-2 nucleic acid detection tests are rapidly increasing, as is the COVID-19 diagnostic literature. Thus, the Infectious Diseases Society of America (IDSA) recognized a significant need for frequently updated systematic reviews of the literature to inform evidence-based best practice guidance. OBJECTIVE: The IDSA's goal was to develop an evidence-based diagnostic guideline to assists clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 nucleic acid amplification tests. In addition, we provide a conceptual framework for understanding molecular diagnostic test performance, discuss the nuance of test result interpretation in a variety of practice settings, and highlight important unmet research needs in the COVID-19 diagnostic testing space. METHODS: IDSA convened a multidisciplinary panel of infectious diseases clinicians, clinical microbiologists, and experts in systematic literature review to identify and prioritize clinical questions and outcomes related to the use of SARS-CoV-2 molecular diagnostics. Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the certainty of evidence and make testing recommendations. RESULTS: The panel agreed on 15 diagnostic recommendations. CONCLUSIONS: Universal access to accurate SARS-CoV-2 nucleic acid testing is critical for patient care, hospital infection prevention and the public response to the COVID-19 pandemic. Information on the clinical performance of available tests is rapidly emerging, but the quality of evidence of the current literature is considered low to very low. Recognizing these limitations, the IDSA panel weighed available diagnostic evidence and recommends nucleic acid testing for all symptomatic individuals suspected of having COVID-19. In addition, testing is recommended for asymptomatic individuals with known or suspected contact with a COVID-19 case. Testing asymptomatic individuals without known exposure is suggested when the results will impact isolation/quarantine/personal protective equipment (PPE) usage decisions, dictate eligibility for surgery, or inform administration of immunosuppressive therapy. Ultimately, prioritization of testing will depend on institutional-specific resources and the needs of different patient populations.",,gp4i8xhv,"['BACKGROUND', 'Accurate', 'molecular', 'diagnostic', 'tests', 'are', 'necessary', 'for', 'confirming', 'a', 'diagnosis', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'Direct', 'detection', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'nucleic', 'acids', 'in', 'respiratory', 'tract', 'specimens', 'informs', 'patient', 'healthcare', 'institution', 'and', 'public', 'health', 'level', 'decision', 'making', 'The', 'numbers', 'of', 'available', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'detection', 'tests', 'are', 'rapidly', 'increasing', 'as', 'is', 'the', 'COVID', '19', 'diagnostic', 'literature', 'Thus', 'the', 'Infectious', 'Diseases', 'Society', 'of', 'America', 'IDSA', 'recognized', 'a', 'significant', 'need', 'for', 'frequently', 'updated', 'systematic', 'reviews', 'of', 'the', 'literature', 'to', 'inform', 'evidence', 'based', 'best', 'practice', 'guidance', 'OBJECTIVE', 'The', 'IDSA', 's', 'goal', 'was', 'to', 'develop', 'an', 'evidence', 'based', 'diagnostic', 'guideline', 'to', 'assists', 'clinicians', 'clinical', 'laboratorians', 'patients', 'and', 'policymakers', 'in', 'decisions', 'related', 'to', 'the', 'optimal', 'use', 'of', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'amplification', 'tests', 'In', 'addition', 'we', 'provide', 'a', 'conceptual', 'framework', 'for', 'understanding', 'molecular', 'diagnostic', 'test', 'performance', 'discuss', 'the', 'nuance', 'of', 'test', 'result', 'interpretation', 'in', 'a', 'variety', 'of', 'practice', 'settings', 'and', 'highlight', 'important', 'unmet', 'research', 'needs', 'in', 'the', 'COVID', '19', 'diagnostic', 'testing', 'space', 'METHODS', 'IDSA', 'convened', 'a', 'multidisciplinary', 'panel', 'of', 'infectious', 'diseases', 'clinicians', 'clinical', 'microbiologists', 'and', 'experts', 'in', 'systematic', 'literature', 'review', 'to', 'identify', 'and', 'prioritize', 'clinical', 'questions', 'and', 'outcomes', 'related', 'to', 'the', 'use', 'of', 'SARS', 'CoV', '2', 'molecular', 'diagnostics', 'Grading', 'of', 'Recommendations', 'Assessment', 'Development', 'and', 'Evaluation', 'GRADE', 'methodology', 'was', 'used', 'to', 'assess', 'the', 'certainty', 'of', 'evidence', 'and', 'make', 'testing', 'recommendations', 'RESULTS', 'The', 'panel', 'agreed', 'on', '15', 'diagnostic', 'recommendations', 'CONCLUSIONS', 'Universal', 'access', 'to', 'accurate', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'testing', 'is', 'critical', 'for', 'patient', 'care', 'hospital', 'infection', 'prevention', 'and', 'the', 'public', 'response', 'to', 'the', 'COVID', '19', 'pandemic', 'Information', 'on', 'the', 'clinical', 'performance', 'of', 'available', 'tests', 'is', 'rapidly', 'emerging', 'but', 'the', 'quality', 'of', 'evidence', 'of', 'the', 'current', 'literature', 'is', 'considered', 'low', 'to', 'very', 'low', 'Recognizing', 'these', 'limitations', 'the', 'IDSA', 'panel', 'weighed', 'available', 'diagnostic', 'evidence', 'and', 'recommends', 'nucleic', 'acid', 'testing', 'for', 'all', 'symptomatic', 'individuals', 'suspected', 'of', 'having', 'COVID', '19', 'In', 'addition', 'testing', 'is', 'recommended', 'for', 'asymptomatic', 'individuals', 'with', 'known', 'or', 'suspected', 'contact', 'with', 'a', 'COVID', '19', 'case', 'Testing', 'asymptomatic', 'individuals', 'without', 'known', 'exposure', 'is', 'suggested', 'when', 'the', 'results', 'will', 'impact', 'isolation', 'quarantine', 'personal', 'protective', 'equipment', 'PPE', 'usage', 'decisions', 'dictate', 'eligibility', 'for', 'surgery', 'or', 'inform', 'administration', 'of', 'immunosuppressive', 'therapy', 'Ultimately', 'prioritization', 'of', 'testing', 'will', 'depend', 'on', 'institutional', 'specific', 'resources', 'and', 'the', 'needs', 'of', 'different', 'patient', 'populations', '']"
132394,Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19,2020,Clin. infect. dis,,"BACKGROUND: Accurate molecular diagnostic tests are necessary for confirming a diagnosis of coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acids in respiratory tract specimens informs patient, healthcare institution and public health level decision-making. The numbers of available SARS-CoV-2 nucleic acid detection tests are rapidly increasing, as is the COVID-19 diagnostic literature. Thus, the Infectious Diseases Society of America (IDSA) recognized a significant need for frequently updated systematic reviews of the literature to inform evidence-based best practice guidance. OBJECTIVE: The IDSA's goal was to develop an evidence-based diagnostic guideline to assists clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 nucleic acid amplification tests. In addition, we provide a conceptual framework for understanding molecular diagnostic test performance, discuss the nuance of test result interpretation in a variety of practice settings, and highlight important unmet research needs in the COVID-19 diagnostic testing space. METHODS: IDSA convened a multidisciplinary panel of infectious diseases clinicians, clinical microbiologists, and experts in systematic literature review to identify and prioritize clinical questions and outcomes related to the use of SARS-CoV-2 molecular diagnostics. Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the certainty of evidence and make testing recommendations. RESULTS: The panel agreed on 15 diagnostic recommendations. CONCLUSIONS: Universal access to accurate SARS-CoV-2 nucleic acid testing is critical for patient care, hospital infection prevention and the public response to the COVID-19 pandemic. Information on the clinical performance of available tests is rapidly emerging, but the quality of evidence of the current literature is considered low to very low. Recognizing these limitations, the IDSA panel weighed available diagnostic evidence and recommends nucleic acid testing for all symptomatic individuals suspected of having COVID-19. In addition, testing is recommended for asymptomatic individuals with known or suspected contact with a COVID-19 case. Testing asymptomatic individuals without known exposure is suggested when the results will impact isolation/quarantine/personal protective equipment (PPE) usage decisions, dictate eligibility for surgery, or inform administration of immunosuppressive therapy. Ultimately, prioritization of testing will depend on institutional-specific resources and the needs of different patient populations.",,pcc40byf,"['BACKGROUND', 'Accurate', 'molecular', 'diagnostic', 'tests', 'are', 'necessary', 'for', 'confirming', 'a', 'diagnosis', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'Direct', 'detection', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'nucleic', 'acids', 'in', 'respiratory', 'tract', 'specimens', 'informs', 'patient', 'healthcare', 'institution', 'and', 'public', 'health', 'level', 'decision', 'making', 'The', 'numbers', 'of', 'available', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'detection', 'tests', 'are', 'rapidly', 'increasing', 'as', 'is', 'the', 'COVID', '19', 'diagnostic', 'literature', 'Thus', 'the', 'Infectious', 'Diseases', 'Society', 'of', 'America', 'IDSA', 'recognized', 'a', 'significant', 'need', 'for', 'frequently', 'updated', 'systematic', 'reviews', 'of', 'the', 'literature', 'to', 'inform', 'evidence', 'based', 'best', 'practice', 'guidance', 'OBJECTIVE', 'The', 'IDSA', 's', 'goal', 'was', 'to', 'develop', 'an', 'evidence', 'based', 'diagnostic', 'guideline', 'to', 'assists', 'clinicians', 'clinical', 'laboratorians', 'patients', 'and', 'policymakers', 'in', 'decisions', 'related', 'to', 'the', 'optimal', 'use', 'of', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'amplification', 'tests', 'In', 'addition', 'we', 'provide', 'a', 'conceptual', 'framework', 'for', 'understanding', 'molecular', 'diagnostic', 'test', 'performance', 'discuss', 'the', 'nuance', 'of', 'test', 'result', 'interpretation', 'in', 'a', 'variety', 'of', 'practice', 'settings', 'and', 'highlight', 'important', 'unmet', 'research', 'needs', 'in', 'the', 'COVID', '19', 'diagnostic', 'testing', 'space', 'METHODS', 'IDSA', 'convened', 'a', 'multidisciplinary', 'panel', 'of', 'infectious', 'diseases', 'clinicians', 'clinical', 'microbiologists', 'and', 'experts', 'in', 'systematic', 'literature', 'review', 'to', 'identify', 'and', 'prioritize', 'clinical', 'questions', 'and', 'outcomes', 'related', 'to', 'the', 'use', 'of', 'SARS', 'CoV', '2', 'molecular', 'diagnostics', 'Grading', 'of', 'Recommendations', 'Assessment', 'Development', 'and', 'Evaluation', 'GRADE', 'methodology', 'was', 'used', 'to', 'assess', 'the', 'certainty', 'of', 'evidence', 'and', 'make', 'testing', 'recommendations', 'RESULTS', 'The', 'panel', 'agreed', 'on', '15', 'diagnostic', 'recommendations', 'CONCLUSIONS', 'Universal', 'access', 'to', 'accurate', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'testing', 'is', 'critical', 'for', 'patient', 'care', 'hospital', 'infection', 'prevention', 'and', 'the', 'public', 'response', 'to', 'the', 'COVID', '19', 'pandemic', 'Information', 'on', 'the', 'clinical', 'performance', 'of', 'available', 'tests', 'is', 'rapidly', 'emerging', 'but', 'the', 'quality', 'of', 'evidence', 'of', 'the', 'current', 'literature', 'is', 'considered', 'low', 'to', 'very', 'low', 'Recognizing', 'these', 'limitations', 'the', 'IDSA', 'panel', 'weighed', 'available', 'diagnostic', 'evidence', 'and', 'recommends', 'nucleic', 'acid', 'testing', 'for', 'all', 'symptomatic', 'individuals', 'suspected', 'of', 'having', 'COVID', '19', 'In', 'addition', 'testing', 'is', 'recommended', 'for', 'asymptomatic', 'individuals', 'with', 'known', 'or', 'suspected', 'contact', 'with', 'a', 'COVID', '19', 'case', 'Testing', 'asymptomatic', 'individuals', 'without', 'known', 'exposure', 'is', 'suggested', 'when', 'the', 'results', 'will', 'impact', 'isolation', 'quarantine', 'personal', 'protective', 'equipment', 'PPE', 'usage', 'decisions', 'dictate', 'eligibility', 'for', 'surgery', 'or', 'inform', 'administration', 'of', 'immunosuppressive', 'therapy', 'Ultimately', 'prioritization', 'of', 'testing', 'will', 'depend', 'on', 'institutional', 'specific', 'resources', 'and', 'the', 'needs', 'of', 'different', 'patient', 'populations', '']"
132395,Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19,2020,Clin. infect. dis,,"BACKGROUND: Accurate molecular diagnostic tests are necessary for confirming a diagnosis of coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acids in respiratory tract specimens informs patient, healthcare institution and public health level decision-making. The numbers of available SARS-CoV-2 nucleic acid detection tests are rapidly increasing, as is the COVID-19 diagnostic literature. Thus, the Infectious Diseases Society of America (IDSA) recognized a significant need for frequently updated systematic reviews of the literature to inform evidence-based best practice guidance. OBJECTIVE: The IDSA's goal was to develop an evidence-based diagnostic guideline to assists clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 nucleic acid amplification tests. In addition, we provide a conceptual framework for understanding molecular diagnostic test performance, discuss the nuance of test result interpretation in a variety of practice settings, and highlight important unmet research needs in the COVID-19 diagnostic testing space. METHODS: IDSA convened a multidisciplinary panel of infectious diseases clinicians, clinical microbiologists, and experts in systematic literature review to identify and prioritize clinical questions and outcomes related to the use of SARS-CoV-2 molecular diagnostics. Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the certainty of evidence and make testing recommendations. RESULTS: The panel agreed on 15 diagnostic recommendations. CONCLUSIONS: Universal access to accurate SARS-CoV-2 nucleic acid testing is critical for patient care, hospital infection prevention and the public response to the COVID-19 pandemic. Information on the clinical performance of available tests is rapidly emerging, but the quality of evidence of the current literature is considered low to very low. Recognizing these limitations, the IDSA panel weighed available diagnostic evidence and recommends nucleic acid testing for all symptomatic individuals suspected of having COVID-19. In addition, testing is recommended for asymptomatic individuals with known or suspected contact with a COVID-19 case. Testing asymptomatic individuals without known exposure is suggested when the results will impact isolation/quarantine/personal protective equipment (PPE) usage decisions, dictate eligibility for surgery, or inform administration of immunosuppressive therapy. Ultimately, prioritization of testing will depend on institutional-specific resources and the needs of different patient populations.",,gsp5tm1f,"['BACKGROUND', 'Accurate', 'molecular', 'diagnostic', 'tests', 'are', 'necessary', 'for', 'confirming', 'a', 'diagnosis', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'Direct', 'detection', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'nucleic', 'acids', 'in', 'respiratory', 'tract', 'specimens', 'informs', 'patient', 'healthcare', 'institution', 'and', 'public', 'health', 'level', 'decision', 'making', 'The', 'numbers', 'of', 'available', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'detection', 'tests', 'are', 'rapidly', 'increasing', 'as', 'is', 'the', 'COVID', '19', 'diagnostic', 'literature', 'Thus', 'the', 'Infectious', 'Diseases', 'Society', 'of', 'America', 'IDSA', 'recognized', 'a', 'significant', 'need', 'for', 'frequently', 'updated', 'systematic', 'reviews', 'of', 'the', 'literature', 'to', 'inform', 'evidence', 'based', 'best', 'practice', 'guidance', 'OBJECTIVE', 'The', 'IDSA', 's', 'goal', 'was', 'to', 'develop', 'an', 'evidence', 'based', 'diagnostic', 'guideline', 'to', 'assists', 'clinicians', 'clinical', 'laboratorians', 'patients', 'and', 'policymakers', 'in', 'decisions', 'related', 'to', 'the', 'optimal', 'use', 'of', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'amplification', 'tests', 'In', 'addition', 'we', 'provide', 'a', 'conceptual', 'framework', 'for', 'understanding', 'molecular', 'diagnostic', 'test', 'performance', 'discuss', 'the', 'nuance', 'of', 'test', 'result', 'interpretation', 'in', 'a', 'variety', 'of', 'practice', 'settings', 'and', 'highlight', 'important', 'unmet', 'research', 'needs', 'in', 'the', 'COVID', '19', 'diagnostic', 'testing', 'space', 'METHODS', 'IDSA', 'convened', 'a', 'multidisciplinary', 'panel', 'of', 'infectious', 'diseases', 'clinicians', 'clinical', 'microbiologists', 'and', 'experts', 'in', 'systematic', 'literature', 'review', 'to', 'identify', 'and', 'prioritize', 'clinical', 'questions', 'and', 'outcomes', 'related', 'to', 'the', 'use', 'of', 'SARS', 'CoV', '2', 'molecular', 'diagnostics', 'Grading', 'of', 'Recommendations', 'Assessment', 'Development', 'and', 'Evaluation', 'GRADE', 'methodology', 'was', 'used', 'to', 'assess', 'the', 'certainty', 'of', 'evidence', 'and', 'make', 'testing', 'recommendations', 'RESULTS', 'The', 'panel', 'agreed', 'on', '15', 'diagnostic', 'recommendations', 'CONCLUSIONS', 'Universal', 'access', 'to', 'accurate', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'testing', 'is', 'critical', 'for', 'patient', 'care', 'hospital', 'infection', 'prevention', 'and', 'the', 'public', 'response', 'to', 'the', 'COVID', '19', 'pandemic', 'Information', 'on', 'the', 'clinical', 'performance', 'of', 'available', 'tests', 'is', 'rapidly', 'emerging', 'but', 'the', 'quality', 'of', 'evidence', 'of', 'the', 'current', 'literature', 'is', 'considered', 'low', 'to', 'very', 'low', 'Recognizing', 'these', 'limitations', 'the', 'IDSA', 'panel', 'weighed', 'available', 'diagnostic', 'evidence', 'and', 'recommends', 'nucleic', 'acid', 'testing', 'for', 'all', 'symptomatic', 'individuals', 'suspected', 'of', 'having', 'COVID', '19', 'In', 'addition', 'testing', 'is', 'recommended', 'for', 'asymptomatic', 'individuals', 'with', 'known', 'or', 'suspected', 'contact', 'with', 'a', 'COVID', '19', 'case', 'Testing', 'asymptomatic', 'individuals', 'without', 'known', 'exposure', 'is', 'suggested', 'when', 'the', 'results', 'will', 'impact', 'isolation', 'quarantine', 'personal', 'protective', 'equipment', 'PPE', 'usage', 'decisions', 'dictate', 'eligibility', 'for', 'surgery', 'or', 'inform', 'administration', 'of', 'immunosuppressive', 'therapy', 'Ultimately', 'prioritization', 'of', 'testing', 'will', 'depend', 'on', 'institutional', 'specific', 'resources', 'and', 'the', 'needs', 'of', 'different', 'patient', 'populations', '']"
132896,"COVID-19 Diagnostics, Tools, and Prevention",2020,,,"The Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), outbreak from Wuhan City, Hubei province, China in 2019 has become an ongoing global health emergency. The emerging virus, SARS-CoV-2, causes coughing, fever, muscle ache, and shortness of breath or dyspnea in symptomatic patients. The pathogenic particles that are generated by coughing and sneezing remain suspended in the air or attach to a surface to facilitate transmission in an aerosol form. This review focuses on the recent trends in pandemic biology, diagnostics methods, prevention tools, and policies for COVID-19 management. To meet the growing demand for medical supplies during the COVID-19 era, a variety of personal protective equipment (PPE) and ventilators have been developed using do-it-yourself (DIY) manufacturing. COVID-19 diagnosis and the prediction of virus transmission are analyzed by machine learning algorithms, simulations, and digital monitoring. Until the discovery of a clinically approved vaccine for COVID-19, pandemics remain a public concern. Therefore, technological developments, biomedical research, and policy development are needed to decipher the coronavirus mechanism and epidemiological characteristics, prevent transmission, and develop therapeutic drugs.",,bzcl1xgf,"['The', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'outbreak', 'from', 'Wuhan', 'City', 'Hubei', 'province', 'China', 'in', '2019', 'has', 'become', 'an', 'ongoing', 'global', 'health', 'emergency', 'The', 'emerging', 'virus', 'SARS', 'CoV', '2', 'causes', 'coughing', 'fever', 'muscle', 'ache', 'and', 'shortness', 'of', 'breath', 'or', 'dyspnea', 'in', 'symptomatic', 'patients', 'The', 'pathogenic', 'particles', 'that', 'are', 'generated', 'by', 'coughing', 'and', 'sneezing', 'remain', 'suspended', 'in', 'the', 'air', 'or', 'attach', 'to', 'a', 'surface', 'to', 'facilitate', 'transmission', 'in', 'an', 'aerosol', 'form', 'This', 'review', 'focuses', 'on', 'the', 'recent', 'trends', 'in', 'pandemic', 'biology', 'diagnostics', 'methods', 'prevention', 'tools', 'and', 'policies', 'for', 'COVID', '19', 'management', 'To', 'meet', 'the', 'growing', 'demand', 'for', 'medical', 'supplies', 'during', 'the', 'COVID', '19', 'era', 'a', 'variety', 'of', 'personal', 'protective', 'equipment', 'PPE', 'and', 'ventilators', 'have', 'been', 'developed', 'using', 'do', 'it', 'yourself', 'DIY', 'manufacturing', 'COVID', '19', 'diagnosis', 'and', 'the', 'prediction', 'of', 'virus', 'transmission', 'are', 'analyzed', 'by', 'machine', 'learning', 'algorithms', 'simulations', 'and', 'digital', 'monitoring', 'Until', 'the', 'discovery', 'of', 'a', 'clinically', 'approved', 'vaccine', 'for', 'COVID', '19', 'pandemics', 'remain', 'a', 'public', 'concern', 'Therefore', 'technological', 'developments', 'biomedical', 'research', 'and', 'policy', 'development', 'are', 'needed', 'to', 'decipher', 'the', 'coronavirus', 'mechanism', 'and', 'epidemiological', 'characteristics', 'prevent', 'transmission', 'and', 'develop', 'therapeutic', 'drugs', '']"
133633,COVID-19 Clinical Diagnostics and Testing Technology,2020,Pharmacotherapy,,"Given the global nature of the COVID-19 pandemic, the need for disease detection and expanding testing capacity remains a critical priority. This review discusses the technological advances in testing capability and methodology that are currently employed or in development for detecting the novel coronavirus. We describe the current clinical diagnostics and technology, including molecular and serological testing approaches, for SARS-CoV-2 testing as well as address their advantages and limitations. Nucleic acid amplification technology for molecular diagnostics remains the gold standard for virus detection. We highlight alternative molecular detection techniques used for developing novel COVID-19 diagnostics on the horizon. Antibody response against SARS-CoV-2 remains poorly understood and proper validation of serology tests is necessary to demonstrate their accuracy and clinical utility. In order to bring the pandemic under control, we must speed up the development of rapid and widespread testing through improvements in clinical diagnostics and testing technology as well as access to these tools.",,afcd4wc9,"['Given', 'the', 'global', 'nature', 'of', 'the', 'COVID', '19', 'pandemic', 'the', 'need', 'for', 'disease', 'detection', 'and', 'expanding', 'testing', 'capacity', 'remains', 'a', 'critical', 'priority', 'This', 'review', 'discusses', 'the', 'technological', 'advances', 'in', 'testing', 'capability', 'and', 'methodology', 'that', 'are', 'currently', 'employed', 'or', 'in', 'development', 'for', 'detecting', 'the', 'novel', 'coronavirus', 'We', 'describe', 'the', 'current', 'clinical', 'diagnostics', 'and', 'technology', 'including', 'molecular', 'and', 'serological', 'testing', 'approaches', 'for', 'SARS', 'CoV', '2', 'testing', 'as', 'well', 'as', 'address', 'their', 'advantages', 'and', 'limitations', 'Nucleic', 'acid', 'amplification', 'technology', 'for', 'molecular', 'diagnostics', 'remains', 'the', 'gold', 'standard', 'for', 'virus', 'detection', 'We', 'highlight', 'alternative', 'molecular', 'detection', 'techniques', 'used', 'for', 'developing', 'novel', 'COVID', '19', 'diagnostics', 'on', 'the', 'horizon', 'Antibody', 'response', 'against', 'SARS', 'CoV', '2', 'remains', 'poorly', 'understood', 'and', 'proper', 'validation', 'of', 'serology', 'tests', 'is', 'necessary', 'to', 'demonstrate', 'their', 'accuracy', 'and', 'clinical', 'utility', 'In', 'order', 'to', 'bring', 'the', 'pandemic', 'under', 'control', 'we', 'must', 'speed', 'up', 'the', 'development', 'of', 'rapid', 'and', 'widespread', 'testing', 'through', 'improvements', 'in', 'clinical', 'diagnostics', 'and', 'testing', 'technology', 'as', 'well', 'as', 'access', 'to', 'these', 'tools', '']"
137306,COVID-19: An update on diagnostic and therapeutic approaches,2020,BMB reports,,"The unexpected pandemic set off by the novel coronavirus 2019 (COVID-19) has caused severe panic among people worldwide COVID-19 has created havoc, and scientists and physicians are urged to test the efficiency and safety of drugs used to treat this disease In such a pandemic situation, various steps have been taken by government to control and prevent the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) This pandemic situation has forced scientists to rework strategies to combat infectious diseases through drugs, treatment, and control measures COVID-19 treatment requires both limiting viral multiplication and neutralizing tissue damage induced by inappropriate immune reaction Currently, various diagnostic kits to test for COVID-19 are available, and repurposing therapeutics for COVID-19 has shown to be clinically effective As the global demand for diagnostics and therapeutics continues to rise, it is essential to rapidly develop various algorithms to successfully identify and contain the virus This review discusses the updates on specimens/samples, recent efficient diagnostics, and therapeutic approaches to control the disease and repurposed drugs mainly focusing on chloroquine/hydroxychloroquine and convalescent plasma (CP) More research is required for further understanding of the influence of diagnostics and therapeutic approaches to developing vaccines and drugs for COVID-19",,0ikvdwkz,"['The', 'unexpected', 'pandemic', 'set', 'off', 'by', 'the', 'novel', 'coronavirus', '2019', 'COVID', '19', 'has', 'caused', 'severe', 'panic', 'among', 'people', 'worldwide', 'COVID', '19', 'has', 'created', 'havoc', 'and', 'scientists', 'and', 'physicians', 'are', 'urged', 'to', 'test', 'the', 'efficiency', 'and', 'safety', 'of', 'drugs', 'used', 'to', 'treat', 'this', 'disease', 'In', 'such', 'a', 'pandemic', 'situation', 'various', 'steps', 'have', 'been', 'taken', 'by', 'government', 'to', 'control', 'and', 'prevent', 'the', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'This', 'pandemic', 'situation', 'has', 'forced', 'scientists', 'to', 'rework', 'strategies', 'to', 'combat', 'infectious', 'diseases', 'through', 'drugs', 'treatment', 'and', 'control', 'measures', 'COVID', '19', 'treatment', 'requires', 'both', 'limiting', 'viral', 'multiplication', 'and', 'neutralizing', 'tissue', 'damage', 'induced', 'by', 'inappropriate', 'immune', 'reaction', 'Currently', 'various', 'diagnostic', 'kits', 'to', 'test', 'for', 'COVID', '19', 'are', 'available', 'and', 'repurposing', 'therapeutics', 'for', 'COVID', '19', 'has', 'shown', 'to', 'be', 'clinically', 'effective', 'As', 'the', 'global', 'demand', 'for', 'diagnostics', 'and', 'therapeutics', 'continues', 'to', 'rise', 'it', 'is', 'essential', 'to', 'rapidly', 'develop', 'various', 'algorithms', 'to', 'successfully', 'identify', 'and', 'contain', 'the', 'virus', 'This', 'review', 'discusses', 'the', 'updates', 'on', 'specimens', 'samples', 'recent', 'efficient', 'diagnostics', 'and', 'therapeutic', 'approaches', 'to', 'control', 'the', 'disease', 'and', 'repurposed', 'drugs', 'mainly', 'focusing', 'on', 'chloroquine', 'hydroxychloroquine', 'and', 'convalescent', 'plasma', 'CP', 'More', 'research', 'is', 'required', 'for', 'further', 'understanding', 'of', 'the', 'influence', 'of', 'diagnostics', 'and', 'therapeutic', 'approaches', 'to', 'developing', 'vaccines', 'and', 'drugs', 'for', 'COVID', '19']"
138433,Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens,2020,J. clin. microbiol,,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel human coronavirus that causes coronavirus disease 2019 (COVID-19), was first discovered in December 2019 as the cause of an outbreak of pneumonia in the city of Wuhan, Hubei province, China. The clinical presentation of COVID-19 is fairly nonspecific, and symptoms overlap those of other seasonal respiratory infections concurrently circulating in the population. Furthermore, it is estimated that up to 80% of infected individuals experience mild symptoms or are asymptomatic, confounding efforts to reliably diagnose COVID-19 empirically. To support infection control measures, there is an urgent need for rapid and accurate molecular diagnostics to identify COVID-19-positive patients. In the present study, we evaluated the analytical sensitivity and clinical performance of the following four SARS-CoV-2 molecular diagnostic assays granted emergency use authorization by the FDA using nasopharyngeal swabs from symptomatic patients: the New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Panel (modified CDC) assay, the Simplexa COVID-19 Direct (Diasorin Molecular) assay, GenMark ePlex SARS-CoV-2 (GenMark) assay, and the Hologic Panther Fusion SARS-CoV-2 (Hologic) assay. This information is crucial for both laboratories and clinical teams as decisions on which testing platform to implement are made.",,mg2xl68q,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'the', 'novel', 'human', 'coronavirus', 'that', 'causes', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'first', 'discovered', 'in', 'December', '2019', 'as', 'the', 'cause', 'of', 'an', 'outbreak', 'of', 'pneumonia', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'province', 'China', 'The', 'clinical', 'presentation', 'of', 'COVID', '19', 'is', 'fairly', 'nonspecific', 'and', 'symptoms', 'overlap', 'those', 'of', 'other', 'seasonal', 'respiratory', 'infections', 'concurrently', 'circulating', 'in', 'the', 'population', 'Furthermore', 'it', 'is', 'estimated', 'that', 'up', 'to', '80', 'of', 'infected', 'individuals', 'experience', 'mild', 'symptoms', 'or', 'are', 'asymptomatic', 'confounding', 'efforts', 'to', 'reliably', 'diagnose', 'COVID', '19', 'empirically', 'To', 'support', 'infection', 'control', 'measures', 'there', 'is', 'an', 'urgent', 'need', 'for', 'rapid', 'and', 'accurate', 'molecular', 'diagnostics', 'to', 'identify', 'COVID', '19', 'positive', 'patients', 'In', 'the', 'present', 'study', 'we', 'evaluated', 'the', 'analytical', 'sensitivity', 'and', 'clinical', 'performance', 'of', 'the', 'following', 'four', 'SARS', 'CoV', '2', 'molecular', 'diagnostic', 'assays', 'granted', 'emergency', 'use', 'authorization', 'by', 'the', 'FDA', 'using', 'nasopharyngeal', 'swabs', 'from', 'symptomatic', 'patients', 'the', 'New', 'York', 'SARS', 'CoV', '2', 'Real', 'time', 'Reverse', 'Transcriptase', 'RT', 'PCR', 'Diagnostic', 'Panel', 'modified', 'CDC', 'assay', 'the', 'Simplexa', 'COVID', '19', 'Direct', 'Diasorin', 'Molecular', 'assay', 'GenMark', 'ePlex', 'SARS', 'CoV', '2', 'GenMark', 'assay', 'and', 'the', 'Hologic', 'Panther', 'Fusion', 'SARS', 'CoV', '2', 'Hologic', 'assay', 'This', 'information', 'is', 'crucial', 'for', 'both', 'laboratories', 'and', 'clinical', 'teams', 'as', 'decisions', 'on', 'which', 'testing', 'platform', 'to', 'implement', 'are', 'made', '']"
138434,Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens,2020,J. clin. microbiol,,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel human coronavirus that causes coronavirus disease 2019 (COVID-19), was first discovered in December 2019 as the cause of an outbreak of pneumonia in the city of Wuhan, Hubei province, China. The clinical presentation of COVID-19 is fairly non-specific, and symptoms overlap with other seasonal respiratory infections concurrently circulating in the population. Furthermore, it is estimated that up to 80% of infected individuals experience mild symptoms or are asymptomatic, confounding efforts to reliably diagnose COVID-19 empirically. To support infection control measures, there is an urgent need for rapid and accurate molecular diagnostics to identify COVID-19 positive patients. In the present study, we have evaluated the analytical sensitivity and clinical performance of four SARS-CoV-2 molecular diagnostic assays granted Emergency Use Authorization by the FDA using nasopharyngeal swabs from symptomatic patients: the New York SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Panel (Modified CDC), the Simplexa COVID-19 Direct (Diasorin Molecular), GenMark ePlex SARS-CoV-2 assay (GenMark) and the Hologic Panther Fusion® SARS-CoV-2 assay (Hologic). This information is crucial for both laboratories and clinical teams, as decisions on which testing platform to implement are made.",,78yzkodj,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'the', 'novel', 'human', 'coronavirus', 'that', 'causes', 'coronavirus', 'disease', '2019', 'COVID', '19', 'was', 'first', 'discovered', 'in', 'December', '2019', 'as', 'the', 'cause', 'of', 'an', 'outbreak', 'of', 'pneumonia', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'province', 'China', 'The', 'clinical', 'presentation', 'of', 'COVID', '19', 'is', 'fairly', 'non', 'specific', 'and', 'symptoms', 'overlap', 'with', 'other', 'seasonal', 'respiratory', 'infections', 'concurrently', 'circulating', 'in', 'the', 'population', 'Furthermore', 'it', 'is', 'estimated', 'that', 'up', 'to', '80', 'of', 'infected', 'individuals', 'experience', 'mild', 'symptoms', 'or', 'are', 'asymptomatic', 'confounding', 'efforts', 'to', 'reliably', 'diagnose', 'COVID', '19', 'empirically', 'To', 'support', 'infection', 'control', 'measures', 'there', 'is', 'an', 'urgent', 'need', 'for', 'rapid', 'and', 'accurate', 'molecular', 'diagnostics', 'to', 'identify', 'COVID', '19', 'positive', 'patients', 'In', 'the', 'present', 'study', 'we', 'have', 'evaluated', 'the', 'analytical', 'sensitivity', 'and', 'clinical', 'performance', 'of', 'four', 'SARS', 'CoV', '2', 'molecular', 'diagnostic', 'assays', 'granted', 'Emergency', 'Use', 'Authorization', 'by', 'the', 'FDA', 'using', 'nasopharyngeal', 'swabs', 'from', 'symptomatic', 'patients', 'the', 'New', 'York', 'SARS', 'CoV', '2', 'Real', 'time', 'Reverse', 'Transcriptase', 'RT', 'PCR', 'Diagnostic', 'Panel', 'Modified', 'CDC', 'the', 'Simplexa', 'COVID', '19', 'Direct', 'Diasorin', 'Molecular', 'GenMark', 'ePlex', 'SARS', 'CoV', '2', 'assay', 'GenMark', 'and', 'the', 'Hologic', 'Panther', 'Fusion', 'SARS', 'CoV', '2', 'assay', 'Hologic', 'This', 'information', 'is', 'crucial', 'for', 'both', 'laboratories', 'and', 'clinical', 'teams', 'as', 'decisions', 'on', 'which', 'testing', 'platform', 'to', 'implement', 'are', 'made', '']"
138444,Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review,2020,Ann Intern Med,,"Diagnostic testing to identify persons infected with severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few countries, the use of diagnostic testing on a massive scale has been a cornerstone of successful containment strategies. In contrast, the United States, hampered by limited testing capacity, has prioritized testing for specific groups of persons. Real-time reverse transcriptase polymerase chain reaction-based assays performed in a laboratory on respiratory specimens are the reference standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging. Although excellent tools exist for the diagnosis of symptomatic patients in well-equipped laboratories, important gaps remain in screening asymptomatic persons in the incubation phase, as well as in the accurate determination of live viral shedding during convalescence to inform decisions to end isolation. Many affluent countries have encountered challenges in test delivery and specimen collection that have inhibited rapid increases in testing capacity. These challenges may be even greater in low-resource settings. Urgent clinical and public health needs currently drive an unprecedented global effort to increase testing capacity for SARS-CoV-2 infection. Here, the authors review the current array of tests for SARS-CoV-2, highlight gaps in current diagnostic capacity, and propose potential solutions.",,wnt1v675,"['Diagnostic', 'testing', 'to', 'identify', 'persons', 'infected', 'with', 'severe', 'acute', 'respiratory', 'syndrome', 'related', 'coronavirus', '2', 'SARS', 'CoV', '2', 'infection', 'is', 'central', 'to', 'control', 'the', 'global', 'pandemic', 'of', 'COVID', '19', 'that', 'began', 'in', 'late', '2019', 'In', 'a', 'few', 'countries', 'the', 'use', 'of', 'diagnostic', 'testing', 'on', 'a', 'massive', 'scale', 'has', 'been', 'a', 'cornerstone', 'of', 'successful', 'containment', 'strategies', 'In', 'contrast', 'the', 'United', 'States', 'hampered', 'by', 'limited', 'testing', 'capacity', 'has', 'prioritized', 'testing', 'for', 'specific', 'groups', 'of', 'persons', 'Real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'based', 'assays', 'performed', 'in', 'a', 'laboratory', 'on', 'respiratory', 'specimens', 'are', 'the', 'reference', 'standard', 'for', 'COVID', '19', 'diagnostics', 'However', 'point', 'of', 'care', 'technologies', 'and', 'serologic', 'immunoassays', 'are', 'rapidly', 'emerging', 'Although', 'excellent', 'tools', 'exist', 'for', 'the', 'diagnosis', 'of', 'symptomatic', 'patients', 'in', 'well', 'equipped', 'laboratories', 'important', 'gaps', 'remain', 'in', 'screening', 'asymptomatic', 'persons', 'in', 'the', 'incubation', 'phase', 'as', 'well', 'as', 'in', 'the', 'accurate', 'determination', 'of', 'live', 'viral', 'shedding', 'during', 'convalescence', 'to', 'inform', 'decisions', 'to', 'end', 'isolation', 'Many', 'affluent', 'countries', 'have', 'encountered', 'challenges', 'in', 'test', 'delivery', 'and', 'specimen', 'collection', 'that', 'have', 'inhibited', 'rapid', 'increases', 'in', 'testing', 'capacity', 'These', 'challenges', 'may', 'be', 'even', 'greater', 'in', 'low', 'resource', 'settings', 'Urgent', 'clinical', 'and', 'public', 'health', 'needs', 'currently', 'drive', 'an', 'unprecedented', 'global', 'effort', 'to', 'increase', 'testing', 'capacity', 'for', 'SARS', 'CoV', '2', 'infection', 'Here', 'the', 'authors', 'review', 'the', 'current', 'array', 'of', 'tests', 'for', 'SARS', 'CoV', '2', 'highlight', 'gaps', 'in', 'current', 'diagnostic', 'capacity', 'and', 'propose', 'potential', 'solutions', '']"
140799,"Virus detections among patients with severe acute respiratory illness, Northern Vietnam",2020,PLoS One,,"Severe acute respiratory illness (SARI) is a major cause of death and morbidity in low- and middle-income countries, however, the etiologic agents are often undetermined due to the lack of molecular diagnostics in hospitals and clinics. To examine evidence for select viral infections among patients with SARI in northern Vietnam, we studied 348 nasopharyngeal samples from military and civilian patients admitted to 4 hospitals in the greater Hanoi area from 2017-2019. Initial screening for human respiratory viral pathogens was performed in Hanoi, Vietnam at the National Institute of Hygiene and Epidemiology (NIHE) or the Military Institute of Preventative Medicine (MIPM), and an aliquot was shipped to Duke-NUS Medical School in Singapore for validation. Patient demographics were recorded and used to epidemiologically describe the infections. Among military and civilian cases of SARI, 184 (52.9%) tested positive for one or more respiratory viruses. Influenza A virus was the most prevalent virus detected (64.7%), followed by influenza B virus (29.3%), enterovirus (3.8%), adenovirus (1.1%), and coronavirus (1.1%). Risk factor analyses demonstrated an increased risk of influenza A virus detection among military hospital patients (adjusted OR, 2.0; 95% CI, 1.2-3.2), and an increased risk of influenza B virus detection among patients enrolled in year 2017 (adjusted OR, 7.9; 95% CI, 2.7-22.9). As influenza A and B viruses were commonly associated with SARI and are treatable, SARI patients entering these hospitals would benefit if the hospitals were able to adapt onsite molecular diagnostics.",,y97ax058,"['Severe', 'acute', 'respiratory', 'illness', 'SARI', 'is', 'a', 'major', 'cause', 'of', 'death', 'and', 'morbidity', 'in', 'low', 'and', 'middle', 'income', 'countries', 'however', 'the', 'etiologic', 'agents', 'are', 'often', 'undetermined', 'due', 'to', 'the', 'lack', 'of', 'molecular', 'diagnostics', 'in', 'hospitals', 'and', 'clinics', 'To', 'examine', 'evidence', 'for', 'select', 'viral', 'infections', 'among', 'patients', 'with', 'SARI', 'in', 'northern', 'Vietnam', 'we', 'studied', '348', 'nasopharyngeal', 'samples', 'from', 'military', 'and', 'civilian', 'patients', 'admitted', 'to', '4', 'hospitals', 'in', 'the', 'greater', 'Hanoi', 'area', 'from', '2017', '2019', 'Initial', 'screening', 'for', 'human', 'respiratory', 'viral', 'pathogens', 'was', 'performed', 'in', 'Hanoi', 'Vietnam', 'at', 'the', 'National', 'Institute', 'of', 'Hygiene', 'and', 'Epidemiology', 'NIHE', 'or', 'the', 'Military', 'Institute', 'of', 'Preventative', 'Medicine', 'MIPM', 'and', 'an', 'aliquot', 'was', 'shipped', 'to', 'Duke', 'NUS', 'Medical', 'School', 'in', 'Singapore', 'for', 'validation', 'Patient', 'demographics', 'were', 'recorded', 'and', 'used', 'to', 'epidemiologically', 'describe', 'the', 'infections', 'Among', 'military', 'and', 'civilian', 'cases', 'of', 'SARI', '184', '52', '9', 'tested', 'positive', 'for', 'one', 'or', 'more', 'respiratory', 'viruses', 'Influenza', 'A', 'virus', 'was', 'the', 'most', 'prevalent', 'virus', 'detected', '64', '7', 'followed', 'by', 'influenza', 'B', 'virus', '29', '3', 'enterovirus', '3', '8', 'adenovirus', '1', '1', 'and', 'coronavirus', '1', '1', 'Risk', 'factor', 'analyses', 'demonstrated', 'an', 'increased', 'risk', 'of', 'influenza', 'A', 'virus', 'detection', 'among', 'military', 'hospital', 'patients', 'adjusted', 'OR', '2', '0', '95', 'CI', '1', '2', '3', '2', 'and', 'an', 'increased', 'risk', 'of', 'influenza', 'B', 'virus', 'detection', 'among', 'patients', 'enrolled', 'in', 'year', '2017', 'adjusted', 'OR', '7', '9', '95', 'CI', '2', '7', '22', '9', 'As', 'influenza', 'A', 'and', 'B', 'viruses', 'were', 'commonly', 'associated', 'with', 'SARI', 'and', 'are', 'treatable', 'SARI', 'patients', 'entering', 'these', 'hospitals', 'would', 'benefit', 'if', 'the', 'hospitals', 'were', 'able', 'to', 'adapt', 'onsite', 'molecular', 'diagnostics', '']"
141010,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review",2020,,,"Rapid diagnostics, vaccines and therapeutics are important interventions for the management of the 2019 novel coronavirus (2019-nCoV) outbreak. It is timely to systematically review the potential of these interventions, including those for Middle East respiratory syndrome-Coronavirus (MERS-CoV) and severe acute respiratory syndrome (SARS)-CoV, to guide policymakers globally on their prioritization of resources for research and development. A systematic search was carried out in three major electronic databases (PubMed, Embase and Cochrane Library) to identify published studies in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Supplementary strategies through Google Search and personal communications were used. A total of 27 studies fulfilled the criteria for review. Several laboratory protocols for confirmation of suspected 2019-nCoV cases using real-time reverse transcription polymerase chain reaction (RT-PCR) have been published. A commercial RT-PCR kit developed by the Beijing Genomic Institute is currently widely used in China and likely in Asia. However, serological assays as well as point-of-care testing kits have not been developed but are likely in the near future. Several vaccine candidates are in the pipeline. The likely earliest Phase 1 vaccine trial is a synthetic DNA-based candidate. A number of novel compounds as well as therapeutics licensed for other conditions appear to have in vitro efficacy against the 2019-nCoV. Some are being tested in clinical trials against MERS-CoV and SARS-CoV, while others have been listed for clinical trials against 2019-nCoV. However, there are currently no effective specific antivirals or drug combinations supported by high-level evidence.",,m95bmi9t,"['Rapid', 'diagnostics', 'vaccines', 'and', 'therapeutics', 'are', 'important', 'interventions', 'for', 'the', 'management', 'of', 'the', '2019', 'novel', 'coronavirus', '2019', 'nCoV', 'outbreak', 'It', 'is', 'timely', 'to', 'systematically', 'review', 'the', 'potential', 'of', 'these', 'interventions', 'including', 'those', 'for', 'Middle', 'East', 'respiratory', 'syndrome', 'Coronavirus', 'MERS', 'CoV', 'and', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'to', 'guide', 'policymakers', 'globally', 'on', 'their', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'A', 'systematic', 'search', 'was', 'carried', 'out', 'in', 'three', 'major', 'electronic', 'databases', 'PubMed', 'Embase', 'and', 'Cochrane', 'Library', 'to', 'identify', 'published', 'studies', 'in', 'accordance', 'with', 'the', 'Preferred', 'Reporting', 'Items', 'for', 'Systematic', 'Reviews', 'and', 'Meta', 'Analyses', 'PRISMA', 'guidelines', 'Supplementary', 'strategies', 'through', 'Google', 'Search', 'and', 'personal', 'communications', 'were', 'used', 'A', 'total', 'of', '27', 'studies', 'fulfilled', 'the', 'criteria', 'for', 'review', 'Several', 'laboratory', 'protocols', 'for', 'confirmation', 'of', 'suspected', '2019', 'nCoV', 'cases', 'using', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'have', 'been', 'published', 'A', 'commercial', 'RT', 'PCR', 'kit', 'developed', 'by', 'the', 'Beijing', 'Genomic', 'Institute', 'is', 'currently', 'widely', 'used', 'in', 'China', 'and', 'likely', 'in', 'Asia', 'However', 'serological', 'assays', 'as', 'well', 'as', 'point', 'of', 'care', 'testing', 'kits', 'have', 'not', 'been', 'developed', 'but', 'are', 'likely', 'in', 'the', 'near', 'future', 'Several', 'vaccine', 'candidates', 'are', 'in', 'the', 'pipeline', 'The', 'likely', 'earliest', 'Phase', '1', 'vaccine', 'trial', 'is', 'a', 'synthetic', 'DNA', 'based', 'candidate', 'A', 'number', 'of', 'novel', 'compounds', 'as', 'well', 'as', 'therapeutics', 'licensed', 'for', 'other', 'conditions', 'appear', 'to', 'have', 'in', 'vitro', 'efficacy', 'against', 'the', '2019', 'nCoV', 'Some', 'are', 'being', 'tested', 'in', 'clinical', 'trials', 'against', 'MERS', 'CoV', 'and', 'SARS', 'CoV', 'while', 'others', 'have', 'been', 'listed', 'for', 'clinical', 'trials', 'against', '2019', 'nCoV', 'However', 'there', 'are', 'currently', 'no', 'effective', 'specific', 'antivirals', 'or', 'drug', 'combinations', 'supported', 'by', 'high', 'level', 'evidence', '']"
141621,Rapid in situ hybridization technique for the detection of ribonucleic acids in tissues using radiolabelled and fluorescein-labelled riboprobes,1997-08-31,Molecular and Cellular Probes,https://www.sciencedirect.com/science/article/pii/S0890850897901146; https://www.ncbi.nlm.nih.gov/pubmed/9281413/; https://api.elsevier.com/content/article/pii/S0890850897901146,"Abstract In situhybridization (ISH) is a useful diagnostic and research tool, but is also time consuming. This study was conducted to determine if a rate enhancement hybridization (REH) buffer, developed for membrane hybridization, could be used to decrease hybridization time for ISH. Tissue from swine with an enteric disease produced by a swine coronavirus, transmissible gastroenteritis virus (TGEV), was used as a model to standardize hybridization conditions for a rapid ISH technique. Small intestinal sections from pigs experimentally and naturally infected with TGEV were hybridized for various times at 52°C and 70°C with a radiolabelled or a fluorescein-labelled RNA probe in a standard hybridization or a REH buffer. Viral RNA was detected in intestines from as early as 30 min of hybridization by using both buffers with the radiolabelled probe; however, the signal was stronger with the REH buffer. With the fluorescein-labelled probe, viral RNA was detected in virus-infected cells of the intestines after 30 min of hybridization by using the REH buffer. Signal intensity was greater with the REH buffer than with the standard hybridization buffer when compared at each hybridization time and hybridization temperature using both radiolabelled and fluorescein-labelled probes. With the REH buffer, hybridization signal intensity was greater at 70°C than at 52°C for both probes. The best results were obtained when small intestinal sections were hybridized at 70°C for 2 h using a radiolabelled or a fluorescein-labelled probe diluted in the REH buffer. The fluorescein-labelled RNA probe with REH buffer resulted in a minimal non-specific signal when compared with the radiolabelled probe. These studies demonstrated that the REH buffer can be used to decrease the time of ISH for the detection of viral RNA. This rapid ISH technique should have broad applications in the utilization of probe technology in diagnostics and research for the detection of target ribonucleic acidsin situ",10.1006/mcpr.1997.0114,hsspggp8,"['Abstract', 'In', 'situhybridization', 'ISH', 'is', 'a', 'useful', 'diagnostic', 'and', 'research', 'tool', 'but', 'is', 'also', 'time', 'consuming', 'This', 'study', 'was', 'conducted', 'to', 'determine', 'if', 'a', 'rate', 'enhancement', 'hybridization', 'REH', 'buffer', 'developed', 'for', 'membrane', 'hybridization', 'could', 'be', 'used', 'to', 'decrease', 'hybridization', 'time', 'for', 'ISH', 'Tissue', 'from', 'swine', 'with', 'an', 'enteric', 'disease', 'produced', 'by', 'a', 'swine', 'coronavirus', 'transmissible', 'gastroenteritis', 'virus', 'TGEV', 'was', 'used', 'as', 'a', 'model', 'to', 'standardize', 'hybridization', 'conditions', 'for', 'a', 'rapid', 'ISH', 'technique', 'Small', 'intestinal', 'sections', 'from', 'pigs', 'experimentally', 'and', 'naturally', 'infected', 'with', 'TGEV', 'were', 'hybridized', 'for', 'various', 'times', 'at', '52', 'C', 'and', '70', 'C', 'with', 'a', 'radiolabelled', 'or', 'a', 'fluorescein', 'labelled', 'RNA', 'probe', 'in', 'a', 'standard', 'hybridization', 'or', 'a', 'REH', 'buffer', 'Viral', 'RNA', 'was', 'detected', 'in', 'intestines', 'from', 'as', 'early', 'as', '30', 'min', 'of', 'hybridization', 'by', 'using', 'both', 'buffers', 'with', 'the', 'radiolabelled', 'probe', 'however', 'the', 'signal', 'was', 'stronger', 'with', 'the', 'REH', 'buffer', 'With', 'the', 'fluorescein', 'labelled', 'probe', 'viral', 'RNA', 'was', 'detected', 'in', 'virus', 'infected', 'cells', 'of', 'the', 'intestines', 'after', '30', 'min', 'of', 'hybridization', 'by', 'using', 'the', 'REH', 'buffer', 'Signal', 'intensity', 'was', 'greater', 'with', 'the', 'REH', 'buffer', 'than', 'with', 'the', 'standard', 'hybridization', 'buffer', 'when', 'compared', 'at', 'each', 'hybridization', 'time', 'and', 'hybridization', 'temperature', 'using', 'both', 'radiolabelled', 'and', 'fluorescein', 'labelled', 'probes', 'With', 'the', 'REH', 'buffer', 'hybridization', 'signal', 'intensity', 'was', 'greater', 'at', '70', 'C', 'than', 'at', '52', 'C', 'for', 'both', 'probes', 'The', 'best', 'results', 'were', 'obtained', 'when', 'small', 'intestinal', 'sections', 'were', 'hybridized', 'at', '70', 'C', 'for', '2', 'h', 'using', 'a', 'radiolabelled', 'or', 'a', 'fluorescein', 'labelled', 'probe', 'diluted', 'in', 'the', 'REH', 'buffer', 'The', 'fluorescein', 'labelled', 'RNA', 'probe', 'with', 'REH', 'buffer', 'resulted', 'in', 'a', 'minimal', 'non', 'specific', 'signal', 'when', 'compared', 'with', 'the', 'radiolabelled', 'probe', 'These', 'studies', 'demonstrated', 'that', 'the', 'REH', 'buffer', 'can', 'be', 'used', 'to', 'decrease', 'the', 'time', 'of', 'ISH', 'for', 'the', 'detection', 'of', 'viral', 'RNA', 'This', 'rapid', 'ISH', 'technique', 'should', 'have', 'broad', 'applications', 'in', 'the', 'utilization', 'of', 'probe', 'technology', 'in', 'diagnostics', 'and', 'research', 'for', 'the', 'detection', 'of', 'target', 'ribonucleic', 'acidsin', 'situ']"
142305,Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes,2020-05-30,bioRxiv,https://www.ncbi.nlm.nih.gov/pubmed/32577660/; https://doi.org/10.1101/2020.05.30.125484,"The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has led to accelerated efforts to develop therapeutics, diagnostics, and vaccines to mitigate this public health emergency. A key target of these efforts is the spike (S) protein, a large trimeric class I fusion protein that is metastable and difficult to produce recombinantly in large quantities. Here, we designed and expressed over 100 structure-guided spike variants based upon a previously determined cryo-EM structure of the prefusion SARS-CoV-2 spike. Biochemical, biophysical and structural characterization of these variants identified numerous individual substitutions that increased protein yields and stability. The best variant, HexaPro, has six beneficial proline substitutions leading to ~10-fold higher expression than its parental construct and is able to withstand heat stress, storage at room temperature, and multiple freeze-thaws. A 3.2 Å-resolution cryo-EM structure of HexaPro confirmed that it retains the prefusion spike conformation. High-yield production of a stabilized prefusion spike protein will accelerate the development of vaccines and serological diagnostics for SARS-CoV-2.",10.1101/2020.05.30.125484,g81ylcxq,"['The', 'COVID', '19', 'pandemic', 'caused', 'by', 'the', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'has', 'led', 'to', 'accelerated', 'efforts', 'to', 'develop', 'therapeutics', 'diagnostics', 'and', 'vaccines', 'to', 'mitigate', 'this', 'public', 'health', 'emergency', 'A', 'key', 'target', 'of', 'these', 'efforts', 'is', 'the', 'spike', 'S', 'protein', 'a', 'large', 'trimeric', 'class', 'I', 'fusion', 'protein', 'that', 'is', 'metastable', 'and', 'difficult', 'to', 'produce', 'recombinantly', 'in', 'large', 'quantities', 'Here', 'we', 'designed', 'and', 'expressed', 'over', '100', 'structure', 'guided', 'spike', 'variants', 'based', 'upon', 'a', 'previously', 'determined', 'cryo', 'EM', 'structure', 'of', 'the', 'prefusion', 'SARS', 'CoV', '2', 'spike', 'Biochemical', 'biophysical', 'and', 'structural', 'characterization', 'of', 'these', 'variants', 'identified', 'numerous', 'individual', 'substitutions', 'that', 'increased', 'protein', 'yields', 'and', 'stability', 'The', 'best', 'variant', 'HexaPro', 'has', 'six', 'beneficial', 'proline', 'substitutions', 'leading', 'to', '10', 'fold', 'higher', 'expression', 'than', 'its', 'parental', 'construct', 'and', 'is', 'able', 'to', 'withstand', 'heat', 'stress', 'storage', 'at', 'room', 'temperature', 'and', 'multiple', 'freeze', 'thaws', 'A', '3', '2', 'Å', 'resolution', 'cryo', 'EM', 'structure', 'of', 'HexaPro', 'confirmed', 'that', 'it', 'retains', 'the', 'prefusion', 'spike', 'conformation', 'High', 'yield', 'production', 'of', 'a', 'stabilized', 'prefusion', 'spike', 'protein', 'will', 'accelerate', 'the', 'development', 'of', 'vaccines', 'and', 'serological', 'diagnostics', 'for', 'SARS', 'CoV', '2', '']"
143322,CRISPR-cas systems based molecular diagnostic tool for infectious diseases and emerging 2019 novel coronavirus (COVID-19) pneumonia,2020-05-26,J Drug Target,https://doi.org/10.1080/1061186x.2020.1769637; https://www.ncbi.nlm.nih.gov/pubmed/32401064/,"Emerging infectious diseases, the persistent potential for destabilising pandemics, remain a global threat leading to excessive morbidity and mortality. The current outbreak of pneumonia caused by 2019 novel coronavirus (COVID-19) illustrated difficulties in lack of effective drugs for treatment. Accurate and rapid diagnostic tools are essential for early recognition and treatment of infectious diseases, allowing timely implementation of infection control, improved clinical care and other public health measures to stop the spread of the disease. CRISPR-Cas technology speed up the development of infectious disease diagnostics with high rapid and accurate. In this review, we summarise current advance regarding diverse CRISPR-Cas systems, including CRISPR-Cas9, CRISPR-Cas12 and CRISPR-Cas13, in the development of fast, accurate and portable diagnostic tests and highlight the potential of CRISPR-Cas13 in COVID-19 Pneumonia and other emerging infectious diseases diagnosis.",10.1080/1061186x.2020.1769637,q52mia0e,"['Emerging', 'infectious', 'diseases', 'the', 'persistent', 'potential', 'for', 'destabilising', 'pandemics', 'remain', 'a', 'global', 'threat', 'leading', 'to', 'excessive', 'morbidity', 'and', 'mortality', 'The', 'current', 'outbreak', 'of', 'pneumonia', 'caused', 'by', '2019', 'novel', 'coronavirus', 'COVID', '19', 'illustrated', 'difficulties', 'in', 'lack', 'of', 'effective', 'drugs', 'for', 'treatment', 'Accurate', 'and', 'rapid', 'diagnostic', 'tools', 'are', 'essential', 'for', 'early', 'recognition', 'and', 'treatment', 'of', 'infectious', 'diseases', 'allowing', 'timely', 'implementation', 'of', 'infection', 'control', 'improved', 'clinical', 'care', 'and', 'other', 'public', 'health', 'measures', 'to', 'stop', 'the', 'spread', 'of', 'the', 'disease', 'CRISPR', 'Cas', 'technology', 'speed', 'up', 'the', 'development', 'of', 'infectious', 'disease', 'diagnostics', 'with', 'high', 'rapid', 'and', 'accurate', 'In', 'this', 'review', 'we', 'summarise', 'current', 'advance', 'regarding', 'diverse', 'CRISPR', 'Cas', 'systems', 'including', 'CRISPR', 'Cas9', 'CRISPR', 'Cas12', 'and', 'CRISPR', 'Cas13', 'in', 'the', 'development', 'of', 'fast', 'accurate', 'and', 'portable', 'diagnostic', 'tests', 'and', 'highlight', 'the', 'potential', 'of', 'CRISPR', 'Cas13', 'in', 'COVID', '19', 'Pneumonia', 'and', 'other', 'emerging', 'infectious', 'diseases', 'diagnosis', '']"
144182,Prevalence and characteristics of acute respiratory virus infections in pediatric cancer patients,2019-02-27,J Med Virol,https://doi.org/10.1002/jmv.25432; https://www.ncbi.nlm.nih.gov/pubmed/30763464/,"BACKGROUND: Patients with pediatric cancer have a higher risk of morbidity and mortality because of respiratory viral infections than other patient populations. OBJECTIVES: To investigate the causative viruses of respiratory infections and their burden among patients with pediatric cancer in Lebanon. STUDY DESIGN: Nasopharyngeal swabs along with clinical and demographic data were collected from patients with pediatric cancer presenting febrile episodes with upper respiratory tract symptoms. Total nucleic acid was extracted from specimens followed by the real‐time PCR analysis targeting 14 respiratory viruses to estimate the frequency of infections. RESULTS: We obtained 89 nasopharyngeal swabs from patients with pediatric cancer (mean age, 5.8 ± 4.2 years). Real‐time PCR confirmed viral infection in 77 swabs (86.5%). Among these, 151 respiratory viruses were detected. Several viruses cocirculated within the same period; respiratory syncytial virus (RSV) being the most common (45.45%), followed by parainfluenza virus (PIV; 26%), influenza type B (26%), human metapneumovirus (24.6%), and human coronavirus (HCoV; 24.6%). Coinfections were detected in 55% of the subjects, and most of them involved RSV with one or more other viruses. A strong correlation was found between PIV, Flu (influenza of any type), RSV, and HCoV with the incidence of coinfections. RSV was associated with lower respiratory tract infections, nasal congestion, bronchitis, and bacteremia. HCoV was associated with bronchiolitis; rhinovirus was associated with hospital admission. CONCLUSION: Patients with pediatric cancer have a high burden of respiratory viral infections and a high incidence of coinfections. Molecular diagnostics can improve management of febrile episodes and reduce antibiotic use.",10.1002/jmv.25432,ea0dh03q,"['BACKGROUND', 'Patients', 'with', 'pediatric', 'cancer', 'have', 'a', 'higher', 'risk', 'of', 'morbidity', 'and', 'mortality', 'because', 'of', 'respiratory', 'viral', 'infections', 'than', 'other', 'patient', 'populations', 'OBJECTIVES', 'To', 'investigate', 'the', 'causative', 'viruses', 'of', 'respiratory', 'infections', 'and', 'their', 'burden', 'among', 'patients', 'with', 'pediatric', 'cancer', 'in', 'Lebanon', 'STUDY', 'DESIGN', 'Nasopharyngeal', 'swabs', 'along', 'with', 'clinical', 'and', 'demographic', 'data', 'were', 'collected', 'from', 'patients', 'with', 'pediatric', 'cancer', 'presenting', 'febrile', 'episodes', 'with', 'upper', 'respiratory', 'tract', 'symptoms', 'Total', 'nucleic', 'acid', 'was', 'extracted', 'from', 'specimens', 'followed', 'by', 'the', 'real', 'time', 'PCR', 'analysis', 'targeting', '14', 'respiratory', 'viruses', 'to', 'estimate', 'the', 'frequency', 'of', 'infections', 'RESULTS', 'We', 'obtained', '89', 'nasopharyngeal', 'swabs', 'from', 'patients', 'with', 'pediatric', 'cancer', 'mean', 'age', '5', '8', '4', '2', 'years', 'Real', 'time', 'PCR', 'confirmed', 'viral', 'infection', 'in', '77', 'swabs', '86', '5', 'Among', 'these', '151', 'respiratory', 'viruses', 'were', 'detected', 'Several', 'viruses', 'cocirculated', 'within', 'the', 'same', 'period', 'respiratory', 'syncytial', 'virus', 'RSV', 'being', 'the', 'most', 'common', '45', '45', 'followed', 'by', 'parainfluenza', 'virus', 'PIV', '26', 'influenza', 'type', 'B', '26', 'human', 'metapneumovirus', '24', '6', 'and', 'human', 'coronavirus', 'HCoV', '24', '6', 'Coinfections', 'were', 'detected', 'in', '55', 'of', 'the', 'subjects', 'and', 'most', 'of', 'them', 'involved', 'RSV', 'with', 'one', 'or', 'more', 'other', 'viruses', 'A', 'strong', 'correlation', 'was', 'found', 'between', 'PIV', 'Flu', 'influenza', 'of', 'any', 'type', 'RSV', 'and', 'HCoV', 'with', 'the', 'incidence', 'of', 'coinfections', 'RSV', 'was', 'associated', 'with', 'lower', 'respiratory', 'tract', 'infections', 'nasal', 'congestion', 'bronchitis', 'and', 'bacteremia', 'HCoV', 'was', 'associated', 'with', 'bronchiolitis', 'rhinovirus', 'was', 'associated', 'with', 'hospital', 'admission', 'CONCLUSION', 'Patients', 'with', 'pediatric', 'cancer', 'have', 'a', 'high', 'burden', 'of', 'respiratory', 'viral', 'infections', 'and', 'a', 'high', 'incidence', 'of', 'coinfections', 'Molecular', 'diagnostics', 'can', 'improve', 'management', 'of', 'febrile', 'episodes', 'and', 'reduce', 'antibiotic', 'use', '']"
144496,Biochemical characterization of SARS-CoV-2 nucleocapsid protein,2020-04-30,Biochem Biophys Res Commun,https://doi.org/10.1016/j.bbrc.2020.04.136; https://www.sciencedirect.com/science/article/pii/S0006291X20308767?v=s5; https://www.ncbi.nlm.nih.gov/pubmed/32416961/; https://api.elsevier.com/content/article/pii/S0006291X20308767,"The nucleocapsid (N) protein is an important antigen for coronavirus, which participate in RNA package and virus particle release. In this study, we expressed the N protein of SARS-CoV-2 and characterized its biochemical properties. Static light scattering, size exclusive chromatography, and small-angle X-ray scattering (SAXS) showed that the purified N protein is largely a dimer in solution. CD spectra showed that it has a high percentage of disordered region at room temperature while it was best structured at 55 °C, suggesting its structural dynamics. Fluorescence polarization assay showed it has non-specific nucleic acid binding capability, which raised a concern in using it as a diagnostic marker. Immunoblot assays confirmed the presence of IgA, IgM and IgG antibodies against N antigen in COVID-19 infection patients' sera, proving the importance of this antigen in host immunity and diagnostics.",10.1016/j.bbrc.2020.04.136,8qcy0nl1,"['The', 'nucleocapsid', 'N', 'protein', 'is', 'an', 'important', 'antigen', 'for', 'coronavirus', 'which', 'participate', 'in', 'RNA', 'package', 'and', 'virus', 'particle', 'release', 'In', 'this', 'study', 'we', 'expressed', 'the', 'N', 'protein', 'of', 'SARS', 'CoV', '2', 'and', 'characterized', 'its', 'biochemical', 'properties', 'Static', 'light', 'scattering', 'size', 'exclusive', 'chromatography', 'and', 'small', 'angle', 'X', 'ray', 'scattering', 'SAXS', 'showed', 'that', 'the', 'purified', 'N', 'protein', 'is', 'largely', 'a', 'dimer', 'in', 'solution', 'CD', 'spectra', 'showed', 'that', 'it', 'has', 'a', 'high', 'percentage', 'of', 'disordered', 'region', 'at', 'room', 'temperature', 'while', 'it', 'was', 'best', 'structured', 'at', '55', 'C', 'suggesting', 'its', 'structural', 'dynamics', 'Fluorescence', 'polarization', 'assay', 'showed', 'it', 'has', 'non', 'specific', 'nucleic', 'acid', 'binding', 'capability', 'which', 'raised', 'a', 'concern', 'in', 'using', 'it', 'as', 'a', 'diagnostic', 'marker', 'Immunoblot', 'assays', 'confirmed', 'the', 'presence', 'of', 'IgA', 'IgM', 'and', 'IgG', 'antibodies', 'against', 'N', 'antigen', 'in', 'COVID', '19', 'infection', 'patients', 'sera', 'proving', 'the', 'importance', 'of', 'this', 'antigen', 'in', 'host', 'immunity', 'and', 'diagnostics', '']"
144961,The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review,2020-07-02,Int J Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/32623083/; https://api.elsevier.com/content/article/pii/S1201971220305336; https://www.sciencedirect.com/science/article/pii/S1201971220305336?v=s5; https://doi.org/10.1016/j.ijid.2020.06.098,"BACKGROUND: the recent outbreak of the coronavirus disease 2019 (COVID‐19) has quickly spread globally since its discovery in Wuhan, China, in December 2019. A comprehensive strategy, including surveillance, diagnostics, research, and clinical treatment is urgently needed to win the battle against COVID-19. Recently, numerous studies reported the incidence of SARS-CoV-2 in asymptomatic patients. Yet, the incidence and viral transmission from the asymptomatic cases are not apparent yet. AIM: this study aims to systematically review the published literature on SARS-CoV-2 in the asymptomatic patients to estimate the incidence of COVID-19 among asymptomatic cases, as well as describe its epidemiological and clinical significance. METHOD: the literature was searched through four scientific databases: PubMed, Web of Science, Scopus, and Science Direct. RESULTS: a total of 63 studies satisfied the inclusion criteria where the majority of the reported studies were from China. However, there was a lack of SARS-CoV-2 epidemiological studies from several countries worldwide, tracing the actual incidence of COVID-19, especially in asymptomatic patients. Studies with a large sample size (n>1000) estimated that percentage of people contracting SARS-CoV-2 and are likely to be asymptomatic ranges from 1.2-12.9%. However, the other studies with a smaller sample size reported a much higher incidence and indicated that up to 87.9% of COVID-19 infected individuals could be asymptomatic. Most of these studies indicated that asymptopatics are a potential source of infection to the community. CONCLUSION: this review highlighted the need for more robust and well-designed studies to better estimate COVID-19 incidence among asymptomatic patients worldwide. The early identification of the asymptomatic cases, as well as monitoring and tracing close contact, could help in mitigating the spread of COVID-19.",10.1016/j.ijid.2020.06.098,lgze4zex,"['BACKGROUND', 'the', 'recent', 'outbreak', 'of', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'has', 'quickly', 'spread', 'globally', 'since', 'its', 'discovery', 'in', 'Wuhan', 'China', 'in', 'December', '2019', 'A', 'comprehensive', 'strategy', 'including', 'surveillance', 'diagnostics', 'research', 'and', 'clinical', 'treatment', 'is', 'urgently', 'needed', 'to', 'win', 'the', 'battle', 'against', 'COVID', '19', 'Recently', 'numerous', 'studies', 'reported', 'the', 'incidence', 'of', 'SARS', 'CoV', '2', 'in', 'asymptomatic', 'patients', 'Yet', 'the', 'incidence', 'and', 'viral', 'transmission', 'from', 'the', 'asymptomatic', 'cases', 'are', 'not', 'apparent', 'yet', 'AIM', 'this', 'study', 'aims', 'to', 'systematically', 'review', 'the', 'published', 'literature', 'on', 'SARS', 'CoV', '2', 'in', 'the', 'asymptomatic', 'patients', 'to', 'estimate', 'the', 'incidence', 'of', 'COVID', '19', 'among', 'asymptomatic', 'cases', 'as', 'well', 'as', 'describe', 'its', 'epidemiological', 'and', 'clinical', 'significance', 'METHOD', 'the', 'literature', 'was', 'searched', 'through', 'four', 'scientific', 'databases', 'PubMed', 'Web', 'of', 'Science', 'Scopus', 'and', 'Science', 'Direct', 'RESULTS', 'a', 'total', 'of', '63', 'studies', 'satisfied', 'the', 'inclusion', 'criteria', 'where', 'the', 'majority', 'of', 'the', 'reported', 'studies', 'were', 'from', 'China', 'However', 'there', 'was', 'a', 'lack', 'of', 'SARS', 'CoV', '2', 'epidemiological', 'studies', 'from', 'several', 'countries', 'worldwide', 'tracing', 'the', 'actual', 'incidence', 'of', 'COVID', '19', 'especially', 'in', 'asymptomatic', 'patients', 'Studies', 'with', 'a', 'large', 'sample', 'size', 'n', '1000', 'estimated', 'that', 'percentage', 'of', 'people', 'contracting', 'SARS', 'CoV', '2', 'and', 'are', 'likely', 'to', 'be', 'asymptomatic', 'ranges', 'from', '1', '2', '12', '9', 'However', 'the', 'other', 'studies', 'with', 'a', 'smaller', 'sample', 'size', 'reported', 'a', 'much', 'higher', 'incidence', 'and', 'indicated', 'that', 'up', 'to', '87', '9', 'of', 'COVID', '19', 'infected', 'individuals', 'could', 'be', 'asymptomatic', 'Most', 'of', 'these', 'studies', 'indicated', 'that', 'asymptopatics', 'are', 'a', 'potential', 'source', 'of', 'infection', 'to', 'the', 'community', 'CONCLUSION', 'this', 'review', 'highlighted', 'the', 'need', 'for', 'more', 'robust', 'and', 'well', 'designed', 'studies', 'to', 'better', 'estimate', 'COVID', '19', 'incidence', 'among', 'asymptomatic', 'patients', 'worldwide', 'The', 'early', 'identification', 'of', 'the', 'asymptomatic', 'cases', 'as', 'well', 'as', 'monitoring', 'and', 'tracing', 'close', 'contact', 'could', 'help', 'in', 'mitigating', 'the', 'spread', 'of', 'COVID', '19', '']"
145945,"Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments",2020-02-08,Vet Q,https://www.ncbi.nlm.nih.gov/pubmed/32036774/; https://doi.org/10.1080/01652176.2020.1727993,"Coronaviruses are the well-known cause of severe respiratory, enteric and systemic infections in a wide range of hosts including man, mammals, fish, and avian. The scientific interest on coronaviruses increased after the emergence of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) outbreaks in 2002-2003 followed by Middle East Respiratory Syndrome CoV (MERS-CoV). This decade’s first CoV, named 2019-nCoV, emerged from Wuhan, China, and declared as ‘Public Health Emergency of International Concern’ on January 30(th), 2020 by the World Health Organization (WHO). As on February 4, 2020, 425 deaths reported in China only and one death outside China (Philippines). In a short span of time, the virus spread has been noted in 24 countries. The zoonotic transmission (animal-to-human) is suspected as the route of disease origin. The genetic analyses predict bats as the most probable source of 2019-nCoV though further investigations needed to confirm the origin of the novel virus. The ongoing nCoV outbreak highlights the hidden wild animal reservoir of the deadly viruses and possible threat of spillover zoonoses as well. The successful virus isolation attempts have made doors open for developing better diagnostics and effective vaccines helping in combating the spread of the virus to newer areas.",10.1080/01652176.2020.1727993,1qkwsh6a,"['Coronaviruses', 'are', 'the', 'well', 'known', 'cause', 'of', 'severe', 'respiratory', 'enteric', 'and', 'systemic', 'infections', 'in', 'a', 'wide', 'range', 'of', 'hosts', 'including', 'man', 'mammals', 'fish', 'and', 'avian', 'The', 'scientific', 'interest', 'on', 'coronaviruses', 'increased', 'after', 'the', 'emergence', 'of', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'coronavirus', 'SARS', 'CoV', 'outbreaks', 'in', '2002', '2003', 'followed', 'by', 'Middle', 'East', 'Respiratory', 'Syndrome', 'CoV', 'MERS', 'CoV', 'This', 'decade', 's', 'first', 'CoV', 'named', '2019', 'nCoV', 'emerged', 'from', 'Wuhan', 'China', 'and', 'declared', 'as', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'on', 'January', '30', 'th', '2020', 'by', 'the', 'World', 'Health', 'Organization', 'WHO', 'As', 'on', 'February', '4', '2020', '425', 'deaths', 'reported', 'in', 'China', 'only', 'and', 'one', 'death', 'outside', 'China', 'Philippines', 'In', 'a', 'short', 'span', 'of', 'time', 'the', 'virus', 'spread', 'has', 'been', 'noted', 'in', '24', 'countries', 'The', 'zoonotic', 'transmission', 'animal', 'to', 'human', 'is', 'suspected', 'as', 'the', 'route', 'of', 'disease', 'origin', 'The', 'genetic', 'analyses', 'predict', 'bats', 'as', 'the', 'most', 'probable', 'source', 'of', '2019', 'nCoV', 'though', 'further', 'investigations', 'needed', 'to', 'confirm', 'the', 'origin', 'of', 'the', 'novel', 'virus', 'The', 'ongoing', 'nCoV', 'outbreak', 'highlights', 'the', 'hidden', 'wild', 'animal', 'reservoir', 'of', 'the', 'deadly', 'viruses', 'and', 'possible', 'threat', 'of', 'spillover', 'zoonoses', 'as', 'well', 'The', 'successful', 'virus', 'isolation', 'attempts', 'have', 'made', 'doors', 'open', 'for', 'developing', 'better', 'diagnostics', 'and', 'effective', 'vaccines', 'helping', 'in', 'combating', 'the', 'spread', 'of', 'the', 'virus', 'to', 'newer', 'areas', '']"
146137,Detection of asymptomatic SARS-CoV-2 exposed individuals by a sensitive S-based ELISA.,2020-06-04,medRxiv : the preprint server for health sciences,https://www.ncbi.nlm.nih.gov/pubmed/32577692/; https://doi.org/10.1101/2020.06.02.20120477; http://medrxiv.org/cgi/content/short/2020.06.02.20120477v1?rss=1,"To assess the current coronavirus pandemic, there is a pressing need to determine the exposure and seroconversion to SARS-CoV-2 on a local and global level. Here, we demonstrate a sensitive and specific S-protein based assay that is well suited for detection of weak SARS- CoV-2-directed IgG responses, and that could identify exposed individuals with asymptomatic infection without the requirement of PCR diagnostics. Our results raise the possibility that on- going population-based studies using less sensitive state-of-the-art serological assays may significantly underestimate the frequency of exposure and seroconversion to SARS-CoV-2.",10.1101/2020.06.02.20120477,frwte0tp,"['To', 'assess', 'the', 'current', 'coronavirus', 'pandemic', 'there', 'is', 'a', 'pressing', 'need', 'to', 'determine', 'the', 'exposure', 'and', 'seroconversion', 'to', 'SARS', 'CoV', '2', 'on', 'a', 'local', 'and', 'global', 'level', 'Here', 'we', 'demonstrate', 'a', 'sensitive', 'and', 'specific', 'S', 'protein', 'based', 'assay', 'that', 'is', 'well', 'suited', 'for', 'detection', 'of', 'weak', 'SARS', 'CoV', '2', 'directed', 'IgG', 'responses', 'and', 'that', 'could', 'identify', 'exposed', 'individuals', 'with', 'asymptomatic', 'infection', 'without', 'the', 'requirement', 'of', 'PCR', 'diagnostics', 'Our', 'results', 'raise', 'the', 'possibility', 'that', 'on', 'going', 'population', 'based', 'studies', 'using', 'less', 'sensitive', 'state', 'of', 'the', 'art', 'serological', 'assays', 'may', 'significantly', 'underestimate', 'the', 'frequency', 'of', 'exposure', 'and', 'seroconversion', 'to', 'SARS', 'CoV', '2', '']"
146649,Novel coronavirus: From discovery to clinical diagnostics,2020-01-30,Infect Genet Evol,https://doi.org/10.1016/j.meegid.2020.104211; https://api.elsevier.com/content/article/pii/S1567134820300435; https://www.sciencedirect.com/science/article/pii/S1567134820300435; https://www.ncbi.nlm.nih.gov/pubmed/32007627/,"A novel coronavirus designated as 2019-nCoV first appeared in Wuhan, China in late December 2019. Dozens of people died in China, and thousands of people infected as 2019-nCoV continues to spread around the world. We have described the discovery, emergence, genomic characteristics, and clinical diagnostics of 2019-nCoV.",10.1016/j.meegid.2020.104211,s9mqv4lo,"['A', 'novel', 'coronavirus', 'designated', 'as', '2019', 'nCoV', 'first', 'appeared', 'in', 'Wuhan', 'China', 'in', 'late', 'December', '2019', 'Dozens', 'of', 'people', 'died', 'in', 'China', 'and', 'thousands', 'of', 'people', 'infected', 'as', '2019', 'nCoV', 'continues', 'to', 'spread', 'around', 'the', 'world', 'We', 'have', 'described', 'the', 'discovery', 'emergence', 'genomic', 'characteristics', 'and', 'clinical', 'diagnostics', 'of', '2019', 'nCoV', '']"
146758,"Clinical presentation, diagnostic findings, and outcome of adult horses with equine coronavirus infection at a veterinary teaching hospital: 33 cases (2012–2018)",2019-06-30,The Veterinary Journal,https://www.ncbi.nlm.nih.gov/pubmed/31113572/; https://api.elsevier.com/content/article/pii/S1090023318303289; https://www.sciencedirect.com/science/article/pii/S1090023318303289; https://doi.org/10.1016/j.tvjl.2019.05.001,"Abstract Equine coronavirus (ECoV) is a recently described enteric virus with worldwide outbreaks; however, there are little data available on clinical presentation, diagnosis, and outcome. The study objective was to document case management of ECoV in adult horses presented to a referral hospital and compare to a cohort of horses that tested negative for ECoV. A retrospective case series was performed based on positive real-time quantitative PCR results for ECoV on faeces from horses treated at the UC Davis Veterinary Medical Teaching Hospital from 1 March 2012 to 31 March 2018. Horses negative for ECoV were matched to the ECoV-positive group as controls. Data collected included signalment, history, exam findings, diagnostics, treatment, and follow-up. Thirty-three horses (median age, 11 years; range, 2–37 years) tested ECoV-positive, including three horses with co-infections. Presenting complaints for ECoV-infected horses included historic fevers (n = 25/30; 83%), anorexia (n = 14/30; 47%), and colic (n = 13/30; 43%). ECoV-positive horses had significantly lower white blood cell (median, 3.0 × 109/L; range, 0.68–16.2 × 109/L), neutrophil (median, 1.26 × 109/L; range, 0.15–14.4 × 109/L), and lymphocyte (median, 0.86 × 109/L; range, 0.42–3.47 × 109/L) counts than ECoV-negative horses. Electrolyte and metabolic derangements and scant faeces were common. Twenty-seven horses were hospitalised for a median of 5 days (range, 0.5–14 days), with 26/27 (96%) horses surviving to discharge. ECoV infection should be a differential diagnosis for adult horses with fever, colic, anorexia, and leukopenia. The disease has a low mortality rate, but horses may require intensive care to resolve severe leukopenia, systemic inflammation, and metabolic disturbances.",10.1016/j.tvjl.2019.05.001,pcvq2e9q,"['Abstract', 'Equine', 'coronavirus', 'ECoV', 'is', 'a', 'recently', 'described', 'enteric', 'virus', 'with', 'worldwide', 'outbreaks', 'however', 'there', 'are', 'little', 'data', 'available', 'on', 'clinical', 'presentation', 'diagnosis', 'and', 'outcome', 'The', 'study', 'objective', 'was', 'to', 'document', 'case', 'management', 'of', 'ECoV', 'in', 'adult', 'horses', 'presented', 'to', 'a', 'referral', 'hospital', 'and', 'compare', 'to', 'a', 'cohort', 'of', 'horses', 'that', 'tested', 'negative', 'for', 'ECoV', 'A', 'retrospective', 'case', 'series', 'was', 'performed', 'based', 'on', 'positive', 'real', 'time', 'quantitative', 'PCR', 'results', 'for', 'ECoV', 'on', 'faeces', 'from', 'horses', 'treated', 'at', 'the', 'UC', 'Davis', 'Veterinary', 'Medical', 'Teaching', 'Hospital', 'from', '1', 'March', '2012', 'to', '31', 'March', '2018', 'Horses', 'negative', 'for', 'ECoV', 'were', 'matched', 'to', 'the', 'ECoV', 'positive', 'group', 'as', 'controls', 'Data', 'collected', 'included', 'signalment', 'history', 'exam', 'findings', 'diagnostics', 'treatment', 'and', 'follow', 'up', 'Thirty', 'three', 'horses', 'median', 'age', '11', 'years', 'range', '2', '37', 'years', 'tested', 'ECoV', 'positive', 'including', 'three', 'horses', 'with', 'co', 'infections', 'Presenting', 'complaints', 'for', 'ECoV', 'infected', 'horses', 'included', 'historic', 'fevers', 'n', '25', '30', '83', 'anorexia', 'n', '14', '30', '47', 'and', 'colic', 'n', '13', '30', '43', 'ECoV', 'positive', 'horses', 'had', 'significantly', 'lower', 'white', 'blood', 'cell', 'median', '3', '0', '109', 'L', 'range', '0', '68', '16', '2', '109', 'L', 'neutrophil', 'median', '1', '26', '109', 'L', 'range', '0', '15', '14', '4', '109', 'L', 'and', 'lymphocyte', 'median', '0', '86', '109', 'L', 'range', '0', '42', '3', '47', '109', 'L', 'counts', 'than', 'ECoV', 'negative', 'horses', 'Electrolyte', 'and', 'metabolic', 'derangements', 'and', 'scant', 'faeces', 'were', 'common', 'Twenty', 'seven', 'horses', 'were', 'hospitalised', 'for', 'a', 'median', 'of', '5', 'days', 'range', '0', '5', '14', 'days', 'with', '26', '27', '96', 'horses', 'surviving', 'to', 'discharge', 'ECoV', 'infection', 'should', 'be', 'a', 'differential', 'diagnosis', 'for', 'adult', 'horses', 'with', 'fever', 'colic', 'anorexia', 'and', 'leukopenia', 'The', 'disease', 'has', 'a', 'low', 'mortality', 'rate', 'but', 'horses', 'may', 'require', 'intensive', 'care', 'to', 'resolve', 'severe', 'leukopenia', 'systemic', 'inflammation', 'and', 'metabolic', 'disturbances', '']"
146829,SARS-CoV-2 testing in infertile patients: different recommendations in Europe and America,2020-07-17,J Assist Reprod Genet,https://doi.org/10.1007/s10815-020-01887-3; https://www.ncbi.nlm.nih.gov/pubmed/32681280/,"The incorporation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing into patient care algorithms has been proposed to mitigate risk. However, the two main professional societies for human reproduction (ESHRE and ASRM) appear divergent on their clinical utility and whether they should be adopted. In this opinion paper, we review the currently available tests and discuss the strengths and weaknesses of the proposed clinical care pathways. Nucleic acid amplification tests are the cornerstone of SARS-CoV-2 testing but test results are largely influenced by viral load, sample site, specimen collection method, and specimen shipment technique, such that a negative result in a symptomatic patient cannot be relied upon. Serological assays for SARS-CoV-2 antibodies exhibit a temporal increase in sensitivity and specificity after symptom onset irrespective of the assay used, with sensitivity estimates ranging from 0 to 50% with the first 3 days of symptoms, to 83 to 88% at 10 days, increasing to almost 100% at ≥ 14 days. These inherent constraints in diagnostics would suggest that at present there is inadequate evidence to utilize SARS-CoV-2 testing to stratify fertility patients and reliably inform clinical decision-making. The failure to appreciate the characteristics and limitations of the diagnostic tests may lead to disastrous consequences for the patient and the multidisciplinary team looking after them.",10.1007/s10815-020-01887-3,qwuivy99,"['The', 'incorporation', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'testing', 'into', 'patient', 'care', 'algorithms', 'has', 'been', 'proposed', 'to', 'mitigate', 'risk', 'However', 'the', 'two', 'main', 'professional', 'societies', 'for', 'human', 'reproduction', 'ESHRE', 'and', 'ASRM', 'appear', 'divergent', 'on', 'their', 'clinical', 'utility', 'and', 'whether', 'they', 'should', 'be', 'adopted', 'In', 'this', 'opinion', 'paper', 'we', 'review', 'the', 'currently', 'available', 'tests', 'and', 'discuss', 'the', 'strengths', 'and', 'weaknesses', 'of', 'the', 'proposed', 'clinical', 'care', 'pathways', 'Nucleic', 'acid', 'amplification', 'tests', 'are', 'the', 'cornerstone', 'of', 'SARS', 'CoV', '2', 'testing', 'but', 'test', 'results', 'are', 'largely', 'influenced', 'by', 'viral', 'load', 'sample', 'site', 'specimen', 'collection', 'method', 'and', 'specimen', 'shipment', 'technique', 'such', 'that', 'a', 'negative', 'result', 'in', 'a', 'symptomatic', 'patient', 'cannot', 'be', 'relied', 'upon', 'Serological', 'assays', 'for', 'SARS', 'CoV', '2', 'antibodies', 'exhibit', 'a', 'temporal', 'increase', 'in', 'sensitivity', 'and', 'specificity', 'after', 'symptom', 'onset', 'irrespective', 'of', 'the', 'assay', 'used', 'with', 'sensitivity', 'estimates', 'ranging', 'from', '0', 'to', '50', 'with', 'the', 'first', '3', 'days', 'of', 'symptoms', 'to', '83', 'to', '88', 'at', '10', 'days', 'increasing', 'to', 'almost', '100', 'at', '14', 'days', 'These', 'inherent', 'constraints', 'in', 'diagnostics', 'would', 'suggest', 'that', 'at', 'present', 'there', 'is', 'inadequate', 'evidence', 'to', 'utilize', 'SARS', 'CoV', '2', 'testing', 'to', 'stratify', 'fertility', 'patients', 'and', 'reliably', 'inform', 'clinical', 'decision', 'making', 'The', 'failure', 'to', 'appreciate', 'the', 'characteristics', 'and', 'limitations', 'of', 'the', 'diagnostic', 'tests', 'may', 'lead', 'to', 'disastrous', 'consequences', 'for', 'the', 'patient', 'and', 'the', 'multidisciplinary', 'team', 'looking', 'after', 'them', '']"
147404,Die Bedeutung von Coronaviren: Das Beispiel SARS,2004,Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz,https://www.ncbi.nlm.nih.gov/pubmed/15254819/,"The emergence of the new SARS coronavirus has shown dramatically the high relevance of human coronavirus infections. This overview presents data of both epidemiological and clinical studies of this new virus infection. Moreover, details of research on the pathogenesis, diagnostics, and therapy are given. The recent infections in December 2003 clearly document that SARS will be a major topic also in 2004.",10.1007/s00103-004-0868-6,sqxmt699,"['The', 'emergence', 'of', 'the', 'new', 'SARS', 'coronavirus', 'has', 'shown', 'dramatically', 'the', 'high', 'relevance', 'of', 'human', 'coronavirus', 'infections', 'This', 'overview', 'presents', 'data', 'of', 'both', 'epidemiological', 'and', 'clinical', 'studies', 'of', 'this', 'new', 'virus', 'infection', 'Moreover', 'details', 'of', 'research', 'on', 'the', 'pathogenesis', 'diagnostics', 'and', 'therapy', 'are', 'given', 'The', 'recent', 'infections', 'in', 'December', '2003', 'clearly', 'document', 'that', 'SARS', 'will', 'be', 'a', 'major', 'topic', 'also', 'in', '2004', '']"
147447,Functional peptide microarrays for specific and sensitive antibody diagnostics,2006-02-03,Proteomics,https://www.ncbi.nlm.nih.gov/pubmed/16456884/,"Peptide microarrays displaying biologically active small synthetic peptides in a high‐density format provide an attractive technology to probe complex samples for the presence and/or function of protein analytes. We present a new approach for manufacturing functional peptide microarrays for molecular immune diagnostics. Our method relies on the efficiency of site‐specific solution‐phase coupling of biotinylated synthetic peptides to NeutrAvidin (NA) and localized microdispensing of peptide‐NA‐complexes onto activated glass surfaces. Antibodies are captured in a sandwich manner between surface immobilized peptide probes and fluorescence‐labeled secondary antibodies. Our work includes a total of 54 peptides derived from immunodominant linear epitopes of the T7 phage capsid protein, Herpes simplex virus glycoprotein D, c‐myc protein, and three domains of the Human coronavirus polymerase polyprotein and their cognate mAbs. By using spacer molecules of different type and length for NA‐mediated peptide presentation, we show that the incorporation of a minimum spacer length is imperative for antibody binding, whereas the peptide immobilization direction has only secondary importance for antibody affinity and binding. We further demonstrate that the peptide array is capable of detecting low‐picomolar concentrations of mAbs in buffered solutions and diluted human serum with high specificity.",10.1002/pmic.200500343,lntwhz05,"['Peptide', 'microarrays', 'displaying', 'biologically', 'active', 'small', 'synthetic', 'peptides', 'in', 'a', 'high', 'density', 'format', 'provide', 'an', 'attractive', 'technology', 'to', 'probe', 'complex', 'samples', 'for', 'the', 'presence', 'and', 'or', 'function', 'of', 'protein', 'analytes', 'We', 'present', 'a', 'new', 'approach', 'for', 'manufacturing', 'functional', 'peptide', 'microarrays', 'for', 'molecular', 'immune', 'diagnostics', 'Our', 'method', 'relies', 'on', 'the', 'efficiency', 'of', 'site', 'specific', 'solution', 'phase', 'coupling', 'of', 'biotinylated', 'synthetic', 'peptides', 'to', 'NeutrAvidin', 'NA', 'and', 'localized', 'microdispensing', 'of', 'peptide', 'NA', 'complexes', 'onto', 'activated', 'glass', 'surfaces', 'Antibodies', 'are', 'captured', 'in', 'a', 'sandwich', 'manner', 'between', 'surface', 'immobilized', 'peptide', 'probes', 'and', 'fluorescence', 'labeled', 'secondary', 'antibodies', 'Our', 'work', 'includes', 'a', 'total', 'of', '54', 'peptides', 'derived', 'from', 'immunodominant', 'linear', 'epitopes', 'of', 'the', 'T7', 'phage', 'capsid', 'protein', 'Herpes', 'simplex', 'virus', 'glycoprotein', 'D', 'c', 'myc', 'protein', 'and', 'three', 'domains', 'of', 'the', 'Human', 'coronavirus', 'polymerase', 'polyprotein', 'and', 'their', 'cognate', 'mAbs', 'By', 'using', 'spacer', 'molecules', 'of', 'different', 'type', 'and', 'length', 'for', 'NA', 'mediated', 'peptide', 'presentation', 'we', 'show', 'that', 'the', 'incorporation', 'of', 'a', 'minimum', 'spacer', 'length', 'is', 'imperative', 'for', 'antibody', 'binding', 'whereas', 'the', 'peptide', 'immobilization', 'direction', 'has', 'only', 'secondary', 'importance', 'for', 'antibody', 'affinity', 'and', 'binding', 'We', 'further', 'demonstrate', 'that', 'the', 'peptide', 'array', 'is', 'capable', 'of', 'detecting', 'low', 'picomolar', 'concentrations', 'of', 'mAbs', 'in', 'buffered', 'solutions', 'and', 'diluted', 'human', 'serum', 'with', 'high', 'specificity', '']"
148243,Comparison of commercial RT-PCR diagnostic kits for COVID-19,2020-05-08,J Clin Virol,https://api.elsevier.com/content/article/pii/S1386653220301542; https://www.sciencedirect.com/science/article/pii/S1386653220301542?v=s5; https://doi.org/10.1016/j.jcv.2020.104412; https://www.ncbi.nlm.nih.gov/pubmed/32416600/,"Abstract The final months of 2019 witnessed the emergence of a novel coronavirus in the human population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread across the globe and is posing a major burden on society. Measures taken to reduce its spread critically depend on timely and accurate identification of virus-infected individuals by the most sensitive and specific method available, i.e. real-time reverse transcriptase PCR (RT-PCR). Many commercial kits have recently become available, but their performance has not yet been independently assessed. The aim of this study was to compare basic analytical and clinical performance of selected RT-PCR kits from seven different manufacturers (Altona Diagnostics, BGI, CerTest Biotec, KH Medical, PrimerDesign, R-Biopharm AG, and Seegene). We used serial dilutions of viral RNA to establish PCR efficiency and estimate the 95% limit of detection (LOD95%). Furthermore, we ran a panel of SARS-CoV-2-positive clinical samples (n = 13) for a preliminary evaluation of clinical sensitivity. Finally, we used clinical samples positive for non-coronavirus respiratory viral infections (n = 6) and a panel of RNA from related human coronaviruses to evaluate assay specificity. PCR efficiency was ≥96% for all assays and the estimated LOD95% varied within a 6-fold range. Using clinical samples, we observed some variations in detection rate between kits. Importantly, none of the assays showed cross-reactivity with other respiratory (corona)viruses, except as expected for the SARS-CoV-1 E-gene. We conclude that all RT-PCR kits assessed in this study may be used for routine diagnostics of COVID-19 in patients by experienced molecular diagnostic laboratories.",10.1016/j.jcv.2020.104412,7d7i3cc8,"['Abstract', 'The', 'final', 'months', 'of', '2019', 'witnessed', 'the', 'emergence', 'of', 'a', 'novel', 'coronavirus', 'in', 'the', 'human', 'population', 'Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'since', 'spread', 'across', 'the', 'globe', 'and', 'is', 'posing', 'a', 'major', 'burden', 'on', 'society', 'Measures', 'taken', 'to', 'reduce', 'its', 'spread', 'critically', 'depend', 'on', 'timely', 'and', 'accurate', 'identification', 'of', 'virus', 'infected', 'individuals', 'by', 'the', 'most', 'sensitive', 'and', 'specific', 'method', 'available', 'i', 'e', 'real', 'time', 'reverse', 'transcriptase', 'PCR', 'RT', 'PCR', 'Many', 'commercial', 'kits', 'have', 'recently', 'become', 'available', 'but', 'their', 'performance', 'has', 'not', 'yet', 'been', 'independently', 'assessed', 'The', 'aim', 'of', 'this', 'study', 'was', 'to', 'compare', 'basic', 'analytical', 'and', 'clinical', 'performance', 'of', 'selected', 'RT', 'PCR', 'kits', 'from', 'seven', 'different', 'manufacturers', 'Altona', 'Diagnostics', 'BGI', 'CerTest', 'Biotec', 'KH', 'Medical', 'PrimerDesign', 'R', 'Biopharm', 'AG', 'and', 'Seegene', 'We', 'used', 'serial', 'dilutions', 'of', 'viral', 'RNA', 'to', 'establish', 'PCR', 'efficiency', 'and', 'estimate', 'the', '95', 'limit', 'of', 'detection', 'LOD95', 'Furthermore', 'we', 'ran', 'a', 'panel', 'of', 'SARS', 'CoV', '2', 'positive', 'clinical', 'samples', 'n', '13', 'for', 'a', 'preliminary', 'evaluation', 'of', 'clinical', 'sensitivity', 'Finally', 'we', 'used', 'clinical', 'samples', 'positive', 'for', 'non', 'coronavirus', 'respiratory', 'viral', 'infections', 'n', '6', 'and', 'a', 'panel', 'of', 'RNA', 'from', 'related', 'human', 'coronaviruses', 'to', 'evaluate', 'assay', 'specificity', 'PCR', 'efficiency', 'was', '96', 'for', 'all', 'assays', 'and', 'the', 'estimated', 'LOD95', 'varied', 'within', 'a', '6', 'fold', 'range', 'Using', 'clinical', 'samples', 'we', 'observed', 'some', 'variations', 'in', 'detection', 'rate', 'between', 'kits', 'Importantly', 'none', 'of', 'the', 'assays', 'showed', 'cross', 'reactivity', 'with', 'other', 'respiratory', 'corona', 'viruses', 'except', 'as', 'expected', 'for', 'the', 'SARS', 'CoV', '1', 'E', 'gene', 'We', 'conclude', 'that', 'all', 'RT', 'PCR', 'kits', 'assessed', 'in', 'this', 'study', 'may', 'be', 'used', 'for', 'routine', 'diagnostics', 'of', 'COVID', '19', 'in', 'patients', 'by', 'experienced', 'molecular', 'diagnostic', 'laboratories', '']"
148327,Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses,2020-04-09,bioRxiv,https://www.ncbi.nlm.nih.gov/pubmed/32511301/; https://doi.org/10.1101/2020.04.05.026450,"SARS-CoV-2 poses an immediate, major threat to public health across the globe. Here we report an in-depth molecular analysis to reconstruct the evolutionary origins of the enhanced pathogenicity of SARS-CoV-2 and other coronaviruses that are severe human pathogens. Using integrated comparative genomics and machine learning techniques, we identify key genomic features that differentiate SARS-CoV-2 and the viruses behind the two previous deadly coronavirus outbreaks, SARS-CoV and MERS-CoV, from less pathogenic coronaviruses. These features include enhancement of the nuclear localization signals in the nucleocapsid protein and distinct inserts in the spike glycoprotein that appear to be associated with high case fatality rate of these coronaviruses as well as the host switch from animals to humans. The identified features could be crucial elements of coronavirus pathogenicity and possible targets for diagnostics, prognostication and interventions.",10.1101/2020.04.05.026450,q85u5v8s,"['SARS', 'CoV', '2', 'poses', 'an', 'immediate', 'major', 'threat', 'to', 'public', 'health', 'across', 'the', 'globe', 'Here', 'we', 'report', 'an', 'in', 'depth', 'molecular', 'analysis', 'to', 'reconstruct', 'the', 'evolutionary', 'origins', 'of', 'the', 'enhanced', 'pathogenicity', 'of', 'SARS', 'CoV', '2', 'and', 'other', 'coronaviruses', 'that', 'are', 'severe', 'human', 'pathogens', 'Using', 'integrated', 'comparative', 'genomics', 'and', 'machine', 'learning', 'techniques', 'we', 'identify', 'key', 'genomic', 'features', 'that', 'differentiate', 'SARS', 'CoV', '2', 'and', 'the', 'viruses', 'behind', 'the', 'two', 'previous', 'deadly', 'coronavirus', 'outbreaks', 'SARS', 'CoV', 'and', 'MERS', 'CoV', 'from', 'less', 'pathogenic', 'coronaviruses', 'These', 'features', 'include', 'enhancement', 'of', 'the', 'nuclear', 'localization', 'signals', 'in', 'the', 'nucleocapsid', 'protein', 'and', 'distinct', 'inserts', 'in', 'the', 'spike', 'glycoprotein', 'that', 'appear', 'to', 'be', 'associated', 'with', 'high', 'case', 'fatality', 'rate', 'of', 'these', 'coronaviruses', 'as', 'well', 'as', 'the', 'host', 'switch', 'from', 'animals', 'to', 'humans', 'The', 'identified', 'features', 'could', 'be', 'crucial', 'elements', 'of', 'coronavirus', 'pathogenicity', 'and', 'possible', 'targets', 'for', 'diagnostics', 'prognostication', 'and', 'interventions', '']"
149529,Production of a Monoclonal Antibody Targeting the M Protein of MERS-CoV for Detection of MERS-CoV Using a Synthetic Peptide Epitope Formulated with a CpG–DNA–Liposome Complex,2018-07-02,Int J Pept Res Ther,https://doi.org/10.1007/s10989-018-9731-8; https://www.ncbi.nlm.nih.gov/pubmed/32214929/,"The Middle East respiratory syndrome-related coronavirus (MERS-CoV) contains four major structural proteins, the spike glycoprotein, nucleocapsid phosphoprotein, membrane (M) glycoprotein and small envelope glycoprotein. The M protein of MERS-CoV has a role in the morphogenesis or assembly of the virus and inhibits type I interferon expression in infected cells. Here, we produced a monoclonal antibody specific against the M protein of MERS-CoV by injecting BALB/c mice with a complex containing the epitope peptide and CpG–DNA encapsulated with a phosphatidyl-β-oleoyl-γ-palmitoyl ethanolamine (DOPE):cholesterol hemisuccinate (CHEMS). The monoclonal antibody was reactive to the epitope peptide of the M protein of MERS-CoV which was confirmed by western blotting and immunoprecipitations. Indirect immunofluorescence assay and confocal image analysis showed that the monoclonal antibody binds specifically to the M protein of MERS-CoV in the virus-infected cells. Further studies using this monoclonal antibody may provide important information on the function of the M protein and its future application in diagnostics.",10.1007/s10989-018-9731-8,o8x7e96w,"['The', 'Middle', 'East', 'respiratory', 'syndrome', 'related', 'coronavirus', 'MERS', 'CoV', 'contains', 'four', 'major', 'structural', 'proteins', 'the', 'spike', 'glycoprotein', 'nucleocapsid', 'phosphoprotein', 'membrane', 'M', 'glycoprotein', 'and', 'small', 'envelope', 'glycoprotein', 'The', 'M', 'protein', 'of', 'MERS', 'CoV', 'has', 'a', 'role', 'in', 'the', 'morphogenesis', 'or', 'assembly', 'of', 'the', 'virus', 'and', 'inhibits', 'type', 'I', 'interferon', 'expression', 'in', 'infected', 'cells', 'Here', 'we', 'produced', 'a', 'monoclonal', 'antibody', 'specific', 'against', 'the', 'M', 'protein', 'of', 'MERS', 'CoV', 'by', 'injecting', 'BALB', 'c', 'mice', 'with', 'a', 'complex', 'containing', 'the', 'epitope', 'peptide', 'and', 'CpG', 'DNA', 'encapsulated', 'with', 'a', 'phosphatidyl', 'β', 'oleoyl', 'γ', 'palmitoyl', 'ethanolamine', 'DOPE', 'cholesterol', 'hemisuccinate', 'CHEMS', 'The', 'monoclonal', 'antibody', 'was', 'reactive', 'to', 'the', 'epitope', 'peptide', 'of', 'the', 'M', 'protein', 'of', 'MERS', 'CoV', 'which', 'was', 'confirmed', 'by', 'western', 'blotting', 'and', 'immunoprecipitations', 'Indirect', 'immunofluorescence', 'assay', 'and', 'confocal', 'image', 'analysis', 'showed', 'that', 'the', 'monoclonal', 'antibody', 'binds', 'specifically', 'to', 'the', 'M', 'protein', 'of', 'MERS', 'CoV', 'in', 'the', 'virus', 'infected', 'cells', 'Further', 'studies', 'using', 'this', 'monoclonal', 'antibody', 'may', 'provide', 'important', 'information', 'on', 'the', 'function', 'of', 'the', 'M', 'protein', 'and', 'its', 'future', 'application', 'in', 'diagnostics', '']"
150282,Cytology in the time of coronavirus disease (covid-19): an Italian perspective,2020-04-19,J Clin Pathol,https://www.ncbi.nlm.nih.gov/pubmed/32312717/; https://doi.org/10.1136/jclinpath-2020-206614,"INTRODUCTION: The coronavirus disease 2019 (covid-19) is changing the way we practice pathology, including fine needle aspiration (FNA) diagnostics. Although recommendations have been issued to prioritise patients at high oncological risk, postponing those with unsuspicious presentations, real world data have not been reported yet. METHODS: The percentages of the cytological sample types processed at the University of Naples Federico II, during the first 3 weeks of Italian national lockdown were compared with those of the same period in 2019. RESULTS: During the emergency, the percentage of cytology samples reported as malignant increased (p<0.001), reflecting higher percentages of breast (p=0.002) and lymph nodes FNAs (p=0.008), effusions (p<0.001) and urine (p=0.005). Conversely, thyroid FNAs (p<0.001) and Pap smears (p=0.003) were reduced. CONCLUSIONS: Even in times of covid-19 outbreak, cytological examination may be safely carried out in patients at high oncological risk, without the need to be postponed.",10.1136/jclinpath-2020-206614,p54ir4rr,"['INTRODUCTION', 'The', 'coronavirus', 'disease', '2019', 'covid', '19', 'is', 'changing', 'the', 'way', 'we', 'practice', 'pathology', 'including', 'fine', 'needle', 'aspiration', 'FNA', 'diagnostics', 'Although', 'recommendations', 'have', 'been', 'issued', 'to', 'prioritise', 'patients', 'at', 'high', 'oncological', 'risk', 'postponing', 'those', 'with', 'unsuspicious', 'presentations', 'real', 'world', 'data', 'have', 'not', 'been', 'reported', 'yet', 'METHODS', 'The', 'percentages', 'of', 'the', 'cytological', 'sample', 'types', 'processed', 'at', 'the', 'University', 'of', 'Naples', 'Federico', 'II', 'during', 'the', 'first', '3', 'weeks', 'of', 'Italian', 'national', 'lockdown', 'were', 'compared', 'with', 'those', 'of', 'the', 'same', 'period', 'in', '2019', 'RESULTS', 'During', 'the', 'emergency', 'the', 'percentage', 'of', 'cytology', 'samples', 'reported', 'as', 'malignant', 'increased', 'p', '0', '001', 'reflecting', 'higher', 'percentages', 'of', 'breast', 'p', '0', '002', 'and', 'lymph', 'nodes', 'FNAs', 'p', '0', '008', 'effusions', 'p', '0', '001', 'and', 'urine', 'p', '0', '005', 'Conversely', 'thyroid', 'FNAs', 'p', '0', '001', 'and', 'Pap', 'smears', 'p', '0', '003', 'were', 'reduced', 'CONCLUSIONS', 'Even', 'in', 'times', 'of', 'covid', '19', 'outbreak', 'cytological', 'examination', 'may', 'be', 'safely', 'carried', 'out', 'in', 'patients', 'at', 'high', 'oncological', 'risk', 'without', 'the', 'need', 'to', 'be', 'postponed', '']"
150447,Neue und seltene pneumotrope Viren,2013-08-15,Pneumologe (Berl),https://www.ncbi.nlm.nih.gov/pubmed/32214958/; https://doi.org/10.1007/s10405-013-0675-6,"While acute viral respiratory tract infections are one of the major reasons for the loss of productivity among the general population in industrialized nations, they are one of the top killers among infants worldwide, in particular in low-income countries. With the advances in molecular diagnostics and the introduction of high-throughput screening techniques a variety of novel, so far unknown viruses have been discovered from respiratory secretions. However, the clinical significance is often difficult to determine. This review article provides an introduction to those novel viruses which have been described since the beginning of the millennium and discusses the clinical relevance in the light of current scientific evidence. The viruses covered by the present review are human metapneumovirus, human bocavirus, human coronaviruses OC43, 229E, NL63, HKU1, SARS and MERS, human polyomaviruses KI, MC and WU and human parechoviruses.",10.1007/s10405-013-0675-6,139ejlgo,"['While', 'acute', 'viral', 'respiratory', 'tract', 'infections', 'are', 'one', 'of', 'the', 'major', 'reasons', 'for', 'the', 'loss', 'of', 'productivity', 'among', 'the', 'general', 'population', 'in', 'industrialized', 'nations', 'they', 'are', 'one', 'of', 'the', 'top', 'killers', 'among', 'infants', 'worldwide', 'in', 'particular', 'in', 'low', 'income', 'countries', 'With', 'the', 'advances', 'in', 'molecular', 'diagnostics', 'and', 'the', 'introduction', 'of', 'high', 'throughput', 'screening', 'techniques', 'a', 'variety', 'of', 'novel', 'so', 'far', 'unknown', 'viruses', 'have', 'been', 'discovered', 'from', 'respiratory', 'secretions', 'However', 'the', 'clinical', 'significance', 'is', 'often', 'difficult', 'to', 'determine', 'This', 'review', 'article', 'provides', 'an', 'introduction', 'to', 'those', 'novel', 'viruses', 'which', 'have', 'been', 'described', 'since', 'the', 'beginning', 'of', 'the', 'millennium', 'and', 'discusses', 'the', 'clinical', 'relevance', 'in', 'the', 'light', 'of', 'current', 'scientific', 'evidence', 'The', 'viruses', 'covered', 'by', 'the', 'present', 'review', 'are', 'human', 'metapneumovirus', 'human', 'bocavirus', 'human', 'coronaviruses', 'OC43', '229E', 'NL63', 'HKU1', 'SARS', 'and', 'MERS', 'human', 'polyomaviruses', 'KI', 'MC', 'and', 'WU', 'and', 'human', 'parechoviruses', '']"
150895,Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9,2016-07-20,Biomed Res Int,https://www.ncbi.nlm.nih.gov/pubmed/27525272/; https://doi.org/10.1155/2016/5717108,"Over the recent decades, China experienced several emerging virus outbreaks including those caused by the severe acute respiratory syndrome- (SARS-) coronavirus (Cov), H5N1 virus, and H7N9 virus. The SARS tragedy revealed faults in China's infectious disease prevention system, propelling the Chinese government to enact reforms that enabled better combating of the subsequent H1N1 and H7N9 avian flu epidemics. The system is buttressed by three fundamental, mutually reinforcing components: (1) enduring government administration reforms, including legislation establishing a unified public health emergency management system; (2) prioritized funding for biotechnology and biomedicine industrialization, especially in the areas of pathogen identification, drug production, and the development of vaccines and diagnostics; and (3) increasing investment for public health and establishment of a rapid-response infectious diseases prevention and control system. China is now using its hard-gained experience to support the fight against Ebola in Africa and the Middle East Respiratory Syndrome in its own country.",10.1155/2016/5717108,zd011ca5,"['Over', 'the', 'recent', 'decades', 'China', 'experienced', 'several', 'emerging', 'virus', 'outbreaks', 'including', 'those', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'coronavirus', 'Cov', 'H5N1', 'virus', 'and', 'H7N9', 'virus', 'The', 'SARS', 'tragedy', 'revealed', 'faults', 'in', 'China', 's', 'infectious', 'disease', 'prevention', 'system', 'propelling', 'the', 'Chinese', 'government', 'to', 'enact', 'reforms', 'that', 'enabled', 'better', 'combating', 'of', 'the', 'subsequent', 'H1N1', 'and', 'H7N9', 'avian', 'flu', 'epidemics', 'The', 'system', 'is', 'buttressed', 'by', 'three', 'fundamental', 'mutually', 'reinforcing', 'components', '1', 'enduring', 'government', 'administration', 'reforms', 'including', 'legislation', 'establishing', 'a', 'unified', 'public', 'health', 'emergency', 'management', 'system', '2', 'prioritized', 'funding', 'for', 'biotechnology', 'and', 'biomedicine', 'industrialization', 'especially', 'in', 'the', 'areas', 'of', 'pathogen', 'identification', 'drug', 'production', 'and', 'the', 'development', 'of', 'vaccines', 'and', 'diagnostics', 'and', '3', 'increasing', 'investment', 'for', 'public', 'health', 'and', 'establishment', 'of', 'a', 'rapid', 'response', 'infectious', 'diseases', 'prevention', 'and', 'control', 'system', 'China', 'is', 'now', 'using', 'its', 'hard', 'gained', 'experience', 'to', 'support', 'the', 'fight', 'against', 'Ebola', 'in', 'Africa', 'and', 'the', 'Middle', 'East', 'Respiratory', 'Syndrome', 'in', 'its', 'own', 'country', '']"
151122,Lifestyle as Risk Factor for Infectious Causes of Death in Young Dogs: A Retrospective Study in Southern Italy (2015–2017),2020-06-05,Vet Med Int,https://www.ncbi.nlm.nih.gov/pubmed/32566119/; https://doi.org/10.1155/2020/6207297,"Infectious diseases are a common cause of death in young dogs. Several factors are thought to predispose young dogs to microbiological infections. Identifying the cause of death is often a challenge, and broad diagnostic analysis is often needed. Here, we aimed to determine the infectious causes of death in young dogs aged up to 1 year, examining how it relates to age (under and over 6 months), lifestyle (owned versus ownerless), breed (purebred and crossbreed), and gender. A retrospective study was conducted in a 3-year period (2015–2017) on 138 dead dogs that had undergone necropsy and microbiological diagnostics. Enteritis and pneumonia were the most commonly observed lesions. Polymicrobism was more prevalent (62.3%) than single-agent infections and associated with a higher rate of generalised lesions. Ownerless dogs showed over a three-fold higher predisposition to viral coinfections than owned dogs. Above all, canine parvovirus was the most prevalent agent (77.5%), followed by canine coronavirus (31.1%) and canine adenovirus (23.9%); ownerless pups had a higher predisposition to these viruses. Escherichia coli (23.9%), Clostridium perfringens type A (18.1%), and Enterococcus spp. (8.7%) were the most commonly identified bacteria, which mostly involved in coinfections. A lower prevalence of CDV and Clostridium perfringens type A was observed in puppies under 6 months of age. In conclusion, this study is the first comprehensive survey on a wide panel of microbiological agents related to necropsy lesions. It lays the groundwork for future studies attempting to understand the circulation of infectious agents in a determined area.",10.1155/2020/6207297,vik30moa,"['Infectious', 'diseases', 'are', 'a', 'common', 'cause', 'of', 'death', 'in', 'young', 'dogs', 'Several', 'factors', 'are', 'thought', 'to', 'predispose', 'young', 'dogs', 'to', 'microbiological', 'infections', 'Identifying', 'the', 'cause', 'of', 'death', 'is', 'often', 'a', 'challenge', 'and', 'broad', 'diagnostic', 'analysis', 'is', 'often', 'needed', 'Here', 'we', 'aimed', 'to', 'determine', 'the', 'infectious', 'causes', 'of', 'death', 'in', 'young', 'dogs', 'aged', 'up', 'to', '1', 'year', 'examining', 'how', 'it', 'relates', 'to', 'age', 'under', 'and', 'over', '6', 'months', 'lifestyle', 'owned', 'versus', 'ownerless', 'breed', 'purebred', 'and', 'crossbreed', 'and', 'gender', 'A', 'retrospective', 'study', 'was', 'conducted', 'in', 'a', '3', 'year', 'period', '2015', '2017', 'on', '138', 'dead', 'dogs', 'that', 'had', 'undergone', 'necropsy', 'and', 'microbiological', 'diagnostics', 'Enteritis', 'and', 'pneumonia', 'were', 'the', 'most', 'commonly', 'observed', 'lesions', 'Polymicrobism', 'was', 'more', 'prevalent', '62', '3', 'than', 'single', 'agent', 'infections', 'and', 'associated', 'with', 'a', 'higher', 'rate', 'of', 'generalised', 'lesions', 'Ownerless', 'dogs', 'showed', 'over', 'a', 'three', 'fold', 'higher', 'predisposition', 'to', 'viral', 'coinfections', 'than', 'owned', 'dogs', 'Above', 'all', 'canine', 'parvovirus', 'was', 'the', 'most', 'prevalent', 'agent', '77', '5', 'followed', 'by', 'canine', 'coronavirus', '31', '1', 'and', 'canine', 'adenovirus', '23', '9', 'ownerless', 'pups', 'had', 'a', 'higher', 'predisposition', 'to', 'these', 'viruses', 'Escherichia', 'coli', '23', '9', 'Clostridium', 'perfringens', 'type', 'A', '18', '1', 'and', 'Enterococcus', 'spp', '8', '7', 'were', 'the', 'most', 'commonly', 'identified', 'bacteria', 'which', 'mostly', 'involved', 'in', 'coinfections', 'A', 'lower', 'prevalence', 'of', 'CDV', 'and', 'Clostridium', 'perfringens', 'type', 'A', 'was', 'observed', 'in', 'puppies', 'under', '6', 'months', 'of', 'age', 'In', 'conclusion', 'this', 'study', 'is', 'the', 'first', 'comprehensive', 'survey', 'on', 'a', 'wide', 'panel', 'of', 'microbiological', 'agents', 'related', 'to', 'necropsy', 'lesions', 'It', 'lays', 'the', 'groundwork', 'for', 'future', 'studies', 'attempting', 'to', 'understand', 'the', 'circulation', 'of', 'infectious', 'agents', 'in', 'a', 'determined', 'area', '']"
151542,COVID-19: an update on diagnostic and therapeutic approaches,2020-04-30,BMB Rep,https://www.ncbi.nlm.nih.gov/pubmed/32336317/,"The unexpected pandemic set off by the novel coronavirus 2019 (COVID-19) has caused severe panic among people worldwide. COVID-19 has created havoc, and scientists and physicians are urged to test the efficiency and safety of drugs used to treat this disease. In such a pandemic situation, various steps have been taken by the government to control and prevent the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). This pandemic situation has forced scientists to rework strategies to combat infectious diseases through drugs, treatment, and control measures. COVID-19 treatment requires both limiting viral multiplication and neutralizing tissue damage induced by an inappropriate immune reaction. Currently, various diagnostic kits to test for COVID-19 are available, and repurposing therapeutics for COVID-19 has shown to be clinically effective. As the global demand for diagnostics and therapeutics continues to rise, it is essential to rapidly develop various algorithms to successfully identify and contain the virus. This review discusses the updates on specimens/samples, recent efficient diagnostics, and therapeutic approaches to control the disease and repurposed drugs mainly focusing on chloroquine/hydroxychloroquine and convalescent plasma (CP). More research is required for further understanding of the influence of diagnostics and therapeutic approaches to develop vaccines and drugs for COVID-19.",10.5483/bmbrep.2020.53.4.080,bisheysk,"['The', 'unexpected', 'pandemic', 'set', 'off', 'by', 'the', 'novel', 'coronavirus', '2019', 'COVID', '19', 'has', 'caused', 'severe', 'panic', 'among', 'people', 'worldwide', 'COVID', '19', 'has', 'created', 'havoc', 'and', 'scientists', 'and', 'physicians', 'are', 'urged', 'to', 'test', 'the', 'efficiency', 'and', 'safety', 'of', 'drugs', 'used', 'to', 'treat', 'this', 'disease', 'In', 'such', 'a', 'pandemic', 'situation', 'various', 'steps', 'have', 'been', 'taken', 'by', 'the', 'government', 'to', 'control', 'and', 'prevent', 'the', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'This', 'pandemic', 'situation', 'has', 'forced', 'scientists', 'to', 'rework', 'strategies', 'to', 'combat', 'infectious', 'diseases', 'through', 'drugs', 'treatment', 'and', 'control', 'measures', 'COVID', '19', 'treatment', 'requires', 'both', 'limiting', 'viral', 'multiplication', 'and', 'neutralizing', 'tissue', 'damage', 'induced', 'by', 'an', 'inappropriate', 'immune', 'reaction', 'Currently', 'various', 'diagnostic', 'kits', 'to', 'test', 'for', 'COVID', '19', 'are', 'available', 'and', 'repurposing', 'therapeutics', 'for', 'COVID', '19', 'has', 'shown', 'to', 'be', 'clinically', 'effective', 'As', 'the', 'global', 'demand', 'for', 'diagnostics', 'and', 'therapeutics', 'continues', 'to', 'rise', 'it', 'is', 'essential', 'to', 'rapidly', 'develop', 'various', 'algorithms', 'to', 'successfully', 'identify', 'and', 'contain', 'the', 'virus', 'This', 'review', 'discusses', 'the', 'updates', 'on', 'specimens', 'samples', 'recent', 'efficient', 'diagnostics', 'and', 'therapeutic', 'approaches', 'to', 'control', 'the', 'disease', 'and', 'repurposed', 'drugs', 'mainly', 'focusing', 'on', 'chloroquine', 'hydroxychloroquine', 'and', 'convalescent', 'plasma', 'CP', 'More', 'research', 'is', 'required', 'for', 'further', 'understanding', 'of', 'the', 'influence', 'of', 'diagnostics', 'and', 'therapeutic', 'approaches', 'to', 'develop', 'vaccines', 'and', 'drugs', 'for', 'COVID', '19', '']"
152433,Emergence of deadly severe acute respiratory syndrome coronavirus-2 during 2019–2020,2020-04-08,Virusdisease,https://doi.org/10.1007/s13337-020-00575-1; https://www.ncbi.nlm.nih.gov/pubmed/32292802/,"Wuhan, the city in Hubei province in China is in the focus of global community due to the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), formerly known as 2019-nCoV. The virus emerged in humans from Wuhan seafood market probably via zoonotic transmission. Within a few days the virus spread its tentacles rapidly to neighboring cities in China and to different geographical regions through travelers and to some extent by human to human transmission leading to significant disease burden globally. More than 2,00,000 people (including more than 8000 deaths) have been infected with this respiratory illness across 167 countries and territories worldwide leading to a pandemic. The present review provides an outline about emergence and spread of SARS-CoV-2 from Wuhan, China in 2019–2020. We have also provided information about the classification, genome, proteins, clinical presentation of COVID-19, type of clinical specimens to be collected and diagnostic methods adopted to identify the respiratory illness. In addition we have also provided information about transmission dynamics, prevention measures and treatment options that are available at the present. Subsequently, we have given a comprehensive overview of the spread of this infection from China to the other parts of the globe. Management of the ongoing outbreak of SARS-CoV-2 encompassing surveillance, clinical, immunological, genetic and evolutionary investigations are likely to provide the desired results. Joint efforts of global scientific community are needed at this hour in terms of enhancement of research on development of accurate diagnostics, antiviral therapeutics and finally into formation of an effective vaccine against the emerging novel coronavirus.",10.1007/s13337-020-00575-1,43gik8e3,"['Wuhan', 'the', 'city', 'in', 'Hubei', 'province', 'in', 'China', 'is', 'in', 'the', 'focus', 'of', 'global', 'community', 'due', 'to', 'the', 'outbreak', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'formerly', 'known', 'as', '2019', 'nCoV', 'The', 'virus', 'emerged', 'in', 'humans', 'from', 'Wuhan', 'seafood', 'market', 'probably', 'via', 'zoonotic', 'transmission', 'Within', 'a', 'few', 'days', 'the', 'virus', 'spread', 'its', 'tentacles', 'rapidly', 'to', 'neighboring', 'cities', 'in', 'China', 'and', 'to', 'different', 'geographical', 'regions', 'through', 'travelers', 'and', 'to', 'some', 'extent', 'by', 'human', 'to', 'human', 'transmission', 'leading', 'to', 'significant', 'disease', 'burden', 'globally', 'More', 'than', '2', '00', '000', 'people', 'including', 'more', 'than', '8000', 'deaths', 'have', 'been', 'infected', 'with', 'this', 'respiratory', 'illness', 'across', '167', 'countries', 'and', 'territories', 'worldwide', 'leading', 'to', 'a', 'pandemic', 'The', 'present', 'review', 'provides', 'an', 'outline', 'about', 'emergence', 'and', 'spread', 'of', 'SARS', 'CoV', '2', 'from', 'Wuhan', 'China', 'in', '2019', '2020', 'We', 'have', 'also', 'provided', 'information', 'about', 'the', 'classification', 'genome', 'proteins', 'clinical', 'presentation', 'of', 'COVID', '19', 'type', 'of', 'clinical', 'specimens', 'to', 'be', 'collected', 'and', 'diagnostic', 'methods', 'adopted', 'to', 'identify', 'the', 'respiratory', 'illness', 'In', 'addition', 'we', 'have', 'also', 'provided', 'information', 'about', 'transmission', 'dynamics', 'prevention', 'measures', 'and', 'treatment', 'options', 'that', 'are', 'available', 'at', 'the', 'present', 'Subsequently', 'we', 'have', 'given', 'a', 'comprehensive', 'overview', 'of', 'the', 'spread', 'of', 'this', 'infection', 'from', 'China', 'to', 'the', 'other', 'parts', 'of', 'the', 'globe', 'Management', 'of', 'the', 'ongoing', 'outbreak', 'of', 'SARS', 'CoV', '2', 'encompassing', 'surveillance', 'clinical', 'immunological', 'genetic', 'and', 'evolutionary', 'investigations', 'are', 'likely', 'to', 'provide', 'the', 'desired', 'results', 'Joint', 'efforts', 'of', 'global', 'scientific', 'community', 'are', 'needed', 'at', 'this', 'hour', 'in', 'terms', 'of', 'enhancement', 'of', 'research', 'on', 'development', 'of', 'accurate', 'diagnostics', 'antiviral', 'therapeutics', 'and', 'finally', 'into', 'formation', 'of', 'an', 'effective', 'vaccine', 'against', 'the', 'emerging', 'novel', 'coronavirus', '']"
153044,A multi-centre pilot proficiency programme to assess the quality of molecular detection of respiratory viruses,2006-01-31,Journal of Clinical Virology,https://www.sciencedirect.com/science/article/pii/S1386653205001435; https://www.ncbi.nlm.nih.gov/pubmed/16019258/; https://api.elsevier.com/content/article/pii/S1386653205001435,"Abstract Objectives To assess the quality of molecular detection of respiratory viruses in clinical diagnostic laboratories. Study design Respiratory virus proficiency panels were produced from diluted stocks of respiratory viruses provided and tested by four reference laboratories. The panels consisted of strong positive, positive, low positive and negative samples for influenza viruses A and B, respiratory syncytial virus, parainfluenza viruses 1 and 3, adenovirus serotypes 4 and 7, human rhinovirus serotypes 16, 72 and 90, human coronaviruses OC43 and 229E. The panels were sent to 17 participants; results and information on methodology was collected. Results All laboratories returned results, of which five submitted complete data sets. So, for analysis all results were combined. Samples were correctly identified by participants in 93.75%, 76.75% and 47.03% for the high positive, positive and low positive samples, respectively. One false positive was reported for all data sets (1.1%). The overall score for all assays using different methodologies was 78.8%. Laboratory performance was not dependant on methodology as all in-house methodologies could achieve optimal results, but dependant on careful optimisation and procedures specific to the laboratory. Conclusions The first proficiency panel showed that in general all participants performed well. Although, it also highlights areas for improvement for all participants in order to generate robust results for use in clinical diagnostics.",10.1016/j.jcv.2005.05.005,h7uwl0pb,"['Abstract', 'Objectives', 'To', 'assess', 'the', 'quality', 'of', 'molecular', 'detection', 'of', 'respiratory', 'viruses', 'in', 'clinical', 'diagnostic', 'laboratories', 'Study', 'design', 'Respiratory', 'virus', 'proficiency', 'panels', 'were', 'produced', 'from', 'diluted', 'stocks', 'of', 'respiratory', 'viruses', 'provided', 'and', 'tested', 'by', 'four', 'reference', 'laboratories', 'The', 'panels', 'consisted', 'of', 'strong', 'positive', 'positive', 'low', 'positive', 'and', 'negative', 'samples', 'for', 'influenza', 'viruses', 'A', 'and', 'B', 'respiratory', 'syncytial', 'virus', 'parainfluenza', 'viruses', '1', 'and', '3', 'adenovirus', 'serotypes', '4', 'and', '7', 'human', 'rhinovirus', 'serotypes', '16', '72', 'and', '90', 'human', 'coronaviruses', 'OC43', 'and', '229E', 'The', 'panels', 'were', 'sent', 'to', '17', 'participants', 'results', 'and', 'information', 'on', 'methodology', 'was', 'collected', 'Results', 'All', 'laboratories', 'returned', 'results', 'of', 'which', 'five', 'submitted', 'complete', 'data', 'sets', 'So', 'for', 'analysis', 'all', 'results', 'were', 'combined', 'Samples', 'were', 'correctly', 'identified', 'by', 'participants', 'in', '93', '75', '76', '75', 'and', '47', '03', 'for', 'the', 'high', 'positive', 'positive', 'and', 'low', 'positive', 'samples', 'respectively', 'One', 'false', 'positive', 'was', 'reported', 'for', 'all', 'data', 'sets', '1', '1', 'The', 'overall', 'score', 'for', 'all', 'assays', 'using', 'different', 'methodologies', 'was', '78', '8', 'Laboratory', 'performance', 'was', 'not', 'dependant', 'on', 'methodology', 'as', 'all', 'in', 'house', 'methodologies', 'could', 'achieve', 'optimal', 'results', 'but', 'dependant', 'on', 'careful', 'optimisation', 'and', 'procedures', 'specific', 'to', 'the', 'laboratory', 'Conclusions', 'The', 'first', 'proficiency', 'panel', 'showed', 'that', 'in', 'general', 'all', 'participants', 'performed', 'well', 'Although', 'it', 'also', 'highlights', 'areas', 'for', 'improvement', 'for', 'all', 'participants', 'in', 'order', 'to', 'generate', 'robust', 'results', 'for', 'use', 'in', 'clinical', 'diagnostics', '']"
153954,Selection and Characterization of Monoclonal Antibodies Targeting Middle East Respiratory Syndrome Coronavirus through a Human Synthetic Fab Phage Display Library Panning,2019-07-31,Antibodies (Basel),https://doi.org/10.3390/antib8030042; https://www.ncbi.nlm.nih.gov/pubmed/31544848/,"Since its first report in the Middle East in 2012, the Middle East respiratory syndrome-coronavirus (MERS-CoV) has become a global concern due to the high morbidity and mortality of individuals infected with the virus. Although the majority of MERS-CoV cases have been reported in Saudi Arabia, the overall risk in areas outside the Middle East remains significant as inside Saudi Arabia. Additional pandemics of MERS-CoV are expected, and thus novel tools and reagents for therapy and diagnosis are urgently needed. Here, we used phage display to develop novel monoclonal antibodies (mAbs) that target MERS-CoV. A human Fab phage display library was panned against the S2 subunit of the MERS-CoV spike protein (MERS-S2P), yielding three unique Fabs (S2A3, S2A6, and S2D5). The Fabs had moderate apparent affinities (Half maximal effective concentration (EC(50) = 123–421 nM) for MERS-S2P, showed no cross-reactivity to spike proteins from other CoVs, and were non-aggregating and thermostable (T(m) = 61.5–80.4 °C). Reformatting the Fabs into IgGs (Immunoglobulin Gs) greatly increased their apparent affinities (K(D) = 0.17–1.2 nM), presumably due to the effects of avidity. These apparent affinities were notably higher than that of a previously reported anti-MERS-CoV S2 reference mAb (K(D) = 8.7 nM). Furthermore, two of the three mAbs (S2A3 and S2D5) bound only MERS-CoV (Erasmus Medical Center (EMC)) and not other CoVs, reflecting their high binding specificity. However, the mAbs lacked MERS-CoV neutralizing activity. Given their high affinity, specificity, and desirable stabilities, we anticipate that these anti-MERS-CoV mAbs would be suitable reagents for developing antibody-based diagnostics in laboratory or hospital settings for point-of-care testing.",10.3390/antib8030042,1zcxw6yu,"['Since', 'its', 'first', 'report', 'in', 'the', 'Middle', 'East', 'in', '2012', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'the', 'high', 'morbidity', 'and', 'mortality', 'of', 'individuals', 'infected', 'with', 'the', 'virus', 'Although', 'the', 'majority', 'of', 'MERS', 'CoV', 'cases', 'have', 'been', 'reported', 'in', 'Saudi', 'Arabia', 'the', 'overall', 'risk', 'in', 'areas', 'outside', 'the', 'Middle', 'East', 'remains', 'significant', 'as', 'inside', 'Saudi', 'Arabia', 'Additional', 'pandemics', 'of', 'MERS', 'CoV', 'are', 'expected', 'and', 'thus', 'novel', 'tools', 'and', 'reagents', 'for', 'therapy', 'and', 'diagnosis', 'are', 'urgently', 'needed', 'Here', 'we', 'used', 'phage', 'display', 'to', 'develop', 'novel', 'monoclonal', 'antibodies', 'mAbs', 'that', 'target', 'MERS', 'CoV', 'A', 'human', 'Fab', 'phage', 'display', 'library', 'was', 'panned', 'against', 'the', 'S2', 'subunit', 'of', 'the', 'MERS', 'CoV', 'spike', 'protein', 'MERS', 'S2P', 'yielding', 'three', 'unique', 'Fabs', 'S2A3', 'S2A6', 'and', 'S2D5', 'The', 'Fabs', 'had', 'moderate', 'apparent', 'affinities', 'Half', 'maximal', 'effective', 'concentration', 'EC', '50', '123', '421', 'nM', 'for', 'MERS', 'S2P', 'showed', 'no', 'cross', 'reactivity', 'to', 'spike', 'proteins', 'from', 'other', 'CoVs', 'and', 'were', 'non', 'aggregating', 'and', 'thermostable', 'T', 'm', '61', '5', '80', '4', 'C', 'Reformatting', 'the', 'Fabs', 'into', 'IgGs', 'Immunoglobulin', 'Gs', 'greatly', 'increased', 'their', 'apparent', 'affinities', 'K', 'D', '0', '17', '1', '2', 'nM', 'presumably', 'due', 'to', 'the', 'effects', 'of', 'avidity', 'These', 'apparent', 'affinities', 'were', 'notably', 'higher', 'than', 'that', 'of', 'a', 'previously', 'reported', 'anti', 'MERS', 'CoV', 'S2', 'reference', 'mAb', 'K', 'D', '8', '7', 'nM', 'Furthermore', 'two', 'of', 'the', 'three', 'mAbs', 'S2A3', 'and', 'S2D5', 'bound', 'only', 'MERS', 'CoV', 'Erasmus', 'Medical', 'Center', 'EMC', 'and', 'not', 'other', 'CoVs', 'reflecting', 'their', 'high', 'binding', 'specificity', 'However', 'the', 'mAbs', 'lacked', 'MERS', 'CoV', 'neutralizing', 'activity', 'Given', 'their', 'high', 'affinity', 'specificity', 'and', 'desirable', 'stabilities', 'we', 'anticipate', 'that', 'these', 'anti', 'MERS', 'CoV', 'mAbs', 'would', 'be', 'suitable', 'reagents', 'for', 'developing', 'antibody', 'based', 'diagnostics', 'in', 'laboratory', 'or', 'hospital', 'settings', 'for', 'point', 'of', 'care', 'testing', '']"
154338,Transmissible gastroenteritis virus: Identification of M protein-binding peptide ligands with antiviral and diagnostic potential,2013-09-30,Antiviral Research,https://api.elsevier.com/content/article/pii/S0166354213001721; https://www.sciencedirect.com/science/article/pii/S0166354213001721; https://www.ncbi.nlm.nih.gov/pubmed/23830854/; https://doi.org/10.1016/j.antiviral.2013.06.015,"Abstract The membrane (M) protein is one of the major structural proteins of coronavirus particles. In this study, the M protein of transmissible gastroenteritis virus (TGEV) was used to biopan a 12-mer phage display random peptide library. Three phages expressing TGEV-M-binding peptides were identified and characterized in more depth. A phage-based immunosorbent assay (phage-ELISA) capable of differentiating TGEV from other coronaviruses was developed using one phage, phTGEV-M7, as antigen. When the phage-ELISA was compared to conventional antibody-based ELISA for detecting infections, phage-ELISA exhibited greater sensitivity. A chemically synthesized, TGEV-M7 peptide (pepTGEV-M7; HALTPIKYIPPG) was evaluated for antiviral activity. Plaque-reduction assays revealed that pepTGEV-M7 was able to prevent TGEV infection in vitro (p <0.01) following pretreatment of the virus with the peptide. Indirect immunofluorescence and real-time RT-PCR confirmed the inhibitory effects of the peptide. These results indicate that pepTGEV-M7 might be utilized for virus-specific diagnostics and treatment.",10.1016/j.antiviral.2013.06.015,59d4aojh,"['Abstract', 'The', 'membrane', 'M', 'protein', 'is', 'one', 'of', 'the', 'major', 'structural', 'proteins', 'of', 'coronavirus', 'particles', 'In', 'this', 'study', 'the', 'M', 'protein', 'of', 'transmissible', 'gastroenteritis', 'virus', 'TGEV', 'was', 'used', 'to', 'biopan', 'a', '12', 'mer', 'phage', 'display', 'random', 'peptide', 'library', 'Three', 'phages', 'expressing', 'TGEV', 'M', 'binding', 'peptides', 'were', 'identified', 'and', 'characterized', 'in', 'more', 'depth', 'A', 'phage', 'based', 'immunosorbent', 'assay', 'phage', 'ELISA', 'capable', 'of', 'differentiating', 'TGEV', 'from', 'other', 'coronaviruses', 'was', 'developed', 'using', 'one', 'phage', 'phTGEV', 'M7', 'as', 'antigen', 'When', 'the', 'phage', 'ELISA', 'was', 'compared', 'to', 'conventional', 'antibody', 'based', 'ELISA', 'for', 'detecting', 'infections', 'phage', 'ELISA', 'exhibited', 'greater', 'sensitivity', 'A', 'chemically', 'synthesized', 'TGEV', 'M7', 'peptide', 'pepTGEV', 'M7', 'HALTPIKYIPPG', 'was', 'evaluated', 'for', 'antiviral', 'activity', 'Plaque', 'reduction', 'assays', 'revealed', 'that', 'pepTGEV', 'M7', 'was', 'able', 'to', 'prevent', 'TGEV', 'infection', 'in', 'vitro', 'p', '0', '01', 'following', 'pretreatment', 'of', 'the', 'virus', 'with', 'the', 'peptide', 'Indirect', 'immunofluorescence', 'and', 'real', 'time', 'RT', 'PCR', 'confirmed', 'the', 'inhibitory', 'effects', 'of', 'the', 'peptide', 'These', 'results', 'indicate', 'that', 'pepTGEV', 'M7', 'might', 'be', 'utilized', 'for', 'virus', 'specific', 'diagnostics', 'and', 'treatment', '']"
154534,Multiplex real-time PCR for detection of respiratory tract infections,2008-01-31,Journal of Clinical Virology,https://www.sciencedirect.com/science/article/pii/S1386653207003940; https://www.ncbi.nlm.nih.gov/pubmed/18093871/; https://api.elsevier.com/content/article/pii/S1386653207003940,"Abstract Background Broad diagnostics of respiratory infection by molecular assays has not yet won acceptance due to technical difficulties and high costs. Objectives To evaluate clinical applicability of multiplex real-time PCR. Study design An assay targeting influenza virus A (IfA) and B (IfB), parainfluenza 1-3 (PIV), human metapneumovirus (MPV), respiratory syncytial virus (RSV), rhinovirus (RV), enterovirus (EV), adenovirus (AdV), human coronaviruses (229E, OC43, NL63), M. pneumoniae and Ch. pneumoniae was developed and run daily on consecutive clinical nasopharyngeal swab samples. Results An etiology was identified in 48% of the 954 samples, with IfA in 25%, RV in 20%, MPV in 10% and M. pneumoniae in 10% of the positive. By a rational procedure costs could be reduced and the customer price set relatively low (€33 per sample). Conclusion Streamlined testing and cost limitation is achievable and probably critical for implementation of a broad molecular diagnostics of respiratory infections.",10.1016/j.jcv.2007.10.029,f2ct57em,"['Abstract', 'Background', 'Broad', 'diagnostics', 'of', 'respiratory', 'infection', 'by', 'molecular', 'assays', 'has', 'not', 'yet', 'won', 'acceptance', 'due', 'to', 'technical', 'difficulties', 'and', 'high', 'costs', 'Objectives', 'To', 'evaluate', 'clinical', 'applicability', 'of', 'multiplex', 'real', 'time', 'PCR', 'Study', 'design', 'An', 'assay', 'targeting', 'influenza', 'virus', 'A', 'IfA', 'and', 'B', 'IfB', 'parainfluenza', '1', '3', 'PIV', 'human', 'metapneumovirus', 'MPV', 'respiratory', 'syncytial', 'virus', 'RSV', 'rhinovirus', 'RV', 'enterovirus', 'EV', 'adenovirus', 'AdV', 'human', 'coronaviruses', '229E', 'OC43', 'NL63', 'M', 'pneumoniae', 'and', 'Ch', 'pneumoniae', 'was', 'developed', 'and', 'run', 'daily', 'on', 'consecutive', 'clinical', 'nasopharyngeal', 'swab', 'samples', 'Results', 'An', 'etiology', 'was', 'identified', 'in', '48', 'of', 'the', '954', 'samples', 'with', 'IfA', 'in', '25', 'RV', 'in', '20', 'MPV', 'in', '10', 'and', 'M', 'pneumoniae', 'in', '10', 'of', 'the', 'positive', 'By', 'a', 'rational', 'procedure', 'costs', 'could', 'be', 'reduced', 'and', 'the', 'customer', 'price', 'set', 'relatively', 'low', '33', 'per', 'sample', 'Conclusion', 'Streamlined', 'testing', 'and', 'cost', 'limitation', 'is', 'achievable', 'and', 'probably', 'critical', 'for', 'implementation', 'of', 'a', 'broad', 'molecular', 'diagnostics', 'of', 'respiratory', 'infections', '']"
154549,Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation,2020-02-15,bioRxiv,https://doi.org/10.1101/2020.02.11.944462; https://www.ncbi.nlm.nih.gov/pubmed/32511295/,"The outbreak of a novel betacoronavirus (2019-nCov) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for urgently needed vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure (MCM) development we determined a 3.5 Å-resolution cryo-EM structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also show biophysical and structural evidence that the 2019-nCoV S binds ACE2 with higher affinity than SARS-CoV S. Additionally we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to nCoV-2019 S, suggesting antibody cross-reactivity may be limited between the two virus RBDs. The atomic-resolution structure of 2019-nCoV S should enable rapid development and evaluation of MCMs to address the ongoing public health crisis.",10.1101/2020.02.11.944462,prqeufwg,"['The', 'outbreak', 'of', 'a', 'novel', 'betacoronavirus', '2019', 'nCov', 'represents', 'a', 'pandemic', 'threat', 'that', 'has', 'been', 'declared', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'The', 'CoV', 'spike', 'S', 'glycoprotein', 'is', 'a', 'key', 'target', 'for', 'urgently', 'needed', 'vaccines', 'therapeutic', 'antibodies', 'and', 'diagnostics', 'To', 'facilitate', 'medical', 'countermeasure', 'MCM', 'development', 'we', 'determined', 'a', '3', '5', 'Å', 'resolution', 'cryo', 'EM', 'structure', 'of', 'the', '2019', 'nCoV', 'S', 'trimer', 'in', 'the', 'prefusion', 'conformation', 'The', 'predominant', 'state', 'of', 'the', 'trimer', 'has', 'one', 'of', 'the', 'three', 'receptor', 'binding', 'domains', 'RBDs', 'rotated', 'up', 'in', 'a', 'receptor', 'accessible', 'conformation', 'We', 'also', 'show', 'biophysical', 'and', 'structural', 'evidence', 'that', 'the', '2019', 'nCoV', 'S', 'binds', 'ACE2', 'with', 'higher', 'affinity', 'than', 'SARS', 'CoV', 'S', 'Additionally', 'we', 'tested', 'several', 'published', 'SARS', 'CoV', 'RBD', 'specific', 'monoclonal', 'antibodies', 'and', 'found', 'that', 'they', 'do', 'not', 'have', 'appreciable', 'binding', 'to', 'nCoV', '2019', 'S', 'suggesting', 'antibody', 'cross', 'reactivity', 'may', 'be', 'limited', 'between', 'the', 'two', 'virus', 'RBDs', 'The', 'atomic', 'resolution', 'structure', 'of', '2019', 'nCoV', 'S', 'should', 'enable', 'rapid', 'development', 'and', 'evaluation', 'of', 'MCMs', 'to', 'address', 'the', 'ongoing', 'public', 'health', 'crisis', '']"
155069,Identification of a Novel Linear B-Cell Epitope on the Nucleocapsid Protein of Porcine Deltacoronavirus,2020-01-19,Int J Mol Sci,https://www.ncbi.nlm.nih.gov/pubmed/31963776/; https://doi.org/10.3390/ijms21020648,"Porcine deltacoronavirus (PDCoV), first identified in 2012, is a swine enteropathogen now found in many countries. The nucleocapsid (N) protein, a core component of PDCoV, is essential for virus replication and is a significant candidate in the development of diagnostics for PDCoV. In this study, monoclonal antibodies (mAbs) were generated and tested for reactivity with three truncations of the full protein (N1, N2, N3) that contained partial overlaps; of the five monoclonals chosen tested, each reacted with only the N3 truncation. The antibody designated 4E88 had highest binding affinity with the N protein and was chosen for in-depth examination. The 4E88 epitope was located to amino acids 308-AKPKQQKKPKK-318 by testing the 4E88 monoclonal for reactivity with a series of N3 truncations, then the minimal epitope, 309-KPKQQKKPK-317 (designated EP-4E88), was pinpointed by testing the 4E88 monoclonal for reactivity with a series of synthetic peptides of this region. Homology analysis showed that the EP-4E88 sequence is highly conserved among PDCoV strains, and also shares high similarity with sparrow coronavirus (HKU17), Asian leopard cat coronavirus (ALCCoV), quail coronavirus (UAE-HKU30), and sparrow deltacoronavirus (SpDCoV). Of note, the PDCoV EP-4E88 sequence shared very low similarity (<22.2%) with other porcine coronaviruses (PEDV, TGEV, PRCV, SADS-CoV, PHEV), demonstrating that it is an epitope that can be used for distinguishing PDCoV and other porcine coronavirus. 3D structural analysis revealed that amino acids of EP-4E88 were in close proximity and may be exposed on the surface of the N protein.",10.3390/ijms21020648,2r101v54,"['Porcine', 'deltacoronavirus', 'PDCoV', 'first', 'identified', 'in', '2012', 'is', 'a', 'swine', 'enteropathogen', 'now', 'found', 'in', 'many', 'countries', 'The', 'nucleocapsid', 'N', 'protein', 'a', 'core', 'component', 'of', 'PDCoV', 'is', 'essential', 'for', 'virus', 'replication', 'and', 'is', 'a', 'significant', 'candidate', 'in', 'the', 'development', 'of', 'diagnostics', 'for', 'PDCoV', 'In', 'this', 'study', 'monoclonal', 'antibodies', 'mAbs', 'were', 'generated', 'and', 'tested', 'for', 'reactivity', 'with', 'three', 'truncations', 'of', 'the', 'full', 'protein', 'N1', 'N2', 'N3', 'that', 'contained', 'partial', 'overlaps', 'of', 'the', 'five', 'monoclonals', 'chosen', 'tested', 'each', 'reacted', 'with', 'only', 'the', 'N3', 'truncation', 'The', 'antibody', 'designated', '4E88', 'had', 'highest', 'binding', 'affinity', 'with', 'the', 'N', 'protein', 'and', 'was', 'chosen', 'for', 'in', 'depth', 'examination', 'The', '4E88', 'epitope', 'was', 'located', 'to', 'amino', 'acids', '308', 'AKPKQQKKPKK', '318', 'by', 'testing', 'the', '4E88', 'monoclonal', 'for', 'reactivity', 'with', 'a', 'series', 'of', 'N3', 'truncations', 'then', 'the', 'minimal', 'epitope', '309', 'KPKQQKKPK', '317', 'designated', 'EP', '4E88', 'was', 'pinpointed', 'by', 'testing', 'the', '4E88', 'monoclonal', 'for', 'reactivity', 'with', 'a', 'series', 'of', 'synthetic', 'peptides', 'of', 'this', 'region', 'Homology', 'analysis', 'showed', 'that', 'the', 'EP', '4E88', 'sequence', 'is', 'highly', 'conserved', 'among', 'PDCoV', 'strains', 'and', 'also', 'shares', 'high', 'similarity', 'with', 'sparrow', 'coronavirus', 'HKU17', 'Asian', 'leopard', 'cat', 'coronavirus', 'ALCCoV', 'quail', 'coronavirus', 'UAE', 'HKU30', 'and', 'sparrow', 'deltacoronavirus', 'SpDCoV', 'Of', 'note', 'the', 'PDCoV', 'EP', '4E88', 'sequence', 'shared', 'very', 'low', 'similarity', '22', '2', 'with', 'other', 'porcine', 'coronaviruses', 'PEDV', 'TGEV', 'PRCV', 'SADS', 'CoV', 'PHEV', 'demonstrating', 'that', 'it', 'is', 'an', 'epitope', 'that', 'can', 'be', 'used', 'for', 'distinguishing', 'PDCoV', 'and', 'other', 'porcine', 'coronavirus', '3D', 'structural', 'analysis', 'revealed', 'that', 'amino', 'acids', 'of', 'EP', '4E88', 'were', 'in', 'close', 'proximity', 'and', 'may', 'be', 'exposed', 'on', 'the', 'surface', 'of', 'the', 'N', 'protein', '']"
155767,Prise en charge des exacerbations : de la ville à l’hôpital,2014-12-31,La Presse Médicale,https://api.elsevier.com/content/article/pii/S0755498214004631; https://www.sciencedirect.com/science/article/pii/S0755498214004631; https://www.ncbi.nlm.nih.gov/pubmed/25451635/; https://doi.org/10.1016/j.lpm.2014.03.034,"Points essentiels La Société de pneumologie de langue française définie l’exacerbation aiguë de bronchopneumopathie chronique obstructive comme une majoration des symptômes respiratoires au-delà des variations quotidiennes (en pratique, d’une durée ≥ 48 h ou justifiant une modification thérapeutique). La cause de ces exacerbations est principalement infectieuse : virale (rhinovirus, virus influenzae et parainfluenzae, coronavirus, adénovirus et virus respiratoire syncytial) ou bactérienne (principalement, Haemophilus influenzae, Streptococcus pneumoniae et Moraxella catarrhalis). Elles peuvent également résulter de l’exposition à certains polluants : NO2, SO2, ozone et pollution particulaire (PM10 et PM2,5). Elle reste indéterminée dans près de 30 % des cas. Les diagnostics différentiels incluent les pneumopathies infectieuses, les pneumothorax, les poussées d’insuffisance cardiaque et les embolies pulmonaires. La présence de signes de gravité conditionne l’hospitalisation : signes d’insuffisance respiratoire aiguë, de choc ou de défaillance neurologique, mais aussi en cas de patient fragile, d’absence de soutien familial à domicile ou de réponse au traitement initial. Le traitement consiste en une majoration des bronchodilatateurs, une kinésithérapie respiratoire, une antibiothérapie en cas d’expectoration franchement purulente. La prescription de corticoïdes systémiques ne doit pas être systématique. La dose recommandée est de 0,5 mg/kg sur une courte période (5–7 jours). Lors d’une hospitalisation, une oxygénothérapie et une thromboprophylaxie peuvent être instaurées. La ventilation non invasive est principalement indiquée en cas de persistance d’une hypercapnie malgré un traitement médical optimal. Que le patient soit pris en charge en ambulatoire ou en hospitalisation, une réévaluation clinique à 48–72 h est indispensable. Key points The Société de pneumologie de langue française defines acute exacerbation of chronic obstructive pulmonary disease (AE COPD) as an increase in daily respiratory symptoms, basically duration ≥ 48h or need for treatment adjustment. Etiology of EA COPD are mainly infectious, viral (rhinovirus, influenzae or parainfluenzae virus, coronavirus, adenovirus and respiratory syncytial virus) or bacterial (Haemophilus influenzae, Streptococcus pneumoniae, or Moraxella catarrhalis). Pollutant exposure can also lead to AE COPD, such as NO2, SO2, ozone or particulates (PM10 and PM2.5). In 30% the etiology remains unknown. Differential diagnoses of AE COPD include infectious pneumonia, pneumothorax, acute heart failure and pulmonary embolism. Presences of signs of severity impose hospitalization: signs of respiratory distress, shock, acute confusion but also fragile patients, insufficient home support or absence of response to initial treatment. AE COPD treatments consist on increase in bronchodilators, chest physiotherapy, and antibiotics if sputum is frankly purulent. Systemic corticosteroids should not be systematic. Recommended dose is 0.5 mg/kg on short course (5–7 days). During hospitalization, oxygen supplementation and thromboprophylaxis could be prescribed. The main interest in non-invasive ventilation is persistent hypercapnia despite optimal medical management. During ambulatory management or hospitalization, clinical assessment at 48–72 h is mandatory.",10.1016/j.lpm.2014.03.034,3xe2jjl4,"['Points', 'essentiels', 'La', 'Société', 'de', 'pneumologie', 'de', 'langue', 'française', 'définie', 'l', 'exacerbation', 'aiguë', 'de', 'bronchopneumopathie', 'chronique', 'obstructive', 'comme', 'une', 'majoration', 'des', 'symptômes', 'respiratoires', 'au', 'delà', 'des', 'variations', 'quotidiennes', 'en', 'pratique', 'd', 'une', 'durée', '48', 'h', 'ou', 'justifiant', 'une', 'modification', 'thérapeutique', 'La', 'cause', 'de', 'ces', 'exacerbations', 'est', 'principalement', 'infectieuse', 'virale', 'rhinovirus', 'virus', 'influenzae', 'et', 'parainfluenzae', 'coronavirus', 'adénovirus', 'et', 'virus', 'respiratoire', 'syncytial', 'ou', 'bactérienne', 'principalement', 'Haemophilus', 'influenzae', 'Streptococcus', 'pneumoniae', 'et', 'Moraxella', 'catarrhalis', 'Elles', 'peuvent', 'également', 'résulter', 'de', 'l', 'exposition', 'à', 'certains', 'polluants', 'NO2', 'SO2', 'ozone', 'et', 'pollution', 'particulaire', 'PM10', 'et', 'PM2', '5', 'Elle', 'reste', 'indéterminée', 'dans', 'près', 'de', '30', 'des', 'cas', 'Les', 'diagnostics', 'différentiels', 'incluent', 'les', 'pneumopathies', 'infectieuses', 'les', 'pneumothorax', 'les', 'poussées', 'd', 'insuffisance', 'cardiaque', 'et', 'les', 'embolies', 'pulmonaires', 'La', 'présence', 'de', 'signes', 'de', 'gravité', 'conditionne', 'l', 'hospitalisation', 'signes', 'd', 'insuffisance', 'respiratoire', 'aiguë', 'de', 'choc', 'ou', 'de', 'défaillance', 'neurologique', 'mais', 'aussi', 'en', 'cas', 'de', 'patient', 'fragile', 'd', 'absence', 'de', 'soutien', 'familial', 'à', 'domicile', 'ou', 'de', 'réponse', 'au', 'traitement', 'initial', 'Le', 'traitement', 'consiste', 'en', 'une', 'majoration', 'des', 'bronchodilatateurs', 'une', 'kinésithérapie', 'respiratoire', 'une', 'antibiothérapie', 'en', 'cas', 'd', 'expectoration', 'franchement', 'purulente', 'La', 'prescription', 'de', 'corticoïdes', 'systémiques', 'ne', 'doit', 'pas', 'être', 'systématique', 'La', 'dose', 'recommandée', 'est', 'de', '0', '5', 'mg', 'kg', 'sur', 'une', 'courte', 'période', '5', '7', 'jours', 'Lors', 'd', 'une', 'hospitalisation', 'une', 'oxygénothérapie', 'et', 'une', 'thromboprophylaxie', 'peuvent', 'être', 'instaurées', 'La', 'ventilation', 'non', 'invasive', 'est', 'principalement', 'indiquée', 'en', 'cas', 'de', 'persistance', 'd', 'une', 'hypercapnie', 'malgré', 'un', 'traitement', 'médical', 'optimal', 'Que', 'le', 'patient', 'soit', 'pris', 'en', 'charge', 'en', 'ambulatoire', 'ou', 'en', 'hospitalisation', 'une', 'réévaluation', 'clinique', 'à', '48', '72', 'h', 'est', 'indispensable', 'Key', 'points', 'The', 'Société', 'de', 'pneumologie', 'de', 'langue', 'française', 'defines', 'acute', 'exacerbation', 'of', 'chronic', 'obstructive', 'pulmonary', 'disease', 'AE', 'COPD', 'as', 'an', 'increase', 'in', 'daily', 'respiratory', 'symptoms', 'basically', 'duration', '48h', 'or', 'need', 'for', 'treatment', 'adjustment', 'Etiology', 'of', 'EA', 'COPD', 'are', 'mainly', 'infectious', 'viral', 'rhinovirus', 'influenzae', 'or', 'parainfluenzae', 'virus', 'coronavirus', 'adenovirus', 'and', 'respiratory', 'syncytial', 'virus', 'or', 'bacterial', 'Haemophilus', 'influenzae', 'Streptococcus', 'pneumoniae', 'or', 'Moraxella', 'catarrhalis', 'Pollutant', 'exposure', 'can', 'also', 'lead', 'to', 'AE', 'COPD', 'such', 'as', 'NO2', 'SO2', 'ozone', 'or', 'particulates', 'PM10', 'and', 'PM2', '5', 'In', '30', 'the', 'etiology', 'remains', 'unknown', 'Differential', 'diagnoses', 'of', 'AE', 'COPD', 'include', 'infectious', 'pneumonia', 'pneumothorax', 'acute', 'heart', 'failure', 'and', 'pulmonary', 'embolism', 'Presences', 'of', 'signs', 'of', 'severity', 'impose', 'hospitalization', 'signs', 'of', 'respiratory', 'distress', 'shock', 'acute', 'confusion', 'but', 'also', 'fragile', 'patients', 'insufficient', 'home', 'support', 'or', 'absence', 'of', 'response', 'to', 'initial', 'treatment', 'AE', 'COPD', 'treatments', 'consist', 'on', 'increase', 'in', 'bronchodilators', 'chest', 'physiotherapy', 'and', 'antibiotics', 'if', 'sputum', 'is', 'frankly', 'purulent', 'Systemic', 'corticosteroids', 'should', 'not', 'be', 'systematic', 'Recommended', 'dose', 'is', '0', '5', 'mg', 'kg', 'on', 'short', 'course', '5', '7', 'days', 'During', 'hospitalization', 'oxygen', 'supplementation', 'and', 'thromboprophylaxis', 'could', 'be', 'prescribed', 'The', 'main', 'interest', 'in', 'non', 'invasive', 'ventilation', 'is', 'persistent', 'hypercapnia', 'despite', 'optimal', 'medical', 'management', 'During', 'ambulatory', 'management', 'or', 'hospitalization', 'clinical', 'assessment', 'at', '48', '72', 'h', 'is', 'mandatory', '']"
155834,Coronavirus disease pandemic (Covid-19): Challenges and a global perspective,2020,Pathogens,https://www.ncbi.nlm.nih.gov/pubmed/32605194/; https://doi.org/10.3390/pathogens9070519,"The technology-driven world of the 21stcentury is currently confronted with a major threat to humankind, represented by the coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome, coronavirus-2 (SARS-CoV-2). As of now, COVID-19 has affected more than 6 million confirmed cases and took 0.39 million human lives. SARS-CoV-2 spreads much faster than its two ancestors, SARS-CoV and Middle East respiratory syndrome-CoV (MERS-CoV), but has low fatality rates. Our analyses speculate that the efficient replication and transmission of SARS-CoV-2 might be due to the high-density basic amino acid residues, preferably positioned in close proximity at both the furin-like cleavage sites (S1/S2 and S2’) within the spike protein. Given the high genomic similarities of SARS-CoV-2 to bat SARS-like CoVs, it is likely that bats serve as a reservoir host for its progenitor. Women and children are less susceptible to SARS-CoV-2 infection, while the elderly and people with comorbidities are more prone to serious clinical outcomes, which may be associated with acute respiratory distress syndrome (ARDS) and cytokine storm. The cohesive approach amongst researchers across the globe has delivered high-end viral diagnostics. However, home-based point-of-care diagnostics are still under development, which may prove transformative in current COVID-19 pandemic containment. Similarly, vaccines and therapeutics against COVID-19 are currently in the pipeline for clinical trials. In this review, we discuss the noteworthy advancements, focusing on the etiological viral agent, comparative genomic analysis, population susceptibility, disease epidemiology and diagnosis, animal reservoirs, laboratory animal models, disease transmission, therapeutics, vaccine challenges, and disease mitigation measures.",10.3390/pathogens9070519,bsz35lrd,"['The', 'technology', 'driven', 'world', 'of', 'the', '21stcentury', 'is', 'currently', 'confronted', 'with', 'a', 'major', 'threat', 'to', 'humankind', 'represented', 'by', 'the', 'coronavirus', 'disease', 'COVID', '19', 'pandemic', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'As', 'of', 'now', 'COVID', '19', 'has', 'affected', 'more', 'than', '6', 'million', 'confirmed', 'cases', 'and', 'took', '0', '39', 'million', 'human', 'lives', 'SARS', 'CoV', '2', 'spreads', 'much', 'faster', 'than', 'its', 'two', 'ancestors', 'SARS', 'CoV', 'and', 'Middle', 'East', 'respiratory', 'syndrome', 'CoV', 'MERS', 'CoV', 'but', 'has', 'low', 'fatality', 'rates', 'Our', 'analyses', 'speculate', 'that', 'the', 'efficient', 'replication', 'and', 'transmission', 'of', 'SARS', 'CoV', '2', 'might', 'be', 'due', 'to', 'the', 'high', 'density', 'basic', 'amino', 'acid', 'residues', 'preferably', 'positioned', 'in', 'close', 'proximity', 'at', 'both', 'the', 'furin', 'like', 'cleavage', 'sites', 'S1', 'S2', 'and', 'S2', 'within', 'the', 'spike', 'protein', 'Given', 'the', 'high', 'genomic', 'similarities', 'of', 'SARS', 'CoV', '2', 'to', 'bat', 'SARS', 'like', 'CoVs', 'it', 'is', 'likely', 'that', 'bats', 'serve', 'as', 'a', 'reservoir', 'host', 'for', 'its', 'progenitor', 'Women', 'and', 'children', 'are', 'less', 'susceptible', 'to', 'SARS', 'CoV', '2', 'infection', 'while', 'the', 'elderly', 'and', 'people', 'with', 'comorbidities', 'are', 'more', 'prone', 'to', 'serious', 'clinical', 'outcomes', 'which', 'may', 'be', 'associated', 'with', 'acute', 'respiratory', 'distress', 'syndrome', 'ARDS', 'and', 'cytokine', 'storm', 'The', 'cohesive', 'approach', 'amongst', 'researchers', 'across', 'the', 'globe', 'has', 'delivered', 'high', 'end', 'viral', 'diagnostics', 'However', 'home', 'based', 'point', 'of', 'care', 'diagnostics', 'are', 'still', 'under', 'development', 'which', 'may', 'prove', 'transformative', 'in', 'current', 'COVID', '19', 'pandemic', 'containment', 'Similarly', 'vaccines', 'and', 'therapeutics', 'against', 'COVID', '19', 'are', 'currently', 'in', 'the', 'pipeline', 'for', 'clinical', 'trials', 'In', 'this', 'review', 'we', 'discuss', 'the', 'noteworthy', 'advancements', 'focusing', 'on', 'the', 'etiological', 'viral', 'agent', 'comparative', 'genomic', 'analysis', 'population', 'susceptibility', 'disease', 'epidemiology', 'and', 'diagnosis', 'animal', 'reservoirs', 'laboratory', 'animal', 'models', 'disease', 'transmission', 'therapeutics', 'vaccine', 'challenges', 'and', 'disease', 'mitigation', 'measures', '']"
156228,Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation,2020-03-13,Science,https://www.ncbi.nlm.nih.gov/pubmed/32075877/; https://doi.org/10.1126/science.abb2507,"The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo–electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.",10.1126/science.abb2507,vp96izcs,"['The', 'outbreak', 'of', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'represents', 'a', 'pandemic', 'threat', 'that', 'has', 'been', 'declared', 'a', 'public', 'health', 'emergency', 'of', 'international', 'concern', 'The', 'CoV', 'spike', 'S', 'glycoprotein', 'is', 'a', 'key', 'target', 'for', 'vaccines', 'therapeutic', 'antibodies', 'and', 'diagnostics', 'To', 'facilitate', 'medical', 'countermeasure', 'development', 'we', 'determined', 'a', '3', '5', 'angstrom', 'resolution', 'cryo', 'electron', 'microscopy', 'structure', 'of', 'the', '2019', 'nCoV', 'S', 'trimer', 'in', 'the', 'prefusion', 'conformation', 'The', 'predominant', 'state', 'of', 'the', 'trimer', 'has', 'one', 'of', 'the', 'three', 'receptor', 'binding', 'domains', 'RBDs', 'rotated', 'up', 'in', 'a', 'receptor', 'accessible', 'conformation', 'We', 'also', 'provide', 'biophysical', 'and', 'structural', 'evidence', 'that', 'the', '2019', 'nCoV', 'S', 'protein', 'binds', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'with', 'higher', 'affinity', 'than', 'does', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'S', 'Additionally', 'we', 'tested', 'several', 'published', 'SARS', 'CoV', 'RBD', 'specific', 'monoclonal', 'antibodies', 'and', 'found', 'that', 'they', 'do', 'not', 'have', 'appreciable', 'binding', 'to', '2019', 'nCoV', 'S', 'suggesting', 'that', 'antibody', 'cross', 'reactivity', 'may', 'be', 'limited', 'between', 'the', 'two', 'RBDs', 'The', 'structure', 'of', '2019', 'nCoV', 'S', 'should', 'enable', 'the', 'rapid', 'development', 'and', 'evaluation', 'of', 'medical', 'countermeasures', 'to', 'address', 'the', 'ongoing', 'public', 'health', 'crisis', '']"
156642,History and Future of Nucleic Acid Amplification Technology Blood Donor Testing,2019-01-01,Transfusion Medicine and Hemotherapy,https://www.ncbi.nlm.nih.gov/pubmed/31191192/; https://doi.org/10.1159/000496749,"The introduction of blood donor screening by virus nucleic acid amplification technology (NAT) in the mid to late 1990s was driven by the so-called AIDS and hepatitis C virus (HCV) epidemic, with thousands of recipients of infected blood products and components. Plasma fractionators were the first to introduce NAT testing besides pathogen reduction procedures, to reduce the virus transmission risk through their products. To achieve a similar safety standard, NAT was then also introduced for labile blood components. German transfusion centres were the first to start in-house NAT testing of their donations in pools of up to 96 samples for HCV, hepatitis B virus (HBV), and human immunodeficiency virus-1 (HIV-1). Years later the diagnostics industry provided commercial HCV and HIV-1 and later HBV NAT tests on automated platforms. NAT tests for HIV-2, hepatitis A virus, and Parvovirus B19 followed, again driven by transfusion centres with their in-house tests. When severe acute respiratory syndrome corona virus (SARS-CoV) and West Nile Virus emerged it was the NAT that enabled the manufacturers and transfusion centres to instantly introduce sensitive and specific screening tests. Subsequent automation including sample preparation has significantly reduced the costs and complexity of the procedure and made it affordable to middle income countries as well. Currently more than 60 million donations per year are NAT tested worldwide and the remaining residual risk of virus transmission by blood components and products could be reduced to almost zero. Automation rendered possible the reduction of pool size in conjunction with increased throughput and sensitivity. Thus, antibody and antigen testing may be dispensable in the long run, particularly in the combination of NAT testing with pathogen reduction. There are new technologies on the horizon like digital droplet PCR, next-generation sequencing, lab-on-a-chip, and digital antigen assays, which are comparably sensitive. However, each of these has limitations, either in throughput, costs, automation, time to result, specificity, or the need for NAT as an integral part of the technology. Thus, NAT is still the shortest and most efficient means to the result. Donor screening NAT also contributed significantly to our knowledge on how fast viruses replicate, and on the respective diagnostic window. In conjunction with animal and patient studies, we have learned more about the minimal infectious dose and the epidemics in the donor population.",10.1159/000496749,q23zf9mj,"['The', 'introduction', 'of', 'blood', 'donor', 'screening', 'by', 'virus', 'nucleic', 'acid', 'amplification', 'technology', 'NAT', 'in', 'the', 'mid', 'to', 'late', '1990s', 'was', 'driven', 'by', 'the', 'so', 'called', 'AIDS', 'and', 'hepatitis', 'C', 'virus', 'HCV', 'epidemic', 'with', 'thousands', 'of', 'recipients', 'of', 'infected', 'blood', 'products', 'and', 'components', 'Plasma', 'fractionators', 'were', 'the', 'first', 'to', 'introduce', 'NAT', 'testing', 'besides', 'pathogen', 'reduction', 'procedures', 'to', 'reduce', 'the', 'virus', 'transmission', 'risk', 'through', 'their', 'products', 'To', 'achieve', 'a', 'similar', 'safety', 'standard', 'NAT', 'was', 'then', 'also', 'introduced', 'for', 'labile', 'blood', 'components', 'German', 'transfusion', 'centres', 'were', 'the', 'first', 'to', 'start', 'in', 'house', 'NAT', 'testing', 'of', 'their', 'donations', 'in', 'pools', 'of', 'up', 'to', '96', 'samples', 'for', 'HCV', 'hepatitis', 'B', 'virus', 'HBV', 'and', 'human', 'immunodeficiency', 'virus', '1', 'HIV', '1', 'Years', 'later', 'the', 'diagnostics', 'industry', 'provided', 'commercial', 'HCV', 'and', 'HIV', '1', 'and', 'later', 'HBV', 'NAT', 'tests', 'on', 'automated', 'platforms', 'NAT', 'tests', 'for', 'HIV', '2', 'hepatitis', 'A', 'virus', 'and', 'Parvovirus', 'B19', 'followed', 'again', 'driven', 'by', 'transfusion', 'centres', 'with', 'their', 'in', 'house', 'tests', 'When', 'severe', 'acute', 'respiratory', 'syndrome', 'corona', 'virus', 'SARS', 'CoV', 'and', 'West', 'Nile', 'Virus', 'emerged', 'it', 'was', 'the', 'NAT', 'that', 'enabled', 'the', 'manufacturers', 'and', 'transfusion', 'centres', 'to', 'instantly', 'introduce', 'sensitive', 'and', 'specific', 'screening', 'tests', 'Subsequent', 'automation', 'including', 'sample', 'preparation', 'has', 'significantly', 'reduced', 'the', 'costs', 'and', 'complexity', 'of', 'the', 'procedure', 'and', 'made', 'it', 'affordable', 'to', 'middle', 'income', 'countries', 'as', 'well', 'Currently', 'more', 'than', '60', 'million', 'donations', 'per', 'year', 'are', 'NAT', 'tested', 'worldwide', 'and', 'the', 'remaining', 'residual', 'risk', 'of', 'virus', 'transmission', 'by', 'blood', 'components', 'and', 'products', 'could', 'be', 'reduced', 'to', 'almost', 'zero', 'Automation', 'rendered', 'possible', 'the', 'reduction', 'of', 'pool', 'size', 'in', 'conjunction', 'with', 'increased', 'throughput', 'and', 'sensitivity', 'Thus', 'antibody', 'and', 'antigen', 'testing', 'may', 'be', 'dispensable', 'in', 'the', 'long', 'run', 'particularly', 'in', 'the', 'combination', 'of', 'NAT', 'testing', 'with', 'pathogen', 'reduction', 'There', 'are', 'new', 'technologies', 'on', 'the', 'horizon', 'like', 'digital', 'droplet', 'PCR', 'next', 'generation', 'sequencing', 'lab', 'on', 'a', 'chip', 'and', 'digital', 'antigen', 'assays', 'which', 'are', 'comparably', 'sensitive', 'However', 'each', 'of', 'these', 'has', 'limitations', 'either', 'in', 'throughput', 'costs', 'automation', 'time', 'to', 'result', 'specificity', 'or', 'the', 'need', 'for', 'NAT', 'as', 'an', 'integral', 'part', 'of', 'the', 'technology', 'Thus', 'NAT', 'is', 'still', 'the', 'shortest', 'and', 'most', 'efficient', 'means', 'to', 'the', 'result', 'Donor', 'screening', 'NAT', 'also', 'contributed', 'significantly', 'to', 'our', 'knowledge', 'on', 'how', 'fast', 'viruses', 'replicate', 'and', 'on', 'the', 'respective', 'diagnostic', 'window', 'In', 'conjunction', 'with', 'animal', 'and', 'patient', 'studies', 'we', 'have', 'learned', 'more', 'about', 'the', 'minimal', 'infectious', 'dose', 'and', 'the', 'epidemics', 'in', 'the', 'donor', 'population', '']"
157005,Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs,2020-06-20,Int J Mol Sci,https://www.ncbi.nlm.nih.gov/pubmed/32575728/; https://doi.org/10.3390/ijms21124396,"The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Meanwhile, increased demand for testing has led to a shortage of reagents and supplies and compromised the performance of diagnostic laboratories in many countries. Both the World Health Organization (WHO) and the Center for Disease Control and Prevention (CDC) recommend multi-step RT-PCR assays using multiple primer and probe pairs, which might complicate the interpretation of the test results, especially for borderline cases. In this study, we describe an alternative RT-PCR approach for the detection of SARS-CoV-2 RNA that can be used for the probe-based detection of clinical isolates in diagnostics as well as in research labs using a low-cost SYBR green method. For the evaluation, we used samples from patients with confirmed SARS-CoV-2 infections and performed RT-PCR assays along with successive dilutions of RNA standards to determine the limit of detection. We identified an M-gene binding primer and probe pair highly suitable for the quantitative detection of SARS-CoV-2 RNA for diagnostic and research purposes.",10.3390/ijms21124396,d65njv7b,"['The', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'is', 'the', 'causative', 'agent', 'of', 'the', 'acute', 'respiratory', 'disease', 'COVID', '19', 'which', 'has', 'become', 'a', 'global', 'concern', 'due', 'to', 'its', 'rapid', 'spread', 'Meanwhile', 'increased', 'demand', 'for', 'testing', 'has', 'led', 'to', 'a', 'shortage', 'of', 'reagents', 'and', 'supplies', 'and', 'compromised', 'the', 'performance', 'of', 'diagnostic', 'laboratories', 'in', 'many', 'countries', 'Both', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'the', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'recommend', 'multi', 'step', 'RT', 'PCR', 'assays', 'using', 'multiple', 'primer', 'and', 'probe', 'pairs', 'which', 'might', 'complicate', 'the', 'interpretation', 'of', 'the', 'test', 'results', 'especially', 'for', 'borderline', 'cases', 'In', 'this', 'study', 'we', 'describe', 'an', 'alternative', 'RT', 'PCR', 'approach', 'for', 'the', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'that', 'can', 'be', 'used', 'for', 'the', 'probe', 'based', 'detection', 'of', 'clinical', 'isolates', 'in', 'diagnostics', 'as', 'well', 'as', 'in', 'research', 'labs', 'using', 'a', 'low', 'cost', 'SYBR', 'green', 'method', 'For', 'the', 'evaluation', 'we', 'used', 'samples', 'from', 'patients', 'with', 'confirmed', 'SARS', 'CoV', '2', 'infections', 'and', 'performed', 'RT', 'PCR', 'assays', 'along', 'with', 'successive', 'dilutions', 'of', 'RNA', 'standards', 'to', 'determine', 'the', 'limit', 'of', 'detection', 'We', 'identified', 'an', 'M', 'gene', 'binding', 'primer', 'and', 'probe', 'pair', 'highly', 'suitable', 'for', 'the', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'RNA', 'for', 'diagnostic', 'and', 'research', 'purposes', '']"
157088,SYBR Green real-time reverse transcription-polymerase chain reaction assay for the generic detection of coronaviruses,2006-08-28,Arch Virol,https://www.ncbi.nlm.nih.gov/pubmed/16941059/,"Coronaviruses are etiologic agents of respiratory and enteric diseases in humans and in animals. In this study, a one-step real-time reverse transcription-polymerase chain reaction (RT-PCR) assay based on SYBR Green chemistry and degenerate primers was developed for the generic detection of coronaviruses. The primers, designed in the open reading frame 1b, enabled the detection of 32 animal coronaviruses including strains of canine coronavirus, feline coronavirus, transmissible gastroenteritis virus (TGEV), bovine coronavirus (BCoV), murine hepatitis virus (MHV) and infectious bronchitis virus (IBV). A specific amplification was also observed with the human coronaviruses (HCoV) HCoV-NL63, HCoV-OC43, HCoV-229E and severe acute respiratory syndrome coronavirus (SARS-CoV). The real-time RT-PCR detected down to 10 cRNA copies from TGEV, BCoV, SARS-CoV and IBV. In addition, the assay exhibited a high sensitivity and specificity on clinical samples from different animal species. The developed assay represents a potential tool for laboratory diagnostics and for detecting still uncharacterized coronaviruses.",10.1007/s00705-006-0840-x,ubg3mj4u,"['Coronaviruses', 'are', 'etiologic', 'agents', 'of', 'respiratory', 'and', 'enteric', 'diseases', 'in', 'humans', 'and', 'in', 'animals', 'In', 'this', 'study', 'a', 'one', 'step', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'assay', 'based', 'on', 'SYBR', 'Green', 'chemistry', 'and', 'degenerate', 'primers', 'was', 'developed', 'for', 'the', 'generic', 'detection', 'of', 'coronaviruses', 'The', 'primers', 'designed', 'in', 'the', 'open', 'reading', 'frame', '1b', 'enabled', 'the', 'detection', 'of', '32', 'animal', 'coronaviruses', 'including', 'strains', 'of', 'canine', 'coronavirus', 'feline', 'coronavirus', 'transmissible', 'gastroenteritis', 'virus', 'TGEV', 'bovine', 'coronavirus', 'BCoV', 'murine', 'hepatitis', 'virus', 'MHV', 'and', 'infectious', 'bronchitis', 'virus', 'IBV', 'A', 'specific', 'amplification', 'was', 'also', 'observed', 'with', 'the', 'human', 'coronaviruses', 'HCoV', 'HCoV', 'NL63', 'HCoV', 'OC43', 'HCoV', '229E', 'and', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'SARS', 'CoV', 'The', 'real', 'time', 'RT', 'PCR', 'detected', 'down', 'to', '10', 'cRNA', 'copies', 'from', 'TGEV', 'BCoV', 'SARS', 'CoV', 'and', 'IBV', 'In', 'addition', 'the', 'assay', 'exhibited', 'a', 'high', 'sensitivity', 'and', 'specificity', 'on', 'clinical', 'samples', 'from', 'different', 'animal', 'species', 'The', 'developed', 'assay', 'represents', 'a', 'potential', 'tool', 'for', 'laboratory', 'diagnostics', 'and', 'for', 'detecting', 'still', 'uncharacterized', 'coronaviruses', '']"
157298,Full-genome sequences of the first two SARS-CoV-2 viruses from India,2020-04-28,Indian J Med Res,https://doi.org/10.4103/ijmr.ijmr_663_20; https://www.ncbi.nlm.nih.gov/pubmed/32242873/,"BACKGROUND & OBJECTIVES: Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has globally affected 195 countries. In India, suspected cases were screened for SARS-CoV-2 as per the advisory of the Ministry of Health and Family Welfare. The objective of this study was to characterize SARS-CoV-2 sequences from three identified positive cases as on February 29, 2020. METHODS: Throat swab/nasal swab specimens for a total of 881 suspected cases were screened by E gene and confirmed by RdRp (1), RdRp (2) and N gene real-time reverse transcription-polymerase chain reactions and next-generation sequencing. Phylogenetic analysis, molecular characterization and prediction of B- and T-cell epitopes for Indian SARS-CoV-2 sequences were undertaken. RESULTS: Three cases with a travel history from Wuhan, China, were confirmed positive for SARS-CoV-2. Almost complete (29,851 nucleotides) genomes of case 1, case 3 and a fragmented genome for case 2 were obtained. The sequences of Indian SARS-CoV-2 though not identical showed high (~99.98%) identity with Wuhan seafood market pneumonia virus (accession number: NC 045512). Phylogenetic analysis showed that the Indian sequences belonged to different clusters. Predicted linear B-cell epitopes were found to be concentrated in the S1 domain of spike protein, and a conformational epitope was identified in the receptor-binding domain. The predicted T-cell epitopes showed broad human leucocyte antigen allele coverage of A and B supertypes predominant in the Indian population. INTERPRETATION & CONCLUSIONS: The two SARS-CoV-2 sequences obtained from India represent two different introductions into the country. The genetic heterogeneity is as noted globally. The identified B- and T-cell epitopes may be considered suitable for future experiments towards the design of vaccines and diagnostics. Continuous monitoring and analysis of the sequences of new cases from India and the other affected countries would be vital to understand the genetic evolution and rates of substitution of the SARS-CoV-2.",10.4103/ijmr.ijmr_663_20,vhb280gz,"['BACKGROUND', 'OBJECTIVES', 'Since', 'December', '2019', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'globally', 'affected', '195', 'countries', 'In', 'India', 'suspected', 'cases', 'were', 'screened', 'for', 'SARS', 'CoV', '2', 'as', 'per', 'the', 'advisory', 'of', 'the', 'Ministry', 'of', 'Health', 'and', 'Family', 'Welfare', 'The', 'objective', 'of', 'this', 'study', 'was', 'to', 'characterize', 'SARS', 'CoV', '2', 'sequences', 'from', 'three', 'identified', 'positive', 'cases', 'as', 'on', 'February', '29', '2020', 'METHODS', 'Throat', 'swab', 'nasal', 'swab', 'specimens', 'for', 'a', 'total', 'of', '881', 'suspected', 'cases', 'were', 'screened', 'by', 'E', 'gene', 'and', 'confirmed', 'by', 'RdRp', '1', 'RdRp', '2', 'and', 'N', 'gene', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reactions', 'and', 'next', 'generation', 'sequencing', 'Phylogenetic', 'analysis', 'molecular', 'characterization', 'and', 'prediction', 'of', 'B', 'and', 'T', 'cell', 'epitopes', 'for', 'Indian', 'SARS', 'CoV', '2', 'sequences', 'were', 'undertaken', 'RESULTS', 'Three', 'cases', 'with', 'a', 'travel', 'history', 'from', 'Wuhan', 'China', 'were', 'confirmed', 'positive', 'for', 'SARS', 'CoV', '2', 'Almost', 'complete', '29', '851', 'nucleotides', 'genomes', 'of', 'case', '1', 'case', '3', 'and', 'a', 'fragmented', 'genome', 'for', 'case', '2', 'were', 'obtained', 'The', 'sequences', 'of', 'Indian', 'SARS', 'CoV', '2', 'though', 'not', 'identical', 'showed', 'high', '99', '98', 'identity', 'with', 'Wuhan', 'seafood', 'market', 'pneumonia', 'virus', 'accession', 'number', 'NC', '045512', 'Phylogenetic', 'analysis', 'showed', 'that', 'the', 'Indian', 'sequences', 'belonged', 'to', 'different', 'clusters', 'Predicted', 'linear', 'B', 'cell', 'epitopes', 'were', 'found', 'to', 'be', 'concentrated', 'in', 'the', 'S1', 'domain', 'of', 'spike', 'protein', 'and', 'a', 'conformational', 'epitope', 'was', 'identified', 'in', 'the', 'receptor', 'binding', 'domain', 'The', 'predicted', 'T', 'cell', 'epitopes', 'showed', 'broad', 'human', 'leucocyte', 'antigen', 'allele', 'coverage', 'of', 'A', 'and', 'B', 'supertypes', 'predominant', 'in', 'the', 'Indian', 'population', 'INTERPRETATION', 'CONCLUSIONS', 'The', 'two', 'SARS', 'CoV', '2', 'sequences', 'obtained', 'from', 'India', 'represent', 'two', 'different', 'introductions', 'into', 'the', 'country', 'The', 'genetic', 'heterogeneity', 'is', 'as', 'noted', 'globally', 'The', 'identified', 'B', 'and', 'T', 'cell', 'epitopes', 'may', 'be', 'considered', 'suitable', 'for', 'future', 'experiments', 'towards', 'the', 'design', 'of', 'vaccines', 'and', 'diagnostics', 'Continuous', 'monitoring', 'and', 'analysis', 'of', 'the', 'sequences', 'of', 'new', 'cases', 'from', 'India', 'and', 'the', 'other', 'affected', 'countries', 'would', 'be', 'vital', 'to', 'understand', 'the', 'genetic', 'evolution', 'and', 'rates', 'of', 'substitution', 'of', 'the', 'SARS', 'CoV', '2', '']"
157709,Co-Infections with Influenza and Other Respiratory Viruses,2012-06-29,Respiratory Regulation - The Molecular Approach,https://www.ncbi.nlm.nih.gov/pubmed/22836647/; https://doi.org/10.1007/978-94-007-4549-0_36,"Clinicians often do not consider the presence of more than one viral etiologic agent in respiratory infection, and in many cases they order diagnostics for influenza viruses or recently even only for A(H1N1)2009 virus. However, in a substantial number of patients with a respiratory tract disease, co-infection with various viral pathogens has been confirmed. Although the association between the occurrence of co-infection and substantially higher severity of disease is still unclear, a rapid and proper diagnostics of wide spectrum of viral respiratory pathogens reveals an accurate picture of the disease and is essential for appropriate therapeutic management and control of infection. In the present study we reported five cases of multiple respiratory infection in hospitalized immunosuppressed patients: two double infections with influenza virus (IV) type A/respiratory syncytial virus (RSV) type A and IV type A/coronavirus (CoV) OC43, one infection with four viruses – IV type A/RSV type A and B/CoV OC43, and two cases of mixed infections caused by five viral agents – IV type A and B/RSV type A and B/ parainfluenza type 3 or CoV OC43. Each patient had an underlying chronic disease and received immunosuppressive treatment. Despite a low number of tested specimens, our study shows that the inclusions of multiplex PCR methods for diagnostics of respiratory tract infections and the extension of diagnostic strategies by clinicians to detect viruses other than influenza are very important and make a contribution to identifying the true rate of co-infections and their correlation with the clinical symptoms and severity of disease.",10.1007/978-94-007-4549-0_36,zb8gphr9,"['Clinicians', 'often', 'do', 'not', 'consider', 'the', 'presence', 'of', 'more', 'than', 'one', 'viral', 'etiologic', 'agent', 'in', 'respiratory', 'infection', 'and', 'in', 'many', 'cases', 'they', 'order', 'diagnostics', 'for', 'influenza', 'viruses', 'or', 'recently', 'even', 'only', 'for', 'A', 'H1N1', '2009', 'virus', 'However', 'in', 'a', 'substantial', 'number', 'of', 'patients', 'with', 'a', 'respiratory', 'tract', 'disease', 'co', 'infection', 'with', 'various', 'viral', 'pathogens', 'has', 'been', 'confirmed', 'Although', 'the', 'association', 'between', 'the', 'occurrence', 'of', 'co', 'infection', 'and', 'substantially', 'higher', 'severity', 'of', 'disease', 'is', 'still', 'unclear', 'a', 'rapid', 'and', 'proper', 'diagnostics', 'of', 'wide', 'spectrum', 'of', 'viral', 'respiratory', 'pathogens', 'reveals', 'an', 'accurate', 'picture', 'of', 'the', 'disease', 'and', 'is', 'essential', 'for', 'appropriate', 'therapeutic', 'management', 'and', 'control', 'of', 'infection', 'In', 'the', 'present', 'study', 'we', 'reported', 'five', 'cases', 'of', 'multiple', 'respiratory', 'infection', 'in', 'hospitalized', 'immunosuppressed', 'patients', 'two', 'double', 'infections', 'with', 'influenza', 'virus', 'IV', 'type', 'A', 'respiratory', 'syncytial', 'virus', 'RSV', 'type', 'A', 'and', 'IV', 'type', 'A', 'coronavirus', 'CoV', 'OC43', 'one', 'infection', 'with', 'four', 'viruses', 'IV', 'type', 'A', 'RSV', 'type', 'A', 'and', 'B', 'CoV', 'OC43', 'and', 'two', 'cases', 'of', 'mixed', 'infections', 'caused', 'by', 'five', 'viral', 'agents', 'IV', 'type', 'A', 'and', 'B', 'RSV', 'type', 'A', 'and', 'B', 'parainfluenza', 'type', '3', 'or', 'CoV', 'OC43', 'Each', 'patient', 'had', 'an', 'underlying', 'chronic', 'disease', 'and', 'received', 'immunosuppressive', 'treatment', 'Despite', 'a', 'low', 'number', 'of', 'tested', 'specimens', 'our', 'study', 'shows', 'that', 'the', 'inclusions', 'of', 'multiplex', 'PCR', 'methods', 'for', 'diagnostics', 'of', 'respiratory', 'tract', 'infections', 'and', 'the', 'extension', 'of', 'diagnostic', 'strategies', 'by', 'clinicians', 'to', 'detect', 'viruses', 'other', 'than', 'influenza', 'are', 'very', 'important', 'and', 'make', 'a', 'contribution', 'to', 'identifying', 'the', 'true', 'rate', 'of', 'co', 'infections', 'and', 'their', 'correlation', 'with', 'the', 'clinical', 'symptoms', 'and', 'severity', 'of', 'disease', '']"
157769,Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG,2020-04-29,J Clin Virol,https://doi.org/10.1016/j.jcv.2020.104394; https://api.elsevier.com/content/article/pii/S1386653220301360; https://www.ncbi.nlm.nih.gov/pubmed/32416599/; https://www.sciencedirect.com/science/article/pii/S1386653220301360?v=s5,"Abstract Background Facing the ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is an urgent need for serological assays identifying individuals with past coronavirus disease 2019 (COVID-19). Study Design Our study is the first to compare four new commercially available assays using 75 sera from patients tested positive or negative by SARS-CoV-2 PCR: the anti SARS-CoV-2 ELISA (IgG) (Euroimmun, Germany), the EDI New Coronavirus COVID-19 IgG ELISA, (Epitope diagnostics (EDI), USA), the recomWell SARS-CoV-2 IgG ELISA (Mikrogen, Germany), and the SARS-CoV-2 Virachip IgG (Viramed, Germany). Results We found a sensitivity of 86.4%, 100%, 86.4%, and 77.3% and a specificity of 96,2%, 88,7%, 100%, and 100% for the Euroimmun assay, the EDI assay, the Mikrogen assay, and the Viramed assay, respectively. Conclusions Commercially available SARS-CoV-2 IgG assays have a sufficient specificity and sensitivity for identifying individuals with past SARS-CoV-2 infection.",10.1016/j.jcv.2020.104394,peq6kyyz,"['Abstract', 'Background', 'Facing', 'the', 'ongoing', 'pandemic', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'there', 'is', 'an', 'urgent', 'need', 'for', 'serological', 'assays', 'identifying', 'individuals', 'with', 'past', 'coronavirus', 'disease', '2019', 'COVID', '19', 'Study', 'Design', 'Our', 'study', 'is', 'the', 'first', 'to', 'compare', 'four', 'new', 'commercially', 'available', 'assays', 'using', '75', 'sera', 'from', 'patients', 'tested', 'positive', 'or', 'negative', 'by', 'SARS', 'CoV', '2', 'PCR', 'the', 'anti', 'SARS', 'CoV', '2', 'ELISA', 'IgG', 'Euroimmun', 'Germany', 'the', 'EDI', 'New', 'Coronavirus', 'COVID', '19', 'IgG', 'ELISA', 'Epitope', 'diagnostics', 'EDI', 'USA', 'the', 'recomWell', 'SARS', 'CoV', '2', 'IgG', 'ELISA', 'Mikrogen', 'Germany', 'and', 'the', 'SARS', 'CoV', '2', 'Virachip', 'IgG', 'Viramed', 'Germany', 'Results', 'We', 'found', 'a', 'sensitivity', 'of', '86', '4', '100', '86', '4', 'and', '77', '3', 'and', 'a', 'specificity', 'of', '96', '2', '88', '7', '100', 'and', '100', 'for', 'the', 'Euroimmun', 'assay', 'the', 'EDI', 'assay', 'the', 'Mikrogen', 'assay', 'and', 'the', 'Viramed', 'assay', 'respectively', 'Conclusions', 'Commercially', 'available', 'SARS', 'CoV', '2', 'IgG', 'assays', 'have', 'a', 'sufficient', 'specificity', 'and', 'sensitivity', 'for', 'identifying', 'individuals', 'with', 'past', 'SARS', 'CoV', '2', 'infection', '']"
157851,Respiratory virus surveillance and outbreak investigation,2007-10-31,Journal of Clinical Virology,https://api.elsevier.com/content/article/pii/S1386653207700069; https://www.sciencedirect.com/science/article/pii/S1386653207700069; https://doi.org/10.1016/s1386-6532(07)70006-9; https://www.ncbi.nlm.nih.gov/pubmed/18162251/,"Abstract Sensitive, rapid detection of respiratory viruses is needed for surveillance and for investigation of epidemiologically linked cases. The utility of rapid antigen-based methods for detection of common respiratory viruses and to confirm the cause of outbreaks is well established. However, nucleic acid amplification tests (NATs) offer some benefits above antigen or culture-based procedures, with the main advantages being sensitivity and range of pathogens detectable. It is important to understand how changes in our testing methodology alter respiratory virus detection and information for epidemiological studies. For viruses such as influenza A, influenza B and respiratory syncytial virus, NATs offer enhanced sensitivity above antigen assays but still identify the seasonal peaks important for predicting disease and managing time-sensitive prophylaxis. For other viruses, such as rhinoviruses, coronaviruses, human bocavirus and parainfluenza virus type 4, culture and antigen-based procedures are not available and/or lack sensitivity. Thus such targets would be missed if NATs were not included in testing for surveillance and outbreak investigation. As more respiratory viruses are identified there is a need to expand surveillance and further evaluate new technologies and automation beyond currently-available diagnostics to address detection of a broad range of potential pathogens.",10.1016/s1386-6532(07)70006-9,zgltws0c,"['Abstract', 'Sensitive', 'rapid', 'detection', 'of', 'respiratory', 'viruses', 'is', 'needed', 'for', 'surveillance', 'and', 'for', 'investigation', 'of', 'epidemiologically', 'linked', 'cases', 'The', 'utility', 'of', 'rapid', 'antigen', 'based', 'methods', 'for', 'detection', 'of', 'common', 'respiratory', 'viruses', 'and', 'to', 'confirm', 'the', 'cause', 'of', 'outbreaks', 'is', 'well', 'established', 'However', 'nucleic', 'acid', 'amplification', 'tests', 'NATs', 'offer', 'some', 'benefits', 'above', 'antigen', 'or', 'culture', 'based', 'procedures', 'with', 'the', 'main', 'advantages', 'being', 'sensitivity', 'and', 'range', 'of', 'pathogens', 'detectable', 'It', 'is', 'important', 'to', 'understand', 'how', 'changes', 'in', 'our', 'testing', 'methodology', 'alter', 'respiratory', 'virus', 'detection', 'and', 'information', 'for', 'epidemiological', 'studies', 'For', 'viruses', 'such', 'as', 'influenza', 'A', 'influenza', 'B', 'and', 'respiratory', 'syncytial', 'virus', 'NATs', 'offer', 'enhanced', 'sensitivity', 'above', 'antigen', 'assays', 'but', 'still', 'identify', 'the', 'seasonal', 'peaks', 'important', 'for', 'predicting', 'disease', 'and', 'managing', 'time', 'sensitive', 'prophylaxis', 'For', 'other', 'viruses', 'such', 'as', 'rhinoviruses', 'coronaviruses', 'human', 'bocavirus', 'and', 'parainfluenza', 'virus', 'type', '4', 'culture', 'and', 'antigen', 'based', 'procedures', 'are', 'not', 'available', 'and', 'or', 'lack', 'sensitivity', 'Thus', 'such', 'targets', 'would', 'be', 'missed', 'if', 'NATs', 'were', 'not', 'included', 'in', 'testing', 'for', 'surveillance', 'and', 'outbreak', 'investigation', 'As', 'more', 'respiratory', 'viruses', 'are', 'identified', 'there', 'is', 'a', 'need', 'to', 'expand', 'surveillance', 'and', 'further', 'evaluate', 'new', 'technologies', 'and', 'automation', 'beyond', 'currently', 'available', 'diagnostics', 'to', 'address', 'detection', 'of', 'a', 'broad', 'range', 'of', 'potential', 'pathogens', '']"
158588,Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?,2020-04-28,Cell Immunol,https://doi.org/10.1016/j.cellimm.2020.104114; https://www.ncbi.nlm.nih.gov/pubmed/32361409/; https://www.sciencedirect.com/science/article/pii/S0008874920302501?v=s5; https://api.elsevier.com/content/article/pii/S0008874920302501,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a severe acute respiratory syndrome that is called COVID-19. Clinical manifestations of COVID-19 include diarrhea, pneumonia, lymphopenia, exhausted lymphocytes, and pro-inflammatory cytokine production. Immunology is part of the process of clinical evolution, but there are some questions around immunity-based protection: (1) why some infected people have only mild symptoms of the disease or are asymptomatic; (2) why delayed and weak antibody responses are associated with severe outcomes; and (3) why positivity in molecular tests does not represent protective antibody IgG. Perhaps T cell responses may be the key to solving those questions. SARS-CoV-2-specific memory T cells persist in peripheral blood and may be capable of providing effective information about protective immunity. The T cells studies can be helpful in elucidating the pathways for development of vaccines, therapies, and diagnostics for COVID-19 and for filling these immunology knowledge gaps.",10.1016/j.cellimm.2020.104114,rsz7ch2a,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'induces', 'a', 'severe', 'acute', 'respiratory', 'syndrome', 'that', 'is', 'called', 'COVID', '19', 'Clinical', 'manifestations', 'of', 'COVID', '19', 'include', 'diarrhea', 'pneumonia', 'lymphopenia', 'exhausted', 'lymphocytes', 'and', 'pro', 'inflammatory', 'cytokine', 'production', 'Immunology', 'is', 'part', 'of', 'the', 'process', 'of', 'clinical', 'evolution', 'but', 'there', 'are', 'some', 'questions', 'around', 'immunity', 'based', 'protection', '1', 'why', 'some', 'infected', 'people', 'have', 'only', 'mild', 'symptoms', 'of', 'the', 'disease', 'or', 'are', 'asymptomatic', '2', 'why', 'delayed', 'and', 'weak', 'antibody', 'responses', 'are', 'associated', 'with', 'severe', 'outcomes', 'and', '3', 'why', 'positivity', 'in', 'molecular', 'tests', 'does', 'not', 'represent', 'protective', 'antibody', 'IgG', 'Perhaps', 'T', 'cell', 'responses', 'may', 'be', 'the', 'key', 'to', 'solving', 'those', 'questions', 'SARS', 'CoV', '2', 'specific', 'memory', 'T', 'cells', 'persist', 'in', 'peripheral', 'blood', 'and', 'may', 'be', 'capable', 'of', 'providing', 'effective', 'information', 'about', 'protective', 'immunity', 'The', 'T', 'cells', 'studies', 'can', 'be', 'helpful', 'in', 'elucidating', 'the', 'pathways', 'for', 'development', 'of', 'vaccines', 'therapies', 'and', 'diagnostics', 'for', 'COVID', '19', 'and', 'for', 'filling', 'these', 'immunology', 'knowledge', 'gaps', '']"
158790,Mutational patterns correlate with genome organization in SARS and other coronaviruses,2004-03-31,Trends in Genetics,https://www.ncbi.nlm.nih.gov/pubmed/15049309/; https://www.sciencedirect.com/science/article/pii/S0168952504000241; https://api.elsevier.com/content/article/pii/S0168952504000241,"Abstract Focused efforts by several international laboratories have resulted in the sequencing of the genome of the causative agent of severe acute respiratory syndrome (SARS), novel coronavirus SARS-CoV, in record time. Using cumulative skew diagrams, I found that mutational patterns in the SARS-CoV genome were strikingly different from other coronaviruses in terms of mutation rates, although they were in general agreement with the model of the coronavirus lifecycle. These findings might be relevant for the development of sequence-based diagnostics and the design of agents to treat SARS.",10.1016/j.tig.2004.01.009,g68g6xxu,"['Abstract', 'Focused', 'efforts', 'by', 'several', 'international', 'laboratories', 'have', 'resulted', 'in', 'the', 'sequencing', 'of', 'the', 'genome', 'of', 'the', 'causative', 'agent', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'novel', 'coronavirus', 'SARS', 'CoV', 'in', 'record', 'time', 'Using', 'cumulative', 'skew', 'diagrams', 'I', 'found', 'that', 'mutational', 'patterns', 'in', 'the', 'SARS', 'CoV', 'genome', 'were', 'strikingly', 'different', 'from', 'other', 'coronaviruses', 'in', 'terms', 'of', 'mutation', 'rates', 'although', 'they', 'were', 'in', 'general', 'agreement', 'with', 'the', 'model', 'of', 'the', 'coronavirus', 'lifecycle', 'These', 'findings', 'might', 'be', 'relevant', 'for', 'the', 'development', 'of', 'sequence', 'based', 'diagnostics', 'and', 'the', 'design', 'of', 'agents', 'to', 'treat', 'SARS', '']"
159346,Scalable Transcriptional Analysis Routine—Multiplexed Quantitative Real-Time Polymerase Chain Reaction Platform for Gene Expression Analysis and Molecular Diagnostics,2005-10-31,The Journal of molecular diagnostics : JMD,https://www.ncbi.nlm.nih.gov/pubmed/16237214/,"We report the development of a new technology for simultaneous quantitative detection of multiple targets in a single sample. Scalable transcriptional analysis routine (STAR) represents a novel integration of reverse transcriptase-polymerase chain reaction and capillary electrophoresis that allows detection of dozens of gene transcripts in a multiplexed format using amplicon size as an identifier for each target. STAR demonstrated similar or better sensitivity and precision compared to two commonly used methods, SYBR Green-based and TaqMan probe-based real-time reverse transcriptase-polymerase chain reaction. STAR can be used as a flexible platform for building a variety of applications to monitor gene expression, from single gene assays to assays analyzing the expression level of multiple genes. Using severe acute respiratory syndrome (SARS) corona virus as a model system, STAR technology detected single copies of the viral genome in a two-gene multiplex. Blinded studies using RNA extracted from various tissues of a SARS-infected individual showed that STAR correctly identified all samples containing SARS virus and yielded negative results for non-SARS control samples. Using alternate priming strategies, STAR technology can be adapted to transcriptional profiling studies without requiring a priori sequence information. Thus, STAR technology offers a flexible platform for development of highly multiplexed assays in gene expression analysis and molecular diagnostics.",,qhftb6d7,"['We', 'report', 'the', 'development', 'of', 'a', 'new', 'technology', 'for', 'simultaneous', 'quantitative', 'detection', 'of', 'multiple', 'targets', 'in', 'a', 'single', 'sample', 'Scalable', 'transcriptional', 'analysis', 'routine', 'STAR', 'represents', 'a', 'novel', 'integration', 'of', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'and', 'capillary', 'electrophoresis', 'that', 'allows', 'detection', 'of', 'dozens', 'of', 'gene', 'transcripts', 'in', 'a', 'multiplexed', 'format', 'using', 'amplicon', 'size', 'as', 'an', 'identifier', 'for', 'each', 'target', 'STAR', 'demonstrated', 'similar', 'or', 'better', 'sensitivity', 'and', 'precision', 'compared', 'to', 'two', 'commonly', 'used', 'methods', 'SYBR', 'Green', 'based', 'and', 'TaqMan', 'probe', 'based', 'real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'STAR', 'can', 'be', 'used', 'as', 'a', 'flexible', 'platform', 'for', 'building', 'a', 'variety', 'of', 'applications', 'to', 'monitor', 'gene', 'expression', 'from', 'single', 'gene', 'assays', 'to', 'assays', 'analyzing', 'the', 'expression', 'level', 'of', 'multiple', 'genes', 'Using', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'corona', 'virus', 'as', 'a', 'model', 'system', 'STAR', 'technology', 'detected', 'single', 'copies', 'of', 'the', 'viral', 'genome', 'in', 'a', 'two', 'gene', 'multiplex', 'Blinded', 'studies', 'using', 'RNA', 'extracted', 'from', 'various', 'tissues', 'of', 'a', 'SARS', 'infected', 'individual', 'showed', 'that', 'STAR', 'correctly', 'identified', 'all', 'samples', 'containing', 'SARS', 'virus', 'and', 'yielded', 'negative', 'results', 'for', 'non', 'SARS', 'control', 'samples', 'Using', 'alternate', 'priming', 'strategies', 'STAR', 'technology', 'can', 'be', 'adapted', 'to', 'transcriptional', 'profiling', 'studies', 'without', 'requiring', 'a', 'priori', 'sequence', 'information', 'Thus', 'STAR', 'technology', 'offers', 'a', 'flexible', 'platform', 'for', 'development', 'of', 'highly', 'multiplexed', 'assays', 'in', 'gene', 'expression', 'analysis', 'and', 'molecular', 'diagnostics', '']"
159371,Supporting pandemic response using genomics and bioinformatics: A case study on the emergent SARS‐CoV‐2 outbreak,2020-05-25,Transbound Emerg Dis,https://www.ncbi.nlm.nih.gov/pubmed/32306500/; https://doi.org/10.1111/tbed.13588,"Pre‐clinical responses to fast‐moving infectious disease outbreaks heavily depend on choosing the best isolates for animal models that inform diagnostics, vaccines and treatments. Current approaches are driven by practical considerations (e.g. first available virus isolate) rather than a detailed analysis of the characteristics of the virus strain chosen, which can lead to animal models that are not representative of the circulating or emerging clusters. Here, we suggest a combination of epidemiological, experimental and bioinformatic considerations when choosing virus strains for animal model generation. We discuss the currently chosen SARS‐CoV‐2 strains for international coronavirus disease (COVID‐19) models in the context of their phylogeny as well as in a novel alignment‐free bioinformatic approach. Unlike phylogenetic trees, which focus on individual shared mutations, this new approach assesses genome‐wide co‐developing functionalities and hence offers a more fluid view of the ‘cloud of variances’ that RNA viruses are prone to accumulate. This joint approach concludes that while the current animal models cover the existing viral strains adequately, there is substantial evolutionary activity that is likely not considered by the current models. Based on insights from the non‐discrete alignment‐free approach and experimental observations, we suggest isolates for future animal models.",10.1111/tbed.13588,k8m19by9,"['Pre', 'clinical', 'responses', 'to', 'fast', 'moving', 'infectious', 'disease', 'outbreaks', 'heavily', 'depend', 'on', 'choosing', 'the', 'best', 'isolates', 'for', 'animal', 'models', 'that', 'inform', 'diagnostics', 'vaccines', 'and', 'treatments', 'Current', 'approaches', 'are', 'driven', 'by', 'practical', 'considerations', 'e', 'g', 'first', 'available', 'virus', 'isolate', 'rather', 'than', 'a', 'detailed', 'analysis', 'of', 'the', 'characteristics', 'of', 'the', 'virus', 'strain', 'chosen', 'which', 'can', 'lead', 'to', 'animal', 'models', 'that', 'are', 'not', 'representative', 'of', 'the', 'circulating', 'or', 'emerging', 'clusters', 'Here', 'we', 'suggest', 'a', 'combination', 'of', 'epidemiological', 'experimental', 'and', 'bioinformatic', 'considerations', 'when', 'choosing', 'virus', 'strains', 'for', 'animal', 'model', 'generation', 'We', 'discuss', 'the', 'currently', 'chosen', 'SARS', 'CoV', '2', 'strains', 'for', 'international', 'coronavirus', 'disease', 'COVID', '19', 'models', 'in', 'the', 'context', 'of', 'their', 'phylogeny', 'as', 'well', 'as', 'in', 'a', 'novel', 'alignment', 'free', 'bioinformatic', 'approach', 'Unlike', 'phylogenetic', 'trees', 'which', 'focus', 'on', 'individual', 'shared', 'mutations', 'this', 'new', 'approach', 'assesses', 'genome', 'wide', 'co', 'developing', 'functionalities', 'and', 'hence', 'offers', 'a', 'more', 'fluid', 'view', 'of', 'the', 'cloud', 'of', 'variances', 'that', 'RNA', 'viruses', 'are', 'prone', 'to', 'accumulate', 'This', 'joint', 'approach', 'concludes', 'that', 'while', 'the', 'current', 'animal', 'models', 'cover', 'the', 'existing', 'viral', 'strains', 'adequately', 'there', 'is', 'substantial', 'evolutionary', 'activity', 'that', 'is', 'likely', 'not', 'considered', 'by', 'the', 'current', 'models', 'Based', 'on', 'insights', 'from', 'the', 'non', 'discrete', 'alignment', 'free', 'approach', 'and', 'experimental', 'observations', 'we', 'suggest', 'isolates', 'for', 'future', 'animal', 'models', '']"
159455,"MERS coronavirus: diagnostics, epidemiology and transmission",2015-12-22,Virol J,https://www.ncbi.nlm.nih.gov/pubmed/26695637/; https://doi.org/10.1186/s12985-015-0439-5,"The first known cases of Middle East respiratory syndrome (MERS), associated with infection by a novel coronavirus (CoV), occurred in 2012 in Jordan but were reported retrospectively. The case first to be publicly reported was from Jeddah, in the Kingdom of Saudi Arabia (KSA). Since then, MERS-CoV sequences have been found in a bat and in many dromedary camels (DC). MERS-CoV is enzootic in DC across the Arabian Peninsula and in parts of Africa, causing mild upper respiratory tract illness in its camel reservoir and sporadic, but relatively rare human infections. Precisely how virus transmits to humans remains unknown but close and lengthy exposure appears to be a requirement. The KSA is the focal point of MERS, with the majority of human cases. In humans, MERS is mostly known as a lower respiratory tract (LRT) disease involving fever, cough, breathing difficulties and pneumonia that may progress to acute respiratory distress syndrome, multiorgan failure and death in 20 % to 40 % of those infected. However, MERS-CoV has also been detected in mild and influenza-like illnesses and in those with no signs or symptoms. Older males most obviously suffer severe disease and MERS patients often have comorbidities. Compared to severe acute respiratory syndrome (SARS), another sometimes- fatal zoonotic coronavirus disease that has since disappeared, MERS progresses more rapidly to respiratory failure and acute kidney injury (it also has an affinity for growth in kidney cells under laboratory conditions), is more frequently reported in patients with underlying disease and is more often fatal. Most human cases of MERS have been linked to lapses in infection prevention and control (IPC) in healthcare settings, with approximately 20 % of all virus detections reported among healthcare workers (HCWs) and higher exposures in those with occupations that bring them into close contact with camels. Sero-surveys have found widespread evidence of past infection in adult camels and limited past exposure among humans. Sensitive, validated reverse transcriptase real-time polymerase chain reaction (RT-rtPCR)-based diagnostics have been available almost from the start of the emergence of MERS. While the basic virology of MERS-CoV has advanced over the past three years, understanding of the interplay between camel, environment, and human remains limited. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12985-015-0439-5) contains supplementary material, which is available to authorized users.",10.1186/s12985-015-0439-5,mwj2qby4,"['The', 'first', 'known', 'cases', 'of', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'associated', 'with', 'infection', 'by', 'a', 'novel', 'coronavirus', 'CoV', 'occurred', 'in', '2012', 'in', 'Jordan', 'but', 'were', 'reported', 'retrospectively', 'The', 'case', 'first', 'to', 'be', 'publicly', 'reported', 'was', 'from', 'Jeddah', 'in', 'the', 'Kingdom', 'of', 'Saudi', 'Arabia', 'KSA', 'Since', 'then', 'MERS', 'CoV', 'sequences', 'have', 'been', 'found', 'in', 'a', 'bat', 'and', 'in', 'many', 'dromedary', 'camels', 'DC', 'MERS', 'CoV', 'is', 'enzootic', 'in', 'DC', 'across', 'the', 'Arabian', 'Peninsula', 'and', 'in', 'parts', 'of', 'Africa', 'causing', 'mild', 'upper', 'respiratory', 'tract', 'illness', 'in', 'its', 'camel', 'reservoir', 'and', 'sporadic', 'but', 'relatively', 'rare', 'human', 'infections', 'Precisely', 'how', 'virus', 'transmits', 'to', 'humans', 'remains', 'unknown', 'but', 'close', 'and', 'lengthy', 'exposure', 'appears', 'to', 'be', 'a', 'requirement', 'The', 'KSA', 'is', 'the', 'focal', 'point', 'of', 'MERS', 'with', 'the', 'majority', 'of', 'human', 'cases', 'In', 'humans', 'MERS', 'is', 'mostly', 'known', 'as', 'a', 'lower', 'respiratory', 'tract', 'LRT', 'disease', 'involving', 'fever', 'cough', 'breathing', 'difficulties', 'and', 'pneumonia', 'that', 'may', 'progress', 'to', 'acute', 'respiratory', 'distress', 'syndrome', 'multiorgan', 'failure', 'and', 'death', 'in', '20', 'to', '40', 'of', 'those', 'infected', 'However', 'MERS', 'CoV', 'has', 'also', 'been', 'detected', 'in', 'mild', 'and', 'influenza', 'like', 'illnesses', 'and', 'in', 'those', 'with', 'no', 'signs', 'or', 'symptoms', 'Older', 'males', 'most', 'obviously', 'suffer', 'severe', 'disease', 'and', 'MERS', 'patients', 'often', 'have', 'comorbidities', 'Compared', 'to', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'another', 'sometimes', 'fatal', 'zoonotic', 'coronavirus', 'disease', 'that', 'has', 'since', 'disappeared', 'MERS', 'progresses', 'more', 'rapidly', 'to', 'respiratory', 'failure', 'and', 'acute', 'kidney', 'injury', 'it', 'also', 'has', 'an', 'affinity', 'for', 'growth', 'in', 'kidney', 'cells', 'under', 'laboratory', 'conditions', 'is', 'more', 'frequently', 'reported', 'in', 'patients', 'with', 'underlying', 'disease', 'and', 'is', 'more', 'often', 'fatal', 'Most', 'human', 'cases', 'of', 'MERS', 'have', 'been', 'linked', 'to', 'lapses', 'in', 'infection', 'prevention', 'and', 'control', 'IPC', 'in', 'healthcare', 'settings', 'with', 'approximately', '20', 'of', 'all', 'virus', 'detections', 'reported', 'among', 'healthcare', 'workers', 'HCWs', 'and', 'higher', 'exposures', 'in', 'those', 'with', 'occupations', 'that', 'bring', 'them', 'into', 'close', 'contact', 'with', 'camels', 'Sero', 'surveys', 'have', 'found', 'widespread', 'evidence', 'of', 'past', 'infection', 'in', 'adult', 'camels', 'and', 'limited', 'past', 'exposure', 'among', 'humans', 'Sensitive', 'validated', 'reverse', 'transcriptase', 'real', 'time', 'polymerase', 'chain', 'reaction', 'RT', 'rtPCR', 'based', 'diagnostics', 'have', 'been', 'available', 'almost', 'from', 'the', 'start', 'of', 'the', 'emergence', 'of', 'MERS', 'While', 'the', 'basic', 'virology', 'of', 'MERS', 'CoV', 'has', 'advanced', 'over', 'the', 'past', 'three', 'years', 'understanding', 'of', 'the', 'interplay', 'between', 'camel', 'environment', 'and', 'human', 'remains', 'limited', 'ELECTRONIC', 'SUPPLEMENTARY', 'MATERIAL', 'The', 'online', 'version', 'of', 'this', 'article', 'doi', '10', '1186', 's12985', '015', '0439', '5', 'contains', 'supplementary', 'material', 'which', 'is', 'available', 'to', 'authorized', 'users', '']"
159604,STRATEGIES AND PERSPECTIVES TO DEVELOP SARS-CoV-2 DETECTION METHODS AND DIAGNOSTICS,2020-06-19,Biomed Pharmacother,https://www.sciencedirect.com/science/article/pii/S0753332220306399?v=s5; https://doi.org/10.1016/j.biopha.2020.110446; https://api.elsevier.com/content/article/pii/S0753332220306399,"To develop diagnostics and detection methods, current research is focussed on targeting the detection of coronavirus based on its RNA. Besides the RNA target, research reports are coming to develop diagnostics by targeting structure and other parts of coronavirus. PCR based detection system is widely used and various improvements in the PCR based detection system can be seen in the recent research reports. This review will discuss multiple detection methods for coronavirus for developing appropriate, reliable, and fast alternative detection methods. Considering the current scenario of COVID-19 diagnostics around the world and an urgent need for the development of reliable and cheap diagnostic, various techniques based on CRISPR technology, antibody, MIP, LAMP, microarray, etc. should be discussed and tried.",10.1016/j.biopha.2020.110446,zcmzpat5,"['To', 'develop', 'diagnostics', 'and', 'detection', 'methods', 'current', 'research', 'is', 'focussed', 'on', 'targeting', 'the', 'detection', 'of', 'coronavirus', 'based', 'on', 'its', 'RNA', 'Besides', 'the', 'RNA', 'target', 'research', 'reports', 'are', 'coming', 'to', 'develop', 'diagnostics', 'by', 'targeting', 'structure', 'and', 'other', 'parts', 'of', 'coronavirus', 'PCR', 'based', 'detection', 'system', 'is', 'widely', 'used', 'and', 'various', 'improvements', 'in', 'the', 'PCR', 'based', 'detection', 'system', 'can', 'be', 'seen', 'in', 'the', 'recent', 'research', 'reports', 'This', 'review', 'will', 'discuss', 'multiple', 'detection', 'methods', 'for', 'coronavirus', 'for', 'developing', 'appropriate', 'reliable', 'and', 'fast', 'alternative', 'detection', 'methods', 'Considering', 'the', 'current', 'scenario', 'of', 'COVID', '19', 'diagnostics', 'around', 'the', 'world', 'and', 'an', 'urgent', 'need', 'for', 'the', 'development', 'of', 'reliable', 'and', 'cheap', 'diagnostic', 'various', 'techniques', 'based', 'on', 'CRISPR', 'technology', 'antibody', 'MIP', 'LAMP', 'microarray', 'etc', 'should', 'be', 'discussed', 'and', 'tried', '']"
160009,Rare and Emerging Viral Infections in Transplant Recipients,2013-10-15,Clin Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/23839998/; https://doi.org/10.1093/cid/cit456,"Emerging viral pathogens include newly discovered viruses as well as previously known viruses that are either increasing, or threatening to increase in incidence. While often first identified in the general population, they may affect transplant recipients, in whom their manifestations may be atypical or more severe. Enhanced molecular methods have increased the rate of viral discovery but have not overcome the problem of demonstrating pathogenicity. At the same time, improved clinical diagnostic methods have increased the detection of reemerging viruses in immunocompromised patients. In this review, we first discuss viral diagnostics and the developing field of viral discovery and then focus on rare and emerging viruses in the transplant population: human T-cell leukemia virus type 1; hepatitis E virus; bocavirus; KI and WU polyomaviruses; coronaviruses HKU1 and NL63; influenza, H1N1; measles; dengue; rabies; and lymphocytic choriomeningitis virus. Detection and reporting of such rare pathogens in transplant recipients is critical to patient care and improving our understanding of posttransplant infections.",10.1093/cid/cit456,98o0dssj,"['Emerging', 'viral', 'pathogens', 'include', 'newly', 'discovered', 'viruses', 'as', 'well', 'as', 'previously', 'known', 'viruses', 'that', 'are', 'either', 'increasing', 'or', 'threatening', 'to', 'increase', 'in', 'incidence', 'While', 'often', 'first', 'identified', 'in', 'the', 'general', 'population', 'they', 'may', 'affect', 'transplant', 'recipients', 'in', 'whom', 'their', 'manifestations', 'may', 'be', 'atypical', 'or', 'more', 'severe', 'Enhanced', 'molecular', 'methods', 'have', 'increased', 'the', 'rate', 'of', 'viral', 'discovery', 'but', 'have', 'not', 'overcome', 'the', 'problem', 'of', 'demonstrating', 'pathogenicity', 'At', 'the', 'same', 'time', 'improved', 'clinical', 'diagnostic', 'methods', 'have', 'increased', 'the', 'detection', 'of', 'reemerging', 'viruses', 'in', 'immunocompromised', 'patients', 'In', 'this', 'review', 'we', 'first', 'discuss', 'viral', 'diagnostics', 'and', 'the', 'developing', 'field', 'of', 'viral', 'discovery', 'and', 'then', 'focus', 'on', 'rare', 'and', 'emerging', 'viruses', 'in', 'the', 'transplant', 'population', 'human', 'T', 'cell', 'leukemia', 'virus', 'type', '1', 'hepatitis', 'E', 'virus', 'bocavirus', 'KI', 'and', 'WU', 'polyomaviruses', 'coronaviruses', 'HKU1', 'and', 'NL63', 'influenza', 'H1N1', 'measles', 'dengue', 'rabies', 'and', 'lymphocytic', 'choriomeningitis', 'virus', 'Detection', 'and', 'reporting', 'of', 'such', 'rare', 'pathogens', 'in', 'transplant', 'recipients', 'is', 'critical', 'to', 'patient', 'care', 'and', 'improving', 'our', 'understanding', 'of', 'posttransplant', 'infections', '']"
160222,Diagnostic accuracy of an automated chemiluminescent immunoassay for anti‐SARS‐CoV‐2 IgM and IgG antibodies: an Italian experience,2020-05-10,J Med Virol,https://www.ncbi.nlm.nih.gov/pubmed/32330291/; https://doi.org/10.1002/jmv.25932,"A pandemic of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been spreading throughout the world. Though molecular diagnostic tests are the gold standard for COVID‐19, serological testing is emerging as a potential surveillance tool, in addition to its complementary role in COVID‐19 diagnostics. Indubitably quantitative serological testing provides greater advantages than qualitative tests but today there is still little known about serological diagnostics and what the most appropriate role quantitative tests might play. Sixty‐one COVID‐19 patients and 64 patients from a control group were tested by iFlash1800 CLIA analyzer for anti‐SARS CoV‐2 antibodies IgM and IgG. All COVID‐19 patients were hospitalized in San Giovanni di Dio Hospital (Florence, Italy) and had a positive oro/nasopharyngeal swab reverse‐transcription polymerase chain reaction result. The highest sensitivity with a very good specificity performance was reached at a cutoff value of 10.0 AU/mL for IgM and of 7.1 for IgG antibodies, hence near to the manufacturer's cutoff values of 10 AU/mL for both isotypes. The receiver operating characteristic curves showed area under the curve values of 0.918 and 0.980 for anti‐SARS CoV‐2 antibodies IgM and IgG, respectively. iFlash1800 CLIA analyzer has shown highly accurate results for the anti‐SARS‐CoV‐2 antibodies profile and can be considered an excellent tool for COVID‐19 diagnostics.",10.1002/jmv.25932,px4fe7mn,"['A', 'pandemic', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'been', 'spreading', 'throughout', 'the', 'world', 'Though', 'molecular', 'diagnostic', 'tests', 'are', 'the', 'gold', 'standard', 'for', 'COVID', '19', 'serological', 'testing', 'is', 'emerging', 'as', 'a', 'potential', 'surveillance', 'tool', 'in', 'addition', 'to', 'its', 'complementary', 'role', 'in', 'COVID', '19', 'diagnostics', 'Indubitably', 'quantitative', 'serological', 'testing', 'provides', 'greater', 'advantages', 'than', 'qualitative', 'tests', 'but', 'today', 'there', 'is', 'still', 'little', 'known', 'about', 'serological', 'diagnostics', 'and', 'what', 'the', 'most', 'appropriate', 'role', 'quantitative', 'tests', 'might', 'play', 'Sixty', 'one', 'COVID', '19', 'patients', 'and', '64', 'patients', 'from', 'a', 'control', 'group', 'were', 'tested', 'by', 'iFlash1800', 'CLIA', 'analyzer', 'for', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'IgM', 'and', 'IgG', 'All', 'COVID', '19', 'patients', 'were', 'hospitalized', 'in', 'San', 'Giovanni', 'di', 'Dio', 'Hospital', 'Florence', 'Italy', 'and', 'had', 'a', 'positive', 'oro', 'nasopharyngeal', 'swab', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'result', 'The', 'highest', 'sensitivity', 'with', 'a', 'very', 'good', 'specificity', 'performance', 'was', 'reached', 'at', 'a', 'cutoff', 'value', 'of', '10', '0', 'AU', 'mL', 'for', 'IgM', 'and', 'of', '7', '1', 'for', 'IgG', 'antibodies', 'hence', 'near', 'to', 'the', 'manufacturer', 's', 'cutoff', 'values', 'of', '10', 'AU', 'mL', 'for', 'both', 'isotypes', 'The', 'receiver', 'operating', 'characteristic', 'curves', 'showed', 'area', 'under', 'the', 'curve', 'values', 'of', '0', '918', 'and', '0', '980', 'for', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'IgM', 'and', 'IgG', 'respectively', 'iFlash1800', 'CLIA', 'analyzer', 'has', 'shown', 'highly', 'accurate', 'results', 'for', 'the', 'anti', 'SARS', 'CoV', '2', 'antibodies', 'profile', 'and', 'can', 'be', 'considered', 'an', 'excellent', 'tool', 'for', 'COVID', '19', 'diagnostics', '']"
160414,RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice,2019-03-22,Clin Transplant,https://doi.org/10.1111/ctr.13511; https://www.ncbi.nlm.nih.gov/pubmed/30817023/,"These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of RNA respiratory viral infections in the pre‐ and post‐transplant period. Viruses reviewed include influenza, respiratory syncytial virus (RSV), parainfluenza, rhinovirus, human metapneumovirus (hMPV), and coronavirus. Diagnosis is by nucleic acid testing due to improved sensitivity, specificity, broad range of detection of viral pathogens, automatization, and turnaround time. Respiratory viral infections may be associated with acute rejection and chronic lung allograft dysfunction in lung transplant recipients. The cornerstone of influenza prevention is annual vaccination and in some cases antiviral prophylaxis. Treatment with neuraminidase inhibitors and other antivirals is reviewed. Prevention of RSV is limited to prophylaxis with palivizumab in select children. Therapy of RSV upper or lower tract disease is controversial but may include oral or aerosolized ribavirin in some populations. There are no approved vaccines or licensed antivirals for parainfluenza, rhinovirus, hMPV, and coronavirus. Potential management strategies for these viruses are given. Future studies should include prospective trials using contemporary molecular diagnostics to understand the true epidemiology, clinical spectrum, and long‐term consequences of respiratory viruses as well as to define preventative and therapeutic measures.",10.1111/ctr.13511,6musyeez,"['These', 'updated', 'guidelines', 'from', 'the', 'Infectious', 'Diseases', 'Community', 'of', 'Practice', 'of', 'the', 'American', 'Society', 'of', 'Transplantation', 'review', 'the', 'diagnosis', 'prevention', 'and', 'management', 'of', 'RNA', 'respiratory', 'viral', 'infections', 'in', 'the', 'pre', 'and', 'post', 'transplant', 'period', 'Viruses', 'reviewed', 'include', 'influenza', 'respiratory', 'syncytial', 'virus', 'RSV', 'parainfluenza', 'rhinovirus', 'human', 'metapneumovirus', 'hMPV', 'and', 'coronavirus', 'Diagnosis', 'is', 'by', 'nucleic', 'acid', 'testing', 'due', 'to', 'improved', 'sensitivity', 'specificity', 'broad', 'range', 'of', 'detection', 'of', 'viral', 'pathogens', 'automatization', 'and', 'turnaround', 'time', 'Respiratory', 'viral', 'infections', 'may', 'be', 'associated', 'with', 'acute', 'rejection', 'and', 'chronic', 'lung', 'allograft', 'dysfunction', 'in', 'lung', 'transplant', 'recipients', 'The', 'cornerstone', 'of', 'influenza', 'prevention', 'is', 'annual', 'vaccination', 'and', 'in', 'some', 'cases', 'antiviral', 'prophylaxis', 'Treatment', 'with', 'neuraminidase', 'inhibitors', 'and', 'other', 'antivirals', 'is', 'reviewed', 'Prevention', 'of', 'RSV', 'is', 'limited', 'to', 'prophylaxis', 'with', 'palivizumab', 'in', 'select', 'children', 'Therapy', 'of', 'RSV', 'upper', 'or', 'lower', 'tract', 'disease', 'is', 'controversial', 'but', 'may', 'include', 'oral', 'or', 'aerosolized', 'ribavirin', 'in', 'some', 'populations', 'There', 'are', 'no', 'approved', 'vaccines', 'or', 'licensed', 'antivirals', 'for', 'parainfluenza', 'rhinovirus', 'hMPV', 'and', 'coronavirus', 'Potential', 'management', 'strategies', 'for', 'these', 'viruses', 'are', 'given', 'Future', 'studies', 'should', 'include', 'prospective', 'trials', 'using', 'contemporary', 'molecular', 'diagnostics', 'to', 'understand', 'the', 'true', 'epidemiology', 'clinical', 'spectrum', 'and', 'long', 'term', 'consequences', 'of', 'respiratory', 'viruses', 'as', 'well', 'as', 'to', 'define', 'preventative', 'and', 'therapeutic', 'measures', '']"
161002,First international external quality assessment of molecular diagnostics for Mers-CoV,2015-08-31,Journal of Clinical Virology,https://doi.org/10.1016/j.jcv.2015.05.022; https://www.sciencedirect.com/science/article/pii/S1386653215001675; https://www.ncbi.nlm.nih.gov/pubmed/26209385/; https://api.elsevier.com/content/article/pii/S1386653215001675,"Abstract Background Since the discovery of Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, diagnostic protocols were quickly published and deployed globally. Objectives We set out to assess the quality of MERS-CoV molecular diagnostics worldwide. Study design Both sensitivity and specificity were assessed using 12 samples containing different viral loads of MERS-CoV or common coronaviruses (OC43, 229E, NL63, HKU1). Results The panel was sent to more than 106 participants, of which 99 laboratories from 6 continents returned 189 panel results.Scores ranged from 100% (84 laboratories) to 33% (1 laboratory). 15% of respondents reported quantitative results, 61% semi-quantitative (Ct-values or time to positivity) and 24% reported qualitative results. The major specific technique used was real-time RT-PCR using the WHO recommended targets upE, ORF1a and ORF1b. The evaluation confirmed that RT-PCRs targeting the ORF1b are less sensitive, and therefore not advised for primary diagnostics. Conclusions The first external quality assessment MERS-CoV panel gives a good insight in molecular diagnostic techniques and their performances for sensitive and specific detection of MERS-CoV RNA globally. Overall, all laboratories were capable of detecting MERS-CoV with some differences in sensitivity. The observation that 8% of laboratories reported false MERS-CoV positive single assay results shows room for improvement, and the importance of using confirmatory targets.",10.1016/j.jcv.2015.05.022,s95ryhiu,"['Abstract', 'Background', 'Since', 'the', 'discovery', 'of', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'in', '2012', 'diagnostic', 'protocols', 'were', 'quickly', 'published', 'and', 'deployed', 'globally', 'Objectives', 'We', 'set', 'out', 'to', 'assess', 'the', 'quality', 'of', 'MERS', 'CoV', 'molecular', 'diagnostics', 'worldwide', 'Study', 'design', 'Both', 'sensitivity', 'and', 'specificity', 'were', 'assessed', 'using', '12', 'samples', 'containing', 'different', 'viral', 'loads', 'of', 'MERS', 'CoV', 'or', 'common', 'coronaviruses', 'OC43', '229E', 'NL63', 'HKU1', 'Results', 'The', 'panel', 'was', 'sent', 'to', 'more', 'than', '106', 'participants', 'of', 'which', '99', 'laboratories', 'from', '6', 'continents', 'returned', '189', 'panel', 'results', 'Scores', 'ranged', 'from', '100', '84', 'laboratories', 'to', '33', '1', 'laboratory', '15', 'of', 'respondents', 'reported', 'quantitative', 'results', '61', 'semi', 'quantitative', 'Ct', 'values', 'or', 'time', 'to', 'positivity', 'and', '24', 'reported', 'qualitative', 'results', 'The', 'major', 'specific', 'technique', 'used', 'was', 'real', 'time', 'RT', 'PCR', 'using', 'the', 'WHO', 'recommended', 'targets', 'upE', 'ORF1a', 'and', 'ORF1b', 'The', 'evaluation', 'confirmed', 'that', 'RT', 'PCRs', 'targeting', 'the', 'ORF1b', 'are', 'less', 'sensitive', 'and', 'therefore', 'not', 'advised', 'for', 'primary', 'diagnostics', 'Conclusions', 'The', 'first', 'external', 'quality', 'assessment', 'MERS', 'CoV', 'panel', 'gives', 'a', 'good', 'insight', 'in', 'molecular', 'diagnostic', 'techniques', 'and', 'their', 'performances', 'for', 'sensitive', 'and', 'specific', 'detection', 'of', 'MERS', 'CoV', 'RNA', 'globally', 'Overall', 'all', 'laboratories', 'were', 'capable', 'of', 'detecting', 'MERS', 'CoV', 'with', 'some', 'differences', 'in', 'sensitivity', 'The', 'observation', 'that', '8', 'of', 'laboratories', 'reported', 'false', 'MERS', 'CoV', 'positive', 'single', 'assay', 'results', 'shows', 'room', 'for', 'improvement', 'and', 'the', 'importance', 'of', 'using', 'confirmatory', 'targets', '']"
161425,Diagnostics of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid antigen using chicken immunoglobulin Y,2012-03-01,Poultry Science,https://doi.org/10.3382/ps.2011-01916; https://api.elsevier.com/content/article/pii/S0032579119402265; https://www.sciencedirect.com/science/article/pii/S0032579119402265; https://www.ncbi.nlm.nih.gov/pubmed/22334738/,"Abstract The goal of this study was to develop a quantitative detection system for severe acute respiratory syndrome-associated coronavirus (SARS-CoV), targeting the nucleocapsid protein (NP), to determine the presence and degree of infection in suspected individuals. Because the NP is the viral protein shed during infection and its template mRNA is the most abundant subgenomic RNA, it is a suitable candidate for developing antibodies for diagnostic applications. In this study, we have prepared full-length SARS-CoV NP expressed in Escherichia coli and purified. Full-length NP was used for the preparation of mouse monoclonal antibody and chicken polyclonal IgY antibodies for the development of heterosandwich ELISA for early diagnostics of SARS-suspected individuals. The sensitivity of the developed heterosandwich ELISA can detect the viral antigen at 18.5 pg/mL of recombinant NP. This study describes ultrasensitive ELISA using 19B6 monoclonal antibody as the capture antibody and IgY as the detecting antibody against the most abundant SARS-CoV NP antigens. One of the most important findings was the use of inexpensive polyclonal IgY antibody to increase the sensitivity of the detection system for SARS-CoV at the picogram level. Furthermore, the immunoassay of SARS-CoV NP antigen developed could be an effective and sensitive method of diagnosing SARS-suspected individuals during a future SARS-CoV outbreak.",10.3382/ps.2011-01916,faymgnts,"['Abstract', 'The', 'goal', 'of', 'this', 'study', 'was', 'to', 'develop', 'a', 'quantitative', 'detection', 'system', 'for', 'severe', 'acute', 'respiratory', 'syndrome', 'associated', 'coronavirus', 'SARS', 'CoV', 'targeting', 'the', 'nucleocapsid', 'protein', 'NP', 'to', 'determine', 'the', 'presence', 'and', 'degree', 'of', 'infection', 'in', 'suspected', 'individuals', 'Because', 'the', 'NP', 'is', 'the', 'viral', 'protein', 'shed', 'during', 'infection', 'and', 'its', 'template', 'mRNA', 'is', 'the', 'most', 'abundant', 'subgenomic', 'RNA', 'it', 'is', 'a', 'suitable', 'candidate', 'for', 'developing', 'antibodies', 'for', 'diagnostic', 'applications', 'In', 'this', 'study', 'we', 'have', 'prepared', 'full', 'length', 'SARS', 'CoV', 'NP', 'expressed', 'in', 'Escherichia', 'coli', 'and', 'purified', 'Full', 'length', 'NP', 'was', 'used', 'for', 'the', 'preparation', 'of', 'mouse', 'monoclonal', 'antibody', 'and', 'chicken', 'polyclonal', 'IgY', 'antibodies', 'for', 'the', 'development', 'of', 'heterosandwich', 'ELISA', 'for', 'early', 'diagnostics', 'of', 'SARS', 'suspected', 'individuals', 'The', 'sensitivity', 'of', 'the', 'developed', 'heterosandwich', 'ELISA', 'can', 'detect', 'the', 'viral', 'antigen', 'at', '18', '5', 'pg', 'mL', 'of', 'recombinant', 'NP', 'This', 'study', 'describes', 'ultrasensitive', 'ELISA', 'using', '19B6', 'monoclonal', 'antibody', 'as', 'the', 'capture', 'antibody', 'and', 'IgY', 'as', 'the', 'detecting', 'antibody', 'against', 'the', 'most', 'abundant', 'SARS', 'CoV', 'NP', 'antigens', 'One', 'of', 'the', 'most', 'important', 'findings', 'was', 'the', 'use', 'of', 'inexpensive', 'polyclonal', 'IgY', 'antibody', 'to', 'increase', 'the', 'sensitivity', 'of', 'the', 'detection', 'system', 'for', 'SARS', 'CoV', 'at', 'the', 'picogram', 'level', 'Furthermore', 'the', 'immunoassay', 'of', 'SARS', 'CoV', 'NP', 'antigen', 'developed', 'could', 'be', 'an', 'effective', 'and', 'sensitive', 'method', 'of', 'diagnosing', 'SARS', 'suspected', 'individuals', 'during', 'a', 'future', 'SARS', 'CoV', 'outbreak', '']"
162435,Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes,2020-02-02,bioRxiv,https://doi.org/10.1101/2020.01.31.928796; https://www.ncbi.nlm.nih.gov/pubmed/32511309/,"Genome Detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present The Genome Detective Coronavirus Typing Tool that can accurately identify novel coronavirus (2019-nCoV) sequences isolated in China and around the world. The tool can accept up to 2,000 sequences per submission and the analysis of a new whole genome sequence will take approximately one minute. The tool has been tested and validated with hundreds of whole genomes from ten coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for 2019-nCoV. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines.",10.1101/2020.01.31.928796,gxstlzuk,"['Genome', 'Detective', 'is', 'a', 'web', 'based', 'user', 'friendly', 'software', 'application', 'to', 'quickly', 'and', 'accurately', 'assemble', 'all', 'known', 'virus', 'genomes', 'from', 'next', 'generation', 'sequencing', 'datasets', 'This', 'application', 'allows', 'the', 'identification', 'of', 'phylogenetic', 'clusters', 'and', 'genotypes', 'from', 'assembled', 'genomes', 'in', 'FASTA', 'format', 'Since', 'its', 'release', 'in', '2019', 'we', 'have', 'produced', 'a', 'number', 'of', 'typing', 'tools', 'for', 'emergent', 'viruses', 'that', 'have', 'caused', 'large', 'outbreaks', 'such', 'as', 'Zika', 'and', 'Yellow', 'Fever', 'Virus', 'in', 'Brazil', 'Here', 'we', 'present', 'The', 'Genome', 'Detective', 'Coronavirus', 'Typing', 'Tool', 'that', 'can', 'accurately', 'identify', 'novel', 'coronavirus', '2019', 'nCoV', 'sequences', 'isolated', 'in', 'China', 'and', 'around', 'the', 'world', 'The', 'tool', 'can', 'accept', 'up', 'to', '2', '000', 'sequences', 'per', 'submission', 'and', 'the', 'analysis', 'of', 'a', 'new', 'whole', 'genome', 'sequence', 'will', 'take', 'approximately', 'one', 'minute', 'The', 'tool', 'has', 'been', 'tested', 'and', 'validated', 'with', 'hundreds', 'of', 'whole', 'genomes', 'from', 'ten', 'coronavirus', 'species', 'and', 'correctly', 'classified', 'all', 'of', 'the', 'SARS', 'related', 'coronavirus', 'SARSr', 'CoV', 'and', 'all', 'of', 'the', 'available', 'public', 'data', 'for', '2019', 'nCoV', 'The', 'tool', 'also', 'allows', 'tracking', 'of', 'new', 'viral', 'mutations', 'as', 'the', 'outbreak', 'expands', 'globally', 'which', 'may', 'help', 'to', 'accelerate', 'the', 'development', 'of', 'novel', 'diagnostics', 'drugs', 'and', 'vaccines', '']"
164417,Prevalence of antibodies against transmissible gastroenteritis virus (TGEV) in Hungary,2018-11-02,Vet Anim Sci,https://doi.org/10.1016/j.vas.2018.11.003; https://www.sciencedirect.com/science/article/pii/S2451943X18300620; https://www.ncbi.nlm.nih.gov/pubmed/32289094/; https://api.elsevier.com/content/article/pii/S2451943X18300620,"Transmissible gastroenteritis (TGE) is a highly contagious enteric disease of swine, which became infrequent with the appearance of porcine respiratory coronavirus (PRCV). TGE was last reported in Hungary in 2013 and the virus has not been found since, therefore a serological survey was planned to estimate the level of protection against it. 908 sera of sows from 93 farms were selected together with 174 archive samples from one farm covering a wider age group. All samples were screened with an indirect immunofluorescence (IF) test with a positive result of 15.42% and 17.82%, respectively. All IF-positive samples were examined with a commercial ELISA, revealing seropositivity against PRCV in almost all cases. These findings should serve as a recommendation to not omit TGE from the diagnostics of diarrhoea in swine.",10.1016/j.vas.2018.11.003,4xhcamks,"['Transmissible', 'gastroenteritis', 'TGE', 'is', 'a', 'highly', 'contagious', 'enteric', 'disease', 'of', 'swine', 'which', 'became', 'infrequent', 'with', 'the', 'appearance', 'of', 'porcine', 'respiratory', 'coronavirus', 'PRCV', 'TGE', 'was', 'last', 'reported', 'in', 'Hungary', 'in', '2013', 'and', 'the', 'virus', 'has', 'not', 'been', 'found', 'since', 'therefore', 'a', 'serological', 'survey', 'was', 'planned', 'to', 'estimate', 'the', 'level', 'of', 'protection', 'against', 'it', '908', 'sera', 'of', 'sows', 'from', '93', 'farms', 'were', 'selected', 'together', 'with', '174', 'archive', 'samples', 'from', 'one', 'farm', 'covering', 'a', 'wider', 'age', 'group', 'All', 'samples', 'were', 'screened', 'with', 'an', 'indirect', 'immunofluorescence', 'IF', 'test', 'with', 'a', 'positive', 'result', 'of', '15', '42', 'and', '17', '82', 'respectively', 'All', 'IF', 'positive', 'samples', 'were', 'examined', 'with', 'a', 'commercial', 'ELISA', 'revealing', 'seropositivity', 'against', 'PRCV', 'in', 'almost', 'all', 'cases', 'These', 'findings', 'should', 'serve', 'as', 'a', 'recommendation', 'to', 'not', 'omit', 'TGE', 'from', 'the', 'diagnostics', 'of', 'diarrhoea', 'in', 'swine', '']"
165348,Metagenomic Sequencing Detects Respiratory Pathogens in Hematopoietic Cellular Transplant Patients,2017-01-24,bioRxiv,https://doi.org/10.1101/102798,"Current microbiologic diagnostics often fail to identify the etiology of lower respiratory tract infections (LRTI) in hematopoietic cellular transplant recipients (HCT), which precludes the implementation of targeted therapies. To address the need for improved LRTI diagnostics, we evaluated the utility of metagenomic next generation sequencing (mNGS) of bronchoalveolar lavage (BAL) to detect microbial pathogens in HCT patients with acute respiratory illnesses. We enrolled 22 post-HCT adults ages 19-69 years with acute respiratory illnesses who underwent BAL at the University of Michigan between January 2012 and May 2013. mNGS was performed on BAL fluid to detect microbes and simultaneously assess the host transcriptional response. Results were compared against conventional microbiologic assays. mNGS demonstrated 100% sensitivity for detecting respiratory microbes (human metapneumovirus, respiratory syncytial virus, Stenotrophomonas maltophilia, human herpesvirus 6 and cytomegalovirus) when compared to standard testing. Previously unrecognized LRTI pathogens were identified in six patients for whom standard testing was negative (human coronavirus 229E, human rhinovirus A, Corynebacterium propinquum and Streptococcus mitis); findings were confirmed by independent PCR and 16S rRNA sequencing. Relative to patients without infection, patients with infection had increased expression of immunity related genes (p=0.022) and significantly lower diversity of their respiratory microbiome (p=0.017). Compared to conventional diagnostics, mNGS enhanced detection of pathogens in BAL fluid from HCT patients. Furthermore, our results suggest that combining unbiased microbial pathogen detection with assessment of host gene biomarkers of immune response may hold promise for enhancing the diagnosis of post-HCT respiratory infections.",10.1101/102798,km0b1z64,"['Current', 'microbiologic', 'diagnostics', 'often', 'fail', 'to', 'identify', 'the', 'etiology', 'of', 'lower', 'respiratory', 'tract', 'infections', 'LRTI', 'in', 'hematopoietic', 'cellular', 'transplant', 'recipients', 'HCT', 'which', 'precludes', 'the', 'implementation', 'of', 'targeted', 'therapies', 'To', 'address', 'the', 'need', 'for', 'improved', 'LRTI', 'diagnostics', 'we', 'evaluated', 'the', 'utility', 'of', 'metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'of', 'bronchoalveolar', 'lavage', 'BAL', 'to', 'detect', 'microbial', 'pathogens', 'in', 'HCT', 'patients', 'with', 'acute', 'respiratory', 'illnesses', 'We', 'enrolled', '22', 'post', 'HCT', 'adults', 'ages', '19', '69', 'years', 'with', 'acute', 'respiratory', 'illnesses', 'who', 'underwent', 'BAL', 'at', 'the', 'University', 'of', 'Michigan', 'between', 'January', '2012', 'and', 'May', '2013', 'mNGS', 'was', 'performed', 'on', 'BAL', 'fluid', 'to', 'detect', 'microbes', 'and', 'simultaneously', 'assess', 'the', 'host', 'transcriptional', 'response', 'Results', 'were', 'compared', 'against', 'conventional', 'microbiologic', 'assays', 'mNGS', 'demonstrated', '100', 'sensitivity', 'for', 'detecting', 'respiratory', 'microbes', 'human', 'metapneumovirus', 'respiratory', 'syncytial', 'virus', 'Stenotrophomonas', 'maltophilia', 'human', 'herpesvirus', '6', 'and', 'cytomegalovirus', 'when', 'compared', 'to', 'standard', 'testing', 'Previously', 'unrecognized', 'LRTI', 'pathogens', 'were', 'identified', 'in', 'six', 'patients', 'for', 'whom', 'standard', 'testing', 'was', 'negative', 'human', 'coronavirus', '229E', 'human', 'rhinovirus', 'A', 'Corynebacterium', 'propinquum', 'and', 'Streptococcus', 'mitis', 'findings', 'were', 'confirmed', 'by', 'independent', 'PCR', 'and', '16S', 'rRNA', 'sequencing', 'Relative', 'to', 'patients', 'without', 'infection', 'patients', 'with', 'infection', 'had', 'increased', 'expression', 'of', 'immunity', 'related', 'genes', 'p', '0', '022', 'and', 'significantly', 'lower', 'diversity', 'of', 'their', 'respiratory', 'microbiome', 'p', '0', '017', 'Compared', 'to', 'conventional', 'diagnostics', 'mNGS', 'enhanced', 'detection', 'of', 'pathogens', 'in', 'BAL', 'fluid', 'from', 'HCT', 'patients', 'Furthermore', 'our', 'results', 'suggest', 'that', 'combining', 'unbiased', 'microbial', 'pathogen', 'detection', 'with', 'assessment', 'of', 'host', 'gene', 'biomarkers', 'of', 'immune', 'response', 'may', 'hold', 'promise', 'for', 'enhancing', 'the', 'diagnosis', 'of', 'post', 'HCT', 'respiratory', 'infections', '']"
165464,Mechanisms of viral impact on asthma exacerbations,2004-02-29,Journal of Allergy and Clinical Immunology,https://api.elsevier.com/content/article/pii/S0091674904004245; https://www.sciencedirect.com/science/article/pii/S0091674904004245,"Abstract Rationale Respiratory viruses are a frequent cause of wheezing in infants and children. 60 - 85% of asthma exacerbations in children and up to 50% of asthma exacerbations in adults are attributed to respiratory viruses. Previous studies investigated the role of rhinoviruses, RS-viruses and adenoviruses in development of asthma exacerbations in children hospitalized in the clinic of the Institute of Immunology (Moscow, Russia). Rhinovirus was the most frequently detected – 33 samples (24.8% of all tested samples), adenovirus – 5 samples (3.8%), RSV– 4 samples (3.0%), and mixed infections (rhinovirus and RSV) – 1 sample (0.7%). Among positive samples rhinovirus accounted for 76.7%, adenovirus - 11.6%, RSV - 9.3%, and mixed infection - 2.3%. Methods Primers for PCR diagnostics of Parainfluenza viruses of 1, 2 and 3 type and coronaviruses OC43 and 229E were developed. Investigation of HLA-alleles and genotypes was conducted in patients with virus-induced bronchial asthma to reveal HLA-associated markers of susceptibility to viral-induced asthma. Results An increased frequency of HLA-DRB1∗13 specificity and reduced frequencies of HLA-DRB1∗04 and HLA-DRB1∗11 specificities were noted in the viral-induced asthmatics compared to the healthy control group. A minimal increase of HLA-DRB1 homozygotes - 21% was also noted in comparison with the control group - 14%. Conclusions Investigation of HLA-haplotype in patients with viral-induced outbreaks of asthma via HLA-genotyping may reveal more evident associations between HLA-haplotypes and individual respiratory viral infections.",10.1016/j.jaci.2004.01.419,d7nj2cdm,"['Abstract', 'Rationale', 'Respiratory', 'viruses', 'are', 'a', 'frequent', 'cause', 'of', 'wheezing', 'in', 'infants', 'and', 'children', '60', '85', 'of', 'asthma', 'exacerbations', 'in', 'children', 'and', 'up', 'to', '50', 'of', 'asthma', 'exacerbations', 'in', 'adults', 'are', 'attributed', 'to', 'respiratory', 'viruses', 'Previous', 'studies', 'investigated', 'the', 'role', 'of', 'rhinoviruses', 'RS', 'viruses', 'and', 'adenoviruses', 'in', 'development', 'of', 'asthma', 'exacerbations', 'in', 'children', 'hospitalized', 'in', 'the', 'clinic', 'of', 'the', 'Institute', 'of', 'Immunology', 'Moscow', 'Russia', 'Rhinovirus', 'was', 'the', 'most', 'frequently', 'detected', '33', 'samples', '24', '8', 'of', 'all', 'tested', 'samples', 'adenovirus', '5', 'samples', '3', '8', 'RSV', '4', 'samples', '3', '0', 'and', 'mixed', 'infections', 'rhinovirus', 'and', 'RSV', '1', 'sample', '0', '7', 'Among', 'positive', 'samples', 'rhinovirus', 'accounted', 'for', '76', '7', 'adenovirus', '11', '6', 'RSV', '9', '3', 'and', 'mixed', 'infection', '2', '3', 'Methods', 'Primers', 'for', 'PCR', 'diagnostics', 'of', 'Parainfluenza', 'viruses', 'of', '1', '2', 'and', '3', 'type', 'and', 'coronaviruses', 'OC43', 'and', '229E', 'were', 'developed', 'Investigation', 'of', 'HLA', 'alleles', 'and', 'genotypes', 'was', 'conducted', 'in', 'patients', 'with', 'virus', 'induced', 'bronchial', 'asthma', 'to', 'reveal', 'HLA', 'associated', 'markers', 'of', 'susceptibility', 'to', 'viral', 'induced', 'asthma', 'Results', 'An', 'increased', 'frequency', 'of', 'HLA', 'DRB1', '13', 'specificity', 'and', 'reduced', 'frequencies', 'of', 'HLA', 'DRB1', '04', 'and', 'HLA', 'DRB1', '11', 'specificities', 'were', 'noted', 'in', 'the', 'viral', 'induced', 'asthmatics', 'compared', 'to', 'the', 'healthy', 'control', 'group', 'A', 'minimal', 'increase', 'of', 'HLA', 'DRB1', 'homozygotes', '21', 'was', 'also', 'noted', 'in', 'comparison', 'with', 'the', 'control', 'group', '14', 'Conclusions', 'Investigation', 'of', 'HLA', 'haplotype', 'in', 'patients', 'with', 'viral', 'induced', 'outbreaks', 'of', 'asthma', 'via', 'HLA', 'genotyping', 'may', 'reveal', 'more', 'evident', 'associations', 'between', 'HLA', 'haplotypes', 'and', 'individual', 'respiratory', 'viral', 'infections', '']"
166361,Geographical Accessibility to Glucose-6-Phosphate Dioxygenase Deficiency Point-of-Care Testing for Antenatal Care in Ghana,2020-04-16,Diagnostics (Basel),https://www.ncbi.nlm.nih.gov/pubmed/32316233/; https://doi.org/10.3390/diagnostics10040229,"Background: Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency screening test is essential for malaria treatment, control, and elimination programs. G6PD deficient individuals are at high risk of severe hemolysis when given anti-malarial drugs such as primaquine, quinine, other sulphonamide-containing medicines, and chloroquine, which has recently been shown to be potent for the treatment of coronavirus disease (COVID-19). We evaluated the geographical accessibility to POC testing for G6PD deficiency in Ghana, a malaria-endemic country. Methods: We obtained the geographic information of 100 randomly sampled clinics previously included in a cross-sectional survey. We also obtained the geolocated data of all public hospitals providing G6PD deficiency testing services in the region. Using ArcGIS 10.5, we quantified geographical access to G6PD deficiency screening test and identified clinics as well as visualize locations with poor access for targeted improvement. The travel time was estimated using an assumed speed of 20 km per hour. Findings: Of the 100 clinics, 58% were Community-based Health Planning and Services facilities, and 42% were sub-district health centers. The majority (92%) were Ghana Health Service facilities, and the remaining 8% were Christian Health Association of Ghana facilities. Access to G6PD deficiency screening test was varied across the districts, and G6PD deficiency screening test was available in all eight public hospitals. This implies that the health facility-to-population ratio for G6PD deficiency testing service was approximately 1:159,210 (8/1,273,677) population. The spatial analysis quantified the current mean distance to a G6PD deficiency testing service from all locations in the region to be 34 ± 14 km, and travel time (68 ± 27 min). The estimated mean distance from a clinic to a district hospital for G6PD deficiency testing services was 15 ± 11 km, and travel time (46 ± 33 min). Conclusion: Access to POC testing for G6PD deficiency in Ghana was poor. Given the challenges associated with G6PD deficiency, it would be essential to improve access to G6PD deficiency POC testing to facilitate administration of sulphadoxine-pyrimethamine to pregnant women, full implementation of the malaria control program in Ghana, and treatment of COVID-19 patients with chloroquine in malaria-endemic countries. To enable the World Health Organization include appropriate G6PD POC diagnostic tests in its list of essential in-vitro diagnostics for use in resource-limited settings, we recommend a wider evaluation of available POC diagnostic tests for G6PD deficiency, particularly in malaria-endemic countries.",10.3390/diagnostics10040229,0i8nkpjf,"['Background', 'Glucose', '6', 'Phosphate', 'Dehydrogenase', 'G6PD', 'deficiency', 'screening', 'test', 'is', 'essential', 'for', 'malaria', 'treatment', 'control', 'and', 'elimination', 'programs', 'G6PD', 'deficient', 'individuals', 'are', 'at', 'high', 'risk', 'of', 'severe', 'hemolysis', 'when', 'given', 'anti', 'malarial', 'drugs', 'such', 'as', 'primaquine', 'quinine', 'other', 'sulphonamide', 'containing', 'medicines', 'and', 'chloroquine', 'which', 'has', 'recently', 'been', 'shown', 'to', 'be', 'potent', 'for', 'the', 'treatment', 'of', 'coronavirus', 'disease', 'COVID', '19', 'We', 'evaluated', 'the', 'geographical', 'accessibility', 'to', 'POC', 'testing', 'for', 'G6PD', 'deficiency', 'in', 'Ghana', 'a', 'malaria', 'endemic', 'country', 'Methods', 'We', 'obtained', 'the', 'geographic', 'information', 'of', '100', 'randomly', 'sampled', 'clinics', 'previously', 'included', 'in', 'a', 'cross', 'sectional', 'survey', 'We', 'also', 'obtained', 'the', 'geolocated', 'data', 'of', 'all', 'public', 'hospitals', 'providing', 'G6PD', 'deficiency', 'testing', 'services', 'in', 'the', 'region', 'Using', 'ArcGIS', '10', '5', 'we', 'quantified', 'geographical', 'access', 'to', 'G6PD', 'deficiency', 'screening', 'test', 'and', 'identified', 'clinics', 'as', 'well', 'as', 'visualize', 'locations', 'with', 'poor', 'access', 'for', 'targeted', 'improvement', 'The', 'travel', 'time', 'was', 'estimated', 'using', 'an', 'assumed', 'speed', 'of', '20', 'km', 'per', 'hour', 'Findings', 'Of', 'the', '100', 'clinics', '58', 'were', 'Community', 'based', 'Health', 'Planning', 'and', 'Services', 'facilities', 'and', '42', 'were', 'sub', 'district', 'health', 'centers', 'The', 'majority', '92', 'were', 'Ghana', 'Health', 'Service', 'facilities', 'and', 'the', 'remaining', '8', 'were', 'Christian', 'Health', 'Association', 'of', 'Ghana', 'facilities', 'Access', 'to', 'G6PD', 'deficiency', 'screening', 'test', 'was', 'varied', 'across', 'the', 'districts', 'and', 'G6PD', 'deficiency', 'screening', 'test', 'was', 'available', 'in', 'all', 'eight', 'public', 'hospitals', 'This', 'implies', 'that', 'the', 'health', 'facility', 'to', 'population', 'ratio', 'for', 'G6PD', 'deficiency', 'testing', 'service', 'was', 'approximately', '1', '159', '210', '8', '1', '273', '677', 'population', 'The', 'spatial', 'analysis', 'quantified', 'the', 'current', 'mean', 'distance', 'to', 'a', 'G6PD', 'deficiency', 'testing', 'service', 'from', 'all', 'locations', 'in', 'the', 'region', 'to', 'be', '34', '14', 'km', 'and', 'travel', 'time', '68', '27', 'min', 'The', 'estimated', 'mean', 'distance', 'from', 'a', 'clinic', 'to', 'a', 'district', 'hospital', 'for', 'G6PD', 'deficiency', 'testing', 'services', 'was', '15', '11', 'km', 'and', 'travel', 'time', '46', '33', 'min', 'Conclusion', 'Access', 'to', 'POC', 'testing', 'for', 'G6PD', 'deficiency', 'in', 'Ghana', 'was', 'poor', 'Given', 'the', 'challenges', 'associated', 'with', 'G6PD', 'deficiency', 'it', 'would', 'be', 'essential', 'to', 'improve', 'access', 'to', 'G6PD', 'deficiency', 'POC', 'testing', 'to', 'facilitate', 'administration', 'of', 'sulphadoxine', 'pyrimethamine', 'to', 'pregnant', 'women', 'full', 'implementation', 'of', 'the', 'malaria', 'control', 'program', 'in', 'Ghana', 'and', 'treatment', 'of', 'COVID', '19', 'patients', 'with', 'chloroquine', 'in', 'malaria', 'endemic', 'countries', 'To', 'enable', 'the', 'World', 'Health', 'Organization', 'include', 'appropriate', 'G6PD', 'POC', 'diagnostic', 'tests', 'in', 'its', 'list', 'of', 'essential', 'in', 'vitro', 'diagnostics', 'for', 'use', 'in', 'resource', 'limited', 'settings', 'we', 'recommend', 'a', 'wider', 'evaluation', 'of', 'available', 'POC', 'diagnostic', 'tests', 'for', 'G6PD', 'deficiency', 'particularly', 'in', 'malaria', 'endemic', 'countries', '']"
166396,"Human bocavirus, coronavirus, and polyomavirus detected among patients hospitalised with severe acute respiratory illness in South Africa, 2012 to 2013",2018-07-18,Health Sci Rep,https://www.ncbi.nlm.nih.gov/pubmed/30623094/; https://doi.org/10.1002/hsr2.59,"AIM: To investigate the prevalence of human bocavirus (hBoV), human coronaviruses (hCoV), and human polyomaviruses (hPyV) among patients with severe acute respiratory illness (SARI), in South Africa. METHODS: The study included 680 South African patients randomly selected in age‐defined categories from hospitalised patients enrolled through SARI surveillance during 2012 to 2013. A multiplex reverse transcription real‐time polymerase chain reaction assay was used to detect hBoV; hCoV‐OC43, hCoV‐229E, hCoV‐NL63, and hCoV‐HKU1; and Washington University hPyV (hPyV‐WU) and Karolinska Insitute hPyV (hPyV‐KI), in respiratory tract specimens collected from patients with SARI. All respiratory specimens from patients enrolled through SARI surveillance were also routinely tested by multiplex reverse transcription real‐time polymerase chain reaction for adenovirus; enterovirus; human metapneumovirus; parainfluenza virus types 1, 2, and 3; respiratory syncytial virus; rhinovirus; influenza A, and influenza B. RESULTS: Human bocavirus, hCoV‐229E, and hPyV‐WU were detected in 3.7% (25/680), 4.1% (28/680), and 4.1% (28/680) of respiratory specimens, respectively. All other viruses were detected in <2% of specimens. Rhinovirus was the most common coinfecting virus (21.4%‐60.7%), followed by adenovirus (21.4%‐39.3%), and respiratory syncytial virus (10.7%‐24.0%). Testing for the additional viruses (hBoV, hCoV, and hPyV) decreased the number of specimens that initially tested negative by 2.9% (20/680). CONCLUSION: Inclusion of laboratory tests for hBoV, hCoV‐229E, and hPyV‐WU in differential testing algorithms for surveillance and diagnostics for suspected cases of respiratory illness of unknown cause may improve our understanding of the etiology of SARI, especially in a country like South Africa with a high number of immune compromised persons.",10.1002/hsr2.59,nx5a9bq9,"['AIM', 'To', 'investigate', 'the', 'prevalence', 'of', 'human', 'bocavirus', 'hBoV', 'human', 'coronaviruses', 'hCoV', 'and', 'human', 'polyomaviruses', 'hPyV', 'among', 'patients', 'with', 'severe', 'acute', 'respiratory', 'illness', 'SARI', 'in', 'South', 'Africa', 'METHODS', 'The', 'study', 'included', '680', 'South', 'African', 'patients', 'randomly', 'selected', 'in', 'age', 'defined', 'categories', 'from', 'hospitalised', 'patients', 'enrolled', 'through', 'SARI', 'surveillance', 'during', '2012', 'to', '2013', 'A', 'multiplex', 'reverse', 'transcription', 'real', 'time', 'polymerase', 'chain', 'reaction', 'assay', 'was', 'used', 'to', 'detect', 'hBoV', 'hCoV', 'OC43', 'hCoV', '229E', 'hCoV', 'NL63', 'and', 'hCoV', 'HKU1', 'and', 'Washington', 'University', 'hPyV', 'hPyV', 'WU', 'and', 'Karolinska', 'Insitute', 'hPyV', 'hPyV', 'KI', 'in', 'respiratory', 'tract', 'specimens', 'collected', 'from', 'patients', 'with', 'SARI', 'All', 'respiratory', 'specimens', 'from', 'patients', 'enrolled', 'through', 'SARI', 'surveillance', 'were', 'also', 'routinely', 'tested', 'by', 'multiplex', 'reverse', 'transcription', 'real', 'time', 'polymerase', 'chain', 'reaction', 'for', 'adenovirus', 'enterovirus', 'human', 'metapneumovirus', 'parainfluenza', 'virus', 'types', '1', '2', 'and', '3', 'respiratory', 'syncytial', 'virus', 'rhinovirus', 'influenza', 'A', 'and', 'influenza', 'B', 'RESULTS', 'Human', 'bocavirus', 'hCoV', '229E', 'and', 'hPyV', 'WU', 'were', 'detected', 'in', '3', '7', '25', '680', '4', '1', '28', '680', 'and', '4', '1', '28', '680', 'of', 'respiratory', 'specimens', 'respectively', 'All', 'other', 'viruses', 'were', 'detected', 'in', '2', 'of', 'specimens', 'Rhinovirus', 'was', 'the', 'most', 'common', 'coinfecting', 'virus', '21', '4', '60', '7', 'followed', 'by', 'adenovirus', '21', '4', '39', '3', 'and', 'respiratory', 'syncytial', 'virus', '10', '7', '24', '0', 'Testing', 'for', 'the', 'additional', 'viruses', 'hBoV', 'hCoV', 'and', 'hPyV', 'decreased', 'the', 'number', 'of', 'specimens', 'that', 'initially', 'tested', 'negative', 'by', '2', '9', '20', '680', 'CONCLUSION', 'Inclusion', 'of', 'laboratory', 'tests', 'for', 'hBoV', 'hCoV', '229E', 'and', 'hPyV', 'WU', 'in', 'differential', 'testing', 'algorithms', 'for', 'surveillance', 'and', 'diagnostics', 'for', 'suspected', 'cases', 'of', 'respiratory', 'illness', 'of', 'unknown', 'cause', 'may', 'improve', 'our', 'understanding', 'of', 'the', 'etiology', 'of', 'SARI', 'especially', 'in', 'a', 'country', 'like', 'South', 'Africa', 'with', 'a', 'high', 'number', 'of', 'immune', 'compromised', 'persons', '']"
167324,Pathogenicity and pathogenesis of a United States porcine deltacoronavirus cell culture isolate in 5-day-old neonatal piglets,2015-08-31,Virology,https://doi.org/10.1016/j.virol.2015.03.024; https://www.sciencedirect.com/science/article/pii/S0042682215001609; https://api.elsevier.com/content/article/pii/S0042682215001609; https://www.ncbi.nlm.nih.gov/pubmed/25817405/,"Abstract Porcine deltacoronavirus (PDCoV) was first identified in Hong Kong in 2009–2010 and reported in United States swine for the first time in February 2014. However, diagnostic tools other than polymerase chain reaction for PDCoV detection were lacking and Koch׳s postulates had not been fulfilled to confirm the pathogenic potential of PDCoV. In the present study, PDCoV peptide-specific rabbit antisera were developed and used in immunofluorescence and immunohistochemistry assays to assist PDCoV diagnostics. The pathogenicity and pathogenesis of PDCoV was investigated following orogastric inoculation of 5-day-old piglets with a plaque-purified PDCoV cell culture isolate (3×104 TCID50 per pig). The PDCoV-inoculated piglets developed mild to moderate diarrhea, shed increasing amount of virus in rectal swabs from 2 to 7 days post inoculation, and developed macroscopic and microscopic lesions in small intestines with viral antigen confirmed by immunohistochemistry staining. This study experimentally confirmed PDCoV pathogenicity and characterized PDCoV pathogenesis in neonatal piglets.",10.1016/j.virol.2015.03.024,p5kjnfyf,"['Abstract', 'Porcine', 'deltacoronavirus', 'PDCoV', 'was', 'first', 'identified', 'in', 'Hong', 'Kong', 'in', '2009', '2010', 'and', 'reported', 'in', 'United', 'States', 'swine', 'for', 'the', 'first', 'time', 'in', 'February', '2014', 'However', 'diagnostic', 'tools', 'other', 'than', 'polymerase', 'chain', 'reaction', 'for', 'PDCoV', 'detection', 'were', 'lacking', 'and', 'Koch', 's', 'postulates', 'had', 'not', 'been', 'fulfilled', 'to', 'confirm', 'the', 'pathogenic', 'potential', 'of', 'PDCoV', 'In', 'the', 'present', 'study', 'PDCoV', 'peptide', 'specific', 'rabbit', 'antisera', 'were', 'developed', 'and', 'used', 'in', 'immunofluorescence', 'and', 'immunohistochemistry', 'assays', 'to', 'assist', 'PDCoV', 'diagnostics', 'The', 'pathogenicity', 'and', 'pathogenesis', 'of', 'PDCoV', 'was', 'investigated', 'following', 'orogastric', 'inoculation', 'of', '5', 'day', 'old', 'piglets', 'with', 'a', 'plaque', 'purified', 'PDCoV', 'cell', 'culture', 'isolate', '3', '104', 'TCID50', 'per', 'pig', 'The', 'PDCoV', 'inoculated', 'piglets', 'developed', 'mild', 'to', 'moderate', 'diarrhea', 'shed', 'increasing', 'amount', 'of', 'virus', 'in', 'rectal', 'swabs', 'from', '2', 'to', '7', 'days', 'post', 'inoculation', 'and', 'developed', 'macroscopic', 'and', 'microscopic', 'lesions', 'in', 'small', 'intestines', 'with', 'viral', 'antigen', 'confirmed', 'by', 'immunohistochemistry', 'staining', 'This', 'study', 'experimentally', 'confirmed', 'PDCoV', 'pathogenicity', 'and', 'characterized', 'PDCoV', 'pathogenesis', 'in', 'neonatal', 'piglets', '']"
167508,Lung ultrasound in the diagnosis of COVID-19 infection - A case series and review of the literature,2020-06-25,Adv Med Sci,https://www.sciencedirect.com/science/article/pii/S1896112620300298?v=s5; https://doi.org/10.1016/j.advms.2020.06.005; https://www.ncbi.nlm.nih.gov/pubmed/32659729/; https://api.elsevier.com/content/article/pii/S1896112620300298,"COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and spreading worldwide has become a serious challenge for the entire health care system as regards infection prevention, rapid diagnosis, and treatment. Lung ultrasound (LUS) is a dynamically developing diagnostic method used in intensive care, cardiology and nephrology, it can also be helpful in diagnosing and monitoring pneumonia. Interstitial pneumonia appears to be the most common clinical manifestation of coronavirus infection. We present 4 case reports of COVID-19 involving the lungs, in which transthoracic lung ultrasound was successfully utilized as a constituent of bedside diagnostics and a review of the literature concerning potential use of LUS in COVID-19 diagnostics. The possibility to perform this examination repeatedly, its non-invasiveness and high sensitivity make it an important element of care provided for patients with viral pneumonia.",10.1016/j.advms.2020.06.005,21m8rdhy,"['COVID', '19', 'pandemic', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'and', 'spreading', 'worldwide', 'has', 'become', 'a', 'serious', 'challenge', 'for', 'the', 'entire', 'health', 'care', 'system', 'as', 'regards', 'infection', 'prevention', 'rapid', 'diagnosis', 'and', 'treatment', 'Lung', 'ultrasound', 'LUS', 'is', 'a', 'dynamically', 'developing', 'diagnostic', 'method', 'used', 'in', 'intensive', 'care', 'cardiology', 'and', 'nephrology', 'it', 'can', 'also', 'be', 'helpful', 'in', 'diagnosing', 'and', 'monitoring', 'pneumonia', 'Interstitial', 'pneumonia', 'appears', 'to', 'be', 'the', 'most', 'common', 'clinical', 'manifestation', 'of', 'coronavirus', 'infection', 'We', 'present', '4', 'case', 'reports', 'of', 'COVID', '19', 'involving', 'the', 'lungs', 'in', 'which', 'transthoracic', 'lung', 'ultrasound', 'was', 'successfully', 'utilized', 'as', 'a', 'constituent', 'of', 'bedside', 'diagnostics', 'and', 'a', 'review', 'of', 'the', 'literature', 'concerning', 'potential', 'use', 'of', 'LUS', 'in', 'COVID', '19', 'diagnostics', 'The', 'possibility', 'to', 'perform', 'this', 'examination', 'repeatedly', 'its', 'non', 'invasiveness', 'and', 'high', 'sensitivity', 'make', 'it', 'an', 'important', 'element', 'of', 'care', 'provided', 'for', 'patients', 'with', 'viral', 'pneumonia', '']"
167906,Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses,2020-06-30,Proc Natl Acad Sci U S A,https://doi.org/10.1073/pnas.2008176117; https://www.ncbi.nlm.nih.gov/pubmed/32522874/,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses an immediate, major threat to public health across the globe. Here we report an in-depth molecular analysis to reconstruct the evolutionary origins of the enhanced pathogenicity of SARS-CoV-2 and other coronaviruses that are severe human pathogens. Using integrated comparative genomics and machine learning techniques, we identify key genomic features that differentiate SARS-CoV-2 and the viruses behind the two previous deadly coronavirus outbreaks, SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), from less pathogenic coronaviruses. These features include enhancement of the nuclear localization signals in the nucleocapsid protein and distinct inserts in the spike glycoprotein that appear to be associated with high case fatality rate of these coronaviruses as well as the host switch from animals to humans. The identified features could be crucial contributors to coronavirus pathogenicity and possible targets for diagnostics, prognostication, and interventions.",10.1073/pnas.2008176117,849kand1,"['Severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'poses', 'an', 'immediate', 'major', 'threat', 'to', 'public', 'health', 'across', 'the', 'globe', 'Here', 'we', 'report', 'an', 'in', 'depth', 'molecular', 'analysis', 'to', 'reconstruct', 'the', 'evolutionary', 'origins', 'of', 'the', 'enhanced', 'pathogenicity', 'of', 'SARS', 'CoV', '2', 'and', 'other', 'coronaviruses', 'that', 'are', 'severe', 'human', 'pathogens', 'Using', 'integrated', 'comparative', 'genomics', 'and', 'machine', 'learning', 'techniques', 'we', 'identify', 'key', 'genomic', 'features', 'that', 'differentiate', 'SARS', 'CoV', '2', 'and', 'the', 'viruses', 'behind', 'the', 'two', 'previous', 'deadly', 'coronavirus', 'outbreaks', 'SARS', 'CoV', 'and', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'from', 'less', 'pathogenic', 'coronaviruses', 'These', 'features', 'include', 'enhancement', 'of', 'the', 'nuclear', 'localization', 'signals', 'in', 'the', 'nucleocapsid', 'protein', 'and', 'distinct', 'inserts', 'in', 'the', 'spike', 'glycoprotein', 'that', 'appear', 'to', 'be', 'associated', 'with', 'high', 'case', 'fatality', 'rate', 'of', 'these', 'coronaviruses', 'as', 'well', 'as', 'the', 'host', 'switch', 'from', 'animals', 'to', 'humans', 'The', 'identified', 'features', 'could', 'be', 'crucial', 'contributors', 'to', 'coronavirus', 'pathogenicity', 'and', 'possible', 'targets', 'for', 'diagnostics', 'prognostication', 'and', 'interventions', '']"
168247,Real-Time Sequence-Validated Loop-Mediated Isothermal Amplification Assays for Detection of Middle East Respiratory Syndrome Coronavirus (MERS-CoV),2015-04-09,PLoS One,https://doi.org/10.1371/journal.pone.0123126; https://www.ncbi.nlm.nih.gov/pubmed/25856093/,"The Middle East respiratory syndrome coronavirus (MERS-CoV), an emerging human coronavirus, causes severe acute respiratory illness with a 35% mortality rate. In light of the recent surge in reported infections we have developed asymmetric five-primer reverse transcription loop-mediated isothermal amplification (RT-LAMP) assays for detection of MERS-CoV. Isothermal amplification assays will facilitate the development of portable point-of-care diagnostics that are crucial for management of emerging infections. The RT-LAMP assays are designed to amplify MERS-CoV genomic loci located within the open reading frame (ORF)1a and ORF1b genes and upstream of the E gene. Additionally we applied one-step strand displacement probes (OSD) for real-time sequence-specific verification of LAMP amplicons. Asymmetric amplification effected by incorporating a single loop primer in each assay accelerated the time-to-result of the OSD-RT-LAMP assays. The resulting assays could detect 0.02 to 0.2 plaque forming units (PFU) (5 to 50 PFU/ml) of MERS-CoV in infected cell culture supernatants within 30 to 50 min and did not cross-react with common human respiratory pathogens.",10.1371/journal.pone.0123126,4jagpyyu,"['The', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'an', 'emerging', 'human', 'coronavirus', 'causes', 'severe', 'acute', 'respiratory', 'illness', 'with', 'a', '35', 'mortality', 'rate', 'In', 'light', 'of', 'the', 'recent', 'surge', 'in', 'reported', 'infections', 'we', 'have', 'developed', 'asymmetric', 'five', 'primer', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'assays', 'for', 'detection', 'of', 'MERS', 'CoV', 'Isothermal', 'amplification', 'assays', 'will', 'facilitate', 'the', 'development', 'of', 'portable', 'point', 'of', 'care', 'diagnostics', 'that', 'are', 'crucial', 'for', 'management', 'of', 'emerging', 'infections', 'The', 'RT', 'LAMP', 'assays', 'are', 'designed', 'to', 'amplify', 'MERS', 'CoV', 'genomic', 'loci', 'located', 'within', 'the', 'open', 'reading', 'frame', 'ORF', '1a', 'and', 'ORF1b', 'genes', 'and', 'upstream', 'of', 'the', 'E', 'gene', 'Additionally', 'we', 'applied', 'one', 'step', 'strand', 'displacement', 'probes', 'OSD', 'for', 'real', 'time', 'sequence', 'specific', 'verification', 'of', 'LAMP', 'amplicons', 'Asymmetric', 'amplification', 'effected', 'by', 'incorporating', 'a', 'single', 'loop', 'primer', 'in', 'each', 'assay', 'accelerated', 'the', 'time', 'to', 'result', 'of', 'the', 'OSD', 'RT', 'LAMP', 'assays', 'The', 'resulting', 'assays', 'could', 'detect', '0', '02', 'to', '0', '2', 'plaque', 'forming', 'units', 'PFU', '5', 'to', '50', 'PFU', 'ml', 'of', 'MERS', 'CoV', 'in', 'infected', 'cell', 'culture', 'supernatants', 'within', '30', 'to', '50', 'min', 'and', 'did', 'not', 'cross', 'react', 'with', 'common', 'human', 'respiratory', 'pathogens', '']"
168689,"High Prevalence of Viral Infections Among Hospitalized Pneumonia Patients in Equatorial Sarawak, Malaysia",2019-02-13,Open Forum Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/30949525/; https://doi.org/10.1093/ofid/ofz074,"BACKGROUND: Although pneumonia is a known cause of morbidity and mortality in Sarawak, Malaysia, the etiology and epidemiology of pneumonia are not well described in this equatorial region. Routine clinical diagnostics for pneumonia etiology at government hospitals in Sarawak had historically involved only bacterial diagnostics. Viral diagnostics were only obtained through outside consultations. METHODS: From June 15, 2017 to May 14, 2018, we collected nasopharyngeal swabs from 600 patients of all ages older than 1 month hospitalized with pneumonia at Sibu and Kapit Hospitals. Specimens were examined at our collaborating institutions with a panel of molecular assays for viral pathogens including influenza A (IAV), IBV, ICV, and IDV, human adenovirus (AdV), human enterovirus (EV), human coronavirus (CoV), respiratory syncytial virus subtype A (RSV-A) or RSV-B, and parainfluenza virus (PIV) types 1–4. RESULTS: Of 599 samples examined, 288 (48%) had molecular evidence of 1 or more respiratory viruses. Overall, the most prevalent virus detected was RSV-A (14.2%) followed by AdV (10.4%) and IAV (10.4%), then RSV-B (6.2%), EV (4.2%), IBV (2.2%), PIV-3 (1.7%), CoV (1.0%), PIV-1 (1.0%), PIV-4 (0.7%), and PIV-2 (0.2%). No specimens were confirmed positive for ICV or IDV. CONCLUSIONS: The high prevalence of viruses detected in this study suggest that respiratory viruses may be responsible for considerable morbidity in equatorial regions such as Sarawak. Access to viral diagnostics are very necessary for medical staff to determine appropriate pneumonia treatments.",10.1093/ofid/ofz074,08kqtw8s,"['BACKGROUND', 'Although', 'pneumonia', 'is', 'a', 'known', 'cause', 'of', 'morbidity', 'and', 'mortality', 'in', 'Sarawak', 'Malaysia', 'the', 'etiology', 'and', 'epidemiology', 'of', 'pneumonia', 'are', 'not', 'well', 'described', 'in', 'this', 'equatorial', 'region', 'Routine', 'clinical', 'diagnostics', 'for', 'pneumonia', 'etiology', 'at', 'government', 'hospitals', 'in', 'Sarawak', 'had', 'historically', 'involved', 'only', 'bacterial', 'diagnostics', 'Viral', 'diagnostics', 'were', 'only', 'obtained', 'through', 'outside', 'consultations', 'METHODS', 'From', 'June', '15', '2017', 'to', 'May', '14', '2018', 'we', 'collected', 'nasopharyngeal', 'swabs', 'from', '600', 'patients', 'of', 'all', 'ages', 'older', 'than', '1', 'month', 'hospitalized', 'with', 'pneumonia', 'at', 'Sibu', 'and', 'Kapit', 'Hospitals', 'Specimens', 'were', 'examined', 'at', 'our', 'collaborating', 'institutions', 'with', 'a', 'panel', 'of', 'molecular', 'assays', 'for', 'viral', 'pathogens', 'including', 'influenza', 'A', 'IAV', 'IBV', 'ICV', 'and', 'IDV', 'human', 'adenovirus', 'AdV', 'human', 'enterovirus', 'EV', 'human', 'coronavirus', 'CoV', 'respiratory', 'syncytial', 'virus', 'subtype', 'A', 'RSV', 'A', 'or', 'RSV', 'B', 'and', 'parainfluenza', 'virus', 'PIV', 'types', '1', '4', 'RESULTS', 'Of', '599', 'samples', 'examined', '288', '48', 'had', 'molecular', 'evidence', 'of', '1', 'or', 'more', 'respiratory', 'viruses', 'Overall', 'the', 'most', 'prevalent', 'virus', 'detected', 'was', 'RSV', 'A', '14', '2', 'followed', 'by', 'AdV', '10', '4', 'and', 'IAV', '10', '4', 'then', 'RSV', 'B', '6', '2', 'EV', '4', '2', 'IBV', '2', '2', 'PIV', '3', '1', '7', 'CoV', '1', '0', 'PIV', '1', '1', '0', 'PIV', '4', '0', '7', 'and', 'PIV', '2', '0', '2', 'No', 'specimens', 'were', 'confirmed', 'positive', 'for', 'ICV', 'or', 'IDV', 'CONCLUSIONS', 'The', 'high', 'prevalence', 'of', 'viruses', 'detected', 'in', 'this', 'study', 'suggest', 'that', 'respiratory', 'viruses', 'may', 'be', 'responsible', 'for', 'considerable', 'morbidity', 'in', 'equatorial', 'regions', 'such', 'as', 'Sarawak', 'Access', 'to', 'viral', 'diagnostics', 'are', 'very', 'necessary', 'for', 'medical', 'staff', 'to', 'determine', 'appropriate', 'pneumonia', 'treatments', '']"
169372,Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review,2020-04-13,Ann Intern Med,https://doi.org/10.7326/m20-1301; https://www.ncbi.nlm.nih.gov/pubmed/32282894/,"Diagnostic testing to identify persons infected with severe acute respiratory syndrome–related coronavirus-2 (SARS–CoV-2) infection is central to control the global pandemic of COVID-19 that began in late 2019. In a few countries, the use of diagnostic testing on a massive scale has been a cornerstone of successful containment strategies. In contrast, the United States, hampered by limited testing capacity, has prioritized testing for specific groups of persons. Real-time reverse transcriptase polymerase chain reaction–based assays performed in a laboratory on respiratory specimens are the reference standard for COVID-19 diagnostics. However, point-of-care technologies and serologic immunoassays are rapidly emerging. Although excellent tools exist for the diagnosis of symptomatic patients in well-equipped laboratories, important gaps remain in screening asymptomatic persons in the incubation phase, as well as in the accurate determination of live viral shedding during convalescence to inform decisions to end isolation. Many affluent countries have encountered challenges in test delivery and specimen collection that have inhibited rapid increases in testing capacity. These challenges may be even greater in low-resource settings. Urgent clinical and public health needs currently drive an unprecedented global effort to increase testing capacity for SARS–CoV-2 infection. Here, the authors review the current array of tests for SARS–CoV-2, highlight gaps in current diagnostic capacity, and propose potential solutions.",10.7326/m20-1301,ho5n7n90,"['Diagnostic', 'testing', 'to', 'identify', 'persons', 'infected', 'with', 'severe', 'acute', 'respiratory', 'syndrome', 'related', 'coronavirus', '2', 'SARS', 'CoV', '2', 'infection', 'is', 'central', 'to', 'control', 'the', 'global', 'pandemic', 'of', 'COVID', '19', 'that', 'began', 'in', 'late', '2019', 'In', 'a', 'few', 'countries', 'the', 'use', 'of', 'diagnostic', 'testing', 'on', 'a', 'massive', 'scale', 'has', 'been', 'a', 'cornerstone', 'of', 'successful', 'containment', 'strategies', 'In', 'contrast', 'the', 'United', 'States', 'hampered', 'by', 'limited', 'testing', 'capacity', 'has', 'prioritized', 'testing', 'for', 'specific', 'groups', 'of', 'persons', 'Real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'based', 'assays', 'performed', 'in', 'a', 'laboratory', 'on', 'respiratory', 'specimens', 'are', 'the', 'reference', 'standard', 'for', 'COVID', '19', 'diagnostics', 'However', 'point', 'of', 'care', 'technologies', 'and', 'serologic', 'immunoassays', 'are', 'rapidly', 'emerging', 'Although', 'excellent', 'tools', 'exist', 'for', 'the', 'diagnosis', 'of', 'symptomatic', 'patients', 'in', 'well', 'equipped', 'laboratories', 'important', 'gaps', 'remain', 'in', 'screening', 'asymptomatic', 'persons', 'in', 'the', 'incubation', 'phase', 'as', 'well', 'as', 'in', 'the', 'accurate', 'determination', 'of', 'live', 'viral', 'shedding', 'during', 'convalescence', 'to', 'inform', 'decisions', 'to', 'end', 'isolation', 'Many', 'affluent', 'countries', 'have', 'encountered', 'challenges', 'in', 'test', 'delivery', 'and', 'specimen', 'collection', 'that', 'have', 'inhibited', 'rapid', 'increases', 'in', 'testing', 'capacity', 'These', 'challenges', 'may', 'be', 'even', 'greater', 'in', 'low', 'resource', 'settings', 'Urgent', 'clinical', 'and', 'public', 'health', 'needs', 'currently', 'drive', 'an', 'unprecedented', 'global', 'effort', 'to', 'increase', 'testing', 'capacity', 'for', 'SARS', 'CoV', '2', 'infection', 'Here', 'the', 'authors', 'review', 'the', 'current', 'array', 'of', 'tests', 'for', 'SARS', 'CoV', '2', 'highlight', 'gaps', 'in', 'current', 'diagnostic', 'capacity', 'and', 'propose', 'potential', 'solutions', '']"
169633,Multicenter evaluation of the QIAstat Respiratory Panel—A new rapid highly multiplexed PCR based assay for diagnosis of acute respiratory tract infections,2020-03-12,PLoS One,https://www.ncbi.nlm.nih.gov/pubmed/32163484/; https://doi.org/10.1371/journal.pone.0230183,"Acute respiratory tract infections (ARTI), including the common cold, pharyngitis, sinusitis, otitis media, bronchiolitis and pneumonia are the most common diagnoses among patients seeking medical care in western countries, and account for most antibiotic prescriptions. While a confirmed and fast ARTI diagnosis is key for antibiotic prescribing, empiric antimicrobial treatment remains common, because viral symptoms are often clinically similar and difficult to distinguish from those caused by bacteria. As a result, inappropriate antibiotic prescriptions are high and in certain settings likely higher than the commonly estimated 30%. The QIAstat Respiratory Panel(®) assay (QIAstat RP) is a multiplexed in vitro diagnostics test for the rapid simultaneous detection of 21 pathogens directly from respiratory samples, including human mastadenovirus A-G, primate bocaparvovirus 1+2, human coronavirus (HKU1, NL63, OC43, 229E), human metapneumovirus A/B, rhinovirus/enterovirus, influenza A virus (no subtype, subtype H1, H1N1/2009, H3), influenza B virus, human respirovirus 1+3, human orthorubulavirus 2+4, human orthopneumovirus, Bordetella pertussis, Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila. We describe the first multicenter study of 445 respiratory samples, collected through the 2016–2017 and 2018 respiratory seasons, with performance compared against BioFire FilmArray RP v1.7 and discrepancy testing by Seegene Allplex RP. The QIAstat RP demonstrated a positive percentage of agreement of 98.0% (95% CI: 96.0–99.1%) and a negative percentage agreement of 99.8% (95% CI: 99.6–99.9%). With use of this comprehensive and rapid test, improved patient outcomes and antimicrobial stewardship may potentially be achieved.",10.1371/journal.pone.0230183,wezrs7gc,"['Acute', 'respiratory', 'tract', 'infections', 'ARTI', 'including', 'the', 'common', 'cold', 'pharyngitis', 'sinusitis', 'otitis', 'media', 'bronchiolitis', 'and', 'pneumonia', 'are', 'the', 'most', 'common', 'diagnoses', 'among', 'patients', 'seeking', 'medical', 'care', 'in', 'western', 'countries', 'and', 'account', 'for', 'most', 'antibiotic', 'prescriptions', 'While', 'a', 'confirmed', 'and', 'fast', 'ARTI', 'diagnosis', 'is', 'key', 'for', 'antibiotic', 'prescribing', 'empiric', 'antimicrobial', 'treatment', 'remains', 'common', 'because', 'viral', 'symptoms', 'are', 'often', 'clinically', 'similar', 'and', 'difficult', 'to', 'distinguish', 'from', 'those', 'caused', 'by', 'bacteria', 'As', 'a', 'result', 'inappropriate', 'antibiotic', 'prescriptions', 'are', 'high', 'and', 'in', 'certain', 'settings', 'likely', 'higher', 'than', 'the', 'commonly', 'estimated', '30', 'The', 'QIAstat', 'Respiratory', 'Panel', 'assay', 'QIAstat', 'RP', 'is', 'a', 'multiplexed', 'in', 'vitro', 'diagnostics', 'test', 'for', 'the', 'rapid', 'simultaneous', 'detection', 'of', '21', 'pathogens', 'directly', 'from', 'respiratory', 'samples', 'including', 'human', 'mastadenovirus', 'A', 'G', 'primate', 'bocaparvovirus', '1', '2', 'human', 'coronavirus', 'HKU1', 'NL63', 'OC43', '229E', 'human', 'metapneumovirus', 'A', 'B', 'rhinovirus', 'enterovirus', 'influenza', 'A', 'virus', 'no', 'subtype', 'subtype', 'H1', 'H1N1', '2009', 'H3', 'influenza', 'B', 'virus', 'human', 'respirovirus', '1', '3', 'human', 'orthorubulavirus', '2', '4', 'human', 'orthopneumovirus', 'Bordetella', 'pertussis', 'Chlamydia', 'pneumoniae', 'Mycoplasma', 'pneumoniae', 'and', 'Legionella', 'pneumophila', 'We', 'describe', 'the', 'first', 'multicenter', 'study', 'of', '445', 'respiratory', 'samples', 'collected', 'through', 'the', '2016', '2017', 'and', '2018', 'respiratory', 'seasons', 'with', 'performance', 'compared', 'against', 'BioFire', 'FilmArray', 'RP', 'v1', '7', 'and', 'discrepancy', 'testing', 'by', 'Seegene', 'Allplex', 'RP', 'The', 'QIAstat', 'RP', 'demonstrated', 'a', 'positive', 'percentage', 'of', 'agreement', 'of', '98', '0', '95', 'CI', '96', '0', '99', '1', 'and', 'a', 'negative', 'percentage', 'agreement', 'of', '99', '8', '95', 'CI', '99', '6', '99', '9', 'With', 'use', 'of', 'this', 'comprehensive', 'and', 'rapid', 'test', 'improved', 'patient', 'outcomes', 'and', 'antimicrobial', 'stewardship', 'may', 'potentially', 'be', 'achieved', '']"
170309,Ophthalmic clinical skills teaching in the time of COVID‐19: A crisis and opportunity,2020-05-23,Med Educ,https://www.ncbi.nlm.nih.gov/pubmed/32324929/; https://doi.org/10.1111/medu.14189,"Despite advances in artificial intelligence-based diagnostics, ophthalmic clinical skills remain an important acquisition during medical school. Simple ophthalmic examination techniques allow future non-ophthalmic physicians to make timely referrals to ophthalmologists for sight-threatening disease. Currently, the coronavirus disease 2019 (COVID-19) pandemic poses a serious public health crisis worldwide and an immediate challenge to traditional methods of medical education.",10.1111/medu.14189,ulzzo2p5,"['Despite', 'advances', 'in', 'artificial', 'intelligence', 'based', 'diagnostics', 'ophthalmic', 'clinical', 'skills', 'remain', 'an', 'important', 'acquisition', 'during', 'medical', 'school', 'Simple', 'ophthalmic', 'examination', 'techniques', 'allow', 'future', 'non', 'ophthalmic', 'physicians', 'to', 'make', 'timely', 'referrals', 'to', 'ophthalmologists', 'for', 'sight', 'threatening', 'disease', 'Currently', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'poses', 'a', 'serious', 'public', 'health', 'crisis', 'worldwide', 'and', 'an', 'immediate', 'challenge', 'to', 'traditional', 'methods', 'of', 'medical', 'education', '']"
170427,An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection,2020-07-29,Antiviral Res,https://api.elsevier.com/content/article/pii/S0166354220302965; https://www.sciencedirect.com/science/article/pii/S0166354220302965?v=s5; https://doi.org/10.1016/j.antiviral.2020.104882,"SARS-CoV-2 is a novel pandemic coronavirus that caused a global health and economic crisis. The development of efficient drugs and vaccines against COVID-19 requires detailed knowledge about SARS-CoV-2 biology. Several techniques to detect SARS-CoV-2 infection have been established, mainly based on counting infected cells by staining plaques or foci, or by quantifying the viral genome by PCR. These methods are laborious, time-consuming and expensive and therefore not suitable for a high sample throughput or rapid diagnostics. We here report a novel enzyme-based immunodetection assay that directly quantifies the amount of de novo synthesized viral spike protein within fixed and permeabilized cells. This in-cell ELISA enables a rapid and quantitative detection of SARS-CoV-2 infection in microtiter format, regardless of the virus isolate or target cell culture. It follows the established method of performing ELISA assays and does not require expensive instrumentation. Utilization of the in-cell ELISA allows to e.g. determine TCID(50) of virus stocks, antiviral efficiencies (IC(50) values) of drugs or neutralizing activity of sera. Thus, the in-cell spike ELISA represents a promising alternative to study SARS-CoV-2 infection and inhibition and may facilitate future research.",10.1016/j.antiviral.2020.104882,4bai2wg7,"['SARS', 'CoV', '2', 'is', 'a', 'novel', 'pandemic', 'coronavirus', 'that', 'caused', 'a', 'global', 'health', 'and', 'economic', 'crisis', 'The', 'development', 'of', 'efficient', 'drugs', 'and', 'vaccines', 'against', 'COVID', '19', 'requires', 'detailed', 'knowledge', 'about', 'SARS', 'CoV', '2', 'biology', 'Several', 'techniques', 'to', 'detect', 'SARS', 'CoV', '2', 'infection', 'have', 'been', 'established', 'mainly', 'based', 'on', 'counting', 'infected', 'cells', 'by', 'staining', 'plaques', 'or', 'foci', 'or', 'by', 'quantifying', 'the', 'viral', 'genome', 'by', 'PCR', 'These', 'methods', 'are', 'laborious', 'time', 'consuming', 'and', 'expensive', 'and', 'therefore', 'not', 'suitable', 'for', 'a', 'high', 'sample', 'throughput', 'or', 'rapid', 'diagnostics', 'We', 'here', 'report', 'a', 'novel', 'enzyme', 'based', 'immunodetection', 'assay', 'that', 'directly', 'quantifies', 'the', 'amount', 'of', 'de', 'novo', 'synthesized', 'viral', 'spike', 'protein', 'within', 'fixed', 'and', 'permeabilized', 'cells', 'This', 'in', 'cell', 'ELISA', 'enables', 'a', 'rapid', 'and', 'quantitative', 'detection', 'of', 'SARS', 'CoV', '2', 'infection', 'in', 'microtiter', 'format', 'regardless', 'of', 'the', 'virus', 'isolate', 'or', 'target', 'cell', 'culture', 'It', 'follows', 'the', 'established', 'method', 'of', 'performing', 'ELISA', 'assays', 'and', 'does', 'not', 'require', 'expensive', 'instrumentation', 'Utilization', 'of', 'the', 'in', 'cell', 'ELISA', 'allows', 'to', 'e', 'g', 'determine', 'TCID', '50', 'of', 'virus', 'stocks', 'antiviral', 'efficiencies', 'IC', '50', 'values', 'of', 'drugs', 'or', 'neutralizing', 'activity', 'of', 'sera', 'Thus', 'the', 'in', 'cell', 'spike', 'ELISA', 'represents', 'a', 'promising', 'alternative', 'to', 'study', 'SARS', 'CoV', '2', 'infection', 'and', 'inhibition', 'and', 'may', 'facilitate', 'future', 'research', '']"
170494,Fighting COVID-19: Integrated Micro- and Nanosystems for Viral Infection Diagnostics,2020-07-09,Matter,https://api.elsevier.com/content/article/pii/S2590238520303052; https://doi.org/10.1016/j.matt.2020.06.015; https://www.sciencedirect.com/science/article/pii/S2590238520303052,"The pandemic of coronavirus disease 2019 (COVID-19) highlights the importance of rapid and sensitive diagnostics of viral infection that enables the efficient tracing of cases and the implementation of public health measures for disease containment. The immediate actions from both academia and industry have led to the development of many COVID-19 diagnostic systems that have secured fast-track regulatory approvals and have been serving our healthcare frontlines since the early stage of the pandemic. On diagnostic technologies, many of these clinically validated systems have significantly benefited from the recent advances in micro- and nanotechnologies in terms of platform design, analytical method, and system integration and miniaturization. The continued development of new diagnostic platforms integrating micro- and nanocomponents will address some of the shortcomings we have witnessed in the existing COVID-19 diagnostic systems. This Perspective reviews the previous and ongoing research efforts on developing integrated micro- and nanosystems for nucleic acid-based virus detection, and highlights promising technologies that could provide better solutions for the diagnosis of COVID-19 and other viral infectious diseases. With the summary and outlook of this rapidly evolving research field, we hope to inspire more research and development activities to better prepare our society for future public health crises.",10.1016/j.matt.2020.06.015,7v6rj65a,"['The', 'pandemic', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'highlights', 'the', 'importance', 'of', 'rapid', 'and', 'sensitive', 'diagnostics', 'of', 'viral', 'infection', 'that', 'enables', 'the', 'efficient', 'tracing', 'of', 'cases', 'and', 'the', 'implementation', 'of', 'public', 'health', 'measures', 'for', 'disease', 'containment', 'The', 'immediate', 'actions', 'from', 'both', 'academia', 'and', 'industry', 'have', 'led', 'to', 'the', 'development', 'of', 'many', 'COVID', '19', 'diagnostic', 'systems', 'that', 'have', 'secured', 'fast', 'track', 'regulatory', 'approvals', 'and', 'have', 'been', 'serving', 'our', 'healthcare', 'frontlines', 'since', 'the', 'early', 'stage', 'of', 'the', 'pandemic', 'On', 'diagnostic', 'technologies', 'many', 'of', 'these', 'clinically', 'validated', 'systems', 'have', 'significantly', 'benefited', 'from', 'the', 'recent', 'advances', 'in', 'micro', 'and', 'nanotechnologies', 'in', 'terms', 'of', 'platform', 'design', 'analytical', 'method', 'and', 'system', 'integration', 'and', 'miniaturization', 'The', 'continued', 'development', 'of', 'new', 'diagnostic', 'platforms', 'integrating', 'micro', 'and', 'nanocomponents', 'will', 'address', 'some', 'of', 'the', 'shortcomings', 'we', 'have', 'witnessed', 'in', 'the', 'existing', 'COVID', '19', 'diagnostic', 'systems', 'This', 'Perspective', 'reviews', 'the', 'previous', 'and', 'ongoing', 'research', 'efforts', 'on', 'developing', 'integrated', 'micro', 'and', 'nanosystems', 'for', 'nucleic', 'acid', 'based', 'virus', 'detection', 'and', 'highlights', 'promising', 'technologies', 'that', 'could', 'provide', 'better', 'solutions', 'for', 'the', 'diagnosis', 'of', 'COVID', '19', 'and', 'other', 'viral', 'infectious', 'diseases', 'With', 'the', 'summary', 'and', 'outlook', 'of', 'this', 'rapidly', 'evolving', 'research', 'field', 'we', 'hope', 'to', 'inspire', 'more', 'research', 'and', 'development', 'activities', 'to', 'better', 'prepare', 'our', 'society', 'for', 'future', 'public', 'health', 'crises', '']"
170517,"Discussing the ABCs of Health Security-Antibiotic Resistance, Biothreats, and Coronavirus.",2020-02-19,JAMA,https://www.ncbi.nlm.nih.gov/pubmed/32074261/; https://doi.org/10.1001/jama.2019.21022,"According to the World Health Organization (WHO), viral diseases continue to emerge and represent a serious issue to public health In the last twenty years, several viral epidemics such as the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 to 2003, and H1N1 influenza in 2009, have been recorded Most recently, the Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia in 2012 In a timeline that reaches the present day, an epidemic of cases with unexplained low respiratory infections detected in Wuhan, the largest metropolitan area in China's Hubei province, was first reported to the WHO Country Office in China, on December 31, 2019 Published literature can trace the beginning of symptomatic individuals back to the beginning of December 2019 As they were unable to identify the causative agent, these first cases were classified as ""pneumonia of unknown etiology "" The Chinese Center for Disease Control and Prevention (CDC) and local CDCs organized an intensive outbreak investigation program The etiology of this illness is now attributed to a novel virus belonging to the coronavirus (CoV) family, COVID-19 On February 11, 2020, the WHO Director-General, Dr Tedros Adhanom Ghebreyesus, announced that the disease caused by this new CoV was a ""COVID-19,"" which is the acronym of ""coronavirus disease 2019"" In the past twenty years, two additional coronavirus epidemics have occurred SARS-CoV provoked a large-scale epidemic beginning in China and involving two dozen countries with approximately 8000 cases and 800 deaths, and the MERS-CoV that began in Saudi Arabia and has approximately 2,500 cases and 800 deaths and still causes as sporadic cases This new virus seems to be very contagious and has quickly spread globally In a meeting on January 30, 2020, per the International Health Regulations (IHR, 2005), the outbreak was declared by the WHO a Public Health Emergency of International Concern (PHEIC) as it had spread to 18 countries with four countries reporting human-to-human transmission An additional landmark occurred on February 26, 2020, as the first case of the disease, not imported from China, was recorded in the United States Initially, the new virus was called 2019-nCoV Subsequently, the task of experts of the International Committee on Taxonomy of Viruses (ICTV) termed it the SARS-CoV-2 virus as it is very similar to the one that caused the SARS outbreak (SARS-CoVs) The CoVs have become the major pathogens of emerging respiratory disease outbreaks They are a large family of single-stranded RNA viruses (+ssRNA) that can be isolated in different animal species For reasons yet to be explained, these viruses can cross species barriers and can cause, in humans, illness ranging from the common cold to more severe diseases such as MERS and SARS Interestingly, these latter viruses have probably originated from bats and then moving into other mammalian hosts — the Himalayan palm civet for SARS-CoV, and the dromedary camel for MERS-CoV — before jumping to humans The dynamics of SARS-Cov-2 are currently unknown, but there is speculation that it also has an animal origin The potential for these viruses to grow to become a pandemic worldwide seems to be a serious public health risk Concerning COVID-19, the WHO raised the threat to the CoV epidemic to the ""very high"" level, on February 28, 2020 Probably, the effects of the epidemic caused by the new CoV has yet to emerge as the situation is quickly evolving World governments are at work to establish countermeasures to stem possible devastating effects Health organizations coordinate information flows and issues directives and guidelines to best mitigate the impact of the threat At the same time, scientists around the world work tirelessly, and information about the transmission mechanisms, the clinical spectrum of disease, new diagnostics, and prevention and therapeutic strategies are rapidly developing Many uncertainties remain with regard to both the virus-host interaction and the evolution of the epidemic, with specific reference to the times when the epidemic will reach its peak At the moment, the therapeutic strategies to deal with the infection are only supportive, and prevention aimed at reducing transmission in the community is our best weapon Aggressive isolation measures in China have led to a progressive reduction of cases in the last few days In Italy, in geographic regions of the north of the peninsula, political and health authorities are making incredible efforts to contain a shock wave that is severely testing the health system In the midst of the crisis, the authors have chosen to use the ""Statpearls"" platform because, within the PubMed scenario, it represents a unique tool that may allow them to make updates in real-time The aim, therefore, is to collect information and scientific evidence and to provide an overview of the topic that will be continuously updated",10.1001/jama.2019.21022,zzpw375i,"['According', 'to', 'the', 'World', 'Health', 'Organization', 'WHO', 'viral', 'diseases', 'continue', 'to', 'emerge', 'and', 'represent', 'a', 'serious', 'issue', 'to', 'public', 'health', 'In', 'the', 'last', 'twenty', 'years', 'several', 'viral', 'epidemics', 'such', 'as', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'SARS', 'CoV', 'in', '2002', 'to', '2003', 'and', 'H1N1', 'influenza', 'in', '2009', 'have', 'been', 'recorded', 'Most', 'recently', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'was', 'first', 'identified', 'in', 'Saudi', 'Arabia', 'in', '2012', 'In', 'a', 'timeline', 'that', 'reaches', 'the', 'present', 'day', 'an', 'epidemic', 'of', 'cases', 'with', 'unexplained', 'low', 'respiratory', 'infections', 'detected', 'in', 'Wuhan', 'the', 'largest', 'metropolitan', 'area', 'in', 'China', 's', 'Hubei', 'province', 'was', 'first', 'reported', 'to', 'the', 'WHO', 'Country', 'Office', 'in', 'China', 'on', 'December', '31', '2019', 'Published', 'literature', 'can', 'trace', 'the', 'beginning', 'of', 'symptomatic', 'individuals', 'back', 'to', 'the', 'beginning', 'of', 'December', '2019', 'As', 'they', 'were', 'unable', 'to', 'identify', 'the', 'causative', 'agent', 'these', 'first', 'cases', 'were', 'classified', 'as', 'pneumonia', 'of', 'unknown', 'etiology', 'The', 'Chinese', 'Center', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'and', 'local', 'CDCs', 'organized', 'an', 'intensive', 'outbreak', 'investigation', 'program', 'The', 'etiology', 'of', 'this', 'illness', 'is', 'now', 'attributed', 'to', 'a', 'novel', 'virus', 'belonging', 'to', 'the', 'coronavirus', 'CoV', 'family', 'COVID', '19', 'On', 'February', '11', '2020', 'the', 'WHO', 'Director', 'General', 'Dr', 'Tedros', 'Adhanom', 'Ghebreyesus', 'announced', 'that', 'the', 'disease', 'caused', 'by', 'this', 'new', 'CoV', 'was', 'a', 'COVID', '19', 'which', 'is', 'the', 'acronym', 'of', 'coronavirus', 'disease', '2019', 'In', 'the', 'past', 'twenty', 'years', 'two', 'additional', 'coronavirus', 'epidemics', 'have', 'occurred', 'SARS', 'CoV', 'provoked', 'a', 'large', 'scale', 'epidemic', 'beginning', 'in', 'China', 'and', 'involving', 'two', 'dozen', 'countries', 'with', 'approximately', '8000', 'cases', 'and', '800', 'deaths', 'and', 'the', 'MERS', 'CoV', 'that', 'began', 'in', 'Saudi', 'Arabia', 'and', 'has', 'approximately', '2', '500', 'cases', 'and', '800', 'deaths', 'and', 'still', 'causes', 'as', 'sporadic', 'cases', 'This', 'new', 'virus', 'seems', 'to', 'be', 'very', 'contagious', 'and', 'has', 'quickly', 'spread', 'globally', 'In', 'a', 'meeting', 'on', 'January', '30', '2020', 'per', 'the', 'International', 'Health', 'Regulations', 'IHR', '2005', 'the', 'outbreak', 'was', 'declared', 'by', 'the', 'WHO', 'a', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'PHEIC', 'as', 'it', 'had', 'spread', 'to', '18', 'countries', 'with', 'four', 'countries', 'reporting', 'human', 'to', 'human', 'transmission', 'An', 'additional', 'landmark', 'occurred', 'on', 'February', '26', '2020', 'as', 'the', 'first', 'case', 'of', 'the', 'disease', 'not', 'imported', 'from', 'China', 'was', 'recorded', 'in', 'the', 'United', 'States', 'Initially', 'the', 'new', 'virus', 'was', 'called', '2019', 'nCoV', 'Subsequently', 'the', 'task', 'of', 'experts', 'of', 'the', 'International', 'Committee', 'on', 'Taxonomy', 'of', 'Viruses', 'ICTV', 'termed', 'it', 'the', 'SARS', 'CoV', '2', 'virus', 'as', 'it', 'is', 'very', 'similar', 'to', 'the', 'one', 'that', 'caused', 'the', 'SARS', 'outbreak', 'SARS', 'CoVs', 'The', 'CoVs', 'have', 'become', 'the', 'major', 'pathogens', 'of', 'emerging', 'respiratory', 'disease', 'outbreaks', 'They', 'are', 'a', 'large', 'family', 'of', 'single', 'stranded', 'RNA', 'viruses', 'ssRNA', 'that', 'can', 'be', 'isolated', 'in', 'different', 'animal', 'species', 'For', 'reasons', 'yet', 'to', 'be', 'explained', 'these', 'viruses', 'can', 'cross', 'species', 'barriers', 'and', 'can', 'cause', 'in', 'humans', 'illness', 'ranging', 'from', 'the', 'common', 'cold', 'to', 'more', 'severe', 'diseases', 'such', 'as', 'MERS', 'and', 'SARS', 'Interestingly', 'these', 'latter', 'viruses', 'have', 'probably', 'originated', 'from', 'bats', 'and', 'then', 'moving', 'into', 'other', 'mammalian', 'hosts', 'the', 'Himalayan', 'palm', 'civet', 'for', 'SARS', 'CoV', 'and', 'the', 'dromedary', 'camel', 'for', 'MERS', 'CoV', 'before', 'jumping', 'to', 'humans', 'The', 'dynamics', 'of', 'SARS', 'Cov', '2', 'are', 'currently', 'unknown', 'but', 'there', 'is', 'speculation', 'that', 'it', 'also', 'has', 'an', 'animal', 'origin', 'The', 'potential', 'for', 'these', 'viruses', 'to', 'grow', 'to', 'become', 'a', 'pandemic', 'worldwide', 'seems', 'to', 'be', 'a', 'serious', 'public', 'health', 'risk', 'Concerning', 'COVID', '19', 'the', 'WHO', 'raised', 'the', 'threat', 'to', 'the', 'CoV', 'epidemic', 'to', 'the', 'very', 'high', 'level', 'on', 'February', '28', '2020', 'Probably', 'the', 'effects', 'of', 'the', 'epidemic', 'caused', 'by', 'the', 'new', 'CoV', 'has', 'yet', 'to', 'emerge', 'as', 'the', 'situation', 'is', 'quickly', 'evolving', 'World', 'governments', 'are', 'at', 'work', 'to', 'establish', 'countermeasures', 'to', 'stem', 'possible', 'devastating', 'effects', 'Health', 'organizations', 'coordinate', 'information', 'flows', 'and', 'issues', 'directives', 'and', 'guidelines', 'to', 'best', 'mitigate', 'the', 'impact', 'of', 'the', 'threat', 'At', 'the', 'same', 'time', 'scientists', 'around', 'the', 'world', 'work', 'tirelessly', 'and', 'information', 'about', 'the', 'transmission', 'mechanisms', 'the', 'clinical', 'spectrum', 'of', 'disease', 'new', 'diagnostics', 'and', 'prevention', 'and', 'therapeutic', 'strategies', 'are', 'rapidly', 'developing', 'Many', 'uncertainties', 'remain', 'with', 'regard', 'to', 'both', 'the', 'virus', 'host', 'interaction', 'and', 'the', 'evolution', 'of', 'the', 'epidemic', 'with', 'specific', 'reference', 'to', 'the', 'times', 'when', 'the', 'epidemic', 'will', 'reach', 'its', 'peak', 'At', 'the', 'moment', 'the', 'therapeutic', 'strategies', 'to', 'deal', 'with', 'the', 'infection', 'are', 'only', 'supportive', 'and', 'prevention', 'aimed', 'at', 'reducing', 'transmission', 'in', 'the', 'community', 'is', 'our', 'best', 'weapon', 'Aggressive', 'isolation', 'measures', 'in', 'China', 'have', 'led', 'to', 'a', 'progressive', 'reduction', 'of', 'cases', 'in', 'the', 'last', 'few', 'days', 'In', 'Italy', 'in', 'geographic', 'regions', 'of', 'the', 'north', 'of', 'the', 'peninsula', 'political', 'and', 'health', 'authorities', 'are', 'making', 'incredible', 'efforts', 'to', 'contain', 'a', 'shock', 'wave', 'that', 'is', 'severely', 'testing', 'the', 'health', 'system', 'In', 'the', 'midst', 'of', 'the', 'crisis', 'the', 'authors', 'have', 'chosen', 'to', 'use', 'the', 'Statpearls', 'platform', 'because', 'within', 'the', 'PubMed', 'scenario', 'it', 'represents', 'a', 'unique', 'tool', 'that', 'may', 'allow', 'them', 'to', 'make', 'updates', 'in', 'real', 'time', 'The', 'aim', 'therefore', 'is', 'to', 'collect', 'information', 'and', 'scientific', 'evidence', 'and', 'to', 'provide', 'an', 'overview', 'of', 'the', 'topic', 'that', 'will', 'be', 'continuously', 'updated']"
171228,"Clinical Epidemiology of Bocavirus, Rhinovirus, Two Polyomaviruses and Four Coronaviruses in HIV-Infected and HIV-Uninfected South African Children",2014-02-03,PLoS One,https://doi.org/10.1371/journal.pone.0086448; https://www.ncbi.nlm.nih.gov/pubmed/24498274/,"BACKGROUND: Advances in molecular diagnostics have implicated newly-discovered respiratory viruses in the pathogenesis of pneumonia. We aimed to determine the prevalence and clinical characteristics of human bocavirus (hBoV), human rhinovirus (hRV), polyomavirus-WU (WUPyV) and –KI (KIPyV) and human coronaviruses (CoV)-OC43, -NL63, -HKU1 and -229E among children hospitalized with lower respiratory tract infections (LRTI). METHODS: Multiplex real-time reverse-transcriptase polymerase chain reaction was undertaken on archived nasopharyngeal aspirates from HIV-infected and –uninfected children (<2 years age) hospitalized for LRTI, who had been previously investigated for respiratory syncytial virus, human metapneumovirus, parainfluenza I–III, adenovirus and influenza A/B. RESULTS: At least one of these viruses were identified in 274 (53.0%) of 517 and in 509 (54.0%) of 943 LRTI-episodes in HIV-infected and -uninfected children, respectively. Human rhinovirus was the most prevalent in HIV-infected (31.7%) and –uninfected children (32.0%), followed by CoV-OC43 (12.2%) and hBoV (9.5%) in HIV-infected; and by hBoV (13.3%) and WUPyV (11.9%) in HIV-uninfected children. Polyomavirus-KI (8.9% vs. 4.8%; p = 0.002) and CoV-OC43 (12.2% vs. 3.6%; p<0.001) were more prevalent in HIV-infected than –uninfected children. Combined with previously-tested viruses, respiratory viruses were identified in 60.9% of HIV-infected and 78.3% of HIV-uninfected children. The newly tested viruses were detected at high frequency in association with other respiratory viruses, including previously-investigated viruses (22.8% in HIV-infected and 28.5% in HIV–uninfected children). CONCLUSIONS: We established that combined with previously-investigated viruses, at least one respiratory virus was identified in the majority of HIV-infected and HIV-uninfected children hospitalized for LRTI. The high frequency of viral co-infections illustrates the complexities in attributing causality to specific viruses in the aetiology of LRTI and may indicate a synergetic role of viral co-infections in the pathogenesis of childhood LRTI.",10.1371/journal.pone.0086448,f9sdt7ax,"['BACKGROUND', 'Advances', 'in', 'molecular', 'diagnostics', 'have', 'implicated', 'newly', 'discovered', 'respiratory', 'viruses', 'in', 'the', 'pathogenesis', 'of', 'pneumonia', 'We', 'aimed', 'to', 'determine', 'the', 'prevalence', 'and', 'clinical', 'characteristics', 'of', 'human', 'bocavirus', 'hBoV', 'human', 'rhinovirus', 'hRV', 'polyomavirus', 'WU', 'WUPyV', 'and', 'KI', 'KIPyV', 'and', 'human', 'coronaviruses', 'CoV', 'OC43', 'NL63', 'HKU1', 'and', '229E', 'among', 'children', 'hospitalized', 'with', 'lower', 'respiratory', 'tract', 'infections', 'LRTI', 'METHODS', 'Multiplex', 'real', 'time', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'was', 'undertaken', 'on', 'archived', 'nasopharyngeal', 'aspirates', 'from', 'HIV', 'infected', 'and', 'uninfected', 'children', '2', 'years', 'age', 'hospitalized', 'for', 'LRTI', 'who', 'had', 'been', 'previously', 'investigated', 'for', 'respiratory', 'syncytial', 'virus', 'human', 'metapneumovirus', 'parainfluenza', 'I', 'III', 'adenovirus', 'and', 'influenza', 'A', 'B', 'RESULTS', 'At', 'least', 'one', 'of', 'these', 'viruses', 'were', 'identified', 'in', '274', '53', '0', 'of', '517', 'and', 'in', '509', '54', '0', 'of', '943', 'LRTI', 'episodes', 'in', 'HIV', 'infected', 'and', 'uninfected', 'children', 'respectively', 'Human', 'rhinovirus', 'was', 'the', 'most', 'prevalent', 'in', 'HIV', 'infected', '31', '7', 'and', 'uninfected', 'children', '32', '0', 'followed', 'by', 'CoV', 'OC43', '12', '2', 'and', 'hBoV', '9', '5', 'in', 'HIV', 'infected', 'and', 'by', 'hBoV', '13', '3', 'and', 'WUPyV', '11', '9', 'in', 'HIV', 'uninfected', 'children', 'Polyomavirus', 'KI', '8', '9', 'vs', '4', '8', 'p', '0', '002', 'and', 'CoV', 'OC43', '12', '2', 'vs', '3', '6', 'p', '0', '001', 'were', 'more', 'prevalent', 'in', 'HIV', 'infected', 'than', 'uninfected', 'children', 'Combined', 'with', 'previously', 'tested', 'viruses', 'respiratory', 'viruses', 'were', 'identified', 'in', '60', '9', 'of', 'HIV', 'infected', 'and', '78', '3', 'of', 'HIV', 'uninfected', 'children', 'The', 'newly', 'tested', 'viruses', 'were', 'detected', 'at', 'high', 'frequency', 'in', 'association', 'with', 'other', 'respiratory', 'viruses', 'including', 'previously', 'investigated', 'viruses', '22', '8', 'in', 'HIV', 'infected', 'and', '28', '5', 'in', 'HIV', 'uninfected', 'children', 'CONCLUSIONS', 'We', 'established', 'that', 'combined', 'with', 'previously', 'investigated', 'viruses', 'at', 'least', 'one', 'respiratory', 'virus', 'was', 'identified', 'in', 'the', 'majority', 'of', 'HIV', 'infected', 'and', 'HIV', 'uninfected', 'children', 'hospitalized', 'for', 'LRTI', 'The', 'high', 'frequency', 'of', 'viral', 'co', 'infections', 'illustrates', 'the', 'complexities', 'in', 'attributing', 'causality', 'to', 'specific', 'viruses', 'in', 'the', 'aetiology', 'of', 'LRTI', 'and', 'may', 'indicate', 'a', 'synergetic', 'role', 'of', 'viral', 'co', 'infections', 'in', 'the', 'pathogenesis', 'of', 'childhood', 'LRTI', '']"
171498,A complete sequence and comparative analysis of a SARS-associated virus (Isolate BJ01),2003,Chin Sci Bull,https://doi.org/10.1007/bf03184203; https://www.ncbi.nlm.nih.gov/pubmed/32214698/,"The genome sequence of the Severe Acute Respiratory Syndrome (SARS)-associated virus provides essential information for the identification of pathogen(s), exploration of etiology and evolution, interpretation of transmission and pathogenesis, development of diagnostics, prevention by future vaccination, and treatment by developing new drugs. We report the complete genome sequence and comparative analysis of an isolate (BJ01) of the coronavirus that has been recognized as a pathogen for SARS. The genome is 29725 nt in size and has 11 ORFs (Open Reading Frames). It is composed of a stable region encoding an RNA-dependent RNA polymerase (composed of 2 ORFs) and a variable region representing 4 CDSs (coding sequences) for viral structural genes (the S, E, M, N proteins) and 5 PUPs (putative uncharacterized proteins). Its gene order is identical to that of other known coronaviruses. The sequence alignment with all known RNA viruses places this virus as a member in the family of Coronaviridae. Thirty putative substitutions have been identified by comparative analysis of the 5 SARS-associated virus genome sequences in GenBank. Fifteen of them lead to possible amino acid changes (non-synonymous mutations) in the proteins. Three amino acid changes, with predicted alteration of physical and chemical features, have been detected in the S protein that is postulated to be involved in the immunoreactions between the virus and its host. Two amino acid changes have been detected in the M protein, which could be related to viral envelope formation. Phylogenetic analysis suggests the possibility of non-human origin of the SARS-associated viruses but provides no evidence that they are man-made. Further efforts should focus on identifying the etiology of the SARS-associated virus and ruling out conclusively the existence of other possible SARS-related pathogen(s).",10.1007/bf03184203,t3t20wji,"['The', 'genome', 'sequence', 'of', 'the', 'Severe', 'Acute', 'Respiratory', 'Syndrome', 'SARS', 'associated', 'virus', 'provides', 'essential', 'information', 'for', 'the', 'identification', 'of', 'pathogen', 's', 'exploration', 'of', 'etiology', 'and', 'evolution', 'interpretation', 'of', 'transmission', 'and', 'pathogenesis', 'development', 'of', 'diagnostics', 'prevention', 'by', 'future', 'vaccination', 'and', 'treatment', 'by', 'developing', 'new', 'drugs', 'We', 'report', 'the', 'complete', 'genome', 'sequence', 'and', 'comparative', 'analysis', 'of', 'an', 'isolate', 'BJ01', 'of', 'the', 'coronavirus', 'that', 'has', 'been', 'recognized', 'as', 'a', 'pathogen', 'for', 'SARS', 'The', 'genome', 'is', '29725', 'nt', 'in', 'size', 'and', 'has', '11', 'ORFs', 'Open', 'Reading', 'Frames', 'It', 'is', 'composed', 'of', 'a', 'stable', 'region', 'encoding', 'an', 'RNA', 'dependent', 'RNA', 'polymerase', 'composed', 'of', '2', 'ORFs', 'and', 'a', 'variable', 'region', 'representing', '4', 'CDSs', 'coding', 'sequences', 'for', 'viral', 'structural', 'genes', 'the', 'S', 'E', 'M', 'N', 'proteins', 'and', '5', 'PUPs', 'putative', 'uncharacterized', 'proteins', 'Its', 'gene', 'order', 'is', 'identical', 'to', 'that', 'of', 'other', 'known', 'coronaviruses', 'The', 'sequence', 'alignment', 'with', 'all', 'known', 'RNA', 'viruses', 'places', 'this', 'virus', 'as', 'a', 'member', 'in', 'the', 'family', 'of', 'Coronaviridae', 'Thirty', 'putative', 'substitutions', 'have', 'been', 'identified', 'by', 'comparative', 'analysis', 'of', 'the', '5', 'SARS', 'associated', 'virus', 'genome', 'sequences', 'in', 'GenBank', 'Fifteen', 'of', 'them', 'lead', 'to', 'possible', 'amino', 'acid', 'changes', 'non', 'synonymous', 'mutations', 'in', 'the', 'proteins', 'Three', 'amino', 'acid', 'changes', 'with', 'predicted', 'alteration', 'of', 'physical', 'and', 'chemical', 'features', 'have', 'been', 'detected', 'in', 'the', 'S', 'protein', 'that', 'is', 'postulated', 'to', 'be', 'involved', 'in', 'the', 'immunoreactions', 'between', 'the', 'virus', 'and', 'its', 'host', 'Two', 'amino', 'acid', 'changes', 'have', 'been', 'detected', 'in', 'the', 'M', 'protein', 'which', 'could', 'be', 'related', 'to', 'viral', 'envelope', 'formation', 'Phylogenetic', 'analysis', 'suggests', 'the', 'possibility', 'of', 'non', 'human', 'origin', 'of', 'the', 'SARS', 'associated', 'viruses', 'but', 'provides', 'no', 'evidence', 'that', 'they', 'are', 'man', 'made', 'Further', 'efforts', 'should', 'focus', 'on', 'identifying', 'the', 'etiology', 'of', 'the', 'SARS', 'associated', 'virus', 'and', 'ruling', 'out', 'conclusively', 'the', 'existence', 'of', 'other', 'possible', 'SARS', 'related', 'pathogen', 's', '']"
173456,"Virus detections among patients with severe acute respiratory illness, Northern Vietnam",2020-05-12,PLoS One,https://doi.org/10.1371/journal.pone.0233117; https://www.ncbi.nlm.nih.gov/pubmed/32396550/,"Severe acute respiratory illness (SARI) is a major cause of death and morbidity in low- and middle-income countries, however, the etiologic agents are often undetermined due to the lack of molecular diagnostics in hospitals and clinics. To examine evidence for select viral infections among patients with SARI in northern Vietnam, we studied 348 nasopharyngeal samples from military and civilian patients admitted to 4 hospitals in the greater Hanoi area from 2017–2019. Initial screening for human respiratory viral pathogens was performed in Hanoi, Vietnam at the National Institute of Hygiene and Epidemiology (NIHE) or the Military Institute of Preventative Medicine (MIPM), and an aliquot was shipped to Duke-NUS Medical School in Singapore for validation. Patient demographics were recorded and used to epidemiologically describe the infections. Among military and civilian cases of SARI, 184 (52.9%) tested positive for one or more respiratory viruses. Influenza A virus was the most prevalent virus detected (64.7%), followed by influenza B virus (29.3%), enterovirus (3.8%), adenovirus (1.1%), and coronavirus (1.1%). Risk factor analyses demonstrated an increased risk of influenza A virus detection among military hospital patients (adjusted OR, 2.0; 95% CI, 1.2–3.2), and an increased risk of influenza B virus detection among patients enrolled in year 2017 (adjusted OR, 7.9; 95% CI, 2.7–22.9). As influenza A and B viruses were commonly associated with SARI and are treatable, SARI patients entering these hospitals would benefit if the hospitals were able to adapt onsite molecular diagnostics.",10.1371/journal.pone.0233117,4b0mshqa,"['Severe', 'acute', 'respiratory', 'illness', 'SARI', 'is', 'a', 'major', 'cause', 'of', 'death', 'and', 'morbidity', 'in', 'low', 'and', 'middle', 'income', 'countries', 'however', 'the', 'etiologic', 'agents', 'are', 'often', 'undetermined', 'due', 'to', 'the', 'lack', 'of', 'molecular', 'diagnostics', 'in', 'hospitals', 'and', 'clinics', 'To', 'examine', 'evidence', 'for', 'select', 'viral', 'infections', 'among', 'patients', 'with', 'SARI', 'in', 'northern', 'Vietnam', 'we', 'studied', '348', 'nasopharyngeal', 'samples', 'from', 'military', 'and', 'civilian', 'patients', 'admitted', 'to', '4', 'hospitals', 'in', 'the', 'greater', 'Hanoi', 'area', 'from', '2017', '2019', 'Initial', 'screening', 'for', 'human', 'respiratory', 'viral', 'pathogens', 'was', 'performed', 'in', 'Hanoi', 'Vietnam', 'at', 'the', 'National', 'Institute', 'of', 'Hygiene', 'and', 'Epidemiology', 'NIHE', 'or', 'the', 'Military', 'Institute', 'of', 'Preventative', 'Medicine', 'MIPM', 'and', 'an', 'aliquot', 'was', 'shipped', 'to', 'Duke', 'NUS', 'Medical', 'School', 'in', 'Singapore', 'for', 'validation', 'Patient', 'demographics', 'were', 'recorded', 'and', 'used', 'to', 'epidemiologically', 'describe', 'the', 'infections', 'Among', 'military', 'and', 'civilian', 'cases', 'of', 'SARI', '184', '52', '9', 'tested', 'positive', 'for', 'one', 'or', 'more', 'respiratory', 'viruses', 'Influenza', 'A', 'virus', 'was', 'the', 'most', 'prevalent', 'virus', 'detected', '64', '7', 'followed', 'by', 'influenza', 'B', 'virus', '29', '3', 'enterovirus', '3', '8', 'adenovirus', '1', '1', 'and', 'coronavirus', '1', '1', 'Risk', 'factor', 'analyses', 'demonstrated', 'an', 'increased', 'risk', 'of', 'influenza', 'A', 'virus', 'detection', 'among', 'military', 'hospital', 'patients', 'adjusted', 'OR', '2', '0', '95', 'CI', '1', '2', '3', '2', 'and', 'an', 'increased', 'risk', 'of', 'influenza', 'B', 'virus', 'detection', 'among', 'patients', 'enrolled', 'in', 'year', '2017', 'adjusted', 'OR', '7', '9', '95', 'CI', '2', '7', '22', '9', 'As', 'influenza', 'A', 'and', 'B', 'viruses', 'were', 'commonly', 'associated', 'with', 'SARI', 'and', 'are', 'treatable', 'SARI', 'patients', 'entering', 'these', 'hospitals', 'would', 'benefit', 'if', 'the', 'hospitals', 'were', 'able', 'to', 'adapt', 'onsite', 'molecular', 'diagnostics', '']"
174139,Assessment of the Angolan (CHERRT) Mobile Laboratory Curriculum for Disaster and Pandemic Response,2020-04-13,West J Emerg Med,https://www.ncbi.nlm.nih.gov/pubmed/32302277/; https://doi.org/10.5811/westjem.2020.4.47385,"INTRODUCTION: As of April 5, 2020, the World Health Organization reported over one million confirmed cases and more than 62,000 confirmed coronavirus (COVID-19) deaths affecting 204 countries/regions. The lack of COVID-19 testing capacity threatens the ability of both the United States (US) and low middle income countries (LMIC) to respond to this growing threat, The purpose of this study was to assess the effectiveness through participant self-assessment of a rapid response team (RRT) mobile laboratory curriculum METHODS: We conducted a pre and post survey for the purpose of a process improvement assessment in Angola, involving 32 individuals. The survey was performed before and after a 14-day training workshop held in Luanda, Angola, in December 2019. A paired t-test was used to identify any significant change on six 7-point Likert scale questions with α< 0.05 (95% confidence interval). RESULTS: All six of the questions – 1) “I feel confident managing a real laboratory sample test for Ebola or other highly contagious sample;” 2) “I feel safe working in the lab environment during a real scenario;” 3) “I feel as if I can appropriately manage a potentially highly contagious laboratory sample;” 4)“I feel that I can interpret a positive or negative sample during a suspected contagious outbreak;” 5) “I understand basic Biobubble/mobile laboratory concepts and procedures;” and 6) “I understand polymerase chain reaction (PCR) principles” – showed statistical significant change pre and post training. Additionally, the final two questions – “I can more effectively perform my role/position because of the training I received during this course;” and “This training was valuable” – received high scores on the Likert scale. CONCLUSION: This Angolan RRT mobile laboratory training curriculum provides the nation of Angola with the confidence to rapidly respond and test at the national level a highly infectious contagion in the region and perform on-scene diagnostics. This mobile RRT laboratory provides a mobile and rapid diagnostic resource when epidemic/pandemic resource allocation may need to be prioritized based on confirmed disease prevalence.",10.5811/westjem.2020.4.47385,qmavade5,"['INTRODUCTION', 'As', 'of', 'April', '5', '2020', 'the', 'World', 'Health', 'Organization', 'reported', 'over', 'one', 'million', 'confirmed', 'cases', 'and', 'more', 'than', '62', '000', 'confirmed', 'coronavirus', 'COVID', '19', 'deaths', 'affecting', '204', 'countries', 'regions', 'The', 'lack', 'of', 'COVID', '19', 'testing', 'capacity', 'threatens', 'the', 'ability', 'of', 'both', 'the', 'United', 'States', 'US', 'and', 'low', 'middle', 'income', 'countries', 'LMIC', 'to', 'respond', 'to', 'this', 'growing', 'threat', 'The', 'purpose', 'of', 'this', 'study', 'was', 'to', 'assess', 'the', 'effectiveness', 'through', 'participant', 'self', 'assessment', 'of', 'a', 'rapid', 'response', 'team', 'RRT', 'mobile', 'laboratory', 'curriculum', 'METHODS', 'We', 'conducted', 'a', 'pre', 'and', 'post', 'survey', 'for', 'the', 'purpose', 'of', 'a', 'process', 'improvement', 'assessment', 'in', 'Angola', 'involving', '32', 'individuals', 'The', 'survey', 'was', 'performed', 'before', 'and', 'after', 'a', '14', 'day', 'training', 'workshop', 'held', 'in', 'Luanda', 'Angola', 'in', 'December', '2019', 'A', 'paired', 't', 'test', 'was', 'used', 'to', 'identify', 'any', 'significant', 'change', 'on', 'six', '7', 'point', 'Likert', 'scale', 'questions', 'with', 'α', '0', '05', '95', 'confidence', 'interval', 'RESULTS', 'All', 'six', 'of', 'the', 'questions', '1', 'I', 'feel', 'confident', 'managing', 'a', 'real', 'laboratory', 'sample', 'test', 'for', 'Ebola', 'or', 'other', 'highly', 'contagious', 'sample', '2', 'I', 'feel', 'safe', 'working', 'in', 'the', 'lab', 'environment', 'during', 'a', 'real', 'scenario', '3', 'I', 'feel', 'as', 'if', 'I', 'can', 'appropriately', 'manage', 'a', 'potentially', 'highly', 'contagious', 'laboratory', 'sample', '4', 'I', 'feel', 'that', 'I', 'can', 'interpret', 'a', 'positive', 'or', 'negative', 'sample', 'during', 'a', 'suspected', 'contagious', 'outbreak', '5', 'I', 'understand', 'basic', 'Biobubble', 'mobile', 'laboratory', 'concepts', 'and', 'procedures', 'and', '6', 'I', 'understand', 'polymerase', 'chain', 'reaction', 'PCR', 'principles', 'showed', 'statistical', 'significant', 'change', 'pre', 'and', 'post', 'training', 'Additionally', 'the', 'final', 'two', 'questions', 'I', 'can', 'more', 'effectively', 'perform', 'my', 'role', 'position', 'because', 'of', 'the', 'training', 'I', 'received', 'during', 'this', 'course', 'and', 'This', 'training', 'was', 'valuable', 'received', 'high', 'scores', 'on', 'the', 'Likert', 'scale', 'CONCLUSION', 'This', 'Angolan', 'RRT', 'mobile', 'laboratory', 'training', 'curriculum', 'provides', 'the', 'nation', 'of', 'Angola', 'with', 'the', 'confidence', 'to', 'rapidly', 'respond', 'and', 'test', 'at', 'the', 'national', 'level', 'a', 'highly', 'infectious', 'contagion', 'in', 'the', 'region', 'and', 'perform', 'on', 'scene', 'diagnostics', 'This', 'mobile', 'RRT', 'laboratory', 'provides', 'a', 'mobile', 'and', 'rapid', 'diagnostic', 'resource', 'when', 'epidemic', 'pandemic', 'resource', 'allocation', 'may', 'need', 'to', 'be', 'prioritized', 'based', 'on', 'confirmed', 'disease', 'prevalence', '']"
174337,New Respiratory Viruses and the Elderly,2011-07-06,Open Respir Med J,https://doi.org/10.2174/1874306401105010061; https://www.ncbi.nlm.nih.gov/pubmed/21760867/,"The diagnostics of respiratory viral infections has improved markedly during the last 15 years with the development of PCR techniques. Since 1997, several new respiratory viruses and their subgroups have been discovered: influenza A viruses H5N1 and H1N1, human metapneumovirus, coronaviruses SARS, NL63 and HKU1, human bocavirus, human rhinoviruses C and D and potential respiratory pathogens, the KI and WU polyomaviruses and the torque teno virus. The detection of previously known viruses has also improved. Currently, a viral cause of respiratory illness is almost exclusively identifiable in children, but in the elderly, the detection rates of a viral etiology are below 40%, and this holds also true for exacerbations of chronic respiratory illnesses. The new viruses cause respiratory symptoms like the common cold, cough, bronchitis, bronchiolitis, exacerbations of asthma and chronic obstructive pulmonary disease and pneumonia. Acute respiratory failure may occur. These viruses are distributed throughout the globe and affect people of all ages. Data regarding these viruses and the elderly are scarce. This review introduces these new viruses and reviews their clinical significance, especially with regard to the elderly population.",10.2174/1874306401105010061,7fwzohmu,"['The', 'diagnostics', 'of', 'respiratory', 'viral', 'infections', 'has', 'improved', 'markedly', 'during', 'the', 'last', '15', 'years', 'with', 'the', 'development', 'of', 'PCR', 'techniques', 'Since', '1997', 'several', 'new', 'respiratory', 'viruses', 'and', 'their', 'subgroups', 'have', 'been', 'discovered', 'influenza', 'A', 'viruses', 'H5N1', 'and', 'H1N1', 'human', 'metapneumovirus', 'coronaviruses', 'SARS', 'NL63', 'and', 'HKU1', 'human', 'bocavirus', 'human', 'rhinoviruses', 'C', 'and', 'D', 'and', 'potential', 'respiratory', 'pathogens', 'the', 'KI', 'and', 'WU', 'polyomaviruses', 'and', 'the', 'torque', 'teno', 'virus', 'The', 'detection', 'of', 'previously', 'known', 'viruses', 'has', 'also', 'improved', 'Currently', 'a', 'viral', 'cause', 'of', 'respiratory', 'illness', 'is', 'almost', 'exclusively', 'identifiable', 'in', 'children', 'but', 'in', 'the', 'elderly', 'the', 'detection', 'rates', 'of', 'a', 'viral', 'etiology', 'are', 'below', '40', 'and', 'this', 'holds', 'also', 'true', 'for', 'exacerbations', 'of', 'chronic', 'respiratory', 'illnesses', 'The', 'new', 'viruses', 'cause', 'respiratory', 'symptoms', 'like', 'the', 'common', 'cold', 'cough', 'bronchitis', 'bronchiolitis', 'exacerbations', 'of', 'asthma', 'and', 'chronic', 'obstructive', 'pulmonary', 'disease', 'and', 'pneumonia', 'Acute', 'respiratory', 'failure', 'may', 'occur', 'These', 'viruses', 'are', 'distributed', 'throughout', 'the', 'globe', 'and', 'affect', 'people', 'of', 'all', 'ages', 'Data', 'regarding', 'these', 'viruses', 'and', 'the', 'elderly', 'are', 'scarce', 'This', 'review', 'introduces', 'these', 'new', 'viruses', 'and', 'reviews', 'their', 'clinical', 'significance', 'especially', 'with', 'regard', 'to', 'the', 'elderly', 'population', '']"
175091,Evaluation of Commercial qPCR Kits for Detection of SARS-CoV-2 in Pooled Samples.,2020-07-11,Diagnostics,https://www.ncbi.nlm.nih.gov/pubmed/32664511/; https://doi.org/10.3390/diagnostics10070472,"Due to the current pandemic, a global shortage of reagents has drawn interest in developing alternatives to increase the number of coronavirus tests. One such alternative is sample pooling. We compared commercial kits that are used in COVID-19 diagnostics in terms of their sensitivity and feasibility for use in pooling. In this preliminary study, we showed that pooling of up to 80 samples did not affect the efficacy of the kits. Additionally, the RNA-dependent RNA polymerase (RdRp) gene is a more suitable target in pooled samples than the envelope (E) gene. This approach could provide an easy method of screening a large number of samples and help adjust different governmental regulations.",10.3390/diagnostics10070472,rz88g3ze,"['Due', 'to', 'the', 'current', 'pandemic', 'a', 'global', 'shortage', 'of', 'reagents', 'has', 'drawn', 'interest', 'in', 'developing', 'alternatives', 'to', 'increase', 'the', 'number', 'of', 'coronavirus', 'tests', 'One', 'such', 'alternative', 'is', 'sample', 'pooling', 'We', 'compared', 'commercial', 'kits', 'that', 'are', 'used', 'in', 'COVID', '19', 'diagnostics', 'in', 'terms', 'of', 'their', 'sensitivity', 'and', 'feasibility', 'for', 'use', 'in', 'pooling', 'In', 'this', 'preliminary', 'study', 'we', 'showed', 'that', 'pooling', 'of', 'up', 'to', '80', 'samples', 'did', 'not', 'affect', 'the', 'efficacy', 'of', 'the', 'kits', 'Additionally', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'gene', 'is', 'a', 'more', 'suitable', 'target', 'in', 'pooled', 'samples', 'than', 'the', 'envelope', 'E', 'gene', 'This', 'approach', 'could', 'provide', 'an', 'easy', 'method', 'of', 'screening', 'a', 'large', 'number', 'of', 'samples', 'and', 'help', 'adjust', 'different', 'governmental', 'regulations', '']"
175297,HRCT imaging features in representative imported cases of 2019 novel coronavirus pneumonia,2020-02-11,Precis Clin Med,https://doi.org/10.1093/pcmedi/pbaa004,"With the spread of novel coronavirus (2019-nCoV) pneumonia, chest high-resolution computed tomography (HRCT) has been one of the key diagnostic tools. To achieve early and accurate diagnostics, determining the radiological characteristics of the disease is of great importance. In this small scale research we retrospectively reviewed and selected six cases confirmed with 2019-nCoV infection in West China Hospital and investigated their initial and follow-up HRCT features, along with the clinical characteristics. The 2019-nCoV pneumonia basically showed a multifocal or unifocal involvement of ground-glass opacity (GGO), sometimes with consolidation and fibrosis. No pleural effusion or lymphadenopathy was identified in our presented cases. The follow-up CT generally demonstrated mild to moderate progression of the lesion, with only one case showing remission by the reducing extent and density of the airspace opacification.",10.1093/pcmedi/pbaa004,95t3zka6,"['With', 'the', 'spread', 'of', 'novel', 'coronavirus', '2019', 'nCoV', 'pneumonia', 'chest', 'high', 'resolution', 'computed', 'tomography', 'HRCT', 'has', 'been', 'one', 'of', 'the', 'key', 'diagnostic', 'tools', 'To', 'achieve', 'early', 'and', 'accurate', 'diagnostics', 'determining', 'the', 'radiological', 'characteristics', 'of', 'the', 'disease', 'is', 'of', 'great', 'importance', 'In', 'this', 'small', 'scale', 'research', 'we', 'retrospectively', 'reviewed', 'and', 'selected', 'six', 'cases', 'confirmed', 'with', '2019', 'nCoV', 'infection', 'in', 'West', 'China', 'Hospital', 'and', 'investigated', 'their', 'initial', 'and', 'follow', 'up', 'HRCT', 'features', 'along', 'with', 'the', 'clinical', 'characteristics', 'The', '2019', 'nCoV', 'pneumonia', 'basically', 'showed', 'a', 'multifocal', 'or', 'unifocal', 'involvement', 'of', 'ground', 'glass', 'opacity', 'GGO', 'sometimes', 'with', 'consolidation', 'and', 'fibrosis', 'No', 'pleural', 'effusion', 'or', 'lymphadenopathy', 'was', 'identified', 'in', 'our', 'presented', 'cases', 'The', 'follow', 'up', 'CT', 'generally', 'demonstrated', 'mild', 'to', 'moderate', 'progression', 'of', 'the', 'lesion', 'with', 'only', 'one', 'case', 'showing', 'remission', 'by', 'the', 'reducing', 'extent', 'and', 'density', 'of', 'the', 'airspace', 'opacification', '']"
175320,"Novel Coronavirus: Current Understanding of Clinical Features, Diagnosis, Pathogenesis, and Treatment Options",2020-04-17,Pathogens,https://doi.org/10.3390/pathogens9040297; https://www.ncbi.nlm.nih.gov/pubmed/32316618/,"Since December 2019, coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in devastating consequences worldwide and infected more than 350,000 individuals and killed more than 16,000 people. SARS-CoV-2 is the seventh member of the coronavirus family to affect humans. Symptoms of COVID-19 include fever (88%), cough (68%), vomiting (5%) and diarrhoea (3.7%), and transmission of SARS-CoV-2 is thought to occur from human to human via respiratory secretions released by the infected individuals when coughing and sneezing. COVID-19 can be detected through computed tomography scans and confirmed through molecular diagnostics tools such as polymerase chain reaction. Currently, there are no effective treatments against SARS-CoV-2, hence antiviral drugs have been used to reduce the development of respiratory complications by reducing viral load. The purpose of this review is to provide a comprehensive update on the pathogenesis, clinical aspects, diagnosis, challenges and treatment of SARS-CoV-2 infections.",10.3390/pathogens9040297,oyr03uw1,"['Since', 'December', '2019', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'resulted', 'in', 'devastating', 'consequences', 'worldwide', 'and', 'infected', 'more', 'than', '350', '000', 'individuals', 'and', 'killed', 'more', 'than', '16', '000', 'people', 'SARS', 'CoV', '2', 'is', 'the', 'seventh', 'member', 'of', 'the', 'coronavirus', 'family', 'to', 'affect', 'humans', 'Symptoms', 'of', 'COVID', '19', 'include', 'fever', '88', 'cough', '68', 'vomiting', '5', 'and', 'diarrhoea', '3', '7', 'and', 'transmission', 'of', 'SARS', 'CoV', '2', 'is', 'thought', 'to', 'occur', 'from', 'human', 'to', 'human', 'via', 'respiratory', 'secretions', 'released', 'by', 'the', 'infected', 'individuals', 'when', 'coughing', 'and', 'sneezing', 'COVID', '19', 'can', 'be', 'detected', 'through', 'computed', 'tomography', 'scans', 'and', 'confirmed', 'through', 'molecular', 'diagnostics', 'tools', 'such', 'as', 'polymerase', 'chain', 'reaction', 'Currently', 'there', 'are', 'no', 'effective', 'treatments', 'against', 'SARS', 'CoV', '2', 'hence', 'antiviral', 'drugs', 'have', 'been', 'used', 'to', 'reduce', 'the', 'development', 'of', 'respiratory', 'complications', 'by', 'reducing', 'viral', 'load', 'The', 'purpose', 'of', 'this', 'review', 'is', 'to', 'provide', 'a', 'comprehensive', 'update', 'on', 'the', 'pathogenesis', 'clinical', 'aspects', 'diagnosis', 'challenges', 'and', 'treatment', 'of', 'SARS', 'CoV', '2', 'infections', '']"
175419,"Oncocardiology: new challenges, new opportunities",2020-06-08,Herz,https://www.ncbi.nlm.nih.gov/pubmed/32514587/; https://doi.org/10.1007/s00059-020-04951-x,"Patients with cancer are at a higher risk of cardiovascular disease, which contributes to significant morbidity and mortality. The rapid progress in the field of oncological treatments has led to a steady increase in long-term cancer survivors. Care for cardiovascular complications is therefore becoming increasingly important. In addition, the establishment of new oncological therapies has resulted in the identification of previously unknown cardiovascular side effects. Oncocardiology aims to detect and treat cardiovascular diseases associated with cancer and cancer therapy. Continuous scientific, clinical, and structural developments are necessary as the basis for the best care of the growing number of affected patients. This review summarizes current developments in the field of oncocardiology with regard to advances in cancer therapy and challenges in clinical oncocardiology work. Cardiovascular side effects by targeted cancer therapies are characterized and recent advances in the field of cardiovascular diagnostics are outlined. Developments to better integrate oncocardiology into the medical care system and perspectives for modern, patient-oriented care are shown. In light of the coronavirus disease 2019 (COVID-19) pandemic, current challenges and opportunities are highlighted. The relevance of profitable further advances in oncocardiology including standardized guidelines and educational programs is delineated as a mandatory requirement for the successful development of oncocardiology.",10.1007/s00059-020-04951-x,m1o0wszu,"['Patients', 'with', 'cancer', 'are', 'at', 'a', 'higher', 'risk', 'of', 'cardiovascular', 'disease', 'which', 'contributes', 'to', 'significant', 'morbidity', 'and', 'mortality', 'The', 'rapid', 'progress', 'in', 'the', 'field', 'of', 'oncological', 'treatments', 'has', 'led', 'to', 'a', 'steady', 'increase', 'in', 'long', 'term', 'cancer', 'survivors', 'Care', 'for', 'cardiovascular', 'complications', 'is', 'therefore', 'becoming', 'increasingly', 'important', 'In', 'addition', 'the', 'establishment', 'of', 'new', 'oncological', 'therapies', 'has', 'resulted', 'in', 'the', 'identification', 'of', 'previously', 'unknown', 'cardiovascular', 'side', 'effects', 'Oncocardiology', 'aims', 'to', 'detect', 'and', 'treat', 'cardiovascular', 'diseases', 'associated', 'with', 'cancer', 'and', 'cancer', 'therapy', 'Continuous', 'scientific', 'clinical', 'and', 'structural', 'developments', 'are', 'necessary', 'as', 'the', 'basis', 'for', 'the', 'best', 'care', 'of', 'the', 'growing', 'number', 'of', 'affected', 'patients', 'This', 'review', 'summarizes', 'current', 'developments', 'in', 'the', 'field', 'of', 'oncocardiology', 'with', 'regard', 'to', 'advances', 'in', 'cancer', 'therapy', 'and', 'challenges', 'in', 'clinical', 'oncocardiology', 'work', 'Cardiovascular', 'side', 'effects', 'by', 'targeted', 'cancer', 'therapies', 'are', 'characterized', 'and', 'recent', 'advances', 'in', 'the', 'field', 'of', 'cardiovascular', 'diagnostics', 'are', 'outlined', 'Developments', 'to', 'better', 'integrate', 'oncocardiology', 'into', 'the', 'medical', 'care', 'system', 'and', 'perspectives', 'for', 'modern', 'patient', 'oriented', 'care', 'are', 'shown', 'In', 'light', 'of', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'pandemic', 'current', 'challenges', 'and', 'opportunities', 'are', 'highlighted', 'The', 'relevance', 'of', 'profitable', 'further', 'advances', 'in', 'oncocardiology', 'including', 'standardized', 'guidelines', 'and', 'educational', 'programs', 'is', 'delineated', 'as', 'a', 'mandatory', 'requirement', 'for', 'the', 'successful', 'development', 'of', 'oncocardiology', '']"
177282,Multifunctional nano-magnetic particles assisted viral RNA-extraction protocol for potential detection of COVID-19,2020-05-18,Mater. Res. Innov.,https://doi.org/10.1080/14328917.2020.1769350,"The enduring outbreak of the corona virus disease (COVID-19) originated from China illustrates global concerns owing to their infective nature and time-consuming incubation. Even though diagnostic tools based on RT-PCR are being extensively employed at present, well-timed and precise diagnostics are still restricted because of the long-period and exhaustive man-power requirement. To tackle this problem, we herewith report the fabrication of the surface functionalised magnetic nanoparticles (MNP’s) and viral RNA-extraction protocol for potential detection of COVID-19. The zinc ferrite nanoparticles were prepared by combustion synthesis and its surface was functionalised by silica and carboxyl-modified polyvinyl alcohol. The MNP’s were characterized to confirm the nano-scale appearance and functionalization. The proposed model may provide the ability to extract the viral RNA from several specimens through automation process. In light of ease and proficiency, this protocol may significantly lessen the operation period and necessities for the present molecular-level diagnostic of COVID-19.",10.1080/14328917.2020.1769350,2v1pqnjt,"['The', 'enduring', 'outbreak', 'of', 'the', 'corona', 'virus', 'disease', 'COVID', '19', 'originated', 'from', 'China', 'illustrates', 'global', 'concerns', 'owing', 'to', 'their', 'infective', 'nature', 'and', 'time', 'consuming', 'incubation', 'Even', 'though', 'diagnostic', 'tools', 'based', 'on', 'RT', 'PCR', 'are', 'being', 'extensively', 'employed', 'at', 'present', 'well', 'timed', 'and', 'precise', 'diagnostics', 'are', 'still', 'restricted', 'because', 'of', 'the', 'long', 'period', 'and', 'exhaustive', 'man', 'power', 'requirement', 'To', 'tackle', 'this', 'problem', 'we', 'herewith', 'report', 'the', 'fabrication', 'of', 'the', 'surface', 'functionalised', 'magnetic', 'nanoparticles', 'MNP', 's', 'and', 'viral', 'RNA', 'extraction', 'protocol', 'for', 'potential', 'detection', 'of', 'COVID', '19', 'The', 'zinc', 'ferrite', 'nanoparticles', 'were', 'prepared', 'by', 'combustion', 'synthesis', 'and', 'its', 'surface', 'was', 'functionalised', 'by', 'silica', 'and', 'carboxyl', 'modified', 'polyvinyl', 'alcohol', 'The', 'MNP', 's', 'were', 'characterized', 'to', 'confirm', 'the', 'nano', 'scale', 'appearance', 'and', 'functionalization', 'The', 'proposed', 'model', 'may', 'provide', 'the', 'ability', 'to', 'extract', 'the', 'viral', 'RNA', 'from', 'several', 'specimens', 'through', 'automation', 'process', 'In', 'light', 'of', 'ease', 'and', 'proficiency', 'this', 'protocol', 'may', 'significantly', 'lessen', 'the', 'operation', 'period', 'and', 'necessities', 'for', 'the', 'present', 'molecular', 'level', 'diagnostic', 'of', 'COVID', '19', '']"
178021,COVID-19 diagnostic approaches: different roads to the same destination,2020-06-13,Virusdisease,https://www.ncbi.nlm.nih.gov/pubmed/32656306/; https://doi.org/10.1007/s13337-020-00599-7,"“SARS-CoV2”, a previously unknown strain of coronaviruses caused a severe respiratory disease called Coronavirus disease (COVID-19) which emerged from Wuhan city of China on 30 December 2019, and declared as Global health problem by World Health Organisation within a month. In less than two and half months (11 March, 2020) it was declared as a pandemic disease due to its rapid spreading ability, it covered more than 211 countries infecting around 1.7 million persons and claiming around 1.1 lakhs lives within merely 100 days of its emergence. Containment of the infection of this virus is the only available measure to control the disease as no vaccine or specific antiviral treatment is available. Confirmed detection of the virus followed by isolation of the infected person at the earliest possible is the only measure to prevent this disease. Although there are number of methods available for detection of virus and to combat this disease in the present pandemic situation, but these available diagnostic methods have their own limitations. The speedy and exponential global spread of this disease strongly urges the fast and economic diagnostics tools. Additional to the available diagnostic methods, there is a sudden surge for development of various of methods and platforms to diagnose the COVID-19. The review summarized the advantage and disadvantage of various diagnostic approaches being used presently for COVID-19, newer detection methods in developmental stage and the feasibility of advanced platforms like newer nano-sensor based on-the-spot detection technologies.",10.1007/s13337-020-00599-7,xjzhilgm,"['', 'SARS', 'CoV2', 'a', 'previously', 'unknown', 'strain', 'of', 'coronaviruses', 'caused', 'a', 'severe', 'respiratory', 'disease', 'called', 'Coronavirus', 'disease', 'COVID', '19', 'which', 'emerged', 'from', 'Wuhan', 'city', 'of', 'China', 'on', '30', 'December', '2019', 'and', 'declared', 'as', 'Global', 'health', 'problem', 'by', 'World', 'Health', 'Organisation', 'within', 'a', 'month', 'In', 'less', 'than', 'two', 'and', 'half', 'months', '11', 'March', '2020', 'it', 'was', 'declared', 'as', 'a', 'pandemic', 'disease', 'due', 'to', 'its', 'rapid', 'spreading', 'ability', 'it', 'covered', 'more', 'than', '211', 'countries', 'infecting', 'around', '1', '7', 'million', 'persons', 'and', 'claiming', 'around', '1', '1', 'lakhs', 'lives', 'within', 'merely', '100', 'days', 'of', 'its', 'emergence', 'Containment', 'of', 'the', 'infection', 'of', 'this', 'virus', 'is', 'the', 'only', 'available', 'measure', 'to', 'control', 'the', 'disease', 'as', 'no', 'vaccine', 'or', 'specific', 'antiviral', 'treatment', 'is', 'available', 'Confirmed', 'detection', 'of', 'the', 'virus', 'followed', 'by', 'isolation', 'of', 'the', 'infected', 'person', 'at', 'the', 'earliest', 'possible', 'is', 'the', 'only', 'measure', 'to', 'prevent', 'this', 'disease', 'Although', 'there', 'are', 'number', 'of', 'methods', 'available', 'for', 'detection', 'of', 'virus', 'and', 'to', 'combat', 'this', 'disease', 'in', 'the', 'present', 'pandemic', 'situation', 'but', 'these', 'available', 'diagnostic', 'methods', 'have', 'their', 'own', 'limitations', 'The', 'speedy', 'and', 'exponential', 'global', 'spread', 'of', 'this', 'disease', 'strongly', 'urges', 'the', 'fast', 'and', 'economic', 'diagnostics', 'tools', 'Additional', 'to', 'the', 'available', 'diagnostic', 'methods', 'there', 'is', 'a', 'sudden', 'surge', 'for', 'development', 'of', 'various', 'of', 'methods', 'and', 'platforms', 'to', 'diagnose', 'the', 'COVID', '19', 'The', 'review', 'summarized', 'the', 'advantage', 'and', 'disadvantage', 'of', 'various', 'diagnostic', 'approaches', 'being', 'used', 'presently', 'for', 'COVID', '19', 'newer', 'detection', 'methods', 'in', 'developmental', 'stage', 'and', 'the', 'feasibility', 'of', 'advanced', 'platforms', 'like', 'newer', 'nano', 'sensor', 'based', 'on', 'the', 'spot', 'detection', 'technologies', '']"
178035,Monitoring approaches for health-care workers during the COVID-19 pandemic,2020-07-23,Lancet Infect Dis,https://api.elsevier.com/content/article/pii/S1473309920304588; https://www.ncbi.nlm.nih.gov/pubmed/32711692/; https://www.sciencedirect.com/science/article/pii/S1473309920304588; https://doi.org/10.1016/s1473-3099(20)30458-8,"Health-care workers are crucial to any health-care system. During the ongoing COVID-19 pandemic, health-care workers are at a substantially increased risk of becoming infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and could come to considerable harm as a result. Depending on the phase of the pandemic, patients with COVID-19 might not be the main source of SARS-CoV-2 infection and health-care workers could be exposed to atypical patients, infected family members, contacts, and colleagues, or live in communities of active transmission. Clear strategies to support and appropriately manage exposed and infected health-care workers are essential to ensure effective staff management and to engender trust in the workplace. These management strategies should focus on risk stratification, suitable clinical monitoring, low-threshold access to diagnostics, and decision making about removal from and return to work. Policy makers need to support health-care facilities in interpreting guidance during a pandemic that will probably be characterised by fluctuating local incidence of SARS-CoV-2 to mitigate the impact of this pandemic on their workforce.",10.1016/s1473-3099(20)30458-8,689at1qx,"['Health', 'care', 'workers', 'are', 'crucial', 'to', 'any', 'health', 'care', 'system', 'During', 'the', 'ongoing', 'COVID', '19', 'pandemic', 'health', 'care', 'workers', 'are', 'at', 'a', 'substantially', 'increased', 'risk', 'of', 'becoming', 'infected', 'with', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'and', 'could', 'come', 'to', 'considerable', 'harm', 'as', 'a', 'result', 'Depending', 'on', 'the', 'phase', 'of', 'the', 'pandemic', 'patients', 'with', 'COVID', '19', 'might', 'not', 'be', 'the', 'main', 'source', 'of', 'SARS', 'CoV', '2', 'infection', 'and', 'health', 'care', 'workers', 'could', 'be', 'exposed', 'to', 'atypical', 'patients', 'infected', 'family', 'members', 'contacts', 'and', 'colleagues', 'or', 'live', 'in', 'communities', 'of', 'active', 'transmission', 'Clear', 'strategies', 'to', 'support', 'and', 'appropriately', 'manage', 'exposed', 'and', 'infected', 'health', 'care', 'workers', 'are', 'essential', 'to', 'ensure', 'effective', 'staff', 'management', 'and', 'to', 'engender', 'trust', 'in', 'the', 'workplace', 'These', 'management', 'strategies', 'should', 'focus', 'on', 'risk', 'stratification', 'suitable', 'clinical', 'monitoring', 'low', 'threshold', 'access', 'to', 'diagnostics', 'and', 'decision', 'making', 'about', 'removal', 'from', 'and', 'return', 'to', 'work', 'Policy', 'makers', 'need', 'to', 'support', 'health', 'care', 'facilities', 'in', 'interpreting', 'guidance', 'during', 'a', 'pandemic', 'that', 'will', 'probably', 'be', 'characterised', 'by', 'fluctuating', 'local', 'incidence', 'of', 'SARS', 'CoV', '2', 'to', 'mitigate', 'the', 'impact', 'of', 'this', 'pandemic', 'on', 'their', 'workforce', '']"
178267,Multiple approaches for massively parallel sequencing of SARS-CoV-2 genomes directly from clinical samples,2020-06-30,Genome Med,https://www.ncbi.nlm.nih.gov/pubmed/32605661/; https://doi.org/10.1186/s13073-020-00751-4,"BACKGROUND: COVID-19 (coronavirus disease 2019) has caused a major epidemic worldwide; however, much is yet to be known about the epidemiology and evolution of the virus partly due to the scarcity of full-length SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) genomes reported. One reason is that the challenges underneath sequencing SARS-CoV-2 directly from clinical samples have not been completely tackled, i.e., sequencing samples with low viral load often results in insufficient viral reads for analyses. METHODS: We applied a novel multiplex PCR amplicon (amplicon)-based and hybrid capture (capture)-based sequencing, as well as ultra-high-throughput metatranscriptomic (meta) sequencing in retrieving complete genomes, inter-individual and intra-individual variations of SARS-CoV-2 from serials dilutions of a cultured isolate, and eight clinical samples covering a range of sample types and viral loads. We also examined and compared the sensitivity, accuracy, and other characteristics of these approaches in a comprehensive manner. RESULTS: We demonstrated that both amplicon and capture methods efficiently enriched SARS-CoV-2 content from clinical samples, while the enrichment efficiency of amplicon outran that of capture in more challenging samples. We found that capture was not as accurate as meta and amplicon in identifying between-sample variations, whereas amplicon method was not as accurate as the other two in investigating within-sample variations, suggesting amplicon sequencing was not suitable for studying virus-host interactions and viral transmission that heavily rely on intra-host dynamics. We illustrated that meta uncovered rich genetic information in the clinical samples besides SARS-CoV-2, providing references for clinical diagnostics and therapeutics. Taken all factors above and cost-effectiveness into consideration, we proposed guidance for how to choose sequencing strategy for SARS-CoV-2 under different situations. CONCLUSIONS: This is, to the best of our knowledge, the first work systematically investigating inter- and intra-individual variations of SARS-CoV-2 using amplicon- and capture-based whole-genome sequencing, as well as the first comparative study among multiple approaches. Our work offers practical solutions for genome sequencing and analyses of SARS-CoV-2 and other emerging viruses.",10.1186/s13073-020-00751-4,fe4q87ot,"['BACKGROUND', 'COVID', '19', 'coronavirus', 'disease', '2019', 'has', 'caused', 'a', 'major', 'epidemic', 'worldwide', 'however', 'much', 'is', 'yet', 'to', 'be', 'known', 'about', 'the', 'epidemiology', 'and', 'evolution', 'of', 'the', 'virus', 'partly', 'due', 'to', 'the', 'scarcity', 'of', 'full', 'length', 'SARS', 'CoV', '2', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'genomes', 'reported', 'One', 'reason', 'is', 'that', 'the', 'challenges', 'underneath', 'sequencing', 'SARS', 'CoV', '2', 'directly', 'from', 'clinical', 'samples', 'have', 'not', 'been', 'completely', 'tackled', 'i', 'e', 'sequencing', 'samples', 'with', 'low', 'viral', 'load', 'often', 'results', 'in', 'insufficient', 'viral', 'reads', 'for', 'analyses', 'METHODS', 'We', 'applied', 'a', 'novel', 'multiplex', 'PCR', 'amplicon', 'amplicon', 'based', 'and', 'hybrid', 'capture', 'capture', 'based', 'sequencing', 'as', 'well', 'as', 'ultra', 'high', 'throughput', 'metatranscriptomic', 'meta', 'sequencing', 'in', 'retrieving', 'complete', 'genomes', 'inter', 'individual', 'and', 'intra', 'individual', 'variations', 'of', 'SARS', 'CoV', '2', 'from', 'serials', 'dilutions', 'of', 'a', 'cultured', 'isolate', 'and', 'eight', 'clinical', 'samples', 'covering', 'a', 'range', 'of', 'sample', 'types', 'and', 'viral', 'loads', 'We', 'also', 'examined', 'and', 'compared', 'the', 'sensitivity', 'accuracy', 'and', 'other', 'characteristics', 'of', 'these', 'approaches', 'in', 'a', 'comprehensive', 'manner', 'RESULTS', 'We', 'demonstrated', 'that', 'both', 'amplicon', 'and', 'capture', 'methods', 'efficiently', 'enriched', 'SARS', 'CoV', '2', 'content', 'from', 'clinical', 'samples', 'while', 'the', 'enrichment', 'efficiency', 'of', 'amplicon', 'outran', 'that', 'of', 'capture', 'in', 'more', 'challenging', 'samples', 'We', 'found', 'that', 'capture', 'was', 'not', 'as', 'accurate', 'as', 'meta', 'and', 'amplicon', 'in', 'identifying', 'between', 'sample', 'variations', 'whereas', 'amplicon', 'method', 'was', 'not', 'as', 'accurate', 'as', 'the', 'other', 'two', 'in', 'investigating', 'within', 'sample', 'variations', 'suggesting', 'amplicon', 'sequencing', 'was', 'not', 'suitable', 'for', 'studying', 'virus', 'host', 'interactions', 'and', 'viral', 'transmission', 'that', 'heavily', 'rely', 'on', 'intra', 'host', 'dynamics', 'We', 'illustrated', 'that', 'meta', 'uncovered', 'rich', 'genetic', 'information', 'in', 'the', 'clinical', 'samples', 'besides', 'SARS', 'CoV', '2', 'providing', 'references', 'for', 'clinical', 'diagnostics', 'and', 'therapeutics', 'Taken', 'all', 'factors', 'above', 'and', 'cost', 'effectiveness', 'into', 'consideration', 'we', 'proposed', 'guidance', 'for', 'how', 'to', 'choose', 'sequencing', 'strategy', 'for', 'SARS', 'CoV', '2', 'under', 'different', 'situations', 'CONCLUSIONS', 'This', 'is', 'to', 'the', 'best', 'of', 'our', 'knowledge', 'the', 'first', 'work', 'systematically', 'investigating', 'inter', 'and', 'intra', 'individual', 'variations', 'of', 'SARS', 'CoV', '2', 'using', 'amplicon', 'and', 'capture', 'based', 'whole', 'genome', 'sequencing', 'as', 'well', 'as', 'the', 'first', 'comparative', 'study', 'among', 'multiple', 'approaches', 'Our', 'work', 'offers', 'practical', 'solutions', 'for', 'genome', 'sequencing', 'and', 'analyses', 'of', 'SARS', 'CoV', '2', 'and', 'other', 'emerging', 'viruses', '']"
178774,RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses,2020-04-06,bioRxiv,https://doi.org/10.1101/2020.03.27.012906; https://www.ncbi.nlm.nih.gov/pubmed/32511306/,"As the COVID-19 outbreak spreads, there is a growing need for a compilation of conserved RNA genome regions in the SARS-CoV-2 virus along with their structural propensities to guide development of antivirals and diagnostics. Using sequence alignments spanning a range of betacoronaviruses, we rank genomic regions by RNA sequence conservation, identifying 79 regions of length at least 15 nucleotides as exactly conserved over SARS-related complete genome sequences available near the beginning of the COVID-19 outbreak. We then confirm the conservation of the majority of these genome regions across 739 SARS-CoV-2 sequences reported to date from the current COVID-19 outbreak, and we present a curated list of 30 ‘SARS-related-conserved’ regions. We find that known RNA structured elements curated as Rfam families and in prior literature are enriched in these conserved genome regions, and we predict additional conserved, stable secondary structures across the viral genome. We provide 106 ‘SARS-CoV-2-conserved-structured’ regions as potential targets for antivirals that bind to structured RNA. We further provide detailed secondary structure models for the 5’ UTR, frame-shifting element, and 3’ UTR. Last, we predict regions of the SARS-CoV-2 viral genome have low propensity for RNA secondary structure and are conserved within SARS-CoV-2 strains. These 59 ‘SARS-CoV-2-conserved-unstructured’ genomic regions may be most easily targeted in primer-based diagnostic and oligonucleotide-based therapeutic strategies.",10.1101/2020.03.27.012906,c8f7a9bq,"['As', 'the', 'COVID', '19', 'outbreak', 'spreads', 'there', 'is', 'a', 'growing', 'need', 'for', 'a', 'compilation', 'of', 'conserved', 'RNA', 'genome', 'regions', 'in', 'the', 'SARS', 'CoV', '2', 'virus', 'along', 'with', 'their', 'structural', 'propensities', 'to', 'guide', 'development', 'of', 'antivirals', 'and', 'diagnostics', 'Using', 'sequence', 'alignments', 'spanning', 'a', 'range', 'of', 'betacoronaviruses', 'we', 'rank', 'genomic', 'regions', 'by', 'RNA', 'sequence', 'conservation', 'identifying', '79', 'regions', 'of', 'length', 'at', 'least', '15', 'nucleotides', 'as', 'exactly', 'conserved', 'over', 'SARS', 'related', 'complete', 'genome', 'sequences', 'available', 'near', 'the', 'beginning', 'of', 'the', 'COVID', '19', 'outbreak', 'We', 'then', 'confirm', 'the', 'conservation', 'of', 'the', 'majority', 'of', 'these', 'genome', 'regions', 'across', '739', 'SARS', 'CoV', '2', 'sequences', 'reported', 'to', 'date', 'from', 'the', 'current', 'COVID', '19', 'outbreak', 'and', 'we', 'present', 'a', 'curated', 'list', 'of', '30', 'SARS', 'related', 'conserved', 'regions', 'We', 'find', 'that', 'known', 'RNA', 'structured', 'elements', 'curated', 'as', 'Rfam', 'families', 'and', 'in', 'prior', 'literature', 'are', 'enriched', 'in', 'these', 'conserved', 'genome', 'regions', 'and', 'we', 'predict', 'additional', 'conserved', 'stable', 'secondary', 'structures', 'across', 'the', 'viral', 'genome', 'We', 'provide', '106', 'SARS', 'CoV', '2', 'conserved', 'structured', 'regions', 'as', 'potential', 'targets', 'for', 'antivirals', 'that', 'bind', 'to', 'structured', 'RNA', 'We', 'further', 'provide', 'detailed', 'secondary', 'structure', 'models', 'for', 'the', '5', 'UTR', 'frame', 'shifting', 'element', 'and', '3', 'UTR', 'Last', 'we', 'predict', 'regions', 'of', 'the', 'SARS', 'CoV', '2', 'viral', 'genome', 'have', 'low', 'propensity', 'for', 'RNA', 'secondary', 'structure', 'and', 'are', 'conserved', 'within', 'SARS', 'CoV', '2', 'strains', 'These', '59', 'SARS', 'CoV', '2', 'conserved', 'unstructured', 'genomic', 'regions', 'may', 'be', 'most', 'easily', 'targeted', 'in', 'primer', 'based', 'diagnostic', 'and', 'oligonucleotide', 'based', 'therapeutic', 'strategies', '']"
178785,An enhanced isothermal amplification assay for viral detection,2020-05-29,bioRxiv,https://www.ncbi.nlm.nih.gov/pubmed/32577657/; https://doi.org/10.1101/2020.05.28.118059,"Rapid, inexpensive, robust diagnostics are essential to control the spread of infectious diseases. Current state of the art diagnostics are highly sensitive and specific, but slow, and require expensive equipment. We developed a molecular diagnostic test for SARS-CoV-2, FIND (Fast Isothermal Nucleic acid Detection), based on an enhanced isothermal recombinase polymerase amplification reaction. FIND has a detection limit on patient samples close to that of RT-qPCR, requires minimal instrumentation, and is highly scalable and cheap. It can be performed in high throughput, does not cross-react with other common coronaviruses, avoids bottlenecks caused by the current worldwide shortage of RNA isolation kits, and takes ~45 minutes from sample collection to results. FIND can be adapted to future novel viruses in days once sequence is available. One sentence summary Sensitive, specific, rapid, scalable, enhanced isothermal amplification method for detecting SARS-CoV-2 from patient samples.",10.1101/2020.05.28.118059,k2ihqdq5,"['Rapid', 'inexpensive', 'robust', 'diagnostics', 'are', 'essential', 'to', 'control', 'the', 'spread', 'of', 'infectious', 'diseases', 'Current', 'state', 'of', 'the', 'art', 'diagnostics', 'are', 'highly', 'sensitive', 'and', 'specific', 'but', 'slow', 'and', 'require', 'expensive', 'equipment', 'We', 'developed', 'a', 'molecular', 'diagnostic', 'test', 'for', 'SARS', 'CoV', '2', 'FIND', 'Fast', 'Isothermal', 'Nucleic', 'acid', 'Detection', 'based', 'on', 'an', 'enhanced', 'isothermal', 'recombinase', 'polymerase', 'amplification', 'reaction', 'FIND', 'has', 'a', 'detection', 'limit', 'on', 'patient', 'samples', 'close', 'to', 'that', 'of', 'RT', 'qPCR', 'requires', 'minimal', 'instrumentation', 'and', 'is', 'highly', 'scalable', 'and', 'cheap', 'It', 'can', 'be', 'performed', 'in', 'high', 'throughput', 'does', 'not', 'cross', 'react', 'with', 'other', 'common', 'coronaviruses', 'avoids', 'bottlenecks', 'caused', 'by', 'the', 'current', 'worldwide', 'shortage', 'of', 'RNA', 'isolation', 'kits', 'and', 'takes', '45', 'minutes', 'from', 'sample', 'collection', 'to', 'results', 'FIND', 'can', 'be', 'adapted', 'to', 'future', 'novel', 'viruses', 'in', 'days', 'once', 'sequence', 'is', 'available', 'One', 'sentence', 'summary', 'Sensitive', 'specific', 'rapid', 'scalable', 'enhanced', 'isothermal', 'amplification', 'method', 'for', 'detecting', 'SARS', 'CoV', '2', 'from', 'patient', 'samples', '']"
179444,28 New and Emerging Infections of the Lung,2019-12-31,Kendig's Disorders of the Respiratory Tract in Children,https://www.sciencedirect.com/science/article/pii/B9780323448871000286; https://api.elsevier.com/content/article/pii/B9780323448871000286,"Abstract In this era of rapid globalization and frequent travel, emerging viral infections have gained an immense potential to spread at an unprecedented speed and scale compared with the past. This poses a significant challenge to coordinated international efforts in global surveillance and infection control. Significantly, respiratory viral infections, spread mostly via droplet transmission, are extremely contagious and have caused significant morbidity and mortality during outbreaks in the last decade. Molecular diagnostics via reverse transcriptase polymerase chain reaction (RT-PCR) have been key in the rapid diagnosis of most of these viral infections. However, a high index of suspicion and early institution of appropriate isolation measures remain as the mainstay in the control and containment of the spread of these viral infections. Although treatment for most of the viral infections remains supportive, efficacious antiviral agents against influenza infections exist. The infections discussed in this chapter include those first described in the 2000s: Middle East respiratory syndrome coronavirus (MERS-CoV) and metapneumovirus and rhinovirus C as well as those that have been described in the past but have reemerged in the last decade in outbreaks resulting in significant morbidity and mortality, including adenovirus, influenza virus, and enterovirus D68 (EV-D68).",10.1016/b978-0-323-44887-1.00028-6,vbdb0x3m,"['Abstract', 'In', 'this', 'era', 'of', 'rapid', 'globalization', 'and', 'frequent', 'travel', 'emerging', 'viral', 'infections', 'have', 'gained', 'an', 'immense', 'potential', 'to', 'spread', 'at', 'an', 'unprecedented', 'speed', 'and', 'scale', 'compared', 'with', 'the', 'past', 'This', 'poses', 'a', 'significant', 'challenge', 'to', 'coordinated', 'international', 'efforts', 'in', 'global', 'surveillance', 'and', 'infection', 'control', 'Significantly', 'respiratory', 'viral', 'infections', 'spread', 'mostly', 'via', 'droplet', 'transmission', 'are', 'extremely', 'contagious', 'and', 'have', 'caused', 'significant', 'morbidity', 'and', 'mortality', 'during', 'outbreaks', 'in', 'the', 'last', 'decade', 'Molecular', 'diagnostics', 'via', 'reverse', 'transcriptase', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'have', 'been', 'key', 'in', 'the', 'rapid', 'diagnosis', 'of', 'most', 'of', 'these', 'viral', 'infections', 'However', 'a', 'high', 'index', 'of', 'suspicion', 'and', 'early', 'institution', 'of', 'appropriate', 'isolation', 'measures', 'remain', 'as', 'the', 'mainstay', 'in', 'the', 'control', 'and', 'containment', 'of', 'the', 'spread', 'of', 'these', 'viral', 'infections', 'Although', 'treatment', 'for', 'most', 'of', 'the', 'viral', 'infections', 'remains', 'supportive', 'efficacious', 'antiviral', 'agents', 'against', 'influenza', 'infections', 'exist', 'The', 'infections', 'discussed', 'in', 'this', 'chapter', 'include', 'those', 'first', 'described', 'in', 'the', '2000s', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'and', 'metapneumovirus', 'and', 'rhinovirus', 'C', 'as', 'well', 'as', 'those', 'that', 'have', 'been', 'described', 'in', 'the', 'past', 'but', 'have', 'reemerged', 'in', 'the', 'last', 'decade', 'in', 'outbreaks', 'resulting', 'in', 'significant', 'morbidity', 'and', 'mortality', 'including', 'adenovirus', 'influenza', 'virus', 'and', 'enterovirus', 'D68', 'EV', 'D68', '']"
179778,Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation,2020-05-27,Clin Res Cardiol,https://doi.org/10.1007/s00392-020-01656-3; https://www.ncbi.nlm.nih.gov/pubmed/32462267/,"Coronavirus diseases 2019 (COVID-19) has become a worldwide pandemic affecting people at high risk and particularly at advanced age, cardiovascular and pulmonary disease. As cardiovascular patients are at high risk but also have dyspnea and fatigue as leading symptoms, prevention, diagnostics and treatment in these patients are important to provide adequate care for those with or without COVID-19 but most importantly when comorbid cardiovascular conditions are present. Severe COVID-19 with acute respiratory distress (ARDS) is challenging as patients with elevated myocardial markers such as troponin are at enhanced high risk for fatal outcomes. As angiotensin-converting enzyme 2 (ACE2) is regarded as the viral receptor for cell entry and as the Coronavirus is downregulating this enzyme, which provides cardiovascular and pulmonary protection, there is ongoing discussions on whether treatment with cardiovascular drugs, which upregulate the viral receptor ACE2 should be modified. As most of the COVID-19 patients have cardiovascular comorbidities like hypertension, diabetes, coronary artery disease and heart failure, which imposes a high risk on these patients, cardiovascular therapy should not be modified or even withdrawn. As cardiac injury is a common feature of COVID-19 associated ARDS and is linked with poor outcomes, swift diagnostic management and specialist care of cardiovascular patients in the area of COVID-19 is of particular importance and deserves special attention.",10.1007/s00392-020-01656-3,2oxe8a6h,"['Coronavirus', 'diseases', '2019', 'COVID', '19', 'has', 'become', 'a', 'worldwide', 'pandemic', 'affecting', 'people', 'at', 'high', 'risk', 'and', 'particularly', 'at', 'advanced', 'age', 'cardiovascular', 'and', 'pulmonary', 'disease', 'As', 'cardiovascular', 'patients', 'are', 'at', 'high', 'risk', 'but', 'also', 'have', 'dyspnea', 'and', 'fatigue', 'as', 'leading', 'symptoms', 'prevention', 'diagnostics', 'and', 'treatment', 'in', 'these', 'patients', 'are', 'important', 'to', 'provide', 'adequate', 'care', 'for', 'those', 'with', 'or', 'without', 'COVID', '19', 'but', 'most', 'importantly', 'when', 'comorbid', 'cardiovascular', 'conditions', 'are', 'present', 'Severe', 'COVID', '19', 'with', 'acute', 'respiratory', 'distress', 'ARDS', 'is', 'challenging', 'as', 'patients', 'with', 'elevated', 'myocardial', 'markers', 'such', 'as', 'troponin', 'are', 'at', 'enhanced', 'high', 'risk', 'for', 'fatal', 'outcomes', 'As', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'is', 'regarded', 'as', 'the', 'viral', 'receptor', 'for', 'cell', 'entry', 'and', 'as', 'the', 'Coronavirus', 'is', 'downregulating', 'this', 'enzyme', 'which', 'provides', 'cardiovascular', 'and', 'pulmonary', 'protection', 'there', 'is', 'ongoing', 'discussions', 'on', 'whether', 'treatment', 'with', 'cardiovascular', 'drugs', 'which', 'upregulate', 'the', 'viral', 'receptor', 'ACE2', 'should', 'be', 'modified', 'As', 'most', 'of', 'the', 'COVID', '19', 'patients', 'have', 'cardiovascular', 'comorbidities', 'like', 'hypertension', 'diabetes', 'coronary', 'artery', 'disease', 'and', 'heart', 'failure', 'which', 'imposes', 'a', 'high', 'risk', 'on', 'these', 'patients', 'cardiovascular', 'therapy', 'should', 'not', 'be', 'modified', 'or', 'even', 'withdrawn', 'As', 'cardiac', 'injury', 'is', 'a', 'common', 'feature', 'of', 'COVID', '19', 'associated', 'ARDS', 'and', 'is', 'linked', 'with', 'poor', 'outcomes', 'swift', 'diagnostic', 'management', 'and', 'specialist', 'care', 'of', 'cardiovascular', 'patients', 'in', 'the', 'area', 'of', 'COVID', '19', 'is', 'of', 'particular', 'importance', 'and', 'deserves', 'special', 'attention', '']"
179904,"Update: Public Health Response to the Coronavirus Disease 2019 Outbreak — United States, February 24, 2020",2020-02-28,MMWR Morb Mortal Wkly Rep,https://doi.org/10.15585/mmwr.mm6908e1; https://www.ncbi.nlm.nih.gov/pubmed/32106216/,"An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in Wuhan, Hubei Province, China in December 2019, and has spread throughout China and to 31 other countries and territories, including the United States (1). As of February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases in locations outside mainland China (1). There have been 2,462 associated deaths worldwide; no deaths have been reported in the United States. Fourteen cases have been diagnosed in the United States, and an additional 39 cases have occurred among repatriated persons from high-risk settings, for a current total of 53 cases within the United States. This report summarizes the aggressive measures (2,3) that CDC, state and local health departments, multiple other federal agencies, and other partners are implementing to slow and try to contain transmission of COVID-19 in the United States. These measures require the identification of cases and contacts of persons with COVID-19 in the United States and the recommended assessment, monitoring, and care of travelers arriving from areas with substantial COVID-19 transmission. Although these measures might not prevent widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare state and local health departments, health care systems, businesses, educational organizations, and the general public in the event that widespread transmission occurs; and 3) better characterize COVID-19 to guide public health recommendations and the development and deployment of medical countermeasures, including diagnostics, therapeutics, and vaccines. U.S. public health authorities are monitoring the situation closely, and CDC is coordinating efforts with the World Health Organization (WHO) and other global partners. Interim guidance is available at https://www.cdc.gov/coronavirus/index.html. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC, state and local health departments, health care providers, and communities.",10.15585/mmwr.mm6908e1,l4o7nicc,"['An', 'outbreak', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'the', '2019', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'began', 'in', 'Wuhan', 'Hubei', 'Province', 'China', 'in', 'December', '2019', 'and', 'has', 'spread', 'throughout', 'China', 'and', 'to', '31', 'other', 'countries', 'and', 'territories', 'including', 'the', 'United', 'States', '1', 'As', 'of', 'February', '23', '2020', 'there', 'were', '76', '936', 'reported', 'cases', 'in', 'mainland', 'China', 'and', '1', '875', 'cases', 'in', 'locations', 'outside', 'mainland', 'China', '1', 'There', 'have', 'been', '2', '462', 'associated', 'deaths', 'worldwide', 'no', 'deaths', 'have', 'been', 'reported', 'in', 'the', 'United', 'States', 'Fourteen', 'cases', 'have', 'been', 'diagnosed', 'in', 'the', 'United', 'States', 'and', 'an', 'additional', '39', 'cases', 'have', 'occurred', 'among', 'repatriated', 'persons', 'from', 'high', 'risk', 'settings', 'for', 'a', 'current', 'total', 'of', '53', 'cases', 'within', 'the', 'United', 'States', 'This', 'report', 'summarizes', 'the', 'aggressive', 'measures', '2', '3', 'that', 'CDC', 'state', 'and', 'local', 'health', 'departments', 'multiple', 'other', 'federal', 'agencies', 'and', 'other', 'partners', 'are', 'implementing', 'to', 'slow', 'and', 'try', 'to', 'contain', 'transmission', 'of', 'COVID', '19', 'in', 'the', 'United', 'States', 'These', 'measures', 'require', 'the', 'identification', 'of', 'cases', 'and', 'contacts', 'of', 'persons', 'with', 'COVID', '19', 'in', 'the', 'United', 'States', 'and', 'the', 'recommended', 'assessment', 'monitoring', 'and', 'care', 'of', 'travelers', 'arriving', 'from', 'areas', 'with', 'substantial', 'COVID', '19', 'transmission', 'Although', 'these', 'measures', 'might', 'not', 'prevent', 'widespread', 'transmission', 'of', 'the', 'virus', 'in', 'the', 'United', 'States', 'they', 'are', 'being', 'implemented', 'to', '1', 'slow', 'the', 'spread', 'of', 'illness', '2', 'provide', 'time', 'to', 'better', 'prepare', 'state', 'and', 'local', 'health', 'departments', 'health', 'care', 'systems', 'businesses', 'educational', 'organizations', 'and', 'the', 'general', 'public', 'in', 'the', 'event', 'that', 'widespread', 'transmission', 'occurs', 'and', '3', 'better', 'characterize', 'COVID', '19', 'to', 'guide', 'public', 'health', 'recommendations', 'and', 'the', 'development', 'and', 'deployment', 'of', 'medical', 'countermeasures', 'including', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'U', 'S', 'public', 'health', 'authorities', 'are', 'monitoring', 'the', 'situation', 'closely', 'and', 'CDC', 'is', 'coordinating', 'efforts', 'with', 'the', 'World', 'Health', 'Organization', 'WHO', 'and', 'other', 'global', 'partners', 'Interim', 'guidance', 'is', 'available', 'at', 'https', 'www', 'cdc', 'gov', 'coronavirus', 'index', 'html', 'As', 'more', 'is', 'learned', 'about', 'this', 'novel', 'virus', 'and', 'this', 'outbreak', 'CDC', 'will', 'rapidly', 'incorporate', 'new', 'knowledge', 'into', 'guidance', 'for', 'action', 'by', 'CDC', 'state', 'and', 'local', 'health', 'departments', 'health', 'care', 'providers', 'and', 'communities', '']"
180098,Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2,2020-05-18,Emerg Microbes Infect,https://www.ncbi.nlm.nih.gov/pubmed/32306853/; https://doi.org/10.1080/22221751.2020.1756698,"The previous outbreaks of SARS-CoV and MERS-CoV have led researchers to study the role of diagnostics in impediment of further spread and transmission. With the recent emergence of the novel SARS-CoV-2, the availability of rapid, sensitive, and reliable diagnostic methods is essential for disease control. Hence, we have developed a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for the specific detection of SARS-CoV-2. The primer sets for RT-LAMP assay were designed to target the nucleocapsid gene of the viral RNA, and displayed a detection limit of 10(2) RNA copies close to that of qRT-PCR. Notably, the assay has exhibited a rapid detection span of 30 min combined with the colorimetric visualization. This test can detect specifically viral RNAs of the SARS-CoV-2 with no cross-reactivity to related coronaviruses, such as HCoV-229E, HCoV-NL63, HCoV-OC43, and MERS-CoV as well as human infectious influenza viruses (type B, H1N1pdm, H3N2, H5N1, H5N6, H5N8, and H7N9), and other respiratory disease-causing viruses (RSVA, RSVB, ADV, PIV, MPV, and HRV). Furthermore, the developed RT-LAMP assay has been evaluated using specimens collected from COVID-19 patients that exhibited high agreement to the qRT-PCR. Our RT-LAMP assay is simple to perform, less expensive, time-efficient, and can be used in clinical laboratories for preliminary detection of SARS-CoV-2 in suspected patients. In addition to the high sensitivity and specificity, this isothermal amplification conjugated with a single-tube colorimetric detection method may contribute to the public health responses and disease control, especially in the areas with limited laboratory capacities.",10.1080/22221751.2020.1756698,sdde8bgd,"['The', 'previous', 'outbreaks', 'of', 'SARS', 'CoV', 'and', 'MERS', 'CoV', 'have', 'led', 'researchers', 'to', 'study', 'the', 'role', 'of', 'diagnostics', 'in', 'impediment', 'of', 'further', 'spread', 'and', 'transmission', 'With', 'the', 'recent', 'emergence', 'of', 'the', 'novel', 'SARS', 'CoV', '2', 'the', 'availability', 'of', 'rapid', 'sensitive', 'and', 'reliable', 'diagnostic', 'methods', 'is', 'essential', 'for', 'disease', 'control', 'Hence', 'we', 'have', 'developed', 'a', 'reverse', 'transcription', 'loop', 'mediated', 'isothermal', 'amplification', 'RT', 'LAMP', 'assay', 'for', 'the', 'specific', 'detection', 'of', 'SARS', 'CoV', '2', 'The', 'primer', 'sets', 'for', 'RT', 'LAMP', 'assay', 'were', 'designed', 'to', 'target', 'the', 'nucleocapsid', 'gene', 'of', 'the', 'viral', 'RNA', 'and', 'displayed', 'a', 'detection', 'limit', 'of', '10', '2', 'RNA', 'copies', 'close', 'to', 'that', 'of', 'qRT', 'PCR', 'Notably', 'the', 'assay', 'has', 'exhibited', 'a', 'rapid', 'detection', 'span', 'of', '30', 'min', 'combined', 'with', 'the', 'colorimetric', 'visualization', 'This', 'test', 'can', 'detect', 'specifically', 'viral', 'RNAs', 'of', 'the', 'SARS', 'CoV', '2', 'with', 'no', 'cross', 'reactivity', 'to', 'related', 'coronaviruses', 'such', 'as', 'HCoV', '229E', 'HCoV', 'NL63', 'HCoV', 'OC43', 'and', 'MERS', 'CoV', 'as', 'well', 'as', 'human', 'infectious', 'influenza', 'viruses', 'type', 'B', 'H1N1pdm', 'H3N2', 'H5N1', 'H5N6', 'H5N8', 'and', 'H7N9', 'and', 'other', 'respiratory', 'disease', 'causing', 'viruses', 'RSVA', 'RSVB', 'ADV', 'PIV', 'MPV', 'and', 'HRV', 'Furthermore', 'the', 'developed', 'RT', 'LAMP', 'assay', 'has', 'been', 'evaluated', 'using', 'specimens', 'collected', 'from', 'COVID', '19', 'patients', 'that', 'exhibited', 'high', 'agreement', 'to', 'the', 'qRT', 'PCR', 'Our', 'RT', 'LAMP', 'assay', 'is', 'simple', 'to', 'perform', 'less', 'expensive', 'time', 'efficient', 'and', 'can', 'be', 'used', 'in', 'clinical', 'laboratories', 'for', 'preliminary', 'detection', 'of', 'SARS', 'CoV', '2', 'in', 'suspected', 'patients', 'In', 'addition', 'to', 'the', 'high', 'sensitivity', 'and', 'specificity', 'this', 'isothermal', 'amplification', 'conjugated', 'with', 'a', 'single', 'tube', 'colorimetric', 'detection', 'method', 'may', 'contribute', 'to', 'the', 'public', 'health', 'responses', 'and', 'disease', 'control', 'especially', 'in', 'the', 'areas', 'with', 'limited', 'laboratory', 'capacities', '']"
180407,Fifty-Five Years of International Epidemic-Assistance Investigations Conducted by CDC’s Disease Detectives,2011-12-01,Am J Epidemiol,https://www.ncbi.nlm.nih.gov/pubmed/22135398/; https://doi.org/10.1093/aje/kwr312,"For more than 60 years, the Centers for Disease Control and Prevention (CDC) has used its scientific expertise to help people throughout the world live healthier, safer, longer lives through science-based health action. In 1951, CDC officially established the Epidemic Intelligence Service to help build public health capacity. During 1950–2005, CDC’s Epidemic Intelligence Service officers conducted 462 international epidemiologic field investigations in 131 foreign countries and 7 territories. Investigations have included responding to emerging infectious and noninfectious disease outbreaks, assisting in disaster response, and evaluating core components of public health programs worldwide. Approximately 81% of investigations were responses to infectious disease outbreaks, but the proportion of investigations related to chronic and other noninfectious conditions increased 7-fold (6%–45%). These investigations have contributed to detecting and characterizing new pathogens (e.g., severe acute respiratory syndrome–associated coronavirus) and conditions, provided insights regarding factors that cause or contribute to disease acquisition (e.g., Ebola hemorrhagic fever), led to development of new diagnostics and surveillance technologies, and provided information upon which global health policies and regulations can be based. CDC’s disease detectives will undoubtedly continue to play a critical role in global health and in responding to emerging global disease threats.",10.1093/aje/kwr312,0u6idk0m,"['For', 'more', 'than', '60', 'years', 'the', 'Centers', 'for', 'Disease', 'Control', 'and', 'Prevention', 'CDC', 'has', 'used', 'its', 'scientific', 'expertise', 'to', 'help', 'people', 'throughout', 'the', 'world', 'live', 'healthier', 'safer', 'longer', 'lives', 'through', 'science', 'based', 'health', 'action', 'In', '1951', 'CDC', 'officially', 'established', 'the', 'Epidemic', 'Intelligence', 'Service', 'to', 'help', 'build', 'public', 'health', 'capacity', 'During', '1950', '2005', 'CDC', 's', 'Epidemic', 'Intelligence', 'Service', 'officers', 'conducted', '462', 'international', 'epidemiologic', 'field', 'investigations', 'in', '131', 'foreign', 'countries', 'and', '7', 'territories', 'Investigations', 'have', 'included', 'responding', 'to', 'emerging', 'infectious', 'and', 'noninfectious', 'disease', 'outbreaks', 'assisting', 'in', 'disaster', 'response', 'and', 'evaluating', 'core', 'components', 'of', 'public', 'health', 'programs', 'worldwide', 'Approximately', '81', 'of', 'investigations', 'were', 'responses', 'to', 'infectious', 'disease', 'outbreaks', 'but', 'the', 'proportion', 'of', 'investigations', 'related', 'to', 'chronic', 'and', 'other', 'noninfectious', 'conditions', 'increased', '7', 'fold', '6', '45', 'These', 'investigations', 'have', 'contributed', 'to', 'detecting', 'and', 'characterizing', 'new', 'pathogens', 'e', 'g', 'severe', 'acute', 'respiratory', 'syndrome', 'associated', 'coronavirus', 'and', 'conditions', 'provided', 'insights', 'regarding', 'factors', 'that', 'cause', 'or', 'contribute', 'to', 'disease', 'acquisition', 'e', 'g', 'Ebola', 'hemorrhagic', 'fever', 'led', 'to', 'development', 'of', 'new', 'diagnostics', 'and', 'surveillance', 'technologies', 'and', 'provided', 'information', 'upon', 'which', 'global', 'health', 'policies', 'and', 'regulations', 'can', 'be', 'based', 'CDC', 's', 'disease', 'detectives', 'will', 'undoubtedly', 'continue', 'to', 'play', 'a', 'critical', 'role', 'in', 'global', 'health', 'and', 'in', 'responding', 'to', 'emerging', 'global', 'disease', 'threats', '']"
180800,"Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned",2020-03-16,Emerg Microbes Infect,https://doi.org/10.1080/22221751.2020.1738905; https://www.ncbi.nlm.nih.gov/pubmed/32174267/,"Unexplained pneumonia (UP) caused by a novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) emerged in China in late December 2019 and has infected more than 9000 cases by 31 January 2020. Shanghai reported the first imported case of COVID-19 (Coronavirus Disease 2019) in 20 January 2020. A combinative approach of real-time RT–PCR, CRISPR-based assay and metagenomic next-generation sequencing (mNGS) were used to diagnose this unexplained pneumonia patient. Real-time RT–PCR and CRISPR-based assay both reported positive. This sample belonged to Betacoronavirus and shared a more than 99% nucleotide (nt) identity with the Wuhan SARS-CoV-2 isolates. We further compared pros and cons of common molecular diagnostics in UP. In this study, we illustrated the importance of combining molecular diagnostics to rule out common pathogens and performed mNGS to obtain unbiased potential pathogen result for the diagnosis of UP.",10.1080/22221751.2020.1738905,vfq5ft08,"['Unexplained', 'pneumonia', 'UP', 'caused', 'by', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'emerged', 'in', 'China', 'in', 'late', 'December', '2019', 'and', 'has', 'infected', 'more', 'than', '9000', 'cases', 'by', '31', 'January', '2020', 'Shanghai', 'reported', 'the', 'first', 'imported', 'case', 'of', 'COVID', '19', 'Coronavirus', 'Disease', '2019', 'in', '20', 'January', '2020', 'A', 'combinative', 'approach', 'of', 'real', 'time', 'RT', 'PCR', 'CRISPR', 'based', 'assay', 'and', 'metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'were', 'used', 'to', 'diagnose', 'this', 'unexplained', 'pneumonia', 'patient', 'Real', 'time', 'RT', 'PCR', 'and', 'CRISPR', 'based', 'assay', 'both', 'reported', 'positive', 'This', 'sample', 'belonged', 'to', 'Betacoronavirus', 'and', 'shared', 'a', 'more', 'than', '99', 'nucleotide', 'nt', 'identity', 'with', 'the', 'Wuhan', 'SARS', 'CoV', '2', 'isolates', 'We', 'further', 'compared', 'pros', 'and', 'cons', 'of', 'common', 'molecular', 'diagnostics', 'in', 'UP', 'In', 'this', 'study', 'we', 'illustrated', 'the', 'importance', 'of', 'combining', 'molecular', 'diagnostics', 'to', 'rule', 'out', 'common', 'pathogens', 'and', 'performed', 'mNGS', 'to', 'obtain', 'unbiased', 'potential', 'pathogen', 'result', 'for', 'the', 'diagnosis', 'of', 'UP', '']"
181484,Prise en charge des exacerbations : de la ville à l’hôpital,2015-04-30,Journal Européen des Urgences et de Réanimation,https://api.elsevier.com/content/article/pii/S2211423815000036; https://www.sciencedirect.com/science/article/pii/S2211423815000036,"Points essentiels La Société de pneumologie de langue française définie l’exacerbation aiguë de bronchopneumopathie chronique obstructive comme une majoration des symptômes respiratoires au-delà des variations quotidiennes (en pratique, d’une durée ≥ 48 h ou justifiant une modification thérapeutique). La cause de ces exacerbations est principalement infectieuse : virale (rhinovirus, virus influenzae et parainfluenzae, coronavirus, adénovirus et virus respiratoire syncytial) ou bactérienne (principalement, Haemophilus influenzae, Streptococcus pneumoniae et Moraxella catarrhalis). Elles peuvent également résulter de l’exposition à certains polluants : NO2, SO2, ozone et pollution particulaire (PM10 et PM2,5). Elle reste indéterminée dans près de 30 % des cas. Les diagnostics différentiels incluent les pneumopathies infectieuses, les pneumothorax, les poussées d’insuffisance cardiaque et les embolies pulmonaires. La présence de signes de gravité conditionne l’hospitalisation : signes d’insuffisance respiratoire aiguë, de choc ou de défaillance neurologique, mais aussi en cas de patient fragile, d’absence de soutien familial à domicile ou de réponse au traitement initial. Le traitement consiste en une majoration des bronchodilatateurs, une kinésithérapie respiratoire, une antibiothérapie en cas d’expectoration franchement purulente. La prescription de corticoïdes systémiques ne doit pas être systématique. La dose recommandée est de 0,5 mg/kg sur une courte période (5–7 jours). Lors d’une hospitalisation, une oxygénothérapie et une thromboprophylaxie peuvent être instaurées. La ventilation non invasive est principalement indiquée en cas de persistance d’une hypercapnie malgré un traitement médical optimal. Que le patient soit pris en charge en ambulatoire ou en hospitalisation, une réévaluation clinique à 48–72 h est indispensable. Key points The Société de pneumologie de langue française defines acute exacerbation of chronic obstructive pulmonary disease (AE COPD) as an increase in daily respiratory symptoms, basically duration ≥ 48h or need for treatment adjustment. Etiology of EA COPD are mainly infectious, viral (rhinovirus, influenzae or parainfluenzae virus, coronavirus, adenovirus and respiratory syncytial virus) or bacterial (Haemophilus influenzae, Streptococcus pneumoniae, or Moraxella catarrhalis). Pollutant exposure can also lead to AE COPD, such as NO2, SO2, ozone or particulates (PM10 and PM2.5). In 30% the etiology remains unknown. Differential diagnoses of AE COPD include infectious pneumonia, pneumothorax, acute heart failure and pulmonary embolism. Presences of signs of severity impose hospitalization: signs of respiratory distress, shock, acute confusion but also fragile patients, insufficient home support or absence of response to initial treatment. AE COPD treatments consist on increase in bronchodilators, chest physiotherapy, and antibiotics if sputum is frankly purulent. Systemic corticosteroids should not be systematic. Recommended dose is 0.5 mg/kg on short course (5–7 days). During hospitalization, oxygen supplementation and thromboprophylaxis could be prescribed. The main interest in non-invasive ventilation is persistent hypercapnia despite optimal medical management. During ambulatory management or hospitalization, clinical assessment at 48–72 h is mandatory.",10.1016/j.jeurea.2015.02.002,icowa7wn,"['Points', 'essentiels', 'La', 'Société', 'de', 'pneumologie', 'de', 'langue', 'française', 'définie', 'l', 'exacerbation', 'aiguë', 'de', 'bronchopneumopathie', 'chronique', 'obstructive', 'comme', 'une', 'majoration', 'des', 'symptômes', 'respiratoires', 'au', 'delà', 'des', 'variations', 'quotidiennes', 'en', 'pratique', 'd', 'une', 'durée', '48', 'h', 'ou', 'justifiant', 'une', 'modification', 'thérapeutique', 'La', 'cause', 'de', 'ces', 'exacerbations', 'est', 'principalement', 'infectieuse', 'virale', 'rhinovirus', 'virus', 'influenzae', 'et', 'parainfluenzae', 'coronavirus', 'adénovirus', 'et', 'virus', 'respiratoire', 'syncytial', 'ou', 'bactérienne', 'principalement', 'Haemophilus', 'influenzae', 'Streptococcus', 'pneumoniae', 'et', 'Moraxella', 'catarrhalis', 'Elles', 'peuvent', 'également', 'résulter', 'de', 'l', 'exposition', 'à', 'certains', 'polluants', 'NO2', 'SO2', 'ozone', 'et', 'pollution', 'particulaire', 'PM10', 'et', 'PM2', '5', 'Elle', 'reste', 'indéterminée', 'dans', 'près', 'de', '30', 'des', 'cas', 'Les', 'diagnostics', 'différentiels', 'incluent', 'les', 'pneumopathies', 'infectieuses', 'les', 'pneumothorax', 'les', 'poussées', 'd', 'insuffisance', 'cardiaque', 'et', 'les', 'embolies', 'pulmonaires', 'La', 'présence', 'de', 'signes', 'de', 'gravité', 'conditionne', 'l', 'hospitalisation', 'signes', 'd', 'insuffisance', 'respiratoire', 'aiguë', 'de', 'choc', 'ou', 'de', 'défaillance', 'neurologique', 'mais', 'aussi', 'en', 'cas', 'de', 'patient', 'fragile', 'd', 'absence', 'de', 'soutien', 'familial', 'à', 'domicile', 'ou', 'de', 'réponse', 'au', 'traitement', 'initial', 'Le', 'traitement', 'consiste', 'en', 'une', 'majoration', 'des', 'bronchodilatateurs', 'une', 'kinésithérapie', 'respiratoire', 'une', 'antibiothérapie', 'en', 'cas', 'd', 'expectoration', 'franchement', 'purulente', 'La', 'prescription', 'de', 'corticoïdes', 'systémiques', 'ne', 'doit', 'pas', 'être', 'systématique', 'La', 'dose', 'recommandée', 'est', 'de', '0', '5', 'mg', 'kg', 'sur', 'une', 'courte', 'période', '5', '7', 'jours', 'Lors', 'd', 'une', 'hospitalisation', 'une', 'oxygénothérapie', 'et', 'une', 'thromboprophylaxie', 'peuvent', 'être', 'instaurées', 'La', 'ventilation', 'non', 'invasive', 'est', 'principalement', 'indiquée', 'en', 'cas', 'de', 'persistance', 'd', 'une', 'hypercapnie', 'malgré', 'un', 'traitement', 'médical', 'optimal', 'Que', 'le', 'patient', 'soit', 'pris', 'en', 'charge', 'en', 'ambulatoire', 'ou', 'en', 'hospitalisation', 'une', 'réévaluation', 'clinique', 'à', '48', '72', 'h', 'est', 'indispensable', 'Key', 'points', 'The', 'Société', 'de', 'pneumologie', 'de', 'langue', 'française', 'defines', 'acute', 'exacerbation', 'of', 'chronic', 'obstructive', 'pulmonary', 'disease', 'AE', 'COPD', 'as', 'an', 'increase', 'in', 'daily', 'respiratory', 'symptoms', 'basically', 'duration', '48h', 'or', 'need', 'for', 'treatment', 'adjustment', 'Etiology', 'of', 'EA', 'COPD', 'are', 'mainly', 'infectious', 'viral', 'rhinovirus', 'influenzae', 'or', 'parainfluenzae', 'virus', 'coronavirus', 'adenovirus', 'and', 'respiratory', 'syncytial', 'virus', 'or', 'bacterial', 'Haemophilus', 'influenzae', 'Streptococcus', 'pneumoniae', 'or', 'Moraxella', 'catarrhalis', 'Pollutant', 'exposure', 'can', 'also', 'lead', 'to', 'AE', 'COPD', 'such', 'as', 'NO2', 'SO2', 'ozone', 'or', 'particulates', 'PM10', 'and', 'PM2', '5', 'In', '30', 'the', 'etiology', 'remains', 'unknown', 'Differential', 'diagnoses', 'of', 'AE', 'COPD', 'include', 'infectious', 'pneumonia', 'pneumothorax', 'acute', 'heart', 'failure', 'and', 'pulmonary', 'embolism', 'Presences', 'of', 'signs', 'of', 'severity', 'impose', 'hospitalization', 'signs', 'of', 'respiratory', 'distress', 'shock', 'acute', 'confusion', 'but', 'also', 'fragile', 'patients', 'insufficient', 'home', 'support', 'or', 'absence', 'of', 'response', 'to', 'initial', 'treatment', 'AE', 'COPD', 'treatments', 'consist', 'on', 'increase', 'in', 'bronchodilators', 'chest', 'physiotherapy', 'and', 'antibiotics', 'if', 'sputum', 'is', 'frankly', 'purulent', 'Systemic', 'corticosteroids', 'should', 'not', 'be', 'systematic', 'Recommended', 'dose', 'is', '0', '5', 'mg', 'kg', 'on', 'short', 'course', '5', '7', 'days', 'During', 'hospitalization', 'oxygen', 'supplementation', 'and', 'thromboprophylaxis', 'could', 'be', 'prescribed', 'The', 'main', 'interest', 'in', 'non', 'invasive', 'ventilation', 'is', 'persistent', 'hypercapnia', 'despite', 'optimal', 'medical', 'management', 'During', 'ambulatory', 'management', 'or', 'hospitalization', 'clinical', 'assessment', 'at', '48', '72', 'h', 'is', 'mandatory', '']"
181943,Qualitative Assessment of Rapid System Transformation to Primary Care Video Visits at an Academic Medical Center,2020-07-06,Ann Intern Med,https://doi.org/10.7326/m20-1814; https://www.ncbi.nlm.nih.gov/pubmed/32628536/,"BACKGROUND: The coronavirus disease 2019 pandemic spurred health systems across the world to quickly shift from in-person visits to safer video visits. OBJECTIVE: To seek stakeholder perspectives on video visits' acceptability and effect 3 weeks after near-total transition to video visits. DESIGN: Semistructured qualitative interviews. SETTING: 6 Stanford general primary care and express care clinics at 6 northern California sites, with 81 providers, 123 staff, and 97 614 patient visits in 2019. PARTICIPANTS: Fifty-three program participants (overlapping roles as medical providers [n = 20], medical assistants [n = 16], nurses [n = 4], technologists [n = 4], and administrators [n = 13]) were interviewed about video visit transition and challenges. INTERVENTION: In 3 weeks, express care and primary care video visits increased from less than 10% to greater than 80% and from less than 10% to greater than 75%, respectively. New video visit providers received video visit training and care quality feedback. New system workflows were created to accommodate the new visit method. MEASUREMENTS: Nine faculty, trained in qualitative research methods, conducted 53 stakeholder interviews in 4 days using purposeful (administrators and technologists) and convenience (medical assistant, nurses, and providers) sampling. A rapid qualitative analytic approach for thematic analysis was used. RESULTS: The analysis revealed 12 themes, including Pandemic as Catalyst; Joy in Medicine; Safety in Medicine; Slipping Through the Cracks; My Role, Redefined; and The New Normal. Themes were analyzed using the RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) framework to identify critical issues for continued program utilization. LIMITATIONS: Evaluation was done immediately after deployment. Although viewpoints may have evolved later, immediate evaluation allowed for prompt program changes and identified broader issues to address for program sustainability. CONCLUSION: After pandemic-related systems transformation at Stanford, critical issues to sustain video visit long-term viability were identified. Specifically, technology ease of use must improve and support multiparty videoconferencing. Providers should be able to care for their patients, regardless of geography. Providers need decision-making support with virtual examination training and home-based patient diagnostics. Finally, ongoing video visit reimbursement should be commensurate with value to the patients' health and well-being. PRIMARY FUNDING SOURCE: Stanford Department of Medicine and Stanford Health Care.",10.7326/m20-1814,gzz5dp90,"['BACKGROUND', 'The', 'coronavirus', 'disease', '2019', 'pandemic', 'spurred', 'health', 'systems', 'across', 'the', 'world', 'to', 'quickly', 'shift', 'from', 'in', 'person', 'visits', 'to', 'safer', 'video', 'visits', 'OBJECTIVE', 'To', 'seek', 'stakeholder', 'perspectives', 'on', 'video', 'visits', 'acceptability', 'and', 'effect', '3', 'weeks', 'after', 'near', 'total', 'transition', 'to', 'video', 'visits', 'DESIGN', 'Semistructured', 'qualitative', 'interviews', 'SETTING', '6', 'Stanford', 'general', 'primary', 'care', 'and', 'express', 'care', 'clinics', 'at', '6', 'northern', 'California', 'sites', 'with', '81', 'providers', '123', 'staff', 'and', '97', '614', 'patient', 'visits', 'in', '2019', 'PARTICIPANTS', 'Fifty', 'three', 'program', 'participants', 'overlapping', 'roles', 'as', 'medical', 'providers', 'n', '20', 'medical', 'assistants', 'n', '16', 'nurses', 'n', '4', 'technologists', 'n', '4', 'and', 'administrators', 'n', '13', 'were', 'interviewed', 'about', 'video', 'visit', 'transition', 'and', 'challenges', 'INTERVENTION', 'In', '3', 'weeks', 'express', 'care', 'and', 'primary', 'care', 'video', 'visits', 'increased', 'from', 'less', 'than', '10', 'to', 'greater', 'than', '80', 'and', 'from', 'less', 'than', '10', 'to', 'greater', 'than', '75', 'respectively', 'New', 'video', 'visit', 'providers', 'received', 'video', 'visit', 'training', 'and', 'care', 'quality', 'feedback', 'New', 'system', 'workflows', 'were', 'created', 'to', 'accommodate', 'the', 'new', 'visit', 'method', 'MEASUREMENTS', 'Nine', 'faculty', 'trained', 'in', 'qualitative', 'research', 'methods', 'conducted', '53', 'stakeholder', 'interviews', 'in', '4', 'days', 'using', 'purposeful', 'administrators', 'and', 'technologists', 'and', 'convenience', 'medical', 'assistant', 'nurses', 'and', 'providers', 'sampling', 'A', 'rapid', 'qualitative', 'analytic', 'approach', 'for', 'thematic', 'analysis', 'was', 'used', 'RESULTS', 'The', 'analysis', 'revealed', '12', 'themes', 'including', 'Pandemic', 'as', 'Catalyst', 'Joy', 'in', 'Medicine', 'Safety', 'in', 'Medicine', 'Slipping', 'Through', 'the', 'Cracks', 'My', 'Role', 'Redefined', 'and', 'The', 'New', 'Normal', 'Themes', 'were', 'analyzed', 'using', 'the', 'RE', 'AIM', 'reach', 'effectiveness', 'adoption', 'implementation', 'and', 'maintenance', 'framework', 'to', 'identify', 'critical', 'issues', 'for', 'continued', 'program', 'utilization', 'LIMITATIONS', 'Evaluation', 'was', 'done', 'immediately', 'after', 'deployment', 'Although', 'viewpoints', 'may', 'have', 'evolved', 'later', 'immediate', 'evaluation', 'allowed', 'for', 'prompt', 'program', 'changes', 'and', 'identified', 'broader', 'issues', 'to', 'address', 'for', 'program', 'sustainability', 'CONCLUSION', 'After', 'pandemic', 'related', 'systems', 'transformation', 'at', 'Stanford', 'critical', 'issues', 'to', 'sustain', 'video', 'visit', 'long', 'term', 'viability', 'were', 'identified', 'Specifically', 'technology', 'ease', 'of', 'use', 'must', 'improve', 'and', 'support', 'multiparty', 'videoconferencing', 'Providers', 'should', 'be', 'able', 'to', 'care', 'for', 'their', 'patients', 'regardless', 'of', 'geography', 'Providers', 'need', 'decision', 'making', 'support', 'with', 'virtual', 'examination', 'training', 'and', 'home', 'based', 'patient', 'diagnostics', 'Finally', 'ongoing', 'video', 'visit', 'reimbursement', 'should', 'be', 'commensurate', 'with', 'value', 'to', 'the', 'patients', 'health', 'and', 'well', 'being', 'PRIMARY', 'FUNDING', 'SOURCE', 'Stanford', 'Department', 'of', 'Medicine', 'and', 'Stanford', 'Health', 'Care', '']"
182894,Implementation of Clinical Diagnostic Criteria and Universal Symptom Survey Contributed to Lower Magnitude and Faster Resolution of the COVID-19 Epidemic in Wuhan,2020-05-07,Engineering (Beijing),https://www.ncbi.nlm.nih.gov/pubmed/32382449/; https://api.elsevier.com/content/article/pii/S2095809920301077; https://doi.org/10.1016/j.eng.2020.04.008; https://www.sciencedirect.com/science/article/pii/S2095809920301077?v=s5,"Abstract The majority of cases infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China centered in the city of Wuhan. Despite a rapid increase in the number of cases and deaths due to the coronavirus disease 2019 (COVID-19), the epidemic was stemmed via a combination of epidemic mitigation and control measures. This study evaluates how the implementation of clinical diagnostics and universal symptom surveys contributed to epidemic control in Wuhan. We extended the susceptibles-exposed-infectious-removed (SEIR) transmission dynamics model by considering three quarantined compartments (SEIR+Q). The SEIR+Q dynamics model was fitted using the daily reported number of confirmed infections and unconfirmed cases by clinical diagnostic criteria up to February 14, 2020 in Wuhan. Applying the model to carry forward the pre-February 14 trend in Wuhan, the number of daily new diagnosed cases would be expected to drop below 100 by March 25, below 10 by April 29, and reach 0 by May 31, 2020. The observed case counts after February 14 demonstrated that the daily new cases fell below 100 by March 6, below 10 by March 11, and reached 0 by March 18, or, respectively, 19, 49, and 74 d earlier than model predictions. By March 30, the observed number of cumulative confirmed cases was 50 006, which was 19 951 cases fewer than the predicted count. Effective reproductive number R(t) analysis using observed frequencies showed a remarkable decline after the implementation of clinical diagnostic criteria and universal symptom surveys, which was significantly below the R(t) curve estimated by the model assuming that the pre-February 14 trend was carried forward. In conclusion, the proposed SEIR+Q dynamics model was a good fit for the epidemic data in Wuhan and explained the large increase in the number of infections during February 12–14, 2020. The implementation of clinical diagnostic criteria and universal symptom surveys contributed to a contraction in both the magnitude and the duration of the epidemic in Wuhan.",10.1016/j.eng.2020.04.008,tre0694x,"['Abstract', 'The', 'majority', 'of', 'cases', 'infected', 'with', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'in', 'China', 'centered', 'in', 'the', 'city', 'of', 'Wuhan', 'Despite', 'a', 'rapid', 'increase', 'in', 'the', 'number', 'of', 'cases', 'and', 'deaths', 'due', 'to', 'the', 'coronavirus', 'disease', '2019', 'COVID', '19', 'the', 'epidemic', 'was', 'stemmed', 'via', 'a', 'combination', 'of', 'epidemic', 'mitigation', 'and', 'control', 'measures', 'This', 'study', 'evaluates', 'how', 'the', 'implementation', 'of', 'clinical', 'diagnostics', 'and', 'universal', 'symptom', 'surveys', 'contributed', 'to', 'epidemic', 'control', 'in', 'Wuhan', 'We', 'extended', 'the', 'susceptibles', 'exposed', 'infectious', 'removed', 'SEIR', 'transmission', 'dynamics', 'model', 'by', 'considering', 'three', 'quarantined', 'compartments', 'SEIR', 'Q', 'The', 'SEIR', 'Q', 'dynamics', 'model', 'was', 'fitted', 'using', 'the', 'daily', 'reported', 'number', 'of', 'confirmed', 'infections', 'and', 'unconfirmed', 'cases', 'by', 'clinical', 'diagnostic', 'criteria', 'up', 'to', 'February', '14', '2020', 'in', 'Wuhan', 'Applying', 'the', 'model', 'to', 'carry', 'forward', 'the', 'pre', 'February', '14', 'trend', 'in', 'Wuhan', 'the', 'number', 'of', 'daily', 'new', 'diagnosed', 'cases', 'would', 'be', 'expected', 'to', 'drop', 'below', '100', 'by', 'March', '25', 'below', '10', 'by', 'April', '29', 'and', 'reach', '0', 'by', 'May', '31', '2020', 'The', 'observed', 'case', 'counts', 'after', 'February', '14', 'demonstrated', 'that', 'the', 'daily', 'new', 'cases', 'fell', 'below', '100', 'by', 'March', '6', 'below', '10', 'by', 'March', '11', 'and', 'reached', '0', 'by', 'March', '18', 'or', 'respectively', '19', '49', 'and', '74', 'd', 'earlier', 'than', 'model', 'predictions', 'By', 'March', '30', 'the', 'observed', 'number', 'of', 'cumulative', 'confirmed', 'cases', 'was', '50', '006', 'which', 'was', '19', '951', 'cases', 'fewer', 'than', 'the', 'predicted', 'count', 'Effective', 'reproductive', 'number', 'R', 't', 'analysis', 'using', 'observed', 'frequencies', 'showed', 'a', 'remarkable', 'decline', 'after', 'the', 'implementation', 'of', 'clinical', 'diagnostic', 'criteria', 'and', 'universal', 'symptom', 'surveys', 'which', 'was', 'significantly', 'below', 'the', 'R', 't', 'curve', 'estimated', 'by', 'the', 'model', 'assuming', 'that', 'the', 'pre', 'February', '14', 'trend', 'was', 'carried', 'forward', 'In', 'conclusion', 'the', 'proposed', 'SEIR', 'Q', 'dynamics', 'model', 'was', 'a', 'good', 'fit', 'for', 'the', 'epidemic', 'data', 'in', 'Wuhan', 'and', 'explained', 'the', 'large', 'increase', 'in', 'the', 'number', 'of', 'infections', 'during', 'February', '12', '14', '2020', 'The', 'implementation', 'of', 'clinical', 'diagnostic', 'criteria', 'and', 'universal', 'symptom', 'surveys', 'contributed', 'to', 'a', 'contraction', 'in', 'both', 'the', 'magnitude', 'and', 'the', 'duration', 'of', 'the', 'epidemic', 'in', 'Wuhan', '']"
183023,"COVID-19: Progress in diagnostics, therapy and vaccination",2020-06-19,Theranostics,https://doi.org/10.7150/thno.47987; https://www.ncbi.nlm.nih.gov/pubmed/32685022/,"Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently become a pandemic. As the sudden emergence and rapid spread of SARS-CoV-2 is endangering global health and the economy, the development of strategies to contain the virus's spread are urgently needed. At present, various diagnostic kits to test for SARS-CoV-2 are available for use to initiate appropriate treatment faster and to limit further spread of the virus. Several drugs have demonstrated in vitro activity against SARS-CoV-2 or potential clinical benefits. In addition, institutions and companies worldwide are working tirelessly to develop treatments and vaccines against COVID-19. However, no drug or vaccine has yet been specifically approved for COVID-19. Given the urgency of the outbreak, we focus here on recent advances in the diagnostics, treatment, and vaccine development for SARS-CoV-2 infection, helping to guide strategies to address the current COVID-19 pandemic.",10.7150/thno.47987,q7d0ysbo,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'recently', 'become', 'a', 'pandemic', 'As', 'the', 'sudden', 'emergence', 'and', 'rapid', 'spread', 'of', 'SARS', 'CoV', '2', 'is', 'endangering', 'global', 'health', 'and', 'the', 'economy', 'the', 'development', 'of', 'strategies', 'to', 'contain', 'the', 'virus', 's', 'spread', 'are', 'urgently', 'needed', 'At', 'present', 'various', 'diagnostic', 'kits', 'to', 'test', 'for', 'SARS', 'CoV', '2', 'are', 'available', 'for', 'use', 'to', 'initiate', 'appropriate', 'treatment', 'faster', 'and', 'to', 'limit', 'further', 'spread', 'of', 'the', 'virus', 'Several', 'drugs', 'have', 'demonstrated', 'in', 'vitro', 'activity', 'against', 'SARS', 'CoV', '2', 'or', 'potential', 'clinical', 'benefits', 'In', 'addition', 'institutions', 'and', 'companies', 'worldwide', 'are', 'working', 'tirelessly', 'to', 'develop', 'treatments', 'and', 'vaccines', 'against', 'COVID', '19', 'However', 'no', 'drug', 'or', 'vaccine', 'has', 'yet', 'been', 'specifically', 'approved', 'for', 'COVID', '19', 'Given', 'the', 'urgency', 'of', 'the', 'outbreak', 'we', 'focus', 'here', 'on', 'recent', 'advances', 'in', 'the', 'diagnostics', 'treatment', 'and', 'vaccine', 'development', 'for', 'SARS', 'CoV', '2', 'infection', 'helping', 'to', 'guide', 'strategies', 'to', 'address', 'the', 'current', 'COVID', '19', 'pandemic', '']"
183348,The R Protein of SARS-CoV: Analyses of Structure and Function Based on Four Complete Genome Sequences of Isolates BJ01-BJ04,2016-11-28,Genomics Proteomics Bioinformatics,https://www.sciencedirect.com/science/article/pii/S1672022903010192; https://api.elsevier.com/content/article/pii/S1672022903010192; https://www.ncbi.nlm.nih.gov/pubmed/15626345/,"The R (replicase) protein is the uniquely defined non-structural protein (NSP) responsible for RNA replication, mutation rate or fidelity, regulation of transcription in coronaviruses and many other ssRNA viruses. Based on our complete genome sequences of four isolates (BJ01-BJ04) of SARS-CoV from Beijing, China, we analyzed the structure and predicted functions of the R protein in comparison with 13 other isolates of SARS-CoV and 6 other coronaviruses. The entire ORF (open-reading frame) encodes for two major enzyme activities, RNA-dependent RNA polymerase (RdRp) and proteinase activities. The R polyprotein undergoes a complex proteolytic process to produce 15 function-related peptides. A hydrophobic domain (HOD) and a hydrophilic domain (HID) are newly identified within NSP1. The substitution rate of the R protein is close to the average of the SARS-CoV genome. The functional domains in all NSPs of the R protein give different phylogenetic results that suggest their different mutation rate under selective pressure. Eleven highly conserved regions in RdRp and twelve cleavage sites by 3CLP (chymotrypsin-like protein) have been identified as potential drug targets. Findings suggest that it is possible to obtain information about the phylogeny of SARS-CoV, as well as potential tools for drug design, genotyping and diagnostics of SARS.",10.1016/s1672-0229(03)01019-2,n22ts166,"['The', 'R', 'replicase', 'protein', 'is', 'the', 'uniquely', 'defined', 'non', 'structural', 'protein', 'NSP', 'responsible', 'for', 'RNA', 'replication', 'mutation', 'rate', 'or', 'fidelity', 'regulation', 'of', 'transcription', 'in', 'coronaviruses', 'and', 'many', 'other', 'ssRNA', 'viruses', 'Based', 'on', 'our', 'complete', 'genome', 'sequences', 'of', 'four', 'isolates', 'BJ01', 'BJ04', 'of', 'SARS', 'CoV', 'from', 'Beijing', 'China', 'we', 'analyzed', 'the', 'structure', 'and', 'predicted', 'functions', 'of', 'the', 'R', 'protein', 'in', 'comparison', 'with', '13', 'other', 'isolates', 'of', 'SARS', 'CoV', 'and', '6', 'other', 'coronaviruses', 'The', 'entire', 'ORF', 'open', 'reading', 'frame', 'encodes', 'for', 'two', 'major', 'enzyme', 'activities', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'and', 'proteinase', 'activities', 'The', 'R', 'polyprotein', 'undergoes', 'a', 'complex', 'proteolytic', 'process', 'to', 'produce', '15', 'function', 'related', 'peptides', 'A', 'hydrophobic', 'domain', 'HOD', 'and', 'a', 'hydrophilic', 'domain', 'HID', 'are', 'newly', 'identified', 'within', 'NSP1', 'The', 'substitution', 'rate', 'of', 'the', 'R', 'protein', 'is', 'close', 'to', 'the', 'average', 'of', 'the', 'SARS', 'CoV', 'genome', 'The', 'functional', 'domains', 'in', 'all', 'NSPs', 'of', 'the', 'R', 'protein', 'give', 'different', 'phylogenetic', 'results', 'that', 'suggest', 'their', 'different', 'mutation', 'rate', 'under', 'selective', 'pressure', 'Eleven', 'highly', 'conserved', 'regions', 'in', 'RdRp', 'and', 'twelve', 'cleavage', 'sites', 'by', '3CLP', 'chymotrypsin', 'like', 'protein', 'have', 'been', 'identified', 'as', 'potential', 'drug', 'targets', 'Findings', 'suggest', 'that', 'it', 'is', 'possible', 'to', 'obtain', 'information', 'about', 'the', 'phylogeny', 'of', 'SARS', 'CoV', 'as', 'well', 'as', 'potential', 'tools', 'for', 'drug', 'design', 'genotyping', 'and', 'diagnostics', 'of', 'SARS', '']"
183356,Comparison of Luminex NxTAG Respiratory Pathogen Panel and xTAG Respiratory Viral Panel FAST Version 2 for the Detection of Respiratory Viruses,2017-02-17,Ann Lab Med,https://doi.org/10.3343/alm.2017.37.3.267; https://www.ncbi.nlm.nih.gov/pubmed/28224774/,"Owing to advancements in molecular diagnostics, recent years have seen an increasing number of laboratories adopting respiratory viral panels to detect respiratory pathogens. In December 2015, the NxTAG respiratory pathogen panel (NxTAG RPP) was approved by the United States Food and Drug Administration. We compared the clinical performance of this new assay with that of the xTAG respiratory viral panel (xTAG RVP) FAST v2 using 142 clinical samples and 12 external quality assessment samples. Discordant results were resolved by using a laboratory-developed respiratory viral panel. The NxTAG RPP achieved 100% concordant negative results and 86.6% concordant positive results. It detected one coronavirus 229E and eight influenza A/H3N2 viruses that were missed by the xTAG RVP FAST v2. On the other hand, the NxTAG RPP missed one enterovirus/rhinovirus and one metapneumovirus that were detected by FAST v2. Both panels correctly identified all the pathogens in the 12 external quality assessment samples. Overall, the NxTAG RPP demonstrated good diagnostic performance. Of note, it was better able to subtype the influenza A/H3N2 viruses compared with the xTAG RVP FAST v2.",10.3343/alm.2017.37.3.267,xiph1ecx,"['Owing', 'to', 'advancements', 'in', 'molecular', 'diagnostics', 'recent', 'years', 'have', 'seen', 'an', 'increasing', 'number', 'of', 'laboratories', 'adopting', 'respiratory', 'viral', 'panels', 'to', 'detect', 'respiratory', 'pathogens', 'In', 'December', '2015', 'the', 'NxTAG', 'respiratory', 'pathogen', 'panel', 'NxTAG', 'RPP', 'was', 'approved', 'by', 'the', 'United', 'States', 'Food', 'and', 'Drug', 'Administration', 'We', 'compared', 'the', 'clinical', 'performance', 'of', 'this', 'new', 'assay', 'with', 'that', 'of', 'the', 'xTAG', 'respiratory', 'viral', 'panel', 'xTAG', 'RVP', 'FAST', 'v2', 'using', '142', 'clinical', 'samples', 'and', '12', 'external', 'quality', 'assessment', 'samples', 'Discordant', 'results', 'were', 'resolved', 'by', 'using', 'a', 'laboratory', 'developed', 'respiratory', 'viral', 'panel', 'The', 'NxTAG', 'RPP', 'achieved', '100', 'concordant', 'negative', 'results', 'and', '86', '6', 'concordant', 'positive', 'results', 'It', 'detected', 'one', 'coronavirus', '229E', 'and', 'eight', 'influenza', 'A', 'H3N2', 'viruses', 'that', 'were', 'missed', 'by', 'the', 'xTAG', 'RVP', 'FAST', 'v2', 'On', 'the', 'other', 'hand', 'the', 'NxTAG', 'RPP', 'missed', 'one', 'enterovirus', 'rhinovirus', 'and', 'one', 'metapneumovirus', 'that', 'were', 'detected', 'by', 'FAST', 'v2', 'Both', 'panels', 'correctly', 'identified', 'all', 'the', 'pathogens', 'in', 'the', '12', 'external', 'quality', 'assessment', 'samples', 'Overall', 'the', 'NxTAG', 'RPP', 'demonstrated', 'good', 'diagnostic', 'performance', 'Of', 'note', 'it', 'was', 'better', 'able', 'to', 'subtype', 'the', 'influenza', 'A', 'H3N2', 'viruses', 'compared', 'with', 'the', 'xTAG', 'RVP', 'FAST', 'v2', '']"
183520,Die Virologie von SARS-CoV-2,2020-07-23,Internist (Berl),https://doi.org/10.1007/s00108-020-00853-6; https://www.ncbi.nlm.nih.gov/pubmed/32705298/,"The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has far reaching effects on society, the economy and medical treatment. It is all the more important to understand the characteristics of the virus and to utilize them diagnostically, therapeutically and epidemiologically. This article firstly elucidates the medical importance of coronaviruses in general. Then angiotensin-converting enzyme 2 (ACE2) as the binding site of SARS-CoV‑2 and the possible influence on the disease susceptibility are explained. The gold standard for detection of an active SARS-CoV‑2 infection is the direct detection of the pathogen with nucleic acid amplification techniques. At the onset of symptoms, a swab of the upper airway is especially suitable due to the high viral burden. At a later stage direct detection can be achieved in samples from the lower airway or a stool or anal swab. Antigen or antibody tests cannot replace the direct detection of the pathogen; however, the detection of immunoglobulin G antibodies are of special interest for epidemiological questions (seroconversion time of sometimes several weeks). The plaque reduction neutralization test exclusively detects antibodies which neutralize viruses but the procedure is complicated. In addition, the importance of these antibodies with respect to immunity against a second infection is uncertain. Thanks to modern techniques thousands of SARS-CoV‑2 sequences are already available, which show a genomic variability. The D614G mutation in the S spikes seems to cause a higher infectiosity. Mutations can impair the diagnostics and treatment, which makes monitoring necessary.",10.1007/s00108-020-00853-6,4rx9ii1j,"['The', 'new', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'has', 'far', 'reaching', 'effects', 'on', 'society', 'the', 'economy', 'and', 'medical', 'treatment', 'It', 'is', 'all', 'the', 'more', 'important', 'to', 'understand', 'the', 'characteristics', 'of', 'the', 'virus', 'and', 'to', 'utilize', 'them', 'diagnostically', 'therapeutically', 'and', 'epidemiologically', 'This', 'article', 'firstly', 'elucidates', 'the', 'medical', 'importance', 'of', 'coronaviruses', 'in', 'general', 'Then', 'angiotensin', 'converting', 'enzyme', '2', 'ACE2', 'as', 'the', 'binding', 'site', 'of', 'SARS', 'CoV', '2', 'and', 'the', 'possible', 'influence', 'on', 'the', 'disease', 'susceptibility', 'are', 'explained', 'The', 'gold', 'standard', 'for', 'detection', 'of', 'an', 'active', 'SARS', 'CoV', '2', 'infection', 'is', 'the', 'direct', 'detection', 'of', 'the', 'pathogen', 'with', 'nucleic', 'acid', 'amplification', 'techniques', 'At', 'the', 'onset', 'of', 'symptoms', 'a', 'swab', 'of', 'the', 'upper', 'airway', 'is', 'especially', 'suitable', 'due', 'to', 'the', 'high', 'viral', 'burden', 'At', 'a', 'later', 'stage', 'direct', 'detection', 'can', 'be', 'achieved', 'in', 'samples', 'from', 'the', 'lower', 'airway', 'or', 'a', 'stool', 'or', 'anal', 'swab', 'Antigen', 'or', 'antibody', 'tests', 'cannot', 'replace', 'the', 'direct', 'detection', 'of', 'the', 'pathogen', 'however', 'the', 'detection', 'of', 'immunoglobulin', 'G', 'antibodies', 'are', 'of', 'special', 'interest', 'for', 'epidemiological', 'questions', 'seroconversion', 'time', 'of', 'sometimes', 'several', 'weeks', 'The', 'plaque', 'reduction', 'neutralization', 'test', 'exclusively', 'detects', 'antibodies', 'which', 'neutralize', 'viruses', 'but', 'the', 'procedure', 'is', 'complicated', 'In', 'addition', 'the', 'importance', 'of', 'these', 'antibodies', 'with', 'respect', 'to', 'immunity', 'against', 'a', 'second', 'infection', 'is', 'uncertain', 'Thanks', 'to', 'modern', 'techniques', 'thousands', 'of', 'SARS', 'CoV', '2', 'sequences', 'are', 'already', 'available', 'which', 'show', 'a', 'genomic', 'variability', 'The', 'D614G', 'mutation', 'in', 'the', 'S', 'spikes', 'seems', 'to', 'cause', 'a', 'higher', 'infectiosity', 'Mutations', 'can', 'impair', 'the', 'diagnostics', 'and', 'treatment', 'which', 'makes', 'monitoring', 'necessary', '']"
183706,Verification and diagnostic evaluation of the RealStar(®) Middle East respiratory syndrome coronavirus (N gene) reverse transcription-PCR kit 1.0,2019-07-02,Future microbiology,https://www.ncbi.nlm.nih.gov/pubmed/31271059/; https://doi.org/10.2217/fmb-2019-0067,"AIM: We report the diagnostic evaluation of a confirmatory reverse transcription-PCR (RT-PCR) kit targeting the Middle East respiratory syndrome coronavirus (MERS-CoV) N gene. MATERIAL & METHODS: 33 patient samples from two collections sites in Riyadh, Saudi Arabia, which were pre-characterized via real-time RT-PCR targeting MERS-CoV orf1a and upE, and were tested using the MERS-CoV N gene, as a confirmatory assay. This diagnostic procedure follows a two-step diagnostics scheme, recommended by the WHO. RESULTS: 18/33 samples tested positive, 11/33 tested negative for MERS-CoV RNA and 2/33 showed uncertain results. CONCLUSION: The results suggest, that the RealStar(®) MERS-CoV (N gene) RT-PCR kit 1.0 can be considered a suitable and reliable confirmatory assay in combination with the RealStar MERS-CoV RT-PCR kit 1.0 according to the diagnostic scheme recommended by WHO.",10.2217/fmb-2019-0067,qj45jefm,"['AIM', 'We', 'report', 'the', 'diagnostic', 'evaluation', 'of', 'a', 'confirmatory', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'kit', 'targeting', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'N', 'gene', 'MATERIAL', 'METHODS', '33', 'patient', 'samples', 'from', 'two', 'collections', 'sites', 'in', 'Riyadh', 'Saudi', 'Arabia', 'which', 'were', 'pre', 'characterized', 'via', 'real', 'time', 'RT', 'PCR', 'targeting', 'MERS', 'CoV', 'orf1a', 'and', 'upE', 'and', 'were', 'tested', 'using', 'the', 'MERS', 'CoV', 'N', 'gene', 'as', 'a', 'confirmatory', 'assay', 'This', 'diagnostic', 'procedure', 'follows', 'a', 'two', 'step', 'diagnostics', 'scheme', 'recommended', 'by', 'the', 'WHO', 'RESULTS', '18', '33', 'samples', 'tested', 'positive', '11', '33', 'tested', 'negative', 'for', 'MERS', 'CoV', 'RNA', 'and', '2', '33', 'showed', 'uncertain', 'results', 'CONCLUSION', 'The', 'results', 'suggest', 'that', 'the', 'RealStar', 'MERS', 'CoV', 'N', 'gene', 'RT', 'PCR', 'kit', '1', '0', 'can', 'be', 'considered', 'a', 'suitable', 'and', 'reliable', 'confirmatory', 'assay', 'in', 'combination', 'with', 'the', 'RealStar', 'MERS', 'CoV', 'RT', 'PCR', 'kit', '1', '0', 'according', 'to', 'the', 'diagnostic', 'scheme', 'recommended', 'by', 'WHO', '']"
183778,"SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities",2020-05-21,Shock,https://doi.org/10.1097/shk.0000000000001565; https://www.ncbi.nlm.nih.gov/pubmed/32433217/,"Approximately 3 billion people around the world have gone into some form of social separation to mitigate the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. The uncontrolled influx of patients in need of emergency care has rapidly brought several national health systems to near-collapse with deadly consequences to those afflicted by Coronavirus Disease 2019 (COVID-19) and other critical diseases associated with COVID-19. Solid scientific evidence regarding SARS-CoV-2/COVID-19 remains scarce; there is an urgent need to expand our understanding of the SARS-CoV-2 pathophysiology to facilitate precise and targeted treatments. The capacity for rapid information dissemination has emerged as a double-edged sword; the existing gap of high-quality data is frequently filled by anecdotal reports, contradictory statements, and misinformation. This review addresses several important aspects unique to the SARS-CoV-2/COVID-19 pandemic highlighting the most relevant knowledge gaps and existing windows-of-opportunity. Specifically, focus is given on SARS-CoV-2 immunopathogenesis in the context of experimental therapies and preclinical evidence and their applicability in supporting efficacious clinical trial planning. The review discusses the existing challenges of SARS-CoV-2 diagnostics and the potential application of translational technology for epidemiological predictions, patient monitoring, and treatment decision-making in COVID-19. Furthermore, solutions for enhancing international strategies in translational research, cooperative networks, and regulatory partnerships are contemplated.",10.1097/shk.0000000000001565,848fswtv,"['Approximately', '3', 'billion', 'people', 'around', 'the', 'world', 'have', 'gone', 'into', 'some', 'form', 'of', 'social', 'separation', 'to', 'mitigate', 'the', 'current', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'pandemic', 'The', 'uncontrolled', 'influx', 'of', 'patients', 'in', 'need', 'of', 'emergency', 'care', 'has', 'rapidly', 'brought', 'several', 'national', 'health', 'systems', 'to', 'near', 'collapse', 'with', 'deadly', 'consequences', 'to', 'those', 'afflicted', 'by', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'and', 'other', 'critical', 'diseases', 'associated', 'with', 'COVID', '19', 'Solid', 'scientific', 'evidence', 'regarding', 'SARS', 'CoV', '2', 'COVID', '19', 'remains', 'scarce', 'there', 'is', 'an', 'urgent', 'need', 'to', 'expand', 'our', 'understanding', 'of', 'the', 'SARS', 'CoV', '2', 'pathophysiology', 'to', 'facilitate', 'precise', 'and', 'targeted', 'treatments', 'The', 'capacity', 'for', 'rapid', 'information', 'dissemination', 'has', 'emerged', 'as', 'a', 'double', 'edged', 'sword', 'the', 'existing', 'gap', 'of', 'high', 'quality', 'data', 'is', 'frequently', 'filled', 'by', 'anecdotal', 'reports', 'contradictory', 'statements', 'and', 'misinformation', 'This', 'review', 'addresses', 'several', 'important', 'aspects', 'unique', 'to', 'the', 'SARS', 'CoV', '2', 'COVID', '19', 'pandemic', 'highlighting', 'the', 'most', 'relevant', 'knowledge', 'gaps', 'and', 'existing', 'windows', 'of', 'opportunity', 'Specifically', 'focus', 'is', 'given', 'on', 'SARS', 'CoV', '2', 'immunopathogenesis', 'in', 'the', 'context', 'of', 'experimental', 'therapies', 'and', 'preclinical', 'evidence', 'and', 'their', 'applicability', 'in', 'supporting', 'efficacious', 'clinical', 'trial', 'planning', 'The', 'review', 'discusses', 'the', 'existing', 'challenges', 'of', 'SARS', 'CoV', '2', 'diagnostics', 'and', 'the', 'potential', 'application', 'of', 'translational', 'technology', 'for', 'epidemiological', 'predictions', 'patient', 'monitoring', 'and', 'treatment', 'decision', 'making', 'in', 'COVID', '19', 'Furthermore', 'solutions', 'for', 'enhancing', 'international', 'strategies', 'in', 'translational', 'research', 'cooperative', 'networks', 'and', 'regulatory', 'partnerships', 'are', 'contemplated', '']"
183780,"Fighting COVID-19: a quick review of diagnoses, therapies, and vaccines",2020-05-30,Biomed J,https://www.sciencedirect.com/science/article/pii/S2319417020300858?v=s5; https://doi.org/10.1016/j.bj.2020.05.021; https://api.elsevier.com/content/article/pii/S2319417020300858; https://www.ncbi.nlm.nih.gov/pubmed/32532623/,"The COVID-19 pandemic caused by a novel coronavirus, SARS-CoV-2, has infected more than 4.9 million individuals and resulted in over 300,000 deaths globally. The rapid spread of the virus and the precipitously increasing numbers of cases necessitate the urgent development of accurate diagnostic methods, effective treatments, and vaccines. Here, we review the progress of developing diagnostic methods, therapies, and vaccines for SARS-CoV-2 with a focus on current clinical trials and their challenges. For diagnosis, nucleic acid amplification tests remain the mainstay diagnostics for laboratory confirmation of SARS-CoV-2 infection, while serological antibody tests are used to aid contact tracing, epidemiological, and vaccine evaluation studies. Viral isolation is not recommended for routine diagnostic procedures due to safety concerns. Currently, no single effective drug or specific vaccine is available against SARS-CoV-2. Some candidate drugs targeting different levels and stages of human responses against COVID-19 such as cell membrane fusion, RNA-dependent RNA polymerase, viral protease inhibitor, interleukin 6 blocker, and convalescent plasma may improve the clinical outcomes of critical COVID-19 patients. Other supportive care measures for critical patients are still necessary. Advances in genetic sequencing and other technological developments have sped up the establishment of a variety of vaccine platforms. Accordingly, numerous vaccines are under development. Vaccine candidates against SARS-CoV-2 are mainly based upon the viral spike protein due to its vital role in viral infectivity, and most of these candidates have recently moved into clinical trials. Before the efficacy of such vaccines in humans is demonstrated, strong international coordination and collaboration among studies, pharmaceutical companies, regulators, and governments are needed to limit further damage due the emerging SARS-CoV-2 virus.",10.1016/j.bj.2020.05.021,0g7a9s5z,"['The', 'COVID', '19', 'pandemic', 'caused', 'by', 'a', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'has', 'infected', 'more', 'than', '4', '9', 'million', 'individuals', 'and', 'resulted', 'in', 'over', '300', '000', 'deaths', 'globally', 'The', 'rapid', 'spread', 'of', 'the', 'virus', 'and', 'the', 'precipitously', 'increasing', 'numbers', 'of', 'cases', 'necessitate', 'the', 'urgent', 'development', 'of', 'accurate', 'diagnostic', 'methods', 'effective', 'treatments', 'and', 'vaccines', 'Here', 'we', 'review', 'the', 'progress', 'of', 'developing', 'diagnostic', 'methods', 'therapies', 'and', 'vaccines', 'for', 'SARS', 'CoV', '2', 'with', 'a', 'focus', 'on', 'current', 'clinical', 'trials', 'and', 'their', 'challenges', 'For', 'diagnosis', 'nucleic', 'acid', 'amplification', 'tests', 'remain', 'the', 'mainstay', 'diagnostics', 'for', 'laboratory', 'confirmation', 'of', 'SARS', 'CoV', '2', 'infection', 'while', 'serological', 'antibody', 'tests', 'are', 'used', 'to', 'aid', 'contact', 'tracing', 'epidemiological', 'and', 'vaccine', 'evaluation', 'studies', 'Viral', 'isolation', 'is', 'not', 'recommended', 'for', 'routine', 'diagnostic', 'procedures', 'due', 'to', 'safety', 'concerns', 'Currently', 'no', 'single', 'effective', 'drug', 'or', 'specific', 'vaccine', 'is', 'available', 'against', 'SARS', 'CoV', '2', 'Some', 'candidate', 'drugs', 'targeting', 'different', 'levels', 'and', 'stages', 'of', 'human', 'responses', 'against', 'COVID', '19', 'such', 'as', 'cell', 'membrane', 'fusion', 'RNA', 'dependent', 'RNA', 'polymerase', 'viral', 'protease', 'inhibitor', 'interleukin', '6', 'blocker', 'and', 'convalescent', 'plasma', 'may', 'improve', 'the', 'clinical', 'outcomes', 'of', 'critical', 'COVID', '19', 'patients', 'Other', 'supportive', 'care', 'measures', 'for', 'critical', 'patients', 'are', 'still', 'necessary', 'Advances', 'in', 'genetic', 'sequencing', 'and', 'other', 'technological', 'developments', 'have', 'sped', 'up', 'the', 'establishment', 'of', 'a', 'variety', 'of', 'vaccine', 'platforms', 'Accordingly', 'numerous', 'vaccines', 'are', 'under', 'development', 'Vaccine', 'candidates', 'against', 'SARS', 'CoV', '2', 'are', 'mainly', 'based', 'upon', 'the', 'viral', 'spike', 'protein', 'due', 'to', 'its', 'vital', 'role', 'in', 'viral', 'infectivity', 'and', 'most', 'of', 'these', 'candidates', 'have', 'recently', 'moved', 'into', 'clinical', 'trials', 'Before', 'the', 'efficacy', 'of', 'such', 'vaccines', 'in', 'humans', 'is', 'demonstrated', 'strong', 'international', 'coordination', 'and', 'collaboration', 'among', 'studies', 'pharmaceutical', 'companies', 'regulators', 'and', 'governments', 'are', 'needed', 'to', 'limit', 'further', 'damage', 'due', 'the', 'emerging', 'SARS', 'CoV', '2', 'virus', '']"
185395,Road toward rapid-molecular point of care test to detect novel SARS-coronavirus 2019 (COVID-19): Review from updated literature,2020-07-01,Allergol Immunopathol (Madr),https://www.ncbi.nlm.nih.gov/pubmed/32636083/; https://doi.org/10.1016/j.aller.2020.06.001; https://www.sciencedirect.com/science/article/pii/S0301054620301051?v=s5; https://api.elsevier.com/content/article/pii/S0301054620301051,"Coronavirus disease 2019 (COVID-19) named by the WHO as a result of the global public health emergency. COVID-19 is caused by a new coronavirus named as novel coronavirus (2019-nCOV). From the first case reported in December 2019 it is now a pandemic situation and a major public health emergency. The COVID-19 transmission rate is very high, infecting two to three persons on average with contact to an already infected person. There is a need for the health system, specially in developing countries such as in Pakistan, to combat such a novel disease by rapid, accurate, and high quality diagnostic testing in order to screen suspected cases and also surveillance of the disease. A rapid, accurate and low-cost diagnostic point-of-care device is needed for timely diagnosis of COVID-19 and is essential to combat such outbreaks for compelling preventive measures against the disease spread. This review is to highlight the importance of point-of-care diagnostics device for robust and accurate diagnosis of COVID-19 in physician offices and other urgent healthcare-type settings and encourage academics and stake holders towards advancement in order to control outbreaks and develop the public health surveillance system.",10.1016/j.aller.2020.06.001,cmm63mr2,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'named', 'by', 'the', 'WHO', 'as', 'a', 'result', 'of', 'the', 'global', 'public', 'health', 'emergency', 'COVID', '19', 'is', 'caused', 'by', 'a', 'new', 'coronavirus', 'named', 'as', 'novel', 'coronavirus', '2019', 'nCOV', 'From', 'the', 'first', 'case', 'reported', 'in', 'December', '2019', 'it', 'is', 'now', 'a', 'pandemic', 'situation', 'and', 'a', 'major', 'public', 'health', 'emergency', 'The', 'COVID', '19', 'transmission', 'rate', 'is', 'very', 'high', 'infecting', 'two', 'to', 'three', 'persons', 'on', 'average', 'with', 'contact', 'to', 'an', 'already', 'infected', 'person', 'There', 'is', 'a', 'need', 'for', 'the', 'health', 'system', 'specially', 'in', 'developing', 'countries', 'such', 'as', 'in', 'Pakistan', 'to', 'combat', 'such', 'a', 'novel', 'disease', 'by', 'rapid', 'accurate', 'and', 'high', 'quality', 'diagnostic', 'testing', 'in', 'order', 'to', 'screen', 'suspected', 'cases', 'and', 'also', 'surveillance', 'of', 'the', 'disease', 'A', 'rapid', 'accurate', 'and', 'low', 'cost', 'diagnostic', 'point', 'of', 'care', 'device', 'is', 'needed', 'for', 'timely', 'diagnosis', 'of', 'COVID', '19', 'and', 'is', 'essential', 'to', 'combat', 'such', 'outbreaks', 'for', 'compelling', 'preventive', 'measures', 'against', 'the', 'disease', 'spread', 'This', 'review', 'is', 'to', 'highlight', 'the', 'importance', 'of', 'point', 'of', 'care', 'diagnostics', 'device', 'for', 'robust', 'and', 'accurate', 'diagnosis', 'of', 'COVID', '19', 'in', 'physician', 'offices', 'and', 'other', 'urgent', 'healthcare', 'type', 'settings', 'and', 'encourage', 'academics', 'and', 'stake', 'holders', 'towards', 'advancement', 'in', 'order', 'to', 'control', 'outbreaks', 'and', 'develop', 'the', 'public', 'health', 'surveillance', 'system', '']"
185638,Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex,2019-06-30,BMB Rep,https://www.ncbi.nlm.nih.gov/pubmed/30355437/,"Middle East respiratory syndrome coronavirus (MERS-CoV) uses the spike (S) glycoprotein to recognize and enter target cells. In this study, we selected two epitope peptide sequences within the receptor binding domain (RBD) of the MERS-CoV S protein. We used a complex consisting of the epitope peptide of the MERS-CoV S protein and CpG-DNA encapsulated in liposome complex to immunize mice, and produced the monoclonal antibodies 506-2G10G5 and 492-1G10E4E2. The western blotting data showed that both monoclonal antibodies detected the S protein and immunoprecipitated the native form of the S protein. Indirect immunofluorescence and confocal analysis suggested strong reactivity of the antibodies towards the S protein of MERS-CoV virus infected Vero cells. Furthermore, the 506-2G10G5 monoclonal antibody significantly reduced plaque formation in MERS-CoV infected Vero cells compared to normal mouse IgG and 492-1G10E4E2. Thus, we successfully produced a monoclonal antibody directed against the RBD domain of the S protein which could be used in the development of diagnostics and therapeutic applications in the future.",10.5483/bmbrep.2019.52.6.185,n7ehxulc,"['Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'uses', 'the', 'spike', 'S', 'glycoprotein', 'to', 'recognize', 'and', 'enter', 'target', 'cells', 'In', 'this', 'study', 'we', 'selected', 'two', 'epitope', 'peptide', 'sequences', 'within', 'the', 'receptor', 'binding', 'domain', 'RBD', 'of', 'the', 'MERS', 'CoV', 'S', 'protein', 'We', 'used', 'a', 'complex', 'consisting', 'of', 'the', 'epitope', 'peptide', 'of', 'the', 'MERS', 'CoV', 'S', 'protein', 'and', 'CpG', 'DNA', 'encapsulated', 'in', 'liposome', 'complex', 'to', 'immunize', 'mice', 'and', 'produced', 'the', 'monoclonal', 'antibodies', '506', '2G10G5', 'and', '492', '1G10E4E2', 'The', 'western', 'blotting', 'data', 'showed', 'that', 'both', 'monoclonal', 'antibodies', 'detected', 'the', 'S', 'protein', 'and', 'immunoprecipitated', 'the', 'native', 'form', 'of', 'the', 'S', 'protein', 'Indirect', 'immunofluorescence', 'and', 'confocal', 'analysis', 'suggested', 'strong', 'reactivity', 'of', 'the', 'antibodies', 'towards', 'the', 'S', 'protein', 'of', 'MERS', 'CoV', 'virus', 'infected', 'Vero', 'cells', 'Furthermore', 'the', '506', '2G10G5', 'monoclonal', 'antibody', 'significantly', 'reduced', 'plaque', 'formation', 'in', 'MERS', 'CoV', 'infected', 'Vero', 'cells', 'compared', 'to', 'normal', 'mouse', 'IgG', 'and', '492', '1G10E4E2', 'Thus', 'we', 'successfully', 'produced', 'a', 'monoclonal', 'antibody', 'directed', 'against', 'the', 'RBD', 'domain', 'of', 'the', 'S', 'protein', 'which', 'could', 'be', 'used', 'in', 'the', 'development', 'of', 'diagnostics', 'and', 'therapeutic', 'applications', 'in', 'the', 'future', '']"
185952,"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review",2020-02-26,J Clin Med,https://doi.org/10.3390/jcm9030623; https://www.ncbi.nlm.nih.gov/pubmed/32110875/,"Rapid diagnostics, vaccines and therapeutics are important interventions for the management of the 2019 novel coronavirus (2019-nCoV) outbreak. It is timely to systematically review the potential of these interventions, including those for Middle East respiratory syndrome-Coronavirus (MERS-CoV) and severe acute respiratory syndrome (SARS)-CoV, to guide policymakers globally on their prioritization of resources for research and development. A systematic search was carried out in three major electronic databases (PubMed, Embase and Cochrane Library) to identify published studies in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Supplementary strategies through Google Search and personal communications were used. A total of 27 studies fulfilled the criteria for review. Several laboratory protocols for confirmation of suspected 2019-nCoV cases using real-time reverse transcription polymerase chain reaction (RT-PCR) have been published. A commercial RT-PCR kit developed by the Beijing Genomic Institute is currently widely used in China and likely in Asia. However, serological assays as well as point-of-care testing kits have not been developed but are likely in the near future. Several vaccine candidates are in the pipeline. The likely earliest Phase 1 vaccine trial is a synthetic DNA-based candidate. A number of novel compounds as well as therapeutics licensed for other conditions appear to have in vitro efficacy against the 2019-nCoV. Some are being tested in clinical trials against MERS-CoV and SARS-CoV, while others have been listed for clinical trials against 2019-nCoV. However, there are currently no effective specific antivirals or drug combinations supported by high-level evidence.",10.3390/jcm9030623,8gncbgot,"['Rapid', 'diagnostics', 'vaccines', 'and', 'therapeutics', 'are', 'important', 'interventions', 'for', 'the', 'management', 'of', 'the', '2019', 'novel', 'coronavirus', '2019', 'nCoV', 'outbreak', 'It', 'is', 'timely', 'to', 'systematically', 'review', 'the', 'potential', 'of', 'these', 'interventions', 'including', 'those', 'for', 'Middle', 'East', 'respiratory', 'syndrome', 'Coronavirus', 'MERS', 'CoV', 'and', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'to', 'guide', 'policymakers', 'globally', 'on', 'their', 'prioritization', 'of', 'resources', 'for', 'research', 'and', 'development', 'A', 'systematic', 'search', 'was', 'carried', 'out', 'in', 'three', 'major', 'electronic', 'databases', 'PubMed', 'Embase', 'and', 'Cochrane', 'Library', 'to', 'identify', 'published', 'studies', 'in', 'accordance', 'with', 'the', 'Preferred', 'Reporting', 'Items', 'for', 'Systematic', 'Reviews', 'and', 'Meta', 'Analyses', 'PRISMA', 'guidelines', 'Supplementary', 'strategies', 'through', 'Google', 'Search', 'and', 'personal', 'communications', 'were', 'used', 'A', 'total', 'of', '27', 'studies', 'fulfilled', 'the', 'criteria', 'for', 'review', 'Several', 'laboratory', 'protocols', 'for', 'confirmation', 'of', 'suspected', '2019', 'nCoV', 'cases', 'using', 'real', 'time', 'reverse', 'transcription', 'polymerase', 'chain', 'reaction', 'RT', 'PCR', 'have', 'been', 'published', 'A', 'commercial', 'RT', 'PCR', 'kit', 'developed', 'by', 'the', 'Beijing', 'Genomic', 'Institute', 'is', 'currently', 'widely', 'used', 'in', 'China', 'and', 'likely', 'in', 'Asia', 'However', 'serological', 'assays', 'as', 'well', 'as', 'point', 'of', 'care', 'testing', 'kits', 'have', 'not', 'been', 'developed', 'but', 'are', 'likely', 'in', 'the', 'near', 'future', 'Several', 'vaccine', 'candidates', 'are', 'in', 'the', 'pipeline', 'The', 'likely', 'earliest', 'Phase', '1', 'vaccine', 'trial', 'is', 'a', 'synthetic', 'DNA', 'based', 'candidate', 'A', 'number', 'of', 'novel', 'compounds', 'as', 'well', 'as', 'therapeutics', 'licensed', 'for', 'other', 'conditions', 'appear', 'to', 'have', 'in', 'vitro', 'efficacy', 'against', 'the', '2019', 'nCoV', 'Some', 'are', 'being', 'tested', 'in', 'clinical', 'trials', 'against', 'MERS', 'CoV', 'and', 'SARS', 'CoV', 'while', 'others', 'have', 'been', 'listed', 'for', 'clinical', 'trials', 'against', '2019', 'nCoV', 'However', 'there', 'are', 'currently', 'no', 'effective', 'specific', 'antivirals', 'or', 'drug', 'combinations', 'supported', 'by', 'high', 'level', 'evidence', '']"
186954,Cryptosporidium infection in herds with and without calf diarrhoeal problems,2010-08-17,Parasitol Res,https://www.ncbi.nlm.nih.gov/pubmed/20714750/; https://doi.org/10.1007/s00436-010-2020-x,"A case–control study was designed to investigate the role of different Cryptosporidium spp. in Swedish dairy herds with and without calf diarrhoeal problems. Faecal samples were collected from preweaned calves, young stock and cows. Cryptosporidium oocysts were detected by sodium chloride flotation and epifluorescence microscopy. Molecular diagnostics were used to identify Cryptosporidium species. Samples containing C. parvum were further analysed to determine subtypes. Calf faecal samples were also analysed for rotavirus, coronavirus and Escherichia coli F5+. Total protein was assessed in 1- to 8-day-old calves. A questionnaire was used to identify differences in management routines. Cryptosporidium infection was diagnosed in all herds, with equal prevalence in case and control herds in all three age groups. Cryptosporidium parvum, Cryptosporidium bovis, Cryptosporidium ryanae and Cryptosporidium andersoni were all identified, as were rotavirus, coronavirus and E. coli F5+. C. ryanae and C. andersoni were only detected in non-diarrhoeal samples, whereas the other pathogens were detected in both diarrhoeal and non-diarrhoeal samples. Diarrhoea was more common in case herd calves. Disinfection of single pens was more common in case herds and several other management routines seemed to differ although results were not significant.",10.1007/s00436-010-2020-x,gdpiaxbr,"['A', 'case', 'control', 'study', 'was', 'designed', 'to', 'investigate', 'the', 'role', 'of', 'different', 'Cryptosporidium', 'spp', 'in', 'Swedish', 'dairy', 'herds', 'with', 'and', 'without', 'calf', 'diarrhoeal', 'problems', 'Faecal', 'samples', 'were', 'collected', 'from', 'preweaned', 'calves', 'young', 'stock', 'and', 'cows', 'Cryptosporidium', 'oocysts', 'were', 'detected', 'by', 'sodium', 'chloride', 'flotation', 'and', 'epifluorescence', 'microscopy', 'Molecular', 'diagnostics', 'were', 'used', 'to', 'identify', 'Cryptosporidium', 'species', 'Samples', 'containing', 'C', 'parvum', 'were', 'further', 'analysed', 'to', 'determine', 'subtypes', 'Calf', 'faecal', 'samples', 'were', 'also', 'analysed', 'for', 'rotavirus', 'coronavirus', 'and', 'Escherichia', 'coli', 'F5', 'Total', 'protein', 'was', 'assessed', 'in', '1', 'to', '8', 'day', 'old', 'calves', 'A', 'questionnaire', 'was', 'used', 'to', 'identify', 'differences', 'in', 'management', 'routines', 'Cryptosporidium', 'infection', 'was', 'diagnosed', 'in', 'all', 'herds', 'with', 'equal', 'prevalence', 'in', 'case', 'and', 'control', 'herds', 'in', 'all', 'three', 'age', 'groups', 'Cryptosporidium', 'parvum', 'Cryptosporidium', 'bovis', 'Cryptosporidium', 'ryanae', 'and', 'Cryptosporidium', 'andersoni', 'were', 'all', 'identified', 'as', 'were', 'rotavirus', 'coronavirus', 'and', 'E', 'coli', 'F5', 'C', 'ryanae', 'and', 'C', 'andersoni', 'were', 'only', 'detected', 'in', 'non', 'diarrhoeal', 'samples', 'whereas', 'the', 'other', 'pathogens', 'were', 'detected', 'in', 'both', 'diarrhoeal', 'and', 'non', 'diarrhoeal', 'samples', 'Diarrhoea', 'was', 'more', 'common', 'in', 'case', 'herd', 'calves', 'Disinfection', 'of', 'single', 'pens', 'was', 'more', 'common', 'in', 'case', 'herds', 'and', 'several', 'other', 'management', 'routines', 'seemed', 'to', 'differ', 'although', 'results', 'were', 'not', 'significant', '']"
187730,Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens,2020-05-27,Infect Genet Evol,https://api.elsevier.com/content/article/pii/S1567134820302136; https://doi.org/10.1016/j.meegid.2020.104382; https://www.sciencedirect.com/science/article/pii/S1567134820302136?v=s5; https://www.ncbi.nlm.nih.gov/pubmed/32473352/,"The 2019 novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak has caused a large number of deaths, with thousands of confirmed cases worldwide. The present study followed computational approaches to identify B- and T-cell epitopes for the spike (S) glycoprotein of SARS-CoV-2 by its interactions with the human leukocyte antigen alleles. We identified 24 peptide stretches on the SARS-CoV-2 S protein that are well conserved among the reported strains. The S protein structure further validated the presence of predicted peptides on the surface, of which 20 are surface exposed and predicted to have reasonable epitope binding efficiency. The work could be useful for understanding the immunodominant regions in the surface protein of SARS-CoV-2 and could potentially help in designing some peptide-based diagnostics. Also, identified T-cell epitopes might be considered for incorporation in vaccine designs.",10.1016/j.meegid.2020.104382,hf7fgtnp,"['The', '2019', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'outbreak', 'has', 'caused', 'a', 'large', 'number', 'of', 'deaths', 'with', 'thousands', 'of', 'confirmed', 'cases', 'worldwide', 'The', 'present', 'study', 'followed', 'computational', 'approaches', 'to', 'identify', 'B', 'and', 'T', 'cell', 'epitopes', 'for', 'the', 'spike', 'S', 'glycoprotein', 'of', 'SARS', 'CoV', '2', 'by', 'its', 'interactions', 'with', 'the', 'human', 'leukocyte', 'antigen', 'alleles', 'We', 'identified', '24', 'peptide', 'stretches', 'on', 'the', 'SARS', 'CoV', '2', 'S', 'protein', 'that', 'are', 'well', 'conserved', 'among', 'the', 'reported', 'strains', 'The', 'S', 'protein', 'structure', 'further', 'validated', 'the', 'presence', 'of', 'predicted', 'peptides', 'on', 'the', 'surface', 'of', 'which', '20', 'are', 'surface', 'exposed', 'and', 'predicted', 'to', 'have', 'reasonable', 'epitope', 'binding', 'efficiency', 'The', 'work', 'could', 'be', 'useful', 'for', 'understanding', 'the', 'immunodominant', 'regions', 'in', 'the', 'surface', 'protein', 'of', 'SARS', 'CoV', '2', 'and', 'could', 'potentially', 'help', 'in', 'designing', 'some', 'peptide', 'based', 'diagnostics', 'Also', 'identified', 'T', 'cell', 'epitopes', 'might', 'be', 'considered', 'for', 'incorporation', 'in', 'vaccine', 'designs', '']"
187925,COVID-19 Outbreak: An Overview,2020-04-07,Chemotherapy,https://doi.org/10.1159/000507423; https://www.ncbi.nlm.nih.gov/pubmed/32259829/,"BACKGROUND: In late December 2019, Chinese health authorities reported an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province. SUMMARY: A few days later, the genome of a novel coronavirus was released (http://virological.org/t/novel-2019-coronavirus-genome/319; Wuhan-Hu-1, GenBank accession No. MN908947) and made publicly available to the scientific community. This novel coronavirus was provisionally named 2019-nCoV, now SARS-CoV-2 according to the Coronavirus Study Group of the International Committee on Taxonomy of Viruses. SARS-CoV-2 belongs to the Coronaviridae family, Betacoronavirus genus, subgenus Sarbecovirus. Since its discovery, the virus has spread globally, causing thousands of deaths and having an enormous impact on our health systems and economies. In this review, we summarize the current knowledge about the epidemiology, phylogenesis, homology modeling, and molecular diagnostics of SARS-CoV-2. KEY MESSAGES: Phylogenetic analysis is essential to understand viral evolution, whereas homology modeling is important for vaccine strategies and therapies. Highly sensitive and specific diagnostic assays are key to case identification, contact tracing, identification of the animal source, and implementation of control measures.",10.1159/000507423,u7tz6xzz,"['BACKGROUND', 'In', 'late', 'December', '2019', 'Chinese', 'health', 'authorities', 'reported', 'an', 'outbreak', 'of', 'pneumonia', 'of', 'unknown', 'origin', 'in', 'Wuhan', 'Hubei', 'Province', 'SUMMARY', 'A', 'few', 'days', 'later', 'the', 'genome', 'of', 'a', 'novel', 'coronavirus', 'was', 'released', 'http', 'virological', 'org', 't', 'novel', '2019', 'coronavirus', 'genome', '319', 'Wuhan', 'Hu', '1', 'GenBank', 'accession', 'No', 'MN908947', 'and', 'made', 'publicly', 'available', 'to', 'the', 'scientific', 'community', 'This', 'novel', 'coronavirus', 'was', 'provisionally', 'named', '2019', 'nCoV', 'now', 'SARS', 'CoV', '2', 'according', 'to', 'the', 'Coronavirus', 'Study', 'Group', 'of', 'the', 'International', 'Committee', 'on', 'Taxonomy', 'of', 'Viruses', 'SARS', 'CoV', '2', 'belongs', 'to', 'the', 'Coronaviridae', 'family', 'Betacoronavirus', 'genus', 'subgenus', 'Sarbecovirus', 'Since', 'its', 'discovery', 'the', 'virus', 'has', 'spread', 'globally', 'causing', 'thousands', 'of', 'deaths', 'and', 'having', 'an', 'enormous', 'impact', 'on', 'our', 'health', 'systems', 'and', 'economies', 'In', 'this', 'review', 'we', 'summarize', 'the', 'current', 'knowledge', 'about', 'the', 'epidemiology', 'phylogenesis', 'homology', 'modeling', 'and', 'molecular', 'diagnostics', 'of', 'SARS', 'CoV', '2', 'KEY', 'MESSAGES', 'Phylogenetic', 'analysis', 'is', 'essential', 'to', 'understand', 'viral', 'evolution', 'whereas', 'homology', 'modeling', 'is', 'important', 'for', 'vaccine', 'strategies', 'and', 'therapies', 'Highly', 'sensitive', 'and', 'specific', 'diagnostic', 'assays', 'are', 'key', 'to', 'case', 'identification', 'contact', 'tracing', 'identification', 'of', 'the', 'animal', 'source', 'and', 'implementation', 'of', 'control', 'measures', '']"
188194,Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19,2020-06-16,Clin Infect Dis,https://doi.org/10.1093/cid/ciaa760; https://www.ncbi.nlm.nih.gov/pubmed/32556191/,"BACKGROUND: Accurate molecular diagnostic tests are necessary for confirming a diagnosis of coronavirus disease 2019 (COVID-19). Direct detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acids in respiratory tract specimens informs patient, healthcare institution and public health level decision-making. The numbers of available SARS-CoV-2 nucleic acid detection tests are rapidly increasing, as is the COVID-19 diagnostic literature. Thus, the Infectious Diseases Society of America (IDSA) recognized a significant need for frequently updated systematic reviews of the literature to inform evidence-based best practice guidance. OBJECTIVE: The IDSA’s goal was to develop an evidence-based diagnostic guideline to assists clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of SARS-CoV-2 nucleic acid amplification tests. In addition, we provide a conceptual framework for understanding molecular diagnostic test performance, discuss the nuance of test result interpretation in a variety of practice settings, and highlight important unmet research needs in the COVID-19 diagnostic testing space. METHODS: IDSA convened a multidisciplinary panel of infectious diseases clinicians, clinical microbiologists, and experts in systematic literature review to identify and prioritize clinical questions and outcomes related to the use of SARS-CoV-2 molecular diagnostics. Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was used to assess the certainty of evidence and make testing recommendations. RESULTS: The panel agreed on 15 diagnostic recommendations. CONCLUSIONS: Universal access to accurate SARS-CoV-2 nucleic acid testing is critical for patient care, hospital infection prevention and the public response to the COVID-19 pandemic. Information on the clinical performance of available tests is rapidly emerging, but the quality of evidence of the current literature is considered low to very low. Recognizing these limitations, the IDSA panel weighed available diagnostic evidence and recommends nucleic acid testing for all symptomatic individuals suspected of having COVID-19. In addition, testing is recommended for asymptomatic individuals with known or suspected contact with a COVID-19 case. Testing asymptomatic individuals without known exposure is suggested when the results will impact isolation/quarantine/personal protective equipment (PPE) usage decisions, dictate eligibility for surgery, or inform administration of immunosuppressive therapy. Ultimately, prioritization of testing will depend on institutional-specific resources and the needs of different patient populations.",10.1093/cid/ciaa760,q2716lda,"['BACKGROUND', 'Accurate', 'molecular', 'diagnostic', 'tests', 'are', 'necessary', 'for', 'confirming', 'a', 'diagnosis', 'of', 'coronavirus', 'disease', '2019', 'COVID', '19', 'Direct', 'detection', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'nucleic', 'acids', 'in', 'respiratory', 'tract', 'specimens', 'informs', 'patient', 'healthcare', 'institution', 'and', 'public', 'health', 'level', 'decision', 'making', 'The', 'numbers', 'of', 'available', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'detection', 'tests', 'are', 'rapidly', 'increasing', 'as', 'is', 'the', 'COVID', '19', 'diagnostic', 'literature', 'Thus', 'the', 'Infectious', 'Diseases', 'Society', 'of', 'America', 'IDSA', 'recognized', 'a', 'significant', 'need', 'for', 'frequently', 'updated', 'systematic', 'reviews', 'of', 'the', 'literature', 'to', 'inform', 'evidence', 'based', 'best', 'practice', 'guidance', 'OBJECTIVE', 'The', 'IDSA', 's', 'goal', 'was', 'to', 'develop', 'an', 'evidence', 'based', 'diagnostic', 'guideline', 'to', 'assists', 'clinicians', 'clinical', 'laboratorians', 'patients', 'and', 'policymakers', 'in', 'decisions', 'related', 'to', 'the', 'optimal', 'use', 'of', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'amplification', 'tests', 'In', 'addition', 'we', 'provide', 'a', 'conceptual', 'framework', 'for', 'understanding', 'molecular', 'diagnostic', 'test', 'performance', 'discuss', 'the', 'nuance', 'of', 'test', 'result', 'interpretation', 'in', 'a', 'variety', 'of', 'practice', 'settings', 'and', 'highlight', 'important', 'unmet', 'research', 'needs', 'in', 'the', 'COVID', '19', 'diagnostic', 'testing', 'space', 'METHODS', 'IDSA', 'convened', 'a', 'multidisciplinary', 'panel', 'of', 'infectious', 'diseases', 'clinicians', 'clinical', 'microbiologists', 'and', 'experts', 'in', 'systematic', 'literature', 'review', 'to', 'identify', 'and', 'prioritize', 'clinical', 'questions', 'and', 'outcomes', 'related', 'to', 'the', 'use', 'of', 'SARS', 'CoV', '2', 'molecular', 'diagnostics', 'Grading', 'of', 'Recommendations', 'Assessment', 'Development', 'and', 'Evaluation', 'GRADE', 'methodology', 'was', 'used', 'to', 'assess', 'the', 'certainty', 'of', 'evidence', 'and', 'make', 'testing', 'recommendations', 'RESULTS', 'The', 'panel', 'agreed', 'on', '15', 'diagnostic', 'recommendations', 'CONCLUSIONS', 'Universal', 'access', 'to', 'accurate', 'SARS', 'CoV', '2', 'nucleic', 'acid', 'testing', 'is', 'critical', 'for', 'patient', 'care', 'hospital', 'infection', 'prevention', 'and', 'the', 'public', 'response', 'to', 'the', 'COVID', '19', 'pandemic', 'Information', 'on', 'the', 'clinical', 'performance', 'of', 'available', 'tests', 'is', 'rapidly', 'emerging', 'but', 'the', 'quality', 'of', 'evidence', 'of', 'the', 'current', 'literature', 'is', 'considered', 'low', 'to', 'very', 'low', 'Recognizing', 'these', 'limitations', 'the', 'IDSA', 'panel', 'weighed', 'available', 'diagnostic', 'evidence', 'and', 'recommends', 'nucleic', 'acid', 'testing', 'for', 'all', 'symptomatic', 'individuals', 'suspected', 'of', 'having', 'COVID', '19', 'In', 'addition', 'testing', 'is', 'recommended', 'for', 'asymptomatic', 'individuals', 'with', 'known', 'or', 'suspected', 'contact', 'with', 'a', 'COVID', '19', 'case', 'Testing', 'asymptomatic', 'individuals', 'without', 'known', 'exposure', 'is', 'suggested', 'when', 'the', 'results', 'will', 'impact', 'isolation', 'quarantine', 'personal', 'protective', 'equipment', 'PPE', 'usage', 'decisions', 'dictate', 'eligibility', 'for', 'surgery', 'or', 'inform', 'administration', 'of', 'immunosuppressive', 'therapy', 'Ultimately', 'prioritization', 'of', 'testing', 'will', 'depend', 'on', 'institutional', 'specific', 'resources', 'and', 'the', 'needs', 'of', 'different', 'patient', 'populations', '']"
188270,"An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies",2020-05-30,Travel Med Infect Dis,https://www.sciencedirect.com/science/article/pii/S1477893920302349?v=s5; https://www.ncbi.nlm.nih.gov/pubmed/32479816/; https://api.elsevier.com/content/article/pii/S1477893920302349; https://doi.org/10.1016/j.tmaid.2020.101755,"Coronavirus Disease 2019 (COVID-19), emerged in early December 2019 in China and became a pandemic situation worldwide by its rapid spread to nearly 190 countries. Bats are considered as the reservoir host, and the search of a probable intermediate host is still going on. The severe form of the infection is associated with death is mainly reported in older and immune-compromised patients with pre-existing disease history. Death in severe cases is attributed to respiratory failure associated with hyperinflammation. Cytokine storm syndrome associated with inflammation in response to SARS-CoV-2 infection is considered as the leading cause of mortality in COVID-19 patients. COVID-19 patients have thus higher levels of many proinflammatory cytokines and chemokines. The blood lab profile of the COVID-19 patients exhibits lymphopenia, leukopenia, thrombocytopenia, and RNAaemia, along with increased levels of aspartate aminotransferase. SARS-CoV-2 infection in pregnant women does not lead to fetus mortality, unlike other zoonotic coronaviruses such as SARS-CoV and MERS-CoV, and there is, to date, no evidence of intrauterine transmission to neonates. Rapid diagnostics have been developed, and significant efforts are being made to develop effective vaccines and therapeutics. In the absence of any virus-specific therapy, internationally, health care authorities are recommending the adoption of effective community mitigation measures to counter and contain this pandemic virus. This paper is an overview of this virus and the disease with a particular focus on SARS-CoV-2/COVID-19 clinical pathology, pathogenesis, and immunopathology, along with recent research developments.",10.1016/j.tmaid.2020.101755,7rh07bii,"['Coronavirus', 'Disease', '2019', 'COVID', '19', 'emerged', 'in', 'early', 'December', '2019', 'in', 'China', 'and', 'became', 'a', 'pandemic', 'situation', 'worldwide', 'by', 'its', 'rapid', 'spread', 'to', 'nearly', '190', 'countries', 'Bats', 'are', 'considered', 'as', 'the', 'reservoir', 'host', 'and', 'the', 'search', 'of', 'a', 'probable', 'intermediate', 'host', 'is', 'still', 'going', 'on', 'The', 'severe', 'form', 'of', 'the', 'infection', 'is', 'associated', 'with', 'death', 'is', 'mainly', 'reported', 'in', 'older', 'and', 'immune', 'compromised', 'patients', 'with', 'pre', 'existing', 'disease', 'history', 'Death', 'in', 'severe', 'cases', 'is', 'attributed', 'to', 'respiratory', 'failure', 'associated', 'with', 'hyperinflammation', 'Cytokine', 'storm', 'syndrome', 'associated', 'with', 'inflammation', 'in', 'response', 'to', 'SARS', 'CoV', '2', 'infection', 'is', 'considered', 'as', 'the', 'leading', 'cause', 'of', 'mortality', 'in', 'COVID', '19', 'patients', 'COVID', '19', 'patients', 'have', 'thus', 'higher', 'levels', 'of', 'many', 'proinflammatory', 'cytokines', 'and', 'chemokines', 'The', 'blood', 'lab', 'profile', 'of', 'the', 'COVID', '19', 'patients', 'exhibits', 'lymphopenia', 'leukopenia', 'thrombocytopenia', 'and', 'RNAaemia', 'along', 'with', 'increased', 'levels', 'of', 'aspartate', 'aminotransferase', 'SARS', 'CoV', '2', 'infection', 'in', 'pregnant', 'women', 'does', 'not', 'lead', 'to', 'fetus', 'mortality', 'unlike', 'other', 'zoonotic', 'coronaviruses', 'such', 'as', 'SARS', 'CoV', 'and', 'MERS', 'CoV', 'and', 'there', 'is', 'to', 'date', 'no', 'evidence', 'of', 'intrauterine', 'transmission', 'to', 'neonates', 'Rapid', 'diagnostics', 'have', 'been', 'developed', 'and', 'significant', 'efforts', 'are', 'being', 'made', 'to', 'develop', 'effective', 'vaccines', 'and', 'therapeutics', 'In', 'the', 'absence', 'of', 'any', 'virus', 'specific', 'therapy', 'internationally', 'health', 'care', 'authorities', 'are', 'recommending', 'the', 'adoption', 'of', 'effective', 'community', 'mitigation', 'measures', 'to', 'counter', 'and', 'contain', 'this', 'pandemic', 'virus', 'This', 'paper', 'is', 'an', 'overview', 'of', 'this', 'virus', 'and', 'the', 'disease', 'with', 'a', 'particular', 'focus', 'on', 'SARS', 'CoV', '2', 'COVID', '19', 'clinical', 'pathology', 'pathogenesis', 'and', 'immunopathology', 'along', 'with', 'recent', 'research', 'developments', '']"
188545,Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance,2020-04-25,bioRxiv,https://doi.org/10.1101/2020.04.24.057323; https://www.ncbi.nlm.nih.gov/pubmed/32511332/,"Since emergence of SARS-CoV-2 in late 2019, there has been a critical need to understand prevalence, transmission patterns, to calculate the burden of disease and case fatality rates. Molecular diagnostics, the gold standard for identifying viremic cases, are not ideal for determining true case counts and rates of asymptomatic infection. Serological detection of SARS-CoV-2 specific antibodies can contribute to filling these knowledge gaps. In this study, we describe optimization and validation of a SARS-CoV-2-specific-enzyme linked immunosorbent assay (ELISA) using the prefusion-stabilized form of the spike protein [1]. We performed receiver operator characteristic (ROC) analyses to define the specificities and sensitivities of the optimized assay and examined cross reactivity with immune sera from persons confirmed to have had infections with other coronaviruses. These assays will be used to perform contact investigations and to conduct large-scale, cross sectional surveillance to define disease burden in the population.",10.1101/2020.04.24.057323,4070r4fc,"['Since', 'emergence', 'of', 'SARS', 'CoV', '2', 'in', 'late', '2019', 'there', 'has', 'been', 'a', 'critical', 'need', 'to', 'understand', 'prevalence', 'transmission', 'patterns', 'to', 'calculate', 'the', 'burden', 'of', 'disease', 'and', 'case', 'fatality', 'rates', 'Molecular', 'diagnostics', 'the', 'gold', 'standard', 'for', 'identifying', 'viremic', 'cases', 'are', 'not', 'ideal', 'for', 'determining', 'true', 'case', 'counts', 'and', 'rates', 'of', 'asymptomatic', 'infection', 'Serological', 'detection', 'of', 'SARS', 'CoV', '2', 'specific', 'antibodies', 'can', 'contribute', 'to', 'filling', 'these', 'knowledge', 'gaps', 'In', 'this', 'study', 'we', 'describe', 'optimization', 'and', 'validation', 'of', 'a', 'SARS', 'CoV', '2', 'specific', 'enzyme', 'linked', 'immunosorbent', 'assay', 'ELISA', 'using', 'the', 'prefusion', 'stabilized', 'form', 'of', 'the', 'spike', 'protein', '1', 'We', 'performed', 'receiver', 'operator', 'characteristic', 'ROC', 'analyses', 'to', 'define', 'the', 'specificities', 'and', 'sensitivities', 'of', 'the', 'optimized', 'assay', 'and', 'examined', 'cross', 'reactivity', 'with', 'immune', 'sera', 'from', 'persons', 'confirmed', 'to', 'have', 'had', 'infections', 'with', 'other', 'coronaviruses', 'These', 'assays', 'will', 'be', 'used', 'to', 'perform', 'contact', 'investigations', 'and', 'to', 'conduct', 'large', 'scale', 'cross', 'sectional', 'surveillance', 'to', 'define', 'disease', 'burden', 'in', 'the', 'population', '']"
189091,Optical techniques for fast screening – towards prevention of the coronavirus COVID-19 outbreak,2020-04-15,Photodiagnosis Photodyn Ther,https://www.sciencedirect.com/science/article/pii/S1572100020301186?v=s5; https://api.elsevier.com/content/article/pii/S1572100020301186; https://www.ncbi.nlm.nih.gov/pubmed/32304912/; https://doi.org/10.1016/j.pdpdt.2020.101765,• Coronavirus disease 2019 (COVID-19) is emerging and requires early diagnostics. • Biomarkers are present for coronaviruses. • Raman and FT-IR spectroscopy are green technologies capable of high-throughput virus sensing.,10.1016/j.pdpdt.2020.101765,3d0tmydv,"['', 'Coronavirus', 'disease', '2019', 'COVID', '19', 'is', 'emerging', 'and', 'requires', 'early', 'diagnostics', 'Biomarkers', 'are', 'present', 'for', 'coronaviruses', 'Raman', 'and', 'FT', 'IR', 'spectroscopy', 'are', 'green', 'technologies', 'capable', 'of', 'high', 'throughput', 'virus', 'sensing', '']"
189098,Technologies to Optimize the Care of Severe Coronavirus Disease 2019 Patients for Health Care Providers Challenged by Limited Resources,2020-05-26,Anesth Analg,https://www.ncbi.nlm.nih.gov/pubmed/32433248/; https://doi.org/10.1213/ane.0000000000004985,"Health care systems are belligerently responding to the new Coronavirus Disease 2019 (COVID-19). The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a specific condition, whose distinctive features are severe hypoxemia associated with (>50% of cases) normal respiratory system compliance.(1) When a patient requires intubation and invasive ventilation, the outcome is poor,(2–4) and the length of stay in the intensive care unit (ICU) is usually 2or 3 weeks.(2) In this article, theauthors review several technological devices, which could support health care providers at the bedside to optimizethe care for COVID-19 patients who are sedated, paralyzed, and ventilated. Particular attention is provided to the use of videolaryngoscopes (VL) because these can assist anesthetists to perform a successful intubation outside the ICU while protecting health care providers from this viral infection. Authors will also review processed electroencephalographic (EEG) monitors which are used to better titrate sedation and the train-of-four monitors which are utilizedto better titrate neuromuscular blocking agents in the view of sparing limited pharmacological resources. COVID-19 can rapidly exhaust human and technological resources too within the ICU. This review features a series of technological advancements that can significantly improve the care of patients requiring isolation. The working conditions in isolation could cause gaps or barriers in communication, fatigue, and poor documentation of provided care. The available technology has several advantages including (a) facilitating appropriate paperless documentation and communication between all health care givers working in isolation rooms or large isolation areas; (b) testing patients and staff at the bedside using smart point-of-care diagnostics (SPOCD) to confirm COVID-19 infection; (c) allowing diagnostics and treatment at the bedside through point-of-care ultrasound (POCUS) and thromboelastography(TEG); (d) adapting the use of anesthetic machines and the use of volatile anesthetics. Implementing technologies for safeguarding health care providers as well as monitoring the limited pharmacological resources are paramount. Only by leveraging new technologies, it will be possible to sustain and support health care systems during the expected long course of this pandemic.",10.1213/ane.0000000000004985,2lp3fead,"['Health', 'care', 'systems', 'are', 'belligerently', 'responding', 'to', 'the', 'new', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'The', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'is', 'a', 'specific', 'condition', 'whose', 'distinctive', 'features', 'are', 'severe', 'hypoxemia', 'associated', 'with', '50', 'of', 'cases', 'normal', 'respiratory', 'system', 'compliance', '1', 'When', 'a', 'patient', 'requires', 'intubation', 'and', 'invasive', 'ventilation', 'the', 'outcome', 'is', 'poor', '2', '4', 'and', 'the', 'length', 'of', 'stay', 'in', 'the', 'intensive', 'care', 'unit', 'ICU', 'is', 'usually', '2or', '3', 'weeks', '2', 'In', 'this', 'article', 'theauthors', 'review', 'several', 'technological', 'devices', 'which', 'could', 'support', 'health', 'care', 'providers', 'at', 'the', 'bedside', 'to', 'optimizethe', 'care', 'for', 'COVID', '19', 'patients', 'who', 'are', 'sedated', 'paralyzed', 'and', 'ventilated', 'Particular', 'attention', 'is', 'provided', 'to', 'the', 'use', 'of', 'videolaryngoscopes', 'VL', 'because', 'these', 'can', 'assist', 'anesthetists', 'to', 'perform', 'a', 'successful', 'intubation', 'outside', 'the', 'ICU', 'while', 'protecting', 'health', 'care', 'providers', 'from', 'this', 'viral', 'infection', 'Authors', 'will', 'also', 'review', 'processed', 'electroencephalographic', 'EEG', 'monitors', 'which', 'are', 'used', 'to', 'better', 'titrate', 'sedation', 'and', 'the', 'train', 'of', 'four', 'monitors', 'which', 'are', 'utilizedto', 'better', 'titrate', 'neuromuscular', 'blocking', 'agents', 'in', 'the', 'view', 'of', 'sparing', 'limited', 'pharmacological', 'resources', 'COVID', '19', 'can', 'rapidly', 'exhaust', 'human', 'and', 'technological', 'resources', 'too', 'within', 'the', 'ICU', 'This', 'review', 'features', 'a', 'series', 'of', 'technological', 'advancements', 'that', 'can', 'significantly', 'improve', 'the', 'care', 'of', 'patients', 'requiring', 'isolation', 'The', 'working', 'conditions', 'in', 'isolation', 'could', 'cause', 'gaps', 'or', 'barriers', 'in', 'communication', 'fatigue', 'and', 'poor', 'documentation', 'of', 'provided', 'care', 'The', 'available', 'technology', 'has', 'several', 'advantages', 'including', 'a', 'facilitating', 'appropriate', 'paperless', 'documentation', 'and', 'communication', 'between', 'all', 'health', 'care', 'givers', 'working', 'in', 'isolation', 'rooms', 'or', 'large', 'isolation', 'areas', 'b', 'testing', 'patients', 'and', 'staff', 'at', 'the', 'bedside', 'using', 'smart', 'point', 'of', 'care', 'diagnostics', 'SPOCD', 'to', 'confirm', 'COVID', '19', 'infection', 'c', 'allowing', 'diagnostics', 'and', 'treatment', 'at', 'the', 'bedside', 'through', 'point', 'of', 'care', 'ultrasound', 'POCUS', 'and', 'thromboelastography', 'TEG', 'd', 'adapting', 'the', 'use', 'of', 'anesthetic', 'machines', 'and', 'the', 'use', 'of', 'volatile', 'anesthetics', 'Implementing', 'technologies', 'for', 'safeguarding', 'health', 'care', 'providers', 'as', 'well', 'as', 'monitoring', 'the', 'limited', 'pharmacological', 'resources', 'are', 'paramount', 'Only', 'by', 'leveraging', 'new', 'technologies', 'it', 'will', 'be', 'possible', 'to', 'sustain', 'and', 'support', 'health', 'care', 'systems', 'during', 'the', 'expected', 'long', 'course', 'of', 'this', 'pandemic', '']"
189132,"COVID-19 Diagnostics, Tools, and Prevention",2020-06-16,Diagnostics (Basel),https://www.ncbi.nlm.nih.gov/pubmed/32560091/; https://doi.org/10.3390/diagnostics10060409,"The Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), outbreak from Wuhan City, Hubei province, China in 2019 has become an ongoing global health emergency. The emerging virus, SARS-CoV-2, causes coughing, fever, muscle ache, and shortness of breath or dyspnea in symptomatic patients. The pathogenic particles that are generated by coughing and sneezing remain suspended in the air or attach to a surface to facilitate transmission in an aerosol form. This review focuses on the recent trends in pandemic biology, diagnostics methods, prevention tools, and policies for COVID-19 management. To meet the growing demand for medical supplies during the COVID-19 era, a variety of personal protective equipment (PPE) and ventilators have been developed using do-it-yourself (DIY) manufacturing. COVID-19 diagnosis and the prediction of virus transmission are analyzed by machine learning algorithms, simulations, and digital monitoring. Until the discovery of a clinically approved vaccine for COVID-19, pandemics remain a public concern. Therefore, technological developments, biomedical research, and policy development are needed to decipher the coronavirus mechanism and epidemiological characteristics, prevent transmission, and develop therapeutic drugs.",10.3390/diagnostics10060409,lx5jhpnc,"['The', 'Coronavirus', 'Disease', '2019', 'COVID', '19', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'outbreak', 'from', 'Wuhan', 'City', 'Hubei', 'province', 'China', 'in', '2019', 'has', 'become', 'an', 'ongoing', 'global', 'health', 'emergency', 'The', 'emerging', 'virus', 'SARS', 'CoV', '2', 'causes', 'coughing', 'fever', 'muscle', 'ache', 'and', 'shortness', 'of', 'breath', 'or', 'dyspnea', 'in', 'symptomatic', 'patients', 'The', 'pathogenic', 'particles', 'that', 'are', 'generated', 'by', 'coughing', 'and', 'sneezing', 'remain', 'suspended', 'in', 'the', 'air', 'or', 'attach', 'to', 'a', 'surface', 'to', 'facilitate', 'transmission', 'in', 'an', 'aerosol', 'form', 'This', 'review', 'focuses', 'on', 'the', 'recent', 'trends', 'in', 'pandemic', 'biology', 'diagnostics', 'methods', 'prevention', 'tools', 'and', 'policies', 'for', 'COVID', '19', 'management', 'To', 'meet', 'the', 'growing', 'demand', 'for', 'medical', 'supplies', 'during', 'the', 'COVID', '19', 'era', 'a', 'variety', 'of', 'personal', 'protective', 'equipment', 'PPE', 'and', 'ventilators', 'have', 'been', 'developed', 'using', 'do', 'it', 'yourself', 'DIY', 'manufacturing', 'COVID', '19', 'diagnosis', 'and', 'the', 'prediction', 'of', 'virus', 'transmission', 'are', 'analyzed', 'by', 'machine', 'learning', 'algorithms', 'simulations', 'and', 'digital', 'monitoring', 'Until', 'the', 'discovery', 'of', 'a', 'clinically', 'approved', 'vaccine', 'for', 'COVID', '19', 'pandemics', 'remain', 'a', 'public', 'concern', 'Therefore', 'technological', 'developments', 'biomedical', 'research', 'and', 'policy', 'development', 'are', 'needed', 'to', 'decipher', 'the', 'coronavirus', 'mechanism', 'and', 'epidemiological', 'characteristics', 'prevent', 'transmission', 'and', 'develop', 'therapeutic', 'drugs', '']"
189939,A Multicenter Consortium to Define the Epidemiology and Outcomes of Inpatient Respiratory Viral Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients,2017-07-01,J Pediatric Infect Dis Soc,https://www.ncbi.nlm.nih.gov/pubmed/29106589/; https://doi.org/10.1093/jpids/pix051,"BACKGROUND: Respiratory virus infections (RVIs) pose a threat to children undergoing hematopoietic stem cell transplantation (HSCT). In this era of sensitive molecular diagnostics, the incidence and outcome of HSCT recipients who are hospitalized with RVI (H-RVI) are not well described. METHODS: A retrospective observational cohort of pediatric HSCT recipients (between January 2010 and June 2013) was assembled from 9 US pediatric transplant centers. Their medical charts were reviewed for H-RVI events within 1 year after their transplant. An H-RVI diagnosis required respiratory signs or symptoms plus viral detection (human rhinovirus/enterovirus, human metapneumovirus, influenza, parainfluenza, coronaviruses, and/or respiratory syncytial virus). The incidence of H-RVI was calculated, and the association of baseline HSCT factors with subsequent pulmonary complications and death was assessed. RESULTS: Among 1560 HSCT recipients, 259 (16.6%) acquired at least 1 H-RVI within 1 year after their transplant. The median age of the patients with an H-RVI was lower than that of patients without an H-RVI (4.8 vs 7.1 years; P < .001). Among the patients with a first H-RVI, 48% required some respiratory support, and 14% suffered significant pulmonary sequelae. The all-cause and attributable case-fatality rates within 3 months of H-RVI onset were 11% and 5.4%, respectively. Multivariate logistic regression revealed that H-RVI onset within 60 days of HSCT, steroid use in the 7 days before H-RVI onset, and the need for respiratory support at H-RVI onset were associated with subsequent morbidity or death. CONCLUSION: Results of this multicenter cohort study suggest that H-RVIs are relatively common in pediatric HSCT recipients and contribute to significant morbidity and death. These data should help inform interventional studies specific to each viral pathogen.",10.1093/jpids/pix051,bql0v4fu,"['BACKGROUND', 'Respiratory', 'virus', 'infections', 'RVIs', 'pose', 'a', 'threat', 'to', 'children', 'undergoing', 'hematopoietic', 'stem', 'cell', 'transplantation', 'HSCT', 'In', 'this', 'era', 'of', 'sensitive', 'molecular', 'diagnostics', 'the', 'incidence', 'and', 'outcome', 'of', 'HSCT', 'recipients', 'who', 'are', 'hospitalized', 'with', 'RVI', 'H', 'RVI', 'are', 'not', 'well', 'described', 'METHODS', 'A', 'retrospective', 'observational', 'cohort', 'of', 'pediatric', 'HSCT', 'recipients', 'between', 'January', '2010', 'and', 'June', '2013', 'was', 'assembled', 'from', '9', 'US', 'pediatric', 'transplant', 'centers', 'Their', 'medical', 'charts', 'were', 'reviewed', 'for', 'H', 'RVI', 'events', 'within', '1', 'year', 'after', 'their', 'transplant', 'An', 'H', 'RVI', 'diagnosis', 'required', 'respiratory', 'signs', 'or', 'symptoms', 'plus', 'viral', 'detection', 'human', 'rhinovirus', 'enterovirus', 'human', 'metapneumovirus', 'influenza', 'parainfluenza', 'coronaviruses', 'and', 'or', 'respiratory', 'syncytial', 'virus', 'The', 'incidence', 'of', 'H', 'RVI', 'was', 'calculated', 'and', 'the', 'association', 'of', 'baseline', 'HSCT', 'factors', 'with', 'subsequent', 'pulmonary', 'complications', 'and', 'death', 'was', 'assessed', 'RESULTS', 'Among', '1560', 'HSCT', 'recipients', '259', '16', '6', 'acquired', 'at', 'least', '1', 'H', 'RVI', 'within', '1', 'year', 'after', 'their', 'transplant', 'The', 'median', 'age', 'of', 'the', 'patients', 'with', 'an', 'H', 'RVI', 'was', 'lower', 'than', 'that', 'of', 'patients', 'without', 'an', 'H', 'RVI', '4', '8', 'vs', '7', '1', 'years', 'P', '001', 'Among', 'the', 'patients', 'with', 'a', 'first', 'H', 'RVI', '48', 'required', 'some', 'respiratory', 'support', 'and', '14', 'suffered', 'significant', 'pulmonary', 'sequelae', 'The', 'all', 'cause', 'and', 'attributable', 'case', 'fatality', 'rates', 'within', '3', 'months', 'of', 'H', 'RVI', 'onset', 'were', '11', 'and', '5', '4', 'respectively', 'Multivariate', 'logistic', 'regression', 'revealed', 'that', 'H', 'RVI', 'onset', 'within', '60', 'days', 'of', 'HSCT', 'steroid', 'use', 'in', 'the', '7', 'days', 'before', 'H', 'RVI', 'onset', 'and', 'the', 'need', 'for', 'respiratory', 'support', 'at', 'H', 'RVI', 'onset', 'were', 'associated', 'with', 'subsequent', 'morbidity', 'or', 'death', 'CONCLUSION', 'Results', 'of', 'this', 'multicenter', 'cohort', 'study', 'suggest', 'that', 'H', 'RVIs', 'are', 'relatively', 'common', 'in', 'pediatric', 'HSCT', 'recipients', 'and', 'contribute', 'to', 'significant', 'morbidity', 'and', 'death', 'These', 'data', 'should', 'help', 'inform', 'interventional', 'studies', 'specific', 'to', 'each', 'viral', 'pathogen', '']"
190307,Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome,2005-01-18,BMC Immunol,https://www.ncbi.nlm.nih.gov/pubmed/15655079/,"BACKGROUND: Severe acute respiratory syndrome (SARS) emerged in later February 2003, as a new epidemic form of life-threatening infection caused by a novel coronavirus. However, the immune-pathogenesis of SARS is poorly understood. To understand the host response to this pathogen, we investigated the gene expression profiles of peripheral blood mononuclear cells (PBMCs) derived from SARS patients, and compared with healthy controls. RESULTS: The number of differentially expressed genes was found to be 186 under stringent filtering criteria of microarray data analysis. Several genes were highly up-regulated in patients with SARS, such as, the genes coding for Lactoferrin, S100A9 and Lipocalin 2. The real-time PCR method verified the results of the gene array analysis and showed that those genes that were up-regulated as determined by microarray analysis were also found to be comparatively up-regulated by real-time PCR analysis. CONCLUSIONS: This differential gene expression profiling of PBMCs from patients with SARS strongly suggests that the response of SARS affected patients seems to be mainly an innate inflammatory response, rather than a specific immune response against a viral infection, as we observed a complete lack of cytokine genes usually triggered during a viral infection. Our study shows for the first time how the immune system responds to the SARS infection, and opens new possibilities for designing new diagnostics and treatments for this new life-threatening disease.",10.1186/1471-2172-6-2,ic4d9dhk,"['BACKGROUND', 'Severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'emerged', 'in', 'later', 'February', '2003', 'as', 'a', 'new', 'epidemic', 'form', 'of', 'life', 'threatening', 'infection', 'caused', 'by', 'a', 'novel', 'coronavirus', 'However', 'the', 'immune', 'pathogenesis', 'of', 'SARS', 'is', 'poorly', 'understood', 'To', 'understand', 'the', 'host', 'response', 'to', 'this', 'pathogen', 'we', 'investigated', 'the', 'gene', 'expression', 'profiles', 'of', 'peripheral', 'blood', 'mononuclear', 'cells', 'PBMCs', 'derived', 'from', 'SARS', 'patients', 'and', 'compared', 'with', 'healthy', 'controls', 'RESULTS', 'The', 'number', 'of', 'differentially', 'expressed', 'genes', 'was', 'found', 'to', 'be', '186', 'under', 'stringent', 'filtering', 'criteria', 'of', 'microarray', 'data', 'analysis', 'Several', 'genes', 'were', 'highly', 'up', 'regulated', 'in', 'patients', 'with', 'SARS', 'such', 'as', 'the', 'genes', 'coding', 'for', 'Lactoferrin', 'S100A9', 'and', 'Lipocalin', '2', 'The', 'real', 'time', 'PCR', 'method', 'verified', 'the', 'results', 'of', 'the', 'gene', 'array', 'analysis', 'and', 'showed', 'that', 'those', 'genes', 'that', 'were', 'up', 'regulated', 'as', 'determined', 'by', 'microarray', 'analysis', 'were', 'also', 'found', 'to', 'be', 'comparatively', 'up', 'regulated', 'by', 'real', 'time', 'PCR', 'analysis', 'CONCLUSIONS', 'This', 'differential', 'gene', 'expression', 'profiling', 'of', 'PBMCs', 'from', 'patients', 'with', 'SARS', 'strongly', 'suggests', 'that', 'the', 'response', 'of', 'SARS', 'affected', 'patients', 'seems', 'to', 'be', 'mainly', 'an', 'innate', 'inflammatory', 'response', 'rather', 'than', 'a', 'specific', 'immune', 'response', 'against', 'a', 'viral', 'infection', 'as', 'we', 'observed', 'a', 'complete', 'lack', 'of', 'cytokine', 'genes', 'usually', 'triggered', 'during', 'a', 'viral', 'infection', 'Our', 'study', 'shows', 'for', 'the', 'first', 'time', 'how', 'the', 'immune', 'system', 'responds', 'to', 'the', 'SARS', 'infection', 'and', 'opens', 'new', 'possibilities', 'for', 'designing', 'new', 'diagnostics', 'and', 'treatments', 'for', 'this', 'new', 'life', 'threatening', 'disease', '']"
190350,Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?,2020-05-28,Nanomedicine,https://www.ncbi.nlm.nih.gov/pubmed/32462968/; https://doi.org/10.2217/nnm-2020-0163,"Prior research on nanotechnologies in diagnostics, prevention and treatment of coronavirus infections is reviewed. Gold nanoparticles and semiconductor quantum dots in colorimetric and immunochromatographic assays, silica nanoparticles in a polymerase chain reaction and spike protein nanospheres as antigen carriers and adjuvants in vaccine formulations present notable examples in diagnostics and prevention, while uses of nanoparticles in coronavirus infection treatments have been merely sporadic. The current absence of antiviral therapeutics that specifically target human coronaviruses, including SARS-CoV-2, might be largely due to the underuse of nanotechnologies. Elucidating the interface between nanoparticles and coronaviruses is timely, but presents the only route to the rational design of precisely targeted therapeutics for coronavirus infections. Such a fundamental approach is also a viable prophylaxis against future pandemics of this type.",10.2217/nnm-2020-0163,ss4ht9vs,"['Prior', 'research', 'on', 'nanotechnologies', 'in', 'diagnostics', 'prevention', 'and', 'treatment', 'of', 'coronavirus', 'infections', 'is', 'reviewed', 'Gold', 'nanoparticles', 'and', 'semiconductor', 'quantum', 'dots', 'in', 'colorimetric', 'and', 'immunochromatographic', 'assays', 'silica', 'nanoparticles', 'in', 'a', 'polymerase', 'chain', 'reaction', 'and', 'spike', 'protein', 'nanospheres', 'as', 'antigen', 'carriers', 'and', 'adjuvants', 'in', 'vaccine', 'formulations', 'present', 'notable', 'examples', 'in', 'diagnostics', 'and', 'prevention', 'while', 'uses', 'of', 'nanoparticles', 'in', 'coronavirus', 'infection', 'treatments', 'have', 'been', 'merely', 'sporadic', 'The', 'current', 'absence', 'of', 'antiviral', 'therapeutics', 'that', 'specifically', 'target', 'human', 'coronaviruses', 'including', 'SARS', 'CoV', '2', 'might', 'be', 'largely', 'due', 'to', 'the', 'underuse', 'of', 'nanotechnologies', 'Elucidating', 'the', 'interface', 'between', 'nanoparticles', 'and', 'coronaviruses', 'is', 'timely', 'but', 'presents', 'the', 'only', 'route', 'to', 'the', 'rational', 'design', 'of', 'precisely', 'targeted', 'therapeutics', 'for', 'coronavirus', 'infections', 'Such', 'a', 'fundamental', 'approach', 'is', 'also', 'a', 'viable', 'prophylaxis', 'against', 'future', 'pandemics', 'of', 'this', 'type', '']"
190512,Causes of endogenous uveitis in cats presented to referral clinics in North Carolina,2015-11-12,Vet Ophthalmol,https://www.ncbi.nlm.nih.gov/pubmed/26559384/; https://doi.org/10.1111/vop.12324,"OBJECTIVE: To investigate the causes of endogenous uveitis in cats presenting to referral ophthalmology clinics in North Carolina. PROCEDURE: Medical records of cats diagnosed with endogenous uveitis at North Carolina State University's College of Veterinary Medicine (NCSU‐CVM) or Animal Eye Care Associates of Cary, NC between 2003 and 2015 were reviewed. Inclusion criteria were cats that had complete diagnostic workups, including clinical, clinicopathological, serological, and histopathological data, as well as imaging modalities. Serology was consistently completed for feline leukemia virus (FeLV), feline immunodeficiency virus (FIV), feline coronavirus (FCoV), Toxoplasma gondii, and Bartonella spp. RESULTS: One hundred and twenty cats met the inclusion criteria. Seroprevalence of FeLV (2.7%), FIV (7.3%), FCoV (34.7%), T. gondii (23.7%), and Bartonella spp. (43.2%) was observed, with a combined seroprevalence of 59.2%. Nineteen cats (15.8%) were diagnosed with feline infectious peritonitis (FIP) based on clinical, hematological, serological, histopathological, and necropsy findings. The average age of all cases was 7.62 years, while the average age of cats diagnosed with FIP was 1.82 years. Neoplasia was diagnosed in six cats (5.0%). No underlying etiology was found in 49 cats (40.8%). CONCLUSIONS: Both idiopathic and neoplastic causes of uveitis were less prevalent than previously reported in studies, while seropositivity was higher than previously reported for the study area. This may be due to improved diagnostic capabilities or that cats with infectious disease were more likely to be referred. Because of the high prevalence of FIP, young cats with uveitis should be evaluated for hyperglobulinemia and FCoV serology should be performed as minimal diagnostics.",10.1111/vop.12324,zdpbrprg,"['OBJECTIVE', 'To', 'investigate', 'the', 'causes', 'of', 'endogenous', 'uveitis', 'in', 'cats', 'presenting', 'to', 'referral', 'ophthalmology', 'clinics', 'in', 'North', 'Carolina', 'PROCEDURE', 'Medical', 'records', 'of', 'cats', 'diagnosed', 'with', 'endogenous', 'uveitis', 'at', 'North', 'Carolina', 'State', 'University', 's', 'College', 'of', 'Veterinary', 'Medicine', 'NCSU', 'CVM', 'or', 'Animal', 'Eye', 'Care', 'Associates', 'of', 'Cary', 'NC', 'between', '2003', 'and', '2015', 'were', 'reviewed', 'Inclusion', 'criteria', 'were', 'cats', 'that', 'had', 'complete', 'diagnostic', 'workups', 'including', 'clinical', 'clinicopathological', 'serological', 'and', 'histopathological', 'data', 'as', 'well', 'as', 'imaging', 'modalities', 'Serology', 'was', 'consistently', 'completed', 'for', 'feline', 'leukemia', 'virus', 'FeLV', 'feline', 'immunodeficiency', 'virus', 'FIV', 'feline', 'coronavirus', 'FCoV', 'Toxoplasma', 'gondii', 'and', 'Bartonella', 'spp', 'RESULTS', 'One', 'hundred', 'and', 'twenty', 'cats', 'met', 'the', 'inclusion', 'criteria', 'Seroprevalence', 'of', 'FeLV', '2', '7', 'FIV', '7', '3', 'FCoV', '34', '7', 'T', 'gondii', '23', '7', 'and', 'Bartonella', 'spp', '43', '2', 'was', 'observed', 'with', 'a', 'combined', 'seroprevalence', 'of', '59', '2', 'Nineteen', 'cats', '15', '8', 'were', 'diagnosed', 'with', 'feline', 'infectious', 'peritonitis', 'FIP', 'based', 'on', 'clinical', 'hematological', 'serological', 'histopathological', 'and', 'necropsy', 'findings', 'The', 'average', 'age', 'of', 'all', 'cases', 'was', '7', '62', 'years', 'while', 'the', 'average', 'age', 'of', 'cats', 'diagnosed', 'with', 'FIP', 'was', '1', '82', 'years', 'Neoplasia', 'was', 'diagnosed', 'in', 'six', 'cats', '5', '0', 'No', 'underlying', 'etiology', 'was', 'found', 'in', '49', 'cats', '40', '8', 'CONCLUSIONS', 'Both', 'idiopathic', 'and', 'neoplastic', 'causes', 'of', 'uveitis', 'were', 'less', 'prevalent', 'than', 'previously', 'reported', 'in', 'studies', 'while', 'seropositivity', 'was', 'higher', 'than', 'previously', 'reported', 'for', 'the', 'study', 'area', 'This', 'may', 'be', 'due', 'to', 'improved', 'diagnostic', 'capabilities', 'or', 'that', 'cats', 'with', 'infectious', 'disease', 'were', 'more', 'likely', 'to', 'be', 'referred', 'Because', 'of', 'the', 'high', 'prevalence', 'of', 'FIP', 'young', 'cats', 'with', 'uveitis', 'should', 'be', 'evaluated', 'for', 'hyperglobulinemia', 'and', 'FCoV', 'serology', 'should', 'be', 'performed', 'as', 'minimal', 'diagnostics', '']"
192037,Hot start reverse transcriptase: an approach for improved real-time RT-PCR performance,2015-06-21,J Anal Sci Technol,https://www.ncbi.nlm.nih.gov/pubmed/32226638/; https://doi.org/10.1186/s40543-015-0063-4,"BACKGROUND: Reverse transcriptase is an indispensable enzyme for real-time reverse transcriptase (RT)-PCR, a standard method in molecular diagnostics for detection and quantification of defined RNA molecules. The prevention of non-specific products due to elongation of misprimed oligonucleotides by the enzyme at temperatures beneath the specific annealing temperature is one of the biggest challenges in real-time RT-PCR. In the present study, an aptamer directed against the reverse transcriptase was analyzed for its potential to attain a temperature-dependent reverse transcriptase (“hot start” RT). FINDINGS: The hot start effect was investigated in a one-step real-time RT-PCR assay for the detection of Middle East respiratory syndrome coronavirus (MERS-CoV). Results with aptamer revealed a reduced RT activity at low temperatures while achieving full activity at the specific annealing temperature of 55 °C. Sensitivity (limit of detection (LoD) 95 %) of the MERS-CoV assay was increased by about two times in the presence of aptamer. CONCLUSIONS: The study demonstrates the potential of aptamer-dependent hot start RT for the improvement of diagnostic real-time RT-PCR assays.",10.1186/s40543-015-0063-4,wlhmcdcn,"['BACKGROUND', 'Reverse', 'transcriptase', 'is', 'an', 'indispensable', 'enzyme', 'for', 'real', 'time', 'reverse', 'transcriptase', 'RT', 'PCR', 'a', 'standard', 'method', 'in', 'molecular', 'diagnostics', 'for', 'detection', 'and', 'quantification', 'of', 'defined', 'RNA', 'molecules', 'The', 'prevention', 'of', 'non', 'specific', 'products', 'due', 'to', 'elongation', 'of', 'misprimed', 'oligonucleotides', 'by', 'the', 'enzyme', 'at', 'temperatures', 'beneath', 'the', 'specific', 'annealing', 'temperature', 'is', 'one', 'of', 'the', 'biggest', 'challenges', 'in', 'real', 'time', 'RT', 'PCR', 'In', 'the', 'present', 'study', 'an', 'aptamer', 'directed', 'against', 'the', 'reverse', 'transcriptase', 'was', 'analyzed', 'for', 'its', 'potential', 'to', 'attain', 'a', 'temperature', 'dependent', 'reverse', 'transcriptase', 'hot', 'start', 'RT', 'FINDINGS', 'The', 'hot', 'start', 'effect', 'was', 'investigated', 'in', 'a', 'one', 'step', 'real', 'time', 'RT', 'PCR', 'assay', 'for', 'the', 'detection', 'of', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'Results', 'with', 'aptamer', 'revealed', 'a', 'reduced', 'RT', 'activity', 'at', 'low', 'temperatures', 'while', 'achieving', 'full', 'activity', 'at', 'the', 'specific', 'annealing', 'temperature', 'of', '55', 'C', 'Sensitivity', 'limit', 'of', 'detection', 'LoD', '95', 'of', 'the', 'MERS', 'CoV', 'assay', 'was', 'increased', 'by', 'about', 'two', 'times', 'in', 'the', 'presence', 'of', 'aptamer', 'CONCLUSIONS', 'The', 'study', 'demonstrates', 'the', 'potential', 'of', 'aptamer', 'dependent', 'hot', 'start', 'RT', 'for', 'the', 'improvement', 'of', 'diagnostic', 'real', 'time', 'RT', 'PCR', 'assays', '']"
192189,The severe acute respiratory syndrome (SARS),2005,J Neurovirol,https://www.ncbi.nlm.nih.gov/pubmed/16287687/,"The world was shocked in early 2003 when a pandemic of severe acute respiratory syndrome (SARS) was imminent. The outbreak of this novel disease, caused by a novel coronavirus (the SARS-coronavirus), hit hardest in the Asian Pacific region, though eventually it spread to five continents. The speed of the spread of the SARS epidemic was unprecedented due to the highly efficient intercontinental transportation. An international collaborative effort through the World Health Organization (WHO) has helped to identify the aetiological agent about 1 month after the onset of the epidemic. The power of molecular biology and bioinformatics has enabled the complete decoding of the viral genome within weeks. Over 1000 publications on the phylogeny, epidemiology, genomics, laboratory diagnostics, antiviral, immunization, pathogenesis, clinical disease, and management accumulated within just 1 year. Although the exact animal reservoir of virus and how it evolved into a human pathogen are still obscure, accurate diagnosis and epidemiological control of the disease are now possible. This article reviews what is currently known about the virus and the disease.",10.1080/13550280500187724,su6vhs49,"['The', 'world', 'was', 'shocked', 'in', 'early', '2003', 'when', 'a', 'pandemic', 'of', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'was', 'imminent', 'The', 'outbreak', 'of', 'this', 'novel', 'disease', 'caused', 'by', 'a', 'novel', 'coronavirus', 'the', 'SARS', 'coronavirus', 'hit', 'hardest', 'in', 'the', 'Asian', 'Pacific', 'region', 'though', 'eventually', 'it', 'spread', 'to', 'five', 'continents', 'The', 'speed', 'of', 'the', 'spread', 'of', 'the', 'SARS', 'epidemic', 'was', 'unprecedented', 'due', 'to', 'the', 'highly', 'efficient', 'intercontinental', 'transportation', 'An', 'international', 'collaborative', 'effort', 'through', 'the', 'World', 'Health', 'Organization', 'WHO', 'has', 'helped', 'to', 'identify', 'the', 'aetiological', 'agent', 'about', '1', 'month', 'after', 'the', 'onset', 'of', 'the', 'epidemic', 'The', 'power', 'of', 'molecular', 'biology', 'and', 'bioinformatics', 'has', 'enabled', 'the', 'complete', 'decoding', 'of', 'the', 'viral', 'genome', 'within', 'weeks', 'Over', '1000', 'publications', 'on', 'the', 'phylogeny', 'epidemiology', 'genomics', 'laboratory', 'diagnostics', 'antiviral', 'immunization', 'pathogenesis', 'clinical', 'disease', 'and', 'management', 'accumulated', 'within', 'just', '1', 'year', 'Although', 'the', 'exact', 'animal', 'reservoir', 'of', 'virus', 'and', 'how', 'it', 'evolved', 'into', 'a', 'human', 'pathogen', 'are', 'still', 'obscure', 'accurate', 'diagnosis', 'and', 'epidemiological', 'control', 'of', 'the', 'disease', 'are', 'now', 'possible', 'This', 'article', 'reviews', 'what', 'is', 'currently', 'known', 'about', 'the', 'virus', 'and', 'the', 'disease', '']"
192327,Seasonality and prevalence of respiratory pathogens detected by multiplex PCR at a tertiary care medical center,2013-07-24,Arch Virol,https://www.ncbi.nlm.nih.gov/pubmed/23881085/; https://doi.org/10.1007/s00705-013-1794-4,"Respiratory tract infections (RTIs) are a leading cause of mortality and morbidity. Seasonality has been reported for many viruses, including influenza virus, respiratory syncytial virus (RSV), and the recently described human metapneumovirus (hMPV). We hypothesize that the availability of rapid, multiplex PCR diagnostics will provide better clinical care and new insights into the etiology and clinical spectrum of RTIs. We conducted a retrospective analysis of the incidence of respiratory pathogens at a 500-bed adult and 154-bed pediatric hospital tertiary care center. A total of 939 specimens from patients with an age range of 5 days to 91 years (median, 2 years) were tested by a multiplex respiratory pathogen PCR from November 14, 2011 to November 13, 2012. Sixty-five percent of specimens were positive for at least one pathogen. As the age of the patient increased, the positivity rate for the PCR decreased proportionately. Rhinoviruses/enteroviruses (Rhino/Entero) were the most prevalent (34.3 %) followed by RSV (19.2 %) and hMPV (6.2 %). Twelve percent of the positive samples were positive for multiple analytes, with Rhino/Entero and RSV being the most common combination. The peak months were September and May for Rhino/Entero infections, January for RSV and February for coronavirus. hMPV peaked 2 months after RSV, as has been observed recently in other studies. Multiplex PCR provides rapid diagnostic information that can be used to make knowledgeable clinical decisions and potentially reduce the use of antibiotics. Active respiratory PCR surveillance could also predict seasonal respiratory epidemics to allow for adequate planning of additional infection control measures.",10.1007/s00705-013-1794-4,0evqo01m,"['Respiratory', 'tract', 'infections', 'RTIs', 'are', 'a', 'leading', 'cause', 'of', 'mortality', 'and', 'morbidity', 'Seasonality', 'has', 'been', 'reported', 'for', 'many', 'viruses', 'including', 'influenza', 'virus', 'respiratory', 'syncytial', 'virus', 'RSV', 'and', 'the', 'recently', 'described', 'human', 'metapneumovirus', 'hMPV', 'We', 'hypothesize', 'that', 'the', 'availability', 'of', 'rapid', 'multiplex', 'PCR', 'diagnostics', 'will', 'provide', 'better', 'clinical', 'care', 'and', 'new', 'insights', 'into', 'the', 'etiology', 'and', 'clinical', 'spectrum', 'of', 'RTIs', 'We', 'conducted', 'a', 'retrospective', 'analysis', 'of', 'the', 'incidence', 'of', 'respiratory', 'pathogens', 'at', 'a', '500', 'bed', 'adult', 'and', '154', 'bed', 'pediatric', 'hospital', 'tertiary', 'care', 'center', 'A', 'total', 'of', '939', 'specimens', 'from', 'patients', 'with', 'an', 'age', 'range', 'of', '5', 'days', 'to', '91', 'years', 'median', '2', 'years', 'were', 'tested', 'by', 'a', 'multiplex', 'respiratory', 'pathogen', 'PCR', 'from', 'November', '14', '2011', 'to', 'November', '13', '2012', 'Sixty', 'five', 'percent', 'of', 'specimens', 'were', 'positive', 'for', 'at', 'least', 'one', 'pathogen', 'As', 'the', 'age', 'of', 'the', 'patient', 'increased', 'the', 'positivity', 'rate', 'for', 'the', 'PCR', 'decreased', 'proportionately', 'Rhinoviruses', 'enteroviruses', 'Rhino', 'Entero', 'were', 'the', 'most', 'prevalent', '34', '3', 'followed', 'by', 'RSV', '19', '2', 'and', 'hMPV', '6', '2', 'Twelve', 'percent', 'of', 'the', 'positive', 'samples', 'were', 'positive', 'for', 'multiple', 'analytes', 'with', 'Rhino', 'Entero', 'and', 'RSV', 'being', 'the', 'most', 'common', 'combination', 'The', 'peak', 'months', 'were', 'September', 'and', 'May', 'for', 'Rhino', 'Entero', 'infections', 'January', 'for', 'RSV', 'and', 'February', 'for', 'coronavirus', 'hMPV', 'peaked', '2', 'months', 'after', 'RSV', 'as', 'has', 'been', 'observed', 'recently', 'in', 'other', 'studies', 'Multiplex', 'PCR', 'provides', 'rapid', 'diagnostic', 'information', 'that', 'can', 'be', 'used', 'to', 'make', 'knowledgeable', 'clinical', 'decisions', 'and', 'potentially', 'reduce', 'the', 'use', 'of', 'antibiotics', 'Active', 'respiratory', 'PCR', 'surveillance', 'could', 'also', 'predict', 'seasonal', 'respiratory', 'epidemics', 'to', 'allow', 'for', 'adequate', 'planning', 'of', 'additional', 'infection', 'control', 'measures', '']"
192949,Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epi-thelial cells with metabolic and protein-protein interaction networks,2020-06-21,Turk J Biol,https://doi.org/10.3906/biy-2005-115; https://www.ncbi.nlm.nih.gov/pubmed/32595353/,"A novel coronavirus (SARS-CoV-2, formerly known as nCoV-2019) that causes an acute respiratory disease has emerged in Wuhan, China and spread globally in early 2020. On January the 30th, the World Health Organization (WHO) declared spread of this virus as an epidemic and a public health emergency. With its highly contagious characteristic and long incubation time, confinement of SARS-CoV-2 requires drastic lock-down measures to be taken and therefore early diagnosis is crucial. We analysed transcriptome of SARS-CoV-2 infected human lung epithelial cells, compared it with mock-infected cells, used network-based reporter metabolite approach and integrated the transcriptome data with protein-protein interaction network to elucidate the early cellular response. Significantly affected metabolites have the potential to be used in diagnostics while pathways of protein clusters have the potential to be used as targets for supportive or novel therapeutic approaches. Our results are in accordance with the literature on response of IL6 family of cytokines and their importance, in addition, we find that matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MMP9) with keratan sulfate synthesis pathway may play a key role in the infection. We hypothesize that MMP9 inhibitors have potential to prevent ""cytokine storm"" in severely affected patients.",10.3906/biy-2005-115,zvic4xc9,"['A', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'formerly', 'known', 'as', 'nCoV', '2019', 'that', 'causes', 'an', 'acute', 'respiratory', 'disease', 'has', 'emerged', 'in', 'Wuhan', 'China', 'and', 'spread', 'globally', 'in', 'early', '2020', 'On', 'January', 'the', '30th', 'the', 'World', 'Health', 'Organization', 'WHO', 'declared', 'spread', 'of', 'this', 'virus', 'as', 'an', 'epidemic', 'and', 'a', 'public', 'health', 'emergency', 'With', 'its', 'highly', 'contagious', 'characteristic', 'and', 'long', 'incubation', 'time', 'confinement', 'of', 'SARS', 'CoV', '2', 'requires', 'drastic', 'lock', 'down', 'measures', 'to', 'be', 'taken', 'and', 'therefore', 'early', 'diagnosis', 'is', 'crucial', 'We', 'analysed', 'transcriptome', 'of', 'SARS', 'CoV', '2', 'infected', 'human', 'lung', 'epithelial', 'cells', 'compared', 'it', 'with', 'mock', 'infected', 'cells', 'used', 'network', 'based', 'reporter', 'metabolite', 'approach', 'and', 'integrated', 'the', 'transcriptome', 'data', 'with', 'protein', 'protein', 'interaction', 'network', 'to', 'elucidate', 'the', 'early', 'cellular', 'response', 'Significantly', 'affected', 'metabolites', 'have', 'the', 'potential', 'to', 'be', 'used', 'in', 'diagnostics', 'while', 'pathways', 'of', 'protein', 'clusters', 'have', 'the', 'potential', 'to', 'be', 'used', 'as', 'targets', 'for', 'supportive', 'or', 'novel', 'therapeutic', 'approaches', 'Our', 'results', 'are', 'in', 'accordance', 'with', 'the', 'literature', 'on', 'response', 'of', 'IL6', 'family', 'of', 'cytokines', 'and', 'their', 'importance', 'in', 'addition', 'we', 'find', 'that', 'matrix', 'metalloproteinase', '2', 'MMP2', 'and', 'matrix', 'metalloproteinase', '9', 'MMP9', 'with', 'keratan', 'sulfate', 'synthesis', 'pathway', 'may', 'play', 'a', 'key', 'role', 'in', 'the', 'infection', 'We', 'hypothesize', 'that', 'MMP9', 'inhibitors', 'have', 'potential', 'to', 'prevent', 'cytokine', 'storm', 'in', 'severely', 'affected', 'patients', '']"
193555,Continuous Invasion by Respiratory Viruses Observed in Rural Households During a Respiratory Syncytial Virus Seasonal Outbreak in Coastal Kenya,2018-11-15,Clin Infect Dis,https://doi.org/10.1093/cid/ciy313; https://www.ncbi.nlm.nih.gov/pubmed/29668861/,"BACKGROUND: Households are high-intensity close-contact environments favorable for transmission of respiratory viruses, yet little is known for low-income settings. METHODS: Active surveillance was completed on 47 households in rural coastal Kenya over 6 months during a respiratory syncytial virus (RSV) season. Nasopharyngeal swabs (NPSs) were taken from 483 household members twice weekly irrespective of symptoms. Using molecular diagnostics, NPSs from 6 households were screened for 15 respiratory viruses and the remainder of households only for the most frequent viruses observed: rhinovirus (RV), human coronavirus (HCoV; comprising strains 229E, OC43, and NL63), adenovirus (AdV), and RSV (A and B). RESULTS: Of 16928 NPSs tested for the common viruses, 4259 (25.2%) were positive for ≥1 target; 596 (13.8%) had coinfections. Detection frequencies were 10.5% RV (1780), 7.5% HCoV (1274), 7.3% AdV (1232), and 3.2% RSV (537). On average, each household and individual had 6 and 3 different viruses detected over the study period, respectively. Rhinovirus and HCoV were detected in all the 47 households while AdV and RSV were detected in 45 (95.7%) and 40 (85.1%) households, respectively. The individual risk of infection over the 6-month period was 93.4%, 80.1%, 71.6%, 61.5%, and 37.1% for any virus, RV, HCoV, AdV, and RSV, respectively. NPSs collected during symptomatic days and from younger age groups had higher prevalence of virus detection relative to respective counterparts. RSV was underrepresented in households relative to hospital admission data. CONCLUSIONS: In this household setting, respiratory virus infections and associated illness are ubiquitous. Future studies should address the health and economic implications of these observations.",10.1093/cid/ciy313,u3wyyks1,"['BACKGROUND', 'Households', 'are', 'high', 'intensity', 'close', 'contact', 'environments', 'favorable', 'for', 'transmission', 'of', 'respiratory', 'viruses', 'yet', 'little', 'is', 'known', 'for', 'low', 'income', 'settings', 'METHODS', 'Active', 'surveillance', 'was', 'completed', 'on', '47', 'households', 'in', 'rural', 'coastal', 'Kenya', 'over', '6', 'months', 'during', 'a', 'respiratory', 'syncytial', 'virus', 'RSV', 'season', 'Nasopharyngeal', 'swabs', 'NPSs', 'were', 'taken', 'from', '483', 'household', 'members', 'twice', 'weekly', 'irrespective', 'of', 'symptoms', 'Using', 'molecular', 'diagnostics', 'NPSs', 'from', '6', 'households', 'were', 'screened', 'for', '15', 'respiratory', 'viruses', 'and', 'the', 'remainder', 'of', 'households', 'only', 'for', 'the', 'most', 'frequent', 'viruses', 'observed', 'rhinovirus', 'RV', 'human', 'coronavirus', 'HCoV', 'comprising', 'strains', '229E', 'OC43', 'and', 'NL63', 'adenovirus', 'AdV', 'and', 'RSV', 'A', 'and', 'B', 'RESULTS', 'Of', '16928', 'NPSs', 'tested', 'for', 'the', 'common', 'viruses', '4259', '25', '2', 'were', 'positive', 'for', '1', 'target', '596', '13', '8', 'had', 'coinfections', 'Detection', 'frequencies', 'were', '10', '5', 'RV', '1780', '7', '5', 'HCoV', '1274', '7', '3', 'AdV', '1232', 'and', '3', '2', 'RSV', '537', 'On', 'average', 'each', 'household', 'and', 'individual', 'had', '6', 'and', '3', 'different', 'viruses', 'detected', 'over', 'the', 'study', 'period', 'respectively', 'Rhinovirus', 'and', 'HCoV', 'were', 'detected', 'in', 'all', 'the', '47', 'households', 'while', 'AdV', 'and', 'RSV', 'were', 'detected', 'in', '45', '95', '7', 'and', '40', '85', '1', 'households', 'respectively', 'The', 'individual', 'risk', 'of', 'infection', 'over', 'the', '6', 'month', 'period', 'was', '93', '4', '80', '1', '71', '6', '61', '5', 'and', '37', '1', 'for', 'any', 'virus', 'RV', 'HCoV', 'AdV', 'and', 'RSV', 'respectively', 'NPSs', 'collected', 'during', 'symptomatic', 'days', 'and', 'from', 'younger', 'age', 'groups', 'had', 'higher', 'prevalence', 'of', 'virus', 'detection', 'relative', 'to', 'respective', 'counterparts', 'RSV', 'was', 'underrepresented', 'in', 'households', 'relative', 'to', 'hospital', 'admission', 'data', 'CONCLUSIONS', 'In', 'this', 'household', 'setting', 'respiratory', 'virus', 'infections', 'and', 'associated', 'illness', 'are', 'ubiquitous', 'Future', 'studies', 'should', 'address', 'the', 'health', 'and', 'economic', 'implications', 'of', 'these', 'observations', '']"
193659,A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses,2008-05-31,Diagnostic Microbiology and Infectious Disease,https://www.sciencedirect.com/science/article/pii/S0732889307005883; https://api.elsevier.com/content/article/pii/S0732889307005883; https://www.ncbi.nlm.nih.gov/pubmed/18191362/; https://doi.org/10.1016/j.diagmicrobio.2007.12.002,"Abstract Most coronaviruses infecting humans cause mild diseases, whereas severe acute respiratory syndrome (SARS)-associated coronavirus is an extremely dangerous pathogen. Here, we report the development of a serologic assay for detection of antibodies to human coronaviruses (HCoVs) based on recombinant nucleocapsid (N) proteins of all known pathogenic strains (229E, NL63, OC43, HKU1, SARS). The novel immunoassay is highly useful for epidemiologic surveys, where use of nucleic acid diagnostics often is limited. Purified recombinant antigens were immobilized on nitrocellulose membranes and applied in a line immunoassay, which allows rapid detection of antibodies to 5 different HCoVs in a single experiment. For assay evaluation, serum samples from persons infected with 229E or OC43 (acute/convalescent), recovered SARS patients and healthy donors were analyzed. Screening for nucleocapsid (N)-specific immunoglobulin G (IgG) in convalescent sera reached 100% sensitivity. With this new technique, we found that recently identified NL63 and HKU1 contribute significantly to the overall spectrum of coronavirus infections. Possibly, cross-reactive antibody responses were observed using 229E and OC43 serum pairs. However, the potential of this assay could clearly be demonstrated employing SARS-positive serum samples, where nonspecific binding to nucleocapsids of other HCoVs was not observed. This coronavirus strain-specific line immunoassay represents a powerful tool for serologic diagnostics.",10.1016/j.diagmicrobio.2007.12.002,m400cal3,"['Abstract', 'Most', 'coronaviruses', 'infecting', 'humans', 'cause', 'mild', 'diseases', 'whereas', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'associated', 'coronavirus', 'is', 'an', 'extremely', 'dangerous', 'pathogen', 'Here', 'we', 'report', 'the', 'development', 'of', 'a', 'serologic', 'assay', 'for', 'detection', 'of', 'antibodies', 'to', 'human', 'coronaviruses', 'HCoVs', 'based', 'on', 'recombinant', 'nucleocapsid', 'N', 'proteins', 'of', 'all', 'known', 'pathogenic', 'strains', '229E', 'NL63', 'OC43', 'HKU1', 'SARS', 'The', 'novel', 'immunoassay', 'is', 'highly', 'useful', 'for', 'epidemiologic', 'surveys', 'where', 'use', 'of', 'nucleic', 'acid', 'diagnostics', 'often', 'is', 'limited', 'Purified', 'recombinant', 'antigens', 'were', 'immobilized', 'on', 'nitrocellulose', 'membranes', 'and', 'applied', 'in', 'a', 'line', 'immunoassay', 'which', 'allows', 'rapid', 'detection', 'of', 'antibodies', 'to', '5', 'different', 'HCoVs', 'in', 'a', 'single', 'experiment', 'For', 'assay', 'evaluation', 'serum', 'samples', 'from', 'persons', 'infected', 'with', '229E', 'or', 'OC43', 'acute', 'convalescent', 'recovered', 'SARS', 'patients', 'and', 'healthy', 'donors', 'were', 'analyzed', 'Screening', 'for', 'nucleocapsid', 'N', 'specific', 'immunoglobulin', 'G', 'IgG', 'in', 'convalescent', 'sera', 'reached', '100', 'sensitivity', 'With', 'this', 'new', 'technique', 'we', 'found', 'that', 'recently', 'identified', 'NL63', 'and', 'HKU1', 'contribute', 'significantly', 'to', 'the', 'overall', 'spectrum', 'of', 'coronavirus', 'infections', 'Possibly', 'cross', 'reactive', 'antibody', 'responses', 'were', 'observed', 'using', '229E', 'and', 'OC43', 'serum', 'pairs', 'However', 'the', 'potential', 'of', 'this', 'assay', 'could', 'clearly', 'be', 'demonstrated', 'employing', 'SARS', 'positive', 'serum', 'samples', 'where', 'nonspecific', 'binding', 'to', 'nucleocapsids', 'of', 'other', 'HCoVs', 'was', 'not', 'observed', 'This', 'coronavirus', 'strain', 'specific', 'line', 'immunoassay', 'represents', 'a', 'powerful', 'tool', 'for', 'serologic', 'diagnostics', '']"
193867,Coronaviruses: emerging and re-emerging pathogens in humans and animals,2015-12-22,Virol J,https://www.ncbi.nlm.nih.gov/pubmed/26690088/; https://doi.org/10.1186/s12985-015-0432-z,"The severe acute respiratory syndrome coronavirus (SARS-CoV) and recently emerged Middle East respiratory syndrome coronavirus (MERS-CoV) epidemics have proven the ability of coronaviruses to cross species barrier and emerge rapidly in humans. Other coronaviruses such as porcine epidemic diarrhea virus (PEDV) are also known to cause major disease epidemics in animals wiith huge economic loss. This special issue in Virology Journal aims to highlight the advances and key discoveries in the animal origin, viral evolution, epidemiology, diagnostics and pathogenesis of the emerging and re-emerging coronaviruses in both humans and animals.",10.1186/s12985-015-0432-z,zhxrlopp,"['The', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'SARS', 'CoV', 'and', 'recently', 'emerged', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'epidemics', 'have', 'proven', 'the', 'ability', 'of', 'coronaviruses', 'to', 'cross', 'species', 'barrier', 'and', 'emerge', 'rapidly', 'in', 'humans', 'Other', 'coronaviruses', 'such', 'as', 'porcine', 'epidemic', 'diarrhea', 'virus', 'PEDV', 'are', 'also', 'known', 'to', 'cause', 'major', 'disease', 'epidemics', 'in', 'animals', 'wiith', 'huge', 'economic', 'loss', 'This', 'special', 'issue', 'in', 'Virology', 'Journal', 'aims', 'to', 'highlight', 'the', 'advances', 'and', 'key', 'discoveries', 'in', 'the', 'animal', 'origin', 'viral', 'evolution', 'epidemiology', 'diagnostics', 'and', 'pathogenesis', 'of', 'the', 'emerging', 'and', 're', 'emerging', 'coronaviruses', 'in', 'both', 'humans', 'and', 'animals', '']"
195264,"Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020",2020-02-07,MMWR Morb Mortal Wkly Rep,https://www.ncbi.nlm.nih.gov/pubmed/32027631/; https://doi.org/10.15585/mmwr.mm6905e1,"On December 31, 2019, Chinese health officials reported a cluster of cases of acute respiratory illness in persons associated with the Hunan seafood and animal market in the city of Wuhan, Hubei Province, in central China. On January 7, 2020, Chinese health officials confirmed that a novel coronavirus (2019-nCoV) was associated with this initial cluster (1). As of February 4, 2020, a total of 20,471 confirmed cases, including 2,788 (13.6%) with severe illness,* and 425 deaths (2.1%) had been reported by the National Health Commission of China (2). Cases have also been reported in 26 locations outside of mainland China, including documentation of some person-to-person transmission and one death (2). As of February 4, 11 cases had been reported in the United States. On January 30, the World Health Organization (WHO) Director-General declared that the 2019-nCoV outbreak constitutes a Public Health Emergency of International Concern.† On January 31, the U.S. Department of Health and Human Services (HHS) Secretary declared a U.S. public health emergency to respond to 2019-nCoV.§ Also on January 31, the president of the United States signed a ""Proclamation on Suspension of Entry as Immigrants and Nonimmigrants of Persons who Pose a Risk of Transmitting 2019 Novel Coronavirus,"" which limits entry into the United States of persons who traveled to mainland China to U.S. citizens and lawful permanent residents and their families (3). CDC, multiple other federal agencies, state and local health departments, and other partners are implementing aggressive measures to slow transmission of 2019-nCoV in the United States (4,5). These measures require the identification of cases and their contacts in the United States and the appropriate assessment and care of travelers arriving from mainland China to the United States. These measures are being implemented in anticipation of additional 2019-nCoV cases in the United States. Although these measures might not prevent the eventual establishment of ongoing, widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare health care systems and the general public to be ready if widespread transmission with substantial associated illness occurs; and 3) better characterize 2019-nCoV infection to guide public health recommendations and the development of medical countermeasures including diagnostics, therapeutics, and vaccines. Public health authorities are monitoring the situation closely. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC and state and local health departments.",10.15585/mmwr.mm6905e1,vj2z52vg,"['On', 'December', '31', '2019', 'Chinese', 'health', 'officials', 'reported', 'a', 'cluster', 'of', 'cases', 'of', 'acute', 'respiratory', 'illness', 'in', 'persons', 'associated', 'with', 'the', 'Hunan', 'seafood', 'and', 'animal', 'market', 'in', 'the', 'city', 'of', 'Wuhan', 'Hubei', 'Province', 'in', 'central', 'China', 'On', 'January', '7', '2020', 'Chinese', 'health', 'officials', 'confirmed', 'that', 'a', 'novel', 'coronavirus', '2019', 'nCoV', 'was', 'associated', 'with', 'this', 'initial', 'cluster', '1', 'As', 'of', 'February', '4', '2020', 'a', 'total', 'of', '20', '471', 'confirmed', 'cases', 'including', '2', '788', '13', '6', 'with', 'severe', 'illness', 'and', '425', 'deaths', '2', '1', 'had', 'been', 'reported', 'by', 'the', 'National', 'Health', 'Commission', 'of', 'China', '2', 'Cases', 'have', 'also', 'been', 'reported', 'in', '26', 'locations', 'outside', 'of', 'mainland', 'China', 'including', 'documentation', 'of', 'some', 'person', 'to', 'person', 'transmission', 'and', 'one', 'death', '2', 'As', 'of', 'February', '4', '11', 'cases', 'had', 'been', 'reported', 'in', 'the', 'United', 'States', 'On', 'January', '30', 'the', 'World', 'Health', 'Organization', 'WHO', 'Director', 'General', 'declared', 'that', 'the', '2019', 'nCoV', 'outbreak', 'constitutes', 'a', 'Public', 'Health', 'Emergency', 'of', 'International', 'Concern', 'On', 'January', '31', 'the', 'U', 'S', 'Department', 'of', 'Health', 'and', 'Human', 'Services', 'HHS', 'Secretary', 'declared', 'a', 'U', 'S', 'public', 'health', 'emergency', 'to', 'respond', 'to', '2019', 'nCoV', 'Also', 'on', 'January', '31', 'the', 'president', 'of', 'the', 'United', 'States', 'signed', 'a', 'Proclamation', 'on', 'Suspension', 'of', 'Entry', 'as', 'Immigrants', 'and', 'Nonimmigrants', 'of', 'Persons', 'who', 'Pose', 'a', 'Risk', 'of', 'Transmitting', '2019', 'Novel', 'Coronavirus', 'which', 'limits', 'entry', 'into', 'the', 'United', 'States', 'of', 'persons', 'who', 'traveled', 'to', 'mainland', 'China', 'to', 'U', 'S', 'citizens', 'and', 'lawful', 'permanent', 'residents', 'and', 'their', 'families', '3', 'CDC', 'multiple', 'other', 'federal', 'agencies', 'state', 'and', 'local', 'health', 'departments', 'and', 'other', 'partners', 'are', 'implementing', 'aggressive', 'measures', 'to', 'slow', 'transmission', 'of', '2019', 'nCoV', 'in', 'the', 'United', 'States', '4', '5', 'These', 'measures', 'require', 'the', 'identification', 'of', 'cases', 'and', 'their', 'contacts', 'in', 'the', 'United', 'States', 'and', 'the', 'appropriate', 'assessment', 'and', 'care', 'of', 'travelers', 'arriving', 'from', 'mainland', 'China', 'to', 'the', 'United', 'States', 'These', 'measures', 'are', 'being', 'implemented', 'in', 'anticipation', 'of', 'additional', '2019', 'nCoV', 'cases', 'in', 'the', 'United', 'States', 'Although', 'these', 'measures', 'might', 'not', 'prevent', 'the', 'eventual', 'establishment', 'of', 'ongoing', 'widespread', 'transmission', 'of', 'the', 'virus', 'in', 'the', 'United', 'States', 'they', 'are', 'being', 'implemented', 'to', '1', 'slow', 'the', 'spread', 'of', 'illness', '2', 'provide', 'time', 'to', 'better', 'prepare', 'health', 'care', 'systems', 'and', 'the', 'general', 'public', 'to', 'be', 'ready', 'if', 'widespread', 'transmission', 'with', 'substantial', 'associated', 'illness', 'occurs', 'and', '3', 'better', 'characterize', '2019', 'nCoV', 'infection', 'to', 'guide', 'public', 'health', 'recommendations', 'and', 'the', 'development', 'of', 'medical', 'countermeasures', 'including', 'diagnostics', 'therapeutics', 'and', 'vaccines', 'Public', 'health', 'authorities', 'are', 'monitoring', 'the', 'situation', 'closely', 'As', 'more', 'is', 'learned', 'about', 'this', 'novel', 'virus', 'and', 'this', 'outbreak', 'CDC', 'will', 'rapidly', 'incorporate', 'new', 'knowledge', 'into', 'guidance', 'for', 'action', 'by', 'CDC', 'and', 'state', 'and', 'local', 'health', 'departments', '']"
195716,Navigating the Diagnostics of COVID-19,2020-07-25,SN Compr Clin Med,https://doi.org/10.1007/s42399-020-00408-8,"The recent outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Hubei province, China, in December 2019 and has spread worldwide at an alarming rate. With over eight million individuals infected and exceeding 400,000 deaths globally, the necessity to develop fast and efficient diagnostic methods is of high importance. This paper reports on currently available diagnostic screening methods for patients infected with SARS-CoV-2 to guide frontline healthcare workers involved with the diagnosis of 2019 novel coronavirus disease (COVID-19) patient. An electronic literature search was performed for peer-reviewed articles published from January 1, 2020, until June 19, 2020. Published articles were then reviewed and included based on the applicability to the topic. The preferred diagnostic approach is the reverse transcription (RT) of the virus’ ribonucleic acid (RNA) followed by polymerase chain reaction (PCR) amplification (RT-PCR). However, this method has been proven to be time-consuming. In improving the speed and efficiency of diagnostics, newer rapid diagnostic serological tests are in development for testing SARS-CoV-2, each with its unique advantages and disadvantages. They could potentially be used as triage tests to rapidly identify patients who are very likely to have COVID-19 in combination with other accurate diagnostic methods, such as diagnostic imaging. A combination of the disease history, clinical manifestations, laboratory diagnostic testing, and diagnostic imaging is crucial for making an accurate and useful diagnosis for COVID-19. Hopefully, the continuous development and use of rapid diagnostic tests and the implementation of public health measures will help control the spread of the disease.",10.1007/s42399-020-00408-8,bqibelvc,"['The', 'recent', 'outbreak', 'of', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'began', 'in', 'Hubei', 'province', 'China', 'in', 'December', '2019', 'and', 'has', 'spread', 'worldwide', 'at', 'an', 'alarming', 'rate', 'With', 'over', 'eight', 'million', 'individuals', 'infected', 'and', 'exceeding', '400', '000', 'deaths', 'globally', 'the', 'necessity', 'to', 'develop', 'fast', 'and', 'efficient', 'diagnostic', 'methods', 'is', 'of', 'high', 'importance', 'This', 'paper', 'reports', 'on', 'currently', 'available', 'diagnostic', 'screening', 'methods', 'for', 'patients', 'infected', 'with', 'SARS', 'CoV', '2', 'to', 'guide', 'frontline', 'healthcare', 'workers', 'involved', 'with', 'the', 'diagnosis', 'of', '2019', 'novel', 'coronavirus', 'disease', 'COVID', '19', 'patient', 'An', 'electronic', 'literature', 'search', 'was', 'performed', 'for', 'peer', 'reviewed', 'articles', 'published', 'from', 'January', '1', '2020', 'until', 'June', '19', '2020', 'Published', 'articles', 'were', 'then', 'reviewed', 'and', 'included', 'based', 'on', 'the', 'applicability', 'to', 'the', 'topic', 'The', 'preferred', 'diagnostic', 'approach', 'is', 'the', 'reverse', 'transcription', 'RT', 'of', 'the', 'virus', 'ribonucleic', 'acid', 'RNA', 'followed', 'by', 'polymerase', 'chain', 'reaction', 'PCR', 'amplification', 'RT', 'PCR', 'However', 'this', 'method', 'has', 'been', 'proven', 'to', 'be', 'time', 'consuming', 'In', 'improving', 'the', 'speed', 'and', 'efficiency', 'of', 'diagnostics', 'newer', 'rapid', 'diagnostic', 'serological', 'tests', 'are', 'in', 'development', 'for', 'testing', 'SARS', 'CoV', '2', 'each', 'with', 'its', 'unique', 'advantages', 'and', 'disadvantages', 'They', 'could', 'potentially', 'be', 'used', 'as', 'triage', 'tests', 'to', 'rapidly', 'identify', 'patients', 'who', 'are', 'very', 'likely', 'to', 'have', 'COVID', '19', 'in', 'combination', 'with', 'other', 'accurate', 'diagnostic', 'methods', 'such', 'as', 'diagnostic', 'imaging', 'A', 'combination', 'of', 'the', 'disease', 'history', 'clinical', 'manifestations', 'laboratory', 'diagnostic', 'testing', 'and', 'diagnostic', 'imaging', 'is', 'crucial', 'for', 'making', 'an', 'accurate', 'and', 'useful', 'diagnosis', 'for', 'COVID', '19', 'Hopefully', 'the', 'continuous', 'development', 'and', 'use', 'of', 'rapid', 'diagnostic', 'tests', 'and', 'the', 'implementation', 'of', 'public', 'health', 'measures', 'will', 'help', 'control', 'the', 'spread', 'of', 'the', 'disease', '']"
196695,PATRIC: The VBI PathoSystems Resource Integration Center,2006-11-16,Nucleic Acids Res,https://www.ncbi.nlm.nih.gov/pubmed/17142235/,"The PathoSystems Resource Integration Center (PATRIC) is one of eight Bioinformatics Resource Centers (BRCs) funded by the National Institute of Allergy and Infection Diseases (NIAID) to create a data and analysis resource for selected NIAID priority pathogens, specifically proteobacteria of the genera Brucella, Rickettsia and Coxiella, and corona-, calici- and lyssaviruses and viruses associated with hepatitis A and E. The goal of the project is to provide a comprehensive bioinformatics resource for these pathogens, including consistently annotated genome, proteome and metabolic pathway data to facilitate research into counter-measures, including drugs, vaccines and diagnostics. The project's curation strategy has three prongs: ‘breadth first’ beginning with whole-genome and proteome curation using standardized protocols, a ‘targeted’ approach addressing the specific needs of researchers and an integrative strategy to leverage high-throughput experimental data (e.g. microarrays, proteomics) and literature. The PATRIC infrastructure consists of a relational database, analytical pipelines and a website which supports browsing, querying, data visualization and the ability to download raw and curated data in standard formats. At present, the site warehouses complete sequences for 17 bacterial and 332 viral genomes. The PATRIC website () will continually grow with the addition of data, analysis and functionality over the course of the project.",10.1093/nar/gkl858,3ulketgy,"['The', 'PathoSystems', 'Resource', 'Integration', 'Center', 'PATRIC', 'is', 'one', 'of', 'eight', 'Bioinformatics', 'Resource', 'Centers', 'BRCs', 'funded', 'by', 'the', 'National', 'Institute', 'of', 'Allergy', 'and', 'Infection', 'Diseases', 'NIAID', 'to', 'create', 'a', 'data', 'and', 'analysis', 'resource', 'for', 'selected', 'NIAID', 'priority', 'pathogens', 'specifically', 'proteobacteria', 'of', 'the', 'genera', 'Brucella', 'Rickettsia', 'and', 'Coxiella', 'and', 'corona', 'calici', 'and', 'lyssaviruses', 'and', 'viruses', 'associated', 'with', 'hepatitis', 'A', 'and', 'E', 'The', 'goal', 'of', 'the', 'project', 'is', 'to', 'provide', 'a', 'comprehensive', 'bioinformatics', 'resource', 'for', 'these', 'pathogens', 'including', 'consistently', 'annotated', 'genome', 'proteome', 'and', 'metabolic', 'pathway', 'data', 'to', 'facilitate', 'research', 'into', 'counter', 'measures', 'including', 'drugs', 'vaccines', 'and', 'diagnostics', 'The', 'project', 's', 'curation', 'strategy', 'has', 'three', 'prongs', 'breadth', 'first', 'beginning', 'with', 'whole', 'genome', 'and', 'proteome', 'curation', 'using', 'standardized', 'protocols', 'a', 'targeted', 'approach', 'addressing', 'the', 'specific', 'needs', 'of', 'researchers', 'and', 'an', 'integrative', 'strategy', 'to', 'leverage', 'high', 'throughput', 'experimental', 'data', 'e', 'g', 'microarrays', 'proteomics', 'and', 'literature', 'The', 'PATRIC', 'infrastructure', 'consists', 'of', 'a', 'relational', 'database', 'analytical', 'pipelines', 'and', 'a', 'website', 'which', 'supports', 'browsing', 'querying', 'data', 'visualization', 'and', 'the', 'ability', 'to', 'download', 'raw', 'and', 'curated', 'data', 'in', 'standard', 'formats', 'At', 'present', 'the', 'site', 'warehouses', 'complete', 'sequences', 'for', '17', 'bacterial', 'and', '332', 'viral', 'genomes', 'The', 'PATRIC', 'website', 'will', 'continually', 'grow', 'with', 'the', 'addition', 'of', 'data', 'analysis', 'and', 'functionality', 'over', 'the', 'course', 'of', 'the', 'project', '']"
196782,"All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for Rapid, Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus",2020-03-21,bioRxiv,https://doi.org/10.1101/2020.03.19.998724; https://www.ncbi.nlm.nih.gov/pubmed/32511323/,"A recent outbreak of novel coronavirus (SARS-CoV-2), the causative agent of COVID-19, has spread rapidly all over the world. Human immunodeficiency virus (HIV) is another deadly virus and causes acquired immunodeficiency syndrome (AIDS). Rapid and early detection of these viruses will facilitate early intervention and reduce disease transmission risk. Here, we present an All-In-One Dual CRISPR-Cas12a (termed “AIOD-CRISPR”) assay method for simple, rapid, ultrasensitive, one-pot, and visual detection of coronavirus SARS-CoV-2 and HIV virus. In our AIOD CRISPR assay, a pair of crRNAs was introduced to initiate dual CRISPR-Cas12a detection and improve detection sensitivity. The AIOD-CRISPR assay system was successfully utilized to detect nucleic acids (DNA and RNA) of SARS-CoV-2 and HIV with a sensitivity of few copies. Also, it was evaluated by detecting HIV-1 RNA extracted from human plasma samples, achieving a comparable sensitivity with real-time RT-PCR method. Thus, our method has a great potential for developing next-generation point-of-care molecular diagnostics.",10.1101/2020.03.19.998724,vlqd192g,"['A', 'recent', 'outbreak', 'of', 'novel', 'coronavirus', 'SARS', 'CoV', '2', 'the', 'causative', 'agent', 'of', 'COVID', '19', 'has', 'spread', 'rapidly', 'all', 'over', 'the', 'world', 'Human', 'immunodeficiency', 'virus', 'HIV', 'is', 'another', 'deadly', 'virus', 'and', 'causes', 'acquired', 'immunodeficiency', 'syndrome', 'AIDS', 'Rapid', 'and', 'early', 'detection', 'of', 'these', 'viruses', 'will', 'facilitate', 'early', 'intervention', 'and', 'reduce', 'disease', 'transmission', 'risk', 'Here', 'we', 'present', 'an', 'All', 'In', 'One', 'Dual', 'CRISPR', 'Cas12a', 'termed', 'AIOD', 'CRISPR', 'assay', 'method', 'for', 'simple', 'rapid', 'ultrasensitive', 'one', 'pot', 'and', 'visual', 'detection', 'of', 'coronavirus', 'SARS', 'CoV', '2', 'and', 'HIV', 'virus', 'In', 'our', 'AIOD', 'CRISPR', 'assay', 'a', 'pair', 'of', 'crRNAs', 'was', 'introduced', 'to', 'initiate', 'dual', 'CRISPR', 'Cas12a', 'detection', 'and', 'improve', 'detection', 'sensitivity', 'The', 'AIOD', 'CRISPR', 'assay', 'system', 'was', 'successfully', 'utilized', 'to', 'detect', 'nucleic', 'acids', 'DNA', 'and', 'RNA', 'of', 'SARS', 'CoV', '2', 'and', 'HIV', 'with', 'a', 'sensitivity', 'of', 'few', 'copies', 'Also', 'it', 'was', 'evaluated', 'by', 'detecting', 'HIV', '1', 'RNA', 'extracted', 'from', 'human', 'plasma', 'samples', 'achieving', 'a', 'comparable', 'sensitivity', 'with', 'real', 'time', 'RT', 'PCR', 'method', 'Thus', 'our', 'method', 'has', 'a', 'great', 'potential', 'for', 'developing', 'next', 'generation', 'point', 'of', 'care', 'molecular', 'diagnostics', '']"
197345,Biophotonic telemedicine for disease diagnosis and monitoring during pandemics: overcoming COVID-19 and shaping the future of healthcare,2020-05-27,Photodiagnosis Photodyn Ther,https://doi.org/10.1016/j.pdpdt.2020.101836; https://www.sciencedirect.com/science/article/pii/S1572100020301903?v=s5; https://api.elsevier.com/content/article/pii/S1572100020301903; https://www.ncbi.nlm.nih.gov/pubmed/32473399/,• Infection prevention and control (IPC) strategies against coronavirus disease 2019 (COVID-19) include social distancing and isolating infected patients. • Telemedicine has become a common clinical practice for early disease diagnostics and monitoring. • Optical and biophotonic technologies have potential to improve treatment outcome and increase survival rates by advancing telemedicine.,10.1016/j.pdpdt.2020.101836,n1e1m3fv,"['', 'Infection', 'prevention', 'and', 'control', 'IPC', 'strategies', 'against', 'coronavirus', 'disease', '2019', 'COVID', '19', 'include', 'social', 'distancing', 'and', 'isolating', 'infected', 'patients', 'Telemedicine', 'has', 'become', 'a', 'common', 'clinical', 'practice', 'for', 'early', 'disease', 'diagnostics', 'and', 'monitoring', 'Optical', 'and', 'biophotonic', 'technologies', 'have', 'potential', 'to', 'improve', 'treatment', 'outcome', 'and', 'increase', 'survival', 'rates', 'by', 'advancing', 'telemedicine', '']"
197760,"Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens",2020-04-23,J Clin Microbiol,https://doi.org/10.1128/jcm.00310-20; https://www.ncbi.nlm.nih.gov/pubmed/32132196/,"On 31 December 2019, the World Health Organization was informed of a cluster of cases of pneumonia of unknown etiology in Wuhan, China. Subsequent investigations identified a novel coronavirus, now named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from the affected patients. Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic. In this study, we developed and compared the performance of three novel real-time reverse transcription-PCR (RT-PCR) assays targeting the RNA-dependent RNA polymerase (RdRp)/helicase (Hel), spike (S), and nucleocapsid (N) genes of SARS-CoV-2 with that of the reported RdRp-P2 assay, which is used in >30 European laboratories. Among the three novel assays, the COVID-19-RdRp/Hel assay had the lowest limit of detection in vitro (1.8 50% tissue culture infective doses [TCID(50)]/ml with genomic RNA and 11.2 RNA copies/reaction with in vitro RNA transcripts). Among 273 specimens from 15 patients with laboratory-confirmed COVID-19 in Hong Kong, 77 (28.2%) were positive by both the COVID-19-RdRp/Hel and RdRp-P2 assays. The COVID-19-RdRp/Hel assay was positive for an additional 42 RdRp-P2-negative specimens (119/273 [43.6%] versus 77/273 [28.2%]; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens. The mean viral load of these specimens was 3.21 × 10(4) RNA copies/ml (range, 2.21 × 10(2) to 4.71 × 10(5) RNA copies/ml). The COVID-19-RdRp/Hel assay did not cross-react with other human-pathogenic coronaviruses and respiratory pathogens in cell culture and clinical specimens, whereas the RdRp-P2 assay cross-reacted with SARS-CoV in cell culture. The highly sensitive and specific COVID-19-RdRp/Hel assay may help to improve the laboratory diagnosis of COVID-19.",10.1128/jcm.00310-20,njne526i,"['On', '31', 'December', '2019', 'the', 'World', 'Health', 'Organization', 'was', 'informed', 'of', 'a', 'cluster', 'of', 'cases', 'of', 'pneumonia', 'of', 'unknown', 'etiology', 'in', 'Wuhan', 'China', 'Subsequent', 'investigations', 'identified', 'a', 'novel', 'coronavirus', 'now', 'named', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'from', 'the', 'affected', 'patients', 'Highly', 'sensitive', 'and', 'specific', 'laboratory', 'diagnostics', 'are', 'important', 'for', 'controlling', 'the', 'rapidly', 'evolving', 'SARS', 'CoV', '2', 'associated', 'coronavirus', 'disease', '2019', 'COVID', '19', 'epidemic', 'In', 'this', 'study', 'we', 'developed', 'and', 'compared', 'the', 'performance', 'of', 'three', 'novel', 'real', 'time', 'reverse', 'transcription', 'PCR', 'RT', 'PCR', 'assays', 'targeting', 'the', 'RNA', 'dependent', 'RNA', 'polymerase', 'RdRp', 'helicase', 'Hel', 'spike', 'S', 'and', 'nucleocapsid', 'N', 'genes', 'of', 'SARS', 'CoV', '2', 'with', 'that', 'of', 'the', 'reported', 'RdRp', 'P2', 'assay', 'which', 'is', 'used', 'in', '30', 'European', 'laboratories', 'Among', 'the', 'three', 'novel', 'assays', 'the', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'had', 'the', 'lowest', 'limit', 'of', 'detection', 'in', 'vitro', '1', '8', '50', 'tissue', 'culture', 'infective', 'doses', 'TCID', '50', 'ml', 'with', 'genomic', 'RNA', 'and', '11', '2', 'RNA', 'copies', 'reaction', 'with', 'in', 'vitro', 'RNA', 'transcripts', 'Among', '273', 'specimens', 'from', '15', 'patients', 'with', 'laboratory', 'confirmed', 'COVID', '19', 'in', 'Hong', 'Kong', '77', '28', '2', 'were', 'positive', 'by', 'both', 'the', 'COVID', '19', 'RdRp', 'Hel', 'and', 'RdRp', 'P2', 'assays', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'was', 'positive', 'for', 'an', 'additional', '42', 'RdRp', 'P2', 'negative', 'specimens', '119', '273', '43', '6', 'versus', '77', '273', '28', '2', 'P', '0', '001', 'including', '29', '120', '24', '2', 'respiratory', 'tract', 'specimens', 'and', '13', '153', '8', '5', 'non', 'respiratory', 'tract', 'specimens', 'The', 'mean', 'viral', 'load', 'of', 'these', 'specimens', 'was', '3', '21', '10', '4', 'RNA', 'copies', 'ml', 'range', '2', '21', '10', '2', 'to', '4', '71', '10', '5', 'RNA', 'copies', 'ml', 'The', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'did', 'not', 'cross', 'react', 'with', 'other', 'human', 'pathogenic', 'coronaviruses', 'and', 'respiratory', 'pathogens', 'in', 'cell', 'culture', 'and', 'clinical', 'specimens', 'whereas', 'the', 'RdRp', 'P2', 'assay', 'cross', 'reacted', 'with', 'SARS', 'CoV', 'in', 'cell', 'culture', 'The', 'highly', 'sensitive', 'and', 'specific', 'COVID', '19', 'RdRp', 'Hel', 'assay', 'may', 'help', 'to', 'improve', 'the', 'laboratory', 'diagnosis', 'of', 'COVID', '19', '']"
198074,Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes,2020-02-28,Bioinformatics,https://doi.org/10.1093/bioinformatics/btaa145; https://www.ncbi.nlm.nih.gov/pubmed/32108862/,"SUMMARY: Genome Detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next generation sequencing datasets. This application allows the identification of phylogenetic clusters and genotypes from assembled genomes in FASTA format. Since its release in 2019, we have produced a number of typing tools for emergent viruses that have caused large outbreaks, such as Zika and Yellow Fever Virus in Brazil. Here, we present The Genome Detective Coronavirus Typing Tool that can accurately identify the novel severe acute respiratory syndrome (SARS) related coronavirus (SARS-CoV-2) sequences isolated in China and around the world. The tool can accept up to 2,000 sequences per submission and the analysis of a new whole genome sequence will take approximately one minute. The tool has been tested and validated with hundreds of whole genomes from ten coronavirus species, and correctly classified all of the SARS-related coronavirus (SARSr-CoV) and all of the available public data for SARS-CoV-2. The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease. AVAILABILITY: https://www.genomedetective.com/app/typingtool/cov SUPPLEMENTARY INFORMATION:",10.1093/bioinformatics/btaa145,st5idleq,"['SUMMARY', 'Genome', 'Detective', 'is', 'a', 'web', 'based', 'user', 'friendly', 'software', 'application', 'to', 'quickly', 'and', 'accurately', 'assemble', 'all', 'known', 'virus', 'genomes', 'from', 'next', 'generation', 'sequencing', 'datasets', 'This', 'application', 'allows', 'the', 'identification', 'of', 'phylogenetic', 'clusters', 'and', 'genotypes', 'from', 'assembled', 'genomes', 'in', 'FASTA', 'format', 'Since', 'its', 'release', 'in', '2019', 'we', 'have', 'produced', 'a', 'number', 'of', 'typing', 'tools', 'for', 'emergent', 'viruses', 'that', 'have', 'caused', 'large', 'outbreaks', 'such', 'as', 'Zika', 'and', 'Yellow', 'Fever', 'Virus', 'in', 'Brazil', 'Here', 'we', 'present', 'The', 'Genome', 'Detective', 'Coronavirus', 'Typing', 'Tool', 'that', 'can', 'accurately', 'identify', 'the', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'related', 'coronavirus', 'SARS', 'CoV', '2', 'sequences', 'isolated', 'in', 'China', 'and', 'around', 'the', 'world', 'The', 'tool', 'can', 'accept', 'up', 'to', '2', '000', 'sequences', 'per', 'submission', 'and', 'the', 'analysis', 'of', 'a', 'new', 'whole', 'genome', 'sequence', 'will', 'take', 'approximately', 'one', 'minute', 'The', 'tool', 'has', 'been', 'tested', 'and', 'validated', 'with', 'hundreds', 'of', 'whole', 'genomes', 'from', 'ten', 'coronavirus', 'species', 'and', 'correctly', 'classified', 'all', 'of', 'the', 'SARS', 'related', 'coronavirus', 'SARSr', 'CoV', 'and', 'all', 'of', 'the', 'available', 'public', 'data', 'for', 'SARS', 'CoV', '2', 'The', 'tool', 'also', 'allows', 'tracking', 'of', 'new', 'viral', 'mutations', 'as', 'the', 'outbreak', 'expands', 'globally', 'which', 'may', 'help', 'to', 'accelerate', 'the', 'development', 'of', 'novel', 'diagnostics', 'drugs', 'and', 'vaccines', 'to', 'stop', 'the', 'COVID', '19', 'disease', 'AVAILABILITY', 'https', 'www', 'genomedetective', 'com', 'app', 'typingtool', 'cov', 'SUPPLEMENTARY', 'INFORMATION', '']"
198387,Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks,2020-05-01,Tissue Eng Part A,https://doi.org/10.1089/ten.tea.2020.0094; https://www.ncbi.nlm.nih.gov/pubmed/32272857/,"In light of the current novel coronavirus (COVID-19) pandemic, as well as other viral outbreaks in the 21st century, there is a dire need for new diagnostic and therapeutic strategies to combat infectious diseases worldwide. As a convergence science, tissue engineering has traditionally focused on the application of engineering principles to biological systems, collaboration across disciplines, and rapid translation of technologies from the benchtop to the bedside. Given these strengths, tissue engineers are particularly well suited to apply their skill set to the current crisis and viral outbreaks in general. This work introduces the basics of virology and epidemiology for tissue engineers, and highlights important developments in the field of tissue engineering relevant to the current pandemic, including in vitro model systems, vaccine technology, and small-molecule drug delivery. COVID-19 serves as a call to arms for scientists across all disciplines, and tissue engineers are well trained to be leaders and contributors in this time of need. IMPACT STATEMENT: Given the steep mortality caused by the recent novel coronavirus (COVID-19) pandemic, there is clear need for advances in diagnostics and therapeutics for viral outbreaks. Tissue engineering has the potential for critical impact on clinical outcomes in viral outbreaks. Tissue engineers, if mobilized, could play key roles as leaders in the outbreak, given their ability to apply engineering principles to biological processes, experience in collaborative environments, and penchant for technological translation from benchtop to bedside. In this work, three areas pioneered by tissue engineers that could be applied to the current COVID-19 crisis and future viral outbreaks are highlighted.",10.1089/ten.tea.2020.0094,b16i6uot,"['In', 'light', 'of', 'the', 'current', 'novel', 'coronavirus', 'COVID', '19', 'pandemic', 'as', 'well', 'as', 'other', 'viral', 'outbreaks', 'in', 'the', '21st', 'century', 'there', 'is', 'a', 'dire', 'need', 'for', 'new', 'diagnostic', 'and', 'therapeutic', 'strategies', 'to', 'combat', 'infectious', 'diseases', 'worldwide', 'As', 'a', 'convergence', 'science', 'tissue', 'engineering', 'has', 'traditionally', 'focused', 'on', 'the', 'application', 'of', 'engineering', 'principles', 'to', 'biological', 'systems', 'collaboration', 'across', 'disciplines', 'and', 'rapid', 'translation', 'of', 'technologies', 'from', 'the', 'benchtop', 'to', 'the', 'bedside', 'Given', 'these', 'strengths', 'tissue', 'engineers', 'are', 'particularly', 'well', 'suited', 'to', 'apply', 'their', 'skill', 'set', 'to', 'the', 'current', 'crisis', 'and', 'viral', 'outbreaks', 'in', 'general', 'This', 'work', 'introduces', 'the', 'basics', 'of', 'virology', 'and', 'epidemiology', 'for', 'tissue', 'engineers', 'and', 'highlights', 'important', 'developments', 'in', 'the', 'field', 'of', 'tissue', 'engineering', 'relevant', 'to', 'the', 'current', 'pandemic', 'including', 'in', 'vitro', 'model', 'systems', 'vaccine', 'technology', 'and', 'small', 'molecule', 'drug', 'delivery', 'COVID', '19', 'serves', 'as', 'a', 'call', 'to', 'arms', 'for', 'scientists', 'across', 'all', 'disciplines', 'and', 'tissue', 'engineers', 'are', 'well', 'trained', 'to', 'be', 'leaders', 'and', 'contributors', 'in', 'this', 'time', 'of', 'need', 'IMPACT', 'STATEMENT', 'Given', 'the', 'steep', 'mortality', 'caused', 'by', 'the', 'recent', 'novel', 'coronavirus', 'COVID', '19', 'pandemic', 'there', 'is', 'clear', 'need', 'for', 'advances', 'in', 'diagnostics', 'and', 'therapeutics', 'for', 'viral', 'outbreaks', 'Tissue', 'engineering', 'has', 'the', 'potential', 'for', 'critical', 'impact', 'on', 'clinical', 'outcomes', 'in', 'viral', 'outbreaks', 'Tissue', 'engineers', 'if', 'mobilized', 'could', 'play', 'key', 'roles', 'as', 'leaders', 'in', 'the', 'outbreak', 'given', 'their', 'ability', 'to', 'apply', 'engineering', 'principles', 'to', 'biological', 'processes', 'experience', 'in', 'collaborative', 'environments', 'and', 'penchant', 'for', 'technological', 'translation', 'from', 'benchtop', 'to', 'bedside', 'In', 'this', 'work', 'three', 'areas', 'pioneered', 'by', 'tissue', 'engineers', 'that', 'could', 'be', 'applied', 'to', 'the', 'current', 'COVID', '19', 'crisis', 'and', 'future', 'viral', 'outbreaks', 'are', 'highlighted', '']"
199029,Production of Recombinant N Protein of Infectious Bronchitis Virus Using the Baculovirus Expression System and Its Assessment as a Diagnostic Antigen,2018-07-09,Appl Biochem Biotechnol,https://doi.org/10.1007/s12010-018-2815-2; https://www.ncbi.nlm.nih.gov/pubmed/29987628/,"The avian coronavirus-infectious bronchitis virus (AvCoV-IBV) is recognized as an important avian pathogen, and new viral variants are a continuous threat to the poultry industry worldwide. Sensitive diagnostics and efficacious vaccines are necessary to combat IBV infections in chickens. The aim of this study was to produce recombinant N protein of IBV in the baculovirus system to use in ELISA diagnostic tests in order to enable the assessment of the sero-prevalence and risk of IBV infections in chickens in Turkey. For this, the gene encoding the N protein of the Beaudette strain of IBV was expressed using a recombinant baculovirus expression system. The recombinant N protein was purified using Ni-NTA affinity chromatography. An estimated 50-kDa recombinant protein corresponding to the expected molecular weight of IBV N including the 6xHis tag was detected using an anti-His monoclonal antibody. Specific immunoreactivity of the recombinant protein was confirmed by Western blot using antiserum obtained from vaccinated and naturally infected chicken from Turkey as well as using a monoclonal antibody raised against the N protein of the IBV Massachusetts strain. The results obtained with the in-house ELISA had high agreement with a commercial ELISA. Immunoreactivity analysis using antisera in Western blotting and the in-house ELISA suggests that the recombinant IBV N protein could be broadly cross-reactive with antisera produced against different IBV strains. We conclude that the recombinant baculovirus expressed IBV N protein could serve as a useful diagnostic antigen for detection of IBV infections in chickens by ELISA.",10.1007/s12010-018-2815-2,qnbgywgy,"['The', 'avian', 'coronavirus', 'infectious', 'bronchitis', 'virus', 'AvCoV', 'IBV', 'is', 'recognized', 'as', 'an', 'important', 'avian', 'pathogen', 'and', 'new', 'viral', 'variants', 'are', 'a', 'continuous', 'threat', 'to', 'the', 'poultry', 'industry', 'worldwide', 'Sensitive', 'diagnostics', 'and', 'efficacious', 'vaccines', 'are', 'necessary', 'to', 'combat', 'IBV', 'infections', 'in', 'chickens', 'The', 'aim', 'of', 'this', 'study', 'was', 'to', 'produce', 'recombinant', 'N', 'protein', 'of', 'IBV', 'in', 'the', 'baculovirus', 'system', 'to', 'use', 'in', 'ELISA', 'diagnostic', 'tests', 'in', 'order', 'to', 'enable', 'the', 'assessment', 'of', 'the', 'sero', 'prevalence', 'and', 'risk', 'of', 'IBV', 'infections', 'in', 'chickens', 'in', 'Turkey', 'For', 'this', 'the', 'gene', 'encoding', 'the', 'N', 'protein', 'of', 'the', 'Beaudette', 'strain', 'of', 'IBV', 'was', 'expressed', 'using', 'a', 'recombinant', 'baculovirus', 'expression', 'system', 'The', 'recombinant', 'N', 'protein', 'was', 'purified', 'using', 'Ni', 'NTA', 'affinity', 'chromatography', 'An', 'estimated', '50', 'kDa', 'recombinant', 'protein', 'corresponding', 'to', 'the', 'expected', 'molecular', 'weight', 'of', 'IBV', 'N', 'including', 'the', '6xHis', 'tag', 'was', 'detected', 'using', 'an', 'anti', 'His', 'monoclonal', 'antibody', 'Specific', 'immunoreactivity', 'of', 'the', 'recombinant', 'protein', 'was', 'confirmed', 'by', 'Western', 'blot', 'using', 'antiserum', 'obtained', 'from', 'vaccinated', 'and', 'naturally', 'infected', 'chicken', 'from', 'Turkey', 'as', 'well', 'as', 'using', 'a', 'monoclonal', 'antibody', 'raised', 'against', 'the', 'N', 'protein', 'of', 'the', 'IBV', 'Massachusetts', 'strain', 'The', 'results', 'obtained', 'with', 'the', 'in', 'house', 'ELISA', 'had', 'high', 'agreement', 'with', 'a', 'commercial', 'ELISA', 'Immunoreactivity', 'analysis', 'using', 'antisera', 'in', 'Western', 'blotting', 'and', 'the', 'in', 'house', 'ELISA', 'suggests', 'that', 'the', 'recombinant', 'IBV', 'N', 'protein', 'could', 'be', 'broadly', 'cross', 'reactive', 'with', 'antisera', 'produced', 'against', 'different', 'IBV', 'strains', 'We', 'conclude', 'that', 'the', 'recombinant', 'baculovirus', 'expressed', 'IBV', 'N', 'protein', 'could', 'serve', 'as', 'a', 'useful', 'diagnostic', 'antigen', 'for', 'detection', 'of', 'IBV', 'infections', 'in', 'chickens', 'by', 'ELISA', '']"
199355,COVID‐19 Clinical Diagnostics and Testing Technology,2020-07-08,Pharmacotherapy,https://doi.org/10.1002/phar.2439; https://www.ncbi.nlm.nih.gov/pubmed/32643218/,"Given the global nature of the COVID‐19 pandemic, the need for disease detection and expanding testing capacity remains a critical priority. This review discusses the technological advances in testing capability and methodology that are currently employed or in development for detecting the novel coronavirus. We describe the current clinical diagnostics and technology, including molecular and serological testing approaches, for SARS‐CoV‐2 testing as well as address their advantages and limitations. Nucleic acid amplification technology for molecular diagnostics remains the gold standard for virus detection. We highlight alternative molecular detection techniques used for developing novel COVID‐19 diagnostics on the horizon. Antibody response against SARS‐CoV‐2 remains poorly understood and proper validation of serology tests is necessary to demonstrate their accuracy and clinical utility. In order to bring the pandemic under control, we must speed up the development of rapid and widespread testing through improvements in clinical diagnostics and testing technology as well as access to these tools.",10.1002/phar.2439,5mf1r24m,"['Given', 'the', 'global', 'nature', 'of', 'the', 'COVID', '19', 'pandemic', 'the', 'need', 'for', 'disease', 'detection', 'and', 'expanding', 'testing', 'capacity', 'remains', 'a', 'critical', 'priority', 'This', 'review', 'discusses', 'the', 'technological', 'advances', 'in', 'testing', 'capability', 'and', 'methodology', 'that', 'are', 'currently', 'employed', 'or', 'in', 'development', 'for', 'detecting', 'the', 'novel', 'coronavirus', 'We', 'describe', 'the', 'current', 'clinical', 'diagnostics', 'and', 'technology', 'including', 'molecular', 'and', 'serological', 'testing', 'approaches', 'for', 'SARS', 'CoV', '2', 'testing', 'as', 'well', 'as', 'address', 'their', 'advantages', 'and', 'limitations', 'Nucleic', 'acid', 'amplification', 'technology', 'for', 'molecular', 'diagnostics', 'remains', 'the', 'gold', 'standard', 'for', 'virus', 'detection', 'We', 'highlight', 'alternative', 'molecular', 'detection', 'techniques', 'used', 'for', 'developing', 'novel', 'COVID', '19', 'diagnostics', 'on', 'the', 'horizon', 'Antibody', 'response', 'against', 'SARS', 'CoV', '2', 'remains', 'poorly', 'understood', 'and', 'proper', 'validation', 'of', 'serology', 'tests', 'is', 'necessary', 'to', 'demonstrate', 'their', 'accuracy', 'and', 'clinical', 'utility', 'In', 'order', 'to', 'bring', 'the', 'pandemic', 'under', 'control', 'we', 'must', 'speed', 'up', 'the', 'development', 'of', 'rapid', 'and', 'widespread', 'testing', 'through', 'improvements', 'in', 'clinical', 'diagnostics', 'and', 'testing', 'technology', 'as', 'well', 'as', 'access', 'to', 'these', 'tools', '']"
199372,Aspects of nano-enabling biosensing systems for intelligent healthcare; towards COVID-19 management,2020-06-05,Mater Today Chem,https://api.elsevier.com/content/article/pii/S2468519420300665; https://doi.org/10.1016/j.mtchem.2020.100306; https://www.sciencedirect.com/science/article/pii/S2468519420300665?v=s5,"Biosensors are emerging as efficient (sensitive and selective) and affordable analytical diagnostic tools for early-stage disease detection, as required for personalized health wellness management. Low-level detection of a targeted disease biomarker (pM level) has emerged extremely useful to evaluate the progression of disease under therapy. Such collected bioinformatics and its multi-aspects-oriented analytics is in demand to explore the effectiveness of prescribed treatment, optimize therapy, and correlate biomarker level with disease pathogenesis. Owing to nanotechnology-enabled advancements in sensing unit fabrication, device integration, interfacing, packaging, and sensing performance at point-of-care (POC) made diagnostics according to the requirements of disease management and patient disease profile i.e., in a personalized manner. Efforts are continuously being made to promote state of art biosensing technology as a next-generation non-invasive disease diagnostics methodology. Keeping this in view, this progressive opinion article describes personalized health care management related analytical tools which provide access to better health for everyone, overall to manage healthy tomorrow timely. Considering accomplishments and predictions, such affordable intelligent diagnostics tools are urgently required to manage COVID-19 pandemic, a life-threatening respiratory infectious disease, where a rapid, selective and sensitive detection of human beta severe acute respiratory system coronavirus (SARS-COoV-2) protein is the key factor.",10.1016/j.mtchem.2020.100306,4vjf6sgs,"['Biosensors', 'are', 'emerging', 'as', 'efficient', 'sensitive', 'and', 'selective', 'and', 'affordable', 'analytical', 'diagnostic', 'tools', 'for', 'early', 'stage', 'disease', 'detection', 'as', 'required', 'for', 'personalized', 'health', 'wellness', 'management', 'Low', 'level', 'detection', 'of', 'a', 'targeted', 'disease', 'biomarker', 'pM', 'level', 'has', 'emerged', 'extremely', 'useful', 'to', 'evaluate', 'the', 'progression', 'of', 'disease', 'under', 'therapy', 'Such', 'collected', 'bioinformatics', 'and', 'its', 'multi', 'aspects', 'oriented', 'analytics', 'is', 'in', 'demand', 'to', 'explore', 'the', 'effectiveness', 'of', 'prescribed', 'treatment', 'optimize', 'therapy', 'and', 'correlate', 'biomarker', 'level', 'with', 'disease', 'pathogenesis', 'Owing', 'to', 'nanotechnology', 'enabled', 'advancements', 'in', 'sensing', 'unit', 'fabrication', 'device', 'integration', 'interfacing', 'packaging', 'and', 'sensing', 'performance', 'at', 'point', 'of', 'care', 'POC', 'made', 'diagnostics', 'according', 'to', 'the', 'requirements', 'of', 'disease', 'management', 'and', 'patient', 'disease', 'profile', 'i', 'e', 'in', 'a', 'personalized', 'manner', 'Efforts', 'are', 'continuously', 'being', 'made', 'to', 'promote', 'state', 'of', 'art', 'biosensing', 'technology', 'as', 'a', 'next', 'generation', 'non', 'invasive', 'disease', 'diagnostics', 'methodology', 'Keeping', 'this', 'in', 'view', 'this', 'progressive', 'opinion', 'article', 'describes', 'personalized', 'health', 'care', 'management', 'related', 'analytical', 'tools', 'which', 'provide', 'access', 'to', 'better', 'health', 'for', 'everyone', 'overall', 'to', 'manage', 'healthy', 'tomorrow', 'timely', 'Considering', 'accomplishments', 'and', 'predictions', 'such', 'affordable', 'intelligent', 'diagnostics', 'tools', 'are', 'urgently', 'required', 'to', 'manage', 'COVID', '19', 'pandemic', 'a', 'life', 'threatening', 'respiratory', 'infectious', 'disease', 'where', 'a', 'rapid', 'selective', 'and', 'sensitive', 'detection', 'of', 'human', 'beta', 'severe', 'acute', 'respiratory', 'system', 'coronavirus', 'SARS', 'COoV', '2', 'protein', 'is', 'the', 'key', 'factor', '']"
199613,Point-of-Care Diagnostic Services as an Integral Part of Health Services during the Novel Coronavirus 2019 Era,2020,Diagnostics,https://www.ncbi.nlm.nih.gov/pubmed/32635234/; https://doi.org/10.3390/diagnostics10070449,"Point-of-care (POC) diagnostic services are commonly associated with pathology laboratory services This issue presents a holistic approach to POC diagnostics services from a variety of disciplines including pathology, radiological and information technology as well as mobile technology and artificial intelligence This highlights the need for transdisciplinary collaboration to ensure the efficient development and implementation of point-of-care diagnostics The advent of the novel coronavirus 2019 (COVID-19) pandemic has prompted rapid advances in the development of new POC diagnostics Global private and public sector agencies have significantly increased their investment in the development of POC diagnostics There is no longer a question about the availability and accessibility of POC diagnostics The question is ""how can POC diagnostic services be integrated into health services in way that is useful and acceptable in the COVID-19 era?""",10.3390/diagnostics10070449,jtce7jpi,"['Point', 'of', 'care', 'POC', 'diagnostic', 'services', 'are', 'commonly', 'associated', 'with', 'pathology', 'laboratory', 'services', 'This', 'issue', 'presents', 'a', 'holistic', 'approach', 'to', 'POC', 'diagnostics', 'services', 'from', 'a', 'variety', 'of', 'disciplines', 'including', 'pathology', 'radiological', 'and', 'information', 'technology', 'as', 'well', 'as', 'mobile', 'technology', 'and', 'artificial', 'intelligence', 'This', 'highlights', 'the', 'need', 'for', 'transdisciplinary', 'collaboration', 'to', 'ensure', 'the', 'efficient', 'development', 'and', 'implementation', 'of', 'point', 'of', 'care', 'diagnostics', 'The', 'advent', 'of', 'the', 'novel', 'coronavirus', '2019', 'COVID', '19', 'pandemic', 'has', 'prompted', 'rapid', 'advances', 'in', 'the', 'development', 'of', 'new', 'POC', 'diagnostics', 'Global', 'private', 'and', 'public', 'sector', 'agencies', 'have', 'significantly', 'increased', 'their', 'investment', 'in', 'the', 'development', 'of', 'POC', 'diagnostics', 'There', 'is', 'no', 'longer', 'a', 'question', 'about', 'the', 'availability', 'and', 'accessibility', 'of', 'POC', 'diagnostics', 'The', 'question', 'is', 'how', 'can', 'POC', 'diagnostic', 'services', 'be', 'integrated', 'into', 'health', 'services', 'in', 'way', 'that', 'is', 'useful', 'and', 'acceptable', 'in', 'the', 'COVID', '19', 'era', '']"
199740,A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19,2020-04-17,Cureus,https://doi.org/10.7759/cureus.7708; https://www.ncbi.nlm.nih.gov/pubmed/32313785/,"Saliva is an exocrine secretion produced from the salivary glands and has numerous functions, such as cleansing and protection of the oral cavity, antimicrobial effects and aids in digestion. Due to the speedy development in the field of salivaomics, saliva is now well accepted as a pool of biological markers that vary from changes in biochemicals, nucleic acids and proteins to the microflora. Saliva has an immense potential as a diagnostic fluid and offers an edge over other biological fluids as its collection method does not require invasive procedure, economical and is useful for monitoring systemic health. Development of sensitive and precise salivary diagnostic tools and the formulation of defined guidelines following meticulous testing will allow salivary diagnostics to be utilised as chair side tests for various oral and systemic diseases in the near future. The coronavirus disease (Covid-19) pandemic is the biggest challenge and global health crisis for the world since World War Two. Rapid and accurate diagnosis of Covid-19 is crucial in controlling the outbreak in the community and in hospitals. Nasopharyngeal and oropharyngeal swabs are the recommended specimen types for Covid-19 diagnostic testing. The collection of these specimen types requires close contact between healthcare workers and patients and poses a risk of transmission of the virus, causes discomfort and may cause bleeding, especially in patients with condition such as thrombocytopenia. Hence, nasopharyngeal or oropharyngeal swabs are not desirable for sequential monitoring of viral load. Saliva specimens can be obtained easily as the patient is asked to spit into a sterile bottle. The collection of saliva is non-invasive and greatly minimizes the exposure of healthcare workers to Covid-19. Saliva has a high consistency rate of greater than 90% with nasopharyngeal specimens in the detection of respiratory viruses, including coronaviruses. Saliva has also been used in screening respiratory viruses among hospitalized patients without pyrexia or respiratory symptoms. SARS-CoV can be detected in saliva at high titers. Salivary diagnostics is a dynamic field that is being incorporated as part of disease diagnosis, clinical monitoring of systemic health and to make significant clinical decisions for patient care. More research is required to analyze the potential diagnostic of Covid-19 in saliva to develop rapid chair side tests for the detection of Covid-19 and it is also pivotal to improve and develop successful strategies for prevention, especially for dentists and healthcare professionals who are involved in performing aerosol-generating procedures.",10.7759/cureus.7708,awy3aans,"['Saliva', 'is', 'an', 'exocrine', 'secretion', 'produced', 'from', 'the', 'salivary', 'glands', 'and', 'has', 'numerous', 'functions', 'such', 'as', 'cleansing', 'and', 'protection', 'of', 'the', 'oral', 'cavity', 'antimicrobial', 'effects', 'and', 'aids', 'in', 'digestion', 'Due', 'to', 'the', 'speedy', 'development', 'in', 'the', 'field', 'of', 'salivaomics', 'saliva', 'is', 'now', 'well', 'accepted', 'as', 'a', 'pool', 'of', 'biological', 'markers', 'that', 'vary', 'from', 'changes', 'in', 'biochemicals', 'nucleic', 'acids', 'and', 'proteins', 'to', 'the', 'microflora', 'Saliva', 'has', 'an', 'immense', 'potential', 'as', 'a', 'diagnostic', 'fluid', 'and', 'offers', 'an', 'edge', 'over', 'other', 'biological', 'fluids', 'as', 'its', 'collection', 'method', 'does', 'not', 'require', 'invasive', 'procedure', 'economical', 'and', 'is', 'useful', 'for', 'monitoring', 'systemic', 'health', 'Development', 'of', 'sensitive', 'and', 'precise', 'salivary', 'diagnostic', 'tools', 'and', 'the', 'formulation', 'of', 'defined', 'guidelines', 'following', 'meticulous', 'testing', 'will', 'allow', 'salivary', 'diagnostics', 'to', 'be', 'utilised', 'as', 'chair', 'side', 'tests', 'for', 'various', 'oral', 'and', 'systemic', 'diseases', 'in', 'the', 'near', 'future', 'The', 'coronavirus', 'disease', 'Covid', '19', 'pandemic', 'is', 'the', 'biggest', 'challenge', 'and', 'global', 'health', 'crisis', 'for', 'the', 'world', 'since', 'World', 'War', 'Two', 'Rapid', 'and', 'accurate', 'diagnosis', 'of', 'Covid', '19', 'is', 'crucial', 'in', 'controlling', 'the', 'outbreak', 'in', 'the', 'community', 'and', 'in', 'hospitals', 'Nasopharyngeal', 'and', 'oropharyngeal', 'swabs', 'are', 'the', 'recommended', 'specimen', 'types', 'for', 'Covid', '19', 'diagnostic', 'testing', 'The', 'collection', 'of', 'these', 'specimen', 'types', 'requires', 'close', 'contact', 'between', 'healthcare', 'workers', 'and', 'patients', 'and', 'poses', 'a', 'risk', 'of', 'transmission', 'of', 'the', 'virus', 'causes', 'discomfort', 'and', 'may', 'cause', 'bleeding', 'especially', 'in', 'patients', 'with', 'condition', 'such', 'as', 'thrombocytopenia', 'Hence', 'nasopharyngeal', 'or', 'oropharyngeal', 'swabs', 'are', 'not', 'desirable', 'for', 'sequential', 'monitoring', 'of', 'viral', 'load', 'Saliva', 'specimens', 'can', 'be', 'obtained', 'easily', 'as', 'the', 'patient', 'is', 'asked', 'to', 'spit', 'into', 'a', 'sterile', 'bottle', 'The', 'collection', 'of', 'saliva', 'is', 'non', 'invasive', 'and', 'greatly', 'minimizes', 'the', 'exposure', 'of', 'healthcare', 'workers', 'to', 'Covid', '19', 'Saliva', 'has', 'a', 'high', 'consistency', 'rate', 'of', 'greater', 'than', '90', 'with', 'nasopharyngeal', 'specimens', 'in', 'the', 'detection', 'of', 'respiratory', 'viruses', 'including', 'coronaviruses', 'Saliva', 'has', 'also', 'been', 'used', 'in', 'screening', 'respiratory', 'viruses', 'among', 'hospitalized', 'patients', 'without', 'pyrexia', 'or', 'respiratory', 'symptoms', 'SARS', 'CoV', 'can', 'be', 'detected', 'in', 'saliva', 'at', 'high', 'titers', 'Salivary', 'diagnostics', 'is', 'a', 'dynamic', 'field', 'that', 'is', 'being', 'incorporated', 'as', 'part', 'of', 'disease', 'diagnosis', 'clinical', 'monitoring', 'of', 'systemic', 'health', 'and', 'to', 'make', 'significant', 'clinical', 'decisions', 'for', 'patient', 'care', 'More', 'research', 'is', 'required', 'to', 'analyze', 'the', 'potential', 'diagnostic', 'of', 'Covid', '19', 'in', 'saliva', 'to', 'develop', 'rapid', 'chair', 'side', 'tests', 'for', 'the', 'detection', 'of', 'Covid', '19', 'and', 'it', 'is', 'also', 'pivotal', 'to', 'improve', 'and', 'develop', 'successful', 'strategies', 'for', 'prevention', 'especially', 'for', 'dentists', 'and', 'healthcare', 'professionals', 'who', 'are', 'involved', 'in', 'performing', 'aerosol', 'generating', 'procedures', '']"
200288,Coronaviren als Ursache respiratorischer Infektionen,2019-08-27,Internist (Berl),https://doi.org/10.1007/s00108-019-00671-5; https://www.ncbi.nlm.nih.gov/pubmed/31455974/,"BACKGROUND: There are six human pathogenic coronaviruses (CoV), which mainly cause infections of the respiratory system. In everyday clinical practice, it is helpful to know the relevance and characteristics of these pathogens. OBJECTIVE: To present the epidemiology, clinical picture and differences of human pathogenic CoV and to provide information on the diagnostics and treatment of patients suspected of having CoV infections. MATERIAL AND METHODS: Selective literature search, presentation of results and discussion of fundamental works and expert recommendations, including publications by the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC) and the Robert Koch Institute. RESULTS: The four endemic human CoVs (HCoV-NL63, HCoV-229E, HCoV-OC43 and HCoV-HKU1) mainly cause mild respiratory tract infections. In addition to these four endemic HCoV, the two epidemic CoV, severe acute respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV can cause severe pneumonia. The SARS-CoV has not been detected in humans in the last 15 years and MERS-CoV has been circulating mainly on the Arabian Peninsula since 2012; however, neither a specific treatment nor approved vaccines exist for any of the six human pathogenic CoVs. CONCLUSION: All six human CoVs can be diagnosed using RT-PCR on respiratory specimens but this is rarely necessary for the four endemic strains. In current clinical practice SARS-CoV has no importance as it has not been detected in humans for 15 years; however, a possible MERS-CoV infection should be taken into account in patients with typical symptoms and travel history to endemic regions. In this case, rapid diagnostic and general hygiene practices are important to prevent further transmission.",10.1007/s00108-019-00671-5,hi3fjne4,"['BACKGROUND', 'There', 'are', 'six', 'human', 'pathogenic', 'coronaviruses', 'CoV', 'which', 'mainly', 'cause', 'infections', 'of', 'the', 'respiratory', 'system', 'In', 'everyday', 'clinical', 'practice', 'it', 'is', 'helpful', 'to', 'know', 'the', 'relevance', 'and', 'characteristics', 'of', 'these', 'pathogens', 'OBJECTIVE', 'To', 'present', 'the', 'epidemiology', 'clinical', 'picture', 'and', 'differences', 'of', 'human', 'pathogenic', 'CoV', 'and', 'to', 'provide', 'information', 'on', 'the', 'diagnostics', 'and', 'treatment', 'of', 'patients', 'suspected', 'of', 'having', 'CoV', 'infections', 'MATERIAL', 'AND', 'METHODS', 'Selective', 'literature', 'search', 'presentation', 'of', 'results', 'and', 'discussion', 'of', 'fundamental', 'works', 'and', 'expert', 'recommendations', 'including', 'publications', 'by', 'the', 'World', 'Health', 'Organization', 'WHO', 'the', 'European', 'Centre', 'for', 'Disease', 'Prevention', 'and', 'Control', 'ECDC', 'and', 'the', 'Robert', 'Koch', 'Institute', 'RESULTS', 'The', 'four', 'endemic', 'human', 'CoVs', 'HCoV', 'NL63', 'HCoV', '229E', 'HCoV', 'OC43', 'and', 'HCoV', 'HKU1', 'mainly', 'cause', 'mild', 'respiratory', 'tract', 'infections', 'In', 'addition', 'to', 'these', 'four', 'endemic', 'HCoV', 'the', 'two', 'epidemic', 'CoV', 'severe', 'acute', 'respiratory', 'syndrome', 'SARS', 'CoV', 'and', 'Middle', 'East', 'respiratory', 'syndrome', 'MERS', 'CoV', 'can', 'cause', 'severe', 'pneumonia', 'The', 'SARS', 'CoV', 'has', 'not', 'been', 'detected', 'in', 'humans', 'in', 'the', 'last', '15', 'years', 'and', 'MERS', 'CoV', 'has', 'been', 'circulating', 'mainly', 'on', 'the', 'Arabian', 'Peninsula', 'since', '2012', 'however', 'neither', 'a', 'specific', 'treatment', 'nor', 'approved', 'vaccines', 'exist', 'for', 'any', 'of', 'the', 'six', 'human', 'pathogenic', 'CoVs', 'CONCLUSION', 'All', 'six', 'human', 'CoVs', 'can', 'be', 'diagnosed', 'using', 'RT', 'PCR', 'on', 'respiratory', 'specimens', 'but', 'this', 'is', 'rarely', 'necessary', 'for', 'the', 'four', 'endemic', 'strains', 'In', 'current', 'clinical', 'practice', 'SARS', 'CoV', 'has', 'no', 'importance', 'as', 'it', 'has', 'not', 'been', 'detected', 'in', 'humans', 'for', '15', 'years', 'however', 'a', 'possible', 'MERS', 'CoV', 'infection', 'should', 'be', 'taken', 'into', 'account', 'in', 'patients', 'with', 'typical', 'symptoms', 'and', 'travel', 'history', 'to', 'endemic', 'regions', 'In', 'this', 'case', 'rapid', 'diagnostic', 'and', 'general', 'hygiene', 'practices', 'are', 'important', 'to', 'prevent', 'further', 'transmission', '']"
200456,Convolutional CapsNet: A novel artificial neural network approach to detect COVID-19 disease from X-ray images using capsule networks,2020-07-13,Chaos Solitons Fractals,https://api.elsevier.com/content/article/pii/S0960077920305191; https://www.sciencedirect.com/science/article/pii/S0960077920305191?v=s5; https://doi.org/10.1016/j.chaos.2020.110122,"Coronavirus is an epidemic that spreads very quickly. For this reason, it has very devastating effects in many areas worldwide. It is vital to detect COVID-19 diseases as quickly as possible to restrain the spread of the disease. The similarity of COVID-19 disease with other lung infections makes the diagnosis difficult. In addition, the high spreading rate of COVID-19 increased the need for a fast system for the diagnosis of cases. For this purpose, interest in various computer-aided (such as CNN, DNN, etc.) deep learning models has been increased. In these models, mostly radiology images are applied to determine the positive cases. Recent studies show that, radiological images contain important information in the detection of coronavirus. In this study, a novel artificial neural network, Convolutional CapsNet for the detection of COVID-19 disease is proposed by using chest X-ray images with capsule networks. The proposed approach is designed to provide fast and accurate diagnostics for COVID-19 diseases with binary classification (COVID-19, and No-Findings), and multi-class classification (COVID-19, and No-Findings, and Pneumonia). The proposed method achieved an accuracy of 97.24%, and 84.22% for binary class, and multi-class, respectively. It is thought that the proposed method may help physicians to diagnose COVID-19 disease and increase the diagnostic performance. In addition, we believe that the proposed method may be an alternative method to diagnose COVID-19 by providing fast screening.",10.1016/j.chaos.2020.110122,xxvydtr4,"['Coronavirus', 'is', 'an', 'epidemic', 'that', 'spreads', 'very', 'quickly', 'For', 'this', 'reason', 'it', 'has', 'very', 'devastating', 'effects', 'in', 'many', 'areas', 'worldwide', 'It', 'is', 'vital', 'to', 'detect', 'COVID', '19', 'diseases', 'as', 'quickly', 'as', 'possible', 'to', 'restrain', 'the', 'spread', 'of', 'the', 'disease', 'The', 'similarity', 'of', 'COVID', '19', 'disease', 'with', 'other', 'lung', 'infections', 'makes', 'the', 'diagnosis', 'difficult', 'In', 'addition', 'the', 'high', 'spreading', 'rate', 'of', 'COVID', '19', 'increased', 'the', 'need', 'for', 'a', 'fast', 'system', 'for', 'the', 'diagnosis', 'of', 'cases', 'For', 'this', 'purpose', 'interest', 'in', 'various', 'computer', 'aided', 'such', 'as', 'CNN', 'DNN', 'etc', 'deep', 'learning', 'models', 'has', 'been', 'increased', 'In', 'these', 'models', 'mostly', 'radiology', 'images', 'are', 'applied', 'to', 'determine', 'the', 'positive', 'cases', 'Recent', 'studies', 'show', 'that', 'radiological', 'images', 'contain', 'important', 'information', 'in', 'the', 'detection', 'of', 'coronavirus', 'In', 'this', 'study', 'a', 'novel', 'artificial', 'neural', 'network', 'Convolutional', 'CapsNet', 'for', 'the', 'detection', 'of', 'COVID', '19', 'disease', 'is', 'proposed', 'by', 'using', 'chest', 'X', 'ray', 'images', 'with', 'capsule', 'networks', 'The', 'proposed', 'approach', 'is', 'designed', 'to', 'provide', 'fast', 'and', 'accurate', 'diagnostics', 'for', 'COVID', '19', 'diseases', 'with', 'binary', 'classification', 'COVID', '19', 'and', 'No', 'Findings', 'and', 'multi', 'class', 'classification', 'COVID', '19', 'and', 'No', 'Findings', 'and', 'Pneumonia', 'The', 'proposed', 'method', 'achieved', 'an', 'accuracy', 'of', '97', '24', 'and', '84', '22', 'for', 'binary', 'class', 'and', 'multi', 'class', 'respectively', 'It', 'is', 'thought', 'that', 'the', 'proposed', 'method', 'may', 'help', 'physicians', 'to', 'diagnose', 'COVID', '19', 'disease', 'and', 'increase', 'the', 'diagnostic', 'performance', 'In', 'addition', 'we', 'believe', 'that', 'the', 'proposed', 'method', 'may', 'be', 'an', 'alternative', 'method', 'to', 'diagnose', 'COVID', '19', 'by', 'providing', 'fast', 'screening', '']"
200830,Identification of Upper Respiratory Tract Pathogens Using Electrochemical Detection on an Oligonucleotide Microarray,2007-09-26,PLoS One,https://www.ncbi.nlm.nih.gov/pubmed/17895966/,"Bacterial and viral upper respiratory infections (URI) produce highly variable clinical symptoms that cannot be used to identify the etiologic agent. Proper treatment, however, depends on correct identification of the pathogen involved as antibiotics provide little or no benefit with viral infections. Here we describe a rapid and sensitive genotyping assay and microarray for URI identification using standard amplification and hybridization techniques, with electrochemical detection (ECD) on a semiconductor-based oligonucleotide microarray. The assay was developed to detect four bacterial pathogens (Bordetella pertussis, Streptococcus pyogenes, Chlamydia pneumoniae and Mycoplasma pneumoniae) and 9 viral pathogens (adenovirus 4, coronavirus OC43, 229E and HK, influenza A and B, parainfluinza types 1, 2, and 3 and respiratory syncytial virus. This new platform forms the basis for a fully automated diagnostics system that is very flexible and can be customized to suit different or additional pathogens. Multiple probes on a flexible platform allow one to test probes empirically and then select highly reactive probes for further iterative evaluation. Because ECD uses an enzymatic reaction to create electrical signals that can be read directly from the array, there is no need for image analysis or for expensive and delicate optical scanning equipment. We show assay sensitivity and specificity that are excellent for a multiplexed format.",10.1371/journal.pone.0000924,yzmt1e0l,"['Bacterial', 'and', 'viral', 'upper', 'respiratory', 'infections', 'URI', 'produce', 'highly', 'variable', 'clinical', 'symptoms', 'that', 'cannot', 'be', 'used', 'to', 'identify', 'the', 'etiologic', 'agent', 'Proper', 'treatment', 'however', 'depends', 'on', 'correct', 'identification', 'of', 'the', 'pathogen', 'involved', 'as', 'antibiotics', 'provide', 'little', 'or', 'no', 'benefit', 'with', 'viral', 'infections', 'Here', 'we', 'describe', 'a', 'rapid', 'and', 'sensitive', 'genotyping', 'assay', 'and', 'microarray', 'for', 'URI', 'identification', 'using', 'standard', 'amplification', 'and', 'hybridization', 'techniques', 'with', 'electrochemical', 'detection', 'ECD', 'on', 'a', 'semiconductor', 'based', 'oligonucleotide', 'microarray', 'The', 'assay', 'was', 'developed', 'to', 'detect', 'four', 'bacterial', 'pathogens', 'Bordetella', 'pertussis', 'Streptococcus', 'pyogenes', 'Chlamydia', 'pneumoniae', 'and', 'Mycoplasma', 'pneumoniae', 'and', '9', 'viral', 'pathogens', 'adenovirus', '4', 'coronavirus', 'OC43', '229E', 'and', 'HK', 'influenza', 'A', 'and', 'B', 'parainfluinza', 'types', '1', '2', 'and', '3', 'and', 'respiratory', 'syncytial', 'virus', 'This', 'new', 'platform', 'forms', 'the', 'basis', 'for', 'a', 'fully', 'automated', 'diagnostics', 'system', 'that', 'is', 'very', 'flexible', 'and', 'can', 'be', 'customized', 'to', 'suit', 'different', 'or', 'additional', 'pathogens', 'Multiple', 'probes', 'on', 'a', 'flexible', 'platform', 'allow', 'one', 'to', 'test', 'probes', 'empirically', 'and', 'then', 'select', 'highly', 'reactive', 'probes', 'for', 'further', 'iterative', 'evaluation', 'Because', 'ECD', 'uses', 'an', 'enzymatic', 'reaction', 'to', 'create', 'electrical', 'signals', 'that', 'can', 'be', 'read', 'directly', 'from', 'the', 'array', 'there', 'is', 'no', 'need', 'for', 'image', 'analysis', 'or', 'for', 'expensive', 'and', 'delicate', 'optical', 'scanning', 'equipment', 'We', 'show', 'assay', 'sensitivity', 'and', 'specificity', 'that', 'are', 'excellent', 'for', 'a', 'multiplexed', 'format', '']"
200837,Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients,2020-06-01,Nat Commun,https://www.ncbi.nlm.nih.gov/pubmed/32483236/; https://doi.org/10.1038/s41467-020-16638-2,"Given the ongoing SARS-CoV-2 pandemic, identification of immunogenic targets against the coronavirus spike glycoprotein will provide crucial advances towards the development of sensitive diagnostic tools and potential vaccine candidate targets. In this study, using pools of overlapping linear B-cell peptides, we report two IgG immunodominant regions on SARS-CoV-2 spike glycoprotein that are recognised by sera from COVID-19 convalescent patients. Notably, one is specific to SARS-CoV-2, which is located in close proximity to the receptor binding domain. The other region, which is localised at the fusion peptide, could potentially function as a pan-SARS target. Functionally, antibody depletion assays demonstrate that antibodies targeting these immunodominant regions significantly alter virus neutralisation capacities. Taken together, identification and validation of these neutralising B-cell epitopes will provide insights towards the design of diagnostics and vaccine candidates against this high priority coronavirus.",10.1038/s41467-020-16638-2,p9u6rlue,"['Given', 'the', 'ongoing', 'SARS', 'CoV', '2', 'pandemic', 'identification', 'of', 'immunogenic', 'targets', 'against', 'the', 'coronavirus', 'spike', 'glycoprotein', 'will', 'provide', 'crucial', 'advances', 'towards', 'the', 'development', 'of', 'sensitive', 'diagnostic', 'tools', 'and', 'potential', 'vaccine', 'candidate', 'targets', 'In', 'this', 'study', 'using', 'pools', 'of', 'overlapping', 'linear', 'B', 'cell', 'peptides', 'we', 'report', 'two', 'IgG', 'immunodominant', 'regions', 'on', 'SARS', 'CoV', '2', 'spike', 'glycoprotein', 'that', 'are', 'recognised', 'by', 'sera', 'from', 'COVID', '19', 'convalescent', 'patients', 'Notably', 'one', 'is', 'specific', 'to', 'SARS', 'CoV', '2', 'which', 'is', 'located', 'in', 'close', 'proximity', 'to', 'the', 'receptor', 'binding', 'domain', 'The', 'other', 'region', 'which', 'is', 'localised', 'at', 'the', 'fusion', 'peptide', 'could', 'potentially', 'function', 'as', 'a', 'pan', 'SARS', 'target', 'Functionally', 'antibody', 'depletion', 'assays', 'demonstrate', 'that', 'antibodies', 'targeting', 'these', 'immunodominant', 'regions', 'significantly', 'alter', 'virus', 'neutralisation', 'capacities', 'Taken', 'together', 'identification', 'and', 'validation', 'of', 'these', 'neutralising', 'B', 'cell', 'epitopes', 'will', 'provide', 'insights', 'towards', 'the', 'design', 'of', 'diagnostics', 'and', 'vaccine', 'candidates', 'against', 'this', 'high', 'priority', 'coronavirus', '']"
201734,Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections,2014-07-28,ISBT Sci Ser,https://www.ncbi.nlm.nih.gov/pubmed/25210533/,"BACKGROUND: In August 2009, a group from the AABB (Stramer et al., Transfusion 2009;99:1S–29S, Emerging Infectious Disease Agents and their Potential Threat to Transfusion Safety; http://www.aabb.org/resources/bct/eid/Pages/default.aspx) published a Supplement to Transfusion that reviewed emerging infectious disease (EID) agents that pose a real or theoretical threat to transfusion safety, but for which an existing effective intervention is lacking. The necessary attributes for transfusion transmission were outlined including: presence of the agent in blood during the donor's asymptomatic phase, the agent's survival/persistence in blood during processing/storage, and lastly that the agent must be recognized as responsible for a clinically apparent outcome in at least a proportion of recipients who become infected. Without these attributes, agents are not considered as a transfusion-transmission threat and were excluded. Sixty-eight such agents were identified with enough evidence/likelihood of transfusion transmission (e.g., blood phase) and potential for clinical disease to warrant further consideration. In the Supplement, Fact Sheets (FS) were published providing information on: agent classification; disease agent's importance; clinical syndromes/diseases caused; transmission modes (including vectors/reservoirs); likelihood of transfusion transmission, and if proven to be transfusion-transmitted, information on known cases; the feasibility/predicted success of interventions for donor screening (questioning) and tests available for diagnostics/ adapted for donor screening; and finally, the efficacy, if known, of inactivation methods for plasma-derived products. The Supplement included a separate section on pathogen reduction using published data. Agents were prioritized relative to their scientific/epidemiologic threat and their perceived threat to the community including concerns expressed by the regulators of blood. Agents given the highest priority due to a known transfusion-transmission threat and severe/fatal disease in recipients were the vCJD prion, dengue viruses and the obligate red-cell parasite that causes babesiosis (B. microti and related Babesia). Although the focus of the Supplement was towards the United States and Canada, many of the agents (and the process) are applicable worldwide. NEXT STEPS: Since the publication of the Supplement, six new FSs (yellow fever viruses-including vaccine breakthrough infections, miscellaneous arboviruses, XMRV, human parvoviruses/bocaviruses other than B19, and most recently the Middle East respiratory syndrome coronavirus, MERS-CoV) were added and 14 existing FSs updated (Anaplasma, Babesia, Bartonella, Erhlichia, chronic wasting disease-CWD, human prions other than vCJD, vCJD, Coxiella burnetii-the agent of Q fever, dengue viruses, HAV, HEV, Japanese encephalitis-JE complex, tick-borne encephalitis viruses-TBEV, and human parvovirus B19). Also, tables were released outlining pathogen reduction clinical trials/results (published) and availability/commercial routine use of such technologies by country. Of necessity, the list of EID agents is not, and can never be, complete due to the nature of emergence. We recognized that a system of assessing the risk/threat of EIDs for their potential impact on blood safety and availability must include processes for monitoring, identifying, evaluating, estimating severity, assessing risk and developing interventions. Thus, a ‘toolkit’ containing the necessary ‘tools’ from EID monitoring (horizon scanning) to validation/effectiveness evaluations of interventions is being developed. The goal is, to develop a systematic approach to risk assessment and intervention development for the impact of emerging infectious upon blood safety intended to educate and provide advise about risks/interventions in a timely/accurate fashion. CONCLUSIONS: The process and final product (toolkit) including methods to monitor EID agent emergence, identification/recognition of a transfusion-transmission threat, methods for quantitative risk assessments, and the appropriate management of such threats should be considered for implementation by all blood systems.",10.1111/voxs.12070,nyocnvvj,"['BACKGROUND', 'In', 'August', '2009', 'a', 'group', 'from', 'the', 'AABB', 'Stramer', 'et', 'al', 'Transfusion', '2009', '99', '1S', '29S', 'Emerging', 'Infectious', 'Disease', 'Agents', 'and', 'their', 'Potential', 'Threat', 'to', 'Transfusion', 'Safety', 'http', 'www', 'aabb', 'org', 'resources', 'bct', 'eid', 'Pages', 'default', 'aspx', 'published', 'a', 'Supplement', 'to', 'Transfusion', 'that', 'reviewed', 'emerging', 'infectious', 'disease', 'EID', 'agents', 'that', 'pose', 'a', 'real', 'or', 'theoretical', 'threat', 'to', 'transfusion', 'safety', 'but', 'for', 'which', 'an', 'existing', 'effective', 'intervention', 'is', 'lacking', 'The', 'necessary', 'attributes', 'for', 'transfusion', 'transmission', 'were', 'outlined', 'including', 'presence', 'of', 'the', 'agent', 'in', 'blood', 'during', 'the', 'donor', 's', 'asymptomatic', 'phase', 'the', 'agent', 's', 'survival', 'persistence', 'in', 'blood', 'during', 'processing', 'storage', 'and', 'lastly', 'that', 'the', 'agent', 'must', 'be', 'recognized', 'as', 'responsible', 'for', 'a', 'clinically', 'apparent', 'outcome', 'in', 'at', 'least', 'a', 'proportion', 'of', 'recipients', 'who', 'become', 'infected', 'Without', 'these', 'attributes', 'agents', 'are', 'not', 'considered', 'as', 'a', 'transfusion', 'transmission', 'threat', 'and', 'were', 'excluded', 'Sixty', 'eight', 'such', 'agents', 'were', 'identified', 'with', 'enough', 'evidence', 'likelihood', 'of', 'transfusion', 'transmission', 'e', 'g', 'blood', 'phase', 'and', 'potential', 'for', 'clinical', 'disease', 'to', 'warrant', 'further', 'consideration', 'In', 'the', 'Supplement', 'Fact', 'Sheets', 'FS', 'were', 'published', 'providing', 'information', 'on', 'agent', 'classification', 'disease', 'agent', 's', 'importance', 'clinical', 'syndromes', 'diseases', 'caused', 'transmission', 'modes', 'including', 'vectors', 'reservoirs', 'likelihood', 'of', 'transfusion', 'transmission', 'and', 'if', 'proven', 'to', 'be', 'transfusion', 'transmitted', 'information', 'on', 'known', 'cases', 'the', 'feasibility', 'predicted', 'success', 'of', 'interventions', 'for', 'donor', 'screening', 'questioning', 'and', 'tests', 'available', 'for', 'diagnostics', 'adapted', 'for', 'donor', 'screening', 'and', 'finally', 'the', 'efficacy', 'if', 'known', 'of', 'inactivation', 'methods', 'for', 'plasma', 'derived', 'products', 'The', 'Supplement', 'included', 'a', 'separate', 'section', 'on', 'pathogen', 'reduction', 'using', 'published', 'data', 'Agents', 'were', 'prioritized', 'relative', 'to', 'their', 'scientific', 'epidemiologic', 'threat', 'and', 'their', 'perceived', 'threat', 'to', 'the', 'community', 'including', 'concerns', 'expressed', 'by', 'the', 'regulators', 'of', 'blood', 'Agents', 'given', 'the', 'highest', 'priority', 'due', 'to', 'a', 'known', 'transfusion', 'transmission', 'threat', 'and', 'severe', 'fatal', 'disease', 'in', 'recipients', 'were', 'the', 'vCJD', 'prion', 'dengue', 'viruses', 'and', 'the', 'obligate', 'red', 'cell', 'parasite', 'that', 'causes', 'babesiosis', 'B', 'microti', 'and', 'related', 'Babesia', 'Although', 'the', 'focus', 'of', 'the', 'Supplement', 'was', 'towards', 'the', 'United', 'States', 'and', 'Canada', 'many', 'of', 'the', 'agents', 'and', 'the', 'process', 'are', 'applicable', 'worldwide', 'NEXT', 'STEPS', 'Since', 'the', 'publication', 'of', 'the', 'Supplement', 'six', 'new', 'FSs', 'yellow', 'fever', 'viruses', 'including', 'vaccine', 'breakthrough', 'infections', 'miscellaneous', 'arboviruses', 'XMRV', 'human', 'parvoviruses', 'bocaviruses', 'other', 'than', 'B19', 'and', 'most', 'recently', 'the', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'were', 'added', 'and', '14', 'existing', 'FSs', 'updated', 'Anaplasma', 'Babesia', 'Bartonella', 'Erhlichia', 'chronic', 'wasting', 'disease', 'CWD', 'human', 'prions', 'other', 'than', 'vCJD', 'vCJD', 'Coxiella', 'burnetii', 'the', 'agent', 'of', 'Q', 'fever', 'dengue', 'viruses', 'HAV', 'HEV', 'Japanese', 'encephalitis', 'JE', 'complex', 'tick', 'borne', 'encephalitis', 'viruses', 'TBEV', 'and', 'human', 'parvovirus', 'B19', 'Also', 'tables', 'were', 'released', 'outlining', 'pathogen', 'reduction', 'clinical', 'trials', 'results', 'published', 'and', 'availability', 'commercial', 'routine', 'use', 'of', 'such', 'technologies', 'by', 'country', 'Of', 'necessity', 'the', 'list', 'of', 'EID', 'agents', 'is', 'not', 'and', 'can', 'never', 'be', 'complete', 'due', 'to', 'the', 'nature', 'of', 'emergence', 'We', 'recognized', 'that', 'a', 'system', 'of', 'assessing', 'the', 'risk', 'threat', 'of', 'EIDs', 'for', 'their', 'potential', 'impact', 'on', 'blood', 'safety', 'and', 'availability', 'must', 'include', 'processes', 'for', 'monitoring', 'identifying', 'evaluating', 'estimating', 'severity', 'assessing', 'risk', 'and', 'developing', 'interventions', 'Thus', 'a', 'toolkit', 'containing', 'the', 'necessary', 'tools', 'from', 'EID', 'monitoring', 'horizon', 'scanning', 'to', 'validation', 'effectiveness', 'evaluations', 'of', 'interventions', 'is', 'being', 'developed', 'The', 'goal', 'is', 'to', 'develop', 'a', 'systematic', 'approach', 'to', 'risk', 'assessment', 'and', 'intervention', 'development', 'for', 'the', 'impact', 'of', 'emerging', 'infectious', 'upon', 'blood', 'safety', 'intended', 'to', 'educate', 'and', 'provide', 'advise', 'about', 'risks', 'interventions', 'in', 'a', 'timely', 'accurate', 'fashion', 'CONCLUSIONS', 'The', 'process', 'and', 'final', 'product', 'toolkit', 'including', 'methods', 'to', 'monitor', 'EID', 'agent', 'emergence', 'identification', 'recognition', 'of', 'a', 'transfusion', 'transmission', 'threat', 'methods', 'for', 'quantitative', 'risk', 'assessments', 'and', 'the', 'appropriate', 'management', 'of', 'such', 'threats', 'should', 'be', 'considered', 'for', 'implementation', 'by', 'all', 'blood', 'systems', '']"
201760,Automated detection of COVID-19 cases using deep neural networks with X-ray images,2020-04-28,Comput Biol Med,https://www.sciencedirect.com/science/article/pii/S0010482520301621?v=s5; https://doi.org/10.1016/j.compbiomed.2020.103792; https://www.ncbi.nlm.nih.gov/pubmed/32568675/; https://api.elsevier.com/content/article/pii/S0010482520301621,"The novel coronavirus 2019 (COVID-2019), which first appeared in Wuhan city of China in December 2019, spread rapidly around the world and became a pandemic. It has caused a devastating effect on both daily lives, public health, and the global economy. It is critical to detect the positive cases as early as possible so as to prevent the further spread of this epidemic and to quickly treat affected patients. The need for auxiliary diagnostic tools has increased as there are no accurate automated toolkits available. Recent findings obtained using radiology imaging techniques suggest that such images contain salient information about the COVID-19 virus. Application of advanced artificial intelligence (AI) techniques coupled with radiological imaging can be helpful for the accurate detection of this disease, and can also be assistive to overcome the problem of a lack of specialized physicians in remote villages. In this study, a new model for automatic COVID-19 detection using raw chest X-ray images is presented. The proposed model is developed to provide accurate diagnostics for binary classification (COVID vs. No-Findings) and multi-class classification (COVID vs. No-Findings vs. Pneumonia). Our model produced a classification accuracy of 98.08% for binary classes and 87.02% for multi-class cases. The DarkNet model was used in our study as a classifier for the you only look once (YOLO) real time object detection system. We implemented 17 convolutional layers and introduced different filtering on each layer. Our model (available at (https://github.com/muhammedtalo/COVID-19)) can be employed to assist radiologists in validating their initial screening, and can also be employed via cloud to immediately screen patients.",10.1016/j.compbiomed.2020.103792,yolo8bb3,"['The', 'novel', 'coronavirus', '2019', 'COVID', '2019', 'which', 'first', 'appeared', 'in', 'Wuhan', 'city', 'of', 'China', 'in', 'December', '2019', 'spread', 'rapidly', 'around', 'the', 'world', 'and', 'became', 'a', 'pandemic', 'It', 'has', 'caused', 'a', 'devastating', 'effect', 'on', 'both', 'daily', 'lives', 'public', 'health', 'and', 'the', 'global', 'economy', 'It', 'is', 'critical', 'to', 'detect', 'the', 'positive', 'cases', 'as', 'early', 'as', 'possible', 'so', 'as', 'to', 'prevent', 'the', 'further', 'spread', 'of', 'this', 'epidemic', 'and', 'to', 'quickly', 'treat', 'affected', 'patients', 'The', 'need', 'for', 'auxiliary', 'diagnostic', 'tools', 'has', 'increased', 'as', 'there', 'are', 'no', 'accurate', 'automated', 'toolkits', 'available', 'Recent', 'findings', 'obtained', 'using', 'radiology', 'imaging', 'techniques', 'suggest', 'that', 'such', 'images', 'contain', 'salient', 'information', 'about', 'the', 'COVID', '19', 'virus', 'Application', 'of', 'advanced', 'artificial', 'intelligence', 'AI', 'techniques', 'coupled', 'with', 'radiological', 'imaging', 'can', 'be', 'helpful', 'for', 'the', 'accurate', 'detection', 'of', 'this', 'disease', 'and', 'can', 'also', 'be', 'assistive', 'to', 'overcome', 'the', 'problem', 'of', 'a', 'lack', 'of', 'specialized', 'physicians', 'in', 'remote', 'villages', 'In', 'this', 'study', 'a', 'new', 'model', 'for', 'automatic', 'COVID', '19', 'detection', 'using', 'raw', 'chest', 'X', 'ray', 'images', 'is', 'presented', 'The', 'proposed', 'model', 'is', 'developed', 'to', 'provide', 'accurate', 'diagnostics', 'for', 'binary', 'classification', 'COVID', 'vs', 'No', 'Findings', 'and', 'multi', 'class', 'classification', 'COVID', 'vs', 'No', 'Findings', 'vs', 'Pneumonia', 'Our', 'model', 'produced', 'a', 'classification', 'accuracy', 'of', '98', '08', 'for', 'binary', 'classes', 'and', '87', '02', 'for', 'multi', 'class', 'cases', 'The', 'DarkNet', 'model', 'was', 'used', 'in', 'our', 'study', 'as', 'a', 'classifier', 'for', 'the', 'you', 'only', 'look', 'once', 'YOLO', 'real', 'time', 'object', 'detection', 'system', 'We', 'implemented', '17', 'convolutional', 'layers', 'and', 'introduced', 'different', 'filtering', 'on', 'each', 'layer', 'Our', 'model', 'available', 'at', 'https', 'github', 'com', 'muhammedtalo', 'COVID', '19', 'can', 'be', 'employed', 'to', 'assist', 'radiologists', 'in', 'validating', 'their', 'initial', 'screening', 'and', 'can', 'also', 'be', 'employed', 'via', 'cloud', 'to', 'immediately', 'screen', 'patients', '']"
201890,Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus,2016-07-31,Emerg Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/27191188/; https://doi.org/10.3201/eid2207.160022,"Preclinical development of and research on potential Middle East respiratory syndrome coronavirus (MERS-CoV) medical countermeasures remain preliminary; advancements are needed before most countermeasures are ready to be tested in human clinical trials. Research priorities include standardization of animal models and virus stocks for studying disease pathogenesis and efficacy of medical countermeasures; development of MERS-CoV diagnostics; improved access to nonhuman primates to support preclinical research; studies to better understand and control MERS-CoV disease, including vaccination studies in camels; and development of a standardized clinical trial protocol. Partnering with clinical trial networks in affected countries to evaluate safety and efficacy of investigational therapeutics will strengthen efforts to identify successful medical countermeasures.",10.3201/eid2207.160022,jtx7ni9b,"['Preclinical', 'development', 'of', 'and', 'research', 'on', 'potential', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'MERS', 'CoV', 'medical', 'countermeasures', 'remain', 'preliminary', 'advancements', 'are', 'needed', 'before', 'most', 'countermeasures', 'are', 'ready', 'to', 'be', 'tested', 'in', 'human', 'clinical', 'trials', 'Research', 'priorities', 'include', 'standardization', 'of', 'animal', 'models', 'and', 'virus', 'stocks', 'for', 'studying', 'disease', 'pathogenesis', 'and', 'efficacy', 'of', 'medical', 'countermeasures', 'development', 'of', 'MERS', 'CoV', 'diagnostics', 'improved', 'access', 'to', 'nonhuman', 'primates', 'to', 'support', 'preclinical', 'research', 'studies', 'to', 'better', 'understand', 'and', 'control', 'MERS', 'CoV', 'disease', 'including', 'vaccination', 'studies', 'in', 'camels', 'and', 'development', 'of', 'a', 'standardized', 'clinical', 'trial', 'protocol', 'Partnering', 'with', 'clinical', 'trial', 'networks', 'in', 'affected', 'countries', 'to', 'evaluate', 'safety', 'and', 'efficacy', 'of', 'investigational', 'therapeutics', 'will', 'strengthen', 'efforts', 'to', 'identify', 'successful', 'medical', 'countermeasures', '']"
202004,Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19),2020-05-01,Clin Infect Dis,https://doi.org/10.1093/cid/ciaa525; https://www.ncbi.nlm.nih.gov/pubmed/32357210/,"Coronavirus-disease-2019 (COVID-19) caused by the severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2) shows a rapid spread over-the-world. Given scarce resources, non-laboratory diagnostics is crucial. In this cross-sectional study, two-thirds of European patients with polymerase chain reaction confirmed COVID-19 reported olfactory and gustatory dysfunction, indicating the significance of this history in the early diagnostics.",10.1093/cid/ciaa525,l28tadhn,"['Coronavirus', 'disease', '2019', 'COVID', '19', 'caused', 'by', 'the', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', 'SARS', 'CoV', '2', 'shows', 'a', 'rapid', 'spread', 'over', 'the', 'world', 'Given', 'scarce', 'resources', 'non', 'laboratory', 'diagnostics', 'is', 'crucial', 'In', 'this', 'cross', 'sectional', 'study', 'two', 'thirds', 'of', 'European', 'patients', 'with', 'polymerase', 'chain', 'reaction', 'confirmed', 'COVID', '19', 'reported', 'olfactory', 'and', 'gustatory', 'dysfunction', 'indicating', 'the', 'significance', 'of', 'this', 'history', 'in', 'the', 'early', 'diagnostics', '']"
202459,Rapid Optical Cavity PCR,2016-01-07,Adv Healthc Mater,https://doi.org/10.1002/adhm.201500708; https://www.ncbi.nlm.nih.gov/pubmed/26592501/,"Recent outbreaks of deadly infectious diseases, such as Ebola and Middle East respiratory syndrome coronavirus, have motivated the research for accurate, rapid diagnostics that can be administered at the point of care. Nucleic acid biomarkers for these diseases can be amplified and quantified via polymerase chain reaction (PCR). In order to solve the problems of conventional PCR—speed, uniform heating and cooling, and massive metal heating blocks—an innovative optofluidic cavity PCR method using light‐emitting diodes (LEDs) is accomplished. Using this device, 30 thermal cycles between 94 °C and 68 °C can be accomplished in 4 min for 1.3 μL (10 min for 10 μL). Simulation results show that temperature differences across the 750 μm thick cavity are less than 2 °C and 0.2 °C, respectively, at 94 °C and 68 °C. Nucleic acid concentrations as low as 10(–8) ng μL(–1) (2 DNA copies per μL) can be amplified with 40 PCR thermal cycles. This simple, ultrafast, precise, robust, and low‐cost optofluidic cavity PCR is favorable for advanced molecular diagnostics and precision medicine. It is especially important for the development of lightweight, point‐of‐care devices for use in both developing and developed countries.",10.1002/adhm.201500708,czb8luhk,"['Recent', 'outbreaks', 'of', 'deadly', 'infectious', 'diseases', 'such', 'as', 'Ebola', 'and', 'Middle', 'East', 'respiratory', 'syndrome', 'coronavirus', 'have', 'motivated', 'the', 'research', 'for', 'accurate', 'rapid', 'diagnostics', 'that', 'can', 'be', 'administered', 'at', 'the', 'point', 'of', 'care', 'Nucleic', 'acid', 'biomarkers', 'for', 'these', 'diseases', 'can', 'be', 'amplified', 'and', 'quantified', 'via', 'polymerase', 'chain', 'reaction', 'PCR', 'In', 'order', 'to', 'solve', 'the', 'problems', 'of', 'conventional', 'PCR', 'speed', 'uniform', 'heating', 'and', 'cooling', 'and', 'massive', 'metal', 'heating', 'blocks', 'an', 'innovative', 'optofluidic', 'cavity', 'PCR', 'method', 'using', 'light', 'emitting', 'diodes', 'LEDs', 'is', 'accomplished', 'Using', 'this', 'device', '30', 'thermal', 'cycles', 'between', '94', 'C', 'and', '68', 'C', 'can', 'be', 'accomplished', 'in', '4', 'min', 'for', '1', '3', 'μL', '10', 'min', 'for', '10', 'μL', 'Simulation', 'results', 'show', 'that', 'temperature', 'differences', 'across', 'the', '750', 'μm', 'thick', 'cavity', 'are', 'less', 'than', '2', 'C', 'and', '0', '2', 'C', 'respectively', 'at', '94', 'C', 'and', '68', 'C', 'Nucleic', 'acid', 'concentrations', 'as', 'low', 'as', '10', '8', 'ng', 'μL', '1', '2', 'DNA', 'copies', 'per', 'μL', 'can', 'be', 'amplified', 'with', '40', 'PCR', 'thermal', 'cycles', 'This', 'simple', 'ultrafast', 'precise', 'robust', 'and', 'low', 'cost', 'optofluidic', 'cavity', 'PCR', 'is', 'favorable', 'for', 'advanced', 'molecular', 'diagnostics', 'and', 'precision', 'medicine', 'It', 'is', 'especially', 'important', 'for', 'the', 'development', 'of', 'lightweight', 'point', 'of', 'care', 'devices', 'for', 'use', 'in', 'both', 'developing', 'and', 'developed', 'countries', '']"
202891,Detection of viral agents in fecal specimens of monkeys with diarrhea,2006-07-17,J Med Primatol,https://www.ncbi.nlm.nih.gov/pubmed/17493140/,"Background Diarrheal disease is a major cause of morbidity and mortality in humans and animals, including non human primates. While the diagnostics for gastrointestinal bacterial and parasitic pathogens and their etiological role in disease are well established, little is known about the epidemiology, prevalence and role of viral agents in diarrheal illness among monkeys. Methods We collected fecal specimens from monkeys with diarrhea that were housed in two primate colonies, the Institute of Laboratory Animal Sciences, Beijing, China and the Yerkes National Primate Research Center, Georgia, USA. We screened these fecal specimens for rotaviruses and enteric adenoviruses 40/41 by using commercial EIA kits (Rotaclone and Adenoclone), enteroviruses by RT‐PCR and Southern blot hybridization, and picobirnaviruses by polyacrylamide gel electrophoresis and silver staining. Some of the specimens were examined by EM for coronaviruses and noroviruses. Results Of the 92 specimens from China, we found 63 (68%) positive for viruses, including enteroviruses (52%), enteric adenoviruses (21%), rotaviruses (20%), and picobirnaviruses (2%). Coronaviruses were detected in some specimens. Mixed infection of two or more viral agents was seen in 23 (25%) specimens. In the US collection, we detected enteroviruses and enteric adenoviruses in 76% (45/59) and 14% (7/50) of the specimens, respectively. Electron microscopy showed norovirus‐like particles in some specimens from both colonies. Conclusions Our findings indicate endemic infections with enteric viruses in monkeys of both colonies. The availability of new simian rotaviruses, enteric adenoviruses, enteroviruses, and coronaviruses and the discovery of noroviruses and picobirnaviruses may allow us to develop better diagnostics for these agents and determine which of these agents are clearly associated with gastroenteritis in monkeys.",10.1111/j.1600-0684.2006.00167.x,z4c3bc6a,"['Background', 'Diarrheal', 'disease', 'is', 'a', 'major', 'cause', 'of', 'morbidity', 'and', 'mortality', 'in', 'humans', 'and', 'animals', 'including', 'non', 'human', 'primates', 'While', 'the', 'diagnostics', 'for', 'gastrointestinal', 'bacterial', 'and', 'parasitic', 'pathogens', 'and', 'their', 'etiological', 'role', 'in', 'disease', 'are', 'well', 'established', 'little', 'is', 'known', 'about', 'the', 'epidemiology', 'prevalence', 'and', 'role', 'of', 'viral', 'agents', 'in', 'diarrheal', 'illness', 'among', 'monkeys', 'Methods', 'We', 'collected', 'fecal', 'specimens', 'from', 'monkeys', 'with', 'diarrhea', 'that', 'were', 'housed', 'in', 'two', 'primate', 'colonies', 'the', 'Institute', 'of', 'Laboratory', 'Animal', 'Sciences', 'Beijing', 'China', 'and', 'the', 'Yerkes', 'National', 'Primate', 'Research', 'Center', 'Georgia', 'USA', 'We', 'screened', 'these', 'fecal', 'specimens', 'for', 'rotaviruses', 'and', 'enteric', 'adenoviruses', '40', '41', 'by', 'using', 'commercial', 'EIA', 'kits', 'Rotaclone', 'and', 'Adenoclone', 'enteroviruses', 'by', 'RT', 'PCR', 'and', 'Southern', 'blot', 'hybridization', 'and', 'picobirnaviruses', 'by', 'polyacrylamide', 'gel', 'electrophoresis', 'and', 'silver', 'staining', 'Some', 'of', 'the', 'specimens', 'were', 'examined', 'by', 'EM', 'for', 'coronaviruses', 'and', 'noroviruses', 'Results', 'Of', 'the', '92', 'specimens', 'from', 'China', 'we', 'found', '63', '68', 'positive', 'for', 'viruses', 'including', 'enteroviruses', '52', 'enteric', 'adenoviruses', '21', 'rotaviruses', '20', 'and', 'picobirnaviruses', '2', 'Coronaviruses', 'were', 'detected', 'in', 'some', 'specimens', 'Mixed', 'infection', 'of', 'two', 'or', 'more', 'viral', 'agents', 'was', 'seen', 'in', '23', '25', 'specimens', 'In', 'the', 'US', 'collection', 'we', 'detected', 'enteroviruses', 'and', 'enteric', 'adenoviruses', 'in', '76', '45', '59', 'and', '14', '7', '50', 'of', 'the', 'specimens', 'respectively', 'Electron', 'microscopy', 'showed', 'norovirus', 'like', 'particles', 'in', 'some', 'specimens', 'from', 'both', 'colonies', 'Conclusions', 'Our', 'findings', 'indicate', 'endemic', 'infections', 'with', 'enteric', 'viruses', 'in', 'monkeys', 'of', 'both', 'colonies', 'The', 'availability', 'of', 'new', 'simian', 'rotaviruses', 'enteric', 'adenoviruses', 'enteroviruses', 'and', 'coronaviruses', 'and', 'the', 'discovery', 'of', 'noroviruses', 'and', 'picobirnaviruses', 'may', 'allow', 'us', 'to', 'develop', 'better', 'diagnostics', 'for', 'these', 'agents', 'and', 'determine', 'which', 'of', 'these', 'agents', 'are', 'clearly', 'associated', 'with', 'gastroenteritis', 'in', 'monkeys', '']"
203689,Gastrointestinal Disease in Exotic Small Mammals,2013-09-05,J Exot Pet Med,https://www.ncbi.nlm.nih.gov/pubmed/32288678/; https://www.sciencedirect.com/science/article/pii/S1557506313000608; https://api.elsevier.com/content/article/pii/S1557506313000608; https://doi.org/10.1053/j.jepm.2013.05.004,"Exotic small mammal medicine is a relatively new specialty area within veterinary medicine. Ferrets, rabbits, and rodents have long been used as animal models in human medical research investigations, resulting in a body of basic anatomic and physiologic information that can be used by veterinarians treating these species. Unfortunately, there is a paucity of veterinary articles that describe clinical presentation, diagnosis, and treatment options of gastrointestinal (GI) disease as it affects exotic small mammals. Although there is little reference material relating to exotic small mammal GI disease, patients are commonly presented to veterinary hospitals with digestive tract disorders. This article provides the latest information available for GI disease in ferrets (Helicobacter mustelae gastritis, inflammatory bowel disease [IBD], GI lymphoma, systemic coronavirus, coccidiosis, and liver disease), rabbits (GI motility disorders, liver lobe torsion, astrovirus, and coccidiosis), guinea pigs (gastric dilatation volvulus [GDV]), rats (Taenia taeniaeformis), and hamsters (Clostridium difficile). Both noninfectious diseases and emerging infectious diseases are reviewed as well as the most up-to-date diagnostics and treatment options.",10.1053/j.jepm.2013.05.004,tya0rvxk,"['Exotic', 'small', 'mammal', 'medicine', 'is', 'a', 'relatively', 'new', 'specialty', 'area', 'within', 'veterinary', 'medicine', 'Ferrets', 'rabbits', 'and', 'rodents', 'have', 'long', 'been', 'used', 'as', 'animal', 'models', 'in', 'human', 'medical', 'research', 'investigations', 'resulting', 'in', 'a', 'body', 'of', 'basic', 'anatomic', 'and', 'physiologic', 'information', 'that', 'can', 'be', 'used', 'by', 'veterinarians', 'treating', 'these', 'species', 'Unfortunately', 'there', 'is', 'a', 'paucity', 'of', 'veterinary', 'articles', 'that', 'describe', 'clinical', 'presentation', 'diagnosis', 'and', 'treatment', 'options', 'of', 'gastrointestinal', 'GI', 'disease', 'as', 'it', 'affects', 'exotic', 'small', 'mammals', 'Although', 'there', 'is', 'little', 'reference', 'material', 'relating', 'to', 'exotic', 'small', 'mammal', 'GI', 'disease', 'patients', 'are', 'commonly', 'presented', 'to', 'veterinary', 'hospitals', 'with', 'digestive', 'tract', 'disorders', 'This', 'article', 'provides', 'the', 'latest', 'information', 'available', 'for', 'GI', 'disease', 'in', 'ferrets', 'Helicobacter', 'mustelae', 'gastritis', 'inflammatory', 'bowel', 'disease', 'IBD', 'GI', 'lymphoma', 'systemic', 'coronavirus', 'coccidiosis', 'and', 'liver', 'disease', 'rabbits', 'GI', 'motility', 'disorders', 'liver', 'lobe', 'torsion', 'astrovirus', 'and', 'coccidiosis', 'guinea', 'pigs', 'gastric', 'dilatation', 'volvulus', 'GDV', 'rats', 'Taenia', 'taeniaeformis', 'and', 'hamsters', 'Clostridium', 'difficile', 'Both', 'noninfectious', 'diseases', 'and', 'emerging', 'infectious', 'diseases', 'are', 'reviewed', 'as', 'well', 'as', 'the', 'most', 'up', 'to', 'date', 'diagnostics', 'and', 'treatment', 'options', '']"
